PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Uekawa, A; Yamanaka, H; Lieben, L; Kimira, Y; Uehara, M; Yamamoto, Y; Kato, S; Ito, K; Carmeliet, G; Masuyama, R				Uekawa, Atsushi; Yamanaka, Hitoki; Lieben, Liesbet; Kimira, Yoshifumi; Uehara, Mariko; Yamamoto, Yoko; Kato, Shigeaki; Ito, Kosei; Carmeliet, Geert; Masuyama, Ritsuko			Phosphate-dependent luminal ATP metabolism regulates transcellular calcium transport in intestinal epithelial cells	FASEB JOURNAL			English	Article						extracellular phosphate; Cx43; ENPP1	VITAMIN-D-RECEPTOR; BONE MINERALIZATION; KNOCKOUT MICE; INORGANIC-PHOSPHATE; RAF/MEK/ERK PATHWAY; PHOSPHORUS INTAKE; DIETARY CALCIUM; ABSORPTION; ACTIVATION; RELEASE	Extracellular low phosphate strongly enhances intestinal calcium absorption independently of active vitamin D [1,25(OH)(2)D-3] signaling, but the underlying mechanisms remain poorly characterized. To elucidate the phosphate-dependent regulation of calcium transport, we investigated part of the enteral environment that is involved in 1,25(OH)(2)D-3-independent calcium absorption, which responds to dietary phosphate levels in mice that lack intestinal vitamin D receptor (Vdr) activity. Impaired calcium absorption in intestinal Vdr-null mice was improved by dietary phosphate restriction. Accordingly, calcium transport in cultured intestinal epithelial cells was increased when the apical side was exposed to low phosphate levels (0.5 mM) compared with normal or high phosphate levels (1.0 or 5.0 mM, respectively). Mechanistically, low phosphate increased ATP in the apical side medium and allowed calcium entry into epithelial cells via the P2X7 purinoreceptor, which results in increased calcium transport. We found that luminal ATP was regulated by the release and degradation of ATP at the epithelium, and phosphate restriction increased ATP release from epithelial cells via connexin-43 hemichannels. Furthermore, ATP degradation by ectonucleotide pyrophosphatase-1 was reduced, which was caused by the reduction of the MAPK cascade. These findings indicate that luminal ATP metabolism regulates transcellular calcium transport in the intestine by an 1,25(OH)(2)D-3-independent mechanism in response to dietary phosphate levels.	[Uekawa, Atsushi; Ito, Kosei; Masuyama, Ritsuko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Bone Biol, 1-7-1 Sakamoto, Nagasaki 8528588, Japan; [Yamanaka, Hitoki] Nagasaki Univ, Ctr Frontier Life Sci, Nagasaki, Japan; [Lieben, Liesbet; Carmeliet, Geert] Katholieke Univ Leuven, Clin & Expt Endocrinol, Leuven, Belgium; [Kimira, Yoshifumi; Uehara, Mariko] Tokyo Univ Agr, Dept Nutr Sci, Tokyo, Japan; [Yamamoto, Yoko] Univ Tokyo, Surg Oncol & Vasc Surg, Tokyo, Japan; [Kato, Shigeaki] Tokiwa Fdn, Res Inst Innovat Med, Iwaki, Fukushima, Japan	Nagasaki University; Nagasaki University; KU Leuven; Tokyo University of Agriculture; University of Tokyo	Masuyama, R (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Bone Biol, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	ritsuko@nagasaki-u.ac.jp			Takeda Science Foundation; Japan Society for the Promotion of Science [26462816, 17H01967]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank Dr. Haruka Kohara (Graduate School of Biochemical Sciences, Nagasaki University, Nagasaki, Japan) for technical assistance. This work was supported by the Japan Society for the Promotion of Science (Grants 26462816 and 17H01967; to R.M.), and by research grants from the Takeda Science Foundation (to R.M.). The authors declare no conflicts of interest.	Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Alvarez A, 2016, BBA-MOL CELL RES, V1863, P2175, DOI 10.1016/j.bbamcr.2016.05.018; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Buzzi N, 2009, BBA-GEN SUBJECTS, V1790, P1651, DOI 10.1016/j.bbagen.2009.10.005; Calvo MS, 2013, SEMIN DIALYSIS, V26, P54, DOI 10.1111/sdi.12042; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Dong X, 2009, AM J PHYSIOL-GASTR L, V296, pG424, DOI 10.1152/ajpgi.90314.2008; Farahbakhsh NA, 2003, INVEST OPHTH VIS SCI, V44, P3952, DOI 10.1167/iovs.02-1213; Garre JM, 2010, P NATL ACAD SCI USA, V107, P22659, DOI 10.1073/pnas.1013793107; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Jones S, 2014, MOL PHARMACOL, V86, P243, DOI 10.1124/mol.114.092528; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Karpuk N, 2011, J NEUROSCI, V31, P414, DOI 10.1523/JNEUROSCI.5247-10.2011; Kemi VE, 2008, BRIT J NUTR, V99, P832, DOI 10.1017/S0007114507831783; Kimata M, 2010, BONE, V47, P938, DOI 10.1016/j.bone.2010.08.006; Kornak U, 2011, JOINT BONE SPINE, V78, P561, DOI 10.1016/j.jbspin.2011.03.020; Koshihara M, 2004, BIOFACTORS, V22, P39, DOI 10.1002/biof.5520220107; Kusu T, 2013, J IMMUNOL, V190, P774, DOI 10.4049/jimmunol.1103067; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Lieben L, 2015, BONE, V81, P502, DOI 10.1016/j.bone.2015.08.023; Lieben L, 2012, J CLIN INVEST, V122, P1803, DOI 10.1172/JCI45890; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Masuyama R, 2001, ENDOCRINOLOGY, V142, P494, DOI 10.1210/en.142.1.494; Masuyama R, 2003, J BONE MINER RES, V18, P1217, DOI 10.1359/jbmr.2003.18.7.1217; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; Masuyama R, 2006, J CLIN INVEST, V116, P3150, DOI 10.1172/JCI29463; Masuyama R, 2012, J BONE MINER RES, V27, P1708, DOI 10.1002/jbmr.1629; McGaraughty S, 2007, NEUROSCIENCE, V146, P1817, DOI 10.1016/j.neuroscience.2007.03.035; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Minns MS, 2016, AM J PATHOL, V186, P285, DOI 10.1016/j.ajpath.2015.10.006; Naishiro Y, 2005, ONCOGENE, V24, P3141, DOI 10.1038/sj.onc.1208517; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Ritz E, 2012, DTSCH ARZTEBL INT, V109, P49, DOI 10.3238/arztebl.2012.0049; Saab JB, 2014, FEBS LETT, V588, P1288, DOI 10.1016/j.febslet.2014.02.059; Sahu G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04955; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Suzuki T, 2004, J NUTR, V134, P1935, DOI 10.1093/jn/134.8.1935; Takai E, 2012, J CELL SCI, V125, P5051, DOI 10.1242/jcs.104976; Uribarri J, 2013, ADV NUTR, V4, P542, DOI 10.3945/an.113.004234; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; Xue YB, 2009, GASTROENTEROLOGY, V136, P1317, DOI 10.1053/j.gastro.2008.12.051; Yamamoto Y, 2013, ENDOCRINOLOGY, V154, P1008, DOI 10.1210/en.2012-1542; Yamazaki M, 2010, J CELL BIOCHEM, V111, P1210, DOI 10.1002/jcb.22842; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Zsembery A, 2003, J BIOL CHEM, V278, P13398, DOI 10.1074/jbc.M212277200	50	6	7	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1903	1915		10.1096/fj.201700631R	http://dx.doi.org/10.1096/fj.201700631R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29282249				2022-12-26	WOS:000429051400014
J	Cui, CH; Chen, XN; Liu, Y; Cao, BJ; Xing, Y; Liu, CJ; Yang, F; Li, YA; Yang, TX; Hua, LY; Tian, M; Wei, YY; Gong, Y; Jiang, JH				Cui, Chunhong; Chen, Xiaoning; Liu, Ying; Cao, Benjin; Xing, Yang; Liu, Chanjuan; Yang, Fan; Li, Yinan; Yang, Tianxiao; Hua, Lingyang; Tian, Mi; Wei, Yuanyan; Gong, Ye; Jiang, Jianhai			1,4-Galactosyltransferase V activates Notch1 signaling in glioma stem-like cells and promotes their transdifferentiation into endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glioblastoma; endothelial cell; glycosyltransferase; cancer stem cells; differentiation; 4GalTV; Notch1; glioma stem-like cell; transdifferentiation	HUMAN BETA-1,4-GALACTOSYLTRANSFERASE-V GENE; POLY-N-ACETYLLACTOSAMINE; GROWTH-FACTOR; MALIGNANT GLIOMA; OVER-EXPRESSION; CANCER-CELLS; TUMOR-GROWTH; COLON-CANCER; GLYCOSYLATION; ANGIOGENESIS	Malignant glioblastoma multiforme is one of the most aggressive human cancers, with very low survival rates. Recent studies have reported that glioma stem-like cells transdifferentiate into endothelial cells, indicating a new mechanism for tumor angiogenesis and potentially providing new therapeutic options for glioblastoma treatment. Glioma malignancy is strongly associated with altered expression of N-linked oligosaccharide structures on the cell surface. We have previously reported that 1,4-galactosyltransferase V (1,4GalTV), which galactosylates the GlcNAc1-6Man arm of the branched N-glycans, is highly expressed in glioma and promotes glioma cell growth in vitro and in vivo. However, the mechanism by which 1,4GalTV stimulates glioma growth is unknown. Here we demonstrate that short hairpin RNA-mediated 1,4GalTV knockdown inhibits the tumorigenesis of glioma stem-like cells and reduces their transdifferentiation into endothelial cells. We also found that 1,4GalTV overexpression increased glioma stem-like cell transdifferentiation into endothelial cells and that this effect required 1,4GalTV galactosylation activity. Moreover, 1,4GalTV promoted 1,4-galactosylation of Notch1 and increased Notch1 protein levels. Of note, ectopic expression of activated Notch1 rescued the inhibitory effect of 1,4GalTV depletion on glioma stem-like cell transdifferentiation. In summary, our findings indicate that 1,4GalTV stimulates transdifferentiation of glioma stem-like cells into endothelial cells by activating Notch1 signaling. These detailed insights shed important light on the mechanisms regulating glioma angiogenesis.	[Cui, Chunhong; Chen, Xiaoning; Liu, Ying; Cao, Benjin; Xing, Yang; Liu, Chanjuan; Yang, Fan; Li, Yinan; Yang, Tianxiao; Wei, Yuanyan; Jiang, Jianhai] Fudan Univ, Key Lab Glycoconjugates Res, Dept Biochem & Mol Biol, Minist Publ Hlth,Shanghai Med Coll, Shanghai 200032, Peoples R China; [Hua, Lingyang; Gong, Ye] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China; [Tian, Mi; Gong, Ye] Fudan Univ, Huashan Hosp, Dept Crit Care Med, Shanghai 200040, Peoples R China	Fudan University; Fudan University; Fudan University	Wei, YY; Jiang, JH (corresponding author), Fudan Univ, Key Lab Glycoconjugates Res, Dept Biochem & Mol Biol, Minist Publ Hlth,Shanghai Med Coll, Shanghai 200032, Peoples R China.; Gong, Y (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China.; Gong, Y (corresponding author), Fudan Univ, Huashan Hosp, Dept Crit Care Med, Shanghai 200040, Peoples R China.	yywei@fudan.edu.cn; drgongye_hs@126.com; jianhaijiang@fudan.edu.cn		Cui, Chunhong/0000-0002-7705-204X	Program for National Natural Scientific Foundation of China [31370807, 81472724, 81773164, 31770856]; National Key R&D Program of China [2016YFA0501303]	Program for National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China	This work was supported by the Program for National Natural Scientific Foundation of China (31370807, 81472724, 81773164, and 31770856) and the National Key R&D Program of China (2016YFA0501303). The authors declare that they have no conflicts of interest with the contents of this article.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Banerjee A, 2011, J BIOL CHEM, V286, P29127, DOI 10.1074/jbc.M110.169771; BANERJEE DK, 1993, INDIAN J BIOCHEM BIO, V30, P389; Batista F, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098103; Beck H, 2000, AM J PATHOL, V157, P1473, DOI 10.1016/S0002-9440(10)64786-4; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Bush G, 2001, DEV BIOL, V229, P494, DOI 10.1006/dbio.2000.9992; CAVENEE WK, 1992, CANCER, V70, P1788, DOI 10.1002/1097-0142(19920915)70:4+<1788::AID-CNCR2820701621>3.0.CO;2-L; Couldrey C, 2000, BREAST CANCER RES, V2, P321, DOI 10.1186/bcr75; Dawson G, 2004, J NEUROCHEM, V89, P1436, DOI 10.1111/j.1471-4159.2004.02435.x; De Falco S, 2002, TRENDS CARDIOVAS MED, V12, P241, DOI 10.1016/S1050-1738(02)00168-8; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fang J, 2006, J CELL PHYSIOL, V209, P261, DOI 10.1002/jcp.20749; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Funasaka T, 2014, GLYCOBIOLOGY, V24, P886, DOI 10.1093/glycob/cwu086; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Ge YQ, 2010, BIOCHEM BIOPH RES CO, V397, P711, DOI 10.1016/j.bbrc.2010.06.015; Guo HB, 2014, J BIOL CHEM, V289, P31534, DOI 10.1074/jbc.M114.602680; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hakomori S, 1996, CANCER RES, V56, P5309; Harvey BM, 2016, J BIOL CHEM, V291, P16348, DOI 10.1074/jbc.M116.732537; Hovinga KE, 2010, STEM CELLS, V28, P1019, DOI 10.1002/stem.429; Hughes RC, 1997, BIOCHEM SOC T, V25, P1194, DOI 10.1042/bst0251194; Ishida H, 2005, FEBS LETT, V579, P71, DOI 10.1016/j.febslet.2004.11.037; Jackson MW, 2002, CANCER RES, V62, P854; Jafar-Nejad H, 2010, GLYCOBIOLOGY, V20, P931, DOI 10.1093/glycob/cwq053; Jiang JH, 2007, MOL CELL BIOL, V27, P8770, DOI 10.1128/MCB.02302-06; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Kolmakova A, 2009, GLYCOCONJUGATE J, V26, P547, DOI 10.1007/s10719-008-9206-9; Lo NW, 1998, GLYCOBIOLOGY, V8, P517, DOI 10.1093/glycob/8.5.517; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Nakajima K, 2014, NEOPLASIA, V16, P939, DOI 10.1016/j.neo.2014.09.005; NGUYEN M, 1993, NATURE, V365, P267, DOI 10.1038/365267a0; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Platonova N, 2015, GENE CHROMOSOME CANC, V54, P516, DOI 10.1002/gcc.22264; Rebbaa A, 1997, J BIOL CHEM, V272, P9275; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Sato T, 2004, J BIOL CHEM, V279, P39574, DOI 10.1074/jbc.M405805200; Sato T, 2001, BIOCHIMIE, V83, P719, DOI 10.1016/S0300-9084(01)01304-9; Sato T, 2007, J BIOL CHEM, V282, P27702, DOI 10.1074/jbc.M611862200; Schuster-Gossler K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-6; Shojaei F, 2008, CANCER RES, V68, P5501, DOI 10.1158/0008-5472.CAN-08-0925; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Wang JG, 2017, NAT PROTOC, V12, P279, DOI 10.1038/nprot.2016.160; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wei YY, 2008, CANCER LETT, V267, P96, DOI 10.1016/j.canlet.2008.03.019; Wei YY, 2010, BIOCHEM BIOPH RES CO, V396, P602, DOI 10.1016/j.bbrc.2010.04.110; Xing Y, 2016, ONCOTARGET, V7, P36395, DOI 10.18632/oncotarget.8954; Xu S, 2002, J EXP CLIN CANC RES, V21, P409; Xu SL, 2001, J CANCER RES CLIN, V127, P502, DOI 10.1007/s004320100246; Yamamoto H, 2000, CANCER RES, V60, P134	60	9	9	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2219	2230		10.1074/jbc.RA117.000682	http://dx.doi.org/10.1074/jbc.RA117.000682			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29269413	Green Published, hybrid			2022-12-26	WOS:000424948000032
J	Wu, JY; Xiang, SY; Zhang, M; Fang, B; Huang, H; Kwon, OK; Zhao, YM; Yang, Z; Bai, WL; Bepler, G; Zhang, XM				Wu, Jheng-Yu; Xiang, Shengyan; Zhang, Mu; Fang, Bin; Huang, He; Kwon, Oh Kwang; Zhao, Yingming; Yang, Zhe; Bai, Wenlong; Bepler, Gerold; Zhang, Xiaohong Mary			Histone deacetylase 6 (HDAC6) deacetylates extracellular signal-regulated kinase 1 (ERK1) and thereby stimulates ERK1 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; histone acetylase; histone deacetylase (HDAC); histone deacetylase 6 (HDAC6); mitogen-activated protein kinase (MAPK); extracellular signal-regulated kinase1; 2 (ERK1; 2); acetylation	PROTEIN-KINASES; CANCER-CELLS; GROWTH; ACETYLATION; INHIBITION; RAS; PHOSPHORYLATION; TRANSCRIPTION; ACTIVATION; APOPTOSIS	Histone deacetylase 6 (HDAC6), a class IIb HDAC, plays an important role in many biological and pathological processes. Previously, we found that ERK1, a downstream kinase in the mitogen-activated protein kinase signaling pathway, phosphorylates HDAC6, thereby increasing HDAC6-mediated deacetylation of -tubulin. However, whether HDAC6 reciprocally modulates ERK1 activity is unknown. Here, we report that both ERK1 and -2 are acetylated and that HDAC6 promotes ERK1 activity via deacetylation. Briefly, we found that both ERK1 and -2 physically interact with HDAC6. Endogenous ERK1/2 acetylation levels increased upon treatment with a pan-HDAC inhibitor, an HDAC6-specific inhibitor, or depletion of HDAC6, suggesting that HDAC6 deacetylates ERK1/2. We also noted that the acetyltransferases CREB-binding protein and p300 both can acetylate ERK1/2. Acetylated ERK1 exhibits reduced enzymatic activity toward the transcription factor ELK1, a well-known ERK1 substrate. Furthermore, mass spectrometry analysis indicated Lys-72 as an acetylation site in the ERK1 N terminus, adjacent to Lys-71, which binds to ATP, suggesting that acetylation status of Lys-72 may affect ERK1 ATP binding. Interestingly, an acetylation-mimicking ERK1 mutant (K72Q) exhibited less phosphorylation than the WT enzyme and a deacetylation-mimicking mutant (K72R). Of note, the K72Q mutant displayed decreased enzymatic activity in an in vitro kinase assay and in a cellular luciferase assay compared with the WT and K72R mutant. Taken together, our findings suggest that HDAC6 stimulates ERK1 activity. Along with our previous report that ERK1 promotes HDAC6 activity, we propose that HDAC6 and ERK1 may form a positive feed-forward loop, which might play a role in cancer.	[Wu, Jheng-Yu; Zhang, Mu; Bepler, Gerold; Zhang, Xiaohong Mary] Karmanos Canc Inst, Dept Oncol, Mol Therapeut Program, Detroit, MI 48201 USA; [Wu, Jheng-Yu; Xiang, Shengyan; Bai, Wenlong] Univ S Florida, Morsani Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Fang, Bin] H Lee Moffitt Canc Ctr & Res Inst, Prote Core, Tampa, FL 33612 USA; [Huang, He; Kwon, Oh Kwang; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Yang, Zhe] Wayne State Univ, Sch Med, Dept Microbiol Immunol & Biochem, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; University of Chicago; Wayne State University	Zhang, XM (corresponding author), Karmanos Canc Inst, 4100 John R St, Detroit, MI 48201 USA.	zhangx@karmanos.org	Bai, Wenlong/A-8977-2013; XIANG, SHENGYAN/C-3176-2013	Bai, Wenlong/0000-0002-9536-0556; XIANG, SHENGYAN/0000-0002-6940-3559	Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida; National Institutes of Health [R01CA164147]; Karmanos Cancer Institute start-up funds; NATIONAL CANCER INSTITUTE [R01CA164147, P30CA022453] Funding Source: NIH RePORTER	Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Karmanos Cancer Institute start-up funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant R01CA164147 and by Karmanos Cancer Institute start-up funds (to X. M. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by the Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida.	Ahn MY, 2015, ONCOL REP, V33, P1899, DOI 10.3892/or.2015.3776; Bahr JC, 2016, ONCOTARGET, V7, P69804, DOI 10.18632/oncotarget.12001; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Carson R, 2015, CLIN CANCER RES, V21, P3230, DOI 10.1158/1078-0432.CCR-14-2701; Chuang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073401, 10.1371/journal.pone.0083116]; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Inks ES, 2012, ACS CHEM BIOL, V7, P330, DOI 10.1021/cb200134p; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kim IA, 2009, RADIOTHER ONCOL, V92, P125, DOI 10.1016/j.radonc.2009.03.008; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Larsen SC, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7329; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Lloyd Alison C, 2006, J Biol, V5, P13, DOI 10.1186/jbiol46; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Patki M, 2013, J BIOL CHEM, V288, P11047, DOI 10.1074/jbc.M112.438473; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pillai VB, 2011, MOL CELL BIOL, V31, P2349, DOI 10.1128/MCB.01205-10; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Robinson MJ, 1996, BIOCHEMISTRY-US, V35, P5641, DOI 10.1021/bi952723e; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Tien SC, 2014, ONCOGENE, V33, P2938, DOI 10.1038/onc.2013.241; Vougiouklakis T, 2015, ONCOTARGET, V6, P43162, DOI 10.18632/oncotarget.6351; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Williams KA, 2013, J BIOL CHEM, V288, P33156, DOI 10.1074/jbc.M113.472506; Yang MH, 2013, MOL CANCER RES, V11, P1072, DOI 10.1158/1541-7786.MCR-13-0040-T; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Yu CR, 2007, CLIN CANCER RES, V13, P1140, DOI 10.1158/1078-0432.CCR-06-1751; Zhang LS, 2015, ONCOTARGET, V6, P9073, DOI 10.18632/oncotarget.3268; Zhang M, 2014, MOL CELL, V55, P31, DOI 10.1016/j.molcel.2014.04.028; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	46	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1976	1993		10.1074/jbc.M117.795955	http://dx.doi.org/10.1074/jbc.M117.795955			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29259132	hybrid, Green Published			2022-12-26	WOS:000424948000012
J	Hertler, B; Hosp, JA; Blanco, MB; Luft, AR				Hertler, Benjamin; Hosp, Jonas Aurel; Blanco, Manuel Buitrago; Luft, Andreas Rudiger			Substance P signalling in primary motor cortex facilitates motor learning in rats	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CONDITIONED PLACE PREFERENCE; LONG-TERM POTENTIATION; CORTICAL-NEURONS; DOPAMINERGIC PROJECTIONS; REINFORCING PROPERTIES; MOLECULAR MECHANISMS; TACHYKININ RECEPTORS; MORPHINE-WITHDRAWAL; FORELIMB CORTEX	Among the genes that are up-regulated in response to a reaching training in rats, Tachykinin 1 (Tac1)-a gene that encodes the neuropeptide Substance P (Sub P)-shows an especially strong expression. Using Real-Time RT-PCR, a detailed time-course of Tac1 expression could be defined: a significant peak occurs 7 hours after training ended at the first and second training session, whereas no up-regulation could be detected at a later time-point (sixth training session). To assess the physiological role of Sub P during movement acquisition, microinjections into the primary motor cortex (M1) contralateral to the trained paw were performed. When Sub P was injected before the first three sessions of a reaching training, effectiveness of motor learning became significantly increased. Injections at a time-point when rats already knew the task (i.e. training session ten and eleven) had no effect on reaching performance. Sub P injections did not influence the improvement of performance within a single training session, but retention of performance between sessions became strengthened at a very early stage (i.e. between baseline-training and first training session). Thus, Sub P facilitates motor learning in the very early phase of skill acquisition by supporting memory consolidation. In line with these findings, learning related expression of the precursor Tac1 occurs at early but not at later time-points during reaching training.	[Hertler, Benjamin; Blanco, Manuel Buitrago; Luft, Andreas Rudiger] Univ & Univ Hosp Zurich, Dept Neurol, Div Vasc Neurol & Rehabil, Zurich, Switzerland; [Hosp, Jonas Aurel] Univ Med Ctr Freiburg, Dept Neurol, Freiburg, Germany; [Blanco, Manuel Buitrago] Univ Calif Los Angeles, Dept Neurosurg, Div Neurocrit Care, Los Angeles, CA USA; [Luft, Andreas Rudiger] Cereneo Ctr Neurol & Rehabil, Vitznau, Switzerland; [Luft, Andreas Rudiger] Johns Hopkins Univ, Dept Neurol, Baltimore, MD USA	University of Zurich; University Zurich Hospital; University of Freiburg; University of California System; University of California Los Angeles; Johns Hopkins University	Luft, AR (corresponding author), Univ & Univ Hosp Zurich, Dept Neurol, Div Vasc Neurol & Rehabil, Zurich, Switzerland.; Luft, AR (corresponding author), Cereneo Ctr Neurol & Rehabil, Vitznau, Switzerland.; Luft, AR (corresponding author), Johns Hopkins Univ, Dept Neurol, Baltimore, MD USA.	andreas.luft@uzh.ch			Swiss National Science Foundation (SNF, NCCR Neuro); P & K Pitringer Foundation	Swiss National Science Foundation (SNF, NCCR Neuro)(Swiss National Science Foundation (SNSF)); P & K Pitringer Foundation	Funding came from the Swiss National Science Foundation (SNF, NCCR Neuro) and the P & K Pitringer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Andero R, 2014, NEURON, V83, P444, DOI 10.1016/j.neuron.2014.05.028; Baloyannis SJ, 2000, INT J NEUROSCI, V101, P89, DOI 10.3109/00207450008986495; BOIX F, 1992, EUR J PHARMACOL, V216, P103, DOI 10.1016/0014-2999(92)90215-P; Buitrago MM, 2004, BEHAV BRAIN RES, V155, P249, DOI 10.1016/j.bbr.2004.04.025; Caioli S, 2011, NEUROBIOL DIS, V44, P92, DOI 10.1016/j.nbd.2011.06.008; Chao OY, 2014, NEUROBIOL LEARN MEM, V114, P178, DOI 10.1016/j.nlm.2014.06.009; Cheung VCK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061496; Choi JIL, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-4; Commons KG, 2010, BRAIN RES, V1314, P175, DOI 10.1016/j.brainres.2009.11.014; Ding YQ, 1996, J COMP NEUROL, V364, P290; Ebner K, 2004, P NATL ACAD SCI USA, V101, P4280, DOI 10.1073/pnas.0400794101; GERARD NP, 1991, J BIOL CHEM, V266, P1354; Gloor C, 2015, NEUROBIOL LEARN MEM, V125, P189, DOI 10.1016/j.nlm.2015.08.009; GREENOUGH WT, 1985, BEHAV NEURAL BIOL, V44, P301, DOI 10.1016/S0163-1047(85)90310-3; Hasenohrl RU, 2000, NEUROPEPTIDES, V34, P272, DOI 10.1054/npep.2000.0824; Hay CW, 2014, PSYCHONEUROENDOCRINO, V47, P43, DOI 10.1016/j.psyneuen.2014.04.017; Hertler B, 2016, NEUROBIOL LEARN MEM; HOLZHAUEROITZL MS, 1988, NEUROPHARMACOLOGY, V27, P749, DOI 10.1016/0028-3908(88)90085-8; HOLZHAUEROITZL MS, 1987, PHARMACOL BIOCHEM BE, V28, P511, DOI 10.1016/0091-3057(87)90514-4; Hosp JA, 2013, NEUROSCIENCE, V250, P557, DOI 10.1016/j.neuroscience.2013.06.060; Hosp JA, 2009, NEUROSCIENCE, V159, P692, DOI 10.1016/j.neuroscience.2008.12.056; Hosp JA, 2015, EXP BRAIN RES, V233, P1365, DOI 10.1007/s00221-015-4211-2; Hosp JA, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/871296; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; HUSTON JP, 1989, NEUROSCI BIOBEHAV R, V13, P171, DOI 10.1016/S0149-7634(89)80027-2; INGI T, 1991, J PHARMACOL EXP THER, V259, P968; Jakab RL, 1997, CEREB CORTEX, V7, P359, DOI 10.1093/cercor/7.4.359; KATO N, 1993, BRAIN RES, V617, P353, DOI 10.1016/0006-8993(93)91105-2; Kertes E, 2010, BEHAV BRAIN RES, V215, P152, DOI 10.1016/j.bbr.2010.06.027; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kleim JA, 1996, J NEUROSCI, V16, P4529; Kolb B, 2008, NEUROBIOL LEARN MEM, V90, P295, DOI 10.1016/j.nlm.2008.04.012; KRAUSE JE, 1987, P NATL ACAD SCI USA, V84, P881, DOI 10.1073/pnas.84.3.881; LAMOUR Y, 1983, NEUROSCIENCE, V10, P107, DOI 10.1016/0306-4522(83)90085-4; Langosch JM, 2005, PROG NEURO-PSYCHOPH, V29, P315, DOI 10.1016/j.pnpbp.2004.11.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LJUNGDAHL A, 1978, NEUROSCIENCE, V3, P861, DOI 10.1016/0306-4522(78)90116-1; MAENO H, 1993, MOL BRAIN RES, V18, P43, DOI 10.1016/0169-328X(93)90172-L; Mitsikostas DD, 2001, BRAIN RES REV, V35, P20, DOI 10.1016/S0165-0173(00)00048-5; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Monfils MH, 2005, NEUROSCIENTIST, V11, P471, DOI 10.1177/1073858405278015; Nakayama T, 2010, NEUROSCI RES, V67, P18, DOI 10.1016/j.neures.2010.01.006; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; PHILLIS JW, 1974, EXP NEUROL, V43, P414, DOI 10.1016/0014-4886(74)90181-2; REID MS, 1990, EXP BRAIN RES, V82, P293; Rioult-Pedotti MS, 2007, J NEUROPHYSIOL, V98, P3688, DOI 10.1152/jn.00164.2007; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Sandweiss AJ, 2015, SUBST ABUSE REHABIL, V6, P93, DOI 10.2147/SAR.S70350; Schank JR, 2017, INT REV NEUROBIOL, V136, P151, DOI 10.1016/bs.irn.2017.06.008; Schubring-Giese M, 2016, BEHAV BRAIN RES, V313, P310, DOI 10.1016/j.bbr.2016.07.040; Silva MAD, 2013, P NATL ACAD SCI USA, V110, P15097, DOI 10.1073/pnas.1306884110; Siuciak JA, 2007, PSYCHOPHARMACOLOGY, V194, P185, DOI 10.1007/s00213-007-0828-6; Smith DW, 1999, BRAIN RES, V848, P90, DOI 10.1016/S0006-8993(99)01976-9; Szapiro G, 2002, NEUROCHEM RES, V27, P1491, DOI 10.1023/A:1021648405461; WHISHAW IQ, 1990, BEHAV BRAIN RES, V41, P49, DOI 10.1016/0166-4328(90)90053-H; WITHERS GS, 1989, NEUROPSYCHOLOGIA, V27, P61, DOI 10.1016/0028-3932(89)90090-0; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yip J, 2000, CLIN EXP PHARMACOL P, V27, P943, DOI 10.1046/j.1440-1681.2000.03366.x; Yu Y, 2014, NEURAL REGEN RES, V9, P857, DOI 10.4103/1673-5374.131603; Zhou Q, 2004, PEPTIDES, V25, P1951, DOI 10.1016/j.peptides.2004.07.011; Zhou Q, 2003, PEPTIDES, V24, P147, DOI 10.1016/S0196-9781(02)00287-5	63	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189812	10.1371/journal.pone.0189812	http://dx.doi.org/10.1371/journal.pone.0189812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281692	Green Submitted, gold, Green Published			2022-12-26	WOS:000419006200043
J	Low, JYQ; Lacy, KE; McBride, RL; Keast, RSJ				Low, Julia Y. Q.; Lacy, Kathleen E.; McBride, Robert L.; Keast, Russell S. J.			Evidence supporting oral sensitivity to complex carbohydrates independent of sweet taste sensitivity in humans	PLOS ONE			English	Article							TIME TRIAL PERFORMANCE; FREE FATTY-ACIDS; MOUTH RINSE; EXERCISE PERFORMANCE; LICKING RESPONSES; SUGAR TASTES; POLYCOSE; GLUCOSE; SUCROSE; RECEPTOR	Compared to simple sugars, complex carbohydrates have been assumed invisible to taste. However, two recent studies proposed that there may be a perceivable taste quality elicited by complex carbohydrates independent of sweet taste. There is precedent with behavioural studies demonstrating that rats are very attracted to complex carbohydrates, and that complex carbohydrates are preferred to simple sugars at low concentrations. This suggests that rats may have independent taste sensors for simple sugars and complex carbohydrates. The aim of this paper is to investigate oral sensitivities of two different classes of complex carbohydrates (a soluble digestible and a soluble non-digestible complex carbohydrate), and to compare these to other caloric and non-nutritive sweeteners in addition to the prototypical tastes using two commonly used psychophysical measures. There were strong correlations between the detection thresholds and mean intensity ratings for complex carbohydrates (maltodextrin, oligofructose) (r = 0.94, P < 0.001). There were no significant correlations between the detection thresholds of the complex carbohydrates (maltodextrin, oligofructose) and the sweeteners (glucose, fructose, sucralose, Rebaudioside A, erythritol) (all P > 0.05). However, moderate correlations were observed between perceived intensities of complex carbohydrates and sweeteners (r = 0.48-0.61, P < 0.05). These data provide evidence that complex carbohydrates can be sensed in the oral cavity over a range of concentrations independent of sweet taste sensitivity at low concentrations, but with partial overlap with sweet taste intensity at higher concentrations.	[Low, Julia Y. Q.; McBride, Robert L.; Keast, Russell S. J.] Deakin Univ, Ctr Adv Sensory Sci, Sch Exercise & Nutr Sci, Burwood, Vic, Australia; [Lacy, Kathleen E.] Deakin Univ, IPAN, Sch Exercise & Nutr Sci, Geelong, Vic, Australia	Deakin University; Deakin University	Keast, RSJ (corresponding author), Deakin Univ, Ctr Adv Sensory Sci, Sch Exercise & Nutr Sci, Burwood, Vic, Australia.	russell.keast@deakin.edu.au	Lacy, Kathleen E/B-4179-2017; Keast, Russell/P-1899-2017	Low, Julia/0000-0001-6882-2877; Keast, Russell/0000-0003-2147-7687	Centre for Advanced Sensory Science (CASS) from Deakin University, Australia	Centre for Advanced Sensory Science (CASS) from Deakin University, Australia	This study was supported by the Centre for Advanced Sensory Science (CASS) funding from Deakin University, Australia.	Ackroff K, 2016, PHYSIOL BEHAV, V165, P286, DOI 10.1016/j.physbeh.2016.08.012; [Anonymous], 1991, ISO3972; Bartoshuk LM, 2000, CHEM SENSES, V25, P447, DOI 10.1093/chemse/25.4.447; Beauchamp GK, 2016, PHYSIOL BEHAV, V164, P432, DOI 10.1016/j.physbeh.2016.05.007; Beaven CM, 2013, APPL PHYSIOL NUTR ME, V38, P633, DOI 10.1139/apnm-2012-0333; Breslin PAS, 1996, PERCEPT PSYCHOPHYS, V58, P327, DOI 10.3758/BF03206809; Carter JM, 2004, MED SCI SPORT EXER, V36, P2107, DOI 10.1249/01.MSS.0000147585.65709.6F; Chale-Rush A, 2007, CHEM SENSES, V32, P423, DOI 10.1093/chemse/bjm007; Chambers ES, 2009, J PHYSIOL-LONDON, V587, P1779, DOI 10.1113/jphysiol.2008.164285; Cicerale S, 2012, J FOOD SCI, V77, pH31, DOI 10.1111/j.1750-3841.2011.02473.x; Cui M, 2006, CURR PHARM DESIGN, V12, P4591, DOI 10.2174/138161206779010350; Davis JD, 2000, PHYSIOL BEHAV, V69, P477, DOI 10.1016/S0031-9384(99)00265-6; de Araujo IE, 2013, CURR BIOL, V23, P878, DOI 10.1016/j.cub.2013.04.001; Silva TDE, 2014, NUTRIENTS, V6, P1, DOI 10.3390/nu6010001; Dehghan P, 2014, NUTRITION, V30, P418, DOI 10.1016/j.nut.2013.09.005; Delwiche JF, 2001, PHYSIOL BEHAV, V74, P329, DOI 10.1016/S0031-9384(01)00568-6; Dokic P, 1998, COLLOID SURFACE A, V141, P435, DOI 10.1016/S0927-7757(97)00118-0; Fares E-J, 2011, J NUTR METABOLISM, V2011; FEIGIN MB, 1987, NEUROSCI BIOBEHAV R, V11, P231, DOI 10.1016/S0149-7634(87)80031-3; GIZA BK, 1991, BRAIN RES, V555, P1, DOI 10.1016/0006-8993(91)90852-M; Glendinning JI, 2005, CHEM SENSES, V30, P601, DOI 10.1093/chemse/bji054; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; GREEN BG, 1993, CHEM SENSES, V18, P683, DOI 10.1093/chemse/18.6.683; Handa C, 2012, J FOOD SCI TECH MYS, V49, P192, DOI 10.1007/s13197-011-0277-4; Hettinger TP, 1996, CHEM SENSES, V21, P341, DOI 10.1093/chemse/21.3.341; Jeukendrup AE, 2010, CURR OPIN CLIN NUTR, V13, P447, DOI 10.1097/MCO.0b013e328339de83; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Keast RS., 2016, CURRENT OPINION BEHA; Keast RS, 2015, FLAVOUR, V4, P5, DOI [10.1186/2044-7248-4-5, DOI 10.1186/2044-7248-4-5]; Keast RSJ, 2004, CHEM SENSES, V29, P513, DOI 10.1093/chemse/bjh053; Keast RSJ, 2007, CHEM SENSES, V32, P245, DOI 10.1093/chemse/bjl052; Kurihara K, 1998, ANN NY ACAD SCI, V855, P393, DOI 10.1111/j.1749-6632.1998.tb10597.x; Lapis TJ, 2016, CHEM SENSES, V41, P755, DOI 10.1093/chemse/bjw088; Lapis TJ, 2014, CHEM SENSES, V39, P737, DOI 10.1093/chemse/bju031; Liber A, 2014, BRIT J NUTR, V112, P2068, DOI 10.1017/S0007114514003110; Lim JY, 2008, CHEM SENSES, V33, P493, DOI 10.1093/chemse/bjn016; Liman ER, 2014, NEURON, V81, P984, DOI 10.1016/j.neuron.2014.02.022; Low JY, 2016, CHEM SENSES; Mandel AL, 2012, J NUTR, V142, P853, DOI 10.3945/jn.111.156984; Mandel AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013352; Mattes RD, 2011, PHYSIOL BEHAV, V104, P624, DOI 10.1016/j.physbeh.2011.05.002; Mattes RD, 2009, CHEMOSENS PERCEPT, V2, P180, DOI 10.1007/s12078-009-9062-4; Meilgaard M.C., 2006, SENSORY EVALUATION T, V4th ed.; Newman L, 2013, NUTRIENTS, V5, P1287, DOI 10.3390/nu5041287; Newman LP, 2016, OBESITY, V24, P328, DOI 10.1002/oby.21357; Newman LP, 2013, CHEMOSENS PERCEPT, V6, P70, DOI 10.1007/s12078-013-9143-2; Niness KR, 1999, J NUTR, V129, p1402S, DOI 10.1093/jn/129.7.1402S; NISSENBAUM JW, 1987, NEUROSCI BIOBEHAV R, V11, P187, DOI 10.1016/S0149-7634(87)80025-8; Poole RL, 2016, CHEM SENSES, V41, P45, DOI 10.1093/chemse/bjv056; Pottier A, 2010, SCAND J MED SCI SPOR, V20, P105, DOI 10.1111/j.1600-0838.2008.00868.x; Rollo I, 2008, INT J SPORT NUTR EXE, V18, P585, DOI 10.1123/ijsnem.18.6.585; Rollo I, 2010, MED SCI SPORT EXER, V42, P798, DOI 10.1249/MSS.0b013e3181bac6e4; Running CA, 2015, CHEM SENSES, V40, P507, DOI 10.1093/chemse/bjv036; SAKO N, 1994, PHYSIOL BEHAV, V56, P741, DOI 10.1016/0031-9384(94)90236-4; SCLAFANI A, 1987, PHYSIOL BEHAV, V40, P563, DOI 10.1016/0031-9384(87)90097-7; SCLAFANI A, 1987, NEUROSCI BIOBEHAV R, V11, P131, DOI 10.1016/S0149-7634(87)80019-2; Sclafani A, 2004, APPETITE, V43, P1, DOI 10.1016/j.appet.2004.03.007; SCLAFANI A, 1991, BRAIN RES BULL, V27, P383, DOI 10.1016/0361-9230(91)90129-8; SCLAFANI A, 1987, NEUROSCI BIOBEHAV R, V11, P173, DOI 10.1016/S0149-7634(87)80023-4; Sinclair J, 2014, EUR J SPORT SCI, V14, P259, DOI 10.1080/17461391.2013.785599; Spector AC, 2016, APPETITE; Stewart JE, 2012, INT J OBESITY, V36, P834, DOI 10.1038/ijo.2011.155; Stewart JE, 2011, PROG LIPID RES, V50, P225, DOI 10.1016/j.plipres.2011.02.002; Stewart JE, 2010, BRIT J NUTR, V104, P145, DOI 10.1017/S0007114510000267; Treesukosol Y, 2012, AM J PHYSIOL-REG I, V303, pR218, DOI 10.1152/ajpregu.00089.2012; Treesukosol Y, 2011, J NEUROSCI, V31, P13527, DOI 10.1523/JNEUROSCI.2179-11.2011; Treesukosol Y, 2009, AM J PHYSIOL-REG I, V296, pR855, DOI 10.1152/ajpregu.90869.2008; Tucker RM, 2014, CHEM SENSES, V39, P349, DOI 10.1093/chemse/bju006; Verhoef S, 2013, EFFECTS OLIGOFRUCTOS, V17; Verhoef SPM, 2011, BRIT J NUTR, V106, P1757, DOI 10.1017/S0007114511002194; VIGORITO M, 1987, NEUROSCI BIOBEHAV R, V11, P201, DOI 10.1016/S0149-7634(87)80027-1; Webb J, 2015, CHEMOSENS PERCEPT, V8, P11, DOI 10.1007/s12078-015-9183-x; Yeomans MR, 2012, PHYSIOL BEHAV, V106, P345, DOI 10.1016/j.physbeh.2012.03.013; Yoshiko K, 2012, FOOD NUTR SCI, V2012; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zukerman S, 2009, AM J PHYSIOL-REG I, V296, pR866, DOI 10.1152/ajpregu.90870.2008	76	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0188784	10.1371/journal.pone.0188784	http://dx.doi.org/10.1371/journal.pone.0188784			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281655	Green Published, Green Submitted, gold			2022-12-26	WOS:000419006200010
J	Peng, YF				Peng, YuFeng			Forced expression of IL-7R promotes CD8 T cell cytotoxicity to self antigen	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; IN-VIVO; CROSS-PRESENTATION; DENDRITIC CELLS; DELETIONAL TOLERANCE; PERIPHERAL DELETION; MICE; INTERLEUKIN-7; AUTOIMMUNITY; EXPANSION	Cross-presentation of apoptotic cell associated antigens by immature dendritic cells prevents the activation of self reactive CD8 T cells. Tolerized self reactive CD8 T cells down-regulate IL-7R expression on their surface. Whether over-expression of IL-7R can reverse their fate and function has not been examined. In this paper, we showed forced expression of IL-7R in OT-I T cells by a transgene enhanced CD8 T cell mediated diabetes in the RIP-mOVA model. Although IL-7R Tg (transgenic) did not completely reverse the deletion of OT-I T cells, it provided a significant survival advantage over w.t OT-I T cells. Furthermore, IL7R Tg OT-I T cells isolated from diabetic pancreata displayed increased production of IFN-gamma, higher expression of T-bet, and increased externalization of CD107a. We also found that immature DCs containing apoptotic cells expressed high levels of PDL-1 on their surface. Although IL-7R Tg did not change PD1 expression on activated OT-I cells in vivo, the transgene enabled a significantly lower number of OT-I T cells to induce diabetes in the absence of PDL-1. Our results demonstrated that forced expression of IL-7R not only improved the functionality of tolerized CD8 T cells, it also acted in synergy with PDL-1 deficiency to further promote CD8 T cell cytotoxicity to self antigens.	[Peng, YuFeng] Univ Washington, Dept Med, Div Rheumatol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Peng, YF (corresponding author), Univ Washington, Dept Med, Div Rheumatol, Seattle, WA 98195 USA.	yfpeng2014@gmail.com	peng, yu/GXW-2071-2022		Juvenile Diabetes Foundation; Arthritis Foundation	Juvenile Diabetes Foundation(Juvenile Diabetes Research Foundation); Arthritis Foundation	This work was supported by the Juvenile Diabetes Foundation (YFP) and the Arthritis Foundation (YFP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Alves NL, 2008, J IMMUNOL, V180, P5201, DOI 10.4049/jimmunol.180.8.5201; Alves NL, 2009, P NATL ACAD SCI USA, V106, P1512, DOI 10.1073/pnas.0809559106; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Becker L, 2013, PLOS ONE, V7; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Buggert M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004251; Chikuma S, 2009, J IMMUNOL, V182, P6682, DOI 10.4049/jimmunol.0900080; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Giliani S, 2005, IMMUNOL REV, V203, P110, DOI 10.1111/j.0105-2896.2005.00234.x; Granucci F, 2001, EUR J IMMUNOL, V31, P2539, DOI 10.1002/1521-4141(200109)31:9<2539::AID-IMMU2539>3.0.CO;2-9; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Kimura MY, 2013, NAT IMMUNOL, V14, P143, DOI 10.1038/ni.2494; Koenen P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2719; Kurts C, 1999, P NATL ACAD SCI USA, V96, P12703, DOI 10.1073/pnas.96.22.12703; Kurts C, 1998, J EXP MED, V188, P415, DOI 10.1084/jem.188.2.415; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lee LF, 2012, P NATL ACAD SCI USA, V109, P12674, DOI 10.1073/pnas.1203795109; Liu XB, 2010, NAT MED, V16, P191, DOI 10.1038/nm.2077; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Martin-Orozco N, 2006, J IMMUNOL, V177, P8291, DOI 10.4049/jimmunol.177.12.8291; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Parish IA, 2009, BLOOD, V113, P4575, DOI 10.1182/blood-2008-10-185223; Parish IA, 2009, P NATL ACAD SCI USA, V106, P3901, DOI 10.1073/pnas.0810427106; Pellegrini M, 2009, NAT MED, V15, P528, DOI 10.1038/nm.1953; Penaranda C, 2012, P NATL ACAD SCI USA, V109, P12668, DOI 10.1073/pnas.1203692109; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Peng YF, 2011, J CLIN INVEST, V121, P2221, DOI 10.1172/JCI43254; Peng YF, 2009, J IMMUNOL, V182, P2777, DOI 10.4049/jimmunol.0803172; Shibaki A, 2004, J INVEST DERMATOL, V123, P109, DOI 10.1111/j.0022-202X.2004.22701.x; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Yu Q, 2004, J EXP MED, V200, P797, DOI 10.1084/jem.20032183; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	39	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0188112	10.1371/journal.pone.0188112	http://dx.doi.org/10.1371/journal.pone.0188112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272267	gold, Green Submitted, Green Published			2022-12-26	WOS:000418651500002
J	Zhou, WB; Barkow, JC; Freed, CR				Zhou, Wenbo; Barkow, Jessica Cummiskey; Freed, Curt R.			Running wheel exercise reduces alpha-synuclein aggregation and improves motor and cognitive function in a transgenic mouse model of Parkinson's disease	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DOPAMINERGIC-NEURONS; HUNTINGTONS-DISEASE; DEPENDENT MANNER; OXIDATIVE STRESS; DJ-1 MUTATIONS; LEWY BODIES; MICE; MPTP; NRF2	Exercise has been recommended to improve motor function in Parkinson patients, but its value in altering progression of disease is unknown. In this study, we examined the neuroprotective effects of running wheel exercise in mice. In adult wild-type mice, one week of running wheel activity led to significantly increased DJ-1 protein concentrations in muscle and plasma. In DJ-1 knockout mice, running wheel performance was much slower and Rotarod performance was reduced, suggesting that DJ-1 protein is required for normal motor activity. To see if exercise can prevent abnormal protein deposition and behavioral decline in transgenic animals expressing a mutant human form of alpha-synuclein in all neurons, we set up running wheels in the cages of pre-symptomatic animals at 12 months old. Activity was monitored for a 3-month period. After 3 months, motor and cognitive performance on the Rotarod and Morris Water Maze were significantly better in running animals compared to control transgenic animals with locked running wheels. Biochemical analysis revealed that running mice had significantly higher DJ-1, Hsp70 and BDNF concentrations and had significantly less alpha-synuclein aggregation in brain compared to control mice. By contrast, plasma concentrations of alpha-synuclein were significantly higher in exercising mice compared to control mice. Our results suggest that exercise may slow the progression of Parkinson's disease by preventing abnormal protein aggregation in brain.	[Zhou, Wenbo; Freed, Curt R.] Univ Colorado Denver, Sch Med, Div Clin Pharmacol & Toxicol, Dept Med, Aurora, CO 80204 USA; Univ Colorado Denver, Sch Med, Div Clin Pharmacol & Toxicol, Dept Pharm, Aurora, CO USA; Univ Colorado Denver, Sch Med, Div Clin Pharmacol & Toxicol, Dept Neurol, Aurora, CO USA; Univ Colorado Denver, Sch Med, Div Clin Pharmacol & Toxicol, Dept Neurosurg, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Zhou, WB; Freed, CR (corresponding author), Univ Colorado Denver, Sch Med, Div Clin Pharmacol & Toxicol, Dept Med, Aurora, CO 80204 USA.	wenbo.zhou@ucdenver.edu; curt.freed@ucdenver.edu			Walter S. and Lucienne Driskill Foundation; Leopold Korn and Michael Korn Professorship in Parkinson's Disease; C.R.F; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048154] Funding Source: NIH RePORTER	Walter S. and Lucienne Driskill Foundation; Leopold Korn and Michael Korn Professorship in Parkinson's Disease; C.R.F; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by The Walter S. and Lucienne Driskill Foundation, the Leopold Korn and Michael Korn Professorship in Parkinson's Disease, and by the personal savings of C.R.F.	Abeliovich A, 2016, NATURE, V539, P207, DOI 10.1038/nature20414; Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Benskey MJ, 2016, J NEUROCHEM, V137, P331, DOI 10.1111/jnc.13570; Bonifati V, 2005, Minerva Med, V96, P175; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bonifati Vincenzo, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS23, DOI 10.1016/S1353-8020(13)70009-9; Campos C, 2016, EXPERT REV NEUROTHER, V16, P723, DOI 10.1080/14737175.2016.1179582; Chao FL, 2015, CURR ALZHEIMER RES, V12, P377, DOI 10.2174/1567205012666150325183011; Chivet M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00145; Clark LN, 2004, MOVEMENT DISORD, V19, P796, DOI 10.1002/mds.20131; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Cooper C, 2017, COLD SPRING HARBOR P; da Silva FC, 2016, J AGING PHYS ACTIV, V24, P484, DOI 10.1123/japa.2015-0162; EHRINGER H, 1960, KLIN WOCHENSCHR, V38, P1236, DOI 10.1007/BF01485901; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Ferreira DG, 2017, NAT NEUROSCI, V20, P1569, DOI 10.1038/nn.4648; Fisher BE, 2008, ARCH PHYS MED REHAB, V89, P1221, DOI 10.1016/j.apmr.2008.01.013; Gan L, 2010, EUR J NEUROSCI, V31, P967, DOI 10.1111/j.1460-9568.2010.07138.x; Gautier V, 2012, J MOL BIOL, V421, P662, DOI 10.1016/j.jmb.2012.01.047; Gerecke KM, 2010, BRAIN RES, V1341, P72, DOI 10.1016/j.brainres.2010.01.053; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gobbi Lilian T B, 2009, Parkinsonism Relat Disord, V15 Suppl 3, pS49, DOI 10.1016/S1353-8020(09)70780-1; Goes ATR, 2014, NEUROSCIENCE, V256, P61, DOI 10.1016/j.neuroscience.2013.09.042; Gorton LM, 2010, BEHAV BRAIN RES, V213, P253, DOI 10.1016/j.bbr.2010.05.009; Harrison DJ, 2013, EXP NEUROL, V248, P457, DOI 10.1016/j.expneurol.2013.07.014; Herbst EAF, 2015, NEUROSCIENCE, V303, P515, DOI 10.1016/j.neuroscience.2015.07.025; Ibanez P, 2003, NEUROLOGY, V61, P1429, DOI 10.1212/01.WNL.0000094121.48373.FD; Im JY, 2012, HUM MOL GENET, V21, P3013, DOI 10.1093/hmg/dds131; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Koo JH, 2017, EXP NEUROL, V288, P142, DOI 10.1016/j.expneurol.2016.11.014; Kumaran R, 2015, HUM MOL GENET, V24, pR32, DOI 10.1093/hmg/ddv236; Larson ME, 2017, P NATL ACAD SCI USA, V114, pE4648, DOI 10.1073/pnas.1704698114; Lauze M, 2016, J PARKINSON DIS, V6, P685, DOI 10.3233/JPD-160790; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023731; Lucas JI, 2007, MOL BIOL EVOL, V24, P551, DOI 10.1093/molbev/msl186; Marlatt MW, 2012, DEV NEUROBIOL, V72, P943, DOI 10.1002/dneu.22009; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Moore KM, 2016, NEUROBIOL DIS, V85, P218, DOI 10.1016/j.nbd.2015.11.004; Mor DE, 2017, NATURE NEUROSCIENCE; Mullin S, 2013, MOL NEUROBIOL, V47, P587, DOI 10.1007/s12035-013-8394-x; Poewe W, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.13, 10.1111/ene.14108]; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Potter MC, 2010, PLOS CURR, V2, DOI [DOI 10.1371/CURRENTS.RRN1201, 10.1371/currents.RRN1201]; Przedborski S, 2017, NAT REV NEUROSCI, V18, P251, DOI 10.1038/nrn.2017.25; Schapansky J, 2015, NEUROSCIENCE, V302, P74, DOI 10.1016/j.neuroscience.2014.09.049; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Shin MS, 2016, NEUROSCI LETT, V621, P28, DOI 10.1016/j.neulet.2016.04.015; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tajiri N, 2010, BRAIN RES, V1310, P200, DOI 10.1016/j.brainres.2009.10.075; Toy WA, 2014, NEUROBIOL DIS, V63, P201, DOI 10.1016/j.nbd.2013.11.017; Trojanowski JQ, 1998, ARCH NEUROL-CHICAGO, V55, P151, DOI 10.1001/archneur.55.2.151; Tsou YH, 2015, EXP NEUROL, V263, P50, DOI 10.1016/j.expneurol.2014.09.021; Um HS, 2008, INT J MOL MED, V22, P529, DOI 10.3892/ijmm_00000052; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Vivar C, 2016, NEUROIMAGE, V131, P29, DOI 10.1016/j.neuroimage.2015.11.031; von Einem B, 2017, AGING-US, V9, P1677, DOI 10.18632/aging.101261; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001; Wood NI, 2011, NEUROBIOL DIS, V42, P427, DOI 10.1016/j.nbd.2011.02.005; Xu XM, 2010, PLANT SIGNAL BEHAV, V5, P1034, DOI 10.4161/psb.5.8.12298; Yang Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180892; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200; Zhou W, 2008, J BIOL CHEM, V283, P9863, DOI 10.1074/jbc.M710232200; Zhou WB, 2011, J BIOL CHEM, V286, P14941, DOI 10.1074/jbc.M110.211029; Zigmond Michael J, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS123, DOI 10.1016/S1353-8020(13)70030-0	72	46	48	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190160	10.1371/journal.pone.0190160	http://dx.doi.org/10.1371/journal.pone.0190160			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272304	gold, Green Published, Green Submitted			2022-12-26	WOS:000418651500040
J	He, C; To, MKT; Cheung, JPY; Cheung, KMC; Chan, CK; Jiang, WW; Zhou, GQ; Lai, KKL; Zheng, YP; Wong, MS				He, Chen; To, Michael Kai-Tsun; Cheung, Jason Pui-Yin; Cheung, Kenneth Man-Chee; Chan, Chi-Kwan; Jiang, Wei-Wei; Zhou, Guang-Quan; Lai, Kelly Ka-Lee; Zheng, Yong-Ping; Wong, Man-Sang			An effective assessment method of spinal flexibility to predict the initial in-orthosis correction on the patients with adolescent idiopathic scoliosis (AIS)	PLOS ONE			English	Article							COTREL-DUBOUSSET INSTRUMENTATION; CURVE FLEXIBILITY; BOSTON BRACE; TRACTION; RADIOGRAPHS; PRONE	Background Spinal flexibility is an essential parameter for clinical decision making on the patients with adolescent idiopathic scoliosis (AIS). Various methods are proposed to assess spinal flexibility, but which assessment method is more effective to predict the effect of orthotic treatment is unclear. Objective To investigate an effective assessment method of spinal flexibility to predict the initial inorthosis correction, among the supine, prone, sitting with lateral bending and prone with lateral bending positions. Methods Thirty-five patients with AIS (mean Cobb angle: 28 E +/- 7 E; mean age: 12 +/- 2 years; Risser sign: 0 +/- 2) were recruited. Before orthosis fitting, spinal flexibility was assessed by an ultrasound system in 4 positions (apart from standing) including supine, prone, sitting with lateral bending and prone with lateral bending. After orthosis fitting, the initial in-orthosis correction was routinely assessed by whole spine standing radiograph. Comparisons and correlation analyses were performed between the spinal flexibility in the 4 positions and the initial inorthosis correction. Results The mean in-orthosis correction was 41% while the mean curve correction (spinal flexibility) in the 4 studied positions were 40% (supine), 42% (prone), 127% (prone with lateral bending) and 143% (sitting with lateral bending). The correlation coefficients between initial inorthosis correction and curve correction (spinal flexibility) in the 4 studied positions were r = 0.66 (supine), r = 0.75 (prone), r = 0.03 (prone with lateral bending) and r = 0.04 (sitting with lateral bending). Conclusions The spinal flexibility in the prone position is the closest to and most correlated with the initial in-orthosis correction among the 4 studied positions. Thus, the prone position could be an effective method to predict the initial effect of orthotic treatment on the patients with AIS.	[He, Chen; Jiang, Wei-Wei; Lai, Kelly Ka-Lee; Zheng, Yong-Ping; Wong, Man-Sang] Hong Kong Polytech Univ, Interdisciplinary Div Biomed Engn, Kowloon, Hong Kong, Peoples R China; [To, Michael Kai-Tsun; Cheung, Jason Pui-Yin; Cheung, Kenneth Man-Chee] Univ Hong Kong, Dept Orthopaed & Traumatol, Pokfulam, Hong Kong, Peoples R China; [Chan, Chi-Kwan] Duchess Kent Childrens Hosp, Dept Prosthet & Orthot, Sandy Bay, Hong Kong, Peoples R China; [Jiang, Wei-Wei] Coll Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China; [Zhou, Guang-Quan] Southeast Univ, State Key Lab Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China	Hong Kong Polytechnic University; University of Hong Kong; Southeast University - China	Wong, MS (corresponding author), Hong Kong Polytech Univ, Interdisciplinary Div Biomed Engn, Kowloon, Hong Kong, Peoples R China.	m.s.wong@polyu.edu.hk	Cheung, Jason Pui Yin/J-2214-2012; Cheung, Jason Pui Yin/AAJ-2016-2020; Zheng, Yong-Ping/M-1197-2015; Zhou, Guangquan/P-2153-2015	Cheung, Jason Pui Yin/0000-0002-7052-0875; WONG, MS/0000-0002-4157-9528; Cheung, Kenneth/0000-0001-8304-0419; Zheng, Yong-Ping/0000-0002-3407-9226; Zhou, Guangquan/0000-0002-6467-3592				Asher MA, 2006, SCOLIOSIS SPINAL DIS, V1, DOI 10.1186/1748-7161-1-2; CARR WA, 1980, J BONE JOINT SURG AM, V62, P599, DOI 10.2106/00004623-198062040-00015; Castro Frank P Jr, 2003, Spine J, V3, P180, DOI 10.1016/S1529-9430(02)00557-0; CHASE AP, 1989, SPINE, V14, P636, DOI 10.1097/00007632-198906000-00018; Chaudry Z, 2017, SCOLIOSIS SPINAL DIS, V12, DOI 10.1186/s13013-017-0122-2; Chen ZQ, 2011, SPINE, V36, P1679, DOI 10.1097/BRS.0b013e31820e6265; Cheung KMC, 1997, J BONE JOINT SURG AM, V79A, P1144, DOI 10.2106/00004623-199708000-00005; Clin J, 2010, SPINE, V35, P1706, DOI 10.1097/BRS.0b013e3181cb46f6; Hamzaoglu A, 2005, SPINE, V30, P1637, DOI 10.1097/01.brs.0000170580.92177.d2; Katz DE, 1997, SPINE, V22, P1302, DOI 10.1097/00007632-199706150-00005; Klepps S J, 2001, Spine (Phila Pa 1976), V26, pE74, DOI 10.1097/00007632-200103010-00002; Knott P, 2013, SCOLIOSIS S1, V8, pO49; Kuroki H, 2012, SCOLIOSIS SPINAL DIS, V7, DOI 10.1186/1748-7161-7-8; Lange JE, 2009, SCOLIOSIS, V4, pO40; LENKE LG, 1992, J BONE JOINT SURG AM, V74A, P1056, DOI 10.2106/00004623-199274070-00013; Li Meng, 2015, Spine Deform, V3, P476, DOI 10.1016/j.jspd.2015.03.001; Li M, 2014, SPINE, V39, P1408, DOI 10.1097/BRS.0000000000000423; Liu RW, 2010, SPINE, V35, P416, DOI 10.1097/BRS.0b013e3181b3564a; O'Brien MF., 2004, SPINAL DEFORMITY STU; Ohrt-Nissen S, 2016, SPINE, V41, P1724, DOI 10.1097/BRS.0000000000001634; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Rodrigues LMR, 2014, ACTA ORTOP BRAS, V22, P78, DOI 10.1590/1413-78522014220200844; Takahashi S, 1997, SPINE, V22, P2542, DOI 10.1097/00007632-199711010-00015; UPADHYAY SS, 1995, SPINE, V20, P537, DOI 10.1097/00007632-199503010-00006; Vidyadhara S, 2008, HONG KONG J ORTHO SU, V12, P89; Wang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135264; Wang Q, 2016, ULTRASOUND MED BIOL, V42, P1473, DOI 10.1016/j.ultrasmedbio.2016.02.011; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3; Wong MS, 1994, P J BONE JOINT SURG, V76-B, P5; Zheng YP, 2016, SCOLIOSIS SPINAL DIS, V11, DOI 10.1186/s13013-016-0074-y	30	19	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190141	10.1371/journal.pone.0190141	http://dx.doi.org/10.1371/journal.pone.0190141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267389	Green Published, gold, Green Submitted			2022-12-26	WOS:000418587400097
J	Ma, L; Sun, K; Tu, K; Pan, LQ; Zhang, W				Ma, Long; Sun, Ke; Tu, Kang; Pan, Leiqing; Zhang, Wei			Identification of double-yolked duck egg using computer vision	PLOS ONE			English	Article							ALBUMIN SECRETION; SHAPE; FERTILITY; DESCRIPTORS; EMBRYOS; WEIGHT	The double-yolked (DY) egg is quite popular in some Asian countries because it is considered as a sign of good luck, however, the double yolk is one of the reasons why these eggs fail to hatch. The usage of automatic methods for identifying DY eggs can increase the efficiency in the poultry industry by decreasing egg loss during incubation or improving sale proceeds. In this study, two methods for DY duck egg identification were developed by using computer vision technology. Transmittance images of DY and single-yolked (SY) duck eggs were acquired by a CCD camera to identify them according to their shape features. The Fisher's linear discriminant (FLD) model equipped with a set of normalized Fourier descriptors (NFDs) extracted from the acquired images and the convolutional neural network (CNN) model using primary preprocessed images were built to recognize duck egg yolk types. The classification accuracies of the FLD model for SY and DY eggs were 100% and 93.2% respectively, while the classification accuracies of the CNN model for SY and DY eggs were 98% and 98.8% respectively. The CNN-based algorithm took about 0.12 s to recognize one sample image, which was slightly faster than the FLD-based (about 0.20 s). Finally, this work compared two classification methods and provided the better method for DY egg identification.	[Ma, Long; Sun, Ke; Tu, Kang; Pan, Leiqing] Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Ma, Long] Bengbu Univ, Coll Food & Biol Engn, Bengbu, Anhui, Peoples R China; [Zhang, Wei] Nanjing Xiaozhuang Univ, Coll Food Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Bengbu University; Nanjing Xiaozhuang University	Tu, K (corresponding author), Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing, Jiangsu, Peoples R China.	kangtu@njau.edu.cn			National Key Technology R&D Program of China [2015BAD19B05]; National Natural Science Foundation of China [31601544]; Natural Science Foundation of the Higher Education Institutions of Jiangsu Province [16KJD550001]	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Higher Education Institutions of Jiangsu Province	The work was financially supported by the National Key Technology R&D Program of China (No. 2015BAD19B05, Recipient: Leiqing Pan), the National Natural Science Foundation of China (No. 31601544, Recipient: Wei Zhang), and the Natural Science Foundation of the Higher Education Institutions of Jiangsu Province (No. 16KJD550001, Recipient: Wei Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur J, 2015, POULTRY SCI, V94, P1942, DOI 10.3382/ps/pev118; Bailey RL, 2014, PEERJ, V2, DOI 10.7717/peerj.273; Burke WH, 1997, POULTRY SCI, V76, P901, DOI 10.1093/ps/76.6.901; Chen WH, 2006, ANIMAL HUSBANDRY VET, V38, P22, DOI DOI 10.3969/J.0529-5130.2006.06.008; CHRISTMAS RB, 1982, POULTRY SCI, V61, P1290, DOI 10.3382/ps.0611290; CONRAD R. M., 1940, POULTRY SCI, V19, P9, DOI 10.3382/ps.0190009; Curtis MR, 1914, BIOL BULL-US, V26, P55, DOI 10.2307/1536071; Damaziak K, 2015, REPROD DOMEST ANIM, V50, P341, DOI 10.1111/rda.12477; Deeming DC, 2011, BRIT POULTRY SCI, V52, P40, DOI 10.1080/00071668.2010.538372; Fasenko GM, 2000, CAN J ANIM SCI, V80, P489, DOI 10.4141/A99-090; FECHHEIMER NS, 1966, J REPROD FERTIL, V12, P363, DOI 10.1530/jrf.0.0120363; Ganesan P, 2014, KOREAN J FOOD SCI AN, V34, P1, DOI 10.5851/kosfa.2014.34.1.1; Gonzalez R.C, 2007, DIGITAL IMAGE PROCES, V3rd; Guan T, 2015, ACM T INTEL SYST TEC, V7, DOI 10.1145/2795234; Horbanczuk Jaroslaw Olav, 2003, Animal Science Papers and Reports, V21, P201; JAAP RG, 1968, POULTRY SCI, V47, P417, DOI 10.3382/ps.0470417; JEFFREY FP, 1953, J HERED, V44, P213, DOI 10.1093/oxfordjournals.jhered.a106397; Ji RR, 2014, IEEE T GEOSCI REMOTE, V52, P1811, DOI 10.1109/TGRS.2013.2255297; Joo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077686; KAUPPINEN H, 1995, IEEE T PATTERN ANAL, V17, P201, DOI 10.1109/34.368168; LeCun Y., 1989, ADV NEURAL INFORM PR, V2, DOI DOI 10.1111/DSU.12130; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li HF, 2009, TURK J VET ANIM SCI, V33, P193, DOI 10.3906/vet-0709-4; Li XF, 2011, PROCEDIA ENGINEER, V15, DOI 10.1016/j.proeng.2011.08.543; Liu JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146484; Lunadei L, 2012, FOOD BIOPROCESS TECH, V5, P3042, DOI 10.1007/s11947-011-0672-x; McDonald LS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155523; Omid M, 2013, J FOOD ENG, V118, P70, DOI 10.1016/j.jfoodeng.2013.03.019; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palm R. B., 2012, THESIS; Paulus I, 1999, J AGR ENG RES, V72, P113, DOI 10.1006/jaer.1998.0352; Sa'ad FSA, 2015, COMPUT ELECTRON AGR, V115, P51, DOI 10.1016/j.compag.2015.05.006; Salamon A., 2013, International Journal of Poultry Science, V12, P254; Salamon A., 2015, THESIS; Salamon A, 2016, REPROD FERT DEVELOP, V28, P440, DOI 10.1071/RD14059; Sun XD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150513; Wang J.D., 2012, AGR MECH RES, V9, P195; WARREN D. C, 1935, POULTRY SCI, V14, P195, DOI 10.3382/ps.0140195; Wei BC, 2015, MULTIMEDIA SYST, V21, P381, DOI 10.1007/s00530-014-0364-2; Yadav RB, 2009, J SCI IND RES INDIA, V68, P484; Yang HP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12786; Yoon SC, 2012, APPL ENG AGRIC, V28, P283; ZAHN CT, 1972, IEEE T COMPUT, VC 21, P269, DOI 10.1109/TC.1972.5008949; Zhang TangJie, 2011, Journal of Animal and Veterinary Advances, V10, P367; Zhang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088659; Zhao KaiXuan, 2015, Transactions of the Chinese Society of Agricultural Engineering, V31, P181	46	6	7	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190054	10.1371/journal.pone.0190054	http://dx.doi.org/10.1371/journal.pone.0190054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267387	Green Submitted, Green Published, gold			2022-12-26	WOS:000418587400084
J	Sarrafzadegan, N; Hassannejad, R; Marateb, HR; Talaei, M; Sadeghi, M; Roohafza, HR; Masoudkabir, F; OveisGharan, S; Mansourian, M; Mohebian, MR; Mananas, MA				Sarrafzadegan, Nizal; Hassannejad, Razieh; Marateb, Hamid Reza; Talaei, Mohammad; Sadeghi, Masoumeh; Roohafza, Hamid Reza; Masoudkabir, Farzad; OveisGharan, Shahram; Mansourian, Marjan; Mohebian, Mohammad Reza; Mananas, Miquel Angel			PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; FOLLOW-UP; PROSPECTIVE COHORTS; POOLED ANALYSIS; POPULATION; SCORE; VALIDATION; PREVENTION; PREDICTION; GUIDELINES	This study was designed to develop a risk assessment chart for the clinical management and prevention of the risk of cardiovascular disease (CVD) in Iranian population, which is vital for developing national prevention programs. The Isfahan Cohort Study (ICS) is a population-based prospective study of 6504 Iranian adults >= 35 years old, followed-up for ten years, from 2001 to 2010. Behavioral and cardiometabolic risk factors were examined every five years, while biennial follow-ups for the occurrence of the events was performed by phone calls or by verbal autopsy. Among these participants, 5432 (2784 women, 51.3%) were CVD free at baseline examination and had at least one follow-up. Cox proportional hazard regression was used to predict the risk of ischemic CVD events, including sudden cardiac death due to unstable angina, myocardial infarction, and stroke. The model fit statistics such as area under the receiver-operating characteristic (AUROC), calibration chisquare and the overall bias were used to assess the model performance. We also tested the Framingham model for comparison. Seven hundred and five CVD events occurred during 49452.8 person-years of follow-up. The event probabilities were calculated and presented color-coded on each gender-specific PARS chart. The AUROC and Harrell's C indices were 0.74 (95% CI, 0.72-0.76) and 0.73, respectively. In the calibration, the Nam-D'Agostino chi(2) was 10.82 (p = 0.29). The overall bias of the proposed model was 95.60%. PARS model was also internally validated using cross-validation. The Android app and the Web-based risk assessment tool were also developed as to have an impact on public health. In comparison, the refitted and recalibrated Framingham models, estimated the CVD incidence with the overall bias of 149.60% and 128.23% for men, and 222.70% and 176.07% for women, respectively. In conclusion, the PARS risk assessment chart is a simple, accurate, and well calibrated tool for predicting a 10-year risk of CVD occurrence in Iranian population and can be used in an attempt to develop national guidelines for the CVD management.	[Sarrafzadegan, Nizal; Talaei, Mohammad; Sadeghi, Masoumeh; Roohafza, Hamid Reza] Isfahan Univ Med Sci, Cardiovasc Res Inst, Isfahan Cardiovasc Res Ctr, Esfahan, Iran; [Sarrafzadegan, Nizal] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Hassannejad, Razieh; Mansourian, Marjan] Isfahan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Esfahan, Iran; [Marateb, Hamid Reza; Mohebian, Mohammad Reza] Univ Isfahan, Engn Fac, Biomed Engn Dept, Esfahan, Iran; [Marateb, Hamid Reza; Mananas, Miquel Angel] Univ Politecn Cataluna, BarcelonaTech UPC, Biomed Engn Res Ctr, Dept Automat Control, Barcelona, Spain; [Talaei, Mohammad] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Masoudkabir, Farzad] Univ Tehran Med Sci, Tehran Heart Ctr, Sch Med, Dept Cardiol, Tehran, Iran; [Masoudkabir, Farzad] Univ Tehran Med Sci, Tehran Heart Ctr, Cardiac Primary Prevent Res Ctr, Tehran, Iran; [OveisGharan, Shahram] Univ Tehran Med Sci, Sch Med, Dept Neurol, Tehran, Iran; [OveisGharan, Shahram] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Mananas, Miquel Angel] CIBER BBN, Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona, Spain	Isfahan University Medical Science; University of British Columbia; Isfahan University Medical Science; University of Isfahan; Universitat Politecnica de Catalunya; National University of Singapore; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Rush University; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Mansourian, M (corresponding author), Isfahan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Esfahan, Iran.	j_mansourian@hlth.mui.ac.ir	Mañanas, Miguel Angel/AAI-2961-2021; Sadeghi, Masoumeh/AAU-8493-2021; Talaei, Mohammad/A-1819-2009; Mansourian, Marjan/AAX-1011-2020; Oveisgharan, Shahram/AAI-5971-2021; Marateb, Hamid Reza/G-5556-2013; Mansourian, Marjan/G-5564-2013; Hassannejad, Razieh/T-3202-2019	Sadeghi, Masoumeh/0000-0001-7179-5558; Talaei, Mohammad/0000-0002-6901-3665; Marateb, Hamid Reza/0000-0003-4408-2397; Mansourian, Marjan/0000-0003-4408-2397; Masoudkabir, Farzad/0000-0001-8098-7121; Hassannejad, Razieh/0000-0001-6905-2931; Mananas, Miguel Angel/0000-0001-9836-6083; Roohafza, Hamidreza/0000-0003-3582-0431; Mohebbian, MohammadReza/0000-0003-2645-4425; Mansourian, Marjan/0000-0002-7217-0282	ICS; People Programme (Marie Curie Actions) of the European Union Seventh Framework Programme (FP7) under REA grant [600388]; Agency for Business Competitiveness of the Government of Catalonia, ACCIO; Spanish Ministry of Economy and Competitiveness, Spain [DPI2014-59049-R];  [31309304]	ICS; People Programme (Marie Curie Actions) of the European Union Seventh Framework Programme (FP7) under REA grant; Agency for Business Competitiveness of the Government of Catalonia, ACCIO; Spanish Ministry of Economy and Competitiveness, Spain; 	The baseline survey was supported by the grant number 31309304. The undersecretary of research of the ministry of health and Isfahan cardiovascular research center, cardiovascular research institute affiliated to Isfahan University of Medical Sciences funded the ICS (NS). This work was also supported by the People Programme (Marie Curie Actions) of the European Union Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no. 600388 (TECNIOspring Programme), and from the Agency for Business Competitiveness of the Government of Catalonia, ACCIO (HRM). This work has been partially supported by the Spanish Ministry of Economy and Competitiveness, Spain (project DPI2014-59049-R) (MAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Bozorgmanesh M, 2011, INT J CLIN PRACT, V65, P264, DOI 10.1111/j.1742-1241.2010.02529.x; Bozorgmanesh M, 2011, EUR J PUBLIC HEALTH, V21, P554, DOI 10.1093/eurpub/ckq074; Bozorgmanesh M, 2010, INT J PUBLIC HEALTH, V55, P315, DOI 10.1007/s00038-010-0130-y; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chalmers J, 1999, CLIN EXP HYPERTENS, V21, P1009; Chow CK, 2009, J EPIDEMIOL COMMUN H, V63, P379, DOI 10.1136/jech.2008.077057; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cooper A, 2008, BRIT MED J, V336, P1246, DOI 10.1136/bmj.39554.624086.AD; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; D'Agostino RB, 2004, HANDB STAT, V23, P1; Friedmann PD, 1996, ANN INTERN MED, V124, P414, DOI 10.7326/0003-4819-124-4-199602150-00005; Goff JDC, 2014, J AM COLL CARDIOLOGY, V63; GOLDBOURT U, 1993, CARDIOLOGY, V82, P100, DOI 10.1159/000175862; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hajifathalian K, 2015, LANCET DIABETES ENDO, V3, P339, DOI 10.1016/S2213-8587(15)00081-9; Hense HW, 2003, EUR HEART J, V24, P937, DOI 10.1016/S0195-668X(03)00081-2; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Icaza G, 2009, REV MED CHILE, V137, P1273, DOI /S0034-98872009001000001; Jackson R, 2005, LANCET, V365, P434, DOI 10.1016/S0140-6736(05)17833-7; Jee SH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005025; Khalili D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105804; Khalili D, 2012, AM J EPIDEMIOL, V176, P177, DOI 10.1093/aje/kws204; Lee J, 2001, INT J EPIDEMIOL, V30, P983, DOI 10.1093/ije/30.5.983; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Masoudkabir F, 2012, INT J PUBLIC HEALTH, V57, P561, DOI 10.1007/s00038-012-0344-2; National CGCUK, 2014, LIP MOD CARD RISK AS; Nouri F, 2016, EUR J CLIN NUTR, V70, P217, DOI 10.1038/ejcn.2015.153; Onat A, 2012, NUTR METAB CARDIOVAS, V22, P643, DOI 10.1016/j.numecd.2010.10.010; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; PYORALA K, 1994, EUR HEART J, V15, P1300; Rogers R., 2009, ANDROID APPL DEV PRO; Sadeghi Masoumeh, 2014, Adv Biomed Res, V3, P242, DOI 10.4103/2277-9175.145749; Sarraf-Zadegan N, 2003, ACTA CARDIOL, V58, P309, DOI 10.2143/AC.58.4.2005288; Sarrafzadegan N, 2011, J HUM HYPERTENS, V25, P545, DOI 10.1038/jhh.2010.99; Sarrafzadegan N, 2008, INT J CARDIOL, V131, P90, DOI 10.1016/j.ijcard.2007.10.049; Sniderman AD, 2007, INT J EPIDEMIOL, V36, P220, DOI 10.1093/ije/dyl245; Spurlock J., 2013, BOOTSTRAP RESPONSIVE; Talaei M, 2013, ARCH IRAN MED, V16, P138, DOI 013163/AIM.004; Talaei M, 2012, INTERNAL MED, V51, P139, DOI 10.2169/internalmedicine.51.6132; Thomsen TF, 2002, INT J EPIDEMIOL, V31, P817, DOI 10.1093/ije/31.4.817; Ueda P, 2017, LANCET DIABETES ENDO, V5, P196, DOI 10.1016/S2213-8587(17)30015-3; Ueshima H, 2006, CIRC J, V70, P1249; Vasheghani-Farahani A, 2013, ATHEROSCLEROSIS, V227, P329, DOI 10.1016/j.atherosclerosis.2013.01.033; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167; World Health Organization, 2007, PREV CARD DIS GUID A, Vvi; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zambanini A, 1999, BMJ-BRIT MED J, V318, P1418, DOI 10.1136/bmj.318.7195.1418; Zhao D, 2015, NAT REV CARDIOL, V12, P301, DOI 10.1038/nrcardio.2015.28	53	14	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189389	10.1371/journal.pone.0189389	http://dx.doi.org/10.1371/journal.pone.0189389			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261727	Green Submitted, Green Published, gold			2022-12-26	WOS:000418554900017
J	Pandey, P; Kunwar, S; Sui, M; Bastola, S; Lee, J				Pandey, Puran; Kunwar, Sundar; Sui, Mao; Bastola, Sushil; Lee, Jihoon			Investigation on the morphological and optical evolution of bimetallic Pd-Ag nanoparticles on sapphire (0001) by the systematic control of composition, annealing temperature and time	PLOS ONE			English	Article							C-PLANE SAPPHIRE; ALLOY NANOPARTICLES; PALLADIUM NANOPARTICLES; AU; GOLD; NANOSTRUCTURES; GROWTH; ARRAYS; NANOCRYSTALS; PERFORMANCE	Multi-metallic alloy nanoparticles (NPs) can offer additional opportunities for modifying the electronic, optical and catalytic properties by the control of composition, configuration and size of individual nanostructures that are consisted of more than single element. In this paper, the fabrication of bimetallic Pd-Ag NPs is systematically demonstrated via the solid state dewetting of bilayer thin films on c-plane sapphire by governing the temperature, time as well as composition. The composition of Pd-Ag bilayer remarkably affects the morphology of alloy nanostructures, in which the higher Ag composition, i.e. Pd0.25Ag0.75, leads to the enhanced dewetting of bilayers whereas the higher Pd composition (Pd0.75Ag0.25) hinders the dewetting. Depending on the annealing temperature, Pd-Ag alloy nanostructures evolve with a series of configurations, i.e. nucleation of voids, porous network, elongated nanoclusters and round alloy NPs. In addition, with the annealing time set, the gradual configuration transformation from the elongated to round alloy NPs as well as size reduction is demonstrated due to the enhanced diffusion and sublimation of Ag atoms. The evolution of various morphology of Pd-Ag nanostructures is described based on the surface diffusion and inter-diffusion of Pd and Ag adatoms along with the Ag sublimation, Rayleigh instability and energy minimization mechanism. The reflectance spectra of bimetallic Pd-Ag nanostructures exhibit various quadrupolar and dipolar resonance peaks, peak shifts and absorption dips owing to the surface plasmon resonance of nanostructures depending on the surface morphology. The intensity of reflectance spectra is gradually decreased along with the surface coverage and NP size evolution. The absorption dips are red-shifted towards the longer wavelength for the larger alloy NPs and vice-versa.	[Pandey, Puran; Kunwar, Sundar; Sui, Mao; Bastola, Sushil; Lee, Jihoon] Kwangwoon Univ, Coll Elect & Informat, Seoul, South Korea; [Lee, Jihoon] Univ Arkansas, Inst Nanoscale Sci & Engn, Fayetteville, AR 72701 USA	Kwangwoon University; University of Arkansas System; University of Arkansas Fayetteville	Lee, J (corresponding author), Kwangwoon Univ, Coll Elect & Informat, Seoul, South Korea.; Lee, J (corresponding author), Univ Arkansas, Inst Nanoscale Sci & Engn, Fayetteville, AR 72701 USA.	jihoonleenano@gmail.com	/B-7688-2019; Pandey, Puran/AFR-7802-2022; KUNWAR, SUNDAR/AAD-1483-2020	/0000-0002-8768-8586; Pandey, Puran/0000-0002-4993-2066; Lee, Jihoon/0000-0002-0508-486X; Kunwar, Sundar/0000-0001-6289-6613	National Research Foundation of Korea [2011-0030079, 2016R1A1A1A05005009]; Kwangwoon University	National Research Foundation of Korea(National Research Foundation of Korea); Kwangwoon University	Financial support from the National Research Foundation of Korea (no. 2011-0030079 and 2016R1A1A1A05005009), and in part by the research grant of Kwangwoon University in 2017 is gratefully acknowledged.	Al-Azawi MA, 2016, SOL ENERGY, V126, P93, DOI 10.1016/j.solener.2015.12.043; Alfano B, 2017, SENSOR ACTUAT B-CHEM, V253, P1163, DOI 10.1016/j.snb.2017.07.146; Aouassa M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/6/063038; Bej A, 2016, RSC ADV, V6, P11446, DOI 10.1039/c5ra26304b; Beszeda I, 2005, APPL PHYS A-MATER, V81, P673, DOI 10.1007/s00339-005-3254-9; Choi JR, 2016, NANO CONVERG, V3, DOI 10.1186/s40580-016-0090-x; Danielson DT, 2006, J APPL PHYS, V100, DOI 10.1063/1.2357345; Farzinpour P, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/49/495604; Feng JW, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.115423; Ge LP, 2014, INT J NANOMED, V9, P2399, DOI 10.2147/IJN.S55015; Giermann AL, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1885180; Goswami A, 2016, SUPERLATTICE MICROST, V91, P252, DOI 10.1016/j.spmi.2016.01.016; Hansen KH, 1999, PHYS REV LETT, V83, P4120, DOI 10.1103/PhysRevLett.83.4120; Jiang TT, 2015, NANOSCALE, V7, P209, DOI 10.1039/c4nr05905k; Kang M, 2017, ACS APPL MATER INTER, V9, P37154, DOI 10.1021/acsami.7b10715; Kunwar S, 2017, PHYS CHEM CHEM PHYS, V19, P15084, DOI 10.1039/c7cp01410d; Leong KH, 2015, BEILSTEIN J NANOTECH, V6, P428, DOI 10.3762/bjnano.6.43; Liu XJ, 2016, SOL ENERG MAT SOL C, V147, P225, DOI 10.1016/j.solmat.2015.12.004; Minamide Y, 2009, VACUUM, V84, P657, DOI 10.1016/j.vacuum.2009.06.015; Mishra YK, 2007, J OPT A-PURE APPL OP, V9, pS410, DOI 10.1088/1464-4258/9/9/S21; Mishra YK, 2007, J NANOSCI NANOTECHNO, V7, P1878, DOI 10.1166/jnn.2007.734; Mishra YK, 2013, PLASMONICS, V8, P811, DOI 10.1007/s11468-013-9477-2; Muller S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.165502; Nanda KK, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.013208; Ojo SA, 2016, IEEE T NANOBIOSCI, V15, P433, DOI 10.1109/TNB.2016.2559161; Pandey P, 2017, PHYS STATUS SOLIDI A, V214, DOI 10.1002/pssa.201600702; Pandey P, 2015, RSC ADV, V5, P66212, DOI 10.1039/c5ra07631e; Ren XL, 2005, SENSOR ACTUAT B-CHEM, V110, P358, DOI 10.1016/j.snb.2005.02.016; Rogers SM, 2017, ACS CATAL, V7, P2266, DOI 10.1021/acscatal.6b03190; Rout L, 2016, RSC ADV, V6, P49923, DOI 10.1039/c6ra04569c; Ruffino F, 2014, J APPL PHYS, V115, DOI 10.1063/1.4866876; Ruffino F, 2013, APPL SURF SCI, V270, P697, DOI 10.1016/j.apsusc.2013.01.130; Ruffino F, 2017, METALS-BASEL, V7, DOI 10.3390/met7090327; Ruffino F, 2014, J MATER SCI, V49, P5714, DOI 10.1007/s10853-014-8290-4; Sarina S, 2013, J AM CHEM SOC, V135, P5793, DOI 10.1021/ja400527a; Seo O, 2016, J ALLOY COMPD, V667, P141, DOI 10.1016/j.jallcom.2016.01.111; Sharma M, 2014, ACS APPL MATER INTER, V6, P15472, DOI 10.1021/am5040939; SHARMA SK, 1980, THIN SOLID FILMS, V65, P339, DOI 10.1016/0040-6090(80)90244-8; Sui M, 2016, SUPERLATTICE MICROST, V100, P1128, DOI 10.1016/j.spmi.2016.10.083; Sui M, 2017, APPL SURF SCI, V416, P1, DOI 10.1016/j.apsusc.2017.04.144; Thouti E, 2013, J OPTICS-UK, V15, DOI 10.1088/2040-8978/15/3/035005; Trung DB, 2017, CATALYSTS, V7, DOI 10.3390/catal7070207; Verma P, 2016, J MATER CHEM A, V4, P10142, DOI 10.1039/c6ta01664b; Wang D, 2011, BEILSTEIN J NANOTECH, V2, P318, DOI 10.3762/bjnano.2.37	44	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189823	10.1371/journal.pone.0189823	http://dx.doi.org/10.1371/journal.pone.0189823			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253017	Green Published, Green Submitted, gold			2022-12-26	WOS:000418389500065
J	Li, ST; Wang, N; Xu, XX; Fujita, M; Nakanishi, H; Kitajima, T; Dean, N; Gao, XD				Li, Sheng-Tao; Wang, Ning; Xu, Xin-Xin; Fujita, Morihisa; Nakanishi, Hideki; Kitajima, Toshihiko; Dean, Neta; Gao, Xiao-Dong			Alternative routes for synthesis of N-linked glycans by Alg2 mannosyltransferase	FASEB JOURNAL			English	Article						N-glycosylation; lipid-linked oligosaccharide; LC-MS	2 ACTIVE-SITES; SACCHAROMYCES-CEREVISIAE; BIOCHEMICAL-CHARACTERIZATION; CONFORMATIONAL-CHANGES; HYALURONAN SYNTHASE; LIPID-COMPOSITION; AMINO-ACIDS; IDENTIFICATION; GLYCOSYLATION; MUTATIONS	Asparagine (N)-linked glycosylation requires the ordered, stepwise synthesis of lipid-linked oligosaccharide (LLO) precursor Glc(3)Man(9)GlcNAc(2)-pyrophosphate-dolichol (G1c(3)Man(9)Gn(2)-PDol) on the endoplasmic reticulum. The fourth and fifth steps of LLO synthesis are catalyzed by Alg2, an unusual mannosyltransferase (MTase) with two different MTase activities; Alg2 adds both an alpha 1,3- and alpha 1,6-mannose onto ManG1cNAc(2)-PDol to form the trimannosyl core Man(3)G1cNAc(2)-PDol. The biochemical properties of Alg2 are controversial and remain undefined. In this study, a liquid chromatography/mass spectrometry-based quantitative assay was established and used to analyze the MTase activities of purified yeast Alg2. Alg2-dependent Man(3)G1cNAc(2)-PDol production relied on net-neutral lipids with a propensity to form bilayers. We further showed addition of the alpha 1,3- and alpha 1,6-mannose can occur independently in either order but at differing rates. The conserved C-terminal EX7E motif, N-terminal cytosolic tail, and 3 G-rich loop motifs in Alg2 play crucial roles for these activities, both in vitro and in vivo. These findings provide insight into the unique bifunctionality of Alg2 during LLO synthesis and lead to a new model in which alternative, independent routes exist for Alg2 catalysis of the trimannosyl core oligosaccharide.	[Li, Sheng-Tao; Wang, Ning; Xu, Xin-Xin; Fujita, Morihisa; Nakanishi, Hideki; Kitajima, Toshihiko; Gao, Xiao-Dong] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi, Peoples R China; [Dean, Neta] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Jiangnan University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Dean, N (corresponding author), SUNY Stony Brook, Stony Brook, NY 11794 USA.; Gao, XD (corresponding author), Jiangnan Univ, 1800 Lihu Ave, Wuxi 214122, Peoples R China.	neta.dean@stonybrook.edu; xdgao@jiangnan.edu.cn	Kitajima, Toshihiko/D-2463-2016; Fujita, Morihisa/AAM-4142-2020	Kitajima, Toshihiko/0000-0001-9677-5086; Wang, Ning/0000-0001-5287-5755	National Natural Science Foundation of China [21778023, 21576118, 31770853, 31400693]; Natural Science Foundation of Jiangsu Province [BK20170174]; Fundamental Research Funds for the Central Universities [JUSRP51629B, JUSRP11727]; Program of Introducing Talents of Discipline to Universities [111-2-06]; Young Thousand Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); Young Thousand Program	This work was supported by grants-in-aid from the National Natural Science Foundation of China (21778023, 21576118, 31770853, 31400693), Natural Science Foundation of Jiangsu Province (BK20170174), Fundamental Research Funds for the Central Universities (JUSRP51629B, JUSRP11727), Program of Introducing Talents of Discipline to Universities (111-2-06), and Young Thousand Program (to M.F.). The authors declare no conflicts of interest.	Abdian PL, 2000, J BIOL CHEM, V275, P40568, DOI 10.1074/jbc.M007496200; Absmanner B, 2010, BIOCHEM J, V426, P205, DOI 10.1042/BJ20091121; Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Agasoster AV, 2003, J BIOL CHEM, V278, P21790, DOI 10.1074/jbc.M211466200; Albesa-Jove D, 2014, GLYCOBIOLOGY, V24, P108, DOI 10.1093/glycob/cwt101; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; CHIRALA SS, 1987, J BIOL CHEM, V262, P4231; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; Cossins J, 2013, BRAIN, V136, P944, DOI 10.1093/brain/awt010; Dowhan W, 2012, BBA-BIOMEMBRANES, V1818, P1097, DOI 10.1016/j.bbamem.2011.09.013; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Geremia RA, 1996, BIOCHEM J, V318, P133, DOI 10.1042/bj3180133; Giganti D, 2013, J BIOL CHEM, V288, P29797, DOI 10.1074/jbc.M113.462705; Guthrie C., 2002, GUIDE YEAST GENETICS; Harada Y, 2013, P NATL ACAD SCI USA, V110, P19366, DOI 10.1073/pnas.1312187110; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang YC, 2016, PLANT MOL BIOL, V90, P127, DOI 10.1007/s11103-015-0401-3; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; JACKSON BJ, 1993, GLYCOBIOLOGY, V3, P357, DOI 10.1093/glycob/3.4.357; JACKSON BJ, 1989, ARCH BIOCHEM BIOPHYS, V272, P203, DOI 10.1016/0003-9861(89)90211-7; Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883; Jing W, 2003, GLYCOBIOLOGY, V13, P661, DOI 10.1093/glycob/cwg085; Kampf M, 2009, J BIOL CHEM, V284, P11900, DOI 10.1074/jbc.M806416200; Kapitonov D, 1999, GLYCOBIOLOGY, V9, P961, DOI 10.1093/glycob/9.10.961; Kirsch T, 1997, BIOCHEMISTRY-US, V36, P3359, DOI 10.1021/bi9626867; Kostova Z, 2003, EUR J BIOCHEM, V270, P4507, DOI 10.1046/j.1432-1033.2003.03844.x; Li ST, 2017, BBA-GEN SUBJECTS, V1861, P2934, DOI 10.1016/j.bbagen.2016.09.023; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu JS, 2012, GLYCOBIOLOGY, V22, P504, DOI 10.1093/glycob/cwr162; O'Reilly MK, 2006, BIOCHEMISTRY-US, V45, P9593, DOI 10.1021/bi060878o; Pabst M, 2008, ANAL CHEM, V80, P7534, DOI 10.1021/ac801024r; PRAKASH C, 1982, BIOCHEMISTRY-US, V21, P4810, DOI 10.1021/bi00262a045; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; QURESHI AA, 1994, J CLIN INVEST, V93, P1812, DOI 10.1172/JCI117166; Ramirez AS, 2017, GLYCOBIOLOGY, V27, P726, DOI 10.1093/glycob/cwx045; Satoh T, 2015, MOLECULES, V20, P2475, DOI 10.3390/molecules20022475; Schmaltz RM, 2011, CHEM REV, V111, P4259, DOI 10.1021/cr200113w; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; Takeuchi K, 1999, GLYCOBIOLOGY, V9, P1287, DOI 10.1093/glycob/9.12.1287; Thiel C, 2003, J BIOL CHEM, V278, P22498, DOI 10.1074/jbc.M302850200; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; van der Wel H, 2002, J BIOL CHEM, V277, P46527, DOI 10.1074/jbc.M208824200; Vitrac H, 2013, J BIOL CHEM, V288, P5873, DOI 10.1074/jbc.M112.442988; Wu R, 2015, J BACTERIOL, V197, P2734, DOI 10.1128/JB.00110-15	51	11	14	1	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2492	2506		10.1096/fj.201701267R	http://dx.doi.org/10.1096/fj.201701267R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29273674				2022-12-26	WOS:000432528000015
J	Sones, JL; Merriam, AA; Seffens, A; Brown-Grant, DA; Butler, SD; Zhao, AM; Xu, XJ; Shawber, CJ; Grenier, JK; Douglas, NC				Sones, Jennifer L.; Merriam, Audrey A.; Seffens, Angelina; Brown-Grant, Dex-Ann; Butler, Scott D.; Zhao, Anna M.; Xu, Xinjing; Shawber, Carrie J.; Grenier, Jennifer K.; Douglas, Nataki C.			Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia	FASEB JOURNAL			English	Article						decidual vasculature; VEGF; sFlt-1; RGC32; implantation; trophoblast	SYSTEMS ACTIVATION FACTORS; GROWTH-FACTOR; MOUSE MODEL; TYROSINE KINASE-1; PREGNANCY LOSS; EXPRESSION; ONSET; HYPERTENSION; TROPHOBLAST; PROTEINURIA	Preeclampsia (PE), a hypertensive disorder of pregnancy, is a leading cause of maternal and fetal morbidity and mortality. Although the etiology is unknown, PE is thought to be caused by defective implantation and decidualization in pregnancy. Pregnant blood pressure high (BPH)/5 mice spontaneously develop placentopathies and maternal features of human PE. We hypothesized that BPH/5 implantation sites have transcriptomic alterations. Next-generation RNA sequencing of implantation sites at peak decidualization, embryonic day (E)7.5, revealed complement gene up-regulation in BPH/5 vs. controls. In BPH/5, expression of complement factor 3 was increased around the decidual vasculature of E7.5 implantation sites and in the trophoblast giant cell layer of E10.5 placentae. Altered expression of VEGF pathway genes in E5.5 BPH/5 implantation sites preceded complement dysregulation, which correlated with abnormal vasculature and increased placental growth factor mRNA and VEGF(164) expression at E7.5. By E10.5, proangiogenic genes were down-regulated, whereas antiangiogenic sFlt-1 was up-regulated in BPH/5 placentae. We found that early local misexpression of VEGF genes and abnormal decidual vasculature preceded sFlt-1 overexpression and increased complement deposition in BPH/5 placentae. Our findings suggest that abnormal decidual angiogenesis precedes complement activation, which in turn contributes to the aberrant trophoblast invasion and poor placentation that underlie PE.	[Sones, Jennifer L.] Louisiana State Univ, Sch Vet Med, Vet Clin Sci, Baton Rouge, LA 70803 USA; [Merriam, Audrey A.; Seffens, Angelina; Brown-Grant, Dex-Ann; Zhao, Anna M.; Xu, Xinjing; Shawber, Carrie J.; Douglas, Nataki C.] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, Div Reprod Sci, 622 West 168th St,P&S 16-440, New York, NY 10032 USA; [Butler, Scott D.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Grenier, Jennifer K.] Cornell Univ, Coll Vet Med, RNA Sequencing Core, Ctr Reprod Gen,Dept Biomed Sci, Ithaca, NY 14853 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Columbia University; Cornell University; Cornell University	Douglas, NC (corresponding author), Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, Div Reprod Sci, 622 West 168th St,P&S 16-440, New York, NY 10032 USA.	nd2058@cumc.columbia.edu		Douglas, Nataki/0000-0001-8443-8875	U.S. National Institutes of Health (NIH) National Heart Lung and Blood Institute Grant [1R01HL127013-01A1]; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [P50-HD076210]; NIH National Cancer Institute Grant [P30 CA013696]; NIH National Center for Research Resources Grant [S10 RR025686]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD076210] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA013696] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025686] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127013] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart Lung and Blood Institute Grant; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; NIH National Cancer Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Center for Research Resources Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Robin L. Davisson for the generous gift of BPH/5 mice and additional support; Michelle A. Hoch for assistance with data analysis; Jan K. Kitajewski and Virginia E. Papaioannou for in-depth discussions and assistance with manuscript editing; and Theresa Swayne and Emilia Laura Munteanu for technical assistance with confocal microscopy. This work was supported by U.S. National Institutes of Health (NIH) National Heart Lung and Blood Institute Grant 1R01HL127013-01A1 (to N.C.D) and NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant P50-HD076210 (to J.L.S. and J.K.G.). Immunofluorescence images were collected in the Confocal and Specialized Microscopy Shared Resource of the Herbert Irving Comprehensive Cancer Center at Columbia University (New York, NY, USA), supported by NIH National Cancer Institute Grant P30 CA013696. The confocal microscope was purchased with NIH National Center for Research Resources Grant S10 RR025686. The authors declare no conflicts of interest.	Burwick RM, 2013, PLACENTA, V34, P201, DOI 10.1016/j.placenta.2012.11.014; Burwick RM, 2013, HYPERTENSION, V62, P1040, DOI 10.1161/HYPERTENSIONAHA.113.01420; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chang YS, 2017, PEDIATR NEONATOL, V58, P529, DOI 10.1016/j.pedneo.2016.10.005; Chen CW, 2014, CARDIOVASC RES, V101, P579, DOI 10.1093/cvr/cvu018; Chu A, 2016, NUTR RES, V36, P1055, DOI 10.1016/j.nutres.2016.08.001; Cui XB, 2013, CARDIOVASC RES, V99, P632, DOI 10.1093/cvr/cvt121; Daikoku T, 2003, J BIOL CHEM, V278, P7683, DOI 10.1074/jbc.M211390200; Davisson RL, 2002, HYPERTENSION, V39, P337, DOI 10.1161/hy02t2.102904; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dokras A, 2006, BIOL REPROD, V75, P899, DOI 10.1095/biolreprod.106.053603; Douglas NC, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-16; Douglas NC, 2009, REPROD BIOMED ONLINE, V19, P257, DOI 10.1016/S1472-6483(10)60082-X; Douglas NC, 2009, ENDOCRINOLOGY, V150, P3845, DOI 10.1210/en.2008-1207; Droge LA, 2017, PREGNANCY HYPERTENS, V8, P31, DOI 10.1016/j.preghy.2017.02.005; Fan XJ, 2014, J CLIN INVEST, V124, P4941, DOI 10.1172/JCI76864; Gelber SE, 2015, J IMMUNOL, V195, P1129, DOI 10.4049/jimmunol.1402220; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Halder JB, 2000, GENESIS, V26, P213, DOI 10.1002/(SICI)1526-968X(200003)26:3<213::AID-GENE7>3.0.CO;2-M; Hazarika S, 2007, CIRC RES, V101, P948, DOI 10.1161/CIRCRESAHA.107.160630; He YD, 2016, HYPERTENS PREGNANCY, V35, P499, DOI 10.1080/10641955.2016.1190845; He YD, 2016, AM J REPROD IMMUNOL, V76, P205, DOI 10.1111/aji.12541; Heyward CY, 2017, J REPROD IMMUNOL, V120, P27, DOI 10.1016/j.jri.2017.04.002; Hoffmann DS, 2008, HYPERTENSION, V51, P1058, DOI 10.1161/HYPERTENSIONAHA.107.107219; Huckle WR, 2004, J CELL BIOCHEM, V93, P120, DOI 10.1002/jcb.20142; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim M, 2013, EMBO MOL MED, V5, P1415, DOI 10.1002/emmm.201302618; Lacko LA, 2014, MECH DEVELOP, V133, P163, DOI 10.1016/j.mod.2014.04.001; Levin HI, 2017, PLACENTA, V55, P5, DOI 10.1016/j.placenta.2017.04.014; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lokki AI, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00312; Lynch AM, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.035; Lynch AM, 2011, OBSTET GYNECOL, V117, P75, DOI 10.1097/AOG.0b013e3181fc3afa; Lynch AM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.044; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Oatley MJ, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.139832; Qing XP, 2011, KIDNEY INT, V79, P331, DOI 10.1038/ki.2010.393; Rampersad R, 2008, PLACENTA, V29, P855, DOI 10.1016/j.placenta.2008.07.008; Redman CWG, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.003; Regal JF, 2015, MOL IMMUNOL, V67, P56, DOI 10.1016/j.molimm.2015.02.030; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Rupprecht TA, 2007, J IMMUNOL, V178, P1861, DOI 10.4049/jimmunol.178.3.1861; SCHLAGER G, 1974, GENETICS, V76, P537; Singh J, 2011, HYPERTENSION, V58, P716, DOI 10.1161/HYPERTENSIONAHA.111.175919; Sones JL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.75351; Sones JL, 2014, AM J PHYSIOL-REG I, V307, pR490, DOI 10.1152/ajpregu.00176.2014; Sovio U, 2017, HYPERTENSION, V69, P731, DOI 10.1161/HYPERTENSIONAHA.116.08620; Spradley FT, 2015, AM J PHYSIOL-REG I, V309, pR1326, DOI 10.1152/ajpregu.00178.2015; Spradley FT, 2015, BIOMOLECULES, V5, P3142, DOI 10.3390/biom5043142; Sutton EF, 2017, AM J PHYSIOL-REG I, V312, pR485, DOI 10.1152/ajpregu.00512.2016; Szalai G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110867; Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244; Thurman JM, 2005, MOL IMMUNOL, V42, P87, DOI 10.1016/j.molimm.2004.07.043; Tidwell SC, 2001, AM J OBSTET GYNECOL, V184, P1267, DOI 10.1067/mob.2001.113129; Tomimatsu T, 2017, HYPERTENS RES, V40, P305, DOI 10.1038/hr.2016.152; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Triunfo S, 2016, PLACENTA, V42, P44, DOI 10.1016/j.placenta.2016.04.005; Vlaicu SI, 2008, ARCH IMMUNOL THER EX, V56, P115, DOI 10.1007/s00005-008-0016-3; Vorontchikhina MA, 2005, GENE EXPR PATTERNS, V5, P701, DOI 10.1016/j.modgep.2005.02.001; Vrachnis N, 2013, J MATERN-FETAL NEO M, V26, P995, DOI 10.3109/14767058.2013.766694; Wang QJ, 2015, PLACENTA, V36, P350, DOI 10.1016/j.placenta.2014.12.012; Wang W, 2012, HYPERTENSION, V60, P712, DOI 10.1161/HYPERTENSIONAHA.112.191817; Woods AK, 2011, HYPERTENSION, V57, P94, DOI 10.1161/HYPERTENSIONAHA.110.160242; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Young CN, 2012, J CLIN INVEST, V122, P3960, DOI 10.1172/JCI64583; Zou L, 2016, J IMMUNOL, V196, P2788, DOI 10.4049/jimmunol.1502106	70	28	29	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2574	2586		10.1096/fj.201701008R	http://dx.doi.org/10.1096/fj.201701008R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29279353	Green Published			2022-12-26	WOS:000432528000022
J	Li, H; Wang, Z; Li, YH; Fang, RP; Wang, HW; Shi, H; Zhang, XD; Zhang, WY; Ye, LH				Li, Hang; Wang, Zhen; Li, Yinghui; Fang, Runping; Wang, Huawei; Shi, Hui; Zhang, Xiaodong; Zhang, Weiying; Ye, Lihong			Hepatitis B X-interacting protein promotes the formation of the insulin gene-transcribing protein complex Pdx-1/Neurod1 in animal pancreatic beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell; glucose; insulin; pancreas; transcription co-activator; transcription regulation; HBXIP; Neurod1; PDX-1	BREAST-CANCER CELLS; ISLET AMYLOID POLYPEPTIDE; CRE RECOMBINASE; TRANSCRIPTIONAL ACTIVATION; DIABETES-MELLITUS; INS-1 CELLS; HBXIP; PDX-1; EXPRESSION; SECRETION	The activation of insulin gene transcription depends on multiple nuclear proteins, including the transcription factors PDX-1 and NEUROD1, which form a transcriptional complex. We recently reported that hepatitis B X-interacting protein (HBXIP, also termed LAMTOR5) can modulate glucose metabolism reprogramming in cancer cells. However, the physiological role of HBXIP in the modulation of glucose metabolism in normal tissues is poorly understood. Here, we report that Hbxip is an essential regulator of the effect of the Pdx-1/Neurod1 complex on insulin gene transcription in murine pancreatic -cells in vitro and in vivo. We found that pancreatic -cell-specific Hbxip-knockout mice displayed higher fasting blood glucose levels and impaired glucose tolerance. Furthermore, Hbxip was involved in the regulation of insulin in the pancreas islets and increased insulin gene expression in rat pancreatic -cells. Mechanistically, Hbxip stimulated insulin enhancer activity by interacting with Pdx-1 and recruiting Neurod1 to Pdx-1. Functionally, we provide evidence that Hbxip is required for Pdx-1/Neurod1-mediated insulin expression in rat pancreatic -cells. Collectively, these results indicate that Hbxip is involved in the transcription of insulin by increasing the levels of the Pdx-1/Neurod1 complex in animal pancreatic -cells. Our finding provides the insight into the mechanism by which Hbxip stimulates the transcription of the insulin gene.	[Li, Hang; Wang, Zhen; Li, Yinghui; Fang, Runping; Wang, Huawei; Shi, Hui; Zhang, Weiying; Ye, Lihong] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Dept Biochem, Tianjin 300071, Peoples R China; [Zhang, Xiaodong] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Dept Canc Res, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhang, WY; Ye, LH (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Dept Biochem, Tianjin 300071, Peoples R China.	zhwybao@nankai.edu.cn; yelihong@nankai.edu.cn	Fang, Runping/AAF-6835-2020		National Basic Research Program of China [2015CB553905]; National Natural Scientific Foundation of China [81372186, 31670771]; Fundamental Research Funds for the Central Universities, Project of Prevention and Control of Key Chronic Non-Infectious Diseases [2016YFC1303401]	National Basic Research Program of China(National Basic Research Program of China); National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, Project of Prevention and Control of Key Chronic Non-Infectious Diseases	This work was supported by National Basic Research Program of China Grant 973 Program No. 2015CB553905, National Natural Scientific Foundation of China Grants 81372186 and 31670771, and the Fundamental Research Funds for the Central Universities, Project of Prevention and Control of Key Chronic Non-Infectious Diseases Grant 2016YFC1303401. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad A, 2016, J CLIN RES PEDIATR E, V8, P270, DOI 10.4274/jcrpe.2819; Alcarraz-Vizan G, 2017, CELL MOL LIFE SCI, V74, P2827, DOI 10.1007/s00018-017-2505-1; Arcidiacono B, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00237; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Bordone Laura, 2015, PLoS Biol, V13, pe1002346, DOI 10.1371/journal.pbio.1002346; BRUN T, 1993, J BIOL CHEM, V268, P18905; Chen F, 2016, DIABETOLOGIA, V59, P316, DOI 10.1007/s00125-015-3805-3; Chen H, 2012, J MOL CELL BIOL, V4, P256, DOI 10.1093/jmcb/mjs032; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Fan BS, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00079; Foti D, 2005, NAT MED, V11, P765, DOI 10.1038/nm1254; Furukawa N, 1999, ENDOCR J, V46, P43, DOI 10.1507/endocrj.46.43; Guo QS, 2012, EXP DIABETES RES, DOI 10.1155/2012/672013; Hambrock A, 2007, J BIOL CHEM, V282, P3347, DOI 10.1074/jbc.M608216200; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Huang P, 2011, CANCER RES, V71, P2938, DOI 10.1158/0008-5472.CAN-10-3524; Hui HX, 2002, EUR J ENDOCRINOL, V146, P129, DOI 10.1530/eje.0.1460129; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Jin J, 2013, BIOCHEM BIOPH RES CO, V430, P1228, DOI 10.1016/j.bbrc.2012.12.071; Josefsen K, 1996, J ENDOCRINOL, V149, P145, DOI 10.1677/joe.0.1490145; Keller DM, 2007, J BIOL CHEM, V282, P32084, DOI 10.1074/jbc.M700899200; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Lee YS, 2013, CELL, V153, P413, DOI 10.1016/j.cell.2013.03.001; Li CR, 2012, J MOL CELL BIOL, V4, P38, DOI 10.1093/jmcb/mjr040; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Li H, 2015, J BIOL CHEM, V290, P22649, DOI 10.1074/jbc.M115.658468; Li HY, 2014, EMBO REP, V15, P714, DOI 10.1002/embr.201338181; Li YH, 2016, CANCER RES, V76, P293, DOI 10.1158/0008-5472.CAN-14-3607; Liu FB, 2015, ONCOTARGET, V6, P27199, DOI 10.18632/oncotarget.4508; Liu Q, 2013, INT J CANCER, V133, P1310, DOI 10.1002/ijc.28154; Liu SP, 2012, J BIOL CHEM, V287, P30228, DOI 10.1074/jbc.M112.343947; Liu XD, 2014, MOL CELL BIOCHEM, V394, P59, DOI 10.1007/s11010-014-2081-8; Marchetti L, 2016, SCI REP-UK, V6, DOI 10.1038/srep36029; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Meinke G, 2016, CHEM REV, V116, P12785, DOI 10.1021/acs.chemrev.6b00077; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Merino B, 2015, SCI REP-UK, V5, DOI 10.1038/srep11622; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nomoto H, 2015, ENDOCRINOLOGY, V156, P3570, DOI 10.1210/en.2014-1906; Ohneda K, 2000, MOL CELL BIOL, V20, P900, DOI 10.1128/MCB.20.3.900-911.2000; Ozcan L, 2013, CELL METAB, V18, P803, DOI 10.1016/j.cmet.2013.10.011; Peng Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029437; Pomplun D, 2007, HORM METAB RES, V39, P336, DOI 10.1055/s-2007-976538; Qiu Y, 2002, MOL CELL BIOL, V22, P412, DOI 10.1128/MCB.22.2.412-420.2002; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Shao SY, 2010, J CELL BIOCHEM, V111, P634, DOI 10.1002/jcb.22750; Shi H, 2016, CANCER LETT, V382, P147, DOI 10.1016/j.canlet.2016.08.025; Skelin M, 2010, ALTEX-ALTERN ANIM EX, V27, P105; Sun Y, 2008, ENDOCRINOLOGY, V149, P662, DOI 10.1210/en.2007-1275; Vikis Haris G, 2004, Methods Mol Biol, V261, P175; Xu FQ, 2014, INT J ONCOL, V45, P255, DOI 10.3892/ijo.2014.2411; Zhang YY, 2013, J BIOL CHEM, V288, P18961, DOI 10.1074/jbc.M113.458638; Zhao Y, 2016, CANCER RES, V76, P4696, DOI 10.1158/0008-5472.CAN-15-1734	56	6	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2053	2065		10.1074/jbc.M117.809582	http://dx.doi.org/10.1074/jbc.M117.809582			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29259128	Green Published, hybrid			2022-12-26	WOS:000424948000018
J	Choi, JY; Surovtseva, YV; Sickle, SM; Kumpf, J; Bunz, UHF; Ben Mamoun, C; Voelker, DR				Choi, Jae-Yeon; Surovtseva, Yulia V.; Van Sickle, Sam M.; Kumpf, Jan; Bunz, Uwe H. F.; Ben Mamoun, Choukri; Voelker, Dennis R.			A novel fluorescence assay for measuring phosphatidylserine decarboxylase catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phospholipid; phosphatidylserine decarboxylase; membrane biogenesis; inhibitor; fluorescence; inhibitor screening	SACCHAROMYCES-CEREVISIAE; PLASMODIUM-FALCIPARUM; ESCHERICHIA-COLI; TOXOPLASMA-GONDII; MEMBRANE-LIPIDS; MITOCHONDRIA; YEAST; GENE; COMPLEMENTATION; IDENTIFICATION	Phosphatidylserine decarboxylases (PSDs) are central enzymes in phospholipid metabolism that produce phosphatidylethanolamine (PE) in bacteria, protists, plants, and animals. We developed a fluorescence-based assay for selectively monitoring production of PE in reactions using a maltose-binding protein fusion with Plasmodium knowlesi PSD (MBP-His(6)-34PkPSD) as the enzyme. The PE detection by fluorescence ((ex) = 403 nm, (em) = 508 nm) occurred after the lipid reacted with a water-soluble distyrylbenzene-bis-aldehyde (DSB-3), and provided strong discrimination against the phosphatidylserine substrate. The reaction conditions were optimized for enzyme, substrate, product, and DSB-3 concentrations with the purified enzyme and also tested with crude extracts and membrane fractions from bacteria and yeast. The assay is readily amenable to application in 96- and 384-well microtiter plates and should prove useful for high-throughput screening for inhibitors of PSD enzymes across diverse phyla.	[Choi, Jae-Yeon; Van Sickle, Sam M.; Voelker, Dennis R.] Natl Jewish Hlth, Dept Med, Basic Sci Sect, Denver, CO 80206 USA; [Surovtseva, Yulia V.] Yale Ctr Mol Discovery, West Haven, CT 06516 USA; [Ben Mamoun, Choukri] Yale Sch Med, Infect Dis Sect, Dept Internal Med, New Haven, CT 06520 USA; [Kumpf, Jan; Bunz, Uwe H. F.] Ruprecht Karls Univ Heidelberg, Inst Organ Chem, Neuenheimer Feld 270, D-69120 Heidelberg, Germany	National Jewish Health; Yale University; Ruprecht Karls University Heidelberg	Voelker, DR (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	voelkerd@njhealth.org			National Institutes of Health [GM104485, AI097218]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM104485 (to D.R.V.) and AI097218 (to C.B.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baunaure F, 2004, MOL MICROBIOL, V51, P33, DOI 10.1046/j.1365-2958.2003.03822.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bobenchik AM, 2013, P NATL ACAD SCI USA, V110, P18262, DOI 10.1073/pnas.1313965110; BOGGS KP, 1995, J BIOL CHEM, V270, P7757, DOI 10.1074/jbc.270.13.7757; BORCH RF, 1971, J AM CHEM SOC, V93, P2897, DOI 10.1021/ja00741a013; Choi JY, 2016, MOL MICROBIOL, V99, P999, DOI 10.1111/mmi.13280; Choi JY, 2015, J BIOL CHEM, V290, P10972, DOI 10.1074/jbc.M115.642413; Choi JY, 2012, J BIOL CHEM, V287, P222, DOI 10.1074/jbc.M111.313676; Choi JY, 2005, ANAL BIOCHEM, V347, P165, DOI 10.1016/j.ab.2005.03.017; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; DENNIS EA, 1972, J LIPID RES, V13, P263; Garg A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09064; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Gonzalez-Bulnes P, 2011, J BIOL CHEM, V286, P28940, DOI 10.1074/jbc.M111.268946; Gupta N, 2012, J BIOL CHEM, V287, P22938, DOI 10.1074/jbc.M112.373639; Hartmann A, 2014, J BIOL CHEM, V289, P6809, DOI 10.1074/jbc.M113.509406; HAWROT E, 1975, P NATL ACAD SCI USA, V72, P1112, DOI 10.1073/pnas.72.3.1112; HAWROT E, 1978, J BIOL CHEM, V253, P8213; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; KANFER J, 1964, J BIOL CHEM, V239, P1720; KUGE O, 1991, J BIOL CHEM, V266, P6370; Kumpf J, 2015, ANALYST, V140, P3136, DOI [10.1039/C5AN00155B, 10.1039/c5an00155b]; Kumpf J, 2012, CHEM-EUR J, V18, P8921, DOI 10.1002/chem.201200930; Nerlich A, 2007, PLANT PHYSIOL, V144, P904, DOI 10.1104/pp.107.095414; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Rontein D, 2003, PLANT PHYSIOL, V132, P1678, DOI 10.1104/pp.103.023242; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Schumacher MM, 2002, J BIOL CHEM, V277, P51033, DOI 10.1074/jbc.M205301200; Smithson DC, 2010, ASSAY DRUG DEV TECHN, V8, P175, DOI 10.1089/adt.2009.0249; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VANGOLDE LM, 1974, BIOCHIM BIOPHYS ACTA, V360, P179, DOI 10.1016/0005-2760(74)90168-4; VOELKER DR, 1991, J BIOL CHEM, V266, P12185; VOELKER DR, 1989, P NATL ACAD SCI USA, V86, P9921, DOI 10.1073/pnas.86.24.9921; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	37	6	6	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1493	1503		10.1074/jbc.RA117.000525	http://dx.doi.org/10.1074/jbc.RA117.000525			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29247006	hybrid, Green Published			2022-12-26	WOS:000424201700001
J	Perez-Peinado, C; Dias, SA; Domingues, MM; Benfield, AH; Freire, JM; Radis-Baptista, G; Gaspar, D; Castanho, MARB; Craik, DJ; Henriques, ST; Veiga, AS; Andreu, D				Perez-Peinado, Clara; Dias, Susana Almeida; Domingues, Marco M.; Benfield, Aurelie H.; Freire, Joao Miguel; Radis-Baptista, Gandhi; Gaspar, Diana; Castanho, Miguel A. R. B.; Craik, David J.; Henriques, Sonia Troeira; Veiga, Ana Salome; Andreu, David			Mechanisms of bacterial membrane permeabilization by crotalicidin (Ctn) and its fragment Ctn(15-34), antimicrobial peptides from rattlesnake venom	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); atomic force microscopy (AFM); surface plasmon resonance (SPR); confocal microscopy; Gram-negative bacteria; bacterial membrane disruption; bactericidal mechanism; time-resolved flow cytometry	CYCLOTIDE KALATA B1; CELL-PENETRATING PEPTIDES; ESCHERICHIA-COLI; ACTIVE PEPTIDES; CATHELICIDIN; IDENTIFICATION; BINDING; PRP(106-126); DESIGN; FAMILY	Crotalicidin (Ctn), a cathelicidin-related peptide from the venom of a South American rattlesnake, possesses potent antimicrobial, antitumor, and antifungal properties. Previously, we have shown that its C-terminal fragment, Ctn(15-34), retains the antimicrobial and antitumor activities but is less toxic to healthy cells and has improved serum stability. Here, we investigated the mechanisms of action of Ctn and Ctn(15-34) against Gram-negative bacteria. Both peptides were bactericidal, killing approximate to 90% of Escherichia coli and Pseudomonas aeruginosa cells within 90-120 and 5-30 min, respectively. Studies of potential at the bacterial cell membrane suggested that both peptides accumulate at and neutralize negative charges on the bacterial surface. Flow cytometry experiments confirmed that both peptides permeabilize the bacterial cell membrane but suggested slightly different mechanisms of action. Ctn(15-34) permeabilized the membrane immediately upon addition to the cells, whereas Ctn had a lag phase before inducing membrane damage and exhibited more complex cell-killing activity, probably because of two different modes of membrane permeabilization. Using surface plasmon resonance and leakage assays with model vesicles, we confirmed that Ctn(15-34) binds to and disrupts lipid membranes and also observed that Ctn(15-34) has a preference for vesicles that mimic bacterial or tumor cell membranes. Atomic force microscopy visualized the effect of these peptides on bacterial cells, and confocal microscopy confirmed their localization on the bacterial surface. Our studies shed light onto the antimicrobial mechanisms of Ctn and Ctn(15-34), suggesting Ctn(15-34) as a promising lead for development as an antibacterial/antitumor agent.	[Perez-Peinado, Clara; Radis-Baptista, Gandhi; Andreu, David] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona Biomed Res Pk, Barcelona 08003, Spain; [Dias, Susana Almeida; Domingues, Marco M.; Freire, Joao Miguel; Gaspar, Diana; Castanho, Miguel A. R. B.; Veiga, Ana Salome] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Benfield, Aurelie H.; Craik, David J.; Henriques, Sonia Troeira] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Freire, Joao Miguel] Inst Pasteur, Dept Virol, F-75724 Paris, France; [Radis-Baptista, Gandhi] Univ Fed Ceara, Inst Marine Sci, Lab Biochem & Biotechnol, BR-60165081 Fortaleza, Ceara, Brazil	Pompeu Fabra University; Universidade de Lisboa; University of Queensland; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade Federal do Ceara	Andreu, D (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona Biomed Res Pk, Barcelona 08003, Spain.; Veiga, AS (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal.; Henriques, ST (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	s.henriques@imb.uq.edu.au; aveiga@medicina.ulisboa.pt; david.andreu@upf.edu	Craik, David/B-1695-2010; RADIS-BAPTISTA, GANDHI/J-4991-2019; RADIS-BAPTISTA, GANDHI/H-9574-2016; Domingues, Marco/AAA-9690-2021; Troeira Henriques, Sonia/J-3500-2016	Craik, David/0000-0003-0007-6796; RADIS-BAPTISTA, GANDHI/0000-0001-9210-092X; RADIS-BAPTISTA, GANDHI/0000-0001-9210-092X; Benfield, Aurelie/0000-0002-3068-906X; Veiga, Ana Salome/0000-0002-9892-2243; Troeira Henriques, Sonia/0000-0001-9564-9651; Dias, Susana/0000-0001-8910-5404	Spanish Ministry of Economy and Competitiveness (MINECO) [SAF2011-24899, AGL2014-52395-C2]; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [PTDC/QEQ-MED/4412/2014]; EU Marie Sklodowska-Curie Research and Innovation Staff Exchange (RISE) program Grant [644167]	Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); EU Marie Sklodowska-Curie Research and Innovation Staff Exchange (RISE) program Grant	This work was supported by Spanish Ministry of Economy and Competitiveness (MINECO) Grants SAF2011-24899 and AGL2014-52395-C2, by Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) Grants PTDC/QEQ-MED/4412/2014, and by EU Marie Sklodowska-Curie Research and Innovation Staff Exchange (RISE) program Grant 644167, 2015-2019. The authors declare that they have no conflicts of interest with the contents of this article.	Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955; Barry A.L., 1999, M26A NCCLS, V19; Blower RJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003862; Falcao CB, 2015, J MED CHEM, V58, P8553, DOI 10.1021/acs.jmedchem.5b01142; Cavalcante CSP, 2017, J ANTIBIOT, V70, P231, DOI 10.1038/ja.2016.135; Chen L, 2017, INT J BIOCHEM CELL B, V83, P71, DOI 10.1016/j.biocel.2016.12.011; Coutinho A, 2003, BIOPHYS J, V84, P3061, DOI 10.1016/S0006-3495(03)70032-0; Daleke DL, 2008, CURR OPIN HEMATOL, V15, P191, DOI 10.1097/MOH.0b013e3282f97af7; Dias SA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00775; Domingues MM, 2008, J PEPT SCI, V14, P394, DOI 10.1002/psc.1007; Du HJ, 2015, BBA-BIOMEMBRANES, V1848, P2394, DOI 10.1016/j.bbamem.2015.07.006; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Falcao CB, 2014, AMINO ACIDS, V46, P2561, DOI 10.1007/s00726-014-1801-4; Faust JE, 2017, BIOPHYS J, V112, P1663, DOI 10.1016/j.bpj.2017.03.003; Freire JM, 2014, FEBS J, V281, P191, DOI 10.1111/febs.12587; Freire JM, 2015, BBA-BIOMEMBRANES, V1848, P554, DOI 10.1016/j.bbamem.2014.11.001; Hallbrink M, 2004, BBA-BIOMEMBRANES, V1667, P222, DOI 10.1016/j.bbamem.2004.10.009; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hao QR, 2013, J PEPT SCI, V19, P173, DOI 10.1002/psc.2488; Henriques ST, 2008, BIOPHYS J, V95, P1877, DOI 10.1529/biophysj.108.131458; Henriques ST, 2012, J BIOL CHEM, V287, P33629, DOI 10.1074/jbc.M112.372011; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Henriques ST, 2009, BIOCHEMISTRY-US, V48, P4198, DOI 10.1021/bi900009d; Hogberg LD, 2010, TRENDS PHARMACOL SCI, V31, P509, DOI 10.1016/j.tips.2010.08.002; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Jin L, 2016, J MED CHEM, V59, P1791, DOI 10.1021/acs.jmedchem.5b01264; Kaplan CW, 2011, ANTIMICROB AGENTS CH, V55, P3446, DOI 10.1128/AAC.00342-11; Kim D, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.00530-17, 10.1128/AAC.00530-17]; Kosciuczuk EM, 2012, MOL BIOL REP, V39, P10957, DOI 10.1007/s11033-012-1997-x; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Levison ME, 2009, INFECT DIS CLIN N AM, V23, P791, DOI 10.1016/j.idc.2009.06.008; Li JG, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00073; Mahlapuu M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00194; Marin-Medina N, 2016, APPL MICROBIOL BIOT, V100, P10251, DOI 10.1007/s00253-016-7975-9; Michael CA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00145; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Mu LX, 2017, AMINO ACIDS, V49, P1571, DOI 10.1007/s00726-017-2449-7; Rios AC, 2016, MICROBIOL RES, V191, P51, DOI 10.1016/j.micres.2016.04.008; Roversi D, 2014, ACS CHEM BIOL, V9, P2003, DOI 10.1021/cb500426r; Samuel R, 2016, BBA-BIOMEMBRANES, V1858, P1974, DOI 10.1016/j.bbamem.2016.05.015; Sani MA, 2016, ACCOUNTS CHEM RES, V49, P1130, DOI 10.1021/acs.accounts.6b00074; Shephard J, 2008, APPL ENVIRON MICROB, V74, P6980, DOI 10.1128/AEM.01117-08; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Termen S, 2003, CELL MOL LIFE SCI, V60, P536, DOI 10.1007/s000180300045; Thabit AK, 2015, EXPERT OPIN PHARMACO, V16, P159, DOI 10.1517/14656566.2015.993381; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002; Uzzell T, 2003, PEPTIDES, V24, P1655, DOI 10.1016/j.peptides.2003.08.024; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024030; Wang YG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, 10.1371/journal.pone.0020422]; Wei L, 2015, J BIOL CHEM, V290, P16633, DOI 10.1074/jbc.M115.642645; Wong JH, 2013, CURR PROTEIN PEPT SC, V14, P504, DOI 10.2174/13892037113149990067; Wright GD, 2007, TRENDS MOL MED, V13, P260, DOI 10.1016/j.molmed.2007.04.004; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang Y, 2010, PEPTIDES, V31, P1488, DOI 10.1016/j.peptides.2010.05.005; Zhao H, 2008, PEPTIDES, V29, P1685, DOI 10.1016/j.peptides.2008.06.008; Zhou HM, 2011, PEPTIDES, V32, P1131, DOI 10.1016/j.peptides.2011.04.002	61	53	54	0	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1536	1549		10.1074/jbc.RA117.000125	http://dx.doi.org/10.1074/jbc.RA117.000125			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29255091	Green Published, hybrid			2022-12-26	WOS:000424201700006
J	Schwander, T; McLean, R; Zarzycki, J; Erb, TJ				Schwander, Thomas; McLean, Richard; Zarzycki, Jan; Erb, Tobias J.			Structural basis for substrate specificity of methylsuccinyl-CoA dehydrogenase, an unusual member of the acyl-CoA dehydrogenase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme purification; enzyme structure; enzyme mutation; enzyme kinetics; enzyme catalysis; X-ray crystallography; bioengineering; flavin adenine dinucleotide (FAD); acyl-CoA dehydrogenase; ethylmalonyl-CoA pathway; glutaryl-CoA dehydrogenase; isobutyryl-CoA dehydrogenase; mesaconyl-CoA	RAT-LIVER MITOCHONDRIA; MEDIUM-CHAIN; COENZYME-A; CRYSTAL-STRUCTURES; GLUTARYL-COA; DECARBOXYLATION; MECHANISM; ELECTRON; IDENTIFICATION; PURIFICATION	(2S)-methylsuccinyl-CoA dehydrogenase (MCD) belongs to the family of FAD-dependent acyl-CoA dehydrogenase (ACD) and is a key enzyme of the ethylmalonyl-CoA pathway for acetate assimilation. It catalyzes the oxidation of (2S)-methylsuccinyl-CoA to ,-unsaturated mesaconyl-CoA and shows only about 0.5% activity with succinyl-CoA. Here we report the crystal structure of MCD at a resolution of 1.37 . The enzyme forms a homodimer of two 60-kDa subunits. Compared with other ACDs, MCD contains an approximate to 170-residue-long N-terminal extension that structurally mimics a dimer-dimer interface of these enzymes that are canonically organized as tetramers. MCD catalyzes the unprecedented oxidation of an -methyl branched dicarboxylic acid CoA thioester. Substrate specificity is achieved by a cluster of three arginines that accommodates the terminal carboxyl group and a dedicated cavity that facilitates binding of the C2 methyl branch. MCD apparently evolved toward preventing the nonspecific oxidation of succinyl-CoA, which is a close structural homolog of (2S)-methylsuccinyl-CoA and an essential intermediate in central carbon metabolism. For different metabolic engineering and biotechnological applications, however, an enzyme that can oxidize succinyl-CoA to fumaryl-CoA is sought after. Based on the MCD structure, we were able to shift substrate specificity of MCD toward succinyl-CoA through active-site mutagenesis.	[Schwander, Thomas; McLean, Richard; Zarzycki, Jan; Erb, Tobias J.] Max Planck Inst Terr Microbiol Marburg, Dept Biochem & Synthet Metab, Karl von Frisch Str 10, D-35043 Marburg, Germany; [Erb, Tobias J.] LOEWE Ctr Synthet Microbiol SYNMIKRO, D-35043 Marburg, Germany		Erb, TJ (corresponding author), Max Planck Inst Terr Microbiol, Karl von Frisch Str 10, D-35043 Marburg, Germany.	toerb@mpi-marburg.mpg.de	; Erb, Tobias/J-5214-2013	Schwander, Thomas/0000-0001-9201-3017; Zarzycki, Jan/0000-0002-6307-6497; McLean, Richard/0000-0002-3237-3288; Erb, Tobias/0000-0003-3685-0894	European Research Council [ERC 637675]; IMPRS-Mic Fellowship; Max Planck Society	European Research Council(European Research Council (ERC)European Commission); IMPRS-Mic Fellowship; Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported in part by European Research Council Grant ERC 637675 "SYBORG," an IMPRS-Mic Fellowship, and the Max Planck Society. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battaile KP, 2004, J BIOL CHEM, V279, P16526, DOI 10.1074/jbc.M400034200; Battaile KP, 2002, J BIOL CHEM, V277, P12200, DOI 10.1074/jbc.M111296200; BESRAT A, 1969, J BIOL CHEM, V244, P1461; Bhattacharyya S, 2007, J PHYS CHEM A, V111, P5729, DOI 10.1021/jp07l526+; CRANE FL, 1956, J BIOL CHEM, V218, P701; CRANE FL, 1956, J BIOL CHEM, V218, P717; Dwyer TM, 2001, J BIOL CHEM, V276, P133, DOI 10.1074/jbc.M007672200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Erb TJ, 2009, MOL MICROBIOL, V73, P992, DOI 10.1111/j.1365-2958.2009.06837.x; Fu ZJ, 2004, BIOCHEMISTRY-US, V43, P9674, DOI 10.1021/bi049290c; GHISLA S, 1984, BIOCHEMISTRY-US, V23, P3154, DOI 10.1021/bi00309a008; IKEDA Y, 1983, J BIOL CHEM, V258, P1066; IKEDA Y, 1985, J BIOL CHEM, V260, P1311; IZAI K, 1992, J BIOL CHEM, V267, P1027; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiefer P, 2013, BIOINFORMATICS, V29, P963, DOI 10.1093/bioinformatics/btt080; Kim JJP, 2004, EUR J BIOCHEM, V271, P483, DOI 10.1046/j.1432-1033.2003.03948.x; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; Kuchler B, 1999, BIOCHEM J, V337, P225, DOI 10.1042/0264-6021:3370225; LEHMAN TC, 1990, ANAL BIOCHEM, V186, P280, DOI 10.1016/0003-2697(90)90080-S; Luo M, 2016, J BIOL CHEM, V291, P24065, DOI 10.1074/jbc.M116.756965; Mackenzie J, 2006, J BIOL CHEM, V281, P31012, DOI 10.1074/jbc.M603405200; McAndrew RP, 2008, J BIOL CHEM, V283, P9435, DOI 10.1074/jbc.M709135200; Nakajima Y, 2002, J BIOCHEM, V131, P365, DOI 10.1093/oxfordjournals.jbchem.a003111; Nguyen TV, 2002, MOL GENET METAB, V77, P68, DOI 10.1016/S1096-7192(02)00152-X; Peter DM, 2016, MOLECULES, V21, DOI 10.3390/molecules21040517; POHL B, 1986, EUR J BIOCHEM, V160, P109, DOI 10.1111/j.1432-1033.1986.tb09946.x; Rosenthal RG, 2014, NAT CHEM BIOL, V10, P50, DOI [10.1038/NCHEMBIO.1385, 10.1038/nchembio.1385]; Schwander T, 2016, SCIENCE, V354, P900, DOI 10.1126/science.aah5237; Tiffany KA, 1997, BIOCHEMISTRY-US, V36, P8455, DOI 10.1021/bi970422u; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wischgoll S, 2010, BIOCHEMISTRY-US, V49, P5350, DOI 10.1021/bi100317m	34	7	8	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1702	1712		10.1074/jbc.RA117.000764	http://dx.doi.org/10.1074/jbc.RA117.000764			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29275330	hybrid, Green Published			2022-12-26	WOS:000424201700021
J	Pineiro-Hermida, S; Alfaro-Arnedo, E; Gregory, JA; Torrens, R; Ruiz-Martinez, C; Adner, M; Lopez, IP; Pichel, JAG				Pineiro-Hermida, Sergio; Alfaro-Arnedo, Elvira; Gregory, Joshua A.; Torrens, Raquel; Ruiz-Martinez, Carlos; Adner, Mikael; Lopez, Iciar P.; Pichel, Jose A. G.			Characterization of the acute inflammatory profile and resolution of airway inflammation after Igf1r-gene targeting in a murine model of HDM-induced asthma	PLOS ONE			English	Article							ALLERGIC INFLAMMATION; RESPIRATORY ALLERGY; MOUSE MODEL; ACTIVATION; MICE; MITE; HYPERRESPONSIVENESS; EXPRESSION; EOTAXIN; MARKER	Asthma is a chronic inflammatory disease characterized by bronchial hyperresponsiveness, mucus overproduction and airway remodeling. Notably, we have recently demonstrated that insulin-like growth factor 1 receptor (IGF1R) deficiency in mice attenuates airway hyperresponsiveness and mucus secretion after chronic house dust mite (HDM) exposure. On this basis, inbred C57BL/6 and Igf1r-deficient mice were given HDM extract to study the acute inflammatory profile and implication of Igf1r in acute asthma pathobiology. Additionally, Igf1r-deficiency was therapeutically induced in mice to evaluate the resolution of HDM-induced inflammation. Acute HDM exposure in inbred C57BL/6 mice led to a progressive increase in inflammation, airway remodeling and associated molecular indicators. Preventively-induced Igf1r-deficiency showed reduced neutrophil and eosinophil numbers in BALF and bone marrow, a significant reduction of airway remodeling and decreased levels of related markers. In addition, therapeutic targeting of Igf1r promoted the resolution of HDM-induced-inflammation. Our results demonstrate for the first time that Igf1r is important in acute asthma pathobiology and resolution of HDM-induced inflammation. Thus, IGF1R is suggested to be a promising candidate for future therapeutic approaches for the treatment and prevention of asthma.	[Pineiro-Hermida, Sergio; Alfaro-Arnedo, Elvira; Torrens, Raquel; Lopez, Iciar P.; Pichel, Jose A. G.] Fdn Rioja Salud, Ctr Invest Biomed Rioja CIBIR, Lung Canc & Resp Dis Unit, Logrono, Spain; [Gregory, Joshua A.; Adner, Mikael] Karolinska Inst, Inst Environm Med IMM, Unit Expt Asthma & Allergy Res, Stockholm, Sweden; [Ruiz-Martinez, Carlos] Hosp San Pedro, Pneumol Serv, Logrono, Spain; [Gregory, Joshua A.] Adlego Biomed AB, Uppsala, Sweden	Karolinska Institutet	Pichel, JAG (corresponding author), Fdn Rioja Salud, Ctr Invest Biomed Rioja CIBIR, Lung Canc & Resp Dis Unit, Logrono, Spain.	jgpichel@riojasalud.es	Pichel, Jose G/AAF-2255-2019	Pichel, Jose G/0000-0001-8580-0952; Alfaro Arnedo, Elvira/0000-0002-5954-8201; Pineiro Hermida, Sergio/0000-0002-8915-5687	Fundacion Rioja Salud (Gobierno de La Rioja, Spain); ERDF (European Regional Development Fund); ESF (European Social Fund); Swedish Heart-Lung Foundation [20150525, 20130636]; Konsul Th C Berghs research foundation; Karolinska Institutet; Centre for Allergy Research at Karolinska Institutet; Sistema Riojano de Innovacion (Gobierno de La Rioja, Spain)	Fundacion Rioja Salud (Gobierno de La Rioja, Spain); ERDF (European Regional Development Fund)(European Commission); ESF (European Social Fund)(European Social Fund (ESF)); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Konsul Th C Berghs research foundation; Karolinska Institutet(Karolinska Institutet); Centre for Allergy Research at Karolinska Institutet(Karolinska Institutet); Sistema Riojano de Innovacion (Gobierno de La Rioja, Spain)	This work was supported by grants from the Fundacion Rioja Salud (Gobierno de La Rioja, Spain), ERDF (European Regional Development Fund) and the ESF (European Social Fund) to JGP; and the Swedish Heart-Lung Foundation (20150525, 20130636), the Konsul Th C Berghs research foundation, the Karolinska Institutet, and the Centre for Allergy Research at Karolinska Institutet to MA.; We are grateful to Drs. J. Bruning (Max-Planck Institute, Cologne, Germany) and E. Brown (UPENN School of Medicine, PA) for providing Igf1r<SUP>fl/fl</SUP> and UBC-CreERT2 mouse lines, respectively. S.P.-H. thanks the Sistema Riojano de Innovacion (Gobierno de La Rioja, Spain) for a PhD grant.	Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Calderon MA, 2015, J ALLERGY CLIN IMMUN, V136, P38, DOI 10.1016/j.jaci.2014.10.012; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Conroy DM, 2001, RESP RES, V2, P150, DOI 10.1186/rr52; Esnault S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067560; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Gaye B, 2015, J IMMUNOL METHODS, V426, P82, DOI 10.1016/j.jim.2015.08.006; Girnita L, 2014, CELL MOL LIFE SCI, V71, P2403, DOI 10.1007/s00018-013-1514-y; Gregory LG, 2009, CLIN EXP ALLERGY, V39, P1597, DOI 10.1111/j.1365-2222.2009.03302.x; Hoshino M, 1998, CLIN EXP ALLERGY, V28, P568; Jacquet A, 2011, TRENDS MOL MED, V17, P604, DOI 10.1016/j.molmed.2011.05.014; Jahromi SR, 2014, J ASTHMA, V51, P1004, DOI 10.3109/02770903.2014.938353; Justice JP, 2001, AM J PHYSIOL-LUNG C, V280, pL363, DOI 10.1152/ajplung.2001.280.2.L363; Kearley J, 2009, AM J RESP CRIT CARE, V179, P772, DOI 10.1164/rccm.200805-666OC; Kim SR, 2012, ALLERGY, V67, P869, DOI 10.1111/j.1398-9995.2012.02837.x; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Lee YC, 2011, J BIOL CHEM, V286, P17898, DOI 10.1074/jbc.M111.231035; Lopez IP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166388; Makrinioti H, 2014, LANCET RESP MED, V2, P226, DOI 10.1016/S2213-2600(13)70261-3; Melgert BN, 2005, CLIN EXP ALLERGY, V35, P1496, DOI 10.1111/j.1365-2222.2005.02362.x; Nakae S, 2003, INT IMMUNOL, V15, P483, DOI 10.1093/intimm/dxg054; Nakae S, 2007, J ALLERGY CLIN IMMUN, V119, P680, DOI 10.1016/j.jaci.2006.11.701; Lopez IP, 2015, TRANSGENIC RES, V24, P279, DOI 10.1007/s11248-014-9837-5; Pineiro-Hermida S, 2017, ALLERGY, V72, P1317, DOI 10.1111/all.13142; Pineiro-Hermida S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04561-4; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Ren XM, 2013, MOL CELL BIOL, V33, P371, DOI 10.1128/MCB.00934-12; Schulman ES, 2015, CHEST, V147, P251, DOI 10.1378/chest.12-0072; Sjoberg LC, 2015, ALLERGY, V70, P514, DOI 10.1111/all.12590; Sonar SS, 2012, EUR RESPIR J, V39, P429, DOI 10.1183/09031936.00197810; Sun LF, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai8583; Swedin L, 2010, INT ARCH ALLERGY IMM, V153, P249, DOI 10.1159/000314365; Tomlinson KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013136; Veraldi KL, 2009, AM J RESP CRIT CARE, V180, P611, DOI 10.1164/rccm.200810-1555OC; Vijayan A, 2013, INT J BIOCHEM CELL B, V45, P2774, DOI 10.1016/j.biocel.2013.10.001; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Wu DD, 2014, J ASTHMA, V51, P847, DOI 10.3109/02770903.2014.917659; Yamashita N, 2005, CELL IMMUNOL, V235, P85, DOI 10.1016/j.cellimm.2005.07.006; Ying S, 1997, EUR J IMMUNOL, V27, P3507, DOI 10.1002/eji.1830271252; Zhang Y., 2013, MATH PROBL ENG, V2013, P10, DOI DOI 10.1016/J.CARBP0L.2013.09.066	41	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190159	10.1371/journal.pone.0190159	http://dx.doi.org/10.1371/journal.pone.0190159			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272313	Green Submitted, Green Published, gold			2022-12-26	WOS:000418651500039
J	Abe, K; Yawo, H				Abe, Kenta; Yawo, Hiromu			Optogenetic conditioning of paradigm and pattern discrimination in the rat somatosensory system	PLOS ONE			English	Article							BARREL CORTEX; MOUSE; INFORMATION; CONNECTIVITY; RESPONSES; BEHAVIOR; COLUMN	The rodent whisker-barrel cortical system is a model for studying somatosensory discrimination at high spatiotemporal precision. Here, we applied optogenetics to produce somatosensory inputs in the whisker area using one of transgenic rat lines, W-TChR2V4, which expresses channelrhodopsin-2 (ChR2) in the mechanoreceptive nerve endings around whisker follicles. An awake W-TChR2V4 rat was head-fixed and irradiated by blue LED light on the whisker area with a paradigm conditioned with a reward. The Go task was designed so the rat is allowed to receive a reward, when it licked the nozzle within 5 s after photostimulation. The No-go task was designed so as the rat has to withhold licking for at least 5 s to obtain a reward after photostimulation. The Go-task conditioning was established within 1 hr of training with a reduction in the reaction time and increase of the success rate. To investigate the relationship between the spatiotemporal pattern of sensory inputs and the behavioral output, we designed a multi-optical fiber system that irradiates the whisker area at 9 spots in a 3x3 matrix. Although the Go-task conditioning was established using synchronous irradiation of 9 spots, the success rate was decreased with an increase of the reaction time for the asynchronous irradiation. After conditioning to the Go task, the rat responded to the blue LED flash irradiated on the barrel cortex, where many neurons also express ChR2, or photostimulation of the contralateral whisker area with a similar reaction time and success rate. Synchronous activation of the peripheral mechanoreceptive nerves is suggested to drive a neural circuit in the somatosensory cortex that efficiently couples with the decision. Our optogenetic system would enable the precise evaluation of the psychophysical values, such as the reaction time and success rate, to gain some insight into the brain mechanisms underlying conditioned behaviors.	[Abe, Kenta; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi, Japan; [Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Ctr Neurosci, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Yawo, H (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi, Japan.; Yawo, H (corresponding author), Tohoku Univ, Grad Sch Life Sci, Ctr Neurosci, Sendai, Miyagi, Japan.	hiromu.yawo.c7@tohoku.ac.jp	Yawo, Hiromu/I-4871-2015	Yawo, Hiromu/0000-0002-4299-3288; Abe, Kenta/0000-0002-1634-7469	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [17J06669, 25250001, 15H01413]; JST, Strategic International Collaborative Research Program, SICORP	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST, Strategic International Collaborative Research Program, SICORP	This study was supported by a Grant-in-Aid for JSPS Fellows (No. 17J06669 to KA), a Grant-in-Aid for Scientific Research (No. 25250001 to HY), a Grant-in-Aid for Scientific Research on Innovative Areas "Adaptive Circuit Shift (No. 15H01413 to HY) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan: http://www.jsps.go.jp/english/e-grants/grants01.html and JST, Strategic International Collaborative Research Program, SICORP (to HY): http://www.jst.go.jp/inter/english/sicorp/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronoff R, 2010, EUR J NEUROSCI, V31, P2221, DOI 10.1111/j.1460-9568.2010.07264.x; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Celikel T, 2007, P NATL ACAD SCI USA, V104, P1395, DOI 10.1073/pnas.0610267104; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Drugowitsch J, 2014, ELIFE, V3, DOI 10.7554/eLife.03005; Honjoh T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093706; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Ji Z.-G., 2015, STRATEGIES PROBE MEC, P305; Ji ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032699; Kuki T, 2013, NEUROSCI RES, V75, P35, DOI 10.1016/j.neures.2012.10.007; Le Be JV, 2007, CEREB CORTEX, V17, P2204, DOI 10.1093/cercor/bhl127; Lubke J, 2007, BRAIN STRUCT FUNCT, V212, P3, DOI 10.1007/s00429-007-0144-2; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; Ohno S, 2012, CEREB CORTEX, V22, P2840, DOI 10.1093/cercor/bhr356; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pierret T, 2000, J NEUROSCI, V20, P7455; Posluszny A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144415; Reig R, 2016, CEREB CORTEX, V26, P4405, DOI 10.1093/cercor/bhw268; Romo R, 2012, CURR OPIN NEUROBIOL, V22, P914, DOI 10.1016/j.conb.2012.08.002; Rubio-Garrido P, 2009, CEREB CORTEX, V19, P2380, DOI 10.1093/cercor/bhn259; Sachidhanandam S, 2013, NAT NEUROSCI, V16, P1671, DOI 10.1038/nn.3532; Saiki A, 2017, CEREB CORTEX; Schwarz C, 2010, SOMATOSENS MOT RES, V27, P131, DOI 10.3109/08990220.2010.513111; Scott BB, 2013, NEURON, V80, P371, DOI 10.1016/j.neuron.2013.08.002; Shuler MG, 2001, J NEUROSCI, V21, P5251, DOI 10.1523/JNEUROSCI.21-14-05251.2001; Templeton JP, 2012, MOL VIS, V18, P2147; Tomita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007679; Topchiy IA, 2009, BEHAV BRAIN RES, V197, P16, DOI 10.1016/j.bbr.2008.07.032; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068; Yamashita T, 2016, ELIFE, V5, DOI 10.7554/eLife.15798	34	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189439	10.1371/journal.pone.0189439	http://dx.doi.org/10.1371/journal.pone.0189439			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267341	Green Published, gold, Green Submitted			2022-12-26	WOS:000418587400031
J	Kim, YT; Park, BK; Kim, SE; Lee, WJ; Moon, JS; Cho, MS; Park, HY; Hwang, I; Kim, SU				Kim, Young Tae; Park, Byung Keun; Kim, Sung Eun; Lee, Won Jung; Moon, Jae Sun; Cho, Min Seop; Park, Ho-Yong; Hwang, Ingyu; Kim, Sung Uk			Organization and characterization of genetic regions in Bacillus subtilis subsp krictiensis ATCC55079 associated with the biosynthesis of iturin and surfactin compounds	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MOLECULAR CHARACTERIZATION; NONRIBOSOMAL SYNTHESIS; LIPOPEPTIDES; BIOCONTROL; CLONING; ANTIBIOTICS; TRANSFERASE; ANTAGONISTS; RESISTANCE	Bacillus subtilis subsp. krictiensis ATCC55079 produces the cyclic lipopeptide antibiotics iturin A-F as well as several surfactins. Here, we analyzed and characterized the biosynthetic genes associated with iturin and surfactin production in this strain. We aligned the sequences of each iturin and surfactin synthetase ORF obtained from a genomic library screen and next generation sequencing. The resulting 37,249-bp and 37,645-bp sequences associated with iturin and surfactin production, respectively, contained several ORFs that are predicted to encode proteins involved in iturin and surfactin biosynthesis. These ORFs showed higher sequence homologies with the respective iturin and surfactin synthetase genes of B. methylotrophicus CAU B946 than with those of B. subtilis RB14 and B. subtilis ATCC6633. Moreover, comparative analysis of the secondary metabolites produced by the wild-type and surfactin-less mutant (with a spectinomycin resistance cassette inserted into the srfAB gene within the putative surfactin gene region) strains demonstrated that the mutant strain showed significantly higher antifungal activity against Fusarium oxysporum than the wild-type strain. In addition, the wild-type strain-specific surfactin high performance liquid chromatography (HPLC) peaks were not observed in the surfactin-less mutant strain. In contrast, the iturin A peak detected by HPLC and liquid chromatography-mass spectrometry (LC/MS) in the surfactin-less mutant strain was 30% greater than that in the wild-type strain. These results suggested that the gene cluster we identified is involved in surfactin biosynthesis, and the biosynthetic pathways for iturin and surfactin in Bacillus strains producing both iturin and surfactin may utilize a common pathway.	[Kim, Young Tae; Park, Byung Keun; Kim, Sung Eun; Lee, Won Jung; Moon, Jae Sun; Park, Ho-Yong; Kim, Sung Uk] Korea Res Inst Biosci & Biotechnol, Div Syst Biol & Bioengn, Daejeon, South Korea; [Cho, Min Seop] Green Biotech Co, Paju, South Korea; [Hwang, Ingyu] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Park, Byung Keun] Jang Sang Doraji Co, Jinju, South Korea; [Kim, Sung Uk] Seowon Univ, Dept Food Sci & Engn, Cheongju, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seowon University	Kim, SU (corresponding author), Korea Res Inst Biosci & Biotechnol, Div Syst Biol & Bioengn, Daejeon, South Korea.; Hwang, I (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.; Kim, SU (corresponding author), Seowon Univ, Dept Food Sci & Engn, Cheongju, South Korea.	ingyu@snu.ac.kr; kimsu@kribb.re.kr	PARK, HO-YONG/AAP-2225-2021		Bioindustry Technology Development Program - Ministry of Agriculture, Food, and Rural Affairs [111048-03]; Green Biotech Co.	Bioindustry Technology Development Program - Ministry of Agriculture, Food, and Rural Affairs; Green Biotech Co.	This work was supported by a grant from the Bioindustry Technology Development Program funded by the Ministry of Agriculture, Food, and Rural Affairs (Grant No. 111048-03) to SUK. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Green Biotech Co. provided support in the form of salaries for author MSC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Arrebola E, 2010, J APPL MICROBIOL, V108, P386, DOI 10.1111/j.1365-2672.2009.04438.x; BESSON F, 1978, J ANTIBIOT, V31, P284, DOI 10.7164/antibiotics.31.284; BESSON F, 1987, J ANTIBIOT, V40, P437, DOI 10.7164/antibiotics.40.437; Blom J, 2012, J BACTERIOL, V194, P1845, DOI 10.1128/JB.06762-11; Bok S. H., 1992, U.S. Patent, Patent No. [5,155,041, 5155041]; Cazorla FM, 2006, MOL PLANT MICROBE IN, V19, P418, DOI 10.1094/MPMI-19-0418; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Cutting SM, 1990, MOL BIOL METHODS BAC, P65; de Boer M, 2003, PHYTOPATHOLOGY, V93, P626, DOI 10.1094/PHYTO.2003.93.5.626; Duitman EH, 1999, P NATL ACAD SCI USA, V96, P13294, DOI 10.1073/pnas.96.23.13294; Dunlap CA, 2015, INT J SYST EVOL MICR, V65, P2104, DOI 10.1099/ijs.0.000226; Earl AM, 2012, J BACTERIOL, V194, P2378, DOI 10.1128/JB.05675-11; Fernandez-Ortuno D, 2006, EUR J PLANT PATHOL, V115, P215, DOI 10.1007/s10658-006-9014-7; FINN RK, 1959, ANAL CHEM, V31, P975, DOI 10.1021/ac60150a040; Grover M, 2010, CURR MICROBIOL, V60, P99, DOI 10.1007/s00284-009-9508-6; Hayashi K, 2005, J BACTERIOL, V187, P6659, DOI 10.1128/JB.187.19.6659-6667.2005; HUANG CC, 1993, J FERMENT BIOENG, V76, P445, DOI 10.1016/0922-338X(93)90238-4; Kim SK, 1991, KOR J APPL MICROBIOL, V19, P598; Kim SW, 1991, KOR J APPL MICROBIOL, V19, P337; Kiss L, 2003, PEST MANAG SCI, V59, P475, DOI 10.1002/ps.689; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Koumoutsi A, 2007, APPL ENVIRON MICROB, V73, P6953, DOI 10.1128/AEM.00565-07; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Leclere V, 2005, APPL ENVIRON MICROB, V71, P4577, DOI 10.1128/AEM.71.8.4577-4584.2005; MAGETDANA R, 1992, BIOCHIMIE, V74, P1047, DOI 10.1016/0300-9084(92)90002-V; McGrath MT, 2001, PLANT DIS, V85, P236, DOI 10.1094/PDIS.2001.85.3.236; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; Moyne AL, 2004, FEMS MICROBIOL LETT, V234, P43, DOI [10.1016/j.femsle.2004.03.011, 10.1111/j.1574-6968.2004.tb09511.x]; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Ongena M, 2007, ENVIRON MICROBIOL, V9, P1084, DOI 10.1111/j.1462-2920.2006.01202.x; Patel H, 2011, BBA-BIOMEMBRANES, V1808, P2000, DOI 10.1016/j.bbamem.2011.04.008; Peypoux F, 1999, APPL MICROBIOL BIOT, V51, P553, DOI 10.1007/s002530051432; PEYPOUX F, 1978, BIOCHEMISTRY-US, V17, P3992, DOI 10.1021/bi00612a018; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Romero D, 2007, MOL PLANT MICROBE IN, V20, P430, DOI 10.1094/MPMI-20-4-0430; Roongsawang N, 2002, EXTREMOPHILES, V6, P499, DOI 10.1007/s00792-002-0287-2; Roongsawang N, 2011, INT J MOL SCI, V12, P141, DOI 10.3390/ijms12010141; Sambrook J, 1989, MOL CLONING LAB MANU, P9; Sharma RR, 2009, BIOL CONTROL, V50, P205, DOI 10.1016/j.biocontrol.2009.05.001; STASKAWICZ B, 1987, J BACTERIOL, V169, P5789, DOI 10.1128/jb.169.12.5789-5794.1987; STEINMETZ M, 1994, J BACTERIOL, V176, P1761, DOI 10.1128/jb.176.6.1761-1763.1994; Tsuge K, 2005, ANTIMICROB AGENTS CH, V49, P4641, DOI 10.1128/AAC.49.11.4641-4648.2005; Tsuge K, 2001, J BACTERIOL, V183, P6265, DOI 10.1128/JB.183.21.6265-6273.2001; UMEZAWA H, 1986, J ANTIBIOT, V39, P737, DOI 10.7164/antibiotics.39.737; Wang XY, 2010, J MICROBIOL BIOTECHN, V20, P301, DOI 10.4014/jmb.0906.06025; Yang YJ, 2015, APPL MICROBIOL BIOT, V99, P841, DOI 10.1007/s00253-014-6311-5; Yao SY, 2003, CURR MICROBIOL, V47, P272, DOI 10.1007/s00284-002-4008-y; Yasueda H, 1999, J BACTERIOL, V181, P7154, DOI 10.1128/JB.181.23.7154-7160.1999; Zhang Z, 2017, LETT APPL MICROBIOL, V64, P452, DOI 10.1111/lam.12739	49	8	8	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0188179	10.1371/journal.pone.0188179	http://dx.doi.org/10.1371/journal.pone.0188179			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267290	Green Published, gold, Green Submitted			2022-12-26	WOS:000418587400007
J	Koday, MT; Leonard, JA; Munson, P; Forero, A; Koday, M; Bratt, DL; Fuller, JT; Murnane, R; Qin, SL; Reinhart, TA; Duus, K; Messaoudi, I; Hartman, AL; Stefano-Cole, K; Morrison, J; Katze, MG; Fuller, DH				Koday, Merika T.; Leonard, Jolie A.; Munson, Paul; Forero, Adriana; Koday, Michael; Bratt, Debra L.; Fuller, James T.; Murnane, Robert; Qin, Shulin; Reinhart, Todd A.; Duus, Karen; Messaoudi, Ilhem; Hartman, Amy L.; Stefano-Cole, Kelly; Morrison, Juliet; Katze, Michael G.; Fuller, Deborah Heydenburg			Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; IMMUNE-RESPONSES; A-VIRUS; TRANSCUTANEOUS IMMUNIZATION; AVIAN INFLUENZA; DENDRITIC CELLS; INFECTIOUS-DISEASES; RHESUS MACAQUES; MICE; INDUCTION	Recent avian and swine-origin influenza virus outbreaks illustrate the ongoing threat of influenza pandemics. We investigated immunogenicity and protective efficacy of a multi-antigen (MA) universal influenza DNA vaccine consisting of HA, M2, and NP antigens in cynomolgus macaques. Following challenge with a heterologous pandemic H1N1 strain, vaccinated animals exhibited significantly lower viral loads and more rapid viral clearance when compared to unvaccinated controls. The MA DNA vaccine induced robust serum and mucosal antibody responses but these high antibody titers were not broadly neutralizing. In contrast, the vaccine induced broadly-reactive NP specific T cell responses that cross-reacted with the challenge virus and inversely correlated with lower viral loads and inflammation. These results demonstrate that a MA DNA vaccine that induces strong cross-reactive T cell responses can, independent of neutralizing antibody, mediate significant cross-protection in a nonhuman primate model and further supports development as an effective approach to induce broad protection against circulating and emerging influenza strains.	[Koday, Merika T.; Leonard, Jolie A.; Munson, Paul; Forero, Adriana; Fuller, James T.; Morrison, Juliet; Katze, Michael G.; Fuller, Deborah Heydenburg] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Koday, Michael; Bratt, Debra L.; Murnane, Robert; Katze, Michael G.; Fuller, Deborah Heydenburg] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; [Qin, Shulin; Reinhart, Todd A.; Hartman, Amy L.; Stefano-Cole, Kelly] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Duus, Karen] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Duus, Karen] Touro Univ Nevada, Coll Osteopath Med, Basic Sci Dept, Henderson, NV USA; [Messaoudi, Ilhem] Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR USA; [Leonard, Jolie A.] Indiana Wesleyan Univ, Dept Biol, Marion, IN USA; [Qin, Shulin] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Reinhart, Todd A.] St Marys Univ, John C Parmer Sch Sci, Winona, MN USA; [Morrison, Juliet] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Albany Medical College; Oregon Health & Science University; Oregon National Primate Research Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University	Fuller, DH (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.; Fuller, DH (corresponding author), Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA.	fullerdh@u.washinton.edu	Bratt, Debra/B-1106-2019; Qin, Shulin/ABA-3986-2020	Qin, Shulin/0000-0003-2496-3007; Morrison, Juliet/0000-0001-7387-6351; Fuller, Deborah/0000-0001-7315-2441	National Institutes of Health, National Institute of Allergy and Infectious Diseases [NIH/NIAID U01 AI074509]; NIH/NIAID, Department of Health and Human Services under Centers of Excellence in Influenza Research and Surveillance (CEIRS) [HHSN272201400005C, NIH/ORIP P51OD010425-51]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIAID, Department of Health and Human Services under Centers of Excellence in Influenza Research and Surveillance (CEIRS); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project has been funded by National Institutes of Health, National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov) NIH/NIAID U01 AI074509 to DHF; NIH/NIAID, Department of Health and Human Services under Centers of Excellence in Influenza Research and Surveillance (CEIRS) (http://www.niaidceirs.org) contract HHSN272201400005C; and NIH/ORIP P51OD010425-51 to MGK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ABERRANT INNATE IMMU, P15; Arrington J, 2011, J VIROL, V76, P4536; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Baskin CR, 2004, J VIROL, V78, P10420, DOI 10.1128/JVI.78.19.10420-10432.2004; Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Belyakov IM, 2004, J CLIN INVEST, V113, P998, DOI 10.1172/JCI200420261; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLACK RA, 1993, J GEN VIROL, V74, P143, DOI 10.1099/0022-1317-74-1-143; Chen Z, 1999, VACCINE, V17, P653, DOI 10.1016/S0264-410X(98)00247-3; Chen Z, 2000, VACCINE, V18, P3214, DOI 10.1016/S0264-410X(00)00149-3; Chu DWS, 2009, VACCINE, V27, P7428, DOI 10.1016/j.vaccine.2009.07.102; Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; De Rosa SC, 2011, J IMMUNOL, V187, P3391, DOI 10.4049/jimmunol.1101421; Dienz O, 2012, MUCOSAL IMMUNOL, V5, P258, DOI 10.1038/mi.2012.2; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Drape RJ, 2006, VACCINE, V24, P4475, DOI 10.1016/j.vaccine.2005.08.012; Enioutina EY, 2000, VACCINE, V18, P2753, DOI 10.1016/S0264-410X(00)00059-1; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Fiers W, 2001, PHILOS T ROY SOC B, V356, P1961, DOI 10.1098/rstb.2001.0980; Forero A, 2015, J VIROLOGY; Fuller DH, 2006, METHODS, V40, P86, DOI 10.1016/j.ymeth.2006.05.022; Fuller DH, 2007, VIROLOGY, V364, P245, DOI 10.1016/j.virol.2007.02.024; Fuller DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033715; Fuller DH, 2002, J VIROL, V76, P3309, DOI 10.1128/JVI.76.7.3309-3317.2002; Fuller JT, 1995, ANN NY ACAD SCI, V772, P282, DOI 10.1111/j.1749-6632.1995.tb44760.x; Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y; Glenn GM, 1998, J IMMUNOL, V161, P3211; Glenn GM, 2000, NAT MED, V6, P1403, DOI 10.1038/82225; Goodman AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025938; Guo Jianqiang, 2011, Sheng Wu Gong Cheng Xue Bao, V27, P876; Haynes JR, 2006, VACCINE, V24, P5016, DOI 10.1016/j.vaccine.2006.03.046; Hooper KA, 2013, J VIROL, V87, P12531, DOI 10.1128/JVI.01889-13; Hutnick NA, 2012, HUM GENE THER, V23, P943, DOI 10.1089/hum.2012.055; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Jones S, 2009, VACCINE, V27, P2506, DOI 10.1016/j.vaccine.2009.02.061; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Khurana S, 2013, J INFECT DIS, V208, P413, DOI 10.1093/infdis/jit178; Kodihalli S, 1997, J VIROL, V71, P3391, DOI 10.1128/JVI.71.5.3391-3396.1997; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Laddy DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002517; Laddy DJ, 2007, VACCINE, V25, P2984, DOI 10.1016/j.vaccine.2007.01.063; Laddy DJ, 2006, INT REV IMMUNOL, V25, P99, DOI 10.1080/08830180600785827; Laddy DJ, 2009, J VIROL, V83, P4624, DOI 10.1128/JVI.02335-08; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Lauder SN, 2013, EUR J IMMUNOL, V43, P2613, DOI 10.1002/eji.201243018; Ledgerwood JE, 2015, CONTEMP CLIN TRIALS, V44, P112, DOI 10.1016/j.cct.2015.08.006; Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Long JP, 2013, ARCH VIROL, V158, P1305, DOI 10.1007/s00705-012-1593-3; Loudon PT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011021; Luo J, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-286; Luxembourg A, 2006, VACCINE, V24, P4490, DOI 10.1016/j.vaccine.2005.08.014; MacGregor RR, 1998, J INFECT DIS, V178, P92, DOI 10.1086/515613; Murasko DM, 2002, EXP GERONTOL, V37, P427, DOI 10.1016/S0531-5565(01)00210-8; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Payne LG, 2002, CURR OPIN MOL THER, V4, P459; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Roy MJ, 2000, VACCINE, V19, P764, DOI 10.1016/S0264-410X(00)00302-9; Sestak K, 2004, J VIROL, V78, P10258, DOI 10.1128/JVI.78.19.10258-10264.2004; Shinya K, 2012, J VIROL, V86, P6055, DOI 10.1128/JVI.00365-12; Swain SL, 2004, VIRAL IMMUNOL, V17, P197, DOI 10.1089/0882824041310577; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Topham DJ, 1996, J IMMUNOL, V157, P2947; Topham DJ, 1996, J VIROL, V70, P1288, DOI 10.1128/JVI.70.2.1288-1291.1996; Topham DJ, 1997, J IMMUNOL, V159, P5197; Trimble CL, 2015, LANCET, V386, P2078, DOI 10.1016/S0140-6736(15)00239-1; Tsybalova LM, 2015, VACCINE, V33, P3398, DOI 10.1016/j.vaccine.2015.04.073; Ugen KE, 1998, VACCINE, V16, P1818, DOI 10.1016/S0264-410X(98)00180-7; Wang WL, 2015, CLIN VACCINE IMMUNOL, V22, P618, DOI 10.1128/CVI.00091-15; Wei CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004273; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; WHO external quality assessment project for detecting influenza virus subtype A by polymerase chain reaction D summary analysis, 2009, REL EP HEBD SEC HYG, V84, P493; Wu L, 2005, J VIROL, V79, P8024, DOI 10.1128/JVI.79.13.8024-8031.2005; Yager Eric J, 2013, Methods Mol Biol, V940, P223, DOI 10.1007/978-1-62703-110-3_19; Yager EJ, 2009, EXPERT REV VACCINES, V8, P1205, DOI [10.1586/erv.09.82, 10.1586/ERV.09.82]; Zhu HP, 2011, VACCINE, V29, P5421, DOI 10.1016/j.vaccine.2011.05.067	79	20	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189780	10.1371/journal.pone.0189780	http://dx.doi.org/10.1371/journal.pone.0189780			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267331	gold, Green Submitted, Green Published			2022-12-26	WOS:000418587400049
J	Bell, AJ; Phillips, ID; Nielsen, SE; Spence, JR				Bell, Aaron J.; Phillips, Iain D.; Nielsen, Scott E.; Spence, John R.			Species traits modify the species-area relationship in ground-beetle (Coleoptera: Carabidae) assemblages on islands in a boreal lake	PLOS ONE			English	Article							BODY-SIZE; URBANIZATION GRADIENT; ALAND ISLANDS; PITFALL TRAPS; POPULATIONS; HABITAT; DENSITY; DISPERSAL; EVOLUTION; COMMUNITY	Life-history traits influence colonization, persistence, and extinction of species on islands and are important aspects of theories predicting the geographical distribution and evolution of species. We used data collected from a large freshwater lake (1,413 km 2) in central Canada to test the effects of island area and isolation on species richness and abundance of carabid beetles as a function of body size, wing length, and breeding season. A total of 10,018 individual beetles from 37 species were collected during the frost-free period of 2013 using transects of pitfall traps on 30 forested islands ranging in area from 0.2 to 980.7 ha. Life-history traits improved the predictive ability and significantly modified the shape of species- area and abundance-area curves. Abundance and richness of small-bodied (< 13.9 mm), macropterous (winged), and spring-breeding species decreased with island area and increased with isolation. In contrast, richness and abundance of larger-bodied (> 14.0 mm) and flightless species increased with area, but not isolation. Body size of female Carabus taedatus Fabricius, the largest-bodied species, was positively related to island area, while body size on the adjacent mainland was most similar to that on smaller islands. Overall, species with large body size and low dispersal ability, as indicated by flightlessness, were most sensitive to reductions in area. We suggest that large-bodied, flightless species are rare on small islands because habitat is less suitable for them and immigration rates are lower because they depend on freshwater drift for dispersal to islands.	[Bell, Aaron J.; Nielsen, Scott E.; Spence, John R.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Bell, Aaron J.; Phillips, Iain D.] Saskatchewan Wildlife Federat, Troutreach Saskatchewan, Moose Jaw, SK, Canada; [Phillips, Iain D.] Univ Saskatchewan, Dept Biol, Saskatoon, SK, Canada; [Phillips, Iain D.] Water Secur Agcy Saskatchewan, Integrated Water Serv, Water Qual Serv, Saskatoon, SK, Canada	University of Alberta; University of Saskatchewan	Bell, AJ (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.; Bell, AJ (corresponding author), Saskatchewan Wildlife Federat, Troutreach Saskatchewan, Moose Jaw, SK, Canada.	ajbell@ualberta.ca	Nielsen, Scott/C-2842-2013; Nielsen, Scott/O-7482-2019; Phillips, Iain/L-3116-2019	Nielsen, Scott/0000-0002-9754-0630; Nielsen, Scott/0000-0002-9754-0630; Phillips, Iain/0000-0003-0955-3771	Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-03850, RGPIN-2014-04842]; Alexander Graham Bell Canada Graduate Scholarship (NSERCCGS-M); Walter H Johns Graduate Fellowship; Boreal Initiative Fund - Ministry of Environment - Saskatchewan, Canada; Alberta Graduate Student Scholarship; Saskatchewan Fishand Wildlife Development Fund	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alexander Graham Bell Canada Graduate Scholarship (NSERCCGS-M); Walter H Johns Graduate Fellowship; Boreal Initiative Fund - Ministry of Environment - Saskatchewan, Canada; Alberta Graduate Student Scholarship; Saskatchewan Fishand Wildlife Development Fund	This work was supported by the Natural Sciences and Engineering Research Council of Canada - grant # RGPIN-2014-03850 to JRS; Natural Sciences and Engineering Research Council of Canada - grant #RGPIN-2014-04842 to SEN; Alexander Graham Bell Canada Graduate Scholarship (NSERCCGS-M) to AJB; Walter H Johns Graduate Fellowship awarded to AJB; Boreal Initiative Fund - Ministry of Environment - Saskatchewan, Canada awarded to IDP and AJB; Alberta Graduate Student Scholarship awarded to AJB and the Saskatchewan Fishand Wildlife Development Fund awarded to AJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripT.	Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; [Anonymous], 2009, ANN SOC ENTOMOLOGIQU, V45, P327; Aranda SC, 2013, GLOBAL ECOL BIOGEOGR, V22, P483, DOI 10.1111/geb.12008; Bell AJ, 2017, CAN ENTOMOL, V149, P491, DOI 10.4039/tce.2017.12; BLAKE S, 1994, PEDOBIOLOGIA, V38, P502; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BOUSQUET Y, 1980, Naturaliste Canadien (Quebec), V107, P175; Bousquet Y., 2010, PENSOFT SERIES FAUNI, V90; CASE TJ, 1978, ECOLOGY, V59, P1, DOI 10.2307/1936628; Castro S, 2010, PLANT ECOL, V207, P359, DOI 10.1007/s11258-009-9679-z; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Currie CR, 1996, COLEOPTS BULL, V50, P135; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; den Boer P. J., 1970, Oecologia, V4, P1, DOI 10.1007/BF00390612; DENBOER PJ, 1980, ENTOMOL GEN, V6, P107; DENBOER PJ, 1987, ACTA PHYTOPATHOL HUN, V22, P71; DENBOER PJ, 1985, OECOLOGIA, V67, P322, DOI 10.1007/BF00384936; DENBOER PJ, 1990, J EVOLUTION BIOL, V3, P19, DOI 10.1046/j.1420-9101.1990.3010019.x; Desender Konjev, 2000, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Entomologie, V70, P13; Digweed SC, 1995, PEDOBIOLOGIA, V39, P561; Dondina O, 2017, J BIOGEOGR, V44, P1041, DOI 10.1111/jbi.12827; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Elek Z, 2007, ACTA OECOL, V32, P104, DOI 10.1016/j.actao.2007.03.008; FOSTER JB, 1964, NATURE, V202, P234, DOI 10.1038/202234a0; Franzen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037359; Gaublomme E, 2008, BIOL CONSERV, V141, P2585, DOI 10.1016/j.biocon.2008.07.022; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Hanski I, 2002, OIKOS, V98, P87, DOI 10.1034/j.1600-0706.2002.980109.x; Hanski I., 1999, METAPOPULATION ECOLO; Hubbel S. P., 2001, UNIFIED NEUTRAL THEO; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jonsson M, 2009, ECOGRAPHY, V32, P963, DOI 10.1111/j.1600-0587.2009.05784.x; Kadmon R, 2007, AM NAT, V170, P443, DOI 10.1086/519853; Karjalainen S., 2000, BEETLE MONITORING E; Kotze DJ, 2008, J INSECT CONSERV, V12, P265, DOI 10.1007/s10841-008-9147-4; Kotze DJ, 2002, J BIOGEOGR, V29, P375, DOI 10.1046/j.1365-2699.2002.00681.x; Kotze DJ, 2000, J BIOGEOGR, V27, P807, DOI 10.1046/j.1365-2699.2000.00456.x; Larocque I, 2000, CAN J FOREST RES, V30, P179, DOI 10.1139/cjfr-30-2-179; Lindroth C.H., 1985, Fauna Entomologica Scandinavica, V15, P1; Lindroth CH, 1969, OPUSCULA ENTOMOLOG S, V20, P24; Lindroth CH, 1986, FAUNA ENTOMOLOGICA 2; Lomolino MV, 2009, Q REV BIOL, V84, P357, DOI 10.1086/648123; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; Lomolino MV, 2001, PROG PHYS GEOG, V25, P1; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; MAC ARTHUR ROBERT H., 1967; MACARTHUR RH, 1972, ECOLOGY, V53, P330, DOI 10.2307/1934090; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Magura T, 2006, BASIC APPL ECOL, V7, P472, DOI 10.1016/j.baae.2005.08.005; Marris JWM, 2000, J ROY SOC NEW ZEAL, V30, P169, DOI 10.1080/03014223.2000.9517616; Matthews TJ, 2014, DIVERS DISTRIB, V20, P1136, DOI 10.1111/ddi.12227; McNab BK, 2002, ECOL LETT, V5, P693, DOI 10.1046/j.1461-0248.2002.00365.x; Nielsen S., 2016, FORESTS, V7, P1; Niemela J, 2002, LANDSCAPE ECOL, V17, P387, DOI 10.1023/A:1021270121630; NIEMELA J, 1988, ACTA OECOL-OEC GEN, V9, P379; NIEMELA J, 1985, J BIOGEOGR, V12, P109, DOI 10.2307/2844835; Palmer M, 2002, ACTA OECOL, V23, P103, DOI 10.1016/S1146-609X(02)01140-2; Parisien MA, 2004, NOR10394 NO FOR CTR, P49; Patino J, 2014, GLOBAL ECOL BIOGEOGR, V23, P1275, DOI 10.1111/geb.12230; R Core Team, 2013, R LANG ENV STAT COMP; Rawson DS, 1953, 1 DEP NAT RES FISH B, P39; Ribera I, 2001, ECOLOGY, V82, P1112, DOI 10.1890/0012-9658(2001)082[1112:EOLDAS]2.0.CO;2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoener T. W., 1976, P 16 INT ORN C, V6, P629; Shibuya S, 2014, J ASIA-PAC ENTOMOL, V17, P775, DOI 10.1016/j.aspen.2014.07.013; Shibuya S, 2011, EUR J ENTOMOL, V108, P453, DOI 10.14411/eje.2011.058; Sirois L, 1997, ECOSCIENCE, V4, P340, DOI 10.1080/11956860.1997.11682413; Solymos P, 2012, GLOBAL ECOL BIOGEOGR, V21, P109, DOI 10.1111/j.1466-8238.2011.00655.x; Spence JR, 1996, ANN ZOOL FENN, V33, P173; SPENCE JR, 1994, CAN ENTOMOL, V126, P881, DOI 10.4039/Ent126881-3; STORK NE, 1993, OIKOS, V67, P483, DOI 10.2307/3545360; SUSTEK Z, 1987, BIOLOGIA, V42, P145; Szyszko Jan, 2000, P289; Teller JT, 2004, GEOL SOC AM BULL, V116, P729, DOI 10.1130/B25316.1; Ulrich W, 2007, BASIC APPL ECOL, V8, P411, DOI 10.1016/j.baae.2006.08.002; Ulrich W, 2010, GLOBAL ECOL BIOGEOGR, V19, P905, DOI 10.1111/j.1466-8238.2010.00565.x; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; WALLIN H, 1992, ENTOMOL EXP APPL, V65, P129, DOI 10.1007/BF00221363; Watson H. C., 1859, CYBELE BRITANNICA BR; Weller B, 2004, BASIC APPL ECOL, V5, P193, DOI 10.1078/1439-1791-00220; WILL KW, 1995, GREAT LAKES ENTOMOL, V28, P55; Zalewski M, 2004, J BIOGEOGR, V31, P1139, DOI 10.1111/j.1365-2699.2004.01097.x; Zalewski M, 2012, ANN ZOOL FENN, V49, P139, DOI 10.5735/086.049.0302	85	9	9	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0190174	10.1371/journal.pone.0190174	http://dx.doi.org/10.1371/journal.pone.0190174			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261805	gold, Green Published, Green Submitted			2022-12-26	WOS:000418564200089
J	Boivin, A; Burban, M; Clere-Jehl, R; Le Borgne, P; Merdji, H; Auger, C; Schini-Kerth, V; Meziani, F; Helms, J				Boivin, Alexandra; Burban, Melanie; Clere-Jehl, Raphael; Le Borgne, Pierrick; Merdji, Hamid; Auger, Cyril; Schini-Kerth, Valerie; Meziani, Ferhat; Helms, Julie			Docosahexaenoic acid, but not eicosapentaenoic acid, improves septic shock-induced arterial dysfunction in rats	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ISCHEMIA-REPERFUSION INJURY; ACTIVATED PROTEIN-C; PARENTERAL-NUTRITION; ENDOTHELIAL DYSFUNCTION; MONOXIDE SYSTEM; OMEGA-3; MODEL; SUPPLEMENTATION; SEPSIS	Introduction Long chain n-3 fatty acid supplementation may modulate septic shock-induced host response to pathogen-induced sepsis. The composition of lipid emulsions for parenteral nutrition however remains a real challenge in intensive care, depending on their fatty acid content. Because they have not been assessed yet, we aimed at determining the respective effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) during septic shock-induced vascular dysfunction. Methods In a peritonitis-induced septic shock model, rats were infused with EPA, DHA, an EPA/DHA mixture or 5% dextrose (D5) during 22 hours. From H18, rats were resuscitated and monitored during 4 hours. At H22, plasma, aorta and mesenteric resistance arteries were collected to perform ex vivo experiments. Results We have shown that septic rats needed an active resuscitation with fluid challenge and norepinephrine treatment, while SHAM rats did not. In septic rats, norepinephrine requirements were significantly decreased in DHA and EPA/DHA groups (10.6 +/- 12.0 and 3.7 +/- 8.0 mu g/kg/min respectively versus 17.4 +/- 19.3 mu g/kg/min in D5 group, p<0.05) and DHA infusion significantly improved contractile response to phenylephrine through nitric oxide pathway inhibition. DHA moreover significantly reduced vascular oxidative stress and nitric oxide production, phosphorylated I.B expression and vasodilative prostaglandin production. DHA also significantly decreased polyunsaturated fatty acid pro-inflammatory mediators and significantly increased several anti-inflammatory metabolites. Conclusions DHA infusion in septic rats improved hemodynamic dysfunction through decreased vascular oxidative stress and inflammation, while EPA infusion did not have beneficial effects.	[Boivin, Alexandra; Burban, Melanie; Clere-Jehl, Raphael; Merdji, Hamid; Auger, Cyril; Schini-Kerth, Valerie; Meziani, Ferhat] Univ Strasbourg UNISTRA, Fac Med, Hop Univ Strasbourg, Serv Reanimat,Nouvel Hop Civil, Strasbourg, France; [Boivin, Alexandra; Clere-Jehl, Raphael; Merdji, Hamid; Meziani, Ferhat; Helms, Julie] INSERM, French Natl Inst Hlth & Med Res, FMTS, UMR 1260,Regenerat Nanomed RNM, Strasbourg, France; [Le Borgne, Pierrick] CHU Strasbourg, Hop Hautepierre, Serv Accueil Urgences, Strasbourg, France; [Helms, Julie] Univ Strasbourg, INSERM, EFS Grand Est, BPPS,UMR S 949,FMTS, Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Helms, J (corresponding author), INSERM, French Natl Inst Hlth & Med Res, FMTS, UMR 1260,Regenerat Nanomed RNM, Strasbourg, France.; Helms, J (corresponding author), Univ Strasbourg, INSERM, EFS Grand Est, BPPS,UMR S 949,FMTS, Strasbourg, France.	Julie.helms@chru-strasbourg.fr	Auger, Cyril/N-4702-2016; merdji, hamid/GXF-7656-2022	merdji, hamid/0000-0002-4670-1596; Helms, Julie/0000-0003-0895-6800				Alexander JW, 1998, NUTRITION, V14, P627, DOI 10.1016/S0899-9007(98)00004-5; Allaire J, 2016, AM J CLIN NUTR, V104, P280, DOI 10.3945/ajcn.116.131896; Barbosa VM, 2010, CRIT CARE, V14, DOI 10.1186/cc8844; BARTON RG, 1991, J TRAUMA, V31, P768, DOI 10.1097/00005373-199106000-00006; Bauer M, 2008, INTENS CARE MED, V34, P640, DOI 10.1007/s00134-008-1010-2; Boisrame-Helms J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147644; Boisrame-Helms J, 2015, PROG LIPID RES, V60, P1, DOI 10.1016/j.plipres.2015.08.002; Boisrame-Helms J, 2014, SHOCK, V42, P548, DOI 10.1097/SHK.0000000000000255; Boisrame-Helms J, 2014, THROMB HAEMOSTASIS, V111, P154, DOI 10.1160/TH13-04-0313; Boisrame-Helms J, 2013, CURR VASC PHARMACOL, V11, P150; Bouazza Y, 2011, INTENS CARE MED, V37, P1857, DOI 10.1007/s00134-011-2327-9; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Burban M, 2016, INTRAVENOUS BOLUS EP; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Calder PC, 2013, P NUTR SOC, V72, P263, DOI 10.1017/S0029665113001250; Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x; Calder PC, 2011, EUR J PHARMACOL, V668, pS50, DOI 10.1016/j.ejphar.2011.05.085; Coquerel D, 2013, INFLAMMATION, V36, P932, DOI 10.1007/s10753-013-9622-2; Daak AA, 2015, BLOOD CELL MOL DIS, V55, P48, DOI 10.1016/j.bcmd.2015.03.014; Dogne JM, 2005, TRENDS PHARMACOL SCI, V26, P639, DOI 10.1016/j.tips.2005.10.001; FISHER M, 1990, AM J CLIN NUTR, V51, P804, DOI 10.1093/ajcn/51.5.804; Friesecke S, 2008, INTENS CARE MED, V34, P1411, DOI 10.1007/s00134-008-1072-1; Ganster F, 2010, CRIT CARE, V14, DOI 10.1186/cc9257; Gortan Cappellari G, 2013, J NUTR BIOCHEM, V24, P371, DOI 10.1016/j.jnutbio.2012.07.012; Gultekin G, 2014, PAK J MED SCI, V30, P299; Hall TC, 2016, PROSTAG LEUKOTR ESS, V112, P1, DOI 10.1016/j.plefa.2016.07.001; Heller AR, 2006, CRIT CARE MED, V34, P972, DOI 10.1097/01.CCM.0000206309.83570.45; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Le Faouder P, 2013, J CHROMATOGR B, V932, P123, DOI 10.1016/j.jchromb.2013.06.014; Levy B, 2010, INTENS CARE MED, V36, P2019, DOI 10.1007/s00134-010-2045-8; Lin MT, 2007, NUTRITION, V23, P179, DOI 10.1016/j.nut.2006.11.005; Lu C, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0282-5; Mayer K, 2003, AM J RESP CRIT CARE, V167, P1321, DOI 10.1164/rccm.200207-674OC; Meziani F, 2007, AM J PATHOL, V171, P1753, DOI 10.2353/ajpath.2007.070316; Mori TA, 2000, CIRCULATION, V102, P1264, DOI 10.1161/01.CIR.102.11.1264; Rockett BD, 2012, J LIPID RES, V53, P674, DOI 10.1194/jlr.M021782; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Sennoun N, 2009, AM J PHYSIOL-HEART C, V297, pH277, DOI 10.1152/ajpheart.01133.2008; Shaikh SR, 2012, PROSTAG LEUKOTR ESS, V87, P205, DOI 10.1016/j.plefa.2012.09.007; Takaki S, 2010, INTENS CARE MED, V36, P42, DOI 10.1007/s00134-009-1575-4; Tuller ER, 2009, MOL PHARMACOL, V76, P588, DOI 10.1124/mol.109.057430; Tunctan B, 2013, NITRIC OXIDE-BIOL CH, V33, P18, DOI 10.1016/j.niox.2013.05.001; Wanten GJA, 2007, AM J CLIN NUTR, V85, P1171; Zeghichi-Hamri S, 2010, NUTR RES, V30, P849, DOI 10.1016/j.nutres.2010.10.010; Zhang R, 2015, NUTRITION, V31, P508, DOI 10.1016/j.nut.2014.10.015	45	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189658	10.1371/journal.pone.0189658	http://dx.doi.org/10.1371/journal.pone.0189658			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261735	Green Published, Green Submitted, gold			2022-12-26	WOS:000418564200052
J	Lee, SR; Choi, EK; Han, KD; Cha, MJ; Oh, S; Lip, GYH				Lee, So-Ryoung; Choi, Eue-Keun; Han, Kyung-Do; Cha, Myung-Jin; Oh, Seil; Lip, Gregory Y. H.			Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study	PLOS ONE			English	Article							RISK-FACTOR; CHA(2)DS(2)-VASC SCORE; ISCHEMIC-STROKE; WARFARIN; METAANALYSIS	Background Following their introduction, the non-vitamin K antagonist oral anticoagulants (NOACs) are increasingly prescribed in Asia for stroke prevention in patients with non-valvular atrial fibrillation (AF). Few contemporary data are available on temporal trends in antithrombotic therapy use in Asian countries, in the era of NOACs. Methods and results Using the National Health Insurance Service database of the entire Korean adult AF population, the use of aspirin, vitamin K antagonist, and NOACs between 2008 and 2015 were analyzed (n = 276,246 in 2015). Most of the included cohort had CHA(2)DS(2)-VASc score >= 2 (78.2% in 2008 and 83.2% in 2015), yet approximately 17% were prescribed no antithrombotic therapy throughout the study period. Aspirin prescription consistently decreased (from 48.2% to 31.5%) over time, while OAC prescription significantly increased from 34.7% to 50.6%. NOAC prescriptions accounted for 50% of total OAC prescription in 2015. Similar trends in antithrombotic therapy were found both in men and in women, but women were more likely to be undertreated with OAC. Female gender, presence of vascular disease and prior intracranial hemorrhage were associated with OAC underuse. Conclusions Between 2008 and 2015, a greater proportion of AF patients received OAC treatment with increasing NOAC prescription trends in the recent 3 years. A substantial proportion (approx. 50%) of Korean patients with AF still remain undertreated.	[Lee, So-Ryoung] Soon Chun Hyang Univ Hosp Seoul, Dept Internal Med, Seoul, South Korea; [Choi, Eue-Keun; Cha, Myung-Jin; Oh, Seil] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Han, Kyung-Do] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Lip, Gregory Y. H.] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England; [Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark	Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea; University of Birmingham; Aalborg University	Choi, EK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.	choiek17@snu.ac.kr	Choi, Eue-Keun/J-5968-2014; Oh, Seil/J-5539-2012; Choi, Eue-Keun/K-3752-2019	Choi, Eue-Keun/0000-0002-0411-6372; Oh, Seil/0000-0002-2504-9615; 	SNUH Research Fund [0620160680, 3020170040]; Korean National Research Foundation of Korea (NRF) - Ministry of Education, Science, Technology [2014R1A1A2A16055218]; Korean Healthcare technology R&D project - Ministry of Health Welfare [HI15C1200]; EKC	SNUH Research Fund; Korean National Research Foundation of Korea (NRF) - Ministry of Education, Science, Technology; Korean Healthcare technology R&D project - Ministry of Health Welfare; EKC	This study was supported by a by grant No. 0620160680, 3020170040 from the SNUH Research Fund, from Korean National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, Technology (2014R1A1A2A16055218), and the Korean Healthcare technology R&D project funded by the Ministry of Health & Welfare (HI15C1200). Person who received the funding: EKC.	Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Bungard TJ, 2000, ARCH INTERN MED, V160, P41, DOI 10.1001/archinte.160.1.41; Camm AJ, 2017, HEART, V103, P307, DOI 10.1136/heartjnl-2016-309832; Camm AJ, 2012, EUR HEART J, V33; Chao TF, 2016, MAYO CLIN PROC, V91, P567, DOI 10.1016/j.mayocp.2016.03.007; Chao TF, 2015, CIRCULATION, V132, P1604, DOI 10.1161/CIRCULATIONAHA.114.013709; Chao TF, 2015, J AM COLL CARDIOL, V65, P635, DOI 10.1016/j.jacc.2014.11.046; Choi EJ, 2016, INT J CARDIOL, V220, P647, DOI 10.1016/j.ijcard.2016.06.177; Dlott JS, 2014, CIRCULATION, V129, P1407, DOI 10.1161/CIRCULATIONAHA.113.002601; Eckman MH, 2011, CIRC-CARDIOVASC QUAL, V4, P14, DOI 10.1161/CIRCOUTCOMES.110.958108; Fauchier L, 2016, STROKE, V47, P1831, DOI 10.1161/STROKEAHA.116.013253; Fosbol EL, 2013, AM HEART J, V166, P864, DOI 10.1016/j.ahj.2013.08.005; Freedman B, 2016, LANCET, V388, P806, DOI 10.1016/S0140-6736(16)31257-0; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hsu JC, 2016, J AM COLL CARDIOL, V67, P2913, DOI 10.1016/j.jacc.2016.03.581; Huisman MV, 2017, J AM COLL CARDIOL, V69, P777, DOI 10.1016/j.jacc.2016.11.061; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Joundi RA, 2016, STROKE, V47, P1364, DOI 10.1161/STROKEAHA.115.012609; Jung BC, 2015, KOREAN CIRC J, V45, P9, DOI 10.4070/kcj.2015.45.1.9; Kang SH, 2017, CIRC J, V81, P1158, DOI 10.1253/circj.CJ-16-1267; Kang SH, 2016, INT J CARDIOL, V215, P449, DOI 10.1016/j.ijcard.2016.04.036; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Lee H, 2017, LIVER INT; Lee H, 2017, INT J CARDIOL, V240, P221, DOI 10.1016/j.ijcard.2017.03.103; Lee IH, 2015, J CARDIOL, V66, P475, DOI 10.1016/j.jjcc.2015.06.013; Lee SR, 2017, INT J CARDIOL, V236, P226, DOI 10.1016/j.ijcard.2017.02.039; Lee SR, 2016, INT J CARDIOL, V223, P953, DOI 10.1016/j.ijcard.2016.08.296; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Oh S, 2016, INT J CARDIOL, V223, P543, DOI 10.1016/j.ijcard.2016.08.236; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Wilke T, 2015, J THROMB THROMBOLYS, V40, P97, DOI 10.1007/s11239-014-1136-8	33	57	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189495	10.1371/journal.pone.0189495	http://dx.doi.org/10.1371/journal.pone.0189495			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261716	Green Submitted, gold, Green Published			2022-12-26	WOS:000418564200043
J	Traore, K; Thera, MA; Bienvenu, AL; Arama, C; Bonnot, G; Lavoignat, A; Doumbo, OK; Picot, S				Traore, Karim; Thera, Mahamadou A.; Bienvenu, Anne-Lise; Arama, Charles; Bonnot, Guillaume; Lavoignat, Adeline; Doumbo, Ogobara K.; Picot, Stephane			Interaction between environment, nutrient-derived metabolites and immunity: A possible role in malaria susceptibility/resistance in Fulani and Dogon of Mali	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; SYMPATRIC ETHNIC-GROUPS; TYPE-2 DIABETES-MELLITUS; RAGE GENE POLYMORPHISMS; OXIDATIVE STRESS; INFLAMMATORY RESPONSE; INFECTED ERYTHROCYTES; RECEPTOR; PARASITE; GLYCOTOXINS	The role of some nutrient-derived metabolites on the innate and adaptive immune responses is now established. Global research approach investigating the interplay between environment, lifestyle and the host's immune responses is crucial in the understanding of malaria susceptibility. Advanced Glycation end products (AGE), which are food-derived metabolites result from the link between reducing sugar and amino group of proteins, lipids or nucleic acids. The level of exposure to AGEs varies depending on the type of diet. The dysfunction of the immune system induced by AGE and the cellular receptors for AGEs (RAGE) in susceptibility to bacterial infection has been described. But no study has yet explored their role in susceptibility to malaria. Therefore, we aimed to evaluate systemic AGE and RAGE gene polymorphism in two sympatric populations with previously described difference of susceptibility to malaria. We measured by ELISA the plasma levels of AGEs, and their soluble receptors (sRAGE) from 170 volunteers (68 Fulani and 102 Dogon). We also determined by real-time quantitative PCR the expression of RAGE, and the -374 T/A, -429 T/C polymorphisms and 63 bp deletion by fragment length restriction polymorphism. The prevalence rate of Plasmodium in Fulani and Dogon were respectively 42.64% and 51.30% for P. falciparum, 5.88% and 6.5% for P. malariae, 0% and 2.6% for P. ovale. The average AGE was 12.65 mu g/ml, and 496.48 pg/ml for sRAGE. Highest levels of sRAGE were observed in Fulani (563,07 pg/ml, 95% CI [547.81 +/- 580.13] vs 465.68 pg/ml, 95% CI [331.19 +/- 467.51]) for Dogon, p = 0.00001. Fulani had the lowest mean of AGE (10.21 mu g/ml, 95% CI [8.02 +/- 10.92]) compared to Dogon (16.88 mu g/ml, 95% CI [13.92 +/- 17.96]; p = 0.00001. RAGE was more expressed in Dogon than Fulani (0.08 vs 0.04), P = 0.08. The -374A polymorphism vas more frequent in Fulani (32%) compared to Dogon (20%). The chronic exposure to dietary AGE could lead to immune responses impairment and polymorphism with implications in malaria susceptibility. More studies are necessary to better investigate this hypothesis.	[Traore, Karim; Thera, Mahamadou A.; Arama, Charles; Doumbo, Ogobara K.] Univ Sci Tech & Technol Bamako, Malaria Res & Training Ctr, MRTC USTTB, Bamako, Mali; [Traore, Karim; Bienvenu, Anne-Lise; Bonnot, Guillaume; Lavoignat, Adeline; Picot, Stephane] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS,CPE,Malaria Res Unit, Inst Chim & Biochim Mol & Supramol,UMR 5246,INSA, Lyon, France; [Bienvenu, Anne-Lise; Picot, Stephane] Hosp Civils Lyon, Inst Parasitol & Mycol Med, Lyon, France	University of Science & Technology of Bamako; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Traore, K (corresponding author), Univ Sci Tech & Technol Bamako, Malaria Res & Training Ctr, MRTC USTTB, Bamako, Mali.; Traore, K (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, CNRS,CPE,Malaria Res Unit, Inst Chim & Biochim Mol & Supramol,UMR 5246,INSA, Lyon, France.	karim@icermali.org	picot, stephane/F-5973-2014	picot, stephane/0000-0002-5735-6759; Thera, Mahamadou A/0000-0002-2679-035X; Traore, Karim/0000-0002-9553-6611; Bienvenu, Anne-Lise/0000-0003-1502-1851	Etablissements Francais du Sang (EFS-Marseille); Malaria Research and Training Center [MRTC-UMI 3381]; Malaria Research Unitc (UCBL, Lyon, France)	Etablissements Francais du Sang (EFS-Marseille); Malaria Research and Training Center; Malaria Research Unitc (UCBL, Lyon, France)	Part of this research has been funded by: Etablissements Francais du Sang (EFS-Marseille); Malaria Research and Training Center (MRTC-UMI 3381, Mali); Malaria Research Unitc (UCBL, Lyon, France). No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034698; Arama C, 2015, ACTA TROP, V146, P152, DOI 10.1016/j.actatropica.2015.03.023; Arama C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018319; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Carter Lucy M., 2013, Evolution Medicine and Public Health, P135, DOI 10.1093/emph/eot011; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; CERAMI A, 1988, DIABETES CARE, V11, P73; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Christaki E, 2012, CURR OPIN INFECT DIS, V25, P304, DOI 10.1097/QCO.0b013e3283519b82; Clark IA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-85; Cornet S, 2014, J ANIM ECOL, V83, P256, DOI 10.1111/1365-2656.12113; Dolo A, 2005, AM J TROP MED HYG, V72, P243, DOI 10.4269/ajtmh.2005.72.243; Dolo A, 2012, Bull Soc Pathol Exot, V105, P364, DOI 10.1007/s13149-012-0262-9; Falcone C, 2013, INT J MOL SCI, V14, P23203, DOI 10.3390/ijms141123203; Farouk SE, 2005, MICROBES INFECT, V7, P110, DOI 10.1016/j.micinf.2004.09.012; Goldberg T, 2004, J AM DIET ASSOC, V104, P1287, DOI 10.1016/j.jada.2004.05.214; GOLENSER J, 1989, SEMIN HEMATOL, V26, P313; Gonzalez I, 2013, IMMUNOBIOLOGY, V218, P790, DOI 10.1016/j.imbio.2012.09.005; Hudson BI, 2014, METABOLISM, V63, P1125, DOI 10.1016/j.metabol.2014.05.011; HUNT NH, 1990, BLOOD CELLS, V16, P499; Ibrahim M. A., 2012, Comparative Clinical Pathology, V21, P1677, DOI 10.1007/s00580-011-1348-7; Isah MB, 2014, PARASITOL RES, V113, P801, DOI 10.1007/s00436-014-3804-1; Israelsson E, 2011, INFECT GENET EVOL, V11, P1608, DOI 10.1016/j.meegid.2011.05.021; Israelsson E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-136; Israelsson E, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-175; Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lokki AI, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-9; Maiga B, 2014, SCAND J IMMUNOL, V79, P43, DOI 10.1111/sji.12122; Martinez PJ, 2014, TRANSL RES, V163, P53, DOI 10.1016/j.trsl.2013.07.005; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Peng WH, 2009, ARCH MED RES, V40, P393, DOI 10.1016/j.arcmed.2009.06.008; Perdijk O, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-432; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Schlienger JL, 2010, MED MALADIES METABOL, V4, P653; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Traore K, 2016, PARASITE, V23, DOI 10.1051/parasite/2016015; Uribarri J, 2005, ANN NY ACAD SCI, V1043, P461, DOI 10.1196/annals.1333.052; Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427; Uribarri J, 2010, J AM DIET ASSOC, V110, P911, DOI 10.1016/j.jada.2010.03.018; van Zoelen Marieke A D, 2011, Front Biosci (Schol Ed), V3, P1119; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; Veldhoen M, 2015, NAT MED, V21, P709, DOI 10.1038/nm.3894; Xu Q, 2012, CANCER BIOMARK, V11, P147, DOI 10.3233/CBM-2012-00277; Yan SF, 2010, BIOCHEM PHARMACOL, V79, P1379, DOI 10.1016/j.bcp.2010.01.013; Yang L, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/264579; Yilmaz B, 2014, CELL, V159, P1277, DOI 10.1016/j.cell.2014.10.053; Zhang GC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-134	48	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189724	10.1371/journal.pone.0189724	http://dx.doi.org/10.1371/journal.pone.0189724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261755	Green Published, Green Submitted, gold			2022-12-26	WOS:000418564200058
J	Dittmann, K; Mayer, C; Czemmel, S; Huber, SM; Rodemann, HP				Dittmann, Klaus; Mayer, Claus; Czemmel, Stefan; Huber, Stephan M.; Rodemann, H. Peter			New roles for nuclear EGFR in regulating the stability and translation of mRNAs associated with VEGF signaling	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; PHOSPHORYLATION; DEADENYLATION; TRANSCRIPTION; ACTIVATION; PROTEINS; DATABASE; IMPORT; CANCER	Cell membrane-associated epidermal growth factor receptor (EGFR) translocates into a perinuclear/nuclear location upon stimulation, where it complexes with mRNAs. Treatment with radiation and cisplatin decreases the amounts of mRNAs present within this complex. Gene array analyses of mRNAs in complex with immunoprecipitated nEGFR revealed significant enrichment of different mRNA species compared to the control immunoprecipitation. Functional annotation with help of DAVID Gene Ontology Analysis identified under other terms the HIF-1A/VEGF signaling pathway as one of the top scoring KEGG pathways. RT-PCR and western blots revealed the radiation-induced expression of mRNAs and proteins involved in HIF-1A/VEGF signaling. Simultaneously, the levels of the corresponding validated miRNAs within the complex containing nEGFR and mRNAs were decreased. This finding argues that an mRNA/miRNA/nEGFR complex regulates protein expression. Indeed, we detected the GW182, AGO2, PABPC1 and cNOT1 proteins, which belong to the deadenylase complex, in a complex with nuclear EGFR. Erlotinib-mediated inhibition of EGFR kinase reduced the radiation-induced increase in mRNA expression. In this context, erlotinib reduced AGO2 phosphorylation by the EGFR kinase at residue Y393, which was associated with increased cNOT1 deadenylase activity and reduced mRNA stability. To prove the roles of miRNAs in this context, we transfected cells with an inhibitor of Hsa-mir-1180p5, which targets the NFATC4 mRNA, an mRNA associated with VEGF signaling, or pretreated cells with erlotinib. Indeed, Hsa-mir-1180p5 knockdown increased and the erlotinib treatment decreased the expression of the NFATC4 protein. The expression of the NFATC4 protein controlled the cloning efficiency and radiosensitivity of A549 and FaDu tumor cells. Thus, this study is the first to show that a membrane-located tyrosine kinase receptor, such as EGFR, is internalized to a nuclear/perinuclear location upon exposure to stress and modulates the stability and translation of miRNA-selected mRNAs. This mechanism enables cells to directly express proteins in response to EGFR activation and may contribute to treatment resistance in EGFR-overexpressing tumors.	[Dittmann, Klaus; Mayer, Claus; Rodemann, H. Peter] Univ Tubingen, Div Radiobiol & Mol Environm Res, Tubingen, Germany; [Dittmann, Klaus; Mayer, Claus; Huber, Stephan M.; Rodemann, H. Peter] Univ Tubingen, Dept Radiat Oncol, Tubingen, Germany; [Dittmann, Klaus; Mayer, Claus; Huber, Stephan M.; Rodemann, H. Peter] German Canc Consortium DKTK, Partner Site Tuebingen, Heidelberg, Germany; [Dittmann, Klaus; Mayer, Claus; Huber, Stephan M.; Rodemann, H. Peter] German Canc Res Ctr, Heidelberg, Germany; [Czemmel, Stefan] Univ Tubingen, Quantitat Biol Ctr QBiC, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen	Dittmann, K (corresponding author), Univ Tubingen, Div Radiobiol & Mol Environm Res, Tubingen, Germany.; Dittmann, K (corresponding author), Univ Tubingen, Dept Radiat Oncol, Tubingen, Germany.; Dittmann, K (corresponding author), German Canc Consortium DKTK, Partner Site Tuebingen, Heidelberg, Germany.; Dittmann, K (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	klaus.dittmann@uni-tuebingen.de		Huber, Stephan/0000-0002-9430-8334	Deutsche Forschungsgemeinschaft [Di402/9-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft, [Di402/9-2].	Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brand TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071518; Brand TM, 2011, DISCOV MED, V12, P419; Chen CYA, 2013, ADV EXP MED BIOL, V768, P183, DOI 10.1007/978-1-4614-5107-5_11; Chen CYA, 2009, NAT STRUCT MOL BIOL, V16, P1160, DOI 10.1038/nsmb.1709; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Das AK, 2007, CANCER RES, V67, P5267, DOI 10.1158/0008-5472.CAN-07-0242; DELALLEMANDBREI.V, 2010, COLD SPRING HARB PER, V2; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dittmann K, 2005, RADIOTHER ONCOL, V76, P157, DOI 10.1016/j.radonc.2005.06.022; Dittmann K, 2015, RADIOTHER ONCOL, V116, P431, DOI 10.1016/j.radonc.2015.08.016; Dittmann K, 2011, RADIOTHER ONCOL, V99, P317, DOI 10.1016/j.radonc.2011.06.001; Dittmann K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-69; Klaus HD, 2008, INT J RADIAT ONCOL, V70, P203, DOI 10.1016/j.ijrobp.2007.08.065; Dweep H, 2014, METHODS MOL BIOL, V1182, P289, DOI 10.1007/978-1-4939-1062-5_25; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Goodisman MAD, 2005, EVOLUTION, V59, P858, DOI 10.1111/j.0014-3820.2005.tb01759.x; Guo G, 2015, CANCER RES, V75, P3436, DOI 10.1158/0008-5472.CAN-15-0989; Harnisch C, 2012, ENZYMES, V31, P181, DOI 10.1016/B978-0-12-404740-2.00009-4; Harper S, 2011, METHODS MOL BIOL, V681, P259, DOI 10.1007/978-1-60761-913-0_14; Hessmann E, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5272498; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Huntzinger E, 2013, NUCLEIC ACIDS RES, V41, P978, DOI 10.1093/nar/gks1078; Inada T, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00135; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacobson A, 2004, MOL CELL, V15, P1, DOI 10.1016/j.molcel.2004.06.031; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kalantari R, 2016, NUCLEIC ACIDS RES, V44, P524, DOI 10.1093/nar/gkv1305; Kim D, 2016, J BIOL CHEM, V291, P16271, DOI 10.1074/jbc.M116.715797; Lee HH, 2015, AM J CANCER RES, V5, P2944; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Maryatiy M, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt972; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Patel PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150291; Piao XH, 2010, MOL CELL BIOL, V30, P1486, DOI 10.1128/MCB.01481-09; Qin JJ, 2014, BBA-REV CANCER, V1846, P297, DOI 10.1016/j.bbcan.2014.07.009; Rankin EB, 2016, SCIENCE, V352, P175, DOI 10.1126/science.aaf4405; Shen J, 2013, NATURE, V497, P383, DOI 10.1038/nature12080; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Tomas A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8324; Wang HY, 2015, ONCOTARGET, V6, P20711, DOI 10.18632/oncotarget.4133; Wang J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.474; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Wang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139285; Wang YN, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-13; Yamaguchi H, 2014, ONCOGENE, V33, P1073, DOI 10.1038/onc.2013.74; Yang M, 2014, MOL CELL, V55, P782, DOI 10.1016/j.molcel.2014.07.018; Yu YL, 2012, J BIOL CHEM, V287, P31015, DOI 10.1074/jbc.M112.358077; Zakharkin SO, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-214	54	15	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189087	10.1371/journal.pone.0189087	http://dx.doi.org/10.1371/journal.pone.0189087			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253018	gold, Green Published, Green Submitted			2022-12-26	WOS:000418389500012
J	Ha, S; Kim, I; Takata, T; Kinouchi, T; Isoyama, M; Suzuki, M; Fujii, N				Ha, Seongmin; Kim, Ingu; Takata, Takumi; Kinouchi, Tadatoshi; Isoyama, Masaharu; Suzuki, Minoru; Fujii, Noriko			Identification of D-amino acid-containing peptides in human serum	PLOS ONE			English	Article							MASS-SPECTROMETRY; ASPARTYL RESIDUES; PLASMA-PROTEOME; ISOMERIZATION; BIOMARKERS; FIBRINOGEN; RACEMIZATION; DEAMIDATION; DISEASE; TISSUES	Biologically uncommon D-aspartate (D-Asp) residues have been shown to accumulate in proteins associated with age-related human disorders, such as cataract and Alzheimer disease. Such D-Asp-containing proteins are unlikely to be broken down completely because metabolic enzymes recognize only proteins or peptides composed exclusively of L-amino acids. Therefore, undigested D-Asp-containing peptides may exist in blood and, if detectable, may be a useful biomarker for associated diseases. In this study, we investigated D-amino acid-containing peptides in adult human serum by a qualitative D-amino acid analysis based on a diastereomer method and LC-MS/MS method. As a result, two D-Asp-containing peptides were detected in serum, both derived from the fibrinogen beta-chain, a glycoprotein that helps in the formation of blood clots. One of the peptides was fibrinopeptide B, which prevents fibrinogen from forming polymers of fibrin, and the other was same peptide with C-terminal Arginine missing. To our knowledge, this is the first report of the presence of D-amino acid-containing peptides in serum and the approach described will provide a new direction on the serum proteome and fragmentome.	[Ha, Seongmin; Kinouchi, Tadatoshi] Kyoto Univ, Grad Sch Sci, Kyoto, Japan; [Kim, Ingu; Takata, Takumi; Kinouchi, Tadatoshi; Suzuki, Minoru; Fujii, Noriko] Kyoto Univ, Inst Res Reactor, Osaka, Japan; [Isoyama, Masaharu] Prot Res Fdn, Osaka, Japan	Kyoto University; Kyoto University	Fujii, N (corresponding author), Kyoto Univ, Inst Res Reactor, Osaka, Japan.	nfujii@rri.kyoto-u.ac.jp		Takata, Takumi/0000-0003-3208-3704	Ministry of Education, Culture, Sports, Science and Technology of Japan [25288075]; Grants-in-Aid for Scientific Research [17K13221] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grant Number: 25288075 (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-25288075/) to NF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Bauer JW, 2006, PLOS MED, V3, P2274, DOI 10.1371/journal.pmed.0030491; Berhane BT, 2005, PROTEOMICS, V5, P3520, DOI 10.1002/pmic.200401308; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; BROCCARDO M, 1981, BRIT J PHARMACOL, V73, P625, DOI 10.1111/j.1476-5381.1981.tb16797.x; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; Ebert MPA, 2006, J PROTEOME RES, V5, P2152, DOI 10.1021/pr060011c; FELBECK H, 1987, BIOL BULL, V173, P252, DOI 10.2307/1541877; Friedman M, 2010, CHEM BIODIVERS, V7, P1491, DOI 10.1002/cbdv.200900225; Fujii N, 2002, BIOCHEM BIOPH RES CO, V294, P1047, DOI 10.1016/S0006-291X(02)00597-1; FUJII N, 1994, BBA-PROTEIN STRUCT M, V1204, P157, DOI 10.1016/0167-4838(94)90003-5; Fujii N, 2002, ORIGINS LIFE EVOL B, V32, P103, DOI 10.1023/A:1016031014871; Fujii N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.399972; Fujii N, 2011, BIOCHEMISTRY-US, V50, P8628, DOI 10.1021/bi200983g; Fujii N, 2016, BBA-GEN SUBJECTS, V1860, P183, DOI 10.1016/j.bbagen.2015.08.001; Furuchi T, 2005, BIOL PHARM BULL, V28, P1566, DOI 10.1248/bpb.28.1566; GEIGER T, 1987, J BIOL CHEM, V262, P785; Guo QQ, 2009, PANCREAS, V38, pE75, DOI 10.1097/MPA.0b013e3181987d86; HASHIMOTO A, 1992, FEBS LETT, V296, P33, DOI 10.1016/0014-5793(92)80397-Y; He QY, 2003, PROTEOMICS, V3, P666, DOI 10.1002/pmic.200300394; JOLLES P, 1998, D AMINO ACIDS SEQUEN; Liao H, 2004, ARTHRITIS RHEUM-US, V50, P3792, DOI 10.1002/art.20720; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; NAGATA Y, 1989, EXPERIENTIA, V45, P330, DOI 10.1007/BF01957466; Ollivaux C, 2014, J PEPT SCI, V20, P595, DOI 10.1002/psc.2637; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Shi YH, 2013, J AM CHEM SOC, V135, P15897, DOI 10.1021/ja407801x; Tian H, 2017, SCI REP-UK, V7, DOI 10.1038/srep46289; Tirumalai RS, 2003, MOL CELL PROTEOMICS, V2, P1096, DOI 10.1074/mcp.M300031-MCP200; Villanueva J, 2006, MOL CELL PROTEOMICS, V5, P1840, DOI 10.1074/mcp.M600229-MCP200; WILHELMSEN L, 1984, NEW ENGL J MED, V311, P501, DOI 10.1056/NEJM198408233110804; YasudaKamatani Y, 1997, PEPTIDES, V18, P347, DOI 10.1016/S0196-9781(96)00343-9	32	14	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189972	10.1371/journal.pone.0189972	http://dx.doi.org/10.1371/journal.pone.0189972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253022	Green Published, gold, Green Submitted			2022-12-26	WOS:000418389500082
J	Steinmann, ME; Schmidt, RS; Macedo, JP; Renggli, CK; Butikofer, P; Rentsch, D; Maser, P; Sigel, E				Steinmann, Michael E.; Schmidt, Remo S.; Macedo, Juan P.; Renggli, Christina Kunz; Butikofer, Peter; Rentsch, Doris; Maser, Pascal; Sigel, Erwin			Identification and characterization of the three members of the CLC family of anion transport proteins in Trypanosoma brucei	PLOS ONE			English	Article							CHLORIDE CHANNEL; GENE-EXPRESSION; REQUIRES OSTM1; MESSENGER-RNA; BETA-SUBUNIT; LOCALIZATION; CLONING; TRANSFORMATION; INHIBITION; SELECTION	CLC type anion transport proteins are homo-dimeric or hetero-dimeric with an integrated transport function in each subunit. We have identified and partially characterized three members of this family named TbVCL1, TbVCL2 and TbVCL3 in Trypanosoma brucei. Among the human CLC family members, the T. brucei proteins display highest similarity to CLC-6 and CLC-7. TbVCL1, but not TbVCL2 and TbVCL3 is able to complement growth of a CLC-deficient Saccharomyces cerevisiae mutant. All TbVCL-HA fusion proteins localize intracellulary in procyclic form trypanosomes. TbVCL1 localizes close to the Golgi apparatus and TbVCL2 and TbVCL3 to the endoplasmic reticulum. Upon expression in Xenopus oocytes, all three proteins induce similar outward rectifying chloride ion currents. Currents are sensitive to low concentrations of DIDS, insensitive to the pH in the range 5.4 to 8.4 and larger in nitrate than in chloride medium.	[Steinmann, Michael E.; Butikofer, Peter; Sigel, Erwin] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Schmidt, Remo S.; Renggli, Christina Kunz; Maser, Pascal] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Schmidt, Remo S.; Renggli, Christina Kunz; Maser, Pascal] Univ Basel, Basel, Switzerland; [Macedo, Juan P.; Rentsch, Doris] Univ Bern, Inst Plant Sci, Bern, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Bern	Sigel, E (corresponding author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.	sigel@ibmm.unibe.ch	; Macedo, Juan/B-4151-2017	Schmidt, Remo S./0000-0002-6599-9201; Rentsch, Doris/0000-0003-4313-7683; Macedo, Juan/0000-0001-5759-1196; Maser, Pascal/0000-0003-3122-1941	Swiss National Science Foundation [CRSII3_141913/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Sinergia grant CRSII3_141913/1 from the Swiss National Science Foundation (http://www.snf.ch) (PB, DR, PM, ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Roland Baur for contributing some experiments. This work was supported by Sinergia grant CRSII3_141913/1 from the Swiss National Science Foundation.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Braun NA, 2010, J CELL SCI, V123, P2342, DOI 10.1242/jcs.068403; Brenndorfer M, 2010, MOL BIOCHEM PARASIT, V172, P52, DOI 10.1016/j.molbiopara.2010.03.007; Burchmore RJS, 2003, J BIOL CHEM, V278, P23502, DOI 10.1074/jbc.M301252200; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Buyse G, 1997, J BIOL CHEM, V272, P3615, DOI 10.1074/jbc.272.6.3615; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; De Angeli A, 2009, PHILOS T R SOC B, V364, P195, DOI 10.1098/rstb.2008.0128; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Dean S, 2017, TRENDS PARASITOL, V33, P80, DOI 10.1016/j.pt.2016.10.009; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Eddy Sean R, 2009, Genome Inform, V23, P205; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enz R, 1999, J NEUROSCI, V19, P9841; Estevez R, 2004, J PHYSIOL-LONDON, V557, P363, DOI 10.1113/jphysiol.2003.058453; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; Gonzalez-Salgado A, 2012, J BIOL CHEM, V287, P13313, DOI 10.1074/jbc.M112.344812; GREENE JR, 1993, MOL GEN GENET, V241, P542, DOI 10.1007/BF00279896; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jentsch TJ, 2015, J PHYSIOL-LONDON, V593, P4091, DOI 10.1113/JP270043; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Jeworutzki E, 2012, NEURON, V73, P951, DOI 10.1016/j.neuron.2011.12.039; Kida Y, 2001, HISTOCHEM CELL BIOL, V115, P189; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maser P, 2003, DRUG RESIST UPDATE, V6, P281, DOI 10.1016/j.drup.2003.09.001; Mathieu C, 2014, BIOCHEM J, V463, P9, DOI 10.1042/BJ20140719; Matulef K, 2005, BIOPHYS J, V89, P1721, DOI 10.1529/biophysj.105.066522; Neagoe I, 2010, J BIOL CHEM, V285, P21689, DOI 10.1074/jbc.M110.125971; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ortiz D, 2009, MOL BIOCHEM PARASIT, V163, P67, DOI 10.1016/j.molbiopara.2008.09.011; Picollo A, 2004, EMBO REP, V5, P584, DOI 10.1038/sj.embor.7400169; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Schmidt RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093875; Schwappach B, 1998, J BIOL CHEM, V273, P15110, DOI 10.1074/jbc.273.24.15110; Serricchio M, 2013, MOL MICROBIOL, V87, P569, DOI 10.1111/mmi.12116; Sigel E, 2005, MOL NUTR FOOD RES, V49, P228, DOI 10.1002/mnfr.200400104; Steinmann ME, 2015, FASEB J, V29, P3228, DOI 10.1096/fj.15-271353; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	49	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0188219	10.1371/journal.pone.0188219	http://dx.doi.org/10.1371/journal.pone.0188219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244877	Green Published, gold, Green Submitted			2022-12-26	WOS:000418184700004
J	Monickaraj, F; McGuire, P; Das, A				Monickaraj, Finny; McGuire, Paul; Das, Arup			Cathepsin D plays a role in endothelial-pericyte interactions during alteration of the blood-retinal barrier in diabetic retinopathy	FASEB JOURNAL			English	Article						DPP4 inhibitor; endothelium; CI-MPR/IGF2R; CaMKII; PKC-alpha	MANNOSE 6-PHOSPHATE RECEPTOR; PEPTIDASE IV INHIBITOR; II BINDING-SITE; N-CADHERIN; VE-CADHERIN; IGF-II; INFLAMMATION; CELLS; NEPHROPATHY; RECOGNITION	Inflammation plays an important role in the pathogenesis of diabetic retinopathy. We have previously demonstrated the effect of cathepsin D (CD) on the mechanical disruption of retinal endothelial cell junctions and increased vasopermeability, as well as increased levels of CD in retinas of diabetic mice. Here, we have also examined the effect of CD on endothelial-pericyte interactions, as well as the effect of dipeptidyl peptidase-4 (DPP4) inhibitor on CD in endothelial-pericyte interactions in vitro and in vivo. Cocultured cells that were treated with pro-CD demonstrated a significant decrease in the expression of platelet-derived growth factor receptor-beta, a tyrosine kinase receptor that is required for pericyte cell survival; N-cadherin, the key adherens junction protein between endothelium and pericytes; and increases in the vessel destabilizing agent, angiopoietin-2. The effect was reversed in cells that were treated with DPP4 inhibitor along with pro-CD. With pro-CD treatment, there was a significant increase in the phosphorylation of the downstream signaling protein, PKC-alpha, and Ca2+/calmodulin-dependent protein kinase II in endothelial cells and pericytes, which disrupts adherens junction structure and function, and this was significantly reduced with DPP4 inhibitor treatment. Increased CD levels, vasopermeability, and alteration in junctional-related proteins were observed in the retinas of diabetic rats, which were significantly changed with DPP4 inhibitor treatment. Thus, DPP4 inhibitors may be used as potential adjuvant therapeutic agents to treat increased vascular leakage observed in patients with diabetic macular edema.	[Monickaraj, Finny; Das, Arup] Univ New Mexico, Sch Med, Dept Surg, Albuquerque, NM 87131 USA; [Monickaraj, Finny; McGuire, Paul; Das, Arup] Univ New Mexico, Sch Med, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA; [Monickaraj, Finny; Das, Arup] New Mexico Vet Affairs Hlth Care Syst, Albuquerque, NM USA	University of New Mexico; University of New Mexico	Das, A (corresponding author), Univ New Mexico, Dept Surg, Ophthalmol, 1 Univ New Mexico,MSC10-5610, Albuquerque, NM 87131 USA.	adas@unm.edu			U.S. National Institutes of Health (NIH) National Eye Institute Grant [R01-EY022327]; Veterans Affairs (VA) Merit Review Award [IO 1BX001801]; NATIONAL EYE INSTITUTE [R01EY022327] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Eye Institute Grant; Veterans Affairs (VA) Merit Review Award(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by U.S. National Institutes of Health (NIH) National Eye Institute Grant R01-EY022327, and Veterans Affairs (VA) Merit Review Award IO 1BX001801. The authors thank Alison Wagner and Susan Baca (New Mexico VA Animal Facility) for their help in the animal study, and Tamara Howard (New Mexico Health Sciences Centre, University of New Mexico) for her technical assistance in confocal microscopy and immunofluorescence. The authors declare no conflicts of interest.	Abu El-Asrar AM, 2012, MIDDLE EAST AFR J OP, V19, P70, DOI 10.4103/0974-9233.92118; Adamis AP, 2002, BRIT J OPHTHALMOL, V86, P363, DOI 10.1136/bjo.86.4.363; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Beltramo E, 2013, CURR MED CHEM, V20, P3218, DOI 10.2174/09298673113209990022; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bianchi R, 2012, J PHARMACOL EXP THER, V340, P64, DOI 10.1124/jpet.111.181529; Chu CH, 2008, J ENDOCRINOL, V197, P381, DOI 10.1677/JOE-07-0619; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dietrich N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167853; Dreymueller D, 2012, EUR J CELL BIOL, V91, P472, DOI 10.1016/j.ejcb.2011.09.003; FRANK RN, 1990, INVEST OPHTH VIS SCI, V31, P999; Garmroudi F, 1996, MOL ENDOCRINOL, V10, P642, DOI 10.1210/me.10.6.642; Gerhardt H, 2000, DEV DYNAM, V218, P472, DOI 10.1002/1097-0177(200007)218:3<472::AID-DVDY1008>3.0.CO;2-#; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Goncalves A, 2012, DIABETES OBES METAB, V14, P454, DOI 10.1111/j.1463-1326.2011.01548.x; Goncalves A, 2014, BBA-MOL BASIS DIS, V1842, P1454, DOI 10.1016/j.bbadis.2014.04.013; Hancock MK, 2002, J BIOL CHEM, V277, P11255, DOI 10.1074/jbc.M109855200; Ikushima H, 2000, P NATL ACAD SCI USA, V97, P8439, DOI 10.1073/pnas.97.15.8439; Ikushima H, 2002, CELL IMMUNOL, V215, P106, DOI 10.1016/S0008-8749(02)00010-2; Keskin D, 2015, CELL REP, V10, P1066, DOI 10.1016/j.celrep.2015.01.035; Kim YH, 2011, MOL CELLS, V31, P289, DOI 10.1007/s10059-011-0038-2; Kirino Y, 2009, J ENDOCRINOL, V200, P53, DOI 10.1677/JOE-08-0424; Looker HC, 2014, BRIT J OPHTHALMOL, V98, P790, DOI 10.1136/bjophthalmol-2013-303948; Maeda S, 2013, OPHTHALMIC RES, V50, P221, DOI 10.1159/000354116; Marques C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/538737; Marron-Terada PG, 2000, BIOCHEMISTRY-US, V39, P2243, DOI 10.1021/bi992226o; MATHIEU M, 1990, MOL ENDOCRINOL, V4, P1327, DOI 10.1210/mend-4-9-1327; McGuire PG, 2011, ARTERIOSCL THROM VAS, V31, pE107, DOI 10.1161/ATVBAHA.111.235408; Mega C, 2011, EXP DIABETES RES, DOI 10.1155/2011/162092; Monickaraj F, 2016, FASEB J, V30, P1670, DOI 10.1096/fj.15-279802; Nakashima Toshihisa, 2012, Gan To Kagaku Ryoho, V39, P1443; Navaratna D, 2007, DIABETES, V56, P2380, DOI 10.2337/db06-1694; Okabe T, 2003, J BIOL CHEM, V278, P9920, DOI 10.1074/jbc.M208872200; Olivares AM, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0913-0; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Panchapakesan U, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00443; Panchapakesan U, 2013, CLIN SCI, V124, P17, DOI 10.1042/CS20120167; Rangasamy S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108508; Rangasamy S, 2011, INVEST OPHTH VIS SCI, V52, P3784, DOI 10.1167/iovs.10-6386; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Romero-Aroca P, 2017, BRIT J OPHTHALMOL, V101, P1346, DOI 10.1136/bjophthalmol-2016-310063; Scharpfenecker M, 2005, J CELL SCI, V118, P771, DOI 10.1242/jcs.01653; SCHMIDT B, 1995, J BIOL CHEM, V270, P14975, DOI 10.1074/jbc.270.25.14975; Schurmann C, 2012, J PHARMACOL EXP THER, V342, P71, DOI 10.1124/jpet.111.191098; Sharma AK, 2012, J BIOMED RES, V26, P200, DOI 10.7555/JBR.26.20110054; Shiba Y, 2013, CURR BIOL, V23, P1945, DOI 10.1016/j.cub.2013.07.087; Takashima T, 2002, EUR J PHARMACOL, V451, P265, DOI 10.1016/S0014-2999(02)02296-3; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Vaghasiya J, 2011, REGUL PEPTIDES, V166, P48, DOI 10.1016/j.regpep.2010.08.007; Wong MG, 2011, AM J PHYSIOL-RENAL, V301, pF84, DOI 10.1152/ajprenal.00287.2010; Zhang CH, 2014, DISCOV MED, V18, P105; Zhou HJ, 2016, NAT MED, V22, P1033, DOI 10.1038/nm.4169; Zhu T, 2006, ARTERIOSCL THROM VAS, V26, P744, DOI 10.1161/01.ATV.0000205591.88522.d4	58	15	15	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2539	2548		10.1096/fj.201700781RR	http://dx.doi.org/10.1096/fj.201700781RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29263022	Green Published			2022-12-26	WOS:000432528000019
J	Volonte, D; Vyas, AR; Chen, C; Dacic, S; Stabile, LP; Kurland, BF; Abberbock, SR; Burns, TF; Herman, JG; Di, YP; Galbiati, F				Volonte, Daniela; Vyas, Avani R.; Chen, Chen; Dacic, Sanja; Stabile, Laura P.; Kurland, Brenda F.; Abberbock, Shira R.; Burns, Timothy F.; Herman, James G.; Di, Yuanpu Peter; Galbiati, Ferruccio			Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caveolae; caveolin; cellular senescence; oncogene; Ras protein; senescence	INDUCED PREMATURE SENESCENCE; LUNG-CANCER; K-RAS; SCAFFOLDING DOMAIN; MOUSE LUNG; TUMORIGENESIS; INHIBITION; MICE; ACTIVATION; EXPRESSION	Oncogene-induced senescence (OIS) is considered a powerful tumor suppressor mechanism. Caveolin-1 acts as a scaffolding protein to functionally regulate signaling molecules. We demonstrate that a lack of caveolin-1 expression inhibits oncogenic K-Ras (K-Ras(G12V))-induced premature senescence in mouse embryonic fibroblasts and normal human bronchial epithelial cells. Oncogenic K-Ras induces senescence by limiting the detoxification function of MTH1. We found that K-Ras(G12V) promotes the interaction of caveolin-1 with MTH1, which results in inhibition of MTH1 activity. Lung cancer cells expressing oncogenic K-Ras have bypassed the senescence barrier. Interestingly, overexpression of caveolin-1 restores cellular senescence in both A549 and H460 lung cancer cells and inhibits their transformed phenotype. In support of these findings, our in vivo data demonstrate that overexpression of oncogenic K-Ras (K-Ras(G12D)) induces cellular senescence in the lung of wildtype but not caveolin-1-null mice. A lack of K-Ras(G12D)-induced premature senescence in caveolin-1-null mice results in the formation of more abundant lung tumors. Consistent with these data, caveolin-1-null mice overexpressing K-Ras(G12D) display accelerated mortality. Finally, our animal data were supported by human sample analysis in which we show that caveolin-1 expression is dramatically down-regulated in lung adenocarcinomas from lung cancer patients, both at the mRNA and protein levels, and that low caveolin-1 expression is associated with poor survival. Together, our data suggest that lung cancer cells escape oncogene-induced premature senescence through down-regulation of caveolin-1 expression to progress from premalignant lesions to cancer.	[Volonte, Daniela; Vyas, Avani R.; Stabile, Laura P.; Galbiati, Ferruccio] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Chen, Chen; Di, Yuanpu Peter] Univ Pittsburgh, Sch Med, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA; [Dacic, Sanja] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; [Kurland, Brenda F.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Stabile, Laura P.; Kurland, Brenda F.; Abberbock, Shira R.; Burns, Timothy F.; Herman, James G.] Univ Pittsburgh, Lung Canc Program, Hillman Canc Ctr, Inst Canc, Pittsburgh, PA 15232 USA; [Vyas, Avani R.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Galbiati, F (corresponding author), 200 Lothrop St, Pittsburgh, PA 15261 USA.	feg5@pitt.edu	Di, Yuanpu Peter/H-4191-2016; Kurland, Brenda F/AAM-9239-2020; Stabile, Laura/AAE-9235-2020; Vyas, Avani/J-1842-2019; Galbiati, Ferruccio/AAF-3527-2020	Di, Yuanpu Peter/0000-0003-2028-2087; Kurland, Brenda F/0000-0002-5669-0595; 	NCI, National Institutes of Health (NIH) [R01-CA205165, P50-CA090440, P30-CA047904]; NHLBI, NIH [R01-HL124747, R01-HL091938]; NATIONAL CANCER INSTITUTE [P50CA090440, R01CA205165, P30CA047904] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091938, R01HL124747] Funding Source: NIH RePORTER	NCI, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NCI, National Institutes of Health (NIH), Grants R01-CA205165 (to F. G.), P50-CA090440, and P30-CA047904 and NHLBI, NIH, Grants R01-HL124747 (to F. G.) and R01-HL091938 (to Y. P. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baek KH, 2013, J CLIN INVEST, V123, P4375, DOI 10.1172/JCI67465; Bartholomew JN, 2009, CANCER RES, V69, P2878, DOI 10.1158/0008-5472.CAN-08-2857; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Capozza F, 2003, AM J PATHOL, V162, P2029, DOI 10.1016/S0002-9440(10)64335-0; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; Feldman R, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.28_suppl.134; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; FOLEY JF, 1991, EXP LUNG RES, V17, P157, DOI 10.3109/01902149109064408; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jagannadham MV, 2002, BIOCHEM BIOPH RES CO, V298, P203, DOI 10.1016/S0006-291X(02)02426-9; Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Karachaliou N, 2013, CLIN LUNG CANCER, V14, P205, DOI 10.1016/j.cllc.2012.09.007; Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Liu PS, 1997, P NATL ACAD SCI USA, V94, P13666, DOI 10.1073/pnas.94.25.13666; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Matveev S, 2001, ADV DRUG DELIVER REV, V49, P237, DOI 10.1016/S0169-409X(01)00138-7; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; MITSUDOMI T, 1991, ONCOGENE, V6, P1353; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; OHSHIMA M, 1985, CANCER RES, V45, P2785; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Patel A, 2015, ONCOGENE, V34, P2586, DOI 10.1038/onc.2014.195; Rai P, 2011, ONCOGENE, V30, P1489, DOI 10.1038/onc.2010.520; Rai Priyamvada, 2012, Small GTPases, V3, P120, DOI 10.4161/sgtp.19556; Rai P, 2009, P NATL ACAD SCI USA, V106, P169, DOI 10.1073/pnas.0809834106; REHM S, 1991, EXP LUNG RES, V17, P181, DOI 10.3109/01902149109064410; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; Segal SS, 1999, AM J PHYSIOL-HEART C, V277, pH1167; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; SMART EJ, 1995, J CELL BIOL, V131, P929, DOI 10.1083/jcb.131.4.929; Song KS, 1997, J BIOL CHEM, V272, P4398, DOI 10.1074/jbc.272.7.4398; Stabile LP, 2011, CLIN CANCER RES, V17, P154, DOI 10.1158/1078-0432.CCR-10-0992; VANZANDWIJK N, 1995, LUNG CANCER-J IASLC, V12, pS27, DOI 10.1016/0169-5002(95)00418-Z; Volonte D, 2002, MOL BIOL CELL, V13, P2502, DOI 10.1091/mbc.01-11-0529; Volonte D, 2015, J BIOL CHEM, V290, P4202, DOI 10.1074/jbc.M114.598268; Volonte D, 2013, MOL BIOL CELL, V24, P1852, DOI 10.1091/mbc.E12-09-0666; Volonte D, 2011, J BIOL CHEM, V286, P28657, DOI 10.1074/jbc.C111.235119; Volonte D, 2009, EMBO REP, V10, P1334, DOI 10.1038/embor.2009.215; Volonte D, 2009, J BIOL CHEM, V284, P5462, DOI 10.1074/jbc.C800225200; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Williams TM, 2004, J BIOL CHEM, V279, P24745, DOI 10.1074/jbc.M402064200; Williams TM, 2003, MOL BIOL CELL, V14, P1027, DOI 10.1091/mbc.E02-08-0503; Young TW, 2004, CANCER RES, V64, P4577, DOI 10.1158/0008-5472.CAN-04-0222	59	28	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1794	1809		10.1074/jbc.M117.815902	http://dx.doi.org/10.1074/jbc.M117.815902			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29247004	Green Published, hybrid			2022-12-26	WOS:000424201700029
J	Andrade-Souza, V; Silva, JG; Hamada, N				Andrade-Souza, Vanderly; Silva, Janisete G.; Hamada, Neusa			Phylogeography and population diversity of Simulium hirtipupa Lutz (Diptera: Simuliidae) based on mitochondrial COI sequences	PLOS ONE			English	Article							BLACK FLIES DIPTERA; GENETIC-STRUCTURE; CRYPTIC BIODIVERSITY; EPIDEMIOLOGY; ECOREGIONS; MORPHOLOGY; PATTERNS; BRAZIL; MAP	High morphological homogeneity and cryptic speciation may cause the diversity within Simuliidae to be underestimated. Recent molecular studies on population genetics and phylogeography have contributed to reveal which factors influenced the diversity within this group. This study aimed at examining the genetic diversity of Simulium hirtipupa Lutz, 1910 in populations from the biomes Caatinga, Cerrado, and Atlantic Forest. In this study, we carried out phylogeographic and population genetic analyses using a fragment of the mitochondrial gene COI. The 19 populations studied were clustered into seven groups, most of which are associated with geography indicating certain genetic structure. The northern region of the state of Minas Gerais is most likely the center of origin of this species. The average inter-group genetic distance was 3.7%, indicating the presence of cryptic species. The species tree as well as the haplotype network recovered all groups forming two major groups: the first comprises groups Gr-Bahia (in which the Sao Francisco river has not acted as geographical barrier), Gr-Pernambuco, and Gr-Mato Grosso do Sul. The second included groups comprising populations of the states of Goias, Tocantins, Minas Gerais, Bahia, Sao Paulo, and Espirito Santo. The mismatch distribution for groups was consistent with the model of demographic expansion, except for the Gr-Central-East_1 group. The diversification in this group occurred about 1.19 Mya during the Pleistocene, influenced by paleoclimatic oscillations during the Quaternary glacial cycles.	[Andrade-Souza, Vanderly; Hamada, Neusa] INPA, Coordenacao Biodiversidade, Lab Citotaxon & Insetos Aquat, Manaus, Amazonas, Brazil; [Silva, Janisete G.] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil	Institute Nacional de Pesquisas da Amazonia; Universidade Estadual de Santa Cruz	Andrade-Souza, V (corresponding author), INPA, Coordenacao Biodiversidade, Lab Citotaxon & Insetos Aquat, Manaus, Amazonas, Brazil.	vanderlyasouza@gmail.com	Hamada, Neusa/E-3383-2013; Silva, Janisete/D-2245-2013	Silva, Janisete/0000-0002-5570-5484; ANDRADE-SOUZA, VANDERLY/0000-0001-7354-6520	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [475663/2012-8, 159153/2010-7]; PCI-CNPq/MCTI/INPA program [301195/2015-3, 313084/2015-7]; Fundacao de Amparo de Pesquisas da Amazonia (FAPEAM-CNPq DCR); CNPq [307849/ 2014-7, 308554/2015-9]; Universidade Estadual de Santa Cruz	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PCI-CNPq/MCTI/INPA program; Fundacao de Amparo de Pesquisas da Amazonia (FAPEAM-CNPq DCR); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Estadual de Santa Cruz	This study was made possible by the financial support provided by Project CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) No. 475663/2012-8 (URL: www.cnpq.br) and to fellowships awarded to VAS CNPq - PDJ/CNPQ - No. 159153/2010-7, PCI-CNPq/MCTI/INPA program - No. 301195/2015-3 and 313084/2015-7, and Fundacao de Amparo de Pesquisas da Amazonia (FAPEAM-CNPq DCR) (URL: http://www.fapeam.am.gov.br/). NH and JGS are CNPq fellows (No. 307849/ 2014-7 and 308554/2015-9). This publication was made possible by the financial support from Universidade Estadual de Santa Cruz (URL: www.uesc.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Adler P. H., 2016, WORLD BLACKFLIES DIP; Adler PH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181679; Adler PH, 2010, INFECT GENET EVOL, V10, P846, DOI 10.1016/j.meegid.2010.07.003; Adler PH, 2004, BLACK FLIES SIMULIID; [Anonymous], 2014, TRACER V1 6; [Anonymous], 1983, LEVANTAMENTO RECURSO, V32, P780; Auler AS, 2004, J QUATERNARY SCI, V19, P693, DOI 10.1002/jqs.876; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Avise John C., 2004, P1; Basanez MG, 2009, ADV PARASIT, V68, P263, DOI 10.1016/S0065-308X(08)00611-8; Batalha H, 2010, APIDOLOGIE, V41, P534, DOI 10.1051/apido/2010001; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Cabanne GS, 2016, BIOL J LINN SOC, V119, P856, DOI 10.1111/bij.12844; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; CETEC-Fundacao Centro Tecnologico de Minas Gerais, FUND CTR TECH MIN GE; Conflitti IM, 2012, CAN ENTOMOL, V144, P323, DOI 10.4039/tce.2012.29; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Coutinho-Abreu IV, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-16; Crosskey RW, 1990, NATURAL HIST BLACK F; Currie DC, 2008, HYDROBIOLOGIA, V595, P469, DOI 10.1007/s10750-007-9114-1; Do Nascimento FF, 2011, J HERED, V102, P260, DOI 10.1093/jhered/esr012; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dusfour I, 2007, INFECT GENET EVOL, V7, P484, DOI 10.1016/j.meegid.2007.02.003; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faria MB, 2013, J HERED, V104, P613, DOI 10.1093/jhered/est039; Figueiro R, 2015, REV BRAS ENTOMOL, V59, P28, DOI 10.1016/j.rbe.2015.02.003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Franco FF, 2013, J BIOGEOGR, V40, P142, DOI 10.1111/j.1365-2699.2012.02777.x; Fu YX, 1997, GENETICS, V147, P915; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamada N, 2010, ZOOTAXA, P22; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heilveil JS, 2006, MOL ECOL, V15, P1627, DOI 10.1111/j.1365-294X.2006.02876.x; Hernandez-Triana LM, 2011, SYSTEMATICS BLACKFLY; Hernandez-Triana LM, 2012, ZOOTAXA, P43; Janzen D.H., 1988, P130; Jedlicka L, 2012, BIOLOGIA, V67, P777, DOI 10.2478/s11756-012-0057-2; Villela FNJ, 2011, BIOTA NEOTROP, V11, P217, DOI 10.1590/S1676-06032011000100023; Latrubesse EM, 2006, SERIE GEOLOGIA MINER, V2; Manni M, 2015, ZOOKEYS, P157, DOI 10.3897/zookeys.540.6713; MANTEL N, 1967, CANCER RES, V27, P209; Mardulyn P, 2001, MOL ECOL, V10, P1751, DOI 10.1046/j.0962-1083.2001.01307.x; Miranda EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164441; Moulton JK, 2000, SYST ENTOMOL, V25, P95, DOI 10.1046/j.1365-3113.2000.00097.x; Nascimento FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061924; Nascimento JMC, 2017, J MED ENTOMOL; NASCIMENTO M. A. L. S, 1991, B GOIANO GEOGRAFIA, V12, P1; Olmos Fabio, 1998, Ornitologia Neotropical, V8, P121; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pellegrino KCM, 2005, BIOL J LINN SOC, V85, P13, DOI 10.1111/j.1095-8312.2005.00472.x; Phayuhasena S, 2010, GENETICA, V138, P633, DOI 10.1007/s10709-010-9437-0; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pramual P, 2005, MOL ECOL, V14, P3989, DOI 10.1111/j.1365-294X.2005.02639.x; Pramual P, 2015, J ASIA-PAC ENTOMOL, V18, P33, DOI 10.1016/j.aspen.2014.11.002; Pramual P, 2014, MOL ECOL RESOUR, V14, P262, DOI 10.1111/1755-0998.12174; Pramual P, 2013, ENTOMOL SCI, V16, P298, DOI 10.1111/ens.12008; Pramual P, 2012, GENOME, V55, P447, DOI [10.1139/G2012-031, 10.1139/g2012-031]; Pramual P, 2012, ENTOMOL SCI, V15, P202, DOI 10.1111/j.1479-8298.2011.00491.x; Pramual P, 2011, ENTOMOL SCI, V14, P428, DOI 10.1111/j.1479-8298.2011.00465.x; Pramual P, 2011, GENOME, V54, P1, DOI 10.1139/G10-100; PROCUNIER WS, 1989, GENOME, V32, P559, DOI 10.1139/g89-483; Pruess KP, 2000, MOL PHYLOGENET EVOL, V16, P286, DOI 10.1006/mpev.2000.0807; Rivera J, 2009, MOL ECOL RESOUR, V9, P224, DOI 10.1111/j.1755-0998.2009.02648.x; Rodrigues MT, 1996, J HERPETOL, V30, P513, DOI 10.2307/1565694; Rodriguez-Perez MA, 2006, J MED ENTOMOL, V43, P701, DOI 10.1603/0022-2585(2006)43[701:AOGVIR]2.0.CO;2; Ruiz-Arce R, 2012, J ECON ENTOMOL, V105, P2147, DOI 10.1603/EC12211; Smith-Caldas Martha R. B., 2001, Neotropical Entomology, V30, P565, DOI 10.1590/S1519-566X2001000400009; Sriphirom P, 2014, GENOME, V57, P45, DOI 10.1139/gen-2013-0145; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Thaijarern J, 2014, GENOME, V57, P411, DOI 10.1139/gen-2014-0103; Low VL, 2016, SCI REP-UK, V6, DOI 10.1038/srep20346; Vasconcelos TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104130	77	6	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190091	10.1371/journal.pone.0190091	http://dx.doi.org/10.1371/journal.pone.0190091			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281704	Green Submitted, gold, Green Published			2022-12-26	WOS:000419006200062
J	Chen, R; Xu, M; Nagati, J; Garcia, JA				Chen, Rui; Xu, Min; Nagati, Jason; Garcia, Joseph A.			Coordinate regulation of stress signaling and epigenetic events by Acss2 and HIF-2 in cancer cells	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; ACETYL-COA SYNTHETASE; HISTONE ACETYLATION; ACETATE SWITCH; TRANSCRIPTIONAL ACTIVITY; GENE-TRANSCRIPTION; MAMMALIAN-CELLS; FACTOR ARCA; BINDING; OXYGEN	Survival of cancer cells in the harsh tumor microenvironment, characterized by oxygen and glucose deprivation, requires rapid initiation of cytoprotective measures. Metabolites whose levels change during stress are ideal signaling cues, particularly if used in post-translational modifications of stress-responsive signal transducers. In cancer cells exposed to oxygen or glucose deprivation, there is an increase in cellular levels of acetate, a substrate for acetate-dependent acetyl CoA synthetase 2 (Acss2) that also stimulates translocation of Acss2 from the cytosol to the nucleus. Nuclear, but not cytosolic, Acss2 promotes acetylation of the stress-responsive Hypoxia Inducible Factor 2 alpha (HIF-2 alpha) subunit by the acetyltransferase/coactivator Creb binding protein (Cbp), a process that facilitates stable Cbp/HIF-2 alpha complex formation. In addition to promoting de novo transcription, Cbp and HIF-2 alpha act in concert to regulate local histone 3 epigenetic marks. Exogenous acetate augments Acss2/HIF-2 dependent cancer growth and metastasis in cell culture and mouse models. Thus, an acetate switch in mammals links nutrient intake and stress signaling with tumor growth and metastasis.	[Chen, Rui; Xu, Min; Nagati, Jason; Garcia, Joseph A.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Garcia, Joseph A.] VA North Texas Hlth Care Syst, Dept Med, Dallas, TX 75216 USA; [Chen, Rui] Southeast Univ, Key Lab Environm Med, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; Southeast University - China	Garcia, JA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.; Garcia, JA (corresponding author), VA North Texas Hlth Care Syst, Dept Med, Dallas, TX 75216 USA.	joseph.garcia@utsouthwestern.edu		Nagati, Jason/0000-0002-4507-6581; Garcia, Joseph/0000-0002-5621-7538	Department of Veterans Affairs (VA Merit Grant) [I016X000446]; National Institutes of Health [HL108104, HL130142]	Department of Veterans Affairs (VA Merit Grant); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by funds provided by the Department of Veterans Affairs (VA Merit Grant I016X000446 to J.G.) and the National Institutes of Health (R01 Grant HL108104 and HL130142 to J.G.).	Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; Bedford DC, 2012, AGING-US, V4, P247, DOI 10.18632/aging.100453; Boukouris AE, 2016, TRENDS BIOCHEM SCI, V41, P712, DOI 10.1016/j.tibs.2016.05.013; Brusselmans K, 2001, J BIOL CHEM, V276, P39192, DOI 10.1074/jbc.C100428200; Chan CH, 2011, MOL MICROBIOL, V80, P168, DOI 10.1111/j.1365-2958.2011.07566.x; Chen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116515; Chen R, 2012, J BIOL CHEM, V287, P30800, DOI 10.1074/jbc.M111.244780; Chen R, 2011, J BIOL CHEM, V286, P13869, DOI 10.1074/jbc.M110.175414; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Falcon AA, 2010, MOL CELL BIOCHEM, V333, P99, DOI 10.1007/s11010-009-0209-z; Gao X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11960; Gonidakis S, 2010, BIOL CHEM, V391, P1139, DOI 10.1515/BC.2010.120; Gonidakis S, 2010, AGING CELL, V9, P868, DOI 10.1111/j.1474-9726.2010.00618.x; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Jaworski DM, 2016, J CELL BIOCHEM, V117, P574, DOI 10.1002/jcb.25305; Johnson AB, 2007, MUTAT RES-FUND MOL M, V618, P149, DOI 10.1016/j.mrfmmm.2006.10.007; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Levanon SS, 2005, BIOTECHNOL BIOENG, V89, P556; Li XJ, 2017, MOL CELL, V66, P684, DOI 10.1016/j.molcel.2017.04.026; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mathew R, 2005, J PHARMACOL EXP THER, V315, P297, DOI 10.1124/jpet.105.087536; Melvin A, 2012, CELL SIGNAL, V24, P35, DOI 10.1016/j.cellsig.2011.08.019; Mews P, 2017, NATURE, V546, P381, DOI 10.1038/nature22405; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Perez-Perri JI, 2011, INT J MOL SCI, V12, P4705, DOI 10.3390/ijms12074705; Phue JN, 2005, METAB ENG, V7, P353, DOI 10.1016/j.ymben.2005.06.003; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Shimazu T, 2010, MECH AGEING DEV, V131, P511, DOI 10.1016/j.mad.2010.05.001; Starai VJ, 2005, J BIOL CHEM, V280, P26200, DOI 10.1074/jbc.M504863200; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Sun DQ, 2006, BIOTECHNIQUES, V41, P59, DOI 10.2144/000112203; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Vordermark D, 2005, CANCER LETT, V230, P122, DOI 10.1016/j.canlet.2004.12.040; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wolfe AJ, 2008, J BACTERIOL, V190, P5735, DOI 10.1128/JB.00825-08; Xu M, 2014, NAT MED, V20, P1018, DOI 10.1038/nm.3587; Yoshii Y, 2009, NUCL MED BIOL, V36, P771, DOI 10.1016/j.nucmedbio.2009.05.006	46	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190241	10.1371/journal.pone.0190241	http://dx.doi.org/10.1371/journal.pone.0190241			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281714	Green Published, Green Submitted, gold			2022-12-26	WOS:000419006200076
J	Del-Rio, G; Rego, MA; Silveira, LF; Itoh, A				Del-Rio, Glaucia; Rego, Marco Antonio; Silveira, Luis Fabio; Itoh, Akira			Plant invasion: Another threat to the Sao Paulo Marsh Antwren (Formicivora paludicola), a species on the verge of extinction	PLOS ONE			English	Article							HOME-RANGE; TERRITORY SIZE; HABITAT USE; ZINGIBERACEAE; AVAILABILITY; CONSERVATION; SELECTION; SOFTWARE; ANTBIRDS; BEHAVIOR	During the past 100 years in densely populated south-eastern Brazil, wetlands have been severely transformed due to urbanization, agriculture and mining. The recently discovered Sao Paulo Marsh Antwren (Formicivora paludicola) is endemic to these wetlands, and is listed as "Critically Endangered" by the IUCN. The species is only found in an area of 1.42 km 2, it has a sparse and fragmented distribution, low dispersal capacity, and has probably lost around 300 km 2 of habitat in the past 100 years. Furthermore, very little is known about F. paludicola natural history, and so it is difficult to construct a robust conservation plan. Using Kernel home range estimations and the Adjusted-SD/Torus Shift test (a novel tool for animal-habitat association studies), we showed that the species avoids patches of the alien invasive ginger lily (Hedychium coronarium). Given the high density of their population (3.6 mature individuals/ha), F. paludicola could thrive in relatively small areas of suitable wetlands protected from human occupation and water contamination, however special attention should be paid to biological invasions, which may represent a serious threat to the remaining populations. Protecting a few small wetlands used by F. paludicola would be an important step towards general conservation and restoration of Atlantic Forest wetlands and its endemic endangered species.	[Del-Rio, Glaucia] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, SP, Brazil; [Del-Rio, Glaucia; Rego, Marco Antonio; Silveira, Luis Fabio] Univ Sao Paulo, Museu Zool, Secao Aves, Sao Paulo, SP, Brazil; [Itoh, Akira] Osaka City Univ, Div Biol & Geosci, Sumiyoshi Ku, Osaka, Japan; [Del-Rio, Glaucia; Rego, Marco Antonio] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Osaka Metropolitan University; Louisiana State University System; Louisiana State University	Del-Rio, G (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, SP, Brazil.; Del-Rio, G (corresponding author), Univ Sao Paulo, Museu Zool, Secao Aves, Sao Paulo, SP, Brazil.; Del-Rio, G (corresponding author), Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA.	gdelri1@lsu.edu	Silveira, Luis/V-6161-2019	Silveira, Luis/0000-0003-2576-7657; Del Rio, Glaucia/0000-0001-7212-8474	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/16251]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq 313818/2009-6]; Cooper Ornithological Society (Mewaldt-King Student Research Award)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Cooper Ornithological Society (Mewaldt-King Student Research Award)	This work was supported by 2011/16251 (http://www.fapesp.br/) Fundacao de Amparo a Pesquisa do Estado de Sao Paulo to GDR; CNPq 313818/2009-6 (http://www.cnpq.br/) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico to LFS; Cooper Ornithological Society (Mewaldt-King Student Research Award) to GDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'Saber AN, 1958, NOTAS GEOMORFOLOAGIC, V1, P1; AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Banko PC, 2002, J BIOGEOGR, V29, P789, DOI 10.1046/j.1365-2699.2002.00724.x; Barthram G.T., 1985, EXPT TECHNIQUES HFRO, P29; Brown J.L., 1970, ANNU REV ECOL SYST, V1, P239; BROWN JL, 1969, WILSON BULL, V81, P293; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; de Castro WAC, 2016, ENVIRON EXP BOT, V127, P55, DOI 10.1016/j.envexpbot.2016.03.010; Coelho V., 2012, PARAIBA RIO ESTRATEG; Buzzetti DRC, 2013, REV BRAS ORNITOL, V21, P269; de Camargo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140145; Del-Rio G, 2016, WILSON J ORNITHOL, V128, P445, DOI 10.1676/1559-4491-128.2.445; Del-Rio G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121315; Duca C, 2006, REV BRAS ZOOL, V23, P692, DOI 10.1590/S0101-81752006000300011; EWALD PW, 1980, ECOLOGY, V61, P80, DOI 10.2307/1937158; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Garcia PCA, 2009, FAUNA AMEACADA EXTIN, P329; GOLDSMITH F B, 1986, P437; Gorrell JV, 2005, J FIELD ORNITHOL, V76, P395, DOI 10.1648/0273-8570-76.4.395; Greenberg R., 1985, ORNITHOL MONOGR, V36, P845; Habitat T., 2008, ACTA ZOOL HUNG, V54, P111; Hall LS, 1997, WILDLIFE SOC B, V25, P173; Hansbauer MM, 2010, BIOTROPICA, V42, P355, DOI 10.1111/j.1744-7429.2009.00593.x; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harris JBC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077902; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOLT RD, 1985, THEOR POPUL BIOL, V28, P181, DOI 10.1016/0040-5809(85)90027-9; HORNER MA, 1990, J MAMMAL, V71, P402, DOI 10.2307/1381953; IBAMA, 1994, MAN ANILH AV SILV; IBGE, 2010, PESQ NAC AM DOM; Iserhagem I, 2009, PACTO PELA RESTAURAC, P87; Itoh A, 2006, FOREST ECOLOGY LONG, p219 ; Itoh A, 2010, FOREST ECOL MANAG, V259, P323, DOI 10.1016/j.foreco.2009.10.022; IUCN, 2016, 2017 IUCN RED LIST T; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; JOLY CA, 1995, FUNCT ECOL, V9, P505, DOI 10.2307/2390016; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Jorge J, 2006, TIETE RIO QUE CIDADE; Kenward R., 1987, WILDLIFE RADIO TAGGI; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Kissmann K.G., 1991, PLANTAS INFESTANTES; Kissmann KG, 1997, PLANTAS INFESTANTES; Laurance WF, 2009, BIOL CONSERV, V142, P1137, DOI 10.1016/j.biocon.2008.10.011; LAVER P. N., 2005, ABODE KERNEL HOME RA; Lawson EJ, 1997, WILDLIFE SOC B, V25, P721; Lorenzi H, 1991, PLANTAS DANINHAS BRA; Maciel LA, 2011, THESIS; Mattos JCF, 2009, BIRD CONSERV INT, V19, P392, DOI 10.1017/S0959270909008697; Mitchell MS, 2003, LANDSCAPE ECOLOGY AND RESOURCE MANAGEMENT: LINKING THEORY WITH PRACTICE, P93; Moonev HA, 2000, INVASIVE SPECIES CHA; Nobre C. A., 2016, Journal of Water Resource and Protection, V8, P252, DOI 10.4236/jwarp.2016.82022; North American Banding Council-NABC, 2001, N AM BAND STUD GUID; ODUM E. P., 1955, AUK, V72, P128; Oyakawa OT., 2009, FAUNA AMEACADA EXTIN, P349; Powell R.A., 1997, ECOLOGY BEHAV N AM B; Powell RA, 2000, METH C CONS, P65; Powell RA., 1987, INT C BEAR, V7, P235; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reinert BL, 2007, BRAZ J ORNITHOL, V15, P493; Reinert BL, 2008, THESIS; Rejmanek M., PLANT INVASIONS GEN; Ridgely R.S., 1994, BIRDS S AM, VII; Schmidt KA, 1999, CONSERV BIOL, V13, P1502, DOI 10.1046/j.1523-1739.1999.99050.x; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Seaman DE, 1993, THESIS; Sick H, 2001, ORNITOLOGIA BRASILEI; Silveira LF, 2009, FAUNA AMEACADA EXTIN; Skutch A.F., 1996, ANTBIRDS OVENBIRDS; STAHLECKER DW, 1993, J RAPTOR RES, V27, P42; Stenger J., 1959, Wilson Bulletin, V71, P125; Stutchbury BJM, 2005, ORNITOL NEOTROP, V16, P397; Sutherland WJ, 2004, TECH ECOL CONSERVAT, P251; TERBORGH J, 1990, ECOL MONOGR, V60, P213, DOI 10.2307/1943045; THOMAS DL, 1990, J WILDLIFE MANAGE, V54, P322, DOI 10.2307/3809050; Van Horne B., 1988, J WILDLIFE MANAGE, V47, P893; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; White G.C., 1990, ANAL WILDLIFE RADIO; Willis EO, 1978, BIRD FAMILIES WORLD; Willis EO, 2001, ORNITOLOGIA CONSERVA, P69; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3; Zimmer K.J., 2003, P448	86	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189465	10.1371/journal.pone.0189465	http://dx.doi.org/10.1371/journal.pone.0189465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281668	Green Published, Green Submitted, gold			2022-12-26	WOS:000419006200029
J	Handeland, K; Vikoren, T; Josefsen, TD; Madslien, K; Valdecanas, B; Uhlig, S				Handeland, Kjell; Vikoren, Turid; Josefsen, Terje D.; Madslien, Knut; Valdecanas, Belinda; Uhlig, Silvio			Yew (Taxus) intoxication in free-ranging cervids	PLOS ONE			English	Article							DEER CAPREOLUS-CAPREOLUS; BACCATA; ALKALOIDS; TOXICITY; INGESTION; CATTLE; MS	Wild ruminants, including deer species (cervids) have incorrectly been regarded as refractory to yew (Taxus) intoxication. This assumption has been based upon anecdotal observations of individual deer browsing on yew over time without apparent adverse effect. A single case of yew intoxication was reported in a free-ranging Norwegian moose (Alces alces) in 2008. The current report describes five additional cases of yew toxicosis in moose, seven in roe deer (Capreolus capreolus) and two in reindeer (Rangifer tarandus tarandus), all in Norway. The animals were found dead during the winter, close to or within gardens containing yew plants showing signs of browsing. Gross findings included lung congestion and edema, thoracic and pericardial effusion, bilateral heart dilatation, epi-and endocardial hemorrhage, and enlarged (congested) spleen. Yew plant remnants were detected in the rumen of all animals with the exception of a single moose. Histology revealed multifocal acute myocardial degeneration and necrosis with hemorrhage in roe deer, but not in the two other species. A qualitative high performance liquid chromatography-ion trap mass spectrometry analysis was used to tentatively identify five major Taxus alkaloids (taxines) in crude yew extracts and in heart and liver samples from the moose cases. All five major taxines were detected with good signal/noise ratio in tissue samples from the four moose with visible ruminal yew content, whereas lower levels of taxines were detected in the moose without visible ruminal yew content. Possible differences in interspecies tolerance to taxines and role of individual protective adaptation are discussed.	[Handeland, Kjell; Vikoren, Turid; Madslien, Knut; Valdecanas, Belinda; Uhlig, Silvio] Norwegian Vet Inst, Oslo, Norway; [Josefsen, Terje D.] Norwegian Vet Inst, Tromso, Norway	Norwegian Veterinary Institute; Norwegian Veterinary Institute	Handeland, K (corresponding author), Norwegian Vet Inst, Oslo, Norway.	kjell.handeland@vetinst.no			Norwegian Environment Agency	Norwegian Environment Agency	The study was carried out within the frame of the Health Surveillance Programme for Wild Cervids and Muskox that is financed by the Norwegian Environment Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDEN CL, 1977, J AM VET MED ASSOC, V170, P314; Andersen KB, 2010, EUR J WILDLIFE RES, V56, P915, DOI 10.1007/s10344-010-0389-6; Angus KW, 2010, VET REC, V166, P216, DOI 10.1136/vr.c552; Baskin SI, 2007, VETERINARY TOXICOLOGY: BASIC AND CLINICAL PRINCIPLES, P193, DOI 10.1016/B978-012370467-2/50110-3; Beike J, 2003, INT J LEGAL MED, V117, P335, DOI 10.1007/s00414-003-0399-y; Burcham GN, 2013, J VET DIAGN INVEST, V25, P147, DOI 10.1177/1040638712466729; Dietz H. H., 1994, Dansk Veterinaertidsskrift, V77, P404; Frommherz L, 2006, INT J LEGAL MED, V120, P346, DOI 10.1007/s00414-005-0071-9; Handeland K, 2008, TOXICON, V52, P829, DOI 10.1016/j.toxicon.2008.08.008; HOFMANN RR, 1992, ALCES S, V1, P91; Jenniskens LHD, 1996, J NAT PROD, V59, P117, DOI 10.1021/np960033l; Lid J, 2007, NORWEGIAN FLORA, P141; Mysterud A, 1995, WILDLIFE BIOL, V1, P249, DOI 10.2981/wlb.1995.0024; OGDEN L, 1988, VET HUM TOXICOL, V30, P563; PANTER KE, 1993, J AM VET MED ASSOC, V202, P1476; Russell FL, 2001, AM MIDL NAT, V146, P1, DOI 10.1674/0003-0031(2001)146[0001:EOWTDO]2.0.CO;2; Sula MJM, 2013, J VET DIAGN INVEST, V25, P522, DOI 10.1177/1040638713489981; Tiwary AK, 2005, J VET DIAGN INVEST, V17, P252, DOI 10.1177/104063870501700307; WACKER R, 1983, TIERARZTL UMSCHAU, V38, P264; Weaver JD, 2004, VET HUM TOXICOL, V46, P300; Wilson CR, 2012, VETERINARY TOXICOLOGY: BASIC AND CLINICAL PRINCIPLES, 2ND EDITION, P1121, DOI 10.1016/B978-0-12-385926-6.00110-1; Wilson CR, 2001, TOXICON, V39, P175, DOI 10.1016/S0041-0101(00)00146-X; Zoltani CK, 2012, VETERINARY TOXICOLOGY: BASIC AND CLINICAL PRINCIPLES, 2ND EDITION, P235, DOI 10.1016/B978-0-12-385926-6.00016-8	23	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0188961	10.1371/journal.pone.0188961	http://dx.doi.org/10.1371/journal.pone.0188961			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281648	Green Published, Green Submitted, gold			2022-12-26	WOS:000419006200013
J	Kim, M; Yoo, J; Kim, J; Park, J; Han, E; Jang, W; Chae, H; Lee, JH; Park, YM; Kim, Y				Kim, Myungshin; Yoo, Jaeeun; Kim, Jiyeon; Park, Joonhong; Han, Eunhee; Jang, Woori; Chae, Hyojin; Lee, Ji Hyun; Park, Young Min; Kim, Yonggoo			Association of FLG single nucleotide variations with clinical phenotypes of atopic dermatitis	PLOS ONE			English	Article							EOSINOPHIL CATIONIC PROTEIN; OF-FUNCTION MUTATIONS; ICHTHYOSIS VULGARIS; FILAGGRIN MUTATIONS; POLYMORPHISM; ECZEMA; GENE; CHILDREN; P478S; CHILDHOOD	Background FLG encodes a large protein called profilaggrin, which plays a key role in maintaining an effective skin barrier against the environment. In this study, we identified FLG single nucleotide variations (FLG-SNVs) and evaluated the association of FLG-SNVs with clinical phenotypes including atopic dermatitis (AD)-associated minor clinical features, presence of specific allergic sensitization, and serum parameters. Methods Eighty-one Korean patients with AD were enrolled. AD-associated minor clinical features as well as allergic rhinitis and asthma were diagnosed by specialists. FLG-SNVs were identified by Sanger sequencing of entire exons through long-range PCR. Allergic sensitization to a specific allergen was evaluated by multiple allergen simultaneous test. Serologic parameters such as serum eosinophil cationic protein (ECP) and eosinophil derived neurotoxin (EDN) were measured. Results A total of seventy-three SNVs and 4 LOF mutations were successfully genotyped. rs71626704 and rs76413899 were significantly associated with a history of asthma and cheilitis (P = 0.002 and P = 0.033, respectively), however, the associations were not found statistically significant after adjustment by multiple comparisons. In addition, we detected haplotype blocks which were correlated with non-specific hand or foot dermatitis and scalp scale. We identified FLG-SNVs which were associated with sensitization to environmental allergens; rs62623409 and rs71625199 (P = 0.038 and P = 0.008, respectively). Patients with FLG P478S TT and history of allergic rhinitis showed a higher EDN level, and among those patients, the ones with asthma showed a higher ECP level. Conclusion This study revealed the association of FLG-SNVs with AD-associated minor clinical features. We firstly identified rs71625199 which was associated with higher environmental allergic sensitization. We also suggest that FLG P478S is a kind of disease modifier which affects serologic parameters such as EDN and ECP.	[Kim, Myungshin; Yoo, Jaeeun; Park, Joonhong; Han, Eunhee; Jang, Woori; Chae, Hyojin; Kim, Yonggoo] Catholic Univ Korea, Coll Med, Dept Lab Med, Seoul, South Korea; [Kim, Myungshin; Yoo, Jaeeun; Kim, Jiyeon; Park, Joonhong; Han, Eunhee; Jang, Woori; Chae, Hyojin; Kim, Yonggoo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Catholic Genet Lab Ctr, Seoul, South Korea; [Kim, Myungshin; Yoo, Jaeeun; Kim, Jiyeon; Park, Joonhong; Han, Eunhee; Jang, Woori; Chae, Hyojin; Kim, Yonggoo] Catholic Univ Korea, Seoul St Marys Hosp, Ctr Appl Genom & Precis Med, Coll Med, Seoul, South Korea; [Lee, Ji Hyun; Park, Young Min] Catholic Univ Korea, Coll Med, Dept Dermatol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Kim, Y (corresponding author), Catholic Univ Korea, Coll Med, Dept Lab Med, Seoul, South Korea.; Kim, Y (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Catholic Genet Lab Ctr, Seoul, South Korea.; Kim, Y (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Ctr Appl Genom & Precis Med, Coll Med, Seoul, South Korea.; Park, YM (corresponding author), Catholic Univ Korea, Coll Med, Dept Dermatol, Seoul, South Korea.	yymmpark6301@hotmail.com; yonggoo@catholic.ac.kr	Kim, Myungshin/AAP-9262-2020; Park, Joonhong/AAZ-9885-2020; Kim, Myungshin/AAK-1544-2021	Kim, Myungshin/0000-0001-8632-0168; Park, Joonhong/0000-0001-7354-4234; Kim, Myungshin/0000-0001-8632-0168	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI14C1062]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	The statistical consultation was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Baurecht H, 2007, J ALLERGY CLIN IMMUN, V120, P1406, DOI 10.1016/j.jaci.2007.08.067; Bisgaard H, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050131; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; CZECH W, 1992, BRIT J DERMATOL, V126, P351, DOI 10.1111/j.1365-2133.1992.tb00677.x; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Flohr C, 2010, BRIT J DERMATOL, V163, P1333, DOI 10.1111/j.1365-2133.2010.10068.x; Ginger RS, 2005, ARCH DERMATOL RES, V297, P235, DOI 10.1007/s00403-005-0590-8; Gold LFS, 2017, SEMIN CUTAN MED SURG, V36, pS39, DOI 10.12788/j.sder.2017.010; Goto Tomoko, 2007, Allergol Int, V56, P433, DOI 10.2332/allergolint.O-07-489; Henderson J, 2008, J ALLERGY CLIN IMMUN, V121, P872, DOI 10.1016/j.jaci.2008.01.026; Kezic S, 2008, J INVEST DERMATOL, V128, P2117, DOI 10.1038/jid.2008.29; Kim SY, 2013, INDIAN J MED RES, V138, P922; Landeck L, 2012, BRIT J DERMATOL, V167, P1302, DOI 10.1111/bjd.12035; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Liang YS, 2016, CLIN REV ALLERG IMMU, V51, P315, DOI 10.1007/s12016-015-8508-5; Margolis DJ, 2015, HUM IMMUNOL, V76, P571, DOI 10.1016/j.humimm.2015.08.003; Meng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098235; Murat-Susic S, 2006, INT J DERMATOL, V45, P1156; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Rawlings A V, 2004, Dermatol Ther, V17 Suppl 1, P43, DOI 10.1111/j.1396-0296.2004.04S1005.x; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Sullivan M, 2017, CLIN DERMATOL, V35, P349, DOI 10.1016/j.clindermatol.2017.03.006; Taniuchi S, 2001, J DERMATOL SCI, V26, P79, DOI 10.1016/S0923-1811(00)00151-1; Thijs JL, 2015, J CLIN MED, V4, P479, DOI 10.3390/jcm4030479; Tomassini M, 1996, J ALLERGY CLIN IMMUN, V97, P1350, DOI 10.1016/S0091-6749(96)70204-X; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433; Venkataraman D, 2014, J ALLERGY CLIN IMMUN, V134, P876, DOI 10.1016/j.jaci.2014.07.033; Wang IJ, 2011, BRIT J DERMATOL, V164, P791, DOI 10.1111/j.1365-2133.2011.10212.x; Wang IJ, 2015, ANN ALLERG ASTHMA IM, V114, P52, DOI 10.1016/j.anai.2014.10.019; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	36	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190077	10.1371/journal.pone.0190077	http://dx.doi.org/10.1371/journal.pone.0190077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281699	Green Submitted, gold, Green Published			2022-12-26	WOS:000419006200061
J	Miao, LJ; Muller, D; Cui, XF; Ma, MH				Miao, Lijuan; Mueller, Daniel; Cui, Xuefeng; Ma, Meihong			Changes in vegetation phenology on the Mongolian Plateau and their climatic determinants	PLOS ONE			English	Article							NDVI TIME-SERIES; INNER-MONGOLIA; GRASSLAND VEGETATION; LEAF SENESCENCE; TIBETAN PLATEAU; GREEN-UP; DYNAMICS; GIMMS; INDEX; PRECIPITATION	Climate change affects the timing of phenological events, such as the start, end, and length of the growing season of vegetation. A better understanding of how the phenology responded to climatic determinants is important in order to better anticipate future climate-ecosystem interactions. We examined the changes of three phenological events for the Mongolian Plateau and their climatic determinants. To do so, we derived three phenological metrics from remotely sensed vegetation indices and associated these with climate data for the period of 1982 to 2011. The results suggested that the start of the growing season advanced by 0.10 days yr(-1), the end was delayed by 0.11 days yr(-1), and the length of the growing season expanded by 6.3 days during the period from 1982 to 2011. The delayed end and extended length of the growing season were observed consistently in grassland, forest, and shrubland, while the earlier start was only observed in grassland. Partial correlation analysis between the phenological events and the climate variables revealed that higher temperature was associated with an earlier start of the growing season, and both temperature and precipitation contributed to the later ending. Overall, our findings suggest that climate change will substantially alter the vegetation phenology in the grasslands of the Mongolian Plateau, and likely also in biomes with similar environmental conditions, such as other semi-arid steppe regions.	[Miao, Lijuan] Nanjing Univ Informat Sci & Technol, Sch Geog, Nanjing, Jiangsu, Peoples R China; [Miao, Lijuan; Mueller, Daniel] Leibniz Inst Agr Dev Transit Econ, Halle, Saale, Germany; [Mueller, Daniel] Humboldt Univ, Geog Dept, Berlin, Germany; [Cui, Xuefeng] Univ Coll Dublin, Sch Math & Stat, Dublin, Ireland; [Cui, Xuefeng] Beijing Normal Univ, Coll Syst Sci, Beijing, Peoples R China; [Ma, Meihong] Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China	Nanjing University of Information Science & Technology; Leibniz Institut fur Agrarentwicklung in Transformationsokonomien (IAMO); Humboldt University of Berlin; University College Dublin; Beijing Normal University; Beijing Normal University	Miao, LJ (corresponding author), Nanjing Univ Informat Sci & Technol, Sch Geog, Nanjing, Jiangsu, Peoples R China.; Miao, LJ (corresponding author), Leibniz Inst Agr Dev Transit Econ, Halle, Saale, Germany.	miaolijuan1111@gmail.com	Change, Structural/W-8306-2019; , IAMO/G-2328-2012; Mueller, Daniel/A-4454-2009; Miao, Lijuan/N-1277-2017	Change, Structural/0000-0002-2459-4646; , IAMO/0000-0001-7922-9665; Mueller, Daniel/0000-0001-8988-0718; Miao, Lijuan/0000-0002-0332-8488	National Key Research and Development Program of China [2017YFC0504301]; Key Project of National Social and Scientific Fund Program [16ZDA047]; Alexander von Humboldt Foundation; Startup Foundation for Introducing Talents of Nanjing University of Information Science and Technology [2243141601048]; National Basic Research Development Program of China [2015CB953602, 2016YFA0602500]; National Science Foundation of China [41271542]; Open Access Fund of the Leibniz Association	National Key Research and Development Program of China; Key Project of National Social and Scientific Fund Program; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Startup Foundation for Introducing Talents of Nanjing University of Information Science and Technology; National Basic Research Development Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Access Fund of the Leibniz Association	The work was financially supported by National Key Research and Development Program of China (Grant no. 2017YFC0504301), the Key Project of National Social and Scientific Fund Program (Grant no. 16ZDA047), Alexander von Humboldt Foundation, Startup Foundation for Introducing Talents of Nanjing University of Information Science and Technology (Grant no. 2243141601048), National Basic Research Development Program of China (Grant no. 2015CB953602, 2016YFA0602500), and the National Science Foundation of China (Grant no. 41271542). The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The work was financially supported by National Key Research and Development Program of China (Grant no. 2017YFC0504301), the Key Project of National Social and Scientific Fund Program (Grant no.16ZDA047), Alexander von Humboldt Foundation, Startup Foundation for Introducing Talents of Nanjing University of Information Science and Technology (Grant no. 2243141601048), National Basic Research Development Program of China (Grant no. 2015CB953602, 2016YFA0602500), and the National Science Foundation of China (Grant no. 41271542). We thank the editor Dr. Sylvain Delzon and the reviewers for their helpful and constructive comments that have greatly helped to improve this manuscript.	Adole T, 2016, ECOL INFORM, V34, P117, DOI 10.1016/j.ecoinf.2016.05.004; Allstadt AJ, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/10/104008; Anderegg WRL, 2013, GLOBAL CHANGE BIOL, V19, P1188, DOI 10.1111/gcb.12100; Angerer J., 2008, RANGELANDS, V30, P46, DOI [DOI 10.2111/1551-501X(2008)30[46:CCAEOA]2.0.CO;2, 10.2111/1551-501X(2008)30]; Detsch F, 2016, REMOTE SENS ENVIRON, V178, P70, DOI 10.1016/j.rse.2016.03.007; Dreesen FE, 2014, BIOGEOSCIENCES, V11, P109, DOI 10.5194/bg-11-109-2014; Du J, 2014, INT J REMOTE SENS, V35, P6490, DOI 10.1080/01431161.2014.955146; Estiarte M, 2015, GLOBAL CHANGE BIOL, V21, P1005, DOI 10.1111/gcb.12804; Fensholt R, 2012, REMOTE SENS ENVIRON, V119, P131, DOI 10.1016/j.rse.2011.12.015; Firmat C, 2017, J EVOLUTION BIOL, V30, P2116, DOI 10.1111/jeb.13185; Fontana F, 2008, SENSORS-BASEL, V8, P2833, DOI 10.3390/s8042833; Fracheboud Y, 2009, PLANT PHYSIOL, V149, P1982, DOI 10.1104/pp.108.133249; Fridley JD, 2016, NAT CLIM CHANGE, V6, P865, DOI 10.1038/NCLIMATE3032; Fu YSH, 2015, GLOBAL CHANGE BIOL, V21, P2687, DOI 10.1111/gcb.12863; Fu YSH, 2014, GLOBAL CHANGE BIOL, V20, P3743, DOI 10.1111/gcb.12610; Fu YSH, 2014, GLOBAL ECOL BIOGEOGR, V23, P1255, DOI 10.1111/geb.12210; Gong Z, 2015, SOLID EARTH, V6, P1185, DOI 10.5194/se-6-1185-2015; Grippa M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024286; He B, 2015, ENVIRON EARTH SCI, V74, P5491, DOI 10.1007/s12665-015-4559-4; IPCCAR5, 2014, IPCCAR5; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Jin ZN, 2013, CLIMATIC CHANGE, V119, P435, DOI 10.1007/s10584-013-0722-7; Keenan TF, 2015, GLOBAL CHANGE BIOL, V21, P2634, DOI 10.1111/gcb.12890; Li FY, 2016, FRONT EARTH SCI-PRC, V10, P328, DOI 10.1007/s11707-015-0519-2; Liu Q, 2016, GLOBAL CHANGE BIOL, V22, P3702, DOI 10.1111/gcb.13311; Liu Q, 2016, GLOBAL CHANGE BIOL, V22, P644, DOI 10.1111/gcb.13081; Liu YL, 2013, GLOBAL PLANET CHANGE, V108, P85, DOI 10.1016/j.gloplacha.2013.06.008; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Miao L, 2015, NAT HAZARDS, V80, P727, DOI DOI 10.1007/S1106; Miao LJ, 2015, ENVIRON EARTH SCI, V73, P2343, DOI 10.1007/s12665-014-3582-1; Miao LJ, 2013, REMOTE SENS-BASEL, V5, P5193, DOI 10.3390/rs5105193; Panchen ZA, 2015, ANN BOT; Panchen ZA, 2015, ANN BOT-LONDON, V116, P865, DOI 10.1093/aob/mcv015; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Pinzon J, 2005, HILBERT HUANG TRANSF, V16; Pinzon JE, 2014, REMOTE SENS-BASEL, V6, P6929, DOI 10.3390/rs6086929; Schwartz M.D., 2003, PHENOLOGY INTEGRATIV; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Sha ZY, 2016, J ARID LAND, V8, P462, DOI 10.1007/s40333-016-0121-9; Shen MG, 2013, P NATL ACAD SCI USA, V110, pE2329, DOI 10.1073/pnas.1304625110; Tao SL, 2015, P NATL ACAD SCI USA, V112, P2281, DOI 10.1073/pnas.1411748112; Tong S, 2017, SCI TOTAL ENV; Tucker C.J., 2004, GLOBAL INVENTORY MOD; Vermote E, 2009, REMOTE SENSING REV, V15, P7; Vitasse Y, AGR FOREST METEOROLO; Vitasse Y, 2009, CAN J FOREST RES, V39, P1259, DOI 10.1139/X09-054; Vitasse Y, 2009, AGR FOREST METEOROL, V149, P735, DOI 10.1016/j.agrformet.2008.10.019; Wang J, 2013, GLOBAL ENVIRON CHANG, V23, P1673, DOI 10.1016/j.gloenvcha.2013.08.014; Wang XH, 2015, GLOBAL ECOL BIOGEOGR, V24, P621, DOI 10.1111/geb.12289; Wu CY, 2016, AGR FOREST METEOROL, V216, P177, DOI 10.1016/j.agrformet.2015.10.015; Xie YY, 2015, P NATL ACAD SCI USA, V112, P13585, DOI 10.1073/pnas.1509991112; Zhang XY, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005263; Zhao JJ, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8050400; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115; Zhu ZC, 2013, REMOTE SENS-BASEL, V5, P927, DOI 10.3390/rs5020927	55	23	26	9	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190313	10.1371/journal.pone.0190313	http://dx.doi.org/10.1371/journal.pone.0190313			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267403	Green Published, gold			2022-12-26	WOS:000418587400110
J	Yun, Y; Yin, H; Gao, ZY; Li, Y; Gao, T; Duan, JL; Yang, R; Dong, XX; Zhang, LM; Duan, WG				Yun, Yu; Yin, Hua; Gao, Zhiyi; Li, Yue; Gao, Tao; Duan, Jinlian; Yang, Rong; Dong, Xianxiang; Zhang, Lumei; Duan, Weigang			Intestinal tract is an important organ for lowering serum uric acid in rats	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; SENSITIVITY MASS-SPECTROMETRY; EXPERIMENTAL-MODEL; METABOLOMICS; METABONOMICS; DYSFUNCTION; METABOLISM; REVEALS	The kidney was recognized as a dominant organ for uric acid excretion. The main aim of the study demonstrated intestinal tract was an even more important organ for serum uric acid (SUA) lowering. Sprague-Dawley rats were treated normally or with antibiotics, uric acid, adenine, or inosine of the same molar dose orally or intraperitoneally for 5 days. Rat's intestinal tract was equally divided into 20 segments except the cecum. Uric acid in serum and intestinal segment juice was assayed. Total RNA in the initial intestinal tract and at the end ileum was extracted and sequenced. Protein expression of xanthine dehydrogenase (XDH) and urate oxidase (UOX) was tested by Western blot analysis. The effect of oral UOX in lowering SUA was investigated in model rats treated with adenine and an inhibitor of uric oxidase for 5 days. SUA in the normal rats was 20.93 +/- 6.98 mu g/ml, and total uric acid in the intestinal juice was 308.27 +/- 16.37 mu g, which is two times more than the total SUA. The uric acid was very low in stomach juice, and attained maximum in the juice of the first segment (duodenum) and then declined all the way till the intestinal end. The level of uric acid in the initial intestinal tissue was very high, where XDH and most of the proteins associated with bicarbonate secretion were up-regulated. In addition, SUA was decreased by oral UOX in model rats. The results suggested that intestinal juice was an important pool for uric acid, and intestinal tract was an important organ for SUA lowering. The uric acid distribution was associated with uric acid synthesis and secretion in the upper intestinal tract, and reclamation in the lower.	[Yun, Yu; Yin, Hua; Gao, Zhiyi; Li, Yue; Gao, Tao; Duan, Jinlian; Yang, Rong; Dong, Xianxiang; Zhang, Lumei; Duan, Weigang] Yunnan Univ Tradit Chinese Med, Kunming Key Lab Mol Biol Sinomed, Fac Basic Med, Kunming, Yunnan, Peoples R China; [Yun, Yu] Kunming Med Univ, Sch Basic Med, Kunming, Yunnan, Peoples R China	Yunnan University of Chinese Medicine; Kunming Medical University	Duan, WG (corresponding author), Yunnan Univ Tradit Chinese Med, Kunming Key Lab Mol Biol Sinomed, Fac Basic Med, Kunming, Yunnan, Peoples R China.	deardwg@126.com	Duan, Weigang/AAN-7980-2020	Duan, Weigang/0000-0002-9006-861X	National College Students' Innovation and Entrepreneurship Training Program of China [201510680001]	National College Students' Innovation and Entrepreneurship Training Program of China	This work was supported by the The National College Students' Innovation and Entrepreneurship Training Program of China (No. 201510680001).	ARCHIMBAUD E, 1991, EUR J CANCER, V27, P174, DOI 10.1016/0277-5379(91)90481-R; Basseville Agnes, 2011, F1000 Biol Rep, V3, P23, DOI 10.3410/B3-23; Bibert S, 2009, AM J PHYSIOL-RENAL, V297, pF612, DOI 10.1152/ajprenal.00139.2009; Chen DQ, 2017, NEPHROL DIAL TRANSPL, V32, P1154, DOI 10.1093/ndt/gfw415; Chen DQ, 2017, REDOX BIOL, V12, P505, DOI 10.1016/j.redox.2017.03.017; Chen H, 2017, J PROTEOME RES, V16, P1566, DOI 10.1021/acs.jproteome.6b00956; Chen H, 2016, REDOX BIOL, V10, P168, DOI 10.1016/j.redox.2016.09.014; Chen L, 2017, CHEM-BIOL INTERACT, V273, P56, DOI 10.1016/j.cbi.2017.05.025; COLE JS, 1971, METABOLISM, V20, P278, DOI 10.1016/0026-0495(71)90111-9; Corson TW, 2011, CHEMBIOCHEM, V12, P1767, DOI 10.1002/cbic.201100007; Ghosh T, 2014, J BIOSCIENCES, V39, P805, DOI 10.1007/s12038-014-9476-2; Hosomi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030456; Hou XL, 2015, NEURAL REGEN RES, V10, P1836, DOI 10.4103/1673-5374.170314; Ichida Kimiyoshi, 2008, Nihon Rinsho, V66, P759; Kosugi Y, 2015, J PHARM SCI-US, V104, P2887, DOI 10.1002/jps.24401; Lin YQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182602; Liu X-Q, 2001, CHINESE J PATHOPHYSI, V17, P1038; Liu YW, 2015, CHIN J INTEGR MED, V21, P823, DOI 10.1007/s11655-015-2052-2; Luo Z, 2008, COMPOSITION BLOOD; Ma Z, 2009, J PHARM PHARMACOL, V61, P1499, DOI 10.1211/jpp/61.11.0009; Maiuolo J, 2016, INT J CARDIOL, V213, P8, DOI 10.1016/j.ijcard.2015.08.109; Mraz M, 2015, UROLITHIASIS, V43, P61, DOI 10.1007/s00240-014-0734-4; Niu YF, 2012, PHARM BIOL, V50, P1177, DOI 10.3109/13880209.2012.663763; OKUMURA J, 1976, BRIT J NUTR, V36, P265, DOI 10.1079/BJN19760078; SEPULCHRE D, 1990, ACTA GASTRO-ENT BELG, V53, P499; Sivera F, 2014, ANN RHEUM DIS, V73, P328, DOI 10.1136/annrheumdis-2013-203325; SORENSEN LEIF B., 1965, ARTHRITIS RHEUM, V8, P694, DOI 10.1002/art.1780080429; Sun X-X, 2001, CHINESE PHARMACOL B, V17, P250; Takada T, 2013, YAKUGAKU ZASSHI, V133, P451, DOI 10.1248/yakushi.12-00258; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Yang DH, 2014, BIOMED ENVIRON SCI, V27, P898, DOI 10.3967/bes2014.126; Yin H, 2015, CELL BIOL INT, V39, P563, DOI 10.1002/cbin.10423; Yun Y, 2016, SCI WORLD J, V2016, P2695718; Zhang X, 2001, CHINESE J PATHOPHYSI, V17, P1038; ZHANG ZM, 2015, SCI REP UK, V5; Zhao YY, 2015, BIOANALYSIS, V7, P685, DOI 10.4155/bio.14.309; Zhao YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115467; Zhao YY, 2014, ADV CLIN CHEM, V65, P69, DOI 10.1016/B978-0-12-800141-7.00003-6; Zhao YY, 2013, CLIN CHIM ACTA, V422, P59, DOI 10.1016/j.cca.2013.03.033; Zhao YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059617; Zhao YY, 2013, CHEM-BIOL INTERACT, V201, P31, DOI 10.1016/j.cbi.2012.12.002; Zhao YY, 2013, J PROTEOME RES, V12, P692, DOI 10.1021/pr3007792; Zhao YY, 2012, CLIN CHIM ACTA, V413, P1438, DOI 10.1016/j.cca.2012.06.005; Zhao YY, 2012, BIOMARKERS, V17, P48, DOI 10.3109/1354750X.2011.637180; Zhao YY, 2012, CLIN CHIM ACTA, V413, P642, DOI 10.1016/j.cca.2011.12.014	45	36	41	8	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190194	10.1371/journal.pone.0190194	http://dx.doi.org/10.1371/journal.pone.0190194			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267361	Green Submitted, gold, Green Published			2022-12-26	WOS:000418587400102
J	Conrad, DJ; Bailey, BA; Hardie, JA; Bakke, PS; Eagan, TML; Aarli, BB				Conrad, Douglas J.; Bailey, Barbara A.; Hardie, Jon A.; Bakke, Per S.; Eagan, Tomas M. L.; Aarli, Bernt B.			Median regression spline modeling of longitudinal FEV1 measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients	PLOS ONE			English	Article							FUNCTION DECLINE; VARIABILITY; RISK	Rationale Clinical phenotyping, therapeutic investigations as well as genomic, airway secretion metabolomic and metagenomic investigations can benefit from robust, nonlinear modeling of FEV1 in individual subjects. We demonstrate the utility of measuring FEV1 dynamics in representative cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) populations. Methods Individual FEV1 data from CF and COPD subjects were modeled by estimating median regression splines and their predicted first and second derivatives. Classes were created from variables that capture the dynamics of these curves in both cohorts. Results Nine FEV1 dynamic variables were identified from the splines and their predicted derivatives in individuals with CF (n = 177) and COPD (n = 374). Three FEV1 dynamic classes (i.e. stable, intermediate and hypervariable) were generated and described using these variables from both cohorts. In the CF cohort, the FEV1 hypervariable class (HV) was associated with a clinically unstable, female-dominated phenotypes while stable FEV1 class (S) individuals were highly associated with the male-dominated milder clinical phenotype. In the COPD cohort, associations were found between the FEV1 dynamic classes, the COPD GOLD grades, with exacerbation frequency and symptoms. Conclusion Nonlinear modeling of FEV1 with splines provides new insights and is useful in characterizing CF and COPD clinical phenotypes.	[Conrad, Douglas J.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Bailey, Barbara A.] San Diego State Univ, Dept Math & Stat, San Diego, CA 92182 USA; [Hardie, Jon A.; Bakke, Per S.; Eagan, Tomas M. L.; Aarli, Bernt B.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Eagan, Tomas M. L.] Haukeland Hosp, Dept Thorac Med, Bergen, Norway	University of California System; University of California San Diego; California State University System; San Diego State University; University of Bergen; University of Bergen; Haukeland University Hospital	Conrad, DJ (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	dconrad@ucsd.edu	Eagan, Tomas Mikal/AHC-9127-2022; Eagan, Tomas ML/P-3554-2014	Eagan, Tomas ML/0000-0001-8725-9960	National Institutes of Health [1R01GM09534-01]; Cystic Fibrosis Foundation Therapeutics; National Foundation for Cancer Research; Centre for Clinical Research	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); National Foundation for Cancer Research; Centre for Clinical Research	This work was supported by the National Institutes of Health. Award Number: 1R01GM09534-01; Cystic Fibrosis Foundation Therapeutics; National Foundation for Cancer Research and the Centre for Clinical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarli BB, 2015, EUR RESPIR J, V45, P625, DOI 10.1183/09031936.00051214; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BURROWS B, 1983, CHEST, V83, P717, DOI 10.1378/chest.83.5.717; Casanova C, 2014, EUR RESPIR J, V43, P745, DOI 10.1183/09031936.00096913; Conrad DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122705; Cystic Fibrosis Foundation Patient Registry, 2014, CYST FIBR FDN; Eagan TML, 2010, EUR RESPIR J, V35, P540, DOI 10.1183/09031936.00088209; Exuzides A, 2015, MED DECIS MAKING; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; FRIENDLY M, 1994, J AM STAT ASSOC, V89, P190; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Konstan MW, 2012, J CYST FIBROS, V11, P405, DOI 10.1016/j.jcf.2012.03.009; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Meyer D, 2006, J STAT SOFTW, V17; Morgan WJ, 2016, J PEDIATR-US, V169, P116, DOI 10.1016/j.jpeds.2015.08.042; Moss A, 2016, STAT MED, V35, P2058, DOI 10.1002/sim.6845; Murrell P., 2005, R GRAPHICS CRC COMPU; Nychka D., 2015, R PACKAGE VERSION, V8, P2; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; R Core Team, 2021, R LANGUAGE ENV STAT; Schluchter MD, 2006, AM J RESP CRIT CARE, V174, P780, DOI 10.1164/rccm.200512-1919OC; Szczesniak RD, 2017, AM J RESP CRIT CARE; Szczesniak RD, 2013, ANN EPIDEMIOL, V23, P771, DOI 10.1016/j.annepidem.2013.08.009; WARE JH, 1990, AM J EPIDEMIOL, V132, P685, DOI 10.1093/oxfordjournals.aje.a115710	25	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0190061	10.1371/journal.pone.0190061	http://dx.doi.org/10.1371/journal.pone.0190061			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261779	Green Published, Green Submitted, gold			2022-12-26	WOS:000418564200083
J	Leonhardt, A; Meier, M; Serbe, E; Currency, HE; Borst, A				Leonhardt, Aljoscha; Meier, Matthias; Serbe, Etienne; Currency, Hubert Eichner; Borst, Alexander			Neural mechanisms underlying sensitivity to reverse-phi motion in the fly	PLOS ONE			English	Article							APPARENT MOTION; VISUAL INTERNEURONS; FUNCTIONAL SPECIALIZATION; DIRECTIONAL SELECTIVITY; TARGETED EXPRESSION; REICHARDT DETECTORS; INPUT ELEMENTS; DROSOPHILA; PERCEPTION; VISION	Optical illusions provide powerful tools for mapping the algorithms and circuits that underlie visual processing, revealing structure through atypical function. Of particular note in the study of motion detection has been the reverse-phi illusion. When contrast reversals accompany discrete movement, detected direction tends to invert. This occurs across a wide range of organisms, spanning humans and invertebrates. Here, we map an algorithmic account of the phenomenon onto neural circuitry in the fruit fly Drosophila melanogaster. Through targeted silencing experiments in tethered walking flies as well as electrophysiology and calcium imaging, we demonstrate that ON-or OFF-selective local motion detector cells T4 and T5 are sensitive to certain interactions between ON and OFF. A biologically plausible detector model accounts for subtle features of this particular form of illusory motion reversal, like the re-inversion of turning responses occurring at extreme stimulus velocities. In light of comparable circuit architecture in the mammalian retina, we suggest that similar mechanisms may apply even to human psychophysics.	[Leonhardt, Aljoscha; Meier, Matthias; Serbe, Etienne; Currency, Hubert Eichner; Borst, Alexander] Max Planck Inst Neurobiol, Martinsried, Germany; [Leonhardt, Aljoscha; Meier, Matthias; Serbe, Etienne] Grad Sch System Neurosci, Munich, Germany; [Currency, Hubert Eichner] Google Inc, Seattle, WA USA	Max Planck Society; Google Incorporated	Leonhardt, A (corresponding author), Max Planck Inst Neurobiol, Martinsried, Germany.; Leonhardt, A (corresponding author), Grad Sch System Neurosci, Munich, Germany.	leonhardt@neuro.mpg.de		Serbe-Kamp, Etienne/0000-0002-7097-6274; Meier, Matthias/0000-0003-3608-4384	Max Planck-Society; Google Inc.	Max Planck-Society(Max Planck SocietyFoundation CELLEX); Google Inc.(Google Incorporated)	This work was supported by the Max Planck-Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Google Inc. provided support in the form of salaries for author HE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Ammer G, 2015, CURR BIOL, V25, P2247, DOI 10.1016/j.cub.2015.07.014; ANSTIS SM, 1970, VISION RES, V10, P1411, DOI 10.1016/0042-6989(70)90092-1; ANSTIS SM, 1975, VISION RES, V15, P957, DOI 10.1016/0042-6989(75)90236-9; Arenz A, 2017, CURR BIOL, V27, P929, DOI 10.1016/j.cub.2017.01.051; Bahl A, 2015, NEURON, V88, P1240, DOI 10.1016/j.neuron.2015.11.004; Bahl A, 2013, NAT NEUROSCI, V16, P730, DOI 10.1038/nn.3386; Baloch AA, 1999, J OPT SOC AM A, V16, P953, DOI 10.1364/JOSAA.16.000953; Behnia R, 2014, NATURE, V512, P427, DOI 10.1038/nature13427; Benton CP, 1997, VISION RES, V37, P2381, DOI 10.1016/S0042-6989(97)00040-0; Borst A, 2003, VISION RES, V43, P1309, DOI 10.1016/S0042-6989(03)00092-0; BORST A, 1986, BIOL CYBERN, V55, P59, DOI 10.1007/BF00363978; Borst A, 2015, NAT NEUROSCI, V18, P1067, DOI 10.1038/nn.4050; Borst A, 2014, NAT REV NEUROSCI, V15, P590, DOI 10.1038/nrn3799; Borst A, 2011, NEURON, V71, P974, DOI 10.1016/j.neuron.2011.08.031; Bours RJE, 2007, J VISION, V7, DOI 10.1167/7.11.8; Bours RJE, 2009, VISION RES, V49, P1, DOI 10.1016/j.visres.2008.09.014; BRADDICK OJ, 1980, PHILOS T ROY SOC B, V290, P137, DOI 10.1098/rstb.1980.0087; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chiappe ME, 2010, CURR BIOL, V20, P1470, DOI 10.1016/j.cub.2010.06.072; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P2985, DOI 10.1073/pnas.86.8.2985; Clark DA, 2014, NAT NEUROSCI, V17, P296, DOI 10.1038/nn.3600; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; EDWARDS M, 1994, VISION RES, V34, P2849, DOI 10.1016/0042-6989(94)90054-X; Edwards M, 2004, VISION RES, V44, P1941, DOI 10.1016/j.visres.2004.03.016; EGELHAAF M, 1992, VISUAL NEUROSCI, V8, P151, DOI 10.1017/S0952523800009317; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; Fisher YE, 2015, NEURON, V88, P390, DOI 10.1016/j.neuron.2015.09.033; Haag J, 2004, P NATL ACAD SCI USA, V101, P16333, DOI 10.1073/pnas.0407368101; Haag J, 2016, ELIFE, V5, DOI 10.7554/eLife.17421; Haikala V, 2013, J NEUROSCI, V33, P13927, DOI 10.1523/JNEUROSCI.0340-13.2013; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; HEEGER DJ, 1987, J OPT SOC AM A, V4, P1455, DOI 10.1364/JOSAA.4.001455; Hu Q, 2010, J VISION, V10, DOI 10.1167/10.3.9; Ibbotson MR, 2001, J NEUROPHYSIOL, V86, P997, DOI 10.1152/jn.2001.86.2.997; Jain S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004536; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2013, J NEUROSCI, V33, P902, DOI 10.1523/JNEUROSCI.3374-12.2013; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; JOHNSTON A, 1995, VISION RES, V35, P1109, DOI 10.1016/0042-6989(94)00175-L; Jung SN, 2011, J NEUROSCI, V31, P9231, DOI 10.1523/JNEUROSCI.1138-11.2011; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Krekelberg B, 2005, J NEUROPHYSIOL, V93, P2908, DOI 10.1152/jn.00473.2004; Leong JCS, 2016, J NEUROSCI, V36, P8078, DOI 10.1523/JNEUROSCI.1272-16.2016; Leonhardt A, 2016, NAT NEUROSCI, V19, P706, DOI 10.1038/nn.4262; Lu ZL, 1999, PERCEPT PSYCHOPHYS, V61, P1075, DOI 10.3758/BF03207615; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; Maruya K, 2003, VISION RES, V43, P2517, DOI 10.1016/S0042-6989(03)00438-3; MATHER G, 1990, Spatial Vision, V5, P1, DOI 10.1163/156856890X00057; Mauss AS, 2015, CELL, V162, P351, DOI 10.1016/j.cell.2015.06.035; Mauss AS, 2014, J NEUROSCI, V34, P2254, DOI 10.1523/JNEUROSCI.3938-13.2014; Mo CH, 2003, NEURAL COMPUT, V15, P735, DOI 10.1162/08997660360581886; Oluk C, 2016, SCI REP-UK, V6, DOI 10.1038/srep34073; Orger MB, 2000, NAT NEUROSCI, V3, P1128, DOI 10.1038/80649; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; Salazar-Gatzimas E, 2016, NEURON, V92, P227, DOI 10.1016/j.neuron.2016.09.017; SATO T, 1989, VISION RES, V29, P1749, DOI 10.1016/0042-6989(89)90157-0; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; Schnell B, 2014, P NATL ACAD SCI USA, V111, P5700, DOI 10.1073/pnas.1400698111; Schnell B, 2012, J COMP PHYSIOL A, V198, P389, DOI 10.1007/s00359-012-0716-3; Serbe E, 2016, NEURON, V89, P829, DOI 10.1016/j.neuron.2016.01.006; Shinomiya K, 2014, CURR BIOL, V24, P1062, DOI 10.1016/j.cub.2014.03.051; SHIOIRI S, 1990, VISION RES, V30, P757, DOI 10.1016/0042-6989(90)90101-P; Silies M, 2013, NEURON, V79, P111, DOI 10.1016/j.neuron.2013.04.029; Strother JA, 2017, NEURON, V94, P168, DOI 10.1016/j.neuron.2017.03.010; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Takemura SY, 2015, P NATL ACAD SCI USA, V112, P13711, DOI 10.1073/pnas.1509820112; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Tuthill JC, 2013, NEURON, V79, P128, DOI 10.1016/j.neuron.2013.05.024; Tuthill JC, 2011, P NATL ACAD SCI USA, V108, P9685, DOI 10.1073/pnas.1100062108; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300; VANSANTEN JPH, 1984, J OPT SOC AM A, V1, P451, DOI 10.1364/JOSAA.1.000451; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Wehrhahn C, 2006, J VISION, V6, P1018, DOI 10.1167/6.10.2	77	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189019	10.1371/journal.pone.0189019	http://dx.doi.org/10.1371/journal.pone.0189019			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261684	Green Published, gold, Green Submitted			2022-12-26	WOS:000418564200022
J	Mounier, R; Lobo, D; Voulgaropoulos, J; Martin, M; Ait-Mamar, B; Bitot, V; Jost, PH; Birnbaum, R; Nebbad, B; Cook, F; Dhonneur, G				Mounier, Roman; Lobo, David; Voulgaropoulos, Julia; Martin, Mathieu; Ait-Mamar, Bouziane; Bitot, Valerie; Jost, Paul-Henri; Birnbaum, Ron; Nebbad, Biba; Cook, Fabrice; Dhonneur, Gilles			The multistep road to ventilator-associated lung abscess: A retrospective study of S-aureus ventilator-associated pneumonia	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PANTON-VALENTINE LEUKOCIDIN; INFECTIONS; MANAGEMENT; PATHOPHYSIOLOGY; ASPIRATION; INJURIES; PROGRESS; ADULTS; DAMAGE	Object We observed some cases of lung abscess (LA) in ICU patients suffering S. aureus ventilator-associated pneumonia (S. aureus-VAP). We aimed to assess which of the host and/or bacteria-related features are associated with LA. Methods We conducted a retrospective study from January 2009 to July 2013 in a trauma surgical ICU within a teaching hospital. All adult patients presenting with S. aureus-VAP were included. We compared two groups of patients according to the formation or not of LA concomitantly to S. aureus-VAP. Results Seventy-nine S. aureus-VAP patients, predominantly males (85%) of rather young age (mean [SD]: 35yr [21-64]) with severe trauma (initial Simplified Acute Score II = 42 [32-52]) related-ICU admission, were included. Among them, 10 (14%) developed LA. Patient's characteristics significantly associated with LA development were: a younger age (p = 0.003), road traffic accidents admission (p = 0.017), head injury (p = 0.002), lower Glasgow Coma Scale (p = 0.009), blunt chest trauma (p = 0.01) pneumothorax (p = 0.01) and lung contusions (p = 0.002). No microbiological factors were significantly associated with LA formation. Abscesses were mostly bilateral, >= 5 cm of diameter and with a posterior location. Conclusions Our results do not favor a specific virulence of S. aureus, but rather highlight the role of multiple insults to the lung, promoting LA formation. Despite a similar severity score, patients with LA had more serious trauma, combining severe both chest and head insults.	[Mounier, Roman; Lobo, David; Martin, Mathieu; Ait-Mamar, Bouziane; Bitot, Valerie; Jost, Paul-Henri; Birnbaum, Ron; Cook, Fabrice; Dhonneur, Gilles] Henri Mondor Univ Hosp Paris, Paris Sch Med 12, Dept Anesthesia & Surg Intens Care, Creteil, France; [Voulgaropoulos, Julia] Bichat Claude Bernard Univ Hosp Paris, Paris Sch Med 12, Dept Anesthesia & Surg Intens Care, Paris, France; [Nebbad, Biba] Henri Mondor Univ Hosp Paris, Paris Sch Med 12, Dept Microbiol, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Mounier, R (corresponding author), Henri Mondor Univ Hosp Paris, Paris Sch Med 12, Dept Anesthesia & Surg Intens Care, Creteil, France.	roman.mounier@laposte.net		Bitot, Valerie/0000-0002-8447-2296				Beitler JR, 2014, CHEST, V146, P1102, DOI 10.1378/chest.14-0555; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; DiBardino DM, 2015, J CRIT CARE, V30, P40, DOI 10.1016/j.jcrc.2014.07.011; Ganie Farooq Ahmad, 2013, Bull Emerg Trauma, V1, P7; Gattinoni L, 2001, AM J RESP CRIT CARE, V164, P1701, DOI 10.1164/ajrccm.164.9.2103121; Gavelli G, 2002, EUR RADIOL, V12, P1273, DOI 10.1007/s00330-002-1439-6; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gleeson K, 1997, CHEST, V111, P1266, DOI 10.1378/chest.111.5.1266; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hoth JJ, 2009, J TRAUMA, V67, P14, DOI 10.1097/TA.0b013e31819ea600; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Kuhajda I, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.07.08; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Matthes G, 2007, ZBL CHIR, V132, P142, DOI 10.1055/s-2007-960646; Niemann S, 2012, J INFECT DIS, V206, P1138, DOI 10.1093/infdis/jis468; Patradoon-Ho P, 2007, PAEDIATR RESPIR REV, V8, P77, DOI 10.1016/j.prrv.2006.10.002; PHAM LH, 1991, AM REV RESPIR DIS, V143, P1055, DOI 10.1164/ajrccm/143.5_Pt_1.1055; Raghavendran K, 2009, SHOCK, V32, P122, DOI 10.1097/SHK.0b013e31819c385c; Shallcross LJ, 2013, LANCET INFECT DIS, V13, P43, DOI 10.1016/S1473-3099(12)70238-4; Stock CT, 2013, SURG INFECT, V14, P335, DOI 10.1089/sur.2012.060; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Valour F, 2013, REV PNEUMOL CLIN, V69, P368, DOI 10.1016/j.pneumo.2013.08.004; Wunderink RG, 2004, INFECT DIS CLIN N AM, V18, P743, DOI 10.1016/j.idc.2004.07.004	26	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189249	10.1371/journal.pone.0189249	http://dx.doi.org/10.1371/journal.pone.0189249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261721	gold, Green Submitted, Green Published			2022-12-26	WOS:000418564200035
J	Perez-Riverol, Y; Kuhn, M; Vizcaino, JA; Hitz, MP; Audain, E				Perez-Riverol, Yasset; Kuhn, Max; Vizcaino, Juan Antonio; Hitz, Marc-Phillip; Audain, Enrique			Accurate and fast feature selection workflow for high-dimensional omics data	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; SUPPORT VECTOR MACHINES; ISOELECTRIC POINT; MICROARRAY DATA; BREAST-CANCER; BIG DATA; CLASSIFICATION; DESCRIPTORS; PROTEOMICS	We are moving into the age of 'Big Data' in biomedical research and bioinformatics. This trend could be encapsulated in this simple formula: D = S * F, where the volume of data generated (D) increases in both dimensions: the number of samples (S) and the number of sample features (F). Frequently, a typical omics classification includes redundant and irrelevant features (e.g. genes or proteins) that can result in long computation times; decrease of the model performance and the selection of suboptimal features (genes and proteins) after the classification/regression step. Multiple algorithms and reviews has been published to describe all the existing methods for feature selection, their strengths and weakness. However, the selection of the correct FS algorithm and strategy constitutes an enormous challenge. Despite the number and diversity of algorithms available, the proper choice of an approach for facing a specific problem often falls in a 'grey zone'. In this study, we select a subset of FS methods to develop an efficient workflow and an R package for bioinformatics machine learning problems. We cover relevant issues concerning FS, ranging from domain's problems to algorithm solutions and computational tools. Finally, we use seven different proteomics and gene expression datasets to evaluate the workflow and guide the FS process.	[Perez-Riverol, Yasset; Vizcaino, Juan Antonio] EBI, EMBL, Wellcome Trust Genome Campus, Cambridge, England; [Kuhn, Max] RStudio Inc, Boston, MA USA; [Hitz, Marc-Phillip; Audain, Enrique] Univ Klinikum Schleswig Holstein Kiel, Dept Congenital Heart Dis & Pediat Cardiol, Kiel, Germany; [Hitz, Marc-Phillip; Audain, Enrique] German Ctr Cardiovasc Res DZHK, Berlin, Germany; [Hitz, Marc-Phillip; Audain, Enrique] Univ Med Ctr Schleswig Holstein UKSH, Dept Human Genet, Kiel, Germany; [Hitz, Marc-Phillip] Wellcome Trust Sanger Inst, Cambridge, England	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; University of Kiel; Schleswig Holstein University Hospital; German Centre for Cardiovascular Research; University of Kiel; Schleswig Holstein University Hospital; Wellcome Trust Sanger Institute	Perez-Riverol, Y (corresponding author), EBI, EMBL, Wellcome Trust Genome Campus, Cambridge, England.; Audain, E (corresponding author), Univ Klinikum Schleswig Holstein Kiel, Dept Congenital Heart Dis & Pediat Cardiol, Kiel, Germany.; Audain, E (corresponding author), German Ctr Cardiovasc Res DZHK, Berlin, Germany.; Audain, E (corresponding author), Univ Med Ctr Schleswig Holstein UKSH, Dept Human Genet, Kiel, Germany.	yperez@ebi.ac.uk; enrique.audain@uksh.de	Vizcaino, Juan Antonio/C-3691-2009; Hitz, Marc/ABD-9495-2021; Hitz, Marc-Phillip/Q-5571-2018; Perez-Riverol, Yasset/H-2873-2019	Vizcaino, Juan Antonio/0000-0002-3905-4335; Hitz, Marc-Phillip/0000-0001-9894-6897; Perez-Riverol, Yasset/0000-0001-6579-6941; Audain, Enrique/0000-0002-9201-7840; Kuhn, Max/0000-0003-2402-136X	BBSRC 'PROCESS' grant [BB/K01997X/1]; Wellcome Trust [WT101477MA]; EMBL core funding; DZHK (German Center for Cardiovascular Research), partner sites: Kiel, Germany; BBSRC [BB/K020145/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K020145/1] Funding Source: researchfish	BBSRC 'PROCESS' grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EMBL core funding; DZHK (German Center for Cardiovascular Research), partner sites: Kiel, Germany; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	YP-R is supported by BBSRC 'PROCESS' grant (BB/K01997X/1). JAV acknowledges the Wellcome Trust (grant number WT101477MA) and EMBL core funding. EA and MPH are supported by DZHK (German Center for Cardiovascular Research), partner sites: Kiel, Germany. The funder provided support in the form of salaries for authors [MK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Audain E, 2016, BIOINFORMATICS, V32, P821, DOI 10.1093/bioinformatics/btv674; Audain E, 2014, CURR TOP MED CHEM, V14, P388, DOI 10.2174/1568026613666131204113537; Barbu A, 2017, IEEE T PATTERN ANAL, V39, P272, DOI 10.1109/TPAMI.2016.2544315; BELLMAN R, 1956, P NATL ACAD SCI USA, V42, P767, DOI 10.1073/pnas.42.10.767; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CHAMBERS SE, 1989, BRIT J OBSTET GYNAEC, V96, P803, DOI 10.1111/j.1471-0528.1989.tb03319.x; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Duffy MJ, 2006, CRIT REV CL LAB SCI, V43, P325, DOI 10.1080/10408360600739218; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lawrence RT, 2015, CELL REP, V11, P630, DOI 10.1016/j.celrep.2015.03.050; Li S, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1178-3; Lynch C, 2008, NATURE, V455, P28, DOI 10.1038/455028a; Michalak K., 2006, International Journal of Applied Mathematics and Computer Science, P503; Perez-Riverol Y, 2017, NAT BIOTECHNOL, V35, P406, DOI 10.1038/nbt.3790; Perez-Riverol Y, 2012, J PROTEOMICS, V75, P2269, DOI 10.1016/j.jprot.2012.01.029; Perez-Riverol Y, 2011, J PROTEOMICS, V74, P2071, DOI 10.1016/j.jprot.2011.05.034; Pochet N, 2004, BIOINFORMATICS, V20, P3185, DOI 10.1093/bioinformatics/bth383; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Romanski P., 2013, PACKAGE FSELECTOR; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Wang JX, 2016, PROCEEDINGS OF 2016 IEEE 9TH UK-EUROPE-CHINA WORKSHOP ON MILLIMETRE WAVES AND TERAHERTZ TECHNOLOGIES (UCMMT), P12, DOI 10.1109/UCMMT.2016.7873945; Wang R, 2014, PROTEOMICS; Wang Y, 2005, COMPUT BIOL CHEM, V29, P37, DOI 10.1016/j.compbiolchem.2004.11.001; Wang YH, 2006, ONCOL REP, V15, P1057, DOI 10.3892/or.15.4.1057; Yang ZR, 2004, BRIEF BIOINFORM, V5, P328, DOI 10.1093/bib/5.4.328; Zou Q, 2016, NEUROCOMPUTING, V173, P346, DOI 10.1016/j.neucom.2014.12.123	32	45	45	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189875	10.1371/journal.pone.0189875	http://dx.doi.org/10.1371/journal.pone.0189875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261781	Green Published, gold, Green Submitted			2022-12-26	WOS:000418564200071
J	Stempien, E; Goddard, ML; Wilhelm, K; Tarnus, C; Bertsch, C; Chong, J				Stempien, Elodie; Goddard, Mary-Lorene; Wilhelm, Kim; Tarnus, Celine; Bertsch, Christophe; Chong, Julie			Grapevine Botryosphaeria dieback fungi have specific aggressiveness factor repertory involved in wood decay and stilbene metabolization	PLOS ONE			English	Article							VITIS-VINIFERA; ESCA DISEASE; NEOFUSICOCCUM-PARVUM; EUTYPA-LATA; PHAEOMONIELLA-CHLAMYDOSPORA; PHYTOTOXIC METABOLITES; DIPLODIA-SERIATA; BOTRYTIS-CINEREA; TRUNK DISEASES; RESVERATROL	Grapevine trunk diseases: Eutypa dieback, esca and Botryosphaeria dieback, which incidence has increased recently, are associated with several symptoms finally leading to the plant death. In the absence of efficient treatments, these diseases are a major problem for the viticulture; however, the factors involved in disease progression are not still fully identified. In order to get a better understanding of Botryosphaeria dieback development in grapevine, we have investigated different factors involved in Botryosphaeriaceae fungi aggressiveness. We first evaluated the activity of the wood-degrading enzymes of different isolates of Neofusicoccum parvum and Diplodia seriata, two major fungi associated with Botryosphaeria dieback. We further examinated the ability of these fungi to metabolize major grapevine phytoalexins: resveratrol and delta-viniferin. Our results demonstrate that Botryosphaeriaceae were characterized by differential wood decay enzymatic activities and have the capacity to rapidly degrade stilbenes. N. parvum is able to degrade parietal polysaccharides, whereas D. seriata has a better capacity to degrade lignin. Growth of both fungi exhibited a low sensitivity to resveratrol, whereas delta-viniferin has a fungistatic effect, especially on N. parvum Bourgogne S-116. We further show that Botryosphaeriaceae are able to metabolize rapidly resveratrol and delta-viniferin. The best stilbene metabolizing activity was measured for D. seriata. In conclusion, the different Botryosphaeriaceae isolates are characterized by a specific aggressiveness repertory. Wood and phenolic compound decay enzymatic activities could enable Botryosphaeriaceae to bypass chemical and physical barriers of the grapevine plant. The specific signature of Botryosphaeriaceae aggressiveness factors could explain the importance of fungi complexes in synergistic activity in order to fully colonize the host.	[Stempien, Elodie; Goddard, Mary-Lorene; Wilhelm, Kim; Bertsch, Christophe; Chong, Julie] Univ Haute Alsace, Lab Vigne Biotechnol & Environm, Colmar, France; [Goddard, Mary-Lorene; Wilhelm, Kim; Tarnus, Celine] Univ Haute Alsace, Lab Chim Organ & Bioorgan, Mulhouse, France	Universites de Strasbourg Etablissements Associes; Universite de Haute-Alsace (UHA); Universites de Strasbourg Etablissements Associes; Universite de Haute-Alsace (UHA)	Chong, J (corresponding author), Univ Haute Alsace, Lab Vigne Biotechnol & Environm, Colmar, France.	julie.chong@uha.fr	GODDARD, Mary-Lorène/AAC-4015-2019	GODDARD, Mary-Lorène/0000-0001-8462-5582	Alsace Region (France); CIVA (Conseil Interprofessionnels des Vins d'Alsace); Interreg Rhin Superieur V project "Vitifutur"; Universite de Haute Alsace	Alsace Region (France)(Region Grand-Est); CIVA (Conseil Interprofessionnels des Vins d'Alsace)(Region Grand-Est); Interreg Rhin Superieur V project "Vitifutur"; Universite de Haute Alsace	Stempien PhD fellowship was financed by the Alsace Region (France) and CIVA (Conseil Interprofessionnels des Vins d'Alsace). This work has been supported by Interreg Rhin Superieur V project "Vitifutur" http://www.interreg-rhin-sup.eu/projet/vitifutur-reseau-transnational-de-recherche-et-de-formation-en-viticulture/. This work has been supported by the Universite de Haute Alsace (Ecovino Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Mansour E, 2015, PHYTOCHEMISTRY, V115, P207, DOI 10.1016/j.phytochem.2015.01.012; Abou-Mansour E, 2009, PHYTOPATHOL MEDITERR, V48, P447; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Alessandro M., 2000, Phytopathologia Mediterranea, V39, P357; Amalfitano C., 2000, Phytopathologia Mediterranea, V39, P178; Andolfi A, 2011, TOXINS, V3, P1569, DOI 10.3390/toxins3121569; Baldrian P, 2008, FUNGAL ECOL, V1, P4, DOI 10.1016/j.funeco.2008.02.001; Bellee A, 2017, PLANT PATHOL, V66, P763, DOI 10.1111/ppa.12623; Benard-Gellon M, 2015, PROTOPLASMA, V252, P679, DOI 10.1007/s00709-014-0716-y; Beneventi E, 2015, TETRAHEDRON, V71, P3052, DOI 10.1016/j.tet.2014.11.012; Bertsch C, 2013, PLANT PATHOL, V62, P243, DOI 10.1111/j.1365-3059.2012.02674.x; BLANCHETTE RA, 1995, CAN J BOT, V73, pS999, DOI 10.1139/b95-350; Bruno G, 2006, PHYSIOL MOL PLANT P, V69, P182, DOI 10.1016/j.pmpp.2007.04.006; Calzarano F, 2008, ANAL LETT, V41, P649, DOI 10.1080/00032710801910585; Chalal M, 2014, MOLECULES, V19, P7679, DOI 10.3390/molecules19067679; Chen SF, 2014, FUNGAL DIVERS, V67, P157, DOI 10.1007/s13225-014-0285-6; Chong JL, 2009, PLANT SCI, V177, P143, DOI 10.1016/j.plantsci.2009.05.012; Cichewicz RH, 2000, J NAT PROD, V63, P29, DOI 10.1021/np990266n; Cristinzio G., 1978, INF FITOPATOL; Crous PW, 2006, STUD MYCOL, P235, DOI 10.3114/sim.55.1.235; De La Fuente M., 2016, GRAPEVINE TRUNK DIS, V1st; Dekker RFH, 2001, BIOTECHNOL LETT, V23, P1987, DOI 10.1023/A:1013742527550; Djoukeng JD, 2009, EUR J PLANT PATHOL, V124, P303, DOI 10.1007/s10658-008-9419-6; ERDTMAN HOLGER, 1939, JUSTUS LIEBIG S ANN CHEM, V539, P116, DOI 10.1002/jlac.19395390111; ERIKSSON KE, 1975, EUR J BIOCHEM, V51, P193, DOI 10.1111/j.1432-1033.1975.tb03919.x; Esteves AC, 2014, CAN J MICROBIOL, V60, P332, DOI 10.1139/cjm-2014-0134; Guan X, 2016, PLANT PATHOL, V65, P273, DOI 10.1111/ppa.12405; Guarnaccia V, 2016, EUR J PLANT PATHOL, V146, P963, DOI 10.1007/s10658-016-0973-z; Hofstetter V, 2012, FUNGAL DIVERS, V54, P51, DOI 10.1007/s13225-012-0171-z; Jeandet P, 2002, J AGR FOOD CHEM, V50, P2731, DOI 10.1021/jf011429s; Jodin P, 2008, PLANT DIS, V92, P519; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Kuntzmann P, 2010, VITIS, V49, P71; Lambert C, 2012, J AGR FOOD CHEM, V60, P11859, DOI 10.1021/jf303290g; LANGCAKE P, 1977, PHYTOCHEMISTRY, V16, P1193, DOI 10.1016/S0031-9422(00)94358-9; Lardner R, 2006, AUST J GRAPE WINE R, V12, P107, DOI 10.1111/j.1755-0238.2006.tb00049.x; Larignon P., 2001, Phytoma, P26; Larignon P, 1997, EUR J PLANT PATHOL, V103, P147, DOI 10.1023/A:1008638409410; Larignon P., 2012, MALADIES CRYPTOGAMIQ, VVolume 2; Larignon P., 1991, THESIS; Larignon P., 2001, PHYTOPATHOL MEDITERR, V40, P336, DOI DOI 10.14601/PHYT0PATH0L_MEDITERR-1629; Larignon P, 2009, CR BIOL, V332, P765, DOI 10.1016/j.crvi.2009.05.005; LEHOCZKY J, 1974, Acta Phytopathologica Academiae Scientiarum Hungaricae, V9, P319; Letousey P, 2010, PHYTOPATHOLOGY, V100, P424, DOI 10.1094/PHYTO-100-5-0424; Li C, 2012, GREEN CHEM, V14, P3281, DOI 10.1039/c2gc36288k; Lima MRM, 2010, J EXP BOT, V61, P4033, DOI 10.1093/jxb/erq214; Luque J, 2009, J PLANT PATHOL, V91, P381; Martin N, 2009, PHYTOPATHOL MEDITERR, V48, P101; Martos S, 2008, EUR J PLANT PATHOL, V121, P451, DOI 10.1007/s10658-007-9263-0; Mathieu Y, 2013, J MICROBIOL METH, V92, P157, DOI 10.1016/j.mimet.2012.11.017; MESSERSCHMIDT A, 1990, EUR J BIOCHEM, V187, P341, DOI 10.1111/j.1432-1033.1990.tb15311.x; Mora-Pale M, 2015, BIOTECHNOL BIOENG, V112, P2417, DOI 10.1002/bit.25686; Morales-Cruz A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1624-z; Mugnai L, 1999, PLANT DIS, V83, P404, DOI 10.1094/PDIS.1999.83.5.404; Pawlus AD, 2012, J INT SCI VIGNE VIN, V46, P57; PENNYCOOK SR, 1985, MYCOTAXON, V24, P445; Pezet R, 2004, PHYSIOL MOL PLANT P, V65, P297, DOI 10.1016/j.pmpp.2005.03.002; Pezet R, 2003, J AGR FOOD CHEM, V51, P5488, DOI 10.1021/jf030227o; Pezet R, 1998, FEMS MICROBIOL LETT, V167, P203, DOI 10.1111/j.1574-6968.1998.tb13229.x; PEZET R, 1988, PLANT PHYSIOL BIOCH, V26, P603; Pitt WM, 2013, AUSTRALAS PLANT PATH, V42, P573, DOI 10.1007/s13313-013-0221-3; R Development Core Team, 2016, R LANG ENV STAT COMP; Ramirez-Suero M, 2014, PROTOPLASMA, V251, P1417, DOI 10.1007/s00709-014-0643-y; Rolshausen PE, 2008, PHYTOPATHOLOGY, V98, P222, DOI 10.1094/PHYTO-98-2-0222; Rovesti L., 1987, Informatore Fitopatologico, V37, P59; Schmidlin L, 2008, PLANT PHYSIOL, V148, P1630, DOI 10.1104/pp.108.126003; Schmidt CS, 1999, Z PFLANZENK PFLANZEN, V106, P1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHOEMAKER R. A., 1964, CAN J BOT, V42, P1297, DOI 10.1139/b64-122; Spagnolo A, 2014, INT J MOL SCI, V15, P9644, DOI 10.3390/ijms15069644; Stempien E, 2017, PROTOPLASMA, P1; Surico G., 2001, PHYTOPATHOL MEDITERR, V40, P407; Taylor A, 2005, AUSTRALAS PLANT PATH, V34, P187, DOI 10.1071/AP05018; Valtaud C, 2009, J PLANT PATHOL, V91, P37; van Niekerk JM, 2004, MYCOLOGIA, V96, P781, DOI 10.2307/3762112; Wood IP, 2012, BIOMASS BIOENERG, V44, P117, DOI 10.1016/j.biombioe.2012.05.003; Yu CKY, 2008, PHYTOCHEMISTRY, V69, P700, DOI 10.1016/j.phytochem.2007.09.012; Yu CKY, 2006, PLANT CELL PHYSIOL, V47, P1017, DOI 10.1093/pcp/pcj061	78	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0188766	10.1371/journal.pone.0188766	http://dx.doi.org/10.1371/journal.pone.0188766			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261692	gold, Green Published, Green Submitted			2022-12-26	WOS:000418564200015
J	Weissmann, H; Kent, R; Michael, Y; Shnerb, NM				Weissmann, Haim; Kent, Rafi; Michael, Yaron; Shnerb, Nadav M.			Empirical analysis of vegetation dynamics and the possibility of a catastrophic desertification transition	PLOS ONE			English	Article							PATTERN-FORMATION; TROPICAL FOREST; TIPPING POINTS; STABLE STATES; REGIME SHIFTS; ECOSYSTEM; SAVANNA; RESILIENCE; DETERMINANTS; DROUGHT	The process of desertification in the semi-arid climatic zone is considered by many as a catastrophic regime shift, since the positive feedback of vegetation density on growth rates yields a system that admits alternative steady states. Some support to this idea comes from the analysis of static patterns, where peaks of the vegetation density histogram were associated with these alternative states. Here we present a large-scale empirical study of vegetation dynamics, aimed at identifying and quantifying directly the effects of positive feedback. To do that, we have analyzed vegetation density across 2.5 x 10(6) km(2) of the African Sahel region, with spatial resolution of 30 x 30 meters, using three consecutive snapshots. The results are mixed. The local vegetation density (measured at a single pixel) moves towards the average of the corresponding rainfall line, indicating a purely negative feedback. On the other hand, the chance of spatial clusters (of many "green" pixels) to expand in the next census is growing with their size, suggesting some positive feedback. We show that these apparently contradicting results emerge naturally in a model with positive feedback and strong demographic stochasticity, a model that allows for a catastrophic shift only in a certain range of parameters. Static patterns, like the double peak in the histogram of vegetation density, are shown to vary between censuses, with no apparent correlation with the actual dynamical features. Our work emphasizes the importance of dynamic response patterns as indicators of the state of the system, while the usefulness of static modality features appears to be quite limited.	[Weissmann, Haim; Shnerb, Nadav M.] Bar Ilan Univ, Dept Phys, IL-52900 Ramat Gan, Israel; [Kent, Rafi; Michael, Yaron] Bar Ilan Univ, Dept Geog & Environm, IL-52900 Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Weissmann, H (corresponding author), Bar Ilan Univ, Dept Phys, IL-52900 Ramat Gan, Israel.	wchaimw@gmail.com			Israel Science Foundation [1427/15]	Israel Science Foundation(Israel Science Foundation)	We acknowledge the support of the Israel Science Foundation (https://www.isf.org.il/#/), grant no. 1427/15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support of the Israel Science Foundation, grant no. 1427/15.	Adams MA, 2013, FOREST ECOL MANAG, V294, P250, DOI 10.1016/j.foreco.2012.11.039; Baudena M, 2015, BIOGEOSCIENCES, V12, P1833, DOI 10.5194/bg-12-1833-2015; Bel G, 2012, THEOR ECOL-NETH, V5, P591, DOI 10.1007/s12080-011-0149-6; Berdugo M, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0003; Bonachela JA, 2012, J STAT PHYS, V148, P723, DOI 10.1007/s10955-012-0506-x; Clark F, 2010, METHODS ECOL EVOL, V1, P253, DOI 10.1111/j.2041-210X.2010.00029.x; Dai L, 2013, NATURE, V496, P355, DOI 10.1038/nature12071; Eby S, 2017, GLOBAL ECOL BIOGEOGR, V26, P638, DOI 10.1111/geb.12570; Falkowski T, 2006, 2006 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE, (WI 2006 MAIN CONFERENCE PROCEEDINGS), P52, DOI 10.1109/WI.2006.118; Foley JA, 2003, ECOSYSTEMS, V6, P524, DOI 10.1007/s10021-002-0227-0; Gilad E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098105; Hanan NP, 2014, GLOBAL ECOL BIOGEOGR, V23, P259, DOI 10.1111/geb.12122; Hartmann T, 2014, ARXIV14013516; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Janssen RHH, 2008, GLOBAL CHANGE BIOL, V14, P1104, DOI 10.1111/j.1365-2486.2008.01540.x; KELTON KF, 1991, SOLID STATE PHYS, V45, P75; Kessler DA, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051138; Martin PV, 2015, P NATL ACAD SCI USA, V112, pE1828, DOI 10.1073/pnas.1414708112; Martinez-Vilalta J, 2016, GLOBAL PLANET CHANGE, V144, P94, DOI 10.1016/j.gloplacha.2016.07.009; Meron E, 2012, ECOL MODEL, V234, P70, DOI 10.1016/j.ecolmodel.2011.05.035; Moreira AG, 1996, PHYS REV E, V54, pR3090, DOI 10.1103/PhysRevE.54.R3090; NOYMEIR I, 1975, J ECOL, V63, P459, DOI 10.2307/2258730; Ratajczak Z, 2014, ECOLOGY, V95, P2633, DOI 10.1890/13-1369.1; Ratajczak Z, 2012, SCIENCE, V336, DOI 10.1126/science.1219346; Reyer CPO, 2015, J ECOL, V103, P5, DOI 10.1111/1365-2745.12337; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Seri E, 2012, AM NAT, V180, pE161, DOI 10.1086/668125; Shrestha B, 2017, MULTI SENSOR TEMPORA; Staal A, 2015, ECOL COMPLEX, V22, P65, DOI 10.1016/j.ecocom.2015.01.003; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Team GEE, 2015, GOOGL EARTH ENG PLAN; Tredennick AT, 2015, AM NAT, V185, pE153, DOI 10.1086/680475; van Nes EH, 2014, GLOBAL CHANGE BIOL, V20, P1016, DOI 10.1111/gcb.12398; Wallace CSA, 2008, GISCI REMOTE SENS, V45, P167, DOI 10.2747/1548-1603.45.2.167; Weissmann H, 2016, J THEOR BIOL, V397, P128, DOI 10.1016/j.jtbi.2016.02.033; Weissmann H, 2014, EPL-EUROPHYS LETT, V106, DOI 10.1209/0295-5075/106/28004	39	8	8	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189058	10.1371/journal.pone.0189058	http://dx.doi.org/10.1371/journal.pone.0189058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261678	Green Submitted, Green Published, gold			2022-12-26	WOS:000418564200025
J	Arafa, RA; Rakha, MT; Soliman, NEK; Moussa, OM; Kamel, SM; Shirasawa, K				Arafa, Ramadan A.; Rakha, Mohamed T.; Soliman, Nour Elden K.; Moussa, Olfat M.; Kamel, Said M.; Shirasawa, Kenta			Rapid identification of candidate genes for resistance to tomato late blight disease using next-generation sequencing technologies	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PHYTOPHTHORA-INFESTANS; LINKAGE MAP; LYCOPERSICON-ESCULENTUM; POLYMORPHISM MARKERS; HORTICULTURAL TRAITS; BEMISIA-TABACI; MULTIPLE QTL; GENOME; WILD	Tomato late blight caused by Phytophthora infestans (Mont.) de Bary, also known as the Irish famine pathogen, is one of the most destructive plant diseases. Wild relatives of tomato possess useful resistance genes against this disease, and could therefore be used in breeding to improve cultivated varieties. In the genome of a wild relative of tomato, Solanum hab-rochaites accession LA1777, we identified a new quantitative trait locus for resistance against blight caused by an aggressive Egyptian isolate of P. infestans. Using double-digest restriction site - associated DNA sequencing (ddRAD-Seq) technology, we determined 6,514 genome-wide SNP genotypes of an F-2 population derived from an interspecific cross. Subsequent association analysis of genotypes and phenotypes of the mapping population revealed that a 6.8 Mb genome region on chromosome 6 was a candidate locus for disease resistance. Whole-genome resequencing analysis revealed that 298 genes in this region potentially had functional differences between the parental lines. Among of them, two genes with missense mutations, Solyc06g071810.1 and Solyc06g083640.3, were considered to be potential candidates for disease resistance. SNP and SSR markers linking to this region can be used in marker-assisted selection in future breeding programs for late blight disease, including introgression of new genetic loci from wild species. In addition, the approach developed in this study provides a model for identification of other genes for attractive agronomical traits.	[Arafa, Ramadan A.; Kamel, Said M.] Agr Res Ctr, Plant Pathol Res Inst, Giza, Egypt; [Rakha, Mohamed T.] Univ Kafrelsheikh, Fac Agr, Dept Hort, Kafr Al Sheikh, Egypt; [Soliman, Nour Elden K.; Moussa, Olfat M.] Cairo Univ, Fac Agr, Dept Plant Pathol, Giza, Egypt; [Arafa, Ramadan A.; Shirasawa, Kenta] Kazusa DNA Res Inst, Dept Frontier Sci, Chiba, Japan; [Rakha, Mohamed T.] World Vegetable Ctr, Tainan, Taiwan	Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; Egyptian Knowledge Bank (EKB); Cairo University; Kazusa DNA Research Institute	Shirasawa, K (corresponding author), Kazusa DNA Res Inst, Dept Frontier Sci, Chiba, Japan.	shirasaw@kazusa.or.jp	Shirasawa, Kenta/L-9141-2019; Arafa, Ramadan/AAE-7300-2021	Shirasawa, Kenta/0000-0001-7880-6221; ARAFA, RAMADAN/0000-0002-8655-4842	Ministry of Higher Education and Scientific Research (MHESR), Egypt [2013/2014-547]; Kazusa DNA Research Institute Foundation, Japan	Ministry of Higher Education and Scientific Research (MHESR), Egypt(Ministry of Higher Education & Scientific Research (MHESR)); Kazusa DNA Research Institute Foundation, Japan	The study was financially supported by The Ministry of Higher Education and Scientific Research (MHESR), Egypt (Grant# 2013/2014-547), and the Kazusa DNA Research Institute Foundation, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Al Abdallat AM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-84; Arafa R. A., 2017, African Journal of Agricultural Research, V12, P2188, DOI 10.5897/ajar2017.12422; Arafa RA, J GEN PLANT IN PRESS; Ashrafi H, 2009, GENOME, V52, P935, DOI [10.1139/G09-065, 10.1139/g09-065]; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergougnoux V, 2014, BIOTECHNOL ADV, V32, P170, DOI 10.1016/j.biotechadv.2013.11.003; BERNATZKY R, 1986, GENETICS, V112, P887; Bolger A, 2014, NAT GENET, V46, P1034, DOI 10.1038/ng.3046; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brouwer DJ, 2004, GENOME, V47, P475, DOI 10.1139/G04-001; Brouwer DJ, 2004, THEOR APPL GENET, V108, P628, DOI 10.1007/s00122-003-1469-8; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; Causse M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-791; Celik I, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3406-7; Chen AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096417; Chunwongse J, 2002, J HORTIC SCI BIOTECH, V77, P281, DOI 10.1080/14620316.2002.11511493; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084; Devran Z, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0294-5; Dorrance AE, 1997, PLANT DIS, V81, P1206, DOI 10.1094/PDIS.1997.81.10.1206; ESHED Y, 1995, GENETICS, V141, P1147; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; FAOSTAT, FAO STAT DAT; Firdaus S, 2012, EUPHYTICA, V187, P31, DOI 10.1007/s10681-012-0704-2; Foolad MR, 2008, CRIT REV PLANT SCI, V27, P75, DOI 10.1080/07352680802147353; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; GALLEGLY ME, 1955, PHYTOPATHOLOGY, V45, P103; Govers F., 2005, Potato in progress: science meets practice, P245; Haggard JE, 2015, G3-GENES GENOM GENET, V5, P219, DOI 10.1534/g3.114.014654; Haggard JE, 2013, G3-GENES GENOM GENET, V3, P2131, DOI 10.1534/g3.113.007195; Ivanovic M, 2004, ACT HORTIC, V729, P499; Jimenez-Gomez JM, 2007, GENOME, V50, P303, DOI 10.1139/G07-009; Kobayashi M, 2014, PLANT CELL PHYSIOL, V55, P445, DOI 10.1093/pcp/pct181; Kole C, 2006, P SOL C U WISC MAD; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li JM, 2011, EUPHYTICA, V179, P427, DOI 10.1007/s10681-010-0340-7; Li Y, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00002; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Lin ZJD, 2015, PLANT PHYSIOL, V169, P2950, DOI 10.1104/pp.15.01391; Luk'yanenko A. N., 1991, Genetic improvement of tomato., P99; Mace E, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0253-z; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; MILLER JC, 1990, THEOR APPL GENET, V80, P437, DOI 10.1007/BF00226743; Momotaz A, 2010, J AM SOC HORTIC SCI, V135, P134, DOI 10.21273/JASHS.135.2.134; Monforte AJ, 2000, GENOME, V43, P803, DOI 10.1139/gen-43-5-803; Montes MS, 2016, PLANT PATHOL, V65, P744, DOI 10.1111/ppa.12462; Ohyama A, 2009, MOL BREEDING, V23, P685, DOI 10.1007/s11032-009-9265-z; Peirce L. C., 1971, REP TOMATO GENET COO, V21, P30; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Robert VJM, 2001, MOL BREEDING, V8, P217, DOI 10.1023/A:1013734024200; Sahu KK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3822-3; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Saville A, 2015, PLANT DIS, V99, P659, DOI 10.1094/PDIS-05-14-0452-RE; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shirasawa K, 2017, SCI REP-UK, V7, DOI 10.1038/srep44207; Shirasawa K, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2016.06.0052; Shirasawa K, 2016, DNA RES, V23, P145, DOI 10.1093/dnares/dsw004; Shirasawa K, 2016, PLANT BIOTECHNOL J, V14, P51, DOI 10.1111/pbi.12348; Shirasawa K, 2013, DNA RES, V20, P593, DOI 10.1093/dnares/dst033; Shirasawa K, 2013, BREEDING SCI, V63, P21, DOI 10.1270/jsbbs.63.21; Shirasawa K, 2010, THEOR APPL GENET, V121, P731, DOI 10.1007/s00122-010-1344-3; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Smart CD, 2007, PLANT DIS, V91, P1045, DOI 10.1094/PDIS-91-8-1045; Truong HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037565; Viquez-Zamora M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-354; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Yamamoto E, 2016, SCI REP-UK, V6, DOI 10.1038/srep19454; Zhao YS, 2012, THEOR APPL GENET, V124, P769, DOI 10.1007/s00122-011-1745-y	74	13	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189951	10.1371/journal.pone.0189951	http://dx.doi.org/10.1371/journal.pone.0189951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253902	Green Submitted, gold, Green Published			2022-12-26	WOS:000418389500079
J	Chen, XG; Kou, M; Tang, ZH; Zhang, AJ; Li, HM; Wei, M				Chen, Xiaoguang; Kou, Meng; Tang, Zhonghou; Zhang, Aijun; Li, Hongmin; Wei, Meng			Responses of root physiological characteristics and yield of sweet potato to humic acid urea fertilizer	PLOS ONE			English	Article							NITROGEN; GROWTH; PRODUCTIVITY; EFFICIENCY	Humic acid (HA), not only promote the growth of crop roots, they can be combined with nitrogen (N) to increase fertilizer use efficiency and yield. However, the effects of HA urea fertilizer (HA-N) on root growth and yield of sweet potato has not been widely investigated. Xushu 28 was used as the experimental crop to investigate the effects of HA-N on root morphology, active oxygen metabolism and yield under field conditions. Results showed that nitrogen application alone was not beneficial for root growth and storage root formation during the early growth stage. HA-N significantly increased the dry weight of the root system, promoted differentiation from adventitious root to storage root, and increased the overall root activity, total root length, root diameter, root surface area, as well as root volume. HA-N thus increased the activity of superoxide dismutase (SOD), peroxidase (POD), and Catalase (CAT) as well as increasing the soluble protein content of roots and decreasing the malondialdehyde (MDA) content. HA-N significantly increased both the number of storage roots per plant increased by 14.01%, and the average fresh weight per storage root increased by 13.7%, while the yield was also obviously increased by 29.56%. In this study, HA-N increased yield through a synergistic increase of biological yield and harvest index.	[Chen, Xiaoguang; Kou, Meng; Tang, Zhonghou; Zhang, Aijun; Li, Hongmin; Wei, Meng] Xuzhou Sweet Potato Res Ctr, Xuzhou Inst Agr Sci Xuhuai Dist Jiangsu Prov, Xuzhou, Jiangsu, Peoples R China; [Kou, Meng] Jiangsu Nornal Univ, Sch Life Sci, Xuzhou, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Chen, XG (corresponding author), Xuzhou Sweet Potato Res Ctr, Xuzhou Inst Agr Sci Xuhuai Dist Jiangsu Prov, Xuzhou, Jiangsu, Peoples R China.	chenxggw@163.com		Chen, Xiaoguang/0000-0002-9660-6263	Nitural Science Foundation of Jiangsu Province [BK20171167]; National Natural Science Foundation of China [31401333]; Six Talent Peaks Project in Jiangsu Province [2015-NY-040]; China Agricultural Research System [CARS-11]	Nitural Science Foundation of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Six Talent Peaks Project in Jiangsu Province; China Agricultural Research System	This work was supported by the Nitural Science Foundation of Jiangsu Province (No. BK20171167) and the National Natural Science Foundation of China (NO. 31401333), the Six Talent Peaks Project in Jiangsu Province (No. 2015-NY-040), and the China Agricultural Research System (No. CARS-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ahsan N, 2007, PLANT SOIL, V295, P37, DOI 10.1007/s11104-007-9258-9; AMAKO K, 1994, PLANT CELL PHYSIOL, V35, P497; Ayuso M, 1996, J SCI FOOD AGR, V72, P493, DOI 10.1002/(SICI)1097-0010(199612)72:4&lt;493::AID-JSFA687&gt;3.0.CO;2-4; BATTEN GD, 1992, PLANT SOIL, V146, P163, DOI 10.1007/BF00012009; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; El-Shabrawi H. M., 2015, Agricultural Sciences, V6, P175; Fitter A., 2002, PLANT ROOTS HIDDEN H, P15; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Inukai Y, 2004, PLANT CELL PHYSIOL, V45, pS17; Jindo K, 2012, PLANT SOIL, V353, P209, DOI 10.1007/s11104-011-1024-3; Kato Y, 2010, FIELD CROP RES, V117, P9, DOI 10.1016/j.fcr.2009.12.003; Kim SH, 2002, PLANT GROWTH REGUL, V37, P207, DOI 10.1023/A:1020844418776; KLAPHECK S, 1990, PLANT CELL PHYSIOL, V31, P1005; [李长志 Li Changzhi], 2016, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V22, P511; Li ZJ, 2004, CHINESE J SOIL SCI, V35, P799; Liu ZengBing, 2010, Plant Nutrition and Fertilizer Science, V16, P208; Mackowiak CL, 2001, SOIL SCI SOC AM J, V65, P1744, DOI 10.2136/sssaj2001.1744; Marti HR, 2002, COMMUN SOIL SCI PLAN, V33, P287, DOI 10.1081/CSS-120002394; Ning YunWang, 2013, Jiangsu Journal of Agricultural Sciences, V29, P1326; OSAKI M, 1991, SOIL SCI PLANT NUTR, V37, P445, DOI 10.1080/00380768.1991.10415057; Samejima H, 2005, J PLANT NUTR, V28, P835, DOI 10.1081/PLN-200055550; Samejima H, 2004, SOIL SCI PLANT NUTR, V50, P545, DOI 10.1080/00380768.2004.10408511; Selladurai R, 2016, J PLANT NUTR, V39, P949, DOI 10.1080/01904167.2015.1109106; Villordon A, 2012, HORTSCIENCE, V47, P961, DOI 10.21273/HORTSCI.47.7.961; Villordon AQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107384; Villordon AQ, 2009, HORTSCIENCE, V44, P651, DOI 10.21273/HORTSCI.44.3.651; Wang KH, 2007, CROP SCI, V47, P232, DOI 10.2135/cropsci2006.07.0498; [王振振 Wang Zhenzhen], 2012, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V18, P249; WILSON LA, 1973, EUPHYTICA, V22, P324, DOI 10.1007/BF00022641; Yan Xiang, 2008, Scientia Agricultura Sinica, V41, P450; Yang CM, 2004, AGR WATER MANAGE, V70, P67, DOI 10.1016/j.agwat.2004.05.003; Yang JianChang, 2011, Scientia Agricultura Sinica, V44, P36; Yildirim E, 2007, ACTA AGR SCAND B-S P, V57, P182, DOI 10.1080/09064710600813107; Zhang H, 2009, FIELD CROP RES, V113, P31, DOI 10.1016/j.fcr.2009.04.004	37	21	25	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189715	10.1371/journal.pone.0189715	http://dx.doi.org/10.1371/journal.pone.0189715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253886	Green Submitted, Green Published, gold			2022-12-26	WOS:000418389500054
J	Favier, V; Zemiti, N; Mora, OC; Subsol, G; Captier, G; Lebrun, R; Crampette, L; Mondain, M; Gilles, B				Favier, Valentin; Zemiti, Nabil; Mora, Oscar Caravaca; Subsol, Gerard; Captier, Guillaume; Lebrun, Renaud; Crampette, Louis; Mondain, Michel; Gilles, Benjamin			Geometric and mechanical evaluation of 3D-printing materials for skull base anatomical education and endoscopic surgery simulation - A first step to create reliable customized simulators	PLOS ONE			English	Article							NASAL CAVITY; SINUS; SEGMENTATION; FORCE; BONE	Introduction Endoscopic skull base surgery allows minimal invasive therapy through the nostrils to treat infectious or tumorous diseases. Surgical and anatomical education in this field is limited by the lack of validated training models in terms of geometric and mechanical accuracy. We choose to evaluate several consumer-grade materials to create a patient-specific 3D-printed skull base model for anatomical learning and surgical training. Methods Four 3D-printed consumer-grade materials were compared to human cadaver bone: calcium sulfate hemihydrate (named Multicolor), polyamide, resin and polycarbonate. We compared the geometric accuracy, forces required to break thin walls of materials and forces required during drilling. Results All materials had an acceptable global geometric accuracy (from 0.083mm to 0.203mm of global error). Local accuracy was better in polycarbonate (0.09mm) and polyamide (0.15mm) than in Multicolor (0.90mm) and resin (0.86mm). Resin and polyamide thin walls were not broken at 200N. Forces needed to break Multicolor thin walls were 1.6-3.5 times higher than in bone. For polycarbonate, forces applied were 1.6-2.5 times higher. Polycarbonate had a mode of fracture similar to the cadaver bone. Forces applied on materials during drilling followed a normal distribution except for the polyamide which was melted.Energy spent during drilling was respectively 1.6 and 2.6 times higher on bone than on PC and Multicolor. Conclusion Polycarbonate is a good substitute of human cadaver bone for skull base surgery simulation. Thanks to short lead times and reasonable production costs, patient-specific 3D printed models can be used in clinical practice for pre-operative training, improving patient safety.	[Favier, Valentin; Subsol, Gerard; Gilles, Benjamin] Montpellier Univ, French Natl Ctr Sci Res CNRS, ICAR Team, Montpellier Lab Informat Robot & Microelect LIRMM, Montpellier, France; [Favier, Valentin; Crampette, Louis; Mondain, Michel] Univ Hosp Montpellier, Gui de Chauliac Hosp, ENT Dept, Montpellier, France; [Zemiti, Nabil; Mora, Oscar Caravaca] Montpellier Univ, CNRS, LIRMM, DEXTER Team, Montpellier, France; [Captier, Guillaume] Montpellier Univ, Sch Med, Anat Lab, Montpellier, France; [Lebrun, Renaud] Univ Montpellier, Evolutionary Sci Inst Montpellier, MRI ISEM, Montpellier, France; [Gilles, Benjamin] AnatoScope SA, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier; Universite de Franche-Comte; Universite de Montpellier	Favier, V (corresponding author), Montpellier Univ, French Natl Ctr Sci Res CNRS, ICAR Team, Montpellier Lab Informat Robot & Microelect LIRMM, Montpellier, France.; Favier, V (corresponding author), Univ Hosp Montpellier, Gui de Chauliac Hosp, ENT Dept, Montpellier, France.	v-favier@chu-montpellier.fr		Lebrun, Renaud/0000-0002-5819-2653; Captier, Guillaume/0000-0002-1705-2339; Favier, Valentin/0000-0002-7999-951X	Agence Regionale de Sante Occitanie; Languedoc-Roussillon Regional Health Agency	Agence Regionale de Sante Occitanie; Languedoc-Roussillon Regional Health Agency	Valentin Favier received a research grant for this study, from the "Agence Regionale de Sante du Languedoc-Roussillon" now named "Agence Regionale de Sante Occitanie" (www.occitanie.ars.sante.fr/). There is no grant number available.; Data used in this work were (partly) produced through the technical facilities of the MRI platform and of the labEx CeMEB. This work was supported by the Languedoc-Roussillon Regional Health Agency.	Alrasheed AS, 2017, INT FORUM ALLERGY RH; Alsufyani NA, 2016, AM J ORTHOD DENTOFAC, V150, P703, DOI 10.1016/j.ajodo.2016.06.024; Bone Health and Osteoporosis, 2004, HLTH CONSMOK 50 YE; Bouxsein ML, 2007, J BONE MINER RES, V22, P825, DOI 10.1359/JBMR.070309; Bui NL, 2015, INT J COMPUT ASS RAD, V10, P1269, DOI 10.1007/s11548-014-1134-5; Chae MP, 2015, FRONT SURG, V2, DOI 10.3389/fsurg.2015.00025; Chan HHL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136370; Das R, 2015, J FORENSIC SCI, V60, P627, DOI 10.1111/1556-4029.12701; Falland-Cheung L, 2017, J MECH BEHAV BIOMED, V68, P303, DOI 10.1016/j.jmbbm.2017.02.023; Fried MP, 2004, QUAL SAF HEALTH CARE, V13, pI19, DOI 10.1136/qshc.2004.009969; Hernandez DD, 2015, IJAAA, V2; Hosemann W, 2013, GMS Curr Top Otorhinolaryngol Head Neck Surg, V12, pDoc06, DOI 10.3205/cto000098; Ivarez P, 2017, WORLD NEUROSURG; Javia L, 2012, OTOLARYNG HEAD NECK, V147, P999, DOI 10.1177/0194599812462007; Joice P, 2012, ALLERGY RHINOL, V3, pE61, DOI 10.2500/ar.2012.3.0032; KESSLER RM, 1984, J COMPUT ASSIST TOMO, V8, P514, DOI 10.1097/00004728-198406000-00028; Malekzadeh S, 2010, OTOLARYNGOLOGY HEA S, V143, pP267; Mavili ME, 2007, J CRANIOFAC SURG, V18, P740, DOI 10.1097/scs.0b013e318069014f; McMenamin PG, 2014, ANAT SCI EDUC, V7, P479, DOI 10.1002/ase.1475; Motherway JA, 2009, J BIOMECH, V42, P2129, DOI 10.1016/j.jbiomech.2009.05.030; Nogueira JF, 2008, OTOLARYNG HEAD NECK, V139, P727, DOI 10.1016/j.otohns.2008.07.017; Radley GJ, 2009, P I MECH ENG H, V223, P875, DOI 10.1243/09544119JEIM577; Rengier F, 2010, INT J COMPUT ASS RAD, V5, P335, DOI 10.1007/s11548-010-0476-x; Sander IM, 2017, ANAT SCI ED; Solyar A, 2008, AM J SURG, V196, P120, DOI 10.1016/j.amjsurg.2007.06.026; Tai BL, 2016, J NEUROSURG, V124, P811, DOI 10.3171/2015.3.JNS1552; Varshney R, 2014, J OTOLARYNGOL-HEAD N, V43, DOI 10.1186/s40463-014-0040-8; Waran V, 2012, AM J RHINOL ALLERGY, V26, pE132, DOI 10.2500/ajra.2012.26.3808; Waridel F, 1997, LARYNGOSCOPE, V107, P1667, DOI 10.1097/00005537-199712000-00017; Yamashita J, 2007, Patent No. [US20070020598 A1, 20070020598]	30	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189486	10.1371/journal.pone.0189486	http://dx.doi.org/10.1371/journal.pone.0189486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29252993	Green Published, Green Submitted, gold			2022-12-26	WOS:000418389500031
J	So, CH; Jeong, HR; Shim, YS				So, Cheol Hwan; Jeong, Hwal Rim; Shim, Young Suk			Association of the urinary sodium to urinary specific gravity ratio with metabolic syndrome in Korean children and adolescents: The Korea National Health and Nutrition Examination Survey 2010-2013	PLOS ONE			English	Article							BODY-MASS INDEX; DIETARY-SODIUM; POTASSIUM EXCRETION; INSULIN-RESISTANCE; CARDIOVASCULAR RISK; BLOOD-PRESSURE; SALT INTAKE; OBESITY; CHILDHOOD; CONSUMPTION	Objectives This study aimed to evaluate the association between sodium intake and metabolic syndrome (MetS) in Korean boys. Methods A total of 1,738 boys aged 10-18 years were included in this study from the Korea National Health and Nutrition Examination Survey (KNHANES) during the years 2010-2013. Sodium intake was assessed using the urinary sodium excretion to urinary specific gravity ratio (UNa to U-SG ratio). Results The median U-Na to U-SG ratio was 133.27 mmol/L (interquartile range: 95.66-178.50 mmol/L). Significant positive associations were found between the U-Na to U-SG ratio and the TG (P = 0.001 for trend) and TG concentrations, and these concentrations were significantly higher in boys with a U-Na to U-SG ratio in the highest quartile compared with those with a ratio in the lowest (P = 0.001) and second (P = 0.033) quartiles, as demonstrated through analysis of covariance (ANCOVA) after adjustment for possible confounders, including age, BMI standard deviation score, ferritin, vitamin D, house income, smoking, alcohol intake, physical activity, season, total intake, total energy intake, protein intake, fat intake, carbohydrate intake, and water intake. Significant inverse associations were found for the U-Na to U-SG ratio with the HDL-C (P = 0.033 for trend) and HDL-C levels, and these values were significantly lower in boys with a ratio in the highest quartile compared with those with a ratio in the second quartile (P = 0.020), as demonstrated through an ANCOVA. Although the trends did not reach statistical significance, a higher U-Na to U-SG ratio tended to be associated with higher SBP (P = 0.086 for trend), DBP (P = 0.063 for trend), and glucose levels (P = 0.099 for trend), as illustrated through ANCOVA. Boys with a ratio in the highest quartile exhibited a 1.73-fold increased risk for elevated TG (95% CI, 1.19-2.51) and a 2.66-fold increased risk for MetS (95% CI, 1.11-6.35) compared with those with a ratio in the lowest quartile, as demonstrated through multivariate logistic regression analyses after adjusting for confounders. Conclusions Our results suggest that high sodium intake may be significantly independently associated with MetS in Korean boys aged 10-18 years.	[So, Cheol Hwan] Wonkwang Univ, Sch Med, Dept Pediat, Iksan, South Korea; [Jeong, Hwal Rim; Shim, Young Suk] Hallym Univ, Coll Med, Dept Pediat, Seoul, South Korea	Wonkwang University; Hallym University	Shim, YS (corresponding author), Hallym Univ, Coll Med, Dept Pediat, Seoul, South Korea.	royjays0217@hallym.or.kr	Shim, Young Suk/AFX-0329-2022	Shim, Young Suk/0000-0002-0850-5279; So, Cheol Hwan/0000-0003-1759-0003				Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Baudrand R, 2014, CLIN ENDOCRINOL, V80, P677, DOI 10.1111/cen.12225; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; Bentley B, 2006, J CARDIOVASC NURS, V21, P63, DOI 10.1097/00005082-200601000-00012; Chun YH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003447; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; de Boer IH, 2013, AM J EPIDEMIOL, V177, P1193, DOI 10.1093/aje/kwt064; ELLISON RC, 1980, HYPERTENSION, V2, pI78, DOI 10.1161/01.HYP.2.4_Pt_2.I78; Fonseca-Alaniz MH, 2007, OBESITY, V15, P2200, DOI 10.1038/oby.2007.261; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grimes CA, 2016, BRIT J NUTR, V115, P1071, DOI 10.1017/S0007114515005243; Grimes CA, 2013, PEDIATRICS, V131, P14, DOI 10.1542/peds.2012-1628; Hattori T, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001312; He FJ, 2008, HYPERTENSION, V51, P629, DOI 10.1161/HYPERTENSIONAHA.107.100990; Hoffmann IS, 2009, NUTR METAB CARDIOVAS, V19, P123, DOI 10.1016/j.numecd.2008.02.011; Juhola J, 2011, J PEDIATR-US, V159, P584, DOI 10.1016/j.jpeds.2011.03.021; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Kim S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100588; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Li L, 2011, AM J CLIN NUTR, V93, P1204, DOI 10.3945/ajcn.110.001222; Libuda L, 2012, PUBLIC HEALTH NUTR, V15, P433, DOI 10.1017/S1368980011002138; Lloyd LJ, 2012, INT J OBESITY, V36, P1, DOI 10.1038/ijo.2011.186; Luther JM, 2014, J CLIN ENDOCR METAB, V99, pE1895, DOI 10.1210/jc.2014-2122; McLean R, 2014, J HUM HYPERTENS, V28, P657, DOI 10.1038/jhh.2014.10; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Moon JS, 2007, KOREAN J PEDIAT, V1, P1, DOI DOI 10.3345/KJP.2008.51.1.1; Morrison JA, 2008, J PEDIATR-US, V152, P201, DOI 10.1016/j.jpeds.2007.09.010; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; Oh SW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001650; Premilovac D, 2014, DIABETOLOGIA, V57, P2586, DOI 10.1007/s00125-014-3373-y; Raisanen JP, 2012, ANN MED, V44, P627, DOI 10.3109/07853890.2011.585657; Reaven PD, 2005, DIABETES CARE, V28, P148, DOI 10.2337/diacare.28.1.148; Rodrigues SL, 2009, HYPERTENS RES, V32, P906, DOI 10.1038/hr.2009.122; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Won JC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003153; Woodruff SJ, 2014, PUBLIC HEALTH NUTR, V17, P1114, DOI 10.1017/S1368980013000335; Yang QH, 2012, PEDIATRICS, V130, P611, DOI 10.1542/peds.2011-3870; Yi KH, 2014, DIABETES RES CLIN PR, V103, P106, DOI 10.1016/j.diabres.2013.10.021; Yu SH, 2014, NUTR RES PRACT, V8, P705, DOI 10.4162/nrp.2014.8.6.705; Zhu HD, 2014, PEDIATRICS, V133, pE635, DOI 10.1542/peds.2013-1794	40	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189934	10.1371/journal.pone.0189934	http://dx.doi.org/10.1371/journal.pone.0189934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253859	Green Submitted, Green Published, gold			2022-12-26	WOS:000418389500076
J	Vongsvivut, J; Truong, VK; Al Kobaisi, M; Maclaughlin, S; Tobin, MJ; Crawford, RJ; Ivanova, EP				Vongsvivut, Jitraporn; Vi Khanh Truong; Al Kobaisi, Mohammad; Maclaughlin, Shane; Tobin, Mark J.; Crawford, Russell J.; Ivanova, Elena P.			Synchrotron macro ATR-FTIR microspectroscopic analysis of silica nanoparticle-embedded polyester coated steel surfaces subjected to prolonged UV and humidity exposure	PLOS ONE			English	Article							MULTIPLICATIVE SIGNAL CORRECTION; INFRARED MICROSPECTROSCOPY; MELAMINE; COATINGS	Surface modification of polymers and paints is a popular and effective way to enhance the properties of these materials. This can be achieved by introducing a thin coating that preserves the bulk properties of the material, while protecting it from environmental exposure. Suitable materials for such coating technologies are inorganic oxides, such as alumina, titania and silica; however, the fate of these materials during long-term environmental exposure is an open question. In this study, polymer coatings that had been enhanced with the addition of silica nanoparticles (SiO(2)NPs) and subsequently subjected to environmental exposure, were characterized both before and after the exposure to determine any structural changes resulting from the exposure. High-resolution synchrotron macro ATR-FTIR micro-spectroscopy and surface topographic techniques, including optical profilometry and atomic force microscopy (AFM), were used to determine the long-term effect of the environment on these dual protection layers after 3 years of exposure to tropical and sub-tropical climates in Singapore and Queensland (Australia). Principal component analysis (PCA) based on the synchrotron macro ATR-FTIR spectral data revealed that, for the 9% (w/w) SiO2NP/polymer coating, a clear discrimination was observed between the control group (no environmental exposure) and those samples subjected to three years of environmental exposure in both Singapore and Queensland. The PCA loading plots indicated that, over the three year exposure period, a major change occurred in the triazine ring vibration in the melamine resins. This can be attributed to the triazine ring being very sensitive to hydrolysis under the high humidity conditions in tropical/sub-tropical environments. This work provides the first direct molecular evidence, acquired using a high-resolution mapping technique, of the climate-induced chemical evolution of a polyester coating. The observed changes in the surface topography of the coating are consistent with the changes in chemical composition.	[Vongsvivut, Jitraporn; Tobin, Mark J.] Australian Synchrotron, Infrared Microspect IRM Beamline, Clayton, Vic, Australia; [Vi Khanh Truong; Al Kobaisi, Mohammad; Ivanova, Elena P.] Swinburne Univ Technol, Sch Sci, Fac Sci Engn & Technol, Hawthorn, Vic, Australia; [Vi Khanh Truong; Maclaughlin, Shane; Ivanova, Elena P.] ARC Res Hub Australian Steel Mfg, Wollongong, NSW, Australia; [Maclaughlin, Shane] BlueScope Steel Res, Port Kembla, NSW, Australia; [Crawford, Russell J.] RMIT Univ, Sch Sci, Coll Sci Engn & Hlth, Melbourne, Vic, Australia	Swinburne University of Technology; Royal Melbourne Institute of Technology (RMIT)	Ivanova, EP (corresponding author), Swinburne Univ Technol, Sch Sci, Fac Sci Engn & Technol, Hawthorn, Vic, Australia.; Ivanova, EP (corresponding author), ARC Res Hub Australian Steel Mfg, Wollongong, NSW, Australia.	eivanova@swin.edu.au	Ivanova, Elena P/B-1255-2019; Truong, Vi Khanh/AAS-1155-2020; Kobaisi, Mohammad Al/ABC-3491-2020; Tobin, Mark/B-8208-2015	Ivanova, Elena P/0000-0002-5509-8071; Truong, Vi Khanh/0000-0002-6016-6438; Vongsvivut, Jitraporn/0000-0003-0699-3464; Al Kobaisi, Mohammad/0000-0002-5971-3991; Tobin, Mark/0000-0003-1862-0649	Australian Research Council Industrial Transformation Research Hubs Scheme [IH130100017]	Australian Research Council Industrial Transformation Research Hubs Scheme(Australian Research Council)	Funding from the Australian Research Council Industrial Transformation Research Hubs Scheme (Project Number IH130100017) is gratefully acknowledged. The funder provided support in the form of salaries for author VKT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	Carr GL, 2001, REV SCI INSTRUM, V72, P1613, DOI 10.1063/1.1347965; Crawford RJ, 2012, ADV COLLOID INTERFAC, V179, P142, DOI 10.1016/j.cis.2012.06.015; De Geyter N, 2006, SURF COAT TECH, V201, P2460, DOI 10.1016/j.surfcoat.2006.04.004; Gamage NJW, 2004, J POLYM SCI POL CHEM, V42, P83, DOI 10.1002/pola.11006; HIRAYAMA T, 1992, PROG ORG COAT, V20, P81, DOI 10.1016/0033-0655(92)85006-H; Hollamby MJ, 2011, ADV MATER, V23, P1361, DOI 10.1002/adma.201003035; Kim S, 2017, J CATAL, V346, P92, DOI 10.1016/j.jcat.2016.11.027; Kohler A, 2008, APPL SPECTROSC, V62, P259, DOI 10.1366/000370208783759669; Kohler A, 2005, APPL SPECTROSC, V59, P707, DOI 10.1366/0003702054280649; Kohler A, 2010, APPL VIBRATIONAL SPE, P89; Li LJ, 2009, CORROSION PROTECTION, V30, P519; Merline DJ, 2013, POLYM J, V45, P413, DOI 10.1038/pj.2012.162; Miller LM, 2005, VIB SPECTROSC, V38, P237, DOI 10.1016/j.vibspec.2005.03.010; Moreira DC, 2016, J COMPOS MATER, V50, P3699, DOI 10.1177/0021998315624253; Naumann D., 1990, MODERN TECHNIQUES RA; Neunhoeffer H, 1978, CHEM HETEROCYCLIC CO, P1005; Nikolic M, 2017, J MATER SCI, V52, P7158, DOI 10.1007/s10853-017-0951-7; Perruchot C, 2002, SURF INTERFACE ANAL, V34, P570, DOI 10.1002/sia.1362; Rieppo L, 2012, OSTEOARTHR CARTILAGE, V20, P451, DOI 10.1016/j.joca.2012.01.010; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SMOLIN E. M., 1959, Interscience Publ.; Tobin MJ, 2016, OSA TECHNICAL DIGEST; Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071; Truong VK, 2016, JOVE-J VIS EXP, DOI 10.3791/54309; Vongsvivut J, 2013, ANALYST, V138, P6016, DOI 10.1039/c3an00485f	25	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0188345	10.1371/journal.pone.0188345	http://dx.doi.org/10.1371/journal.pone.0188345			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253012	gold, Green Submitted, Green Published			2022-12-26	WOS:000418389500006
J	Chi, XY; Zhang, ZM; Chen, N; Zhang, XW; Wang, M; Chen, MN; Wang, T; Pan, LJ; Chen, J; Yang, Z; Guan, XY; Yu, SL				Chi, Xiaoyuan; Zhang, Zhimeng; Chen, Na; Zhang, Xiaowen; Wang, Mian; Chen, Mingna; Wang, Tong; Pan, Lijuan; Chen, Jing; Yang, Zhen; Guan, Xiangyu; Yu, Shanlin			Isolation and functional analysis of fatty acid desaturase genes from peanut (Arachis hypogaea L.)	PLOS ONE			English	Article							HIGH OLEATE TRAIT; HIGH OLEIC-ACID; TIME QUANTITATIVE PCR; OMEGA-3-FATTY-ACID DESATURASE; SPHINGOLIPID DESATURASE; OMEGA-3 DESATURASE; MEMBRANE-FLUIDITY; STRESS TOLERANCE; IDENTIFICATION; BIOSYNTHESIS	Background Fatty acid desaturases are enzymes that introduce double bonds into fatty acyl chains. Extensive studies of fatty acid desaturases have been done in many plants. However, less is known about the diversity of this gene family in peanut (Arachis hypogaea L.), an important oilseed crop that is cultivated worldwide. Results In this study, twelve novel AhFADs genes were identified and isolated from peanut. Quantitative real-time PCR analysis indicated that the transcript abundances of AhFAB2-2 and AhFAD3-1 were higher in seeds than in other tissues examined, whereas the AhADS and AhFAD7-1 transcripts were more abundant in leaves. AhFAB2-3, AhFAD3-2, AhFAD4, AhSLD-4, and AhDES genes were highly expressed in flowers, whereas AhFAD7-2, AhSLD-2, and AhSLD-3 were expressed most strongly in stems. During seed development, the expressions of AhFAB2-2, AhFAD3-1, AhFAD7-1, and AhSLD-3 gradually increased in abundance, reached a maximum expression level, and then decreased. The AhFAB2-3, AhFAD3-2, AhFAD4, AhADS, and AhDES transcript levels remained relatively high at the initial stage of seed development, but decreased thereafter. The AhSLD-4 transcript level remained relatively low at the initial stage of seed development, but showed a dramatic increase in abundance at the final stage. The AhFAD7-2 and AhSLD-2 transcript levels remained relatively high at the initial stage of seed development, but then decreased, and finally increased again. The AhFAD transcripts were differentially expressed following exposure to abiotic stresses or abscisic acid. Moreover, the functions of one AhFAD6 and four AhSLD genes were confirmed by heterologous expression in Synechococcus elongates or Saccharomyces cerevisiae. Conclusions The present study provides valuable information that improves understanding of the biological roles of FAD genes in fatty acid synthesis, and will help peanut breeders improve the quality of peanut oil via molecular design breeding.	[Chi, Xiaoyuan; Zhang, Zhimeng; Chen, Na; Wang, Mian; Chen, Mingna; Wang, Tong; Pan, Lijuan; Chen, Jing; Yang, Zhen; Yu, Shanlin] Shandong Peanut Res Inst, Qingdao, Shandong, Peoples R China; [Zhang, Xiaowen] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Shandong, Peoples R China; [Guan, Xiangyu] China Univ Geosci, Sch Ocean Sci, Beijing, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; China University of Geosciences	Yu, SL (corresponding author), Shandong Peanut Res Inst, Qingdao, Shandong, Peoples R China.; Guan, XY (corresponding author), China Univ Geosci, Sch Ocean Sci, Beijing, Peoples R China.	guanxy@cugb.edu.cn; shanlinyu2012@163.com	peanut, QTL identification for seed weight and size based on a high-density SLAF-seq genetic map in/AAK-2918-2021		National Ten Thousand Youth Talents Plan [W02070268]; China Agriculture Research System [CARS-13]; National Natural Science Foundation of China [31000728, 31200211, 31701464]; Shandong Agriculture Research System [SDAIT-04-06]; Natural Science Fund of Shandong Province [ZR2014YL011, ZR2014YL012]; Youth Scientific Research Foundation of Shandong Academy of Agricultural Sciences [2016YQN14]; Qingdao Civil Science and Technology Project [14-2-3-34-nsh]; Agricultural Scientific and Technological Innovation Project of Shandong Academy of Agricultural Sciences [CXGC2016B02]; Young Talents Training Program of Shandong Academy of Agricultural Sciences	National Ten Thousand Youth Talents Plan; China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Agriculture Research System; Natural Science Fund of Shandong Province; Youth Scientific Research Foundation of Shandong Academy of Agricultural Sciences; Qingdao Civil Science and Technology Project; Agricultural Scientific and Technological Innovation Project of Shandong Academy of Agricultural Sciences; Young Talents Training Program of Shandong Academy of Agricultural Sciences	This study was supported by grants from the National Ten Thousand Youth Talents Plan of 2014 (W02070268 to XC), China Agriculture Research System (CARS-13 to XC), the National Natural Science Foundation of China (31000728 to XC, 31200211 to TW and 31701464 to NC), Shandong Agriculture Research System (SDAIT-04-06 to ZZ), the Natural Science Fund of Shandong Province (ZR2014YL011 to MC and ZR2014YL012 to XC), the Youth Scientific Research Foundation of Shandong Academy of Agricultural Sciences (2016YQN14 to NC), Qingdao Civil Science and Technology Project (14-2-3-34-nsh to SY), Agricultural Scientific and Technological Innovation Project of Shandong Academy of Agricultural Sciences (CXGC2016B02 to JC), Young Talents Training Program of Shandong Academy of Agricultural Sciences (to XC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso DL, 2003, BIOCHEM SYST ECOL, V31, P1111, DOI 10.1016/S0305-1978(03)00041-3; Barkley NA, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue1-fulltext-12; Barkley NA, 2010, MOL BREEDING, V25, P541, DOI 10.1007/s11032-009-9338-z; Berberich T, 1998, PLANT MOL BIOL, V36, P297, DOI 10.1023/A:1005993408270; Bertioli DJ, 2016, NAT GENET, V48, P438, DOI 10.1038/ng.3517; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; CHAPMAN D, 1975, Q REV BIOPHYS, V8, P185, DOI 10.1017/S0033583500001797; Chen M, 2012, PLANT J, V69, P769, DOI 10.1111/j.1365-313X.2011.04829.x; Chen MJ, 2013, PLANT CELL, V25, P1430, DOI 10.1105/tpc.113.111179; Chen XP, 2016, P NATL ACAD SCI USA, V113, P6785, DOI 10.1073/pnas.1600899113; Chen ZB, 2010, PLANT MOL BIOL REP, V28, P542, DOI 10.1007/s11105-010-0181-5; Chi XY, 2008, J MICROBIOL, V46, P189, DOI 10.1007/s12275-007-0223-3; Chi XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105834; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Chi XY, 2011, PLANT CELL REP, V30, P1393, DOI 10.1007/s00299-011-1048-4; Chi XY, 2008, COMP FUNCT GENOM, DOI 10.1155/2008/284508; Chu Y, 2011, PLANT GENOME-US, V4, P110, DOI 10.3835/plantgenome2011.01.0001; Chu Y, 2009, CROP SCI, V49, P2029, DOI 10.2135/cropsci2009.01.0021; Domergue F, 2003, PLANT PHYSIOL, V131, P1648, DOI 10.1104/pp.102.018317; Dong CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149917; Fang CQ, 2012, J OLEO SCI, V61, P143, DOI 10.5650/jos.61.143; Fukuchi-Mizutani M, 1998, PLANT CELL PHYSIOL, V39, P247, DOI 10.1093/oxfordjournals.pcp.a029364; Gao JP, 2009, PLANT J, V60, P832, DOI 10.1111/j.1365-313X.2009.04001.x; GIBSON S, 1994, PLANT PHYSIOL, V106, P1615, DOI 10.1104/pp.106.4.1615; Guan LL, 2014, GENET MOL RES, V13, P6623, DOI [10.4238/2014.August.28.7, 10.4238/2014]; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heilmann I, 2004, P NATL ACAD SCI USA, V101, P10266, DOI 10.1073/pnas.0402200101; Im YJ, 2002, MOL CELLS, V13, P264; Jung S, 2000, MOL GEN GENET, V263, P796, DOI 10.1007/s004380000244; Jung S, 2000, MOL GEN GENET, V263, P806, DOI 10.1007/s004380000243; Kachroo A, 2007, PLANT MOL BIOL, V63, P257, DOI 10.1007/s11103-006-9086-y; Khodakovskaya M, 2006, PLANTA, V223, P1090, DOI 10.1007/s00425-005-0161-4; Kochert G, 1996, AM J BOT, V83, P1282, DOI 10.2307/2446112; Lee KR, 2016, PLANT CELL REP, V35, P2523, DOI 10.1007/s00299-016-2053-4; Li SF, J GENETICS GENOMICS; Liu HL, 2015, BIOL PLANTARUM, V59, P316, DOI 10.1007/s10535-015-0487-0; Liu WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143684; Liu XY, 2006, J INTEGR PLANT BIOL, V48, P1096, DOI 10.1111/j.1744-7909.2006.00335.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez Y, 2000, THEOR APPL GENET, V101, P1131, DOI 10.1007/s001220051589; Los DA, 1998, BBA-LIPID LIPID MET, V1394, P3, DOI 10.1016/S0005-2760(98)00091-5; Markham JE, 2006, J BIOL CHEM, V281, P22684, DOI 10.1074/jbc.M604050200; Merrill AH, 2000, METHOD ENZYMOL, V312, P3; Michaelson LV, 2009, PLANT PHYSIOL, V149, P487, DOI 10.1104/pp.108.129411; Mikami K, 2003, PROG LIPID RES, V42, P527, DOI 10.1016/S0163-7827(03)00036-5; MOORE KM, 1989, J HERED, V80, P252, DOI 10.1093/oxfordjournals.jhered.a110845; Moreno-Perez AJ, 2011, J PLANT PHYSIOL, V168, P831, DOI 10.1016/j.jplph.2010.11.015; Murphy D.J., 1998, PLANT LIPID BIOSYNTH, P95; Nair PMG, 2009, PLANT CELL TISS ORG, V98, P87, DOI 10.1007/s11240-009-9541-y; Nishiuchi T, 1995, PLANT MOL BIOL, V29, P599, DOI 10.1007/BF00020987; Pandey MK, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0133-4; Patel M, 2004, THEOR APPL GENET, V108, P1492, DOI 10.1007/s00122-004-1590-3; RAY TK, 1993, PLANT SCI, V91, P15, DOI 10.1016/0168-9452(93)90184-2; Roman A, 2012, J EXP BOT, V63, P4973, DOI 10.1093/jxb/ers174; Ryan PR, 2007, PLANT PHYSIOL, V144, P1968, DOI 10.1104/pp.107.100446; Sato N, 2007, EUKARYOT CELL, V6, P1006, DOI 10.1128/EC.00393-06; Sayanova O, 2001, J EXP BOT, V52, P1581, DOI 10.1093/jexbot/52.360.1581; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Singh SC, 2002, ACTA PROTOZOOL, V41, P297; Smith MA, 2013, PLANT PHYSIOL, V161, P81, DOI 10.1104/pp.112.202325; SOMERVILLE C, 1991, SCIENCE, V252, P80, DOI 10.1126/science.252.5002.80; Sperling P, 1998, J BIOL CHEM, V273, P28590, DOI 10.1074/jbc.273.44.28590; STALKER HT, 1991, AM J BOT, V78, P238, DOI 10.2307/2445247; Swan TM, 1997, CAN J MICROBIOL, V43, P70, DOI 10.1139/m97-010; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomson TM, 2000, GENOME RES, V10, P1743, DOI 10.1101/gr.GR-1405R; Wang CT, 2011, ELECT J BIOTECHNOL, V14; Wang HS, 2014, PLANT CELL REP, V33, P131, DOI 10.1007/s00299-013-1517-z; Wang YJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0988-x; Yang LT, 2005, PLANT CELL REP, V24, P237, DOI 10.1007/s00299-005-0929-9; Yu SL, 2008, J GENET GENOMICS, V35, P679, DOI 10.1016/S1673-8527(08)60090-9; Zauner S, 2010, ADV EXP MED BIOL, V688, P249; Zhang JT, 2009, BIOCHEM BIOPH RES CO, V390, P469, DOI 10.1016/j.bbrc.2009.09.095; Zhang JZ, 2012, 2012 2ND INTERNATIONAL CONFERENCE ON APPLIED SOCIAL SCIENCE (ICASS 2012), VOL 3, P7; Zhang M, 2005, PLANT J, V44, P361, DOI 10.1111/j.1365-313X.2005.02536.x	78	10	17	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189759	10.1371/journal.pone.0189759	http://dx.doi.org/10.1371/journal.pone.0189759			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244878	gold, Green Published, Green Submitted			2022-12-26	WOS:000418184700059
J	Zhang, XB; Jayaweera, D; Peters, JL; Szecsi, J; Bendahmane, M; Roberts, JA; Gonzalez-Carranza, ZH				Zhang, Xuebin; Jayaweera, Dasuni; Peters, Janny L.; Szecsi, Judit; Bendahmane, Mohammed; Roberts, Jeremy A.; Gonzalez-Carranza, Zinnia H.			The Arabidopsis thaliana F-box gene HAWAIIAN SKIRT is a new player in the microRNA pathway	PLOS ONE			English	Article							CAP-BINDING COMPLEX; RNA BIOGENESIS; FLOWER DEVELOPMENT; PLANT DEVELOPMENT; MIRNA BIOGENESIS; UBIQUITIN LIGASE; ROOT DEVELOPMENT; C-ELEGANS; PROTEINS; FAMILY	In Arabidopsis, the F-box HAWAIIAN SKIRT (HWS) protein is important for organ growth. Loss of function of HWS exhibits pleiotropic phenotypes including sepal fusion. To dissect the HWS role, we EMS-mutagenized hws-1 seeds and screened for mutations that suppress hws-1 associated phenotypes. We identified shs-2 and shs-3 (suppressor of hws-2 and 3) mutants in which the sepal fusion phenotype of hws-1 was suppressed. shs-2 and shs-3 (renamed hst-23/hws-1 and hst-24/hws-1) carry transition mutations that result in premature terminations in the plant homolog of Exportin-5 HASTY (HST), known to be important in miRNA biogenesis, function and transport. Genetic crosses between hws-1 and mutant lines for genes in the miRNA pathway also suppress the phenotypes associated with HWS loss of function, corroborating epistatic relations between the miRNA pathway genes and HWS. In agreement with these data, accumulation of miRNA is modified in HWS loss or gain of function mutants. Our data propose HWS as a new player in the miRNA pathway, important for plant growth.	[Zhang, Xuebin; Jayaweera, Dasuni; Roberts, Jeremy A.; Gonzalez-Carranza, Zinnia H.] Univ Nottingham, Sch Biosci, Plant & Crop Sci Div, Sutton Bonington Campus, Loughborough, Leics, England; [Peters, Janny L.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Mol Plant Physiol, Nijmegen, Netherlands; [Szecsi, Judit; Bendahmane, Mohammed] Univ Claude Bernard Lyon 1, Lab Reprod & Dev Plantes, ENS Lyon, CNRS,INRA, Lyon, France; [Zhang, Xuebin] Brookhaven Natl Lab, Biol Dept, Upton, NY 11973 USA; [Roberts, Jeremy A.] Univ Plymouth, Sch Biol & Marine Sci, Fac Sci & Engn, Plymouth, Devon, England	University of Nottingham; Radboud University Nijmegen; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); United States Department of Energy (DOE); Brookhaven National Laboratory; University of Plymouth	Gonzalez-Carranza, ZH (corresponding author), Univ Nottingham, Sch Biosci, Plant & Crop Sci Div, Sutton Bonington Campus, Loughborough, Leics, England.	zinnia.gonzalez@nottingham.ac.uk	Bendahmane, Mohammed/AAX-1296-2020; Peters, Janny L./K-7745-2013	Bendahmane, Mohammed/0000-0003-1661-1060; Peters, Janny L./0000-0002-1081-5209; Gonzalez-Carranza, Zinnia Haydee/0000-0002-9127-3252	University of Nottingham; French Agence Nationale de la Reserche [ANR-09-BLAN-006, ANR-13-BSV7-0014]	University of Nottingham; French Agence Nationale de la Reserche(French National Research Agency (ANR))	This work was supported by funds from the University of Nottingham (JR), the French Agence Nationale de la Reserche, grants: ANR-09-BLAN-006 (MB) and ANR-13-BSV7-0014 (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achkar NP, 2016, TRENDS PLANT SCI, V21, P1034, DOI 10.1016/j.tplants.2016.09.003; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Autran D, 2002, EMBO J, V21, P6036, DOI 10.1093/emboj/cdf614; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bhat SS, 2016, ACTA BIOCHIM POL, V63, P717, DOI 10.18388/abp.2016_1370; Bollman KM, 2003, DEVELOPMENT, V130, P1493, DOI 10.1242/dev.00362; Borah P, 2017, SCI REP-UK, V7, DOI 10.1038/srep42131; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chaabane SB, 2012, NUC ACIDS RES, V41; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen XM, 2002, DEVELOPMENT, V129, P1085; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung PJ, 2016, PLANT PHYSIOL, V170, P1772, DOI 10.1104/pp.15.01188; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Dezfulian MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050984; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Feng BM, 2016, EMBO REP, V17, P1799, DOI 10.15252/embr.201642486; Flaherty SM, 1997, P NATL ACAD SCI USA, V94, P11893, DOI 10.1073/pnas.94.22.11893; Gonzalez-Carranza ZH, 2007, PLANT PHYSIOL, V144, P1370, DOI 10.1104/pp.106.092288; Gonzalez-Carranza ZH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185106; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Hong JP, 2017, BIOCHEM BIOPH RES CO, V485, P174, DOI 10.1016/j.bbrc.2017.02.046; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; Karlsson P, 2015, P NATL ACAD SCI USA, V112, P14096, DOI 10.1073/pnas.1512865112; Kepinski S, 2005, GENETICS, V156, P1363; Khan GA, 2011, PLANT MOL BIOL, V77, P47, DOI 10.1007/s11103-011-9793-x; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kim S, 2008, PLANT CELL PHYSIOL, V49, P1634, DOI 10.1093/pcp/pcn146; Kim YJ, 2014, EMBO J, V33, P968, DOI 10.1002/embj.201387262; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lang PLM, 2017, PLANT PHYS; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis JD, 1996, GENE DEV, V10, P1683, DOI 10.1101/gad.10.13.1683; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Liu HT, 2013, P NATL ACAD SCI USA, V110, P17582, DOI 10.1073/pnas.1308987110; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Megraw M, 2006, RNA, V12, P1612, DOI 10.1261/rna.130506; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nie SS, 2015, SCI REP-UK, V5, DOI 10.1038/srep14034; OHNO M, 1987, P NATL ACAD SCI USA, V84, P5187, DOI 10.1073/pnas.84.15.5187; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Peters JL, 2004, THEOR APPL GENET, V108, P321, DOI 10.1007/s00122-003-1427-5; Peters JL, 2003, TRENDS PLANT SCI, V8, P484, DOI 10.1016/j.tplants.2003.09.002; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Prigge MJ, 2001, PLANT CELL, V13, P1263, DOI 10.1105/tpc.13.6.1263; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Reis RS, 2015, TRENDS PLANT SCI, V20, P721, DOI 10.1016/j.tplants.2015.08.003; Risseeuw EP, 2003, PLANT J, V34, P753, DOI 10.1046/j.1365-313X.2003.01768.x; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; Serrano-Cartagena J, 2000, NATURE, V435, P446; Sharma B, 2016, FRONTIERS PLANT SCI; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Su CB, 2017, DEV CELL, V41, P527, DOI 10.1016/j.devcel.2017.05.008; Telfer A, 1998, DEVELOPMENT, V125, P1889; Thomas B, 2016, ELS; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Weigel D, 2008, ARABIDOPSIS LAB MANU; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu GX, 2009, P NATL ACAD SCI USA, V106, P835, DOI 10.1073/pnas.0812043106; Xu J, 2010, PLANT CELL, V22, P91, DOI 10.1105/tpc.109.071803; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; You CJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1291-2; Yu B, 2008, P NATL ACAD SCI USA, V105, P10073, DOI 10.1073/pnas.0804218105; Yu HY, 2015, J EXP BOT, V66, P1543, DOI 10.1093/jxb/eru525; Yu HQ, 2017, ANNU REV BIOPHYS, V46, P149, DOI 10.1146/annurev-biophys-070816-033719	82	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189788	10.1371/journal.pone.0189788	http://dx.doi.org/10.1371/journal.pone.0189788			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244865	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000418184700065
J	Yue, ZY; Yuan, ZJ; Zeng, L; Wang, Y; Lai, L; Li, J; Sun, P; Xue, XW; Qi, JY; Yang, ZF; Zheng, YS; Fang, YZ; Li, DL; Siwko, S; Li, Y; Luo, J; Liu, MY				Yue, Zhiying; Yuan, Zengjin; Zeng, Li; Wang, Ying; Lai, Li; Li, Jing; Sun, Peng; Xue, Xiwen; Qi, Junyi; Yang, Zhengfeng; Zheng, Yansen; Fang, Yuanzhang; Li, Dali; Siwko, Stefan; Li, Yi; Luo, Jian; Liu, Mingyao			LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells	FASEB JOURNAL			English	Article						mammary tumorigenesis; tumor progression; epithelial-mesenchymal transition; Wnt	EPITHELIAL-MESENCHYMAL TRANSITION; R-SPONDIN 1; DOWN-REGULATION; POSTNATAL-DEVELOPMENT; MAMMARY-GLAND; UP-REGULATION; RECEPTOR; GENE; PROMOTES; EXPRESSION	The fourth member of the leucine-rich repeat-containing GPCR family (LGR4, frequently referred to as GPR48) and its cognate ligands, R-spondins (RSPOs) play crucial roles in the development of multiple organs as well as the survival of adult stem cells by activation of canonical Wnt signaling. Wnt/beta-catenin signaling acts to regulate breast cancer; however, the molecular mechanisms determining its spatiotemporal regulation are largely unknown. In this study, we identified LGR4 as a master controller of Wnt/beta-catenin signaling-mediated breast cancer tumorigenesis, metastasis, and cancer stem cell (CSC) maintenance. LGR4 expression in breast tumors correlated with poor prognosis. Either Lgr4 haploinsufficiency or mammary-specific deletion inhibited mouse mammary tumor virus (MMTV)-PyMT- and MMTV-Wnt1-driven mammary tumorigenesis and metastasis. Moreover, LGR4 down-regulation decreased in vitro migration and in vivo xenograft tumor growth and lung metastasis. Furthermore, Lgr4 deletion in MMTV-Wnt1 tumor cells or knockdown in human breast cancer cells decreased the number of functional CSCs by similar to 90%. Canonical Wnt signaling was impaired in LGR4-deficient breast cancer cells, and LGR4 knockdown resulted in increased E-cadherin and decreased expression of N-cadherin and snail transcription factor -2 (SNAI2) (also called SLUG), implicating LGR4 in regulation of epithelial-mesenchymal transition. Our findings support a crucial role of the Wnt signaling component LGR4 in breast cancer initiation, metastasis, and breast CSCs.	[Yue, Zhiying; Yuan, Zengjin; Zeng, Li; Sun, Peng; Xue, Xiwen; Qi, Junyi; Yang, Zhengfeng; Zheng, Yansen; Li, Dali; Luo, Jian; Liu, Mingyao] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai, Peoples R China; [Yue, Zhiying; Yuan, Zengjin; Zeng, Li; Sun, Peng; Xue, Xiwen; Qi, Junyi; Yang, Zhengfeng; Zheng, Yansen; Li, Dali; Luo, Jian; Liu, Mingyao] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China; [Zeng, Li; Wang, Ying; Lai, Li; Siwko, Stefan; Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, Inst Biosci & Technol, Houston, TX USA; [Li, Jing] East China Normal Univ, Shanghai Fengxian Dist Cent Hosp, Joint Ctr Translat Med, Shanghai, Peoples R China; [Fang, Yuanzhang; Li, Yi] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA	East China Normal University; East China Normal University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; East China Normal University; Baylor College of Medicine	Luo, J; Liu, MY (corresponding author), East China Normal Univ, Sch Life Sci, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	jluo@bio.ecnu.edu.cn; myliu@bio.ecnu.edu.cn	Fang, Yuanzhang/H-3047-2019; Yang, Zhengfeng/AAA-7014-2020; Li, Yi/A-7635-2009	Siwko, Stefan/0000-0003-4260-2985; Fang, Yuanzhang/0000-0002-6985-9388; Sun, Peng/0000-0002-0615-2510; Li, Yi/0000-0002-9976-518X; Lai, Li/0000-0002-5731-2705	National Key Research and Development Program of China [2016YFC0902102]; National Natural Science Foundation of China [81722020, 81472048, 81272911, 81330049]; Innovation Program of Shanghai Municipal Education Commission [14ZZ051, 2017-01-07-00-05-E00011]; Science and Technology Commission of Shanghai Municipality [12ZR1447900]; U.S. National Institutes of Health, National Cancer Institute [R01CA204926]; U.S. Department of Defense-Congressionally Directory Medical Research Program (DOD-CDMRP) [BC160240]; Fundamental Research Funds for the Central Universities; NATIONAL CANCER INSTITUTE [R01CA204926] Funding Source: NIH RePORTER	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense-Congressionally Directory Medical Research Program (DOD-CDMRP); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dihua Yu [M. D. Anderson Cancer Center (MDACC), Houston, TX, USA] for the gift of the MCF10A-ErbB2-14,3,3 cells; Hans Clevers (Hubrecht Institute for Developmental Biology and Stem Cell Research, Utrecht, The Netherlands) for the gift of the LGR4 expression plasmid; Qingyun (Jim) Liu (University of Texas Health Science Center, Houston, TX, USA) for the gift of the anti-LGR4 antibody; Hong Zhang (MDACC) for pathological consultation; and Yanqing Huang (Methodist Research Institute, Houston, TX, USA) for technical advice and assistance. This work was supported by National Key Research and Development Program of China Grant 2016YFC0902102 (to J.L.); the National Natural Science Foundation of China Grants 81722020, 81472048, and 81272911 (to J.L.), and 81330049 (to M.L.); the Innovation Program of Shanghai Municipal Education Commission Grant 14ZZ051 (to J.L.) and 2017-01-07-00-05-E00011 (to M.L.); Science and Technology Commission of Shanghai Municipality Grant 12ZR1447900 (to J.L.); U.S. National Institutes of Health, National Cancer Institute Grant R01CA204926 (to Y.L.); U.S. Department of Defense-Congressionally Directory Medical Research Program (DOD-CDMRP) Grant BC160240 (to Y.L. and M.L.); and the Fundamental Research Funds for the Central Universities (to J.L.). The authors declare no conflicts of interest.	Carmon KS, 2014, P NATL ACAD SCI USA, V111, pE1221, DOI 10.1073/pnas.1323106111; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chalcrabarti R, 2014, NAT CELL BIOL, V16, P1004, DOI 10.1038/ncb3040; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cho SG, 2011, CANCER RES, V71, P6535, DOI 10.1158/0008-5472.CAN-11-0329; Dang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089835; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Du B, 2013, J BIOL CHEM, V288, P15131, DOI 10.1074/jbc.M113.455535; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; Gao Yun, 2009, Ai Zheng, V28, P104; Gong X, 2015, ONCOGENE, V34, P4692, DOI 10.1038/onc.2014.417; Govindaraj V, 2014, HORM CANCER-US, V5, P1, DOI 10.1007/s12672-013-0164-8; Green JL, 2013, P NATL ACAD SCI USA, V110, P6991, DOI 10.1073/pnas.1303671110; Guan X, 2014, J BIOL CHEM, V289, P26492, DOI 10.1074/jbc.M114.564138; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hoshii T, 2007, BIOL REPROD, V76, P303, DOI 10.1095/biolreprod.106.054619; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang S, 2017, FASEB J, V31; Jin C, 2008, INVEST OPHTH VIS SCI, V49, P4245, DOI 10.1167/iovs.08-1860; Kato S, 2007, FEBS LETT, V581, P4685, DOI 10.1016/j.febslet.2007.08.064; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kida T, 2014, BIOSCI BIOTECH BIOCH, V78, P1813, DOI 10.1080/09168451.2014.936353; Kinzel B, 2014, DEV BIOL, V390, P181, DOI 10.1016/j.ydbio.2014.03.009; Koizumi M, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.123638; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; LEE FS, 1995, P NATL ACAD SCI USA, V92, P2268, DOI 10.1073/pnas.92.6.2268; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Li JY, 2014, ENDOCRINOLOGY, V155, P429, DOI 10.1210/en.2013-1550; Liang F, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0486-1; Liu SJ, 2013, J BIOL CHEM, V288, P8794, DOI 10.1074/jbc.M112.436204; Liu T, 2013, J SURG ONCOL, V107, P188, DOI 10.1002/jso.23240; Liu YF, 2016, CANCER CELL, V30, P243, DOI 10.1016/j.ccell.2016.06.021; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Luo J, 2016, NAT MED, V22, P539, DOI 10.1038/nm.4076; Luo J, 2009, DEVELOPMENT, V136, P2747, DOI 10.1242/dev.033571; Luo WJ, 2017, J BIOL CHEM, V292, P15525, DOI 10.1074/jbc.M116.771931; Luo WJ, 2013, STEM CELLS, V31, P2492, DOI 10.1002/stem.1484; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Mohri Y, 2012, BIOSCI BIOTECH BIOCH, V76, P888, DOI 10.1271/bbb.110834; Mohri Y, 2010, FERTIL STERIL, V94, P2878, DOI 10.1016/j.fertnstert.2010.05.050; Monteiro J, 2014, CARCINOGENESIS, V35, P2, DOI 10.1093/carcin/bgt279; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Nagahata T, 2003, CANCER SCI, V94, P515, DOI 10.1111/j.1349-7006.2003.tb01475.x; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Oyama K, 2011, SEX DEV, V5, P205, DOI 10.1159/000329476; Pan HJ, 2014, ENDOCRINOLOGY, V155, P3624, DOI 10.1210/en.2013-2183; Planas-Paz L, 2016, NAT CELL BIOL, V18, P467, DOI 10.1038/ncb3337; Qian Y, 2013, DEVELOPMENT, V140, P1751, DOI 10.1242/dev.093641; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shi GX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030564; Snyder JC, 2015, J CELL SCI, V128, P1230, DOI 10.1242/jcs.166322; Sone M, 2013, FASEB J, V27, P4917, DOI 10.1096/fj.13-232215; Song HP, 2008, J BIOL CHEM, V283, P36687, DOI 10.1074/jbc.M800721200; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Sun YK, 2015, BIOCHEM BIOPH RES CO, V464, P396, DOI 10.1016/j.bbrc.2015.06.066; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Wang DS, 2015, NATURE, V517, P81, DOI 10.1038/nature13851; Wang F, 2014, J MOL ENDOCRINOL, V52, P133, DOI 10.1530/JME-13-0042; Wang JQ, 2013, NAT CELL BIOL, V15, P1455, DOI 10.1038/ncb2867; Wang J, 2012, J AM SOC NEPHROL, V23, P281, DOI 10.1681/ASN.2011040351; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Wu JH, 2013, CARCINOGENESIS, V34, P2861, DOI 10.1093/carcin/bgt229; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P16654, DOI 10.1073/pnas.1205822109; Xu P, 2016, CANCER LETT, V383, P161, DOI 10.1016/j.canlet.2016.09.005; Yamakami Yukiko, 2016, Biochem Biophys Rep, V8, P174, DOI 10.1016/j.bbrep.2016.08.018; Yamashita R, 2009, DEV DYNAM, V238, P993, DOI 10.1002/dvdy.21900; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang L, 2015, STEM CELLS, V33, P2913, DOI 10.1002/stem.2083; Yi TF, 2014, J BIOL CHEM, V289, P8767, DOI 10.1074/jbc.M113.530816; Yi ZF, 2009, INT J CANCER, V124, P843, DOI 10.1002/ijc.24027; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yu CY, 2013, ASIAN PAC J CANCER P, V14, P4907, DOI 10.7314/APJCP.2013.14.8.4907; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhang ZY, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/125683; Zhou J, 2013, ONCOL LETT, V6, P1128, DOI 10.3892/ol.2013.1516; Zhu C, 2016, CELL SIGNAL, V28, P989, DOI 10.1016/j.cellsig.2016.04.010; Zou YY, 2017, OBESITY, V25, P252, DOI 10.1002/oby.21704	84	37	41	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2422	2437		10.1096/fj.201700897R	http://dx.doi.org/10.1096/fj.201700897R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29269400	Green Published			2022-12-26	WOS:000432528000010
J	Cesa, LC; Shao, H; Srinivasan, SR; Tse, E; Jain, C; Zuiderweg, ERP; Southworth, DR; Mapp, AK; Gestwicki, JE				Cesa, Laura C.; Shao, Hao; Srinivasan, Sharan R.; Tse, Eric; Jain, Chetali; Zuiderweg, Erik R. P.; Southworth, Daniel R.; Mapp, Anna K.; Gestwicki, Jason E.			X-linked inhibitor of apoptosis protein (XIAP) is a client of heat shock protein 70 (Hsp70) and a biomarker of its inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONES; ONCOGENE ADDICTION; SUBSTRATE-BINDING; CO-CHAPERONES; HSP90; CANCER; REVEALS; DEGRADATION; DNAK; COMPLEX	Heat shock protein 70 (Hsp70) and Hsp90 are molecular chaperones that play essential roles in tumor growth by stabilizing pro-survival client proteins. However, although the development of Hsp90 inhibitors has benefited from the identification of clients, such as Raf-1 proto-oncogene, Ser/Thr kinase (RAF1), that are particularly dependent on this chaperone, no equivalent clients for Hsp70 have been reported. Using chemical probes and MDA-MB-231 breast cancer cells, we found here that the inhibitors of apoptosis proteins, including c-IAP1 and X-linked inhibitor of apoptosis protein (XIAP), are obligate Hsp70 clients that are rapidly (within similar to 3-12 h) lost after inhibition of Hsp70 but not of Hsp90. Mutagenesis and pulldown experiments revealed multiple Hsp70-binding sites on XIAP, suggesting that it is a direct, physical Hsp70 client. Interestingly, this interaction was unusually tight (similar to 260 nM) for an Hsp70-client interaction and involved non-canonical regions of the chaperone. Finally, we also found that Hsp70 inhibitor treatments caused loss of c-IAP1 and XIAP in multiple cancer cell lines and in tumor xenografts, but not in healthy cells. These results are expected to significantly accelerate Hsp70 drug discovery by providing XIAP as a pharmacodynamic biomarker. More broadly, our findings further suggest that Hsp70 and Hsp90 have partially non-overlapping sets of obligate protein clients in cancer cells.	[Cesa, Laura C.; Srinivasan, Sharan R.; Southworth, Daniel R.; Mapp, Anna K.] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA; [Jain, Chetali; Mapp, Anna K.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Tse, Eric; Zuiderweg, Erik R. P.; Southworth, Daniel R.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Tse, Eric; Southworth, Daniel R.; Mapp, Anna K.] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Shao, Hao; Gestwicki, Jason E.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Francisco	Gestwicki, JE (corresponding author), Univ Calif San Francisco, Sander Ctr, Rm 311,675 Nelson Rising Lane, San Francisco, CA 94158 USA.	Jason.gestwicki@ucsf.edu	, Dr Anna Mapp/GPX-8261-2022	Tse, Eric/0000-0002-2082-9006; Srinivasan, Sharan/0000-0003-2729-6625; Cesa, Laura/0000-0002-8367-3790; , Chetali/0000-0002-8778-4199	National Institutes of Health [NS059690]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant NS059690 (to J. E. G. and E. R. P. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abisambra J, 2013, BIOL PSYCHIAT, V74, P367, DOI 10.1016/j.biopsych.2013.02.027; Arnaud LT, 2009, J NEUROCHEM, V110, P328, DOI 10.1111/j.1471-4159.2009.06142.x; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; Blagg BSJ, 2006, MED RES REV, V26, P310, DOI 10.1002/med.20052; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Chang L, 2010, J BIOL CHEM, V285, P21282, DOI 10.1074/jbc.M110.124149; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Colvin TA, 2014, CANCER RES, V74, P4731, DOI 10.1158/0008-5472.CAN-14-0747; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Garrido C, 2003, CELL CYCLE, V2, P579, DOI 10.4161/cc.2.6.521; Hinds MG, 1999, NAT STRUCT BIOL, V6, P648; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Kaiser M, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.28; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Kellner R, 2014, P NATL ACAD SCI USA, V111, P13355, DOI 10.1073/pnas.1407086111; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Leu JIJ, 2014, ACS CHEM BIOL, V9, P2508, DOI 10.1021/cb500236y; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Li XK, 2015, MOL CANCER THER, V14, P642, DOI 10.1158/1535-7163.MCT-14-0650; Li XK, 2013, ACS MED CHEM LETT, V4, P1042, DOI 10.1021/ml400204n; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mashaghi A, 2016, NATURE, V539, P448, DOI 10.1038/nature20137; Matts RL, 2011, BIOORGAN MED CHEM, V19, P684, DOI 10.1016/j.bmc.2010.10.029; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; Morozova K, 2016, J BIOL CHEM, V291, P18096, DOI 10.1074/jbc.M116.736744; Nagel R, 2016, EMBO REP, V17, P1516, DOI 10.15252/embr.201643030; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Powers MV, 2009, CELL CYCLE, V8, P518, DOI 10.4161/cc.8.4.7583; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Rauch JN, 2016, J BIOL CHEM, V291, P19848, DOI 10.1074/jbc.M116.742502; Rauch JN, 2014, J BIOL CHEM, V289, P1402, DOI 10.1074/jbc.M113.521997; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Sekhar A, 2015, P NATL ACAD SCI USA, V112, P10395, DOI 10.1073/pnas.1508504112; Sherman MY, 2015, ONCOGENE, V34, P4153, DOI 10.1038/onc.2014.349; Srinivasan SR, 2018, MOL CANCER RES, V16, P58, DOI 10.1158/1541-7786.MCR-17-0408; Srinivasan SR, 2012, MOL BIOSYST, V8, P2323, DOI 10.1039/c2mb25145k; Sun HY, 2008, J MED CHEM, V51, P7169, DOI 10.1021/jm8006849; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Thompson AD, 2012, ACS CHEM BIOL, V7, P1677, DOI 10.1021/cb3002599; Tillotson B, 2010, J BIOL CHEM, V285, P39835, DOI 10.1074/jbc.M110.141580; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Vasko RC, 2010, ACS MED CHEM LETT, V1, P4, DOI 10.1021/ml900003t; Wang AM, 2013, NAT CHEM BIOL, V9, P112, DOI [10.1038/NCHEMBIO.1140, 10.1038/nchembio.1140]; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Young ZT, 2016, CELL CHEM BIOL, V23, P992, DOI 10.1016/j.chembiol.2016.04.014	59	31	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2370	2380		10.1074/jbc.RA117.000634	http://dx.doi.org/10.1074/jbc.RA117.000634			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29255093	Green Published, hybrid			2022-12-26	WOS:000425308300011
J	Kracher, D; Andlar, M; Furtmuller, PG; Ludwig, R				Kracher, Daniel; Andlar, Martina; Furtmueller, Paul G.; Ludwig, Roland			Active-site copper reduction promotes substrate binding of fungal lytic polysaccharide monooxygenase and reduces stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metalloenzyme; protein stability; carbohydrate-binding protein; plant cell wall; polysaccharide; Active-site copper; lytic polysaccharide monooxygenase	CELLOBIOSE DEHYDROGENASE; OXIDATIVE CLEAVAGE; FUNCTIONAL-CHARACTERIZATION; CELLULOSE DEGRADATION; NEUROSPORA-CRASSA; ACTIVATION; HYDROLYSIS; DISCOVERY; INSIGHT; PROTEIN	Lytic polysaccharide monooxygenases (LPMOs) are a class of copper-containing enzymes that oxidatively degrade insoluble plant polysaccharides and soluble oligosaccharides. Upon reductive activation, they cleave the substrate and promote biomass degradation by hydrolytic enzymes. In this study, we employed LPMO9C from Neurospora crassa, which is active toward cellulose and soluble -glucans, to study the enzyme-substrate interaction and thermal stability. Binding studies showed that the reduction of the mononuclear active-site copper by ascorbic acid increased the affinity and the maximum binding capacity of LPMO for cellulose. The reduced redox state of the active-site copper and not the subsequent formation of the activated oxygen species increased the affinity toward cellulose. The lower affinity of oxidized LPMO could support its desorption after catalysis and allow hydrolases to access the cleavage site. It also suggests that the copper reduction is not necessarily performed in the substrate-bound state of LPMO. Differential scanning fluorimetry showed a stabilizing effect of the substrates cellulose and xyloglucan on the apparent transition midpoint temperature of the reduced, catalytically active enzyme. Oxidative auto-inactivation and destabilization were observed in the absence of a suitable substrate. Our data reveal the determinants of LPMO stability under turnover and non-turnover conditions and indicate that the reduction of the active-site copper initiates substrate binding.	[Kracher, Daniel; Andlar, Martina; Ludwig, Roland] BOKU Univ Nat Resources & Life Sci, Biocatalysis & Biosensing Res Grp, Dept Food Sci & Technol, Muthgasse 18, A-1190 Vienna, Austria; [Furtmueller, Paul G.] BOKU Univ Nat Resources & Life Sci, Div Biochem, Dept Chem, Muthgasse 18, A-1190 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Kracher, D; Ludwig, R (corresponding author), BOKU Univ Nat Resources & Life Sci, Biocatalysis & Biosensing Res Grp, Dept Food Sci & Technol, Muthgasse 18, A-1190 Vienna, Austria.	daniel.kracher@boku.ac.at; roland.ludwig@boku.ac.at	Kracher, Daniel/H-6667-2019; Furtmüller, Paul G./Y-5819-2018	Kracher, Daniel/0000-0002-3856-3170; Furtmüller, Paul G./0000-0002-1199-2469; Ludwig, Roland/0000-0002-5058-5874; Andlar, Martina/0000-0002-8745-7921	Austrian Science Fund (FWF) [I2385 N28]; Project BioToP [W1224]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Project BioToP	This work was supported in part by Austrian Science Fund (FWF) Project I2385 N28 and Project BioToP, Grant W1224. The authors declare that they have no conflicts of interest with the contents of this article.	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; BEERS RF, 1952, J BIOL CHEM, V195, P133; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]; Borisova AS, 2015, J BIOL CHEM, V290, P22955, DOI 10.1074/jbc.M115.660183; Courtade G, 2016, P NATL ACAD SCI USA, V113, P5922, DOI 10.1073/pnas.1602566113; Crouch LI, 2016, J BIOL CHEM, V291, P7439, DOI 10.1074/jbc.M115.702365; Danneels B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178446; Eibinger M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01028-y; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Frandsen KEH, 2017, CARBOHYD RES, V448, P187, DOI 10.1016/j.carres.2017.03.010; Frandsen KEH, 2016, NAT CHEM BIOL, V12, P298, DOI [10.1038/NCHEMBIO.2029, 10.1038/nchembio.2029]; Frommhagen M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0284-1; Gregory RC, 2016, DALTON T, V45, P16904, DOI 10.1039/c6dt02793h; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2013, J AM CHEM SOC, V135, P6069, DOI 10.1021/ja402106e; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kjaergaard CH, 2014, P NATL ACAD SCI USA, V111, P8797, DOI 10.1073/pnas.1408115111; Kracher D, 2016, SCIENCE, V352, P1098, DOI 10.1126/science.aaf3165; Kuusk S, 2018, J BIOL CHEM, V293, P523, DOI 10.1074/jbc.M117.817593; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Loose JSM, 2016, PROTEIN SCI, V25, P2175, DOI 10.1002/pro.3043; O'Dell WB, 2017, ANGEW CHEM INT EDIT, V56, P767, DOI 10.1002/anie.201610502; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Sabel CE, 2010, ANAL BIOCHEM, V397, P218, DOI 10.1016/j.ab.2009.10.037; Span EA, 2017, ACS CHEM BIOL, V12, P1095, DOI 10.1021/acschembio.7b00016; Sygmund C, 2012, APPL ENVIRON MICROB, V78, P6161, DOI 10.1128/AEM.01503-12; Tanghe M, 2017, PROTEIN ENG DES SEL, V30, P401, DOI 10.1093/protein/gzx014; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vu VV, 2014, P NATL ACAD SCI USA, V111, P13822, DOI 10.1073/pnas.1408090111; Walton PH, 2016, CURR OPIN CHEM BIOL, V31, P195, DOI 10.1016/j.cbpa.2016.04.001; Westereng B, 2015, SCI REP-UK, V5, DOI 10.1038/srep18561; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j	41	54	57	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1676	1687		10.1074/jbc.RA117.000109	http://dx.doi.org/10.1074/jbc.RA117.000109			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29259126	Green Published, hybrid			2022-12-26	WOS:000424201700019
J	Kavitha, MS; Kurita, T; Parka, SY; Chien, SI; Bae, JS; Ahn, BC				Kavitha, Muthu Subash; Kurita, Takio; Parka, Soon-Yong; Chien, Sung-Il; Bae, Jae-Sung; Ahn, Byeong-Cheol			Deep vector-based convolutional neural network approach for automatic recognition of colonies of induced pluripotent stem cells	PLOS ONE			English	Article								Pluripotent stem cells can potentially be used in clinical applications as a model for studying disease progress. This tracking of disease-causing events in cells requires constant assessment of the quality of stem cells. Existing approaches are inadequate for robust and automated differentiation of stem cell colonies. In this study, we developed a new model of vector-based convolutional neural network (V-CNN) with respect to extracted features of the induced pluripotent stem cell (iPSC) colony for distinguishing colony characteristics. A transfer function from the feature vectors to the virtual image was generated at the front of the CNN in order for classification of feature vectors of healthy and unhealthy colonies. The robustness of the proposed V-CNN model in distinguishing colonies was compared with that of the competitive support vector machine (SVM) classifier based on morphological, textural, and combined features. Additionally, five-fold cross-validation was used to investigate the performance of the V-CNN model. The precision, recall, and F-measure values of the V-CNN model were comparatively higher than those of the SVM classifier, with a range of 87-93%, indicating fewer false positives and false negative rates. Furthermore, for determining the quality of colonies, the V-CNN model showed higher accuracy values based on morphological (95.5%), textural (91.0%), and combined (93.2%) features than those estimated with the SVM classifier (86.7, 83.3, and 83.4%, respectively). Similarly, the accuracy of the feature sets using five-fold cross-validation was above 90% for the V-CNN model, whereas that yielded by the SVM model was in the range of 75 +/- 77%. We thus concluded that the proposed V-CNN model outperforms the conventional SVM classifier, which strongly suggests that it as a reliable framework for robust colony classification of iPSCs. It can also serve as a cost-effective quality recognition tool during culture and other experimental procedures.	[Kavitha, Muthu Subash; Ahn, Byeong-Cheol] Kyungpook Natl Univ, Sch Med & Hosp, Dept Nucl Med, Daegu, South Korea; [Kurita, Takio] Hiroshima Univ, Grad Sch Engn, Hiroshima, Japan; [Parka, Soon-Yong] Kyungpook Natl Univ, Sch Comp Sci & Engn, Daegu, South Korea; [Chien, Sung-Il] Kyungpook Natl Univ, Sch Elect Engn, Daegu, South Korea; [Bae, Jae-Sung] Kyungpook Natl Univ, Sch Med, Dept Physiol, Daegu, South Korea	Kyungpook National University; Hiroshima University; Kyungpook National University; Kyungpook National University; Kyungpook National University	Ahn, BC (corresponding author), Kyungpook Natl Univ, Sch Med & Hosp, Dept Nucl Med, Daegu, South Korea.	abc2000@knu.ac.kr	Kavitha, M.S./AAI-6438-2020; Bae, Jae-sung/AAM-8663-2021; Kurita, Takio/D-8674-2012	Kurita, Takio/0000-0003-3982-6750; Park, Soon-Yong/0000-0001-5090-9667; Kavitha, Muthu Subash/0000-0002-1676-561X; Ahn, Byeong-Cheol/0000-0001-7700-3929	grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI15C0001]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2016R1D1A1A02936968]	grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea)	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number: HI15C0001) to BCA; by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2016R1D1A1A02936968) to BCA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chen WB, 2009, INFORM SYST FRONT, V11, P349, DOI 10.1007/s10796-009-9149-0; Chollet F, 2015, KERAS; Ciresan DC, 2013, LECT NOTES COMPUT SC, V8150, P411, DOI 10.1007/978-3-642-40763-5_51; D'Ambra P., 2015, P MATH MODELS BIOL B, P17, DOI [DOI 10.1007/978-3-319-23497-7_2, 10.1007/978-3-319-23497-7_2]; Dai LZ, 2017, PATTERN RECOGN, V64, P202, DOI 10.1016/j.patcog.2016.11.009; DUDA RO, 2001, PATTERN CLASSIFICATI; Ferrari A, 2015, IEEE ENG MED BIO, P7458, DOI 10.1109/EMBC.2015.7320116; Gizatdinova Y, 2014, IEEE ENG MED BIO, P3361, DOI 10.1109/EMBC.2014.6944343; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; He LF, 2013, J COMPUT SCI TECH-CH, V28, P468, DOI 10.1007/s11390-013-1348-y; Huang L, 2017, COMPUT METH PROG BIO, V143, P67, DOI 10.1016/j.cmpb.2017.02.013; Jaccard N, 2014, BIOTECHNOL BIOENG, V111, P504, DOI 10.1002/bit.25115; Jones E., 2001, SCIPY OPEN SOURCE SC; Joutsijoki H., 2016, COMP MATH MATH PHYS, V2016, P1; Kato R, 2016, SCI REP-UK, V6, DOI 10.1038/srep34009; Kavitha MS, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-1; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Kraus OZ, 2016, BIOINFORMATICS, V32, P52, DOI 10.1093/bioinformatics/btw252; Leha A, 2016, METHODS, V96, P85, DOI 10.1016/j.ymeth.2015.11.012; Lim WF, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt222; Maddah M, 2014, JALA-J LAB AUTOM, P1; Masuda Atsuki, 2015, Machine Learning in Medical Imaging. 6th International Workshop, MLMI 2015, held in conjunction with MICCAI 2015. Proceedings: LNCS 9352, P153, DOI 10.1007/978-3-319-24888-2_19; Nagasaka R, 2017, REGEN THER, V6, P41, DOI 10.1016/j.reth.2016.12.003; Nie D., 2015, P 6 ACM C BIOINF COM, P306, DOI DOI 10.1145/2808719.2808751; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Paduano V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080776; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Raytchev Bisser, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P667, DOI 10.1007/978-3-319-46723-8_77; REDDI SS, 1984, IEEE T SYST MAN CYB, V14, P661, DOI 10.1109/TSMC.1984.6313341; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tokunaga K, 2014, SCI REP, P1; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Van Valen DA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005177; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Zahedi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148642	37	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189974	10.1371/journal.pone.0189974	http://dx.doi.org/10.1371/journal.pone.0189974			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281701	gold, Green Published, Green Submitted			2022-12-26	WOS:000419006200056
J	Assanga, SO; Fuentealba, M; Zhang, GR; Tan, C; Dhakal, S; Rudd, JC; Ibrahim, AMH; Xue, QW; Haley, S; Chen, JL; Chao, SM; Baker, J; Jessup, K; Liu, SY				Assanga, Silvano O.; Fuentealba, Maria; Zhang, Guorong; Tan, ChorTee; Dhakal, Smit; Rudd, Jackie C.; Ibrahim, Amir M. H.; Xue, Qingwu; Haley, Scott; Chen, Jianli; Chao, Shiaoman; Baker, Jason; Jessup, Kirk; Liu, Shuyu			Mapping of quantitative trait loci for grain yield and its components in a US popular winter wheat TAM 111 using 90K SNPs	PLOS ONE			English	Article							STREAK-MOSAIC-VIRUS; MOLECULAR CHARACTERIZATION; COMPLEX TRAITS; PLANT HEIGHT; RESISTANCE; MARKERS; MODEL; QTL; REGISTRATION; VALIDATION	Stable quantitative trait loci (QTL) are important for deployment in marker assisted selection in wheat (Triticum aestivum L.) and other crops. We reported QTL discovery in wheat using a population of 217 recombinant inbred lines and multiple statistical approach including multi-environment, multi-trait and epistatic interactions analysis. We detected nine consistent QTL linked to different traits on chromosomes 1A, 2A, 2B, 5A, 5B, 6A, 6B and 7A. Grain yield QTL were detected on chromosomes 2B. 1 and 5B across three or four models of GenStat, MapQTL, and QTLNetwork while the QTL on chromosomes 5A. 1, 6A. 2, and 7A. 1 were only significant with yield from one or two models. The phenotypic variation explained (PVE) by the QTL on 2B. 1 ranged from 3.3-25.1% based on single and multi-environment models in GenStat and was pleiotropic or co-located with maturity (days to heading) and yield related traits (test weight, thousand kernel weight, harvest index). The QTL on 5B at 211 cM had PVE range of 1.8-9.3% and had no significant pleiotropic effects. Other consistent QTL detected in this study were linked to yield related traits and agronomic traits. The QTL on 1A was consistent for the number of spikes m(-2) across environments and all the four analysis models with a PVE range of 5.8-8.6%. QTL for kernels spike(-1) were found in chromosomes 1A, 2A. 1, 2B. 1, 6A. 2, and 7A. 1 with PVE ranged from 5.6-12.8% while QTL for thousand kernel weight were located on chromosomes 1A, 2B. 1, 5A. 1, 6A. 2, 6B. 1 and 7A. 1 with PVEranged from 2.7-19.5%. Among the consistent QTL, five QTL had significant epistatic interactions (additive x additive) at least for one trait and none revealed significant additive x additive x environment interactions. Comparative analysis revealed that the region within the confidence interval of the QTL on 5B from 211.4-244.2 cM is also linked to genes for aspartate-semialdehyde dehydrogenase, splicing regulatory glutamine/lysine-rich protein 1 isoform X1, and UDP-glucose 6-dehydrogenase 1-like isoform X1. The stable QTL could be important for further validation, high throughput SNP development, and marker-assisted selection (MAS) in wheat.	[Assanga, Silvano O.; Fuentealba, Maria; Tan, ChorTee; Dhakal, Smit; Rudd, Jackie C.; Xue, Qingwu; Baker, Jason; Jessup, Kirk; Liu, Shuyu] Texas A&M AgriLife Res, Amarillo, TX 79106 USA; [Assanga, Silvano O.; Dhakal, Smit; Ibrahim, Amir M. H.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Zhang, Guorong] Kansas State Univ, Agr Res Ctr Hays, Hays, KS USA; [Haley, Scott] Colorado State Univ, Soil & Crop Sci Dept, Ft Collins, CO 80523 USA; [Chen, Jianli] Univ Idaho, Aberdeen Res & Extens Ctr, Dept Plant Soil & Entomol Sci, Aberdeen, ID USA; [Chao, Shiaoman] USDA ARS, Biosci Res Lab, Fargo, ND 58105 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas A&M University System; Texas A&M University College Station; Kansas State University; Colorado State University; Idaho; University of Idaho; United States Department of Agriculture (USDA)	Liu, SY (corresponding author), Texas A&M AgriLife Res, Amarillo, TX 79106 USA.	SLiu@ag.tamu.edu	Liu, Shuyu/J-2022-2019; Xue, Qingwu/AAE-2431-2020	Liu, Shuyu/0000-0003-4748-2900; Xue, Qingwu/0000-0002-6470-3245	Monsanto Beachell-Borlaug International Scholars (MBBIS) program; Texas Wheat Producers Board; Texas A&M AgriLife Research; National Institute of Food and Agriculture (US) [2011-68002-30029, 2017-67007-25939]	Monsanto Beachell-Borlaug International Scholars (MBBIS) program; Texas Wheat Producers Board; Texas A&M AgriLife Research; National Institute of Food and Agriculture (US)	This work was supported by Monsanto Beachell-Borlaug International Scholars (MBBIS) program, Texas Wheat Producers Board, and Texas A&M AgriLife Research, National Institute of Food and Agriculture (US), funding number 2011-68002-30029 to Shuyu Liu; National Institute of Food and Agriculture (US), funding number 2017-67007-25939 to Shuyu Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SOFTWARE CALCULATION; Assanga S, 2017, CROP SCI, V57, P332, DOI 10.2135/cropsci2016.04.0233; Bernardo R, 2013, THEOR APPL GENET, V126, P999, DOI 10.1007/s00122-012-2032-2; Boer MP, 2007, GENETICS, V177, P1801, DOI 10.1534/genetics.107.071068; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Carter GW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003010; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Escobar-Sepulveda HF, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00129; Fehr W.R., 1987, PRINCIPLES CULTIVAR, V2; Gao FM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01099; Gregorio A, 2015, META R MULTI ENV TRI; Gupta PK, 2010, MOL BREEDING, V26, P145, DOI 10.1007/s11032-009-9359-7; Haley SD, 2002, CROP SCI, V42, P1381, DOI 10.2135/cropsci2002.1381; Hossain MA, 2010, J BIOCHEM, V148, P603, DOI 10.1093/jb/mvq094; JANSEN RC, 1994, GENETICS, V136, P1447; Jin H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01032; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Lazar MD, 2004, CROP SCI, V44, P355, DOI 10.2135/cropsci2004.3550; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Liu SY, 2016, CROP SCI, V56, P364, DOI 10.2135/cropsci2015.03.0194; Liu SY, 2014, CROP SCI, V54, P1304, DOI 10.2135/cropsci2013.08.0564; Liu SY, 2013, THEOR APPL GENET, V126, P2485, DOI 10.1007/s00122-013-2149-y; Liu YN, 2012, THEOR APPL GENET, V125, P1, DOI 10.1007/s00122-012-1829-3; Malosetti M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00044; R Core Team, R LANG ENV STAT COMP; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Smith AB, 2005, J AGR SCI-CAMBRIDGE, V143, P449, DOI 10.1017/S0021859605005587; Strasser R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00363; Tan CT, 2017, CROP SCI, V57, P340, DOI 10.2135/cropsci2016.04.0234; Tian XL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01379; Tyler AL, 2014, GENES BRAIN BEHAV, V13, P831, DOI 10.1111/gbb.12178; Tyler AL, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003270; Tyler LA, 2014, CAPE COMBINED ANAL P; van Eeuwijk FA, 2010, CURR OPIN PLANT BIOL, V13, P193, DOI 10.1016/j.pbi.2010.01.001; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; VSN International, 2015, GENSTAT WINDOWS, V18th; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wu JH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00653; Wu MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154501; Wurschum T, 2017, PLANT J, V92, P892, DOI 10.1111/tpj.13726; Wurschum T, 2015, THEOR APPL GENET, V128, P865, DOI 10.1007/s00122-015-2476-2; Xue Q, 2014, CROP SCI, V54, P34, DOI 10.2135/cropsci2013.02.0108; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; ZENG ZB, 1994, GENETICS, V136, P1457; Zhai HJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01617	46	31	31	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189669	10.1371/journal.pone.0189669	http://dx.doi.org/10.1371/journal.pone.0189669			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267314	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400039
J	Hauck, L; Stanley-Hasnain, S; Fung, A; Grothe, D; Rao, V; Mak, TW; Billia, F				Hauck, Ludger; Stanley-Hasnain, Shanna; Fung, Amelia; Grothe, Daniela; Rao, Vivek; Mak, Tak W.; Billia, Filio			Cardiac-specific ablation of the E3 ubiquitin ligase Mdm2 leads to oxidative stress, broad mitochondrial deficiency and early death	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-SUPPRESSOR PATHWAY; CHRONIC HEART-FAILURE; NF-KAPPA-B; IN-VIVO; DNA-DAMAGE; CELL-DEATH; C-MYC; P53-DEPENDENT APOPTOSIS; TRANSCRIPTIONAL TARGET	The maintenance of normal heart function requires proper control of protein turnover. The ubiquitin-proteasome system is a principal regulator of protein degradation. Mdm2 is the main E3 ubiquitin ligase for p53 in mitotic cells thereby regulating cellular growth, DNA repair, oxidative stress and apoptosis. However, which of these Mdm2-related activities are preserved in differentiated cardiomyocytes has yet to be determined. We sought to elucidate the role of Mdm2 in the control of normal heart function. We observed markedly reduced Mdm2 mRNA levels accompanied by highly elevated p53 protein expression in the hearts of wild type mice subjected to myocardial infarction or trans-aortic banding. Accordingly, we generated conditional cardiac-specific Mdm2 gene knockout (Mdm2(f/f); mcm) mice. In adulthood, Mdm2(f/f); mcm mice developed spontaneous cardiac hypertrophy, left ventricular dysfunction with early mortality post-tamoxifen. A decreased polyubiquitination of myocardial p53 was observed, leading to its stabilization and activation, in the absence of acute stress. In addition, transcriptomic analysis of Mdm2-deficient hearts revealed that there is an induction of E2f1 and c-Myc mRNA levels with reduced expression of the Pgc-1a/Ppara/Esrrb/g axis and Pink1. This was associated with a significant degree of cardiomyocyte apoptosis, and an inhibition of redox homeostasis and mitochondrial bioenergetics. All these processes are early, Mdm2-associated events and contribute to the development of pathological hypertrophy. Our genetic and biochemical data support a role for Mdm2 in cardiac growth control through the regulation of p53, the Pgc-1 family of transcriptional coactivators and the pivotal antioxidant Pink1.	[Hauck, Ludger; Stanley-Hasnain, Shanna; Fung, Amelia; Grothe, Daniela; Billia, Filio] Toronto Gen Res Inst, Toronto, ON, Canada; [Rao, Vivek] UHN, Div Cardiovasc Surg, Toronto, ON, Canada; [Mak, Tak W.] Princess Margaret Hosp, Campbell Family Canc Res Inst, Toronto, ON, Canada; [Billia, Filio] Univ Hlth Network, Div Cardiol, Toronto, ON, Canada; [Billia, Filio] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON, Canada; [Billia, Filio] Univ Toronto, Inst Med Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Billia, F (corresponding author), Toronto Gen Res Inst, Toronto, ON, Canada.; Billia, F (corresponding author), Univ Hlth Network, Div Cardiol, Toronto, ON, Canada.; Billia, F (corresponding author), Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON, Canada.; Billia, F (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	phyllis.billia@uhn.ca	Billia, Filio/B-3011-2014	Billia, Filio/0000-0002-2824-1215	Canadian Institutes for Health Research in the form of an operating grant [299339]; Canadian Institute for Health Research, Clinician-Scientist award [314888]	Canadian Institutes for Health Research in the form of an operating grant; Canadian Institute for Health Research, Clinician-Scientist award(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Institutes for Health Research in the form of an operating grant (#299339) and salary support provided by the Canadian Institute for Health Research, Clinician-Scientist award for Dr. Filio Billia (#314888).	Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Ahuja P, 2010, J CLIN INVEST, V120, P1494, DOI 10.1172/JCI38331; Akazawa H, 2015, CIRC J, V79, P2529, DOI 10.1253/circj.CJ-15-0818; Ambrus AM, 2013, DEV CELL, V27, P438, DOI 10.1016/j.devcel.2013.10.002; Angelis E, 2011, J MOL CELL CARDIOL, V51, P919, DOI 10.1016/j.yjmcc.2011.09.012; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Billia F, 2011, P NATL ACAD SCI USA, V108, P9572, DOI 10.1073/pnas.1106291108; BLACK FM, 1991, J CLIN INVEST, V88, P1581, DOI 10.1172/JCI115470; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Braunwald E, 2000, CIRCULATION, V102, P14; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Calise J, 2013, AM J PHYSIOL-HEART C, V304, pH337, DOI 10.1152/ajpheart.00604.2012; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Christians ES, 2012, AM J PHYSIOL-HEART C, V302, pH24, DOI 10.1152/ajpheart.00903.2011; Clegg HV, 2010, CRIT REV EUKAR GENE, V20, P77, DOI 10.1615/CritRevEukarGeneExpr.v20.i1.60; Cohn JN, 1996, NEW ENGL J MED, V335, P490, DOI 10.1056/NEJM199608153350707; Cregan SP, 1999, J NEUROSCI, V19, P7860; Dadson K, 2017, SCI REP, P7; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 1999, MOL CELL BIOL, V19, P1; Day SM, 2013, AM J PHYSIOL-HEART C, V304, pH1283, DOI 10.1152/ajpheart.00249.2012; de Rozieres S, 2000, ONCOGENE, V19, P1691, DOI 10.1038/sj.onc.1203468; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Ehrhardt H, 2008, ONCOGENE, V27, P783, DOI 10.1038/sj.onc.1210666; Eischen CM, 2014, HUM MUTAT, V35, P728, DOI 10.1002/humu.22524; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Espada L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051544; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fortin A, 2004, J BIOL CHEM, V279, P28706, DOI 10.1074/jbc.M400376200; Fortin A, 2001, J CELL BIOL, V155, P207, DOI 10.1083/jcb.200105137; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gajarsa JJ, 2011, HEART FAIL REV, V16, P13, DOI 10.1007/s10741-010-9181-7; Gonzalez A, 2009, CARDIOVASC RES, V81, P509, DOI 10.1093/cvr/cvn235; Grier JD, 2006, MOL CELL BIOL, V26, P192, DOI 10.1128/MCB.26.1.192-198.2006; Gupta S, 2001, J BIOL CHEM, V276, P10585, DOI 10.1074/jbc.C100025200; Hao ZY, 2012, J EXP MED, V209, P173, DOI 10.1084/jem.20111363; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hedhli N, 2008, AM J PHYSIOL-HEART C, V295, pH1385, DOI 10.1152/ajpheart.00532.2008; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Henry RE, 2012, EMBO J, V31, P1266, DOI 10.1038/emboj.2011.498; Hershko T, 2005, CELL DEATH DIFFER, V12, P377, DOI 10.1038/sj.cdd.4401575; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hoshino A, 2012, J MOL CELL CARDIOL, V52, P175, DOI 10.1016/j.yjmcc.2011.10.008; Houweling AC, 2005, CARDIOVASC RES, V67, P583, DOI 10.1016/j.cardiores.2005.06.013; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Ikeda M, 2015, SCI REP, P5; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Kapiloff MS, 2016, CARDIAC ENIGMA CURRE, P5; Kimata M, 2010, AM J PHYSIOL-HEART C, V299, pH1908, DOI 10.1152/ajpheart.00250.2010; Kirshenbaum LA, 1996, DEV BIOL, V179, P402, DOI 10.1006/dbio.1996.0270; KNOWLTON KU, 1995, J CLIN INVEST, V96, P1311, DOI 10.1172/JCI118166; Kolwicz SC, 2013, CIRC RES, V113, P603, DOI 10.1161/CIRCRESAHA.113.302095; Kuwahara K, 2012, J PHARMACOL SCI, V119, P198, DOI 10.1254/jphs.12R04CP; Kuwahara K, 2010, ENDOCR J, V57, P555, DOI 10.1507/endocrj.K10E-150; LaPointe MC, 2005, PEPTIDES, V26, P944, DOI 10.1016/j.peptides.2004.08.028; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Lin WC, 2001, GENE DEV, V15, P1833; Liu G, 2007, J PATHOL, V213, P360, DOI 10.1002/path.2238; Lombardi AA, 2015, AM J PHYSIOL-HEART C, V309, pH393, DOI 10.1152/ajpheart.00475.2015; Lorell BH, 2000, CIRCULATION, V102, P470; Loughran O, 2000, MOL CELL BIOL, V20, P2186, DOI 10.1128/MCB.20.6.2186-2197.2000; Luker GD, 2003, NAT MED, V9, P969, DOI 10.1038/nm894; LUNA RMD, 1995, NATURE, V378, P203; Macleod KF, 2008, NAT REV CANCER, V8, P769, DOI 10.1038/nrc2504; Maejima Y, 2015, AM J PHYSIOL-HEART C, V308, pH259, DOI 10.1152/ajpheart.00711.2014; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Mak TW, 2017, P NATL ACAD SCI USA, V114, P2331, DOI 10.1073/pnas.1621436114; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Matsusaka H, 2006, CARDIOVASC RES, V70, P457, DOI 10.1016/j.cardiores.2006.02.001; MCMURRAY J, 1993, EUR HEART J, V14, P1493, DOI 10.1093/eurheartj/14.11.1493; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; MIYASHITA T, 1995, CELL, V80, P293; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Naito AT, 2010, CIRC RES, V106, P1692, DOI 10.1161/CIRCRESAHA.109.214346; Nakamura H, 2012, CIRC-HEART FAIL, V5, P106, DOI 10.1161/CIRCHEARTFAILURE.111.961565; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Pant V, 2014, ONCOTARGET, V5, P1149, DOI 10.18632/oncotarget.1797; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Perfettini JL, 2004, NAT CELL BIOL, V6, P386, DOI 10.1038/ncb0504-386; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; Phesse TJ, 2014, CELL DEATH DIFFER, V21, P956, DOI 10.1038/cdd.2014.15; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Portbury AL, 2012, J MOL CELL CARDIOL, V52, P526, DOI 10.1016/j.yjmcc.2011.10.023; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Powell SR, 2005, ANTIOXID REDOX SIGN, V7, P538, DOI 10.1089/ars.2005.7.538; Pye J, 2003, AM J PHYSIOL-HEART C, V284, pH919, DOI 10.1152/ajpheart.00851.2002; Riehle C, 2012, TRENDS CARDIOVAS MED, V22, P98, DOI 10.1016/j.tcm.2012.07.003; Riley Maurisa F, 2012, Genes Cancer, V3, P226, DOI 10.1177/1947601912455322; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Schoenfeld JR, 1998, J MOL CELL CARDIOL, V30, P2269, DOI 10.1006/jmcc.1998.0787; Schulz R, 2003, AM J PHYSIOL-HEART C, V285, pH2084, DOI 10.1152/ajpheart.01038.2002; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shukla PC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1601; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Stanley-Hasnain S, 2017, CELL CYCLE, V26, P1; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Takeishi Y, 2002, CARDIOVASC RES, V53, P131, DOI 10.1016/S0008-6363(01)00438-2; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tang DM, 2000, J BIOL CHEM, V275, P9303, DOI 10.1074/jbc.275.13.9303; Toko H, 2010, CIRCULATION, V122, P891, DOI 10.1161/CIRCULATIONAHA.109.935296; Toth A, 2006, J BIOL CHEM, V281, P3679, DOI 10.1074/jbc.M509630200; Toth A, 2006, AM J PHYSIOL-HEART C, V291, pH52, DOI 10.1152/ajpheart.01046.2005; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; van Berlo JH, 2013, J CLIN INVEST, V123, P37, DOI 10.1172/JCI62839; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; von Harsdorf R, 1999, CIRC RES, V85, P128, DOI 10.1161/01.RES.85.2.128; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang EY, 2013, HYPERTENSION, V62, P70, DOI 10.1161/HYPERTENSIONAHA.113.01028; Wang XJ, 2011, AM J PHYSIOL-HEART C, V301, pH2207, DOI 10.1152/ajpheart.00714.2011; Watanabe K, 2000, J BIOL CHEM, V275, P22293, DOI 10.1074/jbc.M000248200; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Willis MS, 2014, J MOL CELL CARDIOL, V71, P43, DOI 10.1016/j.yjmcc.2013.11.008; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Xiong SB, 2006, P NATL ACAD SCI USA, V103, P3226, DOI 10.1073/pnas.0508500103; Xiong SB, 2013, CHIN J CANCER, V32, P371, DOI 10.5732/cjc.012.10286; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; Zarain-Herzberg A, 2011, IUBMB LIFE, V63, P847, DOI 10.1002/iub.545; Zebrowski DC, 2016, AM J PHYSIOL-HEART C, V310, pH1045, DOI 10.1152/ajpheart.00697.2015; Zhang GX, 2010, AM J PHYSIOL-HEART C, V298, pH433, DOI 10.1152/ajpheart.00938.2009	161	20	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189861	10.1371/journal.pone.0189861	http://dx.doi.org/10.1371/journal.pone.0189861			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267372	Green Published, gold, Green Submitted			2022-12-26	WOS:000418587400054
J	Mellerup, E; Andreassen, OA; Bennike, B; Dam, H; Djurovic, S; Jorgensen, MB; Kessing, LV; Koefoed, P; Melle, I; Mors, O; Moeller, GL				Mellerup, Erling; Andreassen, Ole A.; Bennike, Bente; Dam, Henrik; Djurovic, Srdjan; Jorgensen, Martin Balslev; Kessing, Lars Vedel; Koefoed, Pernille; Melle, Ingrid; Mors, Ole; Moeller, Gert Lykke			Combinations of genetic variants associated with bipolar disorder	PLOS ONE			English	Article							NETWORK	The main objective of the study was to find genetic variants that in combination are significantly associated with bipolar disorder. In previous studies of bipolar disorder, combinations of three and four single nucleotide polymorphisms (SNP) genotypes taken from 803 SNPs were analyzed, and five clusters of combinations were found to be significantly associated with bipolar disorder. In the present study, combinations of ten SNP genotypes taken from the same 803 SNPs were analyzed, and one cluster of combinations was found to be significantly associated with bipolar disorder. Combinations from the new cluster and from the five previous clusters were identified in the genomes of 266 or 44% of the 607 patients in the study whereas none of the 1355 control participants had any of these combinations in their genome. The SNP genotypes in the smaller combinations were the normal homozygote, heterozygote or variant homozygote. In the combinations containing 10 SNP genotypes almost all the genotypes were the normal homozygote. Such a finding may indicate that accumulation in the genome of combinations containing few SNP genotypes may be a risk factor for bipolar disorder when those combinations contain relatively many rare SNP genotypes, whereas combinations need to contain many SNP genotypes to be a risk factor when most of the SNP genotypes are the normal homozygote.	[Mellerup, Erling; Bennike, Bente; Koefoed, Pernille] Univ Copenhagen, Dept Neurosci & Pharmacol, Lab Neuropsychiat, Copenhagen, Denmark; [Andreassen, Ole A.; Melle, Ingrid] Oslo Univ Hosp, Dept Psychiat, Oslo, Norway; [Andreassen, Ole A.; Djurovic, Srdjan; Melle, Ingrid] Univ Oslo, Inst Psychiat, Oslo, Norway; [Dam, Henrik; Jorgensen, Martin Balslev; Kessing, Lars Vedel] Copenhagen Univ Hosp, Rigshosp, Psychiat Ctr Copenhagen, Dept O, Copenhagen, Denmark; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Mors, Ole] Aarhus Univ Hosp, Ctr Psyciat Res, Skovagervej 2, Risskov, Denmark; [Moeller, Gert Lykke] Tech Univ Denmark, ScionDTU, Genokey ApS, Agern Alle 3, Horsholm, Denmark	University of Copenhagen; University of Oslo; University of Oslo; Rigshospitalet; University of Copenhagen; University of Oslo; Aarhus University; Technical University of Denmark	Mellerup, E (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Lab Neuropsychiat, Copenhagen, Denmark.	mellerup@sund.ku.dk	Jorgensen, Martin Balslev MBJ/K-5758-2012; Andreassen, Ole A./AAY-7531-2020	Jorgensen, Martin Balslev MBJ/0000-0002-1321-8901; Mellerup, E rling/0000-0001-7150-7755; Kessing, Lars/0000-0001-9377-9436; Djurovic, Srdjan/0000-0002-8140-8061				Bottolo L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003657; Capasso M, 2014, CANCER GENET-NY, V207, P94, DOI 10.1016/j.cancergen.2014.02.004; Climer S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003766; Davis NA, 2010, GENES IMMUN, V11, P630, DOI 10.1038/gene.2010.37; Dong YS, 2014, SCI WORLD J, DOI [10.1155/2014/259139, 10.1155/2014/862019]; Grelck C, 2006, INT J PARALLEL PROG, V34, P383, DOI [10.1007/s10766-006-0018-x, 10.1007/S10766-006-0018-x]; Guo X, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-102; Hibar DP, 2015, NEUROBIOL AGING, V36, pS151, DOI 10.1016/j.neurobiolaging.2014.02.033; Hu T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-364; Koefoed P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023812; Li CX, 2011, GENE, V489, P119, DOI 10.1016/j.gene.2011.08.026; Mellerup E, 2017, COMPUT STRUCT BIOTEC, V15, P286, DOI 10.1016/j.csbj.2017.03.001; Mellerup Erling, 2015, Genes Cancer, V6, P422; Mellerup E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143432; Milne RL, 2014, HUM MOL GENET, V23, P1934, DOI 10.1093/hmg/ddt581; Pesarin F., 2010, PERMUTATION TESTS CO; Sluga D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-216; van Leeuwen EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109290; Wei WH, 2014, NAT REV GENET, V15, P722, DOI 10.1038/nrg3747	19	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189739	10.1371/journal.pone.0189739	http://dx.doi.org/10.1371/journal.pone.0189739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267373	Green Published, gold, Green Submitted			2022-12-26	WOS:000418587400042
J	Stohr, R; Schurgers, L; van Gorp, R; Jaminon, A; Marx, N; Reutelingsperger, C				Stoehr, Robert; Schurgers, Leon; van Gorp, Rick; Jaminon, Armand; Marx, Nikolaus; Reutelingsperger, Chris			Annexin A5 reduces early plaque formation in ApoE -/- mice	PLOS ONE			English	Article							INFLAMMATION	Annexin A5 (AnxA5) exerts anti-inflammatory, anticoagulant and anti-apoptotic effects through its binding to cell surface expressed phosphatidylserine. We previously showed that AnxA5 can stabilize advanced atherosclerotic plaques by reducing macrophage infiltration. We now investigated the effects of AnxA5 administration on the onset of atherosclerosis development. Eight-week-old ApoE-/- mice were fed a western diet while being administered AnxA5 or control (M1234) for a total of 6 weeks. AnxA5 administration reduced plaque size in the aortic root as well as the aortic arch by 36% and 55% respectively. As determined by immunohistochemistry, administration of AnxA5 further stabilized plaque by reducing macrophage content and increasing smooth muscle cell content. Furthermore, the pre-treatment of HUVEC's with AnxA5 reduced monocyte adhesion under flow-conditions. Finally, AnxA5 administration results in a trend to reduced cell death more pronounced in the aortic arch than the aortic root. In conclusion, treatment with AnxA5 before the onset of atherosclerosis reduces plaque formation in a murine model of atherosclerosis in part by reducing apoptotic rates further to its beneficial effect on macrophage infiltration and activation.	[Stoehr, Robert; Marx, Nikolaus] Rhein Westfal TH Aachen, Med Klin 1, Aachen, Germany; [Stoehr, Robert; Schurgers, Leon; van Gorp, Rick; Jaminon, Armand; Reutelingsperger, Chris] Univ Maastricht, Cardiovasc Res Inst, Maastricht Dept Biochem, Maastricht, Netherlands	RWTH Aachen University; Maastricht University	Stohr, R (corresponding author), Rhein Westfal TH Aachen, Med Klin 1, Aachen, Germany.; Stohr, R (corresponding author), Univ Maastricht, Cardiovasc Res Inst, Maastricht Dept Biochem, Maastricht, Netherlands.	rstoehr@ukaachen.de	Schurgers, Leon/AAT-7100-2021	Schurgers, Leon/0000-0001-7867-6957; Stohr, Robert/0000-0002-1468-2554				Authors/Task Force Members:, 2016, Atherosclerosis, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; Burgmaier M, 2014, J CELL MOL MED, V18, P2117, DOI 10.1111/jcmm.12374; Ewing MM, 2012, ATHEROSCLEROSIS, V221, P333, DOI 10.1016/j.atherosclerosis.2012.01.037; Ewing MM, 2011, ARTERIOSCL THROM VAS, V31, P95, DOI 10.1161/ATVBAHA.110.216747; Gidon-Jeangirard C, 1999, BIOCHEM BIOPH RES CO, V265, P709, DOI 10.1006/bbrc.1999.1752; Gistera A, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.51; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Kuijpers MJE, 2008, MICROCIRCULATION, V15, P269, DOI 10.1080/10739680701653517; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Mira JP, 1997, J BIOL CHEM, V272, P10474; Park JH, 2016, MOL MED, V22, P424, DOI 10.2119/molmed.2016.00026; Rahman M, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006778; Satoh M, 2015, CLIN SCI, V129, P93, DOI 10.1042/CS20150027; Schurgers LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043229; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Ungethum L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096749; van Genderen HO, 2008, BBA-MOL CELL RES, V1783, P953, DOI 10.1016/j.bbamcr.2008.01.030	19	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190229	10.1371/journal.pone.0190229	http://dx.doi.org/10.1371/journal.pone.0190229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267398	Green Published, gold, Green Submitted			2022-12-26	WOS:000418587400107
J	He, QL; Su, GM; Liu, KL; Zhang, FC; Jiang, Y; Gao, J; Liu, LD; Jiang, ZR; Jin, MW; Xie, HP				He, Qili; Su, Guoming; Liu, Keliang; Zhang, Fangcheng; Jiang, Yong; Gao, Jun; Liu, Lida; Jiang, Zhongren; Jin, Minwu; Xie, Huiping			Sex-specific reference intervals of hematologic and biochemical analytes in Sprague-Dawley rats using the nonparametric rank percentile method	PLOS ONE			English	Article							CHEMISTRY REFERENCE INTERVALS; BONE-MARROW ABLATION; CLINICAL-CHEMISTRY; SERUM CHEMISTRY; REFERENCE DATABASE; REFERENCE VALUES; AGE; MICE; METABOLISM; GLUCOSE	Background Hematologic and biochemical analytes of Sprague-Dawley rats are commonly used to determine effects that were induced by treatment and to evaluate organ dysfunction in toxicological safety assessments, but reference intervals have not been well established for these analytes. Reference intervals as presently defined for these analytes in Sprague-Dawley rats have not used internationally recommended statistical method nor stratified by sex. Thus, we aimed to establish sex-specific reference intervals for hematologic and biochemical parameters in Sprague-Dawley rats according to Clinical and Laboratory Standards Institute C28-A3 and American Society for Veterinary Clinical Pathology guideline. Methods Hematology and biochemistry blood samples were collected from 500 healthy Sprague-Dawley rats (250 males and 250 females) in the control groups. We measured 24 hematologic analytes with the Sysmex XT-2100i analyzer, 9 biochemical analytes with the Olympus AU400 analyzer. We then determined statistically relevant sex partitions and calculated reference intervals, including corresponding 90% confidence intervals, using nonparametric rank percentile method. Results We observed that most hematologic and biochemical analytes of Sprague-Dawley rats were significantly influenced by sex. Males had higher hemoglobin, hematocrit, red blood cell count, red cell distribution width, mean corpuscular volume, mean corpuscular hemoglobin, white blood cell count, neutrophils, lymphocytes, monocytes, percentage of neutrophils, percentage of monocytes, alanine aminotransferase, aspartate aminotransferase, and triglycerides compared to females. Females had higher mean corpuscular hemoglobin concentration, plateletcrit, platelet count, eosinophils, percentage of lymphocytes, percentage of eosinophils, creatinine, glucose, total cholesterol and urea compared to males. Sex partition was required for most hematologic and biochemical analytes in Sprague-Dawley rats. We established sex-specific reference intervals, including corresponding 90% confidence intervals, for Sprague-Dawley rats. Conclusions Understanding the significant discrepancies in hematologic and biochemical analytes between male and female Sprague-Dawley rats provides important insight into physiological effects in test rats. Establishment of locally sex-specific reference intervals allows a more precise evaluation of animal quality and experimental results of Sprague-Dawley rats in our toxicology safety assessment.	[He, Qili; Liu, Keliang; Jiang, Yong; Gao, Jun; Liu, Lida; Jiang, Zhongren; Jin, Minwu; Xie, Huiping] Sichuan Ctr Dis Control & Prevent, Inst Toxicol Detect, Chengdu, Sichuan, Peoples R China; [Su, Guoming] Sichuan Nursing Vocat Coll, Dept Pharm & Lab, Chengdu, Sichuan, Peoples R China; [Zhang, Fangcheng] Wuhan Univ, Renmin Hosp, Dept Ultrastruct Pathol Ctr, Wuhan, Hubei, Peoples R China	Wuhan University	Liu, KL (corresponding author), Sichuan Ctr Dis Control & Prevent, Inst Toxicol Detect, Chengdu, Sichuan, Peoples R China.	xiaoq0226@163.com	Su, Guoming/W-4976-2019	Su, Guoming/0000-0003-2466-2423				Adeli K, 2015, CLIN CHEM, V61, P1075, DOI 10.1373/clinchem.2015.240531; Agnelli S, 2016, RSC ADV, V6, P11278, DOI 10.1039/c5ra25174e; Aitman TJ, 1997, NAT GENET, V16, P197, DOI 10.1038/ng0697-197; Aleman CL, 1998, LAB ANIM, V32, P457, DOI 10.1258/002367798780599802; ASVCP Quality Assurance and Laboratory Standards Committee, 2012, GUID DET REF INT VET, P1; Bankir L, 2012, KIDNEY INT, V81, P1179, DOI 10.1038/ki.2012.67; Boehm O, 2007, BIOL CHEM, V388, P547, DOI 10.1515/BC.2007.061; Bollard ME, 2005, METABONOMICS IN TOXICITY ASSESSMENT, P397; Broudy VC, 1996, BLOOD, V88, P75; Chichester L, 2015, J AM ASSOC LAB ANIM, V54, P359; CHOI YS, 1988, MECH AGEING DEV, V44, P91, DOI 10.1016/0047-6374(88)90081-4; CLSI, 2008, EP28A3C CLSI; Crincoli CM, 2016, FOOD CHEM TOXICOL, V97, P57, DOI 10.1016/j.fct.2016.08.030; DAVIS E, 1992, J LAB CLIN MED, V120, P767; DAVIS E, 1990, J LAB CLIN MED, V116, P879; De Marinis E, 2008, J ENDOCRINOL, V198, P635, DOI 10.1677/JOE-08-0242; Delaney B, 2008, FOOD CHEM TOXICOL, V46, P3808, DOI 10.1016/j.fct.2008.10.003; DIXON WJ, 1953, BIOMETRICS, V9, P74, DOI 10.2307/3001634; Eisner C, 2010, KIDNEY INT, V77, P519, DOI 10.1038/ki.2009.501; Everds NE, 2015, TOXICOL PATHOL, V43, P90, DOI 10.1177/0192623314555340; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; Goutianos G, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12293; Harvey SB, 2008, J AM ASSOC LAB ANIM, V47, P35; Holsapple MP, 2003, BIRTH DEFECTS RES B, V68, P321, DOI 10.1002/bdrb.10035; Honda T, 2008, J TOXICOL SCI, V33, P375, DOI 10.2131/jts.33.375; Jacob Filho W, 2017, AGING MALE, V11, P1; Jacobs M, 2011, METABOLISM, V60, P969, DOI 10.1016/j.metabol.2010.09.006; Kale VP, 2009, VET CLIN PATH, V38, P361, DOI 10.1111/j.1939-165X.2009.00143.x; Kampfmann I, 2012, VET CLIN PATH, V41, P228, DOI 10.1111/j.1939-165X.2012.00427.x; Kane JD, 2012, J AM ASSOC LAB ANIM, V51, P769; KATOH M, 1992, EXP ANIM TOKYO, V41, P329, DOI 10.1538/expanim1978.41.3_329; Lahti A, 2004, CLIN CHEM, V50, P891, DOI 10.1373/clinchem.2003.027953; Lahti A, 2002, CLIN CHEM, V48, P338; Lee CE, 2008, ANN NUTR METAB, V53, P1, DOI 10.1159/000152867; Li IC, 2014, FOOD CHEM TOXICOL, V70, P61, DOI 10.1016/j.fct.2014.04.040; Liberati TA, 2004, VET CLIN PATH, V33, P68, DOI 10.1111/j.1939-165X.2004.tb00352.x; Lillie LE, 1996, HUM EXP TOXICOL, V15, P612, DOI 10.1177/096032719601500802; Matsche MA, 2014, VET CLIN PATH, V43, P387, DOI 10.1111/vcp.12174; Mazzaccara C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003772; Ministry of Health PRC, 2012, REF INT BLOOD CELL A; Ministry of Health PRC, 2012, REF INT COMM CLIN BI; Ministry of Health PRC, 2015, REF INT COMM CLIN BI; Ministry of Health PRC, REF INT COMM CLIN BI; MIRAND EA, 1965, NATURE, V206, P270, DOI 10.1038/206270a0; Naiken S, 2016, J MED PRIMATOL; National Health and Family Planning Commission of PRC, 2014, REP DOS 28 DAY OR TO; OECD (Organisation for Economic Co-operation and Development), 2008, TEST NO 407 REP DOS; OHNO H, 1993, IMMUNOL LETT, V35, P197, DOI 10.1016/0165-2478(93)90091-F; Otto GP, 2016, J AM ASSOC LAB ANIM, V55, P375; Ozarda Y, 2016, BIOCHEM MEDICA, V26, P5, DOI 10.11613/BM.2016.001; Peters LL, 2002, PHYSIOL GENOMICS, V11, P185, DOI 10.1152/physiolgenomics.00077.2002; Petterino C, 2006, EXP TOXICOL PATHOL, V57, P213, DOI 10.1016/j.etp.2005.10.002; Qiao R, 2014, CLIN CHEM LAB MED, V52, P1025, DOI 10.1515/cclm-2012-0486; REED AH, 1971, CLIN CHEM, V17, P275; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samaneka WP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165821; Sattar N, 2013, BEST PRACT RES CL EN, V27, P501, DOI 10.1016/j.beem.2013.05.006; Schmitt A, 2001, EXP HEMATOL, V29, P1295, DOI 10.1016/S0301-472X(01)00733-0; Selig M, 2016, J ZOO WILDLIFE MED, V47, P106, DOI 10.1638/2015-0040.1; Sugden MC, 2002, J ENDOCRINOL, V175, P757, DOI 10.1677/joe.0.1750757; TAYLOR EH, 1989, CLIN CHEM, V35, P710; Toyota N, 2004, J TOXICOL SCI, V29, P487; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Wang XS, 2005, CURR OPIN LIPIDOL, V16, P127, DOI 10.1097/01.mol.0000162317.09054.9d; White JR, 2016, VET CLIN PATH, V45, P87, DOI 10.1111/vcp.12314; WOLFORD ST, 1986, J TOXICOL ENV HEALTH, V18, P161, DOI 10.1080/15287398609530859; WOLFORD ST, 1987, FUND APPL TOXICOL, V8, P80, DOI 10.1016/0272-0590(87)90102-3; Zhou X, 2007, CLIN BIOCH TESTING; Zierk J, 2015, CLIN CHEM, V61, P964, DOI 10.1373/clinchem.2015.239731	69	51	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189837	10.1371/journal.pone.0189837	http://dx.doi.org/10.1371/journal.pone.0189837			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261747	Green Published, Green Submitted, gold			2022-12-26	WOS:000418564200068
J	Shuryak, I; Matrosov, VY; Gaidamakova, EK; Tkavc, R; Grichenko, O; Klimenkova, P; Volpe, RP; Daly, MJ				Shuryak, Igor; Matrosov, Vera Y.; Gaidamakova, Elena K.; Tkavc, Rok; Grichenko, Olga; Klimenkova, Polina; Volpe, Robert P.; Daly, Michael J.			Microbial cells can cooperate to resist high-level chronic ionizing radiation	PLOS ONE			English	Article							DOUBLE-STRAND BREAK; DEINOCOCCUS-RADIODURANS; GAMMA-RADIATION; DNA-DAMAGE; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; PROTEIN DAMAGE; SINGLE-STRAND; MITOTIC DELAY; DOSE-RATE	Understanding chronic ionizing radiation (CIR) effects is of utmost importance to protecting human health and the environment. Diverse bacteria and fungi inhabiting extremely radioactive waste and disaster sites (e.g. Hanford, Chernobyl, Fukushima) represent new targets of CIR research. We show that many microorganisms can grow under intense gamma-CIR dose rates of 13-126 Gy/h, with fungi identified as a particularly CIR-resistant group of eukaryotes: among 145 phylogenetically diverse strains tested, 78 grew under 36 Gy/h. Importantly, we demonstrate that CIR resistance can depend on cell concentration and that certain resistant microbial cells protect their neighbors (not only conspecifics, but even radiosensitive species from a different phylum), from high-level CIR. We apply a mechanistically-motivated mathematical model of CIR effects, based on accumulation/removal kinetics of reactive oxygen species (ROS) and antioxidants, in bacteria (3 Escherichia coli strains and Deinococcus radiodurans) and in fungi (Candida parapsilosis, Kazachstania exigua, Pichia kudriavzevii, Rhodotorula lysinophila, Saccharomyces cerevisiae, and Trichosporon mucoides). We also show that correlations between responses to CIR and acute ionizing radiation (AIR) among studied microorganisms are weak. For example, in D. radiodurans, the best molecular correlate for CIR resistance is the antioxidant enzyme catalase, which is dispensable for AIR resistance; and numerous CIR-resistant fungi are not AIR-resistant. Our experimental findings and quantitative modeling thus demonstrate the importance of investigating CIR responses directly, rather than extrapolating from AIR. Protection of radiosensitive cell-types by radioresistant ones under high-level CIR is a potentially important new tool for bioremediation of radioactive sites and development of CIR-resistant microbiota as radioprotectors.	[Shuryak, Igor] Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA; [Matrosov, Vera Y.; Gaidamakova, Elena K.; Tkavc, Rok; Grichenko, Olga; Klimenkova, Polina; Volpe, Robert P.; Daly, Michael J.] Uniformed Serv Univ Hlth Sci, Sch Med, Bethesda, MD 20814 USA; [Matrosov, Vera Y.; Gaidamakova, Elena K.; Tkavc, Rok; Grichenko, Olga; Klimenkova, Polina; Volpe, Robert P.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA	Columbia University; Uniformed Services University of the Health Sciences - USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Shuryak, I (corresponding author), Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA.	is144@cumc.columbia.edu	Matrosova, Vera/AAX-4125-2020	Tkavc, Rok/0000-0002-1445-8085	Defense Threat Reduction Agency [HDTRA-18774-M, HDTRA1-17-1-0013]; Department of Energy [DE-NA0002322/0006]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Department of Energy(United States Department of Energy (DOE))	This work was supported by Defense Threat Reduction Agency HDTRA-18774-M, www.dtra.mil, MJD; Department of Energy, DE-NA0002322/0006, https://energy.gov, MJD; Defense Threat Reduction Agency HDTRA1-17-1-0013, www.dtra.mil, IS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnese K, 2012, P NATL ACAD SCI USA, V109, P6892, DOI 10.1073/pnas.1203051109; Brim H, 2000, NAT BIOTECHNOL, V18, P85, DOI 10.1038/71986; Buonanno M, 2011, RADIAT RES, V175, P405, DOI 10.1667/RR2461.1; Carlson DJ, 2011, INT J RADIAT ONCOL, V79, P1188, DOI 10.1016/j.ijrobp.2010.10.007; CHOU FI, 1990, J BACTERIOL, V172, P2029, DOI 10.1128/jb.172.4.2029-2035.1990; Costa CS, 2010, PHOTOCHEM PHOTOBIOL, V86, P1334, DOI 10.1111/j.1751-1097.2010.00800.x; Cucinotta FA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02087-3; Culotta VC, 2013, ANTIOXID REDOX SIGN, V19, P933, DOI 10.1089/ars.2012.5093; Dadachova E, 2008, CURR OPIN MICROBIOL, V11, P525, DOI 10.1016/j.mib.2008.09.013; Daly Michael J, 2007, PLoS Biol, V5, pe92; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; DALY MJ, 1994, J BACTERIOL, V176, P7506, DOI 10.1128/JB.176.24.7506-7515.1994; Davalos A, 2004, J AGR FOOD CHEM, V52, P48, DOI 10.1021/jf0305231; Dighton J, 2008, FEMS MICROBIOL LETT, V281, P109, DOI 10.1111/j.1574-6968.2008.01076.x; Fredrickson JK, 2004, APPL ENVIRON MICROB, V70, P4230, DOI 10.1128/AEM.70.7.4230-4241.2004; Fuma S, 2012, J ENVIRON RADIOACTIV, V104, P81, DOI 10.1016/j.jenvrad.2011.09.005; Fuma S, 2010, J ENVIRON RADIOACTIV, V101, P915, DOI 10.1016/j.jenvrad.2010.06.007; Garcia-Contreras R, 2015, ISME J, V9, P115, DOI 10.1038/ismej.2014.98; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; Harris DR, 2009, J BACTERIOL, V191, P5240, DOI 10.1128/JB.00502-09; Hei Tom K, 2011, Curr Mol Pharmacol, V4, P96; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jeong SW, 2016, BIOCHEM BIOPH RES CO, V469, P443, DOI 10.1016/j.bbrc.2015.12.017; JONES GDD, 1994, INT J RADIAT BIOL, V66, P441, DOI 10.1080/09553009414551431; Kim MHY, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00122; KRISCH RE, 1991, RADIAT RES, V126, P251, DOI 10.2307/3577826; Markillie LM, 1999, J BACTERIOL, V181, P666, DOI 10.1128/JB.181.2.666-669.1999; Matrosova VY, 2017, STAND GENOMIC SCI, V12, DOI 10.1186/s40793-017-0258-y; Milligan JR, 2003, NUCLEIC ACIDS RES, V31, P6258, DOI 10.1093/nar/gkg816; Mironenko NV, 2000, ECOTOX ENVIRON SAFE, V45, P177, DOI 10.1006/eesa.1999.1848; MITCHELL JB, 1979, RADIAT RES, V79, P537, DOI 10.2307/3575179; Pacelli C, 2017, ASTROBIOLOGY, V17, P126, DOI 10.1089/ast.2015.1456; Perdrial N, 2015, J ENVIRON QUAL, V44, P945, DOI 10.2134/jeq2014.09.0388; Purdy A, 2005, J CELL SCI, V118, P3305, DOI 10.1242/jcs.02454; Rainey MD, 2008, ONCOGENE, V27, P896, DOI 10.1038/sj.onc.1210702; Sharma A, 2017, P NATL ACAD SCI USA, V114, pE9253, DOI 10.1073/pnas.1713608114; Sharma A, 2013, P NATL ACAD SCI USA, V110, P5945, DOI 10.1073/pnas.1303376110; Shuryak I, 2012, RADIAT RES, V178, P17, DOI 10.1667/RR2877.1; Shuryak I, 2010, RADIAT ENVIRON BIOPH, V49, P693, DOI 10.1007/s00411-010-0305-1; Shuryak I, 2009, J THEOR BIOL, V261, P305, DOI 10.1016/j.jtbi.2009.08.003; Singh VK, 2014, EXPERT OPIN THER PAT, V24, P1229, DOI 10.1517/13543776.2014.964684; Team RC, 2013, R LANG ENV STAT COMP; Tian B, 2004, LUMINESCENCE, V19, P78, DOI 10.1002/bio.761; Uhl L, 2015, HELIYON, V1, DOI 10.1016/j.heliyon.2015.e00049; Uhl L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159706; Valota A, 2003, INT J RADIAT BIOL, V79, P643, DOI 10.1080/09553000310001596977; Venkateswaran A, 2000, APPL ENVIRON MICROB, V66, P2620, DOI 10.1128/AEM.66.6.2620-2626.2000; Wenzl T, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-171; YI PN, 1993, RADIAT RES, V133, P163, DOI 10.2307/3578352	51	25	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189261	10.1371/journal.pone.0189261	http://dx.doi.org/10.1371/journal.pone.0189261			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261697	Green Published, gold, Green Submitted			2022-12-26	WOS:000418564200038
J	Bhusal, N; Sarial, AK; Sharma, P; Sareen, S				Bhusal, Nabin; Sarial, Ashok Kumar; Sharma, Pradeep; Sareen, Sindhu			Mapping QTLs for grain yield components in wheat under heat stress	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; HIGH-TEMPERATURE; WINTER-WHEAT; FILLING RATE; TOLERANCE; POPULATION; TRAITS; IMPROVEMENT; CULTIVARS; STAGE	The current perspective of increasing global temperature makes heat stress as a major threat to wheat production worldwide. In order to identify quantitative trait loci (QTLs) associated with heat tolerance, 251 recombinant inbred lines (RILs) derived from a cross between HD2808 (heat tolerant) and HUW510 (heat susceptible) were evaluated under timely sown (normal) and late sown (heat stress) conditions for two consecutive crop seasons; 2013-14 and 2014-15. Grain yield (GY) and its components namely, grain weight/spike (GWS), grain number/spike (GNS), thousand grain weight (TGW), grain filling rate (GFR) and grain filling duration (GFD) were recorded for both conditions and years. The data collected for both timely and late sown conditions and heat susceptibility index (HSI) of these traits were used as phenotypic data for QTL identification. The frequency distribution of HSI for all the studied traits was continuous during both the years and also included transgressive segregants. Composite interval mapping identified total 24 QTLs viz., 9 (timely sown traits), 6 (late sown traits) and 9 (HSI of traits) mapped on linkage groups 2A, 2B, and 6D during both the crop seasons 2013-14 and 2014-15. The QTLs were detected for GWS (6), GNS (6), GFR (4), TGW (3), GY (3) and GFD (2). The LOD score of identified QTLs varied from 3.03 (Qtgns.iiwbr-6D) to 21.01 (Qhsitgw.iiwbr-2A) during 201415, explaining 11.2 and 30.6% phenotypic variance, respectively. Maximum no of QTLs were detected in chromosome 2A followed by 6D and 2B. All the QTL detected under late sown and HSI traits were identified on chromosome 2A except for QTLs associated with GFD. Fifteen out of 17 QTL detected on chromosome 2A were clustered within the marker interval between gwm448 and wmc296 and showed tight linkage with gwm122 and these were localized in 49-52 cM region of Somers consensus map of chromosome 2A i.e. within 18-59.56 cM region of chromosome 2A where no QTL related to heat stress were reported earlier. Besides, three consistent QTLs, Qgws.iiwbr-2A, Qgns.iiwbr-2A and Qgns.iiwbr-2A were also detected in all the environments in this region. The nearest QTL detected in earlier studies, QFv/Fm.cgb-2A was approximately 6cM below the presently identified QTLs region, respectively Additionally, QTLs for physiological and phenological traits and plant height under late sown and HSI of these traits were also detected on chromosome 2A. QTL for HSI of plant height and physiological maturity were located in the same genomic region of chromosome 2Awhereas QTLs for physiological and phonological traits under late sown were located 8cM and 33.5 cM below the genomic location associated with grain traits, respectively in consensus map of Somers. This QTL hot-spot region with consistent QTLs could be used to improve heat tolerance after validation.	[Bhusal, Nabin] CCS Haryana Agr Univ, Dept Genet & Plant Breeding, Hisar, Haryana, India; [Sarial, Ashok Kumar] CCS Haryana Agr Univ, Coll Agr, Dept Genet & Plant Breeding, Campus Kaul, Kaithal, Haryana, India; [Sharma, Pradeep; Sareen, Sindhu] ICAR Indian Inst Wheat & Barley Res, Aggarsain Marg, Karnal, Haryana, India; [Sarial, Ashok Kumar] CSK Himachal Pradesh Krishi Vishvavidyalaya, Palampur, Himachal Prades, India	CCS Haryana Agricultural University; CCS Haryana Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research; Ch. Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya	Sareen, S (corresponding author), ICAR Indian Inst Wheat & Barley Res, Aggarsain Marg, Karnal, Haryana, India.	Sindhu.Sareen@icar.gov.in	Sareen, Sindhu/A-8465-2012; Sharma, Pradeep/N-2123-2016	Sareen, Sindhu/0000-0003-2944-0395; Sharma, Pradeep/0000-0003-2099-1959; Bhusal, Nabin/0000-0003-2330-0391	Indian Council of Agricultural Research, New Delhi under IIWBR Institute [CRSCDWRSIL201001400105]	Indian Council of Agricultural Research, New Delhi under IIWBR Institute	This work was supported by Indian Council of Agricultural Research, New Delhi under IIWBR Institute project no. CRSCDWRSIL201001400105.	Acuna-Galindo MA, 2015, CROP SCI, V55, P477, DOI 10.2135/cropsci2013.11.0793; [Anonymous], 2014, SAS I VERS 9 3; Azam FI, 2015, EUPHYTICA, V202, P245, DOI 10.1007/s10681-014-1283-1; Barakat MN, 2011, AUST J CROP SCI, V5, P104; Bennett D, 2012, THEOR APPL GENET, V125, P255, DOI 10.1007/s00122-012-1831-9; Butler EE, 2013, NAT CLIM CHANGE, V3, P68, DOI [10.1038/NCLIMATE1585, 10.1038/nclimate1585]; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/NCLIMATE2153, 10.1038/nclimate2153]; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Mason RE, 2010, EUPHYTICA, V174, P423, DOI 10.1007/s10681-010-0151-x; Farooq M, 2011, CRIT REV PLANT SCI, V30, P491, DOI 10.1080/07352689.2011.615687; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; FISCHER RA, 1985, J AGR SCI, V105, P447, DOI 10.1017/S0021859600056495; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; Garg Bharti, 2012, Physiology and Molecular Biology of Plants, V18, P217, DOI 10.1007/s12298-012-0117-7; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Hertel TW, 2010, GLOBAL ENVIRON CHANG, V20, P577, DOI 10.1016/j.gloenvcha.2010.07.001; *IRRI, 2007, CROPSTAT WIND VERS 7; Joshi AK, 2007, EUPHYTICA, V157, P431, DOI 10.1007/s10681-007-9385-7; Kato K, 2000, THEOR APPL GENET, V101, P1114, DOI 10.1007/s001220051587; Kirigwi FM, 2007, MOL BREEDING, V20, P401, DOI 10.1007/s11032-007-9100-3; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Landjeva S, 2010, EUPHYTICA, V171, P129, DOI 10.1007/s10681-009-0016-3; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lopes MS, 2012, FIELD CROP RES, V128, P129, DOI 10.1016/j.fcr.2011.12.017; Mason RE, 2013, EUPHYTICA, V194, P243, DOI 10.1007/s10681-013-0951-x; Mason RE, 2011, EUPHYTICA, V180, P181, DOI 10.1007/s10681-011-0349-6; Nevo E, 2002, POPULATION GENETICS, P1; Paliwal R, 2012, THEOR APPL GENET, V125, P561, DOI 10.1007/s00122-012-1853-3; Pradeep Sharma, 2014, Australian Journal of Crop Science, V8, P515; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Samra JS, 2005, HEAT WAVE MARCH 2004, P1; Sareen, 2016, ADV LIFE SCI, V5, P5021; Sareen S, 2012, CEREAL RES COMMUN, V40, P267, DOI 10.1556/CRC.40.2012.2.11; Sharma P, 2016, PROCEEDINGS OF THE ELEVENTH EUROPEAN CONFERENCE ON COMPUTER SYSTEMS, (EUROSYS 2016), DOI 10.1145/2901318.2901319; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Streck Nereu Augusto, 2005, Cienc. Rural, V35, P730, DOI 10.1590/S0103-84782005000300041; Pinto RS, 2010, THEOR APPL GENET, V121, P1001, DOI 10.1007/s00122-010-1351-4; TASHIRO T, 1989, ANN BOT-LONDON, V64, P59, DOI 10.1093/oxfordjournals.aob.a087808; Tiwari C, 2013, FIELD CROP RES, V154, P201, DOI 10.1016/j.fcr.2013.08.004; Vijayalakshmi K, 2010, MOL BREEDING, V26, P163, DOI 10.1007/s11032-009-9366-8; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang RX, 2009, THEOR APPL GENET, V118, P313, DOI 10.1007/s00122-008-0901-5; Wang S., 2010, WINDOWS QTL CARTOGRA; WARDLAW IF, 1989, AUST J AGR RES, V40, P15, DOI 10.1071/AR9890015; Yang J, 2002, EUPHYTICA, V126, P275, DOI 10.1023/A:1016350509689; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494	48	43	47	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189594	10.1371/journal.pone.0189594	http://dx.doi.org/10.1371/journal.pone.0189594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261718	Green Published, gold, Green Submitted			2022-12-26	WOS:000418554900023
J	Choudhary, D; Kumar, A; Magliery, TJ; Sotomayor, M				Choudhary, Deepanshu; Kumar, Anusha; Magliery, Thomas J.; Sotomayor, Marcos			Using thermal scanning assays to test protein-protein interactions of inner-ear cadherins	PLOS ONE			English	Article							ISOTHERMAL TITRATION CALORIMETRY; TIP-LINK INTEGRITY; SENSORY HAIR-CELLS; FLUORESCENCE POLARIZATION; MECHANICAL TRANSDUCTION; NONSYNDROMIC DEAFNESS; LIGAND INTERACTIONS; SCREENING METHODS; BINDING-AFFINITY; DRUG DISCOVERY	Protein-protein interactions play a crucial role in biological processes such as cell-cell adhesion, immune system-pathogen interactions, and sensory perception. Understanding the structural determinants of protein-protein complex formation and obtaining quantitative estimates of their dissociation constant (K-D) are essential for the study of these interactions and for the discovery of new therapeutics. At the same time, it is equally important to characterize protein-protein interactions in a high-throughput fashion. Here, we use a modified thermal scanning assay to test interactions of wild type (WT) and mutant variants of N-terminal fragments (EC1+2) of cadherin-23 and protocadherin-15, two proteins essential for innerear mechanotransduction. An environmentally sensitive fluorescent dye (SYPRO orange) is used to monitor melting temperature (T-m) shifts of protocadherin-15 EC1+2 (pcdh15) in the presence of increasing concentrations of cadherin-23 EC1+2 (cdh23). These T-m shifts are absent when we use proteins containing deafness-related missense mutations known to disrupt cdh23 binding to pcdh15, and are increased for some rationally designed mutants expected to enhance binding. In addition, surface plasmon resonance binding experiments were used to test if the Tm shifts correlated with changes in binding affinity. We used this approach to find a double mutation (cdh23(T15E)-pcdh15(G16D)) that enhances binding affinity of the cadherin complex by 1.98 kJ/mol, roughly two-fold that of the WT complex. We suggest that the thermal scanning methodology can be used in high-throughput format to quickly compare binding affinities (K-D from nM up to 100 mu M) for some heterodimeric protein complexes and to screen small molecule libraries to find protein-protein interaction inhibitors and enhancers.	[Choudhary, Deepanshu; Kumar, Anusha; Magliery, Thomas J.; Sotomayor, Marcos] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Sotomayor, M (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.	sotomayor.8@osu.edu	Choudhary, Deepanshu/ABB-8869-2020; Sotomayor, Marcos/T-2411-2019; Sotomayor, Marcos/J-4898-2012	Choudhary, Deepanshu/0000-0002-2912-1610; Sotomayor, Marcos/0000-0002-3333-1805; Sotomayor, Marcos/0000-0002-3333-1805	Ohio State University (OSU); National Institute on Deafness and Other Communications Disorders [NIH NIDCD K99/R00 DC012534]; NIH [GM083114];  [FR-2015-65794]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083114] Funding Source: NIH RePORTER	Ohio State University (OSU)(Ohio State University); National Institute on Deafness and Other Communications Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by The Ohio State University (OSU) and by the National Institute on Deafness and Other Communications Disorders (NIH NIDCD K99/R00 DC012534). A.K. was supported by an NIH R01 grant (GM083114 to T.J.M.). M.S. is an Alfred P. Sloan fellow (FR-2015-65794). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Y. Narui for providing the tag-free WT cdh23 construct. This work was supported by The Ohio State University (OSU) and by the National Institute on Deafness and Other Communications Disorders (NIH NIDCD K99/R00 DC012534). A.K. was supported by an NIH R01 grant (GM083114 to T.J.M.). M.S. is an Alfred P. Sloan fellow (FR-2015-65794). Molecular figures were prepared using VMD. Thermal scanning and SPR experiments were performed at the Plant-Microbe Genomics facility at OSU.	Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Ahmed ZM, 2008, HUM GENET, V124, P215, DOI 10.1007/s00439-008-0543-3; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Alagramam KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019183; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Astuto LM, 2002, AM J HUM GENET, V71, P262, DOI 10.1086/341558; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Crameri A, 1996, NAT MED, V2, P100, DOI 10.1038/nm0196-100; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; de Brouwer APM, 2003, HUM GENET, V112, P156, DOI 10.1007/s00439-002-0833-0; Der BS, 2012, J AM CHEM SOC, V134, P375, DOI 10.1021/ja208015j; Dukes MP, 2015, BIOPHYS J, V108, p212A, DOI 10.1016/j.bpj.2014.11.1171; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Geng RS, 2013, J NEUROSCI, V33, P4395, DOI 10.1523/JNEUROSCI.4514-12.2013; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Gorshkova II, 2008, LANGMUIR, V24, P11577, DOI 10.1021/la801186w; Hanes J, 1998, P NATL ACAD SCI USA, V95, P14130, DOI 10.1073/pnas.95.24.14130; Herling TW, 2016, BIOPHYS J, V110, P1957, DOI 10.1016/j.bpj.2016.03.038; Hirano S, 2012, PHYSIOL REV, V92, P597, DOI 10.1152/physrev.00014.2011; Ho CCM, 2015, J BIOL CHEM, V290, P12650, DOI 10.1074/jbc.M115.648220; Husbands JM, 1999, HEARING RES, V135, P135, DOI 10.1016/S0378-5955(99)00101-X; Indzhykulian AA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001583; Jaiganesh A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029280; Jameson DM, 2003, COMB CHEM HIGH T SCR, V6, P167, DOI 10.2174/138620703106298347; Joughin BA, 2005, PROTEIN SCI, V14, P1363, DOI 10.1110/ps.041283105; Kauth CW, 2006, J BIOL CHEM, V281, P31517, DOI 10.1074/jbc.M604641200; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kurian R, 2003, HEARING RES, V181, P40, DOI 10.1016/S0378-5955(03)00165-5; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; Lanvers-Kaminsky C, 2017, CLIN PHARM THER; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Layton CJ, 2011, PROTEIN SCI, V20, P1439, DOI 10.1002/pro.674; Layton CJ, 2010, BIOCHEMISTRY-US, V49, P10831, DOI 10.1021/bi101414z; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Leckband D, 2012, CURR OPIN CELL BIOL, V24, P620, DOI 10.1016/j.ceb.2012.05.014; Lelli A, 2010, J NEUROSCI, V30, P11259, DOI 10.1523/JNEUROSCI.1949-10.2010; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Magliery TJ, 2015, CURR OPIN STRUC BIOL, V33, P161, DOI 10.1016/j.sbi.2015.09.002; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Masi A, 2010, ADV EXP MED BIOL, V674, P33; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Mayer Chad L, 2009, BMC Res Notes, V2, P135, DOI 10.1186/1756-0500-2-135; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Orwig SD, 2014, ACS CHEM BIOL, V9, P517, DOI 10.1021/cb4007776; Owicki JC, 2000, J BIOMOL SCREEN, V5, P297, DOI 10.1177/108705710000500501; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Ptashne M, 2009, CURR BIOL, V19, pR234, DOI 10.1016/j.cub.2009.02.015; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Salgado EN, 2010, P NATL ACAD SCI USA, V107, P1827, DOI 10.1073/pnas.0906852107; Schacht J, 2012, ANAT REC, V295, P1837, DOI 10.1002/ar.22578; Sotomayor M, 2014, TRENDS CELL BIOL, P1; Sotomayor M, 2012, NATURE, V492, P128, DOI 10.1038/nature11590; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Steinberg TH, 1996, ANAL BIOCHEM, V239, P223, DOI 10.1006/abio.1996.0319; Steyger PS, 2003, JARO-J ASSOC RES OTO, V4, P565, DOI 10.1007/s10162-003-4002-5; Svitel J, 2003, BIOPHYS J, V84, P4062, DOI 10.1016/S0006-3495(03)75132-7; TAKANO K, 1995, J MOL BIOL, V254, P62, DOI 10.1006/jmbi.1995.0599; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Thomas AJ, 2013, J NEUROSCI, V33, P4405, DOI 10.1523/JNEUROSCI.3940-12.2013; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Willander M, 2009, METHODS MOL BIOL, V544, P201, DOI 10.1007/978-1-59745-483-4_14; Wong AG, 2016, PROTEIN SCI, V25, P1834, DOI 10.1002/pro.2992; Yeh AP, 2006, ACTA CRYSTALLOGR D, V62, P451, DOI 10.1107/S0907444906005233; Zhao YD, 1996, P NATL ACAD SCI USA, V93, P15469, DOI 10.1073/pnas.93.26.15469	70	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189546	10.1371/journal.pone.0189546	http://dx.doi.org/10.1371/journal.pone.0189546			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261728	Green Published, Green Submitted, gold			2022-12-26	WOS:000418554900022
J	Fan, HW; Pan, XC; Wang, RB; Sakagami, M				Fan, Hongwei; Pan, Xiaochuan; Wang, Rubin; Sakagami, Masamichi			Differences in reward processing between putative cell types in primate prefrontal cortex	PLOS ONE			English	Article							RAT FRONTAL-CORTEX; PYRAMIDAL NEURONS; WORKING-MEMORY; ELECTROPHYSIOLOGICAL CLASSES; NEOCORTICAL NEURONS; NONPYRAMIDAL CELLS; INHIBITORY NEURONS; EXPECTED REWARD; IN-VIVO; AREA V4	Single-unit studies in monkeys have demonstrated that neurons in the prefrontal cortex predict the reward type, reward amount or reward availability associated with a stimulus. To examine contributions of pyramidal cells and interneurons in reward processing, single-unit activity was extracellularly recorded in prefrontal cortices of four monkeys performing a reward prediction task. Based on their shapes of spike waveforms, prefrontal neurons were classified into broad-spike and narrow-spike units that represented putative pyramidal cells and interneurons, respectively. We mainly observed that narrow-spike neurons showed higher firing rates but less bursty discharges than did broad-spike neurons. Both narrow-spike and broad-spike cells selectively responded to the stimulus, reward and their interaction, and the proportions of each type of selective neurons were similar between the two cell classes. Moreover, the two types of cells displayed equal reliability of reward or stimulus discrimination. Furthermore, we found that broad-spike and narrow-spike cells showed distinct mechanisms for encoding reward or stimulus information. Broad-spike neurons raised their firing rate relative to the baseline rate to represent the preferred reward or stimulus information, whereas narrow-spike neurons inhibited their firing rate lower than the baseline rate to encode the non-preferred reward or stimulus information. Our results suggest that narrow-spike and broad-spike cells were equally involved in reward and stimulus processing in the prefrontal cortex. They utilized a binary strategy to complementarily represent reward or stimulus information, which was consistent with the task structure in which the monkeys were required to remember two reward conditions and two visual stimuli.	[Fan, Hongwei; Sakagami, Masamichi] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan; [Fan, Hongwei] Oracle China Software Syst Co Ltd, Beijing, Peoples R China; [Pan, Xiaochuan; Wang, Rubin] East China Univ Sci & Technol, Inst Cognit Neurodynam, Shanghai, Peoples R China	Oracle; East China University of Science & Technology	Pan, XC (corresponding author), East China Univ Sci & Technol, Inst Cognit Neurodynam, Shanghai, Peoples R China.	pxc@ecust.edu.cn		Pan, Xiaochuan/0000-0001-6605-1140	Strategic Research Program for Brain Sciences from the Japan Agency for Medical Research and Development (AMED); MEXT of Japan [4805]; National Natural Science Foundation of China [11232005, 11472104]; Shanghai Pujiang Program [13PJ1402000]; Oracle China; Grants-in-Aid for Scientific Research [16H06324] Funding Source: KAKEN	Strategic Research Program for Brain Sciences from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Oracle China; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Strategic Research Program for Brain Sciences from the Japan Agency for Medical Research and Development (AMED) to MS, a Grant-in-Aid for Scientific Research on Innovative Areas (4805) from MEXT of Japan to MS. It is supported by National Natural Science Foundation of China (No. 11232005, No. 11472104 to RW) and sponsored by Shanghai Pujiang Program (No. 13PJ1402000 to XP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Oracle (China) Software Systems Co., Ltd. (Oracle China) is not a funder of our study. Oracle China provided support in the form of salaries for authors [HWF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	[Anonymous], 1989, SIGNAL DETECTION THE; Ardid S, 2015, J NEUROSCI, V35, P2975, DOI 10.1523/JNEUROSCI.2700-14.2015; Cauli B, 1997, J NEUROSCI, V17, P3894; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Contreras D, 2004, NEURAL NETWORKS, V17, P633, DOI 10.1016/j.neunet.2004.04.003; Contreras D, 2003, J NEUROSCI, V23, P6936; Diester I, 2008, J NEUROSCI, V28, P7737, DOI 10.1523/JNEUROSCI.1347-08.2008; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hussar CR, 2009, NEURON, V64, P730, DOI 10.1016/j.neuron.2009.11.018; HUSSAR CR, 2012, NEU ROSCI, V2761, P5135, DOI DOI 10.1523/NEUROSCI.5135-11.2012; Insel N, 2015, CEREB CORTEX, V25, P2631, DOI 10.1093/cercor/bhu062; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jacob SN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13218; Karnani MM, 2014, CURR OPIN NEUROBIOL, V26, P96, DOI 10.1016/j.conb.2013.12.015; Kaskan PM, 2016, CEREB CORTEX; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Kriegel HP, 2017, KNOWL INF SYST, V52, P341, DOI 10.1007/s10115-016-1004-2; Krimer LS, 2005, J NEUROPHYSIOL, V94, P3009, DOI 10.1152/jn.00156.2005; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Lee AT, 2014, NEURON, V81, P61, DOI 10.1016/j.neuron.2013.10.031; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mateo C, 2011, CURR BIOL, V21, P1593, DOI 10.1016/j.cub.2011.08.028; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Melchitzky DS, 2001, J COMP NEUROL, V430, P209, DOI 10.1002/1096-9861(20010205)430:2<209::AID-CNE1026>3.0.CO;2-#; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Nowak LG, 2008, CEREB CORTEX, V18, P1058, DOI 10.1093/cercor/bhm137; OOSTENVELD R, 2011, COMPUT INTEL NEUROSC; Pan XC, 2008, NAT NEUROSCI, V11, P703, DOI 10.1038/nn.2128; Pan XC, 2014, J NEUROSCI, V34, P1380, DOI 10.1523/JNEUROSCI.2263-13.2014; Pinto L, 2015, NEURON, V87, P437, DOI 10.1016/j.neuron.2015.06.021; Povysheva NV, 2006, CEREB CORTEX, V16, P541, DOI 10.1093/cercor/bhj002; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; Rao SG, 1999, J NEUROPHYSIOL, V81, P1903, DOI 10.1152/jn.1999.81.4.1903; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Sakagami M, 2007, ANN NY ACAD SCI, V1104, P89, DOI 10.1196/annals.1390.010; Shinomoto S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000433; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Tanaka S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00995; Tepper JM, 2008, BRAIN RES REV, V58, P272, DOI 10.1016/j.brainresrev.2007.10.008; Thiele A, 2016, J NEUROSCI, V36, P7601, DOI 10.1523/JNEUROSCI.0872-16.2016; Vinck M, 2013, NEURON, V80, P1077, DOI 10.1016/j.neuron.2013.08.019; Wang XJ, 2004, P NATL ACAD SCI USA, V101, P1368, DOI 10.1073/pnas.0305337101; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; WILSON FAW, 1994, P NATL ACAD SCI USA, V91, P4009, DOI 10.1073/pnas.91.9.4009; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954	52	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189771	10.1371/journal.pone.0189771	http://dx.doi.org/10.1371/journal.pone.0189771			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261734	Green Submitted, gold, Green Published			2022-12-26	WOS:000418554900028
J	Mumba, C; Skjerve, E; Rich, M; Rich, KM				Mumba, Chisoni; Skjerve, Eystein; Rich, Magda; Rich, Karl M.			Application of system dynamics and participatory spatial group model building in animal health: A case study of East Coast Fever interventions in Lundazi and Monze districts of Zambia	PLOS ONE			English	Article							CENTRAL PROVINCE; THEILERIA-PARVA; CONTROL STRATEGIES; SANGA CATTLE; DISEASES; EPIDEMIOLOGY; ECONOMICS; IMPACTS; AFRICA	East Coast Fever (ECF) is the most economically important production disease among traditional beef cattle farmers in Zambia. Despite the disease control efforts by the government, donors, and farmers, ECF cases are increasing. Why does ECF oscillate over time? Can alternative approaches such as systems thinking contribute solutions to the complex ECF problem, avoid unintended consequences, and achieve sustainable results? To answer these research questions and inform the design and implementation of ECF interventions, we qualitatively investigated the influence of dynamic socio-economic, cultural, and ecological factors. We used system dynamics modelling to specify these dynamics qualitatively, and an innovative participatory framework called spatial group model building (SGMB). SGMB uses participatory geographical information system (GIS) concepts and techniques to capture the role of spatial phenomenon in the context of complex systems, allowing stakeholders to identify spatial phenomenon directly on physical maps and integrate such information in model development. Our SGMB process convened focus groups of beef value chain stakeholders in two distinct production systems. The focus groups helped to jointly construct a series of interrelated system dynamics models that described ECF in a broader systems context. Thus, a complementary objective of this study was to demonstrate the applicability of system dynamics modelling and SGMB in animal health. The SGMB process revealed policy leverage points in the beef cattle value chain that could be targeted to improve ECF control. For example, policies that develop sustainable and stable cattle markets and improve household income availability may have positive feedback effects on investment in animal health. The results obtained from a SGMB process also demonstrated that a "one-size-fits-all" approach may not be equally effective in policing ECF in different agro-ecological zones due to the complex interactions of socio-ecological context with important, and often ignored, spatial patterns.	[Mumba, Chisoni] Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka, Zambia; [Mumba, Chisoni; Skjerve, Eystein] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Sect Epidemiol & Stat, Epictr, Oslo, Norway; [Rich, Magda] Univ Brighton, Coll Arts & Humanities, Grand Parade, England; [Rich, Karl M.] ILRI, East & Southeast Asia Reg Off, Hanoi, Vietnam	University of Zambia; Norwegian University of Life Sciences; University of Brighton	Mumba, C (corresponding author), Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka, Zambia.; Mumba, C (corresponding author), Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Sect Epidemiol & Stat, Epictr, Oslo, Norway.	sulemumba@yahoo.com	Skjerve, Eystein/D-7491-2014; Mumba, Chisoni/J-1497-2019	Skjerve, Eystein/0000-0001-9652-6952; Mumba, Chisoni/0000-0002-4662-0876; Rich, Karl/0000-0002-5581-9553	Capacity Building in Zoonotic Diseases Management [UGA/13003/1]	Capacity Building in Zoonotic Diseases Management	This work was supported by Capacity Building in Zoonotic Diseases Management using the Integrated Approach to Ecosystems Health at Human-Livestock-Wildlife Interface in Eastern and Southern Africa (NORHED CAPAZOMANINTECO, Grant Number UGA/13003/1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DF, 2007, J OPER RES SOC, V58, P691, DOI 10.1057/palgrave.jors.2602339; Andersen DF, 1997, SYST DYNAM REV, V13, P107, DOI 10.1002/(SICI)1099-1727(199722)13:2<107::AID-SDR120>3.3.CO;2-Z; Banda Y, 2016, SAGE OPEN, P6; Billiouw M, 2002, VET PARASITOL, V107, P51, DOI 10.1016/S0304-4017(02)00089-4; Center Statistical Office Zambia, 2010, 2010 CENS POP HOUS; D'Haese L, 1999, TROP MED INT HEALTH, P4; Earle L., 1999, S PACIFIC J PSYCHOL, V11, P1, DOI [10.1017/S0257543400000572, DOI 10.1017/S0257543400000572]; Fandamu P, 2005, INT J PARASITOL, V35, P391, DOI 10.1016/j.ijpara.2004.12.011; Gilioli G, 2009, ECOL MODEL, V220, P1652, DOI 10.1016/j.ecolmodel.2009.03.017; Holt H, 2016, BASELINE STUDY INTEG; HOVMAND PETER S., 2014, COMMUNITY BASED SYST; Kalinda T, 2010, CHARACTERIZATION MAI; Kim DH, 1992, SYSTEM ARCHETYPES; Lie H., 2016, International Journal on Food System Dynamics, V7, P328; Lie H, 2017, DEV PRACT, V27, P785, DOI 10.1080/09614524.2017.1343800; Luna-Reyes LF, 2013, INT C SYST DYN SOC, P1; Luna-Reyes LF, 2006, SYST DYNAM REV, V22, P291, DOI 10.1002/sdr.349; Makala LH, 2003, VET RES, V34, P27, DOI 10.1051/vetres:2002056; Makungu C, 2014, PREV VET MED, V116, P63, DOI 10.1016/j.prevetmed.2014.05.006; Marcotty T, 2002, VET PARASITOL, V110, P45, DOI 10.1016/S0304-4017(02)00314-X; McRoberts KC, 2013, INT FOOD AGRIBUS MAN, P16; Minjauw B, 1999, PREV VET MED, V38, P35, DOI 10.1016/S0167-5877(98)00128-7; Minjauw B, 1997, EXP APPL ACAROL, V21, P715, DOI 10.1023/A:1018417004323; Mubamba C, 2011, PREV VET MED, V101, P163, DOI 10.1016/j.prevetmed.2011.05.013; MUKHEBI AW, 1992, PREV VET MED, V12, P73, DOI 10.1016/0167-5877(92)90070-V; Muleya W, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-255; Mulumba M, 2000, TROP ANIM HEALTH PRO, V32, P303, DOI 10.1023/A:1005217123793; Mumba C, 2017, TROP ANIM HLTH PROD, P1; Munang'andu HM, 2009, VET PARASITOL, V166, P163, DOI 10.1016/j.vetpar.2009.08.010; NAMBOTA A, 1994, JPN J VET RES, V42, P1; Olwoch JM, 2008, J ARID ENVIRON, V72, P108, DOI 10.1016/j.jaridenv.2007.04.003; Penne K, 1999, TROP MED INT HEALTH, V4, pA58, DOI 10.1046/j.1365-3156.1999.00452.x; Rich K., 2013, USING SYSTEM DYNAMIC; Rich KM, 2011, PREV VET MED, V101, P133, DOI 10.1016/j.prevetmed.2010.08.002; Rich KM, 2010, AM J TROP MED HYG, V83, P52, DOI 10.4269/ajtmh.2010.09-0291; Rich KM, 2016, AGR SYST; Rich KM, 2007, AM AGR EC ASS M PORT, P35; Richardson GP, 2013, SYST DYNAM REV, V29, P42, DOI 10.1002/sdr.1487; Scott RJ, 2016, EUR J OPER RES, V249, P908, DOI 10.1016/j.ejor.2015.06.078; Shi RQ, 2009, APPL MATH COMPUT, V212, P305, DOI 10.1016/j.amc.2009.02.017; Shimumbo Nalubamba K, 2015, VET MED RES, V2, P1; Simuunza M, 2011, VET PARASITOL, V175, P331, DOI 10.1016/j.vetpar.2010.09.027; Sitali DC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005580; Sterman J.D., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Stroh DP, 2015, SYSTEMS THINKING SOC; Vennix J.A., 1996, ENCY LIFE SUPPORT SY, V2, P97	46	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189878	10.1371/journal.pone.0189878	http://dx.doi.org/10.1371/journal.pone.0189878			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ2KG	29244862	Green Submitted, gold, Green Published			2022-12-26	WOS:000418184700069
J	Uto, Y; Kuroshima, S; Nakano, T; Ishimoto, T; Inaba, N; Uchida, Y; Sawase, T				Uto, Yusuke; Kuroshima, Shinichiro; Nakano, Takayoshi; Ishimoto, Takuya; Inaba, Nao; Uchida, Yusuke; Sawase, Takashi			Effects of mechanical repetitive load on bone quality around implants in rat maxillae	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; TITANIUM IMPLANTS; CORTICAL BONE; III COLLAGEN; GROWTH; CELLS; DIFFERENTIATION; MICROTHREAD; RESORPTION; ALIGNMENT	Greater understanding and acceptance of the new concept "bone quality", which was proposed by the National Institutes of Health and is based on bone cells and collagen fibers, are required. The novel protein Semaphorin3A (Sema3A) is associated with osteoprotection by regulating bone cells. The aims of this study were to investigate the effects of mechanical loads on Sema3A production and bone quality based on bone cells and collagen fibers around implants in rat maxillae. Grade IV-titanium threaded implants were placed at 4 weeks post-extraction in maxillary first molars. Implants received mechanical loads (10 N, 3 Hz for 1800 cycles, 2 days/week) for 5 weeks from 3 weeks post-implant placement to minimize the effects of wound healing processes by implant placement. Bone structures, bone mineral density (BMD), Sema3A production and bone quality based on bone cells and collagen fibers were analyzed using microcomputed tomography, histomorphometry, immunohistomorphometry, polarized light microscopy and birefringence measurement system inside of the first and second thread (designated as thread A and B, respectively), as mechanical stresses are concentrated and differently distributed on the first two threads from the implant neck. Mechanical load significantly increased BMD, but not bone volume around implants. Inside thread B, but not thread A, mechanical load significantly accelerated Sema3A production with increased number of osteoblasts and osteocytes, and enhanced production of both type I and III collagen. Moreover, mechanical load also significantly induced preferential alignment of collagen fibers in the lower flank of thread B. These data demonstrate that mechanical load has different effects on Sema3A production and bone quality based on bone cells and collagen fibers between the inside threads of A and B. Mechanical load-induced Sema3A production may be differentially regulated by the type of bone structure or distinct stress distribution, resulting in control of bone quality around implants in jaw bones.	[Uto, Yusuke; Kuroshima, Shinichiro; Inaba, Nao; Uchida, Yusuke; Sawase, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Appl Prosthodont, Nagasaki, Japan; [Nakano, Takayoshi; Ishimoto, Takuya] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka, Japan	Nagasaki University; Osaka University	Kuroshima, S (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Appl Prosthodont, Nagasaki, Japan.	kuroshima@nagasaki-u.ac.jp	NAKANO, Takayoshi/F-8140-2011	Ishimoto, Takuya/0000-0003-0081-0591; Nakano, Takayoshi/0000-0001-8052-1698; Kuroshima, Shinichiro/0000-0001-9891-9987	JSPS KAKENHI [25870523, 15K11258]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (grant nos. 25870523 and 15K11258 to TS).	Assenza Bartolomeo, 2003, J Oral Implantol, V29, P1, DOI 10.1563/1548-1336(2003)029<0001:OAALAU>2.3.CO;2; Bagi CM, 2011, COMPARATIVE MED, V61, P76; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Berglundh T, 2005, J CLIN PERIODONTOL, V32, P925, DOI 10.1111/j.1600-051X.2005.00747.X; Catalano A, 2010, J IMMUNOL, V185, P6373, DOI 10.4049/jimmunol.0903527; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; DAUNTON NG, 1973, J COMP PHYSIOL PSYCH, V85, P367, DOI 10.1037/h0035031; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Fernandes H, 2009, TISSUE ENG PT A, V15, P3857, DOI 10.1089/ten.tea.2009.0011; Goto S, 2015, ANGLE ORTHOD, V85, P969, DOI 10.2319/102214-765.1; Haga M, 2009, ANAT REC, V292, P38, DOI 10.1002/ar.20748; Hall J, 2005, CLIN IMPLANT DENT R, V7, pS76, DOI 10.1111/j.1708-8208.2005.tb00078.x; Hansson S, 2003, J BIOMECH, V36, P1247, DOI 10.1016/S0021-9290(03)00164-7; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Holmes D C, 1997, J Oral Implantol, V23, P104; Hudieb MI, 2011, J PERIODONTOL, V82, P1061, DOI 10.1902/jop.2010.100237; Kitamura E, 2005, J ORAL REHABIL, V32, P279, DOI 10.1111/j.1365-2842.2004.01413.x; Kitamura E, 2004, CLIN ORAL IMPLAN RES, V15, P401, DOI 10.1111/j.1600-0501.2004.01022.x; Klein-Nulend J, 2012, EUR CELLS MATER, V24, P278, DOI 10.22203/eCM.v024a20; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Kuroshima S, 2013, J DENT RES, V92, P553, DOI 10.1177/0022034513487558; Kuroshima S, 2017, J PROSTHODONT RES; Kuroshima S, 2017, ACTA BIOMATER, V48, P433, DOI 10.1016/j.actbio.2016.11.021; Kuroshima S, 2015, CLIN IMPLANT DENT R, V17, pE699, DOI 10.1111/cid.12318; Kuroshima S, 2013, BONE, V56, P101, DOI 10.1016/j.bone.2013.05.013; Lee DW, 2007, CLIN ORAL IMPLAN RES, V18, P465, DOI 10.1111/j.1600-0501.2007.01302.x; Liu S, 2012, J MICROSC-OXFORD, V245, P34, DOI 10.1111/j.1365-2818.2011.03541.x; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Liu ZJ, 1998, J DENT RES, V77, P366, DOI 10.1177/00220345980770020501; Lu YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144744; Maehata Y, 2007, MATRIX BIOL, V26, P371, DOI 10.1016/j.matbio.2007.01.005; Matsugaki A, 2015, J BIOMED MATER RES A, V103, P489, DOI 10.1002/jbm.a.35189; Matsugaki A, 2013, ACTA BIOMATER, V9, P7227, DOI 10.1016/j.actbio.2013.03.015; Miyamoto I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073897; Nakano T, 2002, BONE, V31, P479, DOI 10.1016/S8756-3282(02)00850-5; Negishi-Koga Takako, 2012, Bonekey Rep, V1, P183, DOI 10.1038/bonekey.2012.183; Noyama Y, 2013, BONE, V52, P659, DOI 10.1016/j.bone.2012.11.005; Robling AG, 2009, CRIT REV EUKAR GENE, V19, P319, DOI 10.1615/CritRevEukarGeneExpr.v19.i4.50; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; RUSE ND, 1995, J BIOMED MATER RES, V29, P411, DOI 10.1002/jbm.820290316; Sasaki M, 2015, J BIOMECH, V48, P4130, DOI 10.1016/j.jbiomech.2015.10.025; Sekita A, 2016, J STRUCT BIOL; Slaets E, 2007, J PERIODONTOL, V78, P510, DOI 10.1902/jop.2007.060183; Slaets E, 2006, J PERIODONTOL, V77, P1015, DOI 10.1902/jop.2006.050196; Smith N, 1974, Aust Dent J, V19, P250; VIGNERY A, 1980, ANAT REC, V196, P191, DOI 10.1002/ar.1091960210; Zhang M, 2017, IN VIVO, V31, P87, DOI 10.21873/invivo.11029	48	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189893	10.1371/journal.pone.0189893	http://dx.doi.org/10.1371/journal.pone.0189893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244883	gold, Green Published, Green Submitted			2022-12-26	WOS:000418184700070
J	Kumei, S; Yuhki, KI; Kojima, F; Kashiwagi, H; Imamichi, Y; Okumura, T; Narumiya, S; Ushikubi, F				Kumei, Shima; Yuhki, Koh-Ichi; Kojima, Fumiaki; Kashiwagi, Hitoshi; Imamichi, Yoshitaka; Okumura, Toshikatsu; Narumiya, Shuh; Ushikubi, Fumitaka			Prostaglandin I-2 suppresses the development of diet-induced nonalcoholic steatohepatitis in mice	FASEB JOURNAL			English	Article						Kupffer cell; NASH; oxidative stress	FATTY LIVER-DISEASE; SINUSOIDAL ENDOTHELIAL-CELLS; PROSTANOID RECEPTORS; OXIDATIVE STRESS; COX-2 INDUCTION; KUPFFER CELLS; MOUSE MODEL; PROSTACYCLIN; LACKING; IRON	Nonalcoholic steatohepatitis (NASH) is a hepatic manifestation of metabolic syndrome. Although the prostaglandin (PG)I2 receptor IP is expressed broadly in the liver, the role of PGI2-IP signaling in the development of NASH remains to be determined. Here, we investigated the role of the PGI2-IP system in the development of steatohepatitis using mice lacking the PGI2 receptor IP [IP-knockout (IP-KO) mice] and beraprost (BPS), a specific IP agonist. IP-KO and wild-type (WT) mice were fed a methionine-and choline-deficient diet (MCDD) for 2, 5, or 10 wk. BPS was administered orally to mice every day during the experimental periods. The effect of BPS on the expression of chemokine and inflammatory cytokines was examined also in cultured Kupffer cells. WT mice fed MCDD developed steatohepatitis at 10 wk. IP-KO mice developed steatohepatitis at 5 wk with augmented histologic derangements accompanied by increased hepatic monocyte chemoattractant protein-1 (MCP-1) and TNF-a concentrations. After 10 wk of MCDD, IP-KO mice had greater hepatic iron deposition with prominent oxidative stress, resulting in hepatocyte damage. In WT mice, BPS improved histologic and biochemical parameters of steatohe-patitis, accompanied by reduced hepatic concentration of MCP-1 and TNF-alpha. Accordingly, BPS suppressed the LPS-stimulated Mcp-1 and Tnf-a mRNA expression in cultured Kupffer cells prepared from WT mice. PGI2-IP signaling plays a crucial role in the development and progression of steatohepatitis by modulating the inflammatory response, leading to augmented oxidative stress. We suggest that the PGI2-IP system is an attractive therapeutic target for treating patients with NASH.	[Kumei, Shima; Yuhki, Koh-Ichi; Kojima, Fumiaki; Kashiwagi, Hitoshi; Imamichi, Yoshitaka; Ushikubi, Fumitaka] Asahikawa Med Univ, Dept Pharmacol, Asahikawa, Hokkaido, Japan; [Kumei, Shima; Okumura, Toshikatsu] Asahikawa Med Univ, Dept Gen Med, Asahikawa, Hokkaido, Japan; [Narumiya, Shuh] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto, Japan	Asahikawa Medical College; Asahikawa Medical College; Kyoto University	Ushikubi, F (corresponding author), Asahikawa Med Univ, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	ushikubi@asahikawa-med.ac.jp		Kashiwagi, Hitoshi/0000-0001-6385-9988; Okumura, Toshikatsu/0000-0003-1810-007X	Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Agency [15gm0410006h0106]; Smoking Research Foundation	Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Smoking Research Foundation	The authors thank Y. Watanabe and T. Yokoyama for help in breeding and maintenance of mice; Y. Tomonari, T. Ohkubo, N. Niizeki, and T. Ito for assistance with the experiments; and Y. Takashima for secretarial help (all from Asahikawa Medical University). This work was supported by the Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Agency (Grant 15gm0410006h0106), and by a grant from the Smoking Research Foundation. The authors declare no conflicts of interest.	AKIBA T, 1986, BRIT J PHARMACOL, V89, P703, DOI 10.1111/j.1476-5381.1986.tb11174.x; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; BIRMELIN M, 1984, EUR J BIOCHEM, V142, P219, DOI 10.1111/j.1432-1033.1984.tb08274.x; BUNTING S, 1976, PROSTAG OTH LIPID M, V12, P897, DOI 10.1016/0090-6980(76)90125-8; Corbin KD, 2012, CURR OPIN GASTROEN, V28, P159, DOI 10.1097/MOG.0b013e32834e7b4b; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; dela Pena A, 2007, J HEPATOL, V46, P304, DOI 10.1016/j.jhep.2006.08.025; Dorris SL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/926968; EYHORN S, 1988, J HEPATOL, V6, P23, DOI 10.1016/S0168-8278(88)80459-8; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fennekohl A, 1999, J HEPATOL, V30, P38, DOI 10.1016/S0168-8278(99)80006-3; Fujino T, 2004, J CLIN INVEST, V114, P805, DOI 10.1172/JCI200421382; Giannitrapani L, 2009, ANN NY ACAD SCI, V1155, P293, DOI 10.1111/j.1749-6632.2009.03698.x; GRUNDMANN HJ, 1992, J INFECT DIS, V165, P501, DOI 10.1093/infdis/165.3.501; Hara A, 2005, CIRCULATION, V112, P84, DOI 10.1161/CIRCULATIONAHA.104.527077; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Johnston DE, 1996, HEPATOLOGY, V24, P677, DOI 10.1002/hep.510240334; KAWADA N, 1993, EUR J BIOCHEM, V213, P815, DOI 10.1111/j.1432-1033.1993.tb17824.x; Kimura M, 2009, J PHARMACOL SCI, V109, P618, DOI 10.1254/jphs.08338FP; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Koek GH, 2011, CLIN CHIM ACTA, V412, P1297, DOI 10.1016/j.cca.2011.04.013; Leclercq IA, 2004, J HEPATOL, V41, P926, DOI 10.1016/j.jhep.2004.08.010; Lee FP, 2010, J CELL PHYSIOL, V224, P837, DOI 10.1002/jcp.22192; LEE SH, 1985, J EXP MED, V161, P475, DOI 10.1084/jem.161.3.475; Lima-Cabello E, 2011, CLIN SCI, V120, P239, DOI 10.1042/CS20100387; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; MONCADA S, 1977, LANCET, V1, P18; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Nakagawa N, 2012, KIDNEY INT, V82, P158, DOI 10.1038/ki.2012.115; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nelson J, 2011, BBA-BIOMEMBRANES, V1808, P1913, DOI 10.1016/j.bbamem.2011.04.003; Perez S, 2004, MOL CELL BIOCHEM, V266, P183, DOI 10.1023/B:MCBI.0000049159.09349.02; Pietrangelo A, 2009, J HEPATOL, V50, P249, DOI 10.1016/j.jhep.2008.11.011; Requena JR, 1996, NEPHROL DIAL TRANSPL, V11, P48; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Sumida Y, 2006, HEPATOL RES, V36, P315, DOI 10.1016/j.hepres.2006.08.003; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; TOMASI V, 1978, NATURE, V273, P670, DOI 10.1038/273670a0; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Valenti L, 2010, GASTROENTEROLOGY, V138, P905, DOI 10.1053/j.gastro.2009.11.013; Velayudham A, 2009, HEPATOLOGY, V49, P989, DOI 10.1002/hep.22711; VICTOROV AV, 1995, BIOCHEM BIOPH RES CO, V215, P691, DOI 10.1006/bbrc.1995.2519; WALKER RJ, 1971, GUT, V12, P1011, DOI 10.1136/gut.12.12.1011; Xiao CY, 2001, CIRCULATION, V104, P2210, DOI 10.1161/hc4301.098058; Yeh CH, 2011, J INVEST MED, V59, P1109, DOI 10.2310/JIM.0b013e3182281f62; Yin H, 2007, HEPATOLOGY, V45, P159, DOI 10.1002/hep.21493; Yoneda M, 2010, DIGEST DIS SCI, V55, P808, DOI 10.1007/s10620-009-0771-y; Yu J, 2006, HEPATOLOGY, V43, P826, DOI 10.1002/hep.21108	56	6	6	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2354	2365		10.1096/fj.20170059OR	http://dx.doi.org/10.1096/fj.20170059OR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29247122				2022-12-26	WOS:000432528000005
J	Tanaka, T; Zhou, Y; Ozawa, T; Okizono, R; Banba, A; Yamamura, T; Oga, E; Muraguchi, A; Sakurai, H				Tanaka, Tomohiro; Zhou, Yue; Ozawa, Tatsuhiko; Okizono, Ryuya; Banba, Ayako; Yamamura, Tomohiro; Oga, Eiji; Muraguchi, Atsushi; Sakurai, Hiroaki			Ligand-activated epidermal growth factor receptor (EGFR) signaling governs endocytic trafficking of unliganded receptor monomers by non-canonical phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; DOWN-REGULATION; FACTOR-ALPHA; CANCER; STRESS; DOMAIN; INTERNALIZATION; UBIQUITINATION; SUPPRESSION; MECHANISM	The canonical description of transmembrane receptor function is initial binding of ligand, followed by initiation of intracellular signaling and then internalization en route to degradation or recycling to the cell surface. It is known that low concentrations of extracellular ligand lead to a higher proportion of receptor that is recycled and that non-canonical mechanisms of receptor activation, including phosphorylation by the kinase p38, can induce internalization and recycling. However, no connections have been made between these pathways; i.e. it has yet to be established what happens to unbound receptors following stimulation with ligand. Here we demonstrate that a minimal level of activation of epidermal growth factor receptor (EGFR) tyrosine kinase by low levels of ligand is sufficient to fully activate downstream mitogen-activated protein kinase (MAPK) pathways, with most of the remaining unbound EGFR molecules being efficiently phosphorylated at intracellular serine/threonine residues by activated mitogen-activated protein kinase. This non-canonical, p38-mediated phosphorylation of the C-tail of EGFR, near Ser-1015, induces the clathrin-mediated endocytosis of the unliganded EGFR monomers, which occurs slightly later than the canonical endocytosis of ligand-bound EGFR dimers via tyrosine autophosphorylation. EGFR endocytosed via the non-canonical pathway is largely recycled back to the plasma membrane as functional receptors, whereas p38-independent populations are mainly sorted for lysosomal degradation. Moreover, ligand concentrations balance these endocytic trafficking pathways. These results demonstrate that ligand-activated EGFR signaling controls unliganded receptors through feedback phosphorylation, identifying a dual-mode regulation of the endocytic trafficking dynamics of EGFR.	[Tanaka, Tomohiro; Zhou, Yue; Okizono, Ryuya; Banba, Ayako; Yamamura, Tomohiro; Oga, Eiji; Muraguchi, Atsushi; Sakurai, Hiroaki] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Canc Cell Biol, 2630 Sugitani, Toyama 9300194, Japan; [Ozawa, Tatsuhiko; Muraguchi, Atsushi] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Immunol, Toyama 9300194, Japan; [Zhou, Yue] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, MOE Key Lab Standardizat Chinese Med, Shanghai 201203, Peoples R China; [Zhou, Yue] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai Key Lab Compound Chinese Med, Shanghai 201203, Peoples R China	University of Toyama; University of Toyama; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Sakurai, H (corresponding author), Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Canc Cell Biol, 2630 Sugitani, Toyama 9300194, Japan.	hsakurai@pha.u-toyama.ac.jp	Sakurai, Hiroaki/AAE-4294-2019	Ozawa, Tatsuhiko/0000-0002-3112-452X; Zhou, Yue/0000-0002-1335-5703; Sakurai, Hiroaki/0000-0003-0657-9570	JSPS KAKENHI [JP16H04694]; JSPS; Japan Agency for Medical Research and Development	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by JSPS KAKENHI Grant JP16H04694, JSPS Core-to-Core Program, B. Asia-Africa Science Platforms, and the Platform Project for Supporting Drug Discovery and Life Science Research from the Japan Agency for Medical Research and Development. The authors declare that they have no conflicts of interest with the contents of this article.	Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; Francavilla C, 2016, NAT STRUCT MOL BIOL, V23, P608, DOI 10.1038/nsmb.3218; FRENCH AR, 1995, J BIOL CHEM, V270, P4334, DOI 10.1074/jbc.270.9.4334; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Henriksen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058148; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Nishimura M, 2009, MOL CELL BIOL, V29, P5529, DOI 10.1128/MCB.00375-09; Ozawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052383; Parachoniak CA, 2012, TRENDS CELL BIOL, V22, P231, DOI 10.1016/j.tcb.2012.02.002; Refaat A, 2015, BIOCHEM BIOPH RES CO, V458, P856, DOI 10.1016/j.bbrc.2015.02.044; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Sato K, 2013, CANCER SCI, V104, P1315, DOI 10.1111/cas.12225; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sigismund S, 2013, EMBO J, V32, P2140, DOI 10.1038/emboj.2013.149; Singhirunnusorn P, 2007, J BIOL CHEM, V282, P12698, DOI 10.1074/jbc.M608723200; Sun QX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012819; Tan XJ, 2016, TRENDS CELL BIOL, V26, P352, DOI 10.1016/j.tcb.2015.12.006; Tan XJ, 2015, CELL, V160, P145, DOI 10.1016/j.cell.2014.12.006; THEROUX SJ, 1992, J BIOL CHEM, V267, P16620; Tomas A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8324; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Tong JF, 2014, MOL CELL PROTEOMICS, V13, P1644, DOI 10.1074/mcp.M114.038596; Uyemura T, 2005, BIOPHYS J, V88, P3720, DOI 10.1529/biophysj.104.053330; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Wang Q, 2007, EXP CELL RES, V313, P3349, DOI 10.1016/j.yexcr.2007.06.014; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; WILEY HS, 1991, J BIOL CHEM, V266, P11083; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zhou Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8679; Zhou Y, 2014, FEBS LETT, V588, P131, DOI 10.1016/j.febslet.2013.11.020; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	44	27	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2288	2301		10.1074/jbc.M117.811299	http://dx.doi.org/10.1074/jbc.M117.811299			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29255092	Green Published, hybrid			2022-12-26	WOS:000425308300005
J	Wang, Y; Deng, GG; Davies, KP				Wang, Yi; Deng, Gary G.; Davies, Kelvin P.			Urothelial MaxiK-activity regulates mucosal and detrusor metabolism	PLOS ONE			English	Article							BLADDER SMOOTH-MUSCLE; BK CHANNEL; INTERACTOME REVEALS; INTERSTITIAL-CELLS; OVERACTIVE BLADDER; URINARY; CONTRACTILITY; CALCIUM; MITOCHONDRIA	There is increasing evidence for a role of MaxiK potassium channel-activity in regulating the metabolism and intracellular signaling of non-contractile bladder mucosal tissues. At present however no studies have determined the impact of urothelial MaxiK-activity on overall bladder metabolism. To address this we have investigated the effect of bladder lumen instillation of the MaxiK inhibitor, iberiotoxin (IBTX), on mucosal and detrusor metabolism using metabolomics. Since IBTX does not cross plasma membranes, when instilled into the bladder lumen it would only effect urothelially expressed MaxiK-activity. Surprisingly IBTX treatment caused more effect on the metabolome of the detrusor than mucosa (the levels of 17% of detected detrusor metabolites were changed in comparison to 6% of metabolites in mucosal tissue following IBTX treatment). In mucosal tissues, the major effects can be linked to mitochondrial-associated metabolism whereas in detrusor there were additional changes in energy generating pathways (such as glycolysis and the TCA cycle). In the detrusor, changes in metabolism are potentially a result of IBTX effecting MaxiK-linked signaling pathways between the mucosa and detrusor, secondary to changes in physiological activity or a combination of both. Overall we demonstrate that urothelial MaxiK-activity plays a significant role in determining mitochondrially-associated metabolism in mucosal tissues, which effects the metabolism of detrusor tissue. Our work adds further evidence that the urothelium plays a major role in determining overall bladder physiology. Since decreased MaxiK-activity is associated with several bladder pathophysiology's, the changes in mucosal metabolism reported here may represent novel downstream targets for therapeutic interventions.	[Wang, Yi; Davies, Kelvin P.] Albert Einstein Coll Med, Dept Urol, Bronx, NY 10467 USA; [Deng, Gary G.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Davies, Kelvin P.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Eli Lilly; Yeshiva University; Albert Einstein College of Medicine	Davies, KP (corresponding author), Albert Einstein Coll Med, Dept Urol, Bronx, NY 10467 USA.; Davies, KP (corresponding author), Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA.	kelvin.davies@einsten.yu.edu		Davies, Kelvin/0000-0002-0201-9210; Davies, Kelvin/0000-0001-7790-3003	Lilly Innovation Fellowship Award from Eli Lilly and Company; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK107807-01]; DiaComp Grant [16GRU3659]	Lilly Innovation Fellowship Award from Eli Lilly and Company; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DiaComp Grant	Y. Wang is a recipient of the Lilly Innovation Fellowship Award from Eli Lilly and Company. K. P. Davies is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK107807-01) and DiaComp Grant (16GRU3659). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badenhorst CPS, 2013, EXPERT OPIN DRUG MET, V9, P1139, DOI 10.1517/17425255.2013.796929; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; CANDIA S, 1992, BIOPHYS J, V63, P583, DOI 10.1016/S0006-3495(92)81630-2; Chai TC, 2016, AUTON NEUROSCI-BASIC, V200, P49, DOI 10.1016/j.autneu.2015.08.009; Chang SH, 2010, AM J PHYSIOL-RENAL, V298, pF1416, DOI 10.1152/ajprenal.00595.2009; Christ GJ, 2001, AM J PHYSIOL-REG I, V281, pR1699, DOI 10.1152/ajpregu.2001.281.5.R1699; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Ferguson DR, 1997, J PHYSIOL-LONDON, V505, P503, DOI 10.1111/j.1469-7793.1997.503bb.x; GARCIA ML, 1991, J BIOENERG BIOMEMBR, V23, P615, DOI 10.1007/BF00785814; Gevaert T, 2014, J UROLOGY, V192, P1555, DOI 10.1016/j.juro.2014.05.096; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Hristov KL, 2011, AM J PHYSIOL-CELL PH, V301, pC903, DOI 10.1152/ajpcell.00495.2010; Kosan M, 2005, INT J UROL, V12, P677, DOI 10.1111/j.1442-2042.2005.01098.x; Kryshtal' D A, 2011, Fiziol Zh, V57, P25; Lartigue L, 2013, INT J BIOCHEM CELL B, V45, P2052, DOI 10.1016/j.biocel.2013.06.014; Lennerz BS, 2015, MOL GENET METAB, V114, P73, DOI 10.1016/j.ymgme.2014.11.010; LEWIS RS, 1988, SCIENCE, V239, P771, DOI 10.1126/science.2448877; Li MK, 2013, AM J PHYSIOL-RENAL, V305, pF445, DOI 10.1152/ajprenal.00345.2012; Li MK, 2009, AM J PHYSIOL-CELL PH, V297, pC1445, DOI 10.1152/ajpcell.00259.2009; Li Y, 2016, NEUROUROL URODYN; McCloskey KD, 2010, NEUROUROL URODYNAM, V29, P82, DOI 10.1002/nau.20739; Melman A, 2009, BJU INT, V104, P1292, DOI 10.1111/j.1464-410X.2009.08573.x; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; MIYAZAWA S, 1983, J BIOCHEM, V94, P529, DOI 10.1093/oxfordjournals.jbchem.a134384; Monlun M, 2017, J MOL BIOL, V429, P1, DOI 10.1016/j.jmb.2016.10.028; Nakahara Tsutomu, 2004, Journal of Smooth Muscle Research, V40, P97, DOI 10.1540/jsmr.40.97; Negoro H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106269; Negoro H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02152; Petkov GV, 2014, AM J PHYSIOL-REG I, V307, pR571, DOI 10.1152/ajpregu.00142.2014; Shalbuyeva N, 2006, J BIOL CHEM, V281, P37547, DOI 10.1074/jbc.M607263200; Singh H, 2016, NEUROSCIENCE, V317, P76, DOI 10.1016/j.neuroscience.2015.12.058; Thorneloe KS, 2005, AM J PHYSIOL-RENAL, V289, pF604, DOI 10.1152/ajprenal.00060.2005; Toro L, 2014, PFLUG ARCH EUR J PHY, V466, P875, DOI 10.1007/s00424-013-1359-0; Vahabi B, 2011, EUR J PHARMACOL, V660, P431, DOI 10.1016/j.ejphar.2011.03.053; Wang Y, 2016, AM J PHYSIOL-ENDOC M, V311, pE471, DOI 10.1152/ajpendo.00134.2016; Wang Y, 2014, INT J UROL, V21, P1059, DOI 10.1111/iju.12491; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Zhang J, 2017, MITOCHONDRION, V33, P84, DOI 10.1016/j.mito.2016.08.017	38	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189387	10.1371/journal.pone.0189387	http://dx.doi.org/10.1371/journal.pone.0189387			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281667	gold, Green Published, Green Submitted			2022-12-26	WOS:000419006200024
J	Agizew, T; Basotli, J; Alexander, H; Boyd, R; Letsibogo, G; Auld, A; Nyirenda, S; Tedla, Z; Mathoma, A; Mathebula, U; Pals, S; Date, A; Finlay, A				Agizew, Tefera; Basotli, Joyce; Alexander, Heather; Boyd, Rosanna; Letsibogo, Gaoraelwe; Auld, Andrew; Nyirenda, Sambayawo; Tedla, Zegabriel; Mathoma, Anikie; Mathebula, Unami; Pals, Sherri; Date, Anand; Finlay, Alyssa			Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay	PLOS ONE			English	Article								Background Non-tuberculous mycobacteria (NTM) can cause pulmonary infection and disease especially among people living with HIV (PLHIV). PLHIV with NTM disease may clinically present with one of the four symptoms consistent with tuberculosis (TB). We describe the prevalence of NTM and Mycobacterium tuberculosis complex (MTBC) isolated among PLHIV who presented for HIV care and treatment. Methods All PLHIV patients presenting for HIV care and treatment services at 22 clinical sites in Botswana were offered screening for TB and were recruited. Patients who had >= 1 TB symptom were asked to submit sputa for Xpert MTB/RIF and culture. Culture growth was identified as NTM and MTBC using the SD-Bioline TB Ag MPT64 Kit and Ziehl Neelsen microscopy. NTM and MTBC isolates underwent species identification by the Hain GenoType CM and AS line probe assays. Results Among 16, 259 PLHIV enrolled 3068 screened positive for at least one TB symptom. Of these, 1940 submitted >= 1 sputum specimen, 427 (22%) patients had >= 1 positive-culture result identified phenotypically for mycobacterial growth. Of these 247 and 180 patients were identified as having isolates were NTM and MTBC, respectively. Of the 247 patients identified with isolates containing NTM; 19 were later excluded as not having NTM based on additional genotypic testing. Among the remaining 408 patients 228 (56%, 95% confidence interval, 46 +/- 66%) with NTM. M. intracellulare was the most common isolated (47.8%). Other NTMs commonly associated with pulmonary disease included M. malmoense (3.9%), M. avium (2.2%), M. abscessus (0.9%) and M. kansasii (0.4%). After excluding NTM isolates that were non-speciated and M. gordonae 154 (67.5%) of the NTM isolates were potential pathogens. Conclusions In the setting of HIV care and treatment, over-half (56%) of a positive sputum culture among PLHIV with TB symptoms was NTM. Though we were not able to distinguish in our study NTM disease and colonization, the study suggests culture and species identification for PLHIV presenting with TB symptoms remains important to facilitate NTM diagnosis and hasten time to appropriate treatment.	[Agizew, Tefera; Basotli, Joyce; Boyd, Rosanna; Nyirenda, Sambayawo; Tedla, Zegabriel; Mathoma, Anikie; Mathebula, Unami; Finlay, Alyssa] Ctr Dis Control & Prevent, Gaborone, Botswana; [Alexander, Heather; Auld, Andrew; Pals, Sherri; Date, Anand] Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA USA; [Boyd, Rosanna; Finlay, Alyssa] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Letsibogo, Gaoraelwe] Minist Hlth, Natl TB Reference Lab, Gaborone, Botswana	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Agizew, T (corresponding author), Ctr Dis Control & Prevent, Gaborone, Botswana.	tagizew@cdc.gov		Auld, Andrew/0000-0001-5089-9163; Agizew, Tefera/0000-0003-1848-7307	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research has been supported by the President's Emergency Plan for AIDS Relief (PEP FAR) through the U.S. Centers for Disease Control and Prevention.	Aliyu G, 2013, PLOSONE; American Public Health Association, 2005, STAND METH EX WAT WA; [Anonymous], 2011, BOTSW NAT TUB PROGR; [Anonymous], 2013, BOTSWANA AIDS IMPACT; Antonenka U, 2013, BMC INF DIS; Auld A.F, 2016, BIOMED CENTRAL INFEC; BaHammam A, 2005, SAUDI MED J; Brode S.K, 2014, INT J TUBERC LUNG DI; Buijtels P, 2009, EMERGING INFECT DIS; Buijtels P.C, 2010, CLIN MICROBIOL INFEC; Chihota V, 2010, INT J TUBERC LUNG DI; Chung M, 2006, EUR RADIOL; Conde M, 1999, PREDICTIVE VALUE ACI; Crago B, 2014, J HOSP INFECT; Da-Costa A, 2013, PLOSONE; Helb D, 2010, J CLIN MICROB; Hoefsloot W, 2013, EUR RESP J, DOI 10.1183/09031936.00149212 (2013); Hoza A. S, 2016, BIOMED CENTRAL; Johnson M.M, 2014, J THORAC DIS; Kapata N, 2016, PLOS ONE; Kendall B, 2011, DISTINGUISHING TUBER; Lai C, 2010, EMERGING INFECT DIS; Lan R, 2011, INT J TUBERC LUNG DI; Law I, 2015, TROP MED INT J; Lee S, 2006, J KOREAN MED SCI; Maiga M., 2012, PLOSONE; Nyamogoba H DN, 2012, AFRICAN HLTH SCI; Prevots D.R, 2010, AM J RESP CRIT CARE; Rachow A, 2011, PLOSONE; Sonnenberg P, 2000, EUR RESP J, V15; StataCorp, 2015, STAT SOFTW REL 14; Steingart R, 2014, COCHRANE DATABASE SY; Thorell E, 2006, J PEDIAT HEMATOL ONC; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2021, 10 THREATS GLOB HLTH	35	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0189981	10.1371/journal.pone.0189981	http://dx.doi.org/10.1371/journal.pone.0189981			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272273	Green Published, Green Submitted, gold			2022-12-26	WOS:000418651500020
J	Jamali, N; Wang, SJ; Darjatmoko, SR; Sorenson, CM; Sheibani, N				Jamali, Nasim; Wang, Shoujian; Darjatmoko, Soesiawati R.; Sorenson, Christine M.; Sheibani, Nader			Vitamin D receptor expression is essential during retinal vascular development and attenuation of neovascularization by 1, 25(OH)(2)D-3	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; MEDIATED VESSEL OBLITERATION; BLOOD-BRAIN-BARRIER; ENDOTHELIAL-CELLS; MAMMARY-GLAND; MICE EXHIBIT; RETINOPATHY; CANCER; ANGIOGENESIS; CALCITRIOL	Vitamin D provides a significant benefit to human health, and its deficiency has been linked to a variety of diseases including cancer. Vitamin D exhibits anticancer effects perhaps through inhibition of angiogenesis. We previously showed that the active form of vitamin D (1, 25(OH)(2)D-3; calcitriol) is a potent inhibitor of angiogenesis in mouse model of oxygen-induced ischemic retinopathy (OIR). Many of vitamin D's actions are mediated through vitamin D receptor (VDR). However, the role VDR expression plays in vascular development and inhibition of neovascularization by 1, 25(OH)(2)D-3 remains unknown. Here using wild type (Vdr +/+) and Vdr-deficient (Vdr -/-) mice, we determined the impact of Vdr expression on postnatal development of retinal vasculature and retinal neovascularization during OIR. We observed no significant effect on postnatal retinal vascular development in Vdr -/-mice up to postnatal day 21 (P21) compared with Vdr +/+ mice. However, we observed an increase in density of pericytes (PC) and a decrease in density of endothelial cells (EC) in P42 Vdr -/-mice compared with Vdr +/+ mice, resulting in a significant decrease in the EC/PC ratio. Although we observed no significant impact on vessel obliteration and retinal neovascularization in Vdr -/-mice compared with Vdr +/+ mice during OIR, the VDR expression was essential for inhibition of retinal neovascularization by 1, 25(OH)(2)D-3. In addition, the adverse impact of 1, 25(OH)(2)D-3 treatment on the mouse bodyweight was also dependent on VDR expression. Thus, VDR expression plays a significant role during retinal vascular development, especially during maturation of retinal vasculature by promoting PC quiescence and EC survival, and inhibition of ischemia-mediated retinal neovascularization by 1, 25(OH)(2)D-3 .	[Jamali, Nasim; Wang, Shoujian; Darjatmoko, Soesiawati R.; Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol, Madison, WI 53706 USA; [Jamali, Nasim; Wang, Shoujian; Darjatmoko, Soesiawati R.; Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Visual Sci, Madison, WI 53706 USA; [Jamali, Nasim; Sorenson, Christine M.; Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, McPherson Eye Res Inst, Madison, WI 53706 USA; [Sorenson, Christine M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA; [Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Sheibani, Nader] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sheibani, N (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol, Madison, WI 53706 USA.; Sheibani, N (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Visual Sci, Madison, WI 53706 USA.; Sheibani, N (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, McPherson Eye Res Inst, Madison, WI 53706 USA.; Sheibani, N (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53706 USA.; Sheibani, N (corresponding author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.	nsheibanikar@wisc.edu	Jamali, Nasim/Z-3534-2019; Sheibani, Nader/AAG-2379-2020	Jamali, Nasim/0000-0003-1851-6585; Sheibani, Nader/0000-0003-2723-9217	Research to Prevent Blindness; Retina Research Foundation [P30 EY016665, P30 CA014520, EPA 83573701, EY022883, EY012223, EY026078]; RRF/Daniel M. Albert Chair; RPB Stein Innovation Award; NATIONAL EYE INSTITUTE [R01EY026078, P30EY016665] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Retina Research Foundation; RRF/Daniel M. Albert Chair; RPB Stein Innovation Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by an unrestricted award from Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences, Retina Research Foundation, P30 EY016665, P30 CA014520, EPA 83573701, EY022883, EY012223, and EY026078. CMS is supported by the RRF/Daniel M. Albert Chair. NS is a recipient of RPB Stein Innovation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by an unrestricted award from Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences, Retina Research Foundation, P30 EY016665, P30 CA014520, EPA 83573701, EY022883, and EY026078. CMS is supported by the RRF/Daniel M. Albert Chair. NS is a recipient of RPB Stein Innovation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera KY, 2014, CELL MOL LIFE SCI, V71, P299, DOI 10.1007/s00018-013-1432-z; Albert DM, 2007, INVEST OPHTH VIS SCI, V48, P2327, DOI 10.1167/iovs.06-1210; Albert DM NR, 2002, OPHTHALMIC GENET, V23; Alimirah F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016024; Audo I, 2003, INVEST OPHTH VIS SCI, V44, P4192, DOI 10.1167/iovs.02-1198; Beharry KD, 2016, SEMIN PERINATOL, V40, P189, DOI 10.1053/j.semperi.2015.12.006; BURAS RR, 1994, BREAST CANCER RES TR, V31, P191, DOI 10.1007/BF00666153; Cardus A, 2006, KIDNEY INT, V69, P1377, DOI 10.1038/sj.ki.5000304; Cardus A, 2009, ATHEROSCLEROSIS, V204, P85, DOI 10.1016/j.atherosclerosis.2008.08.020; Carlberg C, 2015, CAN J PHYSIOL PHARM, V93, P311, DOI 10.1139/cjpp-2014-0383; Chen MF, 2017, J CLIN INVEST, V127, P3689, DOI 10.1172/JCI94258; Chung I, 2007, J STEROID BIOCHEM, V103, P768, DOI 10.1016/j.jsbmb.2006.12.042; Chung I, 2009, CANCER RES, V69, P967, DOI 10.1158/0008-5472.CAN-08-2307; CLAUDIO L, 1992, BRAIN RES, V594, P233, DOI 10.1016/0006-8993(92)91130-7; Crew KD, 2013, ISRN ONCOL, V2013; Cross HS, 2001, STEROIDS, V66, P287, DOI 10.1016/S0039-128X(00)00153-7; Damera G, 2009, BRIT J PHARMACOL, V158, P1429, DOI 10.1111/j.1476-5381.2009.00428.x; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; DeLuca HF, 2015, J STEROID BIOCHEM, V148, P3, DOI 10.1016/j.jsbmb.2014.08.020; DiMalo TA, 2008, DEV BIOL, V315, P72, DOI 10.1016/j.ydbio.2007.12.008; Dormanen MC, 1714, BIOCH BIOPHYSICAL RE; Evans SRT, 1998, CLIN CANCER RES, V4, P1591; Feng Y, 2008, CELL PHYSIOL BIOCHEM, V21, P129, DOI 10.1159/000113755; Franco CA, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002125; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; FRANK RN, 1990, INVEST OPHTH VIS SCI, V31, P999; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hii CS, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030135; Huang Q, 2008, EXP EYE RES, V87, P226, DOI 10.1016/j.exer.2008.06.003; Jamali N, 2014, FASEB J S, V28; JOHNSON JA, 1995, CURR EYE RES, V14, P101, DOI 10.3109/02713689508999921; Kim SH, 2017, RESP RES, V18, DOI 10.1186/s12931-016-0490-9; Kong LK, 2012, J AAPOS, V16, P501, DOI 10.1016/j.jaapos.2012.09.004; Koul Parvaiz A, 2011, Oman Med J, V26, P201, DOI 10.5001/omj.2011.49; Kwon HJ, 2016, BIOCHEM BIOPH RES CO, V478, P994, DOI 10.1016/j.bbrc.2016.08.070; Kwon HJ, 2016, BIOCHEM BIOPH RES CO, V470, P575, DOI 10.1016/j.bbrc.2016.01.103; Landel V, 2016, J ALZHEIMERS DIS, V53, P419, DOI 10.3233/JAD-150943; Larriba MJ, 2005, BRIT J CANCER, V92, P985, DOI 10.1038/sj.bjc.6602484; Lee V, 2012, NEUROBIOL AGING, V33, P2382, DOI 10.1016/j.neurobiolaging.2011.12.002; Lesiak A, 2011, EXP DERMATOL, V20, P800, DOI 10.1111/j.1600-0625.2011.01328.x; Li W, 1996, DIABETOLOGIA, V39, P537; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Morrison ME, 2013, INT J CELL BIOL, V2013; National Eye Institute, FACTS RET PREM ROP 2; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; PALMER EA, 1991, OPHTHALMOLOGY, V98, P1628; Reins RY, 2015, EXP EYE RES, V134, P101, DOI 10.1016/j.exer.2015.02.019; SHOKRAVI MT, 1995, INVEST OPHTH VIS SCI, V36, P83; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Thorne J, 2008, P NUTR SOC, V67, P115, DOI 10.1017/S0029665108006964; Tizaoui K, 2014, LUNG, V192, P955, DOI 10.1007/s00408-014-9648-8; von Muhlendahl KE, 1999, EUR J PEDIATR, V158, P266, DOI 10.1007/s004310051067; Wang SJ, 2005, DEV BIOL, V279, P205, DOI 10.1016/j.ydbio.2004.12.017; Wang SJ, 2003, DEV DYNAM, V228, P630, DOI 10.1002/dvdy.10412; Wang TJ, 2016, ANNU REV MED, V67, P261, DOI 10.1146/annurev-med-051214-025146; Wang XF, 2017, SCI REP-UK, V7, DOI 10.1038/srep41540; Yamamoto T, 2002, ARCH BIOCHEM BIOPHYS, V398, P1, DOI 10.1006/abbi.2001.2632; Yang MB, 2006, J AAPOS, V10, P253, DOI 10.1016/j.jaapos.2006.01.004; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Zagzag D, 2000, LAB INVEST, V80, P837, DOI 10.1038/labinvest.3780088; Zaitoun IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139994; Zinser GM, 2005, J STEROID BIOCHEM, V97, P153, DOI 10.1016/j.jsbmb.2005.06.024; Zinser GM, 2004, MOL ENDOCRINOL, V18, P2208, DOI 10.1210/me.2003-0469; Zittermann A, 2011, VITAMINS IN THE PREVENTION OF HUMAN DISEASES, P363; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	68	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190131	10.1371/journal.pone.0190131	http://dx.doi.org/10.1371/journal.pone.0190131			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272316	Green Submitted, Green Published, gold			2022-12-26	WOS:000418651500036
J	Dunning, L; Kroon, M; Hsiao, NY; Myer, L				Dunning, Lorna; Kroon, Max; Hsiao, Nei-yuan; Myer, Landon			Field evaluation of HIV point-of-care testing for early infant diagnosis in Cape Town, South Africa	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; MORTALITY	Background Early infant HIV diagnosis (EID) coverage and uptake remains challenging. Point-of-care (POC) testing may improve access and turn-around-times, but, while several POC technologies are in development there are few data on their implementation in the field. Methods We conducted an implementation study of the Alere q Detect POC system for EID at two public sector health facilities in Cape Town. HIV-exposed neonates undergoing routine EID testing at a large maternity hospital and a primary care clinic received both laboratory-based HIV PCR testing per local protocols and a POC test. We analysed the performance of POC versus laboratory testing, and conducted semi-structured interviews with providers to assess acceptability and implementation issues. Results Overall 478 specimens were taken: 311 tests were performed at the obstetric hospital (median child age, 1 days) and 167 six-week tests in primary care (median child age, 42 days). 9.0% of all tests resulted in an error with no differences by site; most errors resolved with retesting. POC was more sensitive (100%; lower 95% CI, 39.8%) and specific (100%, lower 95% CI, 98%) among older children tested in primary care compared with birth testing in hospital (90.0%, 95% CI, 55.5-99.8% and 100.0%, lower 95% CI, 98.4%, respectively). Negative predictive value was high (>99%) at both sites. In interviews, providers felt the device was simple to use and facilitated decision-making in the management of infants. However, many wanted clarity on the cause of errors on the POC device to help guide repeat testing. Conclusions POC EID testing performs well in field implementation in health care facilities and appears highly acceptable to health care providers.	[Dunning, Lorna; Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa; [Dunning, Lorna; Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa; [Kroon, Max] Univ Cape Town, Dept Neonatal Med, Cape Town, South Africa; [Hsiao, Nei-yuan] Univ Cape Town, Div Med Virol, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Dunning, L (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa.; Dunning, L (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa.	ldunning@partners.org			Elizabeth Glaser Pediatric AIDS foundation [02294]	Elizabeth Glaser Pediatric AIDS foundation	LM was awarded a grant from Elizabeth Glaser Pediatric AIDS foundation (grant number 02294). The product manufacturer donated equipment for this research, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alere, 2013, MOL MAD EAS; Becquet R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028510; Bourne DE, 2009, AIDS, V23, P101, DOI 10.1097/QAD.0b013e32831c54bd; Braitstein P, 2011, JAIDS-J ACQ IMM DEF, V57, pE40, DOI 10.1097/QAI.0b013e3182167f0d; Braun M, 2011, J ACQ IMMUN DEF SYND, V56, P1; Chatterjee A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-553; Ciaranello A, 2016, CROI POST PRES, P79214; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; Davies MA, 2015, S AFR J HIV MED, V16, P81, DOI [10.4102/sajhivmed.v16i1.375, 10.4102/SAJHIVMED.V16I1.375]; Hassan AS, 2012, AIDS BEHAV, V16, P5, DOI 10.1007/s10461-010-9877-7; Hsiao NY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152672; Hsiao NY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055308; Jani I V, 2014, NUCLEIC ACID TEST, V67, P1; Kageha S, 2012, J TROP PEDIATRICS, V58, P247, DOI 10.1093/tropej/fmr076; Mallampati D, 2017, J ACQ IMMUN DEF SYND, V160, P1; Meggi B, 2017, C RETR OPP INF SEATT; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Pai NP, 2015, POINT CARE, V14, P81, DOI 10.1097/POC.0000000000000056; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Palamountain KM, 2012, J INFECT DIS, V205, pS181, DOI 10.1093/infdis/jis203; Republic of South Africa National Department of Health, 2015, NAT CONS GUID PREV M; Schito ML, 2011, J INFECT DIS S1, V201, P1; Schulz T., 2013, ALERE MOBILE LAB DIA; Sherman GG, 2005, PEDIATR INFECT DIS J, V24, P993, DOI 10.1097/01.inf.0000187036.73539.8d; Sibanda EL, 2013, AIDS, V27, P2787, DOI 10.1097/QAD.0000000000000027; South African Ministry of Health, 2015, NAT CONS GUID PREV M, P1; Stinson K, 2012, JAIDS J ACQUIR IMMUN, V60; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO, 2015, PROGR REP GLOB PLAN; WHO, 2015, CONSOLIDATED GUIDELI; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2010, REC DIAGN HIV INF IN; Wynberg E, 2014, JIAS, V17, P1, DOI DOI 10.7448/IAS.17.1.18809; ZAZZI M, 1995, J CLIN MICROBIOL, V33, P205, DOI 10.1128/JCM.33.1.205-208.1995	34	24	25	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189226	10.1371/journal.pone.0189226	http://dx.doi.org/10.1371/journal.pone.0189226			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261707	Green Published, gold, Green Submitted			2022-12-26	WOS:000418564200034
J	Monti, S; Borrelli, P; Tedeschi, E; Cocozza, S; Palma, G				Monti, Serena; Borrelli, Pasquale; Tedeschi, Enrico; Cocozza, Sirio; Palma, Giuseppe			RESUME: Turning an SWI acquisition into a fast qMRI protocol	PLOS ONE			English	Article							SUSCEPTIBILITY MAPPING QSM; STEADY-STATE; TISSUE CHARACTERIZATION; CLINICAL-APPLICATIONS; BRAIN-TISSUE; T-1; TIME; MRI; T1; QUANTIFICATION	Susceptibility Weighted Imaging (SWI) is a common MRI technique that exploits the magnetic susceptibility differences between the tissues to provide valuable image contrasts, both in research and clinical contexts. However, despite its increased clinical use, SWI is not intrinsically suitable for quantitation purposes. Conversely, quantitative Magnetic Resonance Imaging (qMRI) provides a way to disentangle the sources of common MR image contrasts (e.g. proton density, T-1, etc.) and to measure physical parameters intrinsically related to tissue microstructure. Unfortunately, the poor signal-to-noise ratio and resolution, coupled with the long imaging time of most qMRI strategies, have hindered the integration of quantitative imaging into clinical protocols. Here we present the RElaxometry and SUsceptibility Mapping Expedient (RESUME) to show that the standard acquisition leading to a clinical SWI dataset can be easily turned into a thorough qMRI protocol at the cost of a further 50% of the SWI scan time. The R-1, R*(2), proton density and magnetic susceptibility maps provided by the RESUME scheme alongside the SWI reconstruction exhibit high reproducibility and accuracy, and a submillimeter resolution is proven to be compatible with a total scan time of 7 minutes.	[Monti, Serena; Borrelli, Pasquale] IRCCS SDN, Naples, Italy; [Tedeschi, Enrico; Cocozza, Sirio] Univ Federico II, Dept Adv Biomed Sci, Naples, Italy; [Palma, Giuseppe] CNR, Inst Biostruct & Bioimaging, Naples, Italy	IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Palma, G (corresponding author), CNR, Inst Biostruct & Bioimaging, Naples, Italy.	giuseppe.palma@ibb.cnr.it	Palma, Giuseppe/GXV-0228-2022; Tedeschi, Enrico/AAN-7112-2020; Cocozza, Sirio/ABD-1161-2020; Monti, Serena/C-1062-2015; Borrelli, Pasquale/N-4880-2019; Palma, Giuseppe/AAX-1413-2020; Borrelli, Pasquale/H-7493-2016	Palma, Giuseppe/0000-0002-0210-268X; Tedeschi, Enrico/0000-0002-0511-0132; Cocozza, Sirio/0000-0002-0300-5160; Monti, Serena/0000-0002-8777-7837; Borrelli, Pasquale/0000-0002-9299-9661; Borrelli, Pasquale/0000-0002-9299-9661				Allkemper T, 2004, RADIOLOGY, V232, P874, DOI 10.1148/radiol.2323030322; Borrelli Pasquale, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P1230, DOI 10.1109/ICASSP.2014.6853793; Borrelli P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126835; Brown RW, 2014, MAGNETIC RESONANCE I, DOI 10.1002/9781118633953.ch18; CERDONIO M, 1977, P NATL ACAD SCI USA, V74, P398, DOI 10.1073/pnas.74.2.398; Cocozza S, 2017, AM J NEUROR IN PRESS; Deistung A, 2016, NMR IN BIO MED; Deoni SCL, 2005, MAGN RESON MED, V53, P237, DOI 10.1002/mrm.20314; Deoni SCL, 2003, MAGNET RESON MED, V49, P515, DOI 10.1002/mrm.10407; Deoni SCL, 2009, J MAGN RESON IMAGING, V30, P411, DOI 10.1002/jmri.21849; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; Doganay S, 2017, MAGNETIC RESONANCE M; Draganski B, 2011, NEUROIMAGE, V55, P1423, DOI 10.1016/j.neuroimage.2011.01.052; Du J, 2007, MAGN RESON MED, V58, P1001, DOI 10.1002/mrm.21397; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haacke EM, 2014, SUSCEPTIBILITY WEIGH; Hattingen E, 2015, CLIN NEURORADIOL, V25, P219, DOI 10.1007/s00062-015-0433-8; Holdsworth SJ, 2015, J MAGN RESON IMAGING, V41, P1447, DOI 10.1002/jmri.24675; JUST M, 1988, RADIOLOGY, V169, P779, DOI 10.1148/radiology.169.3.3187000; KOMIYAMA M, 1987, AM J NEURORADIOL, V8, P65; Kudo K, 2016, J CEREBR BLOOD F MET, V36, P1424, DOI 10.1177/0271678X15606713; Langkammer C, 2012, NEUROIMAGE, V62, P1593, DOI 10.1016/j.neuroimage.2012.05.049; Lee EY, 2015, TOXICOL SCI, V146, P281, DOI 10.1093/toxsci/kfv088; Lee J, 2012, NEUROIMAGE, V59, P3967, DOI 10.1016/j.neuroimage.2011.10.076; Li W, 2015, NEUROIMAGE, V108, P111, DOI 10.1016/j.neuroimage.2014.12.043; Liu CL, 2015, TOMOGRAPHY, V1, P3, DOI 10.18383/j.tom.2015.00136; Liu CL, 2015, J MAGN RESON IMAGING, V42, P23, DOI [10.3969/j.issn.1001-2400.2015.01.004, 10.1002/jmri.24768]; Lutti A, 2014, NEUROIMAGE, V93, P176, DOI 10.1016/j.neuroimage.2013.06.005; Ma YJ, 2015, 3D INTERSLAB ECHO SH; Mezer A, 2013, NAT MED, V19, P1667, DOI 10.1038/nm.3390; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Montesdeoca S. E., 2017, IEEE T MED IMAGING, P1; Monti S, 2015, IEEE ENG MED BIO, P3041, DOI 10.1109/EMBC.2015.7319033; Palma G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134963; Palma G, 2013, FED CONF COMPUT SCI, P495; Robinson RJ, 2011, J NEUROIMAGING, V21, pE189, DOI 10.1111/j.1552-6569.2010.00516.x; Schwarz ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093814; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Schweser F, 2010, MED PHYS, V37, P5165, DOI 10.1118/1.3481505; Sereno MI, 2013, CEREB CORTEX, V23, P2261, DOI 10.1093/cercor/bhs213; Tedeschi E, 2017, MAGNETIC RESONANCE M; Tedeschi E, 2016, EUR RADIOL, P1; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Wang Y, 2015, MAGN RESON MED, V73, P82, DOI 10.1002/mrm.25358; Warnties JBM, 2008, MAGN RESON MED, V60, P320, DOI 10.1002/mrm.21635; Warntjes JBM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070864; West J, 2012, EUR RADIOL, V22, P998, DOI 10.1007/s00330-011-2336-7; Wright PJ, 2008, MAGN RESON MATER PHY, V21, P121, DOI 10.1007/s10334-008-0104-8; Wu ML, 2015, MED PHYS, V42, P4367, DOI 10.1118/1.4922402	50	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189933	10.1371/journal.pone.0189933	http://dx.doi.org/10.1371/journal.pone.0189933			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261786	Green Published, gold, Green Submitted			2022-12-26	WOS:000418564200076
J	Greenfield, J; Hudson, M; Vinet, E; Fortin, PR; Bykerk, V; Pineau, CA; Wang, MB; Bernatsky, S; Baron, M				Greenfield, Julia; Hudson, Marie; Vinet, Evelyne; Fortin, Paul R.; Bykerk, Vivian; Pineau, Christian A.; Wang, Mianbo; Bernatsky, Sasha; Baron, Murray		Canadian Scleroderma Res Grp; Canadian Inflammatory Myopathy	A comparison of health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARDs)	PLOS ONE			English	Article							LUPUS-ERYTHEMATOSUS; FUNCTIONAL STATUS; SCLEROSIS; POPULATION; ARTHRITIS; SF-36	Objectives To compare physical and mental health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARD). Methods Incident subjects enrolled in four SARD cohorts, namely systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA) and idiopathic inflammatory myopathies (IIM) were studied. The outcomes of interest were baseline Short Form Health Survey physical (PCS) and mental (MCS) component summary scores. Multivariate analysis was conducted to determine whether PCS and MCS scores differed across SARD type. Results The study included 118 SLE (93% women, mean age 36 years), 108 SSc (79% women, mean age 55), 64 RA (63% women, mean age 58) and 25 IIM (68% women, mean age 49) subjects. Mean PCS scores were 38.9 +/- 12.2 in SLE, 37.1 +/- 13.3 in RA, 35.0 +/- 13.6 in SSc and 28.0 +/- 15.4 in IIM. Mean MCS scores were 45.0 +/- 13.3 in RA, 44.4 +/- 14.7 in SSc, 40.1 +/- 14.3 in SLE and 33.6 +/- 18.7 in IIM. SARD type was an independent predictor of HRQoL with, in some cases, the magnitude of the differences reaching one standard deviation (IIM worse PCS scores compared to SLE (beta - 12.23 [95% CI - 18.11, - 6.36; p<0.001]); IIM worse MCS scores compared to SSc (beta - 11.05 [95% CI - 17.53, - 4.58; p = 0.001]) and RA (beta - 11.72 [95% CI - 18.62, - 4.81; p = 0.001]). Conclusions Cross-SARD research provides a novel approach to gain greater understanding of commonalities and differences across rheumatic diseases. The differences observed warrant further research into correlates and trajectories over time.	[Greenfield, Julia] McGill Univ, Dept Anat, Montreal, PQ, Canada; [Greenfield, Julia; Hudson, Marie; Vinet, Evelyne; Pineau, Christian A.; Bernatsky, Sasha; Baron, Murray] McGill Univ, Med, Montreal, PQ, Canada; [Hudson, Marie; Baron, Murray] Jewish Gen Hosp, Div Rheumatol, Montreal, PQ, Canada; [Hudson, Marie; Wang, Mianbo; Baron, Murray] Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ, Canada; [Vinet, Evelyne; Pineau, Christian A.; Bernatsky, Sasha] McGill Univ, Hlth Ctr, Div Rheumatol, Montreal, PQ, Canada; [Fortin, Paul R.] Ctr Hosp Univ Quebec, Dept Med, Div Rheumatol, Quebec City, PQ, Canada; [Fortin, Paul R.] Univ Laval, Quebec City, PQ, Canada; [Bykerk, Vivian] Cornell Univ, Hosp Special Surg, Div Rheumatol, New York, NY 10021 USA	McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; McGill University; Laval University; Laval University; Cornell University	Hudson, M (corresponding author), McGill Univ, Med, Montreal, PQ, Canada.; Hudson, M (corresponding author), Jewish Gen Hosp, Div Rheumatol, Montreal, PQ, Canada.; Hudson, M (corresponding author), Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ, Canada.	marie.hudson@mcgill.ca	Pope, Janet/G-3342-2011; Baron, Murray/AAF-9486-2019	Pope, Janet/0000-0003-1479-5302; Vinet, Evelyne/0000-0001-7727-5879; Fortin, Paul R./0000-0002-7278-2596	Janssen Inc.; infrastructure CFI grant [22910]; Canadian Scleroderma Research Group (CSRG) [FRN 83518]; Pfizer; Actelion pharmaceuticals; Fonds de la recherche en Sante du Quebec	Janssen Inc.(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); infrastructure CFI grant; Canadian Scleroderma Research Group (CSRG); Pfizer(Pfizer); Actelion pharmaceuticals; Fonds de la recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This study was funded by an unrestricted research grant from Janssen Inc. and was made possible by an infrastructure CFI grant (22910). The Canadian Scleroderma Research Group (CSRG) received funds and/or gifts in kind Canadian Institutes of Health Research (CIHR) (grant #FRN 83518), the Scleroderma Society of Canada and its provincial Chapters, Scleroderma Society of Ontario, Scleroderma Society of Saskatchewan, Sclerodermie Quebec, Cure Scleroderma Foundation, INOVA Diagnostics Inc. (San Diego, CA), Dr. Fooke Laboratorien GmbH (Neuss, Germany), Euroimmun (Lubeck, Germany), Mikrogen GmbH (Neuried, Germany), Fonds de la recherche en sante du Quebec (FRSQ), the Canadian Arthritis Network (CAN), and the Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC. The CSRG has also received educational grants from Pfizer and Actelion pharmaceuticals. Dr. Hudson is funded by the Fonds de la recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Altinkesen E, 2011, TURK J PHYSIOTHER R, V22, P93; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Higgs BW, 2012, INT J RHEUM DIS, V15, P25, DOI 10.1111/j.1756-185X.2011.01654.x; Hopman WM, 2000, CAN MED ASSOC J, V163, P265; Hudson M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1112, DOI 10.1002/art.24676; Hudson M, 2009, J RHEUMATOL, V36, P768, DOI 10.3899/jrheum.080281; Hurst NP, 1998, BRIT J RHEUMATOL, V37, P862; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606; Johnson SR, 2006, J RHEUMATOL, V33, P1117; Matcham F, 2014, SEMIN ARTHRITIS RHEU, V44, P123, DOI 10.1016/j.semarthrit.2014.05.001; Panopalis P, 2005, RHEUMATOLOGY, V44, P751, DOI 10.1093/rheumatology/keh580; Picchianti-Diamanti A, 2010, QUAL LIFE RES, V19, P821, DOI 10.1007/s11136-010-9651-3; Ramos PS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002406; Ware J.E., 2000, SF 36 HLTH SURVEY MA; Ware JE, 2007, USERS MANUAL SF 36V2; West E, 2009, GENDER MED, V6, P544, DOI 10.1016/j.genm.2009.12.001	21	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189840	10.1371/journal.pone.0189840	http://dx.doi.org/10.1371/journal.pone.0189840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261752	Green Submitted, Green Published, gold			2022-12-26	WOS:000418554900034
J	Jia, LR; Zhou, D; Niu, JQ				Jia, Lirong; Zhou, Dan; Niu, Jiqiang			Numerical calculation of boundary layers and wake characteristics of high-speed trains with different lengths	PLOS ONE			English	Article							AERODYNAMIC PERFORMANCE; SLIPSTREAM	Trains with different numbers of cars running in the open air were simulated using the delayed detached-eddy simulation (DDES). The numbers of cars included in the simulation are 3, 4, 5 and 8. The aim of this study was to investigate how train length influences the boundary layer, the wake flow, the surface pressure, the aerodynamic drag and the friction drag. To certify the accuracy of the mesh and methods, the drag coefficients from numerical simulation of trains with 3 cars were compared with those from the wind tunnel test, and agreement was obtained. The results show that the boundary layer is thicker and the wake vortices are less symmetric as the train length increases. As a result, train length greatly affects pressure. The upper surface pressure of the tail car reduced by 2.9%, the side surface pressure of the tail car reduced by 8.3% and the underneath surface pressure of the tail car reduced by 19.7% in trains that included 3 cars to those including 8 cars. In addition, train length also has a significant effect on the friction drag coefficient and the drag coefficient. The friction drag coefficient of each car in a configuration decreases along the length of the train. In a comparison between trains consisting of 3 cars to those consisting of 8 cars, the friction drag coefficient of the tail car reduced by 8.6% and the drag coefficient of the tail car reduced by 3.7%.	[Jia, Lirong; Zhou, Dan; Niu, Jiqiang] Cent S Univ, Key Lab Traff Safety Track, Minist Educ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China; [Jia, Lirong] CRRC Qingdao Sifang Co Ltd, Qingdao, Peoples R China	Central South University; CRRC Corporation	Zhou, D (corresponding author), Cent S Univ, Key Lab Traff Safety Track, Minist Educ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China.	zd_lzj@126.com	NIU, Jiqiang/AAX-9607-2021	NIU, Jiqiang/0000-0002-9180-9571	Natural Science Foundation of Hunan Province [14JJ3028]; Major Subject of China Railway Corporation [2016ZB17]	Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Major Subject of China Railway Corporation	The funding of Natural Science Foundation of Hunan Province (No. 14JJ3028) provided full support for the study design, data collection and analysis, the research materials, the manuscript preparation and publication. Major Subject of China Railway Corporation (No. 2016ZB17) provided support in the form of salaries for authors [L Jia, J. Niu], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker C, 2010, J WIND ENG IND AEROD, V98, P277, DOI 10.1016/j.jweia.2009.11.002; Baker CJ, 2001, P I MECH ENG F-J RAI, V215, P83, DOI 10.1243/0954409011531422; Bell JR, 2015, J WIND ENG IND AEROD, V136, P127, DOI 10.1016/j.jweia.2014.09.007; Flynn D, 2014, J WIND ENG IND AEROD, V132, P1, DOI 10.1016/j.jweia.2014.06.016; Guo DL, 2016, ACTA MECH SINICA-PRC, V32, P191, DOI 10.1007/s10409-015-0553-z; Hemida H, 2014, P I MECH ENG F-J RAI, V228, P25, DOI 10.1177/0954409712460982; Huang S.-Y, 2014, P IEEE 18 WORKSH SIG, P1, DOI [10.1109/TITS.2014.2341695, DOI 10.1109/TITS.2014.2341695]; [黄志祥 Huang Zhixiang], 2012, [实验流体力学, Journal of Experiments in Fluid Mechanics], V26, P36; Hwang J, 2001, JSME INT J B-FLUID T, V44, P451, DOI 10.1299/jsmeb.44.451; JEONG J, 1995, J FLUID MECH, V285, P69, DOI 10.1017/S0022112095000462; Menter R., 1993, AIAA, V93, P1; Muld TW, 2014, P I MECH ENG F-J RAI, V228, P333, DOI 10.1177/0954409712473922; Muld TW, 2015, APPL COMPUTATIONAL M, V79, P3; Munoz-Paniagua J, 2015, J APPL FLUID MECH, V8, P601; Niu JQ, 2017, EXP THERM FLUID SCI, V80, P117, DOI 10.1016/j.expthermflusci.2016.08.014; Niu JQ, 2016, J WIND ENG IND AEROD, V157, P36, DOI 10.1016/j.jweia.2016.08.007; Raghunathan RS, 2002, PROG AEROSP SCI, V38, P469, DOI 10.1016/S0376-0421(02)00029-5; Stull R.B., 1988, INTROD BOUND LAYER M, DOI DOI 10.1007/978-94-009-3027-8; Tian HQ, 2015, J CENT SOUTH UNIV, V22, P747, DOI 10.1007/s11771-015-2578-7; Tian HQ, 2009, J CENT SOUTH UNIV T, V16, P166, DOI 10.1007/s11771-009-0028-0; Zhang J, 2016, J FLUID STRUCT, V61, P249, DOI 10.1016/j.jfluidstructs.2015.10.006	21	10	10	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189798	10.1371/journal.pone.0189798	http://dx.doi.org/10.1371/journal.pone.0189798			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261758	Green Submitted, Green Published, gold			2022-12-26	WOS:000418554900031
J	Nakata, K; Miki, T; Tanno, M; Ohnishi, H; Yano, T; Muranaka, A; Sato, T; Oshima, H; Tatekoshi, Y; Mizuno, M; Abe, K; Miura, T				Nakata, Kei; Miki, Takayuki; Tanno, Masaya; Ohnishi, Hirofumi; Yano, Toshiyuki; Muranaka, Atsuko; Sato, Tatsuya; Oshima, Hiroto; Tatekoshi, Yuki; Mizuno, Masashi; Abe, Koki; Miura, Tetsuji			Distinct impacts of sleep-disordered breathing on glycemic variability in patients with and without diabetes mellitus	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; APNEA-HYPOPNEA SYNDROME; BODY-MASS INDEX; HEART-FAILURE; INSULIN SENSITIVITY; EJECTION FRACTION; GLUCOSE; HYPERGLYCEMIA; PREVALENCE; THERAPY	Background Sleep-disordered breathing (SDB) is highly prevalent in patients with diabetes mellitus (DM) and heart failure (HF) and contributes to poor cardiovascular outcomes. Enlarged glycemic variability (GV) is a risk factor of cardiac events independently of average blood glucose level, but the influence of SDB on GV is uncertain. In this study, we examined whether the impact of SDB on GV is modified by the presence of DM with or without HF. Methods and results Two hundred three patients (67.5 +/- 14.1 [ SD] years old, 132 males) who were admitted to our institute for examination or treatment of DM and/or HF underwent continuous glucose monitoring and polysomnography. Both HbA1c (8.0 +/- 2.0 vs. 5.7 +/- 0.4%) and mean amplitude of glycemic excursion (MAGE, median: 95.5 vs. 63.5 mg/dl) were significantly higher in a DM group (n = 100) than in a non-DM group (n = 103), but apnea-hypopnea index (AHI: 29.0 +/- 22.7 vs. 29.3 +/- 21.5) was similar in the two groups. AHI was correlated with log MAGE in the non-DM group but not in the DM group, and multivariate regression analysis revealed that AHI was an independent variable for log MAGE in the non-DM group but not in the DM group. We then divided the non-DM patients into two subgroups according to BNP level (100 pg/ml). AHI was positively correlated with log MAGE (r = 0.74, p<0.001) in the non-DM low-BNP subgroup, but such a correlation was not found in the non-DM high-BNP subgroup. Continuous positive airway pressure (CPAP) reduced MAGE from 75.3 to 53.0 mg/dl in the non-DM group but did not reduce MAGE in the DM group. Conclusion Severity of SDB was associated with higher GV, but DM as well as HF diminished the contribution of SDB to GV. Treatment with CPAP was effective for reduction of GV only in patients without DM.	[Nakata, Kei; Miki, Takayuki; Tanno, Masaya; Ohnishi, Hirofumi; Yano, Toshiyuki; Muranaka, Atsuko; Sato, Tatsuya; Oshima, Hiroto; Tatekoshi, Yuki; Mizuno, Masashi; Abe, Koki; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan; [Ohnishi, Hirofumi] Sapporo Med Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Sato, Tatsuya] Sapporo Med Univ, Sch Med, Dept Cellular Physiol & Signal Transduct, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Miki, T (corresponding author), Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan.	tmiki@sapmed.ac.jp		Ohnishi, Hirofumi/0000-0002-5873-6438	Hokkaido Heart Association Grant for Research; Philips Respironics; Novartis Pharma Research Grant	Hokkaido Heart Association Grant for Research; Philips Respironics; Novartis Pharma Research Grant	This study was supported by Hokkaido Heart Association Grant for Research, a grant from Philips Respironics and Novartis Pharma Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjan VY, 2012, AM J CARDIOL, V110, P870, DOI 10.1016/j.amjcard.2012.05.014; Aronsohn RS, 2010, AM J RESP CRIT CARE, V181, P507, DOI 10.1164/rccm.200909-1423OC; Babu AR, 2005, ARCH INTERN MED, V165, P447, DOI 10.1001/archinte.165.4.447; Bitter T, 2009, EUR J HEART FAIL, V11, P602, DOI 10.1093/eurjhf/hfp057; Botros N, 2009, AM J MED, V122, P1122, DOI 10.1016/j.amjmed.2009.04.026; Dawson A, 2008, J CLIN SLEEP MED, V4, P538; Dungan K, 2016, J DIABETES COMPLICAT, V30, P150, DOI 10.1016/j.jdiacomp.2015.09.009; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Feng Y, 2015, NPJ PRIM CARE RESP M, V25, DOI 10.1038/npjpcrm.2015.5; Foster GD, 2009, DIABETES CARE, V32, P1017, DOI 10.2337/dc08-1776; Furugen M, 2012, J HUM HYPERTENS, V26, P325, DOI 10.1038/jhh.2011.23; Gallegos Lucy, 2014, Hosp Pract (1995), V42, P31, DOI 10.3810/hp.2014.04.1101; Gude Francisco, 2017, J Diabetes Sci Technol, V11, P780, DOI 10.1177/1932296816682031; Guo LX, 2015, CHINESE MED J-PEKING, V128, P2301, DOI 10.4103/0366-6999.163382; Hanefeld M, 2016, DIABETES CARE, V39, pS205, DOI 10.2337/dcS15-3014; Heffner JE, 2012, CHEST, V141, P1414, DOI 10.1378/chest.11-1945; Hill SA, 2014, HEART FAIL REV, V19, P421, DOI 10.1007/s10741-014-9447-6; Hla KM, 2015, SLEEP, V38, P677, DOI 10.5665/sleep.4654; Hui PL, 2016, AM J MED SCI, V351, P160, DOI 10.1016/j.amjms.2015.12.002; Jelic S, 2008, CIRCULATION, V117, P2270, DOI 10.1161/CIRCULATIONAHA.107.741512; Kent BD, 2014, EUR RESPIR J, V44, P130, DOI 10.1183/09031936.00162713; Kuroda M, 2015, JACC-CARDIOVASC INTE, V8, P800, DOI 10.1016/j.jcin.2014.11.025; Laakso M, 2014, NAT REV ENDOCRINOL, V10, P293, DOI 10.1038/nrendo.2014.29; Loke YK, 2012, CIRC-CARDIOVASC QUAL, V5, P720, DOI 10.1161/CIRCOUTCOMES.111.964783; Marin JM, 2012, JAMA-J AM MED ASSOC, V307, P2169, DOI 10.1001/jama.2012.3418; Ceron EM, 2015, ARCH BRONCONEUMOL, V51, P128, DOI 10.1016/j.arbres.2014.06.017; Menke A, 2014, ANN INTERN MED, V161, P328, DOI 10.7326/M14-0286; Miki T, 2013, HEART FAIL REV, V18, P149, DOI 10.1007/s10741-012-9313-3; Monnier L, 2003, DIABETES CARE, V26, P881, DOI 10.2337/diacare.26.3.881; Morariu EM, 2017, SLEEP BREATH, V21, P145, DOI 10.1007/s11325-016-1388-y; Muggeo M, 2000, DIABETES CARE, V23, P45, DOI 10.2337/diacare.23.1.45; Pallayova Maria, 2008, Diabetes Res Clin Pract, V81, pe8, DOI 10.1016/j.diabres.2008.03.012; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Pistrosch F, 2013, ACTA DIABETOL, V50, P587, DOI 10.1007/s00592-012-0451-9; Redline S, 2000, AM J RESP CRIT CARE, V161, P369, DOI 10.1164/ajrccm.161.2.9904031; Reichmuth KJ, 2005, AM J RESP CRIT CARE, V172, P1590, DOI 10.1164/rccm.200504-637OC; Riehle C, 2016, CIRC RES, V118, P1151, DOI 10.1161/CIRCRESAHA.116.306206; SERVICE FJ, 1970, DIABETES, V19, P644, DOI 10.2337/diab.19.9.644; Su G, 2013, DIABETES CARE, V36, P1026, DOI 10.2337/dc12-0925; Suh S, 2014, DIABETES METAB, V40, P272, DOI 10.1016/j.diabet.2014.01.006; Tamura A, 2012, SLEEP MED, V13, P1050, DOI 10.1016/j.sleep.2012.04.007; Wang HQ, 2007, J AM COLL CARDIOL, V49, P1625, DOI 10.1016/j.jacc.2006.12.046; Yang D, 2013, SLEEP BREATH, V17, P33, DOI 10.1007/s11325-012-0680-8; Zhou JA, 2011, MED SCI MONITOR, V17, pCR9, DOI 10.12659/MSM.881318	44	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0188689	10.1371/journal.pone.0188689	http://dx.doi.org/10.1371/journal.pone.0188689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261679	Green Submitted, gold, Green Published			2022-12-26	WOS:000418554900009
J	Naves, LL; da Silva, MV; Fajardo, EF; da Silva, RB; De Vito, FB; Rodrigues, V; Lages-Silva, E; Ramirez, LE; Pedrosa, AL				Naves, Lucila Langoni; da Silva, Marcos Vinicius; Fajardo, Emanuella Francisco; da Silva, Raissa Bernardes; De Vito, Fernanda Bernadelli; Rodrigues, Virmondes; Lages-Silva, Eliane; Ramirez, Luis Eduardo; Pedrosa, Andre Luiz			DNA content analysis allows discrimination between Trypanosoma cruzi and Trypanosoma rangeli	PLOS ONE			English	Article							GENETIC EXCHANGE; KP1(-) STRAINS; LINEAGES; PARASITE; SEQUENCE; MARKERS; REGION; GENOME; BRAZIL; RAPD	Trypanosoma cruzi, a human protozoan parasite, is the causative agent of Chagas disease. Currently the species is divided into six taxonomic groups. The genome of the CL Brener clone has been estimated to be 106.4 +/- 110.7 Mb, and DNA content analyses revealed that it is a diploid hybrid clone. Trypanosoma rangeli is a hemoflagellate that has the same reservoirs and vectors as T. cruzi; however, it is non-pathogenic to vertebrate hosts. The haploid genome of T. rangeli was previously estimated to be 24 Mb. The parasitic strains of T. rangeli are divided into KP1(+) and KP1(-). Thus, the objective of this study was to investigate the DNA content in different strains of T. cruzi and T. rangeli by flow cytometry. All T. cruzi and T. rangeli strains yielded cell cycle profiles with clearly identifiable G1-0 (2n) and G2-M (4n) peaks. T. cruzi and T. rangeli genome sizes were estimated using the clone CL Brener and the Leishmania major CC1 as reference cell lines because their genome sequences have been previously determined. The DNA content of T. cruzi strains ranged from 87,41 to 108,16 Mb, and the DNA content of T. rangeli strains ranged from 63,25 Mb to 68,66 Mb. No differences in DNA content were observed between KP1(+) and KP1(-) T. rangeli strains. Cultures containing mixtures of the epimastigote forms of T. cruzi and T. rangeli strains resulted in cell cycle profiles with distinct G1 peaks for strains of each species. These results demonstrate that DNA content analysis by flow cytometry is a reliable technique for discrimination between T. cruzi and T. rangeli isolated from different hosts.	[Naves, Lucila Langoni; Fajardo, Emanuella Francisco; da Silva, Raissa Bernardes; Pedrosa, Andre Luiz] Univ Fed Triangulo Mineiro, Inst Ciencias Biol & Nat, Dept Bioquim Farmacol & Fisiol, Uberaba, Brazil; [da Silva, Marcos Vinicius; Rodrigues, Virmondes; Lages-Silva, Eliane; Ramirez, Luis Eduardo] Univ Fed Triangulo Mineiro, Inst Ciencias Biol & Nat, Dept Imunol Microbiol & Parasitol, Uberaba, Brazil; [De Vito, Fernanda Bernadelli] Univ Fed Triangulo Mineiro, Disciplina Hematol & Hemoterapia, Dept Clin Med, Uberaba, Brazil	Universidade Federal do Triangulo Mineiro; Universidade Federal do Triangulo Mineiro; Universidade Federal do Triangulo Mineiro	Pedrosa, AL (corresponding author), Univ Fed Triangulo Mineiro, Inst Ciencias Biol & Nat, Dept Bioquim Farmacol & Fisiol, Uberaba, Brazil.	andre.pedrosa@uftm.edu.br	Silva, Marcos Vinicius/AAY-1986-2020; De Vito, Fernanda/AAM-1857-2021; da Silva, Raíssa Bernardes/AAE-6357-2020; Pedrosa, Andre/C-1559-2014	Silva, Marcos Vinicius/0000-0002-2966-7621; da Silva, Raíssa Bernardes/0000-0002-2802-3808; Langoni, Lucila/0000-0002-5570-0579; Pedrosa, Andre/0000-0001-8682-813X; Rodrigues Jr, Virmondes/0000-0001-8706-4223; Fajardo, Emanuella/0000-0002-7003-085X	FAPEMIG [APQ-00613-13]; CAPES	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This project was supported by FAPEMIG (www.fapemig.br), grant number APQ-00613-13, and Lucila Langoni Naves received a fellowship from CAPES (www.capes.gov.br).	Cabrine-Santos M, 2011, PARASITOL RES, V108, P459, DOI 10.1007/s00436-010-2087-4; Cabrine-Santos M, 2009, ACTA TROP, V110, P57, DOI 10.1016/j.actatropica.2009.01.004; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Chiurillo MA, 2003, CLIN DIAGN LAB IMMUN, V10, P775, DOI 10.1128/CDLI.10.5.775-779.2003; Cosentino RO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001777; de Moraes MH, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-20; DEGRAVE W, 1988, MOL BIOCHEM PARASIT, V27, P63, DOI 10.1016/0166-6851(88)90025-4; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Ferreira KAM, 2007, PARASITOL RES, V101, P1383, DOI 10.1007/s00436-007-0654-0; Hotez PJ, 2014, PLOS NEGL TROP DIS; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Lewis MD, 2009, INT J PARASITOL, V39, P1305, DOI 10.1016/j.ijpara.2009.04.001; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Ferreira KAM, 2014, PARASITOL RES, V113, P2199, DOI 10.1007/s00436-014-3872-2; Sincero TCM, 2015, INT J PARASITOL, V45, P225, DOI 10.1016/j.ijpara.2014.11.004; Marquez DS, 2007, EXP PARASITOL, V117, P35, DOI 10.1016/j.exppara.2007.03.007; Messenger LA, 2015, ACTA TROP, V151, P150, DOI 10.1016/j.actatropica.2015.05.007; Ortiz PA, 2009, ACTA TROP, V112, P249, DOI 10.1016/j.actatropica.2009.07.036; Pedroso A, 2003, MOL BIOCHEM PARASIT, V129, P79, DOI 10.1016/S0166-6851(03)00096-3; Souto RP, 1999, EXP PARASITOL, V91, P306, DOI 10.1006/expr.1998.4380; Souza RT, 2011, PLOS ONE; STEINDEL M, 1994, J EUKARYOT MICROBIOL, V41, P261, DOI 10.1111/j.1550-7408.1994.tb01506.x; Stoco P, 2014, PLOS NEGL TROP DIS; Suarez BA, 2007, BIOMEDICA, V27, P410, DOI 10.7705/biomedica.v27i3.203; Vallejo GA, 2002, ACTA TROP, V81, P77, DOI 10.1016/S0001-706X(01)00186-3; Wang L., 2017, CURR PROTOC CYTOM; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	29	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189907	10.1371/journal.pone.0189907	http://dx.doi.org/10.1371/journal.pone.0189907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261763	Green Published, gold, Green Submitted			2022-12-26	WOS:000418554900039
J	Renault, V; Tost, J; Pichon, F; Wang-Renault, SF; Letouze, E; Imbeaud, S; Zucman-Rossi, J; Deleuze, JF; How-Kit, A				Renault, Victor; Tost, Jorg; Pichon, Fabien; Wang-Renault, Shu-Fang; Letouze, Eric; Imbeaud, Sandrine; Zucman-Rossi, Jessica; Deleuze, Jean-Francois; How-Kit, Alexandre			aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations	PLOS ONE			English	Article							CANCER; HETEROZYGOSITY; IDENTIFICATION; ABERRATIONS; ANEUPLOIDY; DISCOVERY; MUTATION	Motivation Copy number variations (CNV) include net gains or losses of part or whole chromosomal regions. They differ from copy neutral loss of heterozygosity (cn-LOH) events which do not induce any net change in the copy number and are often associated with uniparental disomy. These phenomena have long been reported to be associated with diseases and particularly in cancer. Losses/gains of genomic regions are often correlated with lower/higher gene expression. On the other hand, loss of heterozygosity (LOH) and cn-LOH are common events in cancer and may be associated with the loss of a functional tumor suppressor gene. Therefore, identifying recurrent CNV and cn-LOH events can be important as they may highlight common biological components and give insights into the development or mechanisms of a disease. However, no currently available tools allow a comprehensive whole-genome visualization of recurrent CNVs and cn-LOH in groups of samples providing absolute quantification of the aberrations leading to the loss of potentially important information. Results To overcome these limitations, we developed aCNViewer (Absolute CNV Viewer), a visualization tool for absolute CNVs and cn-LOH across a group of samples. aCNViewer proposes three graphical representations: dendrograms, bi-dimensional heatmaps showing chromosomal regions sharing similar abnormality patterns, and quantitative stacked histograms facilitating the identification of recurrent absolute CNVs and cn-LOH. We illustrated aCNViewer using publically available hepatocellular carcinomas (HCCs) Affymetrix SNP Array data (Fig 1A). Regions 1q and 8q present a similar percentage of total gains but significantly different copy number gain categories (p-value of 0.0103 with a Fisher exact test), validated by another cohort of HCCs (p-value of 5.6e-7) (Fig 2B). Availability and implementation aCNViewer is implemented in python and R and is available with a GNU GPLv3 license on GitHub	[Renault, Victor; Deleuze, Jean-Francois] Fdn Jean Dausset CEPH, Lab Bioinformat, Paris, France; [Renault, Victor; Deleuze, Jean-Francois; How-Kit, Alexandre] Lab Excellence GenMed, Paris, France; [Tost, Jorg; Pichon, Fabien; Wang-Renault, Shu-Fang; Deleuze, Jean-Francois] CEA, Inst Biol Francois Jacob, Ctr Natl Rech Genom Humaine, Lab Epigenet & Environm, Evry, France; [Letouze, Eric; Imbeaud, Sandrine; Zucman-Rossi, Jessica] INSERM, IUH, Genom Fonct Tumeurs Solides, UMR 1162, Paris, France; [Deleuze, Jean-Francois; How-Kit, Alexandre] Fdn Jean Dausset CEPH, Lab Genom, Paris, France	Foundation Jean Dausset-CEPH; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Foundation Jean Dausset-CEPH	Renault, V (corresponding author), Fdn Jean Dausset CEPH, Lab Bioinformat, Paris, France.; Renault, V; How-Kit, A (corresponding author), Lab Excellence GenMed, Paris, France.; How-Kit, A (corresponding author), Fdn Jean Dausset CEPH, Lab Genom, Paris, France.	victor.renault@cephb.fr; ahowkit@cephb.fr	Letouzé, Eric/AAP-9924-2020; j, zucman-rossi/AAV-3594-2021; Tost, Joerg/H-7129-2019; Kit, Alexandre How/AAE-9891-2019; zucman-rossi, Jessica/B-5098-2009; Imbeaud, Sandrine/P-8780-2017	Letouzé, Eric/0000-0002-6369-2839; j, zucman-rossi/0000-0002-5687-0334; Tost, Joerg/0000-0002-2683-0817; zucman-rossi, Jessica/0000-0002-5687-0334; RENAULT, Shufang/0000-0001-9234-1002; Pichon, Fabien/0000-0002-5746-6018; Imbeaud, Sandrine/0000-0001-8439-6732; Renault, Victor/0000-0001-8351-7168				Abbey DA, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0100-8; Andor N, 2016, NAT MED, V22, P105, DOI 10.1038/nm.3984; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; CHEN W, 2005, BMC BIOINFORMATICS, V6; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Durrbaum M, 2016, FEBS J, V283, P791, DOI 10.1111/febs.13591; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Gamazon ER, 2015, BRIEF FUNCT GENOMICS, V14, P352, DOI 10.1093/bfgp/elv017; Gheldof N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079973; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li A, 2011, NUCLEIC ACIDS RES, V39, P4928, DOI 10.1093/nar/gkr014; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Myers CL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-146; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ryland GL, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0123-z; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Van De Wiel MA, 2007, CANC INFORM, V3; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Yau C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r92; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	35	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189334	10.1371/journal.pone.0189334	http://dx.doi.org/10.1371/journal.pone.0189334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261730	gold, Green Published, Green Submitted			2022-12-26	WOS:000418554900015
J	Bargiotas, P; Eugster, L; Oberholzer, M; Debove, I; Lachenmayer, ML; Mathis, J; Pollo, C; Schupbach, WMM; Bassetti, CL				Bargiotas, Panagiotis; Eugster, Lukas; Oberholzer, Michael; Debove, Ines; Lachenmayer, M. Lenard; Mathis, Johannes; Pollo, Claudio; Schupbach, W. M. Michael; Bassetti, Claudio L.			Sleep-wake functions and quality of life in patients with subthalamic deep brain stimulation for Parkinson's disease	PLOS ONE			English	Article							NUCLEUS STIMULATION; BILATERAL STIMULATION; DAYTIME SLEEPINESS; WAKEFULNESS TEST; APATHY; CRITIQUE; SCALES; DISTURBANCES; ARCHITECTURE; INDIVIDUALS	Objectives Sleep-wake disturbances (SWD) are frequent in Parkinson's disease (PD). The effect of deep brain stimulation (DBS) on SWD is poorly known. In this study we examined the subjective and objective sleep-wake profile and the quality of life (QoL) of PD patients in the context of subthalamic DBS. Patients and methods We retrospectively analyzed data from PD patients and candidates for DBS in the nucleus suthalamicus (STN). Pre-DBS, sleep-wake assessments included subjective and objective (polysomnography, vigilance tests and actigraphy) measures. Post-DBS, subjective measures were collected. QoL was assessed using the Parkinson's Disease Questionnaire (PDQ-39) and the RAND SF-36-item Health Survey (RAND SF-36). Results Data from 74 PD patients (62% male, mean age 62.2 years, SD = 8.9) with a mean UPDRS-III (OFF) of 34.2 (SD = 14.8) and 11.8 (SD = 4.5) years under PD treatment were analyzed. Pre-DBS, daytime sleepiness, apathy, fatigue and depressive symptoms were present in 49%, 34%, 38% and 25% of patients respectively but not always as co-occurring symptoms. Sleep-wake disturbances were significantly correlated with QoL scores. One year after STN DBS, motor signs, QoL and sleepiness improved but apathy worsened. Changes in QoL were associated with changes in sleepiness and apathy but baseline sleep-wake functions were not predictive of STN DBS outcome. Conclusion In PD patients presenting for STN DBS, subjective and objective sleep-wake disturbances are common and have a negative impact on QoL before and after neurosurgery. Given the current preliminary evidence, prospective observational studies assessing subjective and objective sleep-wake variables prior to and after DBS are needed.	[Bargiotas, Panagiotis; Eugster, Lukas; Oberholzer, Michael; Debove, Ines; Lachenmayer, M. Lenard; Mathis, Johannes; Schupbach, W. M. Michael; Bassetti, Claudio L.] Inselspital Bern, Univ Hosp, Dept Neurol, Bern, Switzerland; [Bargiotas, Panagiotis; Eugster, Lukas; Oberholzer, Michael; Debove, Ines; Lachenmayer, M. Lenard; Mathis, Johannes; Pollo, Claudio; Schupbach, W. M. Michael; Bassetti, Claudio L.] Univ Bern, Bern, Switzerland; [Pollo, Claudio] Inselspital Bern, Univ Hosp, Dept Neurosurg, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Bargiotas, P (corresponding author), Inselspital Bern, Univ Hosp, Dept Neurol, Bern, Switzerland.; Bargiotas, P (corresponding author), Univ Bern, Bern, Switzerland.	panagiotis.bargiotas@insel.ch		Bargiotas, Panagiotis/0000-0001-6502-8942; Bassetti, Claudio/0000-0002-4535-0245				Bargiotas P, 2016, CURR OPIN NEUROL, V29, P763, DOI 10.1097/WCO.0000000000000388; Bassetti CL, 2011, NEURODEGENER DIS, V8, P95, DOI 10.1159/000316613; Baumann-Vogel H, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx033; CARSKADON MA, 1982, SLEEP, V5, pS67, DOI 10.1093/sleep/5.S2.S67; CASC I, 2007, AASM MAN SCOR SLEEP; Castelli L, 2007, J NEUROL, V254, P1238, DOI 10.1007/s00415-006-0510-7; Chahine LM, 2011, PARKINSONISM RELAT D, V17, P208, DOI 10.1016/j.parkreldis.2010.11.017; Charles PD, 2002, NEUROLOGY, V59, P932, DOI 10.1212/WNL.59.6.932; Chou KL, 2012, PARKINSONISM RELAT D, V18, P510, DOI 10.1016/j.parkreldis.2012.01.018; Cicolin A, 2004, SLEEP MED, V5, P207, DOI 10.1016/j.sleep.2003.10.010; Czernecki V, 2005, J NEUROL NEUROSUR PS, V76, P775, DOI 10.1136/jnnp.2003.033258; Czernecki V, 2008, MOVEMENT DISORD, V23, P964, DOI 10.1002/mds.21949; Daniels C, 2011, MOVEMENT DISORD, V26, P2516, DOI 10.1002/mds.23907; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Di Fabio N, 2013, EUR NEUROL, V70, P297, DOI 10.1159/000353378; Doghramji K, 1997, ELECTROEN CLIN NEURO, V103, P554, DOI 10.1016/S0013-4694(97)00010-2; Drapier D, 2008, NEUROPSYCHOLOGIA, V46, P2796, DOI 10.1016/j.neuropsychologia.2008.05.006; Drapier D, 2006, J NEUROL, V253, P1083, DOI 10.1007/s00415-006-0177-0; Eugster L, 2016, DEEP BRAIN STIMULATI; Floden D, 2015, MOVEMENT DISORD, V30, P1279, DOI 10.1002/mds.26292; Funkiewiez A, 2006, MOVEMENT DISORD, V21, P1656, DOI 10.1002/mds.21029; Higuchi M, 2015, NEUROMODULATION, V18, P113, DOI 10.1111/ner.12183; Hogl B, 2010, MOVEMENT DISORD, V25, P2704, DOI 10.1002/mds.23190; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Iranzo A, 2002, J NEUROL NEUROSUR PS, V72, P661, DOI 10.1136/jnnp.72.5.661; Jaggi JL, 2004, STEREOT FUNCT NEUROS, V82, P104, DOI 10.1159/000078145; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Landolt HP, 2006, NEUROLOGY, V66, P1418, DOI 10.1212/01.wnl.0000210445.16135.56; Le Jeune F, 2009, NEUROLOGY, V73, P1746, DOI 10.1212/WNL.0b013e3181c34b34; Lewis CJ, 2015, PSYCHOL MED, V45, P73, DOI 10.1017/S0033291714001081; Lezcano E, 2004, EUR J NEUROL, V11, P451, DOI 10.1111/j.1468-1331.2004.00804.x; Lezcano E, 2016, J NEUROLOGY; Lezcano E, 2016, J NEUROL, V263, P895, DOI 10.1007/s00415-016-8077-4; Lhommee E, 2012, BRAIN, V135, P1463, DOI 10.1093/brain/aws078; Lilleeng B, 2015, ACTA NEUROLOGICA SCA; Lyons KE, 2006, J NEUROSURG, V104, P502, DOI 10.3171/jns.2006.104.4.502; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P2371, DOI 10.1002/mds.23834; McDonald LM, 2012, MOVEMENT DISORD, V27, P372, DOI 10.1002/mds.24035; MITLER MM, 1982, ELECTROEN CLIN NEURO, V53, P658, DOI 10.1016/0013-4694(82)90142-0; Monaca C, 2004, J NEUROL, V251, P214, DOI 10.1007/s00415-004-0305-7; Moser D, 2009, SLEEP, V32, P139, DOI 10.1093/sleep/32.2.139; Nishida N, 2011, MOVEMENT DISORD, V26, P2418, DOI 10.1002/mds.23862; Nowacki A, 2017, OPERATIVE NEUROSURGE; Oertel MF, 2017, ACTA NEUROCHIR, V159, P265, DOI 10.1007/s00701-016-3044-5; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Peppe A, 2012, SLEEP, V35, P1637, DOI 10.5665/sleep.2234; PETO V, 1995, QUAL LIFE RES, V4, P241, DOI 10.1007/BF02260863; Pham UHG, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/461453; Pollo C, 2014, BRAIN, V137, P2015, DOI 10.1093/brain/awu102; Rouille A, 2015, J NEUROL SCI, V359, P260, DOI 10.1016/j.jns.2015.11.012; Schrag A, 2000, MOVEMENT DISORD, V15, P1112, DOI 10.1002/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A; Schrag A, 2007, MOVEMENT DISORD, V22, P1077, DOI 10.1002/mds.21333; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Valko PO, 2008, SLEEP, V31, P1601, DOI 10.1093/sleep/31.11.1601; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Welter ML, 2014, NEUROLOGY, V82, P1352, DOI 10.1212/WNL.0000000000000315; Welter ML, 2002, BRAIN, V125, P575, DOI 10.1093/brain/awf050; Witt K, 2011, J NEUROL SCI, V310, P261, DOI 10.1016/j.jns.2011.06.028	60	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0190027	10.1371/journal.pone.0190027	http://dx.doi.org/10.1371/journal.pone.0190027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ5HM	29253029	Green Submitted, Green Published, gold			2022-12-26	WOS:000418389500085
J	Jarvi, SI; Quarta, S; Jacquier, S; Howe, K; Bicakci, D; Dasalla, C; Lovesy, N; Snook, K; McHugh, R; Niebuhr, CN				Jarvi, Susan I.; Quarta, Stefano; Jacquier, Steven; Howe, Kathleen; Bicakci, Deniz; Dasalla, Crystal; Lovesy, Noelle; Snook, Kirsten; McHugh, Robert; Niebuhr, Chris N.			High prevalence of Angiostrongylus cantonensis (rat lungworm) on eastern Hawai'i Island: A closer look at life cycle traits and patterns of infection in wild rats (Rattus spp.)	PLOS ONE			English	Article							NORVEGICUS; BIOLOGY; WORM	The nematode Angiostrongylus cantonensis is a zoonotic pathogen and the etiological agent of human angiostrongyliasis or rat lungworm disease. Hawai'i, particularly east Hawai'i Island, is the epicenter for angiostrongyliasis in the USA. Rats (Rattus spp.) are the definitive hosts while gastropods are intermediate hosts. The main objective of this study was to collect adult A. cantonensis from wild rats to isolate protein for the development of a blood-based diagnostic, in the process we evaluated the prevalence of infection in wild rats. A total of 545 wild rats were sampled from multiple sites in the South Hilo District of east Hawai'i Island. Adult male and female A. cantonensis (3,148) were collected from the hearts and lungs of humanely euthanized Rattus rattus, and R. exulans. Photomicrography and documentation of multiple stages of this parasitic nematode in situ were recorded. A total of 45.5% (197/433) of rats inspected had lung lobe(s) (mostly upper right) which appeared granular indicating this lobe may serve as a filter for worm passage to the rest of the lung. Across Rattus spp., 72.7% (396/545) were infected with adult worms, but 93.9% (512/545) of the rats were positive for A. cantonensis infection based on presence of live adult worms, encysted adult worms, L3 larvae and/or by PCR analysis of brain tissue. In R. rattus we observed an inverse correlation with increased body mass and infection level of adult worms, and a direct correlation between body mass and encysted adult worms in the lung tissue, indicating that larger (older) rats may have developed a means of clearing infections or regulating the worm burden upon reinfection. The exceptionally high prevalence of A. cantonensis infection in Rattus spp. in east Hawai'i Island is cause for concern and indicates the potential for human infection with this emerging zoonosis is greater than previously thought.	[Jarvi, Susan I.; Quarta, Stefano; Jacquier, Steven; Howe, Kathleen; Bicakci, Deniz; Dasalla, Crystal; Lovesy, Noelle; Snook, Kirsten; McHugh, Robert] Univ Hawaii, Dept Pharmaceut Sci, Daniel K Inouye Coll Pharm, Hilo, HI 96720 USA; [Niebuhr, Chris N.] USDA APHIS WS Natl Wildlife Res Ctr, Hawaii Field Stn, Hilo, HI USA	University of Hawaii System; University Hawaii Hilo; United States Department of Agriculture (USDA)	Jarvi, SI (corresponding author), Univ Hawaii, Dept Pharmaceut Sci, Daniel K Inouye Coll Pharm, Hilo, HI 96720 USA.	jarvi@hawaii.edu		Niebuhr, Chris/0000-0002-8892-3605; Jarvi, Susan/0000-0002-9824-0509	Hawaii Community Foundation Medical Research [16CON-78923]; Daniel K. Inouye College of Pharmacy at the University of Hawaii at Hilo; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103466] Funding Source: NIH RePORTER	Hawaii Community Foundation Medical Research; Daniel K. Inouye College of Pharmacy at the University of Hawaii at Hilo; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for this study was provided by the Hawaii Community Foundation Medical Research ID#16CON-78923, https://www.hawaiicommunityfoundation.org/grants/medical-research-grants, and the Daniel K. Inouye College of Pharmacy at the University of Hawaii at Hilo, http://pharmacy.uhh.hawaii.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON IAE, 1977, PAC SCI, V31, P109; AU ACS, 1979, Z PARASITENKD, V58, P233, DOI 10.1007/BF00933930; Barratt J, 2016, PARASITOLOGY, V143, P1087, DOI 10.1017/S0031182016000652; Chan D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128128; Chen H. T., 1935, Annales de Parasitologie Paris, V13, P312; HIRATA DN, 1974, J MAMMAL, V55, P472, DOI 10.2307/1379024; Hollingsworth RG, 2007, PAC SCI, V61, P457, DOI 10.2984/1534-6188(2007)61[457:DOPCMP]2.0.CO;2; Iwanowicz DD, 2015, J WILDLIFE DIS, V51, P749, DOI 10.7589/2014-06-160; Jarvi SI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123064; Jarvi SI, 2012, MOL BIOCHEM PARASIT, V185, P174, DOI 10.1016/j.molbiopara.2012.08.002; Kim JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094969; KLIKS MM, 1992, SOC SCI MED, V34, P199, DOI 10.1016/0277-9536(92)90097-A; KRAMER RJ, 1971, HAWAIIAN LAND MAMMAL; Long JL, 2003, INTRO MAMMALS WORLD; Lv S, 2009, PARASITOL RES, V104, P1351, DOI 10.1007/s00436-009-1334-z; MACKERRAS M. JOSEPHINE, 1955, AUSTRALIAN JOUR ZOOL, V3, P1, DOI 10.1071/ZO9550001; Marsh RE., 1994, PREVENTION CONTROL W, V6, P125; Qvarnstrom Yvonne, 2013, Hawaii J Med Public Health, V72, P63; ROSEN L, 1962, JAMA-J AM MED ASSOC, V179, P620, DOI 10.1001/jama.1962.03050080032007; Shiels AB, 2014, PAC SCI, V68, P145, DOI 10.2984/68.2.1; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Simoes RO, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-100; Sugihara RT, 2002, PROC VERTEBR PEST C, P40; Teem JL, 2013, HAWAII J MED PUBL S2, V72, P10; Tobin M. E., 1994, PREV CONTROL WILDL D, pB121; Walden HDS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177910; Wang QP, 2012, EUR J CLIN MICROBIOL, V31, P389, DOI 10.1007/s10096-011-1328-5; Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9; WEBSTER JP, 1995, PARASITOLOGY, V111, P247, DOI 10.1017/S0031182000081804; Wilmshursta JM, 2011, PNAS, V108; York EM, 2015, EMERG INFECT DIS, V21, P1234, DOI 10.3201/eid2107.141980	31	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189458	10.1371/journal.pone.0189458	http://dx.doi.org/10.1371/journal.pone.0189458			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29252992	Green Published, gold			2022-12-26	WOS:000418389500028
J	Li, X; Zhao, Y; Wang, KJ; Wang, L; Yang, XH; Zhu, SQ				Li, Xiao; Zhao, Yang; Wang, Kaijie; Wang, Lei; Yang, Xiaohui; Zhu, Siquan			Cyclodextrin-containing hydrogels as an intraocular lens for sustained drug release	PLOS ONE			English	Article							POSTERIOR CAPSULE OPACIFICATION; CATARACT-SURGERY; DELIVERY SYSTEM; BETA-CYCLODEXTRIN; RISK-FACTORS; IN-VITRO; EYE; ENDOPHTHALMITIS; DEXAMETHASONE; INFLAMMATION	To improve the efficacy of anti-inflammatory factors in patients who undergo cataract surgery, poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) (p(HEMA-co-MMA)) hydrogels containing beta-cyclodextrin (beta-CD) (pHEMA/MMA/beta-CD) were designed and prepared as intraocular lens (IOLs) biomaterials that could be loaded with and achieve the sustained release of dexamethasone. A series of pHEMA/MMA/beta-CD copolymers containing different ratios of beta-CD (range, 2.77 to 10.24 wt.%) were obtained using thermal polymerization. The polymers had high transmittance at visible wavelengths and good biocompatibility with mouse connective tissue fibroblasts. Drug loading and release studies demonstrated that introducing beta-CD into hydrogels increased loading efficiency and achieved the sustained release of the drug. Administering beta-CD via hydrogels increased the equilibrium swelling ratio, elastic modulus and tensile strength. In addition, beta-CD increased the hydrophilicity of the hydrogels, resulting in a lower water contact angle and higher cellular adhesion to the hydrogels. In summary, pHEMA/MMA/beta-CD hydrogels show great potential as IOL biomaterials that are capable of maintaining the sustained release of anti-inflammatory drugs after cataract surgery.	[Li, Xiao; Zhao, Yang; Wang, Kaijie; Yang, Xiaohui; Zhu, Siquan] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Key Lab Ophthalmol & Visual Sci, Beijing, Peoples R China; [Wang, Lei] Natl Ctr Nanosci & Technol NCNST, CAS Ctr Excellence Nanosci, CAS Key Lab Biol Effects Nanomaterials & Nanosafe, Beijing, Peoples R China; [Yang, Xiaohui] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Capital Medical University	Yang, XH; Zhu, SQ (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Key Lab Ophthalmol & Visual Sci, Beijing, Peoples R China.; Wang, L (corresponding author), Natl Ctr Nanosci & Technol NCNST, CAS Ctr Excellence Nanosci, CAS Key Lab Biol Effects Nanomaterials & Nanosafe, Beijing, Peoples R China.; Yang, XH (corresponding author), Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China.	wanglei@nanoctr.cn; iamtrxhy@163.com; siquanzhu@sina.com			National Natural Science Foundation of China [51573101]; Beijing Nova Program [Z151100000315096]; Program of Beijing Municipal Science and Technology [Z141100000214008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission); Program of Beijing Municipal Science and Technology(Beijing Municipal Science & Technology Commission)	This work is supported by National Natural Science Foundation of China (51573101), Beijing Nova Program (Z151100000315096), Program of Beijing Municipal Science and Technology (Z141100000214008). All the fundings are from government for fundamental research.	Abadia B, 2016, DRUG AGING, V33, P639, DOI 10.1007/s40266-016-0392-z; Alvarez-Lorenzo C, 2010, J PHARM SCI, V91, P2182; An JA, 2014, J CATARACT REFR SURG, V40, P1857, DOI 10.1016/j.jcrs.2014.02.037; Anderson EM, 2009, BIOMATERIALS, V30, P5675, DOI 10.1016/j.biomaterials.2009.06.047; Baillif S, 2013, OPHTHALMIC RES, V50, P165, DOI 10.1159/000348738; Barry P, 2007, J CATARACT REFR SURG, V33, P978, DOI 10.1016/j.jcrs.2007.02.032; Bellan L, 2008, CAN J OPHTHALMOL, V43, pS7, DOI [10.1139/i08-133, 10.3129/i08-133]; Buehl W, 2008, J CATARACT REFR SURG, V34, P1976, DOI 10.1016/j.jcrs.2008.07.029; Cetinel S, 2015, ASIA-PAC J OPHTHALMO, V4, P381, DOI 10.1097/APO.0000000000000156; Chen PQ, 2016, INT J OPHTHALMOL-CHI, V9, P1619, DOI 10.18240/ijo.2016.11.13; de Groot JH, 2003, BIOMACROMOLECULES, V4, P608, DOI 10.1021/bm0257053; ElShaer A, 2014, THER DELIV, V5, P1085, DOI [10.4155/TDE.14.73, 10.4155/tde.14.73]; Eperon S, 2008, INT J PHARMACEUT, V352, P240, DOI 10.1016/j.ijpharm.2007.10.054; Fundueanu G, 2003, J CHROMATOGR B, V791, P407, DOI 10.1016/S1570-0232(03)00258-7; Garty S, 2011, INVEST OPHTH VIS SCI, V52, P6109, DOI 10.1167/iovs.10-6071; Gonzalez-Chomon C, 2011, MATERIALS, V4, P1927, DOI 10.3390/ma4111927; Jabbarvand M, 2016, OPHTHALMOLOGY, V123, P295, DOI 10.1016/j.ophtha.2015.08.023; Katayama Y, 2007, OPHTHALMIC RES, V39, P276, DOI 10.1159/000108121; Kugelberg M, 2008, ACTA OPHTHALMOL, V86, P533, DOI 10.1111/j.1600-0420.2007.01094.x; Kugelberg M, 2010, ACTA OPHTHALMOL, V88, P241, DOI 10.1111/j.1755-3768.2008.01419.x; Lane SS, 2004, J CATARACT REFR SURG, V30, P2397, DOI 10.1016/j.jcrs.2004.03.041; Legeais JM, 1998, J CATARACT REFR SURG, V24, P371, DOI 10.1016/S0886-3350(98)80326-X; Linnola RJ, 1997, J CATARACT REFR SURG, V23, P1539, DOI 10.1016/S0886-3350(97)80026-0; Liu YC, 2013, CURR OPIN OPHTHALMOL, V24, P53, DOI 10.1097/ICU.0b013e32835a93fc; Loftsson T, 2005, INT J PHARMACEUT, V302, P18, DOI 10.1016/j.ijpharm.2005.05.042; Loftsson T, 2002, ACTA OPHTHALMOL SCAN, V80, P144, DOI 10.1034/j.1600-0420.2002.800205.x; MATSUI Y, 1993, B CHEM SOC JPN, V66, P2827, DOI 10.1246/bcsj.66.2827; Mccoy CP, 2012, BIOMATERIALS, V33, P7952, DOI 10.1016/j.biomaterials.2012.07.052; MCDONNELL PJ, 1985, ARCH OPHTHALMOL-CHIC, V103, P1378, DOI 10.1001/archopht.1985.01050090130047; Mealy JE, 2015, J MATER CHEM B, V3, P8010, DOI 10.1039/c5tb00981b; Mishra V, 2014, MACROMOL RAPID COMM, V35, P442, DOI 10.1002/marc.201300585; Musleh M, 2016, BMJ QUAL IMPROV REP, V5; Nibourg LM, 2015, EXP EYE RES, V136, P100, DOI 10.1016/j.exer.2015.03.011; Niu GG, 2009, J CONTROL RELEASE, V138, P49, DOI 10.1016/j.jconrel.2009.04.026; Parra F, 2009, BIOMACROMOLECULES, V10, P3055, DOI 10.1021/bm9006997; Porela-Tiihonen S, 2013, J CATARACT REFR SURG, V39, P789, DOI 10.1016/j.jcrs.2013.03.012; Radmall BR, 2015, CLIN OPHTHALMOL, V9, P1353, DOI 10.2147/OPTH.S86980; RASSING J, 1967, ACTA CHEM SCAND, V21, P1443, DOI 10.3891/acta.chem.scand.21-1443; Riaz Y, 2013, COCHRANE DB SYST REV, V10, DOI DOI 10.1002/14651858.CD008813.PUB2; dos Santos JFR, 2008, ACTA BIOMATER, V4, P745, DOI 10.1016/j.actbio.2007.12.008; Schauersberger J, 2001, J CATARACT REFR SURG, V27, P850, DOI 10.1016/S0886-3350(00)00861-0; Singh B, 2016, INT J BIOL MACROMOL, V92, P390, DOI 10.1016/j.ijbiomac.2016.07.060; Song L, 2011, J BIOMAT SCI-POLYM E, V22, P1, DOI 10.1163/092050609X12567412849136; Song L, 2010, J PHYS CHEM B, V114, P7172, DOI 10.1021/jp100876c; Tan DTH, 2001, OPHTHALMOLOGY, V108, P2172, DOI 10.1016/S0161-6420(01)00839-9; Tan DWN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163857; Tetz M, 2015, CURR EYE RES, V40, P969, DOI 10.3109/02713683.2014.978476; Tran DB, 2016, J CATARACT REFR SURG, V42, P1470, DOI 10.1016/j.jcrs.2016.08.019; Turalba A, 2017, CAN J OPHTHALMOL, V52, P61, DOI 10.1016/j.jcjo.2016.07.019; Walters T, 2015, J CATARACT REFR SURG, V41, P2049, DOI 10.1016/j.jcrs.2015.11.005; Wang YW, 2005, BIOMATERIALS, V26, P755, DOI 10.1016/j.biomaterials.2004.03.023; Wilson ME, 2016, EYE, V30, P1187, DOI 10.1038/eye.2016.132; Wolffsohn JS, 2006, BRIT J OPHTHALMOL, V90, P693, DOI 10.1136/bjo.2006.090951; Xu JK, 2010, ACTA BIOMATER, V6, P486, DOI 10.1016/j.actbio.2009.07.021; Yang TF, 2007, BIOMATERIALS, V28, P725, DOI 10.1016/j.biomaterials.2006.09.035; Zhang HB, 2010, BIOMATERIALS, V31, P5445, DOI 10.1016/j.biomaterials.2010.03.034; Zhang Y, 2013, CARBOHYD POLYM, V98, P638, DOI 10.1016/j.carbpol.2013.06.052	57	15	16	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189778	10.1371/journal.pone.0189778	http://dx.doi.org/10.1371/journal.pone.0189778			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244868	gold, Green Published, Green Submitted			2022-12-26	WOS:000418184700063
J	Meissner, JM; Sikorski, AF; Nawara, T; Grzesiak, J; Marycz, K; Boguslawska, DM; Michalczyk, I; Lecomte, MC; Machnicka, B				Meissner, Justyna M.; Sikorski, Aleksander F.; Nawara, Tomasz; Grzesiak, Jakub; Marycz, Krzysztof; Boguslawska, Dzamila M.; Michalczyk, Izabela; Lecomte, Marie-Christine; Machnicka, Beata			alpha ll-spectrin in T cells is involved in the regulation of cell-cell contact leading to immunological synapse formation?	PLOS ONE			English	Article							ACTIN CYTOSKELETON; DENDRITIC CELLS; SH3 DOMAIN; ACTIVATION; PROTEIN; ADHESION; CD45; TCR; THRESHOLD; INTERACTS	T-lymphocyte activation after antigen presentation to the T-Cell Receptor (TCR) is a critical step in the development of proper immune responses to infection and inflammation. This dynamic process involves reorganization of the actin cytoskeleton and signaling molecules at the cell membrane, leading to the formation of the Immunological Synapse (IS). The mechanisms regulating the formation of the IS are not completely understood. Nonerythroid spectrin is a membrane skeletal protein involved in the regulation of many cellular processes, including cell adhesion, signaling and actin cytoskeleton remodeling. However, the role of spectrin in IS formation has not been explored. We used molecular, imaging and cellular approaches to show that nonerythroid alpha ll-spectrin redistributes to the IS during T-cell activation. The redistribution of spectrin coincides with the relocation of CD45 and LFA-1, two components essential for IS formation and stability. We assessed the role of spectrin by shRNA-mediated depletion from Jurkat T cells and show that spectrin-depleted cells exhibit decreased adhesion and are defective in forming lamellipodia and filopodia. Importantly, IS formation is impaired in spectrin-depleted cells. Thus, spectrin may be engaged in regulation of distinct events necessary for the establishment and maturity of the IS: besides the involvement of spectrin in the control of CD45 and LFA-1 surface display, spectrin acts in the establishment of cell-cell contact and adhesion processes during the formation of the IS.	[Meissner, Justyna M.; Sikorski, Aleksander F.; Michalczyk, Izabela] Univ Wroclaw, Biotechnol Fac, Lab Cytobiochem, Wroclaw, Poland; [Meissner, Justyna M.; Nawara, Tomasz; Grzesiak, Jakub; Marycz, Krzysztof] Univ Environm & Life Sci Wroclaw, Fac Biol, Elect Microscopy Lab, Wroclaw, Poland; [Boguslawska, Dzamila M.; Machnicka, Beata] Univ Zielona Gora, Fac Biol Sci, Zielona Gora, Poland; [Lecomte, Marie-Christine] Univ Antilles, Univ La Reunion, Sorbonne Paris Cite,UMR S1134, Univ Paris Diderot,Inserm,Biol Integree Globule R, Paris, France	University of Wroclaw; Wroclaw University of Environmental & Life Sciences; University of Zielona Gora; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of La Reunion	Machnicka, B (corresponding author), Univ Zielona Gora, Fac Biol Sci, Zielona Gora, Poland.	b.machnicka@wnb.uz.zgora.pl	Sikorski, Aleksander/HGD-5159-2022; Grzesiak, Jakub/ABB-6774-2020; Machnicka, Beata/AAF-1677-2019; Machnicka, Beata/AAF-1814-2019; Bogusławska, Dżamila M./AAH-7281-2021; Sikorski, Aleksander F/C-3361-2009	Machnicka, Beata/0000-0002-9664-8252; Bogusławska, Dżamila M./0000-0001-9270-7510; Sikorski, Aleksander F./0000-0003-3779-8266; Nawara, Tomasz/0000-0002-4801-4095	Ministry of Science and Higher Education [8739/E-382/M/2015]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Ministry of Science and Higher Education 8739/E-382/M/2015 to Justyna M. Meissner, University of Wroclaw and University of Zielona Gora.	Bennett V, 2013, CURR TOP MEMBR, V72, P1, DOI 10.1016/B978-0-12-417027-8.00001-5; Benz PM, 2008, J CELL BIOL, V180, P205, DOI 10.1083/jcb.200709181; Bialkowska K, 2005, J CELL SCI, V118, P381, DOI 10.1242/jcs.01625; Bok E, 2007, CELL BIOL INT, V31, P1482, DOI 10.1016/j.cellbi.2007.06.014; Bournier O, 2006, BIOL CELL, V98, P279, DOI 10.1042/BC20050024; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Byrum JN, 2013, J IMMUNOL, V191, P3073, DOI 10.4049/jimmunol.1300485; Cairo CW, 2010, J BIOL CHEM, V285, P11392, DOI 10.1074/jbc.M109.075648; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Chirathaworn C, 2002, J IMMUNOL, V168, P5530, DOI 10.4049/jimmunol.168.11.5530; Cordoba SP, 2013, BLOOD, V121, P4295, DOI 10.1182/blood-2012-07-442251; Coutts AS, 2003, J CELL SCI, V116, P897, DOI 10.1242/jcs.00278; Derry JM, 1994, CELL, V79, P922; Diakowski W, 2006, FOLIA HISTOCHEM CYTO, V44, P231; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Drusco A, 2005, P NATL ACAD SCI USA, V102, P10947, DOI 10.1073/pnas.0504934102; Dustin ML, 2014, CANCER IMMUNOL RES, V2, P1023, DOI 10.1158/2326-6066.CIR-14-0161; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Gonzalez PA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/450291; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Herman S, 2012, INT IMMUNOL, V24, P417, DOI 10.1093/intimm/dxs039; Kallikourdis M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00433; Le Bras S, 2009, P NATL ACAD SCI USA, V106, P7519, DOI 10.1073/pnas.0806410106; Lin W, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0108-x; Liu JR, 2015, P NATL ACAD SCI USA, V112, pE4864, DOI 10.1073/pnas.1512025112; Lub M, 1997, MOL BIOL CELL, V8, P341, DOI 10.1091/mbc.8.2.341; Machnicka B, 2012, CELL MOL LIFE SCI, V69, P191, DOI 10.1007/s00018-011-0804-5; Machnicka B, 2014, BBA-BIOMEMBRANES, V1838, P620, DOI 10.1016/j.bbamem.2013.05.002; Marwali MR, 2003, BLOOD, V102, P215, DOI 10.1182/blood-2002-10-3195; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; Metral S, 2009, J BIOL CHEM, V284, P2409, DOI 10.1074/jbc.M801324200; Nonoyama S, 1998, CURR OPIN IMMUNOL, V10, P407, DOI 10.1016/S0952-7915(98)80113-1; Padhan K, 2010, IMMUNOLOGY, V129, P322, DOI 10.1111/j.1365-2567.2009.03241.x; Philipsen L, 2013, MOL CELL PROTEOMICS, V12, P2551, DOI 10.1074/mcp.M112.025205; Ponceau A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120781; Pradhan D, 2002, IMMUNITY, V17, P303, DOI 10.1016/S1074-7613(02)00396-5; Ramsay AG, 2008, J CLIN INVEST, V118, P2427, DOI 10.1172/JCI35017; Roszik J, 2011, EUR J IMMUNOL, V41, P1288, DOI 10.1002/eji.200940233; Rotter B, 2005, BIOCHEM J, V388, P631, DOI 10.1042/BJ20041502; Santos RF, 2016, CURR DRUG TARGETS, V17, P630, DOI 10.2174/1389450116666150531152439; Simonson WTN, 2006, J IMMUNOL, V177, P7707, DOI 10.4049/jimmunol.177.11.7707; Stankewich MC, 2011, J CELL SCI, V124, P3956, DOI 10.1242/jcs.080374; Suzuki J, 2007, BLOOD, V109, P168, DOI 10.1182/blood-2005-12-020164; Tabdanov E, 2015, INTEGR BIOL-UK, V7, P1272, DOI 10.1039/c5ib00032g; Toporkiewicz M, 2013, ARCH BIOCHEM BIOPHYS, V535, P205, DOI 10.1016/j.abb.2013.03.009; Trinh-Trang-Tan MM, 2014, EXP CELL RES, V322, P365, DOI 10.1016/j.yexcr.2014.01.012; Ueda H, 2015, J IMMUNOL, V195, P4117, DOI 10.4049/jimmunol.1402175; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Yablonski D, 2001, MOL CELL BIOL, V21, P4208, DOI 10.1128/MCB.21.13.4208-4218.2001; Yu Y, 2013, J CELL SCI, V126, P1049, DOI 10.1242/jcs.098210	52	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189545	10.1371/journal.pone.0189545	http://dx.doi.org/10.1371/journal.pone.0189545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244882	Green Submitted, gold, Green Published			2022-12-26	WOS:000418184700037
J	Vrljicak, P; Lucas, ES; Lansdowne, L; Lucciola, R; Muter, J; Dyer, NP; Brosens, JJ; Ott, S				Vrljicak, Pavle; Lucas, Emma S.; Lansdowne, Lauren; Lucciola, Raffaella; Muter, Joanne; Dyer, Nigel P.; Brosens, Jan J.; Ott, Sascha			Analysis of chromatin accessibility in decidualizing human endometrial stromal cells	FASEB JOURNAL			English	Article						endometrium; decidualization; gene regulation; open chromatin; transposable elements	BINDING-PROTEIN-BETA; PROGESTERONE-RECEPTOR; PROLACTIN EXPRESSION; EVOLUTION; IDENTIFICATION; TRANSCRIPTOME; LANDSCAPE; PREGNANCY; ALIGNMENT; ISOFORMS	Spontaneous decidualization of the endometrium in response to progesterone signaling is confined to menstruating species, including humans and other higher primates. During this process, endometrial stromal cells (EnSCs) differentiate into specialized decidual cells that control embryo implantation. We subjected undifferentiated and decidualizing human EnSCs to an assay for transposase accessible chromatin with sequencing (ATAC-seq) to map the underlying chromatin changes. A total of 185,084 open DNA loci were mapped accurately in EnSCs. Altered chromatin accessibility upon decidualization was strongly associated with differential gene expression. Analysis of 1533 opening and closing chromatin regions revealed over-representation of DNA binding motifs for known decidual transcription factors (TFs) and identified putative new regulators. ATAC-seq footprint analysis provided evidence of TF binding at specific motifs. One of the largest footprints involved the most enriched motif-basic leucine zipper-as part of a triple motif that also comprised the estrogen receptor and Pax domain binding sites. Without exception, triple motifs were located within Alu elements, which suggests a role for this primate-specific transposable element (TE) in the evolution of decidual genes. Although other TEs were generally under-represented in open chromatin of undifferentiated EnSCs, several classes contributed to the regulatory DNA landscape that underpins decidual gene expression.	[Vrljicak, Pavle; Lucas, Emma S.; Brosens, Jan J.; Ott, Sascha] Univ Warwick, Univ Hosp Coventry & Warwickshire Natl Hlth Serv, Tommys Natl Ctr Miscarriage Res, Coventry, W Midlands, England; [Vrljicak, Pavle; Lucas, Emma S.; Lucciola, Raffaella; Muter, Joanne; Brosens, Jan J.] Univ Warwick, Warwick Med Sch, Div Biomed Sci, Coventry, W Midlands, England; [Lansdowne, Lauren; Dyer, Nigel P.; Ott, Sascha] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick; University of Warwick	Ott, S (corresponding author), Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England.	s.ott@warwick.ac.uk	Lucas, Emma S/I-2719-2013; Ott, Sascha/A-1180-2011	Lucas, Emma S/0000-0002-8571-8921; Brosens, Jan/0000-0003-0116-9329	Biomedical Research Unit in Reproductive Health; University Hospitals Coventry; Warwickshire National Health Service (NHS) Trust; Warwick Medical School; Tommy's National Centre for Miscarriage Research; Midlands Integrative Biosciences Training Partnership; BBSRC [1791041] Funding Source: UKRI	Biomedical Research Unit in Reproductive Health; University Hospitals Coventry; Warwickshire National Health Service (NHS) Trust; Warwick Medical School; Tommy's National Centre for Miscarriage Research; Midlands Integrative Biosciences Training Partnership; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Angela Oliveira Pisco (King's College London, London, United Kingdom) for technical advice. The authors also thank patients attending the Implantation Clinic for contributing their endometrial tissue to research. This work was supported by the Biomedical Research Unit in Reproductive Health, a joint initiative between University Hospitals Coventry and Warwickshire National Health Service (NHS) Trust and Warwick Medical School. E.S.L., P.V., and J.J.B. are funded by Tommy's National Centre for Miscarriage Research. L.L. was funded by the Midlands Integrative Biosciences Training Partnership. The authors declare no conflicts of interest.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barros F. S. V., 2016, BIOPROTOCOL, V6; Batzer MA, 1996, J MOL EVOL, V42, P3, DOI 10.1007/BF00163204; Bellofiore N, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.07.041; Brosens JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03894; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Christian M, 2002, J BIOL CHEM, V277, P20825, DOI 10.1074/jbc.M201018200; Christian M, 2002, MOL ENDOCRINOL, V16, P141, DOI 10.1210/me.16.1.141; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emera D, 2012, BIOESSAYS, V34, P26, DOI 10.1002/bies.201100099; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Evans J, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.108175; Evans J, 2012, REV ENDOCR METAB DIS, V13, P277, DOI 10.1007/s11154-012-9223-7; GELLERSEN B, 1989, MOL CELL ENDOCRINOL, V64, P127, DOI 10.1016/0303-7207(89)90073-7; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Gonzalez D, 2012, J CLIN ENDOCR METAB, V97, P957, DOI 10.1210/jc.2011-2366; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jiang YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13735; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kaya HS, 2015, MOL ENDOCRINOL, V29, P882, DOI 10.1210/me.2014-1363; Kessler CA, 2008, MOL CELL ENDOCRINOL, V295, P32, DOI 10.1016/j.mce.2008.08.007; Kim MR, 2005, MOL HUM REPROD, V11, P801, DOI 10.1093/molehr/gah240; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Leitao B, 2010, FASEB J, V24, P1541, DOI 10.1096/fj.09-149153; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lucas ES, 2016, REPRODUCTION, V152, pR159, DOI 10.1530/REP-16-0306; Lucas ES, 2016, STEM CELLS, V34, P346, DOI 10.1002/stem.2222; Lynch VJ, 2015, CELL REP, V10, P551, DOI 10.1016/j.celrep.2014.12.052; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Lynch VJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006845; Macdonald LJ, 2011, MOL HUM REPROD, V17, P626, DOI 10.1093/molehr/gar031; Martin RD, 2007, YEARB PHYS ANTHROPOL, V50, P59, DOI 10.1002/ajpa.20734; Mason CE, 2010, NUCLEIC ACIDS RES, V38, P2355, DOI 10.1093/nar/gkp1188; Mazur EC, 2015, ENDOCRINOLOGY, V156, P2239, DOI 10.1210/en.2014-1566; Muter J, 2016, ENDOCRINOLOGY, V157, P2883, DOI 10.1210/en.2015-1914; NORRIS J, 1995, J BIOL CHEM, V270, P22777, DOI 10.1074/jbc.270.39.22777; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; RAMSEY EM, 1976, AM J OBSTET GYNECOL, V124, P647, DOI 10.1016/0002-9378(76)90068-5; Salker MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052252; Salker MS, 2011, NAT MED, V17, P1509, DOI 10.1038/nm.2498; Strassmann BI, 1996, Q REV BIOL, V71, P181, DOI 10.1086/419369; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vasquez YM, 2015, MOL ENDOCRINOL, V29, P421, DOI 10.1210/me.2014-1292; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	13	13	2	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2467	2477		10.1096/fj.201701098R	http://dx.doi.org/10.1096/fj.201701098R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29259032	Green Published, hybrid			2022-12-26	WOS:000432528000013
J	Fan, FX; Li, X; Pang, B; Zhang, C; Li, Z; Zhang, LJ; Li, J; Zhang, JY; Yan, MY; Liang, WL; Kan, B				Fan, Fenxia; Li, Xu; Pang, Bo; Zhang, Cheng; Li, Zhe; Zhang, Lijuan; Li, Jie; Zhang, Jingyun; Yan, Meiying; Liang, Weili; Kan, Biao			The outer-membrane protein TolC of Vibrio cholerae serves as a second cell-surface receptor for the VP3 phage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; GRAM-NEGATIVE BACTERIA; TRANSMEMBRANE CHANNELS; BORDETELLA-PERTUSSIS; ADENYLATE-CYCLASE; MULTIDRUG EFFLUX; YERSINIA-PESTIS; TERMINAL DOMAIN; HOST-RANGE; IDENTIFICATION	Receptor recognition is a key step in the initiation of phage infection. Previously, we found that VP3, the T7 family phage of the Vibrio cholerae serogroup O1 biotype El Tor, can adsorb the core oligosaccharide (OS) of lipopolysaccharides of V. cholerae. However, some wildtype strains of V. cholerae possessing the intact OS gene cluster still have VP3 binding but are resistant to VP3 infection. Moreover, an OS gene-deletion mutant still exhibits weak VP3 binding, suggesting multiple factors are possibly involved in VP3 binding to V. cholerae. Here, we report that the outer-membrane protein TolC of V. cholerae is involved in the host adsorption of VP3. We observed that TolC directly interacts with the VP3 tail fiber protein gp44 and its C-terminal domains, and we also found that three amino acid residues in the outside loops of TolC, at positions 78, 290, and 291, are critical for binding to gp44. Among the VP3-resistant wildtype V. cholerae strains, frequent amino acid residue mutations were observed in the loops around the sites 78, 290, and 291, which were predicted to be exposed to the cell surface. These findings reveal a co-receptor-binding mechanism for VP3 infection of V. cholerae and that both outer-membrane TolC and OS are necessary for successful VP3 infection of V. cholerae. We conclude that mutations on the outside loops of the receptor may confer V. cholerae strains with VP3 phage resistance, enabling these strains to survive in environments containing VP3 or related phages.	[Fan, Fenxia; Li, Xu; Pang, Bo; Li, Zhe; Zhang, Lijuan; Li, Jie; Zhang, Jingyun; Yan, Meiying; Liang, Weili; Kan, Biao] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China; [Liang, Weili; Kan, Biao] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Cheng] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; National Institute of Biological Sciences, Beijing	Kan, B (corresponding author), 155 Changbai Rd, Beijing 102206, Peoples R China.	kanbiao@icdc.cn	Zhang, JY/ABI-2768-2020	Zhang, JY/0000-0002-8577-7956	National Science Foundation of China [81501724]; National Basic Research Priorities Program [2015CB554201]; State Key Laboratory of Infections Disease Prevention and Control [2014SKLID101]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Priorities Program(National Basic Research Program of China); State Key Laboratory of Infections Disease Prevention and Control	This work was supported by National Science Foundation of China Youth Fund 81501724, National Basic Research Priorities Program Grant 2015CB554201, and Science Priority Grant 2014SKLID101 from the State Key Laboratory of Infections Disease Prevention and Control. The authors declare that they have no conflicts of interest with the contents of this article.	ALHENDY A, 1992, INFECT IMMUN, V60, P870, DOI 10.1128/IAI.60.3.870-875.1992; ALHENDY A, 1991, MICROB PATHOGENESIS, V10, P47, DOI 10.1016/0882-4010(91)90065-I; Aono R, 1998, J BACTERIOL, V180, P938, DOI 10.1128/JB.180.4.938-944.1998; Berrier C, 2000, FEBS LETT, V476, P129, DOI 10.1016/S0014-5793(00)01705-1; Boardman BK, 2004, J BACTERIOL, V186, P8137, DOI 10.1128/JB.186.23.8137-8143.2004; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Cescau S, 2007, J BACTERIOL, V189, P1496, DOI 10.1128/JB.01480-06; Chiang SL, 2000, INFECT IMMUN, V68, P6391, DOI 10.1128/IAI.68.11.6391-6397.2000; DATTA DB, 1977, J BACTERIOL, V131, P821, DOI 10.1128/JB.131.3.821-829.1977; DAVIES JK, 1975, J BACTERIOL, V123, P102, DOI 10.1128/JB.123.1.102-117.1975; DEZWAIG RN, 1967, J BACTERIOL, V94, P1112, DOI 10.1128/JB.94.4.1112-1123.1967; Didelot X, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005072; Disease Control Bureau of the Ministry of Health of China, 2013, 2013 MANUAL OF CHOLE; Duplessis M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/j.1365-2958.2001.02521.x; Eckert B, 2007, J MOL BIOL, V373, P452, DOI 10.1016/j.jmb.2007.07.060; Fan FX, 2014, INFECT IMMUN, V82, P1676, DOI 10.1128/IAI.01377-13; FEELEY JC, 1965, J BACTERIOL, V89, P665, DOI 10.1128/JB.89.3.665-670.1965; FEUCHT A, 1990, J BIOL CHEM, V265, P18561; FRALICK JA, 1994, J BACTERIOL, V176, P6404, DOI 10.1128/jb.176.20.6404-6406.1994; Frost JA, 1999, EPIDEMIOL INFECT, V123, P47, DOI 10.1017/S095026889900254X; Gao S, 1984, FU HUO LUAN ZI LIAO, P237; Garcia-Doval C, 2012, P NATL ACAD SCI USA, V109, P9390, DOI 10.1073/pnas.1119719109; GEHRING K, 1987, J BACTERIOL, V169, P2103, DOI 10.1128/jb.169.5.2103-2106.1987; German GJ, 2001, J MOL BIOL, V308, P579, DOI 10.1006/jmbi.2001.4578; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; HELLER KJ, 1992, ARCH MICROBIOL, V158, P235, DOI 10.1007/BF00245239; Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1; Judson N, 2000, NAT BIOTECHNOL, V18, P740, DOI 10.1038/77305; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kiljunen S, 2011, J BACTERIOL, V193, P4963, DOI 10.1128/JB.00339-11; KILLMANN H, 1995, J BACTERIOL, V177, P694, DOI 10.1128/jb.177.3.694-698.1995; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Koronakis V, 1997, MOL MICROBIOL, V23, P617, DOI 10.1046/j.1365-2958.1997.d01-1880.x; KRUGER DH, 1981, MICROBIOL REV, V45, P9; Kwan KY, 2003, P NATL ACAD SCI USA, V100, P2526, DOI 10.1073/pnas.0437998100; LADANT D, 1988, J BIOL CHEM, V263, P2612; Letellier L, 1999, RES MICROBIOL, V150, P499, DOI 10.1016/S0923-2508(99)00107-2; Li W, 2013, ARCH VIROL, V158, P1865, DOI 10.1007/s00705-013-1676-9; LINDBERG AA, 1973, ANNU REV MICROBIOL, V27, P205, DOI 10.1146/annurev.mi.27.100173.001225; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Miller JH., 1972, EXPT MOL GENETICS; MOFFATT BA, 1988, J BACTERIOL, V170, P2095, DOI 10.1128/jb.170.5.2095-2105.1988; Molineux IJ, 2001, MOL MICROBIOL, V40, P1, DOI 10.1046/j.1365-2958.2001.02357.x; MORONA R, 1984, J BACTERIOL, V159, P570, DOI 10.1128/JB.159.2.570-578.1984; MORONA R, 1985, J BACTERIOL, V164, P539, DOI 10.1128/JB.164.2.539-543.1985; NAKAE T, 1976, BIOCHEM BIOPH RES CO, V71, P877, DOI 10.1016/0006-291X(76)90913-X; NIKAIDO H, 1994, J BIOL CHEM, V269, P3905; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Parent KN, 2014, MOL MICROBIOL, V92, P47, DOI 10.1111/mmi.12536; Paulsen IT, 1997, FEMS MICROBIOL LETT, V156, P1, DOI 10.1111/j.1574-6968.1997.tb12697.x; Porcek NB, 2015, J MOL BIOL, V427, P1964, DOI 10.1016/j.jmb.2015.03.012; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; ROESSNER CA, 1986, J BIOL CHEM, V261, P386; Rosenberg EY, 2003, MOL MICROBIOL, V48, P1609, DOI 10.1046/j.1365-2958.2003.03531.x; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Sao-Jose C, 2004, J BACTERIOL, V186, P8337, DOI 10.1128/JB.186.24.8337-8346.2004; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Shin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043392; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; STEVEN AC, 1988, J MOL BIOL, V200, P351, DOI 10.1016/0022-2836(88)90246-X; Thanassi DG, 2000, CURR OPIN CELL BIOL, V12, P420, DOI 10.1016/S0955-0674(00)00111-3; Tikhonova EB, 2007, MOL MICROBIOL, V63, P895, DOI 10.1111/j.1365-2958.2006.05549.x; Traurig M, 1999, FEMS MICROBIOL LETT, V181, P101, DOI 10.1111/j.1574-6968.1999.tb08831.x; Tsou AM, 2011, MICROBIOL-SGM, V157, P1620, DOI 10.1099/mic.0.046235-0; Vakharia H, 1996, MOL MICROBIOL, V19, P881, DOI 10.1046/j.1365-2958.1996.430957.x; Veesler D, 2011, MICROBIOL MOL BIOL R, V75, P423, DOI 10.1128/MMBR.00014-11; WANDERSMAN C, 1990, P NATL ACAD SCI USA, V87, P4776, DOI 10.1073/pnas.87.12.4776; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xu DL, 2014, J VIROL, V88, P7109, DOI 10.1128/JVI.03186-13; Xu JL, 2013, J BACTERIOL, V195, P798, DOI 10.1128/JB.01770-12; Yang MH, 2013, P NATL ACAD SCI USA, V110, P2348, DOI 10.1073/pnas.1218039110; YU F, 1982, J BACTERIOL, V151, P718, DOI 10.1128/JB.151.2.718-722.1982; Zhang JY, 2009, J BACTERIOL, V191, P2622, DOI 10.1128/JB.01370-08; Zhao XN, 2013, J VIROL, V87, P12260, DOI 10.1128/JVI.01948-13	78	13	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4000	4013		10.1074/jbc.M117.805689	http://dx.doi.org/10.1074/jbc.M117.805689			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29259138	Green Published, hybrid			2022-12-26	WOS:000427587500013
J	Tian, W; de la Vega, MR; Schmidlin, CJ; Ooi, A; Zhang, DD				Tian, Wang; de la Vega, Montserrat Rojo; Schmidlin, Cody J.; Ooi, Aikseng; Zhang, Donna D.			Kelch-like ECH-associated protein 1 (KEAP1) differentially regulates nuclear factor erythroid-2-related factors 1 and 2 (NRF1 and NRF2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein degradation; protein domain; protein motif; protein stability; nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2); KEAP1; NRF1	TRANSCRIPTION FACTOR NRF1; N-TERMINAL DOMAIN; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE; STRESS; FAMILY; DEGRADATION; ACTIVATION; INDUCTION; MECHANISM	Nuclear factor erythroid-2-related factor 1 (NRF1) and NRF2 are essential for maintaining redox homeostasis and coordinating cellular stress responses. They are highly homologous transcription factors that regulate the expression of genes bearing antioxidant-response elements (AREs). Genetic ablation of NRF1 or NRF2 results in vastly different phenotypic outcomes, implying that they play different roles and may be differentially regulated. Kelch-like ECH-associated protein 1 (KEAP1) is the main negative regulator of NRF2 and mediates ubiquitylation and degradation of NRF2 through its NRF2-ECH homology-like domain 2 (Neh2). Here, we report that KEAP1 binds to the Neh2-like (Neh2L) domain of NRF1 and stabilizes it. Consistently, NRF1 is more stable in KEAP1(+/+) than in KEAP1(-/-) isogenic cell lines, whereas NRF2 is dramatically stabilized in KEAP1(-/-) cells. Replacing NRF1's Neh2L domain with NRF2's Neh2 domain renders NRF1 sensitive to KEAP1-mediated degradation, indicating that the amino acids between the DLG and ETGE motifs, not just the motifs themselves, are essential for KEAP1-mediated degradation. Systematic site-directed mutagenesis identified the core amino acid residues required for KEAP1-mediated degradation and further indicated that the DLG and ETGE motifs with correct spacing are insufficient as a KEAP1 degron. Our results offer critical insights into our understanding of the differential regulation of NRF1 and NRF2 by KEAP1 and their different physiological roles.	[Tian, Wang; de la Vega, Montserrat Rojo; Schmidlin, Cody J.; Ooi, Aikseng; Zhang, Donna D.] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	University of Arizona	Zhang, DD (corresponding author), Coll Pharm, Dept Pharmacol & Toxicol, 1703 E Mabel St,Rm 408, Tucson, AZ 85721 USA.	dzhang@pharmacy.arizona.edu			National Institutes of Health [R01 CA154377, R01 DK109555, R01 ES026845]; NATIONAL CANCER INSTITUTE [P30CA023074, R01CA154377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES026845, P30ES006694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health Grants R01 CA154377, R01 DK109555, and R01 ES026845 (to D. D. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amoutzias GD, 2007, MOL BIOL EVOL, V24, P827, DOI 10.1093/molbev/msl211; Baird L, 2013, P NATL ACAD SCI USA, V110, P15259, DOI 10.1073/pnas.1305687110; Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; Bugno M, 2015, BBA-GENE REGUL MECH, V1849, P1260, DOI 10.1016/j.bbagrm.2015.08.001; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen JY, 2015, FEBS LETT, V589, P2347, DOI 10.1016/j.febslet.2015.07.030; Chepelev NL, 2013, REDOX BIOL, V1, P183, DOI 10.1016/j.redox.2013.01.005; Chepelev NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029167; de la Vega Montserrat Rojo, 2016, Current Opinion in Toxicology, V1, P62, DOI 10.1016/j.cotox.2016.10.005; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Fukagai K, 2016, BIOCHEM BIOPH RES CO, V478, P363, DOI 10.1016/j.bbrc.2016.07.045; Fuse Y, 2017, MOLECULES, V22, DOI 10.3390/molecules22030436; Gacesa R, 2016, SCI REP-UK, V6, DOI 10.1038/srep27740; Gameiro I, 2017, SCI REP-UK, V7, DOI 10.1038/srep45701; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hast BE, 2014, CANCER RES, V74, P808, DOI 10.1158/0008-5472.CAN-13-1655; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hirotsu Y, 2014, GENES CELLS, V19, P650, DOI 10.1111/gtc.12165; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kim HM, 2016, GENE, V584, P17, DOI 10.1016/j.gene.2016.03.002; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Koizumi S, 2016, ELIFE, V5, DOI 10.7554/eLife.18357; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Lee CS, 2013, FEBS J, V280, P3609, DOI 10.1111/febs.12350; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Lisek K, 2017, MOL CELL ONCOL, V4, DOI 10.1080/23723556.2016.1217967; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Maher J, 2010, TOXICOL APPL PHARM, V244, P4, DOI 10.1016/j.taap.2010.01.011; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; MIGNOTTE V, 1989, P NATL ACAD SCI USA, V86, P6548, DOI 10.1073/pnas.86.17.6548; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Mulvaney KM, 2016, J BIOL CHEM, V291, P23719, DOI 10.1074/jbc.M116.729418; Murakami S, 2015, FREE RADICAL BIO MED, V88, P168, DOI 10.1016/j.freeradbiomed.2015.06.030; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Rada P, 2012, MOL CELL BIOL, V32, P3486, DOI 10.1128/MCB.00180-12; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Radhakrishnan SK, 2014, ELIFE, V3, DOI [10.7554/elife.01856, 10.7554/eLife.01856]; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Sha Z, 2014, CURR BIOL, V24, P1573, DOI 10.1016/j.cub.2014.06.004; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Tao SS, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00660-16; Tian H, 2012, CANCER LETT, V325, P26, DOI 10.1016/j.canlet.2012.06.007; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Tsuchiya Y, 2011, MOL CELL BIOL, V31, P4500, DOI 10.1128/MCB.05663-11; Tsujita T, 2014, MOL CELL BIOL, V34, P3800, DOI 10.1128/MCB.00110-14; Uruno A, 2013, MOL CELL BIOL, V33, P2996, DOI 10.1128/MCB.00225-13; Vegran F, 2009, BRIT J CANCER, V101, P1357, DOI 10.1038/sj.bjc.6605310; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Woelk T, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-11; Wu TD, 2014, GENE DEV, V28, P708, DOI 10.1101/gad.238246.114; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhang YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12983; Zhang YG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109159, 10.1371/journal.pone.0105725, 10.1371/journal.pone.0093458, 10.1371/journal.pone.0088491]; Zhang YG, 2010, BIOCHEM J, V430, P497, DOI 10.1042/BJ20100471; Zhang YH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01943	71	38	42	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2029	2040		10.1074/jbc.RA117.000428	http://dx.doi.org/10.1074/jbc.RA117.000428			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29255090	hybrid, Green Published			2022-12-26	WOS:000424948000016
J	Eineluoto, JT; Jarvinen, P; Kenttamies, A; Kilpelainen, TP; Vasarainen, H; Sandeman, K; Erickson, A; Mirtti, T; Rannikko, A				Eineluoto, Juho T.; Jarvinen, Petrus; Kenttamies, Anu; Kilpelainen, Tuomas P.; Vasarainen, Hanna; Sandeman, Kevin; Erickson, Andrew; Mirtti, Tuomas; Rannikko, Antti			Repeat multiparametric MRI in prostate cancer patients on active surveillance	PLOS ONE			English	Article							ULTRASOUND-GUIDED BIOPSY; LOW-RISK; DISEASE RECLASSIFICATION; PRIAS; MEN; CANDIDATES; DIAGNOSIS	Introduction This study was conducted to describe the changes in repeat multiparametric MRI (mpMRI) occurring in prostate cancer (PCa) patients during active surveillance (AS), and to study possible associations between mpMRI-related parameters in predicting prostate biopsy (Bx) Gleason score (GS) upgrading > 3+3 and protocol-based treatment change (TC). Materials and methods The study cohort consisted of 76 AS patients with GS 3+3 PCa and at least two consecutive mpMRIs of the prostate performed between 2006-2015. Patients were followed according to the Prostate Cancer Research International Active Surveillance (PRIAS) protocol and an additional mpMRI. The primary end points were GS upgrading (GU) (> 3+3) in protocol-based Bxs and protocol-based TC. Results Out of 76 patients, 53 (69%) had progression (PIRADS upgrade, size increase or new lesion [s]), while 18 (24%) had radiologically stable disease, and 5 (7%) had regression (PIRADS or size decrease, disappearance of lesion[s]) in repeat mpMRIs during AS. PIRADS scores of 4-5 in the initial mpMRI were associated with GU (p = 0.008) and protocol-based TC (p = 0.009). Tumour progression on repeat mpMRIs was associated with TC (p = 0.045) but not with GU (p = 1.00). PIRADS scores of 4-5 predict GU (sensitivity 0.80 [95% confidence interval (CI); 0.51-0.95, specificity 0.62 [95% CI; 0.52-0.77]) with PPV and NPV values of 0.34 (95% CI; 0.21-0.55) and 0.93 (95% CI; 0.80-0.98), respectively. Conclusion mpMRI is a useful tool not only to select but also to monitor PCa patients on AS.	[Eineluoto, Juho T.; Jarvinen, Petrus; Kilpelainen, Tuomas P.; Vasarainen, Hanna; Erickson, Andrew; Rannikko, Antti] Univ Helsinki, Dept Urol, Helsinki, Finland; [Eineluoto, Juho T.; Jarvinen, Petrus; Kenttamies, Anu; Kilpelainen, Tuomas P.; Vasarainen, Hanna; Sandeman, Kevin; Erickson, Andrew; Mirtti, Tuomas; Rannikko, Antti] Helsinki Univ Hosp, Helsinki, Finland; [Kenttamies, Anu] Univ Helsinki, Med Imaging Ctr, Helsinki, Finland; [Sandeman, Kevin; Erickson, Andrew; Mirtti, Tuomas] Univ Helsinki, Dept Pathol HUSLAB, Helsinki, Finland; [Mirtti, Tuomas] Univ Helsinki, Finnish Inst Mol Med, Helsinki, Finland; [Mirtti, Tuomas] Univ Helsinki, Med, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki	Eineluoto, JT (corresponding author), Univ Helsinki, Dept Urol, Helsinki, Finland.; Eineluoto, JT (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	juho.eineluoto@gmail.com	Rannikko, Antti/ABB-8453-2020; Eineluoto, Juho/AAF-9876-2020	Rannikko, Antti/0000-0002-4261-3484; Eineluoto, Juho/0000-0003-1109-2994; Kenttamies, Anu/0000-0002-3937-5307; Erickson, Andrew/0000-0002-4850-4086; Mirtti, Tuomas/0000-0003-0455-9891; Jarvinen, Petrus/0000-0002-3751-4609				Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Bokhorst LP, 2016, BJU INT, V118, P366, DOI 10.1111/bju.13410; Bokhorst LP, 2015, EUR UROL, V68, P814, DOI 10.1016/j.eururo.2015.06.012; Bul M, 2013, EUR UROL, V63, P597, DOI 10.1016/j.eururo.2012.11.005; Dall'Era MA, 2012, EUR UROL, V62, P976, DOI 10.1016/j.eururo.2012.05.072; Felker ER, 2016, J UROLOGY, V195, P1421, DOI 10.1016/j.juro.2015.11.055; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Guo R, 2015, PROSTATE CANCER P D, V18, P221, DOI 10.1038/pcan.2015.20; Hamoen EHJ, 2015, EUR UROL, V67, P1112, DOI 10.1016/j.eururo.2014.10.033; Lahdensuo K, 2015, SCAND J UROL, V49, P90, DOI 10.3109/21681805.2014.936494; Malvezzi M, 2015, ANN ONCOL, V26, P779, DOI 10.1093/annonc/mdv001; Moore CM, 2014, CURR OPIN UROL, V24, P280, DOI 10.1097/MOU.0000000000000040; Pokorny MR, 2014, EUR UROL, V66, P22, DOI 10.1016/j.eururo.2014.03.002; Siddiqui MM, 2015, JAMA-J AM MED ASSOC, V313, P390, DOI 10.1001/jama.2014.17942; Sonn GA, 2014, UROL ONCOL-SEMIN ORI, V32, P903, DOI 10.1016/j.urolonc.2013.08.006; Tosoian JJ, 2013, J UROLOGY, V190, P1218, DOI 10.1016/j.juro.2013.04.071; Turkbey B, 2016, CA-CANCER J CLIN, V66, P326, DOI 10.3322/caac.21333; Turkbey B, 2013, RADIOLOGY, V268, P144, DOI 10.1148/radiol.13121325; van den Bergh RCN, 2007, EUR UROL, V52, P1560, DOI 10.1016/j.eururo.2007.05.011; Vasarainen H, 2013, SCAND J UROL, V47, P456, DOI 10.3109/21681805.2013.765910; Walton Diaz A, 2015, UROL ONCOL, V33, P202, DOI DOI 10.1016/J.UR0L0NC.2015.01.023; Weinreb JC, 2016, EUR UROL, V69, P16, DOI 10.1016/j.eururo.2015.08.052	22	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189272	10.1371/journal.pone.0189272	http://dx.doi.org/10.1371/journal.pone.0189272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281647	gold, Green Published, Green Submitted			2022-12-26	WOS:000419006200019
J	Grandjean, L; Gilman, RH; Iwamoto, T; Koser, CU; Coronel, J; Zimic, M; Torok, ME; Ayabina, D; Kendall, M; Fraser, C; Harris, S; Parkhill, J; Peacock, SJ; Moore, DAJ; Colijn, C				Grandjean, Louis; Gilman, Robert H.; Iwamoto, Tomatada; Koser, Claudio U.; Coronel, Jorge; Zimic, Mirko; Torok, M. Estee; Ayabina, Diepreye; Kendall, Michelle; Fraser, Christophe; Harris, Simon; Parkhill, Julian; Peacock, Sharon J.; Moore, David A. J.; Colijn, Caroline			Convergent evolution and topologically disruptive polymorphisms among multidrug-resistant tuberculosis in Peru	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MICROSCOPIC-OBSERVATION; PHYLOGENETIC ANALYSIS; GENE FAMILY; GENOME; TRANSMISSION; ADAPTATION; DIAGNOSIS; SELECTION; MUTATION	Background Multidrug-resistant tuberculosis poses a major threat to the success of tuberculosis control programs worldwide. Understanding how drug-resistant tuberculosis evolves can inform the development of new therapeutic and preventive strategies. Methods Here, we use novel genome-wide analysis techniques to identify polymorphisms that are associated with drug resistance, adaptive evolution and the structure of the phylogenetic tree. A total of 471 samples from different patients collected between 2009 and 2013 in the Lima suburbs of Callao and Lima South were sequenced on the Illumina MiSeq platform with 150bp paired-end reads. After alignment to the reference H37Rv genome, variants were called using standardized methodology. Genome-wide analysis was undertaken using custom written scripts implemented in R software. Results High quality homoplastic single nucleotide polymorphisms were observed in genes known to confer drug resistance as well as genes in the Mycobacterium tuberculosis ESX secreted protein pathway, pks12, and close to toxin/anti-toxin pairs. Correlation of homoplastic variant sites identified that many were significantly correlated, suggestive of epistasis. Variation in genes coding for ESX secreted proteins also significantly disrupted phylogenetic structure. Mutations in ESX genes in key antigenic epitope positions were also found to disrupt tree topology. Conclusion Variation in these genes have a biologically plausible effect on immunogenicity and virulence. This makes functional characterization warranted to determine the effects of these polymorphisms on bacterial fitness and transmission.	[Grandjean, Louis] UCL, Inst Child Hlth, London, England; [Grandjean, Louis] Imperial Coll, Acad Hlth Sci Ctr, London, England; [Grandjean, Louis; Gilman, Robert H.; Coronel, Jorge; Zimic, Mirko] Univ Peruana Cayetano Heredia, Ave Honorio Delgado San Martin Porras, Lima, Peru; [Grandjean, Louis; Torok, M. Estee; Harris, Simon; Parkhill, Julian; Peacock, Sharon J.] Wellcome Trust Sanger Inst, Genome Campus, Cambridge, England; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Iwamoto, Tomatada] Kobe Inst Hlth, Dept Infect Dis, Chuo Ku, Kobe, Hyogo, Japan; [Koser, Claudio U.] Univ Cambridge, Dept Med, Cambridge, England; [Ayabina, Diepreye; Kendall, Michelle; Colijn, Caroline] Imperial Coll London, Fac Nat Sci, Dept Math, London, England; [Fraser, Christophe] Imperial Coll, Dept Infect Dis Epidemiol, London, England; [Peacock, Sharon J.; Moore, David A. J.] London Sch Trop Med & Hyg, London, England	University of London; University College London; Imperial College London; Universidad Peruana Cayetano Heredia; Wellcome Trust Sanger Institute; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cambridge; Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Grandjean, L (corresponding author), UCL, Inst Child Hlth, London, England.; Grandjean, L (corresponding author), Imperial Coll, Acad Hlth Sci Ctr, London, England.; Grandjean, L (corresponding author), Univ Peruana Cayetano Heredia, Ave Honorio Delgado San Martin Porras, Lima, Peru.; Grandjean, L (corresponding author), Wellcome Trust Sanger Inst, Genome Campus, Cambridge, England.	l.grandjean@imperial.ac.uk	Iwamoto, Tomotada/I-8944-2019; Parkhill, Julian/G-4703-2011; Peacock, Sharon J/ABE-6331-2020; Köser, Claudio/I-3740-2013; Fraser, Christophe/A-8109-2008	Iwamoto, Tomotada/0000-0002-2650-0308; Parkhill, Julian/0000-0002-7069-5958; Köser, Claudio/0000-0002-0232-846X; Fraser, Christophe/0000-0003-2399-9657; Grandjean, Louis/0000-0002-1457-8327; Peacock, Sharon/0000-0002-1718-2782; Kendall, Michelle/0000-0001-7344-7071; Torok, Mili Estee/0000-0001-9098-8590	Wellcome Trust [201470/Z/16/Z, WT098600, HICF-T5-342]; Department of Health [WT098600, HICF-T5-342]; EPSRC [EP/K026003/1] Funding Source: UKRI; MRC [MR/K007467/1, MR/N029399/1] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-CSF4-Torok, SGL014\\1005] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K026003/1] Funding Source: researchfish; Medical Research Council [MR/N029399/1, MR/K007467/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Department of Health; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (Grant Number 201470/Z/16/Z, www.wellcome.ac.uk) to LG. The funding body had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. This publication presents independent research supported by the Health Innovation Challenge Fund (WT098600, HICF-T5-342), a parallel funding partnership between the Department of Health and Wellcome Trust to SP. The views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health or Wellcome Trust.	Agashe D, 2013, MOL BIOL EVOL, V30, P549, DOI 10.1093/molbev/mss273; Ando H, 2014, MOL MICROBIOL, V91, P538, DOI 10.1111/mmi.12476; Ausubel Frederick M., SHORT PROTOCOLS MOL; Brown AC, 2015, J CLIN MICROBIOL, V53, P2230, DOI 10.1128/JCM.00486-15; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Denoeud F, 2014, SCIENCE, V345, P1181, DOI 10.1126/science.1255274; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Garen CR, 2006, ACTA CRYSTALLOGR F, V62, P1201, DOI 10.1107/S1744309106046902; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Grandjean L, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001843; Grandjean L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126271; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2015, TREESCAPE; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kendall M, 2015, BIORXIV, P26641; Kendall M, 2016, MOL BIOL EVOL, V33, P2735, DOI 10.1093/molbev/msw124; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Marvig RL, 2015, NAT GENET, V47, P57, DOI 10.1038/ng.3148; Minch KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6829; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Osorio NS, 2013, MOL BIOL EVOL, V30, P1326, DOI 10.1093/molbev/mst038; Page AJ, 2016, MICROB GENOMICS; Parker J, 2013, NATURE, V502, P228, DOI 10.1038/nature12511; Piatigorsky Joram, 2008, Evolution Education and Outreach, V1, P403, DOI 10.1007/s12052-008-0077-0; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Sirakova TD, 2003, INFECT IMMUN, V71, P3794, DOI 10.1128/IAI.71.7.3794-3801.2003; Skjot RLV, 2002, INFECT IMMUN, V70, P5446, DOI 10.1128/IAI.70.10.5446-5453.2002; Stamatakis A, 2006, PAR DISTR PROC S 200; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Uplekar S, 2011, INFECT IMMUN, V79, P4042, DOI 10.1128/IAI.05344-11; Villarreal DO, 2014, HUM VACC IMMUNOTHER, V10, P2188, DOI 10.4161/hv.29574; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Wood TE, 2005, GENETICA, V123, P157, DOI 10.1007/s10709-003-2738-9; World Health Organization, GLOB TUB REP 2016; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	48	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189838	10.1371/journal.pone.0189838	http://dx.doi.org/10.1371/journal.pone.0189838			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281674	gold, Green Published, Green Accepted			2022-12-26	WOS:000419006200049
J	Hsiehl, TY; Liu, YT; Newell, KM				Hsiehl, Tsung-Yu; Liu, Yeou-Teh; Newell, Karl M.			Submovement control processes in discrete aiming as a function of space-time constraints	PLOS ONE			English	Article							MOVEMENT CONTROL; ACCURACY; VARIABILITY; FEEDBACK; ENTROPY; MODEL; SPEED; TARGET	There is preliminary evidence that there are several types of submovements in movement aiming that reflect different processes of control and can result from particular task constraints. The purpose of the study was to investigate the effect of movement space and time task criteria on the prevalence of different submovement control characteristics in discrete aiming. Twelve participants completed 3 distance x 5 time conditions each with 100 trials in a target-aiming movement task. The kinematic structure of the trajectory determined the prevalence of 5 submovement types (none; pre-peak, post-peak movement velocity; undershoot, overshoot). The findings showed that the overall number of submovements increased in the slower space-time conditions and was predominantly characterized by post-peak trajectory submovements rather than discrete overshoot submovements. Overshoot submovements were more frequent in the high average movement velocity and short time duration conditions. We concluded that there are qualitatively different distributional patterns of submovement types in discrete aiming tasks that are organized by the quantitative scaling of the average movement velocity arising from multiple control processes to meet the specific space-time task constraints.	[Hsiehl, Tsung-Yu; Liu, Yeou-Teh] Natl Taiwan Normal Univ, Taipei, Taiwan; [Newell, Karl M.] Univ Georgia, Athens, GA 30602 USA	National Taiwan Normal University; University System of Georgia; University of Georgia	Hsiehl, TY (corresponding author), Natl Taiwan Normal Univ, Taipei, Taiwan.	yu691207@gmail.com	Liu, Yeou-teh/AAZ-4573-2021	Hsieh, Tsung-Yu/0000-0002-6070-7943	Ministry of Science and Technology of Taiwan [MOST 105-2811-H-003-011, MOST 106-2811-H-003-007, MOST 105-2410-H-003-060-MY2]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by Ministry of Science and Technology of Taiwan, https://www.most.gov.tw/, Grant MOST 105-2811-H-003-011 and MOST 106-2811-H-003-007 awarded to TYH, and Grant MOST 105-2410-H-003-060-MY2 awarded to YTL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS RA, 1993, J MOTOR BEHAV, V25, P288, DOI 10.1080/00222895.1993.9941650; BEGGS WDA, 1972, ACTA PSYCHOL, V36, P171, DOI 10.1016/0001-6918(72)90001-7; BEGGS WDA, 1970, NATURE, V225, P752, DOI 10.1038/225752a0; Berardelli A, 1996, BRAIN, V119, P661, DOI 10.1093/brain/119.2.661; CARLTON L G, 1979, Journal of Human Movement Studies, V5, P115; Carlton L.G., 1992, VISION MOTOR CONTROL, V85, P3, DOI DOI 10.1016/S0166-4115(08)62008-7; CARLTON LG, 1993, VARIABILITY AND MOTOR CONTROL, P15; CARLTON LG, 1994, J MOTOR BEHAV, V26, P43, DOI 10.1080/00222895.1994.9941660; CARLTON LG, 1988, J EXP PSYCHOL HUMAN, V14, P24; CHUA R, 1993, HUM MOVEMENT SCI, V12, P365, DOI 10.1016/0167-9457(93)90026-L; CROSSMAN ERFW, 1983, Q J EXP PSYCHOL-A, V35, P251, DOI 10.1080/14640748308402133; Dounskaia N, 2005, EXP BRAIN RES, V164, P505, DOI 10.1007/s00221-005-2271-4; ELLIOTT D, 1991, HUM MOVEMENT SCI, V10, P393, DOI 10.1016/0167-9457(91)90013-N; Elliott D, 2004, J MOTOR BEHAV, V36, P339, DOI 10.3200/JMBR.36.3.339-351; Elliott D, 2001, PSYCHOL BULL, V127, P342, DOI 10.1037//0033-2909.127.3.342; Elliott D, 2017, NEUROSCI BIOBEHAV R, V72, P95, DOI 10.1016/j.neubiorev.2016.11.016; Elliott D, 2010, PSYCHOL BULL, V136, P1023, DOI 10.1037/a0020958; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Fradet L, 2008, ACTA PSYCHOL, V129, P91, DOI 10.1016/j.actpsy.2008.04.009; Green S., 2003, USING SPSS WINDOWS M; Grierson LEM, 2009, AM J PSYCHOL, V122, P309; Hancock PA., 1985, MOTOR BEHAV PROGRAMM, P153, DOI [DOI 10.1007/978-3-642-69749-4_5, 10.1007/978-3-642-69749-4_5]; Hsieh TY, 2016, J SPORT EXERCISE PSY, V38, pS69; Hsieh TY, 2016, J MOTOR BEHAV, V48, P227, DOI 10.1080/00222895.2015.1079163; Hsieh TY, 2015, HUM MOVEMENT SCI, V44, P201, DOI 10.1016/j.humov.2015.09.005; KEELE SW, 1968, J EXP PSYCHOL, V77, P155, DOI 10.1037/h0025754; KEELE SW, 1968, PSYCHOL BULL, V70, P387, DOI 10.1037/h0026739; Khan MA, 1998, Q J EXP PSYCHOL-A, V51, P425, DOI 10.1080/713755756; Khan MA, 2000, J MOTOR BEHAV, V32, P227, DOI 10.1080/00222890009601374; Kim SJ, 1999, J MOTOR BEHAV, V31, P341, DOI 10.1080/00222899909600999; Lai SC, 2006, J MOTOR BEHAV, V38, P451, DOI 10.3200/JMBR.38.6.451-466; Meyer D. E., 1990, ATTENTION PERFORMANC; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; MILNER TE, 1992, NEUROSCIENCE, V49, P487, DOI 10.1016/0306-4522(92)90113-G; MORASSO P, 1983, ACTA PSYCHOL, V54, P83, DOI 10.1016/0001-6918(83)90025-2; Moritz CT, 2005, J NEUROPHYSIOL, V93, P2449, DOI 10.1152/jn.01122.2004; Newell K.M., 1986, MOTOR DEV CHILDREN A, VVolume 34, P341, DOI DOI 10.1007/978-94-009-4460-2_19; Newell K.M., 1980, TUTORIALS MOTOR BEHA, P501; Novak KE, 2002, EXP BRAIN RES, V144, P351, DOI 10.1007/s00221-002-1060-6; Novak KE, 2000, EXP BRAIN RES, V132, P419, DOI 10.1007/s002210000366; Osu R, 2004, J NEUROPHYSIOL, V92, P1199, DOI 10.1152/jn.00519.2003; Plamondon R, 1997, BEHAV BRAIN SCI, V20, P279, DOI 10.1017/S0140525X97001441; Rand MK, 2013, EXP BRAIN RES, V225, P55, DOI 10.1007/s00221-012-3348-5; Rohrer B, 2006, BIOL CYBERN, V94, P409, DOI 10.1007/s00422-006-0055-y; Schmidt R A, 1976, Exerc Sport Sci Rev, V4, P229; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Shmuelof L, 2012, J NEUROPHYSIOL, V108, P578, DOI 10.1152/jn.00856.2011; ULRICH R, 1991, PSYCHOL REV, V98, P268, DOI 10.1037/0033-295X.98.2.268; VANDONKELAAR P, 1991, EXP BRAIN RES, V83, P618, DOI 10.1007/BF00229840; Wisleder D, 2007, EXP BRAIN RES, V176, P132, DOI 10.1007/s00221-006-0603-7; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1; WRIGHT CE, 1983, Q J EXP PSYCHOL-A, V35, P279, DOI 10.1080/14640748308402134	52	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189328	10.1371/journal.pone.0189328	http://dx.doi.org/10.1371/journal.pone.0189328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR3ZV	29281670	Green Published, gold, Green Submitted			2022-12-26	WOS:000419006200023
J	Kerdaffrec, E; Nordborg, M				Kerdaffrec, Envel; Nordborg, Magnus			The maternal environment interacts with genetic variation in regulating seed dormancy in Swedish Arabidopsis thaliana	PLOS ONE			English	Article							LOCAL ADAPTATION; NATURAL-SELECTION; GERMINATION; TEMPERATURE; LIGHT; VERNALIZATION; DOG1; REPRODUCTION; CONTRIBUTES; MECHANISMS	Seed dormancy is a complex adaptive trait that controls the timing of seed germination, one of the major fitness components in many plant species. Despite being highly heritable, seed dormancy is extremely plastic and influenced by a wide range of environmental cues. Here, using a set of 92 Arabidopsis thaliana lines from Sweden, we investigate the effect of seed maturation temperature on dormancy variation at the population level. The response to temperature differs dramatically between lines, demonstrating that genotype and the maternal environment interact in controlling the trait. By performing a genome-wide association study (GWAS), we identified several candidate genes that could presumably account for this plasticity, two of which are involved in the photoinduction of germination. Altogether, our results provide insight into both the molecular mechanisms and the evolution of dormancy plasticity, and can serve to improve our understanding of environmentally dependent life-history transitions.	[Kerdaffrec, Envel; Nordborg, Magnus] Austrian Acad Sci, Gregor Mendel Inst, Vienna Bioctr VBC, Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Kerdaffrec, E (corresponding author), Austrian Acad Sci, Gregor Mendel Inst, Vienna Bioctr VBC, Vienna, Austria.	envel.kerdaffrec@gmail.com		Kerdaffrec, Envel/0000-0001-8667-6850; Nordborg, Magnus/0000-0001-7178-9748	European Research Council [268962]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by European Research Council https://erc.europa.eu/ grant 268962 (MAXMAP) to MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 2003, GENETICS, V164, P711; Alonso-Blanco C, 2016, CELL, V166, P481, DOI 10.1016/j.cell.2016.05.063; Amasino R, 2004, PLANT CELL, V16, P2553, DOI 10.1105/tpc.104.161070; [Anonymous], 2016, J EXP BOT; Bentsink L, 2006, P NATL ACAD SCI USA, V103, P17042, DOI 10.1073/pnas.0607877103; Burghardt LT, 2016, AM J BOT, V103, P47, DOI 10.3732/ajb.1500286; Burghardt LT, 2016, NEW PHYTOL, V209, P1301, DOI 10.1111/nph.13685; Carol C Baskin, 1998, SEEDS ECOLOGY BIOGEO; Chen M, 2014, P NATL ACAD SCI USA, V111, P18787, DOI 10.1073/pnas.1412274111; Chiang GCK, 2013, EVOLUTION, V67, P883, DOI 10.1111/j.1558-5646.2012.01828.x; Chiang GCK, 2011, MOL ECOL, V20, P3336, DOI 10.1111/j.1365-294X.2011.05181.x; Christoph Lippert, 2014, LIMIX GENETIC ANAL M; Daniele LFiliault, 2012, PLOS GENET, V8; Donohue K, 2005, EVOLUTION, V59, P758, DOI 10.1111/j.0014-3820.2005.tb01751.x; Donohue K, 2002, ECOLOGY, V83, P1006, DOI 10.1890/0012-9658(2002)083[1006:GTINSO]2.0.CO;2; Donohue K, 2010, ANNU REV ECOL EVOL S, V41, P293, DOI 10.1146/annurev-ecolsys-102209-144715; El-Soda M, 2014, TRENDS PLANT SCI, V19, P390, DOI 10.1016/j.tplants.2014.01.001; Envel Kerdaffrec, 2016, ELIFE, V5; Eriko Sasaki, 2015, PLOS GENET, V11; Fenner M., 1991, Seed Science Research, V1, P75, DOI 10.1017/S0960258500000696; Finch-Savage WE, 2017, J EXP BOT, V68, P843, DOI 10.1093/jxb/erw477; Footitt S, 2013, PLANT J, V74, P1003, DOI 10.1111/tpj.12186; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Fournier-Level A, 2016, P NATL ACAD SCI USA, V113, pE2812, DOI 10.1073/pnas.1517456113; Fujimori T, 2004, PLANT CELL PHYSIOL, V45, P1078, DOI 10.1093/pcp/pch124; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Graeber K, 2012, PLANT CELL ENVIRON, V35, P1769, DOI 10.1111/j.1365-3040.2012.02542.x; Halfter U, 2000, P NATL ACAD SCI USA, V97, P3735, DOI 10.1073/pnas.040577697; He HZ, 2014, J EXP BOT, V65, P6603, DOI 10.1093/jxb/eru378; Heschel MS, 2007, NEW PHYTOL, V174, P735, DOI 10.1111/j.1469-8137.2007.02044.x; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Huang XQ, 2010, MOL ECOL, V19, P1335, DOI 10.1111/j.1365-294X.2010.04557.x; Huang Z, 2015, SEED SCI RES, V25, P159, DOI 10.1017/S096025851500001X; Huang ZY, 2014, ANN BOT-LONDON, V113, P921, DOI 10.1093/aob/mcu014; Jack Mitchell, 2016, J EXP BOT; Jiang ZM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12377; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kendall SL, 2011, PLANT CELL, V23, P2568, DOI 10.1105/tpc.111.087643; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Koornneef M, 1998, ANNU REV PLANT PHYS, V49, P345, DOI 10.1146/annurev.arplant.49.1.345; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Kronholm I, 2012, EVOLUTION, V66, P2287, DOI 10.1111/j.1558-5646.2012.01590.x; Li Y, 2014, GENETICS, V196, P569, DOI 10.1534/genetics.113.157628; Long Q, 2013, NAT GENET, V45, P884, DOI 10.1038/ng.2678; MacGregor DR, 2015, NEW PHYTOL, V205, P642, DOI 10.1111/nph.13090; Marilyne Debieu, 2013, PLOS ONE, V8; Morrison GD, 2014, G3-GENES GENOM GENET, V4, P1465, DOI 10.1534/g3.114.012427; Pawel Jedynak, 2013, ACTA BIOL CRAC B, V55; Penfield S, 2012, PHILOS T R SOC B, V367, P291, DOI 10.1098/rstb.2011.0186; PETERS NCB, 1982, WEED RES, V22, P205, DOI 10.1111/j.1365-3180.1982.tb00165.x; Postma FM, 2016, P NATL ACAD SCI USA, V113, P7590, DOI 10.1073/pnas.1606303113; Postma FM, 2015, MOL ECOL, V24, P785, DOI 10.1111/mec.13061; R Core Team, 2021, R LANGUAGE ENV STAT; Rautengarten C, 2014, P NATL ACAD SCI USA, V111, P11563, DOI 10.1073/pnas.1406073111; REDDY LV, 1985, CROP SCI, V25, P455, DOI 10.2135/cropsci1985.0011183X002500030007x; Saranga Y, 2001, GENOME RES, V11, P1988, DOI 10.1101/gr.157201; Schmuths H, 2006, ANN BOT-LONDON, V97, P623, DOI 10.1093/aob/mcl012; Seren U, 2012, PLANT CELL, V24, P4793, DOI 10.1105/tpc.112.108068; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Shindo C, 2006, GENE DEV, V20, P3079, DOI 10.1101/gad.405306; SHINOMURA T, 1994, PLANT PHYSIOL, V104, P363, DOI 10.1104/pp.104.2.363; Simons AM, 2006, EVOLUTION, V60, P2280, DOI 10.1111/j.0014-3820.2006.tb01865.x; Springthorpe V, 2015, ELIFE, V4, DOI 10.7554/eLife.05557; Susan Duncan, 2015, ELIFE, V4; Umezawa T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003509; VENABLE DL, 1988, AM NAT, V131, P360, DOI 10.1086/284795; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Wilczek AM, 2010, PHILOS T R SOC B, V365, P3129, DOI 10.1098/rstb.2010.0128; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao X, 2013, PLANT PHYSIOL, V162, P1539, DOI 10.1104/pp.113.216556	70	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190242	10.1371/journal.pone.0190242	http://dx.doi.org/10.1371/journal.pone.0190242			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281703	Green Submitted, Green Published, gold			2022-12-26	WOS:000419006200077
J	Mobuchon, L; Le Guillou, S; Marthey, S; Laubier, J; Laloe, D; Bes, S; Le Provost, F; Leroux, C				Mobuchon, Lenha; Le Guillou, Sandrine; Marthey, Sylvain; Laubier, Johann; Laloe, Denis; Bes, Sebastien; Le Provost, Fabienne; Leroux, Christine			Sunflower oil supplementation affects the expression of miR-20a-5p and miR-142-5p in the lactating bovine mammary gland	PLOS ONE			English	Article							GENERATION SEQUENCING TECHNOLOGIES; HIGH-CONCENTRATE DIETS; GENE-EXPRESSION; FATTY-ACID; MICRORNA EXPRESSION; MILK-COMPOSITION; HIGH-FORAGE; CELLS; DIFFERENTIATION; TRIACYLGLYCEROL	Oil supplementation in dairy cattle diets is used to modulate milk fat composition, as well as the expression of mammary lipogenic genes, whose regulation remains unclear. MiRNAs are small non-coding RNA considered as crucial regulators of gene expression, offering clues to explain the mechanism underlying gene nutriregulation. The present study was designed to identify miRNAs whose expression in the cow mammary gland is modulated by sunflower oil supplementation. MiRNomes were obtained using RNAseq technology from the mammary gland of lactating cows receiving a low forage diet, supplemented or not with 4% sunflower oil. Among the 272 miRNAs characterized, eight were selected for RT-qPCR validations, showing the significant down-regulation of miR-142-5p and miR-20a-5p by sunflower supplementation. These two miRNAs are predicted to target genes whose expression was reported as differentially expressed by sunflower supplementation. Among their putative targets, ELOVL6 gene involved in lipid metabolism has been studied. However, a first analysis did not show its significant down-regulation, in response to the over-expression of miR-142-5p, of miR-20a-5p, or both, in a bovine mammary epithelial cell line. However, a clearer understanding of the miRNA expression by lipid supplementation would help to decipher the regulation of lactating cow mammary gland in response to nutrition.	[Mobuchon, Lenha; Le Guillou, Sandrine; Marthey, Sylvain; Laubier, Johann; Laloe, Denis; Le Provost, Fabienne] Univ Paris Saclay, AgroParisTech, INRA, GABI, Jouy En Josas, France; [Mobuchon, Lenha; Bes, Sebastien; Leroux, Christine] INRA, Herbivores, UMR1213, St Genes Champanelle, France; [Mobuchon, Lenha; Bes, Sebastien; Leroux, Christine] Clermont Univ, VetAgro Sup, UMR Herbivores, Clermont Ferrand, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; VetAgro Sup; VetAgro Sup	Leroux, C (corresponding author), INRA, Herbivores, UMR1213, St Genes Champanelle, France.; Leroux, C (corresponding author), Clermont Univ, VetAgro Sup, UMR Herbivores, Clermont Ferrand, France.	christine.leroux@inra.fr	Laloe, Denis/O-7045-2019	Laloe, Denis/0000-0001-8359-0760; Leroux, Christine/0000-0001-6835-3978	INRA; ApisGene under the NutriMirMa project; AIP BioRessources	INRA; ApisGene under the NutriMirMa project; AIP BioRessources	This work received support from INRA, ApisGene (http//www.apis-gene.com/, grants under the NutriMirMa project to LM), and AIP BioRessources.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aranda JF, 2013, FREE RADIC BIOL MED, V16; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard L, 2008, ADV EXP MED BIOL, V606, P67, DOI 10.1007/978-0-387-74087-4_2; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Chilliard Y, 2004, REPROD NUTR DEV, V44, P467, DOI 10.1051/rnd:2004052; Cui W, 2011, MOL CELL BIOCHEM, V355, P17, DOI 10.1007/s11010-011-0834-1; Doria ML, 2014, FASEB J, V28, P4247, DOI 10.1096/fj.14-249672; Erhard F, 2014, GENOME RES, V24, P906, DOI 10.1101/gr.166702.113; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Farr VC, 1996, J DAIRY SCI, V79, P543, DOI 10.3168/jds.S0022-0302(96)76398-1; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Garcia-Segura L, 2013, J NUTRIGENET NUTRIGE, V6, P16, DOI 10.1159/000345826; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Izzotti A, 2012, MUTAT RES-REV MUTAT, V751, P287, DOI 10.1016/j.mrrev.2012.05.004; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Ji Z, 2012, PLOS ONE, V7, P14; Ji ZB, 2012, MOL BIOL REP, V39, P9361, DOI 10.1007/s11033-012-1779-5; Karere GM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-320; Le Guillou S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091938; Le Guillou S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045727; Lee MJ, 2013, CELL TISSUE RES, V353, P425, DOI 10.1007/s00441-013-1653-3; Leroux C, 2016, J NUTRIGENET NUTRIGE, V9, P65, DOI 10.1159/000445996; Li HM, 2012, MOLECULES, V17, P12037, DOI 10.3390/molecules171012037; Li R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1965-7; Li R, 2015, INT J MOL SCI, V16, P4997, DOI 10.3390/ijms16034997; Li Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-731; Li ZR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035834, 10.1371/journal.pone.0051597]; Lin XZ, 2013, GENE, V521, P15, DOI 10.1016/j.gene.2013.03.050; Lin XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079258; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynn FC, 2009, TRENDS ENDOCRIN MET, V20, P452, DOI 10.1016/j.tem.2009.05.007; Mach N, 2011, BMC P, V3, P1753; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; Meale SJ, 2014, J ANIM SCI, V92, P3328, DOI 10.2527/jas.2014-7710; Medina-Gomez G, 2007, PUBLIC HEALTH NUTR, V10, P1132, DOI 10.1017/S1368980007000614; Milenkovic D, 2013, FREE RADICAL BIO MED, V64, P40, DOI 10.1016/j.freeradbiomed.2013.05.046; Mobuchon L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140111; Mobuchon L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1471-y; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Moore JH, 1981, LIPID METABOLISM MAM; Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058; Ollier S, 2009, J DAIRY SCI, V92, P5544, DOI 10.3168/jds.2009-2022; Ollier S, 2007, J NUTR, V137, P560, DOI 10.1093/jn/137.3.560; Padovani M, 2009, CANCER PREV RES, V2, P1076, DOI 10.1158/1940-6207.CAPR-09-0034; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Parra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013005; Peng J, 2015, INT J MOL SCI, V16, P1448, DOI 10.3390/ijms16011448; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Piantoni P, 2012, J DAIRY SCI, V95, P2550, DOI 10.3168/jds.2011-4539; Rau A, 2013, BIOINFORMATICS, V29, P2146, DOI 10.1093/bioinformatics/btt350; Rodriguez-Cruz M, 2011, BBA-MOL CELL BIOL L, V1811, P284, DOI 10.1016/j.bbalip.2011.01.007; Romao JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040605; Ross SA, 2011, ADV NUTR, V2, P472, DOI 10.3945/an.111.001206; Shah Manasvi S., 2012, Frontiers in Genetics, V3, P305, DOI 10.3389/fgene.2012.00305; Shingfield KJ, 2008, ADV EXP MED BIOL, V606, P3, DOI 10.1007/978-0-387-74087-4_1; Tam S, 2014, LAB INVEST, V94, P350, DOI 10.1038/labinvest.2013.157; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Toral PG, 2013, ANIMAL, V7, P948, DOI 10.1017/S1751731113000049; Wang H, 2015, J DAIRY SCI, V14; Wang H, 2017, J CELL PHYSIOL, V232, P1030, DOI 10.1002/jcp.25499; Wang H, 2016, RNA BIOL, V13, P500, DOI 10.1080/15476286.2016.1164365; Wang SM, 2017, EPIGENETICS-US, V12, P187, DOI 10.1080/15592294.2016.1273308; Zavizion B, 1996, IN VITRO CELL DEV-AN, V32, P138, DOI 10.1007/BF02723679; Zhang CL, 2014, J NUTR, V144, P1142, DOI 10.3945/jn.114.192575; Zhang JF, 2011, RNA BIOL, V8, P829, DOI 10.4161/rna.8.5.16043	73	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0185511	10.1371/journal.pone.0185511	http://dx.doi.org/10.1371/journal.pone.0185511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281677	Green Submitted, gold, Green Published			2022-12-26	WOS:000419006200001
J	Rodriguez-Madoz, JR; San Jose-Eneriz, E; Rabal, O; Zapata-Linares, N; Miranda, E; Rodriguez, S; Porciuncula, A; Vilas-Zornoza, A; Garate, L; Segura, V; Guruceaga, E; Agirre, X; Oyarzabal, J; Prosper, F				Roberto Rodriguez-Madoz, Juan; San Jose-Eneriz, Edurne; Rabal, Obdulia; Zapata-Linares, Natalia; Miranda, Estibaliz; Rodriguez, Saray; Porciuncula, Angelo; Vilas-Zornoza, Amaia; Garate, Leire; Segura, Victor; Guruceaga, Elizabeth; Agirre, Xabier; Oyarzabal, Julen; Prosper, Felipe			Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genome	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SOMATIC-CELLS; REPROGRAMMING REVEAL; INNATE IMMUNITY; GENERATION; METHYLATION; INDUCTION; MOUSE; OCT4; FIBROBLASTS	The combination of defined factors with small molecules targeting epigenetic factors is a strategy that has been shown to enhance optimal derivation of iPSCs and could be used for disease modelling, high throughput screenings and/or regenerative medicine applications. In this study, we showed that a new first-in-class reversible dual G9a/DNMT1 inhibitor compound (CM272) improves the efficiency of human cell reprogramming and iPSC generation from primary cells of healthy donors and patient samples, using both integrative and non-integrative methods. Moreover, CM272 facilitates the generation of human iPSC with only two factors allowing the removal of the most potent oncogenic factor cMYC. Furthermore, we demonstrated that mechanistically, treatment with CM272 induces heterochromatin relaxation, facilitates the engagement of OCT4 and SOX2 transcription factors to OSKM refractory binding regions that are required for iPSC establishment, and enhances mesenchymal to epithelial transition during the early phase of cell reprogramming. Thus, the use of this new G9a/DNMT reversible dual inhibitor compound may represent an interesting alternative for improving cell reprogramming and human iPSC derivation for many different applications while providing interesting insights into reprogramming mechanisms.	[Roberto Rodriguez-Madoz, Juan; Zapata-Linares, Natalia; Rodriguez, Saray; Porciuncula, Angelo; Prosper, Felipe] Univ Navarra, Cell Therapy Program, Ctr Appl Med Res CIMA, Pamplona, Spain; [San Jose-Eneriz, Edurne; Miranda, Estibaliz; Vilas-Zornoza, Amaia; Garate, Leire; Agirre, Xabier; Prosper, Felipe] Univ Navarra, Oncohematol Program, Ctr Appl Med Res CIMA, Pamplona, Spain; [Rabal, Obdulia; Oyarzabal, Julen] Univ Navarra, Small Mol Discovery Platform, Mol Therapeut Program, Ctr Appl Med Res CIMA, Pamplona, Spain; [Segura, Victor; Guruceaga, Elizabeth] Univ Navarra, Bioinformat Unit, Ctr Appl Med Res CIMA, Pamplona, Spain; [Prosper, Felipe] Univ Navarra, Hematol & Area Cell Therapy, Clin Univ Navarra, Pamplona, Spain; [Zapata-Linares, Natalia] UPMC, Ctr Rech St Antoine, UMR S938, INSERM, Paris, France; [Porciuncula, Angelo] NYU, Sch Med, Dysauton Ctr, New York, NY USA	University of Navarra; University of Navarra; University of Navarra; University of Navarra; University of Navarra; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; New York University	Rodriguez-Madoz, JR; Prosper, F (corresponding author), Univ Navarra, Cell Therapy Program, Ctr Appl Med Res CIMA, Pamplona, Spain.; Prosper, F (corresponding author), Univ Navarra, Oncohematol Program, Ctr Appl Med Res CIMA, Pamplona, Spain.; Prosper, F (corresponding author), Univ Navarra, Hematol & Area Cell Therapy, Clin Univ Navarra, Pamplona, Spain.	jrrodriguez@unav.es; fprosper@unav.es	Prosper, Felipe/H-6859-2017; Vilas-Zornoza, Amaia/AAD-4004-2020; San Jose-Eneriz, Edurne/AAD-7288-2020; Agirre, Xabier/ABE-4110-2020; Rodriguez-Madoz, Juan Roberto/N-3667-2014; Rodriguez-Diaz, Saray/AAA-5507-2019; Oyarzabal, Julen/K-7393-2017; Segura, Victor/E-4531-2010; Guruceaga, Elizabeth/B-1796-2008	Prosper, Felipe/0000-0001-6115-8790; Vilas-Zornoza, Amaia/0000-0001-6693-0989; San Jose-Eneriz, Edurne/0000-0001-5786-5273; Rodriguez-Madoz, Juan Roberto/0000-0003-4327-1866; Rodriguez-Diaz, Saray/0000-0001-6799-8002; Oyarzabal, Julen/0000-0003-1941-7255; Segura, Victor/0000-0002-7740-6290; Guruceaga, Elizabeth/0000-0003-0547-681X	Institute de Salud Carlos III (ISCIII) [PI13/00862, PI13/01469, PI14/01867]; CIBERONC [CB16/12/00489]; FEDER; TERCEL [RD12/0019/0031]; ERA-NET programs TRANSCAN-2 JTC EPICA; EuroNanoMed JTC NanoGene; Ministry of Economy and Competitiveness "Torres Quevedo" Subprogram [PTQ-11-04777]; Fundacion Bancaria Caja Navarra [70270]	Institute de Salud Carlos III (ISCIII); CIBERONC; FEDER(European Commission); TERCEL; ERA-NET programs TRANSCAN-2 JTC EPICA; EuroNanoMed JTC NanoGene; Ministry of Economy and Competitiveness "Torres Quevedo" Subprogram; Fundacion Bancaria Caja Navarra	This work was funded by grants from Institute de Salud Carlos III (ISCIII) PI13/00862 to JRRM, PI13/01469 to XA, PI14/01867 to FP, CIBERONC (Co-finance with FEDER funds) CB16/12/00489 to FP, TERCEL (RD12/0019/0031) to FP, ERA-NET programs TRANSCAN-2 JTC EPICA to FP and EuroNanoMed JTC NanoGene to FP, Ministry of Economy and Competitiveness "Torres Quevedo" Subprogram (PTQ-11-04777) to JRRM and by the Fundacion Bancaria Caja Navarra (70270) to JRRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Becker JS, 2016, TRENDS GENET, V32, P29, DOI 10.1016/j.tig.2015.11.001; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Bolstad B, 2005, BIOINFORMATICS COMPU; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cacchiarelli D, 2015, CELL, V162, P412, DOI 10.1016/j.cell.2015.06.016; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen KS, 2016, EMBO REP, V17, P1641, DOI 10.15252/embr.201642402; Drozd AM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0112-3; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hussein SMI, 2014, NATURE, V516, P198, DOI 10.1038/nature14046; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Jung DW, 2014, ACS CHEM BIOL, V9, P80, DOI 10.1021/cb400754f; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Lin TX, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/794632; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Montserrat N, 2012, J BIOL CHEM, V287, P24131, DOI 10.1074/jbc.M112.350413; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; San Jose-Eneriz E, 2017, NAT COMMUN; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Shu XD, 2014, CURR OPIN GENET DEV, V28, P32, DOI 10.1016/j.gde.2014.08.005; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Zapata-Linares N, 2016, STEM CELL RES, V16, P116, DOI 10.1016/j.scr.2015.12.014; Zapata-Linares N, 2016, STEM CELL RES, V16, P20, DOI 10.1016/j.scr.2015.12.002; Zhang T, 2016, CELL REP, V15, P77, DOI 10.1016/j.celrep.2016.03.007; Zunder ER, 2015, CELL STEM CELL, V16, P323, DOI 10.1016/j.stem.2015.01.015	44	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190275	10.1371/journal.pone.0190275	http://dx.doi.org/10.1371/journal.pone.0190275			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281720	gold, Green Submitted, Green Published			2022-12-26	WOS:000419006200078
J	Kuroki, LM; Jin, XJ; Dmitriev, IP; Kashentseva, EA; Powell, MA; Mutch, DG; Dietz, AB; Curiel, DT; Hawkins, WG; Spitzer, D				Kuroki, Lindsay M.; Jin, Xingjian; Dmitriev, Igor P.; Kashentseva, Elena A.; Powell, Matthew A.; Mutch, David G.; Dietz, Allan B.; Curiel, David T.; Hawkins, William G.; Spitzer, Dirk			Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; GENE-TRANSFER; FUSION PROTEIN; TUMOR-GROWTH; RECEPTOR; EXPRESSION; THERAPY; FIBER; COXSACKIEVIRUS; CARCINOMA	Clinical application of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)based cancer therapeutics has not reached optimal potencies in part due to inadequate drug stability and inefficiencies in cancer-selective drug delivery. As such, innovative strategies regarding drug design and delivery are of utmost importance to achieve improved treatment results. With our current study, we aimed at exploring the groundwork for a two-stage targeting concept, which is based on the intrinsic tumor homing capacity of mesenchymal stem cells (MSCs) as cellular drug factories for the in situ production of our newly designed and biomarker-targeted TRAIL-based TR3 therapeutics. Since MSCs are primary cells, capable in vitro of only a limited number of cell divisions, identification of suitable strategies for their efficient genetic manipulation is of critical importance. We chose adenoviral (Ad) vectors as a transduction vehicle due to its ability to infect dividing and non-dividing cells and because of their limited restrictions regarding the packaging capacity of their genetic payload. In order to enhance the transduction efficacy of MSCs using Ad5 wild-type-based vectors, we tested a variety of fiber knob modifications on a panel of patient-derived MSC lines established from adipose tissue. We identified Ad5pK7, an Ad5 vector containing a polylysine fiber knob modification, exhibiting the highest transduction rates across a panel of 16 patient-derived MSC lines. We further demonstrated that MSCs could be efficiently transduced with an Ad5pK7 vector containing membrane-anchored and secreted TR3 expression units, including the MUC16 (CA125)-targeted variant Meso64-TR3. In both in vitro and in vivo experiments, MSC-derived Meso64-TR3 was far more potent on MUC16expressing ovarian cancer compared to its non-targeted TR3 counterpart. Our findings thus provide the foundation to initiate further preclinical investigations on MSC-mediated treatment options in ovarian cancer using biomarker-targeted TR3-based biologics.	[Kuroki, Lindsay M.; Powell, Matthew A.; Mutch, David G.] Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, St Louis, MO 63110 USA; [Kuroki, Lindsay M.; Powell, Matthew A.; Mutch, David G.; Hawkins, William G.; Spitzer, Dirk] Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA; [Jin, Xingjian; Hawkins, William G.; Spitzer, Dirk] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Dmitriev, Igor P.; Kashentseva, Elena A.; Curiel, David T.] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA; [Dmitriev, Igor P.; Kashentseva, Elena A.; Curiel, David T.] Washington Univ, Sch Med, Biol Therapeut Ctr, St Louis, MO USA; [Dietz, Allan B.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Mayo Clinic	Spitzer, D (corresponding author), Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA.; Spitzer, D (corresponding author), Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA.	spitzerd@wudosis.wustl.edu	Dietz, Allan B/H-7414-2015; Dietz, Allan/AAI-6976-2021	Dietz, Allan B/0000-0003-3410-9621; Dietz, Allan/0000-0003-3410-9621; Spitzer, Dirk/0000-0003-3949-1815	National Institutes of Health [CTSA607 UL1 TR000448]; Washington University Center for Drug Discovery; Staenberg; Eberle family; Washington University ICTS; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Center for Drug Discovery; Staenberg; Eberle family; Washington University ICTS; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by National Institutes of Health CTSA607 UL1 TR000448 (L. Kuroki and D. Spitzer); the content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Dr. Bradley Evanoff is the PI for the Clinical and Translational Science Award that supports all Washington University ICTS and Clinical Research Training Center activities. This work was also supported by Washington University Center for Drug Discovery (D. Spitzer); the Staenberg and the Eberle family donation to the Department of Gynecologic Oncology (M.A. Powell and D.G. Mutch).	Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bremer E, 2005, CANCER RES, V65, P3380, DOI 10.1158/0008-5472.CAN-04-2756; Choi SA, 2011, NEURO-ONCOLOGY, V13, P61, DOI 10.1093/neuonc/noq147; Contreras JL, 2003, TRANSPLANTATION, V76, P252, DOI 10.1097/01.TP.0000066361.02042.CA; Crespo-Diaz R, 2011, CELL TRANSPLANT, V20, P797, DOI 10.3727/096368910X543376; Cripe TP, 2001, CANCER RES, V61, P2953; DIRKS W, 1994, GENE, V149, P387, DOI 10.1016/0378-1119(94)90186-4; Dorr J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-04-j0001.2002; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; FRAS I, 1967, AM J PSYCHIAT, V123, P1553, DOI 10.1176/ajp.123.12.1553; Garg G, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-35; Griffith TS, 2009, CURR GENE THER, V9, P9, DOI 10.2174/156652309787354612; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hemmi S, 1998, HUM GENE THER, V9, P2363, DOI 10.1089/hum.1998.9.16-2363; Howlader N., 2016, SEER CANC STAT REV; Jo M, 2000, NAT MED, V6, P564, DOI 10.1038/75045; Kagawa S, 2001, CANCER RES, V61, P3330; Kanerva A, 2002, CLIN CANCER RES, V8, P275; Kelly FJ, 2000, CLIN CANCER RES, V6, P4323; Kim CY, 2006, GENE THER, V13, P330, DOI 10.1038/sj.gt.3302658; Kim JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055533; Kim SW, 2013, CLIN CANCER RES, V19, P415, DOI 10.1158/1078-0432.CCR-12-1568; Kim SM, 2008, CANCER RES, V68, P9614, DOI 10.1158/0008-5472.CAN-08-0451; Krasnykh VN, 1996, J VIROL, V70, P6839, DOI 10.1128/JVI.70.10.6839-6846.1996; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Li YM, 1999, CANCER RES, V59, P325; Loebinger MR, 2010, BRIT J CANCER, V103, P1692, DOI 10.1038/sj.bjc.6605952; Loebinger MR, 2009, CANCER RES, V69, P4134, DOI 10.1158/0008-5472.CAN-08-4698; LOUIS N, 1994, J VIROL, V68, P4104, DOI 10.1128/JVI.68.6.4104-4106.1994; Luetzkendorf J, 2010, J CELL MOL MED, V14, P2292, DOI 10.1111/j.1582-4934.2009.00794.x; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; McLornan DP, 2014, NEW ENGL J MED, V371, P1725, DOI 10.1056/NEJMra1407390; Menon LG, 2009, STEM CELLS, V27, P2320, DOI 10.1002/stem.136; Miller CR, 1998, CANCER RES, V58, P5738; Mohr A, 2008, J CELL MOL MED, V12, P2628, DOI 10.1111/j.1582-4934.2008.00317.x; Moniri MR, 2012, CANCER GENE THER, V19, P652, DOI 10.1038/cgt.2012.46; Naoum GE, 2017, ONCOL REV, V11, P26, DOI 10.4081/oncol.2017.332; Naoum GE, 2016, ECANCERMEDICALSCIENC, V10, DOI 10.3332/ecancer.2016.660; P Mafi, 2011, Open Orthop J, V5, P253, DOI 10.2174/1874325001105010253; Park SH, 2010, GENE THER, V17, P1052, DOI 10.1038/gt.2010.58; Pereboeva L, 2003, STEM CELLS, V21, P389, DOI 10.1634/stemcells.21-4-389; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Reagan MR, 2012, J BREAST CANCER, V15, P273, DOI 10.4048/jbc.2012.15.3.273; Reagan MR, 2011, STEM CELLS, V29, P920, DOI 10.1002/stem.645; Sage EK, 2014, THORAX, V69, P638, DOI 10.1136/thoraxjnl-2013-204110; Sasportas LS, 2009, P NATL ACAD SCI USA, V106, P4822, DOI 10.1073/pnas.0806647106; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Spitzer D, 2004, MOL IMMUNOL, V40, P911, DOI 10.1016/j.molimm.2003.10.017; Spitzer D, 2010, MOL CANCER THER, V9, P2142, DOI 10.1158/1535-7163.MCT-10-0225; Su Y, 2016, ONCOTARGET; Tatzel K, 2016, SCI REP-UK, V6, DOI 10.1038/srep22661; von Karstedt S, 2017, NAT REV CANCER, V17, P352, DOI 10.1038/nrc.2017.28; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu HJ, 2002, HUM GENE THER, V13, P1647, DOI 10.1089/10430340260201734; Yu R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.19	57	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190125	10.1371/journal.pone.0190125	http://dx.doi.org/10.1371/journal.pone.0190125			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267342	Green Published, gold, Green Submitted			2022-12-26	WOS:000418587400096
J	Muller, M; Guignard, V; Schefold, JC; Leichtle, AB; Exadaktylos, AK; Pfortmueller, CA				Mueller, Martin; Guignard, Viviane; Schefold, Joerg C.; Leichtle, Alexander B.; Exadaktylos, Aristomenis K.; Pfortmueller, Carmen A.			Utility of quick sepsis-related organ failure assessment (qSOFA) to predict outcome in patients with pneumonia	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; INTENSIVE-CARE-UNIT; INTERNATIONAL CONSENSUS DEFINITIONS; INFLAMMATORY RESPONSE SYNDROME; SEPTIC SHOCK SEPSIS-3; IN-HOSPITAL MORTALITY; SUSPECTED INFECTION; EMERGENCY-DEPARTMENT; PROGNOSTIC ACCURACY; ASSESSMENT SCORE	Background Despite on-going advances in medical treatment, the burden of disease of pneumonia remains high. We aimed to determine the association of the qSOFA score with in-hospital mortality, length of hospitalisation, and admission to the intensive care unit (ICU) in patients with pneumonia. Further, in a subgroup analysis, the outcomes were compared for qSOFA in comparison to other risk scores, including the CURB-65 and SIRS scores. Methods In a retrospective analysis, admission data from the ED of the Bern University Hospital, Switzerland, were screened to identify patients admitted for pneumonia. In addition to clinical characteristics, qSOFA and CURB-65 scores and SIRS criteria were assessed and evaluated with respect to the defined study outcomes. Results 527 patients (median age 66 IQR 50-76) were included in this study. The overall in-hospital mortality was 13.3% (n = 70); 22.0% (n = 116) were transferred to the ICU. The median length of hospitalisation was 7 days (IQR 4-12). In comparison to qSOFA-negative patients, qSOFA-positive patients had increased odds ratios for in-hospital mortality (OR 2.6, 95%: 1.4, 4.7, p<0.001) and ICU admission (3.5, 95% CI: 2.0. 5.8, p<0.001) and an increased length of stay (p<0.001). For ICU admission, the specificity of qSOPA-positivity (>= 2) was 82.1% and sensitivity 43.0%. For in-hospital mortality, the specificity of qSOPA-positivity (<= 2) was 88.9% and sensitivity 24.4%. In the subgroup analysis (n = 366). The area under the receiver operating curve for ICU admission was higher for qSOFA than for the CURB-65 score (p = 0.013). The evaluated scores did not differ significantly in their prognostication of in-hospital mortality (p>0.05). Conclusions The qSOFA score is associated with in-hospital mortality, ICU admission and length of hospitalisation in ED patients with pneumonia. Subgroup analysis revealed that qSOFA is superior to CURB-65 in respect to prognostication of ICU admission.	[Mueller, Martin; Guignard, Viviane; Exadaktylos, Aristomenis K.; Pfortmueller, Carmen A.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Emergency Med, Bern, Switzerland; [Schefold, Joerg C.; Pfortmueller, Carmen A.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Intens Care Med, Bern, Switzerland; [Leichtle, Alexander B.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Clin Chem, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Pfortmueller, CA (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Emergency Med, Bern, Switzerland.; Pfortmueller, CA (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Intens Care Med, Bern, Switzerland.	Carmen.pfortmueller@insel.ch	Leichtle, Alexander/C-7262-2011	Pfortmueller, Carmen/0000-0003-0326-2770; Schefold, Joerg C./0000-0001-9162-5724				Almirall J, 1999, EUR RESPIR J, V13, P349, DOI 10.1183/09031936.99.13234999; Alp Emine, 2004, Ann Clin Microbiol Antimicrob, V3, P17, DOI 10.1186/1476-0711-3-17; Askim A, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0399-4; Aujesky D, 2005, AM J MED, V118, P384, DOI 10.1016/j.amjmed.2005.01.006; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Capelastegul A, 2006, EUR RESPIR J, V27, P151, DOI 10.1183/09031936.06.00062505; Chen YX, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1351-0; Churpek MM, 2015, AM J RESP CRIT CARE, V192, P958, DOI 10.1164/rccm.201502-0275OC; Corrado RE, 2017, CHEST, V152, P930, DOI 10.1016/j.chest.2017.04.162; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Donnelly JP, 2017, LANCET INFECT DIS, V17, P661, DOI 10.1016/S1473-3099(17)30117-2; Finkelsztein EJ, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1658-5; Forward E, 2017, INTENS CARE MED, V43, P945, DOI 10.1007/s00134-017-4776-2; Freund Y, 2017, JAMA-J AM MED ASSOC, V317, P301, DOI 10.1001/jama.2016.20329; Henning DJ, 2017, ANN EMERG MED, V70, P544, DOI 10.1016/j.annemergmed.2017.01.008; Ho KM, 2017, J CRIT CARE, V38, P1, DOI 10.1016/j.jcrc.2016.10.005; Kim M, 2017, SUPPORT CARE CANCER, V25, P1557, DOI 10.1007/s00520-016-3567-6; Kolditz M, 2016, RESP MED, V121, P32, DOI 10.1016/j.rmed.2016.10.015; Kolditz M, 2016, INTENS CARE MED, V42, P2108, DOI 10.1007/s00134-016-4517-y; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; McGee S, 2002, J GEN INTERN MED, V17, P646; Quinten VM, 2018, EUR J EMERG MED, V25, P328, DOI 10.1097/MEJ.0000000000000460; Raith EP, 2017, JAMA-J AM MED ASSOC, V317, P290, DOI 10.1001/jama.2016.20328; Ranzani OT, 2017, AM J RESP CRIT CARE, V196, P1287, DOI [10.1164/rccm.201611-2262OC, 10.1164/rccm.201611-2262oc]; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Singer AJ, 2017, ANN EMERG MED, V69, P475, DOI 10.1016/j.annemergmed.2016.10.007; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Wang JY, 2016, AM J EMERG MED, V34, P1788, DOI 10.1016/j.ajem.2016.06.015; Williams JM, 2017, CHEST, V151, P586, DOI 10.1016/j.chest.2016.10.057; Woodhead M, 2006, CRIT CARE, V10, DOI 10.1186/cc4927	32	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0188913	10.1371/journal.pone.0188913	http://dx.doi.org/10.1371/journal.pone.0188913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267291	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400017
J	Backer, V; Cheung, FY; Siveke, JT; Fandrey, J; Winning, S				Baecker, Veronika; Cheung, Fung-Yi; Siveke, Jens T.; Fandrey, Joachim; Winning, Sandra			Knockdown of myeloid cell hypoxia-inducible factor-1 alpha ameliorates the acute pathology in DSS-induced colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; FACTOR-I; DENDRITIC CELLS; MURINE MODEL; T-CELLS; ACTIVATION; HIF-1-ALPHA; MACROPHAGES; INDUCTION; HIF-1	Inflammation and hypoxia are hallmarks of inflammatory bowel disease. Low oxygen levels activate hypoxia-inducible factors as central transcriptional regulators of cellular responses to hypoxia, particularly in myeloid cells where hypoxia-inducible factors control immune cell function and survival. Still, the role of myeloid hypoxia-inducible factor-1 during inflammatory bowel disease remains poorly defined. We therefore investigated the role of hypoxia-inducible factor-1 for myeloid cell function and immune response during colitis. Experimental colitis was induced by administration of 2.5% dextran sulfate sodium to mice with a conditional knockout of hypoxia-inducible factor-1a in myeloid cells and their wild type siblings. Murine colon tissue was examined by histologic analysis, immunohistochemistry, and quantitative polymerase chain reaction. Induction of experimental colitis increased levels of hypoxia and accumulation of hypoxia-inducible factor-1 alpha positive cells in colon tissue of both treated groups. Myeloid hypoxia-inducible factor-1 alpha knockout reduced weight loss and disease activity index when compared to wild type mice. Knockout mice displayed less infiltration of macrophages into intestinal mucosa and reduced mRNA expression of markers for dendritic cells and interleukin-17 secreting T helper cells. Expression of inflammatory and anti-inflammatory cytokines also showed a reduced and delayed induction in myeloid hypoxia-inducible factor-1 alpha knockout mice. Our results show a disease promoting role of myeloid hypoxiainducible factor-1 during intestinal inflammation. This might result from a hypoxia-inducible factor-1 dependent increase in pro-inflammatory interleukin-17 secreting T helper cells in the absence of obvious changes in regulatory T cells. In contrast, knockout mice appear to shift the balance to anti-inflammatory signals and cells resulting in milder intestinal inflammation.	[Baecker, Veronika; Fandrey, Joachim; Winning, Sandra] Univ Duisburg Essen, Inst Phys, Essen, Germany; [Cheung, Fung-Yi; Siveke, Jens T.] Univ Hosp Essen, Div Solid Tumor Translat Oncol, German Canc Consortium DKTK, Partner Site Essen, Essen, Germany	University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen	Fandrey, J (corresponding author), Univ Duisburg Essen, Inst Phys, Essen, Germany.	joachim.fandrey@uni-due.de	Fandrey, Joachim/AAA-3524-2021; Siveke, Jens/AAQ-6170-2021	Fandrey, Joachim/0000-0001-9585-0531				Balzola F., 2010, INFLAMM BOWEL DIS MO, V11, P79; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Clambey ET, 2012, P NATL ACAD SCI USA, V109, pE2784, DOI 10.1073/pnas.1202366109; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; COOPER HS, 1993, LAB INVEST, V69, P238; Cox JH, 2012, MUCOSAL IMMUNOL, V5, P99, DOI 10.1038/mi.2011.54; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; D'Ignazio L, 2016, FEBS J, V283, P413, DOI 10.1111/febs.13578; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Erbel C, 2014, J IMMUNOL, V193, P4344, DOI 10.4049/jimmunol.1400181; Fluck K, 2016, MUCOSAL IMMUNOL, V9, P379, DOI 10.1038/mi.2015.67; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Higashiyama M, 2012, J LEUKOCYTE BIOL, V91, P901, DOI 10.1189/jlb.1011518; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Marks E, 2017, MUCOSAL IMMUNOL, V10, P1224, DOI 10.1038/mi.2016.135; Marshall D, 2007, INFLAMM BOWEL DIS, V13, P219, DOI 10.1002/ibd.20055; Martin SK, 2011, LEUKEMIA, V25, P1533, DOI 10.1038/leu.2011.122; McColl SR, 2002, IMMUNOL CELL BIOL, V80, P489, DOI 10.1046/j.1440-1711.2002.01113.x; Mocsai A, 2003, BLOOD, V101, P4155, DOI 10.1182/blood-2002-07-2346; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Scheerer N, 2013, J IMMUNOL, V191, P407, DOI 10.4049/jimmunol.1103779; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Tambuwala MM, 2015, J CONTROL RELEASE, V217, P221, DOI 10.1016/j.jconrel.2015.09.022; Taylor CT, 2007, J MOL MED, V85, P1295, DOI 10.1007/s00109-007-0277-z; Walmsley SR, 2005, TRENDS IMMUNOL, V26, P434, DOI 10.1016/j.it.2005.06.007; Zhang YZ, 2014, WORLD J GASTROENTERO, V20, P91, DOI 10.3748/wjg.v20.i1.91	35	31	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0190074	10.1371/journal.pone.0190074	http://dx.doi.org/10.1371/journal.pone.0190074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261815	Green Published, gold, Green Submitted			2022-12-26	WOS:000418564200087
J	Wai, PP; Shewade, HD; Kyaw, NTT; Kyaw, KWY; Thein, S; Thu, AS; Oo, MM; Htwe, PS; Tun, MMT; Maung, HMW; Soe, KT; Aung, ST				Wai, Pyae Phyo; Shewade, Hemant Deepak; Nang Thu Thu Kyaw; Kyaw, Khine Wut Yee; Thein, Saw; Thu, Aung Si; Oo, Myo Minn; Htwe, Pyae Sone; Tun, Moe Myint Theingi; Maung, Htet Myet Win; Soe, Kyaw Thu; Aung, Si Thu			Patients with MDR-TB on domiciliary care in programmatic settings in Myanmar: Effect of a support package on preventing early deaths	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; TREATMENT INITIATION; TREATMENT OUTCOMES; METAANALYSIS; IMPACT; INDIA	Background The community-based MDR-TB care (CBMDR-TBC) project was implemented in 2015 by The Union in collaboration with national TB programme (NTP) in 33 townships of upper Myanmar to improve treatment outcomes among patients with MDR-TB registered under NTP. They received community-based support through the project staff, in addition to the routine domiciliary care provided by NTP staff. Each project township had a project nurse exclusively for MDR-TB and a community volunteer who provided evening directly observed therapy (in addition to morning directly observed therapy by NTP). Objectives To determine the effect of CBMDR-TBC project on death and unfavourable outcomes during the intensive phase of MDR-TB treatment. Methods In this cohort study involving record review, all patients diagnosed with MDR-TB between January 2015 and June 2016 in project townships and initiated on treatment till 31 Dec 2016 were included. CBMDR-TBC status was categorized as "receiving support" if project initiation in patient's township was before treatment initiation, "receiving partial support" if project initiation was after treatment initiation, and "not receiving support" if project initiation was after intensive phase treatment outcome declaration. Time to event analysis (censored on 10 April 2017) and cox regression was done. Results Of 261 patients initiated on treatment, death and unfavourable outcomes were accounted for 13% and 21% among "receiving support (n = 163)", 3% and 24% among "receiving partial support (n = 75)" and 13% and 26% among " not receiving support (n = 23) " respectively. After adjusting for other potential confounders, the association between CBMDRTBC and unfavourable outcomes was not statistically significant. However, when compared to " not receiving support ", those "receiving support " and "receiving partial support " had 20% [aHR (0.95 CI: 0.8 (0.2-3.1)] and 90% lower hazard [aHR (0.95 CI: 0.1 (0.02-0.9)] of death, respectively. This was intriguing. Implementation of CBMDR-TBC coincided with implementation of decentralized MDR-TB centers at district level. Hence, patients that would have generally not accessed MDR-TB treatment before decentralization also started receiving treatment and were also included under CBMDR-TBC "received support" group. These patients could possibly be expected to sicker at treatment initiation than patients in other CBMDR-TBC groups. This could be the possible reason for nullifying the effect of CBMDRTBC in "receiving support "group and therefore similar survival was found when compared to "not receiving support". Conclusion CBMDR-TBC may prevent early deaths and has a scope for expansion to other townships of Myanmar and implications for NTPs globally. However, future studies should consider including data on extent of sickness at treatment initiation and patient level support received under CBMDR-TBC.	[Wai, Pyae Phyo; Nang Thu Thu Kyaw; Kyaw, Khine Wut Yee; Thu, Aung Si; Oo, Myo Minn; Htwe, Pyae Sone; Tun, Moe Myint Theingi] Int Union TB & Lung Dis Union, Mandalay, Myanmar; [Shewade, Hemant Deepak] South East Asia Off, Int Union TB & Lung Dis Union, New Delhi, India; [Thein, Saw; Maung, Htet Myet Win; Aung, Si Thu] Minist Hlth & Sports, Natl TB Programme, Mandalay, Myanmar; [Soe, Kyaw Thu] Minist Hlth & Sports, Dept Med Res, Pyin Oo Lwin Branch, Mandalay, Myanmar		Wai, PP (corresponding author), Int Union TB & Lung Dis Union, Mandalay, Myanmar.	dr.p.p.wai2012@gmail.com	Shewade MD PhD, Hemant Deepak/J-3907-2019; Kyaw, Khine Wut Yee/K-4130-2019; Oo, Myo Minn/P-3720-2018	Shewade MD PhD, Hemant Deepak/0000-0002-8242-1911; Kyaw, Khine Wut Yee/0000-0003-0709-484X; Oo, Myo Minn/0000-0003-4089-016X; SOE, KYAW THU/0000-0003-0969-8815	Department for International Development (DFID), UK	Department for International Development (DFID), UK	The training programme within which this paper was developed were funded by the Department for International Development (DFID), UK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Harris RC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1524-0; Isaakidis P, 2015, INT J TUBERC LUNG D, V19, P969, DOI 10.5588/ijtld.15.0123; Kibret KT, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0214-x; Ministry of Immigration and Population M, 2014, POP HOUS CENS MYANM; Nair D, 2016, T ROY SOC TROP MED H, V110, P534, DOI 10.1093/trstmh/trw060; National Tuberculosis Programme (NTP), 2014, NAT TUB PROGR MYANM; National Tuberculosis Programme (NTP), 2016, MYANM NAT STRAT PLAN, P126; National Tuberculosis Programme (NTP), 2016, GUID MAN DR TB MYANM; Podewils LJ, 2011, EPIDEMIOL INFECT, V139, P113, DOI 10.1017/S0950268810000907; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Suryawanshi SL, 2017, PUBLIC HEALTH ACTION, V7, P116, DOI 10.5588/pha.17.0013; The World Bank, 2015, 201516 WORLD BANK; WHO, 2016, GLOB TUB REP; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization (WHO), WHO 3 NAT TUB TB DRU	17	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0187223	10.1371/journal.pone.0187223	http://dx.doi.org/10.1371/journal.pone.0187223			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261669	Green Submitted, Green Published, gold			2022-12-26	WOS:000418564200003
J	Kim, SH; Kim, HJ; Han, S; Yoo, BS; Choi, DJ; Kim, JJ; Jeon, ES; Cho, MC; Chae, SC; Ryu, KH				Kim, Sung Hea; Kim, Hyun-Joong; Han, Seongwoo; Yoo, Byung-Su; Choi, Dong-Ju; Kim, Jae-Joong; Jeon, Eun-Seok; Cho, Myeong-Chan; Chae, Shung Chull; Ryu, Kyu-Hyung			The limited prognostic role of echocardiograms in short-term follow-up after acute decompensated heart failure: An analysis of the Korean Heart Failure (KorHF) Registry	PLOS ONE			English	Article							QUALITY-OF-CARE; SURVEY PROGRAM; PREDICTORS; MORTALITY; SURVIVAL; OUTCOMES; ASSOCIATION; DIAGNOSIS; EUROPE; TRIAL	Background The prognostic values of the left ventricular ejection fraction (LVEF) and end-diastolic dimension (LVEDD) have primarily been shown among patients with chronic heart failure (HF), with little representation of patients with acute HF (AHF). Therefore, we investigated the value of these echocardiographic parameters in predicting clinical outcomes among patients in the Korean Heart Failure (KorHF) Registry. Methods The KorHF Registry consists of 3,200 patients who were hospitalized with AHF from 2005 to 2009. The Kaplan-Meier method was used to estimate survival and readmission, and differences were assessed using the log-rank test. Predictors of survival were identified using univariate and multivariate Cox proportional hazards regression analyses. Results Echocardiograms from 2,910 of the 3,200 patients (90.9%) were evaluated. The median LVEF and LVEDD (37% and 56 mm, respectively) were used as cut-offs for the binary transformation of each parameter. The cumulative death-free survival rates for all patients did not significantly differ based on LVEF or LVEDD quartiles; however, an LVEF greater than the median was associated with a better prognosis in ischemic HF patients (log-rank test; p = 0.039). Among ischemic HF patients, LVEF (dichotomized) was a significant predictor of death in a Cox model after adjusting for a history of HF, age, systolic blood pressure (SBP), serum sodium, sex, diabetes mellitus (DM), chronic obstructive pulmonary disease (COPD), chronic kidney disease (CKD), acute myocardial infarction (AMI), atrial fibrillation (Af) and anemia (hazard ratio (HR) 1.475, 95% confidence interval (CI) 1.099-1.979, p = 0.010). The cumulative readmission-free survival rates significantly differed among ischemic HF patients only when based on LVEDD quartiles (log-rank test; p = 0.001). In multivariate Cox proportional hazards regression analyses, LVEDD (dichotomized) remained a significant variable only among patients with ischemic HF after adjusting for sex, age, AMI, DM, COPD, serum sodium, SBP, blood urea nitrogen (BUN) and anemia (HR 1.401, 95% CI 1.067-1.841, p = 0.015). Conclusions Among ischemic AHF patients in the KorHF Registry, LVEF is associated with mortality, whereas LVEDD is only associated with readmission in a binary transformed form.	[Kim, Sung Hea; Kim, Hyun-Joong] Konkuk Univ, Sch Med, Dongtan Sacred Heart Hosp, Dept Cardiol, Hwaseong, South Korea; [Han, Seongwoo; Ryu, Kyu-Hyung] Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Dept Cardiol, Hwaseong, South Korea; [Yoo, Byung-Su] Yonsei Univ, Wonju Christian Hosp, Dept Internal Med, Wonju, South Korea; [Choi, Dong-Ju] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Kim, Jae-Joong] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea; [Jeon, Eun-Seok] Sungkyunkwan Univ, Coll Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea; [Cho, Myeong-Chan] Chungbuk Natl Univ, Coll Med, Cardiol Dept, Cheongju, South Korea; [Chae, Shung Chull] Kyungpook Natl Univ, Coll Med, Dept Internal Med, Daegu, South Korea	Konkuk University; Hallym University; Yonsei University; Seoul National University (SNU); University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Chungbuk National University; Kyungpook National University	Ryu, KH (corresponding author), Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Dept Cardiol, Hwaseong, South Korea.	khryumd@hanmail.net			Korean Society of Circulation; faculty of Konkuk University	Korean Society of Circulation; faculty of Konkuk University	This study was supported by The Korean Society of Circulation and performed in celebration of its 50th Anniversary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present study was supported by the Korean Society of Circulation and was performed in celebration of its 50th anniversary. We express our sincere gratitude to the secretarial staff and physicians at the following 24 participating university hospitals and medical centers for their contributions to this study (in alphabetical order): Catholic University, Seoul St. Mary's Hospital, Chonnam National University Hospital, Chungbuk National University Hospital, Chungnam National University Hospital, Dongguk University Ilsan Hospital, Eulji University Daejeon Hospital, Ewha Womans University Hospital, Gacheon University Gil Hospital, Hallym University Sacred Heart Hospital, Hanyang University Guri Hospital, Inje University Busan Paik Hospital, Jeju National University Hospital, Keimyung University Hospital, Konkuk University Medical Center, Korea University Guro Hospital, Kyungpook National University Hospital, Seoul National University Bundang Hospital, Seoul National University Hospital, Soonchunhyang University Cheonan Hospital, Sungkyunkwan University Samsung Medical Center, Ulsan University Asan Medical Center, Wonkwang University Hospital, Yeungnam University Hospital, Yonsei University Severance Hospital and Yonsei University Wonju Christian Hospital.; This paper was written as part of the research support program for the faculty of Konkuk University who were on sabbatical leave in 2013.	Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Choi DJ, 2011, KOREAN CIRC J, V41, P363, DOI 10.4070/kcj.2011.41.7.363; Ciampi Quirino, 2007, Cardiovasc Ultrasound, V5, P34, DOI 10.1186/1476-7120-5-34; Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0; Curtis JP, 2003, J AM COLL CARDIOL, V42, P736, DOI 10.1016/S0735-1097(03)00789-7; Damasceno A, 2012, ARCH INTERN MED, V172, P1386, DOI 10.1001/archinternmed.2012.3310; Felker GM, 2000, NEW ENGL J MED, V342, P1077, DOI 10.1056/NEJM200004133421502; Grayburn PA, 2005, J AM COLL CARDIOL, V45, P1064, DOI 10.1016/j.jacc.2004.12.069; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Komajda M, 2003, EUR HEART J, V24, P464, DOI 10.1016/S0195-668X(02)00700-5; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193; Perna ER, 2006, AM HEART J, V151, P84, DOI 10.1016/j.ahj.2005.03.010; Quinones MA, 2000, J AM COLL CARDIOL, V35, P1237, DOI 10.1016/S0735-1097(00)00511-8; Sliwa K, 2013, EUR HEART J, V34, P3151, DOI 10.1093/eurheartj/eht393; Wong ML, 2004, J AM COLL CARDIOL, V43, P2022, DOI 10.1016/j.jacc.2003.12.053; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807	18	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0188938	10.1371/journal.pone.0188938	http://dx.doi.org/10.1371/journal.pone.0188938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261675	Green Submitted, gold, Green Published			2022-12-26	WOS:000418554900012
J	Suntronwong, N; Klinfueng, S; Vichiwattana, P; Korkong, S; Thongmee, T; Vongpunsawad, S; Poovorawan, Y				Suntronwong, Nungruthai; Klinfueng, Sirapa; Vichiwattana, Preeyaporn; Korkong, Sumeth; Thongmee, Thanunrat; Vongpunsawad, Sompong; Poovorawan, Yong			Genetic and antigenic divergence in the influenza A(H3N2) virus circulating between 2016 and 2017 in Thailand	PLOS ONE			English	Article							VACCINE EFFECTIVENESS; RECEPTOR-BINDING; SEASONAL INFLUENZA; A VIRUSES; HEMAGGLUTININ; VARIANTS; SUBSTITUTIONS; EFFICACY; FUSION; SITES	Influenza virus evolves rapidly due to the accumulated genetic variations on the viral sequence. Unlike in North America and Europe, influenza season in the tropical Southeast Asia spans both the rainy and cool seasons. Thus, influenza epidemiology and viral evolution sometimes differ from other regions, which affect the ever-changing efficacy of the vaccine. To monitor the current circulating influenza viruses in this region, we determined the predominant influenza virus strains circulating in Thailand between January 2016 and June 2017 by screening 7,228 samples from patients with influenza-like illness. During this time, influenza A(H3N2) virus was the predominant influenza virus detected. We then phylogenetically compared the hemagglutinin (HA) gene from a subset of these A(H3N2) strains (n = 62) to the reference sequences and evaluated amino acid changes in the dominant antigenic epitopes on the HA protein structure. The divergence of the circulating A(H3N2) from the A/Hong Kong/4801/2014 vaccine strain formed five genetic groups (designated I to V) within the 3C.2a clade. Our results suggest a marked drift of the current circulating A(H3N2) strains in Thailand, which collectively contributed to the declining predicted vaccine effectiveness (VE) from 74% in 2016 down to 48% in 2017.	[Suntronwong, Nungruthai; Klinfueng, Sirapa; Vichiwattana, Preeyaporn; Korkong, Sumeth; Thongmee, Thanunrat; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Dept Pediat, Bangkok, Thailand	Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Dept Pediat, Bangkok, Thailand.	yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Poovorawan, Yong/0000-0002-2337-6807; vongpunsawad, sompong/0000-0001-7520-8728	National Science and Technology Development Agency [P-15-50004]; Center of Excellence in Clinical Virology, Chulalongkorn University [GCE 59-00930-005]; King Chulalongkorn Memorial Hospital; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0084/2558]	National Science and Technology Development Agency; Center of Excellence in Clinical Virology, Chulalongkorn University(Chulalongkorn University); King Chulalongkorn Memorial Hospital(Chulalongkorn University); Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF))	This work was supported by the Research Chair Grant from the National Science and Technology Development Agency (P-15-50004), The Center of Excellence in Clinical Virology, Chulalongkorn University (GCE 59-00930-005), King Chulalongkorn Memorial Hospital and the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program to Nungruthai Suntronwong (PHD/0084/2558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belongia EA, 2016, LANCET INFECT DIS, V16, P942, DOI 10.1016/S1473-3099(16)00129-8; BERTON MT, 1984, J VIROL, V52, P919, DOI 10.1128/JVI.52.3.919-927.1984; Bhatt S, 2011, MOL BIOL EVOL, V28, P2443, DOI 10.1093/molbev/msr044; Castilla J, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.7.30465; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Glatman-Freedman A, 2017, J CLIN VIROL, V93, P71, DOI 10.1016/j.jcv.2017.05.020; Grohskopf LA, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6505a1; Gupta R, 2004, PREDICTION N GLYCOSY, P10; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; Harvala H, 2016, EUROSURVEILLANCE, V22; Hergens M, 2017, EUROSURVEILLANCE, V22, P32, DOI 10.2807/1560-7917.ES.2017.22.8.30469; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; HUANG RTC, 1981, VIROLOGY, V110, P243, DOI 10.1016/0042-6822(81)90030-1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isin B, 2002, BIOPHYS J, V82, P569, DOI 10.1016/S0006-3495(02)75422-2; Kissling E, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.7.30464; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; KRYSTAL M, 1982, P NATL ACAD SCI-BIOL, V79, P4800, DOI 10.1073/pnas.79.15.4800; Melidou A, 2017, J CLIN VIROL, V94, P29, DOI 10.1016/j.jcv.2017.07.003; Melidou A, 2017, VACCINE, V35, P4828, DOI 10.1016/j.vaccine.2017.07.057; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nakajima S, 2000, VIROLOGY, V274, P220, DOI 10.1006/viro.2000.0453; Ndifon W, 2009, P NATL ACAD SCI USA, V106, P8701, DOI 10.1073/pnas.0903427106; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Schweiger B, 2002, MED MICROBIOL IMMUN, V191, P133, DOI 10.1007/s00430-002-0132-3; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Skowronski DM, 2017, EUROSURVEILLANCE, V22, P2, DOI [10.2807/1560-7917.es.2017.22.6.30460, 10.2807/1560-7917.ES.2017.22.6.30460]; Stray SJ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-91; Suwannakarn K, 2008, J VIROL METHODS, V152, P25, DOI 10.1016/j.jviromet.2008.06.002; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tewawong N, 2016, VIRUS GENES, V52, P711, DOI 10.1007/s11262-016-1347-5; Tewawong N, 2016, ARCH VIROL, V161, P1425, DOI 10.1007/s00705-016-2802-2; Tewawong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139958; Trebbien R, 2017, J CLIN VIROL, V94, P1, DOI 10.1016/j.jcv.2017.06.007; Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07; WEBSTER RG, 1980, VIROLOGY, V104, P139, DOI 10.1016/0042-6822(80)90372-4; WHO, WHO CONS INF M COMP; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Yang H, 2015, VIROLOGY, V477, P18, DOI 10.1016/j.virol.2014.12.024	41	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189511	10.1371/journal.pone.0189511	http://dx.doi.org/10.1371/journal.pone.0189511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29252990	gold, Green Published, Green Submitted			2022-12-26	WOS:000418389500035
J	Nemchinov, LG; Shao, J; Lee, MN; Postnikova, OA; Samac, DA				Nemchinov, Lev G.; Shao, Jonathan; Lee, Maya N.; Postnikova, Olga A.; Samac, Deborah A.			Resistant and susceptible responses in alfalfa (Medicago sativa) to bacterial stem blight caused by Pseudomonas syringae pv. syringae	PLOS ONE			English	Article							MILDEW RESISTANCE; BASAL RESISTANCE; GENE-EXPRESSION; PLANT; ARABIDOPSIS; DISEASE; PATHOGENS; EFFECTORS; PROTEINS; NBS	Bacterial stem blight caused by Pseudomonas syringae pv. syringae is a common disease of alfalfa (Medicago sativa L). Little is known about host-pathogen interactions and host defense mechanisms. Here, individual resistant and susceptible plants were selected from cultivars Maverick and ZG9830 and used for transcript profiling at 24 and 72 hours after inoculation (hai) with the isolate PssALF3. Bioinformatic analysis revealed a number of differentially expressed genes (DEGs) in resistant and susceptible genotypes. Although resistant plants from each cultivar produced a hypersensitive response, transcriptome analyses indicated that they respond differently at the molecular level. The number of DEGs was higher in resistant plants of ZG9830 at 24 hai than in Maverick, suggesting that ZG9830 plants had a more rapid effector triggered immune response. Unique up-regulated genes in resistant ZG9830 plants included genes encoding putative nematode resistance HSPRO2like proteins, orthologs for the rice Xa21 and soybean Rpg1-b resistance genes, and TIRcontaining R genes lacking both NBS and LRR domains. The suite of R genes up-regulated in resistant Maverick plants had an over-representation of R genes in the CC-NBS-LRR family including two genes for atypical CCR domains and a putative ortholog of the Arabidopsis RPM1 gene. Resistance in both cultivars appears to be mediated primarily by WRKY family transcription factors and expression of genes involved in protein phosphorylation, regulation of transcription, defense response including synthesis of isoflavonoids, and oxidation- reduction processes. These results will further the identification of mechanisms involved in resistance to facilitate selection of parent populations and development of commercial varieties.	[Nemchinov, Lev G.; Shao, Jonathan; Lee, Maya N.; Postnikova, Olga A.] USDA ARS, Mol Plant Pathol Lab, Beltsville, MD 20705 USA; [Samac, Deborah A.] USDA ARS, Plant Sci Res Unit, St Paul, MN 55108 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Nemchinov, LG (corresponding author), USDA ARS, Mol Plant Pathol Lab, Beltsville, MD 20705 USA.	Lev.Nemchinov@ars.usda.gov	Samac, Deborah/ABC-8744-2021	Samac, Deborah/0000-0002-1847-0508	USDA-ARS-CRIS projects [8042-21000-268-00D, 5062-12210-002D]	USDA-ARS-CRIS projects(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by funds from USDA-ARS-CRIS projects 8042-21000-268-00D and 5062-12210-002D.	Alfano JR, 1996, PLANT CELL, V8, P1683, DOI 10.1105/tpc.8.10.1683; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Arnold DL, 2011, MOL PLANT PATHOL, V12, P617, DOI [10.1111/j.1364-3703.2010.00697.x, 10.1111/J.1364-3703.2010.00697.X]; ASHFIELD T, 1995, GENETICS, V141, P1597; Ashfield T, 2003, MOL PLANT MICROBE IN, V16, P817, DOI 10.1094/MPMI.2003.16.9.817; Ashfield T, 2014, PLANT PHYSIOL, V166, P235, DOI 10.1104/pp.114.244715; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bozso Z, 2009, PLANT MOL BIOL, V70, P627, DOI 10.1007/s11103-009-9496-8; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Choudhury FK, 2017, PLANT J, V90, P856, DOI 10.1111/tpj.13299; Collier SM, 2011, MOL PLANT MICROBE IN, V24, P918, DOI 10.1094/MPMI-03-11-0050; Conde A, 2011, PLANT CELL PHYSIOL, V52, P1583, DOI 10.1093/pcp/pcr107; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; Gissot L, 2006, PLANT PHYSIOL, V142, P931, DOI 10.1104/pp.106.087718; Goff KE, 2007, GENE REGUL SYST BIO, V1, P167; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gray FA, 2015, COMPENDIUM ALFALFA D, P61; Grennan AK, 2006, PLANT PHYSIOL, V142, P809, DOI 10.1104/pp.106.900207; Harighi B, 2007, J PHYTOPATHOL, V155, P593, DOI 10.1111/j.1439-0434.2007.01284.x; Harrison J, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01722-15; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Katagiri F, 2010, MOL PLANT MICROBE IN, V23, P1531, DOI 10.1094/MPMI-04-10-0099; Lai Y, 2017, MOL PLANT PATHOL; Lee SW, 2006, P NATL ACAD SCI USA, V103, P18395, DOI 10.1073/pnas.0605508103; Li X, 2015, CURR OPIN IMMUNOL, V32, P114, DOI 10.1016/j.coi.2015.01.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loutre C, 2009, PLANT J, V60, P1043, DOI 10.1111/j.1365-313X.2009.04024.x; MacQueen A, 2016, J EXP BOT, V67, P2093, DOI 10.1093/jxb/erv530; McCaslin M, 2004, N AM ALF IMPR C; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Mohr TJ, 2010, MOL PLANT MICROBE IN, V23, P1303, DOI 10.1094/MPMI-01-10-0022; Morris CE, 2013, ANNU REV PHYTOPATHOL, V51, P85, DOI 10.1146/annurev-phyto-082712-102402; MOUTRAY JB, 1983, CROP SCI, V23, P801; Murray SL, 2007, MOL PLANT MICROBE IN, V20, P1431, DOI 10.1094/MPMI-20-11-1431; Nandety RS, 2013, PLANT PHYSIOL, V162, P1459, DOI 10.1104/pp.113.219162; Niks RE, 2009, NEW PHYTOL, V182, P817, DOI 10.1111/j.1469-8137.2009.02849.x; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Postnikova OA, 2013, PLANT CELL PHYSIOL, V54, P1041, DOI 10.1093/pcp/pct056; Putnam D, 2001, IMPORTANCE BENEFITS, V36; Quirino BF, 2003, MOL PLANT PATHOL, V4, P517, DOI 10.1046/J.1364-3703.2003.00198.X; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Samac D, 2014, PHYTOPATHOLOGY, V104, P102; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Toueni M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01431; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321; Young JM, 2010, J PLANT PATHOL, V92, pS5; Zou JJ, 2005, MOL PLANT MICROBE IN, V18, P1161, DOI 10.1094/MPMI-18-1161	53	16	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189781	10.1371/journal.pone.0189781	http://dx.doi.org/10.1371/journal.pone.0189781			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244864	gold, Green Submitted, Green Published			2022-12-26	WOS:000418184700064
J	Xu, L; Mowrey, DD; Chirasani, VR; Wang, Y; Pasek, DA; Dokholyan, NV; Meissner, G				Xu, Le; Mowrey, David D.; Chirasani, Venkat R.; Wang, Ying; Pasek, Daniel A.; Dokholyan, Nikolay V.; Meissner, Gerhard			G4941K substitution in the pore-lining S6 helix of the skeletal muscle ryanodine receptor increases RyR1 sensitivity to cytosolic and luminal Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; molecular dynamics; mutagenesis; ryanodine receptor; sarcoplasmic reticulum (SR); skeletal muscle	CALCIUM-RELEASE CHANNEL; AMINO-ACID-RESIDUES; SARCOPLASMIC-RETICULUM; ELECTROSTATICS; ACTIVATION; MUTATIONS; COMPLEX	The ryanodine receptor ion channel RyR1 is present in skeletal muscle and has a large cytoplasmic N-terminal domain and smaller C-terminal pore-forming domain comprising six transmembrane helices, a pore helix, and a selectivity filter. The RyR1 S6 pore-lining helix has two conserved glycines, Gly-4934 and Gly-4941, that facilitate RyR1 channel gating by providing S6 flexibility and minimizing amino acid clashes. Here, we report that substitution of Gly-4941 with Asp or Lys results in functional channels as indicated by caffeine-induced Ca2+ release response in HEK293 cells, whereas a low response of the corresponding Gly-4934 variants suggested loss of function. Following purification, the RyR1 mutants G4934D, G4934K, and G4941D did not noticeably conduct Ca2+ in single-channel measurements. Gly-4941 replacement with Lys resulted in channels having reduced K+ conductance and reduced selectivity for Ca2+ compared with wildtype. RyR1-G4941K did not fully close at nanomolar cytosolic Ca2+ concentrations and nearly fully opened at 2 m cytosolic or sarcoplasmic reticulum luminal Ca2+, and Ca2+- and voltage-dependent regulation of RyR1-G4941K mutant channels was demonstrated. Computational methods and single-channel recordings indicated that the open G4941K variant results in the formation of a salt bridge to Asp-4938. In contrast, wildtype RyR1 was closed and not activated by luminal Ca2+ at low cytosolic Ca2+ levels. A model suggested that luminal Ca2+ activates RyR1 by accessing a recently identified cytosolic Ca2+-binding site in the open channel as the Ca2+ ions pass through the pore.	[Xu, Le; Mowrey, David D.; Chirasani, Venkat R.; Wang, Ying; Pasek, Daniel A.; Dokholyan, Nikolay V.; Meissner, Gerhard] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dokholyan, NV; Meissner, G (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	dokh@unc.edu; meissner@med.unc.edu	Xu, Le/HDN-9623-2022; Chirasani, Venkata Reddy/AFN-6812-2022; Chirasani, Venkata Reddy/ABB-4967-2021; Dokholyan, Nikolay/D-8081-2018	Chirasani, Venkata Reddy/0000-0003-1416-0438; Chirasani, Venkata Reddy/0000-0003-1416-0438; Dokholyan, Nikolay/0000-0002-8225-4025	National Institutes of Health [AR018687]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR018687, R01AR018687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant AR018687. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AHERN GP, 1994, FEBS LETT, V352, P369, DOI 10.1016/0014-5793(94)01001-3; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Callenberg KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012722; Chen SRW, 1998, J BIOL CHEM, V273, P14675, DOI 10.1074/jbc.273.24.14675; des Georges A, 2016, CELL, V167, P145, DOI 10.1016/j.cell.2016.08.075; Dirksen RT, 2002, TRENDS CARDIOVAS MED, V12, P189, DOI 10.1016/S1050-1738(02)00163-9; Du GG, 1998, J BIOL CHEM, V273, P31867, DOI 10.1074/jbc.273.48.31867; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; Euden J, 2013, J BIOL CHEM, V288, P16671, DOI 10.1074/jbc.M113.465310; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gaburjakova J, 2006, J MEMBRANE BIOL, V212, P17, DOI 10.1007/s00232-006-7018-z; Gaburjakova J, 2016, BIOELECTROCHEMISTRY, V109, P49, DOI 10.1016/j.bioelechem.2016.01.002; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; Gao L, 1997, FEBS LETT, V412, P223, DOI 10.1016/S0014-5793(97)00781-3; Gomez AC, 2014, BIOCHEMISTRY-US, V53, P1373, DOI 10.1021/bi401586h; Gyorke I, 1998, BIOPHYS J, V75, P2801, DOI 10.1016/S0006-3495(98)77723-9; Hamilton SL, 2009, J BIOL CHEM, V284, P4047, DOI 10.1074/jbc.R800054200; HerrmannFrank A, 1996, PFLUG ARCH EUR J PHY, V432, P155, DOI 10.1007/s004240050117; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Klauda JB, 2012, J PHYS CHEM B, V116, P9424, DOI 10.1021/jp304056p; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Laver DR, 2007, BIOPHYS J, V92, P3541, DOI 10.1529/biophysj.106.099028; LEE HB, 1994, J BIOL CHEM, V269, P13305; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Marcoline FV, 2015, STRUCTURE, V23, P1526, DOI 10.1016/j.str.2015.05.014; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; Mei YW, 2015, J BIOL CHEM, V290, P17535, DOI 10.1074/jbc.M115.659672; MEISSNER G, 1986, BIOCHEMISTRY-US, V25, P236, DOI 10.1021/bi00349a033; Meissner G, 2002, FRONT BIOSCI, V7, pD2072, DOI 10.2741/meissner; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Mowrey DD, 2017, J BIOL CHEM, V292, P12947, DOI 10.1074/jbc.M116.760199; Murayama T, 2011, J BIOL CHEM, V286, P35571, DOI 10.1074/jbc.M111.255240; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Ramachandran S, 2013, J BIOL CHEM, V288, P6154, DOI 10.1074/jbc.M112.433789; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; SITSAPESAN R, 1995, J MEMBRANE BIOL, V146, P133, DOI 10.1007/BF00238004; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sun B, 2016, J BIOL CHEM, V291, P26024, DOI 10.1074/jbc.M116.758821; Sutko JL, 1997, PHARMACOL REV, V49, P53; Tripathy A, 1996, BIOPHYS J, V70, P2600, DOI 10.1016/S0006-3495(96)79831-4; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Uehara A, 2017, J GEN PHYSIOL, V149, P199, DOI 10.1085/jgp.201611624; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; Wang Y, 2006, J BIOL CHEM, V281, P15572, DOI 10.1074/jbc.M600090200; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; Xu L, 2008, J BIOL CHEM, V283, P6321, DOI 10.1074/jbc.M707353200; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950	54	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2015	2028		10.1074/jbc.M117.803247	http://dx.doi.org/10.1074/jbc.M117.803247			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29255089	Green Published, hybrid			2022-12-26	WOS:000424948000015
J	Deressa, T; Damtie, D; Fonseca, K; Gao, S; Abate, E; Alemu, S; Aleka, Y; Swain, MG; van Marie, G; Coffin, CS				Deressa, Tekalign; Damtie, Debasu; Fonseca, Kevin; Gao, Shan; Abate, Ebba; Alemu, Shitaye; Aleka, Yetemwork; Swain, Mark G.; van Marie, Guido; Coffin, Carla S.			The burden of hepatitis B virus (HBV) infection, genotypes and drug resistance mutations in human immunodeficiency virus-positive patients in Northwest Ethiopia	PLOS ONE			English	Article							NORTHERN ETHIOPIA; GENETIC DIVERSITY; AMERICAN COHORT; NATURAL-HISTORY; SERO-PREVALENCE; RISK-FACTORS; C VIRUS; HIV; COINFECTION; THERAPY	Background In sub-Saharan Africa, the hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infections are endemic. Although there has been great progress in HIV care, universal HBV vaccination and care is lacking. In this study, we aimed to determine the prevalence of HBV, HBV genotypes, and drug resistance mutations in dual infected cases in a cohort of HIV patients in Northwest Ethiopia. Methods A total of 308 HIV-1 positive patients were enrolled into the study and tested for HBsAg in plasma. In HBsAg positive samples, HBV DNA was analyzed for HBV genotype using inhouse nested PCR with HBV-specific pre-core / core or surface primers, and for HBV drug resistance mutations (DRMs) in polymerase region. Odds ratio at 95% confidence interval was calculated. Results Of the 308 HIV-positive subjects, 62.7% were female, median age 38 years (range 18-68, IQR: 27-49), and the median CD4 count 405 cells/mu l (IQR: 75-734). Overall, 94.2% were on antiretroviral therapy (ART) frequently with combinations of Zidovudine (AZT)-Lamivudine (3TC)-Nevirapine (NVP). HBsAg was detected in 5.5% (95% CI 2.95-8.08%) of the study participants, of which the majority were infected with HBV genotype A (7A, 2E, 2D, 1C, 1 G). All HIV/HBV positive cases were on ART with anti-HBV activity (i.e., 3TC) and 3TC associated HBV DRMs (i.e., rtV173L, rtL180M, and rtM204V) were detected in 7/13 (53.8%) subjects. Conclusion In this cross-sectional study of HIV-infected individuals, we found 5.5% HBV/HIV co-infected cases. Most were receiving the first generation anti-HBV therapy with a low genetic barrier to resistance, and several carried mutations associated with anti-HBV (3TC) drug resistance. These data underscore the importance of integrating HBV screening to the HIV treatment guidelines for better management and prevention of HBV-related liver disease.	[Deressa, Tekalign; Damtie, Debasu; Abate, Ebba; Aleka, Yetemwork] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Immunol & Mol Biol, Gondar, Ethiopia; [Fonseca, Kevin] Prov Lab Publ Hlth, Calgary, AB, Canada; [Gao, Shan; Swain, Mark G.; Coffin, Carla S.] Univ Calgary, Div Gastroenterol & Hepatol, Liver Unit, Dept Med, Calgary, AB, Canada; [Gao, Shan; van Marie, Guido; Coffin, Carla S.] Univ Calgary, Fac Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Abate, Ebba] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Alemu, Shitaye] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Gondar, Ethiopia	University of Gondar; University of Calgary; University of Calgary; University of Gondar	Deressa, T (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Immunol & Mol Biol, Gondar, Ethiopia.	tekalign09@gmail.com	Gella, Debasu Damtie/AAU-8457-2020	Gella, Debasu Damtie/0000-0001-8517-7136; van Marle, Guido/0000-0002-5148-6229				Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Archampong TNA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1342-4; Benhamou Y, 1999, HEPATOLOGY, V30, P1302, DOI 10.1002/hep.510300525; BODSWORTH N, 1989, J INFECT DIS, V160, P577, DOI 10.1093/infdis/160.4.577; Burnett RJ, 2005, LIVER INT, V25, P201, DOI 10.1111/j.1478-3231.2005.01054.x; Buti M, 2005, J CLIN VIROL, V34, pS79, DOI 10.1016/S1386-6532(05)80015-0; Centers for Disease Control and Prevention, 2009, GUID PREV TREATM OPP; Coffin CS, 2015, J VIRAL HEPATITIS, V22, P416, DOI 10.1111/jvh.12308; Coffin CS, 2013, J CLIN VIROL, V57, P103, DOI 10.1016/j.jcv.2013.02.004; Coffin CS, 2014, J CLIN VIROL, V60, P347, DOI 10.1016/j.jcv.2014.04.021; Coffin CS, 2011, LIVER TRANSPLANT, V17, P955, DOI 10.1002/lt.22312; Gebreegziabher D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1744-3; Geretti AM, 2010, J CLIN MICROBIOL, V48, P3223, DOI 10.1128/JCM.02231-09; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Hundie GB, 2016, J MED VIROL, V88, P1035, DOI 10.1002/jmv.24437; Kew MC, 2005, J MED VIROL, V75, P513, DOI 10.1002/jmv.20311; Kew MC, 2010, WORLD J HEPATOL, V2, P65, DOI 10.4254/wjh.v2.i2.65; Kouanfack C, 2012, ANTIVIR THER, V17, P321, DOI 10.3851/IMP1911; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Liaw YF, 2010, ANTIVIR THER, V15, P25, DOI 10.3851/IMP1621; Manyazewal T, 2014, J MED MICROBIOL, V63, P742, DOI 10.1099/jmm.0.063321-0; Matthews PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134037; McMahon BJ, 2009, HEPATOL INT, V3, P334, DOI 10.1007/s12072-008-9112-z; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Nyirenda M, 2008, J INFECTION, V57, P72, DOI 10.1016/j.jinf.2008.05.004; Rusine J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063303; Schultz AK, 2012, NUCLEIC ACIDS RES, V40, pW193, DOI 10.1093/nar/gks414; Shimakawa Y, 2016, GUT, V65, P2007, DOI 10.1136/gutjnl-2015-309892; Stewart Balint, 2011, BMC Res Notes, V4, P561, DOI 10.1186/1756-0500-4-561; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tessema B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-111; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Umare A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166936; Weldemhret L, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0090-2; Wondimeneh Y, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-171; World health organization, WHO HEP B HTM; Zenebe Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-118	39	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190149	10.1371/journal.pone.0190149	http://dx.doi.org/10.1371/journal.pone.0190149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281718	Green Published, gold, Green Submitted			2022-12-26	WOS:000419006200070
J	Kimmel, CB; Small, CM; Knope, ML				Kimmel, Charles B.; Small, Clayton M.; Knope, Matthew L.			A rich diversity of opercle bone shape among teleost fishes	PLOS ONE			English	Article							MORPHOLOGICAL DIVERSIFICATION; PHYLOGENETIC SIGNAL; EVOLUTIONARY RATES; MODULARITY; STICKLEBACK; SKELETON; GEIGER; MEF2CA	The opercle is a prominent craniofacial bone supporting the gill cover in all bony fish and has been the subject of morphological, developmental, and genetic investigation. We surveyed the shapes of this bone among 110 families spanning the teleost tree and examined its pattern of occupancy in a principal component-based morphospace. Contrasting with expectations from the literature that suggest the local morphospace would be only sparsely occupied, we find primarily dense, broad filling of the morphological landscape, indicating rich diversity. Phylomorphospace plots suggest that dynamic evolution underlies the observed spatial patterning. Evolutionary transits through the morphospaces are sometimes long, and occur in a variety of directions. The trajectories seem to represent both evolutionary divergences and convergences, the latter supported by convevol analysis. We suggest that that this pattern of occupancy reflects the various adaptations of different groups of fishes, seemingly paralleling their diverse marine and freshwater ecologies and life histories. Opercle shape evolution within the acanthomorphs, spiny ray-finned fishes, appears to have been especially dynamic.	[Kimmel, Charles B.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Small, Clayton M.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA; [Knope, Matthew L.] Univ Hawaii, Dept Biol, Hilo, HI 96720 USA	University of Oregon; University of Oregon; University of Hawaii System; University Hawaii Hilo	Kimmel, CB (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	kimmel@uoneuro.uoregon.edu		Kimmel, Charles/0000-0002-1122-4371	NSF [10S-0818738]; Division Of Human Resource Development [1345247] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Human Resource Development(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	2All of the funding received for this work was from the NSF grant 10S-0818738. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2014, SYST BIOL, V63, P685, DOI 10.1093/sysbio/syu030; Adams DC, 2014, SYST BIOL, V63, P166, DOI 10.1093/sysbio/syt105; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; ALBERCH P, 1980, AM ZOOL, V20, P653; Alberch P., 1989, Geobios Memoire Special (Villeurbanne), P21; Alberch P., 1982, EVOLUTION DEV DAHALE, P311; ANKER G C, 1974, Transactions of the Zoological Society of London, V32, P311; Armbruster WS, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0245; ARRATIA G, 1990, J MORPHOL, V203, P247, DOI 10.1002/jmor.1052030302; Betancur RR, 2013, PLOS CURRENTS TREE L; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; DeLaurier A, 2014, DEV BIOL, V385, P189, DOI 10.1016/j.ydbio.2013.11.016; Denton JSS, 2015, EVOLUTION, V69, P2425, DOI 10.1111/evo.12743; Erwin DH, 2007, PALAEONTOLOGY, V50, P57, DOI 10.1111/j.1475-4983.2006.00614.x; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Friedman M, 2010, P ROY SOC B-BIOL SCI, V277, P1675, DOI 10.1098/rspb.2009.2177; Gould S. J., 1989, WONDERFUL LIFE BURGE; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Gregory W. K., 1933, FISH SKULLS STUDY EV; Hallgrimsson B, 2009, EVOL BIOL, V36, P355, DOI 10.1007/s11692-009-9076-5; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harmon LJ, 2010, EVOLUTION, V64, P2385, DOI 10.1111/j.1558-5646.2010.01025.x; HUGHES GM, 1960, J EXP BIOL, V37, P28; Huycke TR, 2012, DEVELOPMENT, V139, P2371, DOI 10.1242/dev.079806; Kimmel CB, 2014, J APPL ICHTHYOL, V30, P600, DOI 10.1111/jai.12508; Kimmel CB, 2008, BEHAVIOUR, V145, P669, DOI 10.1163/156853908792451395; Kimmel CB, 2012, EVOL DEV, V14, P326, DOI 10.1111/j.1525-142X.2012.00551.x; Kimmel CB, 2012, EVOLUTION, V66, P419, DOI 10.1111/j.1558-5646.2011.01441.x; Kimmel CB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009475; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Maddison WP., 2021, MESQUITE MODULAR SYS; McAllister DE, 1968, B NAT HIST MUS CANAD, V2221; McGhee GR., 2007, GEOMETRY EVOLUTION A; Mitteroecker P, 2004, ANN ANAT, V186, P463, DOI 10.1016/S0940-9602(04)80085-2; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Near TJ, 2013, P NATL ACAD SCI USA, V110, P12738, DOI 10.1073/pnas.1304661110; Nichols JT, 2016, DEVELOPMENT, V143, P4430, DOI 10.1242/dev.141036; Olson ME, 2012, TRENDS ECOL EVOL, V27, P278, DOI 10.1016/j.tree.2011.12.005; Pennell MW, 2014, BIOINFORMATICS, V30, P2216, DOI 10.1093/bioinformatics/btu181; Pigliucci M., 2008, Q REV BIOL, V83, P283, DOI DOI 10.1086/590511; Price SA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0321; Raff R. A., 1996, SHAPE LIFE GENES DEV; RAUP DAVID M., 1966, J PALEONTOL, V40, P1178; RAUP DM, 1965, SCIENCE, V147, P1294, DOI 10.1126/science.147.3663.1294; Revell LJ, PLOTTING METHODS COM; Rohlf F. J., 2008, TPSDIG2 DIGITIZE LAN; Sidlauskas B, 2008, EVOLUTION, V62, P3135, DOI 10.1111/j.1558-5646.2008.00519.x; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Stange M, 2016, ECOL EVO, V6, P1; Stayton CT, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2015.0039; Stayton CT, 2015, EVOLUTION, V69, P2140, DOI 10.1111/evo.12729; Wagner GP, 1996, AM ZOOL, V36, P36; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Wilkins A.S., 2002, EVOLUTION DEV PATHWA; Wilson LAB, 2015, SCI REP-UK, V5, DOI 10.1038/srep16909; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	60	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0188888	10.1371/journal.pone.0188888	http://dx.doi.org/10.1371/journal.pone.0188888			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281662	Green Published, Green Submitted, gold			2022-12-26	WOS:000419006200012
J	Simmatis, L; Krett, J; Scott, SH; Jin, AY				Simmatis, Leif; Krett, Jonathan; Scott, Stephen H.; Jin, Albert Y.			Robotic exoskeleton assessment of transient ischemic attack	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; COGNITIVE IMPAIRMENT; STROKE; SENSORIMOTOR; ADAPTATION; RELIABILITY; DISABILITY; MOTOR; RISK; MRI	We used a robotic exoskeleton to quantify specific patterns of abnormal upper limb motor behaviour in people who have had transient ischemic attack (TIA). A cohort of people with TIA was recruited within two weeks of symptom onset. All individuals completed a robotic-based assessment of 8 behavioural tasks related to upper limb motor and proprioceptive function, as well as cognitive function. Robotic task performance was compared to a large cohort of controls without neurological impairments corrected for the influence of age. Impairment in people with TIA was defined as performance below the 5th percentile of controls. Participants with TIA were also assessed with the National Institutes of Health Stroke Scale (NIHSS) score, Chedoke-McMaster Stroke Assessment (CMSA) of the arm, the Behavioural Inattention Test (BIT), the Purdue pegboard test (PPB), and the Montreal Cognitive Assessment (MoCA). Age-related white matter change (ARWMC), prior infarction and cella-media index (CMI) were assessed from baseline CT scan that was performed within 24 hours of TIA. Acute infarction was assessed from diffusion-weighted imaging in a subset of people with TIA. Twenty-two people with TIA were assessed. Robotic assessment showed impaired upper limb motor function in 7/22 people with TIA patients and upper limb sensory impairment in 4/22 individuals. Cognitive tasks involving robotic assessment of the upper limb were completed in 13 participants, of whom 8 (61.5%) showed significant impairment. Abnormal performance in the CMSA arm inventory was present in 12/22 (54.5%) participants. ARWMC was 11.8 +/- 6.4 and CMI was 5.4 +/- 1.5. DWI was positive in 0 participants. Quantitative robotic assessment showed that people who have had a TIA display a spectrum of upper limb motor and sensory performance deficits as well as cognitive function deficits despite resolution of symptoms and no evidence of tissue infarction.	[Simmatis, Leif; Scott, Stephen H.; Jin, Albert Y.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Krett, Jonathan; Scott, Stephen H.; Jin, Albert Y.] Queens Univ, Dept Med, Kingston, ON, Canada; [Scott, Stephen H.; Jin, Albert Y.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada	Jin, AY (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.; Jin, AY (corresponding author), Queens Univ, Dept Med, Kingston, ON, Canada.; Jin, AY (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	ayj@queensu.ca		Krett, Jonathan/0000-0003-4964-3341; Simmatis, Leif/0000-0002-1234-5335	Canadian Institutes of Health Research [MOP 106662]; Ontario Research Fund [ORF-RE 04-47]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund	This work was funded by Canadian Institutes of Health Research operating grant MOP 106662, http://www.cihr-irsc.gc.ca/e/193.html; and Ontario Research Fund grant ORF-RE 04-47, https://www.ontario.ca/page/ontario-research-fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arba F, 2016, EUROPEAN J NEUROLOGY, P1; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Bock O, 2006, EXP BRAIN RES, V169, P400, DOI 10.1007/s00221-005-0153-4; Bourke TC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0201-2; Coderre AM, 2010, NEUROREHAB NEURAL RE, V24, P528, DOI 10.1177/1545968309356091; Corsi P., 1972, THESIS; Coutts SB, 2012, STROKE, V43, P3018, DOI 10.1161/STROKEAHA.112.665141; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; Gladstone DJ, 2004, CAN MED ASSOC J, V170, P1099, DOI 10.1503/cmaj.1031349; GOWLAND C, 1993, STROKE, V24, P58, DOI 10.1161/01.STR.24.1.58; Granek J, 2013, PLOS ONE, V8, P1; Granek JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046619; Gyldensted C, 1977, NEURORADIOLOGY, V14; HALLIGAN PW, 1989, LANCET, V2, P908; Ihle-Hansen H, 2012, DEMENT GER COGN D EX, V2, P38, DOI 10.1159/000336817; Kasuga S, 2015, J NEUROPHYSIOL, V114, P2187, DOI 10.1152/jn.00096.2015; Lex H, 2014, J MOTOR BEHAV, V46, P389, DOI 10.1080/00222895.2014.920290; Lex H, 2012, EXP BRAIN RES, V223, P457, DOI 10.1007/s00221-012-3273-7; Little CE, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0070-0; Lowrey CR, 2014, J PHYS MED REHABIL; Mai LM, 2013, CAN J NEUROL SCI, V40, P192, DOI 10.1017/S031716710001372X; Mandzia JL, 2016, STROKE, V47, P726, DOI 10.1161/STROKEAHA.115.011507; Mostafavi SM, 2013, INT C REHAB ROBOT; Mostafavi SM, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0104-7; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pendlebury ST, 2011, STROKE, V42, P3116, DOI 10.1161/STROKEAHA.111.621490; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Rasquin SMC, 2004, J NEUROL NEUROSUR PS, V75, P1562, DOI 10.1136/jnnp.2003.024190; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Scott SH, 2011, J REHABIL RES DEV, V48, P335, DOI 10.1682/JRRD.2010.04.0057; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Tippett WJ, 2006, BRAIN RES, V1102, P92, DOI 10.1016/j.brainres.2006.04.049; TWITCHELL TE, 1951, BRAIN, V74, P443, DOI 10.1093/brain/74.4.443; Tyryshkin K, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-47; van der Flier WM, 2005, STROKE, V36, P2116, DOI 10.1161/01.STR.0000179092.59909.42; van Rooij FG, 2014, STROKE, V45, P2270, DOI 10.1161/STROKEAHA.114.005205; Verbraak ME, 2012, J STROKE CEREBROVASC, V21, P124, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.012; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318	38	28	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0188786	10.1371/journal.pone.0188786	http://dx.doi.org/10.1371/journal.pone.0188786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8ZJ	29272289	Green Published, Green Submitted, gold			2022-12-26	WOS:000418651500004
J	Buchholz, PCF; Fademrecht, S; Pleiss, J				Buchholz, Patrick C. F.; Fademrecht, Silvia; Pleiss, Juergen			Percolation in protein sequence space	PLOS ONE			English	Article							EVOLUTION; IDENTIFICATION; SELECTION; FAMILIES	The currently known protein sequences are not distributed equally in sequence space, but cluster into families. Analyzing the cluster size distribution gives a glimpse of the large and unknown extant protein sequence space, which has been explored during evolution. For six protein superfamilies with different fold and function, the cluster size distributions followed a power law with slopes between 2.4 and 3.3, which represent upper limits to the cluster distribution of extant sequences. The power law distribution of cluster sizes is in accordance with percolation theory and strongly supports connectedness of extant sequence space. Percolation of extant sequence space has three major consequences: (1) It transforms our view of sequence space as a highly connected network where each sequence has multiple neighbors, and each pair of sequences is connected by many different paths. A high degree of connectedness is a necessary condition of efficient evolution, because it overcomes the possible blockage by sign epistasis and reciprocal sign epistasis. (2) The Fisher exponent is an indicator of connectedness and saturation of sequence space of each protein superfamily. (3) All clusters are expected to be connected by extant sequences that become apparent as a higher portion of extant sequence space becomes known. Being linked to biochemically distinct homologous families, bridging sequences are promising enzyme candidates for applications in biotechnology because they are expected to have substrate ambiguity or catalytic promiscuity.	[Buchholz, Patrick C. F.; Fademrecht, Silvia; Pleiss, Juergen] Univ Stuttgart, Inst Biochem & Tech Biochem, Stuttgart, Germany	University of Stuttgart	Pleiss, J (corresponding author), Univ Stuttgart, Inst Biochem & Tech Biochem, Stuttgart, Germany.	juergen.pleiss@itb.uni-stuttgart.de		Buchholz, Patrick/0000-0001-5967-3777	German Research Foundation DFG (EXC SimTech) [FOR1296]; German Research Foundation DFG [FOR1296, EXC310]	German Research Foundation DFG (EXC SimTech)(German Research Foundation (DFG)); German Research Foundation DFG(German Research Foundation (DFG))	The authors acknowledge the German Research Foundation DFG (FOR1296, EXC SimTech) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge Lenz Lorenz (University of Stuttgart) for providing the cluster analysis tool, Uta Freiberg (University of Stuttgart) for inspiring discussions, and the German Research Foundation DFG (FOR1296, EXC310) for financial support.	Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chiarabelli C, 2006, CHEM BIODIVERS, V3, P827, DOI 10.1002/cbdv.200690087; Christensen K., 2005, COMPLEXITY CRITICALI, V1, DOI DOI 10.1142/P365; Deeds EJ, 2003, BIOPHYS J, V85, P2962, DOI 10.1016/S0006-3495(03)74716-X; Dryden DTF, 2008, J R SOC INTERFACE, V5, P953, DOI 10.1098/rsif.2008.0085; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Enright AJ, 2003, NUCLEIC ACIDS RES, V31, P4632, DOI 10.1093/nar/gkg495; Fademrecht S, 2016, PROTEINS, V84, P600, DOI 10.1002/prot.25008; FISHER ME, 1967, PHYSICS-NEW YORK, V3, P255, DOI 10.1103/PhysicsPhysiqueFizika.3.255; Frenkel ZM, 2007, J THEOR BIOL, V244, P77, DOI 10.1016/j.jtbi.2006.07.027; Gricman L, 2015, PROTEINS, V83, P1593, DOI 10.1002/prot.24840; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; KAUFFMAN S, 1987, J THEOR BIOL, V128, P11, DOI 10.1016/S0022-5193(87)80029-2; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Manrubia S, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1010; Merkl R, 2016, BIOL CHEM, V397, P1, DOI 10.1515/hsz-2015-0158; Nelson DR, 2011, BBA-PROTEINS PROTEOM, V1814, P14, DOI 10.1016/j.bbapap.2010.08.008; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Persson B, 2013, CHEM-BIOL INTERACT, V202, P111, DOI 10.1016/j.cbi.2012.11.009; Pleiss J, 2000, J MOL CATAL B-ENZYM, V10, P491, DOI 10.1016/S1381-1177(00)00092-8; Rappoport N, 2012, NUCLEIC ACIDS RES, V40, pD313, DOI 10.1093/nar/gkr1027; Rudat J, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-11; Saberi AA, 2015, PHYS REP, V578, P1, DOI 10.1016/j.physrep.2015.03.003; SALISBURY FB, 1969, NATURE, V224, P342, DOI 10.1038/224342a0; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Vogel C, 2014, PROTEINS, V82, P2523, DOI 10.1002/prot.24615; Wu NC, 2016, ELIFE, V5, DOI 10.7554/eLife.16965; Zeil C, 2016, ANTIMICROB AGENTS CH, V60, P2709, DOI 10.1128/AAC.02930-15	33	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189646	10.1371/journal.pone.0189646	http://dx.doi.org/10.1371/journal.pone.0189646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261740	Green Submitted, Green Published, gold			2022-12-26	WOS:000418564200050
J	Hauseux, P; Hale, JS; Bordas, SPA				Hauseux, Paul; Hale, Jack S.; Bordas, Stephane P. A.			Calculating the Malliavin derivative of some stochastic mechanics problems	PLOS ONE			English	Article							GREEKS	The Malliavin calculus is an extension of the classical calculus of variations from deterministic functions to stochastic processes. In this paper we aim to show in a practical and didactic way how to calculate the Malliavin derivative, the derivative of the expectation of a quantity of interest of a model with respect to its underlying stochastic parameters, for four problems found in mechanics. The non-intrusive approach uses the Malliavin Weight Sampling (MWS) method in conjunction with a standard Monte Carlo method. The models are expressed as ODEs or PDEs and discretised using the finite difference or finite element methods. Specifically, we consider stochastic extensions of; a 1D Kelvin-Voigt viscoelastic model discretised with finite differences, a 1D linear elastic bar, a hyperelastic bar undergoing buckling, and incompressible Navier-Stokes flow around a cylinder, all discretised with finite elements. A further contribution of this paper is an extension of the MWS method to the more difficult case of non-Gaussian random variables and the calculation of second-order derivatives. We provide open-source code for the numerical examples in this paper.	[Hauseux, Paul; Hale, Jack S.; Bordas, Stephane P. A.] Univ Luxembourg, Inst Computat Engn, 6 Ave Fonte, Esch Sur Alzette, Luxembourg; [Bordas, Stephane P. A.] Cardiff Univ, Cardiff Sch Engn, Queens Bldg, Cardiff CF24 3AA, S Glam, Wales	University of Luxembourg; Cardiff University	Bordas, SPA (corresponding author), Univ Luxembourg, Inst Computat Engn, 6 Ave Fonte, Esch Sur Alzette, Luxembourg.; Bordas, SPA (corresponding author), Cardiff Univ, Cardiff Sch Engn, Queens Bldg, Cardiff CF24 3AA, S Glam, Wales.	stephane.bordas@uni.lu	Bordas, Stéphane P.A./AAE-6933-2019; Hauseux, Paul/AAW-3061-2020; Bordas, Stéphane P.A./A-1858-2009	Bordas, Stéphane P.A./0000-0001-7622-2193; Bordas, Stéphane P.A./0000-0001-7622-2193; Hauseux, Paul/0000-0002-7988-021X; Hale, Jack S./0000-0001-7216-861X	European Research Council Starting Independent Research Grant (ERC Stg grant) entitled "Towards real time multiscale simulation of cutting in non-linear materials with applications to surgical simulation and computer guided surgery" [279578]; internal MOMENTUM project at the University of Luxembourg; National Research Fund, Luxembourg; Marie Curie Actions of the European Commission (FP7-COFUND) Grant [6693582]; Luxembourg National Research Fund [INTER/MOBILITY/14/8813215/CBM/Bordas]; European Research Council Starting Independent Research Grant (ERC Stg grant) entitled 'Towards real time multiscale simulation of cutting in non-linear materials with applications to surgical simulation and computer guided surgery' [279578]	European Research Council Starting Independent Research Grant (ERC Stg grant) entitled "Towards real time multiscale simulation of cutting in non-linear materials with applications to surgical simulation and computer guided surgery"; internal MOMENTUM project at the University of Luxembourg; National Research Fund, Luxembourg(Luxembourg National Research Fund); Marie Curie Actions of the European Commission (FP7-COFUND) Grant; Luxembourg National Research Fund(Luxembourg National Research Fund); European Research Council Starting Independent Research Grant (ERC Stg grant) entitled 'Towards real time multiscale simulation of cutting in non-linear materials with applications to surgical simulation and computer guided surgery'	We thank the financial support of the European Research Council Starting Independent Research Grant (ERC Stg grant agreement No. 279578) entitled "Towards real time multiscale simulation of cutting in non-linear materials with applications to surgical simulation and computer guided surgery." Paul Hauseux is supported by the internal MOMENTUM project at the University of Luxembourg. Jack S. Hale is supported by the National Research Fund, Luxembourg, and cofunded under the Marie Curie Actions of the European Commission (FP7-COFUND) Grant No. 6693582. We also thank the funding from the Luxembourg National Research Fund (INTER/MOBILITY/14/8813215/CBM/Bordas).; We would like to thank Prof. Ivan Nourdin, University of Luxembourg, for his helpful discussions. We thank the financial support of the European Research Council Starting Independent Research Grant (ERC Stg grant agreement No. 279578) entitled 'Towards real time multiscale simulation of cutting in non-linear materials with applications to surgical simulation and computer guided surgery'. Paul Hauseux is supported by the internal MOMENTUM project at the University of Luxembourg. Jack S. Hale is supported by the National Research Fund, Luxembourg, and cofunded under the Marie Curie Actions of the European Commission (FP7-COFUND) Grant No. 6693582. We also thank the funding from the Luxembourg National Research Fund (INTER/MOBILITY/14/8813215/CBM/Bordas).	Alns MS, 2015, ARCHIVE NUMERICAL SO, V3; Ambrosetti A., 1995, PRIMER NONLINEAR ANA; Atangana A, 2017, UNCERTAIN FRACTIONAL, P121; Atangana A, 2017, PHYSICA A, V476, P1, DOI 10.1016/j.physa.2017.02.016; Atangana A, 2016, THERM SCI, V20, P763, DOI 10.2298/TSCI160111018A; Balay S., 2016, ANL9511REVISION37; Benhamou E, 2003, MATH FINANC, V13, P37, DOI 10.1111/1467-9965.t01-1-00004; Broadie M, 1996, MANAGE SCI, V42, P269, DOI 10.1287/mnsc.42.2.269; Capriotti L, 2008, 2008 WINTER SIMULATION CONFERENCE, VOLS 1-5, P587, DOI 10.1109/WSC.2008.4736117; Chen N, 2007, STOCH PROC APPL, V117, P1689, DOI 10.1016/j.spa.2007.03.012; Falgout RD, 2002, LECT NOTES COMPUT SC, V2331, P632; Farrell PE, 2013, SIAM J SCI COMPUT, V35, pC369, DOI 10.1137/120873558; Fournie E., 2001, FINANC STOCH, V5, DOI [DOI 10.1007/S007800050068, 10.1007/s007800050068]; Hauseux P, 2017, CALCULATING MALLIAVI; Hauseux P, 2017, COMPUT METHOD APPL M, V318, P917, DOI 10.1016/j.cma.2017.01.041; He JH, 2004, CHAOS SOLITON FRACT, V19, P847, DOI 10.1016/S0960-0779(03)00265-0; LECUYER P, 1990, MANAGE SCI, V36, P1364, DOI 10.1287/mnsc.36.11.1364; Logg A, 2010, ACM T MATH SOFTWARE, V37, DOI 10.1145/1731022.1731030; Malliavin P., 1997, STOCHASTIC ANAL; Malliavin Paul, STOCHASTIC CALCULUS; Matthies HG, 2008, ZAMM-Z ANGEW MATH ME, V88, P849, DOI 10.1002/zamm.200800095; Nourdin I., 2012, CAMBRIDGE TRACTS MAT, V192; Nualart D., 2006, MALLIAVIN CALCULUS R, V1995; Szamel G, 2017, EPL-EUROPHYS LETT, V117, DOI 10.1209/0295-5075/117/50010; Warren PB, 2014, ENTROPY-SWITZ, V16, P221, DOI 10.3390/e16010221; Warren PB, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.250601; Yang XJ, 2017, PHYSICA A, V481, P276, DOI 10.1016/j.physa.2017.04.054; Yang XJ, NEW FRACTIONAL DERIV	28	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189994	10.1371/journal.pone.0189994	http://dx.doi.org/10.1371/journal.pone.0189994			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261776	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000418564200080
J	Audet, CM; Ngobeni, S; Graves, E; Wagner, RG				Audet, Carolyn M.; Ngobeni, Sizzy; Graves, Erin; Wagner, Ryan G.			Mixed methods inquiry into traditional healers' treatment of mental, neurological and substance abuse disorders in rural South Africa	PLOS ONE			English	Article							HEALTH-CARE; SEEKING BEHAVIOR; GLOBAL BURDEN; ALCOHOL-USE; SCHIZOPHRENIA; PREVALENCE; AGINCOURT; DISEASE; DISABILITY; MORTALITY	Background Traditional healers are acceptable and highly accessible health practitioners throughout sub-Saharan Africa. Patients in South Africa often seek concurrent traditional and allopathic treatment leading to medical pluralism. Methods & findings We studied the cause of five traditional illnesses known locally as "Mavabyi ya nhloko" (sickness of the head), by conducting 27 in-depth interviews and 133 surveys with a randomly selected sample of traditional healers living and working in rural, northeastern South Africa. These interviews were carried out to identify treatment practices of mental, neurological, and substance abuse (MNS) disorders. Participating healers were primarily female (77%), older in age (median: 58.0 years; interquartile range [IQR]: 50-67), had very little formal education (median: 3.7 years; IQR: 3.2-4.2), and had practiced traditional medicine for many years (median: 17 years; IQR: 9.5-30). Healers reported having the ability to successfully treat: seizure disorders (47%), patients who have lost touch with reality (47%), paralysis on one side of the body (59%), and substance abuse (21%). Female healers reported a lower odds of treating seizure disorders (Odds Ratio (OR): 0.47), patients who had lost touch with reality (OR: 0.26; p-value<0.05), paralysis of one side of the body (OR: 0.36), and substance abuse (OR: 0.36) versus males. Each additional year of education received was found to be associated with lower odds, ranging from 0.13-0.27, of treating these symptoms. Each additional patient seen by healers in the past week was associated with roughly 1.10 higher odds of treating seizure disorders, patients who have lost touch with reality, paralysis of one side of the body, and substance abuse. Healers charged a median of 500 South African Rand (similar to US$35) to treat substance abuse, 1000 Rand (similar to US$70) for seizure disorders or paralysis of one side of the body, and 1500 Rand (similar to US$105) for patients who have lost touch with reality. Conclusions While not all healers elect to treat MNS disorders, many continue to do so, delaying allopathic health services to acutely ill patients.	[Audet, Carolyn M.; Graves, Erin] Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA; [Ngobeni, Sizzy; Wagner, Ryan G.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC,Wits Agincourt Res Unit, Johannesburg, South Africa; [Wagner, Ryan G.] Umea Univ, Umea Ctr Global Hlth Res, Umea, Sweden; [Ngobeni, Sizzy] Univ Witwatersrand, Agincourt Res Unit, Acornhoek, South Africa	Vanderbilt University; University of Witwatersrand; Umea University; University of Witwatersrand	Audet, CM (corresponding author), Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA.	carolyn.m.audet@vanderbilt.edu	Wagner, Ryan G/AFK-7323-2022	Wagner, Ryan G/0000-0003-2741-3676	National Institute of Mental Health [1K01MH107255-01]; National Institutes of Health [KL2TR0000446]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH107255] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was supported by the National Institute of Mental Health (1K01MH107255-01) and the National Institutes of Health (KL2TR0000446). The funders had no role in study design, data collection and analysis, decision or publish or preparation of the manuscript.	Audet C, 2017, MENTAL HLTH TREATMEN; Audet C. M., 2016, USE CD4 CELL COUNT R; Audet CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070326; Audet CM, 2012, SAHARA J-J SOC ASP H, V9, P41, DOI 10.1080/17290376.2012.665257; Babb Dale A, 2007, Psychol Health Med, V12, P314, DOI 10.1080/13548500600621511; Banda Y, 2007, J ALTERN COMPLEM MED, V13, P123, DOI 10.1089/acm.2006.6225; Barker RD, 2006, INT J TUBERC LUNG D, V10, P670; Bowie CR, 2010, AM J PSYCHIAT, V167, P1116, DOI 10.1176/appi.ajp.2010.09101406; Brown S, 2000, BRIT J PSYCHIAT, V177, P212, DOI 10.1192/bjp.177.3.212; Buckley PF, 2009, SCHIZOPHRENIA BULL, V35, P383, DOI 10.1093/schbul/sbn135; Charlson FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110208; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Department of Health, 2013, NAT MENT HEL POL FRA; Dewey ME, 2001, INT J GERIATR PSYCH, V16, P751, DOI 10.1002/gps.397.abs; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fela-Thomas A, 2016, EPILEPSY BEHAV, V54, P58, DOI 10.1016/j.yebeh.2015.11.008; Ferrari AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091936; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Goudge J, 2009, TROP MED INT HEALTH, V14, P458, DOI 10.1111/j.1365-3156.2009.02256.x; GREEN EC, 1985, SOC SCI MED, V20, P277, DOI 10.1016/0277-9536(85)90242-4; Hundt GL, 2004, J BIOSOC SCI, V36, P433, DOI 10.1017/S0021932004006662; Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders Uganda National Academy of Sciences Forum on Health and Nutrition, 2010, MENT NEUR SUBST DIS; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Kakuma R, 2010, AFR J PSYCHIATRY, V13, P116; KALE R, 1995, BRIT MED J, V310, P1182, DOI 10.1136/bmj.310.6988.1182; Lund C, 2015, S AFR MED J, V92, P161; Makundi EA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-58; Marais DL, 2015, INT J MENT HEALTH SY, V9, DOI 10.1186/s13033-015-0004-z; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; McKibbin C, 2004, J NERV MENT DIS, V192, P405, DOI 10.1097/01.nmd.0000130133.32276.83; Meretoja A, 2014, STROKE, V45, P1053, DOI 10.1161/STROKEAHA.113.002910; Moshabela M, 2011, AIDS BEHAV, V15, P842, DOI 10.1007/s10461-010-9747-3; Muliyala KP, 2010, ANN INDIAN ACAD NEUR, V13, P69, DOI 10.4103/0972-2327.74248; Nortje G, 2016, LANCET PSYCHIAT, V3, P154, DOI 10.1016/S2215-0366(15)00515-5; Okasha Ahmed, 2002, World Psychiatry, V1, P32; Opara Jozef A, 2010, J Med Life, V3, P216; Parham GP, 2006, GYNECOL ONCOL, V103, P1017, DOI 10.1016/j.ygyno.2006.06.015; Patel V, 2010, WORLD PSYCHIATRY, V9, P169; Pinkoane M G, 2005, Curationis, V28, P20; PlusNews, 2010, S AFR TRAD HEAL EXT; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Ritsner Michael S, 2015, Clin Schizophr Relat Psychoses, V9, P125, DOI 10.3371/CSRP.RIGR.030813; Rotheram-Borus MJ, 2015, AM J PREV MED, V49, P715, DOI 10.1016/j.amepre.2015.05.004; Schneider M, 2007, SAMJ S AFR MED J, V97, P664; Sibuye R, 2012, PARTICIPATORY LEARNI, V65, P101; Sorsdahl K, 2013, AFR J PSYCHIATRY, V16, P35, DOI [http://dx.doi.org/10.4314/ajpsy.v16i1.6, 10.4314/ajpsy.v16i1.6]; Sorsdahl K, 2010, TRANSCULT PSYCHIATRY, V47, P591, DOI 10.1177/1363461510383330; Sorsdahl K, 2009, J NERV MENT DIS, V197, P434, DOI 10.1097/NMD.0b013e3181a61dbc; Sorsdahl KR, 2010, J NERV MENT DIS, V198, P742, DOI 10.1097/NMD.0b013e3181f4b2d7; Stekelenburg J, 2005, HEALTH POLICY, V71, P67, DOI 10.1016/j.healthpol.2004.05.008; Tollman SM, 1999, S AFR MED J, V89, P858; Tollman SM, 1999, S AFR MED J, V89, P853; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wagner RG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129097; Wandwalo ER, 2000, INT J TUBERC LUNG D, V4, P133; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Williams DR, 2008, PSYCHOL MED, V38, P211, DOI 10.1017/S0033291707001420; Wilson DA, 2014, EPILEPSY BEHAV, V32, P42, DOI 10.1016/j.yebeh.2013.12.035	58	18	19	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0188433	10.1371/journal.pone.0188433	http://dx.doi.org/10.1371/journal.pone.0188433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ7PP	29261705	Green Submitted, Green Published, gold			2022-12-26	WOS:000418554900004
J	Rezek, RJ; Lebreton, B; Sterba-Boatwright, B; Pollack, JB				Rezek, Ryan J.; Lebreton, Benoit; Sterba-Boatwright, Blair; Pollack, Jennifer Beseres			Ecological structure and function in a restored versus natural salt marsh	PLOS ONE			English	Article							SHRIMP PALAEMONETES-PUGIO; SPARTINA-ALTERNIFLORA; GRASS SHRIMP; ECOSYSTEM DEVELOPMENT; BENTHIC INFAUNA; STABLE-ISOTOPES; ORGANIC-MATTER; RELATIVE VALUE; GALVESTON BAY; SITE FIDELITY	Habitat reconstruction is commonly employed to restore degraded estuarine habitats and lost ecological functions. In this study, we use a combination of stable isotope analyses and macrofauna community analysis to compare the ecological structure and function between a recently constructed Spartina alterniflora salt marsh and a natural reference habitat over a 2-year period. The restored marsh was successful in providing habitat for economically and ecologically important macrofauna taxa; supporting similar or greater density, biomass, and species richness to the natural reference during all but one sampling period. Stable isotope analyses revealed that communities from the natural and the restored marshes relied on a similar diversity of food resources and that decapods had similar trophic levels. However, some generalist consumers (Palaemonetes spp. and Penaeus aztecus) were more C-13-enriched in the natural marsh, indicating a greater use of macrophyte derived organic matter relative to restored marsh counterparts. This difference was attributed to the higher quantities of macrophyte detritus and organic carbon in natural marsh sediments. Reduced marsh flooding frequency was associated with a reduction in macrofaunal biomass and decapod trophic levels. The restored marsh edge occurred at lower elevations than natural marsh edge, apparently due to reduced fetch and wind-wave exposure provided by the protective berm structures. The lower elevation of the restored marsh edge mitigated negative impacts in sampling periods with low tidal elevations that affected the natural marsh. The results of this study highlight the importance of considering sediment characteristics and elevation in salt marsh constructions.	[Rezek, Ryan J.; Pollack, Jennifer Beseres] Texas A&M Univ Corpus Christi, Dept Life Sci, Corpus Christi, TX 78412 USA; [Lebreton, Benoit] Univ La Rochelle, CNRS, Littoral Environm & Soc, La Rochelle, France; [Sterba-Boatwright, Blair] Texas A&M Univ Corpus Christi, Dept Math & Stat, Corpus Christi, TX USA	Texas A&M University System; Texas A&M University Corpus Christi; Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite; Texas A&M University System; Texas A&M University Corpus Christi	Pollack, JB (corresponding author), Texas A&M Univ Corpus Christi, Dept Life Sci, Corpus Christi, TX 78412 USA.	jennifer.pollack@tamucc.edu	Lebreton, Benoit/N-6488-2014	Lebreton, Benoit/0000-0001-8802-2287; Beseres Pollack, Jennifer/0000-0002-2995-4006	Ruth Campbell Professorship in Coastal and Marine System Science at Texas A&M University-Corpus Christi; Wetland Foundation	Ruth Campbell Professorship in Coastal and Marine System Science at Texas A&M University-Corpus Christi; Wetland Foundation	The authors thankfully acknowledge funding from the Ruth Campbell Professorship in Coastal and Marine System Science at Texas A&M University-Corpus Christi to JBP and from The Wetland Foundation (http://thewetlandfoundation.org) to RJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the editor and two anonymous reviewers whose comments greatly improved the quality of this manuscript. We thankfully acknowledge funding from the Ruth Campbell Professorship in Coastal and Marine System Science at Texas A&M University-Corpus Christi to J. Beseres Pollack and from The Wetland Foundation to R. J. Rezek. Thank you to Eric White, Lauren Hutchison, Patrick Graham, Kevin De Santiago, Terrence Palmer, Maria Rodriguez, Jason Selwyn, Melissa McCutcheon, Gael Guillou, and Dr. Paula Rose for their assistance in the field and the laboratory. We are grateful to Jake Berryhill and Conrad Blucher Institute for Surveying and Science for technical support. We also thank Rosario Martinez with Coastal Bend Bays and Estuaries Program and Cameron Perry with HDR Engineering for information and expertise related to the marsh construction project.	Allen DM, 2015, MAR BIOL, V162, P1275, DOI 10.1007/s00227-015-2668-y; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Baker R, 2013, MAR ECOL PROG SER, V490, P37, DOI 10.3354/meps10442; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENNER R, 1987, NATURE, V329, P708, DOI 10.1038/329708a0; BOESCH DF, 1984, ESTUARIES, V7, P460, DOI 10.2307/1351627; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Craft C, 1999, ECOL APPL, V9, P1405, DOI 10.1890/1051-0761(1999)009[1405:TFYOED]2.0.CO;2; Craft C, 2003, ECOL APPL, V13, P1417, DOI 10.1890/02-5086; Craft C, 2003, MAR ECOL PROG SER, V257, P45, DOI 10.3354/meps257045; Craft C., 2000, Wetlands Ecology and Management, V8, P197, DOI 10.1023/A:1008448620605; Cravey D., 2011, NUECES BAY PORTLAND; Dahl T.E., 1990, WETLANDS LOSSES US 1, P13; Delaney TP, 2000, TEXAS WETL ECOL MANA, V8, P343; Diener RA., 1975, COOPERATIVE GULF MEX; Dinno A, 2016, DUNN TEST DUNNS TEST; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; EDGAR GJ, 1993, OECOLOGIA, V95, P115, DOI 10.1007/BF00649514; Ehrenfeld JG, 1997, RESTOR ECOL, V5, P307, DOI 10.1046/j.1526-100X.1997.00544.x; Fry B, 2003, ESTUARIES, V26, P82, DOI 10.1007/BF02691696; Galvan K, 2008, MAR ECOL PROG SER, V359, P37, DOI 10.3354/meps07321; Gratton C, 2006, ECOL APPL, V16, P622, DOI 10.1890/1051-0761(2006)016[0622:AFWRFR]2.0.CO;2; Grayson JE, 1999, LANDSCAPE URBAN PLAN, V43, P227, DOI 10.1016/S0169-2046(98)00108-X; Green BC, 2012, OECOLOGIA, V168, P245, DOI 10.1007/s00442-011-2077-y; Gregg CS, 1998, MAR ECOL PROG SER, V175, P77; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kennish MJ, 2001, J COASTAL RES, V17, P731; Kentula ME, 2000, ECOL ENG, V15, P199, DOI 10.1016/S0925-8574(00)00076-8; LAUGHLIN RA, 1982, B MAR SCI, V32, P807; Lebreton B, 2016, ESTUAR COAST SHELF S, V170, P70, DOI 10.1016/j.ecss.2015.12.024; Minello TJ, 2012, ESTUAR COAST, V35, P501, DOI 10.1007/s12237-011-9463-x; Minello TJ, 1997, MAR ECOL PROG SER, V151, P165, DOI 10.3354/meps151165; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Nelson JA, 2015, MAR ECOL PROG SER, V533, P67, DOI 10.3354/meps11389; ODUM HT, 1957, ECOL MONOGR, V27, P55, DOI 10.2307/1948571; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Parnell A, 2015, SIMMR STABLE ISOTOPE; Pennock JR., 1999, BIOGEOCHEMISTRY GULF, P109; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pinheiro J, R PACKAGE VERSION; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Quinones-Rivera ZJ, 2005, ESTUARIES, V28, P274, DOI 10.1007/BF02732861; R Core Team, 2021, R LANGUAGE ENV STAT; Rezek RJ, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3084-2; Riera P, 2000, MAR ECOL PROG SER, V199, P205, DOI 10.3354/meps199205; Robillard MMR, 2010, J SHELLFISH RES, V29, P291, DOI 10.2983/035.029.0203; Roland RM, 2005, J COASTAL RES, V21, P453, DOI 10.2112/03-0079.1; Rozas LP, 2009, MAR ECOL PROG SER, V394, P179, DOI 10.3354/meps08274; Rozas LP, 2005, J COASTAL RES, P37; Society for Ecological Restoration Science and Policy Working Group, 2004, INT PRIM EC REST; Stunz GW, 2010, MAR ECOL PROG SER, V406, P147, DOI 10.3354/meps08556; TEAL JM, 1962, ECOLOGY, V43, P614, DOI 10.2307/1933451; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Whaley SD, 2002, WETLANDS, V22, P753, DOI 10.1672/0277-5212(2002)022[0753:TDOBIO]2.0.CO;2; Wozniak AS, 2006, ESTUAR COAST, V29, P568, DOI 10.1007/BF02784283; Zedler JB, 2000, FUNCTIONAL EQUIVALEN, P565; Zuur Alain F., 2009, P1	59	17	18	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189871	10.1371/journal.pone.0189871	http://dx.doi.org/10.1371/journal.pone.0189871			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261795	Green Published, gold, Green Submitted			2022-12-26	WOS:000418554900037
J	Wang, M; Wu, JH; Luan, JW; Lafleur, P; Chen, H; Zhu, XB				Wang, Mei; Wu, Jianghua; Luan, Junwei; Lafleur, Peter; Chen, Huai; Zhu, Xinbiao			Near-zero methane emission from an abandoned boreal peatland pasture based on eddy covariance measurements	PLOS ONE			English	Article							NET ECOSYSTEM EXCHANGE; CARBON-DIOXIDE; NEURAL-NETWORKS; CH4 EMISSION; NITROUS-OXIDE; FLUXES; NORTHERN; SOILS; CO2; TEMPERATE	Although estimates of the annual methane (CH4) flux from agriculturally managed peatlands exist, knowledge of controls over the variation of CH4 at different time-scales is limited due to the lack of high temporal-resolution data. Here we present CH4 fluxes measured from May 2014 to April 2016 using the eddy covariance technique at an abandoned peatland pasture in western Newfoundland, Canada. The goals of the study were to identify the controls on the seasonal variations in CH4 flux and to quantify the annual CH4 flux. The seasonal variation in daily CH4 flux was not strong in the two study years, however a few periods of pronounced emissions occurred in the late growing season. The daily average CH4 flux was small relative to other studies, ranging from -4.1 to 9.9 nmol m(-2) s(-1) in 2014-15 and from -7.1 to 12.1 nmol m(-2) s(-1) in 2015-16. Stepwise multiple regression was used to investigate controls on CH4 flux and this analysis found shifting controls on CH4 flux at different periods of the growing season. During the early growing season CH4 flux was closely related to carbon dioxide fixation rates, suggesting substrate availability was the main control. The peak growing season CH4 flux was principally controlled by the CH4 oxidation in 2014, where the CH4 flux decreased and increased with soil temperature at 50 cm and soil water content at 10 cm, but a contrasting temperature-CH4 relation was found in 2015. The late growing season CH4 flux was found to be regulated by the variation in water table level and air temperature in 2014. The annual CH4 emission was near zero in both study years (0.36 +/- 0.30 g CH4 m(-2) yr(-1) in 2014-15 and 0.13 +/- 0.38 g CH4 m(-2) yr(-1) in 2015-16), but fell within the range of CH4 emissions reported for agriculturally managed peatlands elsewhere.	[Wang, Mei; Wu, Jianghua; Luan, Junwei] Mem Univ Newfoundland, Sustainable Resource Management, Corner Brook, NF, Canada; [Wang, Mei] South China Normal Univ, Sch Geog Sci, Guangzhou, Guangdong, Peoples R China; [Luan, Junwei] Int Ctr Bamboo & Rattan, Beijing, Peoples R China; [Lafleur, Peter] Trent Univ, Sch Environm, Peterborough, ON, Canada; [Chen, Huai] Chinese Acad Sci, Chengdu Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Sichuan, Peoples R China; [Chen, Huai] Chinese Acad Sci, Chengdu Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Chengdu, Sichuan, Peoples R China; [Zhu, Xinbiao] Nat Resources Canada, Canadian Forest Serv, Atlantic Forestry Ctr, Corner Brook, NF, Canada	Memorial University Newfoundland; South China Normal University; International Centre for Bamboo & Rattan; Trent University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Natural Resources Canada; Canadian Forest Service	Wu, JH (corresponding author), Mem Univ Newfoundland, Sustainable Resource Management, Corner Brook, NF, Canada.	jwu@grenfell.mun.ca	Wu, Jianghua/P-3636-2019; Junwei, Luan/E-2706-2017; Chen, Huai/AAI-1024-2020; Chen, Huai/A-7418-2015	Wu, Jianghua/0000-0002-8178-5203; Junwei, Luan/0000-0002-3848-4747; Chen, Huai/0000-0001-7650-289X; Chen, Huai/0000-0001-7650-289X	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation-John R. Evans Leaders Fund; Research & Development Corporation (RDC, NL)- Leverage R&D, RDC-Ignite RD; Agricultural Research Initiative (NL); Humber River Basin Research Initiative of NL; Grenfell Campus' Start-up Research Fund; Vice-President Research Fund; Institute for Biodiversity, Ecosystem Science, and Sustainability (IBES, NL); School of Graduate Studies, Memorial University; RDC-RCRI (Regional Collaborative Research Initiative)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation-John R. Evans Leaders Fund; Research & Development Corporation (RDC, NL)- Leverage R&D, RDC-Ignite RD; Agricultural Research Initiative (NL); Humber River Basin Research Initiative of NL; Grenfell Campus' Start-up Research Fund; Vice-President Research Fund; Institute for Biodiversity, Ecosystem Science, and Sustainability (IBES, NL); School of Graduate Studies, Memorial University; RDC-RCRI (Regional Collaborative Research Initiative)	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (JW); Canada Foundation for Innovation-John R. Evans Leaders Fund (JW); Research & Development Corporation (RDC, NL)- Leverage R&D, RDC-Ignite R&D (JW); Agricultural Research Initiative (NL) (JW); Humber River Basin Research Initiative of NL (JW); Grenfell Campus' Start-up Research Fund (JW); Vice-President Research Fund (JW); the Graduate Student Stipend funding from the Institute for Biodiversity, Ecosystem Science, and Sustainability (IBES, NL) (JW); and Graduate Student Baseline Fellowship from School of Graduate Studies, Memorial University (MW).; This study was made possible by the support of the following funding to J. Wu: Natural Sciences and Engineering Research Council of Canada (NSERC)-Discovery Grant, Canada Foundation for Innovation-John R. Evans Leaders Fund, Research & Development Corporation (RDC, NL)- Leverage R&D, RDC-Ignite R&D, RDC-RCRI (Regional Collaborative Research Initiative), Agricultural Research Initiative (NL), Humber River Basin Research Initiative of NL, Grenfell Campus' Start-up Research Fund and Vice-President Research Fund, and the Graduate Student Stipend funding from the Institute for Biodiversity, Ecosystem Science, and Sustainability (IBES, NL). M. Wang received a Graduate Student Baseline Fellowship from School of Graduate Studies, Memorial University. Special thanks were given to Prof. Henry Mann for his help in vegetation identification, Ms. Denise Bouzane for her constructive guidance on the selection of our research site, the Department of Facility Management at Grenfell Campus, Memorial University for logistic support, and Mr. Keon Noseworthy for his help in the installation of our EC towers. We would like to thank the two anonymous reviewers and the academic editor for their constructive comments to improve the manuscript.	ADAMSEN APS, 1993, APPL ENVIRON MICROB, V59, P485, DOI 10.1128/AEM.59.2.485-490.1993; Adji FF, 2014, SOIL SCI PLANT NUTR, V60, P216, DOI 10.1080/00380768.2013.872019; Alm J, 1997, OECOLOGIA, V110, P423, DOI 10.1007/s004420050177; Alm J, 2007, BOREAL ENVIRON RES, V12, P191; Aubinet M., 2012, EDDY COVARIANCE PRAC; Bellisario LM, 1999, GLOBAL BIOGEOCHEM CY, V13, P81, DOI 10.1029/1998GB900021; Brown MG, 2014, J GEOPHYS RES-BIOGEO, V119, P826, DOI 10.1002/2013JG002576; BUSINGER JA, 1986, J CLIM APPL METEOROL, V25, P1100, DOI 10.1175/1520-0450(1986)025<1100:EOTAWW>2.0.CO;2; Chanton JP, 1997, GLOBAL BIOGEOCHEM CY, V11, P15, DOI 10.1029/96GB03761; Christensen TR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016848; Crill PM, 1988, GLOBAL BIOGEOCHEM CY, V2, P371, DOI 10.1029/GB002i004p00371; Dengel S, 2013, BIOGEOSCIENCES, V10, P8185, DOI 10.5194/bg-10-8185-2013; DISE NB, 1993, GLOBAL BIOGEOCHEM CY, V7, P123, DOI 10.1029/92GB02299; Dunfield P, 1993, SOIL BIOL BIOCH, V25; Edenhofer O., 2014, CONTRIBUTION WORKING; Elizondo DA, 2005, CURRENT TRENDS KNOWL, P485; Finkelstein PL, 2001, J GEOPHYS RES-ATMOS, V106, P3503, DOI 10.1029/2000JD900731; Forbrich I, 2011, AGR FOREST METEOROL, V151, P864, DOI 10.1016/j.agrformet.2011.02.006; Fortuniak K, 2017, AGR FOREST METEOROL, V232, P306, DOI 10.1016/j.agrformet.2016.08.023; Frolking S, 2011, ENVIRON REV, V19, P371, DOI [10.1139/A11-014, 10.1139/a11-014]; GLENN S, 1993, GLOBAL BIOGEOCHEM CY, V7, P247, DOI 10.1029/93GB00469; Goodrich JP, 2015, J GEOPHYS RES-BIOGEO, V120, P819, DOI 10.1002/2014JG002844; Gronlund Arne, 2006, Archives of Agronomy and Soil Science, V52, P149, DOI 10.1080/03650340600581968; Gronlund A, 2008, NUTR CYCL AGROECOSYS, V81, P157, DOI 10.1007/s10705-008-9171-5; Hargreaves KJ, 2001, THEOR APPL CLIMATOL, V70, P203, DOI 10.1007/s007040170015; Hendriks DMD, 2010, AGR FOREST METEOROL, V150, P757, DOI 10.1016/j.agrformet.2009.06.017; Hommeltenberg J, 2014, AGR FOREST METEOROL, V198, P273, DOI 10.1016/j.agrformet.2014.08.017; Jackowicz Korczynski M, 2010, J GEOPHYS RES BIOGEO, V115; Jain AK, 1996, COMPUTER, V29, P31, DOI 10.1109/2.485891; Jarvi L, 2012, ATMOS CHEM PHYS, V12, P8475, DOI 10.5194/acp-12-8475-2012; Joosten H., 2009, The Global Peatland CO2 Picture: peatland status and drainage related emissions in all countries of the world; KAIMAL JC, 1972, Q J ROY METEOR SOC, V98, P563, DOI 10.1256/smsqj.41706; KING GM, 1992, APPL ENVIRON MICROB, V58, P2758, DOI 10.1128/AEM.58.9.2758-2763.1992; Klemedtsson AK, 2009, EUR J SOIL SCI, V60, P321, DOI 10.1111/j.1365-2389.2009.01124.x; Kljun N, 2004, BOUND-LAY METEOROL, V112, P503, DOI 10.1023/B:BOUN.0000030653.71031.96; Klove B, 2010, GEODERMA, V154, P219, DOI 10.1016/j.geoderma.2009.08.022; Knox SH, 2015, GLOBAL CHANGE BIOL, V21, P750, DOI 10.1111/gcb.12745; Koebsch F, 2015, AGR FOREST METEOROL, V204, P94, DOI 10.1016/j.agrformet.2015.02.002; Kopp BJ, 2013, HYDROL EARTH SYST SC, V17, P3485, DOI 10.5194/hess-17-3485-2013; Kroon PS, 2010, EUR J SOIL SCI, V61, P773, DOI 10.1111/j.1365-2389.2010.01273.x; Lai DYF, 2009, PEDOSPHERE, V19, P409, DOI 10.1016/S1002-0160(09)00003-4; Lai DYF, 2014, J GEOPHYS RES-BIOGEO, V119, P864, DOI 10.1002/2013JG002410; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; LI-COR Biosciences, 2017, EDDYPRO SOFTW INSTR; Lohila A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004715; Long KD, 2010, GLOBAL CHANGE BIOL, V16, P2420, DOI 10.1111/j.1365-2486.2009.02083.x; Luan JW, 2015, AGR ECOSYST ENVIRON, V214, P68, DOI 10.1016/j.agee.2015.08.020; Luan JW, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/105005; Maljanen M, 2004, SOIL BIOL BIOCHEM, V36, P1801, DOI 10.1016/j.soilbio.2004.05.003; Maljanen M, 2003, SOIL USE MANAGE, V19, P73, DOI 10.1111/j.1475-2743.2003.tb00282.x; Maljanen M, 2010, BIOGEOSCIENCES, V7, P2711, DOI 10.5194/bg-7-2711-2010; Maljanen M, 2001, PLANT SOIL, V231, P113, DOI 10.1023/A:1010372914805; Maljanen M., 2003, GREENHOUSE GAS DYNAM; Mauder M, 2011, DOCUMENTATION INSTRU; Mauder M, 2006, METEOROL Z, V15, P597, DOI 10.1127/0941-2948/2006/0167; McEwing KR, 2015, PLANT SOIL, V388, P37, DOI 10.1007/s11104-014-2377-1; Moffat AM, 2007, AGR FOREST METEOROL, V147, P209, DOI 10.1016/j.agrformet.2007.08.011; Moffat AM, 2010, GLOBAL CHANGE BIOL, V16, P2737, DOI 10.1111/j.1365-2486.2010.02171.x; Moncrieff J. B., 1997, Journal of Hydrology (Amsterdam), V188-189, P589, DOI 10.1016/S0022-1694(96)03194-0; MOORE TR, 1993, J SOIL SCI, V44, P651, DOI 10.1111/j.1365-2389.1993.tb02330.x; MOORE TR, 1990, BIOGEOCHEMISTRY, V11, P45; Nadeau DF, 2013, ATMOS ENVIRON, V81, P464, DOI 10.1016/j.atmosenv.2013.09.044; Nakai T, 2012, AGR FOREST METEOROL, V162, P14, DOI 10.1016/j.agrformet.2012.04.004; NESBIT SP, 1992, AGR ECOSYST ENVIRON, V41, P39, DOI 10.1016/0167-8809(92)90178-E; Nguyen HH, 2004, NEURAL COMPUT APPL, V13, P90, DOI 10.1007/s00521-003-0390-z; Nilsson M, 2008, GLOBAL CHANGE BIOL, V14, P2317, DOI 10.1111/j.1365-2486.2008.01654.x; Nykanen H, 1995, J BIOGEOGR, V22, P351, DOI 10.2307/2845930; Oleszczuk  R, 2008, PEATLANDS CLIMATE CH, P70; Olson DM, 2013, J GEOPHYS RES-BIOGEO, V118, P226, DOI 10.1002/jgrg.20031; Oren R, 1999, PLANT CELL ENVIRON, V22, P1515, DOI 10.1046/j.1365-3040.1999.00513.x; Panikov NS, 2000, GLOBAL BIOGEOCHEM CY, V14, P1071, DOI 10.1029/1999GB900097; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; Parmentier FJW, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001637; Pypker TG, 2013, BIOGEOSCIENCES, V10, P7971, DOI 10.5194/bg-10-7971-2013; Regina K, 2007, AGR ECOSYST ENVIRON, V119, P346, DOI 10.1016/j.agee.2006.08.002; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Riedmiller M, 1994, RPROP DESCRIPTION IM; Rinne J, 2007, TELLUS B, V59, P449, DOI 10.1111/j.1600-0889.2007.00261.x; Rogerson PA, 2006, STAT METHODS GEOGRAP, P204; Roulet NT, 2007, GLOBAL CHANGE BIOL, V13, P397, DOI 10.1111/j.1365-2486.2006.01292.x; Salm JO, 2009, WETLANDS, V29, P1081, DOI 10.1672/08-206.1; Schafer CM, 2012, PLANT SOIL, V357, P339, DOI 10.1007/s11104-012-1168-9; Schneider J, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/1/014004; Schrier-Uijl AP, 2010, PLANT SOIL, V329, P509, DOI 10.1007/s11104-009-0180-1; Song WeiMin, 2015, Journal of Geophysical Research: Biogeosciences, V120, P1475, DOI 10.1002/2015JG003043; Sturtevant CS, 2012, BIOGEOSCIENCES, V9, P1423, DOI 10.5194/bg-9-1423-2012; Tarnocai C, 2005, PEATLANDS CANADA AGR; Treat CC, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000210; Tripathee R., 2014, THESIS; Turetsky MR, 2014, GLOBAL CHANGE BIOL, V20, P2183, DOI 10.1111/gcb.12580; vandenPolvanDasselaar A, 1997, PLANT SOIL, V189, P1, DOI 10.1023/A:1004219522404; Vickers D, 1997, J ATMOS OCEAN TECH, V14, P512, DOI 10.1175/1520-0426(1997)014<0512:QCAFSP>2.0.CO;2; Waddington JM, 1996, J GEOPHYS RES-ATMOS, V101, P22775, DOI 10.1029/96JD02014; Wang M, 2018, AGR FOREST METEOROL, V248, P91, DOI 10.1016/j.agrformet.2017.09.010; Wang M, 2014, QUATERNARY SCI REV, V99, P34, DOI 10.1016/j.quascirev.2014.06.004; Webb EK, 1980, Q J ROYAL METEOROLOG, V106; WHITING GJ, 1993, NATURE, V364, P794, DOI 10.1038/364794a0; Wilczak JM, 2001, BOUND-LAY METEOROL, V99, P127, DOI 10.1023/A:1018966204465; YU ZC, 2010, GEOPHYS RES LETT, V37, DOI DOI 10.1029/2010GL043584; Yvon-Durocher G, 2014, NATURE, V507, P488, DOI 10.1038/nature13164	100	5	5	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189692	10.1371/journal.pone.0189692	http://dx.doi.org/10.1371/journal.pone.0189692			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29252998	Green Published, Green Submitted, gold			2022-12-26	WOS:000418389500050
J	Cedo, L; Santos, D; Roglans, N; Julve, J; Pallares, V; Rivas-Urbina, A; Llorente-Cortes, V; Laguna, JC; Blanco-Vaca, F; Escola-Gil, JC				Cedo, Lidia; Santos, David; Roglans, Nuria; Julve, Josep; Pallares, Victor; Rivas-Urbina, Andrea; Llorente-Cortes, Vicenta; Laguna, Joan Carles; Blanco-Vaca, Francisco; Escola-Gil, Joan Carles			Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake	PLOS ONE			English	Article							APOLIPOPROTEIN A-II; DENSITY-LIPOPROTEIN RECEPTOR; TRANSGENIC MICE; DEFICIENT MICE; INTRAABDOMINAL FAT; LIPID-METABOLISM; LIVER-DISEASE; PPAR-ALPHA; DIET; HDL	Human hepatic lipase (hHL) is mainly localized on the hepatocyte cell surface where it hydrolyzes lipids from remnant lipoproteins and high density lipoproteins and promotes their hepatic selective uptake. Furthermore, hepatic lipase (HL) is closely associated with obesity in multiple studies. Therefore, HL may play a key role on lipid homeostasis in liver and white adipose tissue (WAT). In the present study, we aimed to evaluate the effects of hHL expression on hepatic and white adipose triglyceride metabolism in vivo. Experiments were carried out in hHL transgenic and wild-type mice fed a Western-type diet. Triglyceride metabolism studies included beta-oxidation and de novo lipogenesis in liver and WAT, hepatic triglyceride secretion, and adipose lipoprotein lipase (LPL)-mediated free fatty acid (FFA) lipolysis and influx. The expression of hHL promoted hepatic triglyceride accumulation and de novo lipogenesis without affecting triglyceride secretion, and this was associated with an upregulation of Srebf1 as well as the main genes controlling the synthesis of fatty acids. Transgenic mice also exhibited more adiposity and an increased LPL-mediated FFA influx into the WAT without affecting glucose tolerance. Our results demonstrate that hHL promoted hepatic steatosis in mice mainly by upregulating de novo lipogenesis. HL also upregulated WAT LPL and promoted triglyceride-rich lipoprotein hydrolysis and adipose FFA uptake. These data support the important role of hHL in regulating hepatic lipid homeostasis and confirm the broad cardiometabolic role of HL.	[Cedo, Lidia; Santos, David; Julve, Josep; Pallares, Victor; Rivas-Urbina, Andrea; Blanco-Vaca, Francisco; Escola-Gil, Joan Carles] IIB St Pau, Barcelona, Spain; [Cedo, Lidia; Santos, David; Julve, Josep; Blanco-Vaca, Francisco; Escola-Gil, Joan Carles] CIBERDEM, CIBER Diabet & Enfermedades Metab Asociadas, Lhospitalet De Llobregat, Spain; [Roglans, Nuria; Laguna, Joan Carles] Univ Barcelona, Sch Pharm, Dept Pharmacol & Therapeut Chem, Barcelona, Spain; [Julve, Josep; Rivas-Urbina, Andrea; Blanco-Vaca, Francisco; Escola-Gil, Joan Carles] Univ Autonoma Barcelona, Dept Bioquim Biol Mol & Biomed, Barcelona, Spain; [Llorente-Cortes, Vicenta] CSIC ICCC IIB St Pau, Lipids & Cardiovasc Pathol Grp, Barcelona, Spain; [Llorente-Cortes, Vicenta] CSIC, IibB, Barcelona, Spain; [Llorente-Cortes, Vicenta] CIBERCV, Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV	Blanco-Vaca, F; Escola-Gil, JC (corresponding author), IIB St Pau, Barcelona, Spain.; Blanco-Vaca, F; Escola-Gil, JC (corresponding author), CIBERDEM, CIBER Diabet & Enfermedades Metab Asociadas, Lhospitalet De Llobregat, Spain.; Blanco-Vaca, F; Escola-Gil, JC (corresponding author), Univ Autonoma Barcelona, Dept Bioquim Biol Mol & Biomed, Barcelona, Spain.	fblancova@santpau.cat; jescola@santpau.cat	Blanco-Vaca, Francisco/AAC-2600-2022; Roglans, Núria/ABH-1242-2020; Julve, Josep/I-1003-2017; Cedó, Lídia/ABG-1998-2020; Escolà, Joan Carles/U-1521-2019; Laguna, JCLaguna - Juan C./C-5481-2017; Escolà-Gil, Joan Carles/H-9522-2014	Julve, Josep/0000-0002-6531-2246; Cedó, Lídia/0000-0003-4354-3411; Escolà, Joan Carles/0000-0001-9021-2485; Laguna, JCLaguna - Juan C./0000-0002-7082-0704; Rivas-Urbina, Andrea/0000-0002-0111-0477; Santos, David/0000-0003-1157-4969; Roglans, Nuria/0000-0002-5018-021X; Blanco-Vaca, Francisco/0000-0001-7380-5385	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III; FEDER "Una manera de hacer Europa" from La Fundacio La Marato TV3 [FIS 08-1147, CP13-00070, FIS 16-00139, 303/C/2016]; Miguel Servet Type 1 contract	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III(Instituto de Salud Carlos III); FEDER "Una manera de hacer Europa" from La Fundacio La Marato TV3; Miguel Servet Type 1 contract	This work was partly funded by the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, and FEDER "Una manera de hacer Europa", grants FIS 08-1147 (to F.B.-V.), CP13-00070 (to J.J.), FIS 16-00139 (to J.C.E.-G.) and 303/C/2016 (to J.J.) from La Fundacio La Marato TV3. J.J. is recipient of a Miguel Servet Type 1 contract. CIBER de Diabetes y Enfermedades Metabolicas Asociadas is an Instituto de Salud Carlos III Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Blasco I, 2015, J ENDOCRINOL, V227, P179, DOI 10.1530/JOE-15-0219; Annema W, 2011, CURR ATHEROSCLER REP, V13, P257, DOI 10.1007/s11883-011-0175-2; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Braschi S, 1998, BBA-LIPID LIPID MET, V1392, P276, DOI 10.1016/S0005-2760(98)00046-0; Brown JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024124; Carr MC, 1999, ARTERIOSCL THROM VAS, V19, P2701, DOI 10.1161/01.ATV.19.11.2701; Cedo L, 2015, MOL NUTR FOOD RES, V59, P1987, DOI 10.1002/mnfr.201500336; Chen J, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12365; Chiu HK, 2010, ENDOCRINOLOGY, V151, P993, DOI 10.1210/en.2009-1100; DESPRES JP, 1989, ARTERIOSCLEROSIS, V9, P485, DOI 10.1161/01.ATV.9.4.485; Dichek HL, 2006, AM J PHYSIOL-ENDOC M, V290, pE908, DOI 10.1152/ajpendo.00442.2005; Dichek HL, 1998, J BIOL CHEM, V273, P1896, DOI 10.1074/jbc.273.4.1896; Echeverria F, 2016, PROSTAG LEUKOTR ESS, V114, P28, DOI 10.1016/j.plefa.2016.10.001; Escola-Gil JC, 2000, J LIPID RES, V41, P1328; Escola-Gil JC, 1998, J LIPID RES, V39, P457; Fabbrini E, 2016, GASTROENTEROLOGY, V150, P79, DOI 10.1053/j.gastro.2015.09.003; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; FEINGOLD KR, 1987, J CLIN INVEST, V80, P184, DOI 10.1172/JCI113046; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Gao Y, 2014, J LIPID RES, V55, P1622, DOI 10.1194/jlr.M041988; Graham MJ, 2007, J LIPID RES, V48, P763, DOI 10.1194/jlr.C600025-JLR200; Huang Z, 2008, BRIT J PHARMACOL, V155, P596, DOI 10.1038/bjp.2008.331; Julve J, 2000, BBA-MOL CELL BIOL L, V1488, P233, DOI 10.1016/S1388-1981(00)00127-X; Julve J, 2010, ARTERIOSCL THROM VAS, V30, P232, DOI 10.1161/ATVBAHA.109.198226; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Lee MJ, 2014, BBA-MOL BASIS DIS, V1842, P473, DOI 10.1016/j.bbadis.2013.05.029; Lee-Rueckert M, 2016, BBA-MOL CELL BIOL L, V1861, P566, DOI 10.1016/j.bbalip.2016.03.004; Llaverias G, 2013, J NUTR BIOCHEM, V24, P39, DOI 10.1016/j.jnutbio.2012.01.007; Michailidou Z, 2007, J ENDOCRINOL, V194, P161, DOI 10.1677/JOE-07-0090; Miksztowicz V, 2012, DIABETES-METAB RES, V28, P535, DOI 10.1002/dmrr.2312; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Pardina E, 2009, OBES SURG, V19, P894, DOI 10.1007/s11695-008-9739-9; Patel DD, 2001, J LIPID RES, V42, P328; Purnell JQ, 2000, J CLIN ENDOCR METAB, V85, P977, DOI 10.1210/jc.85.3.977; Quiroga AD, 2012, BBA-MOL CELL BIOL L, V1821, P762, DOI 10.1016/j.bbalip.2011.09.007; Rebollo A, 2014, BBA-MOL CELL BIOL L, V1841, P514, DOI 10.1016/j.bbalip.2014.01.002; Valenzuela R, 2015, PROSTAG LEUKOTR ESS, V98, P7, DOI 10.1016/j.plefa.2015.04.002; Valenzuela R, 2011, FOOD FUNCT, V2, P644, DOI 10.1039/c1fo10133a	38	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189834	10.1371/journal.pone.0189834	http://dx.doi.org/10.1371/journal.pone.0189834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244870	Green Published, gold			2022-12-26	WOS:000418184700068
J	Tomkins, S; Chapman, C; Myland, M; Tham, R; de Nobrega, R; Jackson, B; Keshav, S				Tomkins, Susannah; Chapman, Callum; Myland, Melissa; Tham, Rachel; de Nobrega, Rachael; Jackson, Brinley; Keshav, Satish			Treating iron deficiency in patients with gastrointestinal disease: Risk of re-attendance in secondary care	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ORAL IRON; HOSPITAL READMISSIONS; FERRIC CARBOXYMALTOSE; CLINICAL-PRACTICE; HEART-FAILURE; ANEMIA; POPULATION; MANAGEMENT; MORTALITY	Background Patients with gastrointestinal disease may have comorbid iron deficiency anaemia (IDA) and an increased risk of hospitalisation and re-attendance in hospital. The purpose of this study was to determine if oral and intravenous (IV) treatment of IDA in patients with gastrointestinal disease attending hospital were associated with differential rates of subsequent reattendance. Methods and findings Data from the Clinical Practice Research Datalink (primary care) and Hospital Treatment Insights (secondary care) databases in England were used to conduct this retrospective cohort study. Patients with a coded gastrointestinal disease and IDA who attended hospital (inpatient or outpatient) and were dispensed oral or IV iron between 01/01/2010-31/10/2013 were included. Elective and emergency re-attendances in secondary care within 30 days of the initial attendance were determined. Demographics, medical diagnoses and treatments were extracted. Re-attendance rates following oral or IV iron were compared using chisquare tests and a step-wise logistic regression model to adjust for confounders. 2,844 patients contributed 6,294 initial attendances; 80% of patients received oral iron, 14% received intravenous iron, and 6% received both. Of initial attendances recording oral iron, 77% resulted in re-attendance in hospital, compared to 34% of those recording IV iron (unadjusted odds ratio [OR]: 0.16; adjusted OR: 0.52 [95% CI: 0.44 +/- 0.61]). Initial attendances using IV treatment were more likely to result in elective re-attendance (84%) than those recording oral treatment (43%) (p< 0.001). Median length of stay in hospital tended to be shorter for patients using IV iron (1.4 days; interquartile range 0.5 +/- 3.6 days; oral iron: 5.1 days; interquartile range: 2.2 +/- 9.6 days). Conclusions Patients with gastrointestinal disease and IDA who received IV iron were less likely to reattend hospital, more likely to re-attend electively, and tended to have a shorter length of stay in hospital. The mode of IDA treatment could have a real-world impact on healthcare utilisation.	[Tomkins, Susannah; Myland, Melissa; Tham, Rachel] IQVIA, NEMEA Ctr Excellence Retrospect Studies, London, England; [Chapman, Callum] Chelsea & Westminster Hosp, London, England; [de Nobrega, Rachael; Jackson, Brinley] Vifor Pharma UK Ltd, Bagshot, Surrey, England; [Keshav, Satish] John Radcliffe Hosp, Gastroenterol Unit, Oxford, England	IQVIA; Imperial College London; University of Oxford	Keshav, S (corresponding author), John Radcliffe Hosp, Gastroenterol Unit, Oxford, England.	satish.keshav@ndm.ox.ac.uk			Vifor Pharma UK Ltd.	Vifor Pharma UK Ltd.	The study was funded by Vifor Pharma UK Ltd. The funder provided support in the form of consulting fees to QuintilesIMS (authors ST, MM, and RT). The funder did not have any additional role in the study design, data collection and analysis, or decision to publish. The funder did review the manuscript prior to submission. The specific roles of these authors are articulated in the author contributions section.	Abhyankar A, 2015, INFLAMM BOWEL DIS, V21, P1976, DOI 10.1097/MIB.0000000000000386; ANDERSON GF, 1984, NEW ENGL J MED, V311, P1349, DOI 10.1056/NEJM198411223112105; Auerbach M, 2014, BLOOD TRANSFUS-ITALY, V12, P296, DOI 10.2450/2014.0094-14; Avni T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075540; Bhaskaran K, 2014, INT J EPIDEMIOL, V43, P1336, DOI 10.1093/ije/dyu080; Black C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145676; Brugnara C, 2009, ESH HDB DISORDERS IR; Busti F, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00083; Calvet X, 2016, TECHNOL HEALTH CARE, V24, P111, DOI 10.3233/THC-151074; Cook IJ, 1986, BMJ-BRIT MED J, P292; Culleton BF, 2006, BLOOD, V107, P3841, DOI 10.1182/blood-2005-10-4308; Danese S, 2014, EUR J GASTROEN HEPAT, V26, P1385, DOI 10.1097/MEG.0000000000000200; Evstatiev R, 2013, CLIN GASTROENTEROL H, V11, P269, DOI 10.1016/j.cgh.2012.10.013; Gasche C, 2004, GUT, V53, P1190, DOI 10.1136/gut.2003.035758; Goddard AF, 2011, GUT, V60, P1309, DOI 10.1136/gut.2010.228874; Goodnough LT, 2014, AM J HEMATOL, V89, P88, DOI 10.1002/ajh.23598; Halfon P, 2006, MED CARE, V44, P972, DOI 10.1097/01.mlr.0000228002.43688.c2; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Hiller J., 2013, ISPOR; Johnson-Wimbley Terri D, 2011, Therap Adv Gastroenterol, V4, P177, DOI 10.1177/1756283X11398736; KEPCZYK MT, 1995, DIGEST DIS SCI, V40, P1283, DOI 10.1007/BF02065539; Khalil A, 2011, EUR J GASTROEN HEPAT, V23, P1029, DOI 10.1097/MEG.0b013e32834a58d1; Klip IT, 2013, AM HEART J, V165, P575, DOI 10.1016/j.ahj.2013.01.017; Kosiborod M, 2003, AM J MED, V114, P112, DOI 10.1016/S0002-9343(02)01498-5; Mearin F, 2013, GASTROENT HEPAT-BARC, V36, P499, DOI 10.1016/j.gastrohep.2013.05.006; NHS Digital, NHS DIG 1 TREV SQUAR; NHS England, 2014, CCGOIS D 3 2 EM READ; NHS England, 2014, PROACT CAS FIND CAR; Penninx BWJH, 2006, J GERONTOL A-BIOL, V61, P474, DOI 10.1093/gerona/61.5.474; Pharma Vifor, 2013, FERINJECT FERRIC CAR; Schroder O, 2005, AM J GASTROENTEROL, V100, P2503, DOI 10.1111/j.1572-0241.2005.00250.x; Stein J, 2010, NAT REV GASTRO HEPAT, V7, P599, DOI 10.1038/nrgastro.2010.151; Westert GP, 2002, HEALTH POLICY, V61, P269, DOI 10.1016/S0168-8510(01)00236-6	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189952	10.1371/journal.pone.0189952	http://dx.doi.org/10.1371/journal.pone.0189952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244881	Green Published, gold, Green Submitted			2022-12-26	WOS:000418184700071
J	Smith, HK; Omura, S; Vital, SA; Becker, F; Senchenkova, EY; Kaur, G; Tsunoda, I; Peirce, SM; Gavins, FNE				Smith, Helen K.; Omura, Seiichi; Vital, Shantel A.; Becker, Felix; Senchenkova, Elena Y.; Kaur, Gaganpreet; Tsunoda, Ikuo; Peirce, Shayn M.; Gavins, Felicity N. E.			Metallothionein I as a direct link between therapeutic hematopoietic stem/progenitor cells and cerebral protection in stroke	FASEB JOURNAL			English	Article						brain; cerebrovascular disease; neuroprotectants; ischemia-reperfusion injury	MESENCHYMAL STEM-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COLONY-STIMULATING FACTOR; INTRAARTERIAL DELIVERY; FUNCTIONAL RECOVERY; IMPROVE RECOVERY; ISCHEMIC-STROKE; CD34(+) CELLS; BRAIN; EXPRESSION	Stroke continues to be a leading cause of death and disability worldwide, yet effective treatments are lacking. Previous studies have indicated that stem-cell transplantation could be an effective treatment. However, little is known about the direct impact of transplanted cells on injured brain tissue. We wanted to help fill this knowledge gap and investigated effects of hematopoietic stem/progenitor cells (HSPCs) on the cerebral microcirculation after ischemia-reperfusion injury (I/RI). Treatment of HSPCs in I/RI for up to 2 wk after cerebral I/RI led to decreased mortality rate, decreased infarct volume, improved functional outcome, reduced microglial activation, and reduced cerebral leukocyte adhesion. Confocal microscopy and fluorescence-activated cell sorting analyses showed transplanted HSPCs emigrate preferentially into ischemic cortex brain parenchyma. We isolated migrated HSPCs from the brain; using RNA sequencing to investigate the transcriptome, we found metallothionein (MT, particularly MT-I) transcripts were dramatically up-regulated. Finally, to confirm the significance of MT, we exogenously administered MT-I after cerebral I/RI and found that it produced neuroprotection in a manner similar to HSPC treatment. These findings provide novel evidence that the mechanism through which HSPCs promote repair after stroke maybe via direct action of HSPC-derived MT-I and could therefore be exploited as a useful therapeutic strategy for stroke.	[Smith, Helen K.; Vital, Shantel A.; Becker, Felix; Senchenkova, Elena Y.; Kaur, Gaganpreet; Gavins, Felicity N. E.] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Mol & Cellular Physiol, 1501 Kings Highway, Shreveport, LA 71105 USA; [Omura, Seiichi; Tsunoda, Ikuo] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Microbiol & Immunol, Shreveport, LA 71105 USA; [Tsunoda, Ikuo; Gavins, Felicity N. E.] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Neurol, Shreveport, LA 71105 USA; [Smith, Helen K.] Weill Cornell Med Coll, Pathol & Lab Med, New York, NY USA; [Omura, Seiichi; Tsunoda, Ikuo] Kindai Univ, Fac Med, Dept Microbiol, Osakasayama, Osaka, Japan; [Becker, Felix] Univ Hosp Muenster, Dept Gen & Visceral Surg, Munster, Germany; [Peirce, Shayn M.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Cornell University; University of Munster; University of Virginia	Gavins, FNE (corresponding author), Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Mol & Cellular Physiol, 1501 Kings Highway, Shreveport, LA 71105 USA.	fgavin@lsuhsc.edu	Gavins, Felicity N. E./AAU-6010-2020; Omura, Seiichi/J-7793-2018; Tsunoda, Ikuo/B-4722-2008	Gavins, Felicity N. E./0000-0001-7008-5423; Omura, Seiichi/0000-0003-4619-9345; Tsunoda, Ikuo/0000-0003-1798-714X; Kaur, Gaganpreet/0000-0003-4633-7218; Peirce, Shayn/0000-0001-5857-5606	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute [HL125572-01A1]; Malcolm Feist Cardiovascular Fellowship program; NIH/National Institute of General Medical Sciences Centers of Biomedical Research Excellence (COBRE) [P30-GM110703]; Japan Society for the Promotion of Science [16H07356]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL125572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110703] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Malcolm Feist Cardiovascular Fellowship program; NIH/National Institute of General Medical Sciences Centers of Biomedical Research Excellence (COBRE); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank R. Jin (Louisiana State University Health Sciences Center-Shreveport) for his help with immunofluorescence staining, U. Cvek (Louisiana State University) for her help with statistical analysis, and P. Kubes (University of Calgary, Calgary, AB, Canada) for the LyZM mice. F.N.E.G. acknowledges the financial support of the U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (HL125572-01A1). H.K.S. and S.O. acknowledge the financial support of the Malcolm Feist Cardiovascular Fellowship program. I.T. was supported by a NIH/National Institute of General Medical Sciences Centers of Biomedical Research Excellence (COBRE) grant (P30-GM110703), and the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI; 16H07356). The authors declare no conflicts of interest.	[Anonymous], 2011, PRINCIPAL COMPONENT; Banerjee S, 2014, STEM CELL TRANSL MED, V3, P1322, DOI 10.5966/sctm.2013-0178; Chaitanya GV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-125; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Cui LL, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt544; Detante O, 2009, CELL TRANSPLANT, V18, P1369, DOI 10.3727/096368909X474230; Eidizadeh A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144035; England TJ, 2012, STROKE, V43, P405, DOI 10.1161/STROKEAHA.111.636449; Gavins FNE, 2015, J CEREBR BLOOD F MET, V35, P1090, DOI 10.1038/jcbfm.2015.93; Gavins FNE, 2012, FASEB J, V26, P4977, DOI 10.1096/fj.12-205971; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Goldmacher GV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060049; Gutierrez-Fernandez M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt159; Hao L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/468748; Honmou O, 2011, BRAIN, V134, P1790, DOI 10.1093/brain/awr063; Horie N, 2011, STEM CELLS, V29, P274, DOI 10.1002/stem.584; Imai Y, 2010, INT J HEMATOL, V91, P569, DOI 10.1007/s12185-010-0555-3; Ito Y, 2013, CURR PHARM BIOTECHNO, V14, P400, DOI 10.2174/1389201011314040003; Janowski M, 2015, STROKE, V46, P2354, DOI 10.1161/STROKEAHA.114.007803; Lee SJ, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-30; Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Ma XL, 2013, CURR NEUROVASC RES, V10, P103, DOI 10.2174/1567202611310020003; Mitkari B, 2014, BEHAV BRAIN RES, V259, P50, DOI 10.1016/j.bbr.2013.10.030; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ogawa M, 2001, ANN NY ACAD SCI, V938, P139; Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104; Omura S, 2014, CIRC-CARDIOVASC GENE, V7, DOI 10.1161/CIRCGENETICS.114.000505; Paczkowska E, 2005, EUR J HAEMATOL, V75, P461, DOI 10.1111/j.1600-0609.2005.00536.x; Pedersen MO, 2009, BIOFACTORS, V35, P315, DOI 10.1002/biof.44; Prasad K, 2014, STROKE, V45, P3618, DOI 10.1161/STROKEAHA.114.007028; Santos CRA, 2012, IUBMB LIFE, V64, P126, DOI 10.1002/iub.585; Sato F, 2014, CELL IMMUNOL, V292, P85, DOI 10.1016/j.cellimm.2014.10.004; Schwarting S, 2008, STROKE, V39, P2867, DOI 10.1161/STROKEAHA.108.513978; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Smith HK, 2015, J NEUROSCI METH, V249, P99, DOI 10.1016/j.jneumeth.2015.04.008; Smith HK, 2015, FASEB J, V29, P2161, DOI 10.1096/fj.14-263160; Smith HK, 2012, FASEB J, V26, P2239, DOI 10.1096/fj.11-195719; Stroemer P, 2009, NEUROREHAB NEURAL RE, V23, P895, DOI 10.1177/1545968309335978; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; Swamydas M., 2013, JOVE-J VIS EXP, V77, P50586, DOI DOI 10.3791/50586; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tatarishvili J, 2014, RESTOR NEUROL NEUROS, V32, P547, DOI 10.3233/RNN-140404; Tornero D, 2013, BRAIN, V136, P3561, DOI 10.1093/brain/awt278; Trendelenburg G, 2002, J NEUROSCI, V22, P5879; Tsunoda I, 2007, BRAIN PATHOL, V17, P45, DOI 10.1111/j.1750-3639.2006.00042.x; Ulyanova T, 2005, BLOOD, V106, P86, DOI 10.1182/blood-2004-09-3417; Vasconcelos-dos-Santos A, 2012, STEM CELL RES, V9, P1, DOI 10.1016/j.scr.2012.02.002; Vital SA, 2016, CIRCULATION, V133, P2169, DOI 10.1161/CIRCULATIONAHA.115.020633; Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50; WITT PL, 1990, J INTERFERON RES, V10, P393, DOI 10.1089/jir.1990.10.393; Yanagida K, 2017, P NATL ACAD SCI USA, V114, P4531, DOI 10.1073/pnas.1618659114; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yilmaz G, 2011, STROKE, V42, P806, DOI 10.1161/STROKEAHA.110.597088	55	6	6	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2381	2394		10.1096/fj.201700746R	http://dx.doi.org/10.1096/fj.201700746R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29269399	Green Published, Green Submitted			2022-12-26	WOS:000432528000007
J	Howley, BV; Link, LA; Grelet, S; El-Sabban, M; Howe, PH				Howley, Breege V.; Link, Laura A.; Grelet, Simon; El-Sabban, Maya; Howe, Philip H.			A CREB3-regulated ER-Golgi trafficking signature promotes metastatic progression in breast cancer	ONCOGENE			English	Article							RETICULUM STRESS-RESPONSE; TRANSCRIPTION FACTOR; MEMBRANE-PROTEIN; LUMINAL DOMAIN; CELL-DEATH; TGF-BETA; CHOLESTEROL; GENES; PROGNOSIS; APPARATUS	In order to better understand the process of breast cancer metastasis, we have generated a mammary epithelial progression series of increasingly aggressive cell lines that metastasize to lung. Here we demonstrate that upregulation of an endoplasmic reticulum (ER) to Golgi trafficking gene signature in metastatic cells enhances transport kinetics, which promotes malignant progression. We observe increased ER-Golgi trafficking, an altered secretome and sensitivity to the retrograde transport inhibitor brefeldin A (BFA) in cells that metastasize to lung. CREB3 was identified as a transcriptional regulator of upregulated ER-Golgi trafficking genes ARF4, COPB1, and USO1, and silencing of these genes attenuated the metastatic phenotype in vitro and lung colonization in vivo. Furthermore, high trafficking gene expression significantly correlated with increased risk of distant metastasis and reduced relapse-free and overall survival in breast cancer patients, suggesting that modulation of ER-Golgi trafficking plays an important role in metastatic progression.	[Howley, Breege V.; Link, Laura A.; Grelet, Simon; El-Sabban, Maya; Howe, Philip H.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Howley, Breege V.; Link, Laura A.; Grelet, Simon; Howe, Philip H.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Link, Laura A.] Kent State Univ, Dept Biomed Sci, Kent, OH 44242 USA	Medical University of South Carolina; Medical University of South Carolina; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Howe, PH (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.; Howe, PH (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA.	howep@musc.edu		Howe, Philip/0000-0002-1358-1313	National Cancer Institute [CA055536, CA154663]; Abney Foundation; NIH/NIGMS [GM103342, GM103499]; Biorepository & Tissue Analysis Shared Resource, Hollings Cancer Center, MUSC; Gene Targeting and Knockout Shared Resource at MUSC;  [P30 CA138313];  [P30 GM103331]; NATIONAL CANCER INSTITUTE [R01CA154663] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Abney Foundation; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biorepository & Tissue Analysis Shared Resource, Hollings Cancer Center, MUSC; Gene Targeting and Knockout Shared Resource at MUSC; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants CA055536 and CA154663 from the National Cancer Institute to PHH. BVH was supported by funding from the Abney Foundation. This study used the services of the MUSC Proteogenomics Facility supported by NIH/NIGMS (GM103342 and GM103499), the Cell & Molecular Imaging Shared Resource of MUSC supported by P30 CA138313, the MUSC Center for Oral Health Research (COHR), which is partially supported by P30 GM103331, the MUSC Flow Cytometry Facility supported by NIH/NIGMS GM103342, the Biorepository & Tissue Analysis Shared Resource, Hollings Cancer Center, MUSC, and the Gene Targeting and Knockout Shared Resource at MUSC. We thank Annamarie Dalton for assisting us with xenograft experiments and also thank members of the Howe laboratory for providing helpful feedback during the preparation of this manuscript.	Alvarez C, 2001, J BIOL CHEM, V276, P2693, DOI 10.1074/jbc.M007957200; Bard F, 2016, TRENDS CELL BIOL, V26, P379, DOI 10.1016/j.tcb.2015.12.004; Ben-Tekaya H, 2010, MOL BIOL CELL, V21, P4130, DOI 10.1091/mbc.E10-01-0022; BERSHADSKY AD, 1994, P NATL ACAD SCI USA, V91, P5686, DOI 10.1073/pnas.91.12.5686; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chan CP, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-6; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; CLERMONT Y, 1993, ANAT REC, V237, P308, DOI 10.1002/ar.1092370303; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Danilov AV, 2008, CANCER METAST REV, V27, P707, DOI 10.1007/s10555-008-9159-2; Dodonova SO, 2015, SCIENCE, V349, P195, DOI 10.1126/science.aab1121; Donizy P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101619; Feng YX, 2014, CANCER DISCOV, V4, P702, DOI 10.1158/2159-8290.CD-13-0945; Fox RM, 2010, J CELL BIOL, V191, P479, DOI 10.1083/jcb.201004062; Guizzunti G, 2016, P NATL ACAD SCI USA, V113, pE6590, DOI 10.1073/pnas.1610844113; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Halberg N, 2016, CANCER CELL, V29, P339, DOI 10.1016/j.ccell.2016.02.013; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Howley BV, 2016, ONCOGENE, V35, P1725, DOI 10.1038/onc.2015.238; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hussey GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052624; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; Kim HC, 2010, CELL MOL LIFE SCI, V67, P3499, DOI 10.1007/s00018-010-0388-5; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kuzu OF, 2016, CANCER RES, V76, P2063, DOI 10.1158/0008-5472.CAN-15-2613; Li H, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-168; Li T, 2016, MOL NEUROBIOL, V53, P1377, DOI 10.1007/s12035-014-9083-0; Liang GQ, 2006, MOL CELL BIOL, V26, P7999, DOI 10.1128/MCB.01046-06; Ling ZQ, 2014, ANN ONCOL, V25, P1363, DOI 10.1093/annonc/mdu168; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Maag RS, 2003, CURR OPIN CELL BIOL, V15, P456, DOI 10.1016/S0955-0674(03)00075-9; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nadanaka S, 2007, MOL CELL BIOL, V27, P1027, DOI 10.1128/MCB.00408-06; Oku M, 2011, CELL STRUCT FUNCT, V36, P1, DOI 10.1247/csf.10014; Oliveros J.C., 2007, INTERACTIVE TOOL COM; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Popoff V, 2011, J BIOL CHEM, V286, P35634, DOI 10.1074/jbc.M111.261800; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Reiling JH, 2013, NAT CELL BIOL, V15, P1473, DOI 10.1038/ncb2865; Reverter M, 2014, CELL REP, V7, P883, DOI 10.1016/j.celrep.2014.03.043; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Serebrenik Y, 2015, FASEB J, V29; Spang A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013391; Taniguchi M, 2016, CELL STRUCT FUNCT, V41, P93, DOI 10.1247/csf.16005; Taniguchi M, 2015, CELL STRUCT FUNCT, V40, P13, DOI 10.1247/csf.14015; Vellanki RN, 2010, ENDOCRINOLOGY, V151, P4146, DOI 10.1210/en.2010-0137; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; WATERS MG, 1992, J CELL BIOL, V118, P1015, DOI 10.1083/jcb.118.5.1015; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Zhou JX, 2012, J NEURO-ONCOL, V110, P195, DOI 10.1007/s11060-012-0970-9; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	63	35	38	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	10					1308	1325		10.1038/s41388-017-0023-0	http://dx.doi.org/10.1038/s41388-017-0023-0			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ0RI	29249802	Green Accepted			2022-12-26	WOS:000427279300004
J	Banerjee, G; Ghosh, I; Kim, CJ; Debus, RJ; Brudvig, GW				Banerjee, Gourab; Ghosh, Ipsita; Kim, Christopher J.; Debus, Richard J.; Brudvig, Gary W.			Substitution of the D1-Asn(87) site in photosystem II of cyanobacteria mimics the chloride-binding characteristics of spinach photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING COMPLEX; FTIR DIFFERENCE SPECTROSCOPY; PHOTOSYNTHETIC WATER OXIDATION; S-STATE CYCLE; TRANSFORM INFRARED-SPECTROSCOPY; ELECTRON-PARAMAGNETIC-RES; D1 POLYPEPTIDE; MN4CAO5 CLUSTER; UNDERGOES OXIDATION; OXIDIZING COMPLEX	Photoinduced water oxidation at the O-2-evolving complex (OEC) of photosystem II (PSII) is a complex process involving a tetramanganese-calcium cluster that is surrounded by a hydrogen-bonded network of water molecules, chloride ions, and amino acid residues. Although the structure of the OEC has remained conserved over eons of evolution, significant differences in the chloride-binding characteristics exist between cyanobacteria and higher plants. An analysis of amino acid residues in and around the OEC has identified residue 87 in the D1 subunit as the only significant difference between PSII in cyanobacteria and higher plants. We substituted the D1-Asn(87) residue in the cyanobacterium Synechocystis sp. PCC 6803 (wildtype) with alanine, present in higher plants, or with aspartic acid. We studied PSII core complexes purified from D1-N87A and D1-N87D variant strains to probe the function of the D1-Asn87 residue in the water-oxidation mechanism. EPR spectra of the S-2 state and flash-induced FTIR spectra of both D1-N87A and D1-N87D PSII core complexes exhibited characteristics similar to those of wildtype Synechocystis PSII core complexes. However, flash-induced O-2-evolution studies revealed a decreased cycling efficiency of the D1-N87D variant, whereas the cycling efficiency of the D1-N87A PSII variant was similar to that of wildtype PSII. Steady-state O-2-evolution activity assays revealed that substitution of the D1 residue at position 87 with alanine perturbs the chloride-binding site in the proton-exit channel. These findings provide new insight into the role of the D1-Asn87 site in the water-oxidation mechanism and explain the difference in the chloride-binding properties of cyanobacterial and higher-plant PSII.	[Banerjee, Gourab; Ghosh, Ipsita; Brudvig, Gary W.] Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA; [Kim, Christopher J.; Debus, Richard J.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	Yale University; University of California System; University of California Riverside	Brudvig, GW (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.; Debus, RJ (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	richard.debus@ucr.edu; gary.brudvig@yale.edu			Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences;  [DE-FG02-05ER15646];  [DE-SC0005291]	Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences(United States Department of Energy (DOE)); ; 	This work was supported by grants from the Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences. Oxygen-release and EPR studies were supported by Grant DE-FG02-05ER15646 (to G.W.B.). Mutant construction, whole cell fluorescence measurements, and FTIR studies were supported by Grant DE-SC0005291 (to R.J.D.). The authors declare that they have no conflicts of interest with the contents of this article.	BECK WF, 1985, BIOCHEMISTRY-US, V24, P3035, DOI 10.1021/bi00333a035; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Boussac A, 2012, BBA-BIOENERGETICS, V1817, P802, DOI 10.1016/j.bbabio.2012.02.031; Chu HA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00146; Cooper IB, 2008, BIOPHYS J, V95, P5843, DOI 10.1529/biophysj.108.136879; Debus RJ, 2015, BBA-BIOENERGETICS, V1847, P19, DOI 10.1016/j.bbabio.2014.07.007; Debus RJ, 2014, BIOCHEMISTRY-US, V53, P2941, DOI 10.1021/bi500309f; Debus RJ, 2005, BIOCHEMISTRY-US, V44, P1367, DOI 10.1021/bi047558u; Debus RJ, 2001, BIOCHEMISTRY-US, V40, P3690, DOI 10.1021/bi002394c; DISMUKES GC, 1981, P NATL ACAD SCI-BIOL, V78, P274, DOI 10.1073/pnas.78.1.274; Freier E, 2011, P NATL ACAD SCI USA, V108, P11435, DOI 10.1073/pnas.1104735108; Garczarek F, 2006, NATURE, V439, P109, DOI 10.1038/nature04231; Haddy A, 2004, BIOPHYS J, V87, P2885, DOI 10.1529/biophysj.104.040238; Ho FM, 2008, BBA-BIOENERGETICS, V1777, P140, DOI 10.1016/j.bbabio.2007.08.009; Hou LH, 2011, BIOCHEMISTRY-US, V50, P9248, DOI 10.1021/bi200943q; Iwata T, 2009, BIOCHEMISTRY-US, V48, P1220, DOI 10.1021/bi801990s; Kandori H, 2000, J AM CHEM SOC, V122, P11745, DOI 10.1021/ja0032069; Kandori H, 2000, BBA-BIOENERGETICS, V1460, P177, DOI 10.1016/S0005-2728(00)00138-9; Kimura Y, 2005, J BIOL CHEM, V280, P37895, DOI 10.1074/jbc.M505887200; Kimura Y, 2003, BIOCHEMISTRY-US, V42, P13170, DOI 10.1021/bi035420q; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Kuhne H, 1999, BIOCHEMISTRY-US, V38, P6604, DOI 10.1021/bi990341t; LINDBERG K, 1993, PHOTOSYNTH RES, V38, P401, DOI 10.1007/BF00046767; Lindberg K, 1996, BIOCHEMISTRY-US, V35, P14259, DOI 10.1021/bi961244s; Linke K, 2014, BBA-BIOENERGETICS, V1837, P14, DOI 10.1016/j.bbabio.2013.08.003; Marechal A, 2011, P NATL ACAD SCI USA, V108, P8634, DOI 10.1073/pnas.1019419108; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Nakamura S, 2016, BIOCHEMISTRY-US, V55, P597, DOI 10.1021/acs.biochem.5b01120; Noguchi T, 2000, BIOCHEMISTRY-US, V39, P10943, DOI 10.1021/bi001040i; Noguchi T, 1999, BIOCHEMISTRY-US, V38, P10187, DOI 10.1021/bi990631+; Noguchi T, 2003, BIOCHEMISTRY-US, V42, P6035, DOI 10.1021/bi0341612; Noguchi T, 2002, BIOCHEMISTRY-US, V41, P15706, DOI 10.1021/bi020603i; Noguchi T., 1999, FOURIER TRANSFORM SP, P460; Noguchi T, 2008, COORDIN CHEM REV, V252, P336, DOI 10.1016/j.ccr.2007.05.001; Noguchi T, 2008, PHILOS T R SOC B, V363, P1189, DOI 10.1098/rstb.2007.2214; Noguchi T, 2007, PHOTOSYNTH RES, V91, P59, DOI 10.1007/s11120-007-9137-5; Noguchi T, 2013, BIOMED SPECTROSC IMA, V2, P115, DOI 10.3233/BSI-130040; Noguchi T, 2012, BIOCHEMISTRY-US, V51, P3205, DOI 10.1021/bi300294n; ONO T, 1986, BIOCHIM BIOPHYS ACTA, V851, P193, DOI 10.1016/0005-2728(86)90125-8; Pokhrel R, 2015, BIOCHEMISTRY-US, V54, P1663, DOI 10.1021/bi501468h; Pokhrel R, 2014, PHYS CHEM CHEM PHYS, V16, P11812, DOI 10.1039/c4cp00493k; Pokhrel R, 2013, BIOCHEMISTRY-US, V52, P4758, DOI 10.1021/bi301700u; Retegan M, 2016, CHEM SCI, V7, P6463, DOI 10.1039/c6sc02340a; SANDUSKY PO, 1984, BIOCHIM BIOPHYS ACTA, V766, P603, DOI 10.1016/0005-2728(84)90121-X; SANDUSKY PO, 1986, BIOCHIM BIOPHYS ACTA, V849, P85, DOI 10.1016/0005-2728(86)90099-X; Service RJ, 2014, BIOCHEMISTRY-US, V53, P1001, DOI 10.1021/bi401450y; Service RJ, 2013, BIOCHEMISTRY-US, V52, P8452, DOI 10.1021/bi401339f; Service RJ, 2011, BIOCHEMISTRY-US, V50, P63, DOI 10.1021/bi1015937; Service RJ, 2010, BIOCHEMISTRY-US, V49, P6655, DOI 10.1021/bi100730d; Shimada Y, 2009, BIOCHEMISTRY-US, V48, P6095, DOI 10.1021/bi900317a; Strickler MA, 2005, BIOCHEMISTRY-US, V44, P8571, DOI 10.1021/bi050653y; Strickler MA, 2007, BIOCHEMISTRY-US, V46, P3151, DOI 10.1021/bi062195e; Strickler MA, 2006, BIOCHEMISTRY-US, V45, P8801, DOI 10.1021/bi060583a; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Suzuki H, 2008, BIOCHEMISTRY-US, V47, P11024, DOI 10.1021/bi801580e; vanVliet P, 1996, BIOCHEMISTRY-US, V35, P1829, DOI 10.1021/bi9514471; Vassiliev S, 2012, BBA-BIOENERGETICS, V1817, P1671, DOI 10.1016/j.bbabio.2012.05.016; Vinyard DJ, 2017, J PHYS CHEM B, V121, P1020, DOI 10.1021/acs.jpcb.7b00110; Vinyard DJ, 2015, BIOCHEMISTRY-US, V54, P622, DOI 10.1021/bi5014134; Vinyard DJ, 2013, BBA-BIOENERGETICS, V1827, P861, DOI 10.1016/j.bbabio.2013.04.008; Vogt L, 2015, CURR OPIN CHEM BIOL, V25, P152, DOI 10.1016/j.cbpa.2014.12.040; Yamanari T, 2004, BIOCHEMISTRY-US, V43, P7479, DOI 10.1021/bi0362323	62	24	24	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2487	2497		10.1074/jbc.M117.813170	http://dx.doi.org/10.1074/jbc.M117.813170			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29263091	Green Published, hybrid			2022-12-26	WOS:000425308300021
J	To, JY; Smrcka, AV				To, Jesi Y.; Smrcka, Alan V.			Activated heterotrimeric G protein (i) subunits inhibit Rap-dependent cell adhesion and promote cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; cell signaling; G protein; G protein-coupled receptor (GPCR); adhesion; integrin; chemokines	RHO; CHEMOTAXIS; MOTILITY; RADIL	Our recent work uncovered novel roles for activated G(i) signaling in the regulation of neutrophil polarity and adhesion. G(i)GTP-mediated enhancement of neutrophil polarization was dependent on inhibition of cAMP/PKA signaling, whereas reversal of G-stimulated adhesion was cAMP/PKA independent. To uncover the mechanism for G(i) regulation of adhesion, we analyzed the effects of constitutively active G(i1)(Q204L) expression on adhesion driven by constitutively active Rap1a(G12V) or its downstream effector Radil in neutrophil-like HL-60 cells, or in HT-1080 fibrosarcoma cells. In HT-1080 cells, Rap1a(G12V) or Radil cause an increase in cell spreading and adhesion to fibronectin, which are both reversed by G(i1)(Q204L) but not WT G(i1). In contrast, G(i1)(Q204L) did not reverse Rap1-GTP-interacting adaptor molecule (RIAM)-dependent increases in cell adhesion. This indicates that adhesion regulation by G(i)-GTP occurs downstream of Rap1a and Radil, but is upstream of components such as integrins and talin that are regulated by both Radil and RIAM. HL-60 neutrophil-like cells expressing Rap1a(G12V) or Radil have an elongated phenotype because of enhanced uropod adhesion as they attempt to migrate on fibronectin. This elongated phenotype driven by Rap1a(G12V) or Radil is reversed by G(i1)(Q204L), but not by WT G(i1) expression, suggesting that G(i)-GTP also regulates adhesion in immune cells at the level of, or downstream of, Radil. These data identify a novel role of G(i)-GTP in regulation of cell adhesion and migration. Cell migration involves cycles of adhesion and de-adhesion, and we propose that the dynamic spatiotemporal balance between G-promoted adhesion and G(i)-GTP reversal of adhesion is important for this process.	[To, Jesi Y.; Smrcka, Alan V.] Univ Rochester, Sch Med, Dept Physiol & Pharmacol, Rochester, NY 14623 USA; [Smrcka, Alan V.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Rochester; University of Michigan System; University of Michigan	Smrcka, AV (corresponding author), Univ Rochester, Sch Med, Dept Physiol & Pharmacol, Rochester, NY 14623 USA.	avsmrcka@umich.edu			National Institutes of Health [R01GM081772]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by National Institutes of Health Grant R01GM081772 (to A. V. S.). The authors declare that they have no conflicts of interest regarding the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed SM, 2012, J CELL BIOL, V199, P951, DOI 10.1083/jcb.201206051; Ahmed SM, 2010, J BIOL CHEM, V285, P6538, DOI 10.1074/jbc.M109.069948; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Brinkmann T, 2002, J BIOL CHEM, V277, P12525, DOI 10.1074/jbc.M109176200; Gambardella L, 2011, BLOOD, V118, P1087, DOI 10.1182/blood-2010-10-312959; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lagarrigue F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9492; Liu LH, 2012, MOL BIOL CELL, V23, P4751, DOI 10.1091/mbc.E12-05-0408; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Neptune ER, 1999, J BIOL CHEM, V274, P2824, DOI 10.1074/jbc.274.5.2824; Post A, 2015, MOL CELL BIOL, V35, P2495, DOI 10.1128/MCB.01453-14; Post A, 2013, P NATL ACAD SCI USA, V110, P11427, DOI 10.1073/pnas.1306595110; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Smolen GA, 2007, GENE DEV, V21, P2131, DOI 10.1101/gad.1561507; Surve CR, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad8163; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435	22	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1570	1578		10.1074/jbc.RA117.000964	http://dx.doi.org/10.1074/jbc.RA117.000964			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29259127	Green Published, hybrid			2022-12-26	WOS:000424201700010
J	Prinster, A; Cantone, E; Verlezza, V; Magliulo, M; Sarnelli, G; Lengo, M; Cuomo, R; Di Salle, F; Esposito, F				Prinster, Anna; Cantone, Elena; Verlezza, Viviana; Magliulo, Mario; Sarnelli, Giovanni; Lengo, Maurizio; Cuomo, Rosario; Di Salle, Francesco; Esposito, Fabrizio			Cortical representation of different taste modalities on the gustatory cortex: A pilot study	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; STIMULI; BRAIN; PERCEPTION; INFORMATION; CARBONATION; ALIGNMENT; INSULA; TONGUE; SWEET	Background Right insular cortex is involved in taste discrimination, but its functional organization is still poorly known. In general, sensory cortices represent the spatial prevalence of relevant features for each sensory modality (visual, auditory, somatosensory) in an ordered way across the cortical space. Following this analogy, we hypothesized that primary taste cortex is organized in similar ordered way in response to six tastes with known receptorial mechanisms (sweet, bitter, sour, salt, umami, CO2). Design Ten normal subjects were enrolled in a pilot study. We used functional magnetic resonance imaging (fMRI), a high resolution cortical registration method, and specialized procedures of feature prevalence localization, to map fMRI responses within the right insular cortex, to water solutions of quinine hydrochloride (bitter), Acesulfamate K (sweet), sodium chloride (salt), mono potassium glutamate + inosine 5' mono phosphate (Umami), citric acid (sour) and carbonated water (CO2). During an fMRI scan delivery of the solutions was applied in pseudo-random order interleaved with cleaning water. Results Two subjects were discarded due to excessive head movements. In the remaining subjects, statistically significant activations were detected in the fMRI responses to all tastes in the right insular cortex (p< 0.05, family-wise corrected for multiple comparisons). Cortical representation of taste prevalence highlighted two spatially segregated clusters, processing two and three tastes coupled together (sweet-bitter and salt-umami-sour), with CO2 in between. Conclusions Cortical representation of taste prevalence within the right primary taste cortex appears to follow the ecological purpose of enhancing the discrimination between safe nutrients and harmful substances.	[Prinster, Anna; Magliulo, Mario] CNR, Biostruct & Bioimaging Inst, Naples, Italy; [Cantone, Elena; Lengo, Maurizio] Univ Naples Federico II, Sect ENT, Dept Neurosci, Naples, Italy; [Verlezza, Viviana; Sarnelli, Giovanni; Cuomo, Rosario] Univ Naples Federico II, Gastroenterol Unit, Dept Clin & Expt Med, Naples, Italy; [Di Salle, Francesco; Esposito, Fabrizio] Univ Salerno, Dept Med Surg & Dent, Salerno, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II; University of Naples Federico II; University of Salerno	Prinster, A (corresponding author), CNR, Biostruct & Bioimaging Inst, Naples, Italy.	anna.prinster@ibb.cnr.it	Prinster, Anna/AAW-3129-2020; Cantone, Elena/AAN-5191-2020; Sarnelli, Giovanni/AAB-4050-2019; Prinster, Anna/B-8414-2015; Cuomo, Rosario/C-3446-2011	Cantone, Elena/0000-0002-7389-2033; Sarnelli, Giovanni/0000-0002-1467-1134; Prinster, Anna/0000-0003-2706-3071; iengo, maurizio/0000-0001-5938-9231; Cuomo, Rosario/0000-0003-0768-8381	Beverage Institute for Health & Wellness, The Coca Cola Company, L.L.C., Atlanta, USA	Beverage Institute for Health & Wellness, The Coca Cola Company, L.L.C., Atlanta, USA	The study was supported in part by The Beverage Institute for Health & Wellness, The Coca Cola Company, L.L.C., Atlanta, USA and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi RO, 2014, NEUROIMAGE, V99, P509, DOI 10.1016/j.neuroimage.2014.06.042; Accolla R, 2007, J NEUROSCI, V27, P1396, DOI 10.1523/JNEUROSCI.5188-06.2007; Auffarth B, 2013, NEUROSCI BIOBEHAV R, V37, P1667, DOI 10.1016/j.neubiorev.2013.06.009; Barona B, 2011, ENVIRON SCI TECHNOL, V45, P1730, DOI 10.1021/es103359f; Barry MA, 2001, CHEM SENSES, V26, P471, DOI 10.1093/chemse/26.5.471; Carleton A, 2010, TRENDS NEUROSCI, V33, P326, DOI 10.1016/j.tins.2010.04.002; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Chikazoe J, 2014, NAT NEUROSCI, V17, P1114, DOI 10.1038/nn.3749; Crouzet SM, 2015, CURR BIOL, V25, P890, DOI 10.1016/j.cub.2015.01.057; Dalenberg JR, 2015, NEUROIMAGE, V119, P210, DOI 10.1016/j.neuroimage.2015.06.062; De Martino F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2379; Di Salle F, 2013, GASTROENTEROLOGY, V145, P537, DOI 10.1053/j.gastro.2013.05.041; Fletcher ML, 2017, J NEUROSCI, V37, P7595, DOI 10.1523/JNEUROSCI.0649-17.2017; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Frost MA, 2014, HUM BRAIN MAPP, V35, P673, DOI 10.1002/hbm.22191; Frost MA, 2012, NEUROIMAGE, V59, P1369, DOI 10.1016/j.neuroimage.2011.08.035; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Herdener M, 2013, CORTEX, V49, P2822, DOI 10.1016/j.cortex.2013.04.003; Hummel T, 2008, CHEM BIODIVERS, V5, P853, DOI 10.1002/cbdv.200890100; Humphries C, 2010, NEUROIMAGE, V50, P1202, DOI 10.1016/j.neuroimage.2010.01.046; Iannilli E, 2012, NEUROIMAGE, V60, P426, DOI 10.1016/j.neuroimage.2011.12.088; Kaas JH, 2006, ANAT REC PART A, V288A, P182, DOI 10.1002/ar.a.20267; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Lundstrom JN, 2011, ACS CHEM NEUROSCI, V2, P5, DOI 10.1021/cn1000843; Oka Y, 2013, NATURE, V494, P472, DOI 10.1038/nature11905; Roper SD, 2013, SEMIN CELL DEV BIOL, V24, P71, DOI 10.1016/j.semcdb.2012.12.002; Schoenfeld MA, 2004, NEUROSCIENCE, V127, P347, DOI 10.1016/j.neuroscience.2004.05.024; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Seifritz E, 2006, NEUROIMAGE, V29, P1013, DOI 10.1016/j.neuroimage.2005.08.029; Small DM, 2010, BRAIN STRUCT FUNCT, V214, P551, DOI 10.1007/s00429-010-0266-9; Small DM, 1999, NEUROREPORT, V10, P7, DOI 10.1097/00001756-199901180-00002; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Stevenson RJ, 2013, NEUROPSYCHOLOGIA, V51, P1408, DOI 10.1016/j.neuropsychologia.2013.04.010; Sugita M, 2005, SCIENCE, V309, P781, DOI 10.1126/science.1110787; Tu Z, 2008, IEEE T MED IMAGING, V27, P495, DOI 10.1109/TMI.2007.908121; Veldhuizen MG, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00058; Yamaguchi S, 2000, J NUTR, V130, p921S, DOI 10.1093/jn/130.4.921S	40	21	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190164	10.1371/journal.pone.0190164	http://dx.doi.org/10.1371/journal.pone.0190164			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281722	gold, Green Submitted, Green Published			2022-12-26	WOS:000419006200071
J	Min, M; Yan, BX; Wang, P; Landeck, L; Chen, JQ; Li, W; Cai, SQ; Zheng, M; Man, XY				Min, Min; Yan, Bing-Xi; Wang, Ping; Landeck, Lilla; Chen, Jia-Qi; Li, Wei; Cai, Sui-Qing; Zheng, Min; Man, Xiao-Yong			Rottlerin as a therapeutic approach in psoriasis: Evidence from in vitro and in vivo studies	PLOS ONE			English	Article							NF-KAPPA-B; SKIN INFLAMMATION; EPIDERMAL-KERATINOCYTES; HACAT KERATINOCYTES; INHIBITION; APOPTOSIS; AUTOPHAGY; DIFFERENTIATION; ANGIOGENESIS; INVOLUCRIN	Rottlerin is a natural polyphenolic compound that was initially indicated as a PKC delta inhibitor. However, it was recently revealed that it may target a number of molecules and have biological effects on various cell types and is considered as a possible agent for tumor and cell proliferative diseases. Psoriasis is a chronic inflammatory cutaneous disorder with undefined etiology and is characterized by abnormal cellular proliferation, angiogenesis, and inflammation. Therefore, this paper investigates the regulatory effects of rottlerin on normal human epidermal keratinocytes (NHEKs) and imiquimod (IMQ)-induced psoriasiform (IPI) lesions. In vitro results showed that rottlerin inhibited cell proliferation in NHEKs through growth arrest and NF kappa B inhibition. It may also induce apoptosis in an autophagy-dependent pathway. We found that rottlerin inhibited human microvascular endothelial cells tube formation on matrigel. Rottlerin also decreased the cell senescence of keratinocytes and intracellular ROS generation, which indicated its antioxidant effect. We also showed that rottlerin affects the expression of keratinocyte proliferation biomarkers. In 12-O-tetradecanoylphorbol13-acetate (TPA) +/- induced keratinocytes, rottlerin significantly inhibited the expression of the induced pro-inflammatory cytokines in keratinocytes. An animal experiment provided the corresponding evidence based on this evidence in vitro, by using IPI model, we found that rottlerin could relieve the psoriasiform of BALB/c mice by inhibiting keratinocyte proliferation, inflammatory cell infiltration, and vascular proliferation. In conclusion, our results suggest that rottlerin may prove useful in the development of therapeutic agents against psoriasis. However, the deep mechanism still requires further study.	[Min, Min; Yan, Bing-Xi; Wang, Ping; Chen, Jia-Qi; Li, Wei; Cai, Sui-Qing; Zheng, Min; Man, Xiao-Yong] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Dermatol, Hangzhou, Zhejiang, Peoples R China; [Landeck, Lilla] Humboldt Univ, Ernst von Bergmann Gen Hosp, Teaching Hosp, Charite, Potsdam, Germany	Zhejiang University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Klinikum Ernst von Bergmann	Zheng, M; Man, XY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Dermatol, Hangzhou, Zhejiang, Peoples R China.	minz@zju.edu.cn; manxy@zju.edu.cn			National Natural Science Foundation of China (NSFC) [81371740, 81371741, 81630082, 81573039, 91542124]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was supported by the grants from the National Natural Science Foundation of China (NSFC) (81371740, 81371741, 81630082, 81573039 and 91542124).; This research was supported by the grants from the National Natural Science Foundation of China (NSFC) (81371740, 81371741, 81630082, 81573039 and 91542124).	Adli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009428; Armstrong AW, 2011, J DERMATOL SCI, V63, P1, DOI 10.1016/j.jdermsci.2011.04.007; Bikfalvi A, 2012, HAND CLINIC, V104, P35, DOI 10.1016/B978-0-444-52138-5.00003-7; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Briganti S, 2003, J EUR ACAD DERMATOL, V17, P663, DOI 10.1046/j.1468-3083.2003.00751.x; Chen JQ, 2013, CELL BIOCHEM BIOPHYS, V66, P523, DOI 10.1007/s12013-012-9499-y; Chua RA, 2009, AUTOIMMUNITY, V42, P574, DOI 10.1080/08916930903002461; D'Ignazio L, 2017, BIOMEDICINES, V5, DOI 10.3390/biomedicines5020021; Daveri E, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/545838; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Ditsworth D, 2004, CANCER BIOL THER, V3, P1214, DOI 10.4161/cbt.3.12.1391; Escarcega RO, 2007, CLIN ONCOL-UK, V19, P154, DOI 10.1016/j.clon.2006.11.013; Gnanaraj P, 2015, INT J DERMATOL, V54, P302, DOI 10.1111/ijd.12565; Goldklang MP, 2013, FASEB J, V27, P4975, DOI 10.1096/fj.13-235176; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Helwa I, 2015, J PHARMACOL EXP THER, V352, P90, DOI 10.1124/jpet.114.218818; Huang MZ, 2014, CANCER LETT, V353, P32, DOI 10.1016/j.canlet.2014.06.021; Huang SW, 2016, J DERMATOL SCI, V84, P59, DOI 10.1016/j.jdermsci.2016.07.007; Jeon YJ, 2013, EUR J PHARMACOL, V714, P7, DOI 10.1016/j.ejphar.2013.05.041; Joyce CE, 2011, HUM MOL GENET, V20, P4025, DOI 10.1093/hmg/ddr331; Kim BE, 2008, CLIN IMMUNOL, V126, P332, DOI 10.1016/j.clim.2007.11.006; Kim BE, 2011, J INVEST DERMATOL, V131, P1272, DOI 10.1038/jid.2011.24; Kim BH, 2014, J INVEST DERMATOL, V134, P1023, DOI 10.1038/jid.2013.453; Kumar D, 2014, CANCER LETT, V343, P179, DOI 10.1016/j.canlet.2013.10.003; Kumar D, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-171; Lehmann B, 1997, J INVEST DERMATOL, V108, P78, DOI 10.1111/1523-1747.ep12285640; Liu GY, 1998, MOL CARCINOGEN, V22, P235, DOI 10.1002/(SICI)1098-2744(199808)22:4<235::AID-MC5>3.0.CO;2-I; Lu QY, 2013, J CHROMATOGR SEP TEC, V4; Maioli E, 2010, CURR DRUG METAB, V11, P425, DOI 10.2174/138920010791526097; Maioli E, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/742936; Man XY, 2013, CELL MOL LIFE SCI, V70, P2205, DOI 10.1007/s00018-012-1255-3; Ota T, 2014, ACTA HISTOCHEM CYTOC, V47, P175, DOI 10.1267/ahc.14027; Pabla N, 2011, J CLIN INVEST, V121, P2709, DOI 10.1172/JCI45586; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Polewska J, 2012, POSTEP HIG MED DOSW, V66, P921, DOI 10.5604/17322693.1021109; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Sarkar K, 2005, IMMUNOLOGY, V116, P513, DOI 10.1111/j.1365-2567.2005.02253.x; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521; Seo MD, 2012, BIOMOL THER, V20, P171, DOI 10.4062/biomolther.2012.20.2.171; Singh BN, 2012, BIOCHEM PHARMACOL, V84, P1154, DOI 10.1016/j.bcp.2012.08.007; Singh TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051752; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Springael C, 2007, BIOCHEM PHARMACOL, V73, P515, DOI 10.1016/j.bcp.2006.10.034; Taniguchi K, 2014, J INVEST DERMATOL, V134, P1295, DOI 10.1038/jid.2013.500; Torricelli C, 2008, LIFE SCI, V82, P638, DOI 10.1016/j.lfs.2007.12.020; Ulvmar MH, 2009, J INVEST DERMATOL, V129, P2584, DOI 10.1038/jid.2009.126; Valacchi G, 2011, CHEM BIOL DRUG DES, V77, P460, DOI 10.1111/j.1747-0285.2011.01121.x; Valacchi G, 2009, EXP DERMATOL, V18, P516, DOI 10.1111/j.1600-0625.2008.00816.x; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wallerstedt E, 2010, DIABETOLOGIA, V53, P946, DOI 10.1007/s00125-010-1668-1; Watt FM, 1989, CURR OPIN CELL BIOL, V1, P1107, DOI 10.1016/S0955-0674(89)80058-4; Xing LZ, 2014, NAT MED, V20, P1043, DOI 10.1038/nm.3645; Yan S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8652; Yang YP, 2013, ACTA PHARMACOL SIN, V34, P625, DOI 10.1038/aps.2013.5; Yang Y, 2014, ASIAN PAC J CANCER P, V15, P5175, DOI 10.7314/APJCP.2014.15.13.5175; Zhao J, 2015, EUR J PHARM; Zhou LL, 2011, EUR J PHARMACOL, V670, P399, DOI 10.1016/j.ejphar.2011.09.014	58	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190051	10.1371/journal.pone.0190051	http://dx.doi.org/10.1371/journal.pone.0190051			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272319	gold, Green Published, Green Submitted			2022-12-26	WOS:000418651500028
J	Goto, R; Miki, T; Nakamura, N; Fujimoto, M; Okada, N				Goto, Ryosuke; Miki, Tsuyoshi; Nakamura, Nao; Fujimoto, Mayuka; Okada, Nobuhiko			Salmonella Typhimurium PagP- and Ugt-Ldependent resistance to antimicrobial peptides contributes to the gut colonization	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; STREPTOMYCIN MOUSE MODEL; LECTIN REGIII-BETA; FUNCTIONAL-ANALYSIS; OUTER-MEMBRANE; VIRULENCE GENE; PHOP; EXPRESSION; TRANSCRIPTION; ACTIVATION	Mucosal barrier formed by cationic antimicrobial peptides (CAMPs) is believed to be crucial for host protection from pathogenic gut infection. However, some pathogens can develop resistance to the CAMPs to survive in hosts. Salmonella enterica is a common cause of acute diarrhea. During the course of this disease, the pathogen must continuously colonize the gut lumen, which contains CAMPs. However, it is incompletely understood whether the resistance of Salmonella strains to CAMPs contributes to the development of gut infections. PhoPQ two-component system-dependent lipid A modifications confer resistance to CAMPs in S. enterica serovar Typhimurium. Therefore, we introduced mutations into the PhoPQ-regulated genes in an S. Typhimurium strain, obtaining pagP ugtL and pmrA mutant strains. Each mutant strain demonstrated a distinct spectrum of the resistance to CAMPs. Using streptomycin mouse model for Salmonella diarrhea, we show that the pagP ugtL, but not pmrA, mutant strain had a gut colonization defect. Furthermore, the pagP ugtL, but not pmrA, mutant strain had decreased outer membrane integrity and susceptibility to magainin 2, an alpha-helical CAMP. Taken together, the PagP-and UgtL-dependent resistance to CAMPs was demonstrated to contribute to sustained colonization in the gut. This may be due to the robust outer membrane of S. Typhimurium, inducing the resistance to alpha-helical CAMPs such as a-defensins. Our findings indicate that the development of resistance to CAMPs is required for the S. Typhimurium gut infection.	[Goto, Ryosuke; Miki, Tsuyoshi; Nakamura, Nao; Fujimoto, Mayuka; Okada, Nobuhiko] Kitasato Univ, Sch Pharm, Dept Microbiol, Tokyo, Japan	Kitasato University	Miki, T (corresponding author), Kitasato Univ, Sch Pharm, Dept Microbiol, Tokyo, Japan.	mikit@pharm.kitasato-u.ac.jp			Japan society for the promotion of science (JSPS) KAKENHI [JP16K08783]; Grants-in-Aid for Scientific Research [16K08783] Funding Source: KAKEN	Japan society for the promotion of science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan society for the promotion of science (JSPS) KAKENHI (http://www.jsps.go.jp/english/e-grants/index.html), Grant Number JP16K08783. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	ARANDA CMA, 1992, P NATL ACAD SCI USA, V89, P10079, DOI 10.1073/pnas.89.21.10079; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Brodsky IE, 2005, MOL MICROBIOL, V55, P954, DOI 10.1111/j.1365-2958.2004.04444.x; Choi J, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan6284; Choi J, 2016, MOL MICROBIOL, V101, P1024, DOI 10.1111/mmi.13439; Dalebroux ZD, 2014, CURR OPIN MICROBIOL, V17, P106, DOI 10.1016/j.mib.2013.12.005; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Garcia V, 1996, CELL, V84, P165, DOI [DOI 10.1016/S0092-8674(00)81003-X, 10.1016/S0092-8674(00)81003-X]; GROISMAN EA, 1989, P NATL ACAD SCI USA, V86, P7077, DOI 10.1073/pnas.86.18.7077; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matamouros S, 2015, BBA-BIOMEMBRANES, V1848, P3021, DOI 10.1016/j.bbamem.2015.01.013; Merighi M, 2005, J BACTERIOL, V187, P7407, DOI 10.1128/JB.187.21.7407-7416.2005; Miki T, 2017, CELL HOST MICROBE, V21, P195, DOI 10.1016/j.chom.2016.12.008; Miki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069901; Miki T, 2012, J BIOL CHEM, V287, P34844, DOI 10.1074/jbc.M112.399998; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Murata T, 2007, J BACTERIOL, V189, P7213, DOI 10.1128/JB.00973-07; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Richards SM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00102; ROLAND KL, 1993, J BACTERIOL, V175, P4154, DOI 10.1128/JB.175.13.4154-4164.1993; Rosenberger CM, 2004, P NATL ACAD SCI USA, V101, P2422, DOI 10.1073/pnas.0304455101; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Shi YX, 2004, MOL MICROBIOL, V53, P229, DOI 10.1111/j.1365-2958.2004.04107.x; Strandberg KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049588; Strandberg KL, 2012, INFECT IMMUN, V80, P3930, DOI 10.1128/IAI.00672-12; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Woo H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001603; Wotzka SY, 2017, CELL HOST MICROBE, V21, P443, DOI 10.1016/j.chom.2017.03.009; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200	38	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190095	10.1371/journal.pone.0190095	http://dx.doi.org/10.1371/journal.pone.0190095			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267354	gold, Green Published, Green Submitted			2022-12-26	WOS:000418587400091
J	Westbrook, RM; Yang, HL; Langdon, JM; Roy, CN; Kim, JA; Choudhury, PP; Xue, QL; di Francesco, A; de Cabo, R; Walston, J				Westbrook, Reyhan M.; Yang, Huan Le; Langdon, Jackie M.; Roy, Cindy N.; Kim, Jin A.; Choudhury, Parichoy P.; Xue, Qian-Li; di Francesco, Andrea; de Cabo, Rafa; Walston, Jeremy			Aged interleukin-10(tm1Cgn) chronically inflamed mice have substantially reduced fat mass, metabolic rate, and adipokines	PLOS ONE			English	Article							FRAIL MOUSE MODEL; CHRONIC INFLAMMATION; INSULIN SENSITIVITY; ENERGY-EXPENDITURE; WHITE ADIPOSE; OLDER-ADULTS; ADIPONECTIN; ALPHA-1-ANTITRYPSIN; PERFORMANCE; DYSFUNCTION	Interleukin 10(tm1Cgn) (IL 10(tm)) mice have been utilized as a model of chronic inflammation and declining health span because of their propensity to develop chronic activation in NFkB pathways, skeletal muscle and cardiac changes, and mitochondrial dysfunction. We hypothesized that older IL 10(tm) frail mice would have alterations similar to frail, older humans in measured parameters of glucose metabolism, oxygen consumption (VO2), respiratory quotient (RQ), spontaneous locomotor activity, body composition and plasma adipokine levels. To test this hypothesis, we investigated these metabolic parameters in cohorts of 3, 10, and 20 month old IL 10(tm) female mice and age and gender matched C57Bl/6 mice. Insulin sensitivity, glucose homeostasis, locomotor activity and RQ were not significantly altered between the two strains of mice. Interestingly, old IL 10(tm) mice had significantly decreased VO2 when normalized by lean mass, but not when normalized by fat mass or the lean/fat mass ratio. NMR based body composition analysis and dissection weights show that fat mass is decreased with age in IL 10(tm) mice compared to controls. Further, plasma adiponectin and leptin were also decreased in IL 10(tm). These findings suggest that frailty observed in this mouse model of chronic inflammation may in part be driven by alterations in fat mass, hormone secretion and energy metabolism.	[Westbrook, Reyhan M.; Yang, Huan Le; Langdon, Jackie M.; Roy, Cindy N.; Kim, Jin A.; Xue, Qian-Li; Walston, Jeremy] Johns Hopkins Univ, Sch Med, Div Geriatr Med & Gerontol, Baltimore, MD 21218 USA; [Choudhury, Parichoy P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [di Francesco, Andrea; de Cabo, Rafa] NIA, Expt Gerontol Sect, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Westbrook, RM (corresponding author), Johns Hopkins Univ, Sch Med, Div Geriatr Med & Gerontol, Baltimore, MD 21218 USA.	reyhan@jhmi.edu	XUE, QIANLI/AAE-2030-2021	XUE, QIAN-LI/0000-0001-8818-7444	Glenn/AFAR Postdoctoral Fellowship; OAIC [P-30AG021334]; NATIONAL INSTITUTE ON AGING [ZIAAG000363] Funding Source: NIH RePORTER	Glenn/AFAR Postdoctoral Fellowship; OAIC; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Glenn/AFAR Postdoctoral Fellowship for Translational Research on Aging grant (PI Westbrook), and the OAIC P-30AG021334 Johns Hopkins Older American Independence Center, Research Supplement to Promote Diversity in Health-Related Research Program (PI Walston).	Abizanda P, 2015, J GERONTOL A; Akki A, 2014, AGE, V36, P21, DOI 10.1007/s11357-013-9540-0; Bandeen-Roche K, 2015, J GERONTOL A-BIOL, V70, P1427, DOI 10.1093/gerona/glv133; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Burks TN, 2015, ONCOTARGET, V6, P11979, DOI 10.18632/oncotarget.3979; Conde J, 2011, BIOFACTORS, V37, P413, DOI 10.1002/biof.185; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; den Boer MAM, 2006, ENDOCRINOLOGY, V147, P4553, DOI 10.1210/en.2006-0417; Dresner-Pollak R, 2004, GASTROENTEROLOGY, V127, P792, DOI 10.1053/j.gastro.2004.06.013; Fitch KV, 2009, METABOLISM, V58, P608, DOI 10.1016/j.metabol.2008.12.005; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Itoh Y, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0036-8; Jonigk D, 2013, P NATL ACAD SCI USA, V110, P15007, DOI 10.1073/pnas.1309648110; Kalyani RR, 2012, J GERONTOL A-BIOL, V67, P1300, DOI 10.1093/gerona/glr141; Khodabandehloo H, 2015, TRANSL RES; Ko F, 2012, AGE, V34, P705, DOI 10.1007/s11357-011-9269-6; Kowalski GM, 2011, DIABETOLOGIA, V54, P888, DOI 10.1007/s00125-010-2020-5; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Leng S, 2002, J AM GERIATR SOC, V50, P1268, DOI 10.1046/j.1532-5415.2002.50315.x; Luhrmann PM, 2001, METABOLISM, V50, P972, DOI 10.1053/meta.2001.24871; Mansuy-Aubert V, 2013, CELL METAB, V17, P534, DOI 10.1016/j.cmet.2013.03.005; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Park MH, 2014, ARCH PHARM RES, V37, P1507, DOI 10.1007/s12272-014-0474-6; Pini M, 2009, AM J PHYSIOL-GASTR L, V296, pG382, DOI 10.1152/ajpgi.90593.2008; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; RENNICK D, 1995, CLIN IMMUNOL IMMUNOP, V76, pS174, DOI 10.1016/S0090-1229(95)90144-2; Schalk BWM, 2004, AGE AGEING, V33, P266, DOI 10.1093/ageing/afh073; Sikka G, 2013, EXP GERONTOL, V48, P128, DOI 10.1016/j.exger.2012.11.001; Sujino Y, 2015, J CARDIOL, V66, P263, DOI 10.1016/j.jjcc.2014.12.001; Tawara I, 2012, P NATL ACAD SCI USA, V109, P564, DOI 10.1073/pnas.1117665109; Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333; Walston J, 2008, J GERONTOL A-BIOL, V63, P391, DOI 10.1093/gerona/63.4.391; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723	40	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0186811	10.1371/journal.pone.0186811	http://dx.doi.org/10.1371/journal.pone.0186811			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267271	Green Published, gold, Green Submitted			2022-12-26	WOS:000418587400002
J	Bennis, I; Belaid, L; De Brouwere, V; Filali, H; Sahibi, H; Boelaert, M				Bennis, Issam; Belaid, Loubna; De Brouwere, Vincent; Filali, Hind; Sahibi, Hamid; Boelaert, Marleen			"The mosquitoes that destroy your face". Social impact of Cutaneous Leishmaniasis in South-eastern Morocco, A qualitative study	PLOS ONE			English	Article							KNOWLEDGE; ATTITUDES	Objective To document the psychosocial burden of Cutaneous Leishmaniasis (CL) in rural communities in Southeastern Morocco. Method Between March and April 2015, we conducted qualitative research in communities exposed to Leishmania major or L. tropica in Errachidia and Tinghir provinces. Twenty-eight focus groups discussions (FGDs) were realized, with a stratification by gender and tradition of medicine (users of folk versus professional medicine). Data were analyzed using content analysis. Results This rural population most exposed to CL in Morocco lacks access to health care in general and clearly points out there are other major public health issues that need to be resolved. Nonetheless, respondents consider the impact of CL lesions and scars as important and similar to that of burn scar tissue. Young women with CL scars in the face are stigmatized and will often be rejected for marriage in these communities. People usually try a long list of folk remedies on the active lesions, but none was felt adequate. There was a clear demand for better treatment as well as for treatment of the scars. Conclusions The psycho-social impact of CL due to L. major and L. tropica is substantial, especially for young single women with facial scars. These generate social and self-stigma and diminish their marriage prospects. CL is well known, but not considered as a major health priority by these poor rural communities in South-eastern Morocco where gender discrimination is still an issue and access to basic health care is as neglected as CL. Early CL diagnosis and new treatment options with better skin outcomes are urgently needed.	[Bennis, Issam; Filali, Hind] Natl Sch Publ Hlth, Minist Hlth, Rabat, Morocco; [Bennis, Issam; De Brouwere, Vincent; Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Bennis, Issam] Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, Dept Biomed Sci, Antwerp, Belgium; [Belaid, Loubna] Univ Montreal, Ecole Sante Publ, CRCHUM, Montreal, PQ, Canada; [Sahibi, Hamid] Agron & Vet Inst Hassan II, Rabat, Morocco	Institute of Tropical Medicine (ITM); University of Antwerp; Universite de Montreal	Boelaert, M (corresponding author), Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium.	mboelaert@itg.be	Boelaert, Marleen/E-2698-2012; Bennis, Issam/P-6269-2019	Boelaert, Marleen/0000-0001-8051-6776; Bennis, Issam/0000-0002-3553-5430	Belgian Directorate General for Development Cooperation	Belgian Directorate General for Development Cooperation	The financial support of the Belgian Directorate General for Development Cooperation for this research is acknowledged. The funding organization had no role in the design and conduct of the study; collection, management, analysis and interpretation of data; preparation, review or approval of the manuscript; nor the decision to submit for publication.	Abazid N., 2012, Eastern Mediterranean Health Journal, V18, P7; Akram A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130929; Al-Kamel MA, 2016, INT J WOMENS DERMATO; Arana BA, 2000, ANN TROP MED PARASIT, V94, P779, DOI 10.1080/0003490020012416; Asmae H, 2014, ACTA TROP, V130, P94, DOI 10.1016/j.actatropica.2013.10.012; Awosan KJ, 2013, GLOBAL ADV RES J MED, V2, P256; Bailey MS, 2007, CLIN DERMATOL, V25, P203, DOI 10.1016/j.clindermatol.2006.05.008; Bennis I, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0267-5; Bennis I, 2015, TROP MED INT HEALTH, V20, P1297, DOI 10.1111/tmi.12543; Brown BC, 2008, J PLAST RECONSTR AES, V61, P1049, DOI 10.1016/j.bjps.2008.03.020; Costa J M, 1987, Rev Soc Bras Med Trop, V20, P77, DOI 10.1590/S0037-86821987000200003; Hejazi S. H., 2010, Infectious Diseases: Research and Treatment, V3, P35; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kahime K, 2016, J ACUTE DIS, V5, P41, DOI 10.1016/j.joad.2015.08.004; Kebede N, 2016, ASIAN PACIFIC J TROP; Lewis S, 2015, HEALTH PROMOT PRACT, V16, P473, DOI 10.1177/1524839915580941; Mohamed Mahmoud el A, 2016, BIOMED RES INT, V2016; Nandha B, 2014, CUTANEOUS LEISHMANIA; Ramdas S, 2016, SOC SCI MED, V151, P139, DOI 10.1016/j.socscimed.2015.12.044; Reithinger R, 2005, EMERG INFECT DIS, V11, P634, DOI 10.3201/eid1104.040945; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Rhajaoui M, 2007, EMERG INFECT DIS, V13, P1358, DOI 10.3201/eid1309.060946; Riyad M, 2013, E MEDITERR HEALTH J, V19, P495, DOI 10.26719/2013.19.5.495; Ruoti M, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/538629; Saberi S, 2012, VECTOR-BORNE ZOONOT, V12, P306, DOI 10.1089/vbz.2010.0259; Sadeq M, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0135-8; Sarkari Bahador, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P566, DOI 10.12980/APJTB.4.2014C744; Vahabi A, 2013, LIFE SCI J, V10; VAZQUEZ M L, 1991, Boletin de la Oficina Sanitaria Panamericana, V110, P402; Weigel M M, 1994, Bull Pan Am Health Organ, V28, P142; World Health Organization, 2014, MAN CAS MAN CUT LEIS	31	27	28	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189906	10.1371/journal.pone.0189906	http://dx.doi.org/10.1371/journal.pone.0189906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261762	Green Published, gold			2022-12-26	WOS:000418564200074
J	Noll, F; Behnke, J; Leiting, S; Troidl, K; Alves, GT; Muller-Redetzky, H; Preissner, KT; Fischer, S				Noll, Frederik; Behnke, Jonas; Leiting, Silke; Troidl, Kerstin; Alves, Gustavo Teixeira; Mueller-Redetzky, Holger; Preissner, Klaus T.; Fischer, Silvia			Self-extracellular RNA acts in synergy with exogenous danger signals to promote inflammation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CELL-FREE DNA; NUCLEIC-ACIDS; RECOGNITION; BINDING; RECEPTORS; RESPONSES; HISTONES; LIGANDS	Self-extracellular RNA (eRNA), released from stressed or injured cells upon various pathological situations such as ischemia-reperfusion-injury, has been shown to act as an alarmin by inducing procoagulatory and proinflammatory responses. In particular, M1-polarization of macrophages by eRNA resulted in the expression and release of a variety of cytokines, including tumor necrosis factor (TNF)-alpha or interleukin-6 (IL-6). The present study now investigates in which way self-eRNA may influence the response of macrophages towards various Toll-like receptor (TLR)-agonists. Isolated agonists of TLR2 (Pam2CSK4), TLR3 (PolyIC), TLR4 (LPS), or TLR7 (R848) induced the release of TNF-alpha in a concentration-dependent manner in murine macrophages, differentiated from bone marrow-derived stem cells by mouse colony stimulating factor. Here, the presence of eRNA shifted the dose-response curve for Pam2CSK4 (Pam) considerably to the left, indicating that eRNA synergistically enhanced the cytokine liberation from macrophages even at very low Pam-levels. The synergistic activation of TLR2 by eRNA/Pam was duplicated by other TLR2-agonists such as FSL-1 or Pam3CSK4. In contrast, for TLR4-agonists such as LPS a synergistic effect of eRNA was much weaker, and was not existent for TLR3-, or TLR7-agonists. The synergistic eRNA/Pam action was dependent on the NF kappa B-signaling pathway as well as on p38MAP-and MEK1/ERK-kinases and was prevented by predigestion of eRNA with RNase1 or by antibodies against TLR2. Thus, the presence of self-eRNA as alarming molecule sensitizes innate immune responses towards pathogen-associated molecular patterns (PAMPs) in a synergistic way and may thereby contribute to the differentiated outcome of inflammatory responses.	[Noll, Frederik; Behnke, Jonas; Leiting, Silke; Preissner, Klaus T.; Fischer, Silvia] Justus Liebig Univ, Med Sch, Inst Biochem, Giessen, Germany; [Troidl, Kerstin] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Troidl, Kerstin] Univ Hosp Frankfurt, Dept Vasc & Endovasc Surg, Frankfurt, Germany; [Alves, Gustavo Teixeira; Mueller-Redetzky, Holger] Charite Univ Med Berlin, Dept Infect Dis & Pulm Med, Berlin, Germany	Justus Liebig University Giessen; Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Fischer, S (corresponding author), Justus Liebig Univ, Med Sch, Inst Biochem, Giessen, Germany.	silvia.fischer@biochemie.med.uni-giessen.de	Fischer, Silvia/ABG-3104-2021		German Research Foundation (DFG, Bonn, Germany) [SFB TR84, FI 543/4-1]; Excellence Cluster-Cardiopulmonary System (ECCPS, Giessen, Germany); Behring-Rontgen Foundation (Marburg, Germany) [61-0040]; LOEWE Network "Medical RNomics" (Wiesbaden, Germany); German Academic Scholarship Foundation; Pregraduate College of the Medical Faculty of the Justus-Liebig-University Giessen	German Research Foundation (DFG, Bonn, Germany)(German Research Foundation (DFG)); Excellence Cluster-Cardiopulmonary System (ECCPS, Giessen, Germany); Behring-Rontgen Foundation (Marburg, Germany); LOEWE Network "Medical RNomics" (Wiesbaden, Germany); German Academic Scholarship Foundation; Pregraduate College of the Medical Faculty of the Justus-Liebig-University Giessen	Studies were generously supported by grants to K.T. Preissner, S. Fischer, and H. Muller-Redetzky from the German Research Foundation (DFG, Bonn, Germany, http://www.dfg.de), including SFB TR84 (SF and HM-R), FI 543/4-1 (SF), the Excellence Cluster-Cardiopulmonary System (KTP, ECCPS, Giessen, Germany, http://eccps.de), by the Behring-Rontgen Foundation (SF, Marburg, Germany, 61-0040), the LOEWE Network "Medical RNomics" (KTP, Wiesbaden, Germany), and a stipend awarded to F. Noll by the German Academic Scholarship Foundation and the Pregraduate College of the Medical Faculty of the Justus-Liebig-University Giessen.	Bertheloot D, 2016, J IMMUNOL, V197, P4118, DOI 10.4049/jimmunol.1502169; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Cabrera-Fuentes HA, 2015, THROMB HAEMOSTASIS, V113, P473, DOI 10.1160/TH14-06-0507; Cabrera-Fuentes HA, 2014, THROMB HAEMOSTASIS, V112, P1110, DOI 10.1160/TH14-08-0703; Chen C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000683; Chillo O, 2016, CELL REP, V16, P2197, DOI 10.1016/j.celrep.2016.07.040; Feng Y, 2015, J BIOL CHEM, V290, P26688, DOI 10.1074/jbc.M115.661835; Fischer S, 2007, BLOOD, V110, P2457, DOI 10.1182/blood-2006-08-040691; Fischer S, 2014, CELL TISSUE RES, V355, P635, DOI 10.1007/s00441-014-1850-8; Fischer S, 2013, CANCER RES, V73, P5080, DOI 10.1158/0008-5472.CAN-12-4657; Fischer S, 2012, THROMB HAEMOSTASIS, V108, P730, DOI 10.1160/TH12-03-0186; Fuchs TA, 2011, BLOOD, V118, P3708, DOI 10.1182/blood-2011-01-332676; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Jaax ME, 2013, BLOOD, V122, P272, DOI 10.1182/blood-2013-01-478966; Jimenez-Alcazar M, SEMIN THROMB HEMOST; Kleinert E, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003429; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Kumagai Yutaro, 2008, Journal of Infection and Chemotherapy, V14, P86, DOI 10.1007/s10156-008-0596-1; Leifer CA, 2016, J LEUKOCYTE BIOL, V100, P927, DOI 10.1189/jlb.2MR0316-117RR; Marek LR, 2011, FRONT BIOSCI-LANDMRK, V16, P2060, DOI 10.2741/3839; Marsman G, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.410; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Ohashi A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174237; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Roers A, 2016, IMMUNITY, V44, P739, DOI 10.1016/j.immuni.2016.04.002; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Siljan WW, 2016, J INFECTION, V73, P383, DOI 10.1016/j.jinf.2016.07.011; Srikrishna G, 2009, NEOPLASIA, V11, P615, DOI 10.1593/neo.09284; Stieger P, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004541; Tsan MF, 2007, J ENDOTOXIN RES, V13, P6, DOI 10.1177/0968051907078604; Venereau E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00422; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; Zernecke A, 2016, CIRC RES, V118, P469, DOI 10.1161/CIRCRESAHA.115.307961; Zimmermann-Geller B, 2016, J IMMUNOL, V197, P2589, DOI 10.4049/jimmunol.1501580	42	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0190002	10.1371/journal.pone.0190002	http://dx.doi.org/10.1371/journal.pone.0190002			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261777	Green Published, gold, Green Submitted			2022-12-26	WOS:000418564200081
J	Dittmer, KE; Jolly, RD; Mayhew, IG; Ridler, AL; Chernyavtseva, A; Garrick, J; Blair, HT				Dittmer, K. E.; Jolly, R. D.; Mayhew, I. G.; Ridler, A. L.; Chernyavtseva, A.; Garrick, J.; Blair, H. T.			Familial episodic ataxia in lambs is potentially associated with a mutation in the fibroblast growth factor 14 (FGF14) gene	PLOS ONE			English	Article							FACTOR HOMOLOGOUS FACTORS; NONSENSE-MEDIATED DECAY; GROWTH-FACTOR 14; SPINOCEREBELLAR ATAXIA; NEURONAL EXCITABILITY; FRAMESHIFT MUTATION; POLYMORPHISMS; DYSKINESIA; PHENOTYPE; DISRUPTS	Familial episodic ataxia of lambs is a congenital transient autosomal dominant disorder of newborn lambs, with varying expressivity. Affected lambs show episodes of an asymmetric ataxic gait, base-wide extensor hypertonia of the thoracic limbs and flexor hypertonia of the pelvic limbs. The aim of the study was to determine the genetic variant causing familial episodic ataxia in lambs. Using whole genome sequencing of two half-sib affected lambs, their sire, and their two normal dams, a heterozygous C>T transition at OAR10: 77593415 (Oar_v3.1) in exon 1 of the fibroblast growth factor 14 (FGF14) gene (c. 46C>T) was identified. The c. 46C>T transition resulted in a premature stop codon at position 16 of the 247 amino acid FGF14 protein (p. Q16*). PCR and Sanger sequencing was used to genotype an additional 20 clinically affected animals, demonstrating all lambs carried the c. 46C>T variant but 1 clinically more severely affected inbred lamb was homozygous (TT). A further 11 unrelated normal ewes were positionally sequenced, none of which had the variant, while in 18 lambs of unknown status born over 2 years of breeding trials six lambs were found to have the c. 46C>T variant, likely clinically unidentified heterozygotes due to the variable expressivity, while 12 did not. In conclusion, familial episodic ataxia of lambs is potentially associated with a c. 46C>T variant in the FGF14 gene. Further research is required into the mechanism behind the apparent recovery of lambs.	[Dittmer, K. E.; Jolly, R. D.; Mayhew, I. G.; Ridler, A. L.; Chernyavtseva, A.; Garrick, J.; Blair, H. T.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Garrick, J.] Iowa State Univ, Dept Anim Sci, Ames, IA USA	Massey University; Iowa State University	Dittmer, KE (corresponding author), Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand.	K.E.Dittmer@massey.ac.nz	Blair, Hugh/C-5569-2014; Dittmer, Keren/AAR-3148-2021	Blair, Hugh/0000-0003-4415-4282; Dittmer, Keren/0000-0002-1813-2197				Agler C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003991; Chen Z, 2012, NEUROSCI LETT, V520, P16, DOI 10.1016/j.neulet.2012.05.008; Choquet K, 2015, NEUROGENETICS, V16, P233, DOI 10.1007/s10048-014-0436-7; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Coebergh JA, 2014, EUR J PAEDIATR NEURO, V18, P413, DOI 10.1016/j.ejpn.2013.10.006; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dalski A, 2005, EUR J HUM GENET, V13, P118, DOI 10.1038/sj.ejhg.5201286; Forman OP, 2015, MAMM GENOME, V26, P108, DOI 10.1007/s00335-014-9547-6; Goldfarb M, 2007, NEURON, V55, P449, DOI 10.1016/j.neuron.2007.07.006; Hug N, 2016, NUCLEIC ACIDS RES, V44, P1483, DOI 10.1093/nar/gkw010; Jayadev S, 2013, GENET MED, V15, P673, DOI 10.1038/gim.2013.28; Kleiter M, 2011, J VET INTERN MED, V25, P490, DOI 10.1111/j.1939-1676.2011.0720.x; Kyostila K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002759; Laezza F, 2007, J NEUROSCI, V27, P12033, DOI 10.1523/JNEUROSCI.2282-07.2007; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mayhew IG, 2013, NEW ZEAL VET J, V61, P107, DOI 10.1080/00480169.2012.717501; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller JN, 2014, MUTAT RES-REV MUTAT, V762, P52, DOI 10.1016/j.mrrev.2014.05.001; Misceo D, 2009, NEUROGENETICS, V10, P371, DOI 10.1007/s10048-009-0197-x; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Rohdin C, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0115-1; Schoorlemmer J, 2001, CURR BIOL, V11, P793, DOI 10.1016/S0960-9822(01)00232-9; Shakkottai VG, 2009, NEUROBIOL DIS, V33, P81, DOI 10.1016/j.nbd.2008.09.019; Shimojima K, 2012, BRAIN DEV-JPN, V34, P230, DOI 10.1016/j.braindev.2011.04.014; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; Tempia F, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00205; Tucker ME, 2013, J GENET SYNDR GENE T, V4, P1; van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488; Wang Q, 2000, MECH DEVELOP, V90, P283, DOI 10.1016/S0925-4773(99)00241-5; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; Xiao ML, 2007, MOL CELL NEUROSCI, V34, P366, DOI 10.1016/j.mcn.2006.11.020; Yan HD, 2014, ELIFE, V3, DOI 10.7554/eLife.04193; Zeng R, 2011, J VET INTERN MED, V25, P267, DOI 10.1111/j.1939-1676.2010.0666.x	35	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0190030	10.1371/journal.pone.0190030	http://dx.doi.org/10.1371/journal.pone.0190030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253853	Green Published, gold, Green Submitted			2022-12-26	WOS:000418389500086
J	Lang, JC; De Sterck, H; Abrams, DM				Lang, John C.; De Sterck, Hans; Abrams, Daniel M.			The statistical mechanics of human weight change	PLOS ONE			English	Article							BODY-MASS INDEX; OBESITY EPIDEMIC; SOCIAL NETWORKS; UNITED-STATES; SPREAD; BMI	Over the past 35 years there has been a near doubling in the worldwide prevalence of obesity. Body Mass Index (BMI) distributions in high-income societies have increasingly shifted rightwards, corresponding to increases in average BMI that are due to well-studied changes in the socioeconomic environment. However, in addition to this shift, BMI distributions have also shown marked changes in their particular shape over time, exhibiting an ongoing right-skewed broadening that is not well understood. Here, we compile and analyze the largest data set so far of year-over-year BMI changes. The data confirm that, on average, heavy individuals become lighter while light individuals become heavier year-over-year, and also show that year-over-year BMI evolution is characterized by fluctuations with a magnitude that is linearly proportional to BMI. We find that the distribution of human BMIs is intrinsically dynamic-due to the short-term variability of human weight-and its shape is determined by a balance between deterministic drift towards a natural set point and diffusion resulting from random fluctuations in, e.g., diet and physical activity. We formulate a stochastic mathematical model for BMI dynamics, deriving a theoretical shape for the BMI distribution and offering a mechanism that may explain the right-skewed broadening of BMI distributions over time. An extension of the base model investigates the hypothesis that peer-to-peer social influence plays a role in BMI dynamics. While including this effect improves the fit with the data, indicating that correlations in the behavior of individuals with similar BMI may be important for BMI dynamics, testing social transmission against other plausible unmodeled effects and interpretations remains the subject of future work. Implications of our findings on the dynamics of BMI distributions for public health interventions are discussed.	[Lang, John C.] Univ Calif Los Angeles, Dept Commun Studies, Los Angeles, CA 90095 USA; [De Sterck, Hans] Monash Univ, Sch Math Sci, Clayton, Vic, Australia; [Abrams, Daniel M.] Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA; [Abrams, Daniel M.] Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL USA	University of California System; University of California Los Angeles; Monash University; Northwestern University; Northwestern University	Lang, JC (corresponding author), Univ Calif Los Angeles, Dept Commun Studies, Los Angeles, CA 90095 USA.	jclang@ucla.edu	Abrams, Daniel M/H-5532-2012	De Sterck, Hans/0000-0002-1641-932X; Abrams, Daniel/0000-0002-6015-8358	James S. McDonnell Foundation (JSMF) [22002023]	James S. McDonnell Foundation (JSMF)	This work was supported by James S. McDonnell Foundation (JSMF - https://www.jsmf.org): award no. 22002023, awarded to Daniel M. Abrams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andreyeva T, 2004, OBES RES, V12, P1936, DOI 10.1038/oby.2004.243; [Anonymous], 2004, HDB STOCHASTIC METHO; Bahr DB, 2009, OBESITY, V17, P723, DOI 10.1038/oby.2008.615; Blanchflower DG, 2009, J EUR ECON ASSOC, V7, P528, DOI 10.1162/JEEA.2009.7.2-3.528; BROWNELL KD, 1994, ARCH INTERN MED, V154, P1325, DOI 10.1001/archinte.154.12.1325; Burke MA, 2010, OBESITY, V18, P1226, DOI 10.1038/oby.2009.369; Butland B, 2007, FORESIGHT TACKLING O; Centers for Disease Control and Prevention, 2015, BEH RISK FACT SURV S; Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), 2015, NAT HLTH NUTR SURV D; Centola D, 2011, SCIENCE, V334, P1269, DOI 10.1126/science.1207055; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Ejima K, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-17; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2000, INT J OBESITY, V24, P807, DOI 10.1038/sj.ijo.0801232; Gonzalez-Parra G, 2010, PHYSICA A, V389, P3692, DOI 10.1016/j.physa.2010.04.024; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Keesey RE, 1997, J NUTR, V127, pS1875, DOI 10.1093/jn/127.9.1875S; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Krishna A, 2015, AM J CLIN NUTR, V101, P598, DOI 10.3945/ajcn.114.100073; Lang JC, 2017, DATA STAT MECH HUMAN; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Nettle D, 2017, BEHAV BRAIN SCI, P40; Nettle D, 2017, BEHAV BRAIN SCI, V40, DOI 10.1017/S0140525X16000947; Penman Alan D, 2006, Prev Chronic Dis, V3, pA74; Poncela-Casasnovas J, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0686; Razak F, 2015, AM J CLIN NUTR, V101, P1308, DOI 10.3945/ajcn.115.108050; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Rosenquist JN, 2015, P NATL ACAD SCI USA, V112, P354, DOI 10.1073/pnas.1411893111; Shreve S.E., 2004, STOCHASTIC CALCULUS, V11; Smith TG, 2017, 10954 IZA; Speakman JR, 2011, DIS MODEL MECH, V4, P733, DOI 10.1242/dmm.008698; Swinburn B, 2004, BMJ-BRIT MED J, V329, P736, DOI 10.1136/bmj.329.7468.736; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Tyrrell J, 2017, INT J EPIDEMIOL, V46, P559, DOI 10.1093/ije/dyw337; Valente TW, 2009, J ADOLESCENT HEALTH, V45, P202, DOI 10.1016/j.jadohealth.2009.01.007; Villanueva RJ, 2008, J APPL MATH, DOI 10.1155/2008/640154; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Zulman DM, 2008, MILBANK Q, V86, P557, DOI 10.1111/j.1468-0009.2008.00534.x	45	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189795	10.1371/journal.pone.0189795	http://dx.doi.org/10.1371/journal.pone.0189795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ5HM	29253025	gold, Green Published, Green Submitted			2022-12-26	WOS:000418389500059
J	Castelblanco, M; Lugrin, J; Ehirchiou, D; Nasi, S; Ishii, I; So, A; Martinon, F; Busso, N				Castelblanco, Mariela; Lugrin, Jerome; Ehirchiou, Driss; Nasi, Sonia; Ishii, Isao; So, Alexander; Martinon, Fabio; Busso, Nathalie			Hydrogen sulfide inhibits NLRP3 inflammasome activation and reduces cytokine production both in vitro and in a mouse model of inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE GAMMA-LYASE; MONOSODIUM URATE CRYSTALS; ACID PHENETHYL ESTER; INDUCED CELL-DEATH; NRF2 ACTIVATION; INJURY; GOUT; MACROPHAGES; INDUCTION; MECHANISM	A variety of stimuli, including monosodium urate (MSU) crystals, activate the NLRP3 inflammasome, and this activation involves several molecular mechanisms including xanthine oxidase (XO) up-regulation and mitochondrial dysfunction. Upon oligomerization of apoptosis-associated speck-like protein containing a CARD(ASC), caspase-1 becomes active and cleaves the proinflammatory cytokine IL-1 beta into its active secreted form. Hydrogen sulfide (H2S), a gasotransmitter mainly produced by cystathionine gamma-lyase (CSE) in macrophages, could modulate inflammation. Here, we sought to investigate the effects of exogenous and endogenous H2S on NLRP3 inflammasome activation in vitro and in vivo. Primed bone marrow-derived macrophages (BMDM) isolated from wildtype (wt) or CSE-deficient mice and human macrophages (THP1 cells and primary macrophages), were stimulated with MSU crystals in the presence or absence of a H2S donor, sodium thiosulfate (STS) or GYY4137 (GYY). In murine and human macrophages in vitro, both STS and GYY inhibited MSU crystal-induced IL-1 beta secretionin a dose-dependent manner. Moreover, the H2S donors inhibited MSU crystal-induced XO/caspase-1 activities, mitochondrial reactive oxygen species (ROS) generation, and ASC oligomerization. Accordingly, IL-1 beta secretion and XO/caspase-1 activities were higher in CSE-deficient BMDMs than in wt BMDMs. For in vivo studies, we experimentally induced peritonitis by intraperitoneal injection of MSU crystals into mice. GYY pretreatment ameliorated inflammation, evidenced by decreased IL-6/monocyte chemoattractant protein-1 (MCP-1) released into peritoneal lavages. Taken together, our results suggest that both exogenous (via H2S donors) and endogenous (via CSE) H2S production may represent approaches for managing, for example, acute gout or other inflammation conditions	[Castelblanco, Mariela; Nasi, Sonia; So, Alexander; Busso, Nathalie] Univ Lausanne, Serv Rheumatol, DAL, Lausanne Univ Hosp CHUV, CH-1551066 Epalinges, Switzerland; [Lugrin, Jerome; Ehirchiou, Driss; Martinon, Fabio] Univ Lausanne, Dept Biochem, CH-1551066 Epalinges, Switzerland; [Ishii, Isao] Showa Pharmaceut Univ, Tokyo 1948543, Japan	University of Lausanne; University of Lausanne; Showa Pharmaceutical University	Busso, N (corresponding author), Ctr Labs Epalinges, Lab Rheumatol, CLE D04-404 Chemin Boveresses, CH-1551066 Epalinges, Switzerland.	Nathalie.Busso@chuv.ch	Martinon, Fabio/A-5575-2009; Lugrin, Jérôme/N-8772-2019	Martinon, Fabio/0000-0002-6969-822X; Lugrin, Jérôme/0000-0002-1178-2752; Ishii, Isao/0000-0002-5367-205X; Nasi, Sonia/0000-0002-6625-8309	Swiss National Science Foundation [FN 310030_173134]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant FN 310030_173134. The authors declare that they have no conflicts of interest with the contents of this article.	Abais JM, 2015, ANTIOXID REDOX SIGN, V22, P1111, DOI 10.1089/ars.2014.5994; Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Bhatia M, 2005, FASEB J, V19, P623, DOI 10.1096/fj.04-3023fje; Bian JS, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6549625; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; Cullen SP, 2015, CELL REP, V11, P1535, DOI 10.1016/j.celrep.2015.05.003; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Gong ZZ, 2015, MOL NUTR FOOD RES, V59, P2132, DOI 10.1002/mnfr.201500316; Greaney AJ, 2016, J LEUKOCYTE BIOL, V99, P189, DOI 10.1189/jlb.3A0415-155RR; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Hille R, 2011, COORDIN CHEM REV, V255, P1179, DOI 10.1016/j.ccr.2010.11.034; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Hourihan JM, 2013, ANTIOXID REDOX SIGN, V19, P465, DOI 10.1089/ars.2012.4944; Huang CWH, 2016, PHARMACOL RES, V113, P533, DOI 10.1016/j.phrs.2016.09.032; Imhoff BR, 2010, CELL BIOL TOXICOL, V26, P541, DOI 10.1007/s10565-010-9162-6; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Ives A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7555; Jamilloux Y, 2016, METHODS MOL BIOL, V1417, P207, DOI 10.1007/978-1-4939-3566-6_14; Jhang JJ, 2015, CELL MOL IMMUNOL, V12, P424, DOI 10.1038/cmi.2014.65; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; Joosten LAB, 2011, JOINT BONE SPINE, V78, P107, DOI 10.1016/j.jbspin.2010.11.004; Khanna PP, 2014, SEMIN ARTHRITIS RHEU, V44, P31, DOI 10.1016/j.semarthrit.2014.02.003; Kingsbury SR, 2011, J INFLAMM RES, V4, P39, DOI 10.2147/JIR.S11330; Kuo CF, 2015, NAT REV RHEUMATOL, V11, P649, DOI 10.1038/nrrheum.2015.91; Lamkanfi M, 2011, IMMUNOL REV, V243, P163, DOI 10.1111/j.1600-065X.2011.01042.x; Lee HE, 2016, SCI REP-UK, V6, DOI 10.1038/srep38622; Predmore BL, 2012, ANTIOXID REDOX SIGN, V17, P119, DOI 10.1089/ars.2012.4612; Li L, 2009, FREE RADICAL BIO MED, V47, P103, DOI 10.1016/j.freeradbiomed.2009.04.014; Lohninger L, 2015, BIOCHIMIE, V112, P187, DOI 10.1016/j.biochi.2015.03.009; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Marino A, 2016, BRIT J PHARMACOL, V173, P3222, DOI 10.1111/bph.13583; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Marutani E, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002125; McNally JS, 2005, ARTERIOSCL THROM VAS, V25, P1623, DOI 10.1161/01.ATV.0000170827.16296.6e; MOLDAWER LL, 1987, AM J PHYSIOL, V253, pR922, DOI 10.1152/ajpregu.1987.253.6.R922; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Orlowski GM, 2017, J LEUKOCYTE BIOL, V102, P7, DOI 10.1189/jlb.3HI0316-152R; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Rios ECS, 2015, INT J MOL MED, V35, P1741, DOI 10.3892/ijmm.2015.2176; Shi HX, 2016, NAT IMMUNOL, V17, P250, DOI 10.1038/ni.3333; Shi Y, 2015, MED SCI MONITOR, V21, P2774, DOI 10.12659/MSM.895272; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Sorbara MT, 2011, CELL RES, V21, P558, DOI 10.1038/cr.2011.20; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Toldo S, 2014, CIRC-CARDIOVASC GENE, V7, P311, DOI 10.1161/CIRCGENETICS.113.000381; Tozser J., 2016, MEDIAT INFLAMM, V2016, P1; Wallace JL, 2015, NAT REV DRUG DISCOV, V14, P329, DOI 10.1038/nrd4433; Wallace JL, 2012, ANTIOXID REDOX SIGN, V17, P58, DOI 10.1089/ars.2011.4351; Whiteman M, 2010, ANTIOXID REDOX SIGN, V12, P1147, DOI 10.1089/ars.2009.2899; Xie LP, 2016, DIABETES, V65, P3171, DOI 10.2337/db16-0020; Xie ZZ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6043038; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhang HL, 2006, AM J PHYSIOL-LUNG C, V290, pL1193, DOI 10.1152/ajplung.00489.2005; Zhao CC, 2014, J BIOL CHEM, V289, P17020, DOI 10.1074/jbc.M114.563114; Zheng SC, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0070-7; Zheng YY, 2015, ACTA PHARM SIN B, V5, P367, DOI 10.1016/j.apsb.2015.06.004	63	68	72	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2546	2557		10.1074/jbc.M117.806869	http://dx.doi.org/10.1074/jbc.M117.806869			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29279328	Green Published, hybrid			2022-12-26	WOS:000425308300026
J	Thomas, SA; Nandan, D; Kass, J; Reiner, NE				Thomas, Sneha A.; Nandan, Devki; Kass, Jennifer; Reiner, Neil E.			Countervailing, time-dependent effects on host autophagy promotes intracellular survival of Leishmania	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN AUTOPHAGY; MACROPHAGE; INFECTION; MECHANISMS; INDUCTION; DONOVANI; TRANSLATION; AMAZONENSIS; GENERATION; EXPRESSION	Autophagy is essential for cell survival under stress and has also been implicated in host defense. Here, we investigated the interactions between Leishmania donovani, the main etiological agent of visceral leishmaniasis, and the autophagic machinery of human macrophages. Our results revealed that during early infection-and via activation of the Akt pathway-Leishmania actively inhibits the induction of autophagy. However, by 24 h, Leishmania switched from being an inhibitor to an overall inducer of autophagy. These findings of a dynamic, biphasic response were based on the accumulation of lipidated light chain 3 (LC3), an autophagosome marker, by Western blotting and confocal fluorescence microscopy. We also present evidence that Leishmania induces delayed host cell autophagy via a mechanism independent of reduced activity of the mechanistic target of rapamycin (mTOR). Notably, Leishmania actively inhibited mTOR-regulated autophagy even at later stages of infection, whereas there was a clear induction of autophagy via some other mechanism. In this context, we examined host inositol monophosphatase (IMPase), reduced levels of which have been implicated in mTOR-independent autophagy, and we found that IMPase activity is significantly decreased in infected cells. These findings indicate that Leishmania uses an alternative pathway to mTOR to induce autophagy in host macrophages. Finally, RNAi-mediated down-regulation of host autophagy protein 5 (ATG5) or autophagy protein 9A (ATG9A) decreased parasite loads, demonstrating that autophagy is essential for Leishmania survival. We conclude that Leishmania uses an alternative pathway to induce host autophagy while simultaneously inhibiting mTOR-regulated autophagy to fine-tune the timing and magnitude of this process and to optimize parasite survival.	[Thomas, Sneha A.; Nandan, Devki; Kass, Jennifer; Reiner, Neil E.] Univ British Columbia, Div Infect Dis, Dept Med, Vancouver, BC V6H 3Z6, Canada; [Reiner, Neil E.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Reiner, NE (corresponding author), Univ British Columbia, Div Infect Dis, Dept Med, Vancouver, BC V6H 3Z6, Canada.; Reiner, NE (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada.	nreiner@mail.ubc.ca			Canadian Institutes for Health Research [MOP-125879]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Grant MOP-125879 from the Canadian Institutes for Health Research. The authors declare that they have no conflicts of interest with the contents of this article.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Biswas D, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-35; Cheekatla SS, 2012, MED MICROBIOL IMMUN, V201, P37, DOI 10.1007/s00430-011-0202-5; Crauwels P, 2015, AUTOPHAGY, V11, P285, DOI 10.1080/15548627.2014.998904; Cyrino LT, 2012, TISSUE CELL, V44, P401, DOI 10.1016/j.tice.2012.08.003; da Silva LM, 2009, P NATL ACAD SCI USA, V106, P7583, DOI 10.1073/pnas.0901698106; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Franco LH, 2017, J BIOL CHEM, V292, P13087, DOI 10.1074/jbc.M117.780981; Frank B, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0974-3; Gingras AC, 2001, GENE DEV, V15, P2852; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hmama Z, 2015, IMMUNOL REV, V264, P220, DOI 10.1111/imr.12268; Hung CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008771; Hurley JH, 2017, ANNU REV BIOCHEM, V86, P225, DOI 10.1146/annurev-biochem-061516-044820; Jain SK, 2012, JOVE-J VIS EXP, DOI 10.3791/4054; Jaramillo M, 2011, CELL HOST MICROBE, V9, P331, DOI 10.1016/j.chom.2011.03.008; Jiang PD, 2015, METHODS, V75, P13, DOI 10.1016/j.ymeth.2014.11.021; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; Kima PE, 2016, CELL IMMUNOL, V309, P19, DOI 10.1016/j.cellimm.2016.09.004; Klionsky DJ, 2011, AUTOPHAGY, V7, P1273, DOI 10.4161/auto.7.11.17661; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Lambertz U, 2012, J LEUKOCYTE BIOL, V91, P887, DOI 10.1189/jlb.0611326; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Meyuhas O, 2009, PROG MOL BIOL TRANSL, V90, P109, DOI 10.1016/S1877-1173(09)90003-5; Mitroulis I, 2009, PARASITOL INT, V58, P475, DOI 10.1016/j.parint.2009.07.002; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; MOORE KJ, 1994, J IMMUNOL, V152, P2930; Motoi Y, 2014, ACS CHEM NEUROSCI, V5, P434, DOI 10.1021/cn500056q; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; Nalbandian A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122888; Nandan D, 2012, J IMMUNOL, V188, P367, DOI 10.4049/jimmunol.1100076; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; OLIVIER M, 1992, J IMMUNOL, V148, P1188; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paulus GLC, 2015, CURR OPIN GASTROEN, V31, P14, DOI 10.1097/MOG.0000000000000134; Pinheiro RO, 2009, MICROBES INFECT, V11, P181, DOI 10.1016/j.micinf.2008.11.006; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; Ruckdeschel K, 2002, ARCH IMMUNOL THER EX, V50, P131; Ruhland A, 2007, CELL MICROBIOL, V9, P84, DOI 10.1111/j.1462-5822.2006.00769.x; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2013, BIOCHEM SOC T, V41, P1103, DOI 10.1042/BST20130134; Schaible UE, 1999, J CELL SCI, V112, P681; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shadab Md, 2011, Mol Biol Int, V2011, P343961, DOI 10.4061/2011/343961; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Singh AK, 2016, AUTOPHAGY, V12, P1817, DOI 10.1080/15548627.2016.1203500; Singh AK, 2015, INFECT IMMUN, V83, P1853, DOI 10.1128/IAI.02833-14; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Wang YH, 2009, EXP BIOL MED, V234, P171, DOI 10.3181/0808-RM-252; Wang YB, 2009, J BIOL CHEM, V284, P1694, DOI 10.1074/jbc.M807890200; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Winchell CG, 2014, INFECT IMMUN, V82, P2229, DOI 10.1128/IAI.01236-13; Yang YP, 2013, ACTA PHARMACOL SIN, V34, P625, DOI 10.1038/aps.2013.5; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865	70	28	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2617	2630		10.1074/jbc.M117.808675	http://dx.doi.org/10.1074/jbc.M117.808675			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29269416	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000425308300032
J	Larabee, JL; Hauck, GD; Ballard, JD				Larabee, Jason L.; Hauck, Garrett D.; Ballard, Jimmy D.			Cell-penetrating peptides derived from Clostridium difficile TcdB2 and a related large clostridial toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial toxin; biotechnology; cell-penetrating peptide (CPP); peptides; toxin	MAMMALIAN-CELLS; ANTHRAX TOXIN; LETHAL TOXIN; DELIVERY; CARGO; TRANSLOCATION; MAUROCALCINE; MEMBRANE; PROTEINS; EPITOPES	Clostridium difficile TcdB (2366 amino acid residues) is an intracellular bacterial toxin that binds to cells and enters the cytosol where it glucosylates small GTPases. In the current study, we examined a putative cell entry region of TcdB (amino acid residues 1753-1851) for short sequences that function as cell-penetrating peptides (CPPs). To screen for TcdB-derived CPPs, a panel of synthetic peptides was tested for the ability to enhance transferrin (Tf) association with cells. Four candidate CPPs were discovered, and further study on one peptide (PepB2) pinpointed an asparagine residue necessary for CPP activity. PepB2 mediated the cell entry of a wide variety of molecules including dextran, streptavidin, microspheres, and lentivirus particles. Of note, this uptake was dramatically reduced in the presence of the Na+/H+ exchange blocker and micropinocytosis inhibitor amiloride, suggesting that PepB2 invokes macropinocytosis. Moreover, we found that PepB2 had more efficient cell-penetrating activity than several other well-known CPPs (TAT, penetratin, Pep-1, and TP10). Finally, Tf assay-based screening of peptides derived from two other large clostridial toxins, TcdA and TcsL, uncovered two new TcdA-derived CPPs. In conclusion, we have identified six CPPs from large clostridial toxins and have demonstrated the ability of PepB2 to promote cell association and entry of several molecules through a putative fluid-phase macropinocytotic mechanism.	[Larabee, Jason L.; Hauck, Garrett D.; Ballard, Jimmy D.] Univ Oklahoma, Dept Microbiol & Immunol, Hlth Sci Ctr, BMSB 1053,940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Larabee, JL (corresponding author), Univ Oklahoma, Dept Microbiol & Immunol, Hlth Sci Ctr, BMSB 1053,940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	jason-larabee@ouhsc.edu		Larabee, Jason/0000-0001-5757-7247	National Institutes of Health [R21AI121925, R01AI119048]; Oklahoma Center for the Advancement of Science and Technology (OCAST) [HR13-070]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121925, R01AI119048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology (OCAST); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R21AI121925 and R01AI119048 (to J. D. B.) and by Grant HR13-070 from the Oklahoma Center for the Advancement of Science and Technology (OCAST) (to J. L. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Auger A, 2015, MOL PHARMACEUT, V12, P2962, DOI 10.1021/acs.molpharmaceut.5b00233; Bade S, 2004, J NEUROCHEM, V91, P1461, DOI 10.1111/j.1471-4159.2004.02844.x; Ballard JD, 1998, INFECT IMMUN, V66, P4696, DOI 10.1128/IAI.66.10.4696-4699.1998; Beilhartz GL, 2017, BIOCHEM PHARMACOL, V142, P13, DOI 10.1016/j.bcp.2017.04.009; Bolz DD, 2015, SHOCK, V43, P178, DOI 10.1097/SHK.0000000000000266; Carter GP, 2012, TRENDS MICROBIOL, V20, P21, DOI 10.1016/j.tim.2011.11.003; Chen S, 2016, TOXINS, V8, pE241; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Davies AH, 2011, BIOCHEM J, V436, P517, DOI 10.1042/BJ20110106; Deng X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142558; Dupont E, 2015, METHODS MOL BIOL, V1324, P29, DOI 10.1007/978-1-4939-2806-4_2; Falnes PO, 2000, CURR OPIN CELL BIOL, V12, P407, DOI 10.1016/S0955-0674(00)00109-5; Giacca Mauro, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P277, DOI 10.2174/1568008043339767; Gomarasca M, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02545-16, 10.1128/aac.02545-16]; Guidotti G, 2017, TRENDS PHARMACOL SCI, V38, P406, DOI 10.1016/j.tips.2017.01.003; Hunt JJ, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00268-17; Jank T, 2015, CELL MICROBIOL, V17, P1752, DOI 10.1111/cmi.12533; Lanis JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001061; Larabee JL, 2017, MBIO, V8, DOI 10.1128/mBio.00503-17; Larabee JL, 2015, J BIOL CHEM, V290, P6975, DOI 10.1074/jbc.M114.612184; Larabee JL, 2011, INFECT IMMUN, V79, P3302, DOI 10.1128/IAI.05070-11; Mishra A, 2011, P NATL ACAD SCI USA, V108, P16883, DOI 10.1073/pnas.1108795108; Orrell KE, 2017, CRIT REV BIOCHEM MOL, V52, P461, DOI 10.1080/10409238.2017.1325831; Poillot C, 2012, J BIOL CHEM, V287, P17331, DOI 10.1074/jbc.M112.360628; Poillot C, 2010, J BIOL CHEM, V285, P34168, DOI 10.1074/jbc.M110.104919; Pooga M, 1998, FASEB J, V12, P67, DOI 10.1096/fasebj.12.1.67; Pruitt RN, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00028; Qa'Dan M, 2001, INFECT IMMUN, V69, P5487, DOI 10.1128/IAI.69.9.5487-5493.2001; Rabideau AE, 2016, ACS CHEM BIOL, V11, P1490, DOI 10.1021/acschembio.6b00169; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Watson P, 2006, ADV DRUG DELIVER REV, V58, P1581, DOI 10.1016/j.addr.2006.09.016; Wilson BA, 2014, CURR TOP MED CHEM, V14, P2081, DOI 10.2174/1568026614666141022094517; Zhang YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058634	36	2	2	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1810	1819		10.1074/jbc.M117.815373	http://dx.doi.org/10.1074/jbc.M117.815373			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29247010	Green Published, hybrid			2022-12-26	WOS:000424201700030
J	Kurz, S; Thieme, R; Amberg, R; Groth, M; Jahnke, HG; Pieroh, P; Horn, LC; Kolb, M; Huse, K; Platzer, M; Volke, D; Dehghani, F; Buzdin, A; Engel, K; Robitzki, A; Hoffmann, R; Gockel, I; Birkenmeier, G				Kurz, Susanne; Thieme, Rene; Amberg, Ronny; Groth, Marco; Jahnke, Heinz-Georg; Pieroh, Philipp; Horn, Lars-Christian; Kolb, Marlen; Huse, Klaus; Platzer, Matthias; Volke, Daniela; Dehghani, Faramarz; Buzdin, Anton; Engel, Kathrin; Robitzki, Andrea; Hoffmann, Ralf; Gockel, Ines; Birkenmeier, Gerd			The anti-tumorigenic activity of A2M-A lesson from the naked mole-rat	PLOS ONE			English	Article							CIRCADIAN CLOCK; CELL-MIGRATION; HUMAN ALPHA-2-MACROGLOBULIN; MESENCHYMAL TRANSITION; SIGNALING PATHWAY; FACTOR-I; GENE; CANCER; ALPHA(2)-MACROGLOBULIN; RESISTANCE	Cancer resistance is a major cause for longevity of the naked mole-rat. Recent liver transcriptome analysis in this animal compared to wild-derived mice revealed higher expression of alpha2-macroglobulin (A2M) and cell adhesion molecules, which contribute to the naked mole-rat's cancer resistance. Notably, A2M is known to dramatically decrease with age in humans. We hypothesize that this might facilitate tumour development. Here we found that A2M modulates tumour cell adhesion, migration and growth by inhibition of tumour promoting signalling pathways, e.g. PI3K/AKT, SMAD and up-regulated PTEN via down-regulation of miR-21, in vitro and in tumour xenografts. A2M increases the expression of CD29 and CD44 but did not evoke EMT. Transcriptome analysis of A2M-treated tumour cells, xenografts and mouse liver demonstrated a multifaceted regulation of tumour promoting signalling pathways indicating a less tumorigenic environment mediated by A2M. By virtue of these multiple actions the naturally occurring A2M has strong potential as a novel therapeutic agent.	[Kurz, Susanne; Amberg, Ronny; Kolb, Marlen; Engel, Kathrin; Birkenmeier, Gerd] Univ Leipzig, Inst Biochem, Med Fac, Leipzig, Germany; [Thieme, Rene; Gockel, Ines] Univ Leipzig, Med Fac, Dept Visceral Transplantat Thorac & Vasc Surg, Leipzig, Germany; [Groth, Marco; Huse, Klaus; Platzer, Matthias] FLI, Leibniz Inst Aging, Jena, Germany; [Jahnke, Heinz-Georg; Robitzki, Andrea] Univ Leipzig, Ctr Biotechnol & Biomed, Mol Biol Biochem Proc Technol, Leipzig, Germany; [Pieroh, Philipp; Dehghani, Faramarz] Martin Luther Univ Halle Wittenberg, Dept Anat & Cell Biol, Grosse Steinstr 52, Halle, Saale, Germany; [Horn, Lars-Christian] Univ Leipzig, Inst Pathol, Div Breast Gynaecol & Perinatal Pathol, Leipzig, Germany; [Volke, Daniela; Hoffmann, Ralf] Univ Leipzig, Ctr Biotechnol & Biomed, Leipzig, Germany; [Buzdin, Anton] Johns Hopkins Univ Eastern, Pharmaceut Artificial Intelligence Dept, Insilico Med Inc, Emerging Technol Ctr, B301, Baltimore, MD USA; [Buzdin, Anton] OmicsWay Corp, Dept Pathway Engn Canc Res, Walnut, CA USA; [Buzdin, Anton] Natl Res Ctr, Kurchatov Inst, Ctr Convergence Nano Bio Informat & Cognit Sci &, 1 Akad Kurchatova Sq, Moscow, Russia	Leipzig University; Leipzig University; Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Leipzig University; Martin Luther University Halle Wittenberg; Leipzig University; Leipzig University; Johns Hopkins University; National Research Centre - Kurchatov Institute	Birkenmeier, G (corresponding author), Univ Leipzig, Inst Biochem, Med Fac, Leipzig, Germany.	gerd.birkenmeier@medizin.uni-leipzig.de	Buzdin, Anton/R-2611-2016; Engel, Kathrin M/AAQ-1309-2021; Hoffmann, Ralf/ABD-8779-2020	Engel, Kathrin M/0000-0003-0611-7042; Groth, Marco/0000-0002-9199-8990; Pieroh, Philipp/0000-0003-0906-5479; Kolb, Marlen/0000-0002-8397-8295	Europaischer Sozialfond-ESF [100098250]; German Research Foundation (DFG); Leipzig University within the program of Open Access Publishing	Europaischer Sozialfond-ESF; German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University within the program of Open Access Publishing	This work was supported by Europaischer Sozialfond-ESF (100098250). We acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Benegiamo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060527; Birkenmeier G, 2003, EXP NEUROL, V184, P153, DOI 10.1016/S0014-4886(03)00110-9; BIRKENMEIER G, 1993, J IMMUNOL METHODS, V162, P59, DOI 10.1016/0022-1759(93)90407-X; Birkenmeier G, 2006, J PHARMACOL EXP THER, V318, P762, DOI 10.1124/jpet.106.104265; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Brzozowa M, 2015, WSPOLCZESNA ONKOL, V19, P265, DOI 10.5114/wo.2014.42173; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buzdin AA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00055; Chen N, 2016, BRAIN DEV-JPN, V38, P507, DOI 10.1016/j.braindev.2015.11.002; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Cuellar JM, 2016, PHYS MED REH CLIN N, V27, P909, DOI 10.1016/j.pmr.2016.06.008; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Ebbesen SH, 2016, P NATL ACAD SCI USA, V113, P3030, DOI 10.1073/pnas.1523693113; Eckle T, 2012, NAT MED, V18, P774, DOI 10.1038/nm.2728; Ehling J, 2016, CANCER LETT, V379, P173, DOI 10.1016/j.canlet.2015.06.017; Eichler M, 2015, BIOSENS BIOELECTRON, V67, P582, DOI 10.1016/j.bios.2014.09.049; Feillet C, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur2015.00096, 10.3389/fneur.2015.00096]; Florio M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601941; Fragni M, 2016, N-S ARCH PHARMACOL, V389, P529, DOI 10.1007/s00210-016-1224-8; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gatenby RA, 2009, NATURE, V459, P508, DOI 10.1038/459508a; Glander HJ, 1996, HUM REPROD, V11, P2454; GONIAS SL, 1994, ANN NY ACAD SCI, V737, P273, DOI 10.1111/j.1749-6632.1994.tb44318.x; Gorbacheva VY, 2005, P NATL ACAD SCI USA, V102, P3407, DOI 10.1073/pnas.0409897102; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Heidegger I, 2015, CANCER LETT, V367, P113, DOI 10.1016/j.canlet.2015.07.026; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kimura T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030336; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LAMARRE J, 1991, LAB INVEST, V65, P3; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li JR, 2016, NUCLEIC ACIDS RES, V44, pD944, DOI 10.1093/nar/gkv1282; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; Lindner I, 2010, CANCER RES, V70, P277, DOI 10.1158/0008-5472.CAN-09-1462; Long JE, 2016, VACCINE, V34, P2679, DOI 10.1016/j.vaccine.2016.04.032; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Majid S, 2010, CANCER RES, V70, P2809, DOI 10.1158/0008-5472.CAN-09-4176; Malchnkhuu E, 2008, BIOCHEM BIOPH RES CO, V366, P963, DOI 10.1016/j.bbrc.2007.12.054; Marhenke S, 2014, GUT, V63, P1501, DOI 10.1136/gutjnl-2013-304829; Marthandan S, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0038-8; MATTHIJS G, 1992, BIOCHEM BIOPH RES CO, V184, P596, DOI 10.1016/0006-291X(92)90631-T; Mocchegiani E, 2006, EXP GERONTOL, V41, P1094, DOI 10.1016/j.exger.2006.08.010; Molusky MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047970; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NIELSEN H, 1991, PFLUG ARCH EUR J PHY, V419, P51, DOI 10.1007/BF00373747; Perrot G, 2012, MOL CELL BIOL, V32, P3293, DOI 10.1128/MCB.00228-12; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Rabiej VK, 2016, EXP CELL RES, V340, P102, DOI 10.1016/j.yexcr.2015.11.020; Ripperger T, 2007, HAEMATOLOGICA, V92, P460, DOI 10.3324/haematol.10337; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saleem S, 2009, J PATHOL, V219, P182, DOI 10.1002/path.2577; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Spirin PV, 2014, LEUKEMIA, V28, P2222, DOI 10.1038/leu.2014.130; Tang QM, 2017, CANCER RES, V77, P532, DOI 10.1158/0008-5472.CAN-16-1322; te Kamp V, 2015, BIOSENS BIOELECTRON, V67, P386, DOI 10.1016/j.bios.2014.08.066; Thieme R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130470; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Ungefroren H, 2011, INT J ONCOL, V38, P797, DOI 10.3892/ijo.2011.897; UTANS U, 1995, J CLIN INVEST, V95, P2954, DOI 10.1172/JCI118003; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; Vigneri PG, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00230; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Westwood M, 2001, J BIOL CHEM, V276, P41668, DOI 10.1074/jbc.M102793200; Wood PA, 2009, INTEGR CANCER THER, V8, P303, DOI 10.1177/1534735409355292; Yagita K, 2000, GENE DEV, V14, P1353; Yu CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026729; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhou J, 2015, ONCOTARGET, V6, P44332, DOI 10.18632/oncotarget.6293	76	24	25	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189514	10.1371/journal.pone.0189514	http://dx.doi.org/10.1371/journal.pone.0189514			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281661	gold, Green Published, Green Submitted			2022-12-26	WOS:000419006200032
J	Techer, MA; Clemencet, J; Simiand, C; Turpin, P; Garnery, L; Reynaud, B; Delatte, H				Techer, Maeva Angelique; Clemencet, Johanna; Simiand, Christophe; Turpin, Patrick; Garnery, Lionel; Reynaud, Bernard; Delatte, Helene			Genetic diversity and differentiation among insular honey bee populations in the southwest Indian Ocean likely reflect old geographical isolation and modern introductions	PLOS ONE			English	Article							APIS-MELLIFERA L.; EVOLUTIONARY HISTORY; DEMOGRAPHIC HISTORY; MITOCHONDRIAL-DNA; SPECIES RICHNESS; ISLAND; MICROSATELLITE; CONSERVATION; BIOGEOGRAPHY; PATTERNS	With globalization the Western honey bee has become a nearly cosmopolitan species, but it was originally restricted to the Old World. This renowned model of biodiversity has diverged into five evolutionary lineages and several geographic "subspecies." If Apis mellifera unicolor is indubitably an African subspecies endemic to Madagascar, its relationship with honey bees from three archipelagos in the southwest Indian Ocean (SWIO) hotspot of biodiversity is misunderstood. We compared recent mtDNA diversity data to an original characterization of the nuclear diversity from honey bees in the Mascarenes and Comoros archipelagos, using 14 microsatellites, but also additional mtDNA tRNA(Leu)-cox2 analysis. Our sampling offers the most comprehensive dataset for the SWIO populations with a total of 3,270 colonies from 10 islands compared with 855 samples from Madagascar, 113 from Africa, and 138 from Europe. Comprehensive mitochondrial screening confirmed that honey bees from La Re A union, Mauritius, and Comoros archipelagos are mainly of African origin (88.1% out of 2,746 colonies) and that coexistence with European lineages occurs only in the Mascarenes. PCA, Bayesian, and genetic differentiation analysis showed that African colonies are not significantly distinct on each island, but have diversified among islands and archipelagos. F-ST levels progressively decreased in significance from European and African continental populations, to SWIO insular and continental populations, and finally among islands from the same archipelago. Among African populations, Madagascar shared a nuclear background with and was most closely related to SWIO island populations (except Rodrigues). Only Mauritius Island presented clear cytoplasmic disequilibrium and genetic structure characteristic of an admixed population undergoing hybridization, in this case, between A. m. unicolor and A. m. ligustica, A. m. carnica and A. m. mellifera-like individuals. Finally, global genetic clustering analysis helped to better depict the colonization and introduction pattern of honey bee populations in these archipelagos.	[Techer, Maeva Angelique; Clemencet, Johanna; Reynaud, Bernard] Univ La Reunion, UMR PVBMT, St Denis, La Reunion, France; [Techer, Maeva Angelique; Simiand, Christophe; Turpin, Patrick; Reynaud, Bernard; Delatte, Helene] CIRAD, UMR PVBMT, St Pierre, La Reunion, France; [Garnery, Lionel] Univ Versailles St Quentin En Yvelines, Versailles, France; [Techer, Maeva Angelique] Grad Univ, Okinawa Inst Sci & Technol, Ecol & Evolut Unit, Onna, Okinawa, Japan	University of La Reunion; CIRAD; UDICE-French Research Universities; Universite Paris Saclay; Okinawa Institute of Science & Technology Graduate University	Techer, MA (corresponding author), Univ La Reunion, UMR PVBMT, St Denis, La Reunion, France.; Techer, MA; Delatte, H (corresponding author), CIRAD, UMR PVBMT, St Pierre, La Reunion, France.; Techer, MA (corresponding author), Grad Univ, Okinawa Inst Sci & Technol, Ecol & Evolut Unit, Onna, Okinawa, Japan.	maeva.techer@oist.jp; helene.delatte@cirad.fr	TECHER, Maeva/X-5315-2019	TECHER, Maeva/0000-0001-5417-5103	Sciences and Technology Doctoral School of the University of La Reunion; CIRAD; European Union; French government; Region Reunion; Departement of La Reunion	Sciences and Technology Doctoral School of the University of La Reunion; CIRAD; European Union(European Commission); French government; Region Reunion; Departement of La Reunion	Maeva A. Techer was recipient of a Ph.D. fellowship of the Sciences and Technology Doctoral School of the University of La Reunion. This study was partially funded by CIRAD and the Enlargement and sustainability of the Plant Protection Network (e-PRPV) supported by the European Union, the French government, the Region Reunion and the Departement of La Reunion.	Adamack AT, 2014, METHODS ECOL EVOL, V5, P384, DOI 10.1111/2041-210X.12158; Agnarsson I, 2012, GENERATION BIODIVERS, P33; Alburaki M, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-117; Pinto MA, 2014, J APICULT RES, V53, P269, DOI 10.3896/IBRA.1.53.2.08; Alqarni AS, 2011, ZOOKEYS, P83, DOI 10.3897/zookeys.134.1677; [Anonymous], 1996, 5000 CNRS UMR; Ayme A., 2014, SYNTHESE CONNAISSANC; Bappoo DR, 1989, P 4 INT C AP TROP CL; Bloch G, 2010, P NATL ACAD SCI USA, V107, P11240, DOI 10.1073/pnas.1003265107; Branchiccela B, 2014, APIDOLOGIE, V45, P752, DOI 10.1007/s13592-014-0293-2; Canovas F, 2011, APIDOLOGIE, V42, P235, DOI 10.1007/s13592-011-0020-1; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chavez-Galarza J, 2017, APIDOLOGIE, P1; Chavez-Galarza J, 2015, MOL ECOL, V24, P2973, DOI 10.1111/mec.13223; Cheke Anthony, 2010, Phelsuma, V18, P38; Chen C, 2016, MOL BIOL EVOL, V33, P1337, DOI 10.1093/molbev/msw017; Clarke KE, 2002, EVOLUTION, V56, P1462; Clemencet J, 2013, J TROP ECOL, V29, P251, DOI 10.1017/S0266467413000229; Coroian CO, 2014, MOL ECOL, V23, P2353, DOI 10.1111/mec.12731; Cridland JM, 2017, GENOME BIOL EVOL, V9, P457, DOI 10.1093/gbe/evx009; De la Rua P, 2003, GENET SEL EVOL, V35, P339, DOI [10.1051/gse:2003012, 10.1186/1297-9686-35-3-339]; De la Rua P, 2001, MOL ECOL, V10, P1733, DOI 10.1046/j.1365-294X.2001.01303.x; Dietemann V, 2009, APIDOLOGIE, V40, P285, DOI 10.1051/apido/2009013; Douglass K, 2015, AFR ARCHAEOL REV, V32, P267, DOI 10.1007/s10437-015-9188-5; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Engel Michael S., 1999, Journal of Hymenoptera Research, V8, P165; ESTOUP A, 1994, P ROY SOC B-BIOL SCI, V258, P1, DOI 10.1098/rspb.1994.0133; ESTOUP A, 1995, GENETICS, V140, P679; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Finger A, 2011, MOL ECOL, V20, P3773, DOI 10.1111/j.1365-294X.2011.05228.x; Florens FBV, 2012, BIODIVERS CONSERV, V21, P2139, DOI 10.1007/s10531-012-0304-4; Franck P, 1998, EVOLUTION, V52, P1119, DOI [10.2307/2411242, 10.1111/j.1558-5646.1998.tb01839.x]; Franck P, 2001, HEREDITY, V86, P420, DOI 10.1046/j.1365-2540.2001.00842.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; GARNERY L, 1993, EXPERIENTIA, V49, P1016, DOI 10.1007/BF02125651; Garnery L, 1992, MOL ECOL, V1, P145, DOI 10.1111/j.1365-294X.1992.tb00170.x; Garnery L, 1998, GENET SEL EVOL, V30, pS49, DOI 10.1051/gse:19980703; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Han F, 2012, ECOL EVOL, V2, P1949, DOI 10.1002/ece3.312; Hansen DM, 2002, J BIOGEOGR, V29, P721, DOI 10.1046/j.1365-2699.2002.00720.x; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Harpur BA, 2012, MOL ECOL, V21, P4414, DOI 10.1111/j.1365-294X.2012.05614.x; Huttner F, 1988, BIOGEOGRAPHY TAXONOM; Ilyasov RA, 2015, RUSS J GENET+, V51, P163, DOI 10.1134/S1022795415020088; Jacques A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172591; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Janes JK, 2017, MOL ECOL, V26, P3594, DOI 10.1111/mec.14187; Jaros U, 2016, HEREDITY, V116, P434, DOI 10.1038/hdy.2016.1; Jhumun G., 2011, HON MAURIT OIE C REG, P7; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; KAISER CN, 2006, FUNCTIONAL INTEGRITY; Kaiser-Bunbury CN, 2011, J ECOL, V99, P202, DOI 10.1111/j.1365-2745.2010.01732.x; Kaiser-Bunbury CN, 2010, PERSPECT PLANT ECOL, V12, P131, DOI 10.1016/j.ppees.2009.10.002; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; LATTER BDH, 1973, GENETICS, V73, P147; Le Pechon T, 2015, INT J PLANT SCI, V176, P211, DOI 10.1086/679350; Le Pechon T, 2013, J TROP ECOL, V29, P353, DOI 10.1017/S0266467413000278; Le Pechon T, 2010, ANN BOT-LONDON, V106, P343, DOI 10.1093/aob/mcq116; Le Roux JJ, 2014, NEW PHYTOL, V204, P230, DOI 10.1111/nph.12900; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Meeus S, 2011, PLANT SYST EVOL, V292, P143, DOI 10.1007/s00606-010-0400-4; Meixner M. D., 2013, J APICULT RES, V52, P1, DOI [10.3896/IBRA.1.52.4.05, DOI 10.3896/IBRA.1.52.4.05]; Meixner MD, 2011, APIDOLOGIE, V42, P425, DOI 10.1007/s13592-011-0007-y; Meixner MD, 2010, J APICULT RES, V49, P85, DOI 10.3896/IBRA.1.49.1.12; Micheneau C, 2008, MOL PHYLOGENET EVOL, V46, P908, DOI 10.1016/j.ympev.2007.12.001; Miguel I, 2007, APIDOLOGIE, V38, P141, DOI 10.1051/apido:2007007; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, V1st ed., P3; Munoz I, 2013, APIDOLOGIE, P1; Munoz I, 2014, INSECT CONSERV DIVER, V7, P563, DOI 10.1111/icad.12092; Munoz I, 2014, J APICULT RES, V53, P296, DOI 10.3896/IBRA.1.53.2.11; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Nelson R.M., 2017, MOL ECOLOGY; Pailler T, 2002, OIKOS, V99, P308, DOI 10.1034/j.1600-0706.2002.990211.x; Pailler T, 1997, AM J BOT, V84, P315, DOI 10.2307/2446005; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pritchard JK, 2000, GENETICS, V155, P945; QGIS D, 2015, QGIS GEOGR INF SYST; Quezada-Euan JJG, 1998, APIDOLOGIE, V29, P555, DOI 10.1051/apido:19980608; Rangel J, 2016, ECOL EVOL, V6, P2158, DOI 10.1002/ece3.1974; Rasolofoarivao H, 2015, APIDOLOGIE, V46, P735, DOI 10.1007/s13592-015-0362-1; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; Raymond M., 2004, GENEPOP VERSION 3 4; RINDERER T E, 1986, Bulletin of the Entomological Society of America, V32, P226; Rius M, 2014, TRENDS ECOL EVOL, V29, P233, DOI 10.1016/j.tree.2014.02.003; Rocha S, 2006, J BIOGEOGR, V33, P13, DOI 10.1111/j.1365-2699.2005.01375.x; Roffet-Salque M, 2015, NATURE, V527, P226, DOI 10.1038/nature15757; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Seitz N, 2016, J APICULT RES, V54, P292, DOI 10.1080/00218839.2016.1153294; Shaw KL, 2016, P NATL ACAD SCI USA, V113, P7986, DOI 10.1073/pnas.1601078113; Sheppard WS, 1997, APIDOLOGIE, V28, P287, DOI 10.1051/apido:19970505; Sheppard WS, 2003, APIDOLOGIE, V34, P367, DOI 10.1051/apido:2003037; Solignac M, 2003, MOL ECOL NOTES, V3, P307, DOI 10.1046/j.1471-8286.2003.00436.x; Strasberg D, 2005, BIODIVERS CONSERV, V14, P3015, DOI 10.1007/s10531-004-0258-2; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Team RDC, 2013, R LANG ENV STAT COMP; Techer MA, 2016, INSECT CONSERV DIVER, V9, P13, DOI 10.1111/icad.12138; Techer MA, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0520-8; Techer MA, 2015, APIDOLOGIE, V46, P445, DOI 10.1007/s13592-014-0335-9; Thebaud C., 2009, BIOLOGY, V127, P1; Triantis KA, 2015, GLOBAL ECOL BIOGEOGR, V24, P594, DOI 10.1111/geb.12301; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wallberg A, 2014, NAT GENET, V46, P1081, DOI 10.1038/ng.3077; Warren BH, 2015, ECOL LETT, V18, P200, DOI 10.1111/ele.12398; Warren BH, 2005, BIOL J LINN SOC, V85, P271, DOI 10.1111/j.1095-8312.2005.00492.x; Weyeneth N, 2011, J EVOLUTION BIOL, V24, P1298, DOI 10.1111/j.1420-9101.2011.02262.x; Whitfield CW, 2006, SCIENCE, V314, P642, DOI 10.1126/science.1132772	109	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189234	10.1371/journal.pone.0189234	http://dx.doi.org/10.1371/journal.pone.0189234			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281653	Green Published, gold, Green Submitted			2022-12-26	WOS:000419006200016
J	Andrews, K; Bourroul, MLM; Fink, G; Grisi, S; Ferrer, PS; Diniz, EMD; Brentani, A				Andrews, Kathryn; Moraes Bourroul, Maria Lucia; Fink, Gunther; Grisi, Sandra; Ferrer, Paula Scoleze; de Albuquerque Diniz, Edna Maria; Brentani, Alexandra			Time to change focus? Transitioning from higher neonatal to higher stillbirth mortality in Sao Paulo State, Brazil	PLOS ONE			English	Article								Background Differential trends in mortality suggest that stillbirths may dominate neonatal mortality in the medium to long run. Brazil has made major efforts to improve data collection on health indicators at granular geographic levels, and provides an ideal environment to test this hypothesis. Our goals were to examine levels and trends in stillbirths and neonatal deaths and the extent to which the mortality burden caused by stillbirths dominates neonatal mortality at the municipality-and state-level. Methods We used data from the Brazilian Ministry of Health's repository on births, fetal, and neonatal deaths (2010 +/- 2014) to calculate stillbirth and neonatal mortality rates for Sao Paulo state's 645 municipalities. Results At the state level, 7.9 per 1000 pregnancies ended in stillbirth (fetal death >22 weeks gestation or fetal weight >500g), but this varied from 0.0 to 28.4 per 1000 across municipalities. 7.9 per 1000 live births also died within the first 28 days. 42% of municipalities had a higher stillbirth rate than neonatal mortality rate, and in 61% of areas with low neonatal mortality (<8.0 per 1000), stillbirth rates exceeded neonatal mortality rates. Conclusions This analysis suggests large variability and inequality in mortality outcomes at the sub-national level. The results also imply that stillbirth mortality may exceed neonatal mortality in Brazil and similar settings in the next few decades, which suggests a need for a shift in policy. This work further underscores the importance of continued research into causes and prevention of stillbirth.	[Andrews, Kathryn] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Moraes Bourroul, Maria Lucia; Ferrer, Paula Scoleze] Univ Sao Paulo, Childrens Inst, Clin Hosp, Sch Med, Sao Paulo, Brazil; [Fink, Gunther] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Fink, Gunther] Univ Basel, Basel, Switzerland; [Grisi, Sandra; de Albuquerque Diniz, Edna Maria; Brentani, Alexandra] Univ Sao Paulo, Dept Pediat, Sch Med, Sao Paulo, Brazil	Harvard University; Harvard T.H. Chan School of Public Health; Universidade de Sao Paulo; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Andrews, K (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	Kathryn.Andrews@mail.harvard.edu	Diniz, Edna/AAY-9991-2021; Grisi, Sandra/ABB-9976-2020; Brentani, Alexandra/G-4535-2013	Brentani, Alexandra/0000-0001-6650-9705; Grisi, Sandra Josefina Ferraz Ellero/0000-0003-1846-3591				Beringhs Evani Marzagão, 2008, Rev. Bras. Saude Mater. Infant., V8, P319, DOI 10.1590/S1519-38292008000300011; Blencowe H, 2013, TROP MED INT HEALTH, V18, P303, DOI 10.1111/tmi.12048; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; De Lorenzi D R, 2001, Cad Saude Publica, V17, P141, DOI 10.1590/S0102-311X2001000100014; Departmento de Informatica do SUS, OB INF PART 1996 NOT; Departmento de Informatica do SUS, SIM SIST INF MORT; Barbeiro FMD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005568; Every Woman Every Child, 2015, GLOBAL STRATEGY WOME; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-58; Goldenberg Robert L, 2015, Matern Health Neonatol Perinatol, V1, P3, DOI 10.1186/s40748-014-0004-z; Goldenberg RL, 2012, INDIAN PEDIATR, V49, P187; Joint Committee on Reducing Maternal and Neonatal Mortality in Indonesia; Development Security and Cooperation; Policy and Global Affairs; National Research Council; Indonesian Academy of Sciences, 2013, RED MAT NEON MORT IN; Landmann-Szwarcwald C, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0462-1; Lansky S, 2002, REV SAUDE PUBL, V36, P759, DOI 10.1590/S0034-89102002000700017; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Leisher SH, 2016, BMC PREGNANCY CHILDB, V16; MacDorman M, 2013, NATL VITAL STAT REP, V64; Vieira MSM, 2016, MATERN CHILD HLTH J, V20, P1634, DOI 10.1007/s10995-016-1962-8; Silver RM, 2007, AM J OBSTET GYNECOL, V196, P433, DOI 10.1016/j.ajog.2006.11.041; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Smith GCS, 2010, CLIN OBSTET GYNECOL, V53, P597, DOI 10.1097/GRF.0b013e3181eb64a6; The World Bank Group IBRD IDA, 2016, MORT RAT NEON PER 10; UN Inter-agency Group for Child Mortality Estimation, LEV TRENDS CHILD MOR; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; Viellas EF, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00126013; World Health Organization, 2016, WHO NEGL TRAG STILLB; World Health Organization, MAK EV BAB COUNT AUD; World Health Organization, 2014, EV NEWB ACT PLAN END; Yakoob MY, 2010, SEMIN PERINATOL, V34, P387, DOI 10.1053/j.semperi.2010.09.010; Zeitlin J, 2016, J EPIDEMIOL COMMUN H, V70, P609, DOI 10.1136/jech-2015-207013	30	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190060	10.1371/journal.pone.0190060	http://dx.doi.org/10.1371/journal.pone.0190060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272295	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000418651500030
J	Zhi, XY; Han, YC; Li, YB; Wang, GP; Feng, L; Yang, BF; Fan, ZY; Lei, YP; Du, WL; Mao, SC				Zhi, Xiaoyu; Han, Yingchun; Li, Yabing; Wang, Guoping; Feng, Lu; Yang, Beifang; Fan, Zhengyi; Lei, Yaping; Du, Wenli; Mao, Shuchun			Root growth and spatial distribution characteristics for seedlings raised in substrate and transplanted cotton	PLOS ONE			English	Article							LENGTH DENSITY; WATER-UPTAKE; RADIATION INTERCEPTION; PLANT-GROWTH; HYBRID SEED; YIELD; SOIL; IRRIGATION; QUALITY; SYSTEM	In this study, transplanting cotton seedlings grown in artificial substrate is considered due to recent increased interest in cotton planting labor saving approaches. The nursery methods used for growing cotton seedlings affect root growth. However, the underlying functional responses of root growth to variations in cotton seedling transplanting methods are poorly understood. We assessed the responses of cotton (Gossypium hirsutum L.) roots to different planting methods by conducting cotton field experiments in 2012 and 2013. A one-factor random block design was used with three replications and three different cotton planting patterns (substrate seedling transplanted cotton (SSTC), soil-cube seedling transplanted cotton (ScSTC) and directly sown cotton (DSC). The distributions and variances of the root area density (RAD) and root length density (RLD) at different cotton growing stages and several yield components were determined. Overall, the following results were observed: 1) The RAD and RLD were greatest near the plants (a horizontal distance of 0 cm) but were lower at W20 and W40 cm in the absence of film mulching than at E20 and E40 cm with film mulching. 2) The roots were confined to shallow depths (20 +/- 40 cm), and the root depths of SSTC and DSC were greater than the root depths of ScSTC. 3) Strong root growth was observed in the SSTC at the cotton flowering and boll setting stages. In addition, early onset root growth occurred in the ScSTC, and vigorous root growth occurred throughout all cotton growth stages in DSC. 4) The SSTC plants had more lateral roots with higher root biomass (RB) than the ScSTC, which resulted in higher cotton yields. However, the early onset root growth in the ScSTC resulted in greater pre-frost seed cotton (PFSC) yields. These results can be used to infer how cotton roots are distributed in soils and capture nutrients.	[Zhi, Xiaoyu; Han, Yingchun; Li, Yabing; Wang, Guoping; Feng, Lu; Yang, Beifang; Fan, Zhengyi; Lei, Yaping; Du, Wenli; Mao, Shuchun] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Han, YC; Li, YB (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	hyccky@163.com; criliyabing@163.com; criliyabing@163.com	Yabing, Li/GLU-9964-2022	Zhi, Xiaoyu/0000-0003-2028-7267	Industry of National public welfare scientific research [201203057-01]; National Key Technology Support Program [2014BADO3B02-2]	Industry of National public welfare scientific research; National Key Technology Support Program(National Key Technology R&D Program)	This study was supported by the Industry of National public welfare scientific research (201203057-01) to XZ and the National Key Technology Support Program (2014BADO3B02-2).; This study was supported by the Industry of National public welfare scientific research (201203057-01) and the National Key Technology Support Program (2014BAD03B02-2). We greatly appreciate the work of the technicians from the experimental station at the Institute of Cotton Research at the Chinese Academy of Agricultural Sciences.	Adiku SGK, 1996, PLANT SOIL, V185, P125, DOI 10.1007/BF02257569; Adiku SGK, 2001, PLANT SOIL, V235, P85, DOI 10.1023/A:1011847214706; Ahmadi SH, 2011, AGR WATER MANAGE, V98, P1280, DOI 10.1016/j.agwat.2011.03.013; Akpo E, 2014, FOREST ECOL MANAG, V324, P28, DOI 10.1016/j.foreco.2014.03.045; Anil S, 2003, J CROP PROD, V8, P15; Awal MA, 2006, AGR FOREST METEOROL, V139, P74, DOI 10.1016/j.agrformet.2006.06.001; Besharat S, 2010, TURK J AGRIC FOR, V34, P439, DOI 10.3906/tar-0905-39; Cabal B, 2001, CURR SCI, V80, P925; da Luz PB, 2008, J PLANT NUTR, V31, P1313, DOI 10.1080/01904160802135084; Dai JL, 2014, FIELD CROP RES, V155, P99, DOI 10.1016/j.fcr.2013.09.017; Dexter AR, 2004, GEODERMA, V120, P201, DOI 10.1016/j.geoderma.2003.09.004; Dong HZ, 2007, IND CROP PROD, V26, P298, DOI 10.1016/j.indcrop.2007.03.008; Dong HZ, 2005, FIELD CROP RES, V93, P74, DOI 10.1016/j.fcr.2004.09.010; Dong HZ, 2005, J AGRON CROP SCI, V191, P116, DOI 10.1111/j.1439-037X.2004.00130.x; El-Sahrigi A.F., 2001, EGYPT J AGRIC RES, V79, P740; FUSSEDER A, 1987, PLANT SOIL, V101, P257, DOI 10.1007/BF02370653; Garcia VA, 2011, REV ARVORE, V35, P595, DOI 10.1590/S0100-67622011000400003; Gu S, 1992, Chin J Popul Sci, V4, P75; Hou TY, 2015, PLOS ONE, V10; Institute of Cotton Research of China Academy of Agricultural Sciences, 2013, CULT COTT CHIN; Karve AD, 2003, CURR SCI INDIA, V85, P122; Koyama A, 2012, PLANT ECOL, V213, P1729, DOI 10.1007/s11258-012-0126-1; KRAMER PJ, 1989, WATER RELATIONS PLAN; Liang YC, 2003, GEODERMA, V115, P149, DOI 10.1016/S0016-7061(03)00084-3; Luo HH, 2015, J PLANT NUTR SOIL SC, V178, P384, DOI 10.1002/jpln.201400264; Luo HH, 2014, IRRIG DRAIN, V63, P59, DOI 10.1002/ird.1793; [毛树春 MA0 Shuchun], 2008, [棉花学报, Cotton Science], V20, P76; Mao SC, 2012, CHINA COTTON, V39, P1; McMichael BL, 2010, PHYSIOLOGY OF COTTON, P57, DOI 10.1007/978-90-481-3195-2_6; McMichael BL, 1996, ENVIRON EXP BOT, V36, P303, DOI 10.1016/0098-8472(96)01015-5; Min W, 2014, FIELD CROP RES, V169, P1, DOI 10.1016/j.fcr.2014.09.002; MORANO L, 1994, AM J ENOL VITICULT, V45, P345; Ning SR, 2015, FIELD CROP RES, V177, P125, DOI 10.1016/j.fcr.2015.03.012; Niu JF, 2010, J PLANT NUTR SOIL SC, V173, P306, DOI 10.1002/jpln.200800316; Okazaki Y, 1985, POPULATION CHINA FER, P1; Oliver M. A., 1990, International Journal of Geographical Information Systems, V4, P313, DOI 10.1080/02693799008941549; Pettigrew WT, 2002, AGRON J, V94, P997, DOI 10.2134/agronj2002.0997; Rodrigo VHL, 2001, FIELD CROP RES, V69, P237, DOI 10.1016/S0378-4290(00)00147-7; Sanchez-del Castillo F, 2012, AGROCIENCIA-MEXICO, V46, P255; Shen QY, 1992, STUDY CONTROL COTTON; SMITH CW, 1982, AGRON J, V74, P862, DOI 10.2134/agronj1982.00021962007400050022x; Somkuwar RG, 2012, TURK J AGRIC FOR, V36, P543, DOI 10.3906/tar-0911-377; STEVENS RM, 1994, NEW ZEAL J CROP HORT, V22, P381, DOI 10.1080/01140671.1994.9513849; Tang FY, 2013, EXP AGR, V49, P543, DOI 10.1017/S001447971300029X; Tsubo M, 2002, AGR FOREST METEOROL, V110, P203, DOI 10.1016/S0168-1923(01)00287-8; Caldeira MVW, 2012, SCI FOR, V40, P15; Xi BY, 2013, AGR WATER MANAGE, V117, P83, DOI 10.1016/j.agwat.2012.11.006; Yang CH, 2010, PLANT SOIL ENVIRON, V56, P253, DOI 10.17221/251/2009-PSE; Zhang L, 2008, FIELD CROP RES, V107, P29, DOI 10.1016/j.fcr.2007.12.014; Zhang W, 2013, AGROFOREST SYST, V87, P929, DOI 10.1007/s10457-013-9609-x; Zhang Z, 2012, INT J PLANT PROD, V6, P173; Zhao CY, 2010, J ARID LAND, V2, P243, DOI 10.3724/SP.J.1227.2010.00243; Zhou LM, 2009, FIELD CROP RES, V113, P41, DOI 10.1016/j.fcr.2009.04.005; Zubaidi A, 1999, AUST J EXP AGR, V39, P709, DOI 10.1071/EA98184	54	6	6	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190032	10.1371/journal.pone.0190032	http://dx.doi.org/10.1371/journal.pone.0190032			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272298	Green Published, Green Submitted, gold			2022-12-26	WOS:000418651500026
J	Du, WC; Chen, H; Wu, ZH; Sun, HQ; Liao, PX; Zhang, Y				Du, Wenchao; Chen, Hu; Wu, Zhihong; Sun, Huaiqiang; Liao, Peixi; Zhang, Yi			Stacked competitive networks for noise reduction in low-dose CT	PLOS ONE			English	Article							VIEW IMAGE-RECONSTRUCTION; COMPUTED-TOMOGRAPHY; NONLOCAL MEANS; RESTORATION	Since absorption of X-ray radiation has the possibility of inducing cancerous, genetic and other diseases to patients, researches usually attempt to reduce the radiation dose. However, reduction of the radiation dose associated with CT scans will unavoidably increase the severity of noise and artifacts, which can seriously affect diagnostic confidence. Due to the outstanding performance of deep neural networks in image processing, in this paper, we proposed a Stacked Competitive Network (SCN) approach to noise reduction, which stacks several successive Competitive Blocks (CB). The carefully handcrafted design of the competitive blocks was inspired by the idea of multi-scale processing and improvement the network's capacity. Qualitative and quantitative evaluations demonstrate the competitive performance of the proposed method in noise suppression, structural preservation, and lesion detection.	[Du, Wenchao; Chen, Hu; Wu, Zhihong; Zhang, Yi] Sichuan Univ, Sch Comp Sci, Chengdu, Sichuan, Peoples R China; [Du, Wenchao; Chen, Hu; Wu, Zhihong] Sichuan Univ, Natl Key Lab Fundamental Sci Synthet Vis, Chengdu, Sichuan, Peoples R China; [Sun, Huaiqiang] Sichuan Univ, Dept Radiol, West China Hosp, Chengdu, Sichuan, Peoples R China; [Liao, Peixi] Sixth Peoples Hosp Chengdu, Dept Sci Res & Educ, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Zhang, Y (corresponding author), Sichuan Univ, Sch Comp Sci, Chengdu, Sichuan, Peoples R China.	yzhang@scu.edu.cn		Zhang, Yi/0000-0001-7201-2092	National Natural Science Foundation of China [61671312, 61302028, 61202160]; National Key R&D Program of china [2017YFB0802300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of china	This work was supported in part by the National Natural Science Foundation of China under Grants 61671312, 61302028, 61202160, and the National Key R&D Program of china under Grants 2017YFB0802300.; This work was supported in part by the National Natural Science Foundation of China under Grants 61671312, 61302028, 61202160, and the National Key R&D Program of china under Grants 2017YFB0802300.	Balda M, 2012, IEEE T MED IMAGING, V31, P1228, DOI 10.1109/TMI.2012.2187213; Bian ZY, 2013, COMPUT MED IMAG GRAP, V37, P293, DOI 10.1016/j.compmedimag.2013.05.004; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Chen H, 2017, IEEE T MED IMAGING, V36, P2524, DOI 10.1109/TMI.2017.2715284; Chen H, 2017, BIOMED OPT EXPRESS, V8, P679, DOI 10.1364/BOE.8.000679; Chen Y, 2013, PHYS MED BIOL, V58, P5803, DOI 10.1088/0031-9155/58/16/5803; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Huang J, 2011, COMPUT BIOL MED, V41, P195, DOI 10.1016/j.compbiomed.2011.01.009; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Kang E., 2016, ARXIV161009736; Kingma DP., 2014, ADAM METHOD STOCHAST; Lauzier PT, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/9/2461; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Ma JH, 2012, PHYS MED BIOL, V57, P7519, DOI 10.1088/0031-9155/57/22/7519; Ma JH, 2011, MED PHYS, V38, P5713, DOI 10.1118/1.3638125; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Sheng K, 2014, MED PHYS, V41, DOI 10.1118/1.4894714; Sidky EY, 2008, PHYS MED BIOL, V53, P4777, DOI 10.1088/0031-9155/53/17/021; Szegedy C., 2016, P IEEE C COMPUTER VI, P2818, DOI DOI 10.1109/CVPR.2016.308; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Wang SS, 2016, I S BIOMED IMAGING, P514, DOI 10.1109/ISBI.2016.7493320; Xu Q, 2012, IEEE T MED IMAGING, V31, P1682, DOI 10.1109/TMI.2012.2195669; Zeng D, 2016, IEEE T BIO-MED ENG, V63, P1044, DOI 10.1109/TBME.2015.2476371; Zhang H., 2016, ARXIV 1607 08707; Zhang Y, 2016, IEEE T COMPUT IMAG, V2, P510, DOI 10.1109/TCI.2016.2609414; Zhang Y, 2016, BIOMED OPT EXPRESS, V7, P1015, DOI 10.1364/BOE.7.001015; Zhang Y, 2014, J OPT SOC AM A, V31, P981, DOI 10.1364/JOSAA.31.000981; Zhang Y, 2013, INT J IMAG SYST TECH, V23, P249, DOI 10.1002/ima.22058; Zhang YK, 2017, MED PHYS, V44, pE230, DOI 10.1002/mp.12388	29	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190069	10.1371/journal.pone.0190069	http://dx.doi.org/10.1371/journal.pone.0190069			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267360	gold, Green Submitted, Green Published			2022-12-26	WOS:000418587400088
J	Piltch-Loeb, R; Abramson, DM; Merdjanoff, AA				Piltch-Loeb, Rachael; Abramson, David M.; Merdjanoff, Alexis A.			Risk salience of a novel virus: US population risk perception, knowledge, and receptivity to public health interventions regarding the Zika virus prior to local transmission	PLOS ONE			English	Article							MODEL; SARS; BEHAVIORS; COMMUNICATION; NETHERLANDS	Background As the incidence of Zika infection accelerated in Central and South American countries from November 2015 through April 2016, U.S. public health officials developed vector control and risk communication strategies to address mosquito-borne and sexual modes of transmission. This study reports upon U.S. perceptions of the Zika virus prior to domestic transmission, and analyzes the association of socio-economic, political, knowledge and risk factors with population receptivity to selected behavioral, environmental, and clinical intervention strategies. Methods A representative sample of 1,233 U.S. residents was drawn from address-based telephone and mobile phone lists, including an oversample of 208 women of child-bearing age living in five U.S. southern states. Data were collected between April and June, 2016, and weighted to represent U.S. population distributions. Results Overall, 78% of the U.S. population was aware of Zika prior to domestic transmission. Those unaware of the novel virus were more likely to be younger, lower income, and of Hispanic ethnicity. Among those aware of Zika, over half would delay pregnancy for a year or more in response to public health warnings; approximately one third agreed with a possible vector-control strategy of targeted indoor spraying by the government; and nearly two-thirds agreed that the government should make pregnancy-termination services available to women who learn their fetus had a Zika-related birth defect. Receptivity to these public health interventions varied by age, risk perception, and knowledge of the virus. Conclusion Risk salience and population receptivity to public health interventions targeting a novel virus can be conditioned on pre-existing characteristics in the event of an emerging infectious disease. Risk communicators should consider targeted strategies to encourage adoption of behavioral, environmental, and clinical interventions.	[Piltch-Loeb, Rachael; Abramson, David M.; Merdjanoff, Alexis A.] NYU, Coll Global Publ Hlth, New York, NY 10003 USA	New York University	Piltch-Loeb, R (corresponding author), NYU, Coll Global Publ Hlth, New York, NY 10003 USA.	Rpl5@nyu.edu			National Science Foundation RAPID grant [1638545]; NSF RAPID grant [1638545]	National Science Foundation RAPID grant; NSF RAPID grant	This work was supported by National Science Foundation RAPID grant 1638545, Abramson Pl.; Funding acknowledgment: NSF RAPID grant 1638545	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; ArboNET, 2017, ZIK CAS US; Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283; Brug J, 2004, EMERG INFECT DIS, P10; Brug J, 2009, RISK PERCRPTIONS BEH; Covello VT, 2001, J URBAN HEALTH, V78, P382, DOI 10.1093/jurban/78.2.382; FISCHHOFF B, 1978, POLICY SCI, V9, P127, DOI 10.1007/BF00143739; Griffin RJ, 1999, ENVIRON RES, V80, pS230, DOI 10.1006/enrs.1998.3940; Gursky E., 2003, BIOSECUR BIOTERROR, V1, P97; Ho SS, 2013, J HEALTH COMMUN, V18, P773, DOI 10.1080/10810730.2012.743624; Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296; Jiang XY, 2009, INT J BEHAV MED, V16, P58, DOI 10.1007/s12529-008-9005-5; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x; Lindell MK, 2012, RISK ANAL, V32, P616, DOI 10.1111/j.1539-6924.2011.01647.x; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Oster AM, 2016, MMWR-MORBID MORTAL W, P65, DOI [10.15585/mmwr.mm6505-1er, DOI 10.15585/MMWR.MM6505-1ER]; Rojek AM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0760-x; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405; Rudisill C, 2013, J RISK RES, V16, P959, DOI 10.1080/13669877.2012.761271; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Shartzer A, 2016, WOMEN REPRODUCTIVE A; Simeone RM, 2016, MMWR-MORBID MORTAL W, P65; SLOVIC P, 1979, ENVIRONMENT, V21, P14, DOI 10.1080/00139157.1979.9933091; Slovic P., 1992, PERCEPTION RISK REFL; Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004; Wenzel RP, 2003, NEW ENGL J MED, V348, P1947, DOI 10.1056/NEJMp030072; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; Zhang YG, 2009, ASIA-PAC POWER ENERG, P1371	30	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0188666	10.1371/journal.pone.0188666	http://dx.doi.org/10.1371/journal.pone.0188666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8BI	29267308	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400012
J	Silva, C; Betancor, L; Garcia, C; Astocondor, L; Hinostroza, N; Bisio, J; Rivera, J; Perezgasga, L; Escanda, VP; Yim, L; Jacobs, J; Garcia-del Portillo, F; Chabalgoity, JA; Puente, JL				Silva, Claudia; Betancor, Laura; Garcia, Coralith; Astocondor, Lizeth; Hinostroza, Noemi; Bisio, Julieta; Rivera, Javier; Perezgasga, Lucia; Perez Escanda, Victoria; Yim, Lucia; Jacobs, Jan; Garcia-del Portillo, Francisco; Chabalgoity, Jose A.; Puente, Jose L.		SalmoIber CYTED Network	Characterization of Salmonella enterica isolates causing bacteremia in Lima, Peru, using multiple typing methods	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; FLAGELLAR ANTIGENS; VIRULENCE PLASMIDS; MOLECULAR METHODS; IDENTIFICATION; TYPHIMURIUM; TYPHI; PCR; ENTERITIDIS; INFECTIONS	In this study, different molecular typing tools were applied to characterize 95 Salmonella enterica blood isolates collected between 2008 and 2013 from patients at nine public hospitals in Lima, Peru. Combined results of multiplex PCR serotyping, two- and seven-loci multi-locus sequence typing (MLST) schemes, serotyping, IS200 amplification and RAPD fingerprints, showed that these infections were caused by eight different serovars: Enteritidis, Typhimurium, Typhi, Choleraesuis, Dublin, Paratyphi A, Paratyphi B and Infantis. Among these, Enteritidis, Typhimurium and Typhi were the most prevalent, representing 45, 36 and 11% of the isolates, respectively. Most isolates (74%) were not resistant to ten primarily used antimicrobial drugs; however, 37% of the strains showed intermediate susceptibility to ciprofloxacin (ISC). Antimicrobial resistance integrons were carried by one Dublin (dfra1 and aadA1) and two Infantis (aadA1) isolates. The two Infantis isolates were multidrug resistant and harbored a large megaplasmid. Amplification of spvC and spvRA regions showed that all Enteritidis (n = 42), Typhimurium (n = 34), Choleraesuis (n = 3) and Dublin (n = 1) isolates carried the Salmonella virulence plasmid (pSV). We conclude that the classic serotyping method can be substituted by the multiplex PCR and, when necessary, sequencing of only one or two loci of the MLST scheme is a valuable tool to confirm the results. The effectiveness and feasibility of different typing tools is discussed.	[Silva, Claudia; Perezgasga, Lucia; Puente, Jose L.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Microbiol Mol, Cuernavaca, Morelos, Mexico; [Betancor, Laura; Bisio, Julieta; Perez Escanda, Victoria; Yim, Lucia; Chabalgoity, Jose A.] Univ Republica, Fac Med, Inst Higiene, Montevideo, Uruguay; [Garcia, Coralith; Astocondor, Lizeth; Hinostroza, Noemi] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander Humboldt, Lima, Peru; [Rivera, Javier] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Programa Ingn Genom, Cuernavaca, Morelos, Mexico; [Jacobs, Jan] Inst Trop Med Antwerp, Antwerp, Belgium; [Garcia-del Portillo, Francisco] CNB CSIC, Lab Patogenos Bacterianos Intracelulares, Madrid, Spain	Universidad Nacional Autonoma de Mexico; Universidad de la Republica, Uruguay; Universidad Peruana Cayetano Heredia; Universidad Nacional Autonoma de Mexico; Institute of Tropical Medicine (ITM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Silva, C (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Microbiol Mol, Cuernavaca, Morelos, Mexico.	csilvamex1@yahoo.com	García-del Portillo, Francisco/D-2576-2009; Jacobs, Jan/GRX-7316-2022	Silva, Claudia/0000-0003-0104-8412; Garcia-del Portillo, Francisco/0000-0002-4120-0530; Hinostroza, Noemi/0000-0002-9651-9549; Puente, Jose/0000-0002-8411-4974	DGAPA [IN213516]; CONACyT [239659, FC-2015-2/950]; Directorate General for Development Cooperation of the Belgian Government [95502]; Programa I beroamericano de Ciencia y Tecnologia para el Desarrollo (CYTED) [215RT0493]; Spanish Ministry of Economy, Industry and Competitiveness; European Regional Funds for Development [B102016-77639-P]; Comision Sectorial de Investigacion Cientifica (CSIC), Universidad de la Repliblica (Proyecto Grupos I+D);  [FC-2015-2/879]	DGAPA; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Directorate General for Development Cooperation of the Belgian Government; Programa I beroamericano de Ciencia y Tecnologia para el Desarrollo (CYTED); Spanish Ministry of Economy, Industry and Competitiveness; European Regional Funds for Development; Comision Sectorial de Investigacion Cientifica (CSIC), Universidad de la Repliblica (Proyecto Grupos I+D); 	This work was supported by: DGAPA IN213516 and CONACyT 239659 and FC-2015-2/950 to JLP; Directorate General for Development Cooperation of the Belgian Government (Framework Agreement 3, Project 95502) to CG; Programa I beroamericano de Ciencia y Tecnologia para el Desarrollo (CYTED, 215RT0493) and Spanish Ministry of Economy, Industry and Competitiveness and European Regional Funds for Development (B102016-77639-P (MINECO/FEDER) to FGP; and Comision Sectorial de Investigacion Cientifica (CSIC), Universidad de la Repliblica (Proyecto Grupos I+D 2014) to LB and LY. CS was supported by FC-2015-2/879. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accou-Demartin M, 2011, EMERG INFECT DIS, V17, P1091, DOI [10.3201/eid1706.101242, 10.3201/eid/1706.101242]; Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Al-Emran HM, 2016, CLIN INFECT DIS, V62, pS80, DOI 10.1093/cid/civ782; Aviv G, 2016, MBIO, V7, DOI 10.1128/mBio.01395-16; Aviv G, 2014, ENVIRON MICROBIOL, V16, P977, DOI 10.1111/1462-2920.12351; Betancor L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-237; Calva E, 1997, J CLIN MICROBIOL, V35, P3048, DOI 10.1128/JCM.35.12.3048-3053.1997; Campioni F, 2015, APMIS, V123, P422, DOI 10.1111/apm.12367; Chiu CH, 1996, J CLIN MICROBIOL, V34, P2619, DOI 10.1128/JCM.34.10.2619-2622.1996; Chiu CH, 2000, MICROBIOL IMMUNOL, V44, P741, DOI 10.1111/j.1348-0421.2000.tb02558.x; CLSI, 2016, M2A9 CLSI; CLSI, 2017, M100S25 CLSI; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Echeita MA, 2002, RES MICROBIOL, V153, P107, DOI 10.1016/S0923-2508(01)01295-5; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Fabrega A, 2013, CLIN MICROBIOL REV, V26, P308, DOI 10.1128/CMR.00066-12; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feng Y, 2012, INFECT GENET EVOL, V12, P1058, DOI 10.1016/j.meegid.2012.03.004; FIERER J, 1992, J INFECT DIS, V166, P639, DOI 10.1093/infdis/166.3.639; Fluit AC, 2005, FEMS IMMUNOL MED MIC, V43, P1, DOI 10.1016/j.femsim.2004.10.007; Fluit AC, 1999, EUR J CLIN MICROBIOL, V18, P761, DOI 10.1007/s100960050398; Foley SL, 2007, FOODBORNE PATHOG DIS, V4, P253, DOI 10.1089/fpd.2007.0085; Franco A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144802; Garcia C, 2014, J CLIN MICROBIOL, V52, P968, DOI 10.1128/JCM.02663-13; Guibourdenche M, 2010, RES MICROBIOL, V161, P26, DOI 10.1016/j.resmic.2009.10.002; Guiney DG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00129; GULIG PA, 1990, MICROB PATHOGENESIS, V8, P3, DOI 10.1016/0882-4010(90)90003-9; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Herrera-Leon S, 2004, J CLIN MICROBIOL, V42, P2581, DOI 10.1128/JCM.42.6.2581-2586.2004; Herrera-Leon S, 2007, RES MICROBIOL, V158, P122, DOI 10.1016/j.resmic.2006.09.009; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; KIESER T, 1984, PLASMID, V12, P19, DOI 10.1016/0147-619X(84)90063-5; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Koser CU, 2014, TRENDS GENET, V30, P401, DOI 10.1016/j.tig.2014.07.003; Leverstein-van Hall MA, 2003, J INFECT DIS, V187, P251, DOI 10.1086/345880; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Lin AW, 1996, J CLIN MICROBIOL, V34, P870, DOI 10.1128/JCM.34.4.870-876.1996; MacFadden DR, 2016, CURR OPIN INFECT DIS, V29, P453, DOI 10.1097/QCO.0000000000000302; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Martin LJ, 2004, J INFECT DIS, V189, P377, DOI 10.1086/381270; Martinez-Gamboa A, 2015, INT MICROBIOL, V18, P99, DOI 10.2436/20.1501.01.239; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Parry CM, 2008, CURR OPIN INFECT DIS, V21, P531, DOI 10.1097/QCO.0b013e32830f453a; Retamal P, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00464; Rolhion N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005653; Rotger R, 1999, Int Microbiol, V2, P177; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Shi CL, 2015, CRIT REV MICROBIOL, V41, P309, DOI 10.3109/1040841X.2013.837862; Silva C, 2012, SALMONELLA DIVERSIFI, P231; Singh A, 2006, CLIN MICROBIOL REV, V19, P512, DOI 10.1128/CMR.00025-05; Tennant SM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000621; Varma JK, 2005, EMERG INFECT DIS, V11, P943; Wattiau P, 2011, APPL ENVIRON MICROB, V77, P7877, DOI 10.1128/AEM.05527-11; Wiesner M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-131; Zamudio M.L., 2011, PERU REV PERU MED EX, V28, P128, DOI DOI 10.1590/S1726-46342011000100020	57	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189946	10.1371/journal.pone.0189946	http://dx.doi.org/10.1371/journal.pone.0189946			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267322	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400069
J	Skowronski, AA; Ravussin, Y; Leibel, RL; LeDuc, CA				Skowronski, Alicja A.; Ravussin, Yann; Leibel, Rudolph L.; LeDuc, Charles A.			Energy homeostasis in leptin deficient Lep(ob/ob) mice	PLOS ONE			English	Article							REDUCED BODY-WEIGHT; OB-OB MICE; INSULIN-SECRETION; ADAPTIVE THERMOGENESIS; DIABETES-MELLITUS; PANCREATIC-ISLETS; OB/OB MICE; EXPENDITURE; OBESE; FAT	Maintenance of reduced body weight is associated both with reduced energy expenditure per unit metabolic mass and increased hunger in mice and humans. Lowered circulating leptin concentration, due to decreased fat mass, provides a primary signal for this response. However, leptin deficient (Lep(ob/ob)) mice (and leptin receptor deficient Zucker rats) reduce energy expenditure following weight reduction by a necessarily non-leptin dependent mechanisms. To identify these mechanisms, Lep(ob/ob) mice were fed ad libitum (AL group; n = 21) or restricted to 3 kilocalories of chow per day (CR group, n = 21). After losing 20% of initial weight (in approximately 2 weeks), the CR mice were stabilized at 80% of initial body weight for two weeks by titrated refeeding, and then released from food restriction. CR mice conserved energy (-17% below predicted based on body mass and composition during the day; -52% at night); and, when released to ad libitum feeding, CR mice regained fat and lean mass (to AL levels) within 5 weeks. CR mice did so while their ad libitum caloric intake was equal to that of the AL animals. While calorically restricted, the CR mice had a significantly lower respiratory exchange ratio (RER = 0.89) compared to AL (0.94); after release to ad libitum feeding, RER was significantly higher (1.03) than in the AL group (0.93), consistent with their anabolic state. These results confirm that, in congenitally leptin deficient animals, leptin is not required for compensatory reduction in energy expenditure accompanying weight loss, but suggest that the hyperphagia of the weight-reduced state is leptin-dependent.	[Skowronski, Alicja A.; Leibel, Rudolph L.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA; [Skowronski, Alicja A.; Ravussin, Yann] Columbia Univ, Dept Med, New York, NY USA; [Leibel, Rudolph L.; LeDuc, Charles A.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Leibel, Rudolph L.; LeDuc, Charles A.] Columbia Univ, Obes Res Core, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	LeDuc, CA (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10027 USA.; LeDuc, CA (corresponding author), Columbia Univ, Obes Res Core, New York, NY 10032 USA.	cal8@cumc.columbia.edu	Ravussin, Yann/AAE-1440-2020; Ravussin, Yann/ABE-8061-2021	Ravussin, Yann/0000-0002-6699-3944; LeDuc, Charles/0000-0002-2073-5050	NYNORC [5P30DK026687]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687] Funding Source: NIH RePORTER	NYNORC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	CAL received a P&F grant from the NYNORC (5P30DK026687) that supported this work. RLL and CAL work for the MBMG core of the NYNORC (5P30DK026687).	Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Bolze F, 2016, ENDOCRINOLOGY, V157, P233, DOI 10.1210/en.2015-1519; Bouchard C, 1997, J NUTR, V127, pS943, DOI 10.1093/jn/127.5.943S; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Chiba T, 2009, MOL CELL ENDOCRINOL, V309, P17, DOI 10.1016/j.mce.2009.05.001; COLEMAN DL, 1973, DIABETOLOGIA, V9, P294, DOI 10.1007/BF01221857; COLEMAN DL, 1974, DIABETOLOGIA, V10, P607, DOI 10.1007/BF01221993; Cortes VA, 2014, J LIPID RES, V55, P276, DOI 10.1194/jlr.M045799; Doring H, 1998, INT J OBESITY, V22, P83, DOI 10.1038/sj.ijo.0800547; DUBUC PU, 1979, METABOLISM, V28, P633, DOI 10.1016/0026-0495(79)90016-7; DUBUC PU, 1976, METABOLISM, V25, P1567, DOI 10.1016/0026-0495(76)90109-8; Ellacott KLJ, 2010, CELL METAB, V12, P10, DOI 10.1016/j.cmet.2010.06.001; Emilsson V, 1997, DIABETES, V46, P313, DOI 10.2337/diabetes.46.2.313; Evans SA, 2005, AM J PHYSIOL-REG I, V288, pR1468, DOI 10.1152/ajpregu.00602.2004; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Fruhbeck G, 2001, FASEB J, V15, P1996, DOI 10.1096/fj.00-0829hyp; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Halldorsdottir Solveig, 2009, Int J Body Compos Res, V7, P147; Hambly C, 2012, DIS MODEL MECH, V5, P83, DOI 10.1242/dmm.007781; Harris RBS, 2002, AM J PHYSIOL-REG I, V283, pR1094, DOI 10.1152/ajpregu.00339.2002; Harris RBS, 1999, ENDOCRINOLOGY, V140, P138, DOI 10.1210/en.140.1.138; Hernandez TL, 2011, OBESITY, V19, P1388, DOI 10.1038/oby.2011.64; Kaiyala KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119391; Kaiyala KJ, 2011, DIABETES, V60, P17, DOI 10.2337/db10-0909; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kulkarni RN, 1997, J CLIN INVEST, V100, P2729, DOI 10.1172/JCI119818; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; McNay DEG, 2013, MOL METAB, V2, P103, DOI 10.1016/j.molmet.2012.10.003; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Phan LK, 2006, AM J PHYSIOL-ENDOC M, V291, pE611, DOI 10.1152/ajpendo.00034.2006; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; POLONSKY KS, 1988, J CLIN INVEST, V81, P435, DOI 10.1172/JCI113338; Ravussin Y, 2013, INT J OBESITY, V37, P399, DOI 10.1038/ijo.2012.105; Ravussin Y, 2011, AM J PHYSIOL-REG I, V300, pR1352, DOI 10.1152/ajpregu.00429.2010; Ravussin Y, 2012, AM J PHYSIOL-REG I, V303, pR438, DOI 10.1152/ajpregu.00092.2012; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Rosenbaum M, 2000, AM J CLIN NUTR, V71, P1421; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; Seufert J, 1999, J CLIN ENDOCR METAB, V84, P670, DOI 10.1210/jc.84.2.670; Seufert J, 1999, P NATL ACAD SCI USA, V96, P674, DOI 10.1073/pnas.96.2.674; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Sims E A, 1973, Recent Prog Horm Res, V29, P457; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Virtue S, 2012, CELL METAB, V16, P665, DOI 10.1016/j.cmet.2012.10.008; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378	52	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189784	10.1371/journal.pone.0189784	http://dx.doi.org/10.1371/journal.pone.0189784			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261744	Green Published, gold, Green Submitted			2022-12-26	WOS:000418564200066
J	Tanaka, Y; Abella, J; Aguirre-Fernandez, G; Gregori, M; Fordyce, RE				Tanaka, Yoshihiro; Abella, Juan; Aguirre-Fernandez, Gabriel; Gregori, Maria; Fordyce, R. Ewan			A new tropical Oligocene dolphin from Montanita/Olon, Santa Elena, Ecuador	PLOS ONE			English	Article							UPPER MIOCENE; AGOROPHIUS-PYGMAEUS; CETACEA; ODONTOCETI; MAMMALIA; JAPAN; DELPHINOIDEA; PHOCOENIDAE; MORPHOLOGY; PHYLOGENY	A new small probable Oligocene dolphin from Ecuador represents a new genus and species, Urkudelphis chawpipacha. The new taxon is known from a single juvenile skull and earbones; it differs from other archaic dolphins in features including widely exposed frontals at the vertex, a dorsally wide open vomer at the mesorostral groove, and a strongly projected and pointed lateral tuberosity of the periotic. Phylogenetic analysis places it toward the base of the largely-extinct clade Platanistoidea. The fossil is one of a few records of tropical fossil dolphins.	[Tanaka, Yoshihiro] Osaka Museum Nat Hist, Osaka, Japan; [Tanaka, Yoshihiro] Numata Fossil Museum, Numata Town, Hokkaido, Japan; [Tanaka, Yoshihiro] Hokkaido Univ Museum, Div Acad Resources & Specimens, Sapporo, Hokkaido, Japan; [Abella, Juan; Gregori, Maria] Univ Estatal Peninsula Santa Elena, Fac Ciencias Mar, Santa Elena, Ecuador; [Abella, Juan] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, Edifici ICP,Campus UAB, Barcelona, Spain; [Aguirre-Fernandez, Gabriel] Univ Zurich, Paleontol Inst & Museum, Zurich, Switzerland; [Fordyce, R. Ewan] Univ Otago, Dept Geol, Dunedin, New Zealand; [Fordyce, R. Ewan] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Fordyce, R. Ewan] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA	Hokkaido University; Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); University of Zurich; University of Otago; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History	Tanaka, Y (corresponding author), Osaka Museum Nat Hist, Osaka, Japan.; Tanaka, Y (corresponding author), Numata Fossil Museum, Numata Town, Hokkaido, Japan.; Tanaka, Y (corresponding author), Hokkaido Univ Museum, Div Acad Resources & Specimens, Sapporo, Hokkaido, Japan.	tanaka@mus-nh.city.osaka.jp	Aguirre-Fernández, Gabriel/GXV-5147-2022; Abella, Juan/AAB-1040-2020	Abella, Juan/0000-0002-3433-6093; Gregori, Maria/0000-0003-2845-9238; Tanaka, Yoshihiro/0000-0001-9598-5583	UPSE project [IN-P5-2016-1]; Agencia Estatal de Investigacion (AEI) from Spain; European Regional Development Fund of the European Union [CGL2016-76431-P]; MINECO/FEDER, UE [CGL201568333]	UPSE project; Agencia Estatal de Investigacion (AEI) from Spain; European Regional Development Fund of the European Union; MINECO/FEDER, UE	This study was supported by an UPSE project IN-P5-2016-1 for equipment at UPSE, and YT thanks support of a trip to Ecuador. This work has also been supported by the Agencia Estatal de Investigacion (AEI) from Spain and the European Regional Development Fund of the European Union (CGL2016-76431-P) and the project CGL201568333 (MINECO/FEDER, UE).r JA thanks the Marine Biology students and staff from UPSE, who actively participated in the fieldwork, and the "Comuna de Montaffita" and "Comuna de Olen" for their support. JA wishes to thank the "Proyecto Prometeo" of the "Secretaria de Educacion Superior, Ciencia Tecnologia e Innovacion", and the Instituto Nacional de Patrimonio cultural, Republic of Ecuador. JA thanks Cesar Witt (Lille 1 University, France) for discussing the geological age. This study was supported by an UPSE project IN-P5-2016-1 for equipment at UPSE, and YT thanks the project for the support of a trip to Ecuador. We thank Thomas J. DeVries (Burke Museum of Natural History and Culture, University of Washington, Seattle, WA USA), Mario Urbina and Ali Altamirano (Departamento de Paleontologia de Vertebrados, Museo de Historia Natural, Universidad Nacional Mayor de San Marcos, Lima) for providing Peruvian shark age and stratigraphic information. We particularly thank the journal referees, G. Bianucci and O. Lambert, and the academic editor G. J. Vermeij for constructive suggestions.	Aguirre-Fernandez G, 2017, J MAMM EVOL, V24, P71, DOI 10.1007/s10914-016-9353-x; [Anonymous], 2009, MEXICO; Arnold Peter W., 1996, Memoirs of the Queensland Museum, V39, P141; Barnes L.G., 1990, P3; Barnes Lawrence G., 2006, Beitraege zur Palaeontologie, V30, P25; BARNES LG, 1985, MAR MAMMAL SCI, V1, P149, DOI 10.1111/j.1748-7692.1985.tb00003.x; Bianucci G, 2005, RIV ITAL PALEONTOL S, V111, P345, DOI 10.13130/2039-4942/6325; Bianucci G, 2006, CR PALEVOL, V5, P945, DOI 10.1016/j.crpv.2006.06.001; Bianucci G, 2006, PALAEOGEOGR PALAEOCL, V242, P326, DOI 10.1016/j.palaeo.2006.07.004; Bianucci G, 2016, J MAPS, V12, P1037, DOI 10.1080/17445647.2015.1115785; Boersma AT, 2016, PEERJ, V4, DOI 10.7717/peerj.2321; BRISTOW C R, 1975, Newsletters on Stratigraphy, V4, P119; Churchill M, 2016, CURR BIOL, V26, P2144, DOI 10.1016/j.cub.2016.06.004; Cotten PB, 2008, J MORPHOL, V269, P1520, DOI 10.1002/jmor.10668; Cozzi B, 2015, ANAT REC, V298, P1294, DOI 10.1002/ar.23120; de Muizon C., 1987, AM MUS NOVIT, V2904, P1; del Castillo DL, 2014, J MORPHOL, V275, P1366, DOI 10.1002/jmor.20309; DEMUIZON C, 1985, CR ACAD SCI II, V301, P359; Devries TJ, 2016, ACTA PALAEONTOL POL, V61, P661, DOI 10.4202/app.00228.2015; Di Celma C, 2017, RIV ITAL PALEONTOL S, V123, P255, DOI 10.13130/2039-4942/8373; Dubrovo IA, 2000, J VERTEBR PALEONTOL, V20, P577, DOI 10.1671/0272-4634(2000)020[0577:ANSOPM]2.0.CO;2; Fajardo-Mellor L, 2006, MAR MAMMAL SCI, V22, P910, DOI 10.1111/j.1748-7692.2006.00080.x; Fordyce R. Ewan, 2002, Smithsonian Contributions to Paleobiology, V93, P185; Fordyce R. Ewan, 2003, P154; Fordyce R. Ewan, 1994, Proceedings of the San Diego Society of Natural History, V29, P147; FORDYCE RE, 1981, J PALEONTOL, V55, P1028; FORDYCE RE, 1980, PALAEOGEOGR PALAEOCL, V31, P319, DOI 10.1016/0031-0182(80)90024-3; Geisler Jonathan H., 2003, Journal of Mammalian Evolution, V10, P23, DOI 10.1023/A:1025552007291; Geisler JH, 2014, NATURE, V508, P383, DOI 10.1038/nature13086; Geisler JH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-112; Godfrey SJ, 2016, J PALEONTOL, V90, P154, DOI 10.1017/jpa.2016.4; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Heyning JE, 1997, MAR MAMMAL SCI, V13, P596, DOI 10.1111/j.1748-7692.1997.tb00086.x; HEYNING JE, 1989, CONTRIBUTIONS SCI NA, V405, P1; Iturralde-Vinent MA, 1999, B AM MUS NAT HIST, P1; Jaillard E, 1995, BASIN DEV ACCRETIONA, P615; Kasuya T., 1973, Scientific Rep Whales Res Inst Tokyo, VNo. 25, P1; Kellogg AR., 1936, CARNEGIE I WASHINGTO, V482, P1; Kimura Toshiyuki, 2016, Bulletin of Gunma Museum of Natural History, V20, P1; Lambert O, 2005, PALAEONTOLOGY, V48, P653, DOI 10.1111/j.1475-4983.2005.00472.x; Lambert O, 2008, CR PALEVOL, V7, P361, DOI 10.1016/j.crpv.2008.06.002; Lambert O, 2018, J SYST PALAEONTOL, V16, P981, DOI 10.1080/14772019.2017.1359689; Lambert O, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1530; Lambert O, 2015, GEODIVERSITAS, V37, P79, DOI 10.5252/g2015n1a4; Lambert Olivier, 2005, Deinsea (Rotterdam), P7; Lydekker R., 1893, P ZOOL SOC LOND, V1892, P558; Maddison W.P., MESQUITE MODULAR SYS; Marx FG, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170560; Marx FG, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140434; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; Mead James G., 2009, Smithsonian Contributions to Zoology, P1; Messenger SL, 1998, SYST BIOL, V47, P90, DOI 10.1080/106351598261058; Muizon C., 1991, B MUS NATL HIST NA C, V12, P279; Murakami M, 2014, J VERTEBR PALEONTOL, V34, P491, DOI 10.1080/02724634.2013.816720; Murakami M, 2012, J VERTEBR PALEONTOL, V32, P1157, DOI 10.1080/02724634.2012.677299; Murakami M, 2012, J VERTEBR PALEONTOL, V32, P1172, DOI 10.1080/02724634.2012.694337; Nielsen SN, 2009, GEOBIOS-LYON, V42, P73, DOI 10.1016/j.geobios.2008.07.006; Olsson A.A., 1931, BULL AM PALEONTOL, V17, P97; Perrin WF., 1975, B SCRIPPS I OCEANOGR, V21; Pyenson ND, 2011, J MAMM EVOL, V18, P269, DOI 10.1007/s10914-011-9170-1; ROTHAUSEN K, 1968, Palaeontologische Zeitschrift, V42, P83; Sanders AE, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.890107; Seagars D., 1982, JAW STRUCTURE FUNCTI, P179; Slater GJ, 2010, P ROY SOC B-BIOL SCI, V277, P3097, DOI 10.1098/rspb.2010.0408; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; Tanaka Y, 2016, NEW ZEAL J GEOL GEOP, V59, P551, DOI 10.1080/00288306.2016.1211540; Tanaka Y, 2015, J ROY SOC NEW ZEAL, V45, P135, DOI 10.1080/03036758.2015.1016046; Tanaka Y., 2015, PALAEONTOL ELECTRON, P1; Tanaka Y, 2017, J SYST PALAEONTOL, V15, P365, DOI 10.1080/14772019.2016.1202339; Tanaka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107972; Uhen MD, 2007, PALAEONTOL ELECTRON, V10; Uhen MD, 2010, ANNU REV EARTH PL SC, V38, P189, DOI 10.1146/annurev-earth-040809-152453; Uhen MD, 2008, J SYST PALAEONTOL, V6, P433, DOI 10.1017/S1477201908002472; WHITMORE FC, 1976, SYST ZOOL, V25, P304, DOI 10.2307/2412507; Whittaker J.E., 1988, BENTHIC CENOZOIC FOR; Wilson LE, 1935, MIOCENE MARINE MAMMA	77	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0188380	10.1371/journal.pone.0188380	http://dx.doi.org/10.1371/journal.pone.0188380			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261688	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000418564200009
J	Akgul, A; Al-Janabi, N; Das, B; Lawrence, M; Karsi, A				Akgul, Ali; Al-Janabi, Nawar; Das, Bhaskar; Lawrence, Mark; Karsi, Attila			Small molecules targeting LapB protein prevent Listeria attachment to catfish muscle	PLOS ONE			English	Article							MULTICOPY SOLUBLE-RNA; STAINLESS-STEEL; RHABDOID TUMORS; MONOCYTOGENES; VIRULENCE; DERIVATIVES; EXPRESSION; STRAINS; DESIGN; INOCULATION	Listeria monocytogenes is a Gram-positive foodborne pathogen and the causative agent of listeriosis. L. monocytogenes lapB gene encodes a cell wall surface anchor protein, and mutation of this gene causes Listeria attenuation in mice. In this work, the potential role of Listeria LapB protein in catfish fillet attachment was investigated. To achieve this, boron-based small molecules designed to interfere with the active site of the L. monocytogenes LapB protein were developed, and their ability to prevent L. monocytogenes attachment to fish fillet was tested. Results indicated that seven out of nine different small molecules were effective in reducing the Listeria attachment to catfish fillets. Of these, three small molecules (SM3, SM5, and SM7) were highly effective in blocking Listeria attachment to catfish fillets. This study suggests an alternative strategy for reduction of L. monocytogenes contamination in fresh and frozen fish products.	[Akgul, Ali; Al-Janabi, Nawar; Lawrence, Mark; Karsi, Attila] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Das, Bhaskar] Icahn Sch Med Mt Sinai, Dept Med & Pharmacol Sci, New York, NY 10029 USA	Mississippi State University; Icahn School of Medicine at Mount Sinai	Karsi, A (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.; Das, B (corresponding author), Icahn Sch Med Mt Sinai, Dept Med & Pharmacol Sci, New York, NY 10029 USA.	bhaskar.das@mssm.edu; karsi@cvm.msstate.edu	Karsi, Attila/AAG-5046-2019	Karsi, Attila/0000-0001-6845-3346	USDA-ARS [58-6402-2729, MIS501170]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was funded by USDA-ARS Agreement #58-6402-2729, which is operated under USDA CRIS project MIS501170, Mississippi Center for Food Safety and Post-Harvest Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour AH, 2001, INFECT IMMUN, V69, P4657, DOI 10.1128/IAI.69.7.4657-4660.2001; Behravesh CB, 2011, J INFECT DIS, V204, P263, DOI 10.1093/infdis/jir263; Boivin T, 2016, APPL ENVIRON MICROB, V82, P6768, DOI 10.1128/AEM.01908-16; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Das BC, 2008, BIOORG MED CHEM LETT, V18, P4177, DOI 10.1016/j.bmcl.2008.05.097; Das BC, 2008, BIOORG MED CHEM LETT, V18, P3805, DOI 10.1016/j.bmcl.2008.05.021; Das BC, 2013, FUTURE MED CHEM, V5, P653, DOI [10.4155/FMC.13.38, 10.4155/fmc.13.38]; Das BC, 2010, TETRAHEDRON LETT, V51, P1462, DOI 10.1016/j.tetlet.2010.01.003; Das BC, 2009, CHEM COMMUN, P2133, DOI 10.1039/b823063c; Das BC, 2009, TETRAHEDRON LETT, V50, P3031, DOI 10.1016/j.tetlet.2009.04.003; Flint SH, 1997, J APPL MICROBIOL, V83, P508, DOI 10.1046/j.1365-2672.1997.00264.x; Hansen CH, 2006, J FOOD PROTECT, V69, P2113, DOI 10.4315/0362-028X-69.9.2113; Howe K, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-197; Jagadeesan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020694; Karsi A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-10; Kim SH, 2004, INFECT IMMUN, V72, P4318, DOI 10.1128/IAI.72.7.4318-4321.2004; LINNAN MJ, 1988, NEW ENGL J MED, V319, P823, DOI 10.1056/NEJM198809293191303; Little CL, 2010, FOODBORNE PATHOG DIS, V7, P749, DOI 10.1089/fpd.2009.0439; Mengaud J, 1996, INFECT IMMUN, V64, P5430, DOI 10.1128/IAI.64.12.5430-5433.1996; Miya S, 2010, APPL ENVIRON MICROB, V76, P3383, DOI 10.1128/AEM.01456-09; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Norton DM, 2001, APPL ENVIRON MICROB, V67, P646, DOI 10.1128/AEM.67.2.646-653.2001; Parkar SG, 2001, J APPL MICROBIOL, V90, P901, DOI 10.1046/j.1365-2672.2001.01323.x; Popowska Magdalena, 2004, Polish Journal of Microbiology, V53, P75; Reddy S, 2016, MICROB PATHOGENESIS, V92, P19, DOI 10.1016/j.micpath.2015.12.012; Roche SM, 2003, INFECT IMMUN, V71, P3429, DOI 10.1128/IAI.71.6.3429-3436.2003; Salehi S, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0781-9; SHINEMAN TL, 1994, J FOOD PROTECT, V57, P1057, DOI 10.4315/0362-028X-57.12.1057; Sievers S, 2015, RNA BIOL, V12, P985, DOI 10.1080/15476286.2015.1071011; Sievers S, 2014, NUCLEIC ACIDS RES, V42, P9383, DOI 10.1093/nar/gku630; Soriano-Ursua MA, 2014, EXPERT OPIN THER PAT, V24, P485, DOI 10.1517/13543776.2014.881472; Steele CL, 2011, J BACTERIOL, V193, P3679, DOI 10.1128/JB.05236-11; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; TAPPERO JW, 1995, JAMA-J AM MED ASSOC, V273, P1118, DOI 10.1001/jama.273.14.1118; Torregroza I, 2009, CHEM BIOL DRUG DES, V73, P339, DOI 10.1111/j.1747-0285.2009.00782.x; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Wang LR, 2008, MICROBIOL-SGM, V154, P1900, DOI 10.1099/mic.0.2007/015172-0; Werbrouck H, 2008, ZOONOSES PUBLIC HLTH, V55, P242, DOI 10.1111/j.1863-2378.2008.01127.x	38	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189809	10.1371/journal.pone.0189809	http://dx.doi.org/10.1371/journal.pone.0189809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253892	gold, Green Submitted, Green Published			2022-12-26	WOS:000418389500064
J	Xu, K; Wang, CM; Yang, XT				Xu, Ke; Wang, Chunmei; Yang, Xintong			Five-year study of the effects of simulated nitrogen deposition levels and forms on soil nitrous oxide emissions from a temperate forest in northern China	PLOS ONE			English	Article							N2O FLUXES; INORGANIC NITROGEN; SANJIANG PLAIN; INNER-MONGOLIA; NITRIC-OXIDE; GAS FLUXES; WATER; DENITRIFICATION; ECOSYSTEMS; INPUT	Few studies have quantified the effects of different levels and forms of nitrogen (N) deposition on soil nitrous oxide (N2O) emissions from temperate forest soils. A 5-year field experiment was conducted to investigate the effects of multiple forms and levels of N additions on soil N2O emissions, by using the static closed chamber method at Xi Mountain Experimental Forest Station in northern China. The experiment included a control (no N added), and additions of NH4NO3, NaNO3, and (NH4)(2)SO4 that each had two levels: 50 kg N ha(-1) yr(-1) and 150 kg N ha(-1) yr(-1). All plots were treated to simulate increased N deposition on a monthly schedule during the annual growing season (March to October) and soil N2O emissions were measured monthly from March 2011 to February 2016. Simultaneously, the temperature, moisture, and inorganic N contents of soil were also measured to explore how the main factors may have affected soil N2O emission. The results showed that the types and levels of N addition significantly increased soil inorganic N contents, and the accumulation of soil NO3--N was significantly higher than that of soil NH4+-N due to N addition. The three N forms significantly increased the average N2O emissions (P < 0.05) in the order of NH4NO3 > (NH4)(2)SO4 > NaNO3 by 355.95%, 266.35%, and 187.71%, respectively, compared with control. The promotion of N2O emission via the NH4+-N addition was significantly more than that via the NO3--N addition, while N addition at a high level exerted a stronger effect than at the low-level. N addition exerted significantly stronger effects on cumulative N2O emissions in the initial years, especially the third year when the increased cumulative N2O emission reached their maximum. In the later years, the increases persisted but were weakened. Increasing inorganic N concentration could change soil from being N-limited to N-rich, and then N-saturated, and so the promotion on soil available N effect increased and then decreased. Moreover, the soil NH4+-N, NO3--N, temperature, and water-filled pore space were all positively correlated with soil N2O emissions. These findings suggest that atmospheric N deposition can significantly promote soil N2O emission, and that exogenous NH4+-N and NO3--N inputs into temperate forests can have synergic effects on soil N2O emission. In future research, both aspects should be better distinguished in the N cycle and balance of terrestrial ecosystems by using N-15 tracer methods.	[Xu, Ke; Wang, Chunmei; Yang, Xintong] Beijing Forestry Univ, Coll Environm Sci & Engn, Beijing, Peoples R China; [Xu, Ke] Beijing Environm Sanitat Engn Grp Co Ltd, Beijing Solid Waste Treatment Co Ltd, Beijing, Peoples R China	Beijing Forestry University	Wang, CM (corresponding author), Beijing Forestry Univ, Coll Environm Sci & Engn, Beijing, Peoples R China.	sdwcm@126.com						Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Bai E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102765; Bijoor NS, 2008, GLOBAL CHANGE BIOL, V14, P2119, DOI 10.1111/j.1365-2486.2008.01617.x; Buckeridge KM, 2010, BIOGEOCHEMISTRY, V99, P127, DOI 10.1007/s10533-009-9396-7; Butterbach-Bahl K, 1998, ATMOS ENVIRON, V32, P559, DOI 10.1016/S1352-2310(97)00234-3; Chen GC, 2012, SOIL BIOL BIOCHEM, V48, P175, DOI 10.1016/j.soilbio.2012.01.029; Chen H, 2015, ENVIRON POLLUT, V206, P352, DOI 10.1016/j.envpol.2015.07.033; Dalal RC, 2003, AUST J SOIL RES, V41, P165, DOI 10.1071/SR02064; [党旭升 Dang Xusheng], 2015, [生态学报, Acta Ecologica Sinica], V35, P6530; DAVIDSON EA, 1992, SOIL SCI SOC AM J, V56, P95, DOI 10.2136/sssaj1992.03615995005600010015x; Dong YS, 2000, CHINESE SCI BULL, V45, P1590, DOI 10.1007/BF02886219; Drastig K, 2015, ARCH AGRO SOIL SCI, V61, P1; Edith B, 2014, PLOS ONE, V9; Fang HJ, 2011, BIOGEOCHEMISTRY, V102, P251, DOI 10.1007/s10533-010-9438-1; Fang YT, 2008, BIOGEOSCIENCES, V5, P339, DOI 10.5194/bg-5-339-2008; Fang YT, 2009, ECOSYSTEMS, V12, P33, DOI 10.1007/s10021-008-9203-7; Gao YC, 2014, SOIL SCI PLANT NUTR, V60, P404, DOI 10.1080/00380768.2014.893812; GROFFMAN PM, 1987, PLANT SOIL, V97, P445, DOI 10.1007/BF02383235; Gundersen P, 1998, FOREST ECOL MANAG, V101, P37, DOI 10.1016/S0378-1127(97)00124-2; Hefting MM, 2003, J ENVIRON QUAL, V32, P1194, DOI 10.2134/jeq2003.1194; Hodge A, 2000, TRENDS PLANT SCI, V5, P304, DOI 10.1016/S1360-1385(00)01656-3; Jassal RS, 2008, GLOBAL CHANGE BIOL, V14, P1305, DOI 10.1111/j.1365-2486.2008.01573.x; Jiang CM, 2010, ATMOS ENVIRON, V44, P2920, DOI 10.1016/j.atmosenv.2010.03.030; Kim DG, 2013, AGR ECOSYST ENVIRON, V168, P53, DOI 10.1016/j.agee.2012.02.021; Kuzyakov Y, 2013, NEW PHYTOL, V198, P656, DOI 10.1111/nph.12235; Li KH, 2012, GLOBAL CHANGE BIOL, V18, P2546, DOI 10.1111/j.1365-2486.2012.02704.x; Liu DY, 2010, ENVIRON EARTH SCI, V60, P799, DOI 10.1007/s12665-009-0217-z; Liu DeYan, 2008, China Environmental Science, V28, P769; Liu XC, 2015, SOIL TILL RES, V151, P9, DOI 10.1016/j.still.2015.01.008; Liu XJ, 2006, AGR ECOSYST ENVIRON, V113, P370, DOI 10.1016/j.agee.2005.11.002; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Malhi SS, 2006, SOIL TILL RES, V90, P171, DOI 10.1016/j.still.2005.09.001; Malhi SS, 2003, NUTR CYCL AGROECOSYS, V66, P33, DOI 10.1023/A:1023376905096; Meng L, 2011, NEW PHYTOL, V189, P1040; Mosier AR, 2000, NUTR CYCL AGROECOSYS, V57, P107, DOI 10.1023/A:1009716505244; Peng Q, 2011, PLANT SOIL, V342, P345, DOI 10.1007/s11104-010-0699-1; Rafique R, 2011, ECOSYSTEMS, V14, P563, DOI 10.1007/s10021-011-9434-x; Sheng WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089322; Song CC, 2013, J GEOPHYS RES-BIOGEO, V118, P741, DOI 10.1002/jgrg.20063; Stapleton LM, 2005, SOIL BIOL BIOCHEM, V37, P2088, DOI 10.1016/j.soilbio.2005.03.016; Templer PH, 2012, FRONT ECOL ENVIRON, V10, P547, DOI 10.1890/120055; Thornton FC, 1996, SOIL SCI SOC AM J, V60, P1127, DOI 10.2136/sssaj1996.03615995006000040024x; Wang C, 2017, J SOIL SEDI IN PRESS; Wang FM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05615; Wang LF, 2008, SOIL SCI PLANT NUTR, V54, P786, DOI 10.1111/j.1747-0765.2008.00297.x; Wang YF, 2014, LECT NOTES COMPUT SC, V8544, P1, DOI 10.1016/j.biocel.2014.06.008; Xu Ke, 2016, Shengtaixue Zazhi, V35, P2676, DOI 10.13292/j.1000-4890.201610.012; Xu W, 2015, ATMOS CHEM PHYS, V15, P12345, DOI 10.5194/acp-15-12345-2015; Xu Y, J SOIL SEDIMENT, V13, P699; Yang XT, 2017, EUR J SOIL BIOL, V82, P43, DOI 10.1016/j.ejsobi.2017.08.004; Zhang LH, 2007, ATMOS ENVIRON, V41, P1080, DOI 10.1016/j.atmosenv.2006.09.029; Zhang W, 2008, PLANT SOIL, V306, P221, DOI 10.1007/s11104-008-9575-7; Zhang W, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009195; [张艺 Zhang Yi], 2017, [生态学报, Acta Ecologica Sinica], V37, P1956; Zheng XH, 2008, PLANT SOIL, V311, P211, DOI 10.1007/s11104-008-9673-6; Zhu J, 2013, SOIL BIOL BIOCHEM, V57, P577, DOI 10.1016/j.soilbio.2012.09.017	57	9	11	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189831	10.1371/journal.pone.0189831	http://dx.doi.org/10.1371/journal.pone.0189831			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253001	Green Published, Green Submitted, gold			2022-12-26	WOS:000418389500067
J	Yang, S; Govindaiah, G; Lee, SH; Yang, S; Cox, CL				Yang, Sunggu; Govindaiah, Gubbi; Lee, Sang-Hun; Yang, Sungchil; Cox, Charles L.			Distinct kinetics of inhibitory currents in thalamocortical neurons that arise from dendritic or axonal origin	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; POSTERIOR MEDIAL THALAMUS; GABA(A) RECEPTOR-ALPHA; ADULT-RAT BRAIN; PRESYNAPTIC DENDRITES; SYNAPTIC-TRANSMISSION; VISUAL THALAMUS; NITRIC-OXIDE; A RECEPTORS; RELAY CELLS	Thalamocortical neurons in the dorsal lateral geniculate nucleus (dLGN) transfer visual information from retina to primary visual cortex. This information is modulated by inhibitory input arising from local interneurons and thalamic reticular nucleus (TRN) neurons, leading to alterations of receptive field properties of thalamocortical neurons. Local GABAergic interneurons provide two distinct synaptic outputs: axonal (F1 terminals) and dendritic (F2 terminals) onto dLGN thalamocortical neurons. By contrast, TRN neurons provide only axonal output (F1 terminals) onto dLGN thalamocortical neurons. It is unclear if GABA(A) receptor-mediated currents originating from F1 and F2 terminals have different characteristics. In the present study, we examined multiple characteristics (rise time, slope, halfwidth and decay tau) of GABA(A) receptor-mediated miniature inhibitory postsynaptic synaptic currents (mIPSCs) originating from F1 and F2 terminals. The mIPSCs arising from F2 terminals showed slower kinetics relative to those from F1 terminals. Such differential kinetics of GABA(A)R-mediated responses could be an important role in temporal coding of visual signals.	[Yang, Sunggu] Incheon Natl Univ, Dept Nanobioengn, Incheon, South Korea; [Yang, Sunggu; Govindaiah, Gubbi] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Govindaiah, Gubbi; Lee, Sang-Hun] Univ Arkansas Med Sci, Dept Neurol, Little Rock, AR 72205 USA; [Yang, Sungchil] City Univ Hong Kong, Dept Biomed Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China; [Cox, Charles L.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	Incheon National University; University of Illinois System; University of Illinois Urbana-Champaign; University of Arkansas System; University of Arkansas Medical Sciences; City University of Hong Kong; Michigan State University	Yang, S (corresponding author), Incheon Natl Univ, Dept Nanobioengn, Incheon, South Korea.; Yang, S (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.; Cox, CL (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	sungguyang@inu.ac.kr; coxclee@msu.edu		Yang, Sunggu/0000-0002-7567-9949; YANG, Sungchil/0000-0003-3408-2019; Cox, Charles/0000-0002-1179-7014	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2016R1D1A1B04930938]; Incheon National University; National Institutes of Health [EY014024]; College of Medicine, University of Arkansas for Medical Sciences; Bogard Neurology Research and Stroke Prevention Fund; IDeA program at NIGMS [P30 GM110702]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education; Incheon National University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Medicine, University of Arkansas for Medical Sciences; Bogard Neurology Research and Stroke Prevention Fund; IDeA program at NIGMS	This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2016R1D1A1B04930938), an Incheon National University (International Cooperative) Research Grant (SY), the National Institutes of Health grant EY014024 (CLC), the College of Medicine, University of Arkansas for Medical Sciences (startup funding to SHL), Bogard Neurology Research and Stroke Prevention Fund, and Core Facilities of the Center for Translational Neuroscience, Award P30 GM110702 from the IDeA program at NIGMS.	Acuna-Goycolea C, 2008, NEURON, V57, P420, DOI 10.1016/j.neuron.2007.12.022; Bartos M, 2001, J NEUROSCI, V21, P2687, DOI 10.1523/JNEUROSCI.21-08-02687.2001; BERARDI N, 1984, J PHYSIOL-LONDON, V357, P505, DOI 10.1113/jphysiol.1984.sp015514; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; BLOOMFIELD SA, 1989, P NATL ACAD SCI USA, V86, P3911, DOI 10.1073/pnas.86.10.3911; Bright DP, 2011, J NEUROSCI, V31, P753, DOI 10.1523/JNEUROSCI.2996-10.2011; Browne SH, 2001, J NEUROPHYSIOL, V86, P2312, DOI 10.1152/jn.2001.86.5.2312; Cox CL, 2014, CURR OPIN NEUROBIOL, V29, P126, DOI 10.1016/j.conb.2014.07.004; Cox CL, 1998, NATURE, V394, P478, DOI 10.1038/28855; Cox CL, 1997, J NEUROSCI, V17, P70, DOI 10.1523/JNEUROSCI.17-01-00070.1997; Cox CL, 2000, NEURON, V27, P597, DOI 10.1016/S0896-6273(00)00069-6; Crandall SR, 2013, J NEUROPHYSIOL, V110, P470, DOI 10.1152/jn.00559.2012; Crandall SR, 2012, J NEUROSCI, V32, P2513, DOI 10.1523/JNEUROSCI.4402-11.2012; Dixon C, 2014, J BIOL CHEM, V289, P5399, DOI 10.1074/jbc.M113.514695; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Eyre MD, 2012, J NEUROSCI, V32, P5853, DOI 10.1523/JNEUROSCI.6495-11.2012; FAMIGLIETTI EV, 1972, J COMP NEUROL, V144, P285, DOI 10.1002/cne.901440304; FRIEDLANDER MJ, 1981, J NEUROPHYSIOL, V46, P80, DOI 10.1152/jn.1981.46.1.80; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Govindaiah, 2004, NEURON, V41, P611, DOI 10.1016/S0896-6273(04)00013-3; Govindaiah G, 2006, J NEUROSCI, V26, P13443, DOI 10.1523/JNEUROSCI.3578-06.2006; GUILLERY RW, 1969, Z ZELLFORSCH MIK ANA, V96, P1, DOI 10.1007/BF00321474; HOLDEFER RN, 1989, BRAIN RES, V488, P341, DOI 10.1016/0006-8993(89)90727-0; HUGUENARD JR, 1994, J NEUROSCI, V14, P5485; Jager P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13579; KAPLAN E, 1987, J PHYSIOL-LONDON, V391, P267, DOI 10.1113/jphysiol.1987.sp016737; LEE SM, 1994, J NEUROPHYSIOL, V71, P1702, DOI 10.1152/jn.1994.71.5.1702; LEE SM, 1994, J NEUROPHYSIOL, V71, P1716, DOI 10.1152/jn.1994.71.5.1716; LEHMKUHLE S, 1980, J NEUROPHYSIOL, V43, P520, DOI 10.1152/jn.1980.43.2.520; McCormick DA, 2002, INT REV NEUROBIOL, V49, P99; MONTERO VM, 1986, J COMP NEUROL, V254, P228, DOI 10.1002/cne.902540207; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; NORTON TT, 1992, PROG BRAIN RES, V90, P193; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; RALSTON HJ, 1971, NATURE, V230, P585, DOI 10.1038/230585a0; Schofield CM, 2007, J NEUROSCI, V27, P7954, DOI 10.1523/JNEUROSCI.0377-07.2007; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; SILLITO AM, 1983, BRAIN RES, V277, P63, DOI 10.1016/0006-8993(83)90908-3; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Van Horn SC, 2000, J COMP NEUROL, V416, P509; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042; Wulff P, 2007, NAT NEUROSCI, V10, P923, DOI 10.1038/nn1927; Yang S, 2008, J PHYSIOL-LONDON, V586, P3617, DOI 10.1113/jphysiol.2008.153312; Yang SG, 2007, J NEUROPHYSIOL, V97, P3386, DOI 10.1152/jn.01270.2006; Yang SG, 2011, SYNAPSE, V65, P1298, DOI 10.1002/syn.20964; Ye Zhiwen, 2017, Front Cell Neurosci, V11, P95, DOI 10.3389/fncel.2017.00095	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189690	10.1371/journal.pone.0189690	http://dx.doi.org/10.1371/journal.pone.0189690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29252999	gold, Green Submitted, Green Published			2022-12-26	WOS:000418389500049
J	Usukura, E; Yanase, Y; Ishijima, A; Kuboki, T; Kidoaki, S; Okamoto, K; Tamada, K				Usukura, Eiji; Yanase, Yuhki; Ishijima, Ayumi; Kuboki, Thasaneeya; Kidoaki, Satoru; Okamoto, Koichi; Tamada, Kaoru			LSPR-mediated high axial-resolution fluorescence imaging on a silver nanoparticle sheet	PLOS ONE			English	Article							INTERNAL-REFLECTION FLUORESCENCE; MICROSCOPY; CELLS; GUIDE	This paper reports our original technique for visualizing cell-attached nanointerfaces with extremely high axial resolution using homogeneously excited localized surface plasmon resonance (LSPR) on self-assembled silver nanoparticle sheets. The LSPR sheet can confine and enhance the fluorescence at the nanointerface, which provides high signal-to-noise ratio images of focal adhesion at the cell-attached interface. The advantage of this LSPR-assisted technique is its usability, which provides comparable or higher-quality nanointerfacial images than TIRF microscopy, even under epifluorescence microscopy. We also report the cytotoxicity of silver nanoparticles, as determined via morphological analysis of adherent cells on the sheet.	[Usukura, Eiji; Ishijima, Ayumi; Kuboki, Thasaneeya; Kidoaki, Satoru; Okamoto, Koichi; Tamada, Kaoru] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka, Japan; [Usukura, Eiji] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi, Japan; [Yanase, Yuhki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan	Kyushu University; Nagoya University; Hiroshima University	Tamada, K (corresponding author), Kyushu Univ, Inst Mat Chem & Engn, Fukuoka, Japan.	tamada@ms.ifoc.kyushu-u.ac.jp	Yanase, Yuhki/U-6082-2017; Okamoto, Koichi/D-7695-2014; Kidoaki, Satoru/AAR-2704-2020	Okamoto, Koichi/0000-0002-2658-3000; Kidoaki, Satoru/0000-0001-9138-0018; TAMADA, KAORU/0000-0003-2618-9924	NEXT Program; Japan Society for the Promotion of Science (JSPS) KAKENHI in Japan [26246005]; Ministry of Education, Culture, Sports, Science and Technology	NEXT Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science (JSPS) KAKENHI in Japan; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the NEXT Program and by Japan Society for the Promotion of Science (JSPS) KAKENHI grant number 26246005 in Japan (URL: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-26246005/) (Principal Investigator is Kaoru Tamada); and Ministry of Education, Culture, Sports, Science and Technology (Network Joint Research Center for Materials and Devices) to Yuhki Yanase. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2008, TOXICOL LETT, V179, P93, DOI 10.1016/j.toxlet.2008.04.009; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Han RC, 2013, J GENET GENOMICS, V40, P583, DOI 10.1016/j.jgg.2013.11.003; Martin-Fernandez ML, 2013, J MICROSC-OXFORD, V252, P16, DOI 10.1111/jmi.12070; Masuda S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04000-4; Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Tanaka D, 2015, NANOSCALE, V7, P15310, DOI 10.1039/c5nr03601a; Tawa K, 2016, ACS APPL MATER INTER, V8, P29893, DOI 10.1021/acsami.6b07777; Toma M, 2011, PHYS CHEM CHEM PHYS, V13, P7459, DOI 10.1039/c0cp02953j; Usukura E, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869560; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Yanase Y, 2016, OPT MATER EXPRESS, V6, P1339, DOI 10.1364/OME.6.001339; You J, 2011, PHYS CHEM CHEM PHYS, V13, P17625, DOI 10.1039/c1cp21732a	15	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189708	10.1371/journal.pone.0189708	http://dx.doi.org/10.1371/journal.pone.0189708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244869	Green Published, Green Submitted, gold			2022-12-26	WOS:000418184700054
J	Sun, SS; Tan, PC; Huang, XH; Zhang, W; Kong, C; Ren, FF; Su, X				Sun, Shishuo; Tan, Pengcheng; Huang, Xiaoheng; Zhang, Wei; Kong, Chen; Ren, Fangfang; Su, Xiong			Ubiquitinated CD36 sustains insulin-stimulated Akt activation by stabilizing insulin receptor substrate 1 in myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID UPTAKE; PROTEIN-TYROSINE KINASES; GLUCOSE-TRANSPORT; 3T3-L1 ADIPOCYTES; HYPERTENSIVE-RATS; RESISTANCE; PHOSPHORYLATION; MICE; DEGRADATION; SENSITIVITY	Both the magnitude and duration of insulin signaling are important in executing its cellular functions. Insulin-induced degradation of insulin receptor substrate 1 (IRS1) represents a key negative feedback loop that restricts insulin signaling. Moreover, high concentrations of fatty acids (FAs) and glucose involved in the etiology of obesity-associated insulin resistance also contribute to the regulation of IRS1 degradation. The scavenger receptor CD36 binds many lipid ligands, and its contribution to insulin resistance has been extensively studied, but the exact regulation of insulin sensitivity by CD36 is highly controversial. Herein, we found that CD36 knockdown in C2C12 myotubes accelerated insulin-stimulated Akt activation, but the activated signaling was sustained for a much shorter period of time as compared with WT cells, leading to exacerbated insulin-induced insulin resistance. This was likely due to enhanced insulin-induced IRS1 degradation after CD36 knockdown. Overexpression of WTCD36, but not a ubiquitination-defective CD36 mutant, delayed IRS1 degradation. We also found that CD36 functioned through ubiquitination-dependent binding to IRS1 and inhibiting its interaction with cullin 7, a key component of the multisubunit cullin-RING E3 ubiquitin ligase complex. Moreover, dissociation of the Src family kinase Fyn from CD36 by free FAs or Fyn knockdown/inhibition accelerated insulin-induced IRS1 degradation, likely due to disrupted IRS1 interaction with CD36 and thus enhanced binding to cullin 7. In summary, we identified a CD36-dependent FA-sensing pathway that plays an important role in negative feedback regulation of insulin activation and may open up strategies for preventing or managing type 2 diabetes mellitus.	[Sun, Shishuo; Tan, Pengcheng; Huang, Xiaoheng; Ren, Fangfang; Su, Xiong] Soochow Univ, Med Coll, Dept Biochem & Mol Biol, Suzhou 215123, Peoples R China; [Zhang, Wei; Kong, Chen] Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO 63110 USA	Soochow University - China; Washington University (WUSTL)	Su, X (corresponding author), Soochow Univ, Med Coll, 199 Renai Rd, Suzhou 215123, Peoples R China.	xsu@suda.edu.cn		Sun, Shishuo/0000-0001-8608-7204	National Natural Science Foundation of China [31371437, 31570806, 31620103906]; Natural Science Foundation of Jiangsu Province [BK20150006]; Priority Academic Programme Development of Jiangsu Higher Education Institutions; National Institutes of Health [DK097608]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097608, P30DK056341] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Programme Development of Jiangsu Higher Education Institutions; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Natural Science Foundation of China Grants 31371437, 31570806, and 31620103906; Natural Science Foundation of Jiangsu Province Grant BK20150006; a project funded by Priority Academic Programme Development of Jiangsu Higher Education Institutions; and National Institutes of Health Grant DK097608. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; BULL HA, 1994, FEBS LETT, V351, P41, DOI 10.1016/0014-5793(94)00814-0; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Dong LY, 2017, ONCOTARGET, V8, P22550, DOI 10.18632/oncotarget.15123; Duan L, 2014, J BIOL CHEM, V289, P21694, DOI 10.1074/jbc.M114.550038; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Furuhashi M, 2003, DIABETES CARE, V26, P471, DOI 10.2337/diacare.26.2.471; Garbacz WG, 2016, MOL CELL BIOL, V36, P2715, DOI 10.1128/MCB.00138-16; Gobrecht P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5561; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Gual P, 2003, J BIOL CHEM, V278, P26550, DOI 10.1074/jbc.M212273200; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Hajri T, 2002, ANNU REV NUTR, V22, P383, DOI 10.1146/annurev.nutr.22.020402.130846; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Heron-Milhavet L, 2004, ENDOCRINOLOGY, V145, P4667, DOI 10.1210/en.2003-1543; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hu XQ, 2016, J LIPID RES, V57, P663, DOI 10.1194/jlr.M066530; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Ibrahimi A, 2002, CURR OPIN CLIN NUTR, V5, P139, DOI 10.1097/00075197-200203000-00004; Kaiser C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-23; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Lamb CA, 2010, TRAFFIC, V11, P1445, DOI 10.1111/j.1600-0854.2010.01113.x; Lavin DP, 2016, DIABETOLOGIA, V59, P2280, DOI 10.1007/s00125-016-4072-7; Lemmon MA, 2016, CELL, V164, P1172, DOI 10.1016/j.cell.2016.02.047; Lv ZM, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5671803; Mayer CM, 2010, ENDOCRINOLOGY, V151, P75, DOI 10.1210/en.2009-0838; Miyaoka K, 2001, LANCET, V357, P686, DOI 10.1016/S0140-6736(00)04138-6; Morino K, 2008, DIABETES, V57, P2644, DOI 10.2337/db06-0454; Newton JG, 2017, PEDIATR DEVEL PATHOL, V20, P224, DOI 10.1177/1093526616688753; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; Porter HA, 2013, CANCER LETT, V338, P239, DOI 10.1016/j.canlet.2013.03.030; Potashnik R, 2003, DIABETOLOGIA, V46, P639, DOI 10.1007/s00125-003-1097-5; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; Sajan MP, 2010, AM J PHYSIOL-ENDOC M, V298, pE179, DOI 10.1152/ajpendo.00392.2009; Samovski D, 2015, DIABETES, V64, P353, DOI 10.2337/db14-0582; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Smith J, 2008, J BIOL CHEM, V283, P13578, DOI 10.1074/jbc.M800008200; Song JX, 2004, NAT IMMUNOL, V5, P150, DOI 10.1038/ni1030; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Sun XJ, 1999, DIABETES, V48, P1359, DOI 10.2337/diabetes.48.7.1359; Sun XJ, 1996, J BIOL CHEM, V271, P10583, DOI 10.1074/jbc.271.18.10583; Sun YJ, 2010, DIABETES CARE, V33, P2065, DOI 10.2337/dc10-0460; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Zhou DQ, 2012, FASEB J, V26, P4733, DOI 10.1096/fj.12-206862	51	11	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2383	2394		10.1074/jbc.M117.811471	http://dx.doi.org/10.1074/jbc.M117.811471			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29269414	hybrid, Green Published			2022-12-26	WOS:000425308300013
J	Fraile, JM; Campos-Iglesias, D; Rodriguez, F; Astudillo, A; Vilarrasa-Blasi, R; Verdaguer-Dot, N; Prado, MA; Paulo, JA; Gygi, SP; Martin-Subero, JI; Freije, JMP; Lopez-Otin, C				Fraile, Julia M.; Campos-Iglesias, Diana; Rodriguez, Francisco; Astudillo, Aurora; Vilarrasa-Blasi, Roser; Verdaguer-Dot, Nuria; Prado, Miguel A.; Paulo, Joao A.; Gygi, Steven P.; Martin-Subero, Jose I.; Freije, Jose M. P.; Lopez-Otin, Carlos			Loss of the deubiquitinase USP36 destabilizes the RNA helicase DHX33 and causes preimplantation lethality in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deubiquitylation (deubiquitination); nucleolus; protease; protein synthesis; ribosome	RIBOSOME BIOGENESIS; NUCLEOLAR STRUCTURE; UBIQUITIN SYSTEM; POLYMERASE I; ENZYME USP36; CELL-GROWTH; EXPRESSION; GENE; IDENTIFICATION; PROTEASES	Deubiquitinases are proteases with a wide functional diversity that profoundly impact multiple biological processes. Among them, the ubiquitin-specific protease 36 (USP36) has been implicated in the regulation of nucleolar activity. However, its functional relevance in vivo has not yet been fully described. Here, we report the generation of an Usp36-deficient mouse model to examine the function of this enzyme. We show that Usp36 depletion is lethal in preimplantation mouse embryos, where it blocks the transition from morula to blastocyst during embryonic development. USP36 reduces the ubiquitination levels and increases the stability of the DEAH-box RNA helicase DHX33, which is critically involved in ribosomal RNA synthesis and mRNA translation. In agreement with this finding, O-propargyl-puromycin incorporation experiments, Northern blot, and electron microscopy analyses demonstrated the role of USP36 in ribosomal RNA and protein synthesis. Finally, we show that USP36 down-regulation alters cell proliferation in human cancer cells by inducing both apoptosis and cell cycle arrest, and that reducing DHX33 levels through short hairpin RNA interference has the same effect. Collectively, these results support that Usp36 is essential for cell and organism viability because of its role in ribosomal RNA processing and protein synthesis, which is mediated, at least in part, by regulating DHX33 stability.	[Fraile, Julia M.; Campos-Iglesias, Diana; Rodriguez, Francisco; Freije, Jose M. P.; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Astudillo, Aurora] Hosp Univ Cent Asturias, Serv Anat Patol, Oviedo 33006, Spain; [Vilarrasa-Blasi, Roser; Verdaguer-Dot, Nuria; Martin-Subero, Jose I.] Univ Barcelona, IDIBAPS, Dept Anat Patol Farmacol & Microbiol, E-08036 Barcelona, Spain; [Prado, Miguel A.; Paulo, Joao A.; Gygi, Steven P.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Freije, Jose M. P.; Lopez-Otin, Carlos] Ctr Invest Biomed Red Canc, Madrid, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Harvard University; Harvard Medical School; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC	Freije, JMP (corresponding author), Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.; Lopez-Otin, C (corresponding author), Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.	jmpf@uniovi.es; clo@uniovi.es	Prado, Miguel A/P-3922-2017; Freije, José M.P./A-6535-2008; Paulo, Joao/AAO-3981-2020; López-Otín, Carlos/AAB-2106-2020	Prado, Miguel A/0000-0002-4914-1619; Freije, José M.P./0000-0002-4688-8266; Paulo, Joao/0000-0002-4291-413X; López-Otín, Carlos/0000-0001-6964-1904; Campos-Iglesias, Diana/0000-0002-7679-229X; Astudillo Gonzalez, Maria Aurora/0000-0001-8947-8809; Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Verdaguer, Nuria/0000-0002-6523-3038; Vilarrasa-Blasi, Roser/0000-0002-3384-0693	Fundacion Bancaria Caja de Ahorros de Asturias; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK098285] Funding Source: NIH RePORTER	Fundacion Bancaria Caja de Ahorros de Asturias; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. G. Bretones, C. Barcena, G. Velasco, R. Valdes-Mas, V. Quesada, Y. Espanol, D. Rodriguez, A. Salas and J. A. Vega, for helpful comments and assistance, and M. Serrano, B. Vogelstein, and J. Weber for providing reagents. We also thank the generous support by J. I. Cabrera. The Instituto Universitario de Oncologia is supported by Fundacion Bancaria Caja de Ahorros de Asturias.	Ashton-Beaucage D, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002539; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Bourgeois CF, 2016, NAT REV MOL CELL BIO, V17, P426, DOI 10.1038/nrm.2016.50; Brighenti E, 2015, ONCOTARGET, V6, P38617, DOI 10.18632/oncotarget.5775; Buszczak M, 2009, SCIENCE, V323, P248, DOI 10.1126/science.1165678; Chen H, 2008, BIOCHEM BIOPH RES CO, V365, P636, DOI 10.1016/j.bbrc.2007.11.019; Ciechanover A, 2015, NAT REV MOL CELL BIO, V16, P322, DOI 10.1038/nrm3982; Clague MJ, 2015, TRENDS CELL BIOL, V25, P417, DOI 10.1016/j.tcb.2015.03.002; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Endo A, 2009, J BIOL CHEM, V284, P27918, DOI 10.1074/jbc.M109.037218; Endo A, 2009, J CELL SCI, V122, P678, DOI 10.1242/jcs.044461; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Fraile JM, 2013, ONCOTARGET, V4, P1919, DOI 10.18632/oncotarget.1303; Hamdane N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004505; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kim MS, 2011, J CELL BIOCHEM, V112, P498, DOI 10.1002/jcb.22940; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lerch-Gaggl A, 2002, J BIOL CHEM, V277, P45347, DOI 10.1074/jbc.M208338200; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Newton K, 2003, MOL CELL BIOL, V23, P8519, DOI 10.1128/MCB.23.23.8519-8527.2003; Nicolas E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11390; Osorio FG, 2016, NAT MED, V22, P91, DOI 10.1038/nm.4013; Paulo JA, 2015, MOL BIOL CELL, V26, P4063, DOI 10.1091/mbc.E15-07-0499; Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009; Quesada V, 2009, NUCLEIC ACIDS RES, V37, pD239, DOI 10.1093/nar/gkn570; Quiros PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70; Reed BJ, 2015, J BIOL CHEM, V290, P20601, DOI 10.1074/jbc.M115.650952; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Richardson LA, 2012, CELL REP, V2, P372, DOI 10.1016/j.celrep.2012.07.009; Romanova LG, 2006, BIOL REPROD, V75, P690, DOI 10.1095/biolreprod.106.054072; Ronau JA, 2016, CELL RES, V26, P441, DOI 10.1038/cr.2016.38; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun XX, 2015, P NATL ACAD SCI USA, V112, P3734, DOI 10.1073/pnas.1411713112; Taillebourg E, 2012, AUTOPHAGY, V8, P767, DOI 10.4161/auto.19381; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang ZQ, 2016, GENE DEV, V30, P946, DOI 10.1101/gad.271841.115; Zhang YD, 2015, MOL CELL BIOL, V35, P2918, DOI 10.1128/MCB.00315-15; Zhang YD, 2011, MOL CELL BIOL, V31, P4676, DOI 10.1128/MCB.05832-11; Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06	44	18	19	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2183	2194		10.1074/jbc.M117.788430	http://dx.doi.org/10.1074/jbc.M117.788430			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29273634	Green Published, hybrid			2022-12-26	WOS:000424948000029
J	Duchesne, L; D'Orangeville, L; Ouimet, R; Houle, D; Kneeshaw, D				Duchesne, Louis; D'Orangeville, Loic; Ouimet, Rock; Houle, Daniel; Kneeshaw, Daniel			Extracting coherent tree-ring climatic signals across spatial scales from extensive forest inventory data	PLOS ONE			English	Article							BOREAL FOREST; BLACK SPRUCE; GROWTH; RESPONSES; INCREMENT; PATTERNS; QUEBEC; DRIVEN	Increasing access to extensively replicated and broadly distributed tree-ring collections has led to a greater use of these large data sets to investigate climate forcing on tree growth. However, the number of chronologies added to large accessible databases is declining and few are updated, while chronologies are often sparsely distributed and are more representative of marginal growing environments. On the other hand, National Forest Inventories (NFI), although poorly replicated at the plot level as compared to classic dendrochronological sampling, contain a large amount of tree-ring data with high spatial density designed to be spatially representative of the forest cover. We propose an a posteriori approach to validating tree-ring measurements and dating, selecting individual tree-ring width time series, and building average chronologies at various spatial scales based on an extensive collection of ring width measurements of nearly 94,000 black spruce trees distributed over a wide area and collected as part of the NFI in the province of Quebec, Canada. Our results show that reliable signals may be derived at various spatial scales (from 37 to 583,000 km(2)) from NFI increment core samples. Signals from independently built chronologies are spatially coherent with each other and well-correlated with independent reference chronologies built at the stand level. We thus conclude that tree-ring data from NFIs provide an extraordinary opportunity to strengthen the spatial and temporal coverage of tree-ring data and to improve coordination with other contemporary measurements of forest growth to provide a better understanding of tree growth-climate relationships over broad spatial scales.	[Duchesne, Louis; Ouimet, Rock; Houle, Daniel] Minist Forets Faune & Parcs Quebec, Rech Forestiere, Quebec City, PQ, Canada; [D'Orangeville, Loic; Kneeshaw, Daniel] Univ Quebec Montreal, Ctr Etude Foret, Succursale Ctr Ville, Montreal, PQ, Canada; [D'Orangeville, Loic] Indiana Univ, Dept Biol, Bloomington, IN USA; [Houle, Daniel] Consortium Climatol Reg & Adaptat Changements Cli, Montreal, PQ, Canada	University of Quebec; University of Quebec Montreal; Indiana University System; Indiana University Bloomington; Ouranos Consortium	Duchesne, L (corresponding author), Minist Forets Faune & Parcs Quebec, Rech Forestiere, Quebec City, PQ, Canada.	louis.duchesne@mffp.gouv.qc.ca	Ouimet/AAF-1773-2020	Ouimet, Rock/0000-0003-1282-2493; Duchesne, Louis/0000-0001-6784-445X; D'Orangeville, Loic/0000-0001-7841-7082	Ministere des Forets, de la Faune et des Pares du Quebec [142332064]	Ministere des Forets, de la Faune et des Pares du Quebec	This research was supported by the Ministere des Forets, de la Faune et des Pares du Quebec [project number 142332064]. The funder had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2009, NORM CART EC TROIS I; [Anonymous], 1985, TIME SERIES ANAL APP; Babst F, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0008; Babst F, 2014, OECOLOGIA, V176, P307, DOI 10.1007/s00442-014-3031-6; Babst F, 2013, GLOBAL ECOL BIOGEOGR, V22, P706, DOI 10.1111/geb.12023; Biondi F, 1999, ECOL APPL, V9, P216, DOI 10.1890/1051-0761(1999)009[0216:CTRCAR]2.0.CO;2; Bosela M, 2016, DENDROCHRONOLOGIA, V38, P90, DOI 10.1016/j.dendro.2016.03.011; Boulanger Y, 2004, CAN J FOREST RES, V34, P1035, DOI [10.1139/x03-269, 10.1139/X03-269]; Bowman DMJS, 2013, TRENDS PLANT SCI, V18, P11, DOI 10.1016/j.tplants.2012.08.005; Brienen RJW, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004143; Briffa K, 2008, DENDROCLIMATOLOGY PR, P113; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Buras A, 2017, DENDROCHRONOLOGIA, V44, P130, DOI 10.1016/j.dendro.2017.03.005; Cook E.R., 1990, METHODS DENDROCHRONO, P153, DOI DOI 10.1007/978-94-015-7879-0; Cook E.R., 2013, METHODS DENDROCHRONO; D'Orangeville L, 2016, SCIENCE, V352, P1452, DOI 10.1126/science.aaf4951; DeRose JR, 2012, WASATCH DENDROCLIMAT, P92; DeRose R. J., 2016, J FOREST, V114, P1, DOI DOI 10.5849/J0F.15-097; DeRose RJ, 2013, J HYDROMETEOROL, V14, P375, DOI 10.1175/JHM-D-12-0124.1; Drobyshev I, 2013, J ECOL, V101, P231, DOI 10.1111/1365-2745.12007; Drobyshev I, 2010, ECOSYSTEMS, V13, P556, DOI 10.1007/s10021-010-9340-7; Duchesne L, 2012, AGR FOREST METEOROL, V162, P108, DOI 10.1016/j.agrformet.2012.04.016; Fritts H., 1976, TREE RINGS CLIMATE; FRITTS HC, 1989, ADV ECOL RES, V19, P111; Gagnon G, 1994, RESEAU SURVEILLANCE; Garcia-Suarez AM, 2009, DENDROCHRONOLOGIA, V27, P183, DOI 10.1016/j.dendro.2009.05.003; George SS, 2014, QUATERNARY SCI REV, V95, P132, DOI 10.1016/j.quascirev.2014.04.029; Gewehr S, 2014, CAN J FOREST RES, V44, P487, DOI 10.1139/cjfr-2013-0481; Girard F, 2008, J BIOGEOGR, V35, P529, DOI 10.1111/j.1365-2699.2007.01816.x; Girardin M. P., 2012, Biogeosciences, V9, P2523, DOI 10.5194/bg-9-2523-2012; Girardin MP, 2016, P NATL ACAD SCI USA, V113, pE8406, DOI 10.1073/pnas.1610156113; Girardin MP, 2016, GLOBAL CHANGE BIOL, V22, P627, DOI 10.1111/gcb.13072; Girardin MP, 2014, GLOBAL CHANGE BIOL, V20, P851, DOI 10.1111/gcb.12400; GrissinoMayer HD, 1997, HOLOCENE, V7, P235, DOI 10.1177/095968369700700212; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Kaennel M, 1995, MULTILINGUAL GLOSSAR; Larson ER, 2013, TREE-RING RES, V69, P20, DOI 10.3959/1536-1098-69.1.21; Lebourgeois F, 2014, FOREST ECOL MANAG, V328, P209, DOI 10.1016/j.foreco.2014.05.038; Martinez-Vilalta J, 2008, GLOBAL CHANGE BIOL, V14, P2868, DOI 10.1111/j.1365-2486.2008.01685.x; MEKO D, 1993, J CLIMATE, V6, P1773, DOI [10.1175/1520-0442(1993)006<1773:SPOTGA>2.0.CO;2, 10.1175/1520-0442(1993)006&lt;1773:SPOTGA&gt;2.0.CO;2]; Merian P, 2013, DENDROCHRONOLOGIA, V31, P58, DOI 10.1016/j.dendro.2012.07.001; Merian P, 2011, FOREST ECOL MANAG, V261, P1382, DOI 10.1016/j.foreco.2011.01.019; Nehrbass-Ahles C, 2014, GLOBAL CHANGE BIOL, V20, P2867, DOI 10.1111/gcb.12599; Primicia I, 2015, FOREST ECOL MANAG, V354, P77, DOI 10.1016/j.foreco.2015.06.034; R Core Team, 2021, R LANGUAGE ENV STAT; Regniere J, 1996, ENVIRON ENTOMOL, V25, P869, DOI 10.1093/ee/25.5.869; St. George S., 2014, Past Global Changes Magazine, V22, P16; St George S, 2014, QUATERNARY SCI REV, V89, P1, DOI 10.1016/j.quascirev.2014.01.007; St George S, 2013, GEOPHYS RES LETT, V40, P3727, DOI 10.1002/grl.50743; Sullivan PF, 2016, TREE PHYSIOL, V36, P1057, DOI 10.1093/treephys/tpw067; Vaganov EA, 1999, NATURE, V400, P149, DOI 10.1038/22087; Wettstein JJ, 2011, J CLIMATE, V24, P5998, DOI 10.1175/2011JCLI3822.1; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; YAMAGUCHI DK, 1991, CAN J FOREST RES, V21, P414, DOI 10.1139/x91-053; Zuidema PA, 2015, NATURE, V523, P531, DOI 10.1038/523531c	56	13	13	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189444	10.1371/journal.pone.0189444	http://dx.doi.org/10.1371/journal.pone.0189444			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281697	Green Published, Green Submitted, gold			2022-12-26	WOS:000419006200027
J	Hofstetter, AR; Eberle, KC; Venn-Watson, SK; Jensen, ED; Porter, TJ; Waters, TE; Sacco, RE				Hofstetter, Amelia Ruth; Eberle, Kirsten C.; Venn-Watson, Stephanie K.; Jensen, Eric D.; Porter, Tracy J.; Waters, Theresa E.; Sacco, Randy E.			Monitoring bottlenose dolphin leukocyte cytokine mRNA responsiveness by qPCR	PLOS ONE			English	Article							PORPOISES PHOCOENA-PHOCOENA; TURSIOPS-TRUNCATUS; LYMPHOCYTE-TRANSFORMATION; INTERLEUKIN-1 FAMILY; ORCINUS-ORCA; EXPRESSION; BLOOD; CETACEANS; GENDER; HEALTH	Both veterinarians caring for dolphins in managed populations and researchers monitoring wild populations use blood-based diagnostics to monitor bottlenose dolphin (Tursiops truncatus) health. Quantitative PCR (qPCR) can be used to assess cytokine transcription patterns of peripheral blood mononuclear cells (PBMC). This can supplement currently available blood tests with information on immune status. Full realization of this potential requires establishment of normal ranges of cytokine gene transcription levels in bottlenose dolphins. We surveyed four dolphins over the span of seven months by serial bleeds. PBMC were stimulated with phytohaemagglutinin (1, 5, and 10 mu g/mL) and concanavalin A (1 mu g/mL) for 48 H in vitro. RNA from these cultures was probed by qPCR using Tursiops truncatus-specific primers (IL-1 alpha, IL-1 beta, IL-1RA, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p40, IL-13, IL-18, IFN-gamma and TNF-alpha). Two blood samples from an additional bottlenose dolphin diagnosed with acute pulmonary disease add further perspective to the data. We observed that mitogen choice made a significant difference in the magnitude of gene transcription observed. On the other hand, most cytokines tested exhibited limited intra-animal variation. However, IL-6 and IL-12p40 differed between older and younger dolphins. Furthermore, the magnitude of mitogenic response clusters the tested cytokines into three groups. The data provide a reference for the selection of target cytokine mRNAs and their expected range of mitogen-stimulated cytokine gene transcription for future studies.	[Hofstetter, Amelia Ruth; Eberle, Kirsten C.; Porter, Tracy J.; Waters, Theresa E.; Sacco, Randy E.] ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA; [Venn-Watson, Stephanie K.] Natl Marine Mammal Fdn, Translat Med & Res Program, San Diego, CA USA; [Jensen, Eric D.] US Navy, Marine Mammal Program, San Diego, CA 92152 USA	United States Department of Agriculture (USDA)	Hofstetter, AR (corresponding author), ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA.	amelia.hofstetter@ars.usda.gov	Hofstetter, Amelia Ruth/AAM-4896-2020	Hofstetter, Amelia Ruth/0000-0003-4113-5473	Office of Naval Research grant [N0001412IP20029]	Office of Naval Research grant(Office of Naval Research)	This work was supported by the Office of Naval Research grant N0001412IP20029 (https://www.onr.navy.mil/Contracts-Grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SA, 1999, ENVIRON HEALTH PERSP, V107, P681, DOI 10.2307/3434327; Beineke A, 2004, VET IMMUNOL IMMUNOP, V98, P59, DOI 10.1016/j.vetimm.2003.10.002; Beineke A, 2007, VET IMMUNOL IMMUNOP, V115, P100, DOI 10.1016/j.vetimm.2006.09.006; Borras E, 2017, ANAL BIOANAL CHEM, V409, P6523, DOI 10.1007/s00216-017-0581-6; Bossart GD, 2011, DIS AQUAT ORGAN, V97, P103, DOI 10.3354/dao02410; Bouman A, 2004, AM J REPROD IMMUNOL, V52, P19, DOI 10.1111/j.1600-0897.2004.00177.x; Coelho LCBB, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/1594074; Chen IH, 2015, SCI REP-UK, V5, DOI 10.1038/srep15425; CHILSON OP, 1989, EUR J IMMUNOL, V19, P389, DOI 10.1002/eji.1830190225; COLGROVE GS, 1978, AM J VET RES, V39, P141; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Cuneo AA, 2009, CURR VASC PHARMACOL, V7, P267, DOI 10.2174/157016109788340721; Curfs JHAJ, 1997, CLIN MICROBIOL REV, V10, P742, DOI 10.1128/CMR.10.4.742; Deepak P, 2008, AM J REPROD IMMUNOL, V59, P127, DOI 10.1111/j.1600-0897.2007.00541.x; Desforges JPW, 2016, ENVIRON INT, V86, P126, DOI 10.1016/j.envint.2015.10.007; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Fair PA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176202; Fonfara S, 2007, J MAR BIOL ASSOC UK, V87, P305, DOI 10.1017/S0025315407055567; Fonfara S, 2007, MAR MAMMAL SCI, V23, P931, DOI 10.1111/j.1748-7692.2007.00140.x; Funke C, 2003, VET IMMUNOL IMMUNOP, V93, P69, DOI 10.1016/S0165-2427(03)00055-2; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Jaber JR, 2013, RES VET SCI, V95, P556, DOI 10.1016/j.rvsc.2013.05.011; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Ma X, 2015, REGULATION IL 10 IL; Mancia A, 2008, MOL ECOL, V17, P2581, DOI 10.1111/j.1365-294X.2008.03784.x; MEDWAY W, 1970, J AM VET MED ASSOC, V157, P563; Morey JS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3020-8; de Melo CML, 2010, PHYTOTHER RES, V24, P1631, DOI 10.1002/ptr.3156; Muller S, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-145; MUMFORD DM, 1975, EXPERIENTIA, V31, P498, DOI 10.1007/BF02026402; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Sitt T, 2008, DEV COMP IMMUNOL, V32, P1253, DOI 10.1016/j.dci.2008.05.001; Sitt T, 2016, VET IMMUNOL IMMUNOP, V175, P7, DOI 10.1016/j.vetimm.2016.04.011; Sitt T, 2010, VET IMMUNOL IMMUNOP, V137, P181, DOI 10.1016/j.vetimm.2010.05.003; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; Tsai MA, 2017, PEERJ, V5, DOI 10.7717/peerj.3840; Unitt J, 2011, BIOCHEM PHARMACOL, V81, P1324, DOI 10.1016/j.bcp.2011.03.010; Venn-Watson SK, 2015, JAVMA-J AM VET MED A, V246, P893, DOI 10.2460/javma.246.8.893; von der Thusen JH, 2003, PHARMACOL REV, V55, P133, DOI 10.1124/pr.55.1.5; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Wimer BM, 2002, CANCER BIOTHER RADIO, V17, P569, DOI 10.1089/108497802760804808; WOLFORD ST, 1986, J TOXICOL ENV HEALTH, V18, P161, DOI 10.1080/15287398609530859; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Zabka TS, 2003, ANAT REC PART A, V273A, P636, DOI 10.1002/ar.a.10077; Zafra R, 2015, RES VET SCI, V100, P207, DOI 10.1016/j.rvsc.2015.03.021	50	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0189437	10.1371/journal.pone.0189437	http://dx.doi.org/10.1371/journal.pone.0189437			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272269	Green Submitted, gold, Green Published			2022-12-26	WOS:000418651500006
J	Li, M; Li, XJ; Su, YL				Li, Meng; Li, Xiao-Juan; Su, Yun-Lin			Flue-cured tobacco confirmed as a reservoir host plant for Tomato yellow leaf curl virus by agro-inoculation and Bemisia tabaci MED-mediated transmission	PLOS ONE			English	Article							HEMIPTERA ALEYRODIDAE; WEED RESERVOIR; NATURAL HOSTS; 1ST REPORT; BIOTYPE Q; CHINA; CROPS; TYLCV; IDENTIFICATION; GEMINIVIRUSES	Tomato yellow leaf curl virus (TYLCV) causes great losses in tomato production. In addition to tomato, TYLCV infects many crops or weeds as alternative hosts. These alternative hosts may serve as reservoirs for TYLCV survival and spread. Here, we tested the capability of cultivated, flue-cured tobacco to act as a reservoir host plant for TYLCV. TYLCV DNA was detected in nine flue-cured tobacco cultivars inoculated with an infectious TYLCV clone, although no visible symptoms developed on TYLCV-infected tobacco plants. The percentage of whiteflies with viral DNA increased with an increasing acquisition access period (AAP) and reached 100% after a 12 h AAP on infected tobacco plants. Using infected tobacco plants as virus resources, TYLCV was capable of being transmitted to tobacco and tomato plants by whiteflies, and typical symptoms of TYLCV infection were observed on infected tomato plants but not on infected tobacco plants. Our results suggest that fluecured tobacco can serve as a reservoir host plant for TYLCV and may play an important role in the spread of TYLCV epidemics in China.	[Li, Meng; Li, Xiao-Juan] Zhengzhou Univ Light Ind, Sch Food & Bioengn, Zhengzhou, Henan, Peoples R China; [Su, Yun-Lin] Chinese Acad Sci, South China Bot Garden, Key Lab South China Agr Plant Mol Anal & Genet Im, Guangzhou, Guangdong, Peoples R China	Zhengzhou University of Light Industry; Chinese Academy of Sciences; South China Botanical Garden, CAS	Su, YL (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab South China Agr Plant Mol Anal & Genet Im, Guangzhou, Guangdong, Peoples R China.	suyunlin@scbg.ac.cn			National Natural Science Foundation of China [31401810]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Project No. 31401810). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzmon G, 1998, EUR J PLANT PATHOL, V104, P189, DOI 10.1023/A:1008699603559; BEDFORD ID, 1994, EUR J PLANT PATHOL, V100, P243, DOI 10.1007/BF01876239; Bedford ID, 1998, EUR J PLANT PATHOL, V104, P221, DOI 10.1023/A:1008627419450; Dai FM, 2011, PLANT DIS, V95, P362, DOI 10.1094/PDIS-08-10-0608; Dalmon A., 2000, Phytoma, P14; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Ghanim M, 2007, ARTHROPOD-PLANT INTE, V1, P195, DOI 10.1007/s11829-007-9018-z; Hanssen IM, 2010, MOL PLANT MICROBE IN, V23, P539, DOI 10.1094/MPMI-23-5-0539; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Ji YH, 2013, PLANT DIS, V97, P430, DOI 10.1094/PDIS-10-12-0922-PDN; Jorda C., 2001, Plant Disease, V85, P445, DOI 10.1094/PDIS.2001.85.4.445C; Kashina B. D., 2002, Archives of Phytopathology and Plant Protection, V35, P269, DOI 10.1080/03235400216134; Kenyon L, 2014, VIRUS RES, V186, P104, DOI 10.1016/j.virusres.2013.12.026; Kil EJ, 2014, PLANT DIS, V98, P1163, DOI 10.1094/PDIS-02-14-0162-PDN; Kil EJ, 2015, PLANT DIS, V99, P588, DOI 10.1094/PDIS-04-14-0352-RE; Kil EJ, 2014, ARCH VIROL, V159, P2387, DOI 10.1007/s00705-014-2072-9; Kil EJ, 2014, ARCH VIROL, V159, P1305, DOI 10.1007/s00705-013-1913-2; Li G, 2014, J GEN PLANT PATHOL, V80, P449, DOI 10.1007/s10327-014-0531-5; Li M, 2010, INT J PEST MANAGE, V56, P275, DOI 10.1080/09670871003743428; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Liu Y Q, 2012, J BIOSAFETY, V21, P247; Lu Shao-Hua, 2016, Chinese Journal of Applied Entomology, V53, P213, DOI 10.7679/j.issn.2095-1353.2016.027; Lu XP, 2013, J ZHEJIANG UNIV-SC B, V14, P570, DOI 10.1631/jzus.B1200227; MANSOUR A, 1992, PLANT PATHOL, V41, P122, DOI 10.1111/j.1365-3059.1992.tb02328.x; MEHTA P, 1994, J ECON ENTOMOL, V87, P1291, DOI 10.1093/jee/87.5.1291; Morilla G, 2005, PHYTOPATHOLOGY, V95, P1089, DOI 10.1094/PHYTO-95-1089; Moriones E, 2000, VIRUS RES, V71, P123, DOI 10.1016/S0168-1702(00)00193-3; Navas-Castillo J, 1999, PLANT DIS, V83, P29, DOI 10.1094/PDIS.1999.83.1.29; Pan HP, 2015, ECOL APPL, V25, P1585, DOI 10.1890/14-0752.1; Pan HP, 2011, J ECON ENTOMOL, V104, P978, DOI 10.1603/EC11009; Papayiannis LC, 2011, PLANT DIS, V95, P120, DOI 10.1094/PDIS-05-10-0346; Polston JE, 2006, PHYTOPATHOLOGY, V96, P447, DOI 10.1094/PHYTO-96-0447; Qin Li, 2013, Acta Entomologica Sinica, V56, P186; Rubinstein G, 1997, J GEN VIROL, V78, P2683, DOI 10.1099/0022-1317-78-10-2683; Sanchez-Campos S, 2000, EUR J PLANT PATHOL, V106, P391, DOI 10.1023/A:1008758622582; Smith HA, 2015, ENVIRON ENTOMOL, V44, P1101, DOI 10.1093/ee/nvv095; Sohrab Sayed Sartaj, 2016, VirusDisease, V27, P19, DOI 10.1007/s13337-015-0292-6; [孙计平 Sun Jiping], 2016, [中国烟草科学, Chinese Tobacco Science], V37, P86; Teng X, 2010, FLA ENTOMOL, V93, P363, DOI 10.1653/024.093.0307; Wu JB, 2006, PLANT DIS, V90, P1359, DOI 10.1094/PD-90-1359C; Xie Yan, 2002, Acta Phytopathologica Sinica, V32, P182; Xu ZH, 2000, ACTA PHYSIOL PLANT, V22, P379, DOI 10.1007/s11738-000-0061-y; ZEIDAN M, 1991, J GEN VIROL, V72, P2607, DOI 10.1099/0022-1317-72-11-2607; Zubiaur YM, 2004, PLANT DIS, V88, P572, DOI 10.1094/PDIS.2004.88.5.572C	45	1	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190013	10.1371/journal.pone.0190013	http://dx.doi.org/10.1371/journal.pone.0190013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272279	gold, Green Published, Green Submitted			2022-12-26	WOS:000418651500024
J	Chen, Y; Bieber, MM; Bhat, NM; Teng, NNH				Chen, Yi; Bieber, Marcia M.; Bhat, Neelima M.; Teng, Nelson N. H.			Ovarian carcinoma glyco-antigen targeted by human IgM antibody	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HUMAN B-LYMPHOCYTES; MONOCLONAL-ANTIBODIES; CANCER; SURFACE; GENE; GLYCOSYLATION; CHEMOTHERAPY; SPECIFICITY; INHIBITORS	Epithelial Ovarian Cancer (EOC) cells expression of a novel carbohydrate antigen was defined using a human VH4-34 encoded IgM monoclonal antibody (mAb216). MAb216 binds to a poly N-acetyllactosamine epitope expressed on B cells and kills normal and malignant B cells in vitro and in vivo. EOC patient ascites and EOC cell lines were used to study the anti tumor effect of mAb216. Various assays were used to characterize the epitope and demonstrate antibody-mediated binding and cytotoxicity in EOC. Drug and antibody combination effects were determined by calculating the combination index values using the Chou and Talalay method. MAb216 displays direct antibody mediated cytotoxicity on a population of human EOC tumor and ascites samples and EOC cell lines, which express high amounts of poly N-acetyllactosamine epitope, carried by CD147/CD98. Eighty four percent of patient samples, including platin resistant, had a tumor population that bound the monoclonal antibody. The binding pattern of mAb216 and mechanism of cytotoxicity was similar to that seen on normal and malignant B cells with unique general membrane disruption and "pore" formation. In vitro incubation with mAb216 and cisplatin enhanced killing of OVCAR3 cell line. In EOC cell lines percent cytotoxicity correlated with percent expression of epitope. Although in vitro data shows specific EOC cytotoxicity, for possible treatment of EOC MAb216 would need to be evaluated in a clinical trial with or without chemotherapy.	[Chen, Yi; Bieber, Marcia M.; Bhat, Neelima M.; Teng, Nelson N. H.] Stanford Univ, Div Gynecol Oncol, Dept Obstet & Gynecol, Stanford, CA 94305 USA	Stanford University	Bieber, MM (corresponding author), Stanford Univ, Div Gynecol Oncol, Dept Obstet & Gynecol, Stanford, CA 94305 USA.	bieber@stanford.edu			Malloy Research Fund; Department of Obstetrics and Gynecology, Stanford University	Malloy Research Fund; Department of Obstetrics and Gynecology, Stanford University	This work was supported by Malloy Research Fund, Department of Obstetrics and Gynecology, Stanford University, gift fund to NT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2014, MOL ASPECTS MED, V39, P110, DOI 10.1016/j.mam.2013.06.002; Basu A, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/201367; Bhat NM, 2015, J IMMUNOL, V195, P5178, DOI 10.4049/jimmunol.1501697; Bhat NM, 2001, CRIT REV ONCOL HEMAT, V39, P59, DOI 10.1016/S1040-8428(01)00104-4; Bhat NM, 1997, CLIN EXP IMMUNOL, V108, P151, DOI 10.1046/j.1365-2249.1997.d01-976.x; Bieber MM, 2007, PEDIATR BLOOD CANCER, V48, P380, DOI 10.1002/pbc.20770; Cappione AJ, 2004, J IMMUNOL, V172, P4298, DOI 10.4049/jimmunol.172.7.4298; CHAPMAN CJ, 1993, J IMMUNOL, V151, P1051; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Christiansen MN, 2014, PROTEOMICS, V14, P525, DOI 10.1002/pmic.201300387; Cooling Laura, 2010, Immunohematology, V26, P133; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Elit L, 2007, CANCER-AM CANCER SOC, V109, P692, DOI 10.1002/cncr.22466; FEIZI T, 1979, J EXP MED, V149, P975, DOI 10.1084/jem.149.4.975; GARCIAGONZALEZ M, 1988, J IMMUNOL METHODS, V111, P17, DOI 10.1016/0022-1759(88)90054-3; GRILLOTCOURVALIN C, 1992, EUR J IMMUNOL, V22, P1781, DOI 10.1002/eji.1830220717; Hauselmann I, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00028; Liedtke M, 2012, HAEMATOL-HEMATOL J, V97, P30, DOI 10.3324/haematol.2011.045997; Mukhopadhyay A, 2011, BJOG-INT J OBSTET GY, V118, P429, DOI 10.1111/j.1471-0528.2010.02838.x; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Wang LJ, 2012, MOL CELL BIOCHEM, V363, P257, DOI 10.1007/s11010-011-1178-6; Yokota M, 1997, HISTOCHEM J, V29, P555, DOI 10.1023/A:1026475926033	22	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0187222	10.1371/journal.pone.0187222	http://dx.doi.org/10.1371/journal.pone.0187222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267289	Green Published, gold, Green Submitted			2022-12-26	WOS:000418587400004
J	Elnagar, MR; Walls, AB; Helal, GK; Hamada, FM; Thomsen, MS; Jensen, AA				Elnagar, Mohamed R.; Walls, Anne Byriel; Helal, Gouda K.; Hamada, Farid M.; Thomsen, Morten Skott; Jensen, Anders A.			Probing the putative alpha 7 nAChR/NMDAR complex in human and murine cortex and hippocampus: Different degrees of complex formation in healthy and Alzheimer brain tissue	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; PROTEIN-PROTEIN INTERACTIONS; AMYLOID-BETA; NMDA RECEPTOR; TRANSGENIC MODEL; ACH RECEPTORS; CROSS-TALK; DISEASE; 3XTG-AD; SUBUNIT	alpha 7 nicotinic acetylcholine receptors (nAChRs) and N-methyl-D-aspartate receptors (NMDARs) are key mediators of central cholinergic and glutamatergic neurotransmission, respectively. In addition to numerous well-established functional interactions between a7 nAChRs and NMDARs, the two receptors have been proposed to form a multimeric complex, and in the present study we have investigated this putative alpha 7 nAChR/NMDAR assembly in human and murine brain tissues. By alpha-bungarotoxin (BGT) affinity purification, alpha 7 and NMDAR subunits were co-purified from human and murine cortical and hippocampal homogenates, substantiating the notion that the receptors are parts of a multimeric complex in the human and rodent brain. Interestingly, the ratios between GluN1 and alpha 7 levels in BGT pull-downs from cortical homogenates from Alzheimer's disease (AD) brains were significantly lower than those in pull-downs from non-AD controls, indicating a reduced degree of alpha 7 nAChR/NMDAR complex formation in the diseased tissue. A similar difference in GluN1/alpha 7 ratios was observed between pull-downs from cortical homogenates from adult 3xTg-AD and age-matched wild type (WT) mice, whereas the GluN1/alpha 7 ratios determined in pull-downs from young 3xTg-AD and age-matched WT mice did not differ significantly. The observation that pretreatment with oligomeric amyloid-beta(1-42) reduced GluN1/alpha 7 ratios in BGT pull-downs from human cortical homogenate in a concentration-dependent manner provided a plausible molecular mechanism for this observed reduction. In conclusion, while it will be important to further challenge the existence of the putative alpha 7 nAChR/NMDAR complex in future studies applying other methodologies than biochemical assays and to investigate the functional implications of this complex for cholinergic and glutamatergic neurotransmission, this work supports the formation of the complex and presents new insights into its regulation in healthy and diseased brain tissue.	[Elnagar, Mohamed R.; Walls, Anne Byriel; Thomsen, Morten Skott; Jensen, Anders A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Pk, Copenhagen O, Denmark; [Elnagar, Mohamed R.; Helal, Gouda K.; Hamada, Farid M.] Al Azhar Univ, Fac Pharm, Cairo, Egypt; [Thomsen, Morten Skott] H Lundbeck & Co AS, Synapt Transmiss Vitro, Valby, Denmark	University of Copenhagen; Egyptian Knowledge Bank (EKB); Al Azhar University; Lundbeck Corporation	Thomsen, MS; Jensen, AA (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Pk, Copenhagen O, Denmark.; Thomsen, MS (corresponding author), H Lundbeck & Co AS, Synapt Transmiss Vitro, Valby, Denmark.	mokt@lundbeck.com; aaj@sund.ku.dk	Elnagar, Mohamed R./AAJ-7450-2020; Jensen, Anders/AAJ-3335-2020	Elnagar, Mohamed R./0000-0003-0434-2369; Jensen, Anders/0000-0002-7927-5052; Walls, Anne B./0000-0002-5234-5006	Lundbeck Foundation; Augustinus Foundation; Ministry of Higher Education of Denmark; Ministry of Higher Education of Egypt; Lundbeck Foundation [R194-2015-926]; Augustinus Foundation [16-0433]	Lundbeck Foundation(Lundbeckfonden); Augustinus Foundation; Ministry of Higher Education of Denmark; Ministry of Higher Education of Egypt(Ministry of Higher Education & Scientific Research (MHESR)); Lundbeck Foundation(Lundbeckfonden); Augustinus Foundation	The Lundbeck Foundation, the Augustinus Foundation, the Ministry of Higher Education of Denmark, and the Ministry of Higher Education of Egypt funded some of the salary and operational expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by funding from Lundbeck Foundation (grant no.: R194-2015-926), the Augustinus Foundation (grant no.: 16-0433), the Ministry of Higher Education of Denmark, and the Ministry of Higher Education of Egypt. Dr. Imad Damaj is gratefully acknowledged for providing the brain tissues from alpha 7 KO and WT mice, Dr. Wolfgang Hartig is gratefully acknowledged for providing the brain tissues from 3xTg-AD and WT mice, and Dr. Lars H. Pinborg is gratefully acknowledged for providing human brain tissues.	Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Bertrand D, 2015, PHARMACOL REV, V67, P1025, DOI 10.1124/pr.113.008581; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bigford GE, 2012, J BIOL CHEM, V287, P11049, DOI 10.1074/jbc.M111.277806; Blennow K, 2015, TRENDS PHARMACOL SCI, V36, P297, DOI 10.1016/j.tips.2015.03.002; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Carroll JC, 2007, J NEUROSCI, V27, P13357, DOI 10.1523/JNEUROSCI.2718-07.2007; Chang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10256; Chen YX, 2014, MOL NEUROBIOL, V49, P547, DOI 10.1007/s12035-013-8539-y; Cho SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20185; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Counts SE, 2007, ARCH NEUROL-CHICAGO, V64, P1771, DOI 10.1001/archneur.64.12.1771; Court J, 2001, BIOL PSYCHIAT, V49, P175, DOI 10.1016/S0006-3223(00)01116-1; Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x; Delgado L, 2008, CEREBELLUM, V7, P444, DOI 10.1007/s12311-008-0047-7; Delgado LM, 2009, J COMP NEUROL, V514, P459, DOI 10.1002/cne.22023; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Gu SY, 2016, NEURON, V89, P948, DOI 10.1016/j.neuron.2016.01.018; Hansen KB, 2017, METHODS MOL BIOL, V1677, P1, DOI 10.1007/978-1-4939-7321-7_1; Hedberg MM, 2010, NEURODEGENER DIS, V7, P379, DOI 10.1159/000287954; Herber DL, 2004, J HISTOCHEM CYTOCHEM, V52, P1367, DOI 10.1369/jhc.4A6319.2004; Hynd MR, 2004, J NEUROCHEM, V89, P240, DOI 10.1111/j.1471-4159.2003.02330.x; Hynd MR, 2001, J NEUROCHEM, V78, P175, DOI 10.1046/j.1471-4159.2001.00409.x; Ikonomovic MD, 2009, ARCH NEUROL-CHICAGO, V66, P646, DOI 10.1001/archneurol.2009.46; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Jaso BA, 2017, CURR NEUROPHARMACOL, V15, P57, DOI 10.2174/1570159X14666160321123221; Jensen MM, 2015, NEUROBIOL AGING, V36, P1629, DOI 10.1016/j.neurobiolaging.2015.01.001; Koukouli F, 2015, BIOCHEM PHARMACOL, V97, P378, DOI 10.1016/j.bcp.2015.07.018; Kravitz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081244; Lanz TA, 2006, J NEUROSCI METH, V157, P71, DOI 10.1016/j.jneumeth.2006.03.023; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Li SP, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-58; Li SP, 2012, J EXP MED, V209, P2141, DOI 10.1084/jem.20121270; Lin H, 2010, P NATL ACAD SCI USA, V107, P16661, DOI 10.1073/pnas.1007397107; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Liu XY, 2006, NEURON, V52, P897, DOI 10.1016/j.neuron.2006.10.011; Moghaddam B, 2012, NEUROPSYCHOPHARMACOL, V37, P4, DOI 10.1038/npp.2011.181; Morikawa E, 1998, J NEUROSCI, V18, P9727; Moser N, 2007, J NEUROCHEM, V102, P479, DOI 10.1111/j.1471-4159.2007.04498.x; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Neff RA, 2009, ACTA PHARMACOL SIN, V30, P694, DOI 10.1038/aps.2009.52; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2005, P NATL ACAD SCI USA, V102, P3046, DOI 10.1073/pnas.0408500102; Papouin T, 2017, NEURON, V94, P840, DOI 10.1016/j.neuron.2017.04.021; Parri HR, 2011, BIOCHEM PHARMACOL, V82, P931, DOI 10.1016/j.bcp.2011.06.039; Rodriguez-Ruiz M, 2016, MOL NEUROBIOL; Ryan TJ, 2013, NAT NEUROSCI, V16, P25, DOI 10.1038/nn.3277; Schulte U, 2011, SEMIN CELL DEV BIOL, V22, P132, DOI 10.1016/j.semcdb.2010.09.015; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Thomsen MS, 2016, NEUROBIOL AGING, V46, P13, DOI 10.1016/j.neurobiolaging.2016.06.009; Thomsen MS, 2016, CURR PHARM DESIGN, V22, P2015, DOI 10.2174/1381612822666160127112357; Thomsen MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130572; Tyagarajan SK, 2014, NAT REV NEUROSCI, V15, P141, DOI 10.1038/nrn3670; Volianskis A, 2015, BRAIN RES, V1621, P5, DOI 10.1016/j.brainres.2015.01.016; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Wieskopf JS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3009986; Yang Y, 2013, P NATL ACAD SCI USA, V110, P12078, DOI 10.1073/pnas.1307849110; Zhang HL, 2016, J PROTEOMICS, V131, P113, DOI 10.1016/j.jprot.2015.10.018	61	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189513	10.1371/journal.pone.0189513	http://dx.doi.org/10.1371/journal.pone.0189513			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261717	Green Published, gold, Green Submitted			2022-12-26	WOS:000418564200045
J	Oono, R				Oono, Ryoko			A confidence interval analysis of sampling effort, sequencing depth, and taxonomic resolution of fungal community ecology in the era of high-throughput sequencing	PLOS ONE			English	Article							MICROBIAL DIVERSITY; RARE BIOSPHERE; ENDOPHYTES; PATTERNS; READS; ERROR; TAXA; HYPOTHESIS; MILLIONS; ABUNDANT	High-throughput sequencing technology has helped microbial community ecologists explore ecological and evolutionary patterns at unprecedented scales. The benefits of a large sample size still typically outweigh that of greater sequencing depths per sample for accurate estimations of ecological inferences. However, excluding or not sequencing rare taxa may mislead the answers to the questions 'how and why are communities different?' This study evaluates the confidence intervals of ecological inferences from high-throughput sequencing data of foliar fungal endophytes as case studies through a range of sampling efforts, sequencing depths, and taxonomic resolutions to understand how technical and analytical practices may affect our interpretations. Increasing sampling size reliably decreased confidence intervals across multiple community comparisons. However, the effects of sequencing depths on confidence intervals depended on how rare taxa influenced the dissimilarity estimates among communities and did not significantly decrease confidence intervals for all community comparisons. A comparison of simulated communities under random drift suggests that sequencing depths are important in estimating dissimilarities between microbial communities under neutral selective processes. Confidence interval analyses reveal important biases as well as biological trends in microbial community studies that otherwise may be ignored when communities are only compared for statistically significant differences.	[Oono, Ryoko] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Oono, R (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	ryoko.oono@lifesci.ucsb.edu			UC-Mexus-CONACYT [20150989]; Doctor Pearl Chase Grant; Center for Scientific Computing from CNSI; MRL: an NSF MRSEC [DMR-1121053]; NSF [CNS-0960316]	UC-Mexus-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Doctor Pearl Chase Grant; Center for Scientific Computing from CNSI; MRL: an NSF MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NSF(National Science Foundation (NSF))	Research was partially supported by UC-Mexus-CONACYT Collaborative Grant 20150989 (http://ucmexus.ucr.edu/) and the Doctor Pearl Chase Grant (internal UCSB faculty grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; I acknowledge support from the Center for Scientific Computing from the CNSI, MRL: an NSF MRSEC (DMR-1121053) and NSF CNS-0960316. I thank Kathryn McEachern for collecting Torrey pine samples from Santa Rosa Island, as well as Rodolfo Salas-Lizana and Timothy Ho for collecting Torrey pine samples from Torrey Pines State Natural Reserve. I thank Anna Rasmussen, Vanessa Chou, and Austen Apigo for assistance in molecular work and Mark T. Buntaine and anonymous reviewers for feedback on the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arnold AE, 2007, MYCOLOGIA, V99, P185, DOI 10.3852/mycologia.99.2.185; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Balint M, 2016, FEMS MICROBIOL REV, V40, P686, DOI 10.1093/femsre/fuw017; Brown SP, 2015, FUNGAL ECOL, V13, P221, DOI 10.1016/j.funeco.2014.08.006; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Carlsen T, 2012, FUNGAL ECOL, V5, P747, DOI 10.1016/j.funeco.2012.06.003; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cordier T, 2012, FUNGAL ECOL, V5, P509, DOI 10.1016/j.funeco.2011.12.004; Edgar R.C., 2016, UNOISE2 IMPROVED ERR, DOI 10.1101/081257; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Esling P, 2015, NUCLEIC ACIDS RES, V43, P2513, DOI 10.1093/nar/gkv107; Fuentes S, 2016, APPL ENVIRON MICROB, V82, P888, DOI 10.1128/AEM.02625-15; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gobet A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq545; Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037; He Y, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0081-x; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jousset A, 2017, ISME J, V11, P853, DOI 10.1038/ismej.2016.174; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Liu YC, 2013, BIOINFORMATICS, V29, P308, DOI [10.1093/bioinformatics/btt688, 10.1093/bioinformatics/bts690]; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; Lu HP, 2016, ISME J, V10, P2867, DOI 10.1038/ismej.2016.78; Lundin D, 2012, ENV MICROBIOL REP, V4, P367, DOI 10.1111/j.1758-2229.2012.00345.x; Mariadassou M, 2015, ECOL LETT, V18, P974, DOI 10.1111/ele.12478; Mikkelson KM, 2016, APPL ENV MICROBIOL; Oksanen J, 2022, R PACKAGE VERSION; Oono R, 2017, ENVIRON MICROBIOL, V19, P2794, DOI 10.1111/1462-2920.13799; Oono R, 2015, FUNGAL BIOL-UK, V119, P917, DOI 10.1016/j.funbio.2015.07.003; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Reveillaud J, 2014, ISME J, V8, P1198, DOI 10.1038/ismej.2013.227; Shade A, 2014, MBIO, V5, DOI 10.1128/mBio.01371-14; Smith DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090234; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Toju H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6273; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Williams AG, 2014, CURRENT PROTOCOLS HU; Zhan AB, 2013, METHODS ECOL EVOL, V4, P558, DOI 10.1111/2041-210X.12037; Zimmerman NB, 2012, P NATL ACAD SCI USA, V109, P13022, DOI 10.1073/pnas.1209872109	46	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189796	10.1371/journal.pone.0189796	http://dx.doi.org/10.1371/journal.pone.0189796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253889	Green Submitted, Green Published, gold			2022-12-26	WOS:000418389500060
J	Langenegger, N; Koua, D; Schurch, S; Heller, M; Nentwig, W; Kuhn-Nentwig, L				Langenegger, Nicolas; Koua, Dominique; Schurch, Stefan; Heller, Manfred; Nentwig, Wolfgang; Kuhn-Nentwig, Lucia			Identification of a precursor processing protease from the spider Cupiennius salei essential for venom neurotoxin maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); enzyme purification; neurotoxin; protein processing; serine protease; processing quadruplet motif (PQM); propeptide	MULTICOMPONENT VENOM; PEPTIDES; TRANSCRIPTOME; EXPRESSION; ALGORITHM; LATARCINS; CLONING; ARANEAE; CSTX-1; SITE	Spider venom neurotoxins and cytolytic peptides are expressed as elongated precursor peptides, which are post-translationally processed by proteases to yield the active mature peptides. The recognition motifs for these processing proteases, first published more than 10 years ago, include the processing quadruplet motif (PQM) and the inverted processing quadruplet motif (iPQM). However, the identification of the relevant proteases was still pending. Here we describe the purification of a neurotoxin precursor processing protease from the venom of the spider Cupiennius salei. The chymotrypsin-like serine protease is a 28-kDa heterodimer with optimum activity at venom's pH of 6.0. We designed multiple synthetic peptides mimicking the predicted cleavage sites of neurotoxin precursors. Using these peptides as substrates, we confirm the biochemical activity of the protease in propeptide removal from neurotoxin precursors by cleavage C-terminal of the PQM. Furthermore, the PQM protease also cleaves the iPQM relevant for heterodimerization of a subgroup of neurotoxins. An involvement in the maturing of cytolytic peptides is very likely, due to high similarity of present protease recognition motifs. Finally, bioinformatics analysis, identifying sequences of homolog proteins from 18 spiders of 9 families, demonstrate the wide distribution and importance of the isolated enzyme for spiders. In summary, we establish the first example of a PQM protease, essential for maturing of spider venom neurotoxins. In the future, the here described protease may be established as a powerful tool for production strategies of recombinant toxic peptides, adapted to the maturing of spider venom toxins.	[Langenegger, Nicolas; Koua, Dominique; Nentwig, Wolfgang; Kuhn-Nentwig, Lucia] Univ Bern, Inst Ecol & Evolut, Baltzerstr 6, CH-3012 Bern, Switzerland; [Koua, Dominique] Inst Natl Polytech Felix Houphouet Boigny, BP 1093 Yamoussoukro, Yamoussoukro, Cote Ivoire; [Schurch, Stefan] Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland; [Heller, Manfred] Univ Bern, Dept Clin Res, Prote & Mass Spectrometry Core Facil, Freiburgstr 15, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University of Bern	Kuhn-Nentwig, L (corresponding author), Univ Bern, Inst Ecol & Evolut, Baltzerstr 6, CH-3012 Bern, Switzerland.	lucia.kuhn@iee.unibe.ch	Schürch, Stefan/ABE-4977-2022	Schürch, Stefan/0000-0001-5109-4623	Swiss National Science Foundation [31003A_162564]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 31003A_162564 (to W. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Biner O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143963; Brugger V, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14272; Catalan A, 2011, J BIOCHEM MOL TOXIC, V25, P393, DOI 10.1002/jbt.20399; Corzo G, 2002, J BIOL CHEM, V277, P23627, DOI 10.1074/jbc.M200511200; Dubovskii PV, 2015, CELL MOL LIFE SCI, V72, P4501, DOI 10.1007/s00018-015-2016-x; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gunasekera K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-556; Haney RA, 2016, GENOME BIOL EVOL, V8, P228, DOI 10.1093/gbe/evv253; Hanquier J, 2003, APPL ENVIRON MICROB, V69, P1108, DOI 10.1128/AEM.69.2.1108-1113.2003; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Kozlov SA, 2007, TOXICON, V49, P721, DOI 10.1016/j.toxicon.2006.11.007; Kozlov SA, 2006, J BIOL CHEM, V281, P20983, DOI 10.1074/jbc.M602168200; Kuhn-Nentwig L, 2004, TOXICON, V43, P543, DOI 10.1016/j.toxicon.2004.02.009; Kuhn-Nentwig L, 2016, TOXINOLOGY, P47, DOI 10.1007/978-94-007-6389-0_12; Kuhn-Nentwig L, 2012, J BIOL CHEM, V287, P25640, DOI 10.1074/jbc.M112.339051; Kuhn-Nentwig L, 2011, ADV INSECT PHYSIOL, V40, P1, DOI 10.1016/B978-0-12-387668-3.00001-5; KUHNNENTWIG L, 1994, TOXICON, V32, P287, DOI 10.1016/0041-0101(94)90082-5; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200; Nentwig W., 2013, SPIDER ECOPHYSIOLOGY, P505; Oliva MLV, 2003, CURR MED CHEM, V10, P1085, DOI 10.2174/0929867033457548; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Planas E, 2015, TOXICON, V93, P11, DOI 10.1016/j.toxicon.2014.10.005; Polotow D, 2015, INVERTEBR SYST, V29, P124, DOI 10.1071/IS14041; Qian J, 2008, ACTA BIOCH BIOPH SIN, V40, P174, DOI 10.1111/j.1745-7270.2008.00385.x; Richardson M, 2006, COMP BIOCHEM PHYS C, V142, P173, DOI 10.1016/j.cbpc.2005.09.010; Sanggaard KW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4765; SANTOS AD, 1992, J BIOL CHEM, V267, P20701; SHIKATA Y, 1995, J BIOL CHEM, V270, P16719, DOI 10.1074/jbc.270.28.16719; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Trachsel C, 2012, FEBS J, V279, P2683, DOI 10.1111/j.1742-4658.2012.08650.x; Vassilevski AA, 2008, RECENT PATENTS INFLA, V2, P58, DOI 10.2174/187221308783399261; Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109; Vaudel M, 2011, PROTEOMICS, V11, P996, DOI 10.1002/pmic.201000595; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wheeler WC, 2017, CLADISTICS, V33, P574, DOI 10.1111/cla.12182; Wullschleger B, 2004, P NATL ACAD SCI USA, V101, P11251, DOI 10.1073/pnas.0402226101; Zhang YQ, 2010, ZOOLOGY, V113, P10, DOI 10.1016/j.zool.2009.04.001	43	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2079	2090		10.1074/jbc.M117.810911	http://dx.doi.org/10.1074/jbc.M117.810911			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29269415	Green Published, hybrid			2022-12-26	WOS:000424948000020
J	Brown, K; Legros, S; Ortega, FA; Dai, YK; Doss, MX; Christini, DJ; Robinson, RB; Foley, AC				Brown, Kemar; Legros, Stephanie; Ortega, Francis A.; Dai, Yunkai; Doss, Michael Xavier; Christini, David J.; Robinson, Richard B.; Foley, Ann C.			Overexpression of Map3k7 activates sinoatrial node-like differentiation in mouse ES-derived cardiomyocytes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CARDIAC-PACEMAKER CELLS; TGF-BETA; GENE-TRANSFER; IN-VIVO; SINUS NODE; HEART; CHANNEL; SHOX2; TAK1	In vivo, cardiomyocytes comprise a heterogeneous population of contractile cells defined by unique electrophysiologies, molecular markers and morphologies. The mechanisms directing myocardial cells to specific sub-lineages remain poorly understood. Here we report that overexpression of TGF beta-Activated Kinase (TAK1/Map3k7) in mouse embryonic stem (ES) cells faithfully directs myocardial differentiation of embryoid body (EB)-derived cardiac cells toward the sinoatrial node (SAN) lineage. Most cardiac cells in Map3k7-overexpressing EBs adopt markers, cellular morphologies, and electrophysiological behaviors characteristic of the SAN. These data, in addition to the fact that Map3k7 is upregulated in the sinus venous-the source of cells for the SAN-suggest that Map3k7 may be an endogenous regulator of the SAN fate.	[Brown, Kemar; Legros, Stephanie; Ortega, Francis A.; Doss, Michael Xavier; Christini, David J.; Foley, Ann C.] Cornell Univ, Weill Med Coll, Greenberg Div Cardiol, New York, NY 10021 USA; [Dai, Yunkai; Foley, Ann C.] Clemson Univ, Dept Bioengn, Charleston, SC 29634 USA; [Robinson, Richard B.] Columbia Univ, Med Ctr, Dept Pharmacol, New York, NY USA; [Brown, Kemar] Icahn Sch Med Mt Sinai, Dept Internal Med, New York, NY 10029 USA; [Doss, Michael Xavier] BioMarin Pharmaceut Inc, Novato, CA USA	Cornell University; Clemson University; Columbia University; Icahn School of Medicine at Mount Sinai; BioMarin Pharmaceutical Inc.	Foley, AC (corresponding author), Cornell Univ, Weill Med Coll, Greenberg Div Cardiol, New York, NY 10021 USA.; Foley, AC (corresponding author), Clemson Univ, Dept Bioengn, Charleston, SC 29634 USA.	acfoley@Clemson.edu		Ortega, Francis/0000-0003-2735-8865; Christini, David/0000-0003-0852-2922	National Institutes of Health [R01RR020115, 5P20GM103444]; American Heart Association [0930056N, 14GRNT20380403]; Raymond and Beverly Sackler	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Raymond and Beverly Sackler	This work was supported by David Christini's work is supported by the National Institutes of Health (R01RR020115). Ann Foley's work is supported by grants from the American Heart Association (0930056N and 14GRNT20380403); the National Institutes of Health (5P20GM103444) as well as funds from Raymond and Beverly Sackler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama-Uchida Y, 2002, HYPERTENSION, V40, P148, DOI 10.1161/01.HYP.0000025443.61926.12; Bajpai R, 2007, HUMAN STEM CELL MANUAL: A LABORATORY GUIDE, P255, DOI 10.1016/B978-012370465-8/50024-7; Barbuti A, 2015, PHARMACOL REV, V67, P368, DOI 10.1124/pr.114.009597; Blaschke RJ, 2007, CIRCULATION, V115, P1830, DOI 10.1161/CIRCULATIONAHA.106.637819; Boink GJJ, 2008, J GENE MED, V10, P487, DOI 10.1002/jgm.1172; Brown K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013446; Brown K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012016; Bucchi A, 2006, CIRCULATION, V114, P992, DOI 10.1161/CIRCULATIONAHA.106.617613; CHANG F, 1990, CIRC RES, V66, P633, DOI 10.1161/01.RES.66.3.633; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; Cohen IS, 2006, HANDB EXP PHARMACOL, V171, P41; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61, DOI 10.1113/jphysiol.1986.sp016177; Dorn T, 2015, STEM CELLS, V33, P1113, DOI 10.1002/stem.1923; Espinoza-Lewis RA, 2009, DEV BIOL, V327, P376, DOI 10.1016/j.ydbio.2008.12.028; Hashem SI, 2013, MOL CELL BIOCHEM, V383, P161, DOI 10.1007/s11010-013-1764-x; Hescheler J, 1997, CARDIOVASC RES, V36, P149, DOI 10.1016/S0008-6363(97)00193-4; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Hoogaars WMH, 2004, CARDIOVASC RES, V62, P489, DOI 10.1016/j.cardiores.2004.01.030; Ionta V, 2015, STEM CELL REP, V4, P129, DOI 10.1016/j.stemcr.2014.11.004; IRISAWA H, 1978, PHYSIOL REV, V58, P461, DOI 10.1152/physrev.1978.58.2.461; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Jung JJ, 2014, STEM CELL REP, V2, P592, DOI 10.1016/j.stemcr.2014.03.006; Kapoor N, 2013, NAT BIOTECHNOL, V31, P54, DOI 10.1038/nbt.2465; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; Mangoni ME, 2001, CARDIOVASC RES, V52, P51, DOI 10.1016/S0008-6363(01)00370-4; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; Miake J, 2002, NATURE, V419, P132, DOI 10.1038/419132b; Mommersteeg MTM, 2007, CIRC RES, V100, P354, DOI 10.1161/01.RES.0000258019.74591.b3; Mommersteeg MTM, 2010, CARDIOVASC RES, V87, P92, DOI 10.1093/cvr/cvq033; Monzen K, 2001, J CELL BIOL, V153, P687, DOI 10.1083/jcb.153.4.687; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Plotnikov AN, 2007, CIRCULATION, V116, P706, DOI 10.1161/CIRCULATIONAHA.107.703231; Protze SI, 2017, NAT BIOTECHNOL, V35, P56, DOI 10.1038/nbt.3745; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ruhparwar A, 2010, TISSUE ENG PT A, V16, P1867, DOI [10.1089/ten.tea.2009.0537, 10.1089/ten.TEA.2009.0537]; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Scavone A, 2013, CIRC RES, V113, P389, DOI 10.1161/CIRCRESAHA.113.301283; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Shlapakova IN, 2010, HEART RHYTHM, V7, P1835, DOI 10.1016/j.hrthm.2010.08.004; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Tse HF, 2006, CIRCULATION, V114, P1000, DOI 10.1161/CIRCULATIONAHA.106.615385; Van Mierop L H, 1970, Am J Cardiol, V25, P204, DOI 10.1016/0002-9149(70)90580-1; Wiese C, 2011, INT J CARDIOL, V147, P95, DOI 10.1016/j.ijcard.2009.08.021; Wu JY, 2001, AM J PHYSIOL-HEART C, V280, pH1232, DOI 10.1152/ajpheart.2001.280.3.H1232; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; Zhang H, 2011, CELL TRANSPLANT, V20, P1907, DOI 10.3727/096368911X565038; Zhang Z, 2002, CIRC RES, V90, P981, DOI 10.1161/01.RES.0000018003.14304.E2; Zhu WZ, 2010, CIRC RES, V107, P776, DOI 10.1161/CIRCRESAHA.110.223917; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	56	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189818	10.1371/journal.pone.0189818	http://dx.doi.org/10.1371/journal.pone.0189818			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281682	gold, Green Submitted, Green Published			2022-12-26	WOS:000419006200046
J	McAlister, A; Allen, MS				McAlister, Andrew; Allen, Melinda S.			Basalt geochemistry reveals high frequency of prehistoric tool exchange in low hierarchy Marquesas Islands (Polynesia)	PLOS ONE			English	Article							STONE; COLONIZATION; EIAO; ADZE; ARCHIPELAGO; EXAMPLE; ORIGIN; SITE	Exchange activities, formal or otherwise, serve a variety of purposes and were prominent in many Pacific Island societies, both during island settlement and in late prehistory. Recent Polynesian studies highlight the role of exchange in the region's most hierarchical polities where it contributed to wealth economies, emergent leadership, and status rivalry in late prehistory. Building on this research, we hypothesized that exchange in low hierarchy chiefdoms (kin-based polities where there are distinctions between commoners and elites but ranking within the latter is lacking, weak, or ephemeral) would differ in frequency and function from that associated with strongly hierarchical polities. We address this hypothesis through geochemical, morphological, and distributional analyses of stone tools on Nuku Hiva, Marquesas Islands. Non-destructive Energy-Dispersive X-ray Fluorescence (EDXRF) and destructive Wavelength-Dispersive X-ray Fluorescence (WDXRF) analyses of 278 complete and broken tools (adzes, chisels, preforms) from four valleys identify use of stone from at least seven sources on three islands: five on Nuku Hiva and one each on Eiao and Ua Pou. A functional analysis demonstrates that no tool form is limited to a particular source, while inter-valley distributions reveal that the proportions of non-local or extra-valley tools (43 to 94%, mean = 77%) approximate or exceed results from other archipelagoes, including those from elite and ritual sites of Polynesian archaic states. Intra-valley patterns also are unexpected, with non-local stone tools being recovered from both elite and commoner residential areas in near-equal proportions. Our findings unambiguously demonstrate the importance of exchange in late prehistoric Marquesan society, at varied social and geographic scales. We propose the observed patterns are the result of elites using non-local tools as political currency, aimed at reinforcing status, cementing client-patron relations, and building extra-valley alliances, consistent with prestige societies elsewhere and early historic accounts from the Marquesan Islands.	[McAlister, Andrew] Univ Auckland, Sch Social Sci, Anthropol, Auckland, New Zealand; [Allen, Melinda S.] Univ Auckland, Te Punaha Matatini, Sch Social Sci, Anthropol, Auckland, New Zealand	University of Auckland; University of Auckland	McAlister, A (corresponding author), Univ Auckland, Sch Social Sci, Anthropol, Auckland, New Zealand.	andrew.mcalister@auckland.ac.nz	Allen, Melinda S/AAB-7224-2021	Allen, Melinda S/0000-0001-5041-5106	National Geographic Society Research and Exploration Grant [7351-02]; Wenner-Gren Foundation, Post-PhD Research Grant [7220]; Australian Institute of Nuclear Science and Engineering, Researcher Awards [06/002, 07/001, 09/005]; University of Auckland Faculty Research Development Fund [3609254, 3624509]; University of Auckland Research Committee, Staff Research Fund [3608563, 3607864, 3607203, 3605210, 3603834]; Green Foundation for Polynesian Research; University of Auckland Doctoral Scholarship; Royal Society of New Zealand, Skinner Fund	National Geographic Society Research and Exploration Grant(National Geographic Society); Wenner-Gren Foundation, Post-PhD Research Grant; Australian Institute of Nuclear Science and Engineering, Researcher Awards; University of Auckland Faculty Research Development Fund; University of Auckland Research Committee, Staff Research Fund; Green Foundation for Polynesian Research; University of Auckland Doctoral Scholarship; Royal Society of New Zealand, Skinner Fund(Royal Society of New Zealand)	This work received support from the following: 1. National Geographic Society Research and Exploration Grant #7351-02; https://www.nationalgeographic.org/grants; to MSA (P.I). 2. Wenner-Gren Foundation, Post-PhD Research Grant #7220; http://www.wennergren.org/; to MSA. 3. Australian Institute of Nuclear Science and Engineering, Researcher Awards #06/002, #07/001, and # 09/005); http://www.ainse.edu.au/; to MSA. 4. University of Auckland Faculty Research Development Fund, Projects 3609254 and 3624509; https://www.auckland.act.nz/en/about/research/re-research-office/html; to MSA. 5. University of Auckland Research Committee, Staff Research Fund, Projects 3608563, 3607864, 3607203, 3605210, and 3603834; https://www.auckland.ac.nz/en/about/research/re-research-office.html; to MSA. 6. Green Foundation for Polynesian Research; to MSA. 7. University of Auckland Doctoral Scholarship; https://www.auckland.ac.nz/en/study/scholarships-and-awards/scholarship-types/postgraduate-scholarships/doctoral-scholarships.html; to AM. 8. Royal Society of New Zealand, Skinner Fund; https://royalsociety.org.nz/what-we-do/funds-and-opportunities/skinner-fund!; to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison D.J., 2006, THESIS; Allen M. S., 1997, NZ ARCHAEOLOGICAL AS, P111; Allen MS, 2014, J PAC ARCHAEOL, V5, P1; Allen MS, 2013, J PAC ARCHAEOL, V4, P90; Allen MS, 2010, ARCHAEOL OCEAN, V45, P54, DOI 10.1002/j.1834-4453.2010.tb00080.x; Allen MS, 2010, ANTIQUITY, V84, P86, DOI 10.1017/S0003598X00099786; ALLEN MELINDA S, 2010, ASIAN PERSPECT, V48, P342; [Anonymous], 2007, ACCOUNT MARQUESAS IS; Aswani S., 1998, ASIAN PERSPECT, V37, P135; Baxter M. J., 2003, STAT ARCHAEOLOGY; Baxter M.J., 1994, EXPLORATORY MULTIVAR; BEST S, 1992, J POLYNESIAN SOC, V101, P45; Breiman L., 1984, CLASSIFICATION REGRE; Caroff M, 1999, LITHOS, V46, P235, DOI 10.1016/S0024-4937(98)00068-1; CAROFF M, 1995, J PETROL, V36, P1333, DOI 10.1093/petrology/36.5.1333; Charleux M, 2014, J PAC ARCHAEOL, V5, P75; Clark GR, 2014, P NATL ACAD SCI USA, V111, P10491, DOI 10.1073/pnas.1406165111; Clark John E., 1994, FACTIONAL COMPETITIO, P17; Cochrane EE, 2016, ARCHAEOL OCEAN, V51, P150, DOI 10.1002/arco.5090; Conte E, 2014, ARCHAEOL OCEAN, V49, P121, DOI 10.1002/arco.5037; de Sa JPM, 2007, APPL STAT USING SPSS; Di Piazza A, 2001, ARCHAEOL OCEAN, V36, P146, DOI DOI 10.1002/J.1834-4453.2001.TB00488.X; Dye TS, 1990, PACIFIC PRODUCTION S, P70; Earle T, 1997, MONOGRAPH, V21, P224; Earle T, 2015, CURR ANTHROPOL, V56, P515, DOI 10.1086/682284; Earle Timothy, 1997, CHIEFS COME POWER PO; EARLE TK, 1987, ANNU REV ANTHROPOL, V16, P279, DOI 10.1146/annurev.an.16.100187.001431; Emory Kenneth P, 1968, PREHISTORIC CULTURE, P151; Feinman G.M., 1984, ADV ARCHAEOL METH TH, V7, P39; Ferdon E. N., 1993, EARLY OBSERVATIONS M; Friedman J, 1977, EVOLUTION SOCIAL SYS; Garanger P Ottino, 2006, ARCHEOLOGIE CHEZ TAI; GEOROC (Geochemistry of Rocks of the Oceans and Continents), MAX PLANCK I CHEM MA; Glascock MD, 1998, ADV ARC MUS, V3, P15; Gracia M, 1843, LETT ILES MARQUISES; Hancock RGV, 2008, ARCHAEOMETRY, V50, P710, DOI 10.1111/j.1475-4754.2007.00353.x; Handy E.S. Craighill, 1923, NATIVE CULTURE MARQU, P5; Hermann A, 2017, J ARCHAEOL SCI-REP, V13, P75, DOI 10.1016/j.jasrep.2017.03.024; Huebert JM, 2016, QUATERNARY SCI REV, V137, P79, DOI 10.1016/j.quascirev.2016.01.017; Johnson PR, 2011, X-RAY FLUORESCENCE SPECTROMETRY (XRF) IN GEOARCHAEOLOGY, P143, DOI 10.1007/978-1-4419-6886-9_7; Junker Laura L., 1993, ASIAN PERSPECT, V32, P1; Kahn JG, 2016, J POLYNESIAN SOC, V125, P203, DOI 10.15286/jps.125.3.203-238; Kahn JG, 2013, J PAC ARCHAEOL, V4, P50; Kahn JG, 2013, J ARCHAEOL SCI, V40, P1194, DOI 10.1016/j.jas.2012.10.003; Karatzoglou A., 2006, J STAT SOFTW, V15, P1, DOI [10.18637/jss.v015.i09, DOI 10.18637/JSS.V015.I09]; Kirch P. V., 1988, NOR ARCHAEOL REV, V21, P103, DOI DOI 10.1080/00293652.1988.9965475; Kirch P.V., 1984, EVOLUTION POLYNESIAN; Kirch P.V., 1991, CHIEFDOMS POWER EC I, P119; Kirch PV, 2012, P NATL ACAD SCI USA, V109, P1056, DOI 10.1073/pnas.1119009109; KIRCH PV, 1991, ANNU REV ANTHROPOL, V20, P141, DOI 10.1146/annurev.an.20.100191.001041; Lass B., 1994, HAWAIIAN ADZE PRODUC; Lass B, 1998, ARCHAEOLOGICAL PAPER, P19; Legendre C, 2005, J PETROL, V46, P1925, DOI 10.1093/petrology/egi043; Legendre C, 2005, J VOLCANOL GEOTH RES, V143, P293, DOI 10.1016/j.jvolgeores.2004.12.001; Linton R., 1923, MAT CULTURE MARQUESA; Linton Ralph., 1925, ARCHAEOLOGY MARQUESA; Malinowski B., 1961, ARGONAUTS W PACIFIC; Maranda P., 1964, ETHNOHISTORY, V11, P301; MAURY RC, 2014, GEOL FR, P111; Mauss Marcel, 1990, GIFT FORM REASON EXC; McAlister A, 2011, J SOC OCEANISTES, V66, P105; Mcalister A, 2013, J POLYNESIAN SOC, V122, P257, DOI 10.15286/jps.122.3.257-274; McCoy P.C., 1990, PACIFIC PRODUCTION S, P85; Millerstrom S, 2001, THESIS; Mills PR, 2008, AM ANTIQUITY, V73, P743, DOI 10.2307/25470526; Mills PR, 2011, J PAC ARCHAEOL, V2, P79; Mills PR, 2010, J ARCHAEOL SCI, V37, P3385, DOI 10.1016/j.jas.2010.08.005; Molle G, 2013, B SOC ETUDES OCEANIE, V329, P72; Norusis MJ, 2008, SPSS STAT 17 0 STAT; Ottino P, 1990, J SOC OCEANISTES, V90, P3; Ottino P., 2005, DOSSIER ARCHEOLOGIQU, V4, P127; Parker R.J., 1997, NZ ARCHAEOLOGICAL AS, V21, P205; Plog F, 1977, EXCHANGE SYSTEMS PRE, P127; Quinn CP, 2015, LITHIC TECHNOLOGICAL SYSTEMS AND EVOLUTIONARY THEORY, P198; Renfrew C., 1977, EXCHANGE SYSTEMS PRE, P71, DOI DOI 10.1016/B978-0-12-227650-7.50010-9; Rieth T. M., 2013, HAWAIIAN ARCHAEOLOGY, V13, P103; Robarts E, 1974, MARQUESAN J EDWARD R; Rolett B.V., 1997, NZ ARCHAEOLOGICAL AS, V21, P134; Rolett B. V., 2001, B SOC ETUDES OCEANIE, V289, P132; Rolett BV, 2015, J ARCHAEOL SCI, V53, P459, DOI 10.1016/j.jas.2014.10.018; Rolett BV, 1998, HANAMIAI PREHISTORIC; Sheppard P.J., 2004, CHANGE TIME 50 YEARS, P147; Sheppard PJ, 2011, J ARCHAEOL SCI, V38, P45, DOI 10.1016/j.jas.2010.08.007; Sinoto Y. H., 1970, STUDIES OCEANIC CULT, V1, P105; SINOTO YH, 1968, PREHISTORIC CULTURE, P111; Suggs R.C, 1961, ARCHEOLOGY NUKU HIVA; Summerhayes GR, 2014, GEOARCHAEOLOGY, V29, P238, DOI 10.1002/gea.21475; Thomas Nicholas, 1990, MARQUESAN SOC INEQUA; Turner M., 1994, NZ J ARCHAEOLOGY, V16, P5; Turner M.T., 2000, FUNCTION DESIGN DIST; Vapnik V., 1979, ESTIMATION DEPENDENC; Weisler M., 1985, N Z J ARCHAEOL, V7, P129; Weisler M. I., 1997, NZ ARCHAEOLOGICAL AS, V21, P173; Weisler M.I., 2008, HDB LANDSCAPE ARCHAE, P536; Weisler M, 2016, ARCHAEOL OCEAN, V51, P158, DOI 10.1002/arco.5088; Weisler MI, 2016, P NATL ACAD SCI USA, V113, P8150, DOI 10.1073/pnas.1608130113; WEISLER MI, 1995, BIOL J LINN SOC, V56, P377, DOI 10.1111/j.1095-8312.1995.tb01099.x; Weisler MI, 1997, PREHISTORIC LONG DIS; Winterhoff E, 2007, THESIS	99	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0188207	10.1371/journal.pone.0188207	http://dx.doi.org/10.1371/journal.pone.0188207			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR3ZV	29281652	gold, Green Published, Green Submitted			2022-12-26	WOS:000419006200006
J	Eldar-Yedidia, Y; Hillel, M; Cohen, A; Bar-Meir, M; Freier-Dror, Y; Schlesinger, Y				Eldar-Yedidia, Yifat; Hillel, Miriam; Cohen, Amitay; Bar-Meir, Maskit; Freier-Dror, Yossi; Schlesinger, Yechiel			Association of toll-like receptors polymorphism and intrauterine transmission of cytomegalovirus	PLOS ONE			English	Article							TROPHOBLAST RESPONSES; INFECTION; DISEASE; PREGNANCY; FETUS; CMV	Background Congenital Cytomegalovirus (CMV) is a very common intrauterine infection which can cause severe developmental disabilities. Transmission of the virus to the fetus occurs in only 40% of primarily infected women. The probability of intrauterine transmission is higher when infection occurs during the second trimester of pregnancy than in the first trimester. The Toll-like receptors (TLRs) protein family plays a key role in both innate immune response to CMV infections and in normal pregnancy. Specific single nucleotide polymor-phisms (SNPs) in TLRs can affect CMV infections and maternal-fetal interface expression. Therefore, TLR SNPs could be involved in intrauterine transmission determination. Study aim To establish a correlation between TLR2 (rs4696480, rs3804100, rs1898830), TLR3 (rs3775291) and TLR7(rs179008) SNPs with CMV intrauterine transmission during the first and second trimester. Methods SNPs of 83 pregnant women with primary CMV were analyzed by Real-Time PCR and PCR-RFLP assay and compared to intrauterine transmission state. Results Women bearing the GG genotype in the rs1898830 TLR2 SNP who were infected with CMV during the second trimester did not transmit the virus to the fetus. Likewise, in the co-dominant or recessive models of this SNP, a significant association was found between the genotypes and CMV intrauterine transmission. In all cohort women or in women infected during the first trimester, no such associations were found between the tested SNPs and intrauterine transmission of the virus. Conclusion Women bearing the GG genotype in the rs1898830 SNP, who are infected with CMV during the second trimester of pregnancy, have a low likelihood of transmitting the virus to the fetus.	[Eldar-Yedidia, Yifat; Hillel, Miriam; Schlesinger, Yechiel] Hebrew Univ Jerusalem, Med Sch, Shaare Zedek Med Ctr, Res Lab Infect Dis, Jerusalem, Israel; [Cohen, Amitay] Hadassah Hebrew Univ, Med Sch, Jerusalem, Israel; [Bar-Meir, Maskit; Schlesinger, Yechiel] Shaare Zedek Med Ctr, Dept Pediat, Jerusalem, Israel; [Freier-Dror, Yossi] Mashav Appl Res, Jerusalem, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Schlesinger, Y (corresponding author), Hebrew Univ Jerusalem, Med Sch, Shaare Zedek Med Ctr, Res Lab Infect Dis, Jerusalem, Israel.; Schlesinger, Y (corresponding author), Shaare Zedek Med Ctr, Dept Pediat, Jerusalem, Israel.	yechiel@szmc.org.il						Abrahams VM, 2008, J IMMUNOL, V180, P6035, DOI 10.4049/jimmunol.180.9.6035; Abrahams VM, 2004, J IMMUNOL, V173, P4286, DOI 10.4049/jimmunol.173.7.4286; [Anonymous], 2011, CLIN INFECT DIS, DOI DOI 10.1093/cid/ciq085; Arav-Boger Ravit, 2012, BMC Res Notes, V5, P140, DOI 10.1186/1756-0500-5-140; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; De Nardo D, 2015, CYTOKINE, V74, P181, DOI 10.1016/j.cyto.2015.02.025; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Ducloux D, 2005, KIDNEY INT, V67, P2454, DOI 10.1111/j.1523-1755.2005.00354.x; Enders G, 2011, J CLIN VIROL, V52, P244, DOI 10.1016/j.jcv.2011.07.005; Kijpittayarit S, 2007, CLIN INFECT DIS, V44, P1315, DOI 10.1086/514339; Koga K, 2014, AM J REPROD IMMUNOL, V72, P192, DOI 10.1111/aji.12258; Liu J, 2011, ALLERGY, V66, P1020, DOI 10.1111/j.1398-9995.2011.02573.x; Mitsunari M, 2006, J REPROD IMMUNOL, V72, P46, DOI 10.1016/j.jri.2006.02.003; Nahum A, 2012, AUTOIMMUN REV, V11, P341, DOI 10.1016/j.autrev.2011.10.007; Oliver SE, 2009, J CLIN VIROL, V46, pS22, DOI 10.1016/j.jcv.2009.08.012; Revello MG, 1998, J INFECT DIS, V177, P1170, DOI 10.1086/515277; Revello MG, 2002, CLIN MICROBIOL REV, V15, P680, DOI 10.1128/CMR.15.4.680-715.2002; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904; Taniguchi R, 2013, INT J INFECT DIS, V17, pE1092, DOI 10.1016/j.ijid.2013.06.004; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wujcicka W, 2014, PATHOG DIS, V70, P3, DOI 10.1111/2049-632X.12083	23	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189921	10.1371/journal.pone.0189921	http://dx.doi.org/10.1371/journal.pone.0189921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267374	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400063
J	Gharaie, S; Vaas, LAI; Rosberg, AK; Windstam, ST; Karlsson, ME; Bergstrand, KJ; Khalil, S; Wohanka, W; Alsanius, BW				Gharaie, Samareh; Vaas, Lea A. I.; Rosberg, Anna Karin; Windstam, Sofia T.; Karlsson, Maria E.; Bergstrand, Karl-Johan; Khalil, Sammar; Wohanka, Walter; Alsanius, Beatrix W.			Light spectrum modifies the utilization pattern of energy sources in Pseudomonas sp DR 5-09	PLOS ONE			English	Article							BLUE-LIGHT; PHOTODYNAMIC THERAPY; LEAF COLONIZATION; EMITTING DIODE; PHYLLOSPHERE; RADIATION; EVOLUTION; SURVIVAL; RED; WAVELENGTH	Despite the overruling impact of light in the phyllosphere, little is known regarding the influence of light spectra on non-phototrophic bacteria colonizing the leaf surface. We developed an in vitro method to study phenotypic profile responses of bacterial pure cultures to different bands of the visible light spectrum using monochromatic (blue: 460 nm; red: 660 nm) and polychromatic (white: 350-990 nm) LEDs, by modification and optimization of a protocol for the Phenotype MicroArray (TM) technique (Biolog Inc., CA, USA). The new protocol revealed high reproducibility of substrate utilization under all conditions tested. Challenging the non-phototrophic bacterium Pseudomonas sp. DR 5-09 with white, blue, and red light demonstrated that all light treatments affected the respiratory profile differently, with blue LED having the most decisive impact on substrate utilization by impairing respiration of 140 substrates. The respiratory activity was decreased on 23 and 42 substrates under red and white LEDs, respectively, while utilization of one, 16, and 20 substrates increased in the presence of red, blue, and white LEDs, respectively. Interestingly, on four substrates contrasting utilization patterns were found when the bacterium was exposed to different light spectra. Although non-phototrophic bacteria do not rely directly on light as an energy source, Pseudomonas sp. DR 5-09 changed its respiratory activity on various substrates differently when exposed to different lights. Thus, ability to sense and distinguish between different wavelengths even within the visible light spectrum must exist, and leads to differential regulation of substrate usage. With these results, we hypothesize that different light spectra might be a hitherto neglected key stimulus for changes in microbial lifestyle and habits of substrate usage by non-phototrophic phyllospheric microbiota, and thus might essentially stratify leaf microbiota composition and diversity.	[Gharaie, Samareh; Rosberg, Anna Karin; Windstam, Sofia T.; Karlsson, Maria E.; Bergstrand, Karl-Johan; Khalil, Sammar; Alsanius, Beatrix W.] Swedish Univ Agr Sci, Dept Biosyst & Technol, Microbial Hort Unit, Alnarp, Sweden; [Vaas, Lea A. I.] Fraunhofer IME ScreeningPort, Hamburg, Germany; [Windstam, Sofia T.] SUNY Coll Oswego, Dept Biol Sci, Oswego, NY USA; [Wohanka, Walter] Geisenheim Univ, Dept Phytomed, Geisenheim, Germany	Swedish University of Agricultural Sciences; State University of New York (SUNY) System; State University of New York (SUNY) - Oswego	Alsanius, BW (corresponding author), Swedish Univ Agr Sci, Dept Biosyst & Technol, Microbial Hort Unit, Alnarp, Sweden.	beatrix.alsanius@slu.se	Khalil, Sammar/ABG-1846-2021; Bergstrand, Karl-Johan/AAY-7046-2020; Rosberg, Anna/AAK-9041-2020	Rosberg, Anna Karin/0000-0002-4851-7354; Alsanius, Beatrix/0000-0001-6300-2829	European Union Interreg Programme North Sea Region IVB	European Union Interreg Programme North Sea Region IVB	Funded by European Union Interreg Programme North Sea Region IVB; http://archive.northsearegion.eu/ivb/projects/details/&tid=134. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsanius BW, 2017, SCI HORTIC-AMSTERDAM, V216, P234, DOI 10.1016/j.scienta.2017.01.022; Alsanius BW, 2016, SCI HORTICU IN PRESS; [Anonymous], 2010, PLANT PHYSL 5 EDITIO; Armitage JP, 2003, PHOTOSYNTH RES, V76, P145, DOI 10.1023/A:1024974111818; Aruscavage D, 2010, J FOOD SCI, V75, pM187, DOI 10.1111/j.1750-3841.2010.01593.x; Beattie GA, 1998, ANNU REV PHYTOPATHOL, V33, p145 , DOI DOI 10.1146/ANNUREV.PY.33.090195.001045; Beier S, 2015, ISME J, V9, P1141, DOI 10.1038/ismej.2014.206; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BOCHNER BR, 1977, APPL ENVIRON MICROB, V33, P434, DOI 10.1128/AEM.33.2.434-444.1977; Braatsch S, 2004, PHOTOSYNTH RES, V79, P45, DOI 10.1023/B:PRES.0000011924.89742.f9; Bumah VV, 2013, PHOTOMED LASER SURG, V31, P547, DOI 10.1089/pho.2012.3461; Chui C, 2013, J PERIODONTAL RES, V48, P696, DOI 10.1111/jre.12055; Dai TH, 2013, ANTIMICROB AGENTS CH, V57, P1238, DOI 10.1128/AAC.01652-12; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; EHRET DL, 1989, CAN J PLANT SCI, V69, P1309, DOI 10.4141/cjps89-159; Elias-Arnanz M, 2011, CURR OPIN MICROBIOL, V14, P128, DOI 10.1016/j.mib.2010.12.009; Enwemeka CS, 2009, PHOTOMED LASER SURG, V27, P221, DOI 10.1089/pho.2008.2413; Golic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055059; Gomelsky M, 2011, TRENDS MICROBIOL, V19, P441, DOI 10.1016/j.tim.2011.05.002; Gonzalez-Real MM, 2000, PLANT CELL ENVIRON, V23, P351, DOI 10.1046/j.1365-3040.2000.00559.x; Guffey JS, 2006, PHOTOMED LASER SURG, V24, P684, DOI 10.1089/pho.2006.24.684; Han J- H, 2015, GENOME SEQUENC UNPUB; Heuvelink E, 2006, ACTA HORTIC, P25, DOI 10.17660/ActaHortic.2006.711.1; Jacobs JL, 2005, MICROB ECOL, V49, P104, DOI 10.1007/s00248-003-1061-4; Jacobs JL, 2001, APPL ENVIRON MICROB, V67, P5488, DOI 10.1128/AEM.67.12.5488-5496.2001; Kadivar H, 2003, MICROBIAL ECOL, V45, P353, DOI 10.1007/s00248-002-1065-5; Kim S, 2013, PHOTOMED LASER SURG, V31, P554, DOI 10.1089/pho.2012.3343; Kinkel LL, 2000, MICROBIAL ECOL, V39, P1, DOI 10.1007/s002489900182; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; Kraiselburd I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038226; Kramer A, 2008, WALLHAUSSERS PRAXIS, V6th; Leveau JHJ, 2001, P NATL ACAD SCI USA, V98, P3446, DOI 10.1073/pnas.061629598; Leveau JHJ, 2006, ANNU PLANT REV, V23, P334; Li W, 2007, J BACTERIOL, V189, P5413, DOI 10.1128/JB.00432-07; Lindow SE, 2002, CURR OPIN BIOTECH, V13, P238, DOI 10.1016/S0958-1669(02)00313-0; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Losi Aba, 2014, Plants-Basel, V3, P70, DOI 10.3390/plants3010070; Maclean M, 2014, J HOSP INFECT, V88, P1, DOI 10.1016/j.jhin.2014.06.004; Maqbool A, 2015, BIOCHEM SOC T, V43, P1011, DOI 10.1042/BST20150135; Marcell LM, 2002, MOL PLANT MICROBE IN, V15, P1236, DOI 10.1094/MPMI.2002.15.12.1236; Mercier J, 2000, APPL ENVIRON MICROB, V66, P369, DOI 10.1128/AEM.66.1.369-374.2000; Monier JM, 2003, P NATL ACAD SCI USA, V100, P15977, DOI 10.1073/pnas.2436560100; Ondrusch N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016151; PROPSTRICCIUTI C, 1976, J BACTERIOL, V128, P506, DOI 10.1128/JB.128.1.506-509.1976; Purcell EB, 2008, CURR OPIN MICROBIOL, V11, P168, DOI 10.1016/j.mib.2008.02.014; Ricci A, 2015, ENV MICROBIOL REP, V7, P795, DOI 10.1111/1758-2229.12320; Rio-Alvarez I, 2014, ENVIRON MICROBIOL, V16, P2072, DOI 10.1111/1462-2920.12240; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sundin GW, 1999, MICROBIAL ECOL, V38, P27, DOI 10.1007/s002489900152; Team RC, 2016, R LANG ENV STAT COMP; Vaas LAI, 2013, BIOINFORMATICS, V29, P1823, DOI 10.1093/bioinformatics/btt291; Vaas LAI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034846; van der Horst MA, 2007, TRENDS MICROBIOL, V15, P554, DOI 10.1016/j.tim.2007.09.009; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Werner GDA, 2014, P NATL ACAD SCI USA, V111, P1237, DOI 10.1073/pnas.1315980111; Wu L, 2013, MBIO, V4, DOI 10.1128/mBio.00334-13; Yin R, 2013, CURR OPIN PHARMACOL, V13, P731, DOI 10.1016/j.coph.2013.08.009	59	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189862	10.1371/journal.pone.0189862	http://dx.doi.org/10.1371/journal.pone.0189862			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267321	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000418587400055
J	Lee, SW; Lien, HC; Chang, CS; Ko, CW; Tung, CF; Yeh, HZ				Lee, Shou-Wu; Lien, Han-Chung; Chang, Chi-Sen; Ko, Chung-Wang; Tung, Chun-Fang; Yeh, Hong-Zen			Health-related quality of life of subjects with Barrett's esophagus in a Chinese population	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; GENERAL-POPULATION; SYMPTOMS; PREVALENCE; VALIDATION; ENDOSCOPY; RISK	Aim The aim of this study was to investigate health-related quality of life (HRQoL) of a Chinese population with Barrett's esophagus (BE). Methods Data from subjects with BE from a single hospital were prospectively collected from October 2012 to December 2014. The exclusion criteria included total esophagectomy, severe cardiopulmonary deficiency, malignancy, or other unsuitable conditions for scope. All the enrolled cases were asked to complete the Reflux Disease Questionnaire (RDQ), the short form-12, (SF-12), and the Hospital Anxiety and Depression Scale (HADS). Results In total, 139 subjects were enrolled, and the mean age of the cases was 61.85 years old. Most subjects had short-segment BE (SSBE) (92.8%) and non-dysplastic BE tissue (94.2%). The mean physical and mental composite scores, PCS and MCS, of SF-12 were 44.14 and 45.53, respectively. The SF-12 scores in BE individuals were similar in men and women, elderly and non-elderly, LSBE and SSBE, coexisting EE and no-EE, and dysplastic and non-dysplastic. The appearance of reflux symptoms tended to decrease SF-12 scores in affected individuals, especially heartburn. The rates of anxiety and depression accounted for 25.2% and 17.3% of these cases, respectively. Conclusion Our study found HRQoL in BE patients was strongly associated with presentation of reflux symptoms.	[Lee, Shou-Wu; Lien, Han-Chung; Chang, Chi-Sen; Ko, Chung-Wang; Tung, Chun-Fang; Yeh, Hong-Zen] Taichung Vet Gen Hosp, Div Gastroenterol, Dept Internal Med, Taichung, Taiwan; [Lee, Shou-Wu; Chang, Chi-Sen] Chung Shan Med Univ, Dept Internal Med, Taichung, Taiwan; [Lien, Han-Chung; Ko, Chung-Wang; Yeh, Hong-Zen] Natl Yang Ming Univ, Dept Internal Med, Taipei, Taiwan	Taichung Veterans General Hospital; Chung Shan Medical University; National Yang Ming Chiao Tung University	Lee, SW (corresponding author), Taichung Vet Gen Hosp, Div Gastroenterol, Dept Internal Med, Taichung, Taiwan.; Lee, SW (corresponding author), Chung Shan Med Univ, Dept Internal Med, Taichung, Taiwan.	ericest@vghtc.gov.tw	Lee, Shao-Wu/AAT-2594-2021	Lee, Shou-Wu/0000-0002-2412-2665				Chang CY, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0551-2; Csendes A, 2000, DIS ESOPHAGUS, V13, P5, DOI 10.1046/j.1442-2050.2000.00065.x; Eloubeidi MA, 2000, AM J GASTROENTEROL, V95, P1881; Essink-Bot ML, 2007, QUAL LIFE RES, V16, P1309, DOI 10.1007/s11136-007-9239-8; Jenkinson C, 2001, J PUBLIC HEALTH MED, V23, P187, DOI 10.1093/pubmed/23.3.187; Kulig M, 2003, ALIMENT PHARM THER, V18, P767, DOI 10.1046/j.1365-2036.2003.01770.x; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Li L, 2003, J EPIDEMIOL COMMUN H, V57, P259, DOI 10.1136/jech.57.4.259; Lippmann QK, 2009, AM J GASTROENTEROL, V104, P2695, DOI 10.1038/ajg.2009.504; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Rosmolen WD, 2010, ENDOSCOPY, V42, P525, DOI 10.1055/s-0029-1244222; Shaheen NJ, 2016, AM J GASTROENTEROL, V111, P30, DOI 10.1038/ajg.2015.322; Shaw MJ, 2001, AM J GASTROENTEROL, V96, P52; Shiota S, 2015, CLIN GASTROENTEROL H, V13, P1907, DOI 10.1016/j.cgh.2015.07.050; Spechler SJ, 2014, NEW ENGL J MED, V371, P836, DOI 10.1056/NEJMra1314704; Whiteman DC, 2008, GUT, V57, P173, DOI 10.1136/gut.2007.131375; Zagari RM, 2008, GUT, V57, P1354, DOI 10.1136/gut.2007.145177; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	18	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190201	10.1371/journal.pone.0190201	http://dx.doi.org/10.1371/journal.pone.0190201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8BI	29267355	Green Submitted, gold, Green Published			2022-12-26	WOS:000418587400104
J	Limousi, F; Lert, F; du Lou, AD; Dray-Spira, R; Lydie, N				Limousi, Frederike; Lert, France; du Lou, Annabel Desgrees; Dray-Spira, Rosemary; Lydie, Nathalie		PARCOURS Study Grp	Dynamic of HIV-testing after arrival in France for migrants from sub-Saharan Africa: The role of both health and social care systems	PLOS ONE			English	Article							HIGH-INCOME COUNTRIES; BARRIERS; STIGMA; RISK; AIDS	Objective HIV testing is an important tool in the management of the HIV epidemic among key populations. We aimed to explore the dynamic of first-time HIV testing in France for sub-Saharan migrants after their arrival. Methods ANRS-Parcours is a retrospective life-event survey conducted from 2012 to 2013 in health-care facilities in the Paris region, among 926 sub-Saharan HIV-infected migrants and 763 non-infected migrants. After describing the time to first HIV test in France and associated circumstances, we performed a discrete-time logistic regression to analyze the influence of socioeconomic position, contact with the healthcare system and sexual behaviors, on first-time HIV testing in France in migrants who arrived after 2000. Results Median first-time HIV testing occurred during the second year spent in France for noninfected men and women in both groups, and during the first year for men of the HIV group. The probability of testing increased with hospitalization and pregnancy for women of both groups. For non-infected men unemployment and absence of a residence permit were associated with an increased probability of HIV testing [respectively, OR = 2.2 (1.2-4.1) and OR = 2.0 (1.1-3.5)]. Unemployment was also associated with an increased probability of first-time HIV-testing for women of the HIV group [OR: 1.7 (1.0-2.7)]. Occasional and multiple sexual relationships were associated with an increased probability of first-time testing only for HIV-infected women [OR: 2.2 (1.2-4.0) and OR = 2.4 (1.3-4.6)]. Conclusion Access to first HIV testing in France is promoted by contact with the health care system and is facilitated for unemployed and undocumented migrants after arrival. However, testing should be offered more systematically and repeated in order to reduce time between HIV infection and diagnosis, especially for deprived people which are particularly vulnerable regarding HIV infection.	[Limousi, Frederike; Lydie, Nathalie] Sante Publ France, St Maurice, France; [Lert, France] Inst Natl Sante & Rech Medicale INSERM, CESP U 1018, Villejuif, France; [du Lou, Annabel Desgrees] Univ Paris 05, Sorbonne Paris Cite, CEPED, UMR IRD, Paris, France; [Dray-Spira, Rosemary] UPMC Univ Paris 06, Sorbonne Univ, INSERM, IPLESP UMRS 1136, Paris, France	Institute of Public Health Surveillance; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Limousi, F (corresponding author), Sante Publ France, St Maurice, France.	frederike.limousi@gmail.com		Dray-Spira, Rosemary/0000-0001-7646-3667	French National Agency for research on AIDS and Viral hepatitis; General Direction of Health (DGS, French Ministry of Health)	French National Agency for research on AIDS and Viral hepatitis(ANRS); General Direction of Health (DGS, French Ministry of Health)	This study was supported by the French National Agency for research on AIDS and Viral hepatitis (http://www.anrs.fr/) and the General Direction of Health (DGS, French Ministry of Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-del Arco D, 2013, EUR J PUBLIC HEALTH, V23, P1039, DOI 10.1093/eurpub/cks130; [Anonymous], 2012, IMM DESC IMM FRANC; [Anonymous], GAP REPORT; Blondell SJ, 2015, AIDS BEHAV, V19, P2012, DOI 10.1007/s10461-015-1095-x; Burns FM, 2007, AIDS CARE, V19, P102, DOI 10.1080/09540120600908440; Burns FM, 2008, AIDS, V22, P115, DOI 10.1097/QAD.0b013e3282f1d4b6; Champenois K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-200; Clifton S, 2016, AIDS, V30, P943, DOI 10.1097/QAD.0000000000001006; Deblonde J, 2010, EUR J PUBLIC HEALTH, V20, P422, DOI 10.1093/eurpub/ckp231; Del Amo J, 2011, EUR J PUBLIC HEALTH, V21, P620, DOI 10.1093/eurpub/ckq150; Desgrees-du-Lou A, 2015, EUROSURVEILLANCE, V20, P31, DOI 10.2807/1560-7917.ES.2015.20.46.30065; Desgrees-du-Lou A, 2016, AIDS, V30, P645, DOI 10.1097/QAD.0000000000000957; Dray-Spira R., 2013, Bulletin Epidemiologique Hebdomadaire, P285; Fakoya I, 2008, HIV MED, V9, P23, DOI 10.1111/j.1468-1293.2008.00587.x; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Le Vu S., 2007, POPULATIONS AFRICAIN, P129; Loos J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174677; Lydie N, 2007, PERCEPTION RISQUE MA, P97; Maman S, 2009, SOC SCI MED, V68, P2271, DOI 10.1016/j.socscimed.2009.04.002; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Montlahuc C, 2013, JAIDS-J ACQ IMM DEF, V64, P197, DOI 10.1097/QAI.0b013e31829cfbfa; Ndawinz JDA, 2011, AIDS, V25, P1905, DOI 10.1097/QAD.0b013e32834af619; Pharris A, 2016, EUROSURVEILLANCE, V21, DOI 10.2807/1560-7917.ES.2016.21.48.30417; Rigal L, 2011, REV EPIDEMIOL SANTE, V59, P213, DOI 10.1016/j.respe.2011.01.007; Supervie V, 2014, AIDS, V28, P1797, DOI 10.1097/QAD.0000000000000270; UNAIDS, 2014, UND FAST TRACK ACC A; Winskell K, 2011, SOC SCI MED, V73, P1257, DOI 10.1016/j.socscimed.2011.07.007	27	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0188751	10.1371/journal.pone.0188751	http://dx.doi.org/10.1371/journal.pone.0188751			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8BI	29267347	Green Submitted, gold, Green Published			2022-12-26	WOS:000418587400014
J	Campderrich, I; Liste, G; Estevez, I				Campderrich, Irene; Liste, Guiomar; Estevez, Inma			The looks matter; aggression escalation from changes on phenotypic appearance in the domestic fowl	PLOS ONE			English	Article							GROUP-SIZE; LAYING HENS; AGONISTIC BEHAVIOR; SOCIAL-BEHAVIOR; EGG-PRODUCTION; GENETICAL EVOLUTION; KIN RECOGNITION; GALLUS-GALLUS; PECK ORDERS; BODY-WEIGHT	Domestic fowl in small groups are assumed to establish hierarchical systems based on individual recognition. Conversely, interactions in large groups are modulated by badges of status. Previous studies suggested that birds differing in phenotypic appearance (PA) became targets for aggression, possibly mistaking altered PA for badges of status. We evaluated the impact of altering PA on 0, 30, 50, 70 or 100% of the birds' house at three experimental group sizes (GS). Tested GS were 10, 20 or 40 (8 birds/m(2), 3 pens/GSxPA, 45 total). Thus, for each GS we had groups initially homogenous (100U, U = Unmarked; 100M, M = Marked), or heterogeneous M and U phenotypes coexisting in different proportions: 30M/70U, 50M/50U, and 70M/30U, remaining unchanged until 33 weeks of age. Then, homogeneous groups (100U and 100M) were sequentially altered by marking or unmarking 30, 50 and 70% of birds at 34, 38 and 44 weeks, respectively. Aggressive interactions were observed before applying changes at 27-28 weeks (T0), and after each sequential PA change on week 35-36 (T1), 39-40 (T2) and 45-46 (T3). Frequency of aggressive interactions in altered groups at T1, T2, and T3 were compared with non-altered heterogeneous controls. Results indicate no differences across initial PA and GS treatments (T0; P>0.05). However, aggression escalation was observed at T1 immediately after the first PA manipulation (Tukey P<0.05 altered vs controls). Aggression in altered groups remained high at T2 when compared to controls (Tukey, P<0.05), although by T3 interactions declined to almost initial levels (Tukey, P>0.05 altered vs controls). Aggressive interactions at T1 and T2 were predominantly directed from un-altered towards recently altered birds, irrespectively of their initial phenotype and of the GS. These results demonstrate that a sudden change in PA affects group dynamics. Altered birds were exposed to escalated aggression even in small groups, where individual recognition was presumed.	[Campderrich, Irene; Liste, Guiomar; Estevez, Inma] Neiker Tecnalia, Dept Anim Prod, Vitoria, Spain; [Estevez, Inma] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Liste, Guiomar] Royal Vet Coll, Anim Welf Sci & Eth, Hatfield, Herts, England	Basque Foundation for Science; University of London; University of London Royal Veterinary College	Estevez, I (corresponding author), Neiker Tecnalia, Dept Anim Prod, Vitoria, Spain.; Estevez, I (corresponding author), Basque Fdn Sci, IKERBASQUE, Bilbao, Spain.	iestevez@neiker.eus	Liste, Guiomar/J-3271-2019	Estevez, Inma/0000-0002-9054-9528; Liste, Guiomar/0000-0002-8391-3352	Ministry of Science and Innovation, Spain (MODELAY) [AGL2010-18276];  [BES-2011-050055]	Ministry of Science and Innovation, Spain (MODELAY); 	This research was funded by the Ministry of Science and Innovation, Spain (AGL2010-18276, MODELAY), including the salary for G.L. and a PhD Scholarship for I.C. (BES-2011-050055).	Abeyesinghe SM, 2009, BEHAV PROCESS, V81, P1, DOI 10.1016/j.beproc.2008.11.017; Al-Rawi B., 1975, Applied Animal Ethology, V2, P69, DOI 10.1016/0304-3762(75)90066-8; ALRAWI B, 1976, POULTRY SCI, V55, P796, DOI 10.3382/ps.0550796; BARNARD C, 1991, TRENDS ECOL EVOL, V6, P310, DOI 10.1016/0169-5347(91)90035-V; BATESON P, 1979, ANIM BEHAV, V27, P470, DOI 10.1016/0003-3472(79)90184-2; BATESON P, 1990, PHILOS T ROY SOC B, V329, P125, DOI 10.1098/rstb.1990.0157; BELTHOFF JR, 1991, CONDOR, V93, P1010, DOI 10.2307/3247737; BRADSHAW RH, 1992, APPL ANIM BEHAV SCI, V33, P69, DOI 10.1016/S0168-1591(05)80086-3; Campderrich I, 2017, APPL ANIM BEHAV SCI, V189, P41, DOI 10.1016/j.applanim.2017.01.014; Cloutier S, 1996, BEHAV PROCESS, V38, P227, DOI 10.1016/S0376-6357(96)00034-4; Cloutier S, 2000, BEHAVIOUR, V137, P705, DOI 10.1163/156853900502303; CLOUTIER S, 1995, BEHAV PROCESS, V34, P293, DOI 10.1016/0376-6357(95)00006-G; Collias NE, 1996, ANIM BEHAV, V51, P1337, DOI 10.1006/anbe.1996.0137; Cornetto T, 2001, APPL ANIM BEHAV SCI, V71, P141, DOI 10.1016/S0168-1591(00)00171-4; CRAIG JV, 1969, ANIM BEHAV, V17, P498, DOI 10.1016/0003-3472(69)90153-5; D'Eath RB, 1999, APPL ANIM BEHAV SCI, V62, P233, DOI 10.1016/S0168-1591(98)00216-0; DAWKINS MS, 1995, BEHAVIOUR, V132, P591, DOI 10.1163/156853995X00225; DAWKINS MS, 1982, APPL ANIM ETHOL, V8, P365, DOI 10.1016/0304-3762(82)90069-4; Dennis RL, 2008, POULTRY SCI, V87, P1939, DOI 10.3382/ps.2007-00311; Dey CJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2680; Estevez I, 2003, APPL ANIM BEHAV SCI, V84, P213, DOI 10.1016/j.applanim.2003.08.006; Estevez I, 2002, APPL ANIM BEHAV SCI, V76, P307, DOI 10.1016/S0168-1591(02)00013-8; evez I. R. C., 1997, ETOLOGIA, V5, P19; Gerlach G, 2006, ANIM BEHAV, V71, P1371, DOI 10.1016/j.anbehav.2005.10.010; Goodall J., 1986, CHIMPANZEES GOMBE PA; GRAFEN A, 1990, ANIM BEHAV, V39, P42, DOI 10.1016/S0003-3472(05)80724-9; GUHL A. M., 1953, CONDOR, V55, P287, DOI 10.2307/1365008; Guhl A. M., 1968, Transactions of the Kansas Academy of Science, V71, P379, DOI 10.2307/3627156; Guhl A. M., 1944, PHYSIOL ZOOL, V17, P320; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hauser J, 2004, APPL ANIM BEHAV SCI, V85, P65, DOI 10.1016/j.applanim.2003.09.006; Hocking PM, 2003, BRIT POULTRY SCI, V44, P365, DOI [10.1080/0007166031000085535, NO_DOI]; Horak P, 2001, OECOLOGIA, V126, P166, DOI 10.1007/s004420000513; HUGHES BO, 1977, ANIM BEHAV, V25, P1056, DOI 10.1016/0003-3472(77)90056-2; Hughes BO, 1997, APPL ANIM BEHAV SCI, V54, P215, DOI 10.1016/S0168-1591(96)01177-X; Hughes DP, 2007, ANIM BEHAV, V74, P1593, DOI 10.1016/j.anbehav.2006.12.025; HURST JL, 1992, BEHAV ECOL, V3, P196, DOI 10.1093/beheco/3.3.196; JONES RB, 1985, PHYSIOL BEHAV, V34, P917, DOI 10.1016/0031-9384(85)90014-9; Jones RB, 1982, IRCS MED SCI, V10, P847; Keeling LJ, 2003, POULTRY SCI, V82, P1393, DOI 10.1093/ps/82.9.1393; Leenstra F, 2012, BRIT POULTRY SCI, V53, P282, DOI 10.1080/00071668.2012.703774; Lewis K, 1998, J THEOR BIOL, V193, P359, DOI 10.1006/jtbi.1998.0725; Liste G, 2015, APPL ANIM BEHAV SCI, V163, P144, DOI 10.1016/j.applanim.2014.11.013; Lize A, 2006, P R SOC B, V273, P2381, DOI 10.1098/rspb.2006.3598; Lorenz K., 1937, IMPRINTING AUK, V54, P245; MAIER RA, 1964, ANIM BEHAV, V12, P59, DOI 10.1016/0003-3472(64)90103-4; Marin RH, 2014, POULTRY SCI, V93, P1623, DOI 10.3382/ps.2013-03705; MARKS H. L., 1960, ANIMAL BEHAVIOUR, V8, P192, DOI 10.1016/0003-3472(60)90026-9; Martin F, 1997, BEHAV PROCESS, V41, P159, DOI 10.1016/S0376-6357(97)00044-2; Mateo JM, 2000, P ROY SOC B-BIOL SCI, V267, P695, DOI 10.1098/rspb.2000.1058; MCBRIDE G, 1962, NATURE, V194, P102, DOI 10.1038/194102a0; Mench Joy, 2001, P177, DOI 10.1079/9780851993973.0177; Murray DL, 2000, METH C CONS, P15; Nicol CJ, 1999, APPL ANIM BEHAV SCI, V65, P137, DOI 10.1016/S0168-1591(99)00057-X; O'Connor EA, 2011, APPL ANIM BEHAV SCI, V135, P293, DOI 10.1016/j.applanim.2011.09.011; Pagel M, 1997, BEHAV PROCESS, V40, P13, DOI 10.1016/S0376-6357(96)00761-9; Queiroz SA, REV BRAS, V8, P1; ROHWER S, 1978, ANIM BEHAV, V26, P1012, DOI 10.1016/0003-3472(78)90090-8; RUSHEN J, 1982, ANIM BEHAV, V30, P1129, DOI 10.1016/S0003-3472(82)80203-0; Schjelderup-Ebbe T., 1922, Zeitschrift fuer Psychologie Leipzig, V88, P225; SENAR JC, 1993, AUK, V110, P924, DOI 10.2307/4088649; SIEGEL PB, 1962, POULTRY SCI, V41, P141, DOI 10.3382/ps.0410141; TEMPLE W, 1984, BRIT POULTRY SCI, V25, P487, DOI 10.1080/00071668408454890; Tibbetts EA, 2010, CURR BIOL, V20, P1637, DOI 10.1016/j.cub.2010.07.042; Woodgush D. G., 1971, BEHAV DOMESTIC FOWL; ZUK M, 1990, AM NAT, V136, P459, DOI 10.1086/285107	68	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0188931	10.1371/journal.pone.0188931	http://dx.doi.org/10.1371/journal.pone.0188931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ7SY	29261668	Green Submitted, Green Published, gold			2022-12-26	WOS:000418564200019
J	Duhn, PH; Sode, J; Hagen, CM; Christiansen, M; Locht, H				Duhn, Pernille Hurup; Sode, Jacob; Hagen, Christian Munch; Christiansen, Michael; Locht, Henning			Mitochondrial haplogroups in patients with rheumatoid arthritis: No association with disease and disease manifestations	PLOS ONE			English	Article							REACTIVE OXYGEN; MUTATIONS; VARIANTS; HUMANS; RISK	Objective To describe the distribution of specific mitochondrial DNA (mtDNA) haplogroups (hgs) in a cohort of patients with rheumatoid arthritis (RA). Methods Two-hundred nineteen consecutive patients with RA had mtDNA isolated from their blood, sequenced and haplotyped. Patients were diagnosed according to the American College of Rheumatology (ACR)/European league against Rheumatism (EULAR) criteria. Demographic and clinical data were retrieved from the Danish nationwide database (DANBIO). Logistic regression analyses were performed to test for associations. Results One-hundred eighty-four patients were eligible for analysis. Haplogroup frequencies were: H (n = 88; 47.8%), U (n = 37; 20.1%), T (n = 22; 12.0%), J (n = 16; 8.7%), K (n = 11; 5.9%), HV (n = 6; 3.3%) and V (n = 4; 2.2%). The distribution of individual hgs was identical to the background population. Radiographic erosions were significantly associated with hg clusters JT (OR = 2.37, 95% confidence interval (CI): 1.07 +/- 5.53, p = 0.038). Significantly fewer patients from hg cluster JT received biological treatment (OR = 0.17, 95% CI: 0.03 +/- 0.87, p = 0.038). Albeit, none of these associations were significant when corrected for multiple tests. Conclusion There was no significant association between mtDNA hgs and presence of RA or disease manifestations. There was an, albeit insignificant, overrepresentation of patients with hg JT among patients with erosive disease; however, slightly fewer patients in the JT group were treated with biological drugs.	[Duhn, Pernille Hurup; Sode, Jacob; Locht, Henning] Frederiksberg Univ Hosp, Dept Rheumatol, Frederiksberg, Denmark; [Sode, Jacob] Statens Serum Inst, Dept Autoimmunol & Biomarkers, Copenhagen S, Denmark; [Sode, Jacob] Univ Southern Denmark, Ctr Sonderjylland, Inst Reg Hlth Res, Odense M, Denmark; [Hagen, Christian Munch; Christiansen, Michael] Statens Serum Inst, Dept Congenital Disorders, Copenhagen S, Denmark	Statens Serum Institut; University of Southern Denmark; Statens Serum Institut	Duhn, PH (corresponding author), Frederiksberg Univ Hosp, Dept Rheumatol, Frederiksberg, Denmark.	duhnpernille@gmail.com	Christiansen, Michael/B-4588-2009; Sode, Jacob/AAD-9615-2020	Christiansen, Michael/0000-0003-4713-755X; Sode, Jacob/0000-0002-2718-9320; Hagen, Christian/0000-0002-0513-7722; Duhn, Pernille Hurup/0000-0001-8729-0634	Novo Nordisk Foundation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	Andreas Nordholm-Carstensen, MD, PhD, Digestive Disease Center, Bispebjerg Hospital, University of Copenhagen, provided statistical consultancy. This study has been conducted using the Danish National Biobank resource, supported by the Novo Nordisk Foundation.	Abele D, 2002, J EXP BIOL, V205, P1831; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Amo T, 2007, BIOCHEM J, V404, P345, DOI 10.1042/BJ20061609; [Anonymous], 2014, BAGGRUNDSNOTAT BIOLO; Benn M, 2008, CIRCULATION, V117, P2492, DOI 10.1161/CIRCULATIONAHA.107.756809; Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559; Coto-Segura P, 2012, GENET TEST MOL BIOMA, V16, P621, DOI 10.1089/gtmb.2011.0266; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Hagen CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124540; Hagen CM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071904, 10.1371/currents.hd.d8917b4862929772c5a2f2a34ef1c201]; Hart A, 2008, AIDS REV, V42, P157; Henrotin Y, 2007, CURR DRUG TARGETS, V8, P347, DOI 10.2174/138945007779940151; Herrnstadt C, 2004, MITOCHONDRION, V4, P791, DOI 10.1016/j.mito.2004.07.041; Hudson G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004369; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kenney MC, 2014, BBA-MOL BASIS DIS, V1842, P208, DOI 10.1016/j.bbadis.2013.10.016; Kenney MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054339; Larsen S, 2014, BBA-BIOENERGETICS, V1837, P226, DOI 10.1016/j.bbabio.2013.10.009; Marcuello A, 2009, MITOCHONDRION, V9, P326, DOI 10.1016/j.mito.2009.04.007; Marcuello A, 2009, MITOCHONDRION, V9, P27, DOI 10.1016/j.mito.2008.10.002; Martinez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005; Mateen S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152925; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mikkelsen M, 2010, FORENSIC SCI INT-GEN, V4, pE87, DOI 10.1016/j.fsigen.2009.07.007; Mitsunaga S, 2015, J HUM GENET, V60, P449, DOI 10.1038/jhg.2015.50; Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052367; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Phillips DC, 2010, ANTIOXID REDOX SIGN, V12, P743, DOI 10.1089/ars.2009.2607; R Core Team, 2013, R A LANG ENV STAT CO; Rall LC, 2000, J NUTR BIOCHEM, V11, P581, DOI 10.1016/S0955-2863(00)00123-6; Rego I, 2010, ANN RHEUM DIS, V69, P210, DOI 10.1136/ard.2008.105254; Rego-Perez I, 2011, ANN RHEUM DIS, V70, P646, DOI 10.1136/ard.2010.133637; Rego-Perez I, 2008, ARTHRITIS RHEUM-US, V58, P2387, DOI 10.1002/art.23659; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Soto-Hermida A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112735; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Veselinovic M, 2014, MOL CELL BIOCHEM, V391, P225, DOI 10.1007/s11010-014-2006-6; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Zielonka J, 2008, FREE RADICAL BIO MED, V45, P1217, DOI 10.1016/j.freeradbiomed.2008.07.025	40	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0188492	10.1371/journal.pone.0188492	http://dx.doi.org/10.1371/journal.pone.0188492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261674	Green Published, Green Submitted, gold			2022-12-26	WOS:000418564200011
J	Heaf, J; Petersons, A; Vernere, B; Heiro, M; Povlsen, JV; Sorensen, AB; Rosenberg, M; Lokkegaard, N; Alonso-Garcia, F; Kampmann, JD; Clyne, N; Randers, E; Heimburger, O; Lindholm, B				Heaf, James; Petersons, Aivars; Vernere, Baiba; Heiro, Maija; Povlsen, Johan V.; Sorensen, Anette Bagger; Rosenberg, Mai; Lokkegaard, Niels; Alonso-Garcia, Fabiola; Kampmann, Jan Dominik; Clyne, Naomi; Randers, Else; Heimburger, Olof; Lindholm, Bengt			Why do physicians prescribe dialysis? A prospective questionnaire study	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS BACTEREMIA; HEMODIALYSIS-PATIENTS; INITIATION; SURVIVAL; START; COMORBIDITY; MORTALITY; OUTCOMES; DISEASE; COHORT	Introduction The incidence of unplanned dialysis initiation (DI) with consequent increased comorbidity, mortality and reduced modality choice remains high, but the optimal timing of dialysis initiation (DI) remains controversial, and there is a lack of studies of specific reasons for DI. We investigated why and when physicians prescribe dialysis and hypothesized that physician motivation for DI is an independent factor which may have clinical consequences. Methods In the Peridialysis study, an ongoing multicenter prospective study assessing the causes and timing of DI and consequences of unplanned dialysis, physicians in 11 hospitals were asked to describe their primary, secondary and further reasons for prescribing DI. The stated reasons for DI were analyzed in relation to clinical and biochemical data at DI, and characteristics of physicians. Results In 446 patients (median age 67 years; 38% females; diabetes 25.6%), DI was prescribed by 84 doctors who stated 23 different primary reasons for DI. The primary indication was clinical in 63% and biochemical in 37%; 23% started for life-threatening conditions. Reduced renal function accounted for only 19% of primary reasons for DI but was a primary or contributing reason in 69%. The eGFR at DI was 7.2 +/- 3.4 ml/min/1.73 m(2), but varied according to comorbidity and cause of DI. Patients with cachexia, anorexia and pulmonary stasis (34% with heart failure) had the highest eGFR (8.2 +/- 9.8 ml/min/1.73 m(2)), and those with edema, "low GFR", and acidosis, the lowest (4.6 +/- 6.1 ml/min/1.73 m(2)). Patients with multiple comorbidity including diabetes started at a high eGFR (8.7 ml/min/1.73 m(2)). Physician experience played a role in dialysis prescription. Non-specialists were more likely to prescribe dialysis for life-threatening conditions, while older and more experienced physicians were more likely to start dialysis for clinical reasons, and at a lower eGFR. Female doctors started dialysis at a higher eGFR than males (8.0 vs. 7.1 ml/min/1.73 m(2)). Conclusions DI was prescribed mainly based on clinical reasons in accordance with current recommendations while low renal function accounted for only 19% of primary reasons for DI. There are considerable differences in physicians A stated motivations for DI, related to their age, clinical experience and interpretation of biochemical variables. These differences may be an independent factor in the clinical treatment of patients, with consequences for the risk of unplanned DI.	[Heaf, James] Zealand Univ Hosp, Dept Med, Roskilde, Denmark; [Petersons, Aivars; Vernere, Baiba] P Stradins Univ Hosp, Riga, Latvia; [Heiro, Maija] Univ Hosp Turku, Turku, Finland; [Povlsen, Johan V.; Sorensen, Anette Bagger] Aarhus Univ Hosp, Dept Nephrol, Aarhus, Denmark; [Rosenberg, Mai] Univ Hosp Tartu, Tartu, Estonia; [Lokkegaard, Niels] Holbaek Cent Hosp, Dept Med, Holbaek, Denmark; [Alonso-Garcia, Fabiola; Kampmann, Jan Dominik] Hosp Southern Jutland, Dept Nephrol, Sonderborg, Denmark; [Clyne, Naomi] Skane Univ Hosp, Dept Nephrol Lund, Clin Sci Lund, Lund, Sweden; [Clyne, Naomi] Lund Univ, Lund, Sweden; [Randers, Else] Viborg Reg Hosp, Dept Med, Viborg, Denmark; [Heimburger, Olof; Lindholm, Bengt] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden	Pauls Stradins Clinical University Hospital; University of Turku; Aarhus University; Holbaek Hospital; Lund University; Skane University Hospital; Lund University; Aarhus University; Karolinska Institutet	Heaf, J (corresponding author), Zealand Univ Hosp, Dept Med, Roskilde, Denmark.	heaf@dadlnet.dk	Petersons, Aivars/AAO-3945-2020; Kampmann, Jan/GNW-6067-2022; Lindholm, Bengt/P-1334-2017	Kampmann, Jan/0000-0002-8844-8242; Heimburger, Olof/0000-0003-0901-4145; Lindholm, Bengt/0000-0003-4269-4293; Petersons, Aivars/0000-0001-8109-1968	Baxter Healthcare International [14CECPDEU1001]; Baxter Healthcare, Deerfield, Illinois, USA; Baxter Healthcare; Baxter Healthcare Corporation	Baxter Healthcare International; Baxter Healthcare, Deerfield, Illinois, USA; Baxter Healthcare; Baxter Healthcare Corporation	This study was supported by an unrestricted grant 14CECPDEU1001 from Baxter Healthcare International. Baxter Novum is the result of a grant from Baxter Healthcare Corporation to Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, to support research activities at Karolinska Institutet to promote the understanding and treatment of renal disease. Bengt Lindholm is employed by Baxter Healthcare Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.; We thank all physicians and other staff members who participated in this study. The project was supported by an unrestricted grant from Baxter Healthcare, Deerfield, Illinois, USA. Baxter Novum is the result of a grant from Baxter Healthcare to Karolinska Institutet.	Beddhu S, 2003, J AM SOC NEPHROL, V14, P2366, DOI 10.1097/01.ASN.0000083905.72794.E6; Beddhu S, 2003, J AM SOC NEPHROL, V14, P1000, DOI 10.1097/01.ASN.0000057856.88335.DD; Clark WF, 2011, CAN MED ASSOC J, V183, P47, DOI 10.1503/cmaj.100349; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Crews DC, 2010, NEPHRON CLIN PRACT, V114, pC19, DOI 10.1159/000245066; Curtis BM, 2002, CLIN NEPHROL, V58, P282; Da Silva-Gane M, 2012, CLIN J AM SOC NEPHRO, V7, P2002, DOI 10.2215/CJN.01130112; Daugirdas JT, 2015, AM J KIDNEY DIS, V66, P884, DOI 10.1053/j.ajkd.2015.07.015; Engemann JJ, 2005, INFECT CONT HOSP EP, V26, P534, DOI 10.1086/502580; Fysaraki M, 2013, INT J MED SCI, V10, P1632, DOI 10.7150/ijms.6710; Grootendorst DC, 2011, NEPHROL DIAL TRANSPL, V26, P1932, DOI 10.1093/ndt/gfq667; Hwang SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2616, DOI 10.1093/ndt/gfq308; Jones C, 2006, NEPHROL DIAL TRANSPL, V21, P2133, DOI 10.1093/ndt/gfl198; Kazmi WH, 2005, AM J KIDNEY DIS, V46, P887, DOI 10.1053/j.ajkd.2005.08.005; Klevens RM, 2008, SEMIN DIALYSIS, V21, P24, DOI 10.1111/j.1525-139X.2007.00379.x; Lassalle M, 2010, KIDNEY INT, V77, P700, DOI 10.1038/ki.2010.14; Ledebo Ingrid, 2001, Nephrology Dialysis Transplantation, V16, P1132, DOI 10.1093/ndt/16.6.1132; Mendelssohn DC, 2011, NEPHROL DIAL TRANSPL, V26, P2959, DOI 10.1093/ndt/gfq843; Mendelssohn DC, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-22; Nesrallah GE, 2014, CAN MED ASSOC J, V186, P112, DOI 10.1503/cmaj.130363; Nielsen LH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0740-8; O'Hare AM, 2015, J AM SOC NEPHROL, V26, P1975, DOI 10.1681/ASN.2013050531; Rosansky S, 2011, CLIN J AM SOC NEPHRO, V6, P1222, DOI 10.2215/CJN.09301010; Rosansky SJ, 2013, SEMIN DIALYSIS, V26, P650, DOI 10.1111/sdi.12134; Rosansky SJ, 2009, KIDNEY INT, V76, P257, DOI 10.1038/ki.2009.161; Tamura MK, 2010, AM J KIDNEY DIS, V56, P1117, DOI 10.1053/j.ajkd.2010.08.017; Tattersall J, 2011, NEPHROL DIAL TRANSPL, V26, P2082, DOI 10.1093/ndt/gfr168; van de Luijtgaarden MWM, 2012, AM J KIDNEY DIS, V60, P940, DOI 10.1053/j.ajkd.2012.07.015	28	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0188309	10.1371/journal.pone.0188309	http://dx.doi.org/10.1371/journal.pone.0188309			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261657	gold, Green Submitted, Green Published			2022-12-26	WOS:000418564200007
J	Levy, T; Rosen, O; Simons, O; Alkalay, AS; Sagi, A				Levy, Tom; Rosen, Ohad; Simons, Ohad; Alkalay, Amit Savaya; Sagi, Amir			The gene encoding the insulin-like androgenic gland hormone in an all-female parthenogenetic crayfish	PLOS ONE			English	Article							MARMORKREBS MARBLED CRAYFISH; MACROBRACHIUM-ROSENBERGII; DECAPODA CAMBARIDAE; CALLINECTES-SAPIDUS; FACTOR IAG; BLUE-CRAB; PEPTIDE; PRAWN; PALAEMONIDAE; GENDER	Male sexual differentiation in crustaceans is controlled by the androgenic gland (AG), a unique male endocrine organ that, in decapods, is located at the base of the 5th pereiopod. In these animals, the insulin-like androgenic gland hormone (IAG) is the major factor secreted from the AG to induce masculinization and maintain male characteristics. It has, however, recently been proposed that this hormone also plays a role in growth and ovarian development in females. In this study, we tested such a possibility by searching for the IAG gene in the marbled crayfish, a parthenogenetic animal that reproduces asexually to form an all-female genetic clone. Based on the phylogenetic relationship between the marbled crayfish and Procambarus fallax, a gonochoristic species of the same North American Cambaridae family, we searched for the IAG gene in the marbled crayfish and then fully sequenced it. The open reading frame of the gene was found to be completely identical in the two species, and their introns shared over 94% identity. It was also found that, in addition to its expression at the base of the 5th pereiopod and in the testes of male P. fallax crayfish, IAG was expressed in the muscle tissue of P. fallax males and females and even of the parthenogenetic marbled crayfish. These findings provide new insight into possible functions of IAG, in addition to its role as a masculinization-inducing factor, and also constitute the basis for a discussion of the evolutionary relationship between the above two species.	[Levy, Tom; Rosen, Ohad; Simons, Ohad; Alkalay, Amit Savaya; Sagi, Amir] Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel; [Sagi, Amir] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Sagi, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel.; Sagi, A (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Beer Sheva, Israel.	sagia@bgu.ac.il		Sagi, Amir/0000-0002-4229-1059; Levy, Tom/0000-0003-1484-0310	United States-Israel Binational Science Foundation (BSF) [2015073]	United States-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation)	This work was supported by The United States-Israel Binational Science Foundation (BSF grant number 2015073), http://www.bsf.org.il/ BSFPublic/Default.aspx.; This study was partially supported by a grant from the United States-Israel Binational Science Foundation (BSF grant number 2015073). We would also like to thank Robert A. Mattson and his team from the Bureau of Water Resources at St. Johns River Water Management District in Florida, for their dedicated efforts in capturing the P. fallax animals that were used for this study. We also thank Dr. Nili Zmora for her assistance in providing us a laboratory work platform during parts of this project, and Dr. Micha Volokita, Head of the DNA Sequencing Unit at the National Institute for Biotechnology in the Negev (NIBN) for providing us with the means to sequence the marbled crayfish genome.	Alkalay-Savaya A, 2014, PLOS NEGL TROP DIS, V8; CHARNIAUX-COTTON HELENE, 1962, GEN AND COMP ENDOCRINOL SUPPL, V1, P241, DOI 10.1016/0016-6480(62)90095-3; CHARNIAUXCOTTON H, 1954, CR HEBD ACAD SCI, V239, P780; Chung JS, 2011, GEN COMP ENDOCR, V173, P4, DOI 10.1016/j.ygcen.2011.04.017; CRONIN LE, 1947, J MORPHOL, V81, P209, DOI 10.1002/jmor.1050810205; Huang XS, 2017, GEN COMP ENDOCR, V249, P64, DOI 10.1016/j.ygcen.2017.05.001; Huang XS, 2014, GEN COMP ENDOCR, V204, P229, DOI 10.1016/j.ygcen.2014.06.002; Khalaila I, 2002, GEN COMP ENDOCR, V127, P147, DOI 10.1016/S0016-6480(02)00031-X; Levy T, 2016, MAR BIOTECHNOL, V18, P554, DOI 10.1007/s10126-016-9717-5; Lezer Y, 2015, AQUACULTURE, V435, P157, DOI 10.1016/j.aquaculture.2014.09.040; Li FJ, 2015, GEN COMP ENDOCR, V216, P152, DOI 10.1016/j.ygcen.2014.12.007; MALECHA SR, 1992, AQUACULTURE, V105, P201, DOI 10.1016/0044-8486(92)90087-2; Manor R, 2004, INVERTEBR REPROD DEV, V45, P151, DOI 10.1080/07924259.2004.9652584; Manor R, 2007, GEN COMP ENDOCR, V150, P326, DOI 10.1016/j.ygcen.2006.09.006; Mareddy VR, 2011, AQUACULTURE, V318, P364, DOI 10.1016/j.aquaculture.2011.05.027; Martin P, 2007, NATURWISSENSCHAFTEN, V94, P843, DOI 10.1007/s00114-007-0260-0; Martin P, 2016, J ZOOL SYST EVOL RES, V54, P13, DOI 10.1111/jzs.12114; Martin P, 2010, CONTRIB ZOOL, V79, P107, DOI 10.1163/18759866-07903003; NAGAMINE C, 1980, GEN COMP ENDOCR, V41, P442, DOI 10.1016/0016-6480(80)90049-0; NAGAMINE C, 1980, GEN COMP ENDOCR, V41, P423, DOI 10.1016/0016-6480(80)90048-9; RHEINSMI.EL, 1974, COMP BIOCHEM PHYSIOL, V48, P343, DOI 10.1016/0305-0491(74)90269-7; Sagi A, 1997, INVERTEBR REPROD DEV, V31, P55, DOI 10.1080/07924259.1997.9672563; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; Scholtz G, 2003, NATURE, V421, P806, DOI 10.1038/421806a; Simon Thomas P., 2011, Proceedings of the Indiana Academy of Science, V120, P71; Sroyraya M, 2010, TISSUE CELL, V42, P293, DOI 10.1016/j.tice.2010.07.003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ventura T, 2015, GEN COMP ENDOCR, V214, P126, DOI 10.1016/j.ygcen.2014.06.027; Ventura T, 2011, GEN COMP ENDOCR, V173, P381, DOI 10.1016/j.ygcen.2011.05.018; Ventura T, 2009, ENDOCRINOLOGY, V150, P1278, DOI 10.1210/en.2008-0906; Vogt G, 2015, BIOL OPEN, V4, P1583, DOI 10.1242/bio.014241	32	19	20	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189982	10.1371/journal.pone.0189982	http://dx.doi.org/10.1371/journal.pone.0189982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261765	Green Published, gold, Green Submitted			2022-12-26	WOS:000418564200078
J	Parma, D; Ferrer, M; Luce, L; Giliberto, F; Szijan, I				Parma, Diana; Ferrer, Marcela; Luce, Leonela; Giliberto, Florencia; Szijan, Irene			RB1 gene mutations in Argentine retinoblastoma patients. Implications for genetic counseling	PLOS ONE			English	Article							LOW-PENETRANCE RETINOBLASTOMA; UNILATERAL RETINOBLASTOMA; SUSCEPTIBILITY GENE; CANCER; DISEASE; TRANSCRIPTION; SPECTRUM	Retinoblastoma (RB) is an inherited childhood ocular cancer caused by mutations in the tumor suppressor RB1 gene. Identification of RB1 mutations is essential to assess the risk of developing retinoblastoma in the patients A relatives. Retinoblastoma is a potentially curable cancer and an early diagnosis is critical for survival and eye preservation. Unilateral retinoblastoma is mostly non-heritable and results from two somatic mutations whereas bilateral retinoblastoma is heritable and results from one germline and one somatic mutation, both have high penetrance, 90%. The purpose of this study was to identify causative RB1 mutations in RB patients with different clinical presentations. A comprehensive approach was used to study a cohort of 34 patients with unilateral, bilateral and trilateral retinoblastoma. Blood and tumor DNA was analyzed by sequencing and multiplex ligation-dependent probe amplification (MLPA) assay. Validation of an insertion mutation was performed by cloning the PCR product. Most of the patients in our cohort had unilateral RB, eight patients had bilateral RB and one patient had a trilateral tumor with ocular and suprasellar/sellar locations. Other tumors in addition to retinoblastoma were also found in the affected families. One patient had two syndromes, retinoblastoma and schwannomatosis, and another RB patient had a father with a retinoma. Five out of the 25 unilateral RB patients carried germinal mutations (20%), which were mostly missense mutations. The bilateral and trilateral patients carried splice-site, nonsense and frameshift mutations as well as a whole RB1 gene deletion. Missense mutations were associated with mild phenotype: unilateral retinoblastoma, retinoma or no tumor. In this study we identified causative RB1 mutations in most bilateral RB patients and in some unilateral RB patients, including five novel mutations. These data are crucial for genetic counseling and confirm the need to perform complete genetic screening for RB1 mutations in both constitutional and tumor tissues.	[Parma, Diana; Luce, Leonela; Giliberto, Florencia; Szijan, Irene] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Genet, Buenos Aires, DF, Argentina; [Ferrer, Marcela] Univ Buenos Aires, Hosp Clin Jose de San Martin, Div Neurocirugia, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Szijan, I (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Catedra Genet, Buenos Aires, DF, Argentina.	iszijan@ffyb.uba.ar		Giliberto, Florencia/0000-0001-5026-5486	Buenos Aires University [UBACYT 2010-2012 GEF, 20020090200492]; Universidad de Buenos Aires, Buenos Aires, Argentina [20020090200492]	Buenos Aires University(University of Buenos Aires); Universidad de Buenos Aires, Buenos Aires, Argentina(University of Buenos Aires)	The funder of this work is the Buenos Aires University, the Grant number is: UBACYT 2010-2012 GEF, No 20020090200492. The web site is the Universidad de Buenos Aires.; The work was supported by the grant from Universidad de Buenos Aires (2010-2012) No 20020090200492, Buenos Aires, Argentina.	Abramson D H, 1999, Ophthalmic Genet, V20, P193, DOI 10.1076/opge.20.3.193.2284; Abramson DH, 2003, PEDIATRICS, V112, P1248, DOI 10.1542/peds.112.6.1248; Balog ERM, 2011, PROTEINS, V79, P2010, DOI 10.1002/prot.23007; Burke JR, 2012, GENE DEV, V26, P1156, DOI 10.1101/gad.189837.112; Chantada GL, 2011, PEDIATR BLOOD CANCER, V56, P341, DOI 10.1002/pbc.22843; COOPER DN, 1990, HUM GENET, V85, P55; Damgaard CK, 2008, MOL CELL, V29, P271, DOI 10.1016/j.molcel.2007.11.035; den Dunnen JT, 2000, HUM MUTAT, V15, P7; DiCiommo D, 2000, SEMIN CANCER BIOL, V10, P255, DOI 10.1006/scbi.2000.0326; Dimaras H., 2007, MOL PROGR RETINA RET, P158; DRYJA TP, 1993, AM J HUM GENET, V52, P1122; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; Furger A, 2002, GENE DEV, V16, P2792, DOI 10.1101/gad.983602; Gallie BL, 1999, CANCER RES, V59, p1731S; GALLIE BL, 1982, BRIT J CANCER, V45, P513, DOI 10.1038/bjc.1982.87; Harbour JW, 2001, ARCH OPHTHALMOL-CHIC, V119, P1699; Hung CC, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-76; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LEE WH, 1987, NATURE, V329, P642, DOI 10.1038/329642a0; Lohmann DR, 1999, HUM MUTAT, V14, P283, DOI 10.1002/(SICI)1098-1004(199910)14:4<283::AID-HUMU2>3.0.CO;2-J; Ottaviani D, 2015, J GENETICS DISORDERS; Ottaviani D, 2015, MEDICINA-BUENOS AIRE, V75, P137; Ottaviani D, 2013, OPHTHALMIC GENET, V34, P189, DOI 10.3109/13816810.2012.755553; Paulino AC, 1999, CANCER-AM CANCER SOC, V86, P135, DOI 10.1002/(SICI)1097-0142(19990701)86:1<135::AID-CNCR19>3.0.CO;2-0; Rubin Seth M., 2013, TRENDS BIOCHEM SCI, V38, P12; Smith MJ, 2012, NEUROGENETICS, V13, P141, DOI 10.1007/s10048-012-0319-8; Taylor M, 2007, HUM MUTAT, V28, P284, DOI 10.1002/humu.20443; Temming P, 2013, BRIT J OPHTHALMOL, V97, P475, DOI 10.1136/bjophthalmol-2012-302666; VOGEL F, 1979, HUM GENET, V52, P1; Wong FL, 1997, JAMA-J AM MED ASSOC, V278, P1262, DOI 10.1001/jama.278.15.1262	31	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189736	10.1371/journal.pone.0189736	http://dx.doi.org/10.1371/journal.pone.0189736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261756	Green Published, Green Submitted, gold			2022-12-26	WOS:000418564200061
J	Steele, AK; Carrasco-Medina, L; Sodora, DL; Crawley, AM				Steele, Amanda K.; Carrasco-Medina, Lorna; Sodora, Donald L.; Crawley, Angela M.			Increased soluble IL-7 receptor concentrations associate with improved IL-7 therapy outcomes in SIV-infected ART-treated Rhesus macaques	PLOS ONE			English	Article							T-CELL HOMEOSTASIS; INTERLEUKIN-7 RECEPTOR; ANTIRETROVIRAL THERAPY; MULTIPLE-SCLEROSIS; GENE-EXPRESSION; HIV-INFECTION; IN-VIVO; ALPHA; PROLIFERATION; NAIVE	The use of interleukin-7 (IL-7) as an immunorestorative therapeutic has proven effective in HIV infection, cancer and bone marrow transplantation. Mediating its activity through membrane-bound IL-7 receptor a (mCD127), IL-7 therapy increases T-cell numbers and survival. A soluble form, sCD127, is found in plasma, and we have previously identified increased plasma sCD127 concentrations in HIV infection. Furthermore, patients with high sCD127 exhibited the best viral control, implicating a role for IL-7 or sCD127 directly in improved virologic/immunologic outcomes. The role of the cytokine IL-7 in elevating sCD127 levels was addressed here through assessment of retrospective samples obtained from SIV-infected antiretroviral (ART)-treated Rhesus macaques. IL-7 was administered in clustered weekly doses, allowing for an assessment prior, during and following IL-7 administration. The levels of sCD127 remained relatively unchanged during both early SIV infection and following initiation of ART. However, treatment with IL-7 increased sCD127 concentrations in most animals, transiently or persistently, paralleling increased T-cell numbers, correlating significantly with CD8(+) T-cell levels. In addition, proliferating CD4(+) or CD8(+) T-cells (measured by Ki67) increased in association with elevated sCD127 concentrations. Finally, a high concentration of sCD127 in IL7-treated animals was associated with increased retention of T-cells (measured by BrDU). In addition, a lack, or loss of viral control was associated with more pronounced and frequent elevations in plasma sCD127 concentrations with IL-7 therapy. In summary, plasma sCD127 levels in SIV-infected ART-treated macaques was associated with therapeutic IL-7 administration, with higher sCD127 levels in macaques demonstrating the best T-cell responses. This study furthers our knowledge regarding the interrelationship between increased IL-7 levels and elevated sCD127 levels that may have implications for future IL-7 immunotherapeutic approaches in HIV-infected patients.	[Steele, Amanda K.; Sodora, Donald L.] Ctr Infect Dis Res, Seattle, WA USA; [Steele, Amanda K.] Collegiate Peaks Sci Writing, Denver, CO USA; [Carrasco-Medina, Lorna] Ottawa Hosp, Div Infect Dis, Gen Campus, Ottawa, ON, Canada; [Crawley, Angela M.] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON, Canada; [Crawley, Angela M.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Crawley, Angela M.] Carleton Univ, Dept Biol, Ottawa, ON, Canada	Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Carleton University	Crawley, AM (corresponding author), Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON, Canada.; Crawley, AM (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Crawley, AM (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON, Canada.	acrawley@ohri.ca		Crawley, Angela/0000-0002-7453-7922	National Institutes of Health Grants [R01-AI035522, R01-DE017541]; Oregon National Primate Research Center Core Grant [P51-RR00163]; James B. Pendleton Charitable Trust; Canadian Foundation for AIDS Research Grant [501]; Ontario HIV Treatment Network Junior Investigator Development Award [635]; Canadian Institutes of Health Research - New Investigator Award; J.P Bickell Foundation; Canadian Institutes of Health Research; Ontario HIV Treatment Network (OHTN); OHTN; Canadian Foundation for AIDS Research; J.P. Bickell Foundation	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon National Primate Research Center Core Grant; James B. Pendleton Charitable Trust; Canadian Foundation for AIDS Research Grant; Ontario HIV Treatment Network Junior Investigator Development Award; Canadian Institutes of Health Research - New Investigator Award(Canadian Institutes of Health Research (CIHR)); J.P Bickell Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network (OHTN); OHTN; Canadian Foundation for AIDS Research; J.P. Bickell Foundation	This work was supported by National Institutes of Health Grants R01-AI035522 (to D.L.S.), R01-DE017541 (to D.L.S.) (https://www.nih.gov/); Oregon National Primate Research Center Core Grant P51-RR00163 (http://www.ohsu.edu/xd/research/centers-institutes/onprc/); James B. Pendleton Charitable Trust (to D.L.S.) (https://fconline.foundationcenter.org/grantmaker-profile/?key=PEND010 & The Canadian Foundation for AIDS Research Grant #501 (to A.M.C.) (http://www.canfar.com/); The Ontario HIV Treatment Network Junior Investigator Development Award #635 (to A.M.C.) (http://www.ohtn.on.ca/); Canadian Institutes of Health Research - New Investigator Award (to A.M.C.).; and J.P Bickell Foundation (to A.M.C.) (http://www.scotiabank.com/swm/en/0.,9769,00.html).; We acknowledge Dr. Louis Picker for the access to the biological samples in this study. We are very grateful to Dr. Jonathan B. Angel for his assistance in editing this manuscript. A.M.C. is the recipient of a New Investigator salary award from the Canadian Institutes of Health Research, and a Junior Investigator Development Award from the Ontario HIV Treatment Network (OHTN). This research was funded by the OHTN, Canadian Foundation for AIDS Research and the J.P. Bickell Foundation. A.K.L. conducted many experiments in this study, conducted data analysis and assisted in the drafting of the manuscript. L.C-M. conducted experiments in this study. D.L.S assisted in the drafting of the manuscript. A.M.C. designed the study, assisted in data analysis and wrote the manuscript.	Andersson A, 2011, CLIN CANCER RES, V17, P3660, DOI 10.1158/1078-0432.CCR-10-3346; Beq S, 2006, J IMMUNOL, V176, P914, DOI 10.4049/jimmunol.176.2.914; Beq S, 2009, BLOOD, V114, P816, DOI 10.1182/blood-2008-11-191288; Blom-Potar MC, 2009, JAIDS-J ACQ IMM DEF, V51, P104, DOI 10.1097/QAI.0b013e31819d8a20; Booth DR, 2005, J MOL MED, V83, P822, DOI 10.1007/s00109-005-0684-y; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; CARINI C, 1994, EUR J IMMUNOL, V24, P2927, DOI 10.1002/eji.1830241202; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Cote S, 2015, CELL IMMUNOL, V293, P122, DOI 10.1016/j.cellimm.2015.01.001; Crawley AM, 2010, J IMMUNOL, V184, P4679, DOI 10.4049/jimmunol.0903758; Davidson A, MECHANIMS HUMA UNPUB; Dereuddre-Bosquet N, 2007, J MED PRIMATOL, V36, P228, DOI 10.1111/j.1600-0684.2007.00240.x; Faucher S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006690; Fry TJ, 2003, BLOOD, V101, P2294, DOI 10.1182/blood-2002-07-2297; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; Hoe E, 2010, J IMMUNOL, V184, P2512, DOI 10.4049/jimmunol.0902900; Hofmeister R, 1999, CYTOKINE GROWTH F R, V10, P41, DOI 10.1016/S1359-6101(98)00025-2; Janot-Sardet C, 2009, J IMMUNOL METHODS; KASPER LH, 1995, J IMMUNOL, V155, P4798; Khaled AR, 2003, IMMUNOL REV, V193, P48, DOI 10.1034/j.1600-065X.2003.00050.x; Koesters SA, 2006, EUR J IMMUNOL, V36, P336, DOI 10.1002/eji.200535111; Korte A, 2000, CYTOKINE, V12, P1597, DOI 10.1006/cyto.2000.0777; Leone A, 2010, J IMMUNOL, V185, P1650, DOI 10.4049/jimmunol.0902626; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Lopez M, 2013, AIDS REV, V15, P190; Lundstrom W, 2011, J IMMUNOL, V186, P57; Lundstrom W, 2013, P NATL ACAD SCI USA, V110, pE1761, DOI 10.1073/pnas.1222303110; Mackall CL, 2001, BLOOD, V97, P1491, DOI 10.1182/blood.V97.5.1491; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; MacPherson PA, 2001, J ACQ IMMUN DEF SYND, V28, P454, DOI 10.1097/00042560-200112150-00008; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mckay FC, 2008, GENES IMMUN, V9, P1, DOI 10.1038/sj.gene.6364436; Monti P, 2013, DIABETES, V62, P2500, DOI 10.2337/db12-1726; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; O'Doherty C, 2009, TISSUE ANTIGENS, V74, P429, DOI 10.1111/j.1399-0039.2009.01342.x; Okoye AA, 2015, J IMMUNOL, V195, P4292, DOI 10.4049/jimmunol.1500609; Parker R, 2010, BLOOD, V116, P5589, DOI 10.1182/blood-2010-03-276261; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Picker LJ, 2004, J EXP MED, V200, P1299, DOI 10.1084/jem.20041049; Rajasuriar R, 2010, J INFECT DIS, V202, P1254, DOI 10.1086/656369; Rane L, 2011, GENES IMMUN, V12, P513, DOI 10.1038/gene.2011.29; Rose T, 2009, J IMMUNOL, V182, P7389, DOI 10.4049/jimmunol.0900190; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Shamim Z, 2006, BONE MARROW TRANSPL, V37, P485, DOI 10.1038/sj.bmt.1705277; Shamim Z, 2011, PLASM LEV SOL INT 7; Silvestri G, 2005, J VIROL, V79, P4043, DOI 10.1128/JVI.79.7.4043-4054.2005; Singh V, 2010, J INFECT DIS, V202, P480, DOI 10.1086/653827; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Sportes C, 2010, CLIN CANCER RES, V16, P727, DOI 10.1158/1078-0432.CCR-09-1303; Swainson L, 2006, J IMMUNOL, V176, P6702, DOI 10.4049/jimmunol.176.11.6702; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Vranjkovic A, 2007, INT IMMUNOL, V19, P1329, DOI 10.1093/intimm/dxm102; Xu HB, 2012, FASEB J, V26, P2294, DOI 10.1096/fj.11-195180	59	4	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0188427	10.1371/journal.pone.0188427	http://dx.doi.org/10.1371/journal.pone.0188427			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261677	Green Submitted, gold, Green Published			2022-12-26	WOS:000418554900003
J	Wang, XY; Zheng, F; Wang, Y; Tu, T; Ma, R; Su, XY; You, S; Yao, B; Xie, XM; Luo, HY				Wang, Xiaoyu; Zheng, Fei; Wang, Yuan; Tu, Tao; Ma, Rui; Su, Xiaoyun; You, Shuai; Yao, Bin; Xie, Xiangming; Luo, Huiying			Improvement of the catalytic efficiency of a hyperthermophilic xylanase from Bispora sp MEY-1	PLOS ONE			English	Article							GH10 XYLANASE; APPLICATION POTENTIALS; THERMOSTABLE XYLANASE; GLOEOPHYLLUM-TRABEUM; PERFORMANCE; ACID; ENHANCE; ENZYMES; PROTEIN	Extremophilic xylanases have attracted great scientific and industrial interest. In this study, a GH10 xylanase-encoding gene, Xyl10E, was cloned from Bispora sp. MEY-1 and expressed in Pichia pastoris GS115. Deduced Xyl10E shares the highest identities of 62% and 57% with characterized family GH10 xylanases from Talaromyces leycettanus and Penicillium canescens (structure 4F8X), respectively. Xyl10E was most active at 93 to 95 degrees C and pH 4.0, retained more than 75% or 48% of the initial activity when heated at 80 degrees C or 90 degrees C for 30 min, respectively, and hardly lost activity at pH 1.0 to 7.0, but was completely inhibited by SDS. Two residues, A160 and A161, located on loop 4, were identified to play roles in catalysis. Mutants A160D/E demonstrated higher affinity to substrate with lower Km values, while mutants A161D/E mainly displayed elevated V-max values. All of these mutants had significantly improved catalytic efficiency. According to the molecular dynamics simulation, the mutation of A160E was able to affect the important substrate binding site Y204 and then improve the substrate affinity, and the mutation of A161D was capable of forming a hydrogen bond with the substrate to promote the substrate binding or accelerate the product release. This study introduces a highly thermophilic fungal xylanase and reveals the importance of loop 4 for catalytic efficiency.	[Wang, Xiaoyu; Zheng, Fei; Xie, Xiangming] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing, Peoples R China; [Wang, Xiaoyu; Zheng, Fei; Wang, Yuan; Tu, Tao; Ma, Rui; Su, Xiaoyun; You, Shuai; Yao, Bin; Luo, Huiying] Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Xie, XM (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing, Peoples R China.; Luo, HY (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing, Peoples R China.	xiexm1005@163.com; luohuiying@caas.cn			National Natural Science Foundation of China [31472127]; National High-Tech Research and Development Program of China (863 Program) [2013AA102803]; National Science Fund for Distinguished Young Scholars of China [31225026]; China Modern Agriculture Research System [CARS-42]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); China Modern Agriculture Research System	This work was supported by the National Natural Science Foundation of China (grant: no. 31472127; received by HL; http://www.nsfc.gov.cn/) and the National High-Tech Research and Development Program of China (863 Program, grant: no.2013AA102803; received by BY; http://program.most.gov.cn/) and the National Science Fund for Distinguished Young Scholars of China (grant: no. 31225026; received by BY; http://www.nsfc.gov.cn/) and the China Modern Agriculture Research System (grant: no. CARS-42; received by BY; http://www.caas.net.cn/zytj/kjpt/xdnycyjztx/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (no. 31472127), the National High-Tech Research and Development Program of China (863 Program, no.2013AA102803), the National Science Fund for Distinguished Young Scholars of China (no. 31225026), and the China Modern Agriculture Research System (no. CARS-42). We would like to thank LetPub for providing linguistic assistance during the preparation of this manuscript.	Andrade CMMC, 2001, APPL BIOCHEM BIOTECH, V91-3, P655; Bendl J, 2016, NUCLEIC ACIDS RES, V44, pW479, DOI 10.1093/nar/gkw416; Chawachart N, 2014, EXTREMOPHILES, V18, P1023, DOI 10.1007/s00792-014-0679-0; Choi YH, 2016, BIOTECHNOL BIOENG, V113, P1666, DOI 10.1002/bit.25944; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Du YL, 2013, BIORESOURCE TECHNOL, V130, P161, DOI 10.1016/j.biortech.2012.12.067; Hoffmam ZB, 2016, NEW BIOTECHNOL, V33, P467, DOI 10.1016/j.nbt.2016.02.006; Kim HM, 2014, J BIOTECHNOL, V172, P38, DOI 10.1016/j.jbiotec.2013.12.013; Kunze W., 1999, TECHNOLOGY BREWING M, P157; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Rodriguez ML, 2012, J SCI FOOD AGR, V92, P184, DOI 10.1002/jsfa.4561; Luo HY, 2009, EXTREMOPHILES, V13, P849, DOI 10.1007/s00792-009-0272-0; Matsuzawa T, 2016, APPL MICROBIOL BIOT, V100, P8043, DOI 10.1007/s00253-016-7563-z; Mielenz JR, 2001, CURR OPIN MICROBIOL, V4, P324, DOI 10.1016/S1369-5274(00)00211-3; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Paes G, 2012, COMPUT STRUCT BIOTEC, V1, DOI 10.5936/csbj.201207001; Passos AA, 2015, J ANIM SCI, V93, P1721, DOI 10.2527/jas.2014-8435; Pell G, 2004, J BIOL CHEM, V279, P9597, DOI 10.1074/jbc.M312278200; Piovesan D, 2016, NUCLEIC ACIDS RES, V44, pW367, DOI 10.1093/nar/gkw315; Ribeiro LFC, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-115; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Sunna A, 2003, EXTREMOPHILES, V7, P63, DOI 10.1007/s00792-002-0296-1; Talebnia F, 2010, BIORESOURCE TECHNOL, V101, P4744, DOI 10.1016/j.biortech.2009.11.080; Tu T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135413; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Van Campenhout L., 2003, RECENT ADV ENZYMES G, V4, P387; Wang JQ, 2014, J IND MICROBIOL BIOT, V41, P1217, DOI 10.1007/s10295-014-1463-y; Wang Q, 2007, WORLD J MICROB BIOT, V23, P1047, DOI 10.1007/s11274-006-9263-9; Wang XY, 2016, BIORESOURCE TECHNOL, V222, P277, DOI 10.1016/j.biortech.2016.10.003; Wang XY, 2016, FOOD CHEM, V199, P516, DOI 10.1016/j.foodchem.2015.12.028; Wang YZ, 2013, J NANOMATER, V2013, DOI 10.1155/2013/169405; Wang ZY, 2012, WORLD J MICROB BIOT, V28, P2741, DOI 10.1007/s11274-012-1085-3; WINTERHALTER C, 1995, APPL ENVIRON MICROB, V61, P1810, DOI 10.1128/AEM.61.5.1810-1815.1995; Xu X, 2016, ENZYME MICROB TECH, V86, P59, DOI 10.1016/j.enzmictec.2016.02.001; Xue XL, 2015, APPL ENVIRON MICROB, V81, P3823, DOI 10.1128/AEM.00432-15; Zhang F, 2011, APPL MICROBIOL BIOT, V89, P1851, DOI 10.1007/s00253-010-3016-2; Zhao L, 2013, J AGR FOOD CHEM, V61, P6880, DOI 10.1021/jf4001296; Zheng F, 2016, APPL MICROBIOL BIOT, V100, P3555, DOI 10.1007/s00253-015-7176-y	39	6	8	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189806	10.1371/journal.pone.0189806	http://dx.doi.org/10.1371/journal.pone.0189806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253895	Green Published, gold, Green Submitted			2022-12-26	WOS:000418389500063
J	Vinik, Y; Shatz-Azoulay, H; Hiram-Bab, S; Kandel, L; Gabet, Y; Rivkin, G; Zick, Y				Vinik, Yaron; Shatz-Azoulay, Hadas; Hiram-Bab, Sahar; Kandel, Leonid; Gabet, Yankel; Rivkin, Gurion; Zick, Yehiel			Ablation of the mammalian lectin galectin-8 induces bone defects in mice	FASEB JOURNAL			English	Article						glycan-binding protiens; osteoblast differentiation; bone remodeling; estrogen receptor	ESTROGEN-RECEPTOR-ALPHA; OSTEOBLAST DIFFERENTIATION; POSTMENOPAUSAL OSTEOPOROSIS; ANIMAL-MODELS; STEM-CELLS; IN-VITRO; EXPRESSION; TURNOVER; OSTEOCLASTS; MECHANISMS	Mice overexpressing galectin-8 [gal-8 transgenic (Tg)], a secreted mammalian lectin, exhibit enhanced bone turnover and reduced bone mass, similar to cases of postmenopausal osteoporosis. Here, we show that gal-8 knockout (KO) mice have increased bone mass accrual at a young age but exhibit accelerated bone loss during adulthood. These phenotypes can be attributed to a gal-8-mediated increase in receptor activator of NF-kappa B ligand (RANKL) expression that promotes osteoclastogenesis, combined with direct inhibition of osteoblast differentiation, evident by reduced bone morphogenetic protein (BMP) signaling, reduced phosphorylation of receptor regulated mothers against decapentaplegic homolog (R-SMAD) and reduced expression of osteoblast differentiation markers osterix, osteocalcin, runt-related transcription factor 2 (RUNX2), dentin matrix acidic phosphoprotein-1 (DMP1), and alkaline phosphatase. At the same time, gal-8 promotes expression of estrogen receptor alpha (ESR1). Accordingly, the rate of bone loss is accelerated in ovariectomized, estrogen-deficient gal-8 Tg mice, whereas gal-8 KO mice, having low levels of ESR1, are refractory to ovariectomy. Finally, gal-8 mRNA positively correlates with the mRNA levels of osteoclastogenic markers RANKL, tartrate-resistant acid phosphatase, and cathepsin K in human femurs. Collectively, these findings identify gal-8 as a new physiologic player in the regulation of bone mass.	[Vinik, Yaron; Shatz-Azoulay, Hadas; Zick, Yehiel] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Hiram-Bab, Sahar; Gabet, Yankel] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel; [Kandel, Leonid; Rivkin, Gurion] Hadassah Hebrew Univ, Med Ctr, Dept Orthoped Surg, Jerusalem, Israel	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center	Zick, Y (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	yehiel.zick@weizmann.ac.il	Gabet, Yankel/I-6244-2019; Zick, Yehiel/K-1479-2012	Gabet, Yankel/0000-0002-7494-0631; 	Minerva Foundation [711425]; Israel Science Foundation [776/13]	Minerva Foundation; Israel Science Foundation(Israel Science Foundation)	Insightful discussions with Dr. Sanford Sampson (Bar Ilan University, Ramat Gan, Israel) and Dr. Eytan Elhanany (Israel Institute for Biological Research, Ness Ziona, Israel) are greatly acknowledged. This work was supported by The Minerva Foundation (711425) and The Israel Science Foundation (776/13; to Y.Z.). The authors declare no conflicts of interest.	Almeida M, 2013, J CLIN INVEST, V123, P394, DOI 10.1172/JCI65910; Arlot M E, 1990, Osteoporos Int, V1, P41, DOI 10.1007/BF01880415; Bakker A, 2003, METH MOLEC MED, V80, P19; Bhat R, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-6; Bonucci E, 2014, TOXICOL PATHOL, V42, P957, DOI 10.1177/0192623313512428; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Cheung AM, 2016, INT J WOMENS HEALTH, V8, P537, DOI 10.2147/IJWH.S112621; Chim SM, 2013, CYTOKINE GROWTH F R, V24, P297, DOI 10.1016/j.cytogfr.2013.03.008; de Jong DS, 2004, J BONE MINER RES, V19, P947, DOI 10.1359/JBMR.040216; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; Ebeling PR, 1996, J CLIN ENDOCR METAB, V81, P3366, DOI 10.1210/jc.81.9.3366; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Garimella R, 2008, J HISTOCHEM CYTOCHEM, V56, P569, DOI 10.1369/jhc.2008.950394; Garnero P, 1996, J BONE MINER RES, V11, P337, DOI 10.1002/jbmr.5650110307; Idris AI, 2012, METHODS MOL BIOL, V816, P545, DOI 10.1007/978-1-61779-415-5_34; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Khosla S, 2012, TRENDS ENDOCRIN MET, V23, P576, DOI 10.1016/j.tem.2012.03.008; Komori T, 2015, EUR J PHARMACOL, V759, P287, DOI 10.1016/j.ejphar.2015.03.028; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Kruger MC, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060376; Ledeen RW, 2012, ANN NY ACAD SCI, V1253, P206, DOI 10.1111/j.1749-6632.2012.06479.x; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Maeda Y, 2004, J CELL BIOCHEM, V93, P337, DOI 10.1002/jcb.20154; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Manolagas SC, 2013, NAT REV ENDOCRINOL, V9, P699, DOI 10.1038/nrendo.2013.179; Mathieu PS, 2012, TISSUE ENG PART B-RE, V18, P436, DOI [10.1089/ten.teb.2012.0014, 10.1089/ten.TEB.2012.0014]; Matsumoto Y, 2013, STEROIDS, V78, P513, DOI 10.1016/j.steroids.2013.02.011; McNamara LM, 2010, J R SOC INTERFACE, V7, P353, DOI 10.1098/rsif.2009.0282; Melville KM, 2014, J BONE MINER RES, V29, P370, DOI 10.1002/jbmr.2082; Miyazawa K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022095; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Nagy V, 2015, GERONTOLOGY, V61, P534, DOI 10.1159/000371845; Nakajima K, 2014, NEOPLASIA, V16, P939, DOI 10.1016/j.neo.2014.09.005; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Ota K, 2013, J CELL BIOCHEM, V114, P1901, DOI 10.1002/jcb.24537; Oya K, 2017, HISTOCHEM CELL BIOL, V147, P341, DOI 10.1007/s00418-016-1490-z; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Rabinovich GA, 2011, CURR OPIN HEMATOL, V18, P443, DOI 10.1097/MOH.0b013e32834bab18; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Rowe PSN, 2012, CRIT REV EUKAR GENE, V22, P61, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.50; Sebban LE, 2007, J IMMUNOL, V179, P1225, DOI 10.4049/jimmunol.179.2.1225; Song I, 2011, BIOCHEM BIOPH RES CO, V408, P126, DOI 10.1016/j.bbrc.2011.03.135; Takarada T, 2013, J BONE MINER RES, V28, P2064, DOI 10.1002/jbmr.1945; Takeshita S, 2013, J CLIN INVEST, V123, P3914, DOI 10.1172/JCI69493; Tanikawa R, 2010, BIOCHEM BIOPH RES CO, V394, P317, DOI 10.1016/j.bbrc.2010.02.175; Tanizawa T, 1999, BONE, V25, P493, DOI 10.1016/S8756-3282(99)00183-0; Thiemann S, 2011, J CLIN IMMUNOL, V31, P2, DOI 10.1007/s10875-010-9460-z; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Toegel S, 2014, HISTOCHEM CELL BIOL, V142, P373, DOI 10.1007/s00418-014-1234-x; Troncoso MF, 2014, GLYCOBIOLOGY, V24, P907, DOI 10.1093/glycob/cwu054; Vinik Y, 2015, ELIFE, V4, DOI 10.7554/eLife.05914; Zoch ML, 2016, BONE, V82, P42, DOI 10.1016/j.bone.2015.05.046; zur Nieden NI, 2003, DIFFERENTIATION, V71, P18, DOI 10.1046/j.1432-0436.2003.700602.x	63	9	9	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2366	2380		10.1096/fj.201700716R	http://dx.doi.org/10.1096/fj.201700716R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29259034				2022-12-26	WOS:000432528000006
J	Jiang, T; Oh, ES; Bonea, D; Zhao, RM				Jiang, Tim; Oh, Edward Saehong; Bonea, Diana; Zhao, Rongmin			HSP90C interacts with PsbO1 and facilitates its thylakoid distribution from chloroplast stroma in Arabidopsis	PLOS ONE			English	Article							SENESCENCE-ASSOCIATED VACUOLES; MANGANESE-STABILIZING PROTEIN; PHOTOSYSTEM-II; IN-VIVO; CHLORATE-RESISTANT; CHLAMYDOMONAS-REINHARDTII; GENETIC INTERACTIONS; INTERACTION NETWORK; TARGETED HSP90; HIGHER-PLANTS	Arabidopsis plastidic HSP90C is an HSP90 family molecular chaperone that is required for chloroplast development and function. To understand the mechanism of action of HSP90C within the chloroplast, we conducted a yeast two-hybrid screening and revealed it interacts directly with the photosystem II extrinsic protein PsbO1, which performs a canonical function in the thylakoid lumen. To understand the biological significance of HSP90C-PsbO1 interaction, we investigated the role of HSP90C in modulating the stromal and thylakoid distribution of PsbO1GFP fusion protein. Fusion to GFP significantly delays the PsbO1 thylakoid transport and induces a variegation phenotype. Overexpression of HSP90C promotes the thylakoid distribution of PsbO1GFP and alleviates the leaf variegation. By tracking the chloroplast maturation during photomorphogenesis, we observed PsbO1GFP tends to form distinct fluorescent clusters within the stroma with delayed thylakoid membrane biogenesis, while HSP90C overexpression corrects these adverse effects. We also demonstrated that active HSP90C function is specifically required for stable accumulation of mature PsbO1GFP in thylakoid by using specific inhibitor geldanamycin. This study therefore not only identified novel HSP90C interactors, but also reports for the first time that PsbO1 enroute from the cytoplasm to thylakoid lumen is tightly regulated by the HSP90C chaperone complex in plastid stroma; whereas the proper HSP90C homeostasis is also critical for chloroplast maturation and function.	[Zhao, Rongmin] Univ Toronto, Dept Biol Sci, Toronto, ON, Canada; Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	University of Toronto; University of Toronto	Zhao, RM (corresponding author), Univ Toronto, Dept Biol Sci, Toronto, ON, Canada.	rzhao@utsc.utoronto.ca		Oh, Edward S./0000-0001-7512-1622; Zhao, Rongmin/0000-0003-1300-5882	Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-05309]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The work was supported by a Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) Discovery Grant (RGPIN-2014-05309) awarded to RZ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiniak AM, 2012, J EXP BOT, V63, P1689, DOI 10.1093/jxb/err444; Albrecht V, 2006, PLANT MOL BIOL, V60, P507, DOI 10.1007/s11103-005-4921-0; Albrecht V, 2011, METHODS MOL BIOL, V684, P257, DOI [10.1007/978.1.60761.925.3_20, 10.1007/978-1-60761-925-3_20]; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bastien O, 2016, INT REV CEL MOL BIO, V323, P1, DOI 10.1016/bs.ircmb.2015.12.001; Becker K, 2011, J PHOTOCH PHOTOBIO B, V104, P204, DOI 10.1016/j.jphotobiol.2011.02.005; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Cao D, 2000, PLANT CELL, V12, P199, DOI 10.1105/tpc.12.2.199; Cao DS, 2003, PLANT J, V33, P107, DOI 10.1046/j.1365-313X.2003.016011.x; Carrion CA, 2013, J EXP BOT, V64, P4967, DOI 10.1093/jxb/ert285; Chen KM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-43; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dittmar J, 2014, BBA-MOL CELL RES, V1843, P446, DOI 10.1016/j.bbamcr.2013.11.025; Edkins Adrienne L, 2015, Subcell Biochem, V78, P219, DOI 10.1007/978-3-319-11731-7_11; Endow JK, 2015, J BIOL CHEM, V290, P28778, DOI 10.1074/jbc.M115.684829; Falsone SF, 2005, FEBS LETT, V579, P6350, DOI 10.1016/j.febslet.2005.10.020; Feng JJ, 2014, PHYSIOL PLANTARUM, V150, P292, DOI 10.1111/ppl.12083; Fetchko M, 2004, METHODS, V32, P349, DOI 10.1016/j.ymeth.2003.10.010; Gao H, 2009, FEMS MICROBIOL LETT, V292, P63, DOI 10.1111/j.1574-6968.2008.01470.x; Glynn JM, 2007, TRAFFIC, V8, P451, DOI 10.1111/j.1600-0854.2007.00545.x; Henmi T, 2003, PLANT CELL PHYSIOL, V44, P451, DOI 10.1093/pcp/pcg049; Hong F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169260; Inoue H, 2013, P NATL ACAD SCI USA, V110, P3173, DOI 10.1073/pnas.1219229110; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Jarvis P, 2013, NAT REV MOL CELL BIO, V14, P787, DOI 10.1038/nrm3702; Kley J, 2010, ANAL BIOCHEM, V398, P198, DOI 10.1016/j.ab.2009.11.016; Kowalewska L, 2016, PLANT CELL, V28, P875, DOI 10.1105/tpc.15.01053; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; Latijnhouwers M, 2010, PLANTA, V232, P567, DOI 10.1007/s00425-010-1192-z; Lee REC, 2010, P NATL ACAD SCI USA, V107, P13348, DOI 10.1073/pnas.1006610107; Lin Y, 1997, PLANT CELL, V9, P21, DOI 10.1105/tpc.9.1.21; Liu XY, 2010, PLANT PHYSIOL, V154, P1588, DOI 10.1104/pp.110.164111; Lundin B, 2008, PHOTOSYNTH RES, V98, P405, DOI 10.1007/s11120-008-9325-y; Lundin B, 2007, PLANT J, V49, P528, DOI 10.1111/j.1365-313X.2006.02976.x; Marques JP, 2004, J EXP BOT, V55, P1697, DOI 10.1093/jxb/erh191; Marques JP, 2003, MOL GENET GENOMICS, V269, P381, DOI 10.1007/s00438-003-0846-y; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Michaeli S, 2014, PLANT CELL, V26, P4084, DOI 10.1105/tpc.114.129999; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Murakami R, 2005, FEBS J, V272, P2165, DOI 10.1111/j.1742-4658.2005.04636.x; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nordhues A, 2012, PLANT CELL, V24, P637, DOI 10.1105/tpc.111.092692; Offenbacher AR, 2013, J BIOL CHEM, V288, P29056, DOI 10.1074/jbc.M113.487561; Oh Saehong E, 2014, BMC Res Notes, V7, P643, DOI 10.1186/1756-0500-7-643; Olinares PDB, 2011, BBA-BIOENERGETICS, V1807, P999, DOI 10.1016/j.bbabio.2010.12.003; Rast A, 2015, BBA-BIOENERGETICS, V1847, P821, DOI 10.1016/j.bbabio.2015.01.007; Roux Kyle J, 2013, Curr Protoc Protein Sci, V74, DOI 10.1002/0471140864.ps1923s74; Rudowska L, 2012, BBA-BIOENERGETICS, V1817, P1380, DOI 10.1016/j.bbabio.2012.03.013; Schuhmann H, 2012, PHYSIOL PLANTARUM, V145, P224, DOI 10.1111/j.1399-3054.2011.01533.x; Shimada H, 2007, PLANT CELL, V19, P3157, DOI 10.1105/tpc.107.051714; Shutova T, 2000, FEBS LETT, V467, P137, DOI 10.1016/S0014-5793(00)01115-7; Solymosi K, 2010, PHOTOSYNTH RES, V105, P143, DOI 10.1007/s11120-010-9568-2; Song HM, 2009, PLANTA, V229, P955, DOI 10.1007/s00425-008-0886-y; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Suorsa M, 2007, PHOTOSYNTH RES, V93, P89, DOI 10.1007/s11120-007-9154-4; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tillmann B, 2015, MOL PLANT, V8, P228, DOI [10.1016/j.molp.2014.10.005, 10.1016/j.molp.2015.05.011]; Tsai AYL, 2012, PLANT J, V69, P809, DOI 10.1111/j.1365-313X.2011.04832.x; Walter B, 2015, BIOCHEM J, V468, P315, DOI 10.1042/BJ20141425; Wang SH, 2014, PLANT CELL, V26, P4875, DOI 10.1105/tpc.114.133116; Weng J, 2004, BIOCHEMISTRY-US, V43, P4855, DOI 10.1021/bi049903l; Willmund F, 2005, PLANT PHYSIOL, V138, P2310, DOI 10.1104/pp.105.063578; Willmund F, 2008, PLANT PHYSIOL, V148, P2070, DOI 10.1104/pp.108.127944; Yamamoto YY, 2000, PLANT CELL PHYSIOL, V41, P68, DOI 10.1093/pcp/41.1.68; Yi XP, 2008, PHOTOSYNTH RES, V98, P439, DOI 10.1007/s11120-008-9352-8; Yi XP, 2005, J BIOL CHEM, V280, P16170, DOI 10.1074/jbc.M501550200; YUAN JG, 1994, SCIENCE, V266, P796, DOI 10.1126/science.7973633; Zhang LG, 2012, PLANT CELL, V24, P3695, DOI 10.1105/tpc.112.103606; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2007, ADV EXP MED BIOL, V594, P27	75	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190168	10.1371/journal.pone.0190168	http://dx.doi.org/10.1371/journal.pone.0190168			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281724	Green Published, Green Submitted, gold			2022-12-26	WOS:000419006200072
J	John, SA; Rendina, HJ; Grov, C; Parsons, JT				John, Steven A.; Rendina, H. Jonathon; Grov, Christian; Parsons, Jeffrey T.			Home-based pre-exposure prophylaxis (PrEP) services for gay and bisexual men: An opportunity to address barriers to PrEP uptake and persistence	PLOS ONE			English	Article							DRIED BLOOD SPOTS; NEW-YORK-CITY; HIV PREVENTION; UNITED-STATES; HEALTH-CARE; BLACK-MEN; TRANSGENDER WOMEN; NATIONAL SAMPLE; SEX; US	Gay, bisexual, and other men who have sex with men (GBM) are disproportionately affected by the HIV epidemic. Despite the promise of pre-exposure prophylaxis (PrEP) in reducing HIV transmission risk, barriers for uptake and persistence exist. We sought to identify whether GBM in a nationwide cohort who have not yet initiated PrEP (n = 906) would prefer to get PrEP-related care from a primary care provider (PCP) compared to a specialist clinic or provider. We then sought to identify their level of interest and factors associated with preference for using home-based PrEP services (i.e., HB-PrEP), defined to participants as conducting HIV/STI self-testing from home with PrEP prescription mailing after an initial inperson clinic visit. We examined the associations of demographics, sexual HIV transmission risk, concern about frequent medical checkups associated with PrEP, health care access, and PrEP intentions with preferences for healthcare provider type and HB-PrEP. Concern about frequent medical checkups were associated with preferring a PCP for PrEP-related care, but men who perceived a barrier to bringing up the topic of PrEP with a doctor preferred a specialist clinic or provider more than a PCP. HB-PrEP was more appealing for younger men and those engaged in sexual HIV transmission risk, suggesting HB-PrEP could help reach GBM most vulnerable to HIV and in need of PrEP. HB-PrEP expansion has potential to increase PrEP uptake and persistence among GBM, particularly for men with barriers to clinic-based care and higher intentions to initiate PrEP. Clinical guidelines regarding HB-PrEP are needed to expand its use.	[John, Steven A.; Rendina, H. Jonathon; Parsons, Jeffrey T.] CUNY, Ctr HIV AIDS Educ Studies & Training, Hunter Coll, New York, NY 10021 USA; [Rendina, H. Jonathon; Parsons, Jeffrey T.] CUNY, Dept Psychol, Hunter Coll, New York, NY 10021 USA; [Rendina, H. Jonathon; Parsons, Jeffrey T.] CUNY, Grad Ctr, Doctroal Program Hlth Psychol & Clin Sci, New York, NY 10021 USA; [Grov, Christian] CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System	Parsons, JT (corresponding author), CUNY, Ctr HIV AIDS Educ Studies & Training, Hunter Coll, New York, NY 10021 USA.; Parsons, JT (corresponding author), CUNY, Dept Psychol, Hunter Coll, New York, NY 10021 USA.; Parsons, JT (corresponding author), CUNY, Grad Ctr, Doctroal Program Hlth Psychol & Clin Sci, New York, NY 10021 USA.	Jeffrey.parsons@hunter.cuny.edu	John, Steven/Z-5262-2019	John, Steven/0000-0002-1316-3920; Parsons, Jeffrey/0000-0002-6875-7566	National Institute of Drug Abuse [R01-DA036466]; National Institute on Drug Abuse Career Development Award [K01-DA039030]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036466, K01DA039030] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Drug Abuse Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding support was provided by the National Institute of Drug Abuse (R01-DA036466; Pls: Parsons & Grov). H. Jonathon Rendina was supported by a National Institute on Drug Abuse Career Development Award (K01-DA039030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. [https://www.drugabuse.gov/]	Bavinton BR, 2013, AIDS BEHAV, V17, P2084, DOI 10.1007/s10461-013-0450-z; Bernstein KT, 2008, ARCH INTERN MED, V168, P1458, DOI 10.1001/archinte.168.13.1458; Brooks RA, 2015, INT J STD AIDS, V26, P1040, DOI 10.1177/0956462415570159; Castillo-Mancilla JR, 2013, AIDS RES HUM RETROV, V29, P384, DOI [10.1089/aid.2012.0089, 10.1089/AID.2012.0089]; CDC, 2015, HIV SURV REP 2015, V27; Centers for Disease Control and Prevention, 2021, PREEXP PROPH PREV HI; Delaney KP, 2017, CLIN INFECT DIS, V64, P53, DOI 10.1093/cid/ciw666; Eaton LA, 2014, SEX HEALTH, V11, P244, DOI 10.1071/SH14022; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Greene GJ, 2017, AIDS BEHAV, V21, P1336, DOI 10.1007/s10461-016-1565-9; Grov C, 2016, LGBT HEALTH, V3, P252, DOI 10.1089/lgbt.2015.0123; Grov C, 2016, SEX TRANSM DIS, V43, P165, DOI 10.1097/OLQ.0000000000000410; Grov C, 2016, SEX RES SOC POLICY, V13, P1, DOI 10.1007/s13178-015-0212-y; Hoagland B, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21472; Hood JE, 2016, AIDS, V30, P515, DOI 10.1097/QAD.0000000000000937; Johannessen A, 2010, BIOANALYSIS, V2, P1893, DOI 10.4155/BIO.10.120; John SA., 2017, AIDS BEHAV; Bustamante MJ, 2017, INT J STD AIDS, V28, P133, DOI 10.1177/0956462416630674; Krakower D, 2014, AIDS BEHAV, V18, P1712, DOI 10.1007/s10461-014-0839-3; Krakower DS, 2017, AIDS PATIENT CARE ST, V31, P297, DOI 10.1089/apc.2017.0031; Landovitz RJ, 2016, CURR OPIN HIV AIDS, V11, P122, DOI 10.1097/COH.0000000000000219; Lee SJ, 2013, AIDS CARE, V25, P1592, DOI 10.1080/09540121.2013.793272; Lieb S, 2009, J URBAN HEALTH, V86, P887, DOI 10.1007/s11524-009-9401-4; Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683; Maloney KM, 2017, LGBT HEALTH, V4, P310, DOI 10.1089/lgbt.2016.0068; Mera R, 2016, 21 INT AIDS C DURB A; Meyers K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114700; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Oldenburg CE, 2015, AIDS, V29, P837, DOI 10.1097/QAD.0000000000000622; Orasure, 2017, ORASURE HIV 1 OR FLU; Parsons JT, 2017, JAIDS-J ACQ IMM DEF, V74, P285, DOI 10.1097/QAI.0000000000001251; Parsons JT, 2016, AIDS BEHAV, V20, P1390, DOI 10.1007/s10461-016-1370-5; Petroll AE, 2017, AIDS BEHAV, V21, P1256, DOI 10.1007/s10461-016-1625-1; Petroll AE, 2015, LGBT HEALTH, V2, P48, DOI 10.1089/lgbt.2013.0050; Petroll AE, 2011, SEX TRANSM DIS, V38, P63, DOI 10.1097/OLQ.0b013e3181ebd50f; Philbin MM, 2016, AIDS PATIENT CARE ST, V30, P282, DOI 10.1089/apc.2016.0037; Prestage G, 2016, SEX HEALTH, V13, P55, DOI 10.1071/SH15099; Raifman JRG, 2017, AM J PREV MED, V52, P55, DOI 10.1016/j.amepre.2016.07.031; Rendina HJ, 2017, SOC SCI MED, V172, P115, DOI 10.1016/j.socscimed.2016.10.030; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; Smith KS, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2727-4; Strauss BB, 2017, AIDS BEHAV, V21, P1288, DOI 10.1007/s10461-016-1480-0; US Census Bureau, 2015, QUICK FACTS US; US Food and Drug Administration, 2012, FDA APPR 1 MED RED H; Witzel TC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162713; Wu H, 2017, CLIN INFECT DIS, V64, P144, DOI 10.1093/cid/ciw701	47	36	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189794	10.1371/journal.pone.0189794	http://dx.doi.org/10.1371/journal.pone.0189794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR3ZV	29281688	Green Published, gold			2022-12-26	WOS:000419006200042
J	Oyeyemi, AL; Muhammed, S; Oyeyemi, AY; Adegoke, BOA				Oyeyemi, Adewale L.; Muhammed, Suleiman; Oyeyemi, Adetoyeje Y.; Adegoke, Babatunde O. A.			Patterns of objectively assessed physical activity and sedentary time: Are Nigerian health professional students complying with public health guidelines?	PLOS ONE			English	Article							UNIVERSITY-STUDENTS; COLLEGE-STUDENTS; COMPUTER-SCIENCE; YOUNG-ADULTS; METABOLIC SYNDROME; INCOME COUNTRIES; SELF-REPORT; LIFE-STYLE; RISK; ACCELEROMETER	Background Understanding patterns of physical activity and sedentary time is important to effective population- wide primary prevention and control of non-communicable diseases. This study examined the patterns of objectively assessed physical activity and sedentary time, and the prevalence of compliance with physical activity guidelines according to different public health recommendations in a sub-population of health professional students in Nigeria. Methods A cross-sectional study was conducted among 102 health professional students (age = 19-34 years old, 43.1% women) of the University of Maiduguri, Nigeria. Participants wore Actigraph accelerometers on their waist for minimum of 5 days/week to objectively measure intensity and duration of physical activity and sedentary time. Prevalence and demographic patterns of physical activity and sedentary time were examined using descriptive and inferential statistics. Results The students spent most time in sedentary activity (458.6 +/- minutes/day, about 61% of daily time) and the least in vigorous-intensity activity (2.1 +/- 4.4 minutes/day, about 0.3% of daily time). Sedentary time was higher among older than younger students (P<0.038) and among medical laboratory science students than physiotherapy and nursing students (P = 0.046). Total physical activity was higher among nursing and medical students than medical laboratory science students (P = 0.041). Although, 85.3% of the students engaged in 150 minutes/week of moderate-to-vigorous physical activity, only 2.9% met the guideline of 75 minutes/week of vigorous intensity activity. Conclusions Prevalence of sedentary time was high while that of vigorous-intensity activity was very low among health professional students in Nigeria. Compliance with physical activity guidelines was mainly through accumulation of moderate intensity activity. The results suggest that age and academic programme may influence physical activity level and sedentary behaviour of health professional students in Nigeria. These findings provide preliminary evidence that could be used to inform the needs to develop interventions to improve and support active lifestyle behaviour among students in Nigerian universities.	[Oyeyemi, Adewale L.; Muhammed, Suleiman; Oyeyemi, Adetoyeje Y.] Univ Maiduguri, Dept Physiotherapy, Coll Med Sci, Maiduguri, Nigeria; [Adegoke, Babatunde O. A.] Univ Ibadan, Physiotherapy Dept, Coll Med, Ibadan, Nigeria	University of Ibadan	Oyeyemi, AL (corresponding author), Univ Maiduguri, Dept Physiotherapy, Coll Med Sci, Maiduguri, Nigeria.	alaoyeyemi@yahoo.com	Adegoke, Babatunde/L-6704-2019; Oyeyemi, Adewale/AAA-2792-2019; Oyeyemi, Adetoyeje/AER-0978-2022	Adegoke, Babatunde/0000-0001-9769-0201; Oyeyemi, Adetoyeje/0000-0003-4395-443X; Oyeyemi, Adewale/0000-0002-3737-2911				Adegoke BOA, 2008, J PHYS ACT HEALTH, V8, P1135; [Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; Baptista F, 2012, MED SCI SPORT EXER, V44, P466, DOI 10.1249/MSS.0b013e318230e441; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Brage S, 2003, MED SCI SPORT EXER, V35, P1447, DOI 10.1249/01.MSS.0000079078.62035.EC; Buckworth J, 2004, J AM COLL HEALTH, V53, P28, DOI 10.3200/JACH.53.1.28-34; Cain KL, 2012, ACCELEROMETER DATA C; Chastin SFM, 2009, EUR J APPL PHYSIOL, V106, P893, DOI 10.1007/s00421-009-1090-x; Chau JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080000; Clemente FM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152516; Cocca A, 2014, PERCEPT MOTOR SKILL, V118, P247, DOI 10.2466/10.06.PMS.118k16w1; Dinger MK, 2006, MED SCI SPORT EXER, V38, P774, DOI 10.1249/01.mss.0000210191.72081.43; Dunstan DW, 2011, CURR OPIN CARDIOL, V26, P412, DOI 10.1097/HCO.0b013e3283496605; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Haase A, 2004, PREV MED, V39, P182, DOI 10.1016/j.ypmed.2004.01.028; Hagstromer M, 2010, AM J EPIDEMIOL, V171, P1055, DOI 10.1093/aje/kwq069; Hallal PC, 2012, J PHYS ACT HEALTH, V9, pS88, DOI 10.1123/jpah.9.s1.s88; Irwin JD, 2004, PERCEPT MOTOR SKILL, V98, P927; Keating XFD, 2005, J AM COLL HEALTH, V54, P116, DOI 10.3200/JACH.54.2.116-126; Kwan MY, 2012, AM J PREV MED, V42, P14, DOI 10.1016/j.amepre.2011.08.026; Lakka TA, 2007, APPL PHYSIOL NUTR ME, V32, P76, DOI [10.1139/H06-113, 10.1139/h06-113]; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Loney T, 2011, J PHYS ACT HEALTH, V8, P62, DOI 10.1123/jpah.8.1.62; Lopez-Martinez S, 2013, INT J SPORT NUTR EXE, V23, P312, DOI 10.1123/ijsnem.23.4.312; Arias-Palencia NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141977; Maruf FA, 2012, AFRICAN J PHYSIOTHER, V4, P8; MELANSON EL, 1995, MED SCI SPORT EXER, V27, P934; Nichols JF, 2000, RES Q EXERCISE SPORT, V71, P36, DOI 10.1080/02701367.2000.10608878; ONIFADE SA, 1985, INT J SPORT PSYCHOL, V16, P183; Ortega FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060871; Owen N, 2010, MAYO CLIN PROC, V85, P1138, DOI 10.4065/mcp.2010.0444; Owoeye Oluwatoyosi, 2016, Niger Med J, V57, P99, DOI 10.4103/0300-1652.182070; Oyeyemi AL, 2013, J EPIDEMIOL, V23, P169, DOI 10.2188/jea.JE20120116; Pengpid S, 2015, INT J PUBLIC HEALTH, V60, P539, DOI 10.1007/s00038-015-0680-0; Physical Activity Guidelines Advisory Committee (PAGAC), 2008, PHYS ACT GUID ADV CO; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Sallis JF, 2016, LANCET, V388, P1325, DOI 10.1016/S0140-6736(16)30581-5; Scheers T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-136; Spring B, 2014, CIRCULATION, V130, P10, DOI 10.1161/CIRCULATIONAHA.113.005445; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Van Dyck D, 2015, INT J OBESITY, V39, P199, DOI 10.1038/ijo.2014.115; Varela-Mato V, 2012, INT J ENV RES PUB HE, V9, P2728, DOI 10.3390/ijerph9082728; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2015, NONC DIS NCD COUNTR	47	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190124	10.1371/journal.pone.0190124	http://dx.doi.org/10.1371/journal.pone.0190124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR3ZV	29281683	Green Published, gold			2022-12-26	WOS:000419006200068
J	Rouffaerl, LO; Strubbe, D; Teyssier, A; Hudin, NS; Van den Abeele, AM; Cox, I; Haesendonck, R; Delmee, M; Haesebrouck, F; Pasmans, F; Lens, L; Martel, A				Rouffaerl, Lieze Oscar; Strubbe, Diederik; Teyssier, Aimeric; Hudin, Noraine Salleh; Van den Abeele, Anne-Marie; Cox, Ivo; Haesendonck, Roel; Delmee, Michel; Haesebrouck, Freddy; Pasmans, Frank; Lens, Luc; Martel, An			Effects of urbanization on host-pathogen interactions, using Yersinia in house sparrows as a model	PLOS ONE			English	Article							BIOTYPE 1A STRAINS; WILD BIRDS; SPECIES-DIVERSITY; MIGRATORY BIRDS; RURAL GRADIENT; LONG-TERM; PSEUDOTUBERCULOSIS; URBAN; ENTEROCOLITICA; INFECTION	Urbanization strongly affects biodiversity, altering natural communities and often leading to a reduced species richness. Yet, despite its increasingly recognized importance, how urbanization impacts on the health of individual animals, wildlife populations and on disease ecology remains poorly understood. To test whether, and how, urbanization-driven ecosystem alterations influence pathogen dynamics and avian health, we use house sparrows (Passer domesticus) and Yersinia spp. (pathogenic for passerines) as a case study. Sparrows are granivorous urban exploiters, whose western European populations have declined over the past decades, especially in highly urbanized areas. We sampled 329 house sparrows originating from 36 populations along an urbanization gradient across Flanders (Belgium), and used isolation combined with 'matrix-assisted laser desorption ionization-time of flight mass spectrometry' (MALDI-TOF MS) and PCR methods for detecting the presence of different Yersinia species. Yersinia spp. were recovered from 57.43% of the sampled house sparrows, of which 4.06%, 53.30% and 69.54% were identified as Y. pseudotuberculosis, Y. enterocolitica and other Yersinia species, respectively. Presence of Yersinia was related to the degree of urbanization, average daily temperatures and the community of granivorous birds present at sparrow capture locations. Body condition of suburban house sparrows was found to be higher compared to urban and rural house sparrows, but no relationships between sparrows' body condition and presence of Yersinia spp. were found. We conclude that two determinants of pathogen infection dynamics, body condition and pathogen occurrence, vary along an urbanization gradient, potentially mediating the impact of urbanization on avian health.	[Rouffaerl, Lieze Oscar; Haesendonck, Roel; Haesebrouck, Freddy; Pasmans, Frank; Martel, An] Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, Merelbeke, Belgium; [Strubbe, Diederik; Teyssier, Aimeric; Hudin, Noraine Salleh; Lens, Luc] Univ Ghent, Dept Biol, Fac Sci, Terr Ecol Unit, Ghent, Belgium; [Teyssier, Aimeric] Antwerp Univ, Dept Biol, Fac Sci, Antwerp, Belgium; [Hudin, Noraine Salleh] Univ Pendidikan Sultan Idris, Fac Sci & Math, Dept Biol Sci, Tanjong Malim, Perak, Malaysia; [Van den Abeele, Anne-Marie; Cox, Ivo] AZ Sint Lucas Ghent, Microbiol Lab, Ghent, Belgium; [Delmee, Michel] Catholic Univ Louvain, Inst Expt & Clin Res, Brussels, Belgium	Ghent University; Ghent University; University of Antwerp; Universiti Pendidikan Sultan Idris; Ghent University; Universite Catholique Louvain	Rouffaerl, LO (corresponding author), Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, Merelbeke, Belgium.	Lieze.Rouffaer@UGent.be	Haesebrouck, Freddy/M-3857-2014; Pasmans, Frank/D-3667-2014; Strubbe, Diederik/J-4299-2015	Haesebrouck, Freddy/0000-0002-1709-933X; Strubbe, Diederik/0000-0002-2613-4985; Salleh Hudin, Noraine/0000-0001-8440-7921; Lens, Luc/0000-0002-0241-2215	Research Foundation Flanders [11L7516N]; Belgian Science Policy office: Interuniversity Attraction Poles Program: SPatial and Environmental determinants of Eco-evolutionary DYnamics	Research Foundation Flanders(FWO); Belgian Science Policy office: Interuniversity Attraction Poles Program: SPatial and Environmental determinants of Eco-evolutionary DYnamics	This work was supported by Research Foundation Flanders, grant number 11L7516N (LOR); and Belgian Science Policy office: Interuniversity Attraction Poles Program: SPatial and Environmental determinants of Eco-evolutionary DYnamics.	AGIV, 2013, LARG SC REF DAT LRD; AGIV, 2013, GEBOUW GROND GBG; Anderson D. R., 2008, MODEL BASED INFERENC; Artois M, 2001, VET J, V162, P141, DOI 10.1053/tvjl.2001.0601; Ayyadurai S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-285; BARTON K, 2015, MUMIN MULTIMODEL INF, V15, P1; Bates D., 2016, R PACKAGE VERSION, V1, P1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benskin CMH, 2009, BIOL REV, V84, P349, DOI 10.1111/j.1469-185X.2008.00076.x; Bichet C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053866; BirdLife International, 2016, PASS DOM; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Bokony V, 2012, LANDSCAPE URBAN PLAN, V104, P75, DOI 10.1016/j.landurbplan.2011.10.006; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; BRADLEY JM, 1974, J MED MICROBIOL, V7, P383, DOI 10.1099/00222615-7-3-383; Brittingham M.C., 1988, Passenger Pigeon, V50, P195; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; CLARK GM, 1962, AVIAN DIS, V6, P506, DOI 10.2307/1587927; CLSI, 2015, VERF COMM MICR ID AN; Cork SC, 1999, AVIAN PATHOL, V28, P393, DOI 10.1080/03079459994669; CORK SC, 1995, NEW ZEAL VET J, V43, P169, DOI 10.1080/00480169.1995.35883; Cramp S, 1977, P1; De Coster G, 2015, LANDSCAPE URBAN PLAN, V134, P139, DOI 10.1016/j.landurbplan.2014.10.020; De Laet J, 2007, J ORNITHOL, V148, pS275, DOI 10.1007/s10336-007-0154-0; Delgado-V CA, 2009, LANDSCAPE URBAN PLAN, V105, P5; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4329; European Food Safety Authority (EFSA), 2007, EFSA J, V595, P1; Evans KL, 2009, OIKOS, V118, P774, DOI 10.1111/j.1600-0706.2008.17226.x; Evans KL, 2009, IBIS, V151, P19, DOI 10.1111/j.1474-919X.2008.00898.x; Everaert J, 2007, ELECTROMAGN BIOL MED, V26, P63, DOI 10.1080/15368370701205693; Fox J, 2016, EFFECT DISPLAYS LINE; Frolich K, 2003, J WILDLIFE DIS, V39, P751; FUKUSHIMA H, 1989, J CLIN MICROBIOL, V27, P2706, DOI 10.1128/JCM.27.12.2706-2709.1989; FUKUSHIMA H, 1991, J CLIN MICROBIOL, V29, P1271, DOI 10.1128/JCM.29.6.1271-1275.1991; Galbraith JA, 2017, J AVIAN BIOL, V48, P700, DOI 10.1111/jav.01076; Grimm NB, 2000, BIOSCIENCE, V50, P571, DOI 10.1641/0006-3568(2000)050[0571:IATLTO]2.0.CO;2; HAMASAKI S, 1989, J WILDLIFE DIS, V25, P401, DOI 10.7589/0090-3558-25.3.401; Hamer SA, 2012, ZOONOSES PUBLIC HLTH, V59, P355, DOI 10.1111/j.1863-2378.2012.01462.x; Harrell FE, 2016, HARRELL MISCELLANEOU; Hudin NS, 2016, BEHAV ECOL, V27, P1833, DOI 10.1093/beheco/arw108; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kiskova J, 2011, POL J MICROBIOL, V60, P79; Kuznetsova A., 2016, J STAT SOFTW, V2, P33; MACKINTOSH CG, 1984, NEW ZEAL VET J, V32, P208, DOI 10.1080/00480169.1984.35123; Mair N.S., 1973, Journal Wildl Dis, V9, P64; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Meillere A, 2017, LANDSCAPE URBAN PLAN, V160, P127, DOI 10.1016/j.landurbplan.2016.12.014; Meillere A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135685; Melles S, 2003, CONSERV ECOL, V7; Milenkaya O, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot020; Nagano T, 1997, J VET MED SCI, V59, P153, DOI 10.1292/jvms.59.153; NAKANO T, 1989, SCAND J INFECT DIS, V21, P175, DOI 10.3109/00365548909039966; Niskanen T, 2009, INT J FOOD MICROBIOL, V129, P150, DOI 10.1016/j.ijfoodmicro.2008.11.015; Niskanen T, 2002, J FOOD PROTECT, V65, P540, DOI 10.4315/0362-028X-65.3.540; Niskanen T, 2003, APPL ENVIRON MICROB, V69, P4670, DOI 10.1128/AEM.69.8.4670-4675.2003; Nuorti JP, 2004, J INFECT DIS, V189, P766, DOI 10.1086/381766; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Pennycott TW, 2002, VET REC, V151, P563, DOI 10.1136/vr.151.19.563; Perkins AJ, 2007, BIRD STUDY, V54, P46, DOI 10.1080/00063650709461455; R Core Team, 2021, R LANGUAGE ENV STAT; Refsum T, 2003, J WILDLIFE DIS, V39, P64, DOI 10.7589/0090-3558-39.1.64; Reuter S, 2014, P NATL ACAD SCI USA, V111, P6768, DOI 10.1073/pnas.1317161111; Rouffaer LO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175648; Rouffaer LO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155366; Sandmeier P, 2005, ACTA ORNITHOL, VII; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Singh I, 2004, J MED MICROBIOL, V53, P1065, DOI 10.1099/jmm.0.45527-0; Sol D, 2014, ECOL LETT, V17, P942, DOI 10.1111/ele.12297; Stephan R, 2013, EUR J CLIN MICROBIOL, V32, P869, DOI 10.1007/s10096-013-1820-1; Stephan R, 2011, J MICROBIOL METH, V87, P150, DOI 10.1016/j.mimet.2011.08.016; TASHIRO K, 1991, J VET MED SCI, V53, P23, DOI 10.1292/jvms.53.23; Tennant SM, 2003, FEMS IMMUNOL MED MIC, V38, P127, DOI 10.1016/S0928-8244(03)00180-9; Teyssier A, 2018, SCI TOTAL ENVIRON, V612, P1276, DOI 10.1016/j.scitotenv.2017.09.035; Thoerner P, 2003, APPL ENVIRON MICROB, V69, P1810, DOI 10.1128/AEM.69.3.1810-1816.2003; Trusilova K, 2008, J APPL METEOROL CLIM, V47, P1442, DOI 10.1175/2007JAMC1624.1; Vanantwerpen G, 2014, VET MICROBIOL, V169, P223, DOI 10.1016/j.vetmic.2013.12.019; Vangestel C, 2011, MOL ECOL, V20, P4643, DOI 10.1111/j.1365-294X.2011.05316.x; Vangestel C, 2010, BIOL J LINN SOC, V101, P41, DOI 10.1111/j.1095-8312.2010.01493.x; Verbrugghe E, 2012, VET MICROBIOL, V155, P115, DOI 10.1016/j.vetmic.2011.09.012; Vermeersch G, 2004, BIRD CENSUS NEWS, V1/2, P14; Vermeersch G, 2004, ATLAS VLAAMSE BROEDV; Vriens L, 2011, BIOLOGISCHE WAAR DER; Wickham H., 2016, TOOLS SPLITTING APPL	87	9	10	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189509	10.1371/journal.pone.0189509	http://dx.doi.org/10.1371/journal.pone.0189509			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR3ZV	29281672	Green Published, gold, Green Submitted			2022-12-26	WOS:000419006200031
J	Sellers, ZM; Illek, B; Figueira, MF; Hari, G; Joo, NS; Sibley, E; Souza-Menezes, J; Morales, MM; Fischer, H; Wine, JJ				Sellers, Zachary M.; Illek, Beate; Figueira, Miriam Frankenthal; Hari, Gopika; Joo, Nam Soo; Sibley, Eric; Souza-Menezes, Jackson; Morales, Marcelo M.; Fischer, Horst; Wine, Jeffrey J.			Impaired PGE(2)-stimulated Cl- and HCO3- secretion contributes to cystic fibrosis airway disease	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CANINE TRACHEAL MUCOSA; EPITHELIAL-CELLS; BICARBONATE SECRETION; FLUID SECRETION; CYCLIC-AMP; MUCOCILIARY CLEARANCE; CHLORIDE TRANSPORT; FERRET TRACHEA; SEROUS CELLS	Background Airway mucociliary clearance (MCC) is an important defense mechanism against pulmonary infections and is compromised in cystic fibrosis (CF). Cl- and HCO3- epithelial transport are integral to MCC. During pulmonary infections prostaglandin E-2 (PGE(2)) production is abundant. Aim To determine the effect of PGE(2) on airway Cl-and HCO3-secretion and MCC in normal and CF airways. Methods We examined PGE(2) stimulated MCC, Cl- and HCO3- secretion using ferret trachea, human bronchial epithelial cell cultures (CFBE41o- with wildtype CFTR (CFBE41 WT) or homozygous F508del CFTR (CFBE41 CF) and human normal bronchial submucosal gland cell line (Calu-3) in Ussing chambers with or without pH-stat. Results PGE(2) stimulated MCC in a dose-dependent manner and was partially impaired by CFTRinh-172. PGE(2)-stimulated Cl- current in ferret trachea was partially inhibited by CFTRinh-172, with niflumic acid eliminating the residual current. CFBE41 WT cell monolayers produced a robust Cl- and HCO3- secretory response to PGE(2), both of which were completely inhibited by CFTRinh-172. CFBE41 CF cells exhibited no response to PGE(2). In Calu-3 cells, PGE(2) stimulated Cl- and HCO3- secretion. Cl- secretion was partially inhibited by CFTRinh-172, with additional inhibition by niflumic acid. HCO3- secretion was completely inhibited by CFTRinh-172. Conclusions PGE(2) stimulates bronchotracheal MCC and this response is decreased in CF. In CF airway, PGE(2)-stimulated Cl- and HCO3- conductance is impaired and may contribute to decreased MCC. There remains a CFTR-independent Cl- current in submucosal glands, which if exploited, could represent a means of improving airway Cl- secretion and MCC in CF.	[Sellers, Zachary M.; Sibley, Eric] Stanford Univ, Div Pediat Gastroenterol Hepatolfif & Nutr, Palo Alto, CA 94304 USA; [Sellers, Zachary M.; Joo, Nam Soo; Wine, Jeffrey J.] Stanford Univ, Cyst Fibrosis Res Lab, Palo Alto, CA 94304 USA; [Illek, Beate; Hari, Gopika; Fischer, Horst] Childrens Hosp, Oakland Res Inst, 747 52nd St, Oakland, CA 94609 USA; [Figueira, Miriam Frankenthal; Souza-Menezes, Jackson; Morales, Marcelo M.] Univ Fed Rio de Janeiro, Carlos Chagas Filho Biophys Inst, Rio De Janeiro, RJ, Brazil; [Figueira, Miriam Frankenthal; Souza-Menezes, Jackson] Univ Fed Rio de Janeiro, Core Ecol & Socio Environm Dev, Macae, RJ, Brazil	Stanford University; Stanford University; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Sellers, ZM (corresponding author), Stanford Univ, Div Pediat Gastroenterol Hepatolfif & Nutr, Palo Alto, CA 94304 USA.; Sellers, ZM (corresponding author), Stanford Univ, Cyst Fibrosis Res Lab, Palo Alto, CA 94304 USA.	zsellers@stanford.edu	Sellers, Zachary/AAI-1356-2020	Sellers, Zachary/0000-0001-5352-7760	Cystic Fibrosis Foundation [SELLER15B0, SELLER16LO, ILLEK15P0, ILLEK16G0, WINE17G0, WINE07XXO]; Elizabeth Nash Foundation; CAPES [10054-14-6]	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Elizabeth Nash Foundation; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by the Cystic Fibrosis Foundation (www.cff.org; SELLER15B0, SELLER16LO to Z.M.S.; ILLEK15P0, ILLEK16G0 to B.I.; WINE17G0, WINE07XXO to JJW), Elizabeth Nash Foundation (http://www.elizabetnashfoundation.org; BI), and CAPES (http://www.capes.gov.br; 10054-14-6 to MFF).	ALBAZZAZ FJ, 1981, AM REV RESPIR DIS, V123, P295; ALBAZZAZ FJ, 1979, J APPL PHYSIOL, V46, P111, DOI 10.1152/jappl.1979.46.1.111; Chen J, 2012, J CELL PHYSIOL, V227, P2759, DOI 10.1002/jcp.23020; Cho HJ, 2010, AM J PHYSIOL-LUNG C, V299, pL124, DOI 10.1152/ajplung.00049.2010; Conner GE, 2013, AM J RESP CELL MOL, V49, P672, DOI 10.1165/rcmb.2013-0156OC; Cowley EA, 2003, MOL PHARMACOL, V64, P298, DOI 10.1124/mol.64.2.298; CULLEN JJ, 1987, J CLIN INVEST, V79, P73, DOI 10.1172/JCI112811; Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8; Garnett JP, 2011, J BIOL CHEM, V286, P41069, DOI 10.1074/jbc.M111.266734; Gray T, 2004, MOL PHARMACOL, V66, P337, DOI 10.1124/mol.66.2.337; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Haq IJ, 2016, THORAX, V71, P284, DOI 10.1136/thoraxjnl-2015-207588; Hartl D, 2005, FREE RADICAL BIO MED, V39, P463, DOI 10.1016/j.freeradbiomed.2005.03.032; Hoegger MJ, 2014, SCIENCE, V345, P818, DOI 10.1126/science.1255825; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Iovannisci D, 2010, J GEN PHYSIOL, V136, P35, DOI 10.1085/jgp.200910379; Ivonnet P, 2015, BRIT J PHARMACOL, V172, P173, DOI 10.1111/bph.12934; Jakab RL, 2012, DIGEST DIS SCI, V57, P2826, DOI 10.1007/s10620-012-2352-8; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Jeong JH, 2014, AM J PHYSIOL-LUNG C, V307, pL83, DOI 10.1152/ajplung.00009.2014; Joo NS, 2016, SCI REP-UK, V6, DOI 10.1038/srep36806; Joy AP, 2008, AM J RESP CELL MOL, V38, P143, DOI 10.1165/rcmb.2006-0295OC; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Konstan MW, 2007, AM J RESP CRIT CARE, V176, P1084, DOI 10.1164/rccm.200702-181OC; Krouse ME, 2004, AM J PHYSIOL-LUNG C, V287, pL1274, DOI 10.1152/ajplung.00036.2004; Lee MC, 1998, AM J PHYSIOL-LUNG C, V274, pL450, DOI 10.1152/ajplung.1998.274.3.L450; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Liu XM, 2007, AM J RESP CELL MOL, V36, P313, DOI 10.1165/rcmb.2006-0286OC; Luan XJ, 2014, P NATL ACAD SCI USA, V111, P12930, DOI 10.1073/pnas.1406414111; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Namkung W, 2010, MOL BIOL CELL, V21, P2639, DOI 10.1091/mbc.E09-12-1004; Nyberg L, 1998, DIGEST DIS SCI, V43, P1205, DOI 10.1023/A:1018895405362; O'Sullivan Amy K, 2011, Manag Care, V20, P37; Rajagopal M, 2014, AM J PHYSIOL-CELL PH, V306, pC263, DOI 10.1152/ajpcell.00381.2012; Reid DW, 2007, RESPIROLOGY, V12, P63, DOI 10.1111/j.1440-1843.2006.00962.x; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Schwarzer C, 2004, J BIOL CHEM, V279, P36454, DOI 10.1074/jbc.M404983200; Shah VS, 2016, SCIENCE, V351, P503, DOI 10.1126/science.aad5589; Shamsuddin AKM, 2014, AM J RESP CELL MOL, V50, P796, DOI 10.1165/rcmb.2013-0418OC; Shan JJ, 2012, J PHYSIOL-LONDON, V590, P5273, DOI 10.1113/jphysiol.2012.236893; SMITH JJ, 1992, J CLIN INVEST, V89, P1148, DOI 10.1172/JCI115696; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Suprynowicz FA, 2012, P NATL ACAD SCI USA, V109, P20035, DOI 10.1073/pnas.1213241109; Tang XX, 2016, J CLIN INVEST, V126, P879, DOI 10.1172/JCI83922; Tuo BG, 2006, GASTROENTEROLOGY, V130, P349, DOI 10.1053/j.gastro.2005.10.017; Tuo BG, 2007, AM J PHYSIOL-GASTR L, V293, pG279, DOI 10.1152/ajpgi.00488.2006; WIDDICOMBE JH, 1985, P NATL ACAD SCI USA, V82, P6167, DOI 10.1073/pnas.82.18.6167; Yang J, 2012, FREE RADICAL BIO MED, V53, P160, DOI 10.1016/j.freeradbiomed.2012.05.001; Yang N, 2013, J PHYSIOL-LONDON, V591, P4581, DOI 10.1113/jphysiol.2013.257436; ZAKRZEWSKI JT, 1987, BRIT J CLIN PHARMACO, V23, P19, DOI 10.1111/j.1365-2125.1987.tb03004.x; Zhang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104090	51	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189894	10.1371/journal.pone.0189894	http://dx.doi.org/10.1371/journal.pone.0189894			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281691	Green Published, gold, Green Submitted			2022-12-26	WOS:000419006200052
J	Snetselaar, R; van Batenburg, AA; van Oosterhout, MFM; Kazemier, KM; Roothaan, SM; Peeters, T; van der Vis, JJ; Goldschmeding, R; Grutters, JC; van Moorsel, CHM				Snetselaar, Reinier; van Batenburg, Aernoud A.; van Oosterhout, Matthijs F. M.; Kazemier, Karin M.; Roothaan, Suzan M.; Peeters, Ton; van der Vis, Joanne J.; Goldschmeding, Roel; Grutters, Jan C.; van Moorsel, Coline H. M.			Short telomere length in IPF lung associates with fibrotic lesions and predicts survival	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; SURFACTANT PROTEIN-C; FAMILIAL INTERSTITIAL PNEUMONIA; IN-SITU HYBRIDIZATION; STEM-CELLS; HERPESVIRUS-INFECTION; EPITHELIAL-CELLS; MUTATIONS; PATHOGENESIS; DISEASE	Telomere maintenance dysfunction has been implicated in the pathogenesis of Idiopathic Pulmonary Fibrosis (IPF). However, the mechanism of how telomere length is related to fibrosis in the lungs is unknown. Surgical lung biopsies of IPF patients typically show a heterogeneous pattern of non-fibrotic and fibrotic areas. Therefore, telomere length (TL) in both lung areas of patients with IPF and familial interstitial pneumonia was compared, specifically in alveolar type 2 (AT2) cells. Fluorescent in situ hybridization was used to determine TL in non-fibrotic and fibrotic areas of 35 subjects. Monochrome multiplex quantitative polymerase chain reaction (MMqPCR) was used for 51 whole lung biopsies and blood TL measurements. For sporadic IPF subjects, AT2 cell TL in non-fibrotic areas was 56% longer than in fibrotic areas. No such difference was observed in the surrounding lung cells. In subjects carrying a telomerase reverse transcriptase (TERT) mutation, AT2 cell TL was significantly shorter than in sporadic subjects. However, no difference in surrounding cell TL was observed between these subject groups. Finally, using biopsy MMqPCR TL measurements, it was determined that IPF subjects with shortest lung TL had a significantly worse survival than patients with long TL. This study shows that shortening of telomeres critically affects AT2 cells in fibrotic areas, implying TL as a cause of fibrogenesis. Furthermore, short lung telomere length is associated with decreased survival.	[Snetselaar, Reinier; van Batenburg, Aernoud A.; Kazemier, Karin M.; van der Vis, Joanne J.; Grutters, Jan C.; van Moorsel, Coline H. M.] St Antonius Hosp, St Antonius ILD Ctr Excellence, Dept Pulmonol, Nieuwegein, Netherlands; [van Oosterhout, Matthijs F. M.] St Antonius Hosp, St Antonius ILD Ctr Excellence, Dept Pathol, Nieuwegein, Netherlands; [Kazemier, Karin M.; Grutters, Jan C.; van Moorsel, Coline H. M.] Univ Med Ctr Utrecht, Div Heart & Lungs, Utrecht, Netherlands; [Roothaan, Suzan M.; Peeters, Ton; Goldschmeding, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van der Vis, Joanne J.] St Antonius Hosp, St Antonius ILD Ctr Excellence, Dept Clin Chem, Nieuwegein, Netherlands	St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht	van Moorsel, CHM (corresponding author), St Antonius Hosp, St Antonius ILD Ctr Excellence, Dept Pulmonol, Nieuwegein, Netherlands.; van Moorsel, CHM (corresponding author), Univ Med Ctr Utrecht, Div Heart & Lungs, Utrecht, Netherlands.	c.van.moorsel@antoniusziekenhuis.nl			ZonMW-TopZorg St Antonius Science Corner grant [842002003]; 'Pendersfonds' of the lungfibrosis patient association (CHMvM)	ZonMW-TopZorg St Antonius Science Corner grant; 'Pendersfonds' of the lungfibrosis patient association (CHMvM)	This research was enabled by ZonMW-TopZorg St Antonius Science Corner grant (grant number 842002003, www.zonmw.nl; JCG CHMvM JJvdV) and 'Pendersfonds' of the lungfibrosis patient association (CHMvM).	Aida J, 2007, HUM PATHOL, V38, P1192, DOI 10.1016/j.humpath.2006.11.023; Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Alder JK, 2015, P NATL ACAD SCI USA, V112, P5099, DOI 10.1073/pnas.1504780112; [Anonymous], 2002, COMMUNICATION, V165, P277; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Aubert G, 2014, PROG MOL BIOL TRANSL, V125, P89, DOI 10.1016/B978-0-12-397898-1.00004-9; Bhaskaran M, 2007, J BIOL CHEM, V282, P3968, DOI 10.1074/jbc.M609060200; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Chilosi M, 2013, TRANSL RES, V162, P156, DOI 10.1016/j.trsl.2013.06.004; Chilosi M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-3; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Dai JH, 2015, RESPIROLOGY, V20, P947, DOI 10.1111/resp.12566; Gunes C, 2013, CELL, V152, P390, DOI 10.1016/j.cell.2013.01.010; Gunther A, 2012, EUR RESPIR REV, V21, P152, DOI 10.1183/09059180.00001012; Hoffman TW, 2016, FIBROSIS CASE REP PU, V2016; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Khalil N, 1996, AM J RESP CELL MOL, V14, P131, DOI 10.1165/ajrcmb.14.2.8630262; Kreider ME, 2007, ANN THORAC SURG, V83, P1140, DOI 10.1016/j.athoracsur.2006.10.002; Kropski JA, 2015, AM J RESP CRIT CARE, V191, P417, DOI 10.1164/rccm.201406-1162OC; Kropski JA, 2014, CHEST, V146, pE1, DOI 10.1378/chest.13-2224; Kropski JA, 2012, AM J PHYSIOL-LUNG C, V302, pL441, DOI 10.1152/ajplung.00335.2011; Kuwano K, 1996, AM J RESP CRIT CARE, V154, P477, DOI 10.1164/ajrccm.154.2.8756825; Lansdorp PM, 2008, BLOOD, V111, P1759, DOI 10.1182/blood-2007-09-084913; Lawson WE, 2008, AM J PHYSIOL-LUNG C, V294, pL1119, DOI 10.1152/ajplung.00382.2007; Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Minagawa S, 2011, ACCELERATED EPITHELI, V300, P391; Naikawadi RP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86704; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Povedano JM, 2015, CELL REP, V12, P286, DOI 10.1016/j.celrep.2015.06.028; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Reddy R, 2004, AM J PHYSIOL-LUNG C, V286, pL658, DOI 10.1152/ajplung.00159.2003; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Serrano-Mollar A, 2016, CHEST, V150, P533, DOI 10.1016/j.chest.2016.03.021; Snetselaar R, 2015, CHEST, V148, P1011, DOI 10.1378/chest.14-3078; Stuart BD, 2015, NAT GENET, V47, P512, DOI 10.1038/ng.3278; Stuart BD, 2014, LANCET RESP MED, V2, P557, DOI 10.1016/S2213-2600(14)70124-9; ten Brinke A, 2002, BBA-MOL CELL BIOL L, V1583, P253, DOI 10.1016/S1388-1981(02)00248-2; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Tumpel S, 2012, ANN NY ACAD SCI, V1266, P28, DOI 10.1111/j.1749-6632.2012.06547.x; Tzouvelekis A, 2010, PNEUMON, V23, P224; Uhal BD, 1997, CELL CYCLE KINETICS, V272, P1031; Utz JP, 2001, EUR RESPIR J, V17, P175, DOI 10.1183/09031936.01.17201750; van Moorsel CHM, 2015, AM J RESP CRIT CARE, V192, P1249, DOI 10.1164/rccm.201504-0675LE; van Moorsel CHM, 2010, AM J RESP CRIT CARE, V182, P1419, DOI 10.1164/rccm.200906-0953OC; Waisberg DR, 2010, HUM PATHOL, V41, P385, DOI 10.1016/j.humpath.2009.08.019; Wang Y, 2009, AM J HUM GENET, V84, P52, DOI 10.1016/j.ajhg.2008.11.010; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; Wuyts WA, 2013, EUR RESPIR J, V41, P1207, DOI 10.1183/09031936.00073012	50	62	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189467	10.1371/journal.pone.0189467	http://dx.doi.org/10.1371/journal.pone.0189467			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281671	Green Published, Green Submitted, gold			2022-12-26	WOS:000419006200030
J	Wu, B; Hu, W; Ayaad, M; Liu, HB; Xing, YZ				Wu, Bi; Hu, Wei; Ayaad, Mohammed; Liu, Hongbo; Xing, Yongzhong			Intragenic recombination between two non-functional semi-dwarf 1 alleles produced a functional SD1 allele in a tall recombinant inbred line in rice	PLOS ONE			English	Article							GREEN-REVOLUTION; WAXY LOCUS; GENE; GENOME; MAIZE; HOTSPOT; IDENTIFICATION; POPULATION; REGION; PLANTS	Intragenic recombination is one of the most important sources of genetic variability. In our previous study, RI92 a tall line (160 cm of plant height) was observed in the cross progeny between two semi-dwarf indica cultivars Zhenshan 97 and Minghui 63. Genome-wide genotyping and sequencing indicated that the genome constitution of RI92 was completely from both parents. Bulk segregant analysis in a BC3F2 population revealed that "green revolution gene" semi-dwarf 1 (sd1) was most likely the gene controlling the tall plant height in RI92. Sequencing analysis of SD1 revealed that an intragenic recombination occurred between two parental non-functional sd1 alleles and generated a functional SD1 in RI92. Four-fold high recombination rate in SD1 located bins to the genome-wide average was observed in two RIL populations, indicating recombination hotspot in the SD1 region. Intragenic recombination creates new alleles in the progeny distinct from parental alleles and diversifies natural variation.	[Wu, Bi; Hu, Wei; Ayaad, Mohammed; Liu, Hongbo; Xing, Yongzhong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Ayaad, Mohammed] Egyptian Atom Energy Author, Nucl Res Ctr, Cairo, Egypt	Huazhong Agricultural University; Egyptian Knowledge Bank (EKB); Egyptian Atomic Energy Authority (EAEA)	Xing, YZ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	yzxing@mail.hzau.edu.cn		Ayaad, Mohammed/0000-0001-8674-9861; Xing, Yongzhong/0000-0003-1376-1514	National Natural Science Foundation of China [31371248, 91535301]; Natural science foundation of Hubei province, China [2015CFA006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural science foundation of Hubei province, China(Natural Science Foundation of Hubei Province)	This work was supported by the National Natural Science Foundation of China (31371248 and 91535301) http://www.nsfc.gov.cn/ and the Natural science foundation of Hubei province, China (2015CFA006) http://www.hbstd.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano K, 2007, BREEDING SCI, V57, P53, DOI 10.1270/jsbbs.57.53; Asano K, 2011, P NATL ACAD SCI USA, V108, P11034, DOI 10.1073/pnas.1019490108; Ashikari M, 2002, BREEDING SCI, V52, P143, DOI 10.1270/jsbbs.52.143; BROWN J, 1991, THEOR APPL GENET, V81, P185, DOI 10.1007/BF00215721; Cavanagh C, 2008, CURR OPIN PLANT BIOL, V11, P215, DOI 10.1016/j.pbi.2008.01.002; Chen MS, 2002, PLANT CELL, V14, P537, DOI 10.1105/tpc.010485; Choo KHA, 1998, GENOME RES, V8, P81, DOI 10.1101/gr.8.2.81; DARVASI A, 1995, GENETICS, V141, P1199; Dooner HK, 1997, PLANT CELL, V9, P1633, DOI 10.1105/tpc.9.9.1633; Duan LF, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-44; Gill KS, 1996, GENETICS, V144, P1883; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Inukai T, 2000, GENOME, V43, P589, DOI 10.1139/gen-43-4-589; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Kunzel G, 2000, GENETICS, V154, P397; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; MOURAD G, 1994, MOL GEN GENET, V243, P178, DOI 10.1007/BF00280315; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Okagaki RJ, 1997, GENETICS, V147, P815; Pan QC, 2016, NEW PHYTOL, V210, P1083, DOI 10.1111/nph.13810; Rodgers-Melnick E, 2015, P NATL ACAD SCI USA, V112, P3823, DOI 10.1073/pnas.1413864112; Sakamoto T, 2004, CURR OPIN BIOTECH, V15, P144, DOI 10.1016/j.copbio.2004.02.003; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Schnable PS, 1998, CURR OPIN PLANT BIOL, V1, P123, DOI 10.1016/S1369-5266(98)80013-7; Shen GJ, 2014, PLANT SCI, V215, P11, DOI 10.1016/j.plantsci.2013.10.004; SHURE M, 1983, CELL, V35, P225, DOI 10.1016/0092-8674(83)90225-8; Tan C, 2013, J GENET GENOMICS, V40, P629, DOI 10.1016/j.jgg.2013.06.009; Wan XY, 2008, GENETICS, V179, P2239, DOI 10.1534/genetics.108.089862; Wang L, 2011, THEOR APPL GENET, V122, P327, DOI 10.1007/s00122-010-1449-8; WANG ZY, 1990, NUCLEIC ACIDS RES, V18, P5898, DOI 10.1093/nar/18.19.5898; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Xing YZ, 2001, ACTA BOT SIN, V43, P721; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yim KO, 1997, J PLANT GROWTH REGUL, V16, P35, DOI 10.1007/PL00006972	36	7	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190116	10.1371/journal.pone.0190116	http://dx.doi.org/10.1371/journal.pone.0190116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281725	gold, Green Published, Green Submitted			2022-12-26	WOS:000419006200067
J	Czemeres, J; Buse, K; Verkhivker, GM				Czemeres, Josh; Buse, Kurt; Verkhivker, Gennady M.			Atomistic simulations and network-based modeling of the Hsp90-Cdc37 chaperone binding with Cdk4 client protein: A mechanism of chaperoning kinase clients by exploiting weak spots of intrinsically dynamic kinase domains	PLOS ONE			English	Article							HSP90 MOLECULAR CHAPERONE; ESCHERICHIA-COLI HSP90; HIGH-AFFINITY BINDING; CONFORMATIONAL DYNAMICS; CHARGED LINKER; WEB SERVER; POSTTRANSLATIONAL MODIFICATIONS; STATISTICAL POTENTIALS; ALLOSTERIC REGULATION; CRYSTAL-STRUCTURE	A fundamental role of the Hsp90 and Cdc37 chaperones in mediating conformational development and activation of diverse protein kinase clients is essential in signal transduction. There has been increasing evidence that the Hsp90-Cdc37 system executes its chaperoning duties by recognizing conformational instability of kinase clients and modulating their folding landscapes. The recent cryo-electron microscopy structure of the Hsp90-Cdc37-Cdk4 kinase complex has provided a framework for dissecting regulatory principles underlying differentiation and recruitment of protein kinase clients to the chaperone machinery. In this work, we have combined atomistic simulations with protein stability and network-based rigidity decomposition analyses to characterize dynamic factors underlying allosteric mechanism of the chaperone- kinase cycle and identify regulatory hotspots that control client recognition. Through comprehensive characterization of conformational dynamics and systematic identification of stabilization centers in the unbound and client-bound Hsp90 forms, we have simulated key stages of the allosteric mechanism, in which Hsp90 binding can induce instability and partial unfolding of Cdk4 client. Conformational landscapes of the Hsp90 and Cdk4 structures suggested that client binding can trigger coordinated dynamic changes and induce global rigidification of the Hsp90 inter-domain regions that is coupled with a concomitant increase in conformational flexibility of the kinase client. This process is allosteric in nature and can involve reciprocal dynamic exchanges that exert global effect on stability of the Hsp90 dimer, while promoting client instability. The network-based rigidity analysis and emulation of thermal unfolding of the Cdk4-cyclin D complex and Hsp90-Cdc37-Cdk4 complex revealed weak spots of kinase instability that are present in the native Cdk4 structure and are targeted by the chaperone during client recruitment. Our findings suggested that this mechanism may be exploited by the Hsp90-Cdc37 chaperone to recruit and protect intrinsically dynamic kinase clients from degradation. The results of this investigation are discussed and interpreted in the context of diverse experimental data, offering new insights into mechanisms of chaperone regulation and binding.	[Czemeres, Josh; Buse, Kurt; Verkhivker, Gennady M.] Chapman Univ, Dept Computat & Data Sci, Schmid Coll Sci & Technol, Orange, CA 92866 USA; [Verkhivker, Gennady M.] Chapman Univ, Sch Pharm, Dept Biomed & Pharmaceut Sci, Irvine, CA 92618 USA	Chapman University System; Chapman University; Chapman University System; Chapman University	Verkhivker, GM (corresponding author), Chapman Univ, Dept Computat & Data Sci, Schmid Coll Sci & Technol, Orange, CA 92866 USA.; Verkhivker, GM (corresponding author), Chapman Univ, Sch Pharm, Dept Biomed & Pharmaceut Sci, Irvine, CA 92618 USA.	verkhivk@chapman.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471	Chapman University	Chapman University	This work was supported by funding from Chapman University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Bardwell JCA, 2012, TRENDS BIOCHEM SCI, V37, P517, DOI 10.1016/j.tibs.2012.08.006; Beebe K, 2013, ONCOTARGET, V4, P1065, DOI 10.18632/oncotarget.1099; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blacklock K, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003679; Blacklock K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086547; Blacklock K, 2013, J CHEM INF MODEL, V53, P2962, DOI 10.1021/ci400434g; Blacklock K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071936; Boczek EE, 2015, P NATL ACAD SCI USA, V112, pE3189, DOI 10.1073/pnas.1424342112; Burmann BM, 2013, NAT STRUCT MOL BIOL, V20, P1265, DOI 10.1038/nsmb.2677; Callon M, 2014, ANGEW CHEM INT EDIT, V53, P5069, DOI 10.1002/anie.201310963; Chakravarty S, 1999, STRUCT FOLD DES, V7, P723, DOI 10.1016/S0969-2126(99)80097-5; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Chen B, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-156; Chubynsky MV, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041135; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Colombo G, 2008, P NATL ACAD SCI USA, V105, P7976, DOI 10.1073/pnas.0802879105; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; Dahiyat BI, 1997, PROTEIN SCI, V6, P1333, DOI 10.1002/pro.5560060622; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Dehouck Y, 2006, BIOPHYS J, V90, P4010, DOI 10.1529/biophysj.105.079434; Dehouck Y, 2013, NUCLEIC ACIDS RES, V41, pW333, DOI 10.1093/nar/gkt450; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Dellus-Gur E, 2013, J MOL BIOL, V425, P2609, DOI 10.1016/j.jmb.2013.03.033; Dixit A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037605; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Eckl JM, 2016, J MOL BIOL, V428, P4185, DOI 10.1016/j.jmb.2016.09.002; Eckl JM, 2015, J BIOL CHEM, V290, P30843, DOI 10.1074/jbc.M115.693150; Felts S.J., 2007, SCI STKE, V2007, pe22, DOI [DOI 10.1126/STKE.3852007PE22, DOI 10.1126/stke.3852007pe22]; Fernandez-Fuentes N, 2006, NUCLEIC ACIDS RES, V34, pW173, DOI 10.1093/nar/gkl113; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Graf Christian, 2014, Front Mol Biosci, V1, P4, DOI 10.3389/fmolb.2014.00004; Graf C, 2009, EMBO J, V28, P602, DOI 10.1038/emboj.2008.306; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guo JJ, 2016, CHEM REV, V116, P6503, DOI 10.1021/acs.chemrev.5b00590; Guo JJ, 2015, BIOPHYS J, V108, P2771, DOI 10.1016/j.bpj.2015.04.035; Hainzl O, 2009, J BIOL CHEM, V284, P22559, DOI 10.1074/jbc.M109.031658; He LC, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601625; Hekkelman ML, 2010, NUCLEIC ACIDS RES, V38, pW719, DOI 10.1093/nar/gkq453; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hespenheide BM, 2002, J MOL GRAPH MODEL, V21, P195, DOI 10.1016/S1093-3263(02)00146-8; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Jackson SE, 2013, TOP CURR CHEM, V328, P155, DOI 10.1007/128_2012_356; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jacobs DJ, 1997, J COMPUT PHYS, V137, P346, DOI 10.1006/jcph.1997.5809; Jahn M, 2014, P NATL ACAD SCI USA, V111, P17881, DOI 10.1073/pnas.1414073111; Jha SK, 2009, P NATL ACAD SCI USA, V106, P12289, DOI 10.1073/pnas.0905744106; Jiang YQ, 2010, J BIOL CHEM, V285, P21023, DOI 10.1074/jbc.M110.103390; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Karagoz GE, 2015, TRENDS BIOCHEM SCI, V40, P117, DOI 10.1016/j.tibs.2014.12.002; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Karagoz GE, 2011, P NATL ACAD SCI USA, V108, P580, DOI 10.1073/pnas.1011867108; Keramisanou D, 2016, MOL CELL, V62, P260, DOI 10.1016/j.molcel.2016.04.005; Kiel C, 2016, ELIFE, V5, DOI 10.7554/eLife.12814; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kruger DM, 2013, NUCLEIC ACIDS RES, V41, pW340, DOI 10.1093/nar/gkt292; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Krukenberg KA, 2009, J MOL BIOL, V390, P278, DOI 10.1016/j.jmb.2009.04.080; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Li J, 2013, NAT STRUCT MOL BIOL, V20, P326, DOI 10.1038/nsmb.2502; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Li MH, 2014, J CHEM THEORY COMPUT, V10, P1770, DOI 10.1021/ct401022c; Lorenz OR, 2014, MOL CELL, V53, P941, DOI 10.1016/j.molcel.2014.02.003; Lu XA, 2014, BIOCHEM J, V457, P171, DOI 10.1042/BJ20130963; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Makhnevych T, 2012, BBA-MOL CELL RES, V1823, P674, DOI 10.1016/j.bbamcr.2011.09.001; Mandal AK, 2007, J CELL BIOL, V176, P319, DOI 10.1083/jcb.200604106; Mandel AK, 2011, METHODS MOL BIOL, V787, P75, DOI 10.1007/978-1-61779-295-3_6; Marzec M, 2012, BBA-MOL CELL RES, V1823, P774, DOI 10.1016/j.bbamcr.2011.10.013; Matts RL, 2011, ACS CHEM BIOL, V6, P800, DOI 10.1021/cb200052x; Matts RL, 2011, BIOORGAN MED CHEM, V19, P684, DOI 10.1016/j.bmc.2010.10.029; Mayer MP, 2015, MOL CELL, V58, P8, DOI 10.1016/j.molcel.2015.02.022; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Mollapour M, 2012, BBA-MOL CELL RES, V1823, P648, DOI 10.1016/j.bbamcr.2011.07.018; Mollapour M, 2011, MOL CELL, V41, P672, DOI 10.1016/j.molcel.2011.02.011; Moretti R, 2013, PROTEINS, V81, P1980, DOI 10.1002/prot.24356; Morra G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002433; Morra G, 2010, J CHEM THEORY COMPUT, V6, P2978, DOI 10.1021/ct100334n; Morra G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000323; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Navizet I, 2004, BIOPHYS J, V87, P1426, DOI 10.1529/biophysj.104.042085; Paladino A, 2015, J CHEM INF MODEL, V55, P1377, DOI 10.1021/acs.jcim.5b00270; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2016, BIOPOLYMERS, V105, P594, DOI 10.1002/bip.22835; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Pfleger C, 2013, J CHEM INF MODEL, V53, P1007, DOI 10.1021/ci400044m; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Polier S, 2013, NAT CHEM BIOL, V9, P307, DOI [10.1038/NCHEMBIO.1212, 10.1038/nchembio.1212]; Prince T, 2005, BIOCHEMISTRY-US, V44, P15287, DOI 10.1021/bi051423m; Prince T, 2004, J BIOL CHEM, V279, P39975, DOI 10.1074/jbc.M406882200; Prodromou C, 2016, BIOCHEM J, V473, P2439, DOI 10.1042/BCJ20160005; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Rader AJ, 2002, P NATL ACAD SCI USA, V99, P3540, DOI 10.1073/pnas.062492699; Ratzke C, 2010, P NATL ACAD SCI USA, V107, P16101, DOI 10.1073/pnas.1000916107; Ratzke C, 2012, J MOL BIOL, V423, P462, DOI 10.1016/j.jmb.2012.07.026; Ratzke C, 2012, P NATL ACAD SCI USA, V109, P161, DOI 10.1073/pnas.1107930108; Rehn A, 2016, J MOL BIOL, V428, P4559, DOI 10.1016/j.jmb.2016.09.014; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Rohl A, 2013, TRENDS BIOCHEM SCI, V38, P253, DOI 10.1016/j.tibs.2013.02.003; Sacquin-Mora S, 2006, BIOPHYS J, V90, P2706, DOI 10.1529/biophysj.105.074997; Sacquin-Mora S, 2007, PROTEINS, V67, P350, DOI 10.1002/prot.21353; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Schulze A, 2016, NAT CHEM BIOL, V12, P628, DOI [10.1038/NCHEMBIO.2111, 10.1038/nchembio.2111]; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Scroggins BT, 2003, BIOCHEMISTRY-US, V42, P12550, DOI 10.1021/bi035001t; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Smith JR, 2015, ONCOGENE, V34, P15, DOI 10.1038/onc.2013.519; Smith JR, 2009, ONCOGENE, V28, P157, DOI 10.1038/onc.2008.380; Song JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007072; Soroka J, 2012, MOL CELL, V45, P517, DOI 10.1016/j.molcel.2011.12.031; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Sreeramulu S, 2009, J BIOL CHEM, V284, P3885, DOI 10.1074/jbc.M806715200; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Stankiewicz Marta, 2012, Biomol Concepts, V3, P79, DOI 10.1515/bmc.2011.054; Stetz G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143752; Street TO, 2010, PROTEIN SCI, V19, P57, DOI 10.1002/pro.282; Synoradzki K, 2015, BBA-MOL CELL RES, V1853, P445, DOI 10.1016/j.bbamcr.2014.11.026; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Takaki T, 2009, P NATL ACAD SCI USA, V106, P4171, DOI 10.1073/pnas.0809674106; Tan KP, 2013, NUCLEIC ACIDS RES, V41, pW314, DOI 10.1093/nar/gkt503; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Toth-Petroczy A, 2014, CURR OPIN STRUC BIOL, V26, P131, DOI 10.1016/j.sbi.2014.06.007; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Tsaytler PA, 2009, CELL STRESS CHAPERON, V14, P629, DOI 10.1007/s12192-009-0115-z; Tsutsumi S, 2012, P NATL ACAD SCI USA, V109, P2937, DOI 10.1073/pnas.1114414109; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Verba KA, 2017, TRENDS BIOCHEM SCI, V42, P799, DOI 10.1016/j.tibs.2017.07.002; Verba KA, 2016, SCIENCE, V352, P1542, DOI 10.1126/science.aaf5023; Verkhivker GM, 2017, MOL BIOSYST, V13, P2235, DOI 10.1039/c7mb00355b; Verkhivker GM, 2009, CURR TOP MED CHEM, V9, P1369, DOI 10.2174/156802609789895700; Verma S, 2016, BIOCHIMIE, V127, P227, DOI 10.1016/j.biochi.2016.05.018; Vettoretti G, 2016, SCI REP-UK, V6, DOI 10.1038/srep23830; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Woodford MR, 2016, ADV CANCER RES, V129, P31, DOI 10.1016/bs.acr.2015.09.002; Xu WP, 2012, MOL CELL, V47, P434, DOI 10.1016/j.molcel.2012.05.015; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007; Zhang Z, 2012, BIOINFORMATICS, V28, P664, DOI 10.1093/bioinformatics/bts005; Zhao RM, 2007, ADV EXP MED BIOL, V594, P27; Zierer BK, 2016, NAT STRUCT MOL BIOL, V23, P1020, DOI 10.1038/nsmb.3305	161	23	23	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190267	10.1371/journal.pone.0190267	http://dx.doi.org/10.1371/journal.pone.0190267			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267381	gold, Green Published, Green Submitted			2022-12-26	WOS:000418587400109
J	de Groot, T; Damen, L; Kosse, L; Alsady, M; Doty, R; Baumgarten, R; Sheehan, S; van der Vlag, J; Korstanje, R; Deen, PMT				de Groot, Theun; Damen, Lars; Kosse, Leanne; Alsady, Mohammad; Doty, Rosalinda; Baumgarten, Ruben; Sheehan, Susan; van der Vlag, Johan; Korstanje, Ron; Deen, Peter M. T.			Lithium reduces blood glucose levels, but aggravates albuminuria in BTBR-ob/ob mice	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; GLOMERULAR-FILTRATION-RATE; DIABETIC-NEPHROPATHY; PROXIMAL TUBULE; INSULIN-RESISTANCE; KIDNEY; INJURY; GLYCOGEN-SYNTHASE-KINASE-3-BETA; PHOSPHORYLATION; ACETAZOLAMIDE	Glycogen synthase kinase 3 (GSK3) plays an important role in the development of diabetes mellitus and renal injury. GSK3 inhibition increases glucose uptake in insulin-insensitive muscle and adipose tissue, while it reduces albuminuria and glomerulosclerosis in acute kidney injury. The effect of chronic GSK3 inhibition in diabetic nephropathy is not known. We tested the effect of lithium, the only clinical GSK3 inhibitor, on the development of diabetes mellitus and kidney injury in a mouse model of diabetic nephropathy. Twelve-week old female BTBR-ob/ob mice were treated for 12 weeks with 0, 10 and 40 mmolLiCl/kg after which the development of diabetes and diabetic nephropathy were analysed. In comparison to BTBR-WT mice, ob/ob mice demonstrated elevated bodyweight, increased blood glucose/insulin levels, urinary albumin and immunoglobulin G levels, glomerulosclerosis, reduced nephrin abundance and a damaged proximal tubule brush border. The lithium- 10 and -40 diets did not affect body weight and resulted in blood lithium levels of respectively <0.25 mM and 0.48 mM. The Li-40 diet fully rescued the elevated non-fasting blood glucose levels. Importantly, glomerular filtration rate was not affected by lithium, while urine albumin and immunoglobulin G content were further elevated. While lithium did not worsen the glomerulosclerosis, proximal tubule function seemed affected by lithium, as urinary NGAL levels were significantly increased. These results demonstrate that lithium attenuates nonfasting blood glucose levels in diabetic mice, but aggravates urinary albumin and immunoglobulin G content, possibly resulting from proximal tubule dysfunction.	[de Groot, Theun; Kosse, Leanne; Doty, Rosalinda; Sheehan, Susan; Korstanje, Ron] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [de Groot, Theun; Damen, Lars; Kosse, Leanne; Alsady, Mohammad; Deen, Peter M. T.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Nijmegen, Netherlands; [Baumgarten, Ruben] Vivium Care Grp, Huizen, Netherlands; [van der Vlag, Johan] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands	Jackson Laboratory; Radboud University Nijmegen; Radboud University Nijmegen	Deen, PMT (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Nijmegen, Netherlands.	peter.deen@radboudumc.nl	Deen, P.M.T./H-8023-2014; Van der Vlag, Johan/E-4636-2010; Alsady, Mohammad/E-5687-2016; Kosse, Leanne Josien/ABC-5616-2021; Tutakhel, Omar A.Z./G-3638-2016; Deen, Peter MT/B-9854-2013	Deen, P.M.T./0000-0002-7868-4655; Van der Vlag, Johan/0000-0001-7843-5918; Alsady, Mohammad/0000-0001-8287-4120; Kosse, Leanne Josien/0000-0002-9358-2286; Tutakhel, Omar A.Z./0000-0002-1872-8409; Deen, Peter MT/0000-0002-7868-4655; Sheehan, Susan/0000-0003-1409-0679	Society of Experimental Laboratory Medicine; Niels Stensen Fellowship; Marie Curie Fellowship [PIOF-GA-2012-332395]	Society of Experimental Laboratory Medicine; Niels Stensen Fellowship; Marie Curie Fellowship(European Commission)	This project received support from a grant from the Society of Experimental Laboratory Medicine to PMTD and a Niels Stensen Fellowship (nielsstensenfellowship.nl/nl) and Marie Curie Fellowship PIOF-GA-2012-332395 (ec.europa.eu/research/mariecurieactionsiabout_en) to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; Alsaad KO, 2007, J CLIN PATHOL, V60, P18, DOI 10.1136/jcp.2005.035592; [Anonymous], 2012, 8642EY INT 2012 S201, V3, P1; Bao H, 2015, KIDNEY INT; Bao H, 2014, J AM SOC NEPHROL, V25, P488, DOI 10.1681/ASN.2013040350; Bivona BJ, 2011, AM J PHYSIOL-RENAL, V300, pF618, DOI 10.1152/ajprenal.00421.2010; Boini KM, 2009, AM J PHYSIOL-RENAL, V296, pF153, DOI 10.1152/ajprenal.90398.2008; Bolli GB, 1999, DIABETOLOGIA, V42, P1151, DOI 10.1007/s001250051286; Brosnahan G, 2010, SOUTH MED J, V103, P140, DOI 10.1097/SMJ.0b013e3181c99438; COGAN MG, 1979, AM J PHYSIOL, V237, pF447, DOI 10.1152/ajprenal.1979.237.6.F447; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Cohen-Bucay A, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/146987; Coward R, 2015, CURR OPIN NEPHROL HY, V24, P104, DOI 10.1097/MNH.0000000000000078; de Groot T, 2016, J AM SOC NEPHROL, V27, P2082, DOI 10.1681/ASN.2015070796; de Groot T, 2014, J AM SOC NEPHROL, V25, P501, DOI 10.1681/ASN.2013090988; Dickson LE, 2014, J AM SOC NEPHROL, V25, P443, DOI 10.1681/ASN.2013090950; Eisner C, 2010, KIDNEY INT, V77, P519, DOI 10.1038/ki.2009.501; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; EldarFinkelman H, 1997, P NATL ACAD SCI USA, V94, P9660, DOI 10.1073/pnas.94.18.9660; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Goodwin FK, 2002, J CLIN PSYCHIAT, V63, P5; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Ha H, 2001, Curr Diab Rep, V1, P282, DOI 10.1007/s11892-001-0047-1; Henriksen EJ, 2006, CURR DRUG TARGETS, V7, P1435, DOI 10.2174/1389450110607011435; Howard C, 2012, KIDNEY INT, V82, P1000, DOI 10.1038/ki.2012.239; Hu M, 1997, BIOL TRACE ELEM RES, V60, P131, DOI 10.1007/BF02783316; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Jung HJ, 2015, AM J PHYSIOL-RENAL, V308, pF473, DOI 10.1152/ajprenal.00052.2014; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Li CB, 2016, J PATHOL, V239, P23, DOI 10.1002/path.4692; Markowitz GS, 2000, J AM SOC NEPHROL, V11, P1439, DOI 10.1681/ASN.V1181439; Nagaishi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34842; New LA, 2016, J AM SOC NEPHROL, V27, P2422, DOI 10.1681/ASN.2015091048; Nielsen R, 2016, KIDNEY INT, V89, P58, DOI 10.1016/j.kint.2015.11.007; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Oetjen S, 2014, J COMP NEUROL, V522, P3386, DOI 10.1002/cne.23606; Park CH, 2012, J PHARM PHARMACOL, V64, P1730, DOI 10.1111/j.2042-7158.2012.01559.x; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Peres GB, 2013, BBA-MOL BASIS DIS, V1832, P85, DOI 10.1016/j.bbadis.2012.09.011; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Radbill B, 2008, MAYO CLIN PROC, V83, P1373, DOI 10.1016/S0025-6196(11)60786-6; ROSSETTI L, 1989, DIABETES, V38, P648, DOI 10.2337/diabetes.38.5.648; Rudberg S, 1997, NEPHROL DIAL TRANSPL, V12, P1149, DOI 10.1093/ndt/12.6.1149; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Sun YM, 2013, BIOCHEM BIOPH RES CO, V433, P359, DOI 10.1016/j.bbrc.2013.02.120; TABATA I, 1994, DIABETES, V43, P903, DOI 10.2337/diabetes.43.7.903; Tanabe K, 2008, PLOS BIOL, V6, P307, DOI 10.1371/journal.pbio.0060037; THIEBAUD D, 1982, DIABETES, V31, P957, DOI 10.2337/diacare.31.11.957; Tsaih SW, 2010, KIDNEY INT, V77, P201, DOI 10.1038/ki.2009.434; WALKER RG, 1986, KIDNEY INT, V29, P875, DOI 10.1038/ki.1986.80; Wang Z, 2013, FREE RADICAL BIO MED, V65, P849, DOI 10.1016/j.freeradbiomed.2013.08.169; WHO, 2016, GLOB REP PSOR	54	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189485	10.1371/journal.pone.0189485	http://dx.doi.org/10.1371/journal.pone.0189485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244860	Green Published, gold, Green Submitted			2022-12-26	WOS:000418184700034
J	Li, YL; Wu, NJ; Xu, R; Li, LQ; Zhou, W; Zhou, XJ				Li, Yanling; Wu, Nanjun; Xu, Rong; Li, Liqing; Zhou, Wei; Zhou, Xianjun			Empirical analysis of pig welfare levels and their impact on pig breeding efficiency-Based on 773 pig farmers' survey data	PLOS ONE			English	Article							ANIMAL-WELFARE; SYSTEMS	Few studies of the pig production efficiency are from the perspective of animal welfare. Therefore, this study conducted a comprehensive evaluation of pig welfare levels based on survey data from 773 pig farmers from 23 counties in the Chinese provinces of Hunan, Zhe-jiang, Guangdong, Guizhou, and Shanxi. This study used the Delphi method, Analytic Hierarchy Process (AHP), and Data Envelopment Analysis (DEA)-Tobit regression model to analyze farmers' pig production efficiency and its influencing factors. This paper found that most farmers' pig production efficiency is low, and the DEA is invalid. Only 2.9% of pig farmers' who breed pigs are at the optimal level in terms of welfare, and their production efficiency is relatively high. In contrast, 49.34% of the farmers are at the medium welfare level, and compared with the farmers at the optimal welfare level, these farmers' pig production efficiency is low. Additionally, the farmers' age, gender, and number of years of experience with pig breeding have a significant effect. Furthermore, the scale of pig breeding and feeding type, the agriculture facilities for the central treatment of waste in local areas, and the availability of local agricultural science and technology personnel have a considerable influence on pig production efficiency.	[Li, Yanling; Wu, Nanjun; Zhou, Wei; Zhou, Xianjun] Hunan Agr Univ, Coll Publ Management & Law, Changsha, Hunan, Peoples R China; [Xu, Rong] China Agr Univ, Coll Econ & Management, Beijing, Peoples R China; [Li, Liqing] Hunan Agr Univ, Coll Econ, Changsha, Hunan, Peoples R China	Hunan Agricultural University; China Agricultural University; Hunan Agricultural University	Li, YL (corresponding author), Hunan Agr Univ, Coll Publ Management & Law, Changsha, Hunan, Peoples R China.	liyanling1964@163.com	li, li/GPX-3938-2022; li, li/AAT-2097-2020; li, yan/GTI-4638-2022; Li, Li/AEM-3636-2022; li, li/HII-4157-2022; LI, LI QING/GRR-8855-2022; LI, LI/GVS-5344-2022		 [11ZD171]		This work was supported by grant numbers: 11&ZD171, http://www.npopss-cn.gov.cn/.	Bornett HLI, 2003, J AGR ENVIRON ETHIC, V16, P163, DOI 10.1023/A:1022994131594; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Fang Y., 2014, COMPLEXITY, V2014, P1, DOI DOI 10.1016/J.CELREP.2014.03.032; Helgesson A, 2000, 242 SWED U AGR SCI; [李燕凌 Li Yanling], 2008, [中国农村经济, Chinese Rural Economy], P52; Mang Ping, 2004, HENAN SOCIAL SCI, V12, P25; McGlone JJ, 2001, LIVEST PROD SCI, V72, P75, DOI 10.1016/S0301-6226(01)00268-8; Tonsor GT, 2011, FOOD POLICY, V36, P430, DOI 10.1016/j.foodpol.2011.02.001; van de Weerd HA, 2009, APPL ANIM BEHAV SCI, V116, P1, DOI 10.1016/j.applanim.2008.08.001; Wang JH, 2011, RES IMPACT ANIMAL WE; Yan Q.H., 2013, THE J, V3, P99; Zao YJ, 2010, GUIZHOU SOCIAL SCI, V6, P14; Zheng J, 2006, EC RES J, V7, P92	13	12	12	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190108	10.1371/journal.pone.0190108	http://dx.doi.org/10.1371/journal.pone.0190108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281694	Green Submitted, gold, Green Published			2022-12-26	WOS:000419006200064
J	Ness, T; Abdallah, M; Adams, J; Alvarado, C; Gunn, E; House, B; Lamb, J; Macguire, J; Norris, E; Robinson, R; Sapp, M; Sharma, J; Garner, R				Ness, Traci; Abdallah, Mahmud; Adams, Jaime; Alvarado, Claudia; Gunn, Edwin; House, Brittany; Lamb, John; Macguire, Jack; Norris, Emily; Robinson, Rebekah; Sapp, Morgan; Sharma, Jill; Garner, Ronald			Candida albicans-derived mannoproteins activate NF-kappa B in reporter cells expressing TLR4, MD2 and CD14	PLOS ONE			English	Article							GENE-EXPRESSION; IMMUNE-RESPONSES; TNF-ALPHA; MONOCLONAL-ANTIBODY; MOLECULAR-PATTERNS; HEPATIC-CLEARANCE; ENDOTHELIAL TLR4; SEROTYPE-B; MANNAN; RECOGNITION	The ability of soluble C. albicans 20A (serotype A) mannoprotein (CMP) to serve as a ligand for toll-like receptor 4 (TLR4) and its co-receptors was examined using commercially available and stably-transfected HEK293 cells that express human TLR4, MD2 and CD14, but not MR. These TLR4 reporter cells also express an NF-kappa B-dependent, secreted embryonic alkaline phosphatase (SEAP) reporter gene. TLR4-reporter cells exhibited a dose-dependent SEAP response to both LPS and CMP, wherein peak activation was achieved after stimulation with 40-50 mu g/mL of CMP. Incubation on polymyxin B resin had no effect on CMP's ligand activity, but neutralized LPS-spiked controls. HEK293 Null cells lacking TLR4 and possessing the same SEAP reporter failed to respond to LPS or CMP, but produced SEAP when activated with TNF alpha. Reporter cell NF-kappa B responses were accompanied by transcription of IL-8, TNF alpha, and COX-2 genes. Celecoxib inhibited LPS-, CMP-, and TNF alpha-dependent NF-kappa B responses; whereas, indomethacin had limited effect on LPS and CMP responses. SEAP production in response to C. albicans A9 mnn4 Delta mutant CMP, lacking phosphomannosylations on N-linked glycans, was significantly greater (p <= 0.005) than SEAP responses to CMP derived from parental A9 (both serotype B). These data confirm that engineered human cells expressing TLR4, MD2 and CD14 can respond to CMP with NF-kappa B activation and the response can be influenced by variations in CMP-mannosylation. Future characterizations of CMPs from other sources and their application in this model may provide further insight into variations observed with TLR4 dependent innate immune responses targeting different C. albicans strains.	[Ness, Traci; Abdallah, Mahmud; Robinson, Rebekah; Sapp, Morgan] Armstrong State Univ, Dept Biol, Savannah, GA USA; [Adams, Jaime; Alvarado, Claudia; Gunn, Edwin; House, Brittany; Lamb, John; Macguire, Jack; Norris, Emily; Sharma, Jill; Garner, Ronald] Mercer Univ, Sch Med, Dept Biomed Sci, Savannah, GA 31404 USA	University System of Georgia; Armstrong Atlantic State University; Mercer University	Garner, R (corresponding author), Mercer Univ, Sch Med, Dept Biomed Sci, Savannah, GA 31404 USA.	garner_re@mercer.edu		Robinson, Rebekah/0000-0001-9234-6209	Mercer University School of Medicine; Armstrong State University; National Science Foundation's STEP Program [DUE-0856593]	Mercer University School of Medicine; Armstrong State University; National Science Foundation's STEP Program	The authors also thank Mercer University School of Medicine (to Ronald Garner) and Armstrong State University (to Traci Ness) for their support through internal funding. The work at Armstrong was further supported by the National Science Foundation's STEP Program under Award No. DUE-0856593 to Traci Ness. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bahri R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/940383; Bates Steven, 2013, BMC Res Notes, V6, P294, DOI 10.1186/1756-0500-6-294; Chanput W, 2010, FOOD FUNCT, V1, P254, DOI 10.1039/c0fo00113a; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Dauphinee SM, 2013, J IMMUNOL, V191, P892, DOI 10.4049/jimmunol.1200583; Dheer R, 2016, INFECT IMMUN, V84, P798, DOI 10.1128/IAI.01374-15; DOMER JE, 1989, INFECT IMMUN, V57, P693, DOI 10.1128/IAI.57.3.693-700.1989; Eggimann P, 2014, INTENS CARE MED, V40, P1429, DOI 10.1007/s00134-014-3355-z; Fernandez N, 2005, J IMMUNOL, V174, P8154, DOI 10.4049/jimmunol.174.12.8154; GARNER RE, 1990, INFECT IMMUN, V58, P2613, DOI 10.1128/IAI.58.8.2613-2620.1990; Garner RE, 1996, INFECT IMMUN, V64, P4561, DOI 10.1128/IAI.64.11.4561-4566.1996; GARNER RE, 1989, INFECT IMMUN, V57, P1800, DOI 10.1128/IAI.57.6.1800-1808.1989; GARNER RE, 1994, J LEUKOCYTE BIOL, V55, P161, DOI 10.1002/jlb.55.2.161; GARNER RE, 1994, INFECT IMMUN, V62, P738, DOI 10.1128/IAI.62.2.738-741.1994; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Gomez PF, 2005, J IMMUNOL, V175, P6924, DOI 10.4049/jimmunol.175.10.6924; Granger BL, 2005, MICROBIOL-SGM, V151, P1631, DOI 10.1099/mic.0.27663-0; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; Iguchi G, 2009, CANCER LETT, V282, P152, DOI 10.1016/j.canlet.2009.03.006; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Jacobs JFM, 2008, J NEURO-ONCOL, V88, P273, DOI 10.1007/s11060-008-9577-6; Johnson MA, 2012, J BIOL CHEM, V287, P18078, DOI 10.1074/jbc.M112.355578; Karki R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073840; Kim SH, 2011, J BIOL CHEM, V286, P8875, DOI 10.1074/jbc.M110.187815; Knopick PL, 2017, METHODS MOL BIOL, V1531, P165, DOI 10.1007/978-1-4939-6649-3_14; Koley D, 2010, P NATL ACAD SCI USA, V107, P16783, DOI 10.1073/pnas.1011614107; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; Kumamoto CA, 2011, CURR OPIN MICROBIOL, V14, P386, DOI 10.1016/j.mib.2011.07.015; Lee S, 2009, BMB REP, V42, P265, DOI 10.5483/BMBRep.2009.42.5.265; Liu HT, 2000, J IMMUNOL, V164, P4277, DOI 10.4049/jimmunol.164.8.4277; Liu L, 2015, J CELL MOL MED, V19, P2728, DOI 10.1111/jcmm.12659; Martinez-Pomares L, 2012, J LEUKOCYTE BIOL, V92, P1177, DOI 10.1189/jlb.0512231; Masuoka J, 1997, MICROBIOL-UK, V143, P3015, DOI 10.1099/00221287-143-9-3015; McKim JM, 2015, FOOD CHEM TOXICOL, V78, P153, DOI 10.1016/j.fct.2015.01.003; Mora-Montes HM, 2010, J BIOL CHEM, V285, P12087, DOI 10.1074/jbc.M109.081513; Muller V, 2007, J IMMUNOL, V179, P8435, DOI 10.4049/jimmunol.179.12.8435; NAKAJIMA T, 1974, J BIOL CHEM, V249, P7679; Netea MG, 2006, CURR PHARM DESIGN, V12, P4195, DOI 10.2174/138161206778743538; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Netea MG, 2010, MED MYCOL, V48, P897, DOI 10.3109/13693781003621575; Ostrosky-Zeichner L, 2007, EUR J CLIN MICROBIOL, V26, P271, DOI 10.1007/s10096-007-0270-z; Piccioni F, 2004, HUM MOL GENET, V13, P437, DOI 10.1093/hmg/ddh045; Pivarcsi A, 2003, INT IMMUNOL, V15, P721, DOI 10.1093/intimm/dxg068; Poligone B, 2001, J BIOL CHEM, V276, P38658, DOI 10.1074/jbc.M106599200; Ranta K, 2012, CLIN VACCINE IMMUNOL, V19, P1889, DOI 10.1128/CVI.00298-12; Rizzetto L, 2010, J IMMUNOL, V184, P4258, DOI 10.4049/jimmunol.0902972; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; SAWYER RT, 1992, INFECT IMMUN, V60, P213, DOI 10.1128/IAI.60.1.213-218.1992; SAWYER RT, 1990, INFECT IMMUN, V58, P2869, DOI 10.1128/IAI.58.9.2869-2874.1990; SAWYER RT, 1992, INFECT IMMUN, V60, P1041, DOI 10.1128/IAI.60.3.1041-1046.1992; Schaller M, 2004, MICROBIOL-SGM, V150, P2807, DOI 10.1099/mic.0.27169-0; SHIBATA N, 1992, INFECT IMMUN, V60, P4100, DOI 10.1128/IAI.60.10.4100-4110.1992; Singleton DR, 2005, EUKARYOT CELL, V4, P639, DOI 10.1128/EC.4.4.639-648.2005; Sorvillo N, 2012, BLOOD, V119, P3828, DOI 10.1182/blood-2011-09-377754; Takada Y, 2004, ONCOGENE, V23, P9247, DOI 10.1038/sj.onc.1208169; Tang AT, 2017, NATURE, V545, P305, DOI 10.1038/nature22075; Teodorowicz M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173778; Ueno K, 2013, MED MYCOL, V51, P385, DOI 10.3109/13693786.2012.733892; Valera I, 2007, J LEUKOCYTE BIOL, V81, P925, DOI 10.1189/jlb.0706451; Visintin A, 2006, J LEUKOCYTE BIOL, V80, P1584, DOI 10.1189/jlb.0606388; Wang Mingfeng, 2013, Evid Based Complement Alternat Med, V2013, P285489, DOI 10.1155/2013/285489; Weindl G, 2007, J CLIN INVEST, V117, P3664, DOI 10.1172/JCI28115; Xin H, 2011, CLIN VACCINE IMMUNOL, V18, P1656, DOI 10.1128/CVI.05215-11; Xu F, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-16; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x	67	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189939	10.1371/journal.pone.0189939	http://dx.doi.org/10.1371/journal.pone.0189939			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281684	Green Published, Green Submitted, gold			2022-12-26	WOS:000419006200053
J	Scaria, PV; Chen, B; Rowe, CG; Jones, DS; Barnafo, E; Fischer, ER; Anderson, C; MacDonald, NJ; Lambert, L; Rausch, KM; Narum, DL; Duffy, PE				Scaria, Puthupparampil V.; Chen, Beth; Rowe, Christopher G.; Jones, David S.; Barnafo, Emma; Fischer, Elizabeth R.; Anderson, Charles; MacDonald, Nicholas J.; Lambert, Lynn; Rausch, Kelly M.; Narum, David L.; Duffy, Patrick E.			Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity	PLOS ONE			English	Article							TRANSMISSION-BLOCKING ACTIVITY; PLASMODIUM-FALCIPARUM; VACCINE CANDIDATE; IMMUNE-RESPONSES; PARTICULATE VACCINES; ANTIBODY-RESPONSES; PFS25; ADJUVANTS; PROGRESS; RTS,S	Chemical conjugation of polysaccharide to carrier proteins has been a successful strategy to generate potent vaccines against bacterial pathogens. We developed a similar approach for poorly immunogenic malaria protein antigens. Our lead candidates in clinical trials are the malaria transmission blocking vaccine antigens, Pfs25 and Pfs230D1, individually conjugated to the carrier protein Exoprotein A (EPA) through thioether chemistry. These conjugates form nanoparticles that show enhanced immunogenicity compared to unconjugated antigens. In this study, we examined the broad applicability of this technology as a vaccine development platform, by comparing the immunogenicity of conjugates prepared by four different chemistries using different malaria antigens (PfCSP, Pfs25 and Pfs230D1), and carriers such as EPA, TT and CRM197. Several conjugates were synthesized using thioether, amide, ADH and glutaraldehyde chemistries, characterized for average molecular weight and molecular weight distribution, and evaluated in mice for humoral immunogenicity. Conjugates made with the different chemistries, or with different carriers, showed no significant difference in immunogenicity towards the conjugated antigens. Since particle size can influence immunogenicity, we tested conjugates with different average size in the range of 16-73 nm diameter, and observed greater immunogenicity of smaller particles, with significant differences between 16 and 73 nm particles. These results demonstrate the multiple options with respect to carriers and chemistries that are available for protein-protein conjugate vaccine development.	[Scaria, Puthupparampil V.; Chen, Beth; Rowe, Christopher G.; Jones, David S.; Barnafo, Emma; Anderson, Charles; MacDonald, Nicholas J.; Lambert, Lynn; Rausch, Kelly M.; Narum, David L.; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20892 USA; [Fischer, Elizabeth R.] NIAID, Em Unit, RTB Rocky Mt Labs, NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Duffy, PE (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20892 USA.	patrick.duffy@nih.gov			National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001008, ZIAAI001224, ZICAI001052, ZIAAI001009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Intramural Research Program of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank J. Patrick Gorres for his assistance in writing and review of this manuscript. This work was supported by the Intramural Research Program of the National Institutes of Health.	Arevalo-Herrera M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119335; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Ballou WR, 2009, PARASITE IMMUNOL, V31, P492, DOI 10.1111/j.1365-3024.2009.01143.x; BARR PJ, 1991, J EXP MED, V174, P1203, DOI 10.1084/jem.174.5.1203; Benne N, 2016, J CONTROL RELEASE, V234, P124, DOI 10.1016/j.jconrel.2016.05.033; CARTER R, 1995, MOL BIOCHEM PARASIT, V71, P203, DOI 10.1016/0166-6851(94)00054-Q; Carter R, 2001, VACCINE, V19, P2309, DOI 10.1016/S0264-410X(00)00521-1; Chowdhury DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006352; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; De Temmerman ML, 2011, DRUG DISCOV TODAY, V16, P569, DOI 10.1016/j.drudis.2011.04.006; Duffy PE, 2012, EXPERT REV VACCINES, V11, P1261, DOI [10.1586/ERV.12.92, 10.1586/erv.12.92]; Gerloff DL, 2005, P NATL ACAD SCI USA, V102, P13598, DOI 10.1073/pnas.0502378102; Goncalves D, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1163-3; Herrera R, 2015, INFECT IMMUN, V83, P3771, DOI 10.1128/IAI.02676-14; Janitzek CM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1574-1; Jones DS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0138761; Jones RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079538; Jones S, 2015, J INFECTION, V71, P117, DOI 10.1016/j.jinf.2015.03.007; Kaba SA, 2009, J IMMUNOL, V183, P7268, DOI 10.4049/jimmunol.0901957; Kapulu MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep11193; Kaslow DC, 2015, VACCINE, V33, P7425, DOI 10.1016/j.vaccine.2015.09.061; KASLOW DC, 1994, INFECT IMMUN, V62, P5576, DOI 10.1128/IAI.62.12.5576-5580.1994; Khan F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142035; Kumar R, 2015, PHARM RES-DORDR, V32, P3827, DOI 10.1007/s11095-015-1743-x; Kumar R, 2015, VACCINE, V33, P5064, DOI 10.1016/j.vaccine.2015.08.025; LENOIR AA, 1987, PEDIATRICS, V80, P283; Li YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18848; MacDonald NJ, 2016, J BIOL CHEM, V291, P19913, DOI 10.1074/jbc.M116.732305; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Miura Kazutoyo, 2016, Expert Rev Vaccines, V15, P765, DOI 10.1586/14760584.2016.1141680; Nunes JK, 2014, VACCINE, V32, P5531, DOI 10.1016/j.vaccine.2014.07.030; Olotu A, 2016, NEW ENGL J MED, V374, P2519, DOI 10.1056/NEJMoa1515257; Outchkourov NS, 2008, P NATL ACAD SCI USA, V105, P4301, DOI 10.1073/pnas.0800459105; Oyewumi MO, 2010, EXPERT REV VACCINES, V9, P1095, DOI 10.1586/ERV.10.89; Pace D, 2007, ARCH DIS CHILD, V92, P909, DOI 10.1136/adc.2006.111500; Perry CM, 2013, DRUGS, V73, P703, DOI 10.1007/s40265-013-0048-9; Pichichero ME, 2013, HUM VACC IMMUNOTHER, V9, P2505, DOI 10.4161/hv.26109; Pitoiset F, 2015, EXPERT REV VACCINES, V14, P913, DOI 10.1586/14760584.2015.1046440; Plosker GL, 2014, PEDIATR DRUGS, V16, P425, DOI 10.1007/s40272-014-0089-x; Przysiecki C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00146; Pusic K, 2013, FASEB J, V27, P1153, DOI 10.1096/fj.12-218362; Qian F, 2007, VACCINE, V25, P3923, DOI 10.1016/j.vaccine.2007.02.073; Qian F, 2009, MICROBES INFECT, V11, P408, DOI 10.1016/j.micinf.2008.12.009; Radtke AJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40312; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI [10.1038/nbt1332, 10.1038/nbtl332]; Richie TL, 2015, VACCINE, V33, P7452, DOI 10.1016/j.vaccine.2015.09.096; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Roeffen W, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0972-0; Schwarz TF, 2009, ADV THER, V26, P983, DOI 10.1007/s12325-009-0079-5; Seth L, 2017, VACCINE, V35, P5448, DOI 10.1016/j.vaccine.2017.02.040; Shimp RL, 2013, VACCINE, V31, P2954, DOI 10.1016/j.vaccine.2013.04.034; Shinefield HR, 2010, VACCINE, V28, P4335, DOI 10.1016/j.vaccine.2010.04.072; SHULER KR, 1992, J IMMUNOL METHODS, V156, P137, DOI 10.1016/0022-1759(92)90020-T; Singh SK, 2015, VACCINE, V33, P1981, DOI 10.1016/j.vaccine.2015.02.040; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Tachibana M, 2011, CLIN VACCINE IMMUNOL, V18, P1343, DOI 10.1128/CVI.05104-11; Talaat KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163144; Thrane S, 2016, J NANOBIOTECHNOL, V14, DOI 10.1186/s12951-016-0181-1; Thrane S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143071; Tsai CW, 2006, J BIOTECHNOL, V121, P458, DOI 10.1016/j.jbiotec.2005.08.025; Whitacre DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124856; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103	62	25	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190312	10.1371/journal.pone.0190312	http://dx.doi.org/10.1371/journal.pone.0190312			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281708	Green Submitted, Green Published, gold			2022-12-26	WOS:000419006200083
J	Li, J; Bao, WM; Zhang, T; Zhou, Y; Yang, H; Jia, HB; Wang, R; Cao, YT; Xiao, C				Li, Jiang; Bao, Weimin; Zhang, Tie; Zhou, Yun; Yang, Hui; Jia, Hongbing; Wang, Rui; Cao, Yongtong; Xiao, Cheng			Independent relationship between serum ferritin levels and dyslipidemia in Chinese adults: A population study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; INSULIN-RESISTANCE; EARLY-PREGNANCY; RISK; WOMEN; INFLAMMATION	Objective Several studies have indicated that elevated levels of circulating ferritin are associated with disturbances in energy metabolism. But none of this gave a clearly pathologic mechanism. We aimed to explore the independent relationship between serum ferritin levels and dyslipidemia. Methods We performed multivariable logistic regression analyses to estimate the odds ratios (ORs) for dyslipidemia, lipid parameters, the homeostasis model assessment of insulin resistance (HOMA-IR) and the risk of diabetes, according to sex-specific quartiles of serum ferritin by using the data of China Health and Nutrition Survey (2009 CHNS). We used three models to estimate the strength of the correlation. The basic model (Model 1) is without adjustment and the Model 2 and Model 3 are adjusted for demographic, anthropometric, and lifestyle confounding factors. Results In both genders, the ORs for high TG level, TC level and LDL-C level increased progressively and for HDL-C decreased across the ferritin quartiles (P<0.001 for trend). After adjustment for confounding factors in different logistic regression models, the results remained unchanged. The ORs for the risk of diabetes and high HOMA-IR level in the highest quartile group of serum ferritin levels were significantly increased in Model 1, but after adjustment for lipid parameters, the ORs for the risk of diabetes was decreased from 1.91 (95% CI: 1.37 +/- 2.67; P<0.001 for trend) to 1.48 (95% CI: 1.03 +/- 2.12; P = 0.036 for trend) in men, and from 5.40 (95% CI: 3.38 +/- 8.63; P<0.001 for trend) to 1.43 (95% CI: 0.83 +/- 2.43; P = 0.498 for trend) in women, and the ORs for IR was decreased from 1.86 (95% CI: 1.57 +/- 2.20; P<0.001 for trend) to 1.25 (95% CI: 1.05 +/- 1.50; P = 0.114 for trend) in men, and from 1.93 (95% CI: 1.63 +/- 2.28; P<0.001 for trend) to 1.24 (95% CI: 1.01 +/- 1.51; P = 0.012 for trend) in women. Conclusion Our results provide evidence that serum ferritin levels are significantly associated with lipid parameters, independent of glucose metabolism disorders and components of metabolic syndrome (MetS). Thus, serum ferritin plays a key role in energy metabolism disorders and may affect glucose metabolism through lipid metabolism.	[Li, Jiang; Zhang, Tie; Zhou, Yun; Yang, Hui; Jia, Hongbing; Cao, Yongtong] China Japan Friendship Hosp, Dept Lab Med, Beijing, Peoples R China; [Bao, Weimin] Community Hlth Serv Ctr Hepingli Dongcheng Dist, Beijing, Peoples R China; [Wang, Rui] Beijing Red Cross Blood Ctr, Blood Screening Lab, Beijing, Peoples R China; [Xiao, Cheng] China Japan Friendship Hosp, Inst Clin Med, Beijing, Peoples R China	China-Japan Friendship Hospital; China-Japan Friendship Hospital	Cao, YT (corresponding author), China Japan Friendship Hosp, Dept Lab Med, Beijing, Peoples R China.; Xiao, C (corresponding author), China Japan Friendship Hosp, Inst Clin Med, Beijing, Peoples R China.	caoyongtong92@sina.com; xc2002812@126.com	Xiao, Cheng/AAM-7764-2020		National Institute for Nutrition and Health; China Center for Disease Control and Prevention; Carolina Population Center [P2C HD050924, T32 HD007168]; University of North Carolina at Chapel Hill; NIH [R01-HD30880, DK056350, R24 HD050924, R01-HD38700]; NIH Fogarty International Center [D43 TW009077, D43 TW007709]; China-Japan Friendship Hospital, Ministry of Health; National Science Foundation of China [81400356, 81373773]; NIH Fogarty International Center; Carolina Population Center	National Institute for Nutrition and Health; China Center for Disease Control and Prevention; Carolina Population Center; University of North Carolina at Chapel Hill; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); China-Japan Friendship Hospital, Ministry of Health; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Carolina Population Center	This research uses data from China Health and Nutrition Survey (CHNS). We thank the National Institute for Nutrition and Health, China Center for Disease Control and Prevention, Carolina Population Center (P2C HD050924, T32 HD007168), the University of North Carolina at Chapel Hill, the NIH (R01-HD30880, DK056350, R24 HD050924, and R01-HD38700) and the NIH Fogarty International Center (D43 TW009077, D43 TW007709) for financial support for the CHNS data collection and analysis files from 1989 to 2015 and future surveys, and the China-Japan Friendship Hospital, Ministry of Health for support for CHNS 2009, Chinese National Human Genome Center at Shanghai since 2009, and Beijing Municipal Center for Disease Prevention and Control since 2011. This study was also supported by the National Science Foundation of China (No. 81400356 and 81373773).; This research uses data from China Health and Nutrition Survey (CHNS). We thank the National Institute for Nutrition and Health, China Center for Disease Control and Prevention, Carolina Population Center, the University of North Carolina at Chapel Hill, and the NIH Fogarty International Center for financial support for the CHNS data collection and analysis files from 1989 to 2015 and future surveys, and the China-Japan Friendship Hospital, Ministry of Health for support for CHNS 2009, Chinese National Human Genome Center at Shanghai since 2009, and Beijing Municipal Center for Disease Prevention and Control since 2011.	Akter S, 2017, J DIABETES INVEST, V8, P462, DOI 10.1111/jdi.12617; Amiri Fatemeh Nasiri, 2013, J Nat Sci Biol Med, V4, P302, DOI 10.4103/0976-9668.116977; Andrews M, 2015, NUTRITION, V31, P51, DOI 10.1016/j.nut.2014.04.019; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 2011, Zhonghua Xue Ye Xue Za Zhi, V32, P572; Ansari Iqra, 2014, Arab J Nephrol Transplant, V7, P13; Aranda N, 2016, EUR J CLIN INVEST, V46, P520, DOI 10.1111/eci.12625; Bao W, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-119; Basuli D, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00117; Bowers KA, 2016, J NUTR, V146, P1756, DOI 10.3945/jn.115.227793; Cnop M, 2008, BIOCHEM SOC T, V36, P348, DOI 10.1042/BST0360348; Jehn ML, 2007, AM J EPIDEMIOL, V165, P1047, DOI 10.1093/aje/kwk093; Jeon Yeon Jin, 2013, Ann Pediatr Endocrinol Metab, V18, P141, DOI 10.6065/apem.2013.18.3.141; Jiang LP, 2010, NEPHRON CLIN PRACT, V114, pC295, DOI 10.1159/000276582; Kang HT, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111058; Karakochuk CD, 2015, J NUTR, V145, P2765, DOI 10.3945/jn.115.218636; Kerner W, 2014, EXP CLIN ENDOCR DIAB, V122, P384, DOI 10.1055/s-0034-1366278; Kim MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148466; Klip IT, 2016, EUR J HEART FAIL; Kunutsor SK, 2013, DIABETES-METAB RES, V29, P308, DOI 10.1002/dmrr.2394; Luan DC, 2008, DIABETES CARE, V31, P285, DOI 10.2337/dc07-0921; Mainous AG, 2009, AM J CARDIOL, V103, P115, DOI 10.1016/j.amjcard.2008.08.046; Nakamura K, 2017, EXP CLIN ENDOCR DIAB, V125, P12, DOI 10.1055/s-0042-118175; Organization WH, 2008, WORLDWIDE PREVALENCE; Parhofer KG, 2015, DIABETES METAB J, V39, P353, DOI 10.4093/dmj.2015.39.5.353; POPKIN BM, 1993, EUR J CLIN NUTR, V47, P333; Popkin BM, 2009, INT J EPIDEMIOLOGY; Qing YF, 2012, RHEUMATOL INT, V32, P2503, DOI 10.1007/s00296-011-1992-x; Seyhan S, 2014, EUR J RHEUMATOL, V1, P92, DOI 10.5152/eurjrheumatol.2014.032; Soheilykhah S, 2017, INT J REPROD BIOMED, V15, P155; Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Tiwari AKM, 2011, CLIN NUTR, V30, P188, DOI 10.1016/j.clnu.2010.08.001; Tudor-Locke C, 2003, INT J OBESITY, V27, P1093, DOI 10.1038/sj.ijo.0802377; Weiss G, 2009, BBA-GEN SUBJECTS, V1790, P682, DOI 10.1016/j.bbagen.2008.08.006; Yadav KS, 2016, J ASSOC PHYSICIAN I, V64, P47; Yang WY, 2012, CIRCULATION, V125, P2212, DOI 10.1161/CIRCULATIONAHA.111.065904; Zandman-Goddard G, 2007, AUTOIMMUN REV, V6, P457, DOI 10.1016/j.autrev.2007.01.016; Zhao S P, 2016, Zhonghua Xin Xue Guan Bing Za Zhi, V44, P827, DOI 10.3760/cma.j.issn.0253-3758.2016.10.003	39	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190310	10.1371/journal.pone.0190310	http://dx.doi.org/10.1371/journal.pone.0190310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272309	Green Submitted, Green Published, gold			2022-12-26	WOS:000418651500050
J	Zhang, J; Zhang, S; Wang, YT; Cheng, H; Hao, LL; Zhai, YH; Zhang, ZR; An, XL; Ma, XL; Zhang, XM; Li, ZY; Tang, B				Zhang, Jian; Zhang, Sheng; Wang, Yutian; Cheng, Hui; Hao, Linlin; Zhai, Yanhui; Zhang, Zhiren; An, Xinglan; Ma, Xiaoling; Zhang, Xueming; Li, Ziyi; Tang, Bo			Effect of TET inhibitor on bovine parthenogenetic embryo development	PLOS ONE			English	Article							NOVO DNA METHYLATION; EARLY MOUSE EMBRYO; GENE-EXPRESSION; MAMMALIAN DNA; STEM-CELLS; 5-HYDROXYMETHYLCYTOSINE; DEMETHYLATION; EMBRYOGENESIS; DIOXYGENASE; REGULATORS	DNA demethylation catalysed by the ten-eleven translocation (TET) protein is an important step during extensive global epigenetic reprogramming in mammals. However, whether TET proteins play a key role in DNA demethylation during the development of bovine pre-implanted embryos is still unclear. In this study, we utilized dimethyloxallyl glycine (DMOG), a small-molecule inhibitor of the TET protein, to impede the enzymatic activity of TET and explore subsequent effects on bovine parthenogenetic embryo development. We first detected the expression of the TET family, consisting of TET1, TET2 and TET3, in bovine MII stage oocytes and found that TET3 is more highly expressed than TET1 and TET2. Treatment with 1 mM DMOG increased 5mC levels (30.4% vs 79.8% at the 8-cell stage for satellite I, 25.3% vs 40.6% at the 8-cell stage for alpha-satellite, 20.5% vs 73.5% at the blastocyst stage for satellite I and 16.6% vs 30.0% at the blastocyst stage for alpha-satellite) at every bovine parthenogenetic embryo developmental stage. At the same time, DNA methylation level of satellite DNA and pluripotency gene promoters increased significantly. Realtime PCR analysis results indicated that the transcription levels of NANOG and OCT-4 decreased in the DMOG-treated group. Furthermore, TET inhibition negatively affected blastocyst formation, resulting in a decline in the blastocyst rate (17.1 +/- 1.3% vs 24.1 +/- 0.6%); however, the percentage of apoptotic cells was significantly increased according to the results of a TUNEL assay. Additionally, expression levels of the apoptosis-related gene BAX were up-regulated, while the expression of BCL-2 was down-regulated. In conclusion, these results support that TET plays important roles in bovine parthenogenetic embryo development by influencing DNA methylation reprogramming, gene expression and apoptosis.	[Zhang, Jian; Wang, Yutian; Cheng, Hui; Zhai, Yanhui; Zhang, Zhiren; Zhang, Xueming; Tang, Bo] Jilin Univ, Coll Vet Med, Changchun, Jilin, Peoples R China; [Zhang, Jian; Zhang, Sheng; An, Xinglan; Ma, Xiaoling; Li, Ziyi] Jilin Univ, Acad Translat Med, Hosp 1, Changchun, Jilin, Peoples R China; [Hao, Linlin] Jilin Univ, Hosp 2, Oncol Dept, Changchun, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Tang, B (corresponding author), Jilin Univ, Coll Vet Med, Changchun, Jilin, Peoples R China.	tang_bo@jlu.edu.cn	MA, XIAO/HHN-5611-2022		Natural Science Foundation of China [31472093]; National Science and Technology Major Projects [2014ZX-08-007-002-008]; PCSIRT [IRT_16R32]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects; PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (31472093) to Bo Tang, PCSIRT (IRT_16R32) to Ziyi Li, and National Science and Technology Major Projects (2014ZX-08-007-002-008) to Ziyi Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from Natural Science Foundation of China (No. 31472093), National Science and Technology Major Projects (No. 2014ZX-08-007-002-008) and PCSIRT (IRT_16R32). We appreciate the help and discussion contributed by other group members in Dr. Li's lab. We would also like to thank slaughterhouse ovary collectors.	Amouroux R, 2016, NAT CELL BIOL, V18, P225, DOI 10.1038/ncb3296; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Cao ZB, 2014, THERIOGENOLOGY, V81, P496, DOI 10.1016/j.theriogenology.2013.10.025; Dai HQ, 2016, NATURE, V538, P528, DOI 10.1038/nature20095; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; De Sousa PA, SOMATIC CELL NUCL TR; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Goissis MD, 2013, CELL REPROGRAM, V15, P24, DOI 10.1089/cell.2012.0055; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Kang J, 2013, CELL RES, V23, P6, DOI 10.1038/cr.2012.117; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Li Y, 2016, REPRODUCTION, V151, P83, DOI 10.1530/REP-15-0207; Liu L, FACTORS AFFECTING EL; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuzaki H, 2015, DEVELOPMENT, V142, P3833, DOI 10.1242/dev.126003; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Neri F, 2015, ONCOGENE, V34, P4168, DOI 10.1038/onc.2014.356; Nguyen NT, SONIC HEDGEHOG IMPRO; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Ozil JP, ACTIVATION RABBIT OO; Page-Lariviere F, 2014, CELL REPROGRAM, V16, P40, DOI 10.1089/cell.2013.0055; Peng M, EXPRESSION GCN5 HDAC; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Salvaing J, ASSESSMENT ONE STEP; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Stice SL, CLONING NEW BREAKTHR; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Zaitseva I, 2007, MOL REPROD DEV, V74, P1255, DOI 10.1002/mrd.20704	33	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189542	10.1371/journal.pone.0189542	http://dx.doi.org/10.1371/journal.pone.0189542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267337	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400033
J	de Lima, ALS; Hahn, T; Evers, LJW; de Vries, NM; Cohen, E; Afek, M; Bataille, L; Daeschler, M; Claes, K; Boroojerdi, B; Terricabras, D; Little, MA; Baldus, H; Bloem, BR; Faber, MJ				Silva de Lima, Ana Ligia; Hahn, Tim; Evers, Luc J. W.; de Vries, Nienke M.; Cohen, Eli; Afek, Michal; Bataille, Lauren; Daeschler, Margaret; Claes, Kasper; Boroojerdi, Babak; Terricabras, Dolors; Little, Max A.; Baldus, Heribert; Bloem, Bastiaan R.; Faber, Marjan J.			Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease	PLOS ONE			English	Article							RATING-SCALE; TRIAL	Wearable devices can capture objective day-to-day data about Parkinson's Disease (PD). This study aims to assess the feasibility of implementing wearable technology to collect data from multiple sensors during the daily lives of PD patients. The Parkinson@home study is an observational, two-cohort (North America, NAM; The Netherlands, NL) study. To recruit participants, different strategies were used between sites. Main enrolment criteria were self-reported diagnosis of PD, possession of a smartphone and age >= 18 years. Participants used the Fox Wearable Companion app on a smartwatch and smartphone for a minimum of 6 weeks (NAM) or 13 weeks (NL). Sensor-derived measures estimated information about movement. Additionally, medication intake and symptoms were collected via self-reports in the app. A total of 953 participants were included (NL: 304, NAM: 649). Enrolment rate was 88% in the NL (n = 304) and 51% (n = 649) in NAM. Overall, 84% (n = 805) of participants contributed sensor data. Participants were compliant for 68% (16.3 hours/participant/day) of the study period in NL and for 62% (14.8 hours/participant/day) in NAM. Daily accelerometer data collection decreased 23% in the NL after 13 weeks, and 27% in NAM after 6 weeks. Data contribution was not affected by demographics, clinical characteristics or attitude towards technology, but was by the platform usability score in the NL (chi(2) (2) = 32.014, p<0.001), and self-reported depression in NAM (chi(2) (2) = 6.397, p = .04). The Parkinson@home study shows that it is feasible to collect objective data using multiple wearable sensors in PD during daily life in a large cohort.	[Silva de Lima, Ana Ligia; Hahn, Tim; Evers, Luc J. W.; de Vries, Nienke M.; Bloem, Bastiaan R.; Faber, Marjan J.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Neurol, Med Ctr, Nijmegen, Netherlands; [Silva de Lima, Ana Ligia] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Cohen, Eli; Afek, Michal] Intel, Adv Analyt, Tel Aviv, Israel; [Bataille, Lauren; Daeschler, Margaret] Michael J Fox Fdn Parkinsons Res, New York, NY USA; [Claes, Kasper; Boroojerdi, Babak; Terricabras, Dolors] UCB Biopharma, Brussels, Belgium; [Little, Max A.] Aston Univ, Birmingham, W Midlands, England; [Little, Max A.] MIT, Media Lab, Cambridge, MA 02139 USA; [Baldus, Heribert] Philips Res, Dept Personal Hlth, Eindhoven, Netherlands; [Faber, Marjan J.] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Sci Ctr Qual Healthcare, Med Ctr, Nijmegen, Netherlands	Radboud University Nijmegen; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Intel Corporation; Aston University; Massachusetts Institute of Technology (MIT); Philips; Philips Research; Radboud University Nijmegen	de Lima, ALS (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Neurol, Med Ctr, Nijmegen, Netherlands.; de Lima, ALS (corresponding author), Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil.	ana.silvadelima@radboudumc.nl	Meinders, Marjan J/L-4302-2015; Bloem, Bastiaan/H-8013-2014; de Vries, Nienke M./B-7010-2018; Evers, Luc J.W./D-2008-2017; Evers, Luc/ABE-1976-2021	Meinders, Marjan J/0000-0001-6491-7035; Bloem, Bastiaan/0000-0002-6371-3337; de Vries, Nienke M./0000-0002-1972-2703; Evers, Luc J.W./0000-0002-8241-5087; Evers, Luc/0000-0002-8241-5087; Silva de Lima, Ana Ligia/0000-0002-0948-9290	Michael J Fox Foundation; Intel Corporation [10231.01]; Stichting Parkinson Fonds; Netherlands Organisation for Health Research and Development; Philips Research; UCB pharma; Movement Disorders Society; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES [0428-140]; Parkinson&quot;s UK [J-0901, J-1403] Funding Source: researchfish	Michael J Fox Foundation; Intel Corporation(Intel Corporation); Stichting Parkinson Fonds; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Philips Research; UCB pharma(UCB Pharma SA); Movement Disorders Society; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was gratefully supported by the Michael J Fox Foundation (https://www.michaeljfox.org/), Intel Corporation (Tel Aviv, Israel-https://www.intel.com) [grant number 10231.01], the Stichting Parkinson Fonds (https://www.parkinsonfonds.nl/), The Netherlands Organisation for Health Research and Development (https://www.zonmw.nl/en/), Philips Research (https://www.philips.com/aw/research/home.html), UCB pharma (http://www.ucb.com/), and the Movement Disorders Society (https://www.movementdisorders.org/MDS.htm). The author Ana Ligia Silva de Lima is supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES (http://www.capes.gov.br/) [grant number 0428-140]. The Michael J Fox Foundation was involved in the data collection, interpretation of the data in the NAM cohort and manuscript revision. The funder Intel Corporation provided support in the form of salaries for authors EC and MA, participated in study design, data collection and writing the report. The founders Philips Research and UCB pharma provided support in the form of salaries for authors [Philips Research: HB; UCB pharma: KC, BB and DT] and participated in writing the report, but did not have any additional role in the study design, data collection and analysis or decision to publish. The specific roles of these authors are articulated in the Author contributions section. All other sponsors did not have any role in study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.	[Anonymous], 2016, PARKINSONS DIS, DOI DOI 10.21037/MHEALTH.2016.04.02; [Anonymous], 2015, TELECOMPAPER    0619, P2015; Arora S, 2015, PARKINSONISM RELAT D, V21, P650, DOI 10.1016/j.parkreldis.2015.02.026; Bangor A, 2009, J USABILITY STUD, V4, P114; Bloem BR, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1838; Bot BM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.11; Brannon EE, 2016, TRANSL BEHAV MED, V6, P558, DOI 10.1007/s13142-016-0442-4; Brooke J., 1996, USABILITY EVALUATION, V189, P4; CUTSON TM, 1995, PHYS THER, V75, P363, DOI 10.1093/ptj/75.5.363; de Lau LML, 2004, NEUROLOGY, V63, P1240, DOI 10.1212/01.WNL.0000140706.52798.BE; de Lima ALS, 2016, JMIR RES PROTOCOLS, V5; Espay AJ, 2016, MOVEMENT DISORD, V31, P1272, DOI 10.1002/mds.26642; Etter JF, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e2; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; Farvolden Peter, 2005, J Med Internet Res, V7, pe7, DOI 10.2196/jmir.7.1.e7; Ferreira JJ, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0343-z; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Giugni JC, 2014, CURR OPIN NEUROL, V27, P450, DOI 10.1097/WCO.0000000000000118; Goetz CG, 2005, MOVEMENT DISORD, V20, P523, DOI 10.1002/mds.20464; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Griffiths RI, 2012, J PARKINSON DIS, V2, P47, DOI 10.3233/JPD-2012-11071; Hauser RA, 2004, MOVEMENT DISORD, V19, P1409, DOI 10.1002/mds.20248; Heusinkveld L, 2017, J PARKINSON DIS, V7, P89, DOI 10.3233/JPD-161031; Hobert MA, 2014, ACTA NEUROL SCAND, V130, P139, DOI 10.1111/ane.12248; Hoops S, 2009, NEUROLOGY, V73, P1738, DOI 10.1212/WNL.0b013e3181c34b47; Keus SH., 2014, EUROPEAN PHYSIOTHERA; Lakshminarayana Rashmi, 2014, Trials, V15, P374, DOI 10.1186/1745-6215-15-374; Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530; Maetzler W, 2013, MOVEMENT DISORD, V28, P1628, DOI 10.1002/mds.25628; Marek K, 2011, PROG NEUROBIOL, V95, P629, DOI 10.1016/j.pneurobio.2011.09.005; Mehanna R, 2013, TRANSL NEURODEGENER, V2, DOI 10.1186/2047-9158-2-22; Mera TO, 2012, J NEUROSCI METH, V203, P152, DOI 10.1016/j.jneumeth.2011.09.019; Meunier CC, 2012, MOVEMENT DISORD, V27, pE2; Patel S, 2011, IEEE ENG MED BIO, P1552, DOI 10.1109/IEMBS.2011.6090452; Patel S, 2009, IEEE T INF TECHNOL B, V13, P864, DOI 10.1109/TITB.2009.2033471; Rose, 2000, HDB PSYCHIAT MEASURE, P544; Schwab R, 1969, 3 S PARK DIS ED GILL; Sharma V, 2014, INT C DES US EXP US; Sullivan W., 2015, TRENDS TUESDAY 186 3; Tsanas Athanasios, 2012, IEEE T BIOMEDICAL EN; Tzallas AT, 2014, SENSORS-BASEL, V14, P21329, DOI 10.3390/s141121329; Zhan A., 2016, ARXIV160100960	42	72	73	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189161	10.1371/journal.pone.0189161	http://dx.doi.org/10.1371/journal.pone.0189161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261709	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000418564200033
J	Ershadi, NY				Yaghoobi Ershadi, Nastaran			Improving vehicle tracking rate and speed estimation in dusty and snowy weather conditions with a vibrating camera	PLOS ONE			English	Article								Traffic surveillance systems are interesting to many researchers to improve the traffic control and reduce the risk caused by accidents. In this area, many published works are only concerned about vehicle detection in normal conditions. The camera may vibrate due to wind or bridge movement. Detection and tracking of vehicles is a very difficult task when we have bad weather conditions in winter (snowy, rainy, windy, etc.), dusty weather in arid and semi-arid regions, at night, etc. Also, it is very important to consider speed of vehicles in the complicated weather condition. In this paper, we improved our method to track and count vehicles in dusty weather with vibrating camera. For this purpose, we used a background subtraction based strategy mixed with an extra processing to segment vehicles. In this paper, the extra processing included the analysis of the headlight size, location, and area. In our work, tracking was done between consecutive frames via a generalized particle filter to detect the vehicle and pair the headlights using the connected component analysis. So, vehicle counting was performed based on the pairing result, with Centroid of each blob we calculated distance between two frames by simple formula and hence dividing it by the time between two frames obtained from the video. Our proposed method was tested on several video surveillance records in different conditions such as dusty or foggy weather, vibrating camera, and in roads with medium-level traffic volumes. The results showed that the new proposed method performed better than our previously published method and other methods, including the Kalman filter or Gaussian model, in different traffic conditions.	[Yaghoobi Ershadi, Nastaran] Univ Politecn Madrid, ETS Ingenieros Telecomunicac, Madrid, Spain	Universidad Politecnica de Madrid; ETS de Ingenieros de Telecomunicacion	Ershadi, NY (corresponding author), Univ Politecn Madrid, ETS Ingenieros Telecomunicac, Madrid, Spain.	n.yaghoobi@alumnos.upm.es	Yaghoobi Ershadi, Nastaran/H-8372-2017	Yaghoobi Ershadi, Nastaran/0000-0002-1112-2068				Afolabi D, 2015, J VIBROENG, V17, P655; Chan YM, 2012, IET INTELL TRANSP SY, V6, P1, DOI 10.1049/iet-its.2011.0019; Du W, 2005, AVSS 2005: ADVANCED VIDEO AND SIGNAL BASED SURVEILLANCE, PROCEEDINGS, P165; Ikoma Norikazu, 2014, 2014 World Automation Congress (WAC), P279, DOI 10.1109/WAC.2014.6935890; Ilyas A, 2009, AVSS: 2009 6TH IEEE INTERNATIONAL CONFERENCE ON ADVANCED VIDEO AND SIGNAL BASED SURVEILLANCE, P454, DOI 10.1109/AVSS.2009.85; Li H, 2014, 2014 7TH INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING (CISP 2014), P27, DOI 10.1109/CISP.2014.7003744; Litzenberger M, 2006, 2006 IEEE 12TH DIGITAL SIGNAL PROCESSING WORKSHOP & 4TH IEEE SIGNAL PROCESSING EDUCATION WORKSHOP, VOLS 1 AND 2, P173, DOI 10.1109/DSPWS.2006.265448; Meng Cao, 2007, 2007 IEEE Intelligent Transportation Systems Conference, P648; Meshram S. A., 2015, INT J INNOVATIVE SCI, V2; Sun ZH, 2006, IEEE T PATTERN ANAL, V28, P694, DOI 10.1109/TPAMI.2006.104; Sun ZH, 2002, DSP 2002: 14TH INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING PROCEEDINGS, VOLS 1 AND 2, P1019, DOI 10.1109/ICDSP.2002.1028263; Tripathi J., 2015, INT J INNOVATIVE EME, V2; Ershadi NY, 2017, J SENSORS, V2017, DOI 10.1155/2017/3812301; Yang CJ, 2005, IEEE I CONF COMP VIS, P212; Zhang GH, 2007, TRANSPORT RES REC, P138, DOI 10.3141/1993-19	15	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189145	10.1371/journal.pone.0189145	http://dx.doi.org/10.1371/journal.pone.0189145			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261719	Green Published, gold			2022-12-26	WOS:000418564200031
J	Bydlon, TM; Langhout, GC; Lalezari, F; Hartemink, KJ; Nijkamp, J; de Koning, SGB; Burgers, S; Hendriks, BHW; Ruers, TJM				Bydlon, Torre M.; Langhout, Gerrit C.; Lalezari, Ferry; Hartemink, Koen J.; Nijkamp, Jasper; de Koning, Susan G. Brouwer; Burgers, Sjaak; Hendriks, Benno H. W.; Ruers, Theodoor J. M.			Optimal endobronchial tool sizes for targeting lung lesions based on 3D modeling	PLOS ONE			English	Article							OPTICAL SPECTROSCOPY; DIFFUSE-REFLECTANCE; DIAGNOSTIC YIELD; VIVO DIAGNOSIS; CANCER; TOMOGRAPHY; BRONCHOSCOPY; ULTRASOUND; GUIDANCE; DESIGN	Background For patients with suspicious lung lesions found on chest x-ray or CT, endo/trans-bronchial biopsy of the lung is the preferred method for obtaining a diagnosis. With the addition of new screening programs, a higher number of patients will require diagnostic biopsy which will prove even more challenging due to the small size of lesions found with screening. There are many endobronchial tools available on the market today and a wide range of new tools under investigation to improve diagnostic yield. However, there is little information available about the optimal tool size required to reach the majority of lesions, especially peripheral ones. In this manuscript we investigate the percentage of lesions that can be reached for various diameter tools if the tools remain inside the airways (i.e. endobronchial biopsy) and the distance a tool must travel "off-road" (or outside of the airways) to reach all lesions. Methods and findings To further understand the distribution of lung lesions with respect to airway sizes and distances from the airways, six 3D models of the lung were generated. The airways were modeled at two different respiratory phases (inspiration and expiration). Three sets of 1,000 lesions were randomly distributed throughout the lung for each respiratory phase. The simulations showed that the percentage of reachable lesions decreases with increasing tool diameter and decreasing lesion diameter. A 1mm diameter tool will reach < 25% of 1cm lesions if it remains inside the airways. To reach all 1cm lesions this 1mm tool would have to navigate through the parenchyma up to 8.5mm. CT scans of 21 patient lesions confirm these results reasonably well. Conclusions The smaller the tool diameter the more likely it will be able to reach a lung lesion, whether it be for diagnostic biopsy, ablation, or resection. However, even a 1mm tool is not small enough to reach the majority of small (1-2cm) lesions. Therefore, it is necessary for endobronchial tools to be able to navigate through the parenchyma to reach the majority of lesions.	[Bydlon, Torre M.] Philips Res, 2 Canal Pk,Third Floor, Cambridge, MA USA; [Bydlon, Torre M.; Hendriks, Benno H. W.] Philips Res, High Tech Campus 34, Ae Eindhoven, Netherlands; [Langhout, Gerrit C.; Hartemink, Koen J.; Nijkamp, Jasper; de Koning, Susan G. Brouwer; Ruers, Theodoor J. M.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Surg, Plesmanlaan 121, Amsterdam, Netherlands; [Lalezari, Ferry] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiol, Plesmanlaan 121, Amsterdam, Netherlands; [Burgers, Sjaak] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Thorac Oncol, Plesmanlaan 121, Amsterdam, Netherlands; [Hendriks, Benno H. W.] Delft Univ Technol, Biomech Engn Dept, Mekelweg 2, Cd Delft, Netherlands; [Ruers, Theodoor J. M.] Univ Twente, MIRA Inst, Enschede, Netherlands	Philips; Philips Research; Philips; Philips Research; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Delft University of Technology; University of Twente	Bydlon, TM (corresponding author), Philips Res, 2 Canal Pk,Third Floor, Cambridge, MA USA.; Bydlon, TM (corresponding author), Philips Res, High Tech Campus 34, Ae Eindhoven, Netherlands.	Torre.Bydlon@philips.com		Nijkamp, Jasper/0000-0001-7523-5881; Hartemink, Koen/0000-0003-4282-1096	Philips Research	Philips Research	The authors received no specific funding for this work. TMB and BHWH are employees of Philips Research. The funder [Philips Research] provided support in the form of salaries for authors [TMB and BHWH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aerts JGJV, 2007, LUNG CANCER, V57, P317, DOI 10.1016/j.lungcan.2007.03.023; Amelink A, 2004, OPT LETT, V29, P1087, DOI 10.1364/OL.29.001087; Bard MPL, 2006, CHEST, V129, P995, DOI 10.1378/chest.129.4.995; Bard MPL, 2005, AM J RESP CRIT CARE, V171, P1178, DOI 10.1164/rccm.200501-046OC; Chen A, 2015, CHEST, V147, P1275, DOI 10.1378/chest.14-1425; Dooms C, 2013, EUR RESPIR REV, V22, P169, DOI 10.1183/09059180.00001113; Evers DJ, 2012, CLIN LUNG CANCER, V13, P424, DOI 10.1016/j.cllc.2012.02.001; Fawzy YS, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2337529; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Gilbert C, 2014, RESPIROLOGY, V19, P636, DOI 10.1111/resp.12301; Hariri LP, 2015, ANN AM THORAC SOC, V12, P193, DOI 10.1513/AnnalsATS.201408-370OC; Hariri LP, 2013, CHEST, V144, P1261, DOI 10.1378/chest.13-0534; Hariri LP, 2013, AM J RESP CRIT CARE, V187, P125, DOI 10.1164/rccm.201208-1483OE; Hariri LP, 2012, ARCH PATHOL LAB MED, V136, P1492, DOI 10.5858/arpa.2012-0252-SA; Horeweg N, 2014, LANCET ONCOL; Horeweg N, 2013, EUR RESPIR J, V42, P1659, DOI 10.1183/09031936.00197712; Horeweg N, 2013, AM J RESP CRIT CARE, V188, P1035, DOI 10.1164/rccm.201305-0935LE; Horeweg N, 2013, AM J RESP CRIT CARE, V187, P848, DOI 10.1164/rccm.201209-1651OC; Huang ZW, 2003, INT J CANCER, V107, P1047, DOI 10.1002/ijc.11500; Ishida T, 2011, THORAX, V66, P1072, DOI 10.1136/thx.2010.145490; Kitaoka H, 1999, J APPL PHYSIOL, V87, P2207, DOI 10.1152/jappl.1999.87.6.2207; Lee KA, 2014, LUNG CANCER MANAG, V3, P135, DOI 10.2217/LMT.14.5; Magee ND, 2009, J PHYS CHEM B, V113, P8137, DOI 10.1021/jp900379w; Mahajan AK, 2011, J BRONCHOL INTERN PU, V18, P133, DOI 10.1097/LBR.0b013e318216cee6; Mazzone P, 2002, CLIN CHEST MED, V23, P137, DOI 10.1016/S0272-5231(03)00065-0; Mazzone P, 2012, CLEV CLIN J MED, V79, P337, DOI 10.3949/ccjm.79a.12018; Midthun D, 2014, OVERVIEW INITIAL EVA; Ofiara LM, 2012, CURR ONCOL, V19, pS16, DOI 10.3747/co.19.1062; Oudkerk M, 2013, JBR-BTR, V96, P163, DOI 10.5334/jbr-btr.240; Pedersen JH, 2009, J THORAC ONCOL, V4, P608, DOI 10.1097/JTO.0b013e3181a0d98f; Ru Zhao Ying, 2011, Cancer Imaging, V11 Spec No A, pS79, DOI 10.1102/1470-7330.2011.9020; Seijo LM, 2010, CHEST, V138, P1316, DOI 10.1378/chest.09-2708; Short MA, 2008, OPT LETT, V33, P711, DOI 10.1364/OL.33.000711; Spliethoff JW, 2013, LUNG CANCER, V80, P165, DOI 10.1016/j.lungcan.2013.01.016; Tan KM, 2012, BIOMED OPT EXPRESS, V3, P1947, DOI 10.1364/BOE.3.001947; Zeng HS, 2004, PHOTODIAGN PHOTODYN, V1, P111, DOI 10.1016/S1572-1000(04)00042-0	37	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189963	10.1371/journal.pone.0189963	http://dx.doi.org/10.1371/journal.pone.0189963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261769	Green Published, gold, Green Submitted			2022-12-26	WOS:000418554900044
J	Eich, G; Bartosova, M; Tischer, C; Wlodkowski, TT; Schaefer, B; Pichl, S; Kraewer, N; Ranchin, B; Vondrak, K; Liebau, MC; Hackert, T; Schmitt, CP				Eich, Gwendolyn; Bartosova, Maria; Tischer, Christian; Wlodkowski, Tanja Tamara; Schaefer, Betti; Pichl, Sebastian; Kraewer, Nicole; Ranchin, Bruno; Vondrak, Karel; Liebau, Max Christoph; Hackert, Thilo; Schmitt, Claus Peter			Bicarbonate buffered peritoneal dialysis fluid upregulates angiopoietin-1 and promotes vessel maturation	PLOS ONE			English	Article							MESOTHELIAL CELLS; INDUCED ANGIOGENESIS; MEMBRANE; GLUCOSE; TRANSPORT; CHILDREN; LACTATE; MODEL	Background Ultrafiltration decline is a progressive issue for patients on chronic peritoneal dialysis (PD) and can be caused by peritoneal angiogenesis induced by PD fluids. A recent pediatric trial suggests better preservation of ultrafiltration with bicarbonate versus lactate buffered fluid; underlying molecular mechanisms are unknown. Methods Angiogenic cytokine profile, tube formation capacity and Receptor Tyrosine Kinase translocation were assessed in primary human umbilical vein endothelial cells following incubation with bicarbonate (BPDF) and lactate buffered (LPDF), pH neutral PD fluid with low glucose degradation product content and lactate buffered, acidic PD fluid with high glucose degradation product content (CPDF). Peritoneal biopsies from age-, PD-vintage- and dialytic glucose exposure matched, peritonitis-free children on chronic PD underwent automated histomorphometry and immunohistochemistry. Results In endothelial cells angiopoietin-1 mRNA and protein abundance increased 200% upon incubation with BPDF, but decreased by 70% with LPDF as compared to medium control; angiopoietin-2 remained unchanged. Angiopoietin-1/Angiopoietin-2 protein ratio was 15 and 3-fold increased with BPDF compared to LPDF and medium. Time-lapse microscopy with automated network analysis demonstrated less endothelial cell tube formation with BPDF compared to LPDF and CPDF incubation. Receptor Tyrosine Kinase translocated to the cell membrane in BPDF but not in LPDF or CPDF incubated endothelial cells. In children dialyzed with BPDF peritoneal vessels were larger and angiopoietin-1 abundance in CD31 positive endothelium higher compared to children treated with LPDF. Conclusion Bicarbonate buffered PD fluid promotes vessel maturation via upregulation of angiopoietin-1 in vitro and in children on dialysis. Our findings suggest a molecular mechanism for the observed superior preservation of ultrafiltration capacity with bicarbonate buffered PD fluid with low glucose degradation product content.	[Eich, Gwendolyn; Bartosova, Maria; Wlodkowski, Tanja Tamara; Schaefer, Betti; Pichl, Sebastian; Kraewer, Nicole; Schmitt, Claus Peter] Univ Hosp Heidelberg, Ctr Pediat & Adolescent Med, Heidelberg, Germany; [Tischer, Christian] European Mol Biol Lab, Heidelberg, Germany; [Ranchin, Bruno] Hosp Civils Lyon, Hop Femme Mere Enfant, Serv Nephrol Pediat, Lyon, France; [Vondrak, Karel] Univ Hosp Motol, Dept Pediat, Prague, Czech Republic; [Liebau, Max Christoph] Univ Hosp Cologne, Dept Pediat, Pediat Nephrol, Cologne, Germany; [Liebau, Max Christoph] Univ Hosp Cologne, Ctr Mol Med, Cologne, Germany; [Hackert, Thilo] Univ Hosp Heidelberg, Dept Surg, Heidelberg, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); CHU Lyon; Motol University Hospital; University of Cologne; University of Cologne; Ruprecht Karls University Heidelberg	Schmitt, CP (corresponding author), Univ Hosp Heidelberg, Ctr Pediat & Adolescent Med, Heidelberg, Germany.	claus.peter.schmitt@med.uni-heidelberg.de	Liebau, Max Christoph/K-3470-2019	Liebau, Max Christoph/0000-0003-0494-9080	European Training and Research in Peritoneal Dialysis Programme - European Union [287813]; Fresenius Medical Care; Amgen	European Training and Research in Peritoneal Dialysis Programme - European Union; Fresenius Medical Care; Amgen(Amgen)	The study was supported by the European Training and Research in Peritoneal Dialysis Programme, funded by the European Union within the Marie Curie Scheme (287813). http://www.eutripd.eu (Maria Bartosova). Claus Peter Schmitt obtained lecturing and consulting honoraria (Baxter, Fresenius Medical Care) and financial research support (Fresenius Medical Care, Amgen). The other authors have declared that no competing interests exist.	Albrektsson A, 2006, ASAIO J, V52, P276, DOI 10.1097/01.mat.0000219065.26807.27; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Borzych D, 2011, CLIN J AM SOC NEPHRO, V6, P1934, DOI 10.2215/CJN.11411210; Buchel J, 2015, PERITON DIALYSIS INT, V35, P259, DOI 10.3747/pdi.2013.00010; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen YT, 2014, J AM SOC NEPHROL, V25, P2847, DOI 10.1681/ASN.2013101079; Cooker LA, 2001, PERITON DIALYSIS INT, V21, pS102; Davies SJ, 1998, KIDNEY INT, V54, P2207, DOI 10.1046/j.1523-1755.1998.00180.x; Davies SJ, 2001, J AM SOC NEPHROL, V12, P1046, DOI 10.1681/ASN.V1251046; Deramaudt BMJM, 1998, J CELL BIOCHEM, V68, P121, DOI 10.1002/(SICI)1097-4644(19980101)68:1<121::AID-JCB12>3.0.CO;2-K; Eklund L, 2013, EXP CELL RES, V319, P1271, DOI 10.1016/j.yexcr.2013.03.011; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Fagiani E, 2013, CANCER LETT, V328, P18, DOI 10.1016/j.canlet.2012.08.018; Flessner M, 2003, PERITON DIALYSIS INT, V23, P542; Forster B, 2004, MICROSC RES TECHNIQ, V65, P33, DOI 10.1002/jemt.20092; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Grossin N, 2006, PERITON DIALYSIS INT, V26, P664; Inagi R, 1999, FEBS LETT, V463, P260, DOI 10.1016/S0014-5793(99)01642-7; Johnson DW, 2012, J AM SOC NEPHROL, V23, P1097, DOI 10.1681/ASN.2011121201; Korhonen EA, 2016, J CLIN INVEST, V126, P3495, DOI 10.1172/JCI84923; Margetts PJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133721; Plum J, 2001, AM J KIDNEY DIS, V38, P867, DOI 10.1053/ajkd.2001.27709; Rippe B, 2001, KIDNEY INT, V59, P348, DOI 10.1046/j.1523-1755.2001.00497.x; Rippe B, 2007, AM J PHYSIOL-RENAL, V292, pF1035, DOI 10.1152/ajprenal.00251.2006; Schaefer B, 2016, SCI REP-UK, V6, DOI 10.1038/srep21344; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmitt CP, 2013, CLIN J AM SOC NEPHRO, V8, P108, DOI 10.2215/CJN.00690112; STYLIANOU E, 1990, KIDNEY INT, V37, P1563, DOI 10.1038/ki.1990.150; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Williams JD, 2004, KIDNEY INT, V66, P408, DOI 10.1111/j.1523-1755.2004.00747.x; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Zhai YH, 2012, PEDIATR NEPHROL, V27, P1165, DOI 10.1007/s00467-012-2120-1	33	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189903	10.1371/journal.pone.0189903	http://dx.doi.org/10.1371/journal.pone.0189903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253861	Green Submitted, Green Published, gold			2022-12-26	WOS:000418389500073
J	Gallego-Jara, J; Conesa, AE; Puente, TD; Terol, GL; Diaz, MC				Gallego-Jara, Julia; Ecija Conesa, Ana; de Diego Puente, Teresa; Lozano Terol, Gema; Canovas Diaz, Manuel			Characterization of CobB kinetics and inhibition by nicotinamide	PLOS ONE			English	Article							ACETYL-COA SYNTHETASE; LYSINE ACETYLATION; ESCHERICHIA-COLI; STRUCTURAL BASIS; RESPONSE REGULATOR; SUBSTRATE-SPECIFICITY; PROTEIN ACETYLATION; BASE-EXCHANGE; YEAST SIR2; DEACETYLASE	Lysine acetylation has emerged as a global protein regulation system in all domains of life. Sirtuins, or Sir2-like enzymes, are a family of histone deacetylases characterized by their employing NAD(+) as a co-substrate. Sirtuins can deacetylate several acetylated proteins, but a consensus substrate recognition sequence has not yet been established. Product inhibition of many eukaryotic sirtuins by nicotinamide and its analogues has been studied in vitro due to their potential role as anticancer agents. In this work, the kinetics of CobB, the main Escherichia coli deacetylase, have been characterized. To our knowledge, this is the first kinetic characterization of a sirtuin employing a fully acetylated and natively folded protein as a substrate. CobB deacetylated several acetyl-CoA synthetase acetylated lysines with a single kinetic rate. In addition, in vitro nicotinamide inhibition of CobB has been characterized, and the intracellular nicotinamide concentrations have been determined under different growth conditions. The results suggest that nicotinamide can act as a CobB regulator in vivo. A nicotinamidase deletion strain was thus phenotypically characterized, and it behaved similarly to the Delta cobB strain. The results of this work demonstrate the potential regulatory role of the nicotinamide metabolite in vivo.	[Gallego-Jara, Julia; Ecija Conesa, Ana; de Diego Puente, Teresa; Lozano Terol, Gema; Canovas Diaz, Manuel] Univ Murcia, Fac Chem, Dept Biochem & Mol Biol & Immunol B, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain	University of Murcia	Gallego-Jara, J (corresponding author), Univ Murcia, Fac Chem, Dept Biochem & Mol Biol & Immunol B, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain.	julia.gallego@um.es	de Diego, Teresa/N-9215-2013; Aithani, Anchal/AGX-7498-2022; , Julia/ABH-6754-2020; Gallego, Julia/H-2395-2017; de Diego, Teresa/ABH-4509-2020; Canovas, Manuel/K-3860-2014	de Diego, Teresa/0000-0003-3501-5483; Aithani, Anchal/0000-0003-1260-2554; , Julia/0000-0002-6680-359X; Gallego, Julia/0000-0002-6680-359X; de Diego, Teresa/0000-0003-3501-5483; Canovas, Manuel/0000-0003-3254-1736	Ministerio de Industria, Economia y Competitividad (ERDF European) (Espana) [BIO2014-54411-C2-1-R]; Fundacion Seneca (CARM, Murcia, Espana) [19236/PI/14]; Fundacion Seneca (CARM, Murcia)	Ministerio de Industria, Economia y Competitividad (ERDF European) (Espana); Fundacion Seneca (CARM, Murcia, Espana)(Fundacion Seneca); Fundacion Seneca (CARM, Murcia)(Fundacion Seneca)	This work was supported Ministerio de Industria, Economia y Competitividad (which includes ERDF European co-funding) (Espana) (http://www.mineco.gob.es/portal/site/mineco/), Grant number: BIO2014-54411-C2-1-R to MCD and Fundacion Seneca (CARM, Murcia, Espana) (https://fseneca.es/#), Grant number: 19236/PI/14 to MCD. JG and AE are recipients of a PhD fellowship from Fundacion Seneca (CARM, Murcia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouElfetouh A, 2015, MICROBIOLOGYOPEN, V4, P66, DOI 10.1002/mbo3.223; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Baeza J, 2014, J BIOL CHEM, V289, P21326, DOI 10.1074/jbc.M114.581843; Barak R, 2004, J MOL BIOL, V342, P383, DOI 10.1016/j.jmb.2004.07.020; Baron S, 2017, FEBS LETT, V591, P1958, DOI 10.1002/1873-3468.12699; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Bernal V, 2014, NEW BIOTECHNOL, V31, P586, DOI 10.1016/j.nbt.2014.03.002; Bheda P, 2016, ANNU REV BIOCHEM, V85, P405, DOI 10.1146/annurev-biochem-060815-014537; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blander G, 2005, J BIOL CHEM, V280, P9780, DOI 10.1074/jbc.M414080200; Castano-Cerezo S, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145227; Christensen DG, 2017, APPL ENVIRON MICROB, V83, P1; Cosgrove MS, 2006, BIOCHEMISTRY-US, V45, P7511, DOI 10.1021/bi0526332; Crosby HA, 2010, MOL MICROBIOL, V76, P874, DOI 10.1111/j.1365-2958.2010.07127.x; Puente TD, 2015, J BIOL CHEM, V290, P23077, DOI 10.1074/jbc.M115.649806; Duportet X, 2012, METABOLOMICS, V8, P410, DOI 10.1007/s11306-011-0324-1; Feldman JL, 2015, BIOCHEMISTRY-US, V54, P3037, DOI 10.1021/acs.biochem.5b00150; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Fischer F., 2012, PLOS ONE, V7; French JB, 2010, BIOCHEMISTRY-US, V49, P10421, DOI 10.1021/bi1012518; Friedmann DR, 2013, FEBS J, V280, P5570, DOI 10.1111/febs.12373; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gardner JG, 2009, J BACTERIOL, V191, P1749, DOI 10.1128/JB.01674-08; Garske AL, 2006, BIOCHEMISTRY-US, V45, P94, DOI 10.1021/bi052015l; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guan X, 2014, PLOS ONE, V9; Guarente L, 2013, METHODS MOL BIOL, V1077, P3, DOI 10.1007/978-1-62703-637-5_1; Gurard-Levin ZA, 2010, ACS CHEM BIOL, V5, P863, DOI 10.1021/cb100088g; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HAGINO Y, 1968, J BIOL CHEM, V243, P4980; Hayden JD, 2013, MICROBIOL-SGM, V159, P1986, DOI 10.1099/mic.0.068585-0; Hentchel KL, 2015, MICROBIOL MOL BIOL R, V79, P321, DOI 10.1128/MMBR.00020-15; Horswill AR, 2002, BIOCHEMISTRY-US, V41, P2379, DOI 10.1021/bi015647q; HOSHINO J, 1984, BIOCHIM BIOPHYS ACTA, V801, P250, DOI 10.1016/0304-4165(84)90074-6; Hu LDI, 2013, J BACTERIOL, V195, P4174, DOI 10.1128/JB.00383-13; Hwang ES, 2017, CELL MOL LIFE SCI, V74, P3347, DOI 10.1007/s00018-017-2527-8; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Kapp EA, 2005, PROTEOMICS, V5, P3475, DOI 10.1002/pmic.200500126; Khan AN, 2005, J BIOL CHEM, V280, P36073, DOI 10.1074/jbc.M508247200; Kim D, 2013, PROTEOMICS, V13, P1726, DOI 10.1002/pmic.201200001; Kim EJ, 2008, BMB REP, V41, P751, DOI 10.5483/BMBRep.2008.41.11.751; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kleszcz R, 2015, PHARMACOL REP, V67, P1068, DOI 10.1016/j.pharep.2015.03.021; Knyphausen P, 2016, J BIOL CHEM, V291, P14677, DOI 10.1074/jbc.M116.726307; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Liarzi O, 2010, MOL MICROBIOL, V76, P932, DOI 10.1111/j.1365-2958.2010.07148.x; Liu CX, 2014, ACTA BIOCH BIOPH SIN, V46, P548, DOI 10.1093/abbs/gmu038; Mei Z, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0461-5; Moulder R, 2005, PROTEOMICS, V5, P2748, DOI 10.1002/pmic.200401187; Nambi S, 2013, J BIOL CHEM, V288, P14114, DOI 10.1074/jbc.M113.463992; Okanishi H, 2013, J PROTEOME RES, V12, P3952, DOI 10.1021/pr400245k; Rauh D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3327; Renilla S, 2012, APPL MICROBIOL BIOT, V93, P2109, DOI 10.1007/s00253-011-3536-4; Sanders BD, 2007, MOL CELL, V25, P463, DOI 10.1016/j.molcel.2006.12.022; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Schilling B, 2015, MOL MICROBIOL, V98, P847, DOI 10.1111/mmi.13161; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Sebastian C, 2012, J BIOL CHEM, V287, P42444, DOI 10.1074/jbc.R112.402768; Seiner DR, 2010, BIOCHEMISTRY-US, V49, P9613, DOI 10.1021/bi1011157; Smith BC, 2011, ACS CHEM BIOL, V6, P146, DOI 10.1021/cb100218d; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; Smythe GA, 2002, ANAL BIOCHEM, V301, P21, DOI 10.1006/abio.2001.5490; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Tu S, 2015, ELIFE, V4, DOI 10.7554/eLife.05322; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang T, 2013, ONCOL LETT, V6, P600, DOI 10.3892/ol.2013.1400; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Williamson J, 1969, METHOD ENZYMOL, P494; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Xie LX, 2015, INT J BIOCHEM CELL B, V59, P193, DOI 10.1016/j.biocel.2014.11.010; Yan JS, 2008, J MOL BIOL, V376, P1260, DOI 10.1016/j.jmb.2007.12.070; Yang TL, 2006, AAPS J, V8, pE632, DOI 10.1208/aapsj080472; Yuan H, 2012, J BIOL CHEM, V287, P42428, DOI 10.1074/jbc.R112.372300; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang QF, 2013, FEBS J, V280, P1966, DOI 10.1111/febs.12216; Zhao KH, 2004, J MOL BIOL, V337, P731, DOI 10.1016/j.jmb.2004.01.060; Zhao KH, 2004, P NATL ACAD SCI USA, V101, P8563, DOI 10.1073/pnas.0401057101; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	88	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189689	10.1371/journal.pone.0189689	http://dx.doi.org/10.1371/journal.pone.0189689			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253849	Green Submitted, Green Published, gold			2022-12-26	WOS:000418389500048
J	Khan, SU; Rahim, MKA; Aminu-Baba, M; Murad, NA				Khan, Shafqat Ullah; Rahim, M. K. A.; Aminu-Baba, Murtala; Murad, N. A.			Correction of failure in linear antenna arrays with greedy sparseness constrained optimization technique	PLOS ONE			English	Article							NUMBER; ELEMENTS; BEAMPATTERN; ALGORITHM	This paper proposes the correction of faulty sensors using a synthesis of the greedy sparse constrained optimization GSCO) technique. The failure of sensors can damage the radiation power pattern in terms of sidelobes and nulls. The synthesis problem can recover the wanted power pattern with reduced number of sensors into the background of greedy algorithm and solved with orthogonal matching pursuit (OMP) technique. Numerical simulation examples of linear arrays are offered to demonstrate the effectiveness of getting the wanted power pattern with a reduced number of antenna sensors which is compared with the available techniques in terms of sidelobes level and number of nulls.	[Khan, Shafqat Ullah; Rahim, M. K. A.; Murad, N. A.] Univ Teknol Malaysia, Fac Elect Engn, Dept Commun Engn, Adv RF & Microwave Res Grp, Skudai, Johor, Malaysia; [Aminu-Baba, Murtala] Abubakar Tafawa Univ, Fac Engn & Engn Technol, Dept Comp & Commun Engn, Yelwa Bauchi, Nigeria	Universiti Teknologi Malaysia	Aminu-Baba, M (corresponding author), Abubakar Tafawa Univ, Fac Engn & Engn Technol, Dept Comp & Commun Engn, Yelwa Bauchi, Nigeria.	mababa@atbu.edu.ng	Aminu-Baba, Murtala/AAJ-9008-2020; Rahim, Mohamad Kamal A/K-5691-2012	Aminu-Baba, Murtala/0000-0003-0716-0552; Rahim, Mohamad Kamal A/0000-0002-5488-9277	Ministry of Higher Education (MOHE); Research Management Centre (RMC), School of Postgraduate Studies (SPS), Communication Engineering Department, Faculty of Electrical Engineering (FKE), Universiti Teknologi Malaysia (UTM) Johor Bahru [12H09, 03E20]	Ministry of Higher Education (MOHE)(Ministry of Higher Education & Scientific Research (MHESR)); Research Management Centre (RMC), School of Postgraduate Studies (SPS), Communication Engineering Department, Faculty of Electrical Engineering (FKE), Universiti Teknologi Malaysia (UTM) Johor Bahru	The authors thank the Ministry of Higher Education (MOHE) for supporting the research work; Research Management Centre (RMC), School of Postgraduate Studies (SPS), Communication Engineering Department, Faculty of Electrical Engineering (FKE), Universiti Teknologi Malaysia (UTM) Johor Bahru under grant number 12H09 and 03E20.	Acharya OP, 2014, INT J RF MICROW C E, V24, P635, DOI 10.1002/mmce.20807; Acharya OP, 2011, APPL COMPUT INTELL S, V2011, DOI 10.1155/2011/692197; [Anonymous], 1937, P IRE, V25, P630; Balanis C. A., 2005, ANTENNA THEORY ANAL; Basit A, 2015, 2015 12TH INTERNATIONAL BHURBAN CONFERENCE ON APPLIED SCIENCES AND TECHNOLOGY (IBCAST), P641, DOI 10.1109/IBCAST.2015.7058575; Basit A., 2013, WORLD APPL SCI J, V26, P232, DOI DOI 10.5829/idosi.wasj.2013.26.02.1387; Basit A, 2014, INT J ANTENN PROPAG, V2014, DOI 10.1155/2014/129172; Choudhury B, 2013, INT J RF MICROW C E, V23, P141, DOI 10.1002/mmce.20659; Fuchs B, 2016, IEEE T ANTENN PROPAG, V64, P2227, DOI 10.1109/TAP.2016.2547023; Fuchs B, 2015, IEEE ANTENNAS PROP, P398, DOI 10.1109/APS.2015.7304585; Fuchs B, 2012, IEEE T ANTENN PROPAG, V60, P3499, DOI 10.1109/TAP.2012.2196951; Grewal NS, 2012, PROG ELECTROMA RES M, V27, DOI 10.2528/PIERM12101903; Khan S., 2017, APPL COMPUTATIONAL E, V32; Khan S. U., 2015, MEHRAN U RES J, V34; Khan SU, 2018, FRONT INFORM TECH EL, V19, P1191, DOI 10.1631/FITEE.1601694; Khan SU, 2017, FRONT INFORM TECH EL, V18, P235, DOI 10.1631/FITEE.1500315; Khan SU, 2016, J SENSORS, V2016, DOI 10.1155/2016/6139802; Khan SU, 2015, 2015 12TH INTERNATIONAL BHURBAN CONFERENCE ON APPLIED SCIENCES AND TECHNOLOGY (IBCAST), P633, DOI 10.1109/IBCAST.2015.7058573; Khan SU, 2016, WIRELESS PERS COMMUN, V91, P1; Khan SU., 2013, PROGR ELECTROMEGNA B, V52, P165, DOI [10.2528/PIERB13032712, DOI 10.2528/PIERB13032712]; Khan SU, 2014, SCI WORLD J, V2014, P1, DOI DOI 10.1155/2014/986567; Klhan SU, 2016, J INF SCI ENG, V32, P611; Liu YH, 2008, IEEE T ANTENN PROPAG, V56, P2955, DOI 10.1109/TAP.2008.928801; Liu YH, 2014, IEEE T ANTENN PROPAG, V62, P652, DOI 10.1109/TAP.2013.2292529; Massa A, 2004, IEEE T ANTENN PROPAG, V52, P2919, DOI 10.1109/TAP.2004.837523; Morabito AF, 2016, IEEE T ANTENN PROPAG, V64, P3260, DOI 10.1109/TAP.2016.2562669; Nai SE, 2010, IEEE T ANTENN PROPAG, V58, P3923, DOI 10.1109/TAP.2010.2078446; Oliveri G, 2012, IEEE T ANTENN PROPAG, V60, P4627, DOI 10.1109/TAP.2012.2207344; Oliveri G, 2010, IEEE T ANTENN PROPAG, V58, P1935, DOI 10.1109/TAP.2010.2046858; PETERS TJ, 1991, IEEE T ANTENN PROPAG, V39, P1497, DOI 10.1109/8.97381; Poli L, 2014, IET RADAR SONAR NAV, V8, P195, DOI 10.1049/iet-rsn.2013.0027; Shoaib B., 2014, CHINESE PHYS B, V23; Yeo BK, 1999, IEEE T ANTENN PROPAG, V47, P823, DOI 10.1109/8.774136; Zhang WJ, 2011, IEEE T ANTENN PROPAG, V59, P3106, DOI 10.1109/TAP.2011.2158943; Zhu CL, 2015, IEEE SENS J, V15, P3773, DOI 10.1109/JSEN.2015.2399510	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189240	10.1371/journal.pone.0189240	http://dx.doi.org/10.1371/journal.pone.0189240			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253852	Green Submitted, Green Published, gold			2022-12-26	WOS:000418389500018
J	Zhao, LY; Deng, LW; Li, GL; Jin, H; Cai, JS; Shang, H; Li, Y; Wu, HM; Xu, WB; Zeng, LD; Zhang, RL; Zhao, H; Wu, P; Zhou, ZL; Zheng, J; Ezanno, P; Yang, AX; Yan, Q; Deem, MW; He, JK				Zhao, Luyang; Deng, Liwei; Li, Gailing; Jin, Huan; Cai, Jinsen; Shang, Huan; Li, Yan; Wu, Haomin; Xu, Weibin; Zeng, Lidong; Zhang, Renli; Zhao, Huan; Wu, Ping; Zhou, Zhiliang; Zheng, Jiao; Ezanno, Pierre; Yang, Andrew X.; Yan, Qin; Deem, Michael W.; He, Jiankui			Single molecule sequencing of the M13 virus genome without amplification	PLOS ONE			English	Article							PRECISION MEDICINE; GENERATION; DIAGNOSIS	Next generation sequencing (NGS) has revolutionized life sciences research. However, GC bias and costly, time-intensive library preparation make NGS an ill fit for increasing sequencing demands in the clinic. A new class of third-generation sequencing platforms has arrived to meet this need, capable of directly measuring DNA and RNA sequences at the single-molecule level without amplification. Here, we use the new GenoCare single-molecule sequencing platform from Direct Genomics to sequence the genome of the M13 virus. Our platform detects single-molecule fluorescence by total internal reflection microscopy, with sequencing-by-synthesis chemistry. We sequenced the genome of M13 to a depth of 316x, with 100% coverage. We determined a consensus sequence accuracy of 100%. In contrast to GC bias inherent to NGS results, we demonstrated that our single-molecule sequencing method yields minimal GC bias.	[Zhao, Luyang; Deng, Liwei; Li, Gailing; Jin, Huan; Cai, Jinsen; Shang, Huan; Li, Yan; Wu, Haomin; Xu, Weibin; Zeng, Lidong; Wu, Ping; Zhou, Zhiliang; Zheng, Jiao; Ezanno, Pierre; Yan, Qin] Direct Genom Co Ltd, Shenzhen, Guangdong, Peoples R China; [Zhang, Renli] Guangdong Gen Hosp, Reprod Med Ctr, Guangzhou, Guangdong, Peoples R China; [Zhang, Renli] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; [Zhao, Huan] Shenzhen Armed Police Hosp Reprod Ctr, Shenzhen, Peoples R China; [Yang, Andrew X.; He, Jiankui] South Univ Sci & Technol China, Dept Biol, Shenzhen, Guangdong, Peoples R China; [Deem, Michael W.] Rice Univ, Dept Bioengn, Houston, TX USA; [Deem, Michael W.] Rice Univ, Dept Phys & Astron, Houston, TX USA	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern University of Science & Technology; Rice University; Rice University	He, JK (corresponding author), South Univ Sci & Technol China, Dept Biol, Shenzhen, Guangdong, Peoples R China.	hejk@sustc.edu.cn	Deem, Michael W/P-3595-2014	Deem, Michael W/0000-0002-4298-3450	Key Research Program of China [2016YFA0501604]; Direct Genomics	Key Research Program of China; Direct Genomics	We acknowledge funding from Key Research Program of China (Grant No: 2016YFA0501604) to JH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The funder (Direct Genomics) provided support in the form of salaries for authors Luyang Zhao, Liwei Deng, Gailing Li, Huan Jin, Jinsen Cai, Huan Shang, Yan Li, Haomin Wu, Weibin Xu, Lidong Zeng, Ping Wu, Zhiliang Zhou, Jiao Sheng, Pierre Ezanno, Yan Gao and Qin Yan, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Aly S M, 2015, Arch Med Sadowej Kryminol, V65, P260; Borsting C, 2015, FORENSIC SCI INT-GEN, V18, P78, DOI 10.1016/j.fsigen.2015.02.002; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Buermans HPJ, 2014, BBA-MOL BASIS DIS, V1842, P1932, DOI 10.1016/j.bbadis.2014.06.015; Chen YJ, 2013, ADV MECH ENG, DOI 10.1155/2013/175347; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Daoud H, 2016, CMAJ, V188, P254; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dong L, 2015, CURR GENOMICS, V16, P253, DOI 10.2174/1389202915666150511205313; Gao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23916; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; JETT JH, 1989, J BIOMOL STRUCT DYN, V7, P301, DOI 10.1080/07391102.1989.10507773; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Miller RR, 2013, GENOME MED, V5, DOI 10.1186/gm485; Milos P, 2008, PHARMACOGENOMICS, V9, P477, DOI 10.2217/14622416.9.4.477; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Reuter JA, 2015, MOL CELL, V58, P586, DOI 10.1016/j.molcel.2015.05.004; Roden DM, 2013, CLIN PHARMACOL THER, V94, P168, DOI 10.1038/clpt.2013.101; Sam LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017305; Thompson John F, 2010, Curr Protoc Mol Biol, VChapter 7, DOI 10.1002/0471142727.mb0710s92; Thorburn F, 2015, J CLIN VIROL, V69, P96, DOI 10.1016/j.jcv.2015.06.082; van Dijk EL, 2014, EXP CELL RES, V322, P12, DOI 10.1016/j.yexcr.2014.01.008; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Xue Y, 2016, CANCER BIOL MED, V13, P12, DOI 10.28092/j.issn.2095-3941.2016.0003; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003; Zhang W, 2014, TOP CURR CHEM, V336, P19, DOI 10.1007/128_2012_325	30	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0188181	10.1371/journal.pone.0188181	http://dx.doi.org/10.1371/journal.pone.0188181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253901	Green Published, Green Submitted, gold			2022-12-26	WOS:000418389500005
J	Zhang, HK; Yu, F; Qin, FX; Shao, Y; Chong, W; Guo, ZF; Liu, XL; Fu, L; Gu, F; Ma, YJ				Zhang, Huikun; Yu, Feng; Qin, Fengxia; Shao, Ying; Chong, Wei; Guo, Zhifang; Liu, Xiaoli; Fu, Li; Gu, Feng; Ma, Yongjie			Combination of cytoplasmic and nuclear girdin expression is an independent prognosis factor of breast cancer	FASEB JOURNAL			English	Article						subcellular distribution; topoisomerase-II alpha; survival; recurrence; metastasis	ACTIN-BINDING PROTEIN; CLINICAL-IMPLICATIONS; CELL MOTILITY; RECURRENCE; GIV/GIRDIN; MIGRATION; INVASION; SURVIVAL; PROLIFERATION; ACTIVATION	Girdin is an actin-binding protein playing key roles in the development of various carcinomas. Although online tools have predicted nuclear localization of girdin with a high probability, convincing proof has rarely been provided until now. The purpose of this study was to discover girdin's precise subcellular distribution and the potential prognostic value corresponding to its localization. The subcellular distribution of girdin was detected in a human breast cancer cell line and in >800 samples of human breast tissue by clinical pathologic analysis. In this study, we discovered for the first time that girdin could attach to chromatin and interact with topoisomerase-II alpha in nucleus. Cytoplasmic and nuclear girdin exhibited different roles in prognosis of breast cancer cytoplasmic girdin expression was an independent prognostic factor for progression-free survival (PFS), whereas nuclear girdin expression was an independent prognostic factor for overall survival (OS). More important, combination cytoplasmic and nuclear girdin was an independent prognosis factor of both OS and PFS. In conclusion, our research results strongly recommend combination analysis of cytoplasmic and nuclear girdin for a precise prognostic prediction in breast cancer.	[Zhang, Huikun; Qin, Fengxia; Shao, Ying; Chong, Wei; Fu, Li; Gu, Feng] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Breast Canc Pathol, Tianjin, Peoples R China; [Yu, Feng; Guo, Zhifang; Liu, Xiaoli; Ma, Yongjie] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Res Lab, Tianjin, Peoples R China; [Yu, Feng; Ma, Yongjie] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Tumor Cell Biol, Tianjin, Peoples R China; [Yu, Feng; Ma, Yongjie] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China; [Yu, Feng; Ma, Yongjie] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Yu, Feng; Ma, Yongjie] Tianjin Med Univ, Minist Educ, Key Lab Breast Canc Prevent & Therapy, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Ma, YJ (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Huanhu West Rd, Tianjin 300060, Peoples R China.	mayongjie@tjmuch.com	Liu, Xiaoli/HGE-7614-2022	Chong, Wei/0000-0002-1074-8595	National Scientific Foundation of China [81572851, 81672636]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 81572851 (to Y.M.) and 81672636 (to F.G.) from the National Scientific Foundation of China. The authors declare no conflicts of interest.	Bednarski JJ, 2016, J EXP MED, V213, P209, DOI 10.1084/jem.20151048; Cao K, 2014, MOL MED REP, V10, P848, DOI 10.3892/mmr.2014.2268; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Christensen MO, 2002, J CELL BIOL, V157, P31, DOI 10.1083/jcb.200112023; Cossetti RJD, 2015, J CLIN ONCOL, V33, P65, DOI 10.1200/JCO.2014.57.2461; Dai XF, 2016, J CANCER, V7, P1281, DOI 10.7150/jca.13141; Dunkel Y, 2016, FASEB J, V30, P3702, DOI 10.1096/fj.201600500; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Fulcoli FG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11688; Garcia-Marcos M, 2015, J BIOL CHEM, V290, P6697, DOI 10.1074/jbc.R114.613414; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Ghosh P, 2016, CLIN CANCER RES, V22, P3488, DOI 10.1158/1078-0432.CCR-15-2290; Ghosh P, 2015, CELL CYCLE, V14, P2561, DOI 10.1080/15384101.2015.1066538; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Gu F, 2014, J NEUROCHEM, V131, P457, DOI 10.1111/jnc.12831; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Hasan UA, 2013, J EXP MED, V210, P1369, DOI 10.1084/jem.20122394; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Jiang P, 2013, TUMORI J, V99, P530, DOI 10.1700/1361.15106; Jin F, 2013, ONCOL LETT, V5, P1549, DOI 10.3892/ol.2013.1249; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Khoshnoud MR, 2008, BREAST CANCER RES TR, V107, P71, DOI 10.1007/s10549-007-9520-0; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Ling Y, 2011, CANCER INVEST, V29, P405, DOI 10.3109/07357907.2011.568568; Liu CG, 2012, MED ONCOL, V29, P1554, DOI 10.1007/s12032-011-0087-6; Lopez-Sanchez I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5451; Lopez-Sanchez I, 2013, P NATL ACAD SCI USA, V110, P5510, DOI 10.1073/pnas.1303392110; Nishimae K, 2015, BREAST CANCER-TOKYO, V22, P445, DOI 10.1007/s12282-013-0501-3; Ohara K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036681; Pegram M D, 2000, Cancer Treat Res, V103, P57; Peng WT, 2014, ANN SURG ONCOL, V21, pS648, DOI 10.1245/s10434-014-3746-y; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Shibata T, 2013, ONCOL REP, V29, P2127, DOI 10.3892/or.2013.2406; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song JY, 2014, ONCOL LETT, V7, P337, DOI 10.3892/ol.2013.1745; Tomiyama L, 2015, ONCOGENE, V34, P1141, DOI 10.1038/onc.2014.31; Wang CH, 2014, MOL CLIN ONCOL, V2, P425, DOI 10.3892/mco.2014.265; Wang YF, 2015, MOBILE SOCIAL NETWORKING AND COMPUTING: A MULTIDISCIPLINARY INTEGRATED PERSPECTIVE, P3; WOESSNER RD, 1991, CELL GROWTH DIFFER, V2, P209; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA	46	4	4	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2395	2410		10.1096/fj.201700825RR	http://dx.doi.org/10.1096/fj.201700825RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29259035				2022-12-26	WOS:000432528000008
J	Alvarez, M; Nevot, M; Mendieta, J; Martinez, MA; Menendez-Arias, L				Alvarez, Mar; Nevot, Maria; Mendieta, Jesus; Martinez, Miguel A.; Menendez-Arias, Luis			Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL DRUG-RESISTANCE; THYMIDINE NUCLEOTIDE ANALOGS; DEPENDENT PRIMER UNBLOCKING; IN-VITRO; MOLECULAR-MECHANISMS; DIPEPTIDE INSERTION; CATALYTIC COMPLEX; THUMB SUBDOMAIN; AZT RESISTANCE	Nucleoside reverse transcriptase (RT) inhibitors (NRTIs) are the backbone of current antiretroviral treatments. However, the emergence of viral resistance against NRTIs is a major threat to their therapeutic effectiveness. In HIV-1, NRTI resistance-associated mutations either reduce RT-mediated incorporation of NRTI triphosphates (discrimination mechanism) or confer an ATP-mediated nucleotide excision activity that removes the inhibitor from the 3' terminus of DNA primers, enabling further primer elongation (excision mechanism). In HIV-2, resistance to zidovudine (3'-azido-3'-deoxythymidine (AZT)) and other NRTIs is conferred by mutations affecting nucleotide discrimination. Mutations of the excision pathway such as M41L, D67N, K70R, or S215Y (known as thymidine-analogue resistance mutations (TAMs)) are rare in the virus from HIV-2-infected individuals. Here, we demonstrate that mutant M41L/D67N/K70R/S215Y HIV-2 RT lacks ATP-dependent excision activity, and recombinant virus containing this RT remains susceptible to AZT inhibition. Mutant HIV-2 RTs were tested for their ability to unblock and extend DNA primers terminated with AZT and other NRTIs, when complexed with RNA or DNA templates. Our results show that Met(73) and, to a lesser extent, Ile(75) suppress excision activity when TAMs are present in the HIV-2 RT. Interestingly, recombinant HIV-2 carrying a mutant D67N/K70R/M73K RT showed 10-fold decreased AZT susceptibility and increased rescue efficiency on AZT- or tenofovir-terminated primers, as compared with the double-mutant D67N/K70R. Molecular dynamics simulations reveal that Met(73) influences beta 3-beta 4 hairpin loop conformation, whereas its substitution affects hydrogen bond interactions at position 70, required for NRTI excision. Our work highlights critical HIV-2 RT residues impeding the development of excision-mediated NRTI resistance.	[Alvarez, Mar; Mendieta, Jesus; Menendez-Arias, Luis] CSIC, Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera 1,Campus Cantoblanco, Madrid 28049, Spain; [Mendieta, Jesus; Menendez-Arias, Luis] Univ Autonoma Madrid, C Nicolas Cabrera 1,Campus Cantoblanco, E-28049 Madrid, Spain; [Nevot, Maria; Martinez, Miguel A.] Hosp Badalona Germans Trias & Pujol, Fundacio IrsiCaixa, Lab Retrovirol, Barcelona 08916, Spain; [Mendieta, Jesus] Univ Francisco de Vitoria, Dept Biotecnol, Madrid 28223, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Universidad Francisco de Vitoria	Menendez-Arias, L (corresponding author), Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera 1,Campus Cantoblanco, Madrid 28049, Spain.	lmenendez@cbm.csic.es	Nevot, Maria/AAC-7839-2022; Nevot, Maria/E-6187-2016; Menendez Arias, Luis/N-7447-2016; Martinez, Miguel Angel/K-6435-2014	Nevot, Maria/0000-0003-4947-4648; Nevot, Maria/0000-0003-4947-4648; Alvarez, Mar/0000-0002-6086-6557; Menendez Arias, Luis/0000-0002-1251-6640; Martinez, Miguel Angel/0000-0002-6681-4950; Mendieta, Jesus/0000-0001-9286-2166	Fundacion Ramon Areces	Fundacion Ramon Areces	An institutional grant from the Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa is also acknowledged.	Allner O, 2012, J CHEM THEORY COMPUT, V8, P1493, DOI 10.1021/ct3000734; Alvarez M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44834; Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Betancor G, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-68; Betancor G, 2010, ANTIMICROB AGENTS CH, V54, P4799, DOI 10.1128/AAC.00716-10; Boretto J, 2001, ANAL BIOCHEM, V292, P139, DOI 10.1006/abio.2001.5045; Boyer PL, 2006, PLOS PATHOG, V2, P101, DOI 10.1371/journal.ppat0020010; Boyer PL, 2012, J VIROL, V86, P5885, DOI 10.1128/JVI.06597-11; Brandin E, 2003, AIDS RES HUM RETROV, V19, P543, DOI 10.1089/088922203322230905; Campbell-Yesufu OT, 2011, CLIN INFECT DIS, V52, P780, DOI 10.1093/cid/ciq248; Cases-Gonzalez CE, 2007, J MOL BIOL, V365, P298, DOI 10.1016/j.jmb.2006.09.073; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430; Colson P, 2005, J MED VIROL, V75, P381, DOI 10.1002/jmv.20296; Damond F, 2005, ANTIVIR THER, V10, P861; Damond F, 2004, ANTIVIR THER, V9, P635; Descamps D, 2004, J MED VIROL, V74, P197, DOI 10.1002/jmv.20174; Deuzing IP, 2015, J VIROL, V89, P833, DOI 10.1128/JVI.02259-14; Deval J, 2002, J BIOL CHEM, V277, P42097, DOI 10.1074/jbc.M206725200; Foley B., 2014, HIV SEQUENCE COMPEND; Fujita Y, 2013, VIROLOGY, V436, P100, DOI 10.1016/j.virol.2012.10.036; Gottlieb GS, 2009, CLIN INFECT DIS, V48, P848, DOI 10.1086/597577; Gottlieb GS, 2008, AIDS, V22, P2069, DOI 10.1097/QAD.0b013e32830edd44; Gottlieb GS, 2009, CLIN INFECT DIS, V48, P476, DOI 10.1086/596504; Hachiya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016242; Hu WS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006882; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kim B, 1996, J BIOL CHEM, V271, P4872, DOI 10.1074/jbc.271.9.4872; Kisic M, 2008, J MOL BIOL, V382, P327, DOI 10.1016/j.jmb.2008.07.030; Kisic M, 2011, J BIOL CHEM, V286, P20615, DOI 10.1074/jbc.M111.226100; LARDER BA, 1994, J GEN VIROL, V75, P951, DOI 10.1099/0022-1317-75-5-951; Lloyd SB, 2016, VIROLOGY, V492, P1, DOI 10.1016/j.virol.2016.02.008; Mas A, 2002, J MOL BIOL, V323, P181, DOI 10.1016/S0022-2836(02)00911-7; Mas A, 2000, EMBO J, V19, P5752, DOI 10.1093/emboj/19.21.5752; Matamoros T, 2005, J MOL BIOL, V349, P451, DOI 10.1016/j.jmb.2005.04.004; Matamoros T, 2004, J BIOL CHEM, V279, P24569, DOI 10.1074/jbc.M312658200; Matamoros T, 2009, J BIOL CHEM, V284, P32792, DOI 10.1074/jbc.M109.038885; Matsumi S, 2003, AIDS, V17, P1127, DOI 10.1097/00002030-200305230-00003; Mendieta J, 2008, PROTEINS, V71, P565, DOI 10.1002/prot.21711; Menendez-Arias L, 1998, BIOCHEMISTRY-US, V37, P16636, DOI 10.1021/bi981830g; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Menendez-Arias L, 2008, TRENDS PHARMACOL SCI, V29, P42, DOI 10.1016/j.tips.2007.10.013; Menendez-Arias L, 2014, ANTIVIR RES, V102, P70, DOI 10.1016/j.antiviral.2013.12.001; Menendez-Arias L, 2013, ANTIVIR RES, V98, P93, DOI 10.1016/j.antiviral.2013.01.007; Meyer PR, 2002, ANTIMICROB AGENTS CH, V46, P1540, DOI 10.1128/AAC.46.5.1540-1545.2002; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2000, ANTIMICROB AGENTS CH, V44, P3465, DOI 10.1128/AAC.44.12.3465-3472.2000; Ntemgwa ML, 2009, ANTIMICROB AGENTS CH, V53, P3611, DOI 10.1128/AAC.00154-09; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; Reid P, 2005, VIROLOGY, V336, P251, DOI 10.1016/j.virol.2005.03.030; Ren J, 2002, P NATL ACAD SCI USA, V99, P14410, DOI 10.1073/pnas.222366699; Rodes B, 2000, J CLIN MICROBIOL, V38, P1370; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Sevilya Z, 2001, J MOL BIOL, V311, P957, DOI 10.1006/jmbi.2001.4904; SHIRASAKA T, 1995, P NATL ACAD SCI USA, V92, P2398, DOI 10.1073/pnas.92.6.2398; Smith RA, 2008, ANTIMICROB AGENTS CH, V52, P329, DOI 10.1128/AAC.01004-07; Smith RA, 2009, J INFECT DIS, V199, P1323, DOI 10.1086/597802; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; Trevino A, 2011, J ANTIMICROB CHEMOTH, V66, P1484, DOI 10.1093/jac/dkr164; Tu XY, 2010, NAT STRUCT MOL BIOL, V17, P1202, DOI 10.1038/nsmb.1908; van der Ende ME, 2000, J ACQ IMMUN DEF SYND, V25, P11, DOI 10.1097/00126334-200009010-00002; White KL, 2004, ANTIMICROB AGENTS CH, V48, P992, DOI 10.1128/AAC.48.3.992-1003.2004; Yahi N, 1999, J CLIN MICROBIOL, V37, P4099, DOI 10.1128/JCM.37.12.4099-4106.1999	64	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2247	2259		10.1074/jbc.RA117.000177	http://dx.doi.org/10.1074/jbc.RA117.000177			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29275329	Green Published, hybrid			2022-12-26	WOS:000425308300002
J	Saldate, JJ; Shiau, J; Cazares, VA; Stuenkel, EL				Saldate, Johnny J.; Shiau, Jason; Cazares, Victor A.; Stuenkel, Edward L.			The ubiquitin-proteasome system functionally links neuronal Tomosyn-1 to dendritic morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LETHAL-GIANT-LARVAE; SYNAPTIC PLASTICITY; NEUROTRANSMITTER RELEASE; STRUCTURAL BASIS; YEAST HOMOLOGS; LIGASE HRD1; RAB GTPASE; PROTEIN; DEGRADATION; SNARE	Altering the expression of Tomosyn-1 (Tomo-1), a soluble, R-SNARE domain-containing protein, significantly affects behavior in mice, Drosophila, and Caenorhabditis elegans. Yet, the mechanisms that modulate Tomo-1 expression and its regulatory activity remain poorly defined. Here, we found that Tomo-1 expression levels influence postsynaptic spine density. Tomo-1 overexpression increased dendritic spine density, whereas Tomo-1 knockdown (KD) decreased spine density. These findings identified a novel action of Tomo-1 on dendritic spines, which is unique because it occurs independently of Tomo-1' s C-terminal R-SNARE domain. We also demonstrated that the ubiquitin-proteasome system (UPS), which is known to influence synaptic strength, dynamically regulates Tomo-1 protein levels. Immunoprecipitated and affinity-purified Tomo-1 from cultured rat hippocampal neurons was ubiquitinated, and the levels of ubiquitinated Tomo-1 dramatically increased upon pharmacological proteasome blockade. Moreover, Tomo-1 ubiquitination appeared to be mediated through an interaction with the E3 ubiquitin ligase HRD1, as immunoprecipitation of Tomo-1 from neurons co-precipitated HRD1, and this interaction increases upon proteasome inhibition. Further, in vitro reactions indicated direct, HRD1 concentration-dependent Tomo-1 ubiquitination. We also noted that the UPS regulates both Tomo-1 expression and functional output, as HRD1 KD in hippocampal neurons increased Tomo-1 protein level and dendritic spine density. Notably, the effect of HRD1 KD on spine density was mitigated by additional KD of Tomo-1, indicating a direct HRD1/Tomo-1 effector relationship. In summary, our results indicate that the UPS is likely to participate in tuning synaptic efficacy and spine dynamics by precise regulation of neuronal Tomo-1 levels.	[Saldate, Johnny J.; Stuenkel, Edward L.] Univ Michigan, Med Sch, Neurosci Grad Program, Ann Arbor, MI 48109 USA; [Shiau, Jason; Cazares, Victor A.; Stuenkel, Edward L.] Univ Michigan, Med Sch, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Stuenkel, EL (corresponding author), Univ Michigan, Med Sch, Neurosci Grad Program, Ann Arbor, MI 48109 USA.; Stuenkel, EL (corresponding author), Univ Michigan, Med Sch, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	esterm@umich.edu		Saldate, Johnny/0000-0003-4912-6299; Stuenkel, Edward/0000-0001-8225-5725; Cazares, Victor A/0000-0002-6625-7103	National Institutes of Health [R01 NS097498, F31 NS087883]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS097498, F31NS087883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01 NS097498 (to E. L. S.). Additional training support was provided by National Institutes of Health Grant F31 NS087883 (to J. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez-Castelao B, 2015, J BIOL CHEM, V290, P28623, DOI 10.1074/jbc.R115.657130; Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Barak B, 2013, NEUROMOL MED, V15, P351, DOI 10.1007/s12017-013-8223-4; Barak B, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00149; Ben-Simon Y, 2015, CELL REP, V12, P396, DOI 10.1016/j.celrep.2015.06.037; Bhatnagar S, 2014, J BIOL CHEM, V289, P25276, DOI 10.1074/jbc.M114.575985; Bianchetta MJ, 2011, J NEUROSCI, V31, P12029, DOI 10.1523/JNEUROSCI.2388-11.2011; Bielopolski N, 2014, J BIOL CHEM, V289, P17087, DOI 10.1074/jbc.M113.515296; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bolte ER, 2003, MED HYPOTHESES, V60, P119, DOI 10.1016/S0306-9877(02)00345-6; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burdina AO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026185; Cazares VA, 2016, J NEUROSCI, V36, P11208, DOI 10.1523/JNEUROSCI.1297-16.2016; Chen KY, 2011, P NATL ACAD SCI USA, V108, P18482, DOI 10.1073/pnas.1110184108; Cheviet S, 2006, J CELL SCI, V119, P2912, DOI 10.1242/jcs.03037; Cohen LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063191; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Davis LK, 2009, J NEURODEV DISORD, V1, P292, DOI 10.1007/s11689-009-9013-z; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gangar A, 2005, CURR BIOL, V15, P1136, DOI 10.1016/j.cub.2005.05.046; Garcia-Reitbock P, 2010, BRAIN, V133, P2032, DOI 10.1093/brain/awq132; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Geerts CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091697; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Groffen AJA, 2005, J NEUROCHEM, V92, P554, DOI 10.1111/j.1471-4159.2004.02890.x; Guntupalli S, 2017, J BIOL CHEM, V292, P8186, DOI 10.1074/jbc.M116.774554; Hamilton A. M., 2013, NEURAL PLAST, V2013, P1; Hamilton AM, 2012, NEURON, V74, P1023, DOI 10.1016/j.neuron.2012.04.031; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Hegde AN, 2017, NEUROBIOL LEARN MEM, V138, P98, DOI 10.1016/j.nlm.2016.09.003; Hegde AN, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00096; Hu ZT, 2012, SCIENCE, V337, P980, DOI 10.1126/science.1224896; Huang J, 2015, NEURON, V86, P726, DOI 10.1016/j.neuron.2015.03.049; Hung AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009842; Jakawich SK, 2010, NEURON, V68, P1143, DOI 10.1016/j.neuron.2010.11.034; Jiang XP, 2010, J NEUROSCI, V30, P1798, DOI 10.1523/JNEUROSCI.4965-09.2010; Kagami M, 1998, GENETICS, V149, P1717; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kawada K, 2014, J NEUROSCI RES, V92, P1122, DOI 10.1002/jnr.23389; Kienle N, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-19; Kim H, 2016, J NEUROSCI, V36, P4888, DOI 10.1523/JNEUROSCI.4204-15.2016; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Lin YC, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00263; Lussier MP, 2012, P NATL ACAD SCI USA, V109, P19426, DOI 10.1073/pnas.1217477109; Mabb AM, 2014, NEURON, V82, P1299, DOI 10.1016/j.neuron.2014.05.016; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Mao JH, 2017, HUM MOL GENET, V26, P1877, DOI 10.1093/hmg/ddx096; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Murakami T, 2007, NEUROSCIENCE, V146, P1, DOI 10.1016/j.neuroscience.2007.01.069; Nadav E, 2003, BIOCHEM BIOPH RES CO, V303, P91, DOI 10.1016/S0006-291X(03)00279-1; Nagano K, 2015, INT J BIOCHEM CELL B, V62, P62, DOI 10.1016/j.biocel.2015.02.013; Nalavadi VC, 2012, J NEUROSCI, V32, P2582, DOI 10.1523/JNEUROSCI.5057-11.2012; Omura T, 2008, J NEUROSCI RES, V86, P1577, DOI 10.1002/jnr.21616; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Patrick GN, 2006, CURR OPIN NEUROBIOL, V16, P90, DOI 10.1016/j.conb.2006.01.007; Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Rosenberg T, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00086; Rossi G, 2011, MOL BIOL CELL, V22, P842, DOI 10.1091/mbc.E10-07-0570; Rossi G, 2015, J BIOL CHEM, V290, P612, DOI 10.1074/jbc.M114.595892; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schreiber J, 2015, J CELL BIOL, V211, P569, DOI 10.1083/jcb.201506048; Schwarz LA, 2012, MOL CELL NEUROSCI, V49, P387, DOI 10.1016/j.mcn.2011.08.006; Sharma M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004028; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tsai NP, 2014, BBA-MOL CELL RES, V1843, P2838, DOI 10.1016/j.bbamcr.2014.08.006; Waites CL, 2013, EMBO J, V32, P954, DOI 10.1038/emboj.2013.27; Watson K, 2015, MOL BIOL CELL, V26, P3289, DOI 10.1091/mbc.E15-04-0228; Williams AL, 2011, J BIOL CHEM, V286, P14542, DOI 10.1074/jbc.M110.215624; Yamamoto Y, 2010, J BIOL CHEM, V285, P40943, DOI 10.1074/jbc.M110.156893; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Ying HY, 2012, INT REV CEL MOL BIO, V294, P223, DOI 10.1016/B978-0-12-394305-7.00005-7; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x; ZHANG Peng, 2015, ADV METEOROLOGICAL S, V5, P6; Zhang Q, 2013, CELL MOL LIFE SCI, V70, P153, DOI 10.1007/s00018-012-1103-5; Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015	93	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2232	2246		10.1074/jbc.M117.815514	http://dx.doi.org/10.1074/jbc.M117.815514			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29269412	Green Published, hybrid			2022-12-26	WOS:000425308300001
J	Bitterman, K; Goss, KU				Bitterman, Kai; Goss, Kai-Uwe			Predicting apparent passive permeability of Caco-2 and MDCK cell-monolayers: A mechanistic model	PLOS ONE			English	Article							LIPID-BILAYER-MEMBRANES; BLOOD-BRAIN-BARRIER; GLYCOPROTEIN-MEDIATED EFFLUX; IN-VITRO PERMEABILITY; OVERTON STILL RULE; PARTITION-COEFFICIENTS; UNSTIRRED LAYER; P-GLYCOPROTEIN; PERMEATION EXPERIMENTS; CHEMICAL-REACTIONS	Experimentally derived apparent permeabilities, P-app, through cell monolayers such as Caco-2 and MDCK are considered to be an in-vitro gold standard for assessing the uptake efficiency of drugs. Here, we present a mechanistic model that describes 'passive' P-app values (i.e., neglecting active transport) by accounting for the different resistances solutes encounter when permeating a cell monolayer. We described three parallel permeation pathways, namely a cytosolic-, paracellular-, and lateral route, each of which consists of a number of serial resistances. These resistances were accounted for via a mechanistic depiction of the underlying processes that are largely based on literature work. For the present P-app dataset, about as much chemicals are dominated by the cytosolic route as were dominated by the paracellular route, while the lateral route was negligible. For the cytosolic route by far the most chemicals found their main resistance in the various water layers and not in the membrane. Although correlations within the subclasses of chemicals dominated by a specific permeation route were rather poor, we could overall satisfyingly predict P-app for 151 chemicals at a pH of 7.4 (R-2 = 0.77, RMSE = 0.48). For a specific evaluation of the intrinsic membrane permeability, P-m, a second experimental dataset based on experiments with black lipid membranes, BLM, was evaluated. P-m could be predicted for 37 chemicals with R-2 = 0.91 and RMSE = 0.64 log units.	[Bitterman, Kai; Goss, Kai-Uwe] UFZ Helmholtz Ctr Environm Res, Analyt Environm Chem, Leipzig, Germany; [Goss, Kai-Uwe] Univ Halle Wittenberg, Dept Chem, Halle, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Martin Luther University Halle Wittenberg	Goss, KU (corresponding author), UFZ Helmholtz Ctr Environm Res, Analyt Environm Chem, Leipzig, Germany.; Goss, KU (corresponding author), Univ Halle Wittenberg, Dept Chem, Halle, Germany.	kai-uwe.goss@ufz.de			Federal Ministry for Economic Affairs and Energy	Federal Ministry for Economic Affairs and Energy	This research was funded by the Federal Ministry for Economic Affairs and Energy due to a decision of the German Federal Parliament. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the Federal Ministry for Economic Affairs and Energy due to a decision of the German Federal Parliament. We would like to thank the two anonymous reviewers for their critical reading which helped to improve the manuscript.	ADSON A, 1995, J PHARM SCI, V84, P1197, DOI 10.1002/jps.2600841011; ADSON A, 1994, J PHARM SCI, V83, P1529, DOI 10.1002/jps.2600831103; Al-Awqati Q, 1999, NAT CELL BIOL, V1, pE201, DOI 10.1038/70230; Alsenz J, 2003, PHARM RES, V20, P1961, DOI 10.1023/B:PHAM.0000008043.71001.43; ANTONENKO YN, 1993, BIOPHYS J, V64, P1701, DOI 10.1016/S0006-3495(93)81542-X; Artursson P, 2012, ADV DRUG DELIVER REV, V64, P280, DOI 10.1016/j.addr.2012.09.005; Avdeef A, 2005, EUR J PHARM SCI, V24, P333, DOI 10.1016/j.ejps.2004.11.011; Avdeef A., 2012, ABSORPTION DRUG DEV; Avdeef A, 2010, J MED CHEM, V53, P3566, DOI 10.1021/jm901846t; Avdeef Alex, 2001, Current Topics in Medicinal Chemistry, V1, P277, DOI 10.2174/1568026013395100; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bittermann K, 2016, CHEMOSPHERE, V144, P382, DOI 10.1016/j.chemosphere.2015.08.065; Bittermann K, 2014, J PHYS CHEM B, V118, P14833, DOI 10.1021/jp509348a; BRIGHT GR, 1987, J CELL BIOL, V104, P1019, DOI 10.1083/jcb.104.4.1019; CHAKRABARTI AC, 1992, BIOCHIM BIOPHYS ACTA, V1111, P171, DOI 10.1016/0005-2736(92)90308-9; DIAMOND JM, 1974, J MEMBRANE BIOL, V17, P121, DOI 10.1007/BF01870176; Doan KMM, 2002, J PHARMACOL EXP THER, V303, P1029, DOI 10.1124/jpet.102.039255; Endo S, 2011, ENVIRON SCI TECHNOL, V45, P5912, DOI 10.1021/es200855w; Escher BI, 2004, PHYSICOCHEMICAL KINE, P205; FINKELSTEIN A, 1976, J GEN PHYSIOL, V68, P127, DOI 10.1085/jgp.68.2.127; Garberg P, 2005, TOXICOL IN VITRO, V19, P299, DOI 10.1016/j.tiv.2004.06.011; GUTKNECHT J, 1973, SCIENCE, V182, P1258, DOI 10.1126/science.182.4118.1258; GUTKNECHT J, 1981, BIOCHIM BIOPHYS ACTA, V649, P149, DOI 10.1016/0005-2736(81)90401-6; GUTKNECHT J, 1981, BIOCHIM BIOPHYS ACTA, V644, P153, DOI 10.1016/0005-2736(81)90071-7; Hayeshi R, 2006, EUR J PHARM SCI, V29, P70, DOI 10.1016/j.ejps.2006.05.009; Heikkinen AT, 2010, EUR J PHARM SCI, V40, P132, DOI 10.1016/j.ejps.2010.03.012; Heikkinen AT, 2009, J PHARMACOL EXP THER, V328, P882, DOI 10.1124/jpet.108.145797; Hill WG, 2000, J BIOL CHEM, V275, P30176, DOI 10.1074/jbc.M003494200; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Irvine JD, 1999, J PHARM SCI, V88, P28, DOI 10.1021/js9803205; Jain MK, 1980, INTRO BIOL MEMBR; KARLSSON J, 1991, INT J PHARM, V71, P55, DOI 10.1016/0378-5173(91)90067-X; Korjamo T, 2008, PHARM RES-DORDR, V25, P1714, DOI 10.1007/s11095-008-9573-8; Korjamo T, 2009, J PHARM SCI-US, V98, P4469, DOI 10.1002/jps.21762; Krylov AV, 2001, J GEN PHYSIOL, V118, P333, DOI 10.1085/jgp.118.4.333; LEBLANC OH, 1971, J MEMBRANE BIOL, V4, P227, DOI 10.1007/BF02431973; Lee KJ, 2005, EUR J PHARM SCI, V25, P193, DOI 10.1016/j.ejps.2005.02.012; Luby-Phelps K, 2000, CYTOARCHITECTURE PHY, P189; Marrink SJ, 1996, J PHYS CHEM-US, V100, P16729, DOI 10.1021/jp952956f; Obradovic T, 2007, PHARM RES-DORDR, V24, P318, DOI 10.1007/s11095-006-9149-4; Oliver RE, 1998, J PHARM SCI, V87, P634, DOI 10.1021/js9701216; ORBACH E, 1980, J GEN PHYSIOL, V75, P427, DOI 10.1085/jgp.75.4.427; Pohl P, 1997, BBA-BIOMEMBRANES, V1323, P163, DOI 10.1016/S0005-2736(96)00185-X; Pohl P, 1998, BIOPHYS J, V75, P1403, DOI 10.1016/S0006-3495(98)74058-5; Raeissi SD, 1999, J PHARM PHARMACOL, V51, P35, DOI 10.1211/0022357991772060; Robertson SM, 2005, SURV OPHTHALMOL, V50, pS32, DOI 10.1016/j.survophthal.2005.07.001; Saparov SM, 2006, BIOPHYS J, V90, pL86, DOI 10.1529/biophysj.106.084343; Smith D, 2014, MOL PHARMACEUT, V11, P1727, DOI 10.1021/mp400713v; Summerfield SG, 2007, J PHARMACOL EXP THER, V322, P205, DOI 10.1124/jpet.107.121525; Tan CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031882; Thiel-Demby VE, 2009, MOL PHARMACEUT, V6, P11, DOI 10.1021/mp800122b; Tsinman O, 2011, PHARM RES-DORDR, V28, P337, DOI 10.1007/s11095-010-0280-x; Verkman AS, 2002, TRENDS BIOCHEM SCI, V27, P27, DOI 10.1016/S0968-0004(01)02003-5; von Richter O, 2009, N-S ARCH PHARMACOL, V379, P11, DOI 10.1007/s00210-008-0345-0; WALTER A, 1984, J MEMBRANE BIOL, V77, P255, DOI 10.1007/BF01870573; WALTER A, 1986, J MEMBRANE BIOL, V90, P207, DOI 10.1007/BF01870127; WALTER A, 1982, J GEN PHYSIOL, V79, P917, DOI 10.1085/jgp.79.5.917; Wang Q, 2005, INT J PHARMACEUT, V288, P349, DOI 10.1016/j.ijpharm.2004.10.007; WILSON FA, 1974, BIOCHIM BIOPHYS ACTA, V363, P112, DOI 10.1016/0005-2736(74)90010-8; XIANG TX, 1994, J MEMBRANE BIOL, V140, P111; XIANG TX, 1994, J PHARM SCI, V83, P1511; XIANG TX, 1992, BIOPHYS J, V63, P78, DOI 10.1016/S0006-3495(92)81581-3; Zocher F, 2013, BIOPHYS J, V105, P2760, DOI 10.1016/j.bpj.2013.11.003	63	24	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190319	10.1371/journal.pone.0190319	http://dx.doi.org/10.1371/journal.pone.0190319			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281711	Green Published, gold, Green Submitted			2022-12-26	WOS:000419006200085
J	Helm, RR; Dunn, CW				Helm, Rebecca R.; Dunn, Casey W.			Indoles induce metamorphosis in a broad diversity of jellyfish, but not in a crown jelly (Coronatae)	PLOS ONE			English	Article							COMPLEX LIFE-CYCLES; AURELIA-AURITA; CHRYSAORA-QUINQUECIRRHA; ASEXUAL REPRODUCTION; SCYPHOZOAN JELLYFISH; MEDUSA FORMATION; STROBILATION; INDOMETHACIN; EVOLUTION; PHYLOGENY	Many animals go through one or more metamorphoses during their lives, however, the molecular underpinnings of metamorphosis across diverse species are not well understood. Medusozoa (Cnidaria) is a clade of animals with complex life cycles, these life cycles can include a polyp stage that metamorphoses into a medusa (jellyfish). Medusae are produced through a variety of different developmental mechanisms-in some species polyps bud medusae (Hydrozoa), in others medusae are formed through polyp fission (Scyphozoa), while in others medusae are formed through direct transformation of the polyp (Cubozoa). To better understand the molecular mechanisms that may coordinate these different forms of metamorphosis, we tested two compounds first identified to induce metamorphosis in the moon jellyfish Aurelia aurita (indomethacin and 5-methoxy-2-methylindole) on a broad diversity of medusozoan polyps. We discovered that indole-containing compounds trigger metamorphosis across a broad diversity of species. All tested discomedusan polyps metamorphosed in the presence of both compounds, including species representatives of several major lineages within the clade (Pelagiidae, Cyaneidae, both clades of Rhizostomeae). In a cubozoan, low levels of 5-methoxy-2-methylindole reliably induced complete and healthy metamorphosis. In contrast, neither compound induced medusa metamorphosis in a coronate scyphozoan, or medusa production in either hydrozoan tested. Our results support the hypothesis that metamorphosis is mediated by a conserved induction pathway within discomedusan scyphozoans, and possibly cubozoans. However, failure of these compounds to induce metamorphosis in a coronate suggests this induction mechanism may have been lost in this clade, or is convergent between Scyphozoa and Cubozoa.	[Helm, Rebecca R.; Dunn, Casey W.] Brown Univ, Providence, RI 02912 USA; [Helm, Rebecca R.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Helm, Rebecca R.] Natl Museum Nat Hist, Smithsonian Inst, Washington, DC 20560 USA; [Dunn, Casey W.] Yale Univ, New Haven, CT USA	Brown University; Woods Hole Oceanographic Institution; Smithsonian Institution; Smithsonian National Museum of Natural History; Yale University	Helm, RR (corresponding author), Brown Univ, Providence, RI 02912 USA.; Helm, RR (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.; Helm, RR (corresponding author), Natl Museum Nat Hist, Smithsonian Inst, Washington, DC 20560 USA.	rrhelm@gmail.com		Dunn, Casey/0000-0003-0628-5150	National Science Foundation Graduate Research Fellowship [DGE - 1058262]; Evo-Devo-Eco Network (IOS) Research Exchange Funds [0955517]; National Science Foundation Rhode Island Established Program [DEB-1256695]; Brown University Ecology and Evolutionary Biology Dissertation Development Grant from the Bushnell Research and Education Fund	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Evo-Devo-Eco Network (IOS) Research Exchange Funds; National Science Foundation Rhode Island Established Program; Brown University Ecology and Evolutionary Biology Dissertation Development Grant from the Bushnell Research and Education Fund	National Science Foundation Graduate Research Fellowship (DGE - 1058262; https://www.nsfgrfp.org/general_resources/about) to RRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Evo-Devo-Eco Network (IOS # 0955517; http://edenrcn.com/) Research Exchange Funds, awarded to RRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Science Foundation Rhode Island Established Program to Stimulate Competitive Graduate Research Fellowship to RRH (DEB-1256695; http://web.uri.edu/rinsfepscor/grad-fellowships/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Brown University Ecology and Evolutionary Biology Dissertation Development Grant from the Bushnell Research and Education Fund awarded to RRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayha KM, 2010, INTEGR COMP BIOL, V50, P436, DOI 10.1093/icb/icq074; Berking S, 2005, INT J DEV BIOL, V49, P969, DOI 10.1387/ijdb.052024sb; Berrill N. J., 1950, Quarterly Review of Biology, V25, P292, DOI 10.1086/397707; BERRILL NJ, 1949, BIOL REV, V24, P393, DOI 10.1111/j.1469-185X.1949.tb00581.x; Brekhman V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1320-z; Cabrales-Arellano P, 2017, PEERJ, V5, DOI 10.7717/peerj.2979; CALDER DR, 1974, BIOL BULL, V146, P326, DOI 10.2307/1540408; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Courtney R, 2016, PLOS ONE, V11; da Silveira FL, 1998, P BIOL SOC WASH, V111, P781; Dunn CW, 2013, INTEGR COMP BIOL, V53, P847, DOI 10.1093/icb/ict068; EBENMAN B, 1992, AM NAT, V139, P990, DOI 10.1086/285370; Fuchs B, 2014, CURR BIOL, V24, P263, DOI 10.1016/j.cub.2013.12.003; Gershwin LA, 2002, J NAT HIST, V36, P127, DOI 10.1080/00222930010003819; Goette A., 2013, ENTWICKELUNGSGESCHIC, P1; Helm RR, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0005-7; Holstein TW, 2014, CURR BIOL, V24, pR159, DOI 10.1016/j.cub.2014.01.003; Kramp P. L., 1961, J MAR BIOL ASSOC UK, V40, P469; Kraus JEM, 2015, ADOPTION CONSERVED D, P1; Kuniyoshi H, 2012, BIOSCI BIOTECH BIOCH, V76, P1397, DOI 10.1271/bbb.120076; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; Miranda LS, 2017, MARINE BIODIVERSITY, P1; MORAN NA, 1994, ANNU REV ECOL SYST, V25, P573, DOI 10.1146/annurev.es.25.110194.003041; Pechenik J., 1999, BIOL INVERTEBRATES; Purcell JE, 1999, MAR ECOL PROG SER, V180, P187, DOI 10.3354/meps180187; Reitzel AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-230; Seipel K, 2006, INT J DEV BIOL, V50, P589, DOI 10.1387/ijdb.062150ks; SPANGENBERG DB, 1971, J EXP ZOOL, V178, P183, DOI 10.1002/jez.1401780205; SPANGENBERG DB, 1967, J EXP ZOOL, V165, P441, DOI 10.1002/jez.1401650312; Straehler-Pohl I, 2005, MAR BIOL, V147, P1271, DOI 10.1007/s00227-005-0031-4; Toshino S, 2015, EVOL DEV, V17, P231, DOI 10.1111/ede.12127; Werner B., 1973, Publications Seto Mar Biol Lab, V20, P35; WERNER B, 1971, NATURE, V232, P582, DOI 10.1038/232582a0; Yamamori L, 2017, ZOOL SCI, V34, P173, DOI 10.2108/zs160161; Zapata F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139068	35	12	13	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0188601	10.1371/journal.pone.0188601	http://dx.doi.org/10.1371/journal.pone.0188601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281657	Green Published, gold, Green Submitted			2022-12-26	WOS:000419006200008
J	Lesage-Padilla, A; Forde, N; Poiree, M; Healey, GD; Giraud-Delville, C; Reinaud, P; Eozenou, C; Carvalho, AV; Galio, L; Raliou, M; Oudin, JF; Richard, C; Sheldon, IM; Charpigny, G; Lonergan, P; Sandra, O				Lesage-Padilla, Audrey; Forde, Niamh; Poiree, Melanie; Healey, Gareth D.; Giraud-Delville, Corinne; Reinaud, Pierrette; Eozenou, Caroline; Carvalho, Anais Vitorino; Galio, Laurent; Raliou, Mariam; Oudin, Jean-Francois; Richard, Christophe; Sheldon, I. Martin; Charpigny, Gilles; Lonergan, Pat; Sandra, Olivier			Maternal metabolism affects endometrial expression of oxidative stress and FOXL2 genes in cattle	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXL2; NEGATIVE-ENERGY-BALANCE; POSTPARTUM DAIRY-COWS; EARLY-PREGNANCY; EMBRYO-TRANSFER; ESTROUS-CYCLE; FOLLICULAR DEVELOPMENT; CONCEPTUS ELONGATION; SIGNALING PATHWAYS; EARLY LACTATION	Intensive selection for milk production has led to reduced reproductive efficiency in high-producing dairy cattle. The impact of intensive milk production on oocyte quality as well as early embryo development has been established but few analyses have addressed this question at the initiation of implantation, a critical milestone ensuring a successful pregnancy and normal post-natal development. Our study aimed to determine if contrasted maternal metabolism affects the previously described sensory properties of the endometrium to the conceptus in cattle. Following embryo transfer at Day 7 post-oestrus, endometrial caruncular (CAR) and intercaruncular (ICAR) areas were collected at Day 19 from primiparous postpartum Holstein-Friesian cows that were dried-off immediately after parturition (i.e., never milked; DRY) or milked twice daily (LACT). Gene quantification indicated no significant impact of lactation on endometrial expression of transcripts previously reported as conceptus-regulated (PLET1, PTGS2, SOCS6) and interferon-tau stimulated (RSAD2, SOCS1, SOCS3, STAT1) factors or known as female hormone-regulated genes (FOXL2, SCARA5, PTGS2). Compared with LACT cows, DRY cows exhibited mRNA levels with increased expression for FOXL2 transcription factor and decreased expression for oxidative stress-related genes (CAT, SOD1, SOD2). In vivo and in vitro experiments highlighted that neither interferon-tau nor FOXL2 were involved in transcriptional regulation of CAT, SOD1 and SOD2. In addition, our data showed that variations in maternal metabolism had a higher impact on gene expression in ICAR areas. Collectively, our findings prompt the need to fully understand the extent to which modifications in endometrial physiology drive the trajectory of conceptus development from implantation onwards when maternal metabolism is altered.	[Lesage-Padilla, Audrey; Poiree, Melanie; Giraud-Delville, Corinne; Reinaud, Pierrette; Eozenou, Caroline; Carvalho, Anais Vitorino; Galio, Laurent; Raliou, Mariam; Oudin, Jean-Francois; Richard, Christophe; Charpigny, Gilles; Sandra, Olivier] Univ Paris Saclay, ENVA, INRA, UMR BDR, Jouy En Josas, France; [Forde, Niamh; Lonergan, Pat] Univ Coll Dublin, Sch Agr & Food Sci, Dublin, Ireland; [Healey, Gareth D.; Sheldon, I. Martin] Swansea Univ, Med Sch, Inst Life Sci, Swansea, W Glam, Wales; [Forde, Niamh] Univ Leeds, Sch Med, Leeds Inst Cardiovasc & Mol Med, Div Reprod & Early Dev, Clarendon Way, Leeds, W Yorkshire, England	Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; UDICE-French Research Universities; Universite Paris Saclay; University College Dublin; Swansea University; University of Leeds	Sandra, O (corresponding author), Univ Paris Saclay, ENVA, INRA, UMR BDR, Jouy En Josas, France.	olivier.sandra@inra.fr	Healey, Gareth/T-5948-2019; Sheldon, I Martin/E-1567-2013	Healey, Gareth/0000-0001-9531-1220; Sheldon, I Martin/0000-0001-7902-5558; EOZENOU, Caroline/0000-0001-6968-0110; Forde, Niamh/0000-0002-3539-9643; GALIO, Laurent/0000-0003-1520-8181	European Union Seventh Framework Programme FP7 ('FECUND') [312097]; UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I017240/1]; French Ministry for Teaching and Research Doctoral School Universite Paris Saclay [ED568]; BBSRC [BB/I017240/1] Funding Source: UKRI	European Union Seventh Framework Programme FP7 ('FECUND'); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); French Ministry for Teaching and Research Doctoral School Universite Paris Saclay; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement no 312097 ('FECUND', http://www.fecund-project.eu/) to PL and OS; by UK Biotechnology and Biological Sciences Research Council (BBSRC; BB/I017240/1) to MS. AL, CE and AVC were PhD recipient from the French Ministry for Teaching and Research Doctoral School ED568 Universite Paris Saclay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Gubory KH, 2016, SMALL RUMINANT RES, V141, P77, DOI 10.1016/j.smallrumres.2016.07.006; Al-Gubory KH, 2012, INT J BIOCHEM CELL B, V44, P1511, DOI 10.1016/j.biocel.2012.06.017; Al-Katanani YM, 2002, THERIOGENOLOGY, V58, P171, DOI 10.1016/S0093-691X(02)00916-0; [Anonymous], BIOL REPROD; Arosh JA, 2002, BIOL REPROD, V67, P161, DOI 10.1095/biolreprod67.1.161; Batista F, 2007, P NATL ACAD SCI USA, V104, P3330, DOI 10.1073/pnas.0611326104; Bazer FW, 2010, MOL HUM REPROD, V16, P135, DOI 10.1093/molehr/gap095; Bazer FW, 2008, REPROD BIOL, V8, P179, DOI 10.1016/S1642-431X(12)60012-6; Benayoun BA, 2011, HUM MOL GENET, V20, P1673, DOI 10.1093/hmg/ddr042; Benayoun BA, 2009, HUM MOL GENET, V18, P632, DOI 10.1093/hmg/ddn389; Bernabucci U, 2005, J DAIRY SCI, V88, P2017, DOI 10.3168/jds.S0022-0302(05)72878-2; Biase FH, 2016, P NATL ACAD SCI USA, V113, P14492, DOI 10.1073/pnas.1520945114; Broughton DE, 2017, FERTIL STERIL, V107, DOI 10.1016/j.fertnstert.2017.01.017; Butler WR, 2003, LIVEST PROD SCI, V83, P211, DOI 10.1016/S0301-6226(03)00112-X; Carter F, 2008, REPROD FERT DEVELOP, V20, P368, DOI 10.1071/RD07204; Carvalho AV, 2016, REPROD FERT DEVELOP, V28, P459, DOI 10.1071/RD14034; Carvalho AV, 2014, REPRODUCTION, V148, P545, DOI 10.1530/REP-14-0214; Castillo C, 2005, VET J, V169, P286, DOI 10.1016/j.tvjl.2004.02.001; Cerri RLA, 2012, J DAIRY SCI, V95, P5657, DOI 10.3168/jds.2011-5114; Charpigny G, 1997, ENDOCRINOLOGY, V138, P2163, DOI 10.1210/en.138.5.2163; Collard BL, 2000, J DAIRY SCI, V83, P2683, DOI 10.3168/jds.S0022-0302(00)75162-9; Cronin JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092718; Degrelle SA, 2005, DEV BIOL, V288, P448, DOI 10.1016/j.ydbio.2005.09.043; Demetrio DGB, 2007, J DAIRY SCI, V90, P5073, DOI 10.3168/jds.2007-0223; Diskin MG, 2008, REPROD DOMEST ANIM, V43, P260, DOI 10.1111/j.1439-0531.2008.01171.x; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Elzaiat M, 2017, CLIN GENET, V91, P173, DOI 10.1111/cge.12862; Eozenou C, 2013, BIOL REPRODUCTION S, P337; Eozenou C, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101584; Forde N, 2011, BIOL REPROD, V85, P144, DOI 10.1095/biolreprod.110.090019; Forde N, 2009, BIOL REPROD, V81, P784, DOI 10.1095/biolreprod.108.074336; Forde N, 2016, REPROD FERT DEVELOP, V28, P1882, DOI 10.1071/RD14348; Friggens NC, 2010, ANIMAL, V4, P1197, DOI 10.1017/S1751731109991601; Gonzalez-Recio O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051816; Gray CA, 2001, BIOL REPROD, V64, P1608, DOI 10.1095/biolreprod64.6.1608; Hasler JF, 2001, THERIOGENOLOGY, V56, P1401, DOI 10.1016/S0093-691X(01)00643-4; Hue I, 2016, REPROD FERT DEVELOP, V28, P51, DOI 10.1071/RD15355; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Jarvie E, 2010, CLIN SCI, V119, P123, DOI 10.1042/CS20090640; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lee KY, 2004, REPRODUCTION, V128, P679, DOI 10.1530/rep.1.00340; Leroy JLMR, 2015, REPROD FERT DEVELOP, V27, P693, DOI 10.1071/RD14363; LUCY MC, 1992, REPROD NUTR DEV, V32, P331, DOI 10.1051/rnd:19920403; Mansouri-Attia N, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101121; Mansouri-Attia N, 2009, PHYSIOL GENOMICS, V39, P14, DOI 10.1152/physiolgenomics.90404.2008; Mansouri-Attia N, 2009, P NATL ACAD SCI USA, V106, P5687, DOI 10.1073/pnas.0812722106; Norman HD, 2009, J DAIRY SCI, V92, P3517, DOI 10.3168/jds.2008-1768; Omidi A, 2016, J DAIRY RES, P1; Pannetier M, 2005, GENOMICS, V85, P715, DOI 10.1016/j.ygeno.2005.02.011; Ramos RS, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0036-x; Roberts RM, 2008, SEMIN CELL DEV BIOL, V19, P170, DOI 10.1016/j.semcdb.2007.10.007; Sandra O, 2017, ANNU REV ANIM BIOSCI, V5, P205, DOI 10.1146/annurev-animal-022516-022900; Sandra O, 2015, J REPROD IMMUNOL, V108, P105, DOI 10.1016/j.jri.2014.12.005; Sandra O, 2012, REPROD FERT DEVELOP, V24, P68, DOI 10.1071/RD11908; Sartori R, 2010, REPROD FERT DEVELOP, V22, P151, DOI 10.1071/RD09221; Silva JCE, 2002, THERIOGENOLOGY, V58, P51; Song G, 2007, REPRODUCTION, V133, P285, DOI 10.1530/REP-06-0092; Spencer TE, 2017, REPROD FERT DEVELOP, V29, P84, DOI [10.1071/RD16359, 10.1071/rd16359]; Spencer TE, 2004, REPRODUCTION, V128, P657, DOI 10.1530/rep.1.00398; Spencer TE, 2008, REPRODUCTION, V135, P165, DOI 10.1530/REP-07-0327; Spencer TE, 2016, J DAIRY SCI, V99, P5941, DOI 10.3168/jds.2015-10070; Spencer TE, 2012, MOL CELL ENDOCRINOL, V354, P34, DOI 10.1016/j.mce.2011.09.035; Thompson IM, 2012, J DAIRY SCI, V95, P5645, DOI 10.3168/jds.2011-5113; Valour D, 2014, PHYSIOL GENOMICS, V46, P39, DOI 10.1152/physiolgenomics.00091.2013; Vasconcelos JLM, 2006, THERIOGENOLOGY, V65, P192, DOI 10.1016/j.theriogenology.2005.09.030; Walker CG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-474; Wathes DC, 2007, THERIOGENOLOGY, V68, pS232, DOI 10.1016/j.theriogenology.2007.04.006; Wathes DC, 2009, PHYSIOL GENOMICS, V39, P1, DOI 10.1152/physiolgenomics.00064.2009; Wilson RD, 2006, THERIOGENOLOGY, V65, P1007, DOI 10.1016/j.theriogenology.2005.07.007	69	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189942	10.1371/journal.pone.0189942	http://dx.doi.org/10.1371/journal.pone.0189942			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281695	Green Submitted, Green Published, gold			2022-12-26	WOS:000419006200054
J	Loeschcke, A; Dienst, D; Wewer, V; Hage-Hulsmann, J; Dietsch, M; Kranz-Finger, S; Huren, V; Metzger, S; Urlacher, VB; Gigolashvili, T; Kopriva, S; Axmann, IM; Drepper, T; Jaeger, KE				Loeschcke, Anita; Dienst, Dennis; Wewer, Vera; Hage-Huelsmann, Jennifer; Dietsch, Maximilian; Kranz-Finger, Sarah; Hueren, Vanessa; Metzger, Sabine; Urlacher, Vlada B.; Gigolashvili, Tamara; Kopriva, Stanislav; Axmann, Ilka M.; Drepper, Thomas; Jaeger, Karl-Erich			The photosynthetic bacteria Rhodobacter capsulatus and Synechocystis sp PCC 6803 as new hosts for cyclic plant triterpene biosynthesis	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; HETEROLOGOUS EXPRESSION; OXIDOSQUALENE CYCLASE; LOTUS-JAPONICUS; BIOTECHNOLOGICAL PRODUCTION; CYANOBACTERIAL INOCULATION; HYDROCARBON PRODUCTION; CYCLOARTENOL SYNTHASE; SQUALENE SYNTHASE; MOLECULAR-CLONING	Cyclic triterpenes constitute one of the most diverse groups of plant natural products. Besides the intriguing biochemistry of their biosynthetic pathways, plant triterpenes exhibit versatile bioactivities, including antimicrobial effects against plant and human pathogens. While prokaryotes have been extensively used for the heterologous production of other classes of terpenes, the synthesis of cyclic triterpenes, which inherently includes the two-step catalytic formation of the universal linear precursor 2,3-oxidosqualene, is still a major challenge. We thus explored the suitability of the metabolically versatile photosynthetic alpha-proteobacterium Rhodobacter capsulatus SB1003 and cyanobacterium Synechocystis sp. PCC 6803 as alternative hosts for biosynthesis of cyclic plant triterpenes. Therefore, 2,3-oxidosqualene production was implemented and subsequently combined with different cyclization reactions catalyzed by the representative oxidosqualene cyclases CAS1 (cycloartenol synthase), LUP1 (lupeol synthase), THAS1 (thalianol synthase) and MRN1 (marneral synthase) derived from model plant Arabidopsis thaliana. While successful accumulation of 2,3-oxidosqualene could be detected by LC-MS analysis in both hosts, cyclase expression resulted in differential production profiles. CAS1 catalyzed conversion to only cycloartenol, but expression of LUP1 yielded lupeol and a triterpenoid matching an oxidation product of lupeol, in both hosts. In contrast, THAS1 expression did not lead to cyclic product formation in either host, whereas MRN1-dependent production of marnerol and hydroxymarnerol was observed in Synechocystis but not in R. capsulatus. Our findings thus indicate that 2,3-oxidosqualene cyclization in heterologous phototrophic bacteria is basically feasible but efficient conversion depends on both the respective cyclase enzyme and individual host properties. Therefore, photosynthetic alpha-proteo- and cyanobacteria are promising alternative candidates for providing new bacterial access to the broad class of triterpenes for biotechnological applications.	[Loeschcke, Anita; Hage-Huelsmann, Jennifer; Drepper, Thomas; Jaeger, Karl-Erich] Heinrich Heine Univ Dusseldorf, Inst Mol Enzyme Technol, Forschungszentrum Julich, Julich, Germany; [Loeschcke, Anita; Dienst, Dennis; Wewer, Vera; Hage-Huelsmann, Jennifer; Dietsch, Maximilian; Kranz-Finger, Sarah; Hueren, Vanessa; Metzger, Sabine; Urlacher, Vlada B.; Gigolashvili, Tamara; Kopriva, Stanislav; Axmann, Ilka M.; Drepper, Thomas; Jaeger, Karl-Erich] Cluster Excellence Plant Sci CEPLAS, Dusseldorf, Germany; [Dienst, Dennis; Dietsch, Maximilian; Hueren, Vanessa; Axmann, Ilka M.] Heinrich Heine Univ Dusseldorf, Inst Synthet Microbiol, Dept Biol, Dusseldorf, Germany; [Wewer, Vera; Metzger, Sabine] Univ Cologne, Dept Biol, MS Platform, Cologne, Germany; [Kranz-Finger, Sarah; Urlacher, Vlada B.] Heinrich Heine Univ Dusseldorf, Inst Biochem 2, Dept Chem, Dusseldorf, Germany; [Gigolashvili, Tamara; Kopriva, Stanislav] Univ Cologne, Bot Inst, Cologne, Germany; [Jaeger, Karl-Erich] Forschungszentrum Julich, Inst Bio & Geosci IBG 1, Julich, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; University of Cologne; Heinrich Heine University Dusseldorf; University of Cologne; Heinrich Heine University Dusseldorf; University of Cologne; Helmholtz Association; Research Center Julich	Drepper, T (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Mol Enzyme Technol, Forschungszentrum Julich, Julich, Germany.; Axmann, IM; Drepper, T (corresponding author), Cluster Excellence Plant Sci CEPLAS, Dusseldorf, Germany.; Axmann, IM (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Synthet Microbiol, Dept Biol, Dusseldorf, Germany.	llka.Axmann@uni-duesseldorf.de; t.drepper@fz-julich.de	Urlacher, Vlada B./AAV-5999-2021; jaeger, karl/ABB-1955-2020; Dienst, Dennis/AAA-4595-2021; Drepper, Thomas/ABA-8291-2020; Kopriva, Stanislav/C-7401-2013; drepper, thomas/ABB-4717-2020	Urlacher, Vlada B./0000-0003-1312-4574; Dienst, Dennis/0000-0001-9217-8364; Drepper, Thomas/0000-0002-0096-8084; Kopriva, Stanislav/0000-0002-7416-6551; drepper, thomas/0000-0002-0096-8084; Wewer, Vera/0000-0002-0199-5228; Gigolashvili, Tamara/0000-0002-0416-4796	Deutsche Forschungsgemeinschaft via CEPLAS - Cluster of Excellence on Plant Science [EXC1028]; Ministry of Innovation, Science and Research of the German State of North Rhine-Westphalia within the NRW Strategieprojekt BioSC [313/323-400-00213]	Deutsche Forschungsgemeinschaft via CEPLAS - Cluster of Excellence on Plant Science; Ministry of Innovation, Science and Research of the German State of North Rhine-Westphalia within the NRW Strategieprojekt BioSC	This work was supported by the Deutsche Forschungsgemeinschaft via CEPLAS - Cluster of Excellence on Plant Science (EXC1028) and by the Ministry of Innovation, Science and Research of the German State of North Rhine-Westphalia within the framework of the NRW Strategieprojekt BioSC (No. 313/323-400-00213). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak A, 2016, J PLANT NUTR, V39, P1216, DOI 10.1080/01904167.2016.1148723; Agger SA, 2008, J BACTERIOL, V190, P6084, DOI 10.1128/JB.00759-08; Al-Haj Lamya, 2016, Life-Basel, V6, P42, DOI 10.3390/life6040042; Alder A, 2009, FEBS J, V276, P5416, DOI 10.1111/j.1742-4658.2009.07224.x; ARMSTRONG GA, 1990, J BIOL CHEM, V265, P8329; ARMSTRONG GA, 1994, J BACTERIOL, V176, P4795, DOI 10.1128/jb.176.16.4795-4802.1994; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Babiychuk E, 2008, P NATL ACAD SCI USA, V105, P3163, DOI 10.1073/pnas.0712190105; Banta AB, 2017, P NATL ACAD SCI USA, V114, P245, DOI 10.1073/pnas.1617231114; Beekwilder J, 2014, PLANT BIOTECHNOL J, V12, P174, DOI 10.1111/pbi.12124; Bentley FK, 2014, MOL PLANT, V7, P71, DOI 10.1093/mp/sst134; Bentley FK, 2013, BIOENERG RES, V6, P917, DOI 10.1007/s12155-013-9325-4; Beyer HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137652; Busquets A, 2008, PLANT MOL BIOL, V67, P25, DOI 10.1007/s11103-008-9299-3; Chen MW, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-20; Choi SY, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0617-8; Chung PY, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-25; COREY EJ, 1993, P NATL ACAD SCI USA, V90, P11628, DOI 10.1073/pnas.90.24.11628; Davies Fiona K, 2014, Front Bioeng Biotechnol, V2, P21, DOI 10.3389/fbioe.2014.00021; Delis C, 2011, NEW PHYTOL, V189, P335, DOI 10.1111/j.1469-8137.2010.03463.x; Diaz AM, 2000, BIOL PHARM BULL, V23, P1307, DOI 10.1248/bpb.23.1307; Dutton A, 2002, J CHEM ECOL, V28, P103, DOI 10.1023/A:1013514903036; Dziggel C, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600145; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; Englund E, 2015, ACS SYNTH BIOL, V4, P1270, DOI 10.1021/acssynbio.5b00070; Englund E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090270; Fazio GC, 2004, J AM CHEM SOC, V126, P5678, DOI 10.1021/ja0318784; Field B, 2011, P NATL ACAD SCI USA, V108, P16116, DOI 10.1073/pnas.1109273108; Formighieri C, 2016, PHOTOSYNTH RES, V130, P123, DOI 10.1007/s11120-016-0233-2; Gamal-Eldin H, 2011, CURR MICROBIOL, V62, P391, DOI 10.1007/s00284-010-9719-x; Gao X, 2016, ENERG ENVIRON SCI, V9, P1400, DOI 10.1039/c5ee03102h; Georg J, 2014, PLANT CELL, V26, P3661, DOI 10.1105/tpc.114.129767; Go YS, 2012, PLANT J, V72, P791, DOI 10.1111/j.1365-313X.2012.05120.x; GOLLUB EG, 1977, J BIOL CHEM, V252, P2846; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hayashi H, 2000, BIOL PHARM BULL, V23, P231, DOI 10.1248/bpb.23.231; Heck A, 2017, MODERN TOPICS PHOTOT, P395, DOI DOI 10.1007/978-3-319-46261-5_12; Herrera JBR, 1998, PHYTOCHEMISTRY, V49, P1905, DOI 10.1016/S0031-9422(98)00366-5; Iturbe-Ormaetxe I, 2003, PLANT MOL BIOL, V51, P731, DOI 10.1023/A:1022519709298; Jongedijk E, 2016, APPL MICROBIOL BIOT, V100, P2927, DOI 10.1007/s00253-016-7337-7; Katzke N, 2010, PROTEIN EXPRES PURIF, V69, P137, DOI 10.1016/j.pep.2009.08.008; Ke N, 2005, ARCH BIOCHEM BIOPHYS, V436, P110, DOI 10.1016/j.abb.2005.01.011; Kemen AC, 2014, P NATL ACAD SCI USA, V111, P8679, DOI 10.1073/pnas.1401553111; Khan NE, 2015, BIOTECHNOL BIOENG, V112, P1523, DOI 10.1002/bit.25573; KLIPP W, 1988, J BACTERIOL, V170, P693, DOI 10.1128/jb.170.2.693-699.1988; Krokida A, 2013, NEW PHYTOL, V200, P675, DOI 10.1111/nph.12414; Kushiro T, 1998, EUR J BIOCHEM, V256, P238, DOI 10.1046/j.1432-1327.1998.2560238.x; Kushiro T, 2006, ORG LETT, V8, P5589, DOI 10.1021/ol062310d; Laden BP, 2000, ARCH BIOCHEM BIOPHYS, V374, P381, DOI 10.1006/abbi.1999.1629; Li DS, 2016, BIOTECHNOL LETT, V38, P603, DOI 10.1007/s10529-015-2032-9; Liang YL, 2012, LETT APPL MICROBIOL, V55, P323, DOI 10.1111/j.1472-765X.2012.03295.x; Loeschcke A, 2013, ACS SYNTH BIOL, V2, P22, DOI 10.1021/sb3000657; Lu WQ, 2014, BIOTECHNOL BIOENG, V111, P761, DOI 10.1002/bit.25130; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Majdi M, 2016, APPL MICROBIOL BIOT, V100, P1041, DOI 10.1007/s00253-015-7128-6; Mannowetz N, 2017, P NATL ACAD SCI USA, V114, P5743, DOI 10.1073/pnas.1700367114; McKersie B, 2015, J EXP BOT, V66, P3435, DOI 10.1093/jxb/eru547; Milla P, 2002, LIPIDS, V37, P1171, DOI 10.1007/s11745-002-1017-9; Milla P, 2002, J BIOL CHEM, V277, P2406, DOI 10.1074/jbc.M104195200; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Moshelion M, 2015, TRENDS BIOTECHNOL, V33, P337, DOI 10.1016/j.tibtech.2015.03.001; NAKASHIMA T, 1995, P NATL ACAD SCI USA, V92, P2328, DOI 10.1073/pnas.92.6.2328; Pattanaik Bagmi, 2015, Life-Basel, V5, P269, DOI 10.3390/life5010269; Peca L, 2007, ACTA BIOL HUNG, V58, P11, DOI 10.1556/ABiol.58.2007.Suppl.2; Prasanna R, 2015, ECOL ENG, V84, P532, DOI 10.1016/j.ecoleng.2015.09.033; Priya H, 2015, MICROBIOL RES, V171, P78, DOI 10.1016/j.micres.2014.12.011; Rasbery JM, 2007, J BIOL CHEM, V282, P17002, DOI 10.1074/jbc.M611831200; Rezanka T., 2009, Anti-Infective Agents in Medicinal Chemistry, V8, P193; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Robert F, 2010, CURR OPIN MICROBIOL, V13, P301, DOI 10.1016/j.mib.2010.02.007; Salmon M, 2016, P NATL ACAD SCI USA, V113, pE4407, DOI 10.1073/pnas.1605509113; Segura MJR, 2000, ORG LETT, V2, P2257, DOI 10.1021/ol006016b; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Singh S, 2014, J APPL MICROBIOL, V117, P1221, DOI 10.1111/jam.12612; Strnad H, 2010, J BACTERIOL, V192, P3545, DOI 10.1128/JB.00366-10; Szakiel A, 2012, PHYTOCHEM REV, V11, P263, DOI 10.1007/s11101-012-9241-9; Takaichi S, 2007, CELL MOL LIFE SCI, V64, P2607, DOI 10.1007/s00018-007-7190-z; Thimmappa R, 2014, ANNU REV PLANT BIOL, V65, P225, DOI 10.1146/annurev-arplant-050312-120229; Wang X, 2016, P NATL ACAD SCI USA, V113, P14225, DOI 10.1073/pnas.1613340113; WEAVER PF, 1975, ARCH MICROBIOL, V105, P207, DOI 10.1007/BF00447139; Wink Michael, 2015, Medicines (Basel), V2, P251, DOI 10.3390/medicines2030251; Wlodarczyk A, 2016, METAB ENG, V33, P1, DOI 10.1016/j.ymben.2015.10.009; [席佳 XI Jia], 2009, [中国新药杂志, Chinese Journal New Drugs], V18, P507; Xie M, 2017, APPL MICROBIOL BIOT, V101, P905, DOI 10.1007/s00253-016-8064-9; Xiong QB, 2006, ANGEW CHEM INT EDIT, V45, P1285, DOI 10.1002/anie.200503420; Xue Y, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00057; Yamaguchi H, 2008, J HEALTH SCI, V54, P654, DOI 10.1248/jhs.54.654; Zhang LF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130904; Zinchenko VV, 1999, RUSS J GENET+, V35, P228	89	20	20	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189816	10.1371/journal.pone.0189816	http://dx.doi.org/10.1371/journal.pone.0189816			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281679	Green Submitted, gold, Green Published			2022-12-26	WOS:000419006200045
J	Dona, O; Hall, GB; Noseworthy, MD				Dona, Olga; Hall, Geoffrey B.; Noseworthy, Michael D.			Temporal fractal analysis of the rs-BOLD signal identifies brain abnormalities in autism spectrum disorder	PLOS ONE			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; SPONTANEOUS FLUCTUATIONS; CORPUS-CALLOSUM; IMAGING DATA; TIME-SERIES; AMYGDALA; COMPLEXITY; CHILDREN	Background Brain connectivity in autism spectrum disorders (ASD) has proven difficult to characterize due to the heterogeneous nature of the spectrum. Connectivity in the brain occurs in a complex, multilevel and multi-temporal manner, driving the fluctuations observed in local oxygen demand. These fluctuations can be characterized as fractals, as they auto-correlate at different time scales. In this study, we propose a model-free complexity analysis based on the fractal dimension of the rs-BOLD signal, acquired with magnetic resonance imaging. The fractal dimension can be interpreted as measure of signal complexity and connectivity. Previous studies have suggested that reduction in signal complexity can be associated with disease. Therefore, we hypothesized that a detectable difference in rs-BOLD signal complexity could be observed between ASD patients and Controls. Methods and findings Anatomical and functional data from fifty-five subjects with ASD (12.7 +/- 2.4 y/o) and 55 age-matched (14.1 +/- 3.1 y/o) healthy controls were accessed through the NITRC database and the ABIDE project. Subjects were scanned using a 3T GE Signa MRI and a 32-channel RF-coil. Axial FSPGR-3D images were used to prescribe rs-BOLD (TE/TR = 30/2000ms) where 300 time points were acquired. Motion correction was performed on the functional data and anatomical and functional images were aligned and spatially warped to the N27 standard brain atlas. Fractal analysis, performed on a grey matter mask, was done by estimating the Hurst exponent in the frequency domain using a power spectral density approach and refining the estimation in the time domain with de-trended fluctuation analysis and signal summation conversion methods. Voxel-wise fractal dimension (FD) was calculated for every subject in the control group and in the ASD group to create ROI-based Z-scores for the ASD patients. Voxel-wise validation of FD normality across controls was confirmed, and non-Gaussian voxels were eliminated from subsequent analysis. To maintain a 95% confidence level, only regions where Z-score values were at least 2 standard deviations away from the mean (i.e. where |Z| > 2.0) were included in the analysis. We found that the main regions, where signal complexity significantly decreased among ASD patients, were the amygdala (p = 0.001), the vermis (p = 0.02), the basal ganglia (p = 0.01) and the hippocampus (p = 0.02). No regions reported significant increase in signal complexity in this study. Our findings were correlated with ADIR and ADOS assessment tools, reporting the highest correlation with the ADOS metrics. Conclusions Brain connectivity is best modeled as a complex system. Therefore, a measure of complexity as the fractal dimension of fluctuations in brain oxygen demand and utilization could provide important information about connectivity issues in ASD. Moreover, this technique can be used in the characterization of a single subject, with respect to controls, without the need for group analysis. Our novel approach provides an ideal avenue for personalized diagnostics, thus providing unique patient specific assessment that could help in individualizing treatments.	[Dona, Olga; Noseworthy, Michael D.] McMaster Univ, McMaster Sch Biomed Engn, Hamilton, ON, Canada; [Dona, Olga; Hall, Geoffrey B.; Noseworthy, Michael D.] St Josephs Healthcare, Imaging Res Ctr, Hamilton, ON, Canada; [Noseworthy, Michael D.] McMaster Univ, Dept Elect & Comp Engn, Engn Technology Bldg, Hamilton, ON, Canada; [Noseworthy, Michael D.] McMaster Univ, Dept Radiol, Hamilton, ON, Canada; [Hall, Geoffrey B.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Noseworthy, MD (corresponding author), McMaster Univ, McMaster Sch Biomed Engn, Hamilton, ON, Canada.; Noseworthy, MD (corresponding author), St Josephs Healthcare, Imaging Res Ctr, Hamilton, ON, Canada.; Noseworthy, MD (corresponding author), McMaster Univ, Dept Elect & Comp Engn, Engn Technology Bldg, Hamilton, ON, Canada.; Noseworthy, MD (corresponding author), McMaster Univ, Dept Radiol, Hamilton, ON, Canada.	nosewor@mcmaster.ca	; Noseworthy, Michael/B-2957-2011	/0000-0002-3398-6692; Noseworthy, Michael/0000-0003-1464-159X				Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Aylward EH, 1999, NEUROLOGY, V53, P2145, DOI 10.1212/WNL.53.9.2145; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; BASSINGTHWAIGHTE JB, 1995, ANN BIOMED ENG, V23, P491, DOI 10.1007/BF02584449; Betancur C, 2000, BRAIN RES, V1380, P836; Bullmore ET, 2009, NEUROIMAGE, V47, P1125, DOI 10.1016/j.neuroimage.2009.05.032; Carper RA, 2000, BRAIN, V123, P836, DOI 10.1093/brain/123.4.836; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Chevallier C, 2012, TRENDS COGN SCI, V16, P231, DOI 10.1016/j.tics.2012.02.007; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Dona O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169647; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eke A, 2000, PFLUG ARCH EUR J PHY, V439, P403, DOI 10.1007/s004249900135; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; El Boustani S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000519; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Gomez C, 2009, MED ENG PHYS, V31, P306, DOI 10.1016/j.medengphy.2008.06.010; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Herman P, 2011, NEUROIMAGE, V58, P1060, DOI 10.1016/j.neuroimage.2011.06.082; Herrington JD, 2016, SOC COGN AFFECT NEUR, V11, P907, DOI 10.1093/scan/nsw015; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Jann K, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.358; Jung M, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-35; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kana RK, 2006, BRAIN, V129, P2484, DOI 10.1093/brain/awl164; Kannathal N, 2004, P ANN INT IEEE EMBS, V26, P604; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Kosaka H, 2010, NEUROIMAGE, V50, P1357, DOI 10.1016/j.neuroimage.2010.01.085; Kwan V, 2016, CELL REP, V17, P1892, DOI 10.1016/j.celrep.2016.10.047; Leergaard TB, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00014; Li XL, 2005, J NEURAL ENG, V2, P11, DOI 10.1088/1741-2560/2/2/002; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Logothetis NK, 2003, CURR OPIN NEUROBIOL, V13, P630, DOI 10.1016/j.conb.2003.09.017; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mandelbrot JWV, 1967, SIAM REV, V10, P422; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; Mizuno A, 2006, BRAIN RES, V1104, P160, DOI 10.1016/j.brainres.2006.05.064; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Noonan SK, 2009, BRAIN RES, V1262, P48, DOI 10.1016/j.brainres.2008.12.076; Pelphrey KA, 2011, J CHILD PSYCHOL PSYC, V52, P631, DOI 10.1111/j.1469-7610.2010.02349.x; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Qiu AQ, 2010, J AM ACAD CHILD PSY, V49, P539, DOI 10.1016/j.jaac.2010.02.012; Rickles D, 2007, J EPIDEMIOL COMMUN H, V61, P933, DOI 10.1136/jech.2006.054254; Rutter M., 2003, SOCIAL COMMUNICATION; Sinha S, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.3.FOCUS1548; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; Smith T, 1999, CLIN PSYCHOL-SCI PR, V6, P33, DOI 10.1093/clipsy/6.1.33; Smits FM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149587; Spence SH, 1997, J ABNORM PSYCHOL, V106, P280, DOI 10.1037/0021-843X.106.2.280; Turner Katherine C, 2006, Behav Brain Funct, V2, P34, DOI 10.1186/1744-9081-2-34; van Steensel FJA, 2011, ANXIETY DISORDERS CH; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Warsi MA, 2012, MAGN RESON MATER PHY, V25, P335, DOI 10.1007/s10334-012-0312-0; Weber AM, 2014, MAGN RESON MATER PHY, V27, P291, DOI 10.1007/s10334-013-0420-5; Welch JM, 2007, CORTICO STRIATAL SYN; Welchew DE, 2005, BIOL PSYCHIAT, V57, P991, DOI 10.1016/j.biopsych.2005.01.028; Wicker B, 2008, SOC COGN AFFECT NEUR, V3, P135, DOI 10.1093/scan/nsn007; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006; Yoshikawa T, 2003, J NEUROL, V250, P194, DOI 10.1007/s00415-003-0972-9; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263	65	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190081	10.1371/journal.pone.0190081	http://dx.doi.org/10.1371/journal.pone.0190081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8ZJ	29272297	gold, Green Published, Green Submitted			2022-12-26	WOS:000418651500031
J	Fukushima, M; Tomioka, N; Jutagate, T; Hiroki, M; Murata, T; Preecha, C; Avakul, P; Phomikong, P; Imai, A				Fukushima, Michio; Tomioka, Noriko; Jutagate, Tuantong; Hiroki, Mikiya; Murata, Tomoyoshi; Preecha, Chatchai; Avakul, Piyathap; Phomikong, Pisit; Imai, Akio			The dynamics of pico-sized and bloom-forming cyanobacteria in large water bodies in the Mekong River Basin	PLOS ONE			English	Article							PICOPLANKTON; PHYTOPLANKTON; ABUNDANCE; RESERVOIR; THAILAND; CLIMATE; MARINE	In the face of plans for increased construction of dams and reservoirs in the Mekong River Basin, it is critically important to better understand the primary-producer community of phytoplankton, especially the warm-water cyanobacteria. This is because these algae can serve as the primary source of carbon for higher trophic levels, including fishes, but can also form harmful blooms, threatening local fisheries and environmental and human health. We monitored the dynamics of three cyanobacteria-Synechococcus spp., Microcystis aeruginosa, and Dolichospermum spp.-for two years in nine large lakes and reservoirs in the Mekong River Basin. The densities of these algae were largely system-specific such that their abundance was uniquely determined within individual water bodies. However, after accounting for the system-specific effect, we found that cell densities of Synechococcus spp., M. aeruginosa, and Dolichospermum spp. varied in response to changes in photosynthetically active radiation (PAR), total nitrogen, and water level, respectively. Because both PAR and water level tend to fluctuate concordantly over a wide geographic area, Synechococcus spp., and to a lesser extent Dolichospermum spp., varied synchronously among the water bodies. Sustaining the production of pico-sized primary producers while preventing harmful algal blooms will be a key management goal for the proposed reservoirs in the Mekong Basin.	[Fukushima, Michio; Hiroki, Mikiya] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan; [Tomioka, Noriko; Murata, Tomoyoshi] Natl Inst Environm Studies, Ctr Reg Environm Res, Tsukuba, Ibaraki, Japan; [Jutagate, Tuantong] Ubon Ratchathani Univ, Fac Agr, Ubon Ratchathani, Thailand; [Preecha, Chatchai] Khon Kaen Univ, Fac Appl Sci & Engn, Nong Khai, Thailand; [Avakul, Piyathap] Mahidol Univ, Nakhon Sawan Campus, Nakhon Sawan, Thailand; [Phomikong, Pisit] Dept Fisheries, Inland Fisheries Res & Dev Div, Bangkok, Thailand; [Imai, Akio] Natl Inst Environm Studies, Lake Biwa Branch Off, Otsu, Shiga, Japan	National Institute for Environmental Studies - Japan; National Institute for Environmental Studies - Japan; Ubon Ratchathani University; Khon Kaen University; Mahidol University	Fukushima, M (corresponding author), Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan.	michio@nies.go.jp		Fukushima, Michio/0000-0003-4099-0451	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [4D-1202]	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan)	This study was supported by the Environment Research and Technology Development Fund (grant no.:4D-1202, URL: http://www.env.go.jp/policy/kenkyu/suishin/gaiyou/0) of the Ministry of the Environment, Japan to MF.	Amarasinghe, 2009, NACA MONOGRAPH, V2; Bell T, 2001, LIMNOL OCEANOGR, V46, P1243, DOI 10.4319/lo.2001.46.5.1243; Bertazzini M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00288; Bright E. A., 2007, LANDSCAN 2006; Callieri C, 2006, FRESHWATER BIOL, V51, P263, DOI 10.1111/j.1365-2427.2005.01489.x; Callieri C, 2004, J PLANKTON RES, V26, P1471, DOI 10.1093/plankt/fbh134; Callieri C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109526; Callieri Cristiana, 2008, Freshwater Reviews, V1, P1, DOI 10.1608/FRJ-1.1.1; Campbell IC, 2009, AQUAT ECOL SER, P1; Carrick HJ, 1997, LIMNOL OCEANOGR, V42, P1613, DOI 10.4319/lo.1997.42.7.1613; Downing JA, 2001, CAN J FISH AQUAT SCI, V58, P1905, DOI 10.1139/cjfas-58-10-1905; Dugan PJ, 2010, AMBIO, V39, P344, DOI 10.1007/s13280-010-0036-1; Giani A, 2005, CAN J FISH AQUAT SCI, V62, P2100, DOI 10.1139/F05-124; GOPHEN M, 1984, OECOLOGIA, V64, P408, DOI 10.1007/BF00379140; Hart BT, 2001, TRANSBOUNDARY WATER; Hirose M, 2003, AQUAT ECOL, V37, P37, DOI 10.1023/A:1022128306570; Hortle K.G., 2007, MRC TECH PAP; Hortle KG, 2009, AQUAT ECOL-SAN DIEGO, P197, DOI 10.1016/B978-0-12-374026-7.00009-7; Jutagate T, 2003, FISHERIES MANAG ECOL, V10, P221, DOI 10.1046/j.1365-2400.2003.00338.x; Jutagate T., 2009, STATUS RESERVOIR FIS, P99; Legendre P, 2005, J AGR BIOL ENVIR ST, V10, P226, DOI 10.1198/108571105X46642; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Li XC, 2016, HARMFUL ALGAE, V54, P54, DOI 10.1016/j.hal.2015.10.015; Mahakhant Aparat, 1998, Phycological Research, V46, P25, DOI 10.1046/j.1440-1835.1998.00119.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Motwani NH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079230; MRC, 2005, OV HYDR MEK BAS; MRC - Mekong River Commission, 2008, 19 MRC; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2013, MICROB ECOL, V65, P995, DOI 10.1007/s00248-012-0159-y; Patton C.J., 2003, 034174 US DEP INT US; Peerapornpisal Y, 1999, JSM MYCOTOXINS S2, P257; Rainboth W J, 1996, FAO SPECIES IDENTIFI, P265; Raven JA, 1998, FUNCT ECOL, V12, P503, DOI 10.1046/j.1365-2435.1998.00233.x; Sarkkula J, 2004, CONTR 29 INT C LIMN; Sarmento H, 2008, FRESHWATER BIOL, V53, P756, DOI 10.1111/j.1365-2427.2007.01939.x; Schonhuber W, 1999, APPL ENVIRON MICROB, V65, P1259; SIMEK K, 1995, LIMNOL OCEANOGR, V40, P1077, DOI 10.4319/lo.1995.40.6.1077; Somdee T, 2013, ENVIRON MONIT ASSESS, V185, P9521, DOI 10.1007/s10661-013-3270-8; Somogyi B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174316; Stockner J, 2000, ECOLOGY CYANOBACTERI, P195, DOI [10.1007/0-306-46855-7_7, DOI 10.1007/0-306-46855-7_7]; STOCKNER JG, 1988, LIMNOL OCEANOGR, V33, P765, DOI 10.4319/lo.1988.33.4_part_2.0765; Takamura N, 2003, ECOL RES, V18, P381, DOI 10.1046/j.1440-1703.2003.00563.x; Tarbe AL, 2011, MICROB ECOL, V62, P314, DOI 10.1007/s00248-011-9817-8; Thothong W, 2011, AGR ECOSYST ENVIRON, V140, P521, DOI 10.1016/j.agee.2011.02.006; Tomioka N, 2011, J PLANKTON RES, V33, P1263, DOI 10.1093/plankt/fbr020; VOROS L, 1991, INT REV GES HYDROBIO, V76, P617, DOI 10.1002/iroh.19910760412; Weisburd Richard S. J., 1995, Japanese Journal of Limnology, V56, P221; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Winder M, 2009, J PLANKTON RES, V31, P1307, DOI 10.1093/plankt/fbp074; Wohlfarth B, 2012, GLOBAL PLANET CHANGE, V92-93, P148, DOI 10.1016/j.gloplacha.2012.05.008; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	52	8	9	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12								10.1371/journal.pone.0189609	http://dx.doi.org/10.1371/journal.pone.0189609			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272288	Green Submitted, gold, Green Published			2022-12-26	WOS:000418651500007
J	Yin, HC; Zhao, LL; Jiang, XJ; Li, SQ; Huo, H; Chen, HY				Yin, Haichang; Zhao, Lili; Jiang, Xinjie; Li, Siqi; Huo, Hong; Chen, Hongyan			DEV induce autophagy via the endoplasmic reticulum stress related unfolded protein response	PLOS ONE			English	Article							DUCK ENTERITIS VIRUS; ER STRESS; CELL; INFECTION; REPLICATION; INHIBITION; PATHWAY; CULTURE	Duck enteritis virus (DEV) can infect ducks, geese, and many other poultry species and leads to acute, septic and highly fatal infectious disease. Autophagy is an evolutionarily ancient pathway that plays an important role in many viral infections. We previously reported that DEV infection induces autophagy for its own benefit, but how this occurs remains unclear. In this study, endoplasmic reticulum (ER) stress was triggered by DEV infection, as demonstrated by the increased expression of the ER stress marker glucose-regulated protein 78 (GRP78) and the dilated morphology of the ER. Pathways associated with the unfolded protein response (UPR), including the PKR-like ER protein kinase (PERK) and inositol-requiring enzyme 1 (IRE1) pathways, but not the activating transcription factor 6 (ATF6) pathway, were activated in DEV-infected duck embryo fibroblast (DEF) cells. In addition, the knockdown of both PERK and IRE1 by small interfering RNAs (siRNAs) reduced the level of LC3-II and viral yields, which suggested that the PERK-eukaryotic initiation factor 2a (eIF2 alpha) and IRE1-x-box protein1 (XBP1) pathways may contribute to DEV-induced autophagy. Collectively, these data offer new insight into the mechanisms of DEV-induced autophagy through activation of the ER stress-related UPR pathway.	[Yin, Haichang; Zhao, Lili; Jiang, Xinjie; Li, Siqi; Huo, Hong; Chen, Hongyan] Chinese Acad Agr Sci, Harbin Vet Res Inst, Lab Anim & Comparat Med, Heilongjiang Prov Key Lab,State Key Lab Vet Biote, Harbin, Heilongjiang, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Chen, HY (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Lab Anim & Comparat Med, Heilongjiang Prov Key Lab,State Key Lab Vet Biote, Harbin, Heilongjiang, Peoples R China.	hychen@hvri.ac.cn			Chinese Academy of Agricultural Sciences Fundamental Scientific Research Funds [0302016013]	Chinese Academy of Agricultural Sciences Fundamental Scientific Research Funds	This work was supported by the Chinese Academy of Agricultural Sciences Fundamental Scientific Research Funds (0302016013). Lili Zhao is associated with the funding sources.	Alexander DE, 2007, J VIROL, V81, P12128, DOI 10.1128/JVI.01356-07; Ambrose RL, 2013, J VIROL, V87, P2206, DOI 10.1128/JVI.02097-12; Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Carpenter JE, 2011, J VIROL, V85, P9414, DOI 10.1128/JVI.00281-11; Cheng JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24721; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Esclatine A, 2009, CURR TOP MICROBIOL, V335, P33, DOI 10.1007/978-3-642-00302-8_2; Fung TS, 2015, VIRUSES-BASEL, V7, P2834, DOI 10.3390/v7062749; Gong J, 2017, J ZHEJIANG UNIV-SC B, V18, P1, DOI 10.1631/jzus.B1600043; Hassan H, 2016, J AM SOC NEPHROL, V27, P1055, DOI 10.1681/ASN.2015020191; Hou L, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-156; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Hu Y, 2009, VIRUS GENES, V38, P295, DOI 10.1007/s11262-009-0329-2; Jacolot S, 2008, BLOOD CELL MOL DIS, V41, P100, DOI 10.1016/j.bcmd.2008.01.006; Kania E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/352794; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Lv S, 2015, BIOCHEM BIOPH RES CO, V466, P406, DOI 10.1016/j.bbrc.2015.09.039; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074; Sandhu T. S, 2008, DIS POULTRY, P384; Shinohara Y, 2013, BIOCHEM BIOPH RES CO, V432, P326, DOI 10.1016/j.bbrc.2013.01.103; Trujillo-Alonso V, 2011, J VIROL, V85, P12594, DOI 10.1128/JVI.05620-11; Wati S, 2009, J VIROL, V83, P12871, DOI 10.1128/JVI.01419-09; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yin HC, 2017, J GEN VIROL, V98, P486, DOI 10.1099/jgv.0.000696; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhang YB, 2016, J VIROL METHODS, V232, P33, DOI 10.1016/j.jviromet.2016.02.001	31	18	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0189704	10.1371/journal.pone.0189704	http://dx.doi.org/10.1371/journal.pone.0189704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272280	gold, Green Submitted, Green Published			2022-12-26	WOS:000418651500010
J	Bastos, MS; Del Vesco, AP; Santana, TP; Santos, TS; de Oliveira, GM; Fernandes, RPM; Barbosa, LT; Gasparino, E				Bastos, Marisa Silva; Del Vesco, Ana Paula; Santana, Thais Pacheco; Santos, Thailine Santana; de Oliveira Junior, Gregorio Murilo; Miranda Fernandes, Roberta Pereira; Barbosa, Leandro Teixeira; Gasparino, Eliane			The role of cinnamon as a modulator of the expression of genes related to antioxidant activity and lipid metabolism of laying quails	PLOS ONE			English	Article							OXIDATIVE STRESS; FREE-RADICALS; EGG-PRODUCTION; SUPPLEMENTATION; PERFORMANCE; LIVER; HENS; ACID; INHIBITION; QUALITY	Since cinnamon has vitamins and minerals in addition to antioxidants compounds in its chemical composition studies have shown the potential of cinnamon supplementation on some important characteristics in the performance of birds. Thus, this study was conducted under the hypothesis that the inclusion of cinnamon in the laying quail diet could influence the performance of the birds through the expression of genes related to antioxidant activity and lipid metabolism. To test this hypothesis, 144 Japanese quail (Coturnix japonica) with an initial age of 18 weeks and average weight of 133g were distributed in a completely randomized design with two treatments: no cinnamon supplementation (NCS-control group) and with supplementation of 9g/kg of cinnamon powder (CPS). The experiment lasted for 84 days. At the end of the experimental period, six animals from each treatment were euthanized by cervical dislocation, blood was collected and organs weighed. Liver tissue was collected for gene expression and biochemical analyses. We observed a significant effect of cinnamon inclusion on the weight of the pancreas (P = 0.0418), intestine (P = 0.0209) and ovary (P = 0.0389). Lower weights of the pancreas and intestine, and a higher ovary weight was observed in birds receiving the CPS diet. Quails fed with cinnamon supplementation also had better feed conversion per egg mass (2.426 g/g, P = 0.0126), and higher triglyceride (1516.60 mg/dL, P = 0.0207), uric acid (7.40 mg/dL, P = 0.0003) and VLDL (300.40 mg/dL, P = 0.0252) contents. A decreased content of thiobarbituric acid reactive substances (TBARS) and lower catalase activity was observed in the liver of quails from the CPS diet (0.086 nmoles/mg PTN, and 2.304 H2O2/min/mg PTN, respectively). Quails from the CPS group presented significantly greater expression of FAS (fatty acid synthase, 36,03 AU), ACC (Acetyl-CoA Carboxylase, 31.33 AU), APOAI (apolipoprotein A-I, 803,9 AU), ESR2 (estrogen receptor 2, 0.73 AU) SOD (superoxide dismutase, 4,933.9 AU) and GPx7 (glutathione peroxidase 7, 9.756 AU) than quails from the control group. These results allow us to suggest that cinnamon powder supplementation in the diet of laying quails can promote balance in the metabolism and better performance through the modulation of antioxidant activity and the expression of genes related to lipid metabolism.	[Bastos, Marisa Silva; Del Vesco, Ana Paula; Santana, Thais Pacheco; Santos, Thailine Santana; de Oliveira Junior, Gregorio Murilo; Barbosa, Leandro Teixeira] Univ Fed Sergipe, Anim Sci Dept, Sao Cristovao S-N, Sao Cristovao, Sergipe, Brazil; [Miranda Fernandes, Roberta Pereira] Univ Fed Sergipe, Physiol Dept, Sao Cristovao S-N, Sao Cristovao, Sergipe, Brazil; [Gasparino, Eliane] Estadual Univ Maringa, Anim Sci Dept, Maringa, Parana, Brazil	Universidade Federal de Sergipe; Universidade Federal de Sergipe	Del Vesco, AP (corresponding author), Univ Fed Sergipe, Anim Sci Dept, Sao Cristovao S-N, Sao Cristovao, Sergipe, Brazil.	apaulavesco@gmail.com	Del Vesco, Ana/AAW-5174-2021; Barbosa, Leandro/V-3649-2019; Del+Vesco, Ana/AAT-5956-2021; Fernandes, Roberta/J-4301-2014	Del Vesco, Ana/0000-0002-0145-7817; Barbosa, Leandro/0000-0002-1580-8913; Fernandes, Roberta/0000-0003-1467-3946; Silva Bastos, Marisa/0000-0002-2616-0622	Fundacao de Apoio a Pesquisa e Extensao de Sergipe [08/2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [14/2014]	Fundacao de Apoio a Pesquisa e Extensao de Sergipe; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Apoio a Pesquisa e Extensao de Sergipe, grant number 08/2013, GMOJ; and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grant number 14/2014, GMOJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Bozkurt M, 2012, POULTRY SCI, V91, P1379, DOI 10.3382/ps.2011-02023; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi YI, 2012, ASIAN AUSTRAL J ANIM, V25, P1145, DOI 10.5713/ajas.2011.11418; Delles RM, 2014, POULTRY SCI, V93, P1561, DOI 10.3382/ps.2013-03682; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4; FREEMAN BA, 1982, LAB INVEST, V47, P412; Georgakouli K, 2015, EXP THER MED, V10, P2015, DOI 10.3892/etm.2015.2792; Gulcin I, 2011, J MED FOOD, V14, P975, DOI 10.1089/jmf.2010.0197; Halliwell B., 2015, Free radicals in biology and medicine; Iqbal M, 2001, POULTRY SCI, V80, P656, DOI 10.1093/ps/80.5.656; Iskender H, REV BRASILEIRA CIENC, P201; Jang I, 2014, J POULT SCI, V51, P58, DOI 10.2141/jpsa.0130017; Jiang RR, 2014, J ANIM PHYSIOL AN N, V98, P822, DOI 10.1111/jpn.12138; Laudadio V, 2014, REPROD DOMEST ANIM, V49, P158, DOI 10.1111/rda.12245; Lavelin I, 2000, POULTRY SCI, V79, P1014, DOI 10.1093/ps/79.7.1014; Li H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1943-0; Lin WC, 2016, POULTRY SCI; Liu CP, 2015, BIOMETALS, V28, P163, DOI 10.1007/s10534-014-9812-x; Liu L, 2012, ASIAN AUSTRAL J ANIM, V25, P1300, DOI 10.5713/ajas.2012.12153; Machin M, 2004, COMP BIOCHEM PHYS B, V137, P383, DOI 10.1016/j.cbpc.2004.01.002; Mehdipour Z, 2013, LIVEST SCI, V154, P152, DOI 10.1016/j.livsci.2013.03.014; Nadia L. R., 2008, International Journal of Poultry Science, V7, P134, DOI 10.3923/ijps.2008.134.150; Nelson D.L., 2008, LEHNINGER PRINCIPLES; Panda AK, 2014, J POULT SCI, V51, P109, DOI 10.2141/jpsa.0130134; Poureslami R, 2010, BRIT J NUTR, V104, P204, DOI 10.1017/S0007114510000541; Qotbi AAA, 2016, J BABYLON U PURE APP, V24; RAO PV, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/642942; Rodriguez R, 2006, CUBAN J AGR SCI, V40, P343; Rompelberg CJM, 1996, CHEM-BIOL INTERACT, V99, P85, DOI 10.1016/0009-2797(95)03662-8; Rostagno H. S., 2011, BRAZILIAN TABLES POU, V3nd; Schneider WJ, 1997, CURR OPIN LIPIDOL, V8, P315, DOI 10.1097/00041433-199710000-00011; Shumaila Gul, 2009, Pakistan Journal of Nutrition, V8, P1456; Simsek UG, 2013, KAFKAS UNIV VET FAK, V19, P889, DOI 10.9775/kvfd.2013.9049; Sivapriya T., 2016, World Journal of Pharmaceutical Research, V5, P475; Stinefelt B, 2005, ANN CLIN LAB SCI, V35, P37; Tabatabaei SM, 2015, PESQUI VET BRASIL, V35, P781, DOI 10.1590/S0100-736X2015000900003; Wang J, 2016, INT J BIOL SCI, V12, P1382, DOI 10.7150/ijbs.16472; Wang XJ, 2013, J LIPID RES, V54, P1860, DOI 10.1194/jlr.M036301; Xing JinYi, 2012, African Journal of Biotechnology, V11, P6633; Zhuo Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135810; Zou XT, 2007, ASIAN AUSTRAL J ANIM, V20, P1606, DOI 10.5713/ajas.2007.1606	43	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189619	10.1371/journal.pone.0189619	http://dx.doi.org/10.1371/journal.pone.0189619			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267351	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400036
J	Yamanaka, S; Huh, JY; Nishiyama, K; Hayashi, H				Yamanaka, Syunsuke; Huh, Ji Young; Nishiyama, Kei; Hayashi, Hiroyuki			The optimal number of personnel for good quality of chest compressions: A prospective randomized parallel manikin trial	PLOS ONE			English	Article							HOSPITAL CARDIAC-ARREST; BASIC LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; RESCUER FATIGUE; RATES; CPR; PERFORMANCE; DEPTH; GUIDELINES; SURVIVAL	Background Long durational chest compression (CC) deteriorates cardiopulmonary resuscitation (CPR) quality. The appropriate number of CC personnel for minimizing rescuer's fatigue is mostly unknown. Objective We determined the optimal number of personnel needed for 30-min CPR in a rescue-team. Methods We conducted a randomized, manikin trial on healthcare providers. We divided them into Groups A to D according to the assigned different rest period to each group between the 2 min CCs. Groups A, B, C, and D performed CCs at 2, 4, 6, and 8 min rest period. All participants performed CCs for 30 min with a different rest period; participants allocated to Groups A, B, C, and D performed, eight, five, four, and three cycles, respectively. We compared a quality change of CCs among these groups to investigate how the assigned rest period affects the maintenance of CC quality during the 30-min CPR. Results This study involved 143 participants (male 58 [41%]; mean age, 24 years,) for the evaluation. As participants had less rest periods, the quality of their CCs such as sufficient depth ratio declined over 30-min CPR. A significant decrease in the sufficient CC depth ratio was observed in the second to the last cycle as compared to the first cycle. (median changes; A: -4%, B: -3%, C: 0%, and D: 0% p < 0.01). Conclusions A 6 min rest period after 2 min CC is vital in order to sustain the quality of CC during a 30min CPR cycle. At least four personnel may be needed to reduce rescuer's fatigue for a 30min CPR cycle when the team consists of men and women.	[Yamanaka, Syunsuke] Univ Fukui Hosp, Dept Emergency Med, Fukui, Japan; [Huh, Ji Young] Adventist Med Ctr, Dept Family Med, Okinawa, Japan; [Nishiyama, Kei] Natl Hosp Org, Kyoto Med Ctr, Dept Trauma, Kyoto, Japan; [Nishiyama, Kei] Natl Hosp Org, Kyoto Med Ctr, Crit Care Ctr, Kyoto, Japan; [Hayashi, Hiroyuki] Univ Fukui Hosp, Dept Family Med, Family Med, Fukui, Japan	University of Fukui; University of Fukui	Yamanaka, S (corresponding author), Univ Fukui Hosp, Dept Emergency Med, Fukui, Japan.	yamanakasyunsuke@yahoo.co.jp	Yamanaka, Syunsuke/AAT-9326-2021	Yamanaka, Syunsuke/0000-0003-4510-1959; Nishiyama, Kei/0000-0003-3676-0135				Abella BS, 2005, CIRCULATION, V111, P428, DOI 10.1161/01.CIR.0000153811.84257.59; Ashton A, 2002, RESUSCITATION, V55, P151, DOI 10.1016/S0300-9572(02)00168-5; Bae J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010873; Bridgewater FHG, 2000, RESUSCITATION, V45, P97, DOI 10.1016/S0300-9572(00)00172-6; Edelson DP, 2006, RESUSCITATION, V71, P137, DOI 10.1016/j.resuscitation.2006.04.008; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Field RA, 2012, RESUSCITATION, V83, P360, DOI 10.1016/j.resuscitation.2011.07.012; Finn JC, 2015, RESUSCITATION, V95, pE203, DOI 10.1016/j.resuscitation.2015.07.046; Goldberger ZD, 2012, LANCET, V380, P1473, DOI 10.1016/S0140-6736(12)60862-9; Hasegawa T, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-16; Hong MY, 2014, AM J EMERG MED, V32, P1455, DOI 10.1016/j.ajem.2014.08.074; Idris AH, 2015, CRIT CARE MED, V43, P840, DOI 10.1097/CCM.0000000000000824; Kleinman ME, 2015, CIRCULATION, V132, pS414, DOI 10.1161/CIR.0000000000000259; Kramer-Johansen J, 2006, RESUSCITATION, V71, P283, DOI 10.1016/j.resuscitation.2006.05.011; Lucia A, 1999, CHEST, V115, P158, DOI 10.1378/chest.115.1.158; McDonald CH, 2013, EMERG MED J, V30, P623, DOI 10.1136/emermed-2012-201610; Monsieurs KG, 2012, RESUSCITATION, V83, P1319, DOI 10.1016/j.resuscitation.2012.07.015; Ochoa FJ, 1998, RESUSCITATION, V37, P149, DOI 10.1016/S0300-9572(98)00057-4; Riera SQ, 2007, RESUSCITATION, V74, P108, DOI 10.1016/j.resuscitation.2006.10.031; Shimizu Yoshitaka, 2014, Hiroshima Journal of Medical Sciences, V63, P7; Stiell IG, 2012, CRIT CARE MED, V40, P1192, DOI 10.1097/CCM.0b013e31823bc8bb; Wang J, 2015, WORLD J EMERG MED, V6, P179, DOI 10.5847/wjem.j.1920-8642.2015.03.003; Wik L, 2005, JAMA-J AM MED ASSOC, V293, P299, DOI 10.1001/jama.293.3.299	23	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189412	10.1371/journal.pone.0189412	http://dx.doi.org/10.1371/journal.pone.0189412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267300	gold, Green Submitted, Green Published			2022-12-26	WOS:000418587400029
J	Schiffthaler, B; Bernhardsson, C; Ingvarsson, PK; Street, NR				Schiffthaler, Bastian; Bernhardsson, Carolina; Ingvarsson, Par K.; Street, Nathaniel R.			BatchMap: A parallel implementation of the OneMap R package for fast computation of F-1 linkage maps in outcrossing species	PLOS ONE			English	Article							CONSTRUCTION	With the rapid advancement of high throughput sequencing, large numbers of genetic markers can be readily and cheaply acquired, but most current software packages for genetic map construction cannot handle such dense input. Modern computer architectures and server farms represent untapped resources that can be used to enable higher marker densities to be processed in tractable time. Here we present a pipeline using a modified version of OneMap that parallelizes over bottleneck functions and achieves substantial speedups for producing a high density linkage map (N = 20,000). Using simulated data we show that the outcome is as accurate as the traditional pipeline. We further demonstrate that there is a direct relationship between the number of markers used and the level of deviation between true and estimated order, which in turn impacts the final size of a genetic map.	[Schiffthaler, Bastian; Street, Nathaniel R.] Umea Univ, Dept Plant Physiol, UPSC, Umea, Sweden; [Bernhardsson, Carolina] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Ingvarsson, Par K.] Swedish Univ Agr Sci, Dept Plant Biol, Uppsala BioCtr, Uppsala, Sweden	Umea University; Umea University; Swedish University of Agricultural Sciences	Schiffthaler, B (corresponding author), Umea Univ, Dept Plant Physiol, UPSC, Umea, Sweden.	bastian.schiffthaler@umu.se	Ingvarsson, Pär/G-2748-2010; Street, Nathaniel Robert/B-3920-2008	Street, Nathaniel Robert/0000-0001-6031-005X; Ingvarsson, Par/0000-0001-9225-7521	Knut and Alice Wallenberg foundation; Trees and Crops for the Future (TC4F) program; Swedish Research Council (VR); Swedish Governmental Agency for Innovation Systems (VINNOVA); Swedish Research Council (FORMAS) through the UPSC Berzelii Centre for Forest Biotechnology	Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Trees and Crops for the Future (TC4F) program; Swedish Research Council (VR)(Swedish Research Council); Swedish Governmental Agency for Innovation Systems (VINNOVA)(Vinnova); Swedish Research Council (FORMAS) through the UPSC Berzelii Centre for Forest Biotechnology	This study was supported by funding from the Knut and Alice Wallenberg foundation. NRS is supported by the Trees and Crops for the Future (TC4F) program. This work was supported by funds from the Swedish Research Council (VR), the Swedish Governmental Agency for Innovation Systems (VINNOVA), The Swedish Research Council (FORMAS) through the UPSC Berzelii Centre for Forest Biotechnology.	Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cartwright DA, 2007, GENETICS, V176, P2521, DOI 10.1534/genetics.106.063982; Fierst JL, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00220; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Margarido GRA, 2007, HEREDITAS, V144, P78, DOI 10.1111/j.2007.0018-0661.02000.x; Mascher M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00208; Mollinari M, 2009, HEREDITY, V103, P494, DOI 10.1038/hdy.2009.96; R Development Core Team, 2016, R LANG ENV STAT COMP; Rastas P, 2013, BIOINFORMATICS, V29, P3128, DOI 10.1093/bioinformatics/btt563; Sargolzaei M, 2009, BIOINFORMATICS, V25, P680, DOI 10.1093/bioinformatics/btp045; Van Ooijen J., 2006, SOFTWARE CALCULATION; Van Os H, 2005, THEOR APPL GENET, V112, P30, DOI 10.1007/s00122-005-0097-x; Vickerstaff R. J., 2017, BIORXIV; Wu RL, 2002, THEOR POPUL BIOL, V61, P349, DOI 10.1006/tpbi.2002.1577; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Zhang LY, 2015, G3-GENES GENOM GENET, V5, P427, DOI 10.1534/g3.114.016022	16	8	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189256	10.1371/journal.pone.0189256	http://dx.doi.org/10.1371/journal.pone.0189256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261725	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000418564200037
J	Macdonald-Wallis, C; Solomon-Moore, E; Sebire, SJ; Thompson, JL; Lawlor, DA; Jago, R				Macdonald-Wallis, Corrie; Solomon-Moore, Emma; Sebire, Simon J.; Thompson, Janice L.; Lawlor, Deborah A.; Jago, Russell			A longitudinal study of the associations of children's body mass index and physical activity with blood pressure	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; CARDIOMETABOLIC RISK; SEDENTARY TIME; PRIMARY-SCHOOL; CHILDHOOD; HEART; POPULATION; OBESITY; INTERVENTIONS; OVERWEIGHT	Childhood blood pressure is a marker of cardiovascular disease risk in later life. We examined how body mass index (BMI) and physical activity, and changes in these, are associated with blood pressure in primary school-aged children. Data are from 1223 children aged 9 years (Year 4) in Bristol, UK, 685 of whom had been assessed at 6 years (Year 1). Child height and weight were measured, and children wore accelerometers for five days, from which average counts per minute, and moderate-to-vigorous-intensity physical activity and sedentary minutes per day were derived. At age 9 years, blood pressure was measured. Multiple imputation of missing data and adjusted linear regression models were used to examine associations. Child BMI at 9 years was cross-sectionally associated with higher systolic (SBP) and diastolic (DBP) blood pressure (mean difference [95% CI]: 1.10 [0.34, 1.87] mmHg and 0.86 [0.13, 1.60] mmHg, respectively, per SD of BMI). Prospective associations of BMI at age 6 with blood pressure at age 9 were consistent with these cross-sectional associations. However, change in BMI between 6 and 9 years was not strongly associated with subsequent SBP or DBP (0.68 [-0.61, 1.98] mmHg and 1.23 [-0.09, 2.54] mmHg, respectively). There was little evidence that physical activity or sedentary time were associated with blood pressure in either cross-sectional or prospective analyses. Greater childhood BMI is associated with higher blood pressure, and this association persists over several years. Prevention of excessive bodyweight from early childhood may be important in stemming the development of cardiovascular risk.	[Macdonald-Wallis, Corrie; Solomon-Moore, Emma; Sebire, Simon J.; Jago, Russell] Univ Bristol, Ctr Exercise Nutr & Hlth Sci, Sch Policy Studies, Bristol, Avon, England; [Thompson, Janice L.] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England; [Lawlor, Deborah A.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Lawlor, Deborah A.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Bristol; University of Birmingham; University of Bristol; University of Bristol	Jago, R (corresponding author), Univ Bristol, Ctr Exercise Nutr & Hlth Sci, Sch Policy Studies, Bristol, Avon, England.	russ.jago@bris.ac.uk	Jago, Russell/ABD-6271-2021	Jago, Russell/0000-0002-3394-0176; Thompson, Janice/0000-0002-7312-3226; Macdonald-Wallis, Corrie/0000-0002-4447-3817; Lawlor, Debbie A/0000-0002-6793-2262	British Heart Foundation [PG/11/51/28986, SP 14/4/31123]; University of Bristol; UK Medical Research Council [MC_UU_1201/5]; UK National Institute of Health and Research Senior Investigator [NF-SI-0166-10196]; MRC [MC_UU_12013/5] Funding Source: UKRI; British Heart Foundation [SP/14/4/31123] Funding Source: researchfish; Medical Research Council [MC_UU_12013/5] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10196] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); University of Bristol; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute of Health and Research Senior Investigator; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by grants from the British Heart Foundation (ref PG/11/51/28986 and SP 14/4/31123) to RJ. DAL works in a unit that receives funding from the University of Bristol and UK Medical Research Council (MC_UU_1201/5); she is also a UK National Institute of Health and Research Senior Investigator (NF-SI-0166-10196). The funders had no involvement in data analysis, data interpretation or writing of the paper.	Artinian NT, 2010, CIRCULATION, V122, P406, DOI 10.1161/CIR.0b013e3181e8edf1; Bailey D, 2017, J RES EDUC EFF, V10, P7, DOI 10.1080/19345747.2016.1232459; Barba G, 2006, NUTR METAB CARDIOVAS, V16, P239, DOI 10.1016/j.numecd.2006.02.005; Bekkers MBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051801; Berenson GS, 2002, AM J CARDIOL, V90, p3L, DOI 10.1016/S0002-9149(02)02953-3; Berentzen NE, 2016, INT J OBESITY, V40, P58, DOI 10.1038/ijo.2015.196; Boreham C, 1999, PUBLIC HEALTH, V113, P7, DOI 10.1016/S0033-3506(99)00106-7; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Cesa CC, 2014, PREV MED, V69, P54, DOI 10.1016/j.ypmed.2014.08.014; Chaput JP, 2013, APPL PHYSIOL NUTR ME, V38, P477, DOI 10.1139/apnm-2012-0382; Charakida M, 2012, J AM COLL CARDIOL, V60, P2643, DOI 10.1016/j.jacc.2012.08.1017; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; COOK NR, 1995, ARCH INTERN MED, V155, P701, DOI 10.1001/archinte.155.7.701; Craig SB, 1996, PEDIATRICS, V98, P389; Department for Communities and Local Government, 2015, ENGL IND DEPR 2015 S; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Edwards NM, 2016, PEDIATR EXERC SCI, V28, P397, DOI 10.1123/pes.2015-0189; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Falaschetti E, 2010, EUR HEART J, V31, P3063, DOI 10.1093/eurheartj/ehq355; Ferreira de Moraes AC, 2015, INT J CARDIOL, V180, P165, DOI 10.1016/j.ijcard.2014.11.175; Friedemann C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4759; Gidding SS, 2006, PEDIATRICS, V118, P2388, DOI 10.1542/peds.2006-1785; Giussani M, 2013, J HYPERTENS, V31, P983, DOI 10.1097/HJH.0b013e32835f17c7; Hay J, 2012, ARCH PEDIAT ADOL MED, V166, P1022, DOI 10.1001/archpediatrics.2012.1028; Hjorth MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104677; Jago R, 2001, J SPORT SCI, V19, P527, DOI 10.1080/026404101750238980; Jago R, 2014, BMC PUBLIC HLTH, V14; Jago R, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0492-0; 이종국, 2011, Clinical Hypertension, V17, P114; KLESGES RC, 1990, J PEDIATR-US, V116, P888, DOI 10.1016/S0022-3476(05)80645-6; Knowles G, 2013, HYPERTENSION, V61, P70, DOI 10.1161/HYPERTENSIONAHA.112.201277; Lawlor DA, 2016, INT J EPIDEMIOL, V45, P1866, DOI 10.1093/ije/dyw314; Lawlor DA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6224; Lazarou C, 2009, J HUM HYPERTENS, V23, P456, DOI 10.1038/jhh.2008.151; Leary SD, 2008, HYPERTENSION, V51, P92, DOI 10.1161/HYPERTENSIONAHA.107.099051; Mark AE, 2008, MED SCI SPORT EXER, V40, P1007, DOI 10.1249/MSS.0b013e318169032d; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Owen CG, 2010, DIABETOLOGIA, V53, P1620, DOI 10.1007/s00125-010-1781-1; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Skinner AC, 2015, NEW ENGL J MED, V373, P1307, DOI 10.1056/NEJMoa1502821; Stamatakis E, 2015, PEDIATRICS, V135, pE1432, DOI 10.1542/peds.2014-3750; Sterne JAC, 2009, BRIT MED J, V338, pb2393; Torrance B, 2007, VASC HEALTH RISK MAN, V3, P139; Vaisto J, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-55; Zhang XY, 2003, J SPEECH LANG HEAR R, V46, P1340, DOI 10.1044/1092-4388(2003/104)	47	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0188618	10.1371/journal.pone.0188618	http://dx.doi.org/10.1371/journal.pone.0188618			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261666	Green Submitted, Green Published, gold			2022-12-26	WOS:000418554900007
J	Omodaka, K; An, GZ; Tsuda, S; Shiga, Y; Takada, N; Kikawa, T; Takahashi, H; Yokota, H; Akiba, M; Nakazawa, T				Omodaka, Kazuko; An, Guangzhou; Tsuda, Satoru; Shiga, Yukihiro; Takada, Naoko; Kikawa, Tsutomu; Takahashi, Hidetoshi; Yokota, Hideo; Akiba, Masahiro; Nakazawa, Toru			Classification of optic disc shape in glaucoma using machine learning based on quantified ocular parameters	PLOS ONE			English	Article							VISUAL-FIELD; RISK-FACTORS; BLOOD-FLOW; PROGRESSION; APPEARANCES; PRESSURE; EYES	Purpose This study aimed to develop a machine learning-based algorithm for objective classification of the optic disc in patients with open-angle glaucoma (OAG), using quantitative parameters obtained from ophthalmic examination instruments. Methods This study enrolled 163 eyes of 105 OAG patients (age: 62.3 +/- 12.6, mean deviation of Humphrey field analyzer: -8.9 +/- 7.5 dB). The eyes were classified into Nicolela's 4 optic disc types by 3 glaucoma specialists. Randomly, 114 eyes were selected for training data and 49 for test data. A neural network (NN) was trained with the training data and evaluated with the test data. We used 91 types of quantitative data, including 7 patient background characteristics, 48 quantified OCT (swept-source OCT; DRI OCT Atlantis, Topcon) values, including optic disc topography and circumpapillary retinal nerve fiber layer thickness (cpRNFLT), and 36 blood flow parameters from laser speckle flowgraphy, to build the machine learning classification model. To extract the important features among 91 parameters, minimum redundancy maximum relevance and a genetic feature selection were used. Results The validated accuracy against test data for the NN was 87.8% (Cohen's Kappa = 0.83). The important features in the NN were horizontal disc angle, spherical equivalent, cup area, age, 6-sector superotemporal cpRNFLT, average cup depth, average nasal rim disc ratio, maximum cup depth, and superior-quadrant cpRNFLT. Conclusion The proposed machine learning system has proved to be good identifiers for different disc types with high accuracy. Additionally, the calculated confidence levels reported here should be very helpful for OAG care.	[Omodaka, Kazuko; Tsuda, Satoru; Shiga, Yukihiro; Takada, Naoko; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan; [Omodaka, Kazuko; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalm Imaging & Informat Analyt, Sendai, Miyagi, Japan; [An, Guangzhou; Kikawa, Tsutomu; Akiba, Masahiro] TOPCON Corp, R&D Div, Tokyo, Japan; [An, Guangzhou; Yokota, Hideo; Akiba, Masahiro] RIKEN, Cloud Based Eye Dis Diag Joint Res Team, Wako, Saitama, Japan; [Takahashi, Hidetoshi] Tohoku Med & Pharmaceut Univ, Dept Med, Div Ophthalmol, Sendai, Miyagi, Japan; [Yokota, Hideo; Nakazawa, Toru] RIKEN, Image Proc Res Team, Wako, Saitama, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Ophthalmol, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Topcon Corporation; RIKEN; Tohoku Medical & Pharmaceutical University; RIKEN; Tohoku University; Tohoku University	Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalm Imaging & Informat Analyt, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), RIKEN, Image Proc Res Team, Wako, Saitama, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Ophthalmol, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan.	ntoru@oph.med.tohoku.ac.jp	An, Guangzhou/AAR-8850-2021; An, Guangzhou/P-5406-2019; An, Guangzhou/O-5202-2018	An, Guangzhou/0000-0002-0875-4494; 	JSPS KAKENHI [T.N. 17H04349, T. N. 16K15730]; KAKENHI [K.O. 17K16957]; Public Trust Suda Memorial Fund for Glaucoma Research; JST Center for Revitalization Promotion	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Public Trust Suda Memorial Fund for Glaucoma Research; JST Center for Revitalization Promotion	Topcon Corporation provided support in the form of salaries for authors GA, TK, and MA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This paper was supported in part by a JST grant from JSPS KAKENHI Grants-in-Aid for Scientific Research (B) (T.N. 17H04349) and for Exploratory Research (T. N. 16K15730), and by the JST Center for Revitalization Promotion and KAKENHI Grant-in Aid for young scientists (B) (K.O. 17K16957) and Public Trust Suda Memorial Fund for Glaucoma Research, and joint research project with Topcon Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2003, AM J OPHTHALMOL, V136, P820, DOI 10.1016/S0002-9394(03)00478-1; Anderson DR., 1999, AUTOMATED STATIC PER; Belghith A, 2015, ARTIF INTELL MED, V64, P105, DOI 10.1016/j.artmed.2015.04.002; Bonomi L, 2000, OPHTHALMOLOGY, V107, P1287, DOI 10.1016/S0161-6420(00)00138-X; Bowe A, 2015, AM J HYPERTENS, V28, P1077, DOI 10.1093/ajh/hpv016; Caixinha M, 2017, CURR EYE RES, V42, P1, DOI 10.1080/02713683.2016.1175019; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Ernest PJ, 2013, OPHTHALMOLOGY, V120, P512, DOI 10.1016/j.ophtha.2012.09.005; Himori N, 2016, GRAEF ARCH CLIN EXP, V254, P333, DOI 10.1007/s00417-015-3203-z; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kim KE, 2017, CURR OPIN OPHTHALMOL, V28, P105, DOI 10.1097/ICU.0000000000000345; Konieczka K, 2014, EPMA J, V5, DOI 10.1186/1878-5085-5-11; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Meng NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062723; Mookiah MRK, 2015, COMPUT BIOL MED, V63, P208, DOI 10.1016/j.compbiomed.2015.05.019; Nakazawa T, 2016, ASIA-PAC J OPHTHALMO, V5, P38, DOI 10.1097/APO.0000000000000183; Nakazawa T, 2012, J GLAUCOMA, V21, P426, DOI 10.1097/IJG.0b013e3182182897; Nicolela MT, 2003, OPHTHALMOLOGY, V110, P2178, DOI 10.1016/S0161-6420(03)00801-7; Nicolela MT, 1996, OPHTHALMOLOGY, V103, P640, DOI 10.1016/S0161-6420(96)30640-4; Omodaka K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153707; Omodaka K, 2015, JPN J OPHTHALMOL, V59, P223, DOI 10.1007/s10384-015-0379-z; Sawada Y, 2015, INVEST OPHTH VIS SCI, V56, P5777, DOI 10.1167/iovs.14-15942; Takada N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160226; Tanito M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169858; Torok Z, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-40; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0	26	23	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0190012	10.1371/journal.pone.0190012	http://dx.doi.org/10.1371/journal.pone.0190012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261773	Green Submitted, Green Published, gold			2022-12-26	WOS:000418554900047
J	Gaciarz, A; Ruddock, LW				Gaciarz, Anna; Ruddock, Lloyd W.			Complementarity determining regions and frameworks contribute to the disulfide bond independent folding of intrinsically stable scFv	PLOS ONE			English	Article							SINGLE-CHAIN FV; RESHAPING HUMAN-ANTIBODIES; CHIMERIC B72.3 ANTIBODY; ESCHERICHIA-COLI; VARIABLE DOMAINS; ANTIGEN-BINDING; FAB FRAGMENT; STABILITY; EXPRESSION; CONFORMATION	CyDisCo is a system facilitating disulfide bond formation in recombinant proteins in the cytoplasm of Escherichia coli. Previously we screened for soluble expression of single chain antibody fragments (scFv) in the cytoplasm of E. coli in the presence and absence of CyDisCo, with >90% being solubly expressed. Two scFv, those derived from natalizumab and trastuzumab, were solubly produced in high amounts even in the absence of folding catalysts i.e. disulfide bond formation is not critical for their folding. Here we investigate the contribution of the framework and the complementarity determining regions (CDRs) of scFv to the disulfide-independence of folding. We swapped CDRs between four scFv that have different properties, including two scFv that can efficiently fold independently from disulfide bonds and two more disulfide-dependent scFv. To confirm disulfide-independence we generated cysteine to alanine mutants of the disulfide-independent scFv. All of the scFv were tested for soluble expression in the cytoplasm of E. coli in the presence and absence of the oxidative folding catalysts Erv1p and PDI. Eight of the hybrid scFv were solubly produced in the presence of CyDisCo, while seven were solubly produced in the absence of CyDisCo, though the yields were often much lower when CyDisCo was absent. Soluble expression was also observed for scFv natalizumab and trastuzumab containing no cysteines. We compared yields, thermal stability and secondary structure of solubly produced scFv and undertook binding studies by western blotting, dot blotting or surface plasmon resonance of those produced in good yields. Our results indicate that both the CDRs and the framework contribute to the disulfide-dependence of soluble production of scFv, with the CDRs having the largest effect. In addition, there was no correlation between thermal stability and disulfide-dependence of folding and only a weak correlation between the yield of protein and the thermal stability of the protein.	[Gaciarz, Anna; Ruddock, Lloyd W.] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland	University of Oulu	Ruddock, LW (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.	lloyd.ruddock@oulu.fi		Ruddock, Lloyd/0000-0002-6247-686X; Gaciarz, Anna/0000-0002-1637-0669	Academy of Finland; Sigrid Juselius Foundation; Biocenter Oulu; Magnus Ehrnrooth Foundation; University of Oulu Scholarship Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocenter Oulu; Magnus Ehrnrooth Foundation; University of Oulu Scholarship Foundation	This work was supported by Academy of Finland (http://www.aka.fi/en; LWR), Sigrid Juselius Foundation (http://sigridjuselius.fi/en/main-page/; LWR), Biocenter Oulu (http://www..oulu.fi/biocenter/; LWR), Magnus Ehrnrooth Foundation (https://www.magnusehrnroothinsaatio.fi/en/; AG) and University of Oulu Scholarship Foundation (http://www.oulu.fi/university/node/38384; AG).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BIOCCA S, 1994, BIO-TECHNOL, V12, P396, DOI 10.1038/nbt0494-396; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Correa A, 2013, ACTA CRYSTALLOGR D, V69, P388, DOI 10.1107/S0907444912048664; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; der Maur AA, 2001, FEBS LETT, V508, P407, DOI 10.1016/S0014-5793(01)03101-5; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; Gaciarz A, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0419-5; GLOCKSHUBER R, 1992, BIOCHEMISTRY-US, V31, P1270, DOI 10.1021/bi00120a002; HOUDAYER M, 1993, J IMMUNOL, V150, P311; Jager M, 1997, FEBS LETT, V418, P106, DOI 10.1016/S0014-5793(97)01350-1; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Jung S, 1997, PROTEIN ENG, V10, P959, DOI 10.1093/protein/10.8.959; KETTLEBOROUGH CA, 1991, PROTEIN ENG, V4, P773, DOI 10.1093/protein/4.7.773; Krissinel E, 2015, NUCLEIC ACIDS RES, V43, pW314, DOI 10.1093/nar/gkv314; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Martineau P, 1998, J MOL BIOL, V280, P117, DOI 10.1006/jmbi.1998.1840; Ohage EC, 1999, J MOL BIOL, V291, P1129, DOI 10.1006/jmbi.1999.3020; Potter KN, 2002, J IMMUNOL, V169, P3777, DOI 10.4049/jimmunol.169.7.3777; Pritsch O, 2000, EUR J IMMUNOL, V30, P3387, DOI 10.1002/1521-4141(2000012)30:12<3387::AID-IMMU3387>3.0.CO;2-K; Proba K, 1998, J MOL BIOL, V275, P245, DOI 10.1006/jmbi.1997.1457; Proba K, 1997, J MOL BIOL, V265, P161, DOI 10.1006/jmbi.1996.0726; Ramm K, 1999, J MOL BIOL, V290, P535, DOI 10.1006/jmbi.1999.2854; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Sela-Culang I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00302; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; Tavladoraki P, 1999, EUR J BIOCHEM, V262, P617, DOI 10.1046/j.1432-1327.1999.00443.x; TRAMONTANO A, 1990, J MOL BIOL, V215, P175, DOI 10.1016/S0022-2836(05)80102-0; Valabrega G, 2007, ANN ONCOL, V18, P977, DOI 10.1093/annonc/mdl475; VERHOEYEN M, 1988, SCIENCE, V239, P1534, DOI 10.1126/science.2451287; Willuda J, 1999, CANCER RES, V59, P5758; Worn A, 1998, FEBS LETT, V427, P357, DOI 10.1016/S0014-5793(98)00463-3; Worn A, 1998, BIOCHEMISTRY-US, V37, P13120, DOI 10.1021/bi980712q; Xiang J, 1999, PROTEIN ENG, V12, P417, DOI 10.1093/protein/12.5.417; XIANG J, 1995, J MOL BIOL, V253, P385, DOI 10.1006/jmbi.1995.0560; Yu YM, 2013, J BIOL CHEM, V288, P32314, DOI 10.1074/jbc.M113.501668	39	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189964	10.1371/journal.pone.0189964	http://dx.doi.org/10.1371/journal.pone.0189964			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253024	Green Published, gold, Green Submitted			2022-12-26	WOS:000418389500081
J	Milano, T; Gulzar, A; Narzi, D; Guidoni, L; Pascarella, S				Milano, Teresa; Gulzar, Adnan; Narzi, Daniele; Guidoni, Leonardo; Pascarella, Stefano			Molecular dynamics simulation unveils the conformational flexibility of the interdomain linker in the bacterial transcriptional regulator GabR from Bacillus subtilis bound to pyridoxal 5 '-phosphate	PLOS ONE			English	Article							ASPARTATE-AMINOTRANSFERASE; DEPENDENT ENZYMES; DNA-BINDING; VITAMIN-B-6 BIOSYNTHESIS; CRYSTAL-STRUCTURE; GNTR FAMILY; PROTEIN; DOMAIN; PDXR; PLP	GabR from Bacillus subtilis is a transcriptional regulator belonging to the MocR subfamily of the GntR regulators. The structure of the MocR regulators is characterized by the presence of two domains: i) a N-terminal domain, about 60 residue long, possessing the winged-Helix-Turn-Helix (wHTH) architecture with DNA recognition and binding capability; ii) a C-terminal domain (about 350 residue) folded as the pyridoxal 5'-phosphate (PLP) dependent aspartate aminotransferase (AAT) with dimerization and effector binding functions. The two domains are linked to each other by a peptide bridge. Although structural and functional characterization of MocRs is proceeding at a fast pace, virtually nothing is know about the molecular changes induced by the effector binding and on how these modifications influence the properties of the regulator. An extensive molecular dynamics simulation on the crystallographic structure of the homodimeric B. subtilis GabR has been undertaken with the aim to envisage the role and the importance of conformational flexibility in the action of GabR. Molecular dynamics has been calculated for the apo (without PLP) and holo (with PLP bound) forms of the GabR. A comparison between the molecular dynamics trajectories calculated for the two GabR forms suggested that one of the wHTH domain detaches from the AAT-like domain in the GabR PLP-bound form. The most evident conformational change in the holo PLP-bound form is represented by the rotation and the subsequent detachment from the subunit surface of one of the wHTH domains. The movement is mediated by a rearrangement of the linker connecting the AAT domain possibly triggered by the presence of the negative charge of the PLP cofactor. This is the second most significant conformational modification. The C-terminal section of the linker docks into the "active site" pocket and establish stabilizing contacts consisting of hydrogen-bonds, salt-bridges and hydrophobic interactions.	[Milano, Teresa; Pascarella, Stefano] Sapienza Univ Roma, Dipartimento Sci Biochim A Rossi Fanelli, Rome, Italy; [Gulzar, Adnan; Narzi, Daniele; Guidoni, Leonardo] Univ Aquila, Dipartimento Sci Fis & Chim, Laquila, Italy; [Gulzar, Adnan] Albert Ludwigs Univ, Inst Phys, Freiburg, Germany; [Narzi, Daniele] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Lausanne, Switzerland	Sapienza University Rome; University of L'Aquila; University of Freiburg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Pascarella, S (corresponding author), Sapienza Univ Roma, Dipartimento Sci Biochim A Rossi Fanelli, Rome, Italy.	Stefano.Pascarella@uniroma1.it		Narzi, Daniele/0000-0003-2731-6286; Gulzar, Adnan/0000-0002-8444-2169; Guidoni, Leonardo/0000-0002-2497-9482	Regione Lazio [FILAS-RU-2014-1020 A/15/2015]; Sapienza Universita di Roma [C26N158EP9, B52F16001750005]	Regione Lazio(Regione Lazio); Sapienza Universita di Roma	T.M. received a one-year fellowship from Regione Lazio, code FILAS-RU-2014-1020 A/15/2015. T.M. was funded by Sapienza Universita di Roma: grant codes C26N158EP9 (2015) and B52F16001750005 (2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zyoud WA, 2016, NUCLEIC ACIDS RES, V44, P1411, DOI 10.1093/nar/gkv1466; Aleksandrov A, 2008, J MOL BIOL, V378, P898, DOI 10.1016/j.jmb.2008.03.022; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amidani D, 2017, BBA-GEN SUBJECTS, V1861, P3474, DOI 10.1016/j.bbagen.2016.09.013; Angelaccio S, 2016, DATA BRIEF, V9, P292, DOI 10.1016/j.dib.2016.08.064; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Bagchi A, 2015, GENE, V554, P249, DOI 10.1016/j.gene.2014.10.044; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Belitsky BR, 2014, MOL MICROBIOL, V92, P1113, DOI 10.1111/mmi.12618; Belitsky BR, 2004, J MOL BIOL, V340, P655, DOI 10.1016/j.jmb.2004.05.020; Belitsky BR, 2002, MOL MICROBIOL, V45, P569, DOI 10.1046/j.1365-2958.2002.03036.x; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NAT STRUCT BIOL, V7, P957, DOI 10.1038/80734; Best RB, 2006, P NATL ACAD SCI USA, V103, P10901, DOI 10.1073/pnas.0511156103; Bramucci E, 2011, BIOCHEM BIOPH RES CO, V415, P88, DOI 10.1016/j.bbrc.2011.10.017; Brunger AT, 1997, NAT STRUCT BIOL, V4, P862; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Edayathumangalam R, 2013, P NATL ACAD SCI USA, V110, P17820, DOI 10.1073/pnas.1315887110; El Qaidi S, 2013, J BACTERIOL, V195, P2187, DOI 10.1128/JB.00041-13; Falconi M, 2007, FEBS J, V274, P2385, DOI 10.1111/j.1742-4658.2007.05773.x; Frisch M. J., 2004, GAUSSIAN; Gokcan H, 2016, PROTEINS, V84, P875, DOI 10.1002/prot.24991; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hoskisson Paul A, 2009, Adv Appl Microbiol, V69, P1, DOI 10.1016/S0065-2164(09)69001-8; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAGER J, 1994, J MOL BIOL, V239, P285, DOI 10.1006/jmbi.1994.1368; Jain D, 2015, IUBMB LIFE, V67, P556, DOI 10.1002/iub.1401; Jochmann N, 2011, MICROBIOL-SGM, V157, P77, DOI 10.1099/mic.0.044818-0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; KIRSCH JF, 1984, J MOL BIOL, V174, P497, DOI 10.1016/0022-2836(84)90333-4; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liao S, 2015, MOL ORAL MICROBIOL, V30, P255, DOI 10.1111/omi.12090; Madani A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179601; Meng HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086104; Milano Teresa, 2016, Biochim Open, V3, P8, DOI 10.1016/j.biopen.2016.07.002; Milano T, 2016, BIOCHEM RES INT, V2016, DOI 10.1155/2016/4360285; Milano T, 2015, COMPUT BIOL CHEM, V58, P55, DOI 10.1016/j.compbiolchem.2015.05.003; Nishi H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00270; Novichkov PS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-745; Okuda K, 2015, J BIOCHEM, V158, P225, DOI 10.1093/jb/mvv040; Okuda K, 2015, MOL MICROBIOL, V95, P245, DOI 10.1111/mmi.12861; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Park SA, 2017, BIOCHEM BIOPH RES CO, V487, P287, DOI 10.1016/j.bbrc.2017.04.052; Perera IC, 2009, J MOL BIOL, V390, P1019, DOI 10.1016/j.jmb.2009.06.002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Reichheld SE, 2009, P NATL ACAD SCI USA, V106, P22263, DOI 10.1073/pnas.0911566106; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; ROSSBACH S, 1994, MOL GEN GENET, V245, P11, DOI 10.1007/BF00279746; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Schroedinger LLC, 2015, PYMOL MOL GRAPH SYST; Sievers Fabian, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0313s48; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Spellmon N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145758; Takenaka T, 2015, FEBS J, V282, P4201, DOI 10.1111/febs.13415; Tramonti A, 2016, FEBS J; Tramonti A, 2015, FEBS J, V282, P2966, DOI 10.1111/febs.13338; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wiethaus J, 2008, J BACTERIOL, V190, P487, DOI 10.1128/JB.01510-07; Wu R, 2017, P NATL ACAD SCI USA, V114, P3891, DOI 10.1073/pnas.1703019114; YORK DM, 1993, J CHEM PHYS, V99, P8345, DOI 10.1063/1.465608	67	7	7	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189270	10.1371/journal.pone.0189270	http://dx.doi.org/10.1371/journal.pone.0189270			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253008	Green Published, gold, Green Submitted			2022-12-26	WOS:000418389500019
J	Takahashi, Y; Yasui, T; Tamari, K; Minami, K; Otani, K; Isohashi, F; Seo, Y; Kambe, R; Koizumi, M; Ogawa, K				Takahashi, Yutaka; Yasui, Tomohiro; Tamari, Keisuke; Minami, Kazumasa; Otani, Keisuke; Isohashi, Fumiaki; Seo, Yuji; Kambe, Ryosuke; Koizumi, Masahiko; Ogawa, Kazuhiko			Radiation enhanced the local and distant antitumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma	PLOS ONE			English	Article							ANTIBODY BLOCKADE; UP-REGULATION; PD-1; CELLS; IRRADIATION; ANTI-PD-1; RADIOTHERAPY; SUPERFAMILY; LYMPHOCYTES; REGRESSION	Radiation therapy has been long utilized as localized cancer treatment. Recent studies have also demonstrated that it has a distant effect by the enhanced immunity, but it rarely occurs. The purpose of this study was to investigate whether X-ray irradiation combined with anti-PD-L1 and anti-CTLA-4 antibodies (P1C4) provides a higher probability of this distant effect as well as enhanced local antitumor efficacy for osteosarcoma. LM8 mouse osteosarcoma cells were inoculated into both legs of C3H mice assigned to one of four groups, namely no treatment (No Tx), P1C4, X-ray irradiation (RAD) to the leg of one side, and combination (COMB) groups. Survival and treatment-related immune molecular changes were analyzed. Administration of P1C4 produced a tumor growth delay on day 30 in 18% of the mice. In contrast, combination therapy produced the strongest tumor growth inhibition not only at the irradiated tumor but also at unirradiated tumor in 67% of the mice. Accordingly, lung metastasis in the COMB group was strongly reduced by 98%, with a significant survival benefit. Unirradiated tumor in mice in the COMB group significantly recruited CD8 + tumor-infiltrating lymphocytes with a moderate reduction of Treg, producing a significant increase in the CD8/Treg ratio. These results suggest that radiation enhances the efficacy of P1C4 treatment against distant metastasis as well as local control in osteosarcoma. Our data suggest that radiation therapy combined with dual checkpoint blockade may be a promising therapeutic option for osteosarcoma.	[Takahashi, Yutaka; Tamari, Keisuke; Otani, Keisuke; Isohashi, Fumiaki; Seo, Yuji; Ogawa, Kazuhiko] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Suita, Osaka, Japan; [Yasui, Tomohiro; Minami, Kazumasa; Kambe, Ryosuke; Koizumi, Masahiko] Osaka Univ, Grad Sch Med, Dept Med Phys & Engn, Suita, Osaka, Japan	Osaka University; Osaka University	Takahashi, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Suita, Osaka, Japan.	ytakahashi@radonc.med.osaka-u.ac.jp			Japanese Society of Promotion of Sciences [Kiban C: 16K07173, Kiban B: 26290055]; Grants-in-Aid for Scientific Research [16K07173] Funding Source: KAKEN	Japanese Society of Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the grant in aid from Japanese Society of Promotion of Sciences (Kiban C: 16K07173 and Kiban B: 26290055).	Belcaid Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101764; Borghaei H, N ENGL J MED, V201, P1627; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; Burnette BC, 2011, CANCER RES, V71, P2488, DOI 10.1158/0008-5472.CAN-10-2820; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Deng LF, 2014, J CLIN INVEST, V124, P687, DOI 10.1172/JCI67313; Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265; Dovedi SJ, 2017, CLIN CANCER RES, V23, P5514, DOI 10.1158/1078-0432.CCR-16-1673; Draghiciu O, 2014, INT J CANCER, V134, P859, DOI 10.1002/ijc.28418; Habel N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.405; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Jiang W, 2016, TRENDS CANCER, V2, P638, DOI 10.1016/j.trecan.2016.09.007; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kim JE, 2017, CLIN CANCER RES, V23, P124, DOI 10.1158/1078-0432.CCR-15-1535; Koyama S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10501; Lussier DM, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0067-z; Lussier DM, 2015, J IMMUNOTHER, V38, P96, DOI 10.1097/CJI.0000000000000065; Maki Robert G., 2013, Sarcoma, V2013, P168145, DOI 10.1155/2013/168145; Matsumura S, 2008, J IMMUNOL, V181, P3099, DOI 10.4049/jimmunol.181.5.3099; Matsumura S, 2010, RADIAT RES, V173, P418, DOI 10.1667/RR1860.1; Ogata T, 2005, CANCER RES, V65, P113; Ohba K, 1998, GUT, V43, P575, DOI 10.1136/gut.43.4.575; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Park B, 2014, INT J MOL SCI, V15, P927, DOI 10.3390/ijms15010927; Perez CA, 2009, INT J RADIAT BIOL, V85, P1126, DOI 10.3109/09553000903242099; Ruiz VE, 2012, J IMMUNOL METHODS, V384, P157, DOI 10.1016/j.jim.2012.07.002; Sakamoto A, 2008, REV RECENT CLIN TRIA, V3, P228, DOI 10.2174/157488708785700267; Shiraishi K, 2008, CLIN CANCER RES, V14, P1159, DOI 10.1158/1078-0432.CCR-07-4485; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Wan J, 2016, ONCOL LETT, V11, P511, DOI 10.3892/ol.2015.3962; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Yoshimoto Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092572; Zuch D, 2012, J CELL BIOCHEM, V113, P1282, DOI 10.1002/jcb.24002	42	25	26	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189697	10.1371/journal.pone.0189697	http://dx.doi.org/10.1371/journal.pone.0189697			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253865	gold, Green Published, Green Submitted			2022-12-26	WOS:000418389500051
J	Barrado-Gil, L; Galindo, I; Martinez-Alonso, D; Viedma, S; Alonso, C				Barrado-Gil, Lucia; Galindo, Inmaculada; Martinez-Alonso, Diego; Viedma, Sergio; Alonso, Covadonga			The ubiquitin-proteasome system is required for African swine fever replication	PLOS ONE			English	Article							CONJUGATING ENZYME; DEPENDENT ENDOCYTOSIS; VIRUS-INFECTION; VERO CELLS; PROTEINS; INHIBITION; ENTRY; UBIQUITYLATION; POLYPROTEIN; DEGRADATION	Several viruses manipulate the ubiquitin-proteasome system (UPS) to initiate a productive infection. Determined viral proteins are able to change the host's ubiquitin machinery and some viruses even encode their own ubiquitinating or deubiquitinating enzymes. African swine fever virus (ASFV) encodes a gene homologous to the E2 ubiquitin conjugating (UBC) enzyme. The viral ubiquitin-conjugating enzyme (UBCv1) is expressed throughout ASFV infection and accumulates at late times post infection. UBCv is also present in the viral particle suggesting that the ubiquitin-proteasome pathway could play an important role at early ASFV infection. We determined that inhibition of the final stage of the ubiquitinproteasome pathway blocked a post-internalization step in ASFV replication in Vero cells. Under proteasome inhibition, ASF viral genome replication, late gene expression and viral production were severely reduced. Also, ASFV enhanced proteasome activity at late times and the accumulation of polyubiquitinated proteins surrounding viral factories. Core-associated and/or viral proteins involved in DNA replication may be targets for the ubiquitin-proteasome pathway that could possibly assist virus uncoating at final core breakdown and viral DNA release. At later steps, polyubiquitinated proteins at viral factories could exert regulatory roles in cell signaling.	[Barrado-Gil, Lucia; Galindo, Inmaculada; Martinez-Alonso, Diego; Viedma, Sergio; Alonso, Covadonga] INIA, Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotechnol, Madrid, Spain; [Alonso, Covadonga] CNIO, Cell Div & Canc Grp, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Centro Nacional de Investigaciones Oncologicas (CNIO)	Alonso, C (corresponding author), INIA, Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotechnol, Madrid, Spain.	calonso@inia.es	Barrado-Gil, Lucía/H-4691-2015; Galindo, inmaculada/Q-6603-2018; Alonso, Covadonga/A-8000-2011	Barrado-Gil, Lucía/0000-0002-1053-2997; Galindo, inmaculada/0000-0001-8257-9797; Alonso, Covadonga/0000-0002-0862-6177; Martinez Alonso, Diego/0000-0003-0521-5134	Ministerio de Economia, lndustria y Competitividad Spain [AGL2015-69598-R, AGL2012-34533]	Ministerio de Economia, lndustria y Competitividad Spain	This study was supported by Ministerio de Economia, lndustria y Competitividad Spain, URL: http://www.mineco.gob.es/portal/site/mineco/idi, AGL2015-69598-R to author CA and AGL2012-34533 to author CA.	ALCAMI A, 1990, VIRUS RES, V17, P93, DOI 10.1016/0168-1702(90)90071-I; ALCAMI A, 1989, VIROLOGY, V171, P68, DOI 10.1016/0042-6822(89)90511-4; Andres G, 1997, J VIROL, V71, P2331; Andres G, 1998, J VIROL, V72, P8988; Andres G, 2001, J BIOL CHEM, V276, P780, DOI 10.1074/jbc.M006844200; Cuesta-Geijo MA, 2016, J VIROL, V90, P1534, DOI 10.1128/JVI.02694-15; Biard-Piechaczyk M, 2012, BIOL CELL, V104, P165, DOI 10.1111/boc.201100112; BLASCO R, 1995, GENE, V158, P157, DOI 10.1016/0378-1119(95)00149-Z; Bulimo WD, 2000, FEBS LETT, V471, P17, DOI 10.1016/S0014-5793(00)01352-1; Byk LA, 2016, MBIO, V7, DOI 10.1128/mBio.00804-16; CARRASCOSA AL, 1982, J VIROL METHODS, V3, P303, DOI 10.1016/0166-0934(82)90034-9; CARRASCOSA AL, 1985, J VIROL, V54, P337, DOI 10.1128/JVI.54.2.337-344.1985; Cheng S, 2014, VIROLOGY, V456, P198, DOI 10.1016/j.virol.2014.03.028; Cuesta-Geijo MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048853; Delboy MG, 2008, J VIROL, V82, P3381, DOI 10.1128/JVI.02296-07; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dixon L.K., 2005, VIRUS TAXONOMY, P135, DOI DOI 10.1186/1743-422X-2-64; ENJUANES L, 1976, J GEN VIROL, V32, P479, DOI 10.1099/0022-1317-32-3-479; Fernandez-Garcia MD, 2011, J VIROL, V85, P2980, DOI 10.1128/JVI.02483-10; Galindo I, 2017, VIRUSES, V9; Galindo I, 2015, VIRUS RES, V200, P45, DOI 10.1016/j.virusres.2015.01.022; Gao G, 2006, CAN J PHYSIOL PHARM, V84, P5, DOI 10.1139/y05-144; GomezPuertas P, 1996, J VIROL, V70, P5689; Groll M, 2009, J PEPT SCI, V15, P58, DOI 10.1002/psc.1107; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hernaez B, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005595; Hernaez B, 2010, J VIROL, V84, P2100, DOI 10.1128/JVI.01557-09; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HINGAMP PM, 1992, EMBO J, V11, P361, DOI 10.1002/j.1460-2075.1992.tb05058.x; HINGAMP PM, 1995, J VIROL, V69, P1785, DOI 10.1128/JVI.69.3.1785-1793.1995; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Keck F, 2015, ANTIVIR RES, V120, P48, DOI 10.1016/j.antiviral.2015.05.004; King DP, 2003, J VIROL METHODS, V107, P53, DOI 10.1016/S0166-0934(02)00189-1; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lin LX, 2015, VIRUS RES, V195, P207, DOI 10.1016/j.virusres.2014.10.012; Lopez T, 2011, J VIROL, V85, P11964, DOI 10.1128/JVI.05286-11; Luo HL, 2016, CURR OPIN VIROL, V17, P1, DOI 10.1016/j.coviro.2015.09.005; Lupfer C, 2010, VIRUS RES, V149, P36, DOI 10.1016/j.virusres.2009.12.010; Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Moss B, 2001, CURR PROTOC PROTEIN; Neznanov N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001887; Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rodriguez JM, 2004, J VIROL, V78, P4299, DOI 10.1128/JVI.78.8.4299-4313.2004; RODRIGUEZ JM, 1992, VIROLOGY, V186, P40, DOI 10.1016/0042-6822(92)90059-X; RODRIGUEZ JM, 1992, VIROLOGY, V188, P67, DOI 10.1016/0042-6822(92)90735-8; Salas ML, 2013, VIRUS RES, V173, P29, DOI 10.1016/j.virusres.2012.09.016; Sanchez EG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002754; Satheshkumar PS, 2009, J VIROL, V83, P2469, DOI 10.1128/JVI.01986-08; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Silva GM, 2015, NAT STRUCT MOL BIOL, V22, P116, DOI 10.1038/nsmb.2955; Simon-Mateo C, 1997, J VIROL, V71, P5799; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Teale A, 2009, J VIROL, V83, P2099, DOI 10.1128/JVI.01753-08; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tran K, 2010, J VIROL, V84, P3079, DOI 10.1128/JVI.02236-09; Valdeira ML, 1998, VET MICROBIOL, V60, P131, DOI 10.1016/S0378-1135(98)00152-7; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Widjaja I, 2010, J VIROL, V84, P9625, DOI 10.1128/JVI.01048-10; Williamson A, 2013, MOL CELL, V49, P591, DOI 10.1016/j.molcel.2013.01.028; Zheng ZH, 2016, VIRUS GENES, V52, P597, DOI 10.1007/s11262-016-1341-y	66	24	26	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189741	10.1371/journal.pone.0189741	http://dx.doi.org/10.1371/journal.pone.0189741			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244872	gold, Green Published, Green Submitted			2022-12-26	WOS:000418184700057
J	Espaillat, MP; Snider, AJ; Qiu, ZJ; Channer, B; Coant, N; Schuchman, EH; Kew, RR; Sheridan, BS; Hannun, YA; Obeid, LM				Espaillat, Mel Pilar; Snider, Ashley J.; Qiu, Zhijuan; Channer, Breana; Coant, Nicolas; Schuchman, Edward H.; Kew, Richard R.; Sheridan, Brian S.; Hannun, Yusuf A.; Obeid, Lina M.			Loss of acid ceramidase in myeloid cells suppresses intestinal neutrophil recruitment	FASEB JOURNAL			English	Article						sphingolipids; IBD; ulcerative colitis; colitis-associated cancer; MDSC	INFLAMMATORY-BOWEL-DISEASE; SPHINGOSINE KINASE 1; ULCERATIVE-COLITIS; IMMUNE-SYSTEM; UP-REGULATION; MECHANISMS; CANCER; PATHOGENESIS; DEFICIENCY; GENE	Bioactive sphingolipids are modulators of immune processes and their metabolism is often dysregulated in ulcerative colitis, a major category of inflammatory bowel disease (IBD). While multiple axes of sphingolipid metabolism have been investigated to delineate mechanisms regulating ulcerative colitis, the role of acid ceramidase (AC) in intestinal inflammation is yet to be characterized. Here we demonstrate that AC expression is elevated selectively in the inflammatory infiltrate in human and murine colitis. To probe for mechanistic insight into how AC up-regulation can impact intestinal inflammation, we investigated the selective loss of AC expression in the myeloid population. Using a model of intestinal epithelial injury, we demonstrate that myeloid AC conditional knockout mice exhibit impairment of neutrophil recruitment to the colon mucosa as a result of defective cytokine and chemokine production. Furthermore, the loss of myeloid AC protects from tumor incidence in colitis-associated cancer (CAC) and inhibits the expansion of neutrophils and granulocytic myeloid-derived suppressor cells in the tumor microenvironment. Collectively, our results demonstrate a tissue-specific role for AC in regulating neutrophilic inflammation and cytokine production. We demonstrate novel mechanisms of how granulocytes are recruited to the colon that may have therapeutic potential in intestinal inflammation, IBD, and CAC.	[Espaillat, Mel Pilar; Qiu, Zhijuan; Sheridan, Brian S.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY USA; [Espaillat, Mel Pilar; Snider, Ashley J.; Channer, Breana; Coant, Nicolas; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Dept Med, Stony Brook, NY USA; [Snider, Ashley J.; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY USA; [Channer, Breana] SUNY Stony Brook, Dept Biol, Stony Brook, NY USA; [Kew, Richard R.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY USA; [Snider, Ashley J.; Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northport, NY USA; [Schuchman, Edward H.] Plexcera Therapeut, New York, NY USA; [Schuchman, Edward H.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Icahn School of Medicine at Mount Sinai	Snider, AJ; Obeid, LM (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Med, L-4 179, Stony Brook, NY 11794 USA.	ashley.snider@stonybrookmedicine.edu; lina.obeid@stonybrookmedicine.edu		COANT, Nicolas/0000-0001-9237-2132	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [F31 DK105711-01]; U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [9R01GM097741-13A1]; Research Supplement to Promote Diversity in Health-Related Research; NIH National Cancer Institute [P01 CA097132]; Stony Brook University W. Burghardt Turner Graduate Fellowship Award; Undergraduate IMSD-MERGE Program; U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development Service [2 I01 BX000156]; NATIONAL CANCER INSTITUTE [P01CA097132, R01CA172517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK105711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097741] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; Research Supplement to Promote Diversity in Health-Related Research; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stony Brook University W. Burghardt Turner Graduate Fellowship Award; Undergraduate IMSD-MERGE Program; U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development Service; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Dr. Vincent W. Yang for his expert advice in clinical gastroenterology and colorectal cancer, and Dr. James B. Bliska for his expert advice in BMDM differentiation and culturing (both from the Stony Brook University School of Medicine). The authors also thank the Sphingolipid Animal Cancer Pathobiology Shared Resource Core (P01 CA097132) for the genetically modified models; the Lipidomics, Research Histology, and Flow Cytometry facilities at Stony Brook University for the technical and analytical work carried out in support of this manuscript; the Lipidomics Shared Resource at Hollings Cancer Center, Medical University of South Carolina (MUSC; Charleston, SC, USA); and the Lipidomics Core in the MUSC Center of Biomedical Research Excellence in Lipidomics and Pathobiology for providing lipid analyses and LCL385. This work was supported, in part, by a Merit Review Award 2 I01 BX000156 from the U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development Service (to L.M.O.); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant F31 DK105711-01 (to M.P.E.); U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant 9R01GM097741-13A1 (to L.M.O.); and a Research Supplement to Promote Diversity in Health-Related Research (to M.P.E.); NIH National Cancer Institute Grant P01 CA097132 (to Y.A.H., L.M.O., and A.J.S.); Stony Brook University W. Burghardt Turner Graduate Fellowship Award (to M.P.E.) and Undergraduate IMSD-MERGE Program (to B.C.). Edward H. Schuchman is an equity holder and consultant for Plexcera Therapeutics LLC, a company founded to develop acid ceramidase therapies for ceramide diseases. He is also named as an inventor on several acid ceramidase-related patents that have been licensed to Plexcera, and will derive royalty income from them should they be commercialized. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. All other authors declare no conflicts of interest.	Adada MM, 2013, J BIOL CHEM, V288, P27667, DOI 10.1074/jbc.M113.489443; Ahn GO, 2010, P NATL ACAD SCI USA, V107, P8363, DOI 10.1073/pnas.0911378107; Alayoubi AM, 2013, EMBO MOL MED, V5, P827, DOI 10.1002/emmm.201202301; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bar J, 2001, HUM MUTAT, V17, P199, DOI 10.1002/humu.5; Beckham TH, 2012, INT J CANCER, V131, P2034, DOI 10.1002/ijc.27480; Begagne E, 2014, J CLIN INVEST, V124, P5368, DOI 10.1172/JCI74188; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; Bilsborough J., 2016, AM J GASTROENTEROL S, V3, P27, DOI [10.1038/ajgsup.2016.18, DOI 10.1038/ajgsup.2016.18]; Carrigan SO, 2007, J LEUKOCYTE BIOL, V82, P1575, DOI 10.1189/jlb.0806528; Chung LK, 2016, CELL HOST MICROBE, V20, P296, DOI 10.1016/j.chom.2016.07.018; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; CROSS M, 1988, P NATL ACAD SCI USA, V85, P6232, DOI 10.1073/pnas.85.17.6232; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dworski S, 2017, BBA-MOL BASIS DIS, V1863, P386, DOI 10.1016/j.bbadis.2016.11.031; Dworski S, 2015, HAEMATOLOGICA, V100, DOI 10.3324/haematol.2014.108530; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Eliyahu E, 2007, FASEB J, V21, P1403, DOI 10.1096/fj.06-7016com; Eliyahu E, 2012, CELL PHYSIOL BIOCHEM, V30, P735, DOI 10.1159/000341453; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Espaillat Mel Pilar, 2017, Advances in Biological Regulation, V63, P140, DOI 10.1016/j.jbior.2016.11.001; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gonzalez-Cabrera Pedro J, 2014, F1000Prime Rep, V6, P109, DOI 10.12703/P6-109; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HO MK, 1983, J BIOL CHEM, V258, P636; Holtmann MH, 2006, ADV EXP MED BIOL, V579, P227; Hu XL, 2011, CANCER RES, V71, P2882, DOI 10.1158/0008-5472.CAN-10-2493; Huang WC, 2016, FASEB J, V30, P2945, DOI 10.1096/fj.201600394R; Jenkins RW, 2011, J BIOL CHEM, V286, P13292, DOI 10.1074/jbc.M110.163378; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim ND, 2015, TRENDS IMMUNOL, V36, P547, DOI 10.1016/j.it.2015.07.007; Knoop KA, 2016, GUT, V65, P1100, DOI 10.1136/gutjnl-2014-309059; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kuhl AA, 2007, GASTROENTEROLOGY, V133, P1882, DOI 10.1053/j.gastro.2007.08.073; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Lee PY, 2013, J LEUKOCYTE BIOL, V94, P585, DOI 10.1189/jlb.0113014; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li CM, 2002, GENOMICS, V79, P218, DOI 10.1006/geno.2002.6686; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Liu TC, 2016, ANNU REV PATHOL-MECH, V11, P127, DOI 10.1146/annurev-pathol-012615-044152; MacDonald TT, 2012, INFLAMM BOWEL DIS, V18, P2180, DOI 10.1002/ibd.22967; MacDonald TT, 2011, GASTROENTEROLOGY, V140, P1768, DOI 10.1053/j.gastro.2011.02.047; MacDonald TT, 2006, ADV EXP MED BIOL, V579, P98; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Morad SAF, 2016, CANCER LETT, V376, P199, DOI 10.1016/j.canlet.2016.03.049; Morad SAF, 2015, BBA-MOL CELL BIOL L, V1851, P1134, DOI 10.1016/j.bbalip.2015.05.001; Muthas D, 2017, SCAND J GASTROENTERO, V52, P125, DOI 10.1080/00365521.2016.1235224; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; PARKOS CA, 1991, J CLIN INVEST, V88, P1605, DOI 10.1172/JCI115473; Peloquin JM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87899; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; de Mattos BRR, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/493012; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Schmid MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/201026; Shang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051848; Sheridan Brian S, 2012, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s99; Snider AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113998; Snider AJ, 2012, PROSTAG OTH LIPID M, V99, P124, DOI 10.1016/j.prostaglandins.2012.08.003; Snider AJ, 2010, BIOCHIMIE, V92, P707, DOI 10.1016/j.biochi.2010.02.008; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Sun W, 2008, J INVEST DERMATOL, V128, P389, DOI 10.1038/sj.jid.5701025; Tan SF, 2016, ONCOTARGET, V7, P83208, DOI 10.18632/oncotarget.13079; Trujillo G, 2011, MOL IMMUNOL, V49, P495, DOI 10.1016/j.molimm.2011.09.024; Wang K, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.36; Wang Y, 2014, MUCOSAL IMMUNOL, V7, P1106, DOI 10.1038/mi.2013.126; Williams IR, 2007, GASTROENTEROLOGY, V133, P2049, DOI 10.1053/j.gastro.2007.10.031; Wu D, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/436307; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zeidan YH, 2006, J BIOL CHEM, V281, P24695, DOI 10.1074/jbc.M604713200; Zeng MY, 2017, MUCOSAL IMMUNOL, V10, P18, DOI 10.1038/mi.2016.75; Zhang QQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15948; ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387; Zilio S, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4030031	81	15	16	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2339	2353		10.1096/fj.201700585R	http://dx.doi.org/10.1096/fj.201700585R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29259036	Green Published			2022-12-26	WOS:000432528000004
J	Cornelius, F; Tsunekawa, N; Toyoshima, C				Cornelius, Flemming; Tsunekawa, Naoki; Toyoshima, Chikashi			Distinct pH dependencies of Na+/K+ selectivity at the two faces of Na,K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; membrane transport; enzyme kinetics; enzyme mechanism; membrane protein; E1; E2 conformations; pH; pKa; protonation of binding sites	SODIUM-PUMP; CRYSTAL-STRUCTURE; ADENOSINE-TRIPHOSPHATASE; ACIDIC RESIDUES; ALPHA-SUBUNIT; POTASSIUM; NA+,K+-ATPASE; TRANSPORT; SITES; K+	The sodium pump (Na,K-ATPase) in animal cells is vital for actively maintaining ATP hydrolysis-powered Na+ and K+ electrochemical gradients across the cell membrane. These ion gradients drive co- and countertransport and are critical for establishing the membrane potential. It has been an enigma how Na,K-ATPase discriminates between Na+ and K+, despite the pumped ion on each side being at a lower concentration than the other ion. Recent crystal structures of analogs of the intermediate conformations E2Pi2K(+) and Na+-bound E1 approximate to PADP suggest that the dimensions of the respective binding sites in Na,K-ATPase are crucial in determining its selectivity. Here, we found that the selectivity at each membrane face is pH-dependent and that this dependence is unique for each face. Most notable was a strong increase in the specific affinity for K+ at the extracellular face (i.e. E2 conformation) as the pH is lowered from 7.5 to 5. We also observed a smaller increase in affinity for K+ on the cytoplasmic side (E1 conformation), which reduced the selectivity for Na+. Theoretical analysis of the pK(a) values of ion-coordinating acidic amino acid residues suggested that the face-specific pH dependences and Na+/K+ selectivities may arise from the protonation or ionization of key residues. The increase in K+ selectivity at low pH on the cytoplasmic face, for instance, appeared to be associated with Asp(808) protonation. We conclude that changes in the ionization state of coordinating residues in Na,K-ATPase could contribute to altering face-specific ion selectivity.	[Cornelius, Flemming] Univ Aarhus, Dept Biomed, Ole Worms Alle 6, DK-8000 Aarhus C, Denmark; [Tsunekawa, Naoki; Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Aarhus University; University of Tokyo	Cornelius, F (corresponding author), Univ Aarhus, Dept Biomed, Ole Worms Alle 6, DK-8000 Aarhus C, Denmark.	fc@biomed.au.dk	Toyoshima, Chikashi/R-4153-2019; Cornelius, Flemming/C-1912-2019	Cornelius, Flemming/0000-0003-1566-0020; Toyoshima, Chikashi/0000-0001-9640-0778	Danish Medical Research Council; Danish Agency for Science, Technology, and Innovation; Novo Nordisk Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Agency for Science, Technology, and Innovation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by grants from the Danish Medical Research Council, the Danish Agency for Science, Technology, and Innovation, and the Novo Nordisk Foundation. The authors declare that they have no conflicts of interests with the contents of this article.	BAGINSKI ES, 1967, CLIN CHIM ACTA, V15, P155, DOI 10.1016/0009-8981(67)90340-3; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BREITWIESER GE, 1987, AM J PHYSIOL, V253, pC547, DOI 10.1152/ajpcell.1987.253.4.C547; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; Cymes GD, 2016, P NATL ACAD SCI USA, V113, pE7106, DOI 10.1073/pnas.1608519113; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; GARAY RP, 1973, J PHYSIOL-LONDON, V231, P297, DOI 10.1113/jphysiol.1973.sp010234; GARRAHAN PJ, 1967, J PHYSIOL-LONDON, V192, P217, DOI 10.1113/jphysiol.1967.sp008297; GLYNN IM, 1962, J PHYSIOL-LONDON, V160, pP18; Han M, 2017, SCI REP-UK, V7, DOI 10.1038/srep39829; Holm R, 2015, J BIOL CHEM, V290, P9801, DOI 10.1074/jbc.M114.625509; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Koenderink JB, 2003, J BIOL CHEM, V278, P51213, DOI 10.1074/jbc.M306384200; Lervik A, 2012, PHYS CHEM CHEM PHYS, V14, P3543, DOI 10.1039/c2cp23002j; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahmmoud YA, 2002, BIOPHYS J, V82, P1907, DOI 10.1016/S0006-3495(02)75540-9; Milanick MA, 2002, J GEN PHYSIOL, V120, P497, DOI 10.1085/jgp.20028573; Musgaard M, 2011, BIOCHEMISTRY-US, V50, P11109, DOI 10.1021/bi201164b; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; OTTOLENGHI P, 1975, BIOCHEM J, V151, P61, DOI 10.1042/bj1510061; Peluffo RD, 2009, BIOCHEMISTRY-US, V48, P8105, DOI 10.1021/bi900687u; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Rui H, 2016, ELIFE, V5, DOI 10.7554/eLife.16616; SACHS JR, 1986, J PHYSIOL-LONDON, V381, P149, DOI 10.1113/jphysiol.1986.sp016319; Salonikidis PS, 2000, BBA-BIOMEMBRANES, V1509, P496, DOI 10.1016/S0005-2736(00)00356-4; SEN AK, 1964, J BIOL CHEM, V239, P345; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SIMONS TJB, 1974, J PHYSIOL-LONDON, V237, P123, DOI 10.1113/jphysiol.1974.sp010474; SKOU JC, 1980, BIOCHIM BIOPHYS ACTA, V601, P386, DOI 10.1016/0005-2736(80)90543-X; SKOU JC, 1974, Q REV BIOPHYS, V7, P401, DOI 10.1017/S0033583500001475; SKOU JC, 1979, BIOCHIM BIOPHYS ACTA, V567, P421, DOI 10.1016/0005-2744(79)90128-1; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; Sugita Y, 2005, J AM CHEM SOC, V127, P6150, DOI 10.1021/ja0427505; Terkildsen JR, 2007, AM J PHYSIOL-HEART C, V293, pH3036, DOI 10.1152/ajpheart.00771.2007; Therien AG, 1999, AM J PHYSIOL-CELL PH, V277, pC891, DOI 10.1152/ajpcell.1999.277.5.C891; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Vedovato N, 2014, J GEN PHYSIOL, V143, P449, DOI 10.1085/jgp.201311148; VILSEN B, 1993, BIOCHEMISTRY-US, V32, P13340, DOI 10.1021/bi00211a048; WHITTAM R, 1965, BIOCHEM J, V97, P214, DOI 10.1042/bj0970214; Yu HB, 2011, NAT STRUCT MOL BIOL, V18, P1159, DOI 10.1038/nsmb.2113	44	1	1	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2195	2205		10.1074/jbc.RA117.000700	http://dx.doi.org/10.1074/jbc.RA117.000700			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29247005	Green Published, hybrid			2022-12-26	WOS:000424948000030
J	Lambert, RF; Orrell, C; Haberer, JE				Lambert, R. Frederick; Orrell, Catherine; Haberer, Jessica E.			"It was pain. That's it. It was pain." Lack of oral health care among otherwise healthy young adults living with HIV in South Africa: A qualitative study	PLOS ONE			English	Article								Introduction The purpose of this study is to understand engagement with and availability of dental services among people living with HIV in a low-income community of South Africa. Methods In depth qualitative interviewing was used to collect data, which was analyzed using an inductive content analytical approach. The study was conducted in Gugulethu, a township community located outside of Cape Town, South Africa. Local public sector health services provided free of charge are the main source of primary health and dental care for this population. Participants included South African adults (age 18-35) recently diagnosed with HIV who had a CD4 count >350 cells/mm(3). Results Many participants had little to no experience with dental care, did not know which health care providers are appropriate to address oral health concerns, were not aware of available dental services, utilized home remedies to treat oral health problems, harbored many misperceptions of dental care, avoided dental services due to fear, and experienced poverty as a barrier to dental services. Conclusions Our findings suggest that integration of oral healthcare into medical care may increase patient knowledge about oral health and access to care. Leveraging the relatively robust HIV infrastructure to address oral disease may also be an effective approach to reaching these participants and those living in resource poor communities generally.	[Lambert, R. Frederick] Harvard Univ, Harvard Sch Dent Med, Boston, MA 02115 USA; [Orrell, Catherine] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Fdn, Cape Town, South Africa; [Haberer, Jessica E.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Haberer, Jessica E.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Harvard School of Dental Medicine; University of Cape Town; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Haberer, JE (corresponding author), Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA.; Haberer, JE (corresponding author), Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.	JHaberer@Partners.org	Haberer, Jessica/AAH-7976-2019; Orrell, Catherine/AAF-3405-2019	Haberer, Jessica/0000-0001-5845-3190; Orrell, Catherine/0000-0003-1134-7475	Bill and Melinda Gates Foundation [0PP113634]; Harvard Medical School Class of Scholarship; Harvard Medical School Center for Primary Care	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Harvard Medical School Class of Scholarship; Harvard Medical School Center for Primary Care	Financial support for the qualitative research presented in this work was provided by the Bill and Melinda Gates Foundation (Grant No. 0PP113634 to JEH and CO), the Harvard Medical School Class of 1984 Scholarship (RFL), and the Harvard Medical School Center for Primary Care (RFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Bhayat A, 2003, COMMUNITY DENT ORAL; Challacombe SJ, 2016, ORAL DIS; Dept of Health, 2003, REP OR HLTH S AFR 19; Dimba E, 2016, ORAL DIS; Dios P Diz, 2014, ORAL DIS; Ferrante JM, 2010, J AM BOARD FAM MED, V23, P736, DOI 10.3122/jabfm.2010.06.100085; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Greenberg BL, 2010, J AM DENT ASS; Hamza OJ, 2006, BMC ORAL HLTH; Holms HK, 2002, ORAL DIS; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Lai H, 2016, COMMUNITY DENT ORAL; Lalla E, 2011, J DENT RES, V90, P855, DOI 10.1177/0022034511407069; Lambert RF, 2017, AIDS BEHAV; Lamptey P, 2012, GLOB HEART, V7, P67, DOI 10.1016/j.gheart.2012.01.010; Leung C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3661-1; Maxey H., INTEGRATION ORAL HLT; Mickenautsch S, 2007, J PUBLIC HEALTH DENT, V67, P179, DOI 10.1111/j.1752-7325.2007.00017.x; Peerbhay F, 2012, SADJ, V67, P14; Petersen PE, 2003, COMMUNITY DENT ORAL; Petersen PE, 2006, ADV DENT RES; Petersen PE, 2005, B WORLD HEALTH ORGAN; Rabkin M, 2011, GLOB PUBLIC HEALTH, V6, P247, DOI 10.1080/17441692.2011.552068; Rong WS, 2003, COMMUNITY DENT ORAL; Singh S., 2011, Southern African Journal of Epidemiology & Infection, V26, P259; Singh S, 2010, GLOB HEALTH PROMOT, V17, P16, DOI 10.1177/1757975909356631; Strachan B, 2011, SAMJ S AFR MED J, V101, P523; Thema LK, 2013, AFR PRIM HLTH CARE F, V5, P1, DOI DOI 10.4102/PHCFM.V5I1.413; Thorpe SJ, 2006, J DENT ED, V70, P8, DOI [10.1002/j.0022-0337.2006.70.11_suppl.tb04209.x, DOI 10.1002/J.0022-0337.2006.70.11_SUPPL.TB04209.X]; van Wyk P J, 2004, SADJ, V59, P240; van Wyk PJ, 2004, INT DENT J; Vernon LT, 2014, AIDS CARE, V26, P763, DOI 10.1080/09540121.2013.845291; Ware NC, 2009, PLOS MED; Watt RG, 2005, B WORLD HEALTH ORGAN; Wells KJ, 2017, PATIENT ED COUNS; WHORegional Office for Africa, 2016, PROM OR HLTH AFR PRE; World Health Organization, 2015, GUID START ANT THER; Yengopal V, 2016, ORAL DIS; Yengopal V, 2008, ORAL SURG ORAL MED O	40	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0188353	10.1371/journal.pone.0188353	http://dx.doi.org/10.1371/journal.pone.0188353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8ZJ	29272290	Green Published, Green Submitted, gold			2022-12-26	WOS:000418651500003
J	Lituma, CM; Buehler, DA; Tanner, EP; Tanner, AM; Keyser, PD; Harper, CA				Lituma, Christopher M.; Buehler, David A.; Tanner, Evan P.; Tanner, Ashley M.; Keyser, Patrick D.; Harper, Craig A.			Factors affecting availability for detection: An example using radio-collared Northern Bobwhite (Colinus virginianus)	PLOS ONE			English	Article							CONSPECIFIC ATTRACTION; DETECTION PROBABILITIES; HABITAT MANIPULATION; CALLING BEHAVIOR; ESTIMATE DENSITY; GRASSLAND; ABUNDANCE; SONG; POPULATIONS; SELECTION	Avian monitoring strategies are usually linked to bird singing or calling behavior. Individual availability for detection can change as a result of conspecific factors affecting bird behavior, though the magnitude of these effects is difficult to quantify. We evaluated behavioral and temporal factors affecting Northern Bobwhite (Colinus virginianus) breeding season individual availability for detection during three common survey times (3 min, 5 min, 10 min). We conducted 10-minute surveys associated with radio-collared male Northern Bobwhites on Peabody Wildlife Management Area, Kentucky, from 2010 +/- 2011. We homed to within 50 m of radio-collared males and recorded number of distinct Northern Bobwhite whistles (singing rate) per 1-minute interval, number of other males calling during the survey, minutes-since-sunrise, and day-of-season. We also recorded the number of minutes during a 10-minute survey that radio-collared male Northern Bobwhites called. We used logistic regression to estimate availability of radio-collared individuals for 3-minute, 5-minute, and 10-minute surveys. We also modeled number of minutes during 10-minute surveys that radio-collared Northern Bobwhites called, and we modeled singing rate. Individual availability for detection of radio-collared individuals during a 10-minute survey increased by 100% when at least 1 other Northern Bobwhite called during a survey (6.5% to 13.1%) and by 626% when 6 other Northern Bobwhites were calling (6.5% to 47.6%). Individual availability was 30% greater for 10-minute surveys than 5-minute surveys or 55% greater for 10-minute surveys than 3-minute surveys. Northern Bobwhite called most (2.8 +/- 0.66 minutes/10-min survey) and at a greater rate (11.8 +/- 1.3 calls/10-min period) when at least 5 other Northern Bobwhites called. Practitioners risk biasing population estimates low if individual availability is unaccounted for because species with low populations will not be stimulated by other calling males, are less likely to call, call less frequently, and call fewer times per minute, reducing their individual availability and likelihood to be counted on a survey even when they are present.	[Lituma, Christopher M.; Buehler, David A.; Tanner, Evan P.; Tanner, Ashley M.; Keyser, Patrick D.; Harper, Craig A.] Univ Tennessee, Dept Forestry Wildlife & Fisheries, Knoxville, TN 37996 USA; [Lituma, Christopher M.] West Virginia Univ, Div Forestry & Nat Resources, Morgantown, WV 26506 USA; [Tanner, Evan P.; Tanner, Ashley M.] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; West Virginia University; Oklahoma State University System; Oklahoma State University - Stillwater	Lituma, CM (corresponding author), Univ Tennessee, Dept Forestry Wildlife & Fisheries, Knoxville, TN 37996 USA.; Lituma, CM (corresponding author), West Virginia Univ, Div Forestry & Nat Resources, Morgantown, WV 26506 USA.	cml0017@mail.wvu.edu	Tanner, Evan/K-9325-2015	Tanner, Evan/0000-0003-0063-7004	Kentucky Department of Fish and Wildlife Resources, American Bird Conservancy; Natural Resources Conservation Service	Kentucky Department of Fish and Wildlife Resources, American Bird Conservancy; Natural Resources Conservation Service	This project was part of a larger project supported by the Kentucky Department of Fish and Wildlife Resources, American Bird Conservancy, and Natural Resources Conservation Service. It was not directly funded by any single grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the Kentucky Department of Fish and Wildlife Resources. We thank Eric Williams for his survey assistance on Peabody Wildlife Management Area, Kentucky, USA. We thank John Morgan and Ben Robinson of the Kentucky Department of Fish and Wildlife Resources for their unwavering support of this project. We thank Dr. Christopher T. Rota for his insightful review of the manuscript. We thank previous anonymous reviewers of this manuscript for their valued inputs. We also thank all of the dedicated work of the research technicians who conducted surveys and radio-tracked Northern Bobwhite. Trapping, banding, and handling protocols complied with the University of Tennessee Institutional Animal Care and Use Committee Permit 2042-0911.	Ahlering MA, 2006, AUK, V123, P301, DOI 10.1642/0004-8038(2006)123[301:AHMMCA]2.0.CO;2; Alkon PU, 2015, WILSON J ORNITHOL, V127, P181, DOI 10.1676/wils-127-02-181-199.1; Alldredge MW, 2007, AUK, V124, P653, DOI 10.1642/0004-8038(2007)124[653:TMFEAF]2.0.CO;2; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brewster JP, 2009, J FIELD ORNITHOL, V80, P178, DOI 10.1111/j.1557-9263.2009.00220.x; Brooke JM, 2015, J WILDLIFE MANAGE, V79, P1264, DOI 10.1002/jwmg.944; Buckland S.T., 2001, pi; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Campomizzi AJ, 2008, J WILDLIFE MANAGE, V72, P331, DOI 10.2193/2007-204; Commission for Environmental Cooperation, 1997, PRAV CHEL SBORN ZAK, P25; Conway CJ, 2003, J WILDLIFE MANAGE, V67, P501, DOI 10.2307/3802708; Conway CJ, 2010, WETLANDS, V30, P358, DOI 10.1007/s13157-010-0030-1; Cox JA, 2004, J FIELD ORNITHOL, V75, P359, DOI 10.1648/0273-8570-75.4.359; Cram DS, 2002, J WILDLIFE MANAGE, V66, P1031, DOI 10.2307/3802935; Crosby AD, 2015, BIOL CONSERV, V186, P233, DOI 10.1016/j.biocon.2015.03.018; Diefenbach DR, 2007, AUK, V124, P96, DOI 10.1642/0004-8038(2007)124[96:IAFDIE]2.0.CO;2; Duren KR, 2012, WILDLIFE SOC B, V36, P16, DOI 10.1002/wsb.82; Evans KO, 2011, NATL BOBWHITE CONSER, P191; Farnsworth GL, 2002, AUK, V119, P414, DOI 10.1642/0004-8038(2002)119[0414:ARMFED]2.0.CO;2; Farrell SL, 2012, J ANIM ECOL, V81, P1056, DOI 10.1111/j.1365-2656.2012.01995.x; Finity L, 2012, CONDOR, V114, P323, DOI 10.1525/cond.2012.110145; Gallo T, 2016, BIOL CONSERV, V197, P47, DOI 10.1016/j.biocon.2016.02.032; Hansen HM, 2001, WILDLIFE SOC B, V29, P145; HAUG EA, 1993, J FIELD ORNITHOL, V64, P188; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; KENNEDY PL, 1993, J WILDLIFE MANAGE, V57, P249, DOI 10.2307/3809421; Koenig WD, 2005, ECOLOGY, V86, P1873, DOI 10.1890/04-1175; KREBS J, 1978, NATURE, V271, P539, DOI 10.1038/271539a0; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lituma CM, 2014, THESIS; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mariette MM, 2012, OIKOS, V121, P823, DOI 10.1111/j.1600-0706.2011.20014.x; Marshall DC, 2001, ANN ENTOMOL SOC AM, V94, P386, DOI 10.1603/0013-8746(2001)094[0386:PCHCLC]2.0.CO;2; Mazerolle MJ, 2016, AICCMODAVG MODEL SEL; McCarthy MA, 2013, OIKOS, V122, P717, DOI 10.1111/j.1600-0706.2012.20781.x; MCGREGOR PK, 1991, BIOL REV, V66, P57, DOI 10.1111/j.1469-185X.1991.tb01135.x; McNeil DJ, 2014, WILDLIFE SOC B, V38, P586, DOI 10.1002/wsb.428; Mori E, 2014, BIRD STUDY, V61, P277, DOI 10.1080/00063657.2014.897303; Murray LD, 2011, J WILDLIFE MANAGE, V75, P1072, DOI 10.1002/jwmg.131; Nichols JD, 2009, INFERENCES LANDBIRD, P201; OTIS DL, 1978, WILDLIFE MONOGR, P1; Palmer WE, 2005, WILDLIFE SOC B, V33, P1398, DOI 10.2193/0091-7648(2005)33[1398:EOFBAN]2.0.CO;2; Palmer WE, 2011, NATL BOBWHITE CONSER; Penteriani V, 2002, J FIELD ORNITHOL, V73, P387, DOI 10.1648/0273-8570-73.4.387; Peters DC, 2015, J WILDLIFE MANAGE, V79, P605, DOI 10.1002/jwmg.873; R Core Team, 2021, R LANGUAGE ENV STAT; Rae LF, 2015, J FIELD ORNITHOL, V86, P51, DOI 10.1111/jofo.12088; Riddle JD, 2010, J WILDLIFE MANAGE, V74, P1319, DOI 10.2193/2009-220; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Sauer J. R., 2014, N AM BREEDING BIRD S, P3; Sexton K, 2007, BEHAVIOUR, V144, P1273, DOI 10.1163/156853907781890922; Sillett TS, 2004, ECOLOGY, V85, P2467, DOI 10.1890/03-0272; Stanley CQ, 2016, ANIM BEHAV, V112, P255, DOI 10.1016/j.anbehav.2015.12.003; Twedt DJ, 2007, J WILDLIFE MANAGE, V71, P1808, DOI 10.2193/2006-567; Vabishchevich AP, 2011, ANN ZOOL FENN, V48, P376, DOI 10.5735/086.048.0606; Veech JA, 2006, CONSERV BIOL, V20, P1422, DOI 10.1111/j.1523-1739.2006.00487.x; Veech JA, 2016, METHODS ECOL EVOL, V7, P1019, DOI 10.1111/2041-210X.12566; Virzi T, 2012, CONDOR, V114, P846, DOI 10.1525/cond.2012.100197; Warren CC, 2013, AUK, V130, P677, DOI 10.1525/auk.2013.13022; Wellendorf SD, 2004, J WILDLIFE MANAGE, V68, P672, DOI 10.2193/0022-541X(2004)068[0672:ECRONB]2.0.CO;2; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; White G.C., 1990, ANAL WILDLIFE RADIO; Williams CK, 2004, WILDLIFE SOC B, V32, P861, DOI 10.2193/0091-7648(2004)032<0861:TNBDSO>2.0.CO;2; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	65	6	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190376	10.1371/journal.pone.0190376	http://dx.doi.org/10.1371/journal.pone.0190376			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272300	Green Published, gold, Green Submitted			2022-12-26	WOS:000418651500051
J	Przybyla, B; Pinomaki, A; Petaja, J; Joutsi-Korhonen, L; Strandberg, K; Hillarp, A; Ohlin, AK; Ruutu, T; Volin, L; Lassila, R				Przybyla, Beata; Pinomaki, Anne; Petaja, Jari; Joutsi-Korhonen, Lotta; Strandberg, Karin; Hillarp, Andreas; Ohlin, Ann-Kristin; Ruutu, Tapani; Volin, Liisa; Lassila, Riitta			Coordinated responses of natural anticoagulants to allogeneic stem cell transplantation and acute GVHD - A longitudinal study	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; ACTIVATED PROTEIN-C; VERSUS-HOST-DISEASE; THROMBOMODULIN; COMPLICATIONS; COAGULATION; DEFICIENCY; RECIPIENTS; COMPLEX; PLASMA	Background Allogeneic stem cell transplantation (SCT) enhances coagulation via endothelial perturbation and inflammation. Role of natural anticoagulants in interactions between coagulation and inflammation as well as in acute graft-versus-host disease (GVHD) are not well known. The purpose of this study was to define changes in natural anticoagulants over time in association with GVHD. Patients and methods This prospective study included 30 patients who received grafts from siblings (n = 19) or unrelated donors (n = 11). Eight patients developed GVHD. Standard clinical assays were applied to measure natural anticoagulants, represented by protein C (PC), antithrombin (AT), protein S (PS), complex of activated PC with its inhibitor (APC-PCI) and by markers of endothelial activation: Factor VIII coagulant activity (FVIII: C) and soluble thrombomodulin (s-TM) at 6-8 time points over three months. Results Overall, PC, AT and FVIII: C increased in parallel after engraftment. Significant correlations between PC and FVIII: C (r = 0.64-0.82, p<0.001) and between PC and AT (r = 0.62-0.81, p<0.05) were observed at each time point. Patients with GVHD had 21% lower PC during conditioning therapy and 55% lower APC-PCI early after transplantation, as well as 37% higher values of s-TM after engraftment. The GVHD group had also increases of PC (24%), FVIII: C (28%) and AT (16%) three months after transplantation. Conclusion The coordinated activation of natural anticoagulants in our longitudinal study indicates the sustained ability of adaptation to endothelial and inflammatory activation during allogenic SCT treatment. The suboptimal control of coagulation by natural anticoagulants at early stage of SCT may contribute to onset of GVHD.	[Przybyla, Beata; Lassila, Riitta] Helsinki Univ Hosp, Coagulat Disorders Unit, Helsinki, Finland; [Przybyla, Beata; Lassila, Riitta] Univ Helsinki, Helsinki, Finland; [Pinomaki, Anne; Ruutu, Tapani; Volin, Liisa] Helsinki Univ Hosp, Stem Cell Transplantat Unit, Ctr Comprehens Canc, Helsinki, Finland; [Petaja, Jari] Helsinki Univ Hosp, Dept Paediat, Helsinki, Finland; [Joutsi-Korhonen, Lotta; Lassila, Riitta] Helsinki Univ Hosp, Hematol & Clin Chem & HUSLAB Lab Serv, Helsinki, Finland; [Strandberg, Karin; Hillarp, Andreas; Ohlin, Ann-Kristin] Lund Univ, Dept Clin Chem, Univ Lund Hosp, Lund, Sweden; [Strandberg, Karin; Hillarp, Andreas; Ohlin, Ann-Kristin] Skane Cty Council, Univ & Reg Labs, Coagulat Lab, Clin Chem, Malmo, Sweden	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Lund University; Skane University Hospital	Przybyla, B (corresponding author), Helsinki Univ Hosp, Coagulat Disorders Unit, Helsinki, Finland.; Przybyla, B (corresponding author), Univ Helsinki, Helsinki, Finland.	Beata.Przybyla@helsinki.fi	Strandberg, Karin/AAW-2777-2021	Strandberg, Karin/0000-0001-5554-6631; Volin, Liisa/0000-0002-9731-8335; Przybyla, Beata/0000-0003-1014-668X	special Finnish government	special Finnish government	Research was supported by a grant from special Finnish government subsidy for health sciences (EVO) to RL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown SA, 1999, BRIT J HAEMATOL, V104, P468, DOI 10.1046/j.1365-2141.1999.01223.x; COLLINS PW, 1992, BONE MARROW TRANSPL, V10, P499; Cutler C, 2010, BIOL BLOOD MARROW TR, V16, P1180, DOI 10.1016/j.bbmt.2010.02.016; Danese S, 2010, BLOOD, V115, P1121, DOI 10.1182/blood-2009-09-201616; DEAGOSTINI AI, 1994, J CELL BIOCHEM, V54, P174, DOI 10.1002/jcb.240540206; Faust SN, 2001, NEW ENGL J MED, V345, P408, DOI 10.1056/NEJM200108093450603; Ferrara J L, 1999, Biol Blood Marrow Transplant, V5, P347, DOI 10.1016/S1083-8791(99)70011-X; Ferrara JLM, 1998, BONE MARROW TRANSPL, V21, pS13; FIJNVANDRAAT K, 1995, THROMB HAEMOSTASIS, V73, P15; FREYSSINET JM, 1986, BIOCHEM J, V238, P151, DOI 10.1042/bj2380151; GORDON B, 1991, BONE MARROW TRANSPL, V8, P497; Gordon B, 1996, BONE MARROW TRANSPL, V17, P415; GRUBER A, 1992, BLOOD, V79, P2340; Ikezoe T, 2012, LEUKEMIA RES, V36, P1398, DOI 10.1016/j.leukres.2012.08.012; Jevtic D, 2011, J PEDIAT HEMATOL ONC, V33, P227, DOI 10.1097/MPH.0b013e31820539fd; LEBLOND V, 1993, BONE MARROW TRANSPL, V11, P299; Lee JH, 1998, BONE MARROW TRANSPL, V22, P883, DOI 10.1038/sj.bmt.1701445; Matsuda Y, 2001, BONE MARROW TRANSPL, V27, P977, DOI 10.1038/sj.bmt.1703026; Morel O, 2011, SEMIN IMMUNOPATHOL, V33, P469, DOI 10.1007/s00281-010-0239-3; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2003, BIOCHEM J, V373, P65, DOI 10.1042/BJ20030341; Ohlin AK, 2005, J THROMB HAEMOST, V3, P976, DOI 10.1111/j.1538-7836.2005.01267.x; Penack O, 2011, BLOOD, V117, P4181, DOI 10.1182/blood-2010-10-312934; Pihusch V, 2006, TRANSPLANTATION, V81, P1405, DOI 10.1097/01.tp.0000209218.24916.ba; Pinomaki A, 2010, BONE MARROW TRANSPL, V45, P730, DOI 10.1038/bmt.2009.227; Politikos I, 2017, BIOL BLOOD MARROW TR, V23, P103, DOI 10.1016/j.bbmt.2016.10.013; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Raivio P, 2007, J THORAC CARDIOV SUR, V133, P44, DOI 10.1016/j.jtcvs.2006.10.003; REMBERGER M, 1995, BONE MARROW TRANSPL, V15, P99; Ruutu T, 2000, BLOOD, V96, P2391; Salat C, 1997, BONE MARROW TRANSPL, V19, P909, DOI 10.1038/sj.bmt.1700767; Schots R, 2003, LEUKEMIA, V17, P1150, DOI 10.1038/sj.leu.2402946; Strandberg K, 2003, THROMB HAEMOSTASIS, V89, P947, DOI 10.1055/s-0037-1613485; Takatsuka H, 2000, BONE MARROW TRANSPL, V26, P419, DOI 10.1038/sj.bmt.1702517; Tamaki S, 2002, CLIN APPL THROMB-HEM, V8, P125, DOI 10.1177/107602960200800207; Testa S, 1996, BONE MARROW TRANSPL, V18, P383; Zeng L, 2010, TRANSPL P, V42, P2720, DOI 10.1016/j.transproceed.2010.04.024	37	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190007	10.1371/journal.pone.0190007	http://dx.doi.org/10.1371/journal.pone.0190007			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272282	Green Published, Green Submitted, gold			2022-12-26	WOS:000418651500023
J	Seely, E; Osborne, RW; Koski, K; Larson, S				Seely, Elizabeth; Osborne, Richard W.; Koski, Kari; Larson, Shawn			Soundwatch: Eighteen years of monitoring whale watch vessel activities in the Salish Sea	PLOS ONE			English	Article							KILLER WHALES; ORCINUS-ORCA; BRITISH-COLUMBIA; WASHINGTON; BEHAVIOR	The Soundwatch Boater Education Program is a vessel monitoring and public education outreach program. Soundwatch has been run by The Whale Museum (TWM) during the whale watch season (May through September) in the Haro Strait Region of the Central Salish Sea since 1993. Data collection has been in a consistent manner since 1998 and is presented here. The program compiles data on vessel types and vessel interactions with marine mammals with a focus on the Southern Resident killer whale (SRKW), Orcinas orca, which was listed as endangered under the U.S. Endangered Species Act (ESA) in 2005. The primary goal of the Soundwatch program is to reduce vessel disturbance to SRKWs and other marine wildlife through the education of boaters on regional, local and federal guidelines and regulations and the systematic monitoring of vessel activities around cetaceans. Since 1998, the number of active commercial whale watching vessels has increased over time; ranging from a low of 63 in 1999, to a high of 96 in 2015. In addition, the number of vessel incidents or violation of regulations and guidelines has also increased; ranging from a low of 398 in 1998 to a high of 2621 in 2012. Soundwatch collected data on 23 incident types, some remaining the same over the 18-year data set and some changing over time. The most common incidents over the 18 years were "Within 880 m of Lime Kiln" and "Crossing the path of whales". The numbers of people kayaking near whales also significantly increased since 2004 with the incident "kayaks spread out" with a significantly increasing trend making it difficult for whales to avoid vessels. These results suggest a need for further outreach for effective education and enforcement of whale watching guidelines and regulations in the Central Salish Sea.	[Seely, Elizabeth; Koski, Kari; Larson, Shawn] Whale Museum, Friday Harbor, WA 98250 USA; [Osborne, Richard W.] Univ Washington, Olymp Nat Resources Ctr, Forks, WA USA	University of Washington	Seely, E (corresponding author), Whale Museum, Friday Harbor, WA 98250 USA.	elizabeth@whalemuseum.org			National Marine Fisheries Science Center (NOAA) [RA-133F-12-CQ-0057]; Section 6 Endangered Species Act Grant: Joint Grant with Washington State Fish and Wildlife	National Marine Fisheries Science Center (NOAA); Section 6 Endangered Species Act Grant: Joint Grant with Washington State Fish and Wildlife	This work was supported by National Marine Fisheries Science Center (NOAA): 5 year Contract Number RA-133F-12-CQ-0057, ES and KK. The funders had no role in data collection and analysis, decision to publish or preparation of the manuscript. Funders provided financial support to complete the survey days on the water and to complete annual contract reports at the end of each year; www.nmfs.noaa.gov, ES, KK. This work was also supported by Section 6 Endangered Species Act Grant: Joint Grant with Washington State Fish and Wildlife. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. Funders provided financial support for survey days on the water, printing of education materials and annual data analysis. Some of the data analysis from each season has been included in the manuscript. The grant can be viewed at the following link: https://www.fws.gov/endangered/grants/index.html, ES. The Soundwatch Boater Education Program also receives small quantities of monetary funding from private donations.	[Anonymous], 2004, ECOL SOC; Ayres KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036842; Baird RW, 2005, CAN J ZOOL, V83, P257, DOI 10.1139/Z05-007; Baird RW, 2001, CAN FIELD NAT, V115, P676; BAIRD RW, 1988, CAN J ZOOL, V66, P2582, DOI 10.1139/z88-380; Balcomb K. C., 1986, BEHAV BIOL KILLER WH, P85; Barrett-Lennard Lance Godfrey, 2000, THESIS U BRIT COLUMB; Bigg M.A., 1990, Reports of the International Whaling Commission Special Issue, P383; BIGG MA, 1975, J FISH RES BOARD CAN, V32, P1213, DOI 10.1139/f75-140; Cogan Jane, 2015, 2015 SIGHTINGS REPOR; Dahlheim ME, 2008, MAR MAMMAL SCI, V24, P719, DOI 10.1111/j.1748-7692.2008.00206.x; de Bruyn PJN, 2013, BIOL REV, V88, P62, DOI 10.1111/j.1469-185X.2012.00239.x; Eisenhardt E., 2012, RA133F12CQ0057 NAT O; FORD JKB, 1991, CAN J ZOOL, V69, P1454, DOI 10.1139/z91-206; Ford MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144956; Ham S. H., 2002, SUSTAINABLE TOURISM, P35, DOI DOI 10.1016/B978-0-7506-8946-5.50007-1; Hanson M. Bradley, 2010, Endangered Species Research, V11, P69, DOI 10.3354/esr00263; HEYNING J E, 1988, Mammalian Species, P1, DOI 10.2307/3504225; HOELZEL AR, 1991, HEREDITY, V66, P191, DOI 10.1038/hdy.1991.24; Holt MM, 2011, J ACOUST SOC AM, V130, P3100, DOI 10.1121/1.3641446; Houghton J., 2015, PLOSONE; Jelinski DE, 2002, APPL GEOGR, V22, P393, DOI 10.1016/S0143-6228(02)00051-6; Koski K., 2004, AB133F07CN0221 NAT O; Krahn M. M., 2004, NMFSNWFSC62 NOAA US; Kruse S., 1991, P149; Leatherwood JS, 1978, TECH REP, V443, P1; Mead JG, 2005, MAMMAL SPECIES WORLD, P723; Meissner AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116962; MITCHELL E, 1975, J FISH RES BOARD CAN, V32, P985, DOI 10.1139/f75-118; Morell V, 2011, SCIENCE, V331, P274, DOI 10.1126/science.331.6015.274; Morin PA, 2006, MAR MAMMAL SCI, V22, P897, DOI 10.1111/j.1748-7692.2006.00070.x; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Olson J, 2015, RA133F12CQ0057 NAT O; Osborne R, 2002, TRENDS WHALE WATCHIN; Osborne R.W., 1986, Zoo Biology Monographs, V1, P211; Osborne R. W, 1999, THESIS; Osborne RW, 1996, SOUNDWATCH END SEASO; Osborne RW, 1991, P PUG SOUND RES, P672; Parsons C.M., 2012, J MAR BIOL, V5, DOI DOI 10.1155/2012/807294; Parsons KM, 2009, ANIM BEHAV, V77, P963, DOI 10.1016/j.anbehav.2009.01.018; Powell RB, 2008, J SUSTAIN TOUR, V16, P467, DOI [10.2167/jost797.0, 10.1080/09669580802154223]; Russell S, 2014, NMFSNWFSC126 NOAA US; Seely E, 2015, RA133F12CQ0057 NAT O; Williams R, 2002, J ZOOL, V256, P255, DOI 10.1017/S0952836902000298	44	8	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0189764	10.1371/journal.pone.0189764	http://dx.doi.org/10.1371/journal.pone.0189764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272275	Green Published, Green Submitted, gold			2022-12-26	WOS:000418651500012
J	Liao, CD; Tsauo, JY; Hsiao, DJ; Liou, TH; Huang, SW; Lin, LF				Liao, Chun-De; Tsauo, Jau-Yih; Hsiao, Dun-Jen; Liou, Tsan-Hon; Huang, Shih-Wei; Lin, Li-Fong			Association of physical capacity with heart rate variability based on a short-duration measurement of resting pulse rate in older adults with obesity	PLOS ONE			English	Article							QUALITY-OF-LIFE; METABOLIC SYNDROME; AUTONOMIC DYSFUNCTION; FOLLOW-UP; SARCOPENIC-OBESITY; BODY-COMPOSITION; BALANCE TESTS; ALL-CAUSE; MORTALITY; WOMEN	Background Obesity can limit physical capacity and lower physical activity levels in elderly people. Low physical activity levels may be mediated by autonomic dysfunction with decreased heart rate variability (HRV). However, the relationship between autonomic dysfunction and low physical capability remains unclear. This cross-sectional study investigated the association of low physical capability with HRV in older adults with obesity. Materials and methods We recruited 231 old man and 210 old women with a mean (range) age of 65.5 (51-78) and 62.9 (52-76) years, respectively. Physical capability was measured using mobility tasks, including functional reach, single-leg stance (SLS), gait speed (GS), timed up and go, and timed chair rise (TCR), and the scores on these tasks were merged and transformed into a global physical capability score (GPCS). HRV was measured using a 7-min resting pulse-based technique, and the time-and frequency-domain indices of HRV were obtained including standard deviation of normal-to-normal intervals (SDNN), root mean square of successive differences at rest (rMSSD), and high-frequency (HF) power. All HRV indices were natural log (ln) transformed for analysis. Participants were divided into high, moderate, and low physical-capability groups according to their physical performance. Multivariate analysis of covariance was performed to test differences in HRV indices among physical-capability groups with participants' characteristics serving as covariates. A stepwise regression model was established to identify the determinants of HRV indices. We used hierarchical regression analysis to identify the association of the GPCS with HRV indices. Results In both men and women, the low physical-capability group exhibited significantly increased heart rate (P <0.05) and decreased HRV in terms of a decreased ln[SDNN] (P <0.001), ln [rMSSD] (P <0.05) and ln[HF] (P <0.05), compared with the high physical-capability group. GS positively predicted ln[SDNN], whereas SLS, GS, and TCR were determinants of ln[HF], regardless of gender. The GPCS in older men and women independently accounted for 29.9% (P <0.001) and 23.7% (P <0.001), respectively, in variance in ln[SDNN]. Conclusions A low physical-capability level is an independent determinant of decreased HRV in older adults with obesity.	[Liao, Chun-De; Tsauo, Jau-Yih] Natl Taiwan Univ, Coll Med, Sch & Grad Inst Phys Therapy, Taipei, Taiwan; [Liao, Chun-De; Liou, Tsan-Hon; Huang, Shih-Wei; Lin, Li-Fong] Taipei Med Univ, Shuang Ho Hosp, Dept Phys Med & Rehabil, New Taipei, Taiwan; [Hsiao, Dun-Jen] Taipei Med Univ, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Liou, Tsan-Hon] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Liou, Tsan-Hon] Taipei Med Univ, Coll Med, Sch Med, Dept Phys Med & Rehabil, Taipei, Taiwan; [Lin, Li-Fong] Taipei Med Univ, Coll Nursing, Sch Gerontol Hlth Management, Taipei, Taiwan	National Taiwan University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University	Lin, LF (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Phys Med & Rehabil, New Taipei, Taiwan.; Lin, LF (corresponding author), Taipei Med Univ, Coll Nursing, Sch Gerontol Hlth Management, Taipei, Taiwan.	08168@s.tmu.edu.tw	Liou, Tsan-Hon/I-8808-2019; Lin, Li-Fong/AAU-4368-2021; Huang, ShihWei/S-9278-2019; Liao, Chun-De/AAW-5990-2020	Liao, Chun-De/0000-0002-1930-4915; Liou, Tsan-Hon/0000-0002-0959-4023; Lin, Li-Fong/0000-0002-8586-4136; Tsauo, Jau-Yih/0000-0003-4607-4454	Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare [105-SHH-HCP-06]	Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare	This study was funded by Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare (105-SHH-HCP-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official view of the funding sources.	Abizanda Soler Pedro, 2010, Rev Esp Geriatr Gerontol, V45, P219, DOI 10.1016/j.regg.2009.10.009; Ahmad S, 2009, 2009 IEEE INT WORKSH; Amarya S, 2014, J CLIN GERONTOL GERI, V5, P63, DOI 10.1016/j.jcgg.2014.01.004; Anderson LJ, 2012, NUTR RES, V32, P479, DOI 10.1016/j.nutres.2012.05.009; Anna MD, 2015, ARQ BRAS CARDIOL, V105, P580, DOI 10.5935/abc.20150125; Baek J, 2013, CLIN AUTON RES, V23, P325, DOI 10.1007/s10286-013-0215-9; Baumgartner RN, 2000, ANN NY ACAD SCI, V904, P437; Bjordal JM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-51; Bouchard DR, 2009, OBESITY, V17, P2082, DOI 10.1038/oby.2009.109; Buchheit M, 2006, INT J SPORTS MED, V27, P697, DOI 10.1055/s-2005-872929; Buchheit M, 2005, MED SCI SPORT EXER, V37, P1530, DOI 10.1249/01.mss.0000177556.05081.77; Buchheit M, 2004, MED SCI SPORT EXER, V36, P601, DOI 10.1249/01.MSS.0000121956.76237.B5; Buttery AK, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0377-0; Camm AJ, 1996, EUR HEART J, V17, P354; Choi YM, 2014, PHYS THER, V94, P696, DOI 10.2522/ptj.20130266; Cooper AJM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126465; Corona LP, 2017, PUBLIC HEALTH NUTR, V20, P1046, DOI 10.1017/S1368980016003505; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fidan-Yaylali G, 2016, MED PRIN PRACT, V25, P442, DOI 10.1159/000446915; Gill S, 2008, PHYSIOTHER RES INT, V13, P141, DOI 10.1002/pri.411; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Haapanen-Niemi N, 2000, INT J OBESITY, V24, P1465, DOI 10.1038/sj.ijo.0801426; HAGEMAN PA, 1995, ARCH PHYS MED REHAB, V76, P961, DOI 10.1016/S0003-9993(95)80075-1; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; Huikuri HV, 2013, PROG CARDIOVASC DIS, V56, P153, DOI 10.1016/j.pcad.2013.07.003; Idland G, 2013, ARCH GERONTOL GERIAT, V56, P501, DOI 10.1016/j.archger.2012.12.005; Isles RC, 2004, J AM GERIATR SOC, V52, P1367, DOI 10.1111/j.1532-5415.2004.52370.x; Jensen MT, 2013, HEART, V99, P882, DOI 10.1136/heartjnl-2012-303375; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Jorgensen RM, 2016, ANN NONINVAS ELECTRO, V21, P60, DOI 10.1111/anec.12297; Kaikkonen KM, 2014, J PHYS ACT HEALTH, V11, P1614, DOI 10.1123/jpah.2012-0405; Kalish VB, 2016, PRIMARY CARE, V43, P137, DOI 10.1016/j.pop.2015.10.002; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; Kawasaki T, 2003, J ELECTROCARDIOL, V36, P333, DOI 10.1016/j.jelectrocard.2003.08.005; Keevil VL, 2016, MED SCI SPORT EXER, V48, P421, DOI 10.1249/MSS.0000000000000785; Kemp AH, 2013, INT J PSYCHOPHYSIOL, V89, P288, DOI 10.1016/j.ijpsycho.2013.06.018; Kostka T, 2007, Z GERONTOL GERIATR, V40, P43, DOI 10.1007/s00391-006-0374-6; Kuh D, 2007, J GERONTOL A-BIOL, V62, P717, DOI 10.1093/gerona/62.7.717; Laederach-Hofmann K, 2000, J ENDOCRINOL, V164, P59, DOI 10.1677/joe.0.1640059; Lang IA, 2008, J AM GERIATR SOC, V56, P1474, DOI 10.1111/j.1532-5415.2008.01813.x; Liao CD, 2016, PAIN MED; Liao CD, 2015, CLIN REHABIL, V29, P855, DOI 10.1177/0269215514564086; Lu WC, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0555-y; Lustig RH, 2003, REV ENDOCR METAB DIS, V4, P23, DOI 10.1023/A:1021819318484; Nam S, 2016, GERIATR GERONTOL INT, V16, P1324, DOI 10.1111/ggi.12650; Neeland IJ, 2013, OBESITY, V21, pE439, DOI [10.1002/oby.20135, 10.1038/oby.20135]; Oh KJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010008; Portegijs E, 2017, ARCH GERONTOL GERIAT, V69, P69, DOI 10.1016/j.archger.2016.11.011; Reid N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153398; Rennie KL, 2003, AM J EPIDEMIOL, V158, P135, DOI 10.1093/aje/kwg120; Rolland Y, 2009, AM J CLIN NUTR, V89, P1895, DOI 10.3945/ajcn.2008.26950; Saito I, 2015, J EPIDEMIOL, V25, P583, DOI 10.2188/jea.JE20140254; Sammito S., 2016, INT CARDIOVASC FORUM, V6, P18, DOI [DOI 10.17987/ICFJ.V6I0.242, 10.17987/icfj.v6i0.242]; Schafer A, 2013, INT J CARDIOL, V166, P15, DOI 10.1016/j.ijcard.2012.03.119; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Skrapari I, 2007, OBESITY, V15, P1685, DOI 10.1038/oby.2007.201; Skrapari I, 2006, CURR DIABETES REV, V2, P329, DOI 10.2174/157339906777950589; Soares-Miranda L, 2012, DIABETES-METAB RES, V28, P363, DOI 10.1002/dmrr.2281; Stenholm S, 2016, J GERONTOL A-BIOL, V71, P496, DOI 10.1093/gerona/glv111; Strath SJ, 2000, MED SCI SPORT EXER S, V32, P105; Stuckey MI, 2015, APPL PHYSIOL NUTR ME, V40, P734, DOI 10.1139/apnm-2014-0528; Takacs J, 2014, PHYS THER, V94, P866, DOI 10.2522/ptj.20130385; Thayer JF, 2006, ANN NY ACAD SCI, V1088, P361, DOI 10.1196/annals.1366.014; Tomlinson DJ, 2016, BIOGERONTOLOGY, V17, P467, DOI 10.1007/s10522-015-9626-4; Tonhajzerova I, 2013, RESP PHYSIOL NEUROBI, V187, P78, DOI 10.1016/j.resp.2013.02.002; Usui H, 2015, J STROKE CEREBROVASC, V24, P840, DOI 10.1016/j.jstrokecerebrovasdis.2014.11.026; Vincent HK, 2010, OBES REV, V11, P568, DOI 10.1111/j.1467-789X.2009.00703.x; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wahba IM, 2007, CLIN J AM SOC NEPHRO, V2, P550, DOI 10.2215/CJN.04071206; Wang YZ, 2013, J NANOMATER, V2013, DOI 10.1155/2013/169405; Zamboni M, 2008, NUTR METAB CARDIOVAS, V18, P388, DOI 10.1016/j.numecd.2007.10.002	73	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189150	10.1371/journal.pone.0189150	http://dx.doi.org/10.1371/journal.pone.0189150			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8BI	29267296	gold, Green Submitted, Green Published			2022-12-26	WOS:000418587400021
J	Tripathy, JP; Thakur, JS; Jeet, G; Chawla, S; Jain, S				Tripathy, Jaya Prasad; Thakur, Jarnail Singh; Jeet, Gursimer; Chawla, Sohan; Jain, Sanjay			Alarmingly high prevalence of hypertension and pre-hypertension in North India-results from a large cross-sectional STEPS survey	PLOS ONE			English	Article							RISK-FACTORS; UNCONTROLLED HYPERTENSION; URBAN-POPULATION; AWARENESS; DISEASE; EPIDEMIOLOGY; CHENNAI; OBESITY; BURDEN; TRENDS	Objectives The study was primarily aimed at estimating the prevalence of hypertension and pre-hypertension and the risk factors of hypertension in the North Indian state of Punjab. It also aimed at assessing the magnitude of undiagnosed cases of hypertension in the community and ascertaining the blood pressure control status of those on treatment. Methods A non-communicable disease risk factor survey (based on WHO-STEPS approach) was done in the state of Punjab, India in a multistage stratified sample of 5127 individuals. The study subjects were administered the WHO STEPS-questionnaire and also underwent anthropometric and blood pressure measurements. Results Overall prevalence of HTN among the study participants was found out to be 40.1% (95% CI: 38.8 +/- 41.5%) whereas prevalence of pre-hypertension, isolated diastolic and isolated systolic hypertension were 40.8% (39.5 +/- 42.2%), 9.2% (8.4 +/- 10.0%) and 6.5% (5.9 +/- 7.2%) respectively. Age group (45 +/- 69 years), male gender, social group, marital status, alcohol use, obesity and salt intake (> = 5 gms/day) were the risk factors significantly associated with HTN. Among all persons with HTN, only 30.1% were known case of HTN or on treatment, among whom nearly 61% had controlled blood pressure. Patients with uncontrolled BP were more frequently male, obese patients, with sedentary lifestyle and patients with diabetes. Conclusions The study reported alarmingly high prevalence of hypertension, especially of undiagnosed or untreated cases amongst the adult population, a significant proportion of whom have uncontrolled blood pressure levels. This indicates the need for systematic screening and awareness program to identify the undiagnosed cases in the community and offer early treatment and regular follow up.	[Tripathy, Jaya Prasad] Union South East Asia Off, Int Union TB & Lung Dis, New Delhi, India; [Thakur, Jarnail Singh; Jeet, Gursimer; Chawla, Sohan] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Dept Community Med, Chandigarh, India; [Jain, Sanjay] Post Grad Inst Med Educ & Res, Dept Internal Med, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Thakur, JS (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Hlth, Dept Community Med, Chandigarh, India.	jsthakur64@gmail.com		/0000-0003-3727-9941; Jain, Sanjay K/0000-0002-9241-3114	National Health Mission, Punjab, India; Department for International Development (DFID), UK; Department of Health and Family Welfare of Punjab state; National Health Mission (NHM); National Health Mission; Ministry of Health and Family Welfare, Government of India; World Health Organization	National Health Mission, Punjab, India; Department for International Development (DFID), UK; Department of Health and Family Welfare of Punjab state; National Health Mission (NHM); National Health Mission; Ministry of Health and Family Welfare, Government of India; World Health Organization(World Health Organization)	This project was funded by the National Health Mission, Punjab, India. We also thank the Department for International Development (DFID), UK, for funding this open access publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support of Ms Vini Mahajan, Principal Secretary, Department of Health and Family Welfare of Punjab state for granting responsibility of conducting the NCD Risk Factors Survey in Punjab and funding this project through National Health Mission (NHM). We sincerely acknowledge the support received from National Health Mission, Ministry of Health and Family Welfare, Government of India, World Health Organization and participating institutions. We also thank the Department for International Development (DFID), UK, for funding the Global Operational Research Fellowship Programme at the International Union Against Tuberculosis and Lung Disease (The Union), Paris, France in which Jaya Prasad Tripathy works as a Senior Operational Research Fellow.	Acharyya Tushar, 2014, Indian J Public Health, V58, P195, DOI 10.4103/0019-557X.138632; Agrawal V K, 2008, Med J Armed Forces India, V64, P21, DOI 10.1016/S0377-1237(08)80139-6; Anchala R, 2014, J HYPERTENS, V32, P1170, DOI 10.1097/HJH.0000000000000146; Anjana RM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-26; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Bansal Sushil K, 2012, J Cardiovasc Dis Res, V3, P117, DOI 10.4103/0975-3583.95365; Bhadoria AS, 2014, J FAM COMMUNITY MED, V21, P29, DOI 10.4103/2230-8229.128775; Bhansali A, 2015, J HUM HYPERTENS, V29, P204, DOI 10.1038/jhh.2014.57; Chockalingam A, 2005, ANGIOLOGY, V56, P557, DOI 10.1177/000331970505600506; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Cordero A, 2011, REV ESP CARDIOL, V64, P587, DOI [10.1016/j.rec.2011.03.007, 10.1016/j.recesp.2011.03.008]; Farag YMK, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-42; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Goswami AK, 2016, J CLIN DIAGN RES, V10, pLC1, DOI 10.7860/JCDR/2016/17284.7366; Government of Punjab India, BAS STAT PUNJ; Greenlund KJ, 2004, ARCH INTERN MED, V164, P2113, DOI 10.1001/archinte.164.19.2113; Gupta PC, 2004, J HUM HYPERTENS, V18, P907, DOI 10.1038/sj.jhh.1001763; Gupta R, 2004, J HUM HYPERTENS, V18, P73, DOI 10.1038/sj.jhh.1001633; Gupta R, 2013, AM J HYPERTENS, V26, P83, DOI 10.1093/ajh/hps013; Harries AD, 2015, TROP MED INT HEALTH, V20, P961, DOI 10.1111/tmi.12506; He FJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004937.pub2; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Joshi SR, 2012, DIABETES TECHNOL THE, V14, P8, DOI 10.1089/dia.2011.0243; Kaur P, 2012, INT J PUBLIC HEALTH, V57, P87, DOI 10.1007/s00038-011-0303-3; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liszka HA, 2005, ANN FAM MED, V3, P294, DOI 10.1370/afm.312; Mohan V, 2007, J Assoc Physicians India, V55, P326; Moser KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086043; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; O'Brien E, 2010, BLOOD PRESS MONIT, V15, P23, DOI 10.1097/MBP.0b013e3283360e98; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Sathish T, 2012, PUBLIC HEALTH, V126, P25, DOI 10.1016/j.puhe.2011.11.002; Shanthirani C S, 2003, J Assoc Physicians India, V51, P20; Singh RB, 2011, ACTA CARDIOL, V66, P29, DOI 10.1080/AC.66.1.2064964; Sixty-sixth World Health Assembly, 2013, FOLL UP POL DECL HIG; Stegenga H, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6608; Suryanarayana M.H., 2011, INEQUALITY ADJUSTED, P31; Thakur JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157705; Thankappan K R, 2013, Indian Heart J, V65, P504, DOI 10.1016/j.ihj.2013.08.023; Trieu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130247; Tripathy JP, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0207-3; Tripathy JP, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3489-8; Vimala A, 2009, SAUDI J KIDNEY DIS T, V20, P685; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2004, LANCET, V363, P902; WHO, 2021, WHO STEPWISE APPR SU; World Health Organization, 2005, WHO STEPS SURV MAN W; Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]; Yang L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-903	50	47	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0188619	10.1371/journal.pone.0188619	http://dx.doi.org/10.1371/journal.pone.0188619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267338	gold, Green Published, Green Submitted			2022-12-26	WOS:000418587400011
J	Eldor, R; Norton, L; Fourcaudot, M; Galindo, C; DeFronzo, RA; Abdul-Ghani, M				Eldor, Roy; Norton, Luke; Fourcaudot, Marcel; Galindo, Cynthia; DeFronzo, Ralph A.; Abdul-Ghani, Muhammad			Increased lipid availability for three days reduces whole body glucose uptake, impairs muscle mitochondrial function and initiates opposing effects on PGC-1 alpha promoter methylation in healthy subjects	PLOS ONE			English	Article							FREE FATTY-ACIDS; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; NON-CPG METHYLATION; SKELETAL-MUSCLE; SUSTAINED REDUCTION; INSULIN-SECRETION; GENE-EXPRESSION; FAMILY-HISTORY; PATHOGENESIS; LIPOTOXICITY	Aims FFA and FFA metabolites cause insulin resistance and impair beta cell function. The goal of our research was to examine whether elevation of plasma FFA impairs mitochondrial function and alters PGC-1 alpha promoter methylation. Methods In this uncontrolled, change from baseline study design, insulin sensitivity and glucose-stimulated insulin secretion were measured in 9 normal glucose tolerant subjects before and after 3 day lipid infusion to elevate plasma FFA concentration. Vastus lateralis muscle biopsies were obtained and mitochondrial function, PGC-1 alpha expression, and PGC-1 alpha promoter methylation were quantitated. Results Increased plasma FFA (440 +/- 93 mu mol/Lto 997 +/- 242 mu M, p< 0.001) decreased insulin-stimulated total glucose disposal (TGD) by 25% (p = 0.008), impaired suppression of endogenous glucose production (p = 0.01), and reduced mitochondrial ATP synthesis with complex 1 (34%, p< 0.05) and complex 2 (30%, p< 0.05) substrates. Lipid infusion had no effect on muscle PGC-1 alpha RNA expression, total methylation or non-CpG methylation, but methylation of the alternative PGC-1 alpha promoter decreased (1.30 +/- 0.30 to 0.84 +/- 0.15% methylated residues/patient . strand, p = 0.055). Within PGC-1 alpha promoter there was demethylation of CpT residues (0.72 +/- 0.16 vs. 0.28 +/- 0.10 methylated residues/patient . strand) (p = 0.002), which was inversely correlated with PGC-1a mRNA expression (r = -0.94, p< 0.0001) and ATP synthesis with complex 1 (r = -0.80, p< 0.01) and complex 2 (r = -0.69, p< 0.05) substrates. Lipid infusion increased DNMT-3B (methyltransferase associated with PGC-1 alpha promoter nonCpG methylation) mRNA expression (0.87 +/- 0.09 to 1.62 +/- 0.22 arbitrary units, p = 0.005), which correlated inversely with CpT demethylation (r = 0.67, p< 0.05). Conclusion/Interpretation Physiologic plasma FFA elevation in NGT individuals has opposing effects on PGC-1a nonCpG residue methylation (CpT demethylation and increased DNMT-3B expression), which is correlated with changes in PGC-1 alpha expression and skeletal muscle mitochondrial function.	[Eldor, Roy] Tel Aviv Sourasky Med Ctr, Inst Metab Endocrinol & Hypertens, Diabet Unit, Tel Aviv, Israel; [Norton, Luke; Fourcaudot, Marcel; Galindo, Cynthia; DeFronzo, Ralph A.; Abdul-Ghani, Muhammad] Univ Texas Hlth Sci Ctr San Antonio, Div Diabet, San Antonio, TX 78229 USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of Texas System; University of Texas Health San Antonio	Eldor, R (corresponding author), Tel Aviv Sourasky Med Ctr, Inst Metab Endocrinol & Hypertens, Diabet Unit, Tel Aviv, Israel.	eldorroy@yahoo.com	Eldor, Roy/AAD-4397-2022; Norton, Luke/F-6685-2015	Norton, Luke/0000-0002-0231-5722	NIH grant [R01 DK097554-01, NIH-DK 24092-42]; Bristol Myers Squibb; Boehringer-lngelheim; Takeda; Astra Zeneca; South Texas Veterans Health Care System	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol Myers Squibb(Bristol-Myers Squibb); Boehringer-lngelheim(Boehringer Ingelheim); Takeda(Takeda Pharmaceutical Company Ltd); Astra Zeneca(AstraZeneca); South Texas Veterans Health Care System	This study was supported by an NIH grant (R01 DK097554-01) to MAG, and (NIH-DK 24092-42) to RAD. Furthermore, RAD received research support from the following: Bristol Myers Squibb, Boehringer-lngelheim, Takeda, and Astra Zeneca. Dr. Ralph A. DeFronzo's salary is supported, in part, by the South Texas Veterans Health Care System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by an NIH grant (R01 DK097554-01) to MAG, and (NIH-DK 24092-42) to RAD. Furthermore, RAD received research support from: Bristol Myers Squibb, Boehringer-Ingelheim, Takeda, and Astra Zeneca. Dr. Ralph A. DeFronzo's salary is supported, in part, by the South Texas Veterans Health Care System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2009, DIABETOLOGIA, V52, P574, DOI 10.1007/s00125-009-1264-4; Abdul-Ghani MA, 2008, AM J PHYSIOL-ENDOC M, V295, pE678, DOI 10.1152/ajpendo.90287.2008; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Bajaj M, 2004, J CLIN ENDOCR METAB, V89, P4649, DOI 10.1210/jc.2004-0224; Bajaj M, 2002, DIABETES, V51, P3043, DOI 10.2337/diabetes.51.10.3043; Bajaj M, 2007, DIABETES, V56, P743, DOI 10.2337/db06-0840; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Bays H, 2004, J CLIN ENDOCR METAB, V89, P463, DOI 10.1210/jc.2003-030723; Bellizzi D, 2013, DNA RES, V20, P537, DOI 10.1093/dnares/dst029; BODEN G, 1991, J CLIN INVEST, V88, P960, DOI 10.1172/JCI115399; BONADONNA RC, 1989, AM J PHYSIOL, V257, pE49, DOI 10.1152/ajpendo.1989.257.1.E49; Brons C, 2010, J CLIN ENDOCR METAB, V95, P3048, DOI 10.1210/jc.2009-2413; Carey N, 2011, DRUG DISCOV TODAY, V16, P683, DOI 10.1016/j.drudis.2011.05.004; Chavez AO, 2010, J CLIN ENDOCR METAB, V95, P422, DOI 10.1210/jc.2009-1387; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Daniele G, 2014, DIABETES, V63, P2812, DOI 10.2337/db13-1130; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; FERRANNINI E, 1983, J CLIN INVEST, V72, P1737, DOI 10.1172/JCI111133; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jiang YD, 2012, ACTA BIOCH BIOPH SIN, V44, P866, DOI 10.1093/abbs/gms075; Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461; Kashyap SR, 2004, AM J PHYSIOL-ENDOC M, V287, pE537, DOI 10.1152/ajpendo.00541.2003; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Lehman JJ, 2008, AM J PHYSIOL-HEART C, V295, pH185, DOI 10.1152/ajpheart.00081.2008; Liang HY, 2013, J PHYSIOL-LONDON, V591, P2897, DOI 10.1113/jphysiol.2012.247510; Lochmann TL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129647; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; PETERSEN KF, 2004, NEW ENGL J MED, V350, P664, DOI [10.1056/NEJMoa031314, DOI 10.1056/NEJMOA031314]; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Richardson DK, 2005, J BIOL CHEM, V280, P10290, DOI 10.1074/jbc.M408985200; Roden M, 1999, DIABETES, V48, P358, DOI 10.2337/diabetes.48.2.358; STEELE R, 1956, AM J PHYSIOL, V187, P15, DOI 10.1152/ajplegacy.1956.187.1.15; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoshioka T, 2009, BIOCHEM BIOPH RES CO, V381, P537, DOI 10.1016/j.bbrc.2009.02.077	41	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0188208	10.1371/journal.pone.0188208	http://dx.doi.org/10.1371/journal.pone.0188208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261667	Green Published, Green Submitted, gold			2022-12-26	WOS:000418564200006
J	Song, S; Hong, S; Jang, J; Yeom, JH; Park, N; Lee, J; Lim, Y; Jeon, JY; Choi, HK; Lee, M; Ha, NC; Lee, K				Song, Saemee; Hong, Seokho; Jang, Jinyang; Yeom, Ji-Hyun; Park, Nohra; Lee, Jaejin; Lim, Yeri; Jeon, Jun-Yeong; Choi, Hyung-Kyoon; Lee, Minho; Ha, Nam-Chul; Lee, Kangseok			Functional implications of hexameric assembly of RraA proteins from Vibrio vulnificus	PLOS ONE			English	Article							ESCHERICHIA-COLI RRAA; RNASE-E ACTIVITY; RIBONUCLEOLYTIC ACTIVITY; STREPTOMYCES-COELICOLOR; CRYSTAL-STRUCTURE; STRUCTURAL-ANALYSIS; INHIBITOR RRAA; MESSENGER-RNA; E. COLI; BINDING	RNase E has a pivotal role in the degradation and processing of RNAs in Escherichia coli, and protein inhibitors RraA and RraB control its enzymatic activity. The halophilic pathogenic bacterium Vibrio vulnificus also expresses orthologs of RNase E and RraA-RNase EV, RraAV1, and RraAV2 (herein renamed as VvRNase E, VvRraA1, and VvRraA2). A previous study showed that VvRraA1 actively inhibits the ribonucleolytic activity of VvRNase E by interacting with the C-terminal region of VvRNase E. However, the molecular mechanism underlying the effect of VvRraA1 on the ribonucleolytic activity of VvRNase E has not yet been elucidated. In this study, we report that the oligomer formation of VvRraA proteins affects binding efficiency to VvRNase E as well as inhibitory activity on VvRNase E action. The hexameric structure of VvRraA1 was converted to lower oligomeric forms when the Cys 9 residue was substituted with an Asp residue (VvRraA1-C9D), showing decreased inhibitory activity of VvRraA1 on VvRNase E in vivo. These results indicated that the intermolecular disulfide linkage contributed critically to the hexamerization of VvRraA1 for its proper function. On the contrary, the VvRraA2 that existed in a trimeric state did not bind to or inhibit VvRNase E. An in vitro cleavage assay further showed the reduced inhibitory effect of VvRraA-C9D on VvRNase E activity compared to wild-type VvRraA1. These findings provide insight into how VvRraA proteins can regulate VvRNase E action on its substrate RNA in V. vulnificus. In addition, based on structural and functional comparison of RraA homologs, we suggest that hexameric assembly of RraA homologs may well be required for their action on RNase E-like proteins.	[Song, Saemee; Hong, Seokho; Park, Nohra; Ha, Nam-Chul] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Song, Saemee] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA; [Jang, Jinyang; Yeom, Ji-Hyun; Lee, Jaejin; Lim, Yeri; Lee, Minho; Lee, Kangseok] Chung Ang Univ, Dept Life Sci, Seoul, South Korea; [Jeon, Jun-Yeong; Choi, Hyung-Kyoon] Chung Ang Univ, Sch Pharm, Seoul, South Korea	Seoul National University (SNU); Northwestern University; Chung Ang University; Chung Ang University	Ha, NC (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.; Lee, K (corresponding author), Chung Ang Univ, Dept Life Sci, Seoul, South Korea.	hanc210@snu.ac.kr; kangseok@cau.ac.kr	Lee, Minho/AAK-4109-2021; Hong, Seokho/AGZ-9428-2022	Lee, Minho/0000-0002-8404-5702; Hong, Seokho/0000-0003-4603-8445	National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2014R1A2A2A09052791, NRF-2017H1A2A1042661]; Chung-Ang University Graduate Research Scholarship	National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning; Chung-Ang University Graduate Research Scholarship	This research was supported by the National Research Foundation of Korea (NRF), which is funded by the Ministry of Science, ICT, and Future Planning (2014R1A2A2A09052791 to KL and NRF-2017H1A2A1042661-Global Ph.D. Fellowship Program to SH). It was also supported by the Chung-Ang University Graduate Research Scholarship in 2016 to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Callaghan AJ, 2004, J MOL BIOL, V340, P965, DOI 10.1016/j.jmb.2004.05.046; Cohen SN, 1997, MOL MICROBIOL, V23, P1099, DOI 10.1111/j.1365-2958.1997.tb02593.x; Gao JJ, 2006, MOL MICROBIOL, V61, P394, DOI 10.1111/j.1365-2958.2006.05246.x; Go H, 2011, RNA BIOL, V8, P1022, DOI 10.4161/rna.8.6.18063; Gorna MW, 2010, RNA, V16, P553, DOI 10.1261/rna.1858010; Heo J, 2016, J MICROBIOL, V54, P660, DOI 10.1007/s12275-016-6417-9; JAIN C, 1995, GENE DEV, V9, P84, DOI 10.1101/gad.9.1.84; Johnston JM, 2003, J BACTERIOL, V185, P4057, DOI 10.1128/JB.185.14.4057-4065.2003; Kim D, 2016, CURR MICROBIOL, V72, P716, DOI 10.1007/s00284-016-1007-y; Lee K, 2003, MOL MICROBIOL, V48, P349, DOI 10.1046/j.1365-2958.2003.03435.x; Lee KS, 2003, CELL, V114, P623, DOI 10.1016/j.cell.2003.08.003; Lee M, 2011, CURR MICROBIOL, V62, P861, DOI 10.1007/s00284-010-9771-6; Lee M, 2009, CURR MICROBIOL, V58, P349, DOI 10.1007/s00284-009-9360-8; Li ZW, 2002, RNA, V8, P97, DOI 10.1017/S1355838202014929; Monzingo AF, 2003, J MOL BIOL, V332, P1015, DOI 10.1016/S0022-2836(03)00970-7; Park N, 2017, J MICROBIOL, V55, P388, DOI 10.1007/s12275-017-7053-8; Rehse PH, 2004, ACTA CRYSTALLOGR D, V60, P1997, DOI 10.1107/S0907444904021146; Seo S, 2017, J MICROBIOL, V55, P37, DOI 10.1007/s12275-017-6518-0; Tang JA, 2010, PROTEIN J, V29, P583, DOI 10.1007/s10930-010-9293-x; Yeom JH, 2008, FEMS MICROBIOL LETT, V285, P10, DOI 10.1111/j.1574-6968.2008.01205.x; Zhao M, 2006, J BACTERIOL, V188, P3257, DOI 10.1128/JB.188.9.3257-3263.2006	22	4	4	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0190064	10.1371/journal.pone.0190064	http://dx.doi.org/10.1371/journal.pone.0190064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261778	Green Published, gold, Green Submitted			2022-12-26	WOS:000418564200084
J	Wang, TL; Fang, YW; Leu, JG; Tsai, MH				Wang, Tzu-Lin; Fang, Yu-Wei; Leu, Jyh-Gang; Tsai, Ming-Hsien			Association between serum aluminum levels and cardiothoracic ratio in patients on chronic hemodialysis	PLOS ONE			English	Article							LONG-TERM DIALYSIS; CHEST RADIOGRAPHS; HEART; MORTALITY; DISEASE; MALNUTRITION; INFLAMMATION; DIAGNOSIS; MARKER; COHORT	The cardiothoracic ratio (CTR) and serum aluminum levels are both associated with mortality in hemodialysis patients. However, limited data regarding the association between serum aluminum levels and the CTR have been published to date. Therefore, we aimed to elucidate this association in patients on chronic hemodialysis (CHD). We investigated the association between the serum aluminum level and the CTR in CHD in a retrospective cross-sectional study of 547 Taiwanese patients on CHD. The mean age of patients was 62.5 +/- 13.2 years, with a mean hemodialysis time of 7.1 +/- 5.2 years. Among the patients, 36.9% were diabetic and 47.9% were male. After natural logarithmic transformation (ln(aluminum)), the serum aluminum level exhibited an independent and linear relationship with the CTR (beta: 1.40, 95% confidence interval (CI), 0.6-2.2). A high serum aluminum level (>= 6 ng/dL) was significantly associated with a CTR >0.5 in the crude analysis (odds ratio (OR): 2.15, 95% CI, 1.52-3.04) and remained significant after multivariable adjustment (OR: 2.45, 95% CI, 1.63-3.67). Moreover, the ln(aluminum) value was significantly associated with a CTR >0.5 (OR: 1.71, 95% CI, 1.28-2.29) in multivariable analysis, indicating a dose effect of aluminum on cardiomegaly. In conclusion, the serum aluminum level was independently associated with cardiac remodeling (elevated CTR) in patients on CHD.	[Wang, Tzu-Lin] Shin Kong Wu Ho Su Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Fang, Yu-Wei; Leu, Jyh-Gang; Tsai, Ming-Hsien] Shin Kong Wu Ho Su Mem Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Fang, Yu-Wei; Leu, Jyh-Gang; Tsai, Ming-Hsien] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Tsai, Ming-Hsien] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Div Biostat, Taipei, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; National Taiwan University	Tsai, MH (corresponding author), Shin Kong Wu Ho Su Mem Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan.; Tsai, MH (corresponding author), Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan.; Tsai, MH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Div Biostat, Taipei, Taiwan.	chaosmyth.tw@gmail.com		Tsai, Ming Hsien/0000-0003-3561-4689				Adamek S, 2011, ACTA CHIR ORTHOP TR, V78, P355; Agarwal AK, 2006, J AM MED DIR ASSOC, V7, pS7, DOI 10.1016/j.jamda.2006.09.005; ANDRESS DL, 1986, J BONE MINER RES, V1, P391; Asakawa T, 2014, CARDIORENAL MED, V4, P189, DOI 10.1159/000368200; Bikbov B, 2017, HEMODIAL INT, V21, P393, DOI 10.1111/hdi.12503; Bohrer D, 2007, NEPHROL DIAL TRANSPL, V22, P605, DOI 10.1093/ndt/gfl569; Bohrer D, 2009, NEPHROL DIAL TRANSPL, V24, P1277, DOI 10.1093/ndt/gfn631; CHAZAN JA, 1991, ARCH INTERN MED, V151, P319, DOI 10.1001/archinte.151.2.319; Chen KH, 2008, KIDNEY BLOOD PRESS R, V31, P143, DOI 10.1159/000127388; Chen KH, 2011, THER APHER DIAL, V15, P81, DOI 10.1111/j.1744-9987.2010.00860.x; Clark AL, 2000, POSTGRAD MED J, V76, P289, DOI 10.1136/pmj.76.895.289; Dimopoulos K, 2013, INT J CARDIOL, V166, P453, DOI 10.1016/j.ijcard.2011.10.125; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; FRISHMAN WH, 1992, AM HEART J, V124, P1026, DOI 10.1016/0002-8703(92)90987-7; Gault PM, 2005, ANN CLIN BIOCHEM, V42, P51, DOI 10.1258/0004563053026862; Ghorbel I, 2015, FOOD FUNCT, V6, P3098, DOI [10.1039/C5FO00342C, 10.1039/c5fo00342c]; Giamouzis G, 2008, AM J CARDIOL, V101, P343, DOI 10.1016/j.amjcard.2007.08.039; Gura KM, 2014, CURR OPIN CLIN NUTR, V17, P551, DOI 10.1097/MCO.0000000000000091; Gura KM, 2010, NUTRITION, V26, P585, DOI 10.1016/j.nut.2009.10.015; HAMMERMEISTER KE, 1979, CIRCULATION, V59, P89, DOI 10.1161/01.CIR.59.1.89; Jaffe JA, 2005, AM J KIDNEY DIS, V46, P316, DOI 10.1053/j.ajkd.2005.04.020; Kearney MT, 2004, HEART, V90, P1137, DOI 10.1136/hrt.2003.021733; KONO T, 1992, JPN CIRC J, V56, P359, DOI 10.1253/jcj.56.359; Liou KY, 2016, SCI REP-UK, V6, DOI 10.1038/srep38458; Mihl C, 2008, NETH HEART J, V16, P129, DOI 10.1007/BF03086131; Morena Marion, 2005, Hemodial Int, V9, P37, DOI 10.1111/j.1492-7535.2005.01116.x; Murakami K, 2004, J CELL BIOCHEM, V93, P1267, DOI 10.1002/jcb.20261; MURPHY ML, 1985, INVEST RADIOL, V20, P21, DOI 10.1097/00004424-198501000-00005; NAKAMORI N, 1991, INVEST RADIOL, V26, P546, DOI 10.1097/00004424-199106000-00008; Neophytou AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156613; Ogata H, 2017, CLIN EXP NEPHROL, V21, P797, DOI 10.1007/s10157-017-1380-2; Okute Y, 2017, J ATHEROSCLER THROMB, V24, P412, DOI 10.5551/jat.36426; Philbin EF, 1998, ARCH INTERN MED, V158, P501, DOI 10.1001/archinte.158.5.501; Rayner BL, 2004, AM J HYPERTENS, V17, P507, DOI 10.1016/j.amjhyper.2004.02.012; Reinke CM, 2003, DRUG SAFETY, V26, P1011, DOI 10.2165/00002018-200326140-00003; Rob PM, 2001, CNS DRUGS, V15, P691, DOI 10.2165/00023210-200115090-00003; SALUSKY IB, 1991, NEW ENGL J MED, V324, P527, DOI 10.1056/NEJM199102213240804; Tsai MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128968; Yen TH, 2009, AM J MED SCI, V337, P421, DOI 10.1097/MAJ.0b013e31819bbec1; Yotsueda R, 2017, AM J KIDNEY DIS, V70, P84, DOI 10.1053/j.ajkd.2016.11.026	40	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0190008	10.1371/journal.pone.0190008	http://dx.doi.org/10.1371/journal.pone.0190008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261793	gold, Green Published, Green Submitted			2022-12-26	WOS:000418564200082
J	Long, A; Napierala, JS; Polak, U; Hauser, L; Koeppen, AH; Lynch, DR; Napierala, M				Long, Ashlee; Napierala, Jill S.; Polak, Urszula; Hauser, Lauren; Koeppen, Arnulf H.; Lynch, David R.; Napierala, Marek			Somatic instability of the expanded GAA repeats in Friedreich's ataxia	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; TRIPLET-REPEAT; CLINICAL-FEATURES; MOUSE MODEL; FXN LOCUS; EXPANSION; GENE; TRANSCRIPTION; SEQUENCE; MOSAICISM	Friedreich's ataxia (FRDA) is a genetic neurodegenerative disorder caused by transcriptional silencing of the frataxin gene (FXN) due to expansions of GAA repeats in intron 1. FRDA manifests with multiple symptoms, which may include ataxia, cardiomyopathy and diabetes mellitus. Expanded GAA tracts are genetically unstable, exhibiting both expansions and contractions. GAA length correlates with severity of FRDA symptoms and inversely with age of onset. Thus, tissue-specific somatic instability of long GAA repeats may be implicated in the development of symptoms and disease progression. Herein, we determined the extent of somatic instability of the GAA repeats in heart, cerebral cortex, spinal cord, cerebellar cortex, and pancreatic tissues from 15 FRDA patients. Results demonstrate differences in the lengths of the expanded GAAs among different tissues, with significantly longer GAA tracts detected in heart and pancreas than in other tissues. The expansion bias detected in heart and pancreas may contribute to disease onset and progression, making the mechanism of somatic instability an important target for therapy. Additionally, we detected significant differences in GAA tract lengths between lymphocytes and fibroblast pairs derived from 16 FRDA patients, with longer GAA tracts present in the lymphocytes. This result urges caution in direct comparisons of data obtained in these frequently used FRDA models. Furthermore, we conducted a longitudinal analysis of the GAA repeat length in lymphocytes collected over a span of 7 +/- 9 years and demonstrated progressive expansions of the GAAs with maximum gain of approximately 9 repeats per year. Continuous GAA expansions throughout the patient's lifespan, as observed in FRDA lymphocytes, should be considered in clinical trial designs and data interpretation.	[Long, Ashlee; Napierala, Jill S.; Napierala, Marek] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Polak, Urszula] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Dept Mol Carcinogenesis, Smithville, TX USA; [Hauser, Lauren; Lynch, David R.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Koeppen, Arnulf H.] VA Med Ctr, Albany, NY USA	University of Alabama System; University of Alabama Birmingham; University of Texas System; UTMD Anderson Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Napierala, M (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	mnapiera@uab.edu		Napierala, Jill/0000-0002-5141-0822	National Institute of Neurological Disorders and Stroke [R01NS081366]; Friedreich's Ataxia Research Alliance; FARA Ireland; FARA; Neurochemical Research, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081366] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Friedreich's Ataxia Research Alliance; FARA Ireland; FARA; Neurochemical Research, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant R01NS081366 from the National Institute of Neurological Disorders and Stroke (to M.N.) and Friedreich's Ataxia Research Alliance and FARA Ireland (to M.N. and J.S.N.) and separate grants from FARA to D.R.L. The FRDA tissue repository in Albany, NY, USA, receives financial support from Friedreich's Ataxia Research Alliance and Neurochemical Research, Inc. (to A. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Bidichandani SI, 1999, HUM MOL GENET, V8, P2425, DOI 10.1093/hmg/8.13.2425; Bidichandani SI, 2000, ARCH NEUROL-CHICAGO, V57, P246, DOI 10.1001/archneur.57.2.246; Budworth H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005267; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Clark RM, 2007, HUM GENET, V120, P633, DOI 10.1007/s00439-006-0249-3; Clark RM, 2006, GENOMICS, V87, P57, DOI 10.1016/j.ygeno.2005.09.006; Coppola G, 2009, HUM MOL GENET, V18, P2452, DOI 10.1093/hmg/ddp183; Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452; De Biase I, 2007, GENOMICS, V90, P1, DOI 10.1016/j.ygeno.2007.04.001; De Blase I, 2007, ANN NEUROL, V61, P55, DOI 10.1002/ana.21052; De Michele G, 1998, HUM MOL GENET, V7, P1901, DOI 10.1093/hmg/7.12.1901; Delatycki MB, 2014, MOVEMENT DISORD, V29, P940, DOI 10.1002/mds.25795; Delatycki MB, 2012, J CHILD NEUROL, V27, P1133, DOI 10.1177/0883073812448230; Du JT, 2012, J BIOL CHEM, V287, P29861, DOI 10.1074/jbc.M112.391961; Halabi A, 2012, J BIOL CHEM, V287, P29958, DOI 10.1074/jbc.M112.356758; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hick A, 2013, DIS MODEL MECH, V6, P608, DOI 10.1242/dmm.010900; Kim E, 2011, NUCLEIC ACIDS RES, V39, P8366, DOI 10.1093/nar/gkr542; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; Li YC, 2015, EXP THER MED, V10, P1089, DOI 10.3892/etm.2015.2616; Li YJ, 2015, HUM MOL GENET, V24, P6932, DOI 10.1093/hmg/ddv397; Li YJ, 2015, MOL THER, V23, P1055, DOI 10.1038/mt.2015.41; Lynch DR, 2015, LANCET NEUROL, V14, P130, DOI 10.1016/S1474-4422(14)70327-8; Machkhas H, 1998, MUSCLE NERVE, V21, P390, DOI 10.1002/(SICI)1097-4598(199803)21:3<390::AID-MUS13>3.0.CO;2-3; Mateo I, 2004, ACTA NEUROL SCAND, V109, P75, DOI 10.1034/j.1600-0404.2003.00190.x; Montermini L, 1997, ANN NEUROL, V41, P675, DOI 10.1002/ana.410410518; Montermini L, 1997, HUM MOL GENET, V6, P1261, DOI 10.1093/hmg/6.8.1261; Montermini L, 1997, NEUROLOGY, V49, P606, DOI 10.1212/WNL.49.2.606; MR P, 2006, NUCLEIC ACIDS RES, V34, P6352; Napierala JS, 2017, DIS MODEL MECH, V10, P1353, DOI 10.1242/dmm.030536; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Polak U, 2016, STEM CELLS DEV, V25, P1788, DOI 10.1089/scd.2016.0147; Pollard LM, 2004, NUCLEIC ACIDS RES, V32, P5962, DOI 10.1093/nar/gkh933; Reetz K, 2015, LANCET NEUROL, V14, P174, DOI 10.1016/S1474-4422(14)70321-7; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Sharma R, 2002, HUM MOL GENET, V11, P2175, DOI 10.1093/hmg/11.18.2175; Tsou AY, 2011, J NEUROL SCI, V307, P46, DOI 10.1016/j.jns.2011.05.023; Virmouni SA, 2015, DIS MODEL MECH, V8, P225, DOI 10.1242/dmm.018952	42	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189990	10.1371/journal.pone.0189990	http://dx.doi.org/10.1371/journal.pone.0189990			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261783	Green Submitted, Green Published, gold			2022-12-26	WOS:000418554900046
J	Pan, R; Xu, L; Wei, Q; Wu, C; Tang, WL; Oelmuller, R; Zhang, WY				Pan, Rui; Xu, Le; Wei, Qiao; Wu, Chu; Tang, Wenlin; Oelmueller, Ralf; Zhang, Wenying			Piriformospora indica promotes early flowering in Arabidopsis through regulation of the photoperiod and gibberellin pathways	PLOS ONE			English	Article							FLORAL-TRANSITION; TIME; EXPRESSION; PLANT; PROTEIN; ROOTS; MECHANISMS; INDUCTION; TOLERANCE; PHOSPHATE	Flowering in plants is synchronized by both environmental cues and internal regulatory factors. Previous studies have shown that the endophytic fungus Piriformospora indica promotes the growth and early flowering in Coleus forskohlii (a medicinal plant) and Arabidopsis. To further dissect the impact of P. indica on pathways responsible for flowering time in Arabidopsis, we co-cultivated Arabidopsis with P. indica and used RT-qPCR to analyze the main gene regulation networks involved in flowering. Our results revealed that the symbiotic interaction of Arabidopsis with P. indica promotes early flower development and the number of siliques. In addition, expression of the core flowering regulatory gene FLOWERING LOCUS T (FT), of genes controlling the photoperiod [CRYPTOCHROMES (CRY1, CRY2) and PHYTOCHROME B (PHYB)] and those related to gibberellin (GA) functions (RGA1, AGL24, GA3, and MYB5) were induced by the fungus, while key genes controlling the age and autonomous pathways remained unchanged. Moreover, early flowering promotion conferred by P. indica was promoted by exogenous GA and inhabited by GA inhibitor, and this effect could be observed under long day and neutral day photoperiod. Therefore, our data suggested that P. indica promotes early flowering in Arabidopsis likely through photoperiod and GA rather than age or the autonomous pathway.	[Pan, Rui; Xu, Le; Wei, Qiao; Tang, Wenlin; Zhang, Wenying] Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Hubei Key Lab Waterlogging Disaster & Agr Use Wet, Jingzhou, Peoples R China; [Wu, Chu] Yangtze Univ, Coll Hort & Gardening, Jingzhou, Peoples R China; [Oelmueller, Ralf] Friedrich Schiller Univ Jena, Inst Gen Bot & Plant Physiol, Jena, Germany	Yangtze University; Yangtze University; Friedrich Schiller University of Jena	Zhang, WY (corresponding author), Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Hubei Key Lab Waterlogging Disaster & Agr Use Wet, Jingzhou, Peoples R China.; Oelmuller, R (corresponding author), Friedrich Schiller Univ Jena, Inst Gen Bot & Plant Physiol, Jena, Germany.	ralf.oelmueller@uni-jena.de; wyzhang@yangtzeu.edu.cn	Wu, Chu/AAE-6602-2022; Zhang, Wenying/P-2509-2018	Wu, Chu/0000-0001-7609-3336; Zhang, Wenying/0000-0002-9926-4115; Pan, Rui/0000-0001-5807-8116	Engineering Research Center of Ecology and Agricultural Use of Wetland, Ministry of Education [KF201515];  [CRC1127]	Engineering Research Center of Ecology and Agricultural Use of Wetland, Ministry of Education; 	RO was supported by CRC1127. The financial support was provided by the Engineering Research Center of Ecology and Agricultural Use of Wetland, Ministry of Education (KF201515).	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Achard P, 2007, P NATL ACAD SCI USA, V104, P6484, DOI 10.1073/pnas.0610717104; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Azpiroz R, 1998, PLANT CELL, V10, P219, DOI 10.1105/tpc.10.2.219; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; CHORY J, 1991, PLANT CELL, V3, P445, DOI 10.1105/tpc.3.5.445; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Das A, 2012, PLANT SIGNAL BEHAV, V7, P103, DOI 10.4161/psb.7.1.18472; Davis SJ, 2009, PLANT CELL ENVIRON, V32, P1201, DOI 10.1111/j.1365-3040.2009.01968.x; Dolatabadi HK, 2011, J BASIC MICROB, V51, P33, DOI 10.1002/jobm.201000214; Domagalska MA, 2007, DEVELOPMENT, V134, P2841, DOI 10.1242/dev.02866; Domagalska MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014012; Fakhro A, 2010, MYCORRHIZA, V20, P191, DOI 10.1007/s00572-009-0279-5; Hedden P, 2008, ANNU REV PLANT BIOL, V20, P317; Hills CB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01906; Hosseini F, 2017, PLANT PHYSIOL BIOCH, V118, P107, DOI 10.1016/j.plaphy.2017.06.005; Hussin S, 2017, J AGRON CROP SCI, V203, P373, DOI 10.1111/jac.12199; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Kim D, 2017, BIOCHEM BIOPH RES CO, V490, P1162, DOI 10.1016/j.bbrc.2017.06.169; Komeda Y, 2004, ANNU REV PLANT BIOL, V55, P521, DOI 10.1146/annurev.arplant.55.031903.141644; Kotchoni SO, 2009, PLANT PHYSIOL, V149, P803, DOI 10.1104/pp.108.132324; Kumar M, 2011, PLANT SIGNAL BEHAV, V6, P723, DOI 10.4161/psb.6.5.15106; Kumar M, 2009, MICROBIOL-SGM, V155, P780, DOI 10.1099/mic.0.019869-0; Kumari R, 2003, CURR SCI INDIA, V85, P1672; Lee YC, 2011, MOL PLANT MICROBE IN, V24, P421, DOI 10.1094/MPMI-05-10-0110; Lin YL, 2017, J EXP BOT, V68, P2603, DOI 10.1093/jxb/erx053; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Oelmuller R, 2009, SYMBIOSIS, V49, P1, DOI 10.1007/s13199-009-0009-y; Park HJ, 2016, INT REV CEL MOL BIO, V327, P371, DOI 10.1016/bs.ircmb.2016.07.001; Schafer P, 2009, PLANT J, V59, P461, DOI 10.1111/j.1365-313X.2009.03887.x; Shahollari B, 2005, J PLANT PHYSIOL, V162, P945, DOI 10.1016/j.jplph.2004.08.012; Sherameti I, 2005, J BIOL CHEM, V280, P26241, DOI 10.1074/jbc.M500447200; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Song YH, 2015, ANNU REV PLANT BIOL, V66, P441, DOI 10.1146/annurev-arplant-043014-115555; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Turk EM, 2005, PLANT J, V42, P23, DOI 10.1111/j.1365-313X.2005.02358.x; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Varma A, 2001, PIRIFORMOSPORA INDIC; Wada KC, 2010, PLANT SIGNAL BEHAV, V5, P944, DOI 10.4161/psb.5.8.11826; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Wang JW, 2014, J EXP BOT, V65, P4723, DOI 10.1093/jxb/eru246; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xu L, 2017, CROP J, V5, P251, DOI 10.1016/j.cj.2016.10.002; Yadav V, 2010, J BIOL CHEM, V285, P26532, DOI 10.1074/jbc.M110.111021; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928	45	17	19	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189791	10.1371/journal.pone.0189791	http://dx.doi.org/10.1371/journal.pone.0189791			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261746	Green Published, Green Submitted, gold			2022-12-26	WOS:000418554900030
J	Hamid, PH; Prastowo, J; Ghiffari, A; Taubert, A; Hermosilla, C				Hamid, Penny Humaidah; Prastowo, Joko; Ghiffari, Ahmad; Taubert, Anja; Hermosilla, Carlos			Aedes aegypti resistance development to commonly used insecticides in Jakarta, Indonesia	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; KNOCKDOWN RESISTANCE; ZIKA VIRUS; CROSS-RESISTANCE; MOLECULAR-BASIS; DENGUE; MUTATIONS; F1534C; EVOLUTION; MALARIA	Aedes aegypti is the primary vector of various relevant arthropod-borne viral infectious diseases worldwide. The mosquito control is still mainly performed by using insecticides but their effectiveness is increasingly questioned nowadays. We here conducted a study on Ae. aegypti resistance development towards several commonly used insecticides in the capital city of Jakarta, Indonesia. In order to achieve this goal, Ae. aegypti eggs from Jakarta were collected with ovitraps and hatched in the insectary of the Gadjah Mada University, Indonesia. The F0 generations were used for WHO resistance tests and knockdown resistance (kdr) assays. Presented results clearly showed that there was resistance development of Ae. aegypti populations to the here tested pyrethroid insecticides (i.e. permethrin). Observed mortalities were less than 90% with highest resistance against 0.75% permethrin concentrations. Furthermore, a significant association of V1016G gene mutations with resistance phenotypes to 0.75% permethrin was observed. Nevertheless, the F1534C mutation did not show a significant correlation to resistance development. In conclusion, our results show that populations of Ae. aegypti mosquitoes within the city of Jakarta have developed resistance against several routinely used pyrethroid insecticides in local performed control programs. Thus, the regular verification/assessment of resistance development status will hopefully help in the future to assist local public health authorities in their mosquito control programs by recommending and managing the rotation of different routinely used insecticides with diverse effector mechanisms in order to delay Ae. aegypti resistance development.	[Hamid, Penny Humaidah; Prastowo, Joko] Univ Gadjah Mada, Dept Parasitol, Karangmalang, Yogyakarta, Indonesia; [Ghiffari, Ahmad] Univ Muhammadiyah, Fac Med, Palembang, Indonesia; [Taubert, Anja; Hermosilla, Carlos] Justus Liebig Univ Giessen, Inst Parasitol, Biomed Res Ctr Seltersberg, Giessen, Germany	Gadjah Mada University; Justus Liebig University Giessen	Hamid, PH (corresponding author), Univ Gadjah Mada, Dept Parasitol, Karangmalang, Yogyakarta, Indonesia.	penny_hamid@ugm.ac.id	Ghiffari, Ahmad/O-3562-2018; Ghiffari, Ahmad/AAO-1409-2020; Anwar, Chairil/O-3561-2018	Ghiffari, Ahmad/0000-0003-1518-2364; Hamid, Penny Humaidah/0000-0001-8477-908X	Direktorat Jenderal Pendidikan Tinggi Indonesia (DIKTI)-INSINAS [226/SP2H/LT/DRPM/III/2016]	Direktorat Jenderal Pendidikan Tinggi Indonesia (DIKTI)-INSINAS(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	This work was supported by the Direktorat Jenderal Pendidikan Tinggi Indonesia (DIKTI)-INSINAS research grant No. 226/SP2H/LT/DRPM/III/2016 (simlitabmas.ristekdikti.go.id). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta EG, 2016, EXPERT REV VACCINES, V15, P467, DOI 10.1586/14760584.2016.1121814; Alagarasu K, 2016, VACCINE, V34, P2759, DOI 10.1016/j.vaccine.2016.04.070; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Alvarez LC, 2015, PEST MANAG SCI, V71, P863, DOI 10.1002/ps.3846; Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159; Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9; Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0; Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281; Central Bureau of Statistic Republic of Indonesia, 2013, IND POP PROJ; Delatte H, 2011, INFECT GENET EVOL, V11, P1769, DOI 10.1016/j.meegid.2011.07.016; Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110; Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420; Grisales N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002438; Hamid PH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2215-4; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085; Hu HM, 2016, HUM VACC IMMUNOTHER, V12, P1678, DOI 10.1080/21645515.2016.1143576; Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2; Katanami Y, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax031; Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653; Kushwah RBS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003332; Li CX, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0933-z; Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046; Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783; Ministry of Health Republic of Indonesia, 2015, DEM BERD BIAS MUL ME; Ministry of Health Republic of Indonesia, 2016, CEG ZIK KKP SOET LAK; Ministry of Health Republic of Indonesia, 2016, SIT DBD; Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9; Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913; Paul A, 2006, J MED ENTOMOL, V43, P55, DOI 10.1603/0022-2585(2006)043[0055:EONIFC]2.0.CO;2; Plernsub S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1713-0; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Sayono S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150577; Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005; Stenhouse SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-253; Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2; Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249; Tikar SN, 2009, PARASITOL RES, V105, P57, DOI 10.1007/s00436-009-1362-8; WHO, 2013, TEST PROC INS RES MA; World Health Organization, 2006, PEST THEIR APPL CONT; Wuliandari JR, 2015, INSECTS, V6, P658, DOI 10.3390/insects6030658; Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x; Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14	46	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189680	10.1371/journal.pone.0189680	http://dx.doi.org/10.1371/journal.pone.0189680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253003	gold, Green Submitted, Green Published			2022-12-26	WOS:000418389500047
J	Lallias, D; Quillet, E; Begout, ML; Auperin, B; Khaw, HL; Millot, S; Valotaire, C; Kerneais, T; Labbe, L; Prunet, P; Dupont-Nivet, M				Lallias, Delphine; Quillet, Edwige; Begout, Marie-Laure; Auperin, Benoit; Khaw, Hooi Ling; Millot, Sandie; Valotaire, Claudiane; Kerneais, Thierry; Labbe, Laurent; Prunet, Patrick; Dupont-Nivet, Mathilde			Genetic variability of environmental sensitivity revealed by phenotypic variation in body weight and (its) correlations to physiological and behavioral traits	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; STRESS-COPING STYLES; RAINBOW-TROUT; PUMPKINSEED SUNFISH; ISOGENIC LINES; PLASTICITY; FISH; EVOLUTION; WELFARE; RESPONSES	Adaptive phenotypic plasticity is a key component of the ability of organisms to cope with changing environmental conditions. Fish have been shown to exhibit a substantial level of phenotypic plasticity in response to abiotic and biotic factors. In the present study, we investigate the link between environmental sensitivity assessed globally (revealed by phenotypic variation in body weight) and more targeted physiological and behavioral indicators that are generally used to assess the sensitivity of a fish to environmental stressors. We took advantage of original biological material, the rainbow trout isogenic lines, which allowed the disentangling of the genetic and environmental parts of the phenotypic variance. Ten lines were characterized for the changes of body weight variability (weight measurements taken every month during 18 months), the plasma cortisol response to confinement stress (3 challenges) and a set of selected behavioral indicators. This study unambiguously demonstrated the existence of genetic determinism of environmental sensitivity, with some lines being particularly sensitive to environmental fluctuations and others rather insensitive. Correlations between coefficient of variation (CV) for body weight and behavioral and physiological traits were observed. This confirmed that CV for body weight could be used as an indicator of environmental sensitivity. As the relationship between indicators (CV weight, risk-taking, exploration and cortisol) was shown to be likely depending on the nature and intensity of the stressor, the joint use of several indicators should help to investigate the biological complexity of environmental sensitivity.	[Lallias, Delphine; Quillet, Edwige; Khaw, Hooi Ling; Dupont-Nivet, Mathilde] Univ Paris Saclay, AgroParisTech, INRA, GABI, Jouy En Josas, France; [Begout, Marie-Laure; Millot, Sandie] IFREMER, Lab Ressources Halieut, Pl Gaby Coll, Lhoumeau, France; [Auperin, Benoit; Valotaire, Claudiane; Prunet, Patrick] INRA, UR Lab Physiol & Genom Poissons 1037, Campus Beaulieu, Rennes, France; [Kerneais, Thierry; Labbe, Laurent] INRA, UE PEIMA Pisciculture Expt INRA Mt Arree 0937, Sizun, France; [Khaw, Hooi Ling] Nofima, As, Norway	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ifremer; INRAE; INRAE; Nofima	Lallias, D (corresponding author), Univ Paris Saclay, AgroParisTech, INRA, GABI, Jouy En Josas, France.	delphine.lallias@inra.fr	, Dupont-Nivet/J-2850-2019; Lallias, Delphine/ABC-4000-2021; Begout, Marie-Laure/L-7730-2019	Begout, Marie-Laure/0000-0003-1416-3479; Lallias, Delphine/0000-0002-1609-0827; Dupont-Nivet, Mathilde/0000-0002-9299-0560	ANR (Agence Nationale de la Recherche) [ANR 06-PADD-05]	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR))	This work was part of the COSADD project. The project was funded by ANR (Agence Nationale de la Recherche; http://www.agence-nationale-recherche.fr/). Grant number ANR 06-PADD-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auperin B, 1997, GEN COMP ENDOCR, V108, P35, DOI 10.1006/gcen.1997.6938; Barton B.A., 1991, Annual Review of Fish Diseases, V1, P3, DOI 10.1016/0959-8030(91)90019-G; Benjamini Y, 2001, ANN STAT, V29, P1165; Castanheira MF, 2017, REV AQUACULT, V9, P23, DOI 10.1111/raq.12100; Ruiz-Gomez MD, 2011, PHYSIOL BEHAV, V102, P317, DOI 10.1016/j.physbeh.2010.11.023; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Doughty Paul, 2004, P126; Dupont-Nivet M, 2012, J FISH BIOL, V81, P1754, DOI 10.1111/j.1095-8649.2012.03437.x; Ellis T, 2012, FISH PHYSIOL BIOCHEM, V38, P163, DOI 10.1007/s10695-011-9568-y; GAVRILETS S, 1993, J EVOLUTION BIOL, V6, P31, DOI 10.1046/j.1420-9101.1993.6010031.x; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Hill WG, 2010, GENET RES, V92, P381, DOI 10.1017/S0016672310000546; Huntingford FA, 2006, J FISH BIOL, V68, P332, DOI 10.1111/j.0022-1112.2006.001046.x; Janhunen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038766; Knap PW, 2008, RESOURCE ALLOCATION THEORY APPLIED TO FARM ANIMAL PRODUCTION, P288, DOI 10.1079/9781845933944.0288; Knap PW, 2005, AUST J EXP AGR, V45, P763, DOI 10.1071/EA05041; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Laursen DC, 2011, APPL ANIM BEHAV SCI, V132, P211, DOI 10.1016/j.applanim.2011.03.011; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Madaro A, 2015, J EXP BIOL, V218, P2538, DOI 10.1242/jeb.120535; Martins CIM, 2012, FISH PHYSIOL BIOCHEM, V38, P17, DOI 10.1007/s10695-011-9518-8; Mazzarella AB, 2015, J EVOLUTION BIOL, V28, P667, DOI 10.1111/jeb.12597; Millot S, 2009, J FISH BIOL, V75, P1733, DOI 10.1111/j.1095-8649.2009.02425.x; Millot S, 2014, BEHAV GENET, V44, P383, DOI 10.1007/s10519-014-9652-z; Millot S, 2009, APPL ANIM BEHAV SCI, V119, P108, DOI 10.1016/j.applanim.2009.03.009; Mormede P, 2007, PHYSIOL BEHAV, V92, P317, DOI 10.1016/j.physbeh.2006.12.003; Mulder HA, 2007, GENETICS, V175, P1895, DOI 10.1534/genetics.106.063743; Overli O, 2005, INTEGR COMP BIOL, V45, P463, DOI 10.1093/icb/45.3.463; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Pankhurst NW, 2011, MAR FRESHWATER RES, V62, P1015, DOI 10.1071/MF10269; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pottinger TG, 1999, GEN COMP ENDOCR, V116, P122, DOI 10.1006/gcen.1999.7355; Quillet E, 2007, FISH SHELLFISH IMMUN, V22, P510, DOI 10.1016/j.fsi.2006.07.002; Robinson BW, 1996, EVOL ECOL, V10, P631, DOI 10.1007/BF01237711; Ros M, 2004, GENETICS, V168, P2089, DOI 10.1534/genetics.104.032672; Sae-Lim P, 2016, REV AQUACULT, V8, P369, DOI 10.1111/raq.12098; SanCristobal-Gaudy M, 2001, GENET SEL EVOL, V33, P249, DOI 10.1051/gse:2001101; Schaefer J, 2006, J FISH BIOL, V69, P722, DOI 10.1111/j.1095-8649.2006.01145.x; Schjolden J, 2005, HORM BEHAV, V48, P537, DOI 10.1016/j.yhbeh.2005.04.008; Sorensen D, 2003, GENET RES, V82, P207, DOI 10.1017/S0016672303006426; Torres-Dowdall J, 2012, EVOLUTION, V66, P3432, DOI 10.1111/j.1558-5646.2012.01694.x; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Yavno S, 2013, J EVOLUTION BIOL, V26, P2383, DOI 10.1111/jeb.12230	44	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189943	10.1371/journal.pone.0189943	http://dx.doi.org/10.1371/journal.pone.0189943			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253015	Green Submitted, Green Published, gold			2022-12-26	WOS:000418389500077
J	Mitra, S; Schiller, D; Anderson, C; Gamboni, F; D'Alessandro, A; Kelher, M; Silliman, CC; Banerjee, A; Jones, KL				Mitra, Sanchayita; Schiller, Daran; Anderson, Cameron; Gamboni, Fabia; D'Alessandro, Angelo; Kelher, Margeurite; Silliman, Christopher C.; Banerjee, Anirban; Jones, Kenneth L.			Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; INNATE IMMUNE-RESPONSE; MULTIPLE-ORGAN FAILURE; HEMORRHAGIC-SHOCK; NEUTROPHIL ACTIVATION; PREVENTS INFLAMMATION; AIRWAY INFLAMMATION; RESUSCITATION; INJURY; CELLS	Trauma/hemorrhagic shock is a complex physiological phenomenon that leads to dysregulation of many molecular pathways. For over a decade, hypertonic saline (HTS) has been used as an alternative resuscitation fluid in the setting of trauma/hemorrhagic shock. In addition to restoring circulating volume within the vascular space, studies have shown a positive immunomodulatory effect of HTS. Targeted studies have shown that HTS affects the transcription of several pro-inflammatory cytokines by inhibiting the NF-kappa B-I kappa B pathway in model cell lines and rats. However, few studies have been undertaken to assess the unbiased effects of HTS on the whole transcriptome. This study was designed to interrogate the global transcriptional responses induced by HTS and provides insight into the underlying molecular mechanisms and pathways affected by HTS. In this study, RNA sequencing was employed to explore early changes in transcriptional response, identify key mediators, signaling pathways, and transcriptional modules that are affected by HTS in the presence of a strong inflammatory stimulus. Our results suggest that primary human small airway lung epithelial cells (SAECS) exposed to HTS in the presence and absence of a strong pro-inflammatory stimulus exhibit very distinct effects on cellular response, where HTS is highly effective in attenuating cytokine-induced pro-inflammatory responses via mechanisms that involve transcriptional regulation of inflammation which is cell type and stimulus specific. HTS is a highly effective anti-inflammatory agent that inhibits the chemotaxis of leucocytes towards a pro-inflammatory gradient and may attenuate the progression of both the innate and adaptive immune response.	[Mitra, Sanchayita; Schiller, Daran; Anderson, Cameron; Gamboni, Fabia; D'Alessandro, Angelo; Kelher, Margeurite; Silliman, Christopher C.; Banerjee, Anirban] Univ Colorado Denver, Sch Med, Trauma Res Ctr, Dept Surg, Aurora, CO USA; [D'Alessandro, Angelo] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA; [Kelher, Margeurite; Silliman, Christopher C.] Bonfils Blood Ctr, Denver, CO USA; [Jones, Kenneth L.] Univ Colorado Denver, Sch Med, Dept Pediat, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Jones, KL (corresponding author), Univ Colorado Denver, Sch Med, Dept Pediat, Aurora, CO 80045 USA.	Kenneth.L.Jones@ucdenver.edu	D'Alessandro, Angelo/AAA-4695-2019; Jones, Kenneth/GXF-4945-2022	D'Alessandro, Angelo/0000-0002-2258-6490; 	National Institute of General Medical Sciences; National Institutes of Health [P50GM049222]; Cancer Center Support Grant [P30CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institute of General Medical Sciences and National Institutes of Health under award no. P50GM049222.; We want to thank the Protein Production, Monoclonal Antibody and Tissue Culture, Genomics, and Bioinformatics Shared Resources of the University of Colorado Cancer Center (supported by the Cancer Center Support Grant, P30CA046934) for their help with this project. The authors are grateful to Ms. Victoria Bress (Research Manager Trauma Res. Ctr) for administrative help and support.	Albaiceta GM, 2010, AM J RESP CELL MOL, V43, P555, DOI 10.1165/rcmb.2009-0034OC; Angle N, 1998, SHOCK, V9, P164, DOI 10.1097/00024382-199803000-00002; Bahrami S, 2006, SHOCK, V25, P283, DOI 10.1097/01.shk.0000208808.03148.ea; Baird NL, 2014, J VIROL, V88, P5877, DOI 10.1128/JVI.00476-14; Bakowitz M, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-54; Banerjee A, 2013, SHOCK, V39, P366, DOI 10.1097/SHK.0b013e3182894016; Bastarache JA, 2011, EXP LUNG RES, V37, P509, DOI 10.3109/01902148.2011.605512; Brunner PM, 2015, EXP DERMATOL, V24, P522, DOI 10.1111/exd.12709; Chan JK, 2012, J CLIN INVEST, V122, P2711, DOI 10.1172/JCI62423; Ciesla DJ, 2005, SURGERY, V138, P749, DOI 10.1016/j.surg.2005.07.020; Cuschieri J, 2002, J IMMUNOL, V168, P1389, DOI 10.4049/jimmunol.168.3.1389; Davidson G, 2010, TRENDS CELL BIOL, V20, P453, DOI 10.1016/j.tcb.2010.05.002; Deitch EA, 2003, SHOCK, V19, P328, DOI 10.1097/00024382-200304000-00006; Diamond G, 2000, IMMUNOL REV, V173, P27, DOI 10.1034/j.1600-065X.2000.917304.x; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Gamboni F, 2016, J PROTEOME RES, V15, P3813, DOI 10.1021/acs.jproteome.6b00602; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Groppera MA, 2008, CURR OPIN CRIT CARE, V14, P11, DOI 10.1097/MCC.0b013e3282f417a0; Hastbacka J, 2014, ANESTH ANALG, V118, P790, DOI 10.1213/ANE.0000000000000120; Henderson HH, 2016, J VIROL, V90, P1231, DOI 10.1128/JVI.02617-15; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Hsu AT, 2015, SHOCK, V44, P128, DOI 10.1097/SHK.0000000000000386; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Junger WG, 1997, SHOCK, V8, P235, DOI 10.1097/00024382-199710000-00001; Kelly EAB, 2009, J IMMUNOL, V182, P1404, DOI 10.4049/jimmunol.182.3.1404; Knight D, 2001, PULM PHARMACOL THER, V14, P169, DOI 10.1006/pupt.2001.0282; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Kreimeier U, 2002, ACTA ANAESTH SCAND, V46, P625, DOI 10.1034/j.1399-6576.2002.460601.x; Kudo M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-19; Manicone AM, 2009, EXPERT REV CLIN IMMU, V5, P63, DOI 10.1586/1744666X.5.1.63; Manson J, 2012, BRIT J SURG, V99, P12, DOI 10.1002/bjs.7717; Matthay MA, J CLIN INVESTIGATION, V122, P2731; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Maycotte P, 2015, MOL CANCER RES, V13, P651, DOI 10.1158/1541-7786.MCR-14-0487; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Murphy GEJ, 2010, ANN RHEUM DIS, V69, P43, DOI 10.1136/ard.2009.120113; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nydam TL, 2009, SHOCK, V31, P466, DOI 10.1097/SHK.0b013e31818ec47d; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pazdrak K, 1998, J EXP MED, V188, P421, DOI 10.1084/jem.188.3.421; Powers KA, 2005, SURGERY, V137, P66, DOI 10.1016/j.surg.2004.05.051; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Reeves Emer P, 2015, World J Crit Care Med, V4, P179, DOI 10.5492/wjccm.v4.i3.179; Reeves EP, 2011, AM J RESP CRIT CARE, V183, P1517, DOI 10.1164/rccm.201101-0072OC; Richie JP, 2015, J UROLOGY, V194, P706, DOI 10.1016/j.juro.2015.06.010; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Sauaia A, 2014, J TRAUMA ACUTE CARE, V76, P582, DOI 10.1097/TA.0000000000000147; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P805, DOI 10.1189/jlb.1109767; Sokol CL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016303; Su R, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-121; Sun Y, 2013, CYTOKINE, V63, P303, DOI 10.1016/j.cyto.2013.06.256; Teng MWL, 2015, NAT MED, V21, P719, DOI 10.1038/nm.3895; Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC; Tisherman SA, 2015, ANN SURG, V261, P586, DOI 10.1097/SLA.0000000000000837; Tohyama M, 2007, INT IMMUNOL, V19, P1095, DOI 10.1093/intimm/dxm083; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang Z, 2015, ONCOL REP, V33, P1097, DOI 10.3892/or.2014.3704; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Weigand Markus A, 2004, Best Pract Res Clin Anaesthesiol, V18, P455, DOI 10.1016/j.bpa.2003.12.005; Wohlauer M, 2012, CRIT CARE MED, V40, P2647, DOI 10.1097/CCM.0b013e3182592006; Wright FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114129; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	65	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189536	10.1371/journal.pone.0189536	http://dx.doi.org/10.1371/journal.pone.0189536			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253007	gold, Green Published, Green Submitted			2022-12-26	WOS:000418389500037
J	da Silva, ERP; de Souza, AS; de Souza, TGB; Tsuha, DH; Barbieri, AR				Prudencio da Silva, Elaine Regina; de Souza, Albert Schiaveto; Barbosa de Souza, Taiana Gabriela; Tsuha, Daniel Henrique; Barbieri, Ana Rita			Screening for cervical cancer in imprisoned women in Brazil	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; INFECTION; RISK	Context and objective Incarcerated women are more vulnerable to developing cervical cancer than women in general; therefore, screening and intervention programs must be included in their healthcare provision. We therefore aimed to investigate the state of cervical cancer screening for imprisoned women in Mato Grosso do Sul, and to analyze the interventions geared toward the control of cervical cancer. Materials and methods This was a cross-sectional study with analysis of primary and secondary data. Interviews were held with 510 women in seven prisons in the Brazilian state of Mato Grosso do Sul. The data for 352 medical records were analyzed statistically with the significance level set at 5%. Associations were assessed by the chi-squared test, adjusted by the Bonferroni correction. Results Most female prisoners had limited education, used tobacco, and had key risk factors for the development of cervical cancer. Half of the women interviewed (n = 255) stated that they had received a Papanicolaou (Pap) test in prison, but 134 (52.5%) of these did not know the result. Of those who had not received a Pap test, 149 (58.4%) stated that this was because of a lack of opportunity. There was no information regarding the provision of Pap tests or subsequent treatment in the medical records of 211 (59.9%) women. No protocols were in place for the provision of Pap tests in prison. There were statistical differences between prisons in terms of test frequency, the information provided to women, and how information was recorded in medical records. Conclusion The screening of cervical cancer in prisons is neither systematic nor regular, and the results are not communicated to women in a significant number of cases. It is necessary to organize health services within the prison environment, ensuring that tests are done and that there is investigation for human papillomavirus. This could increase the diagnosis of cervical cancer at less advanced stages of the disease.	[Prudencio da Silva, Elaine Regina; de Souza, Albert Schiaveto; Barbosa de Souza, Taiana Gabriela; Barbieri, Ana Rita] Fdn Fed Univ Mato Grosso do Sul, Campo Grande, MS, Brazil; [Tsuha, Daniel Henrique] State Hlth Dept Mato Grosso do Sul, Campo Grande, MS, Brazil		da Silva, ERP (corresponding author), Fdn Fed Univ Mato Grosso do Sul, Campo Grande, MS, Brazil.	laine_prudencio@hotmail.com	Schiaveto de Souza, Albert/GRF-1569-2022	Schiaveto de Souza, Albert/0000-0003-0017-672X; Silva, Elaine Regina Prudencio Hipolito/0000-0002-4234-0383				Costa RFA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138945; Anjos Saiwori de Jesus Silva Bezerra dos, 2013, Rev. Bras. Enferm., V66, P508, DOI 10.1590/S0034-71672013000400007; Balogun M R, 2012, Afr J Reprod Health, V16, P75; Binswager I., 2014, BMJ, V349, P4542; Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662; Binswanger IA, 2011, J WOMENS HEALTH, V20, P1839, DOI 10.1089/jwh.2011.2864; Brasil, 2011, DIR BRAS RASTR CANC; Damiani G, 2015, PREV MED, V81, P281, DOI 10.1016/j.ypmed.2015.09.011; DEPEN-Departamento Penitenciario Nacional, 2014, LEV NAC INF PEN; Di J, 2015, PLOSONE; Farias A. M, 2014, THESIS; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fonseca-Moutinho JA, 2011, INT SCHOLARLY RES NE; INCA, 2015, EST 2016 INC CANC BR; Lessa PRA, 2012, REV LATINOAM ENFERMA, V20; Lince-Deroche N, 2015, PLOSONE; Lopez-Hernandez D, 2016, MEDCLIN BARC, V147, P101; Melo A, 2014, REV CHIL INFECTOL, V31, P542, DOI 10.4067/S0716-10182014000500005; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Nicolau AIO, 2015, REV MIN ENFERM, V19, P725; Nitschmann C, 2016, J WOMENS HEALTH, V25, P826, DOI 10.1089/jwh.2015.5394; Pankey T, 2015, INT J PRISON HEALTH, V11, P49, DOI 10.1108/IJPH-05-2014-0012; Ramaswamy M, 2015, HEALTH PROMOT PRACT, V16, P432, DOI 10.1177/1524839914541658; Roura E, 2016, PLOS ONE; Salcedo MMBP, 2015, ARCH GYNECOL OBSTET, V292, P1273, DOI 10.1007/s00404-015-3752-8; Thuler LCS, 2014, REV BRAS GINECOL OBS, V36, P237, DOI 10.1590/S0100-720320140005010; Sasieni P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2968; SEJUSP State Secretariat for Justice and Public Security and State Agency for the Administration of the Penitentiary (AGEPEN), 2016, OP MAN DOP REF PRIS; Souza CM, 2011, DST J BRAS DOENCAS S, V23, P12; Trottier H, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0675-0; Udesen, 2014, PRISONS AND HLTH, P159; van den Bergh BJ, 2011, B WORLD HEALTH ORGAN, V89, P689, DOI 10.2471/BLT.10.082842; Vera-Remartínez E.J., 2014, Rev. esp. sanid. penit., V16, P38, DOI 10.4321/S1575-06202014000200003; Walmsley R., 2017, WORLD FEMALE IMPRISO; Walmsley R., 2015, WORLD PRISON POPULAT; World Health Organisation (WHO), 2009, WOM HLTH PRIS CORR G	36	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0187873	10.1371/journal.pone.0187873	http://dx.doi.org/10.1371/journal.pone.0187873			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29252994	Green Submitted, Green Published, gold			2022-12-26	WOS:000418389500004
J	Ciobanasu, C; Wang, H; Henriot, V; Mathieu, C; Fente, A; Csillag, S; Vigouroux, C; Faivre, B; Le Clainche, C				Ciobanasu, Corina; Wang, Hong; Henriot, Veronique; Mathieu, Cecile; Fente, Annabelle; Csillag, Sandrine; Vigouroux, Clemence; Faivre, Bruno; Le Clainche, Christophe			Integrin-bound talin head inhibits actin filament barbed-end elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESIONS; IN-VITRO; VINCULIN-BINDING; STRUCTURAL BASIS; ACTIVATION; DOMAIN; PROTEINS; DYNAMICS; COMPLEX; FORMIN	Focal adhesions (FAs) mechanically couple the extracellular matrix to the dynamic actin cytoskeleton, via transmembrane integrins and actin-binding proteins. The molecular mechanisms by which protein machineries control force transmission along this molecular axis (i.e. modulating integrin activation and controlling actin polymerization) remain largely unknown. Talin is a major actin-binding protein that controls both the inside-out activation of integrins and actin filament anchoring and thus plays a major role in the establishment of the actin-extracellular matrix mechanical coupling. Talin contains three actin-binding domains (ABDs). The N-terminal head domain contains both the F3 integrin-activating domain and ABD1, whereas the C-terminal rod contains the actin-anchoring ABD2 and ABD3. Integrin binding is regulated by an intramolecular interaction between the N-terminal head and a C-terminal five-helix bundle (R9). Whether talin ABDs regulate actin polymerization in a constitutive or regulated manner has not been fully explored. Here, we combine kinetics assays using fluorescence spectroscopy and single actin filament observation in total internal reflection fluorescence microscopy, to examine relevant functions of the three ABDs of talin. We find that the N-terminal ABD1 blocks actin filament barbed-end elongation, whereas ABD2 and ABD3 do not show any activity. By mutating residues in ABD1, we find that this activity is mediated by a positively charged surface that is partially masked by its intramolecular interaction with R9. Our results also demonstrate that, once this intramolecular interaction is released, the integrin-bound talin head retains the ability to inhibit actin assembly.	[Ciobanasu, Corina; Wang, Hong; Henriot, Veronique; Mathieu, Cecile; Fente, Annabelle; Csillag, Sandrine; Vigouroux, Clemence; Faivre, Bruno; Le Clainche, Christophe] Univ Paris Saclay, Univ Paris Sud, CNRS, I2BC,CEA, F-91198 Gif Sur Yvette, France; [Ciobanasu, Corina] Alexandru I Cuza Univ, Interdisciplinary Res Dept, Blvd Carol 1, RO-700506 Iasi, Romania	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Alexandru Ioan Cuza University	Le Clainche, C (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, I2BC,CEA, F-91198 Gif Sur Yvette, France.	christophe.leclainche@i2bc.paris-saclay.fr	Ciobanasu, Corina/O-4117-2014; Le Clainche, Christophe/A-4782-2015	Ciobanasu, Corina/0000-0003-1107-8738; Le Clainche, Christophe/0000-0001-5659-677X; Nguyen-Vigouroux, Clemence/0000-0002-8684-9835; WANG, Hong/0000-0002-3120-1679	Agence Nationale pour la Recherche [ANR-09-JCJC-0111 ADERACTIN, ANR-16-CE13-0007-02 PHAGOMECANO]; China Scholarship Council (CSC)	Agence Nationale pour la Recherche(French National Research Agency (ANR)); China Scholarship Council (CSC)(China Scholarship Council)	This work was supported in part by Agence Nationale pour la Recherche Grants ANR-09-JCJC-0111 ADERACTIN (to C.L.C.) and ANR-16-CE13-0007-02 PHAGOMECANO (to C.L.C.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Ph.D. fellowship from the China Scholarship Council (CSC).	Anthis NJ, 2010, STRUCTURE, V18, P1654, DOI 10.1016/j.str.2010.09.018; Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Atherton P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10038; Austen K, 2015, NAT CELL BIOL, V17, P1597, DOI 10.1038/ncb3268; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Breitsprecher D, 2009, METHODS MOL BIOL, V571, P401, DOI 10.1007/978-1-60761-198-1_27; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; CHUANG JZ, 1995, J CELL BIOL, V128, P1095, DOI 10.1083/jcb.128.6.1095; Ciobanasu C, 2015, NAT PROTOC, V10, P75, DOI 10.1038/nprot.2014.200; Ciobanasu C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4095; Ciobanasu C, 2013, EUR J CELL BIOL, V92, P339, DOI 10.1016/j.ejcb.2013.10.009; Ciobanasu Corina, 2012, Int J Cell Biol, V2012, P941292, DOI 10.1155/2012/941292; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Doolittle LK, 2013, METHODS MOL BIOL, V1046, P273, DOI 10.1007/978-1-62703-538-5_16; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2010, J BIOL CHEM, V285, P29577, DOI 10.1074/jbc.M109.095455; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; Haining AWM, 2016, FASEB J, V30, P2073, DOI 10.1096/fj.201500080R; Hemmings L, 1996, J CELL SCI, V109, P2715; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Le Clainche C, 2010, J BIOL CHEM, V285, P23418, DOI 10.1074/jbc.M110.102830; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Lee HS, 2004, J MOL BIOL, V343, P771, DOI 10.1016/j.jmb.2004.08.069; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; OHALLORAN T, 1986, METHOD ENZYMOL, V134, P69; OHALLORAN T, 1985, NATURE, V317, P449, DOI 10.1038/317449a0; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Skau CT, 2015, P NATL ACAD SCI USA, V112, pE2447, DOI 10.1073/pnas.1505035112; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P569, DOI 10.1016/j.ceb.2012.06.010; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; Yang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6880; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	43	11	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2586	2596		10.1074/jbc.M117.808204	http://dx.doi.org/10.1074/jbc.M117.808204			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29276177	hybrid, Green Published			2022-12-26	WOS:000425308300029
J	Thibeaux, S; Siddiqi, S; Zhelyabovska, O; Moinuddin, F; Masternak, MM; Siddiqi, SA				Thibeaux, Simeon; Siddiqi, Shaila; Zhelyabovska, Olga; Moinuddin, Faisal; Masternak, Michal M.; Siddiqi, Shadab A.			Cathepsin B regulates hepatic lipid metabolism by cleaving liver fatty acid-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cathepsin B (CTSB); endoplasmic reticulum (ER); Golgi; low-density lipoprotein (LDL); triglyceride; liver fatty acid binding protein (LFABP); very low-density lipoprotein (VLDL); VLDL transport vesicle (VTV); apolipoprotein B; triacylglycerol	LOW-DENSITY-LIPOPROTEIN; VLDL-TRANSPORT VESICLE; ENDOPLASMIC-RETICULUM; APOLIPOPROTEIN-B; GROWTH-HORMONE; RAT-LIVER; INSULIN-RESISTANCE; GOLGI; SECRETION; ALPHA	Synthesis and secretion of hepatic triglycerides (TAG) associated with very-low-density lipoprotein (VLDL) play a major role in maintaining overall lipid homeostasis. This study aims to identify factors affecting synthesis and secretion of VLDL-TAG using the growth hormone-deficient Ames dwarf mouse model, which has reduced serum TAG. Proteomic analysis coupled with a bioinformatics-driven approach revealed that these mice express greater amounts of hepatic cathepsin B and lower amounts of liver fatty acid-binding protein (LFABP) than their wildtype littermates. siRNA-mediated knockdown of cathepsin B in McA-RH7777 cells resulted in a 39% increase in [H-3]TAG associated with VLDL secretion. Cathepsin B knockdown was accompanied by a 74% increase in cellular LFABP protein levels, but only when cells were exposed to 0.4 mm oleic acid (OA) complexed to BSA. The cathepsin B knockdown and 24-h treatment with OA resulted in increased CD36 expression alone and additively. Co-localization of LFABP and cathepsin B was observed in a distinct Golgi apparatus-like pattern, which required a 1-h OA treatment. Moreover, we observed co-localization of LFABP and apoB, independent of the OA treatment. Overexpression of cathepsin B resulted in decreased OA uptake and VLDL secretion. Co-expression of cathepsin B and cathepsin B-resistant mutant LFABP in McA-RH7777 cells resulted in an increased TAG secretion as compared with cells co-expressing cathepsin B and wildtype LFABP. Together, these data indicate that cathepsin B regulates VLDL secretion and free fatty acid uptake via cleavage of LFABP, which occurs in response to oleic acid exposure.	[Thibeaux, Simeon; Siddiqi, Shaila; Zhelyabovska, Olga; Moinuddin, Faisal; Masternak, Michal M.; Siddiqi, Shadab A.] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 6900 Lake Nona Blvd,Rm 349, Orlando, FL 32827 USA	State University System of Florida; University of Central Florida	Siddiqi, SA (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 6900 Lake Nona Blvd,Rm 349, Orlando, FL 32827 USA.	shadab.siddiqi@ucf.edu			NIDDK, National Institutes of Health (NIH) [R01 DK081413]; NIA, NIH [R01 AG032290]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032290] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIA, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by NIDDK, National Institutes of Health (NIH), Grant R01 DK081413 (to S. A. S.) and NIA, NIH, Grant R01 AG032290 (to M. M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arpegard J, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003085; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Carlsson L, 2001, AM J PHYSIOL-ENDOC M, V281, pE772, DOI 10.1152/ajpendo.2001.281.4.E772; Coburn CT, 2001, J MOL NEUROSCI, V16, P117, DOI 10.1385/JMN:16:2-3:117; ELAM MB, 1992, ENDOCRINOLOGY, V131, P2717, DOI 10.1210/en.131.6.2717; ELOVSON J, 1988, J LIPID RES, V29, P1461; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Feldstein AE, 2006, AM J PHYSIOL-GASTR L, V290, pG1339, DOI 10.1152/ajpgi.00509.2005; Fisher EA, 2012, BBA-MOL CELL BIOL L, V1821, P778, DOI 10.1016/j.bbalip.2012.02.001; Fisher EA, 2011, J LIPID RES, V52, P1170, DOI 10.1194/jlr.M011726; Frick F, 2002, AM J PHYSIOL-ENDOC M, V283, pE1023, DOI 10.1152/ajpendo.00260.2002; Fukuo Y, 2014, HEPATOL RES, V44, P1026, DOI 10.1111/hepr.12282; Ginsberg HN, 2009, J LIPID RES, V50, pS162, DOI 10.1194/jlr.R800090-JLR200; Ginsberg HN, 2002, CIRCULATION, V106, P2137, DOI 10.1161/01.CIR.0000035280.64322.31; Guicciardi ME, 2001, AM J PATHOL, V159, P2045, DOI 10.1016/S0002-9440(10)63056-8; HIGGINS JA, 1988, FEBS LETT, V232, P405, DOI 10.1016/0014-5793(88)80780-4; HONMA Y, 1994, J BIOCHEM, V116, P1025, DOI 10.1093/oxfordjournals.jbchem.a124623; Hook V, 2012, BBA-PROTEINS PROTEOM, V1824, P89, DOI 10.1016/j.bbapap.2011.08.015; Hossain T, 2014, BIOCHEM J, V459, P47, DOI 10.1042/BJ20131215; Howell KW, 2011, J SURG RES, V171, pE27, DOI 10.1016/j.jss.2011.06.033; KELLER U, 1991, HORM RES, V36, P36, DOI 10.1159/000182186; Kumar NS, 1997, AM J PHYSIOL-GASTR L, V273, pG18, DOI 10.1152/ajpgi.1997.273.1.G18; Masternak MM, 2012, PATHOBIOL AGING AGE, V2, DOI 10.3402/pba.v2i0.17293; Neeli I, 2007, J BIOL CHEM, V282, P17974, DOI 10.1074/jbc.M610765200; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Rahim A, 2012, J PROTEOMICS, V75, P2225, DOI 10.1016/j.jprot.2012.01.026; REAVEN GM, 1988, AM J MED, V85, P106, DOI 10.1016/0002-9343(88)90402-0; Shelness GS, 1999, J NUTR, V129, p456S, DOI 10.1093/jn/129.2.456S; Siddiqi SA, 2003, J CELL SCI, V116, P415, DOI 10.1242/jcs.00215; Siddiqi SA, 2008, BIOCHEM J, V413, P333, DOI 10.1042/BJ20071469; Siddiqi Shadab A, 2015, Curr Protoc Cell Biol, V67, DOI 10.1002/0471143030.cb1121s67; Siddiqi S, 2010, BIOCHEM J, V429, P391, DOI 10.1042/BJ20100336; Sparks JD, 2012, ARTERIOSCL THROM VAS, V32, P2104, DOI 10.1161/ATVBAHA.111.241463; STAHN R, 1970, J CELL BIOL, V46, P576, DOI 10.1083/jcb.46.3.576; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Swift LL, 1996, J BIOL CHEM, V271, P31491; Tiwari S, 2016, J BIOL CHEM, V291, P12514, DOI 10.1074/jbc.M115.705269; Tiwari S, 2013, J BIOL CHEM, V288, P5157, DOI 10.1074/jbc.M112.434258; Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471; Tran K, 2002, J BIOL CHEM, V277, P31187, DOI 10.1074/jbc.M200249200; Vida M, 2013, LIVER INT, V33, P1019, DOI 10.1111/liv.12156; Wang ZH, 2006, J GERONTOL A-BIOL, V61, P323, DOI 10.1093/gerona/61.4.323; Yamaguchi J, 2003, J BIOL CHEM, V278, P42643, DOI 10.1074/jbc.M306920200	45	9	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1910	1923		10.1074/jbc.M117.778365	http://dx.doi.org/10.1074/jbc.M117.778365			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29259130	Green Published, hybrid			2022-12-26	WOS:000424948000007
J	Bawankar, P; Shanbhag, N; Smitha, KS; Dhawan, B; Palsule, A; Kumar, D; Chandel, S; Sood, S				Bawankar, Pritam; Shanbhag, Nita; Smitha, S. K.; Dhawan, Bodhraj; Palsule, Aratee; Kumar, Devesh; Chandel, Shailja; Sood, Suneet			Sensitivity and specificity of automated analysis of single-field non-mydriatic fundus photographs by Bosch DR Algorithm-Comparison with mydriatic fundus photography (ETDRS) for screening in undiagnosed diabetic retinopathy	PLOS ONE			English	Article							RETINAL IMAGES; TELEMEDICINE; PREVALENCE; DIAGNOSIS; CARE; EPIDEMIOLOGY; POPULATION; ACCURACY; ONSET; RISK	Diabetic retinopathy (DR) is a leading cause of blindness among working-age adults. Early diagnosis through effective screening programs is likely to improve vision outcomes. The ETDRS seven-standard-field 35-mm stereoscopic color retinal imaging (ETDRS) of the dilated eye is elaborate and requires mydriasis, and is unsuitable for screening. We evaluated an image analysis application for the automated diagnosis of DR from non-mydriatic single-field images. Patients suffering from diabetes for at least 5 years were included if they were 18 years or older. Patients already diagnosed with DR were excluded. Physiologic mydriasis was achieved by placing the subjects in a dark room. Images were captured using a Bosch Mobile Eye Care fundus camera. The images were analyzed by the Retinal Imaging Bosch DR Algorithm for the diagnosis of DR. All subjects also subsequently underwent pharmacological mydriasis and ETDRS imaging. Non-mydriatic and mydriatic images were read by ophthalmologists. The ETDRS readings were used as the gold standard for calculating the sensitivity and specificity for the software. 564 consecutive subjects (1128 eyes) were recruited from six centers in India. Each subject was evaluated at a single outpatient visit. Forty-four of 1128 images (3.9%) could not be read by the algorithm, and were categorized as inconclusive. In four subjects, neither eye provided an acceptable image: these four subjects were excluded from the analysis. This left 560 subjects for analysis (1084 eyes). The algorithm correctly diagnosed 531 of 560 cases. The sensitivity, specificity, and positive and negative predictive values were 91%, 97%, 94%, and 95% respectively. The Bosch DR Algorithm shows favorable sensitivity and specificity in diagnosing DR from non-mydriatic images, and can greatly simplify screening for DR. This also has major implications for telemedicine in the use of screening for retinopathy in patients with diabetes mellitus.	[Bawankar, Pritam] Sri Sankaradeva Nethralaya, Gauhati, India; [Shanbhag, Nita] Dr DY Patil Hosp & Res Ctr, Dept Ophthalmol, Bombay, Maharashtra, India; [Smitha, S. K.] KLES Dr Prabhakar Kore Hosp & Res Ctr, Belgavi, Karnataka, India; [Dhawan, Bodhraj] NKP Salve Inst Med Sci & Res Ctr, Nagpur, Maharashtra, India; [Palsule, Aratee] Deenanath Mangeshkar Hosp, Pune, Maharashtra, India; [Chandel, Shailja] Think i, Noida, Uttar Pradesh, India; [Kumar, Devesh; Sood, Suneet] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Johor Baharu, Malaysia	K.L.E. Academy of Higher Education & Research; Monash University; Monash University Sunway	Sood, S (corresponding author), Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Johor Baharu, Malaysia.	suneet.sood@monash.edu	Sood, Suneet/AAE-7431-2021; ks, smitha/AAS-9781-2020	ks, smitha/0000-0002-0489-0659; Sood, Suneet/0000-0003-1125-1721	Robert Bosch Engineering and Business Solutions Private Limited	Robert Bosch Engineering and Business Solutions Private Limited	The study was funded by Robert Bosch Engineering and Business Solutions Private Limited. Investigators were given grant per completed subject by Think-i, Unit of Tenet Health Edutech Pvt. Ltd., the CRO conducting the study.	Abramoff MD, 2013, JAMA OPHTHALMOL, V131, P351, DOI 10.1001/jamaophthalmol.2013.1743; Abramoff MD, 2010, OPHTHALMOLOGY, V117, P1147, DOI 10.1016/j.ophtha.2010.03.046; Abramoff MD, 2008, DIABETES CARE, V31, P193, DOI 10.2337/dc07-1312; Akbar S, 2017, J MED SYST, V41, DOI 10.1007/s10916-017-0712-9; Al Alawi E, 2012, MIDDLE EAST AFR J OP, V19, P295, DOI 10.4103/0974-9233.97928; American Academy of Ophthalmology Retina/Vitreous Panel, 2016, PREF PRACT PATT GUID; [Anonymous], 1991, Ophthalmology, V98, P823; [Anonymous], 1991, Ophthalmology, V98, P786; Besenczi R, 2016, COMPUT STRUCT BIOTEC, V14, P371, DOI 10.1016/j.csbj.2016.10.001; Bhaskaranand M, 2016, J DIABET SCI TECHNOL, V10, P254, DOI [10.1177/1932296816628546, DOI 10.1177/1932296816628546]; Boucher MC, 2005, CAN J OPHTHALMOL, V40, P734, DOI 10.1016/S0008-4182(05)80091-2; Bruce BB, 2013, ANN EMERG MED, V62, P28, DOI 10.1016/j.annemergmed.2013.01.010; Castro AF, 2007, TELEMED J E-HEALTH, V13, P287, DOI 10.1089/tmj.2006.0046; Chew EY, 2015, ENDOCRINE, V49, P1, DOI 10.1007/s12020-015-0553-6; Chin EK, 2014, TELEMED E-HEALTH, V20, P102, DOI 10.1089/tmj.2013.0042; Choremis J, 2003, CAN J OPHTHALMOL, V38, P575, DOI 10.1016/S0008-4182(03)80111-4; Das T, 2016, INDIAN J OPHTHALMOL, V64, P84, DOI 10.4103/0301-4738.178151; Das T, 2015, MIDDLE EAST AFR J OP, V22, P174, DOI 10.4103/0974-9233.154391; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; Eszes DJ, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/4529824; Farley TF, 2008, ANN FAM MED, V6, P428, DOI 10.1370/afm.857; Fatima KN, 2017, BIOMED OPT EXPRESS, V8, P1005, DOI 10.1364/BOE.8.001005; FERRIS FL, 1994, PREV MED, V23, P740, DOI 10.1006/pmed.1994.1127; Fong DS, 2003, DIABETES CARE, V26, P226, DOI 10.2337/diacare.26.1.226; Frcophth AT, 2017, OPHTHALMOLOGY, V124, P343, DOI 10.1016/j.ophtha.2016.11.014; Gadkari SS, 2016, INDIAN J OPHTHALMOL, V64, P38, DOI 10.4103/0301-4738.178144; Garg S., 2017, JAMA OPHTHALMOL; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Gupta V, 2014, INDIAN J OPHTHALMOL, V62, P851, DOI 10.4103/0301-4738.141039; Hansen AB, 2004, ACTA OPHTHALMOL SCAN, V82, P666, DOI 10.1111/j.1600-0420.2004.00350.x; Hansen MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139148; Hipwell JH, 2000, DIABETIC MED, V17, P588, DOI 10.1046/j.1464-5491.2000.00338.x; Hoover A, 2003, IEEE T MED IMAGING, V22, P951, DOI 10.1109/TMI.2003.815900; Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178; Idil A, 2004, EUR J OPHTHALMOL, V14, P298, DOI 10.1177/112067210401400404; Issac R, 2017, TELE CONSULTING RURA; Jaafar HF, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3643719; Kapetanakis VV, 2015, J MED SCREEN, V22, P112, DOI 10.1177/0969141315571953; Kauppi T, 2007, DIARETDB1 STANDARD D; Klein BEK, 2007, OPHTHAL EPIDEMIOL, V14, P179, DOI 10.1080/09286580701396720; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Liesenfeld B, 2000, DIABETES CARE, V23, P345, DOI 10.2337/diacare.23.3.345; Lin DY, 2002, AM J OPHTHALMOL, V134, P204, DOI 10.1016/S0002-9394(02)01522-2; Lovshin JA, 2017, J DIABETES COMPLICAT, V31, P664, DOI 10.1016/j.jdiacomp.2016.12.011; Mansberger SL, 2013, TELEMED E-HEALTH, V19, P942, DOI 10.1089/tmj.2012.0313; Marks Jennifer B., 1992, Journal of Diabetes and its Complications, V6, P247, DOI 10.1016/1056-8727(92)90060-X; Mookiah MRK, 2013, COMPUT BIOL MED, V43, P2136, DOI 10.1016/j.compbiomed.2013.10.007; Moreton RB, 2017, DIABETIC MED J BRIT; Neelakantan A., 2015, ARXIV151106807; Nguyen HV, 2016, OPHTHALMOLOGY, V123, P2571, DOI 10.1016/j.ophtha.2016.08.021; Ouyang YL, 2013, INVEST OPHTH VIS SCI, V54, P5694, DOI 10.1167/iovs.13-12043; Panwar N, 2016, TELEMED E-HEALTH, V22, P198, DOI 10.1089/tmj.2015.0068; Perez-de-Arcelus M, 2013, CURR DIABETES REV, V9, P2, DOI 10.2174/157339913804143180; Rahim Sarni Suhaila, 2016, Brain Inform, V3, P249, DOI 10.1007/s40708-016-0045-3; Raman R, 2007, TELEMED J E-HEALTH, V13, P597, DOI 10.1089/tmj.2006.0084; Raman R, 2011, OPHTHALMIC RES, V45, P36, DOI 10.1159/000314720; Ramavat PR, 2013, J CLIN DIAGN RES, V7, P1387, DOI 10.7860/JCDR/2013/5259.3146; Roychowdhury S, 2016, IEEE ENG MED BIO, P3256, DOI 10.1109/EMBC.2016.7591423; Roychowdhury S, 2016, IEEE ENG MED BIO, P1300, DOI 10.1109/EMBC.2016.7590945; RYDER REJ, 1985, BRIT MED J, V291, P1256, DOI 10.1136/bmj.291.6504.1256; Schuster AKG, 2014, ACTA OPHTHALMOL, V92, pE42, DOI 10.1111/aos.12242; Silva PS, 2012, AM J OPHTHALMOL, V154, P549, DOI 10.1016/j.ajo.2012.03.019; Sinthanayothin C, 2002, DIABETIC MED, V19, P105, DOI 10.1046/j.1464-5491.2002.00613.x; Squirrell DM, 2003, J ROY SOC MED, V96, P273, DOI 10.1258/jrsm.96.6.273; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Vashist Praveen, 2011, Indian J Community Med, V36, P247, DOI 10.4103/0970-0218.91324; Vujosevic S, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/3627465; Vujosevic S, 2009, AM J OPHTHALMOL, V148, P111, DOI 10.1016/j.ajo.2009.02.031; WILLIAMS R, 1986, BRIT MED J, V293, P1140, DOI 10.1136/bmj.293.6555.1140; Zhao YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122332	73	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189854	10.1371/journal.pone.0189854	http://dx.doi.org/10.1371/journal.pone.0189854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281690	Green Submitted, Green Published, gold			2022-12-26	WOS:000419006200050
J	Fatima, I; El-Ayachi, I; Taotao, L; Lillo, MA; Krutilina, R; Seagroves, TN; Radaszkiewicz, TW; Hutnan, M; Bryja, V; Krum, SA; Rivas, F; Miranda-Carboni, GA				Fatima, Iram; El-Ayachi, Ikbale; Taotao, Ling; Lillo, M. Angeles; Krutilina, Raya; Seagroves, Tiffany N.; Radaszkiewicz, Tomasz W.; Hutnan, Miroslav; Bryja, Viterslav; Krum, Susan A.; Rivas, Fatima; Miranda-Carboni, Gustavo A.			The natural compound Jatrophone interferes with Wnt/beta-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer	PLOS ONE			English	Article							AFRICAN-AMERICAN WOMEN; BETA-CATENIN; WNT; PRODUCTS; PATHWAY; DISEASE; CELLS; AXIN; PHOSPHORYLATION; DISPARITIES	Metastatic breast cancer is the leading cause of worldwide cancer-related deaths among women. Triple negative breast cancers (TNBC) are highly metastatic and are devoid of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) amplification. TNBCs are unresponsive to Herceptin and/or anti-estrogen therapies and too often become highly chemoresistant when exposed to standard chemotherapy. TNBCs frequently metastasize to the lung and brain. We have previously shown that TNBCs are active for oncogenic Wnt10b/beta-catenin signaling and that WNT10B ligand and its downstream target HMGA2 are predictive of poorer outcomes and are strongly associated with chemoresistant TNBC metastatic disease. In search of new chemicals to target the oncogenic WNT10B/beta-CATENIN/HMGA2 signaling axis, the anti-proliferative activity of the diterpene Jatrophone (JA), derived from the plant Jatropha isabelli, was tested on TNBC cells. JA interfered with the WNT TOPFLASH reporter at the level between receptor complex and beta-catenin activation. JA efficacy was determined in various subtypes of TNBC conventional cell lines or in TNBC cell lines derived from TNBC PDX tumors. The differential IC50 (DCI50) responsiveness was compared among the TNBC models based on etiological-subtype and their cellular chemoresistance status. Elevated WNT10B expression also coincided with increased resistance to JA exposure in several metastatic cell lines. JA interfered with cell cycle progression, and induced loss of expression of the canonical Wnt-direct targets genes AXIN2, HMGA2, MYC, PCNA and CCND1. Mechanistically, JA reduced steady-state, non-phosphorylated (activated) beta-catenin protein levels, but not total beta-catenin levels. JA also caused the loss of expression of key EMT markers and significantly impaired wound healing in scratch assays, suggesting a direct role for JA inhibiting migration of TNBC cells. These results indicate that Jatrophone could be a powerful new chemotherapeutic agent against highly chemoresistant triple negative breast cancers by targeting the oncogenic Wnt10b/beta-catenin signaling pathway.	[Fatima, Iram; El-Ayachi, Ikbale; Miranda-Carboni, Gustavo A.] UTHSC, Coll Med, UTHSC Ctr Canc Res Memphis, Dept Med, Memphis, TN 38163 USA; [Taotao, Ling; Rivas, Fatima] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Lillo, M. Angeles; Krum, Susan A.] UTHSC, Ctr Canc Res, Dept Orthopaed Surg & Biomed Engn, Memphis, TN USA; [Krutilina, Raya; Seagroves, Tiffany N.] UTHSC, Coll Med, UTHSC Ctr Canc Res Memphis, Dept Pathol & Lab Med, Memphis, TN USA; [Radaszkiewicz, Tomasz W.; Hutnan, Miroslav; Bryja, Viterslav] Masaryk Univ, Fac Sci, Dept Expt Biol, Brno, Czech Republic	University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Masaryk University Brno	Miranda-Carboni, GA (corresponding author), UTHSC, Coll Med, UTHSC Ctr Canc Res Memphis, Dept Med, Memphis, TN 38163 USA.	GMirand1@UTHSC.edu	Bryja, Vítězslav/P-4217-2019; Fatima, Iram/AAO-3159-2020; Rivas, Fatima/J-4514-2013; Seagroves, Tiffany/AAE-3278-2019; Krum, Susan A./D-7282-2013; Fatima, Iram/P-1237-2016	Bryja, Vítězslav/0000-0002-9136-5085; Rivas, Fatima/0000-0003-3643-2035; Seagroves, Tiffany/0000-0002-6937-943X; Krum, Susan A./0000-0002-6414-6397; Krutilina, Raisa/0000-0002-2118-4019; Fatima, Iram/0000-0003-3492-3068	Development of the Luc2-labeled HCI PDX - NCI [CA138488]; Susan G. Komen for the Cure Grant [KG110317]; R21 grant from NCI/Center to Reduce Cancer Health Disparities [CA179735]; NIH U01 grant [CM 89283]	Development of the Luc2-labeled HCI PDX - NCI; Susan G. Komen for the Cure Grant(Susan G. Komen Breast Cancer Foundation); R21 grant from NCI/Center to Reduce Cancer Health Disparities; NIH U01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Development of the Luc2-labeled HCI PDX subline was supported by NCI CA138488 (to T.N.S.); a Susan G. Komen for the Cure Grant KG110317 to SAK. GAMC is currently supported by a R21 grant from NCI/Center to Reduce Cancer Health Disparities (CA179735) and a NIH U01 grant (CM 89283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos KD, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/385978; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Benafif S, 2015, ONCOTARGETS THER, V8, P519, DOI 10.2147/OTT.S30793; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Carey LA, 2011, ONCOLOGIST, V16, P71, DOI 10.1634/theoncologist.2011-S1-71; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cui H, 1998, DEV BRAIN RES, V111, P177, DOI 10.1016/S0165-3806(98)00136-9; Dawood S, 2009, J CLIN ONCOL, V27, P220, DOI 10.1200/JCO.2008.17.9952; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Devappa RK, 2010, J AGR FOOD CHEM, V58, P6543, DOI 10.1021/jf100003z; Dietze EC, 2015, NAT REV CANCER, V15, P248, DOI 10.1038/nrc3896; Griffiths Carrie L, 2012, J Pharm Pract, V25, P319, DOI 10.1177/0897190012442062; Hadi V, 2013, EUR J MED CHEM, V65, P376, DOI 10.1016/j.ejmech.2013.04.030; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Kriz V, 2014, J BIOL CHEM, V289, P1128, DOI 10.1074/jbc.M113.498444; Lillo MA, 2017, J APPL TOXICOL, V37, P417, DOI 10.1002/jat.3374; Ling TT, 2015, EUR J MED CHEM, V102, P9, DOI 10.1016/j.ejmech.2015.07.034; Ling THV, 2015, JATROPHA NATURAL PRO; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Maher MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010184; MCGREW LL, 1992, DEVELOPMENT, V115, P463; Miranda-Carboni GA, 2008, GENE DEV, V22, P3121, DOI 10.1101/gad.1692808; Modder UI, 2011, J CELL BIOCHEM, V112, P1392, DOI 10.1002/jcb.23048; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Noutsou M, 2011, J MOL BIOL, V405, P773, DOI 10.1016/j.jmb.2010.11.013; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Tu Y, 2010, J NAT PROD, V73, P751, DOI 10.1021/np9007359; Vidal G, 2017, CANCER MED-US, V6, P1776, DOI 10.1002/cam4.1117; Wend P, 2013, EMBO MOL MED, V5, P264, DOI 10.1002/emmm.201201320; Zhang Y, 2014, ASIAN PAC J CANCER P, V15, P6829, DOI 10.7314/APJCP.2014.15.16.6829	36	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189864	10.1371/journal.pone.0189864	http://dx.doi.org/10.1371/journal.pone.0189864			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281678	Green Submitted, Green Published, gold			2022-12-26	WOS:000419006200051
J	Jimenez-Mejias, P; Benitez-Benitez, C; Fernandez-Mazuecos, M; Martin-Bravo, S				Jimenez-Mejias, Pedro; Benitez-Benitez, Carmen; Fernandez-Mazuecos, Mario; Martin-Bravo, Santiago			Cut from the same cloth: The convergent evolution of dwarf morphotypes of the Carex flava group (Cyperaceae) in Circum-Mediterranean mountains	PLOS ONE			English	Article							COMPLEX CYPERACEAE; PHYLOGENETIC ANALYSIS; SPECIES DISTRIBUTION; GENETIC DIVERSITY; NORTHERN EURASIA; DIFFERENTIATION; MORPHOLOGY; TAXONOMY; PLANT; HYBRIDIZATION	Plants growing in high-mountain environments may share common morphological features through convergent evolution resulting from an adaptative response to similar ecological conditions. The Carex flava species complex (sect. Ceratocystis, Cyperaceae) includes four dwarf morphotypes from Circum-Mediterranean mountains whose taxonomic status has remained obscure due to their apparent morphological resemblance. In this study we investigate whether these dwarf mountain morphotypes result from convergent evolution or common ancestry, and whether there are ecological differences promoting differentiation between the dwarf morphotypes and their taxonomically related large, well-developed counterparts. We used phylogenetic analyses of nrDNA (ITS) and ptDNA (rps16 and 5'trnK) sequences, ancestral state reconstruction, multivariate analyses of macro-and micromorphological data, and species distribution modeling. Dwarf morphotype populations were found to belong to three different genetic lineages, and several morphotype shifts from well-developed to dwarf were suggested by ancestral state reconstructions. Distribution modeling supported differences in climatic niche at regional scale between the large forms, mainly from lowland, and the dwarf mountain morphotypes. Our results suggest that dwarf mountain morphotypes within this sedge group are small forms of different lineages that have recurrently adapted to mountain habitats through convergent evolution.	[Jimenez-Mejias, Pedro; Benitez-Benitez, Carmen; Martin-Bravo, Santiago] Univ Pablo Olavide, Dept Mol Biol & Biochem Engn, Seville, Spain; [Fernandez-Mazuecos, Mario] CSIC, Dept Biodivers & Conservat, RJB, Madrid, Spain	Universidad Pablo de Olavide; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Jimenez-Mejias, P (corresponding author), Univ Pablo Olavide, Dept Mol Biol & Biochem Engn, Seville, Spain.	pjimmej@gmail.com	Martín-Bravo, Santiago/I-3554-2017; Jiménez-Mejías, Pedro/H-7274-2015; Fernández-Mazuecos, Mario/F-9699-2011	Martín-Bravo, Santiago/0000-0003-0626-0770; Jiménez-Mejías, Pedro/0000-0003-2815-4477; Fernández-Mazuecos, Mario/0000-0003-4027-6477				Aguirre-Gutierrez J, 2015, DIVERS DISTRIB, V21, P245, DOI 10.1111/ddi.12268; Albach DC, 2004, PLANT SYST EVOL, V246, P177, DOI 10.1007/s00606-004-0148-9; [Anonymous], PLANT TAXONOMY; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blackstock N., 2001, Watsonia, V23, P505; Blackstock N, 2010, PLANT SYST EVOL, V287, P37, DOI 10.1007/s00606-010-0287-0; Bolos O, 2001, FLORA PAISOS CATALAN, V4; Boucher FC, 2016, PERSPECT PLANT ECOL, V20, P22, DOI 10.1016/j.ppees.2016.03.002; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Chan LM, 2011, MOL PHYLOGENET EVOL, V59, P523, DOI 10.1016/j.ympev.2011.01.020; Chater A.O., 1980, FLORA EUROPAEA, V5, P290; Cola V, 2016, ECOGRAPHY, V40, P774; Cordell S, 1998, OECOLOGIA, V113, P188, DOI 10.1007/s004420050367; CRINS WJ, 1989, CAN J BOT, V67, P1048, DOI 10.1139/b89-138; CRINS WJ, 1989, CAN J BOT, V67, P1032, DOI 10.1139/b89-137; Derieg NJ, 2008, AM J BOT, V95, P1287, DOI 10.3732/ajb.2007069; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Gehrke B, ANN BOT IN PRESS; Givnish TJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-3; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gurushidze M, 2008, MOL PHYLOGENET EVOL, V49, P997, DOI 10.1016/j.ympev.2008.09.003; Hassel K, 2005, ECOGRAPHY, V28, P71, DOI 10.1111/j.0906-7590.2005.03910.x; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hedren M, 2002, NORD J BOT, V22, P257, DOI 10.1111/j.1756-1051.2002.tb01373.x; Hedren M, 1996, BIOL J LINN SOC, V59, P179; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2009, AUSTRAL ECOL, V34, P780, DOI 10.1111/j.1442-9993.2009.01984.x; Jimenez-Mejias P, 2016, SYST BOT, V41, P519, DOI 10.1600/036364416X692488; Jimenez-Mejias P, 2014, SYST BOT, V39, P117, DOI 10.1600/036364414X677973; Jimenez-Mejias P, 2012, J BIOGEOGR, V39, P2279, DOI 10.1111/j.1365-2699.2012.02740.x; Jimenez-Mejias P, 2012, SYST BOT, V37, P382, DOI 10.1600/036364412X635449; Jimenez-Mejias Pedro, 2009, Acta Botanica Malacitana, V34, P231; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; KORNER C, 1989, FLORA, V182, P353; Kropf M, 2006, NEW PHYTOL, V172, P169, DOI 10.1111/j.1469-8137.2006.01795.x; KUKENTHAL G., 1909, PFLANZENREICH, V20, P1; Liu BB, 2013, J SYST EVOL, V51, P134, DOI 10.1111/j.1759-6831.2012.00225.x; Lu L, 2010, MOL PHYLOGENET EVOL, V57, P364, DOI 10.1016/j.ympev.2010.06.002; Luceno M, 1994, MONOGRAFIA GENERO CA, P14; Luceno M, 2008, FLORA IBERICA, V18, P191; Ma XG, 2015, J SYST EVOL, V53, P104, DOI 10.1111/jse.12122; Maddison W. P, 2014, MESQUITE MODULAR SYS; Maire R. C. J. E., 1957, FLORA AFRIQUE NORD, V4; Mamayev, 1972, PINACEAE URALE TYPES; MENAPACE FJ, 1987, BRITTONIA, V39, P278, DOI 10.2307/2807393; Molina A., 2006, LAGASCALIA, V26, P25; Muellner AN, 2009, MOL PHYLOGENET EVOL, V52, P461, DOI 10.1016/j.ympev.2009.03.025; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pillon Y, 2009, BOT J LINN SOC, V161, P137, DOI 10.1111/j.1095-8339.2009.00997.x; Polatschek A, 2001, FLORA NORDTIROL OSTT; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PYKALA J, 1994, NORD J BOT, V14, P173, DOI 10.1111/j.1756-1051.1994.tb00583.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roquet C, 2013, J BIOGEOGR, V40, P1874, DOI 10.1111/jbi.12135; SALO V, 1994, ANN BOT FENN, V31, P45; Sanchez-Baracaldo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110618; SCHMID B, 1982, Feddes Repertorium, V93, P23; Schmid B., 1986, SYMBOLAE BOT UPPSALI, V27, P113; Schmid B, 1983, WATSONIA, V14, P309; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; SMITH AP, 1987, ANNU REV ECOL SYST, V18, P137, DOI 10.1146/annurev.es.18.110187.001033; Sobel JM, 2010, EVOLUTION, V64, P295, DOI 10.1111/j.1558-5646.2009.00877.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STANDLEY LA, 1987, BOT GAZ, V148, P507, DOI 10.1086/337682; Starr JR, 2001, CAN J BOT, V79, P362, DOI 10.1139/cjb-79-3-362; STOEVA M P, 1990, Preslia (Prague), V62, P1; Tsukaya H, 2001, PLANT BIOLOGY, V3, P536, DOI 10.1055/s-2001-17727; Valcarcel V, 2006, TAXON, V55, P297, DOI 10.2307/25065579; Valcarcel V, 2010, AM J BOT, V97, P1555, DOI 10.3732/ajb.1000115; Valdes B., 2002, CHECKLIST VASCULAR P, V2; Vicioso C., 1959, B I FORESTAL INVESTI; Wang YJ, 2004, ACTA PHYTOTAXON SIN, V42, P481; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; WATERWAY MJ, 1990, AM J BOT, V77, P826, DOI 10.2307/2444373; Wieclaw H., 2014, Biodiversity: Research and Conservation, V33, P3; Wieclaw H, 2013, NORD J BOT, V31, P464, DOI 10.1111/j.1756-1051.2013.00095.x; Zhang ShuRen, 2006, Nordic Journal of Botany, V24, P301, DOI 10.1111/j.1756-1051.2004.tb00846.x	78	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189769	10.1371/journal.pone.0189769	http://dx.doi.org/10.1371/journal.pone.0189769			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281689	Green Published, Green Submitted, gold			2022-12-26	WOS:000419006200040
J	Watts, EL; Appleby, PN; Albanese, D; Black, A; Chan, JM; Chen, C; Cirillo, PM; Cohn, BA; Cook, MB; Donovan, JL; Ferrucci, L; Garland, CF; Giles, GG; Goodman, PJ; Habel, LA; Haiman, CA; Holly, JMP; Hoover, RN; Kaaks, R; Knekt, P; Kolonel, LN; Kubo, T; Le Marchand, L; Luostarinen, T; Maclnnis, RJ; Maenpaa, HO; Mannisto, S; Metter, EJ; Milne, RL; Nomura, AMY; Oliver, SE; Parsons, JK; Peeters, PH; Platz, EA; Riboli, E; Ricceri, F; Rinaldi, S; Rissanen, H; Sawada, N; Schaefer, CA; Schenk, JM; Stanczyk, FZ; Stampfer, M; Stattin, P; Stenman, UH; Tjonneland, A; Trichopoulou, A; Thompson, IM; Tsugane, S; Vatten, L; Whittemore, AS; Ziegler, RG; Allen, NE; Key, TJ; Travis, RC				Watts, Eleanor L.; Appleby, Paul N.; Albanese, Demetrius; Black, Amanda; Chan, June M.; Chen, Chu; Cirillo, Piera M.; Cohn, Barbara A.; Cook, Michael B.; Donovan, Jenny L.; Ferrucci, Luigi; Garland, Cedric F.; Giles, Graham G.; Goodman, Phyllis J.; Habel, Laurel A.; Haiman, Christopher A.; Holly, Jeff M. P.; Hoover, Robert N.; Kaaks, Rudolf; Knekt, Paul; Kolonel, Laurence N.; Kubo, Tatsuhiko; Le Marchand, Loic; Luostarinen, Tapio; Maclnnis, Robert J.; Maenpaa, Hanna O.; Mannisto, Satu; Metter, E. Jeffrey; Milne, Roger L.; Nomura, Abraham M. Y.; Oliver, Steven E.; Parsons, J. Kellogg; Peeters, Petra H.; Platz, Elizabeth A.; Riboli, Elio; Ricceri, Fulvio; Rinaldi, Sabina; Rissanen, Harri; Sawada, Norie; Schaefer, Catherine A.; Schenk, Jeannette M.; Stanczyk, Frank Z.; Stampfer, Meir; Stattin, Par; Stenman, Ulf-Hakan; Tjonneland, Anne; Trichopoulou, Antonia; Thompson, Ian M.; Tsugane, Shoichiro; Vatten, Lars; Whittemore, Alice S.; Ziegler, Regina G.; Allen, Naomi E.; Key, Timothy J.; Travis, Ruth C.			Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men	PLOS ONE			English	Article							PROSTATE-CANCER RISK; LIFE-STYLE FACTORS; BINDING GLOBULIN CONCENTRATIONS; OLDER AFRICAN-AMERICAN; PITUITARY-ADRENAL AXIS; MIDDLE-AGED MEN; SERUM ANDROGENS; STEROID-HORMONES; DEHYDROEPIANDROSTERONE-SULFATE; LONGITUDINAL CHANGES	Introduction Sex hormones have been implicated in the etiology of a number of diseases. To better understand disease etiology and the mechanisms of disease-risk factor associations, this analysis aimed to investigate the associations of anthropometric, sociodemographic and behavioural factors with a range of circulating sex hormones and sex hormone-binding globulin. Methods Statistical analyses of individual participant data from 12,330 male controls aged 25-85 years from 25 studies involved in the Endogenous Hormones Nutritional Biomarkers and Prostate Cancer Collaborative Group. Analysis of variance was used to estimate geometric means adjusted for study and relevant covariates. Results Older age was associated with higher concentrations of sex hormone-binding globulin and dihydrotestosterone and lower concentrations of dehydroepiandrosterone sulfate, free testosterone, androstenedione, androstanediol glucuronide and free estradiol. Higher body mass index was associated with higher concentrations of free estradiol, androstanediol glucuronide, estradiol and estrone and lower concentrations of dihydrotestosterone, testosterone, sex hormone-binding globulin, free testosterone, androstenedione and dehydroepiandrosterone sulfate. Taller height was associated with lower concentrations of androstenedione, testosterone, free testosterone and sex hormone-binding globulin and higher concentrations of androstanediol glucuronide. Current smoking was associated with higher concentrations of androstenedione, sex hormone-binding globulin and testosterone. Alcohol consumption was associated with higher concentrations of dehydroepiandrosterone sulfate, androstenedione and androstanediol glucuronide. East Asians had lower concentrations of androstanediol glucuronide and African Americans had higher concentrations of estrogens. Education and marital status were modestly associated with a small number of hormones. Conclusion Circulating sex hormones in men are strongly associated with age and body mass index, and to a lesser extent with smoking status and alcohol consumption.	[Watts, Eleanor L.; Appleby, Paul N.; Key, Timothy J.; Travis, Ruth C.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England; [Albanese, Demetrius; Black, Amanda; Cook, Michael B.; Hoover, Robert N.; Ziegler, Regina G.] US Natl Canc Inst, Div Canc Epidemiol & Genet, Bethesda, MD USA; [Chan, June M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Chan, June M.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Chen, Chu] Fred Hutchinson Canc Res Ctr, Program Epidemiol, 1124 Columbia St, Seattle, WA 98104 USA; [Cirillo, Piera M.; Cohn, Barbara A.] Publ Hlth Inst, Child Hlth & Dev Studies, Berkeley, CA USA; [Donovan, Jenny L.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Ferrucci, Luigi] NIA, Intramural Res Program, Bethesda, MD 20892 USA; [Garland, Cedric F.] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Giles, Graham G.; Maclnnis, Robert J.; Milne, Roger L.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Giles, Graham G.; Maclnnis, Robert J.; Milne, Roger L.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Goodman, Phyllis J.] Fred Hutchinson Canc Res Ctr, SWOG Stat Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Habel, Laurel A.] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA; [Haiman, Christopher A.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA USA; [Holly, Jeff M. P.] Univ Bristol, Fac Hlth Sci, Sch Clin Sci, Bristol, Avon, England; [Kaaks, Rudolf] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Knekt, Paul; Mannisto, Satu; Rissanen, Harri] Natl Inst Hlth & Welf, Dept Hlth, Helsinki, Finland; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Canc Ctr, Honolulu, HI 96822 USA; [Kubo, Tatsuhiko] Univ Occupat & Environm Hlth, Dept Publ Hlth, Kitakyushu, Fukuoka, Japan; [Luostarinen, Tapio] Inst Stat & Epidemiol Canc Res, Finnish Canc Registry, Helsinki, Finland; [Maenpaa, Hanna O.] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; [Metter, E. Jeffrey] Univ Tennessee, Hlth Sci Ctr, Dept Neurol, Memphis, TN USA; [Nomura, Abraham M. Y.] Kuakini Med Ctr, Japan Hawaii Canc Study, Honolulu, HI USA; [Oliver, Steven E.] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Parsons, J. Kellogg] Univ Calif San Diego, Moores Canc Ctr, Div Urol Oncol, San Diego, CA 92103 USA; [Peeters, Petra H.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [Peeters, Petra H.] Imperial Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC PHE Ctr Environm & Hlth, London, England; [Platz, Elizabeth A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Riboli, Elio] Imperial Coll London, Sch Publ Hlth, London, England; [Ricceri, Fulvio] Univ Turin, Dept Clin & Biol Sci, Orbassano, Italy; [Ricceri, Fulvio] Reg Hlth Serv ASL T03, Epidemiol Unit, Grugliasco, Italy; [Rinaldi, Sabina] Int Agcy Res Canc, Biomarkers Grp, Lyon, France; [Sawada, Norie] Natl Canc Ctr, Ctr Publ Hlth Sci, Epidemiol & Prevent Grp, Tokyo, Japan; [Schenk, Jeannette M.] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA USA; [Stanczyk, Frank Z.] Univ Southern Calif, Keck Sch Med, Div Reprod Endocrinol & Infertil, Los Angeles, CA 90033 USA; [Stampfer, Meir] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Stampfer, Meir] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Stampfer, Meir] Harvard Med Sch, Channing Div Network Med, Boston, MA USA; [Stattin, Par] Umea Univ, Dept Surg & Perioperat Sci, Urol & Androl, Umea, Sweden; [Stenman, Ulf-Hakan] Univ Helsinki, Dept Clin Chem, Med, Helsinki, Finland; [Tjonneland, Anne] Danish Canc Soc Res Ctr, Dept Diet Genes & Environm, Copenhagen, Denmark; [Trichopoulou, Antonia] Hellen Hlth Fdn, Athens, Greece; [Trichopoulou, Antonia] Natl & Kapodistrian Univ Athens, Sch Med, WHO Collaborating Ctr Nutr & Hlth, Unit Nutrit Epidemiol & Nutr Publ Hlth,Dept Hyg, Athens, Greece; [Thompson, Ian M.] CHRISTUS Med Ctr Hosp, San Antonio, TX USA; [Vatten, Lars] Norwegian Univ Sci & Technol, Dept Publ Hlth, Trondheim, Norway; [Whittemore, Alice S.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA USA; [Whittemore, Alice S.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Allen, Naomi E.] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit & Epidemiol Studies Unit, Oxford, England	University of Oxford; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; Public Health Institute; University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Diego; Cancer Council Victoria; University of Melbourne; Fred Hutchinson Cancer Center; Southwest Oncology Group; Kaiser Permanente; University of Southern California; University of Bristol; Helmholtz Association; German Cancer Research Center (DKFZ); Finland National Institute for Health & Welfare; Cancer Research Center of Hawaii; University of Hawaii System; University of Occupational & Environmental Health - Japan; Finnish Cancer Registry; University of Helsinki; Helsinki University Central Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of York - UK; University of California System; University of California San Diego; Utrecht University; Utrecht University Medical Center; Imperial College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Imperial College London; University of Turin; World Health Organization; International Agency for Research on Cancer (IARC); National Cancer Center - Japan; Fred Hutchinson Cancer Center; University of Southern California; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Umea University; University of Helsinki; Danish Cancer Society; Athens Medical School; National & Kapodistrian University of Athens; Norwegian University of Science & Technology (NTNU); Stanford University; Stanford University; University of Oxford	Watts, EL (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England.	ellie.watts@ceu.ox.ac.uk	TRICHOPOULOU, ANTONIA/ABF-8727-2021; Vatten, Lars/AAF-9380-2022; Vatten, Lars/AFK-2073-2022; Cook, Michael B/A-5641-2009; Tsugane, Shoichiro/A-2424-2015; Ricceri, Fulvio/I-9910-2018	TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Cook, Michael B/0000-0002-0533-7302; Tsugane, Shoichiro/0000-0003-4105-2774; Ricceri, Fulvio/0000-0001-8749-9737; Tjonneland, Anne/0000-0003-4385-2097; Watts, Eleanor/0000-0001-9229-2589; Habel, Laurel/0000-0002-7230-587X; Riboli, Elio/0000-0001-6795-6080; Chan, June/0000-0002-7620-569X; Luostarinen, Tapio/0000-0003-3231-8550; Stanczyk, Frank/0000-0002-3607-121X	Cancer Research UK [C8221/A19170, C8221/A20986]; Eunice Kennedy Shriver National Institute of Child Health and Development, National Institutes of Health and Department of Health and Human Services [HHSN275201100020C]; California Department of Public Health as part of California Health and Safety Code Section [103885]; National Cancer Institute's Surveillance, Epidemiology and End Results Program [HHSN261201000140C, HHSN261201000035C]; Centers for Disease Control and Prevention's National Program of Cancer Registries [HHSN261201000034C]; California Department of Public Health [U58DP003862-01]; Cancer Research Fund [97-12013]; University of California [98-00924V]; Department of Health Services, Cancer Research Program [UM1 CM 82883]; National Cancer Institute, National Institutes of Health/National Cancer Institute [CA167552, CA055075, CA133891, CA141298, CA09001, CA131945, CA34944, CA40360, CA097193]; National Institutes of Health/National Heart, Lung and Blood Institute [HL26490, HL34595]; Hellenic Health Foundation; NATIONAL CANCER INSTITUTE [ZIACP010152, UM1CA182883] Funding Source: NIH RePORTER; Cancer Research UK [19170, 16491] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Eunice Kennedy Shriver National Institute of Child Health and Development, National Institutes of Health and Department of Health and Human Services; California Department of Public Health as part of California Health and Safety Code Section; National Cancer Institute's Surveillance, Epidemiology and End Results Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention's National Program of Cancer Registries(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); California Department of Public Health; Cancer Research Fund; University of California(University of California System); Department of Health Services, Cancer Research Program; National Cancer Institute, National Institutes of Health/National Cancer Institute; National Institutes of Health/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Hellenic Health Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	Centralized pooling, checking and data analysis was supported by Cancer Research UK grants C8221/A19170 and C8221/A20986 (https://www.cancerresearchuk.org/). Details of funding for the original studies are in the relevant publications (see Subjects and methods section for individual study details). These include: Eunice Kennedy Shriver National Institute of Child Health and Development, National Institutes of Health and Department of Health and Human Services, grant number: HHSN275201100020C; California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program awarded to the Cancer Prevention Institute of California, grant number: HHSN261201000140C; the National Cancer Institute's Surveillance, Epidemiology and End Results Program awarded to the University of Southern California, HHSN261201000035C; National Cancer Institute's Surveillance, Epidemiology and End Results Program awarded to the Public Health Institute; the Centers for Disease Control and Prevention's National Program of Cancer Registries, grant number: HHSN261201000034C; the California Department of Public Health, grant number: U58DP003862-01; the Cancer Research Fund, under Interagency Agreement #97-12013 (University of California contract #98-00924V) with the Department of Health Services, Cancer Research Program, UM1 CM 82883; the National Cancer Institute, National Institutes of Health/National Cancer Institute (grant numbers CA167552, CA055075, CA133891, CA141298, CA09001, CA131945, CA34944, CA40360, CA097193), National Institutes of Health/National Heart, Lung and Blood Institute (grant numbers HL26490, HL34595) and the Hellenic Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2002, CANCER CAUSE CONTROL, V13, P353, DOI 10.1023/A:1015238102830; BARRETTCONNOR E, 1990, CANCER RES, V50, P169; BARTSCH W, 1980, MATURITAS, V2, P109, DOI 10.1016/0378-5122(80)90044-4; BELANGER A, 1994, J CLIN ENDOCR METAB, V79, P1086; Bjornerem A, 2004, J CLIN ENDOCR METAB, V89, P6039, DOI 10.1210/jc.2004-0735; BREMNER WJ, 1983, J CLIN ENDOCR METAB, V56, P1278, DOI 10.1210/jcem-56-6-1278; Bu HJ, 2016, HUM MUTAT, V37, P52, DOI 10.1002/humu.22909; Camacho EM, 2013, EUR J ENDOCRINOL, V168, P445, DOI 10.1530/EJE-12-0890; Chen C, 2003, CANCER EPIDEM BIOMAR, V12, P1410; Cohen PG, 2001, MED HYPOTHESES, V56, P702, DOI 10.1054/mehy.2000.1169; de Ronde W, 2005, CLIN ENDOCRINOL, V62, P498, DOI 10.1111/j.1365-2265.2005.02252.x; Dechanet C, 2011, HUM REPROD UPDATE, V17, P76, DOI 10.1093/humupd/dmq033; Dorgan JP, 1998, CANCER EPIDEM BIOMAR, V7, P1069; DUNN JF, 1981, J CLIN ENDOCR METAB, V53, P58, DOI 10.1210/jcem-53-1-58; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Frias J, 2002, ALCOHOL ALCOHOLISM, V37, P169, DOI 10.1093/alcalc/37.2.169; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Frost M, 2013, CLIN ENDOCRINOL, V78, P743, DOI 10.1111/cen.12042; Gann PH, 1996, J NATL CANCER I, V88, P1118, DOI 10.1093/jnci/88.16.1118; Gapstur SM, 2002, CANCER EPIDEM BIOMAR, V11, P1041; Gill JK, 2010, PROSTATE, V70, P906, DOI 10.1002/pros.21125; Guess HA, 1997, CANCER EPIDEM BIOMAR, V6, P21; Handelsman DJ, 2013, J CLIN ENDOCR METAB, V98, P3971, DOI 10.1210/jc.2013-3375; Hautanen A, 2000, INT J OBESITY, V24, pS64, DOI 10.1038/sj.ijo.0801281; Hawkins VN, 2008, MED SCI SPORT EXER, V40, P223, DOI 10.1249/mss.0b013e31815bbba9; Heikkila R, 1999, CANCER, V86, P312, DOI 10.1002/(SICI)1097-0142(19990715)86:2<312::AID-CNCR15>3.3.CO;2-Z; Kaltenboeck A, 2012, J SEX MED, V9, P2438, DOI 10.1111/j.1743-6109.2012.02810.x; Kelsey TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109346; Kiechl S, 2000, ARTERIOSCL THROM VAS, V20, P1094, DOI 10.1161/01.ATV.20.4.1094; Lecomte P, 1998, EUR J ENDOCRINOL, V139, P178, DOI 10.1530/eje.0.1390178; LEWIS JG, 1976, ACTA ENDOCRINOL-COP, V82, P444; LOOKINGBILL DP, 1991, J CLIN ENDOCR METAB, V72, P1242, DOI 10.1210/jcem-72-6-1242; Maggi M, 2007, J SEX MED, V4, P1056, DOI 10.1111/j.1743-6109.2007.00531.x; Manolagas SC, 2013, NAT REV ENDOCRINOL, V9, P699, DOI 10.1038/nrendo.2013.179; MARRAMA P, 1982, MATURITAS, V4, P131, DOI 10.1016/0378-5122(82)90039-1; Mlynarcikova Alzbeta, 2005, Endocr Regul, V39, P21; Mohr BA, 2001, UROLOGY, V57, P930, DOI 10.1016/S0090-4295(00)01116-X; MORIMOTO I, 1981, J CLIN ENDOCR METAB, V52, P772, DOI 10.1210/jcem-52-4-772; Morley JE, 1997, METABOLISM, V46, P410, DOI 10.1016/S0026-0495(97)90057-3; Muller M, 2003, EUR J ENDOCRINOL, V149, P583, DOI 10.1530/eje.0.1490583; NOMURA A, 1988, CANCER RES, V48, P3515; Nomura AMY, 1996, CANCER EPIDEM BIOMAR, V5, P621; Oliver SE, 2004, INT J CANCER, V108, P887, DOI 10.1002/ijc.11631; ORENTREICH N, 1992, J CLIN ENDOCR METAB, V75, P1002, DOI 10.1210/jc.75.4.1002; Ozasa K, 2004, CANCER SCI, V95, P65, DOI 10.1111/j.1349-7006.2004.tb03172.x; PARKER L, 1981, METABOLISM, V30, P601, DOI 10.1016/0026-0495(81)90139-6; Pasquali R, 2000, INT J OBESITY, V24, pS47, DOI 10.1038/sj.ijo.0801277; Perry RJ, 2008, CLIN ENDOCRINOL, V68, P4; Peter A, 2010, DIABETES, V59, P3167, DOI 10.2337/db10-0179; Pierorazio PM, 2010, BJU INT, V105, P824, DOI 10.1111/j.1464-410X.2009.08853.x; PIRKE KM, 1973, ACTA ENDOCRINOL-COP, V74, P792, DOI 10.1530/acta.0.0740792; Platz EA, 2005, CANCER EPIDEM BIOMAR, V14, P1262, DOI 10.1158/1055-9965.EPI-04-0371; Ravaglia G, 2002, EXP GERONTOL, V37, P701, DOI 10.1016/S0531-5565(01)00232-7; Rochira V, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/165215; Roddam AW, 2008, J NATL CANCER I, V100, P170, DOI 10.1093/jnci/djm323; Rohrmann S, 2007, J CLIN ENDOCR METAB, V92, P2519, DOI 10.1210/jc.2007-0028; Rohrmann S, 2011, CANCER CAUSE CONTROL, V22, P1141, DOI 10.1007/s10552-011-9790-z; ROSS RK, 1992, LANCET, V339, P887, DOI 10.1016/0140-6736(92)90927-U; Sawada N, 2010, CANCER SCI, V101, P2652, DOI 10.1111/j.1349-7006.2010.01721.x; Schenk JM, 2016, CANCER CAUSE CONTROL, V27, P175, DOI 10.1007/s10552-015-0695-0; Selvin E, 2007, DIABETES CARE, V30, P234, DOI 10.2337/dc06-1579; Severi G, 2006, CANCER EPIDEM BIOMAR, V15, P86, DOI 10.1158/1055-9965.EPI-05-0633; Shi ZM, 2013, J CLIN ENDOCR METAB, V98, P3289, DOI 10.1210/jc.2012-3842; Simo R, 2015, TRENDS ENDOCRIN MET, V26, P376, DOI 10.1016/j.tem.2015.05.001; SODERGARD R, 1982, J STEROID BIOCHEM, V16, P801, DOI 10.1016/0022-4731(82)90038-3; SPARROW D, 1980, J CLIN ENDOCR METAB, V51, P508, DOI 10.1210/jcem-51-3-508; Stattin P, 2004, INT J CANCER, V108, P418, DOI 10.1002/ijc.11572; Svartberg J, 2007, INT J ANDROL, V30, P137, DOI 10.1111/j.1365-2605.2006.00720.x; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Travis RC, 2007, INT J CANCER, V121, P1331, DOI 10.1002/ijc.22814; Travison TG, 2007, J CLIN ENDOCR METAB, V92, P196, DOI 10.1210/jc.2006-1375; Tsai CJ, 2006, CANCER CAUSE CONTROL, V17, P1237, DOI 10.1007/s10552-006-0052-4; Ukkola O, 2001, EUR J ENDOCRINOL, V145, P1, DOI 10.1530/eje.0.1450001; Vatten LJ, 1997, CANCER EPIDEM BIOMAR, V6, P967; Wang Q, 2015, INT J EPIDEMIOL, V44, P623, DOI 10.1093/ije/dyv093; Weiss JM, 2008, INT J CANCER, V122, P2345, DOI 10.1002/ijc.23326; Wiren S, 2007, PROSTATE, V67, P1230, DOI 10.1002/pros.20588; WU AH, 1995, CANCER EPIDEM BIOMAR, V4, P735; Wu AH, 2001, CANCER EPIDEM BIOMAR, V10, P533; Wu FCW, 2008, J CLIN ENDOCR METAB, V93, P2737, DOI 10.1210/jc.2007-1972	82	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0187741	10.1371/journal.pone.0187741	http://dx.doi.org/10.1371/journal.pone.0187741			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281666	Green Published, Green Accepted, gold			2022-12-26	WOS:000419006200002
J	Shtyka, O; Przybysz, L; Blaszczyk, M; Sek, J				Shtyka, Olga; Przybysz, Lukasz; Blaszczyk, Mariola; Sek, Jerzy			Kozeny-Carman theory for modeling of porous granular structures saturation with emulsion during imbibition process	PLOS ONE			English	Article							DYNAMIC CONTACT-ANGLE; CAPILLARY IMBIBITION; LIQUID ABSORPTION; MEDIA; ROUGHNESS; SORBENTS; WICKING; IMPACT; ROCKS; RISE	The issue discussed in the current publication is a process of emulsions penetration in the granular media driven by the capillary force. The research work focuses on the study of rate and height of multiphase liquids penetration in a porous bed. Changes of the medium porosity and saturation level occurring as a result of pores obstruction by the droplets of an inner phase, were considered. The surfactant-stabilized emulsions with the different dispersed phase concentrations were investigated applying a classical wicking test. The modified version of Kozeny-Carman theory was proposed in order to describe the observed imbibition process in porous structures composed of spherical grains. This approach allowed to predict transport of emulsions considering an effect of bed saturation and porosity changes. In practice, the introduced concept can be appropriable in the numerous industries and scientific fields to predict the imbibition process of the multiphase liquids in granular structures regarding variation of the investigated bed permeability.	[Shtyka, Olga; Przybysz, Lukasz; Blaszczyk, Mariola; Sek, Jerzy] Lodz Univ Technol, Dept Chem Engn, Lodz, Poland	Lodz University of Technology	Shtyka, O (corresponding author), Lodz Univ Technol, Dept Chem Engn, Lodz, Poland.	olga.shtyka@edu.p.lodz.pl	Błaszczyk, Mariola/G-9234-2019; Sęk, Jerzy P/H-1794-2019	Błaszczyk, Mariola/0000-0001-6397-568X; Sęk, Jerzy P/0000-0001-8767-5788; Przybysz, Lukasz/0000-0003-3581-9414	Lodz University of Technology [501/10-34-2-1016, 501/10-34-2-1026]; Science Foundation Program in Lodz University of Technology, Poland [501/10-34-2-1016, 501/10-34-2-1026]	Lodz University of Technology; Science Foundation Program in Lodz University of Technology, Poland	This work was supported by Lodz University of Technology, Grant wewnetrzny z Funduszu Mlodych Naukowcow, Grant No. 501/10-34-2-1016 - Lukasz Przybysz, Grant No. 501/10-34-2-1026 - Olga Shtyka.; This study was funded in framework of the Science Foundation Program in Lodz University of Technology, Poland (Grant No. 501/10-34-2-1016 and Grant No. 501/10-34-2-1026)	Andersen PO, 2014, TRANSPORT POROUS MED, V101, P299, DOI 10.1007/s11242-013-0246-7; [Anonymous], 2006, PHYSICOCHEM PROBL MI; Benavente D, 2002, TRANSPORT POROUS MED, V49, P59, DOI 10.1023/A:1016047122877; Blaszczyk MM, 2016, J DISPERSION SCI TEC; Cai JC, 2014, LANGMUIR, V30, P5142, DOI 10.1021/la5007204; Cai JC, 2012, COLLOID SURFACE A, V414, P228, DOI 10.1016/j.colsurfa.2012.08.047; Cai JC, 2011, TRANSPORT POROUS MED, V89, P251, DOI 10.1007/s11242-011-9767-0; Cai JC, 2010, ENERG FUEL, V24, P1860, DOI 10.1021/ef901413p; Carman PC, 1937, T I CHEM ENG-LOND, V15, P150; Digilov RM, 2008, LANGMUIR, V24, P13663, DOI 10.1021/la801807j; Dubrovski PD, 2016, FIBER POLYM, V17, P801, DOI 10.1007/s12221-016-6347-5; Geistlinger H, 2015, WATER RESOUR RES, V51, P9094, DOI 10.1002/2015WR017852; Gladkikh M, 2005, J COLLOID INTERF SCI, V288, P526, DOI 10.1016/j.jcis.2005.03.029; HAMMECKER C, 1993, TRANSPORT POROUS MED, V12, P125, DOI 10.1007/BF00616976; Hamraoui A, 2002, J COLLOID INTERF SCI, V250, P415, DOI 10.1006/jcis.2002.8288; Hilpert M, 2010, J COLLOID INTERF SCI, V351, P267, DOI 10.1016/j.jcis.2010.07.016; Hwang W, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021508; Kemblowski Z., 1985, PODSTAWY TEORETYCZNE; Kowalski SJ, 2004, INZYNIERIA MAT POROW; Lemarchand C, 2003, INT J PHARMACEUT, V254, P77, DOI 10.1016/S0378-5173(02)00687-7; Liu GD, 2014, COLLOID SURFACE A, V443, P286, DOI 10.1016/j.colsurfa.2013.11.033; Marmur A, 2009, ANNU REV MATER RES, V39, P473, DOI 10.1146/annurev.matsci.38.060407.132425; Martic G, 2003, J COLLOID INTERF SCI, V263, P213, DOI 10.1016/S0021-9797(03)00283-2; Masoodi R, 2007, AICHE J, V53, P2769, DOI 10.1002/aic.11322; Masoodi R, 2010, AICHE J, V56, P2257, DOI 10.1002/aic.12163; Morales VL, 2007, VADOSE ZONE J, V8, P1; Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434; Sek J, 2015, J ENVIRON ENG LANDSC, V23, P83, DOI 10.3846/16486897.2014.961926; Shou DH, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.053007; Shou DH, 2014, LANGMUIR, V30, P149, DOI 10.1021/la4034063; Shtyka OS, 2016, INT J ENVIRON SCI TE, V13, P2401, DOI 10.1007/s13762-016-1076-2; Strzelecki T., 2008, MODELOWANIE PRZEPLYW; Washburn EW, 1921, PHYS REV, V17, P273, DOI 10.1103/PhysRev.17.273; Xue HT, 2006, CHEM PHYS LETT, V432, P326, DOI 10.1016/j.cplett.2006.10.017; Yu BM, 2008, APPL MECH REV, V61, DOI 10.1115/1.2955849; Zhao HY, 2009, SPE; Zhmud BV, 2000, J COLLOID INTERF SCI, V228, P263, DOI 10.1006/jcis.2000.6951	37	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0188376	10.1371/journal.pone.0188376	http://dx.doi.org/10.1371/journal.pone.0188376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267274	Green Published, gold, Green Submitted			2022-12-26	WOS:000418587400008
J	Zamponi, E; Buratti, F; Cataldi, G; Caicedo, HH; Song, YY; Jungbauer, LM; LaDu, MJ; Bisbal, M; Lorenzo, A; Ma, JY; Helguera, PR; Morfini, GA; Brady, ST; Pigino, GF				Zamponi, Emiliano; Buratti, Fiamma; Cataldi, Gabriel; Caicedo, Hector Hugo; Song, Yuyu; Jungbauer, Lisa M.; LaDu, Mary J.; Bisbal, Mariano; Lorenzo, Alfredo; Ma, Jiyan; Helguera, Pablo R.; Morfini, Gerardo A.; Brady, Scott T.; Pigino, Gustavo F.			Prion protein inhibits fast axonal transport through a mechanism involving casein kinase 2	PLOS ONE			English	Article							CEREBRAL AMYLOID ANGIOPATHY; MOTOR-NEURON DISEASE; KINESIN HEAVY-CHAIN; SQUID GIANT-AXON; NEURODEGENERATIVE DISEASES; TRANSGENIC MICE; CYTOPLASMIC DYNEIN; ALZHEIMERS-DISEASE; IN-VIVO; EXTRUDED AXOPLASM	Prion diseases include a number of progressive neuropathies involving conformational changes in cellular prion protein (PrPc) that may be fatal sporadic, familial or infectious. Pathological evidence indicated that neurons affected in prion diseases follow a dying-back pattern of degeneration. However, specific cellular processes affected by PrP c that explain such a pattern have not yet been identified. Results from cell biological and pharmacological experiments in isolated squid axoplasm and primary cultured neurons reveal inhibition of fast axonal transport (FAT) as a novel toxic effect elicited by PrPc. Pharmacological, biochemical and cell biological experiments further indicate this toxic effect involves casein kinase 2 (CK2) activation, providing a molecular basis for the toxic effect of PrPc on FAT. CK2 was found to phosphorylate and inhibit light chain subunits of the major motor protein conventional kinesin. Collectively, these findings suggest CK2 as a novel therapeutic target to prevent the gradual loss of neuronal connectivity that characterizes prion diseases.	[Zamponi, Emiliano; Buratti, Fiamma; Cataldi, Gabriel; Bisbal, Mariano; Lorenzo, Alfredo; Helguera, Pablo R.; Pigino, Gustavo F.] Univ Nacl Cordoba, Lab Neuropatol Expt, Inst Invest Med Mercedes & Martin Ferreyra, INIMEC CONICET, Cordoba, Argentina; [Caicedo, Hector Hugo; Jungbauer, Lisa M.; LaDu, Mary J.; Morfini, Gerardo A.; Brady, Scott T.; Pigino, Gustavo F.] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL USA; [Song, Yuyu; Morfini, Gerardo A.; Brady, Scott T.; Pigino, Gustavo F.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Song, Yuyu] Harvard Med Sch, Harvard Program Therapeut Sci, Boston, MA USA; [Ma, Jiyan] Van Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Marine Biological Laboratory - Woods Hole; Harvard University; Harvard Medical School; Van Andel Institute	Pigino, GF (corresponding author), Univ Nacl Cordoba, Lab Neuropatol Expt, Inst Invest Med Mercedes & Martin Ferreyra, INIMEC CONICET, Cordoba, Argentina.; Brady, ST (corresponding author), Univ Illinois, Dept Anat & Cell Biol, Chicago, IL USA.; Brady, ST; Pigino, GF (corresponding author), Marine Biol Lab, Woods Hole, MA 02543 USA.	stbrady@uic.edu; pigino@immf.uncor.edu	Pigino, Gustavo/L-7002-2019; Song, Yuyu/J-8939-2019; Bisbal, Mariano/AAE-9308-2021	Song, Yuyu/0000-0002-9196-1610; Bisbal, Mariano/0000-0002-3870-6151; Jungbauer Nikolas, Lisa/0000-0002-5429-3393; LaDu, Mary Jo/0000-0003-2141-1450; Ma, Jiyan/0000-0001-7150-1898	Alzheimer Association New Investigator Research Grant [NIRGD-11-206379]; Consejo Nacional de Investigaciones Cientfficas y Tecnicas [PIP 112 20150100954 CO]; National Institutes of Health [NS066942A, NS096642, R01-NS023868, R01-NS041170]	Alzheimer Association New Investigator Research Grant; Consejo Nacional de Investigaciones Cientfficas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Alzheimer Association New Investigator Research Grant to Promote Diversity NIRGD-11-206379 and Consejo Nacional de Investigaciones Cientfficas y Tecnicas PIP 112 20150100954 CO (to GP), National Institutes of Health NS066942A and NS096642 (to GM), R01-NS023868 and R01-NS041170 (to STB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2009, CELL, V137, P994, DOI 10.1016/j.cell.2009.05.041; Andrews PLR, 2013, J EXP MAR BIOL ECOL, V447, P46, DOI 10.1016/j.jembe.2013.02.010; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Baumann F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006707; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Blasier KR, 2014, J NEUROSCI RES, V92, P1143, DOI 10.1002/jnr.23388; Brady S, 2010, MOL NEUROBIOL, V42, P25, DOI 10.1007/s12035-010-8128-2; BRADY ST, 1982, METHOD CELL BIOL, V25, P365, DOI 10.1016/S0091-679X(08)61434-X; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; BRADY ST, 1982, SCIENCE, V218, P1129, DOI 10.1126/science.6183745; BRADY ST, 1985, CELL MOTIL CYTOSKEL, V5, P81, DOI 10.1002/cm.970050203; BRADY ST, 1991, NEURON, V7, P521, DOI 10.1016/0896-6273(91)90365-7; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; BRADY ST, 1993, METHOD CELL BIOL, V39, P191, DOI 10.1016/S0091-679X(08)60171-5; Brandenburg LO, 2009, ANN ANAT, V191, P459, DOI 10.1016/j.aanat.2009.06.003; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; BROWN DR, 1994, NEUROREPORT, V5, P2057, DOI 10.1097/00001756-199410270-00017; Buckman JF, 2001, J NEUROSCI METH, V104, P165, DOI 10.1016/S0165-0270(00)00340-X; Carimalo J, 2005, EUR J NEUROSCI, V21, P2311, DOI 10.1111/j.1460-9568.2005.04080.x; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen JM, 2008, ACTA BIOCH BIOPH SIN, V40, P1039, DOI 10.1111/j.1745-7270.2008.00486.x; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Chiesa R, 2005, P NATL ACAD SCI USA, V102, P238, DOI 10.1073/pnas.0406173102; Chiesa R, 2016, PRION, V10, P93, DOI 10.1080/19336896.2016.1139276; Chiesa R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004745; Chiesa R, 2008, J NEUROSCI, V28, P13258, DOI 10.1523/JNEUROSCI.3109-08.2008; Choi SI, 1998, ACTA NEUROPATHOL, V96, P279, DOI 10.1007/s004010050895; Chou ST, 2016, J CONTROL RELEASE, V244, P14, DOI 10.1016/j.jconrel.2016.11.001; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Crimella C, 2011, CLIN GENET; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Diack AB, 2014, EMERG INFECT DIS, V20, P1969, DOI 10.3201/eid2012.140214; Donelan MJ, 2002, J BIOL CHEM, V277, P24232, DOI 10.1074/jbc.M203345200; Ermolayev V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000558; Ermolayev V, 2009, BIOPHYS J, V96, P3390, DOI 10.1016/j.bpj.2009.01.032; Faas H, 2010, NEUROIMAGE, V49, P2607, DOI 10.1016/j.neuroimage.2009.10.009; Fioriti L, 2005, MOL CELL NEUROSCI, V28, P165, DOI 10.1016/j.mcn.2004.09.006; FORLONI G, 1994, EUR J NEUROSCI, V6, P1415, DOI 10.1111/j.1460-9568.1994.tb01003.x; Forloni G, 1996, MOL CHEM NEUROPATHOL, V28, P163, DOI 10.1007/BF02815218; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Gibbs KL, 2015, TRENDS BIOCHEM SCI, V40, P597, DOI 10.1016/j.tibs.2015.08.003; Gotz J, 2006, J NEUROCHEM, V98, P993, DOI 10.1111/j.1471-4159.2006.03955.x; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hirokawa N, 2004, CURR OPIN NEUROBIOL, V14, P564, DOI 10.1016/j.conb.2004.08.011; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Kanaan NM, 2012, EXP NEUROL; Kandan NM, 2013, EXP NEUROL, V246, P44, DOI 10.1016/j.expneurol.2012.06.003; Karki S, 1997, J BIOL CHEM, V272, P5887, DOI 10.1074/jbc.272.9.5887; Kim-Han JS, 2011, J NEUROSCI, V31, P7212, DOI 10.1523/JNEUROSCI.0711-11.2011; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Lazarov O, 2007, J NEUROSCI, V27, P7011, DOI 10.1523/JNEUROSCI.4272-06.2007; Leo L, 2017, HUM MOL GENET, V26, P2321, DOI 10.1093/hmg/ddx125; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Liu SY, 2012, SCI WORLD J, DOI 10.1100/2012/614263; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; MARIN O, 1994, BIOCHEM BIOPH RES CO, V198, P898, DOI 10.1006/bbrc.1994.1128; Mead S, 2013, NEW ENGL J MED, V369, P1904, DOI 10.1056/NEJMoa1214747; Medrano AZ, 2008, NEUROBIOL DIS, V31, P20, DOI 10.1016/j.nbd.2008.03.006; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Meggio F, 2000, BIOCHEM J, V352, P191, DOI 10.1042/0264-6021:3520191; Mitchell DJ, 2012, J NEUROSCI, V32, P15495, DOI 10.1523/JNEUROSCI.5599-11.2012; Moreno H, 2016, NEUROSCIENCE, V325, P30, DOI 10.1016/j.neuroscience.2016.03.044; Moreno H, 2009, P NATL ACAD SCI USA, V106, P5901, DOI 10.1073/pnas.0900944106; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2007, P NATL ACAD SCI USA, V104, P2442, DOI 10.1073/pnas.0611231104; Morfini G, 2005, TRENDS MOL MED, V11, P64, DOI 10.1016/j.molmed.2004.12.002; Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237; Morfini G, 2002, NEUROMOL MED, V2, P89, DOI 10.1385/NMM:2:2:089; Morfini G, 2001, DEV NEUROSCI-BASEL, V23, P364, DOI 10.1159/000048720; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Morfini GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065235; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; Pagano MA, 2006, BIOCHEM SOC T, V34, P1303, DOI 10.1042/BST0341303; Pagano MA, 2004, BIOCHEM BIOPH RES CO, V321, P1040, DOI 10.1016/j.bbrc.2004.07.067; Perez M, 2003, BIOCHEM J, V372, P129, DOI 10.1042/BJ20021596; Pigino G, 2003, J NEUROSCI, V23, P4499; Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106; Pigino G, 2001, J NEUROSCI, V21, P834, DOI 10.1523/JNEUROSCI.21-03-00834.2001; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Puls I, 2005, ANN NEUROL, V57, P687, DOI 10.1002/ana.20468; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Saa P, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2016.8; Sanchez-Garcia J, 2013, HUM MOL GENET, V22, P4253, DOI 10.1093/hmg/ddt276; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Schafer B, 2008, BIOCHEM BIOPH RES CO, V375, P179, DOI 10.1016/j.bbrc.2008.07.107; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Scott D, 2012, J NEUROSCI, V32, P10129, DOI 10.1523/JNEUROSCI.0535-12.2012; Senatore A, 2013, INT J CELL BIOL, V2013, DOI DOI 10.1155/2013/543803; Senatore A, 2012, NEURON, V74, P300, DOI 10.1016/j.neuron.2012.02.027; Serulle Y, 2007, P NATL ACAD SCI USA, V104, P2437, DOI 10.1073/pnas.0611227104; Simon D, 2014, NEUROPATH APPL NEURO, V40, P311, DOI 10.1111/nan.12066; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Sleegers K, 2006, BRAIN, V129, P2977, DOI 10.1093/brain/awl203; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; Song YY, 2016, METHOD CELL BIOL, V131, P331, DOI 10.1016/bs.mcb.2015.07.004; Song YY, 2013, METHOD CELL BIOL, V115, P125, DOI 10.1016/B978-0-12-407757-7.00009-8; Stenoien DL, 1997, MOL BIOL CELL, V8, P675, DOI 10.1091/mbc.8.4.675; Tang Y, 2012, TRAFFIC, V13, P681, DOI 10.1111/j.1600-0854.2012.01340.x; TATEISHI J, 1995, BRAIN PATHOL, V5, P53, DOI 10.1111/j.1750-3639.1995.tb00577.x; Turnbaugh JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025675; Uchiyama K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2873; Wang F, 2010, BIOCHEMISTRY-US, V49, P8169, DOI 10.1021/bi101146v; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang XH, 2006, J BIOL CHEM, V281, P13559, DOI 10.1074/jbc.M512306200; Wang XH, 2009, BBA-MOL BASIS DIS, V1792, P555, DOI 10.1016/j.bbadis.2009.02.014; Wang XN, 2009, METHOD ENZYMOL, V457, P319, DOI 10.1016/S0076-6879(09)05018-6; Westergard L, 2011, J NEUROSCI, V31, P14005, DOI 10.1523/JNEUROSCI.1243-11.2011; Zhou MH, 2012, P NATL ACAD SCI USA, V109, P3113, DOI 10.1073/pnas.1118090109	119	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0188340	10.1371/journal.pone.0188340	http://dx.doi.org/10.1371/journal.pone.0188340			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261664	Green Published, Green Submitted, gold			2022-12-26	WOS:000418564200008
J	Citro, V; Cimmaruta, C; Liguori, L; Viscido, G; Cubellis, MV; Andreotti, G				Citro, Valentina; Cimmaruta, Chiara; Liguori, Ludovica; Viscido, Gaetano; Cubellis, Maria Vittoria; Andreotti, Giuseppina			A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG	PLOS ONE			English	Article							SYNDROME TYPE 1A; PROTEIN; GLYCOSYLATION; PMM1; MUTATIONS; GENE; DISORDER; BINDING; PHENOTYPE; ISOMERASE	The most frequent disorder of glycosylation, PMM2-CDG, is caused by a deficiency of phosphomannomutase activity. In humans two paralogous enzymes exist, both of them require mannose 1,6-bis-phosphate or glucose 1,6-bis-phosphate as activators, but only phosphomannomutase1 hydrolyzes bis-phosphate hexoses. Mutations in the gene encoding phosphomannomutase2 are responsible for PMM2-CDG. Although not directly causative of the disease, the role of the paralogous enzyme in the disease should be clarified. Phosphomannomutase1 could have a beneficial effect, contributing to mannose 6-phosphate isomerization, or a detrimental effect, hydrolyzing the bis-phosphate hexose activator. A pivotal role in regulating mannose-1phosphate production and ultimately protein glycosylation might be played by inosine monophosphate that enhances the phosphatase activity of phosphomannomutase1. In this paper we analyzed human phosphomannomutases by conventional enzymatic assays as well as by novel techniques such as P-31-NMR and thermal shift assay. We characterized a triple mutant of phospomannomutase1 that retains mutase and phosphatase activity, but is unable to bind inosine monophosphate.	[Citro, Valentina; Cimmaruta, Chiara; Viscido, Gaetano; Cubellis, Maria Vittoria] Univ Federico II, Dipartimento Biol, Naples, Italy; [Liguori, Ludovica; Cubellis, Maria Vittoria; Andreotti, Giuseppina] CNR, Ist Chim Biomol, Pozzuoli, Italy; [Liguori, Ludovica] Univ Campania Luigi Vanvitelli, Dipartimento Sci & Tecnol Ambientali Biol & Farma, Caserta, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Universita della Campania Vanvitelli	Cubellis, MV (corresponding author), Univ Federico II, Dipartimento Biol, Naples, Italy.; Cubellis, MV (corresponding author), CNR, Ist Chim Biomol, Pozzuoli, Italy.	cubellis@unina.it	ANDREOTTI, GIUSEPPINA/AAX-8952-2020	ANDREOTTI, GIUSEPPINA/0000-0002-1594-0156; Citro, Valentina/0000-0002-0289-404X; Cimmaruta, Chiara/0000-0001-7586-6659; Liguori, Ludovica/0000-0002-8480-0501; cubellis, maria vittoria/0000-0001-6147-6553	MIUR PRIN [2015JHLY35]	MIUR PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by a grant from MIUR PRIN 2015 2015JHLY35 to MVC. The funder had no role or competing interest.	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Andreotti G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139882; Andreotti G, 2015, DRUG TEST ANAL, V7, P831, DOI 10.1002/dta.1798; Andreotti G, 2014, J BIOL CHEM, V289, P34900, DOI 10.1074/jbc.M114.586362; Andreotti G, 2013, MOL GENET GENOM MED, V1, P32, DOI 10.1002/mgg3.3; Borrelli KW, 2005, J CHEM THEORY COMPUT, V1, P1304, DOI 10.1021/ct0501811; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cammisa M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S9; Cromphout K, 2006, MOL CELL BIOL, V26, P5621, DOI 10.1128/MCB.02357-05; Cromphout K, 2005, EUR J NEUROSCI, V22, P991, DOI 10.1111/j.1460-9568.2005.04266.x; Hansen SH, 1997, GLYCOBIOLOGY, V7, P829, DOI 10.1093/glycob/7.6.829; Jaeken J, 2008, J INHERIT METAB DIS, V31, P669, DOI 10.1007/s10545-008-0983-x; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kjaergaard S, 1999, EUR J HUM GENET, V7, P884, DOI 10.1038/sj.ejhg.5200398; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Madadkar-Sobhani A, 2013, NUCLEIC ACIDS RES, V41, pW322, DOI 10.1093/nar/gkt454; Maeda Y, 2008, BBA-GEN SUBJECTS, V1780, P861, DOI 10.1016/j.bbagen.2008.03.005; Matthijs G, 1997, GENOMICS, V40, P41, DOI 10.1006/geno.1996.4536; Matthijs G, 1998, AM J HUM GENET, V62, P542, DOI 10.1086/301763; Matthijs G, 1997, NAT GENET, V16, P88, DOI 10.1038/ng0597-88; Mele BH, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0273-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PINDAR DF, 1975, BIOCHEM J, V152, P617, DOI 10.1042/bj1520617; Pirard M, 1999, FEBS LETT, V452, P319, DOI 10.1016/S0014-5793(99)00673-0; Pirard M, 1999, BIOCHEM J, V339, P201, DOI 10.1042/0264-6021:3390201; Pirard M, 1997, FEBS LETT, V411, P251, DOI 10.1016/S0014-5793(97)00704-7; Quental R, 2010, J MOL EVOL, V71, P119, DOI 10.1007/s00239-010-9368-5; SACORREIA I, 1987, J BACTERIOL, V169, P3224, DOI 10.1128/jb.169.7.3224-3231.1987; Schollen E, 1998, HUM MOL GENET, V7, P157, DOI 10.1093/hmg/7.2.157; Sharma V, 2011, J BIOL CHEM, V286, P39431, DOI 10.1074/jbc.M111.285502; Silvaggi NR, 2006, J BIOL CHEM, V281, P14918, DOI 10.1074/jbc.M601505200; Takahashi R, 2014, J CHEM THEORY COMPUT, V10, P282, DOI 10.1021/ct400678g; Thiel C, 2006, MOL CELL BIOL, V26, P5615, DOI 10.1128/MCB.02391-05; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; Veiga-da-Cunha M, 2008, J BIOL CHEM, V283, P33988, DOI 10.1074/jbc.M805224200; Wizard P.P., 2011, EPIK VERSION 2 2 IMP; Yuste-Checa P, 2015, HUM MUTAT, V36, P851, DOI 10.1002/humu.22817	38	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189629	10.1371/journal.pone.0189629	http://dx.doi.org/10.1371/journal.pone.0189629			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261720	Green Published, Green Submitted, gold			2022-12-26	WOS:000418554900025
J	Coll, M; Striano, P; Ferrer-Costa, C; Campuzano, O; Mates, J; del Olmo, B; Iglesias, A; Perez-Serra, A; Mademont, I; Pico, F; Oliva, A; Brugada, R				Coll, Monica; Striano, Pasquale; Ferrer-Costa, Carles; Campuzano, Oscar; Mates, Jesus; del Olmo, Bernat; Iglesias, Anna; Perez-Serra, Alexandra; Mademont, Irene; Pico, Ferran; Oliva, Antonio; Brugada, Ramon			Targeted next-generation sequencing provides novel clues for associated epilepsy and cardiac conduction disorder/SUDEP	PLOS ONE			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; SUDDEN UNEXPECTED DEATH; LONG QT SYNDROME; GENETIC-VARIATION; MUTATION; FAMILY; MECHANISMS; PREVENTION; SEIZURES; FEBRILE	Sudden unexpected death in epilepsy is an unpredicted condition in patients with a diagnosis of epilepsy, and autopsy does not conclusively identify cause of death. Although the pathophysiological mechanisms that underlie this entity remain unknown, the fact that epilepsy can affect cardiac function is not surprising. The genetic factors involving ion channels co-expressed in the heart and brain and other candidate genes have been previously described. In the present study, 20 epilepsy patients with personal or family history of heart rhythm disturbance/cardiac arrhythmias/sudden death were sequenced using a custom resequencing panel. Twenty-six relatives were genetically analysed to ascertain the family segregation in ten individuals. Four subjects revealed variants with positive genotype-phenotype segregation: four missense variants in the CDKL5, CNTNAP2, GRIN2A and ADGRV1 genes and one copy number variant in KCNQ1. The potential pathogenic role of variants in new candidate genes will need further studies in larger cohorts, and the evaluation of the potential pathogenic role in the cardio-cerebral mechanisms requires in vivo/in vitro studies. In addition to family segregation, evaluation of the potential pathogenic roles of these variants in cardio-cerebral mechanisms by in vivo/in vitro studies should also be performed. The potential pathogenic role of variants in new candidate genes will need further studies in larger cohorts.	[Coll, Monica; Campuzano, Oscar; Mates, Jesus; del Olmo, Bernat; Iglesias, Anna; Perez-Serra, Alexandra; Mademont, Irene; Pico, Ferran; Brugada, Ramon] Dr Trueta Univ Hosp, Cardiovasc Genet Ctr, IDIBGI, Parc Hosp Marti & Julia, Salt, Spain; [Striano, Pasquale] Univ Genoa, G Gaslini Inst, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Pediat Neurol & Muscular Dis Unit, Genoa, Italy; [Ferrer-Costa, Carles] Gendiag SL, Barcelona, Spain; [Campuzano, Oscar; Brugada, Ramon] Univ Girona, Sch Med, Dept Med Sci, Girona, Spain; [Campuzano, Oscar; Perez-Serra, Alexandra; Brugada, Ramon] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain; [Oliva, Antonio] Catholic Univ, Inst Publ Hlth, Sect Legal Med, Rome, Italy; [Brugada, Ramon] Hosp Josep Trueta, Cardiac Genet Unit, Cardiol Serv, Girona, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); University of Genoa; IRCCS Istituto Giannina Gaslini; Universitat de Girona; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Universitat de Girona; Girona University Hospital Dr. Josep Trueta	Coll, M (corresponding author), Dr Trueta Univ Hosp, Cardiovasc Genet Ctr, IDIBGI, Parc Hosp Marti & Julia, Salt, Spain.	mcoll@gencardio.com	Oliva, Antonio/K-1105-2018; Striano, Pasquale/F-9117-2014; campuzano, oscar/J-1968-2014; Coll, Monica/H-3176-2015	Striano, Pasquale/0000-0002-6065-1476; campuzano, oscar/0000-0001-5298-5276; Mates, Jesus/0000-0002-3822-745X; Mademont-Soler, Irene/0000-0002-6501-9250; del Olmo Cabestre, Bernat/0000-0002-7109-7626; Coll, Monica/0000-0003-1214-803X; Oliva, Antonio/0000-0001-7112-9096				Ackerman MJ, 2017, HEART RHYTHM, V14, pE41, DOI 10.1016/j.hrthm.2016.09.012; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Camfield P, 2015, EPILEPTIC DISORD, V17, P124, DOI 10.1684/epd.2015.0737; Campuzano O, 2015, SCI REPORTS; Campuzano O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114894; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Coll M, 2016, INT J LEGAL MED, V130, P331, DOI 10.1007/s00414-015-1269-0; Delgado-Escueta AV, 2013, EPILEPSY BEHAV, V28, pS52, DOI 10.1016/j.yebeh.2012.06.033; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Devinsky O, 2016, LANCET NEUROL, V15, P1075, DOI 10.1016/S1474-4422(16)30158-2; Dibbens LM, 2009, ANN NEUROL, V66, P532, DOI 10.1002/ana.21765; Dlouhy BJ, 2016, J NEUROL NEUROSUR PS, V87, P402, DOI 10.1136/jnnp-2013-307442; Glasscock E, 2013, EPILEPSY BEHAV E B; Hata Y, 2016, BRAIN PATHOL; Hortiguela M, 2017, J HUM GENET, V62, P185, DOI 10.1038/jhg.2016.104; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lodola F, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.304; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Nakayama J, 2002, ANN NEUROL, V52, P654, DOI 10.1002/ana.10347; Napolitano C., 1993, GENEREVIEWS R; Nashef L, 1997, EPILEPSIA S11, V38, P8, DOI DOI 10.1111/J.1528-1157.1997.TB06130.X; Olson H, 2014, ANN NEUROL, V75, P943, DOI 10.1002/ana.24178; Parisi P, 2013, EPILEPSY RES, V105, P415, DOI 10.1016/j.eplepsyres.2013.02.024; Partemi S, 2014, INT J LEGAL MED; Partemi S, 2013, EPILEPSIA, V54, pE112, DOI 10.1111/epi.12259; Pertea M, 2001, NUCLEIC ACIDS RES, V29, P1185, DOI 10.1093/nar/29.5.1185; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rodenas-Cuadrado P, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0272-8; Roston TM, 2017, J ELECTROCARDIOL, V50, P227, DOI 10.1016/j.jelectrocard.2016.09.006; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shorvon S, 2011, LANCET, V378, P2028, DOI 10.1016/S0140-6736(11)60176-1; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Striano P, 2012, NAT REV NEUROL, V8, P542, DOI 10.1038/nrneurol.2012.178; Terra VC, 2012, EPILSEPY BEHAV; Willis BC, 2016, CIRCULATION, V133, P2348, DOI 10.1161/CIRCULATIONAHA.116.021936; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	41	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189618	10.1371/journal.pone.0189618	http://dx.doi.org/10.1371/journal.pone.0189618			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261713	Green Published, Green Submitted, gold			2022-12-26	WOS:000418554900024
J	Park, JB; Kim, SA; Sung, KC; Kim, JY				Park, Jeong Bae; Kim, Su-A; Sung, Ki-Chul; Kim, Jang Young			Gender-specific differences in the incidence of microalbuminuria in metabolic syndrome patients after treatment with fimasartan: The K-MetS study	PLOS ONE			English	Article							ANGIOTENSIN RECEPTOR BLOCKERS; KOREAN NATIONAL-HEALTH; END-POINT REDUCTION; CARDIOVASCULAR MORBIDITY; ANTIHYPERTENSIVE THERAPY; LOSARTAN INTERVENTION; RANDOMIZED TRIAL; RISK-FACTORS; PREVALENCE; HYPERTENSION	Background The effect of resolving metabolic syndrome on target organ damage in hypertensive patients is not well described. We evaluated whether treating metabolic syndrome (MetS) with an angiotensin receptor blocker subsequently reduced microalbuminuria in the K-MetS cohort. Methods Among 10,601 total metabolic syndrome patients, 3,250 (52.2% male, 56.2 +/- 10.0 years) with sufficient data on five specific metabolic components were included in this study. Patients were divided into four groups based on MetS status at baseline and 3 months. All patients received an angiotensin receptor blocker, fimasartan, for these 3 months; thereafter, treatment was modified at the discretion of each patient's physician. Microalbuminuria and the albumin/creatine ratio were evaluated as a proxy of organ damage. Results Blood pressure and waist circumference decreased from baseline to 3 months and 1 year. The average albumin/creatinine ratio significantly improved during the first three months of the study from 36.0 +/- 147.4 to 21.0 +/- 74.9 mg/g (p<0.05) and was persistently high in patients with MetS at baseline and 3 months versus other groups. Women in comparison with men showed significantly lower ACR among patients with newly developed MetS at 3-month. Conclusions Treatment of hypertensive patients for one year with the angiotensin receptor blocker fimasartan significantly reduced the albumin/creatine ratio, irrespective of whether the patient had MetS; however, the albumin/creatinine ratio was significantly higher in patents with persistent or newly developed MetS compared to patients without MetS. Additionally, these findings were more prominent in women than in men.	[Park, Jeong Bae] JB Lab & Clin, Seoul, South Korea; [Park, Jeong Bae] Dankook Univ, Coll Med, Dept Med, Cheil Gen Hosp, Seoul, South Korea; [Kim, Su-A] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea; [Sung, Ki-Chul] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea; [Kim, Jang Young] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Cardiol, Gangwon Do, South Korea	Dankook University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University	Park, JB (corresponding author), JB Lab & Clin, Seoul, South Korea.; Park, JB (corresponding author), Dankook Univ, Coll Med, Dept Med, Cheil Gen Hosp, Seoul, South Korea.	mdparkjb@gmail.com		Park, Jeong Bae/0000-0002-5623-7010	Boryung Pharmaceutical Company	Boryung Pharmaceutical Company	Dr. Jeong Bae Park received the funding from Boryung Pharmaceutical Company(http://www.boryung.co.kr/eng/index.do). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuissa H, 2005, J AM COLL CARDIOL, V46, P821, DOI 10.1016/j.jacc.2005.05.051; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Black HR, 2008, DIABETES CARE, V31, P353, DOI 10.2337/dc07-1452; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Cheserek MJ, 2014, J CLIN DIAGN RES, V8, P65, DOI 10.7860/JCDR/2014/6515.4010; Chrysant SG, 2010, AM J CARDIOVASC DRUG, V10, P315, DOI 10.2165/11538850-000000000-00000; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Fischer M, 2002, CARDIOVASC RES, V53, P672, DOI 10.1016/S0008-6363(01)00479-5; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hoang Khiet C, 2007, J Cardiometab Syndr, V2, P276, DOI 10.1111/j.1559-4564.2007.07491.x; Hoshi-Fukushima R, 2008, AM J NEPHROL, V28, P413, DOI 10.1159/000112806; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kim JY, 2013, DIABETES CARE, V36, P1547, DOI 10.2337/dc12-0223; Komukai K, 2010, FUND CLIN PHARMACOL, V24, P687, DOI 10.1111/j.1472-8206.2010.00854.x; Lee JW, 2014, SCI REP-UK, V4, DOI 10.1038/srep06804; Lee SR, 2013, INT J CARDIOL, V166, P633, DOI 10.1016/j.ijcard.2011.11.095; Li JB, 2010, J INT MED RES, V38, P1142, DOI 10.1177/147323001003800343; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; McNeill AM, 2005, DIABETES CARE, V28, P385, DOI 10.2337/diacare.28.2.385; Mule G, 2006, Minerva Cardioangiol, V54, P173; Nestel P, 2007, ASIA PAC J CLIN NUTR, V16, P362; Padwal R, 2004, DIABETES CARE, V27, P247, DOI 10.2337/diacare.27.1.247; Rantala AO, 1999, J INTERN MED, V245, P163, DOI 10.1046/j.1365-2796.1999.00429.x; Sone H, 2005, DIABETES CARE, V28, P1463, DOI 10.2337/diacare.28.6.1463; World Health Organization Western Pacific Region, 2000, INT ASS STUD OB TASK, P15; Yoshida H, 2011, CURR PHARM DESIGN, V17, P1090, DOI 10.2174/138161211795656909	30	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189342	10.1371/journal.pone.0189342	http://dx.doi.org/10.1371/journal.pone.0189342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261715	Green Published, gold, Green Submitted			2022-12-26	WOS:000418554900016
J	Kishi, Y; Shimada, K; Fujii, T; Uchiyama, T; Yoshimoto, C; Konishi, N; Ohbayashi, C; Kobayashi, H				Kishi, Yohei; Shimada, Keiji; Fujii, Tomomi; Uchiyama, Tomoko; Yoshimoto, Chiharu; Konishi, Noboru; Ohbayashi, Chiho; Kobayashi, Hiroshi			Phenotypic characterization of adenomyosis occurring at the inner and outer myometrium	PLOS ONE			English	Article							GENE-EXPRESSION; LUNG FIBROSIS; MUSCLE; LEIOMYOMA; DIFFERENTIATION; DIAGNOSIS; RECEPTOR; MIDKINE; DISEASE; DESMIN	Objective To estimate the phenotypic characterization of fibrotic process in adenomyosis occurring at the inner or the outer myometrium. Methods Eight cases of adenomyosis occurring at the inner myometrium (Subtype I) and 10 cases of adenomyosis occurring at the outer myometrium (Subtype II), and 10 normal counterparts were used in this study. A immunohistochemical study for smooth muscle cells (SMCs) was performed using cytoskeletal proteins, Type I and III collagen, TGF-beta and its signaling molecules. Results An increased expression of Type I collagen was observed in the extracellular matrix of adenomyotic foci. In normal uteri, immunostaining of SMC differentiation marker proteins (Desmin, Smoothelin, Myosin heavy chain (MHC)) were absent or only found in low numbers at the inner myometrium, while all of these marker proteins were clearly stained at the outer myometrium. In both types of adenomyotic foci, Desmin, Smoothelin, and MHC commonly showed a negative staining at the adjacent area to the glands. A significant staining of Nonmuscle myosin IIB, TGF-beta, and phosphorylated TGF-beta type I receptors were found only at the SMCs of Subtype II adenomyosis. The Smad3/2 ratio of Subtype II adenomyosis was significantly higher than that of Subtype I. Conclusions The inner myometrium of normal uteri was composed of undifferentiated phenotypes of SMCs, while the outer myometrium was composed of terminally differentiated SMCs. Various fibrotic processes have been suggested in the development of uterine adenomyosis. Distinct expression patterns of fibrosis related proteins have been shown to be implicated with differences in the subtypes of adenomyosis.	[Kishi, Yohei; Yoshimoto, Chiharu; Kobayashi, Hiroshi] Nara Med Univ, Dept Obstet & Gynecol, Nara, Japan; [Kishi, Yohei] Takanohara Cent Hosp, Dept Obstet & Gynecol, Nara, Japan; [Shimada, Keiji; Fujii, Tomomi; Uchiyama, Tomoko; Konishi, Noboru; Ohbayashi, Chiho] Nara Med Univ, Dept Diagnost Pathol, Nara, Japan	Nara Medical University; Nara Medical University	Kishi, Y (corresponding author), Nara Med Univ, Dept Obstet & Gynecol, Nara, Japan.; Kishi, Y (corresponding author), Takanohara Cent Hosp, Dept Obstet & Gynecol, Nara, Japan.	kishi@takanohara-ch.or.jp						Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; Duan WJ, 2014, AM J PATHOL, V184, P2275, DOI 10.1016/j.ajpath.2014.04.014; Fujisawa C, 2014, J CELL COMMUN SIGNAL, V8, P179, DOI 10.1007/s12079-014-0234-x; Goldfarb LG, 2008, ADV EXP MED BIOL, V642, P131; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Ibrahim MG, 2017, REPROD SCI, V24, P1410, DOI 10.1177/1933719116687855; Kishi Y, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.027; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; Leyendecker G, 2009, ARCH GYNECOL OBSTET, V280, P529, DOI 10.1007/s00404-009-1191-0; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Liu XS, 2016, HUM REPROD, V31, P734, DOI 10.1093/humrep/dew018; MARK AS, 1987, RADIOLOGY, V163, P527, DOI 10.1148/radiology.163.2.3562836; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Meyer GA, 2012, AM J PHYSIOL-CELL PH, V302, pC1609, DOI 10.1152/ajpcell.00441.2011; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pan X, 2013, TRANSFORMING GROWTH, V8; Paulin D, 2004, J PATHOL, V204, P418, DOI 10.1002/path.1639; Paulin D, 2004, EXP CELL RES, V301, P1, DOI 10.1016/j.yexcr.2004.08.004; Shi XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093995; Souchelnytskyi S, 1996, EMBO J, V15, P6231, DOI 10.1002/j.1460-2075.1996.tb01013.x; TOGASHI K, 1988, RADIOLOGY, V166, P111, DOI 10.1148/radiology.166.1.3336669; TOGASHI K, 1989, RADIOLOGY, V171, P531, DOI 10.1148/radiology.171.2.2704819; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yamada H, 1997, ARCH DERMATOL RES, V289, P429, DOI 10.1007/s004030050216; Young VJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106773; Zhang R, 2015, AM J RESP CRIT CARE, V192, P315, DOI 10.1164/rccm.201412-2326OC	26	29	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189522	10.1371/journal.pone.0189522	http://dx.doi.org/10.1371/journal.pone.0189522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253010	Green Published, gold, Green Submitted			2022-12-26	WOS:000418389500036
J	Luroni, LT; Gabriel, M; Tukahebwa, E; Onapa, AW; Tinkitina, B; Tukesiga, E; Nyaraga, M; Auma, AM; Habomugisha, P; Byamukama, E; Oguttu, D; Katabarwa, M; Unnasch, TR				Luroni, Lakwo Thomson; Gabriel, Matwale; Tukahebwa, Edridah; Onapa, Ambrose Winston; Tinkitina, Benjamin; Tukesiga, Ephraim; Nyaraga, Michael; Auma, Anna Mary; Habomugisha, Peace; Byamukama, Edson; Oguttu, David; Katabarwa, Moses; Unnasch, Thomas Raymond			The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda	PLOS ONE			English	Article							VECTOR SIMULIUM-NEAVEI; LYMPHATIC FILARIASIS; ELIMINATION; ANTIGEN; DIETHYLCARBAMAZINE; ALBENDAZOLE; INFECTION; DIAGNOSIS; AFRICA	Intervention Few studies have documented the interruption of onchocerciasis and Lymphatic Filariasis (LF) by integrated chemotherapy in Uganda. The study describes the interruption of transmission of the two diseases co-endemic in Obongi focus, north western Uganda. Base line data for Onchocerciasis and LF were collected in 1994 and 2006, respectively. Annual mass drug administration for onchocerciasis (Ivermectin) and Lymphatic Filariasis (Ivermectin + albendazole) was conducted for 20 and 6 years, respectively. Thereafter, assessments by skin snip, larval searches in rivers and human landing catches were performed. Children <10 years were screened for IgG4 antibodies using Ov16 ELISA technique in 2013. LF Pre-TAS and TAS1 were conducted in sentinel sites. ITN coverage and utilization for the implementation unit was also reported. Intervention coverage Onchocerciasis treatment coverage was <80% but improved with the introduction of CDTI in 1999. While for LF, effective coverage of >65% was achieved in the six treatment rounds. Household ownership of ITN's and utilization was 96% and 72.4%., respectively. Impact Parasitological examinations conducted for onchocerciasis among 807 adults and children, revealed a reduction in mf prevalence from 58% in 1994 to 0% in 2012. Entomological monitoring conducted at the two sites had no single Simulium damnosum fly caught. Serological analysis using Ov16 ELISA for onchocerciasis revealed that out of the 3,308 children <10 years old screened in 2013, only 3/3308 (0.091%) positive cases were detected. All Ov16 positive children were negative when tested for patent infection by skin snip PCR. A reduction in LF microfilaria prevalence from 2.5% (n = 13/522) in 2006 to 0.0% (n = 602) in 2014 was observed. LF TAS1 conducted in 2015 among 1,532 children 6-7 years, all were negative for antigens of W. bancrofti. Conclusion The results concluded that interruption of onchocerciasis and LF has been achieved.	[Luroni, Lakwo Thomson; Gabriel, Matwale; Tukahebwa, Edridah; Tinkitina, Benjamin; Auma, Anna Mary; Oguttu, David] Minist Hlth, Vector Control Div, Kampala, Uganda; [Onapa, Ambrose Winston] Envision, RTI Neglected Trop Dis Control Programme, Kampala, Uganda; [Tukesiga, Ephraim] Kabarole Dist Local Govt, Ft Portal, Uganda; [Nyaraga, Michael] Moyo Dist Local Govt, Med Dept, Moyo, Uganda; [Habomugisha, Peace; Byamukama, Edson] Carter Ctr, Uganda Off, Kampala, Uganda; [Katabarwa, Moses] Carter Ctr, Atlanta, GA USA; [Unnasch, Thomas Raymond] Univ S Florida, Global Hlth Infect Dis Res, Coll Publ Hlth, Tampa, FL USA	State University System of Florida; University of South Florida	Luroni, LT (corresponding author), Minist Hlth, Vector Control Div, Kampala, Uganda.	tlakwo@gmail.com			Carter Center; Envision/RTI	Carter Center; Envision/RTI	The Carter Center and Envision/RTI for providing the financial support for mass drug administration activities in Moyo district. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, World Health Organ Tech Rep Ser, V852, P1; [Anonymous], 2014, NATL GUIDELINES RES, P16; APN, 2017, AM PHARM NEWS R 0425; Ashton RA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-134; Bockarie MJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0144; Chanda E, 2017, TRENDS PARASITOL, V33, P30, DOI 10.1016/j.pt.2016.09.006; Chu BK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002584; Crump A, 2012, TRENDS PARASITOL, V28, P280, DOI 10.1016/j.pt.2012.04.005; Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497; Garms R, 2009, ACTA TROP, V111, P203, DOI 10.1016/j.actatropica.2009.04.001; Gass K, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001479; Golden A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069231; Gustavsen K, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0185-5; Katabarwa M, 2014, AM J TROP MED HYG, V90, P1159, DOI 10.4269/ajtmh.13-0501; Katabarwa Moses N, 2012, J Parasitol Res, V2012, P748540, DOI 10.1155/2012/748540; Kelly-Hope LA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-39; Lakwo T, 2017, ACTA TROP, V167, P128, DOI 10.1016/j.actatropica.2016.12.029; Lakwo TL, 2013, ACTA TROP, V126, P218, DOI 10.1016/j.actatropica.2013.02.016; Lakwo T L, 2006, East Afr Med J, V83, P326; Liang JL, 2008, AM J TROP MED HYG, V78, P924, DOI 10.4269/ajtmh.2008.78.924; LOBOS E, 1991, SCIENCE, V251, P1603, DOI 10.1126/science.2011741; MOH, 2012, GUID CERT ONCH EL UG; NGOUMOU P, 1993, TDRTDEONCHO934; Oguttu D, 2014, AM J TROP MED HYG, V90, P339, DOI 10.4269/ajtmh.13-0546; Onapa AW, 2005, ANN TROP MED PARASIT, V99, P141, DOI 10.1179/136485905X19829; Onapa AW, 2001, T ROY SOC TROP MED H, V95, P161, DOI 10.1016/S0035-9203(01)90145-2; Prentice M. A., 1974, Scientific Publication, Pan American Health Organization, P87; Ramzy RMR, 2006, LANCET, V367, P992, DOI 10.1016/S0140-6736(06)68426-2; Raybould J. N., TROPENMEDIZIN PARASI, V30, P505; Rosenblatt JE, 2009, CLIN INFECT DIS, V49, P1103, DOI 10.1086/605574; Simonsen PE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000696; Steel C, 2013, CLIN VACCINE IMMUNOL, V20, P1155, DOI 10.1128/CVI.00252-13; Steel R., 1997, PRINCIPLES PROCEDURE; TFGH, 2009, SURV SAMPL BUILD VER; Uganda Bureau of Statistics (UBOS) and ICF International, 2015, UG MAL IND SURV 2014; Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7; WHO, 1996, TDRAFRORP961 WHO; WHO, 2011, GLOB PROGR EL LYMPH; WHO, 2013, 2 WHO, P113; WHO, 2007, GLOB PLAN COMB NEGL; WHO, 2016, CRIT PROC; WHO/APOC, 2002, TRAIN MOD NAT ENT MA	42	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189306	10.1371/journal.pone.0189306	http://dx.doi.org/10.1371/journal.pone.0189306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253862	gold, Green Published, Green Submitted			2022-12-26	WOS:000418389500023
J	Ngufor, C; Fongnikin, A; Rowland, M; N'Guessan, R				Ngufor, Corine; Fongnikin, Augustin; Rowland, Mark; N'Guessan, Raphael			Indoor residual spraying with a mixture of clothianidin (a neonicotinoid insecticide) and deltamethrin provides improved control and long residual activity against pyrethroid resistant Anopheles gambiae sl in Southern Benin	PLOS ONE			English	Article								Introduction There is an urgent need for new insecticides for indoor residual spraying (IRS) which can provide improved and prolonged control of malaria vectors that have developed resistance to existing insecticides. The neonicotinoid, clothianidin represents a class of chemistry new to public health. Clothianidin acts as an agonist on nicotinic acetyl choline receptors. IRS with a mixture of Clothianidin and another WHO approved insecticide such as deltamethrin could provide improved control of insecticide resistant malaria vector populations and serve as a tool for insecticide resistance management. Methods The efficacy and residual activity of a novel IRS mixture of deltamethrin and clothianidin was evaluated against wild pyrethroid resistant An. gambiae sl in experimental huts in Cove, Benin. Two application rates of the mixture were tested and comparison was made with clothianidin and deltamethrin applied alone. To assess the residual efficacy of the treatments on different local wall substrates, the inner walls of the experimental huts were covered with either cement, mud or plywood. Results Clothianidin demonstrated a clear delayed expression in mortality of wild pyrethroid resistant An. gambiae sl in the experimental huts which reached its full effect 120 hours after exposure. Overall mortality over the 12-month hut trial was 15% in the control hut and 24-29% in the deltamethrin-treated huts. The mixture of clothianidin 200mg/m(2) and deltamethrin 25mg/m(2) induced high overall hut mortality rates (87% on mud walls, 82% on cement walls and 61% on wooden walls) largely due to the clothianidin component and high hut exiting rates (67-76%) mostly due to the deltamethrin component. Mortality rates remained >80% for 8-9 months on mud and cement walls. The residual activity trend was confirmed by results from monthly in situ cone bioassays with laboratory susceptible An. gambiae Kisumu strain. Conclusion IRS campaigns with the mixture of clothianidin plus deltamethrin have the potential to provide prolonged control of malaria transmitted by pyrethroid resistant mosquito populations.	[Ngufor, Corine; Rowland, Mark; N'Guessan, Raphael] LSHTM, London, England; [Ngufor, Corine; Fongnikin, Augustin; N'Guessan, Raphael] CREC, Cotonou, Benin	University of London; London School of Hygiene & Tropical Medicine; Entomological Research Center of Cotonou (CREC)	Ngufor, C (corresponding author), LSHTM, London, England.; Ngufor, C (corresponding author), CREC, Cotonou, Benin.	corine.ngufor@lshtm.ac.uk		NGuessan, Raphael/0000-0003-4930-4534; Ngufor, Corine/0000-0002-7755-9609	Bayer CropSciences	Bayer CropSciences(Bayer AG)	This project was an independent research study funded by a research grant from Bayer CropSciences to Raphael N'Guessan. Funding covered research costs and operational expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akogbeto M, 2011, AM J TROP MED HYG, V85, P586, DOI 10.4269/ajtmh.2011.10-0668; Alou LPA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-167; [Anonymous], WHOHTMNTDWHOPES20131; [Anonymous], 2013, WHO REC INS IND RES; Chuang YY, 2008, J ECON ENTOMOL, V101, P352, DOI 10.1603/0022-0493(2008)101[352:EOASUM]2.0.CO;2; Corbel V, 2004, J MED ENTOMOL, V41, P712, DOI 10.1603/0022-2585-41.4.712; DENHOLM I, 1992, ANNU REV ENTOMOL, V37, P91, DOI 10.1146/annurev.en.37.010192.000515; Edi C, 2012, EMERG INFECT DIS, V18; Etang J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-333; FAO, 2010, CLOTH; N'Guessan R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165925; Namountougou M, 2012, ACTA TROP, V7, P48412, DOI DOI 10.1371/J0URNAL.P0NE.0048412; Ngufor C, 2014, MALAR J, V13; Ngufor C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162210; Ngufor C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0981-z; Oxborough RM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1201-1; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Reid MC, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1162-4; Rowland M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069516; Tchicaya ES, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-332; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Tomizawa M, 2000, J AGR FOOD CHEM, V48, P6016, DOI 10.1021/jf000873c; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2006, GUIDELINES TESTING M; WHO (World Health Organization), 2011, TECHN BAS COORD ACT; World Health Organization, 2012, WHO GLOB MAL PROGR G; 2012, WORLD MAL REP 2012, P1	28	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189575	10.1371/journal.pone.0189575	http://dx.doi.org/10.1371/journal.pone.0189575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29252986	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000418389500039
J	Silver, AC				Silver, Adam C.			Pathogen-associated molecular patterns alter molecular clock gene expression in mouse splenocytes	PLOS ONE			English	Article							INNATE IMMUNITY; CIRCADIAN-RHYTHM; STREPTOCOCCUS-PNEUMONIAE; BACTERIAL COINFECTIONS; MACROPHAGES; SLEEP; TOLL-LIKE-RECEPTOR-9; TRANSCRIPTION; OSCILLATORS; DYSFUNCTION	Circadian rhythms are endogenous 24-h oscillations that influence a multitude of physiological processes. The pathogen-associated molecular pattern (PAMP), lipopolysaccharide, has been shown to modify the circadian molecular clock. The aim of this study was to determine if other PAMPs alter clock gene expression. Therefore, mRNA levels of clock genes (Per2, Bmal1, Rev-erba, and Dbp) were measured after an ex vivo challenge with several PAMPs and to further test the relevance of PAMP alteration of the molecular clock, an in vivo poly(I:C) challenge was performed. This study revealed that several other PAMPs are also capable of altering clock gene expression.	[Silver, Adam C.] Univ Hartford, Dept Biol, Hartford, CT 06117 USA	University of Hartford	Silver, AC (corresponding author), Univ Hartford, Dept Biol, Hartford, CT 06117 USA.	asilver@hartford.edu		Silver, Adam/0000-0002-2483-6668	Faculty Research grants from the College of Arts and Sciences Dean's Office at the University of Hartford	Faculty Research grants from the College of Arts and Sciences Dean's Office at the University of Hartford	This work was supported by Faculty Research grants from the College of Arts and Sciences Dean's Office at the University of Hartford. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I thank A.K. Hastings for helpful comments regarding the manuscript and B. Zhu for assistance with the statistical analyses. This work was supported by Faculty Research grants from the College of Arts and Sciences Dean's Office at the University of Hartford.	Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Arjona A, 2012, TRENDS IMMUNOL, V33, P607, DOI 10.1016/j.it.2012.08.007; Bakaletz LO, 2017, CURR OPIN MICROBIOL, V35, P30, DOI 10.1016/j.mib.2016.11.003; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bovbjerg DH, 2003, BRAIN BEHAV IMMUN, V17, pS48; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Curtis AM, 2015, P NATL ACAD SCI USA, V112, P7231, DOI 10.1073/pnas.1501327112; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Franken P, 2000, J NEUROSCI, V20, P617, DOI 10.1523/JNEUROSCI.20-02-00617.2000; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gachon F, 2006, CIRCADIAN PAR DOMAIN, P25; Germain A, 2008, HUM PSYCHOPHARM CLIN, V23, P571, DOI 10.1002/hup.964; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Haimovich B, 2010, CRIT CARE MED, V38, P751, DOI 10.1097/CCM.0b013e3181cd131c; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Hamamura K, 2016, J BIOL CHEM, V291, P4913, DOI 10.1074/jbc.M115.696930; Haspel JA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5753; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Lee KS, 2007, CELL IMMUNOL, V245, P103, DOI 10.1016/j.cellimm.2007.04.003; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Metzger DW, 2013, J IMMUNOL, V191, P2047, DOI 10.4049/jimmunol.1301152; Mogensen TH, 2006, J LEUKOCYTE BIOL, V80, P267, DOI 10.1189/jlb.1105626; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Okada K, 2008, J SURG RES, V145, P5, DOI 10.1016/j.jss.2007.01.010; Paladino N, 2010, J NEUROIMMUNOL, V225, P62, DOI 10.1016/j.jneuroim.2010.04.015; Pollard LC, 2006, RHEUMATOLOGY, V45, P885, DOI 10.1093/rheumatology/kel021; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Silver A.C., 2012, IMMUNITY; Silver AC, 2012, BRAIN BEHAV IMMUN, V26, P407, DOI 10.1016/j.bbi.2011.10.001; Spengler ML, 2012, CORE CIRCADIAN PROTE, V109; Wang YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155075; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zee Phyllis C, 2013, Continuum (Minneap Minn), V19, P132, DOI 10.1212/01.CON.0000427209.21177.aa	39	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189949	10.1371/journal.pone.0189949	http://dx.doi.org/10.1371/journal.pone.0189949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253904	gold, Green Published, Green Submitted			2022-12-26	WOS:000418389500078
J	Pollard, AM; Sourjik, V				Pollard, Abiola M.; Sourjik, Victor			Transmembrane region of bacterial chemoreceptor is capable of promoting protein clustering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial signal transduction; chemotaxis; protein self-assembly; protein-protein interaction; transmembrane domain	ACCEPTING CHEMOTAXIS PROTEINS; ESCHERICHIA-COLI; IN-VIVO; ABUNDANCE CHEMORECEPTORS; ASPARTATE RECEPTOR; MEMBRANE-PROTEINS; CROSS-LINKING; ARRAYS; ORGANIZATION; COMMUNICATION	Many membrane proteins are known to form higher-order oligomers, but the degree to which membrane regions could facilitate protein complex assembly remains largely unclear. Clusters of chemotaxis receptors are among the most prominent structures in the bacterial cell membrane, and they play important functions in processing of chemotactic signals. Although much work has been done to elucidate mechanisms of cluster formation, it almost exclusively focused on cytoplasmic interactions among receptors and other chemotaxis proteins, whereas involvement of membrane-mediated interactions was only hypothesized. Here we used imaging of constructs composed of only a fluorescent protein and the TM helices of Tar to demonstrate that interactions between the lipid bilayer and transmembrane (TM) helices of Escherichia coli chemoreceptors alone are sufficient to mediate clustering. We found that the ability to cluster depends on the sequence or length of the TM helices, implying that certain conformations of these helices facilitate clustering, whereas others do not. Notably, observed sequence specificity was apparently consistent with differences in clustering between native E. coli receptors, with the TM sequence of better-clustering high-abundance receptors being more efficient in promoting membrane-mediated complex formation. These results indicate that being more than just membrane anchors, TM helices could play an important role in the clustering and organization of membrane proteins in bacteria.	[Pollard, Abiola M.; Sourjik, Victor] Max Planck Inst Terr Microbiol, Karl von Frisch Str 16, D-35043 Marburg, Germany; [Pollard, Abiola M.; Sourjik, Victor] LOEWE Ctr Synthet Microbiol SYNMIKRO, Karl von Frisch Str 16, D-35043 Marburg, Germany	Max Planck Society	Pollard, AM; Sourjik, V (corresponding author), Max Planck Inst Terr Microbiol, Karl von Frisch Str 16, D-35043 Marburg, Germany.; Pollard, AM; Sourjik, V (corresponding author), LOEWE Ctr Synthet Microbiol SYNMIKRO, Karl von Frisch Str 16, D-35043 Marburg, Germany.	abiola.pollard@synmikro.mpi-marburg.mpg.de; victor.sourjik@synmikro.mpi-marburg.mpg.de			Deutsche Forschungsgemeinschaft [SO 568/1-1, TRR174/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grants SO 568/1-1 and TRR174/1 from the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Bondar AN, 2012, BBA-BIOMEMBRANES, V1818, P942, DOI 10.1016/j.bbamem.2011.11.035; Briegel A, 2012, P NATL ACAD SCI USA, V109, P3766, DOI 10.1073/pnas.1115719109; Briegel A, 2009, P NATL ACAD SCI USA, V106, P17181, DOI 10.1073/pnas.0905181106; CALLAHAN AM, 1985, J BACTERIOL, V161, P96, DOI 10.1128/JB.161.1.96-104.1985; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; Cymer F, 2012, BBA-BIOMEMBRANES, V1818, P963, DOI 10.1016/j.bbamem.2011.07.035; Dukhovny A, 2009, J CELL SCI, V122, P1759, DOI 10.1242/jcs.039339; Endres RG, 2009, BIOPHYS J, V96, P453, DOI 10.1016/j.bpj.2008.10.021; Endres RG, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.49; Gestwicki JE, 2002, NATURE, V415, P81, DOI 10.1038/415081a; Govindarajan S, 2012, FEMS MICROBIOL REV, V36, P1005, DOI 10.1111/j.1574-6976.2012.00348.x; Haselwandter CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003932; Jones CW, 2015, TRENDS MICROBIOL, V23, P247, DOI 10.1016/j.tim.2015.03.004; Kaiser HJ, 2011, J BIOL CHEM, V286, P40631, DOI 10.1074/jbc.M111.276444; Kentner D, 2006, MOL MICROBIOL, V61, P407, DOI 10.1111/j.1365-2958.2006.05250.x; Killian JA, 2006, CURR OPIN STRUC BIOL, V16, P473, DOI 10.1016/j.sbi.2006.06.007; Liberman L, 2004, J BACTERIOL, V186, P6643, DOI 10.1128/JB.186.19.6643-6646.2004; Liu J, 2012, P NATL ACAD SCI USA, V109, pE1481, DOI 10.1073/pnas.1200781109; Lybarger SR, 2000, P NATL ACAD SCI USA, V97, P8057, DOI 10.1073/pnas.130195397; Lybarger SR, 2005, MOL MICROBIOL, V56, P1078, DOI 10.1111/j.1365-2958.2005.04593.x; MADDOCK JR, 1993, SCIENCE, V259, P1717; Melnyk RA, 2001, BIOCHEMISTRY-US, V40, P11106, DOI 10.1021/bi010642e; Milovanovic D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6984; Ortega DR, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004723; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; Piasta KN, 2014, BIOCHEMISTRY-US, V53, P5592, DOI 10.1021/bi500849p; Pinas GE, 2016, P NATL ACAD SCI USA, V113, P3335, DOI 10.1073/pnas.1600216113; Rudner DZ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000307; Sal-Man N, 2005, J BIOL CHEM, V280, P27449, DOI 10.1074/jbc.M503095200; Sal-Man N, 2004, J MOL BIOL, V344, P855, DOI 10.1016/j.jmb.2004.09.066; Sal-Man N, 2004, BIOCHEMISTRY-US, V43, P2309, DOI 10.1021/bi0356294; Shiomi D, 2005, J BACTERIOL, V187, P7647, DOI 10.1128/JB.187.22.7647-7654.2005; SLOCUM MK, 1985, J BACTERIOL, V163, P586, DOI 10.1128/JB.163.2.586-594.1985; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Sourjik V, 2010, EMBO J, V29, P2724, DOI 10.1038/emboj.2010.178; Strahl H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9728; Studdert CA, 2005, P NATL ACAD SCI USA, V102, P15623, DOI 10.1073/pnas.0506040102; Studdert CA, 2004, P NATL ACAD SCI USA, V101, P2117, DOI 10.1073/pnas.0308622100; Thanbichler M, 2008, NAT REV MICROBIOL, V6, P28, DOI 10.1038/nrmicro1795; Thiem S, 2007, EMBO J, V26, P1615, DOI 10.1038/sj.emboj.7601610; Wingreen NS, 2015, ANNU REV MICROBIOL, V69, P361, DOI 10.1146/annurev-micro-091014-104313; Yang YL, 2015, MOL MICROBIOL, V96, P1272, DOI 10.1111/mmi.13006; Zhou Q, 2011, MOL MICROBIOL, V80, P596, DOI 10.1111/j.1365-2958.2011.07577.x	44	10	10	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2149	2158		10.1074/jbc.M117.796722	http://dx.doi.org/10.1074/jbc.M117.796722			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29259129	hybrid, Green Published			2022-12-26	WOS:000424948000026
J	Al-Araimi, NA; Gaafar, OM; Costa, V; Neira, AL; Al-Atiyat, RM; Beja-Pereira, A				Al-Araimi, Nasser Ali; Gaafar, Osman Mahgoub; Costa, Vania; Neira, Agusto Luzuriaga; Al-Atiyat, Raed Mahmoud; Beja-Pereira, Albano			Genetic origin of goat populations in Oman revealed by mitochondrial DNA analysis	PLOS ONE			English	Article							CAPRA-HIRCUS; PHYLOGEOGRAPHIC STRUCTURE; MOLECULAR PHYLOGEOGRAPHY; DIVERSITY; DOMESTICATION; ARABIA; GROWTH; BREEDS	The Sultanate of Oman has a complex mosaic of livestock species and production systems, but the genetic diversity, demographic history or origins of these Omani animals has not been expensively studied. Goats might constitute one of the most abundant and important domestic livestock species since the Neolithic transition. Here, we examined the genetic diversity, origin, population structure and demographic history of Omani goats. Specifically, we analyzed a 525-bp fragment of the first hypervariable region of the mitochondrial DNA (mtDNA) control region from 69 Omani individuals and compared this fragment with 17 mtDNA sequences from Somalia and Yemen as well as 18 wild goat species and 1,198 previously published goat sequences from neighboring countries. The studied goat breeds show substantial diversity. The haplotype and nucleotide diversities of Omani goats were found equal to 0.983 +/- 0.006 and 0.0284 +/- 0.014, respectively. The phylogenetic analyses allowed us to classify Omani goats into three mtDNA haplogroups (A, B and G): haplogroup A was found to be predominant and widely distributed and accounted for 80% of all samples, and haplogroups B and G exhibited low frequencies. Phylogenetic comparisons with wild goats revealed that five of the native Omani goat populations originate from Capra aegagrus. Furthermore, most comparisons of pairwise population FST values within and between these five Omani goat breeds as well as between Omani goats and nine populations from nearby countries were not significant. These results suggest strong gene flow among goat populations caused by the extensive transport of goats and the frequent movements of human populations in ancient Arabia. The findings improve our understanding of the migration routes of modern goats from their region of domestication into southeastern Arabia and thereby shed light on human migratory and commercial networks during historical times.	[Al-Araimi, Nasser Ali; Costa, Vania; Neira, Agusto Luzuriaga; Beja-Pereira, Albano] Univ Porto, Res Ctr Biodivers & Genet Resources CIBIO, Oporto, Portugal; [Gaafar, Osman Mahgoub] Sultan Qaboos Univ, Dept Anim & Vet Sci, Coll Agr & Marine Sci, Al Khoud, Oman; [Al-Atiyat, Raed Mahmoud] Mutah Univ, Dept Anim Prod, Fac Agr, Al Karak, Jordan	Universidade do Porto; Sultan Qaboos University; Mutah University	Al-Araimi, NA (corresponding author), Univ Porto, Res Ctr Biodivers & Genet Resources CIBIO, Oporto, Portugal.	nsralaraimi@cibio.up.pt	Beja-Pereira, Albano/B-3681-2008; Al-Araimi, Nasser Ali/L-7636-2013	Beja-Pereira, Albano/0000-0002-1607-7382; Al-Atiyat, Raed/0000-0003-1182-6150; Al-Araimi, Nasser Ali/0000-0001-8158-0200; Luzuriaga-Neira, Agusto Rey/0000-0001-5516-9661	Ministry of Higher Education (MOHE) of the Sultanate of Oman [PGE047856]; Portuguese Foundation for Science and Technology (FCT) through an IF-FCT contract; FCT [SFRH / BD / 88129 /2012]; Secretary of Higher Education Science and Technology of Ecuador (SENESCYT)	Ministry of Higher Education (MOHE) of the Sultanate of Oman; Portuguese Foundation for Science and Technology (FCT) through an IF-FCT contract; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Secretary of Higher Education Science and Technology of Ecuador (SENESCYT)	N.A. Al-Araimi was supported by PhD scholarships from the Ministry of Higher Education (MOHE) of the Sultanate of Oman under project reference number PGE047856. A. Beja-Pereira is supported by the Portuguese Foundation for Science and Technology (FCT) through an IF-FCT contract. V. Costa is funded by an FCT grant (SFRH / BD / 88129 /2012). AL-N is funded by the Secretary of Higher Education Science and Technology of Ecuador (SENESCYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2017, MITOCHONDRIAL DNA A, V28, P711, DOI 10.3109/24701394.2016.1174225; Al-Abri A, 2012, AM J PHYS ANTHROPOL, V149, P291, DOI 10.1002/ajpa.22131; Al-Shahri A., 1994, DHOFAR ITS ANCIENT W; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beja-Pereira A, 2004, SCIENCE, V304, P1781, DOI 10.1126/science.1096008; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; Chen SY, 2010, MOL BIOL EVOL, V27, P1, DOI 10.1093/molbev/msp213; Chen SY, 2005, MOL PHYLOGENET EVOL, V37, P804, DOI 10.1016/j.ympev.2005.06.014; Clutton-Brock J, 1981, DOMESTICATED ANIMALS; Colli L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2342-2; Curci A, 2014, ANTHROPOZOOLOGICA, V49, P207, DOI 10.5252/az2014n2a04; Daar S, 2000, AM J HEMATOL, V64, P39, DOI 10.1002/(SICI)1096-8652(200005)64:1<39::AID-AJH7>3.0.CO;2-#; ElMahi A. T, 2001, ADUMATU, V3, P15; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fan B, 2007, SMALL RUMINANT RES, V73, P262, DOI 10.1016/j.smallrumres.2006.12.007; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fossati AE., 2015, 24 VALC S 2015 CAP P, P113; Fu YX, 1997, GENETICS, V147, P915; Guo J, 2005, ANIM GENET, V36, P331, DOI 10.1111/j.1365-2052.2005.01310.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Joshi MB, 2004, MOL BIOL EVOL, V21, P454, DOI 10.1093/molbev/msh038; Khan M, 2013, ARTS, V2, P447, DOI 10.3390/arts2040447; Kibegwa FM, 2016, J ANIM BREED GENET, V133, P238, DOI 10.1111/jbg.12182; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knights M, 1997, SMALL RUMINANT RES, V26, P203, DOI 10.1016/S0921-4488(96)00977-7; Lin BZ, 2013, ANIM GENET, V44, P79, DOI 10.1111/j.1365-2052.2012.02358.x; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; Lv FH, 2015, MOL BIOL EVOL, V32, P2515, DOI 10.1093/molbev/msv139; Mannen H, 2001, BIOCHEM GENET, V39, P145, DOI 10.1023/A:1010266207735; Maraqten M, 2015, ARAB ARCHAEOL EPIGR, V26, P208, DOI 10.1111/aae.12059; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Mery S., 2013, REV ETHNOECOLOGIE, V4; Ministry of Agriculture and Fisheries Wealth, 2013, RES AGR CENS 2012 20; Mwacharo JM, 2011, MOL PHYLOGENET EVOL, V58, P374, DOI 10.1016/j.ympev.2010.11.027; Naderi S, 2008, P NATL ACAD SCI USA, V105, P17659, DOI 10.1073/pnas.0804782105; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Nomura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067775; Payne W.J.A., 1999, INTRO ANIMAL HUSBAND; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pietro P, 2003, DNA SEQUENCE, V14, P199, DOI 10.1080/1042517031000089487; Porter V., 1996, GOATS OF THE WORLD; Rose J.I., 2007, P SEMINAR ARABIAN ST, V37, P219; Rowold DJ, 2007, J HUM GENET, V52, P436, DOI 10.1007/s10038-007-0132-7; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sardina MT, 2006, ANIM GENET, V37, P376, DOI 10.1111/j.1365-2052.2006.01451.x; Shackleton DM, 1997, WILD SHEEP GOATS THE; Sultana S, 2003, ANIM GENET, V34, P417, DOI 10.1046/j.0268-9146.2003.01040.x; Sultana Saira, 2004, Animal Science Journal, V75, P303, DOI 10.1111/j.1740-0929.2004.00190.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vigne J-D., 2005, 1 STEPS ANIMAL DOMES; Wilson RT, 1984, THE CAMEL; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254; Zhao YJ, 2014, MOL BIOL REP, V41, P3695, DOI 10.1007/s11033-014-3234-2	55	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190235	10.1371/journal.pone.0190235	http://dx.doi.org/10.1371/journal.pone.0190235			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281717	Green Published, Green Submitted, gold			2022-12-26	WOS:000419006200075
J	Yu, HA; Daeid, NN; Dawson, LA; DeTata, DA; Lewis, SW				Yu, Holly A.; Daeid, Niamh Nic; Dawson, Lorna A.; DeTata, David A.; Lewis, Simon W.			Explosive detonation causes an increase in soil porosity leading to increased TNT transformation	PLOS ONE			English	Article							RAY COMPUTED-TOMOGRAPHY; DEGRADATION-PRODUCTS; HEXAHYDRO-1,3,5-TRINITRO-1,3,5-TRIAZINE RDX; GAS-CHROMATOGRAPHY; ENVIRONMENTAL FATE; NITROAROMATIC TNT; NITRAMINE RDX; RESIDUES; SORPTION; HMX	Explosives are a common soil contaminant at a range of sites, including explosives manufacturing plants and areas associated with landmine detonations. As many explosives are toxic and may cause adverse environmental effects, a large body of research has targeted the remediation of explosives residues in soil. Studies in this area have largely involved spiking 'pristine' soils using explosives solutions. Here we investigate the fate of explosives present in soils following an actual detonation process and compare this to the fate of explosives spiked into 'pristine' undetonated soils. We also assess the effects of the detonations on the physical properties of the soils. Our scanning electron microscopy analyses reveal that detonations result in newly-fractured planes within the soil aggregates, and novel micro Computed Tomography analyses of the soils reveal, for the first time, the effect of the detonations on the internal architecture of the soils. We demonstrate that detonations cause an increase in soil porosity, and this correlates to an increased rate of TNT transformation and loss within the detonated soils, compared to spiked pristine soils. We propose that this increased TNT transformation is due to an increased bioavailability of the TNT within the now more porous post-detonation soils, making the TNT more easily accessible by soil-borne bacteria for potential biodegradation. This new discovery potentially exposes novel remediation methods for explosive contaminated soils where actual detonation of the soil significantly promotes subsequent TNT degradation. This work also suggests previously unexplored ramifications associated with high energy soil disruption.	[Yu, Holly A.; Lewis, Simon W.] Curtin Univ, Dept Chem, Perth, WA, Australia; [Yu, Holly A.; Lewis, Simon W.] Curtin Univ, Curtin Inst Funct Mol & Interfaces, Perth, WA, Australia; [Yu, Holly A.; Daeid, Niamh Nic] Univ Dundee, Sch Sci & Engn, Ctr Anat & Human Identificat, Dundee, Scotland; [Dawson, Lorna A.] James Hutton Inst, Aberdeen, Scotland; [DeTata, David A.] ChemCentre, Forens Sci Lab, Perth, WA, Australia	Curtin University; Curtin University; University of Dundee; James Hutton Institute	Daeid, NN (corresponding author), Univ Dundee, Sch Sci & Engn, Ctr Anat & Human Identificat, Dundee, Scotland.	n.nicdaeid@dundee.ac.uk	Dawson, Lorna/K-4063-2012; Lewis, Simon/A-5181-2012	Lewis, Simon/0000-0002-2049-1586; NicDaeid, Niamh/0000-0002-9338-0887; Yu, Holly/0000-0002-9559-3376	Curtin International Postgraduate Research Scholarship	Curtin International Postgraduate Research Scholarship	Many thanks to members of the Western Australia Police Tactical Response Group-Bomb Response Unit for their expertise during the range days required for this work. The explosives standards used throughout this work were kindly provided by the Forensic Science Laboratory, ChemCentre, WA, Australia. SEM analyses were kindly performed by Dr Kari Pitts, ChemCentre, WA, and Evelyne Delbos, The James Hutton Institute, Aberdeen. HAY is supported by a Curtin International Postgraduate Research Scholarship. Dr Laszlo Csetenyi, University of Dundee, is gratefully acknowledged for his help with the micro CT analysis.	Ainsworth C.C., 1993, RELATIONSHIP LEACHAB; Akbari A, 2015, ENVIRON SCI TECHNOL, V49, P14368, DOI 10.1021/acs.est.5b03618; Alavi G, 2011, J HAZARD MATER, V185, P1600, DOI 10.1016/j.jhazmat.2010.10.039; Allen T., 2003, POWDER SAMPLING PART, P1; Batlle R, 2005, ANAL CHEM, V77, P4241, DOI 10.1021/ac050339+; BAYNE CK, 1994, ENVIRON SCI TECHNOL, V28, P1430, DOI 10.1021/es00057a009; Collins CD, 1999, TRENDS PLANT SCI, V4, P45, DOI 10.1016/S1360-1385(99)01374-6; DeTata D, 2013, AUST J FORENSIC SCI, V45, P71, DOI 10.1080/00450618.2012.691548; Dontsova KM, 2009, J ENVIRON QUAL, V38, P1458, DOI 10.2134/jeq2008.0183; Douglas TA, 2012, WATER AIR SOIL POLL, V223, P2189, DOI 10.1007/s11270-011-1015-2; Douglas TA, 2011, ENVIRON TOXICOL CHEM, V30, P345, DOI 10.1002/etc.383; Douglas TA, 2009, J ENVIRON QUAL, V38, P2285, DOI 10.2134/jeq2008.0477; GRANT CL, 1995, ENVIRON TOXICOL CHEM, V14, P1865, DOI 10.1002/etc.5620141108; Groom CA, 2001, J CHROMATOGR A, V909, P53, DOI 10.1016/S0021-9673(00)01043-8; Haderlein SB, 1996, ENVIRON SCI TECHNOL, V30, P612, DOI 10.1021/es9503701; Hairston D, 1998, CHEM ENG-NEW YORK, V105, P28; Halasz A, 2002, J CHROMATOGR A, V963, P411, DOI 10.1016/S0021-9673(02)00553-8; Hawari J, 2000, APPL MICROBIOL BIOT, V54, P605, DOI 10.1007/s002530000445; Heinegg A, BROWNFIELD REMEDIATI; Jaramillo AM, 2011, CHEMOSPHERE, V84, P1058, DOI 10.1016/j.chemosphere.2011.04.066; Jayamani I, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1745-4; Kalderis D, 2011, PURE APPL CHEM, V83, P1407, DOI 10.1351/PAC-REP-10-01-05; Larson SL, 2008, ENVIRON SCI TECHNOL, V42, P786, DOI 10.1021/es0717360; Lewis TA, 2004, J ENVIRON MANAGE, V70, P291, DOI 10.1016/j.jenvman.2003.12.005; Longo A, 2017, ENVIRON RESOUR ECON, V67, P261, DOI 10.1007/s10640-015-9985-y; Marchuk A, 2012, SOIL RES, V50, P638, DOI 10.1071/SR12276; Maskarinec MP, 1991, STABILITY EXPLOSIVES; Mayfield HT, 2006, ANAL LETT, V39, P1463, DOI 10.1080/00032710600669358; Monteil-Rivera F, 2003, ENVIRON SCI TECHNOL, V37, P3878, DOI 10.1021/es030407e; Nielsen BD, 2004, THESIS; Nunan N, 2006, GEODERMA, V133, P398, DOI 10.1016/j.geoderma.2005.08.004; Oxley JC, 2003, J FORENSIC SCI, V48, P742; Pennington JC, 2002, THERMOCHIM ACTA, V384, P163, DOI 10.1016/S0040-6031(01)00801-2; Peth S, 2008, SOIL SCI SOC AM J, V72, P897, DOI 10.2136/sssaj2007.0130; PICHTEL J, 2012, APPL ENVIRON SOIL SC, V2012, DOI DOI 10.1155/2012/617236; Rafson HJ, 2000, BROWNFIELDS REDEVELO; Sagi-Ben Moshe S, 2012, J HAZARD MATER, V203, P333, DOI 10.1016/j.jhazmat.2011.12.029; Sheremata TW, 2001, ENVIRON SCI TECHNOL, V35, P1037, DOI 10.1021/es001389t; Singh A, 2009, BIOL REMEDIATION SOI, P1; Singh N, 2008, J ENVIRON SCI HEAL A, V43, P348, DOI 10.1080/10934520701795434; Sissell K, 1997, CHEM WEEK, pS20; Walsh ME, 2011, ACS SYM SER, V1069, P91; Walsh ME, 2001, TALANTA, V54, P427, DOI 10.1016/S0039-9140(00)00541-5; Yamamoto H, 2004, SOIL SEDIMENT CONTAM, V13, P459, DOI 10.1080/10588330490500419; Yu HA, 2017, TALANTA, V164, P716, DOI 10.1016/j.talanta.2016.07.001	45	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189177	10.1371/journal.pone.0189177	http://dx.doi.org/10.1371/journal.pone.0189177			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281650	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000419006200015
J	De Silva, DA; Proctor, L; von Dadelszen, P; McCoach, M; Lee, T; Magee, LA				De Silva, Dane A.; Proctor, Lily; von Dadelszen, Peter; McCoach, Meghan; Lee, Tang; Magee, Laura A.		Canadian Perinatal Network CPN	Determinants of magnesium sulphate use in women hospitalized at < 29 weeks with severe or non-severe pre-eclampsia	PLOS ONE			English	Article							SOCIETY CONSENSUS CONFERENCE; HYPERTENSIVE DISORDERS; MANAGEMENT; PREVENTION; DIAGNOSIS; ECLAMPSIA	Objective Magnesium sulphate is recommended by international guidelines to prevent eclampsia among women with pre-eclampsia, especially when it is severe, but fewer than 70% of such women receive magnesium sulphate. We aimed to identify variables that prompt Canadian physicians to administer magnesium sulphate to women with pre-eclampsia. Methods Data were used from the Canadian Perinatal Network (2005 +/- 11) of women hospitalized at < 29 weeks' who were thought to be at high risk of delivery due to pre-eclampsia (using broad Canadian definition). Unadjusted analyses of relative risks were estimated directly and population attributable risk percent (PAR%) calculated to identify variables associated with magnesium sulphate use. A multivariable model was created and a generalized estimating equation was used to estimate the adjusted RR that explained magnesium sulphate use in pre-eclampsia. The adjusted PAR% was estimated by bootstrapping. Results Of 631 women with pre-eclampsia, 174 (30.1%) had severe pre-eclampsia, of whom 131 (75.3%) received magnesium sulphate. 457 (69.9%) women had non-severe pre-eclamspia, of whom 291 (63.7%) received magnesium sulphate. Use of magnesium sulphate among women with pre-eclampsia could be attributed to the following clinical factors (PAR %): delivery for 'adverse conditions' (48.7%), severe hypertension (21.9%), receipt of antenatal corticosteroids (20.0%), maternal transport prior to delivery (9.9%), heavy proteinuria (7.8%), and interventionist care (3.4%). Conclusions Clinicians are more likely to administer magnesium sulphate for eclampsia prophylaxis in the presence of more severe maternal clinical features, in addition to concomitant antenatal corticosteroid administration, and shorter admission to delivery periods related to transport from another institution or plans for interventionist care.	[De Silva, Dane A.; Proctor, Lily; McCoach, Meghan; Lee, Tang] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada; [von Dadelszen, Peter; Magee, Laura A.] St Thomas Hosp, Dept Women & Childrens Hlth, London, England; [von Dadelszen, Peter; Magee, Laura A.] Kings Coll London, Sch Life Course Sci, Fac Life Sci & Med, London, England	University of British Columbia; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Magee, LA (corresponding author), St Thomas Hosp, Dept Women & Childrens Hlth, London, England.; Magee, LA (corresponding author), Kings Coll London, Sch Life Course Sci, Fac Life Sci & Med, London, England.	Laura.A.Magee@kcl.ac.uk	von Dadelszen, Peter/AAP-7480-2021; De Silva, Dane/AAC-9050-2022	De Silva, Dane/0000-0001-6558-2716; Magee, Laura/0000-0002-1355-610X; von Dadelszen, Peter/0000-0003-4136-3070	Canadian Institutes of Health Research [MOP-74720]; Ontario Ministry of Long-term Care	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Long-term Care	The CPN was funded by the Canadian Institutes of Health Research (LAM, MOP-74720) and Ontario Ministry of Long-term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	De Silva DA, 2015, J OBSTET GYNAECOL CA, V37, P975, DOI 10.1016/S1701-2163(16)30047-0; DULEY L, 1995, LANCET, V345, P1455; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Gillon TER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113715; Girard P, 2014, OBSTET MED, V7, P71, DOI 10.1177/1753495X13518319; Helewa ME, 1997, CAN MED ASSOC J, V157, P715; Magee LA, 2014, J OBSTET GYNAECOL CA, V36, P575, DOI [10.1016/S1701-2163(15)30532-6, 10.1016/S1701-2163(15)30533-8]; Magee LA, 2014, PREGNANCY HYPERTENS, V4, P105, DOI 10.1016/j.preghy.2014.01.003; Magee LA, 2011, J OBSTET GYNAECOL CA, V33, P111, DOI 10.1016/S1701-2163(16)34795-8; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; Morgenstern H., 2008, ENCY EPIDEMIOLOGY, V2, P56; Moutquin JM, 1997, CAN MED ASSOC J, V157, P907; Rey E, 1997, CAN MED ASSOC J, V157, P1245; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Simon J, 2006, BJOG-INT J OBSTET GY, V113, P144, DOI 10.1111/j.1471-0528.2005.00785.x; von Dadelszen P, 2011, LANCET, V377, P219, DOI 10.1016/S0140-6736(10)61351-7; World Health Organization, 2011, WHO REC PREV TREATM	17	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0189966	10.1371/journal.pone.0189966	http://dx.doi.org/10.1371/journal.pone.0189966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272274	Green Published, gold, Green Submitted			2022-12-26	WOS:000418651500019
J	Milczarski, P; Masojc, P; Krajewski, P; Stochmal, A; Kowalczyk, M; Angelov, M; Ivanova, V; Schollenberger, M; Wakulinski, W; Banaszak, Z; Banaszak, K; Rakoczy-Trojanowska, M				Milczarski, Pawel; Masojc, Piotr; Krajewski, Pawel; Stochmal, Anna; Kowalczyk, Mariusz; Angelov, Mihail; Ivanova, Valentina; Schollenberger, Malgorzata; Wakulinski, Wojciech; Banaszak, Zofia; Banaszak, Katarzyna; Rakoczy-Trojanowska, Monika			QTL mapping for benzoxazinoid content, preharvest sprouting, alpha-amylase activity, and leaf rust resistance in rye (Secale cereale L.)	PLOS ONE			English	Article							GENETIC-ANALYSIS; HYDROXAMIC ACIDS; WHEAT; BIOSYNTHESIS; CLUSTER	Mapping population of recombinant inbred lines (RILs) representing 541 x Ot1-3 cross exhibited wide variations of benzoxazinoid (BX) content in leaves and roots, brown rust resistance, a-amylase activity in the grain, and resistance to preharvest sprouting. QTL mapping of major BX species using a DArT-based map revealed a complex genetic architecture underlying the production of these main secondary metabolites engaged in stress and allelopathy responses. The synthesis of BX in leaves and roots was found to be regulated by different QTL. The QTL for the BX content, rust resistance, alpha-amylase activity, and preharvest sprouting partially overlapped; this points to their common genetic regulation by a definite subset of genes. Only one QTL for BX located on chromosome 7R coincided with the loci of the ScBx genes, which were mapped as two clusters on chromosomes 5RS (Bx3Bx5) and 7R (Bx1-Bx2). The QTL common for several BX species, rust resistance, preharvest sprouting, and a-amylase activity are interesting objects for further exploration aimed at developing common markers for these important agronomic traits.	[Milczarski, Pawel; Masojc, Piotr; Angelov, Mihail; Ivanova, Valentina] West Pomeranian Univ Technol, Szczecin, Poland; [Krajewski, Pawel] Polish Acad Sci, Inst Plant Genet, Poznan, Poland; [Stochmal, Anna; Kowalczyk, Mariusz] State Res Inst, Inst Soil Sci & Plant Cultivat, Pulawy, Poland; [Schollenberger, Malgorzata; Wakulinski, Wojciech; Rakoczy-Trojanowska, Monika] Warsaw Univ Life Sci, Warsaw, Poland; [Banaszak, Zofia; Banaszak, Katarzyna] Danko Plant Breeders LTD, Koscian, Poland; [Rakoczy-Trojanowska, Monika] Polish Acad Sci, Ctr Biol Div Conservat Powsin Warszawa, Bot Garden, Warsaw, Poland	West Pomeranian University of Technology; Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences; Institute of Soil Science & Plant Cultivation; Warsaw University of Life Sciences; Polish Academy of Sciences	Milczarski, P (corresponding author), West Pomeranian Univ Technol, Szczecin, Poland.	pawel.milczarski@zut.edu.pl	Ivanova, Valentina/Y-8855-2019; Kowalczyk, Mariusz/ABD-2910-2020; Angelov, Mihail/GQZ-4129-2022; Milczarski, Paweł/M-6657-2016; Stochmal, Anna/AAR-1759-2021; Masojć, Piotr/J-4795-2016	Ivanova, Valentina/0000-0001-7150-9371; Kowalczyk, Mariusz/0000-0001-7454-4762; Angelov, Mihail/0000-0002-7228-5581; Milczarski, Paweł/0000-0003-2622-8938; Masojc, Piotr/0000-0002-3376-5988; Krajewski, Pawel/0000-0001-5318-9896; Wakulinski, Wojciech/0000-0002-6441-4590; Schollenberger, Malgorzata/0000-0001-5475-704X; Rakoczy-Trojanowska, Monika/0000-0001-6891-0471	National Centre for Research and Development [PBS1/A8/12/2012]; Danko Plant Breeders LTD	National Centre for Research and Development(National Centre for Research & Development, Poland); Danko Plant Breeders LTD	This work was financially supported by the National Centre for Research and Development, Project No. PBS1/A8/12/2012 (http://www.ncbr.gov.pl/programy.krajowe/program-badan-stosowanych/). Danko Plant Breeders LTD provided partial funding for this project as a commercial partner. Danko Plant Breeders LTD also provided support in the form of salaries for Zofia Banaszak and Katarzyna Banaszak, but had no further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bakera B, 2015, J APPL GENET, V56, P287, DOI 10.1007/s13353-015-0271-z; Brooks AM, 2012, PLANT BREEDING, V131, P104, DOI 10.1111/j.1439-0523.2011.01885.x; Butron A, 2010, THEOR APPL GENET, V120, P721, DOI 10.1007/s00122-009-1192-1; Cullis BR, 2006, J AGR BIOL ENVIR ST, V11, P381, DOI 10.1198/108571106X154443; DEVOS KM, 1993, THEOR APPL GENET, V85, P673, DOI 10.1007/BF00225004; Dutartre L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-64; International VSN, 2013, GENSTAT WINDOWS; Kato-Noguchi H, 2010, J PLANT PHYSIOL, V167, P1221, DOI 10.1016/j.jplph.2010.04.006; MASOJC P, 1991, SWED J AGR RES, V21, P141; Masojc P, 2009, EUPHYTICA, V170, P123, DOI 10.1007/s10681-009-9952-1; Masojc P, 2007, J APPL GENET, V48, P211, DOI 10.1007/BF03195215; Masojc Piotr, 2005, Journal of Applied Genetics, V46, P115; Masojc P, 2016, J APPL GENET, V57, P165, DOI 10.1007/s13353-015-0321-6; Masojc P, 2013, J APPL GENET, V54, P11, DOI 10.1007/s13353-012-0127-8; Masojc P, 2012, MOL BREEDING, V30, P1355, DOI 10.1007/s11032-012-9721-z; Masojc P, 2011, J APPL GENET, V52, P153, DOI 10.1007/s13353-010-0025-x; Masojc P, 2009, MOL BREEDING, V23, P75, DOI 10.1007/s11032-008-9215-1; Miedaner T, 2002, PLANT BREEDING, V121, P475, DOI 10.1046/j.1439-0523.2002.00765.x; Miedaner T, 1995, J PHYTOPATHOL, V143, P725, DOI 10.1111/j.1439-0434.1995.tb00230.x; Milczarski P, 2007, J APPL GENET, V48, P11, DOI 10.1007/BF03194653; Milczarski P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028495; Myskow B, 2012, MOL BREEDING, V30, P367, DOI 10.1007/s11032-011-9627-1; NIEMEYER HM, 1988, PHYTOCHEMISTRY, V27, P3349, DOI 10.1016/0031-9422(88)80731-3; Nomura T, 2003, PLANTA, V217, P776, DOI 10.1007/s00425-003-1040-5; PEREZ FJ, 1991, J CHEM ECOL, V17, P1037, DOI 10.1007/BF01402932; Poschenrieder C, 2005, J INORG BIOCHEM, V99, P1830, DOI 10.1016/j.jinorgbio.2005.05.017; Rakoczy-Trojanowska M, 2017, PLANT MOL BIOL REP, V35, P366, DOI 10.1007/s11105-017-1030-6; Rakoczy-Trojanowska M, 2017, J APPL GENET, V58, P1, DOI 10.1007/s13353-016-0356-3; Schulz M, 2013, J CHEM ECOL, V39, P154, DOI 10.1007/s10886-013-0235-x; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Sue M, 2011, PLANT PHYSIOL, V157, P985, DOI 10.1104/pp.111.182378; Tanwir F, 2013, FOOD CHEM, V141, P444, DOI 10.1016/j.foodchem.2013.02.109; Twardowska M, 2005, EUPHYTICA, V143, P257, DOI 10.1007/s10681-005-7873-1; Wang S, 2012, WINDOWS QTL CARTOGRA; Wehling P, 2003, THEOR APPL GENET, V107, P432, DOI 10.1007/s00122-003-1263-7; Zheng LL, 2015, J EXP BOT, V66, P3917, DOI 10.1093/jxb/erv192	36	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189912	10.1371/journal.pone.0189912	http://dx.doi.org/10.1371/journal.pone.0189912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267335	gold, Green Published, Green Submitted			2022-12-26	WOS:000418587400062
J	Singhal, S; Guerrero, CML; Whang, SG; McClure, EM; Busch, HG; Kerr, B				Singhal, Sonia; Guerrero, Cierra M. Leon; Whang, Stella G.; McClure, Erin M.; Busch, Hannah G.; Kerr, Benjamin			Adaptations of an RNA virus to increasing thermal stress	PLOS ONE			English	Article							EXPERIMENTAL YEAST POPULATIONS; DSRNA BACTERIOPHAGE PHI-6; MINUS-STRAND SYNTHESIS; CHANGING ENVIRONMENT; EVOLUTIONARY RESCUE; PROMOTES EVOLVABILITY; ASEXUAL POPULATION; MOVING OPTIMUM; EXTINCTION; PROTEIN	Environments can change in incremental fashions, where a shift from one state to another occurs over multiple organismal generations. The rate of the environmental change is expected to influence how and how well populations adapt to the final environmental state. We used a model system, the lytic RNA bacteriophage Phi 6, to investigate this question empirically. We evolved viruses for thermostability by exposing them to heat shocks that increased to a maximum temperature at different rates. We observed increases in the ability of many heat-shocked populations to survive high temperature heat shocks. On their first exposure to the highest temperature, populations that experienced a gradual increase in temperature had higher average survival than populations that experienced a rapid temperature increase. However, at the end of the experiment, neither the survival of populations at the highest temperature nor the number of mutations per population varied significantly according to the rate of thermal change. We also evaluated mutations from the endpoint populations for their effects on viral thermostability and growth. As expected, some mutations did increase viral thermostability. However, other mutations decreased thermostability but increased growth rate, suggesting that benefits of an increased replication rate may have sometimes outweighed the benefits of enhanced thermostability. Our study highlights the importance of considering the effects of multiple selective pressures, even in environments where a single factor changes.	[Singhal, Sonia; Guerrero, Cierra M. Leon; Whang, Stella G.; McClure, Erin M.; Busch, Hannah G.; Kerr, Benjamin] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Singhal, Sonia] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill	Singhal, S (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.; Singhal, S (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	ssinghal@email.unc.edu		McClure, Erin/0000-0002-6604-1273; Singhal, Sonia/0000-0002-5531-8193	National Science Foundation (NSF) [DBI-0939454]; NSF CAREER Award [DEB0952825]; NSF Graduate Research Fellowship [DGE-0718124, DGE-1256082]; Ronald E. McNair Post-Baccalaureate Scholarship; Mary Gates Research Scholarship; Walter and Margaret Sargent Award from the University of Washington Department of Biology; Kathryn C. Hahn Writing Fellowship from the University of Washington Department of Biology	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Ronald E. McNair Post-Baccalaureate Scholarship; Mary Gates Research Scholarship; Walter and Margaret Sargent Award from the University of Washington Department of Biology; Kathryn C. Hahn Writing Fellowship from the University of Washington Department of Biology	This work was supported by the following grants: the National Science Foundation (NSF; https://www.nsf.gov/) under Cooperative Agreement DBI-0939454 (to BK); an NSF CAREER Award to BK (Grant DEB0952825); an NSF Graduate Research Fellowship to SS (Awards DGE-0718124 and DGE-1256082); a Ronald E. McNair Post-Baccalaureate Scholarship to CMLG http://depts.washington.edu/uwmcnair/); a Mary Gates Research Scholarship to EMM http://expd.uw.edu/mge/about/); and a Walter and Margaret Sargent Award (to EMM) and Kathryn C. Hahn Writing Fellowship (to SS) from the University of Washington Department of Biology (https://www.biology.washington.edu/about-us/support-uw-biology).	Alto BW, 2013, EVOLUTION, V67, P969, DOI 10.1111/evo.12034; Arribas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100940; Baym M, 2016, SCIENCE, V353, P1147, DOI 10.1126/science.aag0822; Bell G, 2008, EVOL APPL, V1, P3, DOI 10.1111/j.1752-4571.2007.00011.x; Bell G, 2011, SCIENCE, V332, P1327, DOI 10.1126/science.1203105; Bello Y, 2006, J THEOR BIOL, V239, P152, DOI 10.1016/j.jtbi.2005.08.044; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Broom M, 2003, MATH BIOSCI, V186, P93, DOI 10.1016/S0025-5564(03)00097-X; BURGER R, 1995, EVOLUTION, V49, P151, DOI 10.1111/j.1558-5646.1995.tb05967.x; Chevin LM, 2013, EVOLUTION, V67, P708, DOI 10.1111/j.1558-5646.2012.01809.x; Collins S, 2007, GENETICS, V176, P1089, DOI 10.1534/genetics.107.072926; Collins S, 2009, EVOLUTION, V63, P2952, DOI 10.1111/j.1558-5646.2009.00770.x; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dessau M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003102; Duffy S, 2006, GENETICS, V172, P751, DOI 10.1534/genetics.105.051136; Fisher, 1958, GENETICAL THEORY NAT; Ford BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113078; FRILANDER M, 1992, J VIROL, V66, P5013, DOI 10.1128/JVI.66.8.5013-5017.1992; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Goldhill D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00035; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Gomulkiewicz R, 2009, AM NAT, V174, pE218, DOI 10.1086/645086; Gong LI, 2013, ELIFE, V2, DOI 10.7554/eLife.00631; Gorter FA, 2016, AM NAT, V187, P110, DOI 10.1086/684104; GOTTLIEB P, 1992, J VIROL, V66, P2611, DOI 10.1128/JVI.66.5.2611-2616.1992; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hao YQ, 2015, ECOL LETT, V18, P892, DOI 10.1111/ele.12465; KEELING CD, 1995, NATURE, V375, P666, DOI 10.1038/375666a0; Kirkpatrick M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0082; Kopp M, 2007, GENETICS, V176, P715, DOI 10.1534/genetics.106.067215; Kopp M, 2014, EVOL APPL, V7, P169, DOI 10.1111/eva.12127; Lindsey HA, 2013, NATURE, V494, P463, DOI 10.1038/nature11879; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; LYNCH M, 1991, LIMNOL OCEANOGR, V36, P1301, DOI 10.4319/lo.1991.36.7.1301; McBride RC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-231; Mindich L, 1999, ADV VIRUS RES, V53, P341, DOI 10.1016/S0065-3527(08)60355-3; MINDICH L, 1994, VIROLOGY, V202, P258, DOI 10.1006/viro.1994.1341; MINDICH L, 1985, J BACTERIOL, V162, P992, DOI 10.1128/JB.162.3.992-999.1985; MINDICH L, 1979, J VIROL, V30, P489, DOI 10.1128/JVI.30.2.489-496.1979; Morley VJ, 2017, EVOLUTION, V71, P872, DOI 10.1111/evo.13193; Morley VJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0801; OLKKONEN VM, 1991, J MOL BIOL, V218, P569, DOI 10.1016/0022-2836(91)90702-8; ONODERA S, 1992, J VIROL, V66, P190, DOI 10.1128/JVI.66.1.190-196.1992; ONODERA S, 1993, J VIROL, V67, P4914, DOI 10.1128/JVI.67.8.4914-4922.1993; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; PEASE CM, 1989, ECOLOGY, V70, P1657, DOI 10.2307/1938100; Peischl S, 2012, GENETICS, V191, P895, DOI 10.1534/genetics.112.140756; Perron GG, 2008, J EVOLUTION BIOL, V21, P1724, DOI 10.1111/j.1420-9101.2008.01596.x; Samani P, 2010, J EVOLUTION BIOL, V23, P791, DOI 10.1111/j.1420-9101.2010.01945.x; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Sun Y, 2004, VIROLOGY, V319, P274, DOI 10.1016/j.virol.2003.10.022; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Turner PE, 2010, EVOLUTION, V64, P3273, DOI 10.1111/j.1558-5646.2010.01051.x; Uecker H, 2011, GENETICS, V188, P915, DOI 10.1534/genetics.110.124297; Vogwill T, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0749; Wahl LM, 2002, GENETICS, V162, P961; Warneke C, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017899; Waxman D, 1999, GENETICS, V153, P1041	62	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189602	10.1371/journal.pone.0189602	http://dx.doi.org/10.1371/journal.pone.0189602			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267297	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400035
J	Dabi, Y; Darrigues, L; Pons, K; Mabille, M; Abd alsamad, I; Mitri, R; Skalli, D; Haddad, B; Touboul, C				Dabi, Yohann; Darrigues, Lauren; Pons, Kelly; Mabille, Mylene; Abd alsamad, Issam; Mitri, Rana; Skalli, Dounia; Haddad, Bassam; Touboul, Cyril			Incidence of inflammatory breast cancer in patients with clinical inflammatory breast symptoms	PLOS ONE			English	Article							CARCINOMA; GUIDELINES; PREGNANCY; MASTITIS; MRI	Background To describe a large cohort of women with non-puerperal inflammatory breast and to identify characteristics of inflammatory breast cancer. Methods All patients consulting for inflammatory breast syndrome in the breast unit of our tertiary University hospital between September 2013 and December 2015 were prospectively included. We excluded women who were pregnant or in the postpartum period. Patients underwent systematic clinical examination and imaging (breast ultrasonography and mammography). A biopsy was performed if the clinician suspected a malignant lesion of the breast. Clinicopathologic and radiologic data were registered. Statistics were performed using R (3.0.2 version) software. Results Among the 76 patients screened and included, 38 (50%) had a malignant lesion at final diagnosis, 21 (27.6%) were diagnosed with infectious disease and 17 (22.4%) with inflammatory disease of the breast. When compared to patients with benign disease, patients with a malignant lesion were significantly older (p = 0.022, CI95% 1.78-14.7), had a significantly bigger palpable mass (p<0.001, CI 95% 22.8-58.9), were more likely to have skin thickening (p = 0.05) and had more suspicious lymph nodes at clinical examination (p<0.001, CI 95% 2.72-65.3). Precise limits on ultrasonography were significantly associated with benign lesions. The presence of a mass (p = 0.04), micro calcifications (p = 0.04) or of focal asymmetry (p<0.001, CI95% 1.3-618) on mammography was significantly associated with malignant disease. Conclusion Inflammatory breast cancer was common in our cohort of women consulting for inflammatory breast syndrome. Identifying these patients with high-risk malignancy is crucial in the management of an inflammatory breast.	[Dabi, Yohann; Darrigues, Lauren; Pons, Kelly; Skalli, Dounia; Haddad, Bassam; Touboul, Cyril] Ctr Hosp Intercommunal Creteil, Serv Gynecol Obstet & Med Reprod, Fac Med Creteil UPEC Paris 12, Creteil, France; [Mabille, Mylene] Ctr Hosp Intercommunal Creteil, Serv Radiol, Creteil, France; [Abd alsamad, Issam; Mitri, Rana] Ctr Hosp Intercommunal Creteil, Serv Anatomopathol, Creteil, France; [Touboul, Cyril] Hop Lariboisiere, Angiogenese & Rech Translat, INSERM, UMR,U965, Paris, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Touboul, C (corresponding author), Ctr Hosp Intercommunal Creteil, Serv Gynecol Obstet & Med Reprod, Fac Med Creteil UPEC Paris 12, Creteil, France.; Touboul, C (corresponding author), Hop Lariboisiere, Angiogenese & Rech Translat, INSERM, UMR,U965, Paris, France.	cyril.touboul@gmail.com	Haddad, Bassam/Q-7767-2018					Boisserie-Lacroix M, 2012, Diagn Interv Imaging, V93, P126, DOI 10.1016/j.diii.2011.12.005; Boutet G, 2012, Diagn Interv Imaging, V93, P78, DOI 10.1016/j.diii.2011.12.001; Cariati M, 2005, SURG ONCOL, V14, P133, DOI 10.1016/j.suronc.2005.07.004; CROWE DJ, 1995, INVEST RADIOL, V30, P582, DOI 10.1097/00004424-199510000-00003; Dawood S, 2011, ONCOLOGY-NY, V25, P264; Ferron S, 2012, Diagn Interv Imaging, V93, P85, DOI 10.1016/j.diii.2011.12.002; Froman J, 2011, SURGERY, V149, P813, DOI 10.1016/j.surg.2010.12.013; Gunhan-Bilgen I, 2002, RADIOLOGY, V223, P829, DOI 10.1148/radiol.2233010198; Hance KW, 2005, JNCI-J NATL CANCER I, V97, P966, DOI 10.1093/jnci/dji172; Kamal RM, 2009, BREAST J, V15, P367, DOI 10.1111/j.1524-4741.2009.00740.x; Laas E, 2015, J GYNECOL OBST BIO R, V44, P996, DOI 10.1016/j.jgyn.2015.09.055; Lavoue V, 2016, EUR J OBSTET GYN R B, V200, P16, DOI 10.1016/j.ejogrb.2016.02.017; Le-Petross HT, 2011, AM J ROENTGENOL, V197, pW769, DOI 10.2214/AJR.10.6157; Lequin MH, 1995, EUR J RADIOL, V21, P138, DOI 10.1016/0720-048X(95)00699-Q; Renz DM, 2008, EUR RADIOL, V18, P2370, DOI 10.1007/s00330-008-1029-3; Robertson FM, 2010, CA-CANCER J CLIN, V60, P351, DOI 10.3322/caac.20082; Rosa M, 2010, ARCH GYNECOL OBSTET, V281, P901, DOI 10.1007/s00404-009-1236-4; Touboul C, 2015, J GYNECOL OBST BIO R, V44, P913, DOI 10.1016/j.jgyn.2015.09.041; Walshe Janice M, 2005, Breast Dis, V22, P35; Yang WT, 2008, BREAST CANCER RES TR, V109, P417, DOI 10.1007/s10549-007-9671-z	20	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189385	10.1371/journal.pone.0189385	http://dx.doi.org/10.1371/journal.pone.0189385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261724	Green Published, gold, Green Submitted			2022-12-26	WOS:000418564200042
J	Shiga, Y; Nishiguchi, KM; Kawai, Y; Kojima, K; Sato, K; Fujita, K; Takahashi, M; Omodaka, K; Araie, M; Kashiwagi, K; Aihara, M; Iwata, T; Mabuchi, F; Takamoto, M; Ozaki, M; Kawase, K; Fuse, N; Yamamoto, M; Yasuda, J; Nagasaki, M; Nakazawa, T				Shiga, Yukihiro; Nishiguchi, Koji M.; Kawai, Yosuke; Kojima, Kaname; Sato, Kota; Fujita, Kosuke; Takahashi, Mai; Omodaka, Kazuko; Araie, Makoto; Kashiwagi, Kenji; Aihara, Makoto; Iwata, Takeshi; Mabuchi, Fumihiko; Takamoto, Mitsuko; Ozaki, Mineo; Kawase, Kazuhide; Fuse, Nobuo; Yamamoto, Masayuki; Yasuda, Jun; Nagasaki, Masao; Nakazawa, Toru		JGS OG	Genetic analysis of Japanese primary open-angle glaucoma patients and clinical characterization of risk alleles near CDKN2B-AS1, SIX6 and GAS7	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OPTIC-NERVE HEAD; OCULAR BLOOD-FLOW; NORMAL-TENSION GLAUCOMA; FIBER LAYER THICKNESS; COMMON VARIANTS; LASER SPECKLE; SUSCEPTIBILITY LOCI; INTRAOCULAR-PRESSURE; POPULATION	Purpose To test the genetic association between Japanese patients with primary open-angle glaucoma (POAG) and the previously reported POAG susceptibility loci and to perform genotype +/- phenotype analysis. Methods Genetic associations for 27 SNPs from 16 loci previously linked to POAG were assessed using genome-wide SNP data of the primary cohort (565 Japanese POAG patients and 1,104 controls). Reproducibility of the assessment was tested in 607 POAG cases and 455 controls (second cohort) with a targeted genotyping approach. For POAG-associated variants, a genotype +/- phenotype correlation study (additive, dominant, recessive model) was performed using the objective clinical data derived from 598 eyes of 598 POAG patients. Results Among 27 SNPs from 16 loci previously linked to POAG, genotypes for total of 20 SNPs in 13 loci were available for targeted association study. Among 8 SNPs in 3 loci that showed at least nominal association (P < 5.00E-02) in the primary cohort, a representative SNP for each loci (rs2157719 for CDKN2B-AS1, rs33912345 for SIX6, and rs9913911 for GAS7) were selected. For these SNPs the association was found significant in both the second cohort analysis and meta-analysis. The genotype-phenotype analysis revealed significant correlations between CDKN2B-AS1 (rs2157719) and decreased intraocular pressure (beta = -6.89 mmHg, P = 1.70E-04; dominant model) after multiple corrections. In addition, nominal correlation was observed between CDKN2B-AS1 (rs2157719) and optic nerve head blood flow (beta = -0.54 and -0.67 arbitrary units (AU), P = 2.00E-02 and 1.39E-02), between SIX6 (rs33912345) and decreased total peripapillary retinal nerve fiber layer thickness (beta = -2.16 and -2.82 mu m, P = 4.68E-02 and 2.40E-02, additive and recessive model, respectively) and increased optic nerve head blood flow (beta = 0.44 AU, P = 2.20E-02; additive model) and between GAS7 (rs9913911) and increased cup volume (beta = 0.03 mm(3), P = 4.60E-02) and mean cup depth (beta = 0.03 mm 3, P = 4.11E-02; additive model) and decreased pattern standard deviation (beta = -0.87 dB, P = 2.44E-02; dominant model). Conclusion The association between SNPs near GAS7 and POAG was found in Japanese patients for the first time. Clinical characterization of the risk variants is an important step toward understanding the pathology of the disease and optimizing treatment of patients with POAG.	[Shiga, Yukihiro; Sato, Kota; Fujita, Kosuke; Takahashi, Mai; Omodaka, Kazuko; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan; [Nishiguchi, Koji M.; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan; [Kawai, Yosuke; Kojima, Kaname; Fuse, Nobuo; Yamamoto, Masayuki; Yasuda, Jun; Nagasaki, Masao] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Genom, Sendai, Miyagi, Japan; [Kawai, Yosuke; Kojima, Kaname; Fuse, Nobuo; Yasuda, Jun; Nagasaki, Masao] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan; [Kojima, Kaname; Nagasaki, Masao] Tohoku Univ, Tohoku Med Megabank Org, Dept Cohort Genome Informat Anal, Sendai, Miyagi, Japan; [Sato, Kota; Omodaka, Kazuko] Tohoku Univ, Grad Sch Med, Dept Ophthalm Imaging & Informat Analyt, Sendai, Miyagi, Japan; [Fujita, Kosuke; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi, Japan; [Araie, Makoto] Kanto Cent Hosp, Mutual Aid Assoc Publ Sch Teachers, Tokyo, Japan; [Kashiwagi, Kenji; Mabuchi, Fumihiko] Univ Yamanashi, Fac Med, Dept Ophthalmol, Yamanashi, Japan; [Aihara, Makoto; Takamoto, Mitsuko] Univ Tokyo, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Iwata, Takeshi] Natl Hosp Org, Tokyo Med Ctr, Natl Inst Sensory Organs, Div Mol & Cellular Biol, Tokyo, Japan; [Ozaki, Mineo] Ozaki Eye Hosp, Hyuga, Miyazaki, Japan; [Kawase, Kazuhide] Gifu Univ Hosp, Gifu, Japan; [Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Med Biochem, Sendai, Miyagi, Japan; [Nagasaki, Masao] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; University of Yamanashi; University of Tokyo; Gifu University; Tohoku University; Tohoku University	Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi, Japan.	ntoru@oph.med.tohoku.ac.jp	Kawai, Yosuke/S-4496-2019; Yamamoto, Masayuki/A-4873-2010	Kawai, Yosuke/0000-0003-0666-1224; Yamamoto, Masayuki/0000-0002-9073-9436; Nagasaki, Masao/0000-0002-4292-8785; Yasuda, Jun/0000-0002-3887-6871	Japan Society For The Promotion Of Science KAKENHI [26293372]; Senju Pharmaceutical Co. Ltd., Osaka, Japan; Center of Innovation Program from Japan Science and Technology Agency, JST	Japan Society For The Promotion Of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Senju Pharmaceutical Co. Ltd., Osaka, Japan; Center of Innovation Program from Japan Science and Technology Agency, JST	This paper was supported in part by the Japan Society For The Promotion Of Science KAKENHI Grants-in-Aid for Scientific Research (B) (T.N. 26293372) and by an unrestricted grant from Senju Pharmaceutical Co. Ltd., Osaka, Japan. Part of SNP genotyping was supported by the Center of Innovation Program from Japan Science and Technology Agency, JST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Naoto Imadome, Hidetoshi Takahashi, Shota Ono, Ryosuke Wakusawa, Tomoki Yasui, Keiichi Kato, Hitoshi Okabe, Makoto Ohmura, Nobuo Maekawa, Yuya Sato, members of Japan Glaucoma Society Omics Group (Makoto Araie, Kenji Kashiwagi, Makoto Aihara, Takeshi Iwata, Fumihiko Mabuchi, Mistuko Takamoto, Mineo ozaki and Kazuhide Kawase) for their contribution in sample collection and Sakiko Fujita, Testuya Osato, Shiori Suzuki, Junko Ouchi, for technical support. Computational resources for genotype imputation were provided by the Tohoku Medical Megabank Organization supercomputer system. This research is (partially) supported by the Center of Innovation Program from Japan Science and Technology Agency, JST. The manuscript has been proof read by an English editing service (Enago Ltd., Tokyo, Japan).	Aizawa N, 2014, INVEST OPHTH VIS SCI, V55, P7991, DOI 10.1167/iovs.14-15373; Aizawa N, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-113; Bailey JNC, 2016, NAT GENET, V48, P189, DOI 10.1038/ng.3482; Burdon KP, 2012, OPHTHALMOLOGY, V119, P1539, DOI 10.1016/j.ophtha.2012.02.004; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Carnes MU, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004372; Chen YH, 2014, NAT GENET, V46, P1115, DOI 10.1038/ng.3078; Cheng CY, 2015, INVEST OPHTH VIS SCI, V56, P478, DOI 10.1167/iovs.14-15863; Chiba N, 2011, CLIN OPHTHALMOL, V5, P1549, DOI 10.2147/OPTH.S22097; Cull G, 2013, INVEST OPHTH VIS SCI, V54, P4271, DOI 10.1167/iovs.13-12013; EHLERS N, 1975, ACTA OPHTHALMOL, V53, P34; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Gharahkhani P, 2014, NAT GENET, V46, P1120, DOI 10.1038/ng.3079; Hysi PG, 2014, NAT GENET, V46, P1126, DOI 10.1038/ng.3087; Isono Hiroaki, 1997, Nippon Ganka Gakkai Zasshi, V101, P684; Kawai Y, 2015, J HUM GENET, V60, P581, DOI 10.1038/jhg.2015.68; Klein BEK, 2004, INVEST OPHTH VIS SCI, V45, P59, DOI 10.1167/iovs.03-0516; Kobayashi W, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/468908; Kuo JZ, 2015, AM J OPHTHALMOL, V160, P123, DOI 10.1016/j.ajo.2015.04.001; Kuriyama S, 2016, J EPIDEMIOL; Li Z, 2015, HUM MOL GENET, V24, P3880, DOI 10.1093/hmg/ddv128; Mabuchi F, 2005, MOL VIS, V11, P609; Maekawa S, 2014, CLIN EXP OPHTHALMOL, V42, P887, DOI 10.1111/ceo.12354; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; Meguro A, 2010, OPHTHALMOLOGY, V117, P1331, DOI 10.1016/j.ophtha.2009.12.001; Nagasaki M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9018; Nakano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033389; Nakano M, 2009, P NATL ACAD SCI USA, V106, P12838, DOI 10.1073/pnas.0906397106; Nakazawa T, 2016, ASIA-PAC J OPHTHALMO, V5, P38, DOI 10.1097/APO.0000000000000183; Osman W, 2012, HUM MOL GENET, V21, P2836, DOI 10.1093/hmg/dds103; Ozel AB, 2014, HUM GENET, V133, P41, DOI 10.1007/s00439-013-1349-5; Pasquale LR, 2013, AM J OPHTHALMOL, V155, P342, DOI 10.1016/j.ajo.2012.07.023; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Shiga Y, 2016, CURR EYE RES, P1; Shiga Y, 2013, INVEST OPHTH VIS SCI, V54, P7699, DOI 10.1167/iovs.13-12930; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Takahashi M, 2013, CURR EYE RES, V38, P1133, DOI 10.3109/02713683.2013.807932; Takamoto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040107; TAMAKI Y, 1995, EXP EYE RES, V60, P373, DOI 10.1016/S0014-4835(05)80094-6; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; TIELSCH JM, 1994, ARCH OPHTHALMOL-CHIC, V112, P69, DOI 10.1001/archopht.1994.01090130079022; van Koolwijk LME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002611; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P8303, DOI 10.1167/iovs.12-10911; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Yaoeda K, 2003, ACTA OPHTHALMOL SCAN, V81, P253, DOI 10.1034/j.1600-0420.2003.00073.x; Yokoyama Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099138	46	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0186678	10.1371/journal.pone.0186678	http://dx.doi.org/10.1371/journal.pone.0186678			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261660	Green Published, gold, Green Submitted			2022-12-26	WOS:000418564200002
J	Pino-Bodas, R; Laakso, I; Stenroos, S				Pino-Bodas, Raquel; Laakso, Into; Stenroos, Soili			Genetic variation and factors affecting the genetic structure of the lichenicolous fungus Heterocephalacria bachmannii (Filobasidiales, Basidiomycota)	PLOS ONE			English	Article							POPULATION-STRUCTURE; LICHEN; EVOLUTION; HOST; DNA; MITOCHONDRIAL; SUBDIVISION; SOFTWARE; PROGRAM; CLASSIFICATION	Heterocephalacria bachmannii is a lichenicolous fungus that takes as hosts numerous lichen species of the genus Cladonia. In the present study we analyze whether the geographical distance, the host species or the host secondary metabolites determine the genetic structure of this parasite. To address the question, populations mainly from the Southern Europe, Southern Finland and the Azores were sampled. The specimens were collected from 20 different host species representing ten chemotypes. Three loci, ITS rDNA, LSU rDNA and mtSSU, were sequenced. The genetic structure was assessed by AMOVA, redundance analyses and Bayesian clustering methods. The results indicated that the host species and the host secondary metabolites are the most influential factors over the genetic structure of this lichenicolous fungus. In addition, the genetic structure of H. bachmannii was compared with that of one of its hosts, Cladonia rangiformis. The population structure of parasite and host were discordant. The contents in phenolic compounds and fatty acids of C. rangiformis were quantified in order to test whether it had some influence on the genetic structure of the species. But no correlation was found with the genetic clusters of H. bachmannii.	[Pino-Bodas, Raquel] CSIC, Real Jardin Bot Madrid, Madrid, Spain; [Laakso, Into] Univ Helsinki, Div Pharmaceut Biosci, Fac Pharm, Helsinki, Finland; [Stenroos, Soili] Univ Helsinki, Bot Museum, Finnish Museum Nat Hist, Helsinki, Finland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; University of Helsinki; University of Helsinki	Pino-Bodas, R (corresponding author), CSIC, Real Jardin Bot Madrid, Madrid, Spain.	rpino@rjb.csic.es	Pino-Bodas, Raquel/ABH-7623-2020; Pino-Bodas, Raquel/O-1221-2017	Pino-Bodas, Raquel/0000-0001-5228-5368; Stenroos, Soili/0000-0003-0331-792X	European Union [PIEF-GA-2013-625653]; MINECO [2015-23526]	European Union(European Commission); MINECO(Spanish Government)	This study has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no PIEF-GA-2013-625653, CLADOF. R. Pino-Bodas thanks the MINECO for a Juan de la Cierva-Incorporacion no 2015-23526 support.	Ahti T., 2000, FL NEOTROP MONOGR, V78, P1; Ahti T., 2013, NORDIC LICHEN FLORA, V5, P1; BAILEY RH, 1979, LICHENOLOGIST, V11, P105, DOI 10.1017/S0024282979000141; Bergemann SE, 2006, NEW PHYTOL, V170, P177, DOI 10.1111/j.1469-8137.2006.01654.x; Cao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073174; CLARKWALKER GD, 1991, CURR GENET, V20, P195, DOI 10.1007/BF00326232; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Culberson C.F., 1969, CHEM BOT GUIDE LICHE; de Vienne DM, 2013, NEW PHYTOL, V198, P347, DOI 10.1111/nph.12150; Delmotte F, 1999, HEREDITY, V82, P300, DOI 10.1038/sj.hdy.6884850; Diederich P., 1996, BIBLIOTHECA LICHENOL, V61; Diederich P., 2000, 4 IAL S PROGR PROBL, V102, P523; Dybdahl MF, 1996, EVOLUTION, V50, P2264, DOI [10.1111/j.1558-5646.1996.tb03615.x, 10.2307/2410696]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; FOURNIER A, 1990, NUCLEIC ACIDS RES, V18, P365, DOI 10.1093/nar/18.2.365; Galloway David J., 1995, Cryptogamic Botany, V5, P184; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GINNS J, 1986, MYCOLOGIA, V78, P619, DOI 10.2307/3807775; Hale M.E., 1973, LICHENS, P117, DOI DOI 10.1016/B978-0-12-044950-7.50009-X; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAWKSWORTH D L, 1982, Notes from the Royal Botanic Garden Edinburgh, V40, P375; Hawksworth D.L., 1979, B BRIT MUS NAT HIST, V6, P183; Huneck S, 1996, IDENTIFICATION LICHE; Huneck S., 2004, HERZOGIA, V17, P51; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; James PMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025359; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kretzer AM, 2000, MOL ECOL, V9, P1190, DOI 10.1046/j.1365-294x.2000.00954-12.x; Kretzer AM, 2005, MOL ECOL, V14, P2259, DOI 10.1111/j.1365-294X.2005.02547.x; Lawrey JD, 1997, SYMBIOSIS, V23, P107; LAWREY JD, 1993, AM J BOT, V80, P1109, DOI 10.2307/2445537; Lawrey JD, 2000, J CHEM ECOL, V26, P1821, DOI 10.1023/A:1005540622612; Lawrey JD, 2003, BRYOLOGIST, V106, P80, DOI 10.1639/0007-2745(2003)106[0080:LFIEAB]2.0.CO;2; LAWREY JD, 1986, BRYOLOGIST, V89, P111, DOI 10.2307/3242751; Leavitt SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085240; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindgren H, 2015, FUNGAL BIOL-UK, V119, P844, DOI 10.1016/j.funbio.2015.06.005; Liu XZ, 2015, STUD MYCOL, P85, DOI 10.1016/j.simyco.2015.12.001; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Meltzer C. von, 2000, Forest Genetics, V7, P85; Merinero S, 2015, FUNGAL ECOL, V14, P125, DOI 10.1016/j.funeco.2014.12.002; Millanes AM, 2014, EVOLUTION, V68, P1576, DOI 10.1111/evo.12374; Millanes AM, 2011, MOL PHYLOGENET EVOL, V61, P12, DOI 10.1016/j.ympev.2011.05.014; Molina MC, 2005, MYCOLOGIA, V97, P454, DOI 10.3852/mycologia.97.2.454; Myllys L, 2003, MOL PHYLOGENET EVOL, V27, P58, DOI 10.1016/S1055-7903(02)00398-6; NADLER SA, 1995, J PARASITOL, V81, P395, DOI 10.2307/3283821; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Orange A., 2001, MICROCHEMICAL METHOD; Park CH, 2012, ANTARCT SCI, V24, P359, DOI 10.1017/S0954102012000223; Pino-Bodas R, 2015, LICHENOLOGIST, V47, P287, DOI 10.1017/S0024282915000225; Pino-Bodas R, 2013, MOL ECOL RESOUR, V13, P1058, DOI 10.1111/1755-0998.12086; Price P. W., 1980, EVOLUTIONARY BIOL PA; Printzen C, 2003, MYCOLOGIA, V95, P399, DOI 10.2307/3761881; Pritchard JK, 2000, GENETICS, V155, P945; Robert S, 2012, MOL ECOL, V21, P1098, DOI 10.1111/j.1365-294X.2011.05432.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Roturier S, 2007, SILVA FENN, V41, P269, DOI 10.14214/sf.296; SALIOLA M, 1990, YEAST, V6, P193, DOI 10.1002/yea.320060304; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stocker-Worgotter E, 2004, BRYOLOGIST, V107, P152, DOI 10.1639/0007-2745(2004)107[0152:SCOLFC]2.0.CO;2; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Vercken E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001229; VILGALYS R, 1990, Journal of Bacteriology, V172, P4238; Walser JC, 2004, AM J BOT, V91, P1273, DOI 10.3732/ajb.91.8.1273; Weiss M, 2014, SYSTEMATICS EVOLUTIO, VVII, P331, DOI DOI 10.1007/978-3-642-55318-9_12; Werth S, 2014, FUNGAL BIOL-UK, V118, P126, DOI 10.1016/j.funbio.2013.10.009; Werth S, 2013, FUNGAL BIOL-UK, V117, P71, DOI 10.1016/j.funbio.2012.11.007; White F. J., 1985, B BRIT LICHEN SOC S, V75, P1; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wirtz N, 2008, MYCOL RES, V112, P472, DOI 10.1016/j.mycres.2007.05.006; Yahr R, 2006, NEW PHYTOL, V171, P847, DOI 10.1111/j.1469-8137.2006.01792.x; YOSHIMURA I, 1994, PHYTOCHEM ANALYSIS, V5, P197, DOI 10.1002/pca.2800050405; Zhan J, 2003, FUNGAL GENET BIOL, V38, P286, DOI 10.1016/S1087-1845(02)00538-8; Zhou ZH, 2001, NEW PHYTOL, V149, P339, DOI 10.1046/j.1469-8137.2001.00029.x; Zhurbenko M. P., 2017, OPUSCULA PHILOLICHEN, V16, P188	78	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189603	10.1371/journal.pone.0189603	http://dx.doi.org/10.1371/journal.pone.0189603			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253026	Green Published, Green Submitted, gold			2022-12-26	WOS:000418389500041
J	Partearroyo, T; Samaniego-Vaesken, MD; Ruiz, E; Olza, J; Aranceta-Bartrina, J; Gil, A; Gonzalez-Gross, M; Ortega, RM; Serra-Majem, L; Varela-Moreiras, G				Partearroyo, Teresa; de Lourdes Samaniego-Vaesken, Maria; Ruiz, Emma; Olza, Josune; Aranceta-Bartrina, Javier; Gil, Angel; Gonzalez-Gross, Marcela; Ortega, Rosa M.; Serra-Majem, Lluis; Varela-Moreiras, Gregorio			Dietary sources and intakes of folates and vitamin B-12 in the Spanish population: Findings from the ANIBES study	PLOS ONE			English	Article							FOLIC-ACID FORTIFICATION; ENERGY-INTAKE; MICRONUTRIENT INTAKE; B-VITAMINS; HOMOCYSTEINE NEUROTOXICITY; COGNITIVE IMPAIRMENT; LIFE-STYLE; FOOD; CHILDREN; NUTRIENT	Background Folates and vitamin B-12 are key nutrients in one- carbon metabolism and related diseases. Updated and plausible information on population intakes and their major dietary sources is scarce and urgently needed in Spain in order to increase the knowledge that can lead as previous step to prevention by fortification and supplementation policies. Aims The present study aims to evaluate main dietary folate and vitamin B-12 sources and intakes in the Spanish population. Materials and methods Results were derived from the ANIBES cross- sectional study using a nationally representative sample of the Spanish population (9 +/- 75 years, n = 2,009). Results Food groups with the highest mean proportional contribution to total folate intakes in both males and females were vegetables (21.7 +/- 24.9%) and cereals (10.7 +/- 11.2%), while meat and meat products (26.4%) and milk and dairy products (27.3%) were for B-12. Total median folate and B-12 intakes amongst women were 156.3 mu g/d and 4.0 mu g/d while for men were 163.6 mu g/d and 4.5 mu g/d, respectively. In all age groups, vitamin intakes were significantly higher in plausible than in non- plausible energy reporters. Conclusion A limited number of participants had adequate folate intakes, whereas vitamin B-12 intakes were adequate for practically the entire population. There is a clear need for improving folates intake in the Spanish population.	[Partearroyo, Teresa; de Lourdes Samaniego-Vaesken, Maria; Varela-Moreiras, Gregorio] CEU San Pablo Univ, Dept Pharmaceut & Hlth Sci, Fac Pharm, Madrid, Spain; [Ruiz, Emma; Varela-Moreiras, Gregorio] Spanish Nutr Fdn FEN, Madrid, Spain; [Olza, Josune; Gil, Angel; Gonzalez-Gross, Marcela; Serra-Majem, Lluis] Univ Granada, Dept Biochem & Mol Biol 2, Granada, Spain; [Olza, Josune; Gil, Angel; Gonzalez-Gross, Marcela; Serra-Majem, Lluis] Univ Granada, Inst Nutr & Food Sci, Granada, Spain; [Olza, Josune; Aranceta-Bartrina, Javier; Gil, Angel; Gonzalez-Gross, Marcela; Serra-Majem, Lluis] Univ Navarra, Dept Prevent Med & Publ Hlth, Pamplona, Spain; [Aranceta-Bartrina, Javier] Carlos III Hlth Inst, Biomed Res Networking Ctr Physiopathol Obes & Nut, CIBEROBN, Madrid, Spain; [Gonzalez-Gross, Marcela] Tech Univ Madrid, Dept Hlth & Human Performance, ImFINE Res Grp, Madrid, Spain; [Ortega, Rosa M.] Madrid Complutense Univ, Dept Nutr, Fac Pharm, Madrid, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Res Inst Biomed & Hlth Sci, Las Palmas Gran Canaria, Spain	San Pablo CEU University; University of Granada; University of Granada; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universidad Politecnica de Madrid; Complutense University of Madrid; Universidad de Las Palmas de Gran Canaria	Varela-Moreiras, G (corresponding author), CEU San Pablo Univ, Dept Pharmaceut & Hlth Sci, Fac Pharm, Madrid, Spain.; Varela-Moreiras, G (corresponding author), Spanish Nutr Fdn FEN, Madrid, Spain.	gvarela@ceu.es	Moreno, Emma Ruiz/S-7210-2018; Serra-Majem, Lluis/I-6708-2019; Olza, Josune/Y-3333-2019; Samaniego-Vaesken, M.L./E-4637-2015; Gil, Angel/ABA-7621-2020; Ortega, Rosa M/S-5760-2016; Samaniego-Vaesken, María de Lourdes/GPK-1233-2022; Olza, Josune/N-7718-2013; Gonzalez-Gross, Marcela/W-8000-2018; Partearroyo, Teresa/J-7322-2017	Moreno, Emma Ruiz/0000-0003-3662-4440; Serra-Majem, Lluis/0000-0002-9658-9061; Olza, Josune/0000-0001-8840-8542; Samaniego-Vaesken, M.L./0000-0001-7323-4420; Gil, Angel/0000-0001-7663-0939; Ortega, Rosa M/0000-0003-3837-9450; Samaniego-Vaesken, María de Lourdes/0000-0001-7323-4420; Olza, Josune/0000-0001-8840-8542; Partearroyo, Teresa/0000-0002-4401-1233; VARELA-MOREIRAS, GREGORIO/0000-0001-5158-4999	Coca-Cola Iberia; Spanish Nutrition Foundation (Fundacion Espanola de la Nutricion (FEN)); IPSOS	Coca-Cola Iberia; Spanish Nutrition Foundation (Fundacion Espanola de la Nutricion (FEN)); IPSOS	The study was financially supported by a grant from Coca-Cola Iberia through an agreement with the Spanish Nutrition Foundation (Fundacion Espanola de la Nutricion (FEN)). The funding sponsor had no role in the design of the study, the collection, analysis nor interpretation of the data, the writing of the manuscript nor in the decision to publish the results.; The authors would like to thank Coca-Cola Iberia and IPSOS for its support and technical advice, particularly Rafael Urrialde and Javier Ruiz.	AESAN, 2011, ENC NAC ING DIET ESP; Agostoni C, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3408; Aranceta J, 2010, REV ESP NUTR COMUNIT, V16, P173; Archer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076632; Bandini LG, 1997, AM J CLIN NUTR, V65, P1138; Banjari Ines, 2014, Med Pregl, V67, P313; Becker W, 1999, BRIT J NUTR, V81, pS127, DOI 10.1017/S0007114599000975; Black AE, 2000, EUR J CLIN NUTR, V54, P395, DOI 10.1038/sj.ejcn.1600971; Briefel RR, 1997, AM J CLIN NUTR, V65, P1203; Carmel Ralph, 2006, Curr Hematol Rep, V5, P23; Carmel R, 2012, CURR OPIN GASTROEN, V28, P151, DOI 10.1097/MOG.0b013e3283505852; Carrera PM, 2007, J AM DIET ASSOC, V107, P1735, DOI 10.1016/j.jada.2007.07.016; Diethelm K, 2014, PUBLIC HEALTH NUTR, V17, P486, DOI 10.1017/S1368980013000463; Fabian E, 2008, ANN NUTR METAB S1, V52, P57; Ferrari P, 2002, PUBLIC HEALTH NUTR, V5, P1329, DOI 10.1079/PHN2002409; Flour Fortification Innitiative (FFI) Wheat Flour Fortification Status, 2016, MAP GLOB PROGR COUNT; Gille D, 2015, NUTR REV, V73, P106, DOI 10.1093/nutrit/nuu011; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; Gonzalez-Gross M, 2012, NUTR RES, V32, P817, DOI 10.1016/j.nutres.2012.09.016; Haan MN, 2007, AM J CLIN NUTR, V85, P511, DOI 10.1093/ajcn/85.2.511; Heerstrass DW, 1998, INT J EPIDEMIOL, V27, P186, DOI 10.1093/ije/27.2.186; HERBERT V, 1967, AM J CLIN NUTR, V20, P562, DOI 10.1093/ajcn/20.6.562; Ho PI, 2002, J NEUROSCI RES, V70, P694, DOI 10.1002/jnr.10416; Hogeveen M, 2008, EUR J NUTR, V47, P26, DOI 10.1007/s00394-007-0692-5; Horvath Z, 2013, EFSA SUPP PUBL, V10; Huang TTK, 2005, OBES RES, V13, P1205, DOI 10.1038/oby.2005.143; Johansson L, 1998, AM J CLIN NUTR, V68, P266, DOI 10.1093/ajcn/68.2.266; Kado DM, 2005, AM J MED, V118, P161, DOI 10.1016/j.amjmed.2004.08.019; Kerr MA, 2009, PEDIATRICS, V123, P627, DOI 10.1542/peds.2008-1049; Kim YI, 2004, AM J CLIN NUTR, V80, P1123, DOI 10.1093/ajcn/80.5.1123; Kontogianni MD, 2010, J AM DIET ASSOC, V110, P215, DOI 10.1016/j.jada.2009.10.035; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Lioret S, 2011, BRIT J NUTR, V105, P1671, DOI 10.1017/S0007114510005465; Martinez-Vega R, NUTRIENTS; Martinez-Vega R, 2015, FASEB J, V29, P418, DOI 10.1096/fj.14-259283; Mills JL, 2000, NEW ENGL J MED, V342, P1442, DOI 10.1056/NEJM200005113421911; Moreiras O, TABLAS COMPOSICION A, V15; Moreiras O, 2015, TABLAS COMPOSICION A, V17th, P258; Murakami K, 2013, BRIT J NUTR, V110, P1512, DOI 10.1017/S000711451300072X; Murakami K, 2012, NUTRITION, V28, P532, DOI 10.1016/j.nut.2011.08.011; Ngo J, 2009, BRIT J NUTR, V101, pS102, DOI 10.1017/S0007114509990638; Obeid R, 2006, FEBS LETT, V580, P2994, DOI 10.1016/j.febslet.2006.04.088; Obeid R, 2016, J PERINAT MED, V44, P261, DOI 10.1515/jpm-2014-0346; Okubo H, 2004, PUBLIC HEALTH NUTR, V7, P911, DOI 10.1079/PHN2004635; Olza J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020168; Partearroyo T, 2013, NUTRIENTS, V5, P4836, DOI 10.3390/nu5124836; Paul L, 2016, MOL ASPECTS MED; Pavlovic M, 2007, ANN NUTR METAB, V51, P108, DOI 10.1159/000102458; Pinhas-Hamiel O, 2006, ARCH PEDIAT ADOL MED, V160, P933, DOI 10.1001/archpedi.160.9.933; Planells E, 2003, EUR J CLIN NUTR, V57, P777, DOI 10.1038/sj.ejcn.1601610; Poppitt S, 1998, INT J OBESITY RELATE, V22; Poslusna K, 2009, BRIT J NUTR, V101, pS73, DOI 10.1017/S0007114509990602; Rangan AM, 2011, NUTRIENTS, V3, P186, DOI 10.3390/nu3020186; Ravaglia G, 2005, AM J CLIN NUTR, V82, P636, DOI 10.1093/ajcn/82.3.636; Regist F, 1996, FOOD STANDARDS AMEND, P8781; Vinas BR, 2011, ANN NUTR METAB, V59, P84, DOI 10.1159/000332762; Rosell MS, 2003, AM J CLIN NUTR, V78, P84, DOI 10.1093/ajcn/78.1.84; Ruiz E, 2015, NUTRIENTS, V7, P4739, DOI 10.3390/nu7064739; Ruiz E, 2015, NUTRIENTS, V7, P970, DOI 10.3390/nu7020970; Samaniego-Vaesken ML, 2016, FOOD CHEM, V193, P148, DOI 10.1016/j.foodchem.2014.06.046; Samaniego-Vaesken ML, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030234; Selhub J, 2009, AM J CLIN NUTR, V89, p702S, DOI 10.3945/ajcn.2008.26947C; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Sharma S, 2013, J HUM NUTR DIET, V26, P156, DOI 10.1111/jhn.12035; Shea TB, 2002, MOL BRAIN RES, V108, P1, DOI 10.1016/S0169-328X(02)00412-6; Smith AD, 2002, AM J CLIN NUTR, V75, P785, DOI 10.1093/ajcn/75.5.785; Steluti J, 2017, EUR J CLIN NUTR, V71, P1173, DOI 10.1038/ejcn.2017.60; Strain JJ, 2004, P NUTR SOC, V63, P597, DOI 10.1079/PNS2004390; Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092; Tabacchi G, 2009, BRIT J NUTR, V101, pS29, DOI 10.1017/S0007114509990560; Talegawkar SA, 2008, J AM DIET ASSOC, V108, P2013, DOI 10.1016/j.jada.2008.09.004; Tjiattas L, 2004, AGING CELL, V3, P71, DOI 10.1111/j.1474-9728.2004.00086.x; van Wijngaarden JP, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/486186; Moreiras GV, 2015, NUTR HOSP, V31, P101, DOI 10.3305/nh.2015.31.sup3.8758; Vissers PAJ, 2011, J AM COLL NUTR, V30, p415S, DOI 10.1080/07315724.2011.10719985; WALD N, 1991, LANCET, V338, P131; Williams J, 2015, MMWR-MORBID MORTAL W, V64, P1; Yanetz R, 2008, J AM DIET ASSOC, V108, P455, DOI 10.1016/j.jada.2007.12.004	78	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189230	10.1371/journal.pone.0189230	http://dx.doi.org/10.1371/journal.pone.0189230			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244867	Green Submitted, Green Published, gold			2022-12-26	WOS:000418184700023
J	Tanaka, N; Zhao, M; Tang, L; Patel, AA; Xi, Q; Van, HT; Takahashi, H; Osman, AA; Zhang, JX; Wang, J; Myers, JN; Zhou, G				Tanaka, Noriaki; Zhao, Mei; Tang, Lin; Patel, Ameeta A.; Xi, Qing; Van, Hieu T.; Takahashi, Hideaki; Osman, Abdullah A.; Zhang, Jiexin; Wang, Jing; Myers, Jeffrey N.; Zhou, Ge			Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1	ONCOGENE			English	Article							EVOLUTIONARY ACTION SCORE; BREAST-CANCER; TUMOR-SUPPRESSOR; TP53 MUTATIONS; EXPRESSION; PATHWAY; PROTEINS; SURVIVAL; TUMORIGENESIS; PROGRESSION	Many mutant p53 proteins exert oncogenic gain-of-function (GOF) properties that promote cancer cell invasive growth and metastasis, yet the mechanisms mediating these functions still largely remain elusive. We show here that overexpression of the GOF mutant p53 G245D and other GOF p53 mutants enhances the invasive cell growth of p53-deficient head and neck squamous cell carcinoma (HNSCC) UM-SCC-1 cells both in in vitro three-dimensional culture and in an in vivo orthotopic nude mouse model of HNSCC through a novel transcription-independent mechanism. We demonstrate that the expression of the oncogenic forkhead transcription factor FOXM1 is upregulated by GOF mutant p53s. Moreover, we show that overexpression of GOF mutant p53 G245D decreases the AMP-activated protein kinase (AMPK)-mediated phosphorylation of FOXO3a, a tumor suppressive forkhead transcription factor, leading to its cytoplasmic accumulation. This downregulation of FOXO3a's activity, in turn, leads to de-repression of FOXM1 expression. Importantly, we show that either overexpression of FOXO3a or downregulation of FOXM1 impairs both GOF mutant p53-mediated cell invasion in vitro and pulmonary metastases of UM-SCC-1 cells in vivo. Finally, not only do oral cancer patients with p53 mutations exhibit higher levels of FOXM1 expression than patients with wild-type p53, but also HNSCC patients with TP53 mutations and high levels of FOXM1 expression have the poorest survival outcomes. Given our prior demonstration that GOF mutant p53s inhibit AMPK, our current study, establishes and demonstrates a novel transcription-independent GOF mutant p53-AMPK-FOXO3a-FOXM1 signaling cascade that plays an important role in mediating mutant p53s' gain-of-function activities in HNSCCs.	[Tanaka, Noriaki; Zhao, Mei; Tang, Lin; Patel, Ameeta A.; Xi, Qing; Van, Hieu T.; Takahashi, Hideaki; Osman, Abdullah A.; Myers, Jeffrey N.; Zhou, Ge] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Zhang, Jiexin; Wang, Jing] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Myers, JN; Zhou, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA.	jmyers@mdanderson.org; gzhou@mdanderson.org	Van, Hieu Thuan/GMX-1075-2022	Takahashi, Hideaki/0000-0003-3783-9961; Van, Hieu Thuan/0000-0002-3328-915X	National Institute of Health [5R01DE014613-13]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014613] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the National Institute of Health Grant No. 5R01DE014613-13 (J.N.M.).	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Di Agostino S, 2016, EMBO REP, V17, P188, DOI 10.15252/embr.201540488; Di Minin G, 2014, MOL CELL, V56, P617, DOI 10.1016/j.molcel.2014.10.013; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Fontemaggi G, 2009, NAT STRUCT MOL BIOL, V16, P1086, DOI 10.1038/nsmb.1669; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Halasi M, 2013, BIOCHEM PHARMACOL, V85, P644, DOI 10.1016/j.bcp.2012.10.013; Ho KK, 2012, J BIOL CHEM, V287, P1545, DOI 10.1074/jbc.M111.284224; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Karadedou CT, 2012, ONCOGENE, V31, P1845, DOI 10.1038/onc.2011.368; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Mizuno T, 2012, ONCOGENE, V31, P5117, DOI 10.1038/onc.2012.5; Morris BJ, 2015, GERONTOLOGY, V61, P515, DOI 10.1159/000375235; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Myers JN, 2002, CLIN CANCER RES, V8, P293; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Neskey DM, 2015, CANCER RES, V75, P1527, DOI 10.1158/0008-5472.CAN-14-2735; Nho RS, 2014, AM J PHYSIOL-LUNG C, V307, pL632, DOI 10.1152/ajplung.00127.2014; Osman AA, 2015, CANCER RES, V75, P1205, DOI 10.1158/0008-5472.CAN-14-2729; Pandit B, 2009, CELL CYCLE, V8, P3425, DOI 10.4161/cc.8.20.9628; Pfister NT, 2015, GENE DEV, V29, P1298, DOI 10.1101/gad.263202.115; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Renault VM, 2011, ONCOGENE, V30, P3207, DOI 10.1038/onc.2011.35; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Senturk S, 2014, P NATL ACAD SCI USA, V111, pE3287, DOI 10.1073/pnas.1321640111; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Walerych D, 2016, NAT CELL BIOL, V18, P897, DOI 10.1038/ncb3380; Wang F, 2008, J MOL BIOL, V384, P590, DOI 10.1016/j.jmb.2008.09.025; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827; You H, 2006, P NATL ACAD SCI USA, V103, P9051, DOI 10.1073/pnas.0600889103; Zhao M, 2011, CLIN CANCER RES, V17, P7248, DOI 10.1158/1078-0432.CCR-11-0690; Zhou G, 2016, J CELL BIOCHEM, V117, P2682, DOI 10.1002/jcb.25592; Zhou G, 2014, MOL CELL, V54, P960, DOI 10.1016/j.molcel.2014.04.024; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	47	34	34	3	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	10					1279	1292		10.1038/s41388-017-0032-z	http://dx.doi.org/10.1038/s41388-017-0032-z			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ0RI	29269868	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000427279300002
J	Shen, L; Liu, Y; Tso, P; Wang, DQH; Davidson, WS; Woods, SC; Liu, M				Shen, Ling; Liu, Yin; Tso, Patrick; Wang, David Q. -H.; Davidson, W. Sean; Woods, Stephen C.; Liu, Min			Silencing steroid receptor coactivator-1 in the nucleus of the solitary tract reduces estrogenic effects on feeding and apolipoprotein A-IV expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						estrogen; estrogen receptor; apolipoprotein; small interfering RNA (siRNA); energy metabolism; obesity	CENTRAL-NERVOUS-SYSTEM; OVARIECTOMIZED RATS; BODY-WEIGHT; FOOD-INTAKE; GENE-EXPRESSION; ENERGY-BALANCE; DIETARY-FAT; MEAL SIZE; ESTRADIOL; ALPHA	We previously found that 17-estradiol (E2) stimulates apolipoprotein A-IV (apoA-IV) gene expression in the nucleus of the solitary tract (NTS) of lean ovariectomized (OVX) rodents. Here we report that in the NTS of high-fat diet-induced obese (DIO) rats, the apoA-IV mRNA level is significantly reduced and that the estrogenic effects on apoA-IV gene expression and food intake are impaired. E2 regulates apoA-IV gene expression through its nuclear receptor (ER), which requires co-activators, such as steroid receptor coactivator-1 (SRC-1), to facilitate the transcription of targeted genes. Interestingly, SRC-1 gene expression is significantly reduced in DIO OVX rats. SRC-1 is colocalized with apoA-IV in the cells of the NTS and E2 treatment enhances the recruitment of ER and SRC-1 to the estrogen response element at the apoA-V promoter, implying the participation of SRC-1 in E2's stimulatory effect on apoA-IV gene expression. Using small hairpin RNA (shRNA), which was validated in cultured neuronal cells, we found that SRC-1 gene knockdown specifically in the NTS significantly diminished E2's anorectic action, leading to increased food intake and body weight. More importantly, the stimulatory effect of E2 on apoA-IV gene expression in the NTS was significantly attenuated in SRC-1 knockdown rats. These results collectively demonstrate the critical roles of NTS SRC-1 in mediating E2's actions on food intake and apoA-IV gene expression and suggest that reduced levels of endogenous SRC-1 and apoA-IV expression are responsible for the impaired E2's anorectic action in obese females.	[Shen, Ling; Liu, Yin; Tso, Patrick; Davidson, W. Sean; Liu, Min] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA; [Woods, Stephen C.] Univ Cincinnati, Coll Med, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45237 USA; [Wang, David Q. -H.] Albert Einstein Coll Med, Dept Med, Div Gastroenterol & Liver Dis, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Yeshiva University; Albert Einstein College of Medicine	Liu, M (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA.	lium@uc.edu		Davidson, William/0000-0003-2756-2989	National Institutes of Health [DK92779, DK95440]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL140962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059630, P30DK078392, R01DK092779, R01DK103557, P30DK041296, R01DK095440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA025737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grants DK92779 and DK95440 (to M. L. and S. C. W). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asarian L, 2002, HORM BEHAV, V42, P461, DOI 10.1006/hbeh.2002.1835; Asarian L, 2007, ENDOCRINOLOGY, V148, P5656, DOI 10.1210/en.2007-0341; Asarian L, 2006, PHILOS T R SOC B, V361, P1251, DOI 10.1098/rstb.2006.1860; Asarian L, 2013, AM J PHYSIOL-REG I, V305, pR1215, DOI 10.1152/ajpregu.00446.2012; Billeci AMR, 2008, CURR VASC PHARMACOL, V6, P112, DOI 10.2174/157016108783955338; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P1021, DOI 10.1210/en.2012-1989; Cui J, 2013, TRENDS MOL MED, V19, P197, DOI 10.1016/j.molmed.2012.12.007; Eckel LA, 2004, PHYSIOL BEHAV, V82, P35, DOI 10.1016/j.physbeh.2004.04.023; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FUJIMOTO K, 1993, J CLIN INVEST, V91, P1830, DOI 10.1172/JCI116395; Fukuhara M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45815; Geary N, 2001, ENDOCRINOLOGY, V142, P4751, DOI 10.1210/en.142.11.4751; Geary N, 2000, APPETITE, V35, P273, DOI 10.1006/appe.2000.0362; Geary N., 2007, SEX DIFFERENCES BRAI, P253; Giraud S, 2002, J BIOL CHEM, V277, P8004, DOI 10.1074/jbc.M111486200; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Jutras Brandon L, 2012, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01f01s24; Kantor B, 2011, MOL THER, V19, P547, DOI 10.1038/mt.2010.277; Kuller LH, 1997, J AM DIET ASSOC, V97, pS9, DOI 10.1016/S0002-8223(97)00724-4; Lichtenstein AH, 1998, NUTR REV, V56, pS3; Litwak SA, 2014, ENDOCRINOLOGY, V155, P4447, DOI 10.1210/en.2014-1342; Liu M, 2004, AM J PHYSIOL-ENDOC M, V287, pE366, DOI 10.1152/ajpendo.00448.2003; Liu M, 2001, AM J PHYSIOL-REG I, V280, pR1382, DOI 10.1152/ajpregu.2001.280.5.R1382; Mahler SV, 2014, NAT NEUROSCI, V17, P577, DOI 10.1038/nn.3664; May AA, 2016, PHYSIOL BEHAV, V165, P392, DOI 10.1016/j.physbeh.2016.08.025; May AA, 2016, PHYSIOL BEHAV, V163, P312, DOI 10.1016/j.physbeh.2016.05.019; Molenda-Figueira HA, 2008, ENDOCRINOLOGY, V149, P5272, DOI 10.1210/en.2008-0048; Na SY, 1998, J BIOL CHEM, V273, P10831, DOI 10.1074/jbc.273.18.10831; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; ONATE SA, 1995, SCIENCE, V270, P1354; Paxinos G., 2004, J CHEM INF MODEL, V5th; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Rogers NH, 2009, ENDOCRINOLOGY, V150, P2161, DOI 10.1210/en.2008-1405; Santollo J, 2007, AM J PHYSIOL-REG I, V293, pR2194, DOI 10.1152/ajpregu.00385.2007; Shen L, 2008, PHYSIOL BEHAV, V95, P161, DOI 10.1016/j.physbeh.2008.05.022; Shen L, 2008, DIABETES, V57, P2092, DOI 10.2337/db08-0291; Shen L, 2007, ENDOCRINOLOGY, V148, P2681, DOI 10.1210/en.2006-1596; Shen L, 2017, ONCOTARGET, V8, P84028, DOI 10.18632/oncotarget.21062; Shen L, 2014, ENDOCRINOLOGY, V155, P3882, DOI 10.1210/en.2014-1239; Shen L, 2010, ENDOCRINOLOGY, V151, P3163, DOI 10.1210/en.2010-0203; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Smith SN, 2015, J PAIN, V16, P283, DOI 10.1016/j.jpain.2014.12.007; Spary EJ, 2010, J NEUROENDOCRINOL, V22, P492, DOI 10.1111/j.1365-2826.2010.01977.x; Thammacharoen S, 2008, ENDOCRINOLOGY, V149, P1609, DOI 10.1210/en.2007-0340; Woods SC, 2004, PHYSIOL BEHAV, V83, P573, DOI 10.1016/j.physbeh.2004.07.026; Woods SC, 2003, J NUTR, V133, P1081, DOI 10.1093/jn/133.4.1081; Xiong Y, 2010, DIABETES, V59, P2505, DOI 10.2337/db10-0315; Xu Jianming, 2002, Rev Endocr Metab Disord, V3, P185, DOI 10.1023/A:1020016208071; Yie JM, 1999, P NATL ACAD SCI USA, V96, P13108, DOI 10.1073/pnas.96.23.13108; Zhu LR, 2013, ENDOCRINOLOGY, V154, P150, DOI 10.1210/en.2012-2007; Zhu Z, 2013, HORM BEHAV, V63, P533, DOI 10.1016/j.yhbeh.2013.01.009	53	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2091	2101		10.1074/jbc.RA117.000237	http://dx.doi.org/10.1074/jbc.RA117.000237			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29263093	hybrid, Green Published			2022-12-26	WOS:000424948000021
J	Huang, WG; Wang, XY; Endo-Streeter, S; Barrett, M; Waybright, J; Wohlfeld, C; Hajicek, N; Harden, TK; Sondek, J; Zhang, QS				Huang, Weigang; Wang, Xiaoyang; Endo-Streeter, Stuart; Barrett, Matthew; Waybright, Jarod; Wohlfeld, Christian; Hajicek, Nicole; Harden, T. Kendall; Sondek, John; Zhang, Qisheng			A membrane-associated, fluorogenic reporter for mammalian phospholipase C isozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Phospholipase C; lipid metabolism; inositol phospholipid; G protein-coupled receptor (GPCR); receptor tyrosine kinase; fluorogenic reporter	CATALYTIC DOMAIN; CONTINUOUS ASSAY; BETA; CA2+; PHOSPHOINOSITIDES; ACTIVATION; PLC; PROTEINS; BINDING; CELLS	A diverse group of cell-surface receptors, including many G protein-coupled receptors and receptor tyrosine kinases, activate phospholipase C (PLC) isozymes to hydrolyze phosphatidylinositol 4,5-bisphosphate into the second messengers diacylglycerol and 1,4,5-inositol trisphosphate. Consequently, PLCs control various cellular processes, and their aberrant regulation contributes to many diseases, including cancer, atherosclerosis, and rheumatoid arthritis. Despite the widespread importance of PLCs in human biology and disease, it has been impossible to directly monitor the real-time activation of these enzymes at membranes. To overcome this limitation, here we describe XY-69, a fluorogenic reporter that preferentially partitions into membranes and provides a selective tool for measuring the real-time activity of PLCs as either purified enzymes or in cellular lysates. Indeed, XY-69 faithfully reported the membrane-dependent activation of PLC-3 by G(q). Therefore, XY-69 can replace radioactive phosphatidylinositol 4,5-bisphosphate used in conventional PLC assays and will enable high-throughput screens to identify both orthosteric and allosteric PLC inhibitors. In the future, cell-permeable variants of XY-69 represent promising candidates for reporting the activation of PLCs in live cells with high spatiotemporal resolution.	[Huang, Weigang; Wang, Xiaoyang; Waybright, Jarod; Wohlfeld, Christian; Zhang, Qisheng] Univ North Carolina Chapel Hill, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Endo-Streeter, Stuart; Barrett, Matthew; Hajicek, Nicole; Harden, T. Kendall; Sondek, John; Zhang, Qisheng] Univ North Carolina Chapel Hill, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Sondek, John] Univ North Carolina Chapel Hill, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Sondek, John; Zhang, Qisheng] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Zhang, QS (corresponding author), Eshelman Sch Pharm, Div Chem Biol & Med Chem, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA.	qszhang@unc.edu		Zhang, Qisheng/0000-0001-9808-5038	National Institutes of Health [GM098894, GM057391, CA177993]; University of North Carolina at Chapel Hill Small Grant Program; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA177993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057391, R01GM098894] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina at Chapel Hill Small Grant Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM098894 (to J. S. and Q. Z.), GM057391 (to J. S.), and CA177993 (to Q. Z.) and by University of North Carolina at Chapel Hill Small Grant Program (to W. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bartlett PJ, 2005, J BIOL CHEM, V280, P21837, DOI 10.1074/jbc.M411843200; Charpentier TH, 2014, J BIOL CHEM, V289, P29545, DOI 10.1074/jbc.M114.586784; Cremasco V, 2008, ARTHRITIS RHEUM-US, V58, P2712, DOI 10.1002/art.23757; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Ellis MV, 1998, J BIOL CHEM, V273, P11650, DOI 10.1074/jbc.273.19.11650; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Grobler JA, 1998, BIOCHEMISTRY-US, V37, P5020, DOI 10.1021/bi972952w; Harden TK, 2009, J LIPID RES, V50, pS243, DOI 10.1194/jlr.R800045-JLR200; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Huang WG, 2011, ACS CHEM BIOL, V6, P223, DOI 10.1021/cb100308n; Jenco JM, 1997, BIOCHEM J, V327, P431; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kataoka K, 2015, NAT GENET, V47, P1304, DOI 10.1038/ng.3415; Kim JK, 2011, ADV ENZYME REGUL, V51, P138, DOI 10.1016/j.advenzreg.2010.10.004; Kleusch C, 2012, MOLECULES, V17, P1055, DOI 10.3390/molecules17011055; Kubiak RJ, 2003, J ORG CHEM, V68, P960, DOI 10.1021/jo0206418; Martins M, 2014, P NATL ACAD SCI USA, V111, P4239, DOI 10.1073/pnas.1311500111; Mentel M, 2011, ANGEW CHEM INT EDIT, V50, P3811, DOI 10.1002/anie.201007796; Nahorski SR, 2003, TRENDS NEUROSCI, V26, P444, DOI 10.1016/S0166-2236(03)00178-4; Ozaki S, 2000, P NATL ACAD SCI USA, V97, P11286, DOI 10.1073/pnas.210197897; Rebres RA, 2011, J BIOL CHEM, V286, P942, DOI 10.1074/jbc.M110.198200; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rukavishnikov AV, 1999, BIOORG MED CHEM LETT, V9, P1133, DOI 10.1016/S0960-894X(99)00166-3; Rusten TE, 2006, NAT METHODS, V3, P251, DOI 10.1038/nmeth867; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Subramanian D, 2010, NAT CHEM BIOL, V6, P324, DOI 10.1038/nchembio.348; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Vaque JP, 2014, BLOOD, V123, P2034, DOI 10.1182/blood-2013-05-504308; Wang XY, 2012, BIOCHEMISTRY-US, V51, P5300, DOI 10.1021/bi300637h; Wang ZL, 2008, J CLIN INVEST, V118, P195, DOI 10.1172/JCI33139; Zaikova TO, 2001, BIOCONJUGATE CHEM, V12, P307, DOI 10.1021/bc0001138	36	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1728	1735		10.1074/jbc.RA117.000926	http://dx.doi.org/10.1074/jbc.RA117.000926			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29263090	Green Published, hybrid			2022-12-26	WOS:000424201700023
J	Barnes, ML; Breshears, DD; Law, DJ; van Leeuwen, WJD; Monson, RK; Fojtik, AC; Barron-Gafford, GA; Moore, DJP				Barnes, Mallory L.; Breshears, David D.; Law, Darin J.; van Leeuwen, Willem J. D.; Monson, Russell K.; Fojtik, Alec C.; Barron-Gafford, Greg A.; Moore, David J. P.			Beyond greenness: Detecting temporal changes in photosynthetic capacity with hyperspectral reflectance data	PLOS ONE			English	Article							LIGHT-USE EFFICIENCY; GROSS PRIMARY PRODUCTION; LEAF OPTICAL-PROPERTIES; EARTH SYSTEM MODELS; SPECTRAL REFLECTANCE; CARBON-CYCLE; CHLOROPHYLL FLUORESCENCE; STOMATAL CONDUCTANCE; VEGETATION INDEXES; BIOCHEMICAL-MODEL	Earth's future carbon balance and regional carbon exchange dynamics are inextricably linked to plant photosynthesis. Spectral vegetation indices are widely used as proxies for vegetation greenness and to estimate state variables such as vegetation cover and leaf area index. However, the capacity of green leaves to take up carbon can change throughout the season. We quantify photosynthetic capacity as the maximum rate of RuBP carboxylation (V-cmax) and regeneration (J(max)). V-cmax and J(max) vary within-season due to interactions between ontogenetic processes and meteorological variables. Remote sensing-based estimation of V-cmax and J(max) using leaf reflectance spectra is promising, but temporal variation in relationships between these key determinants of photosynthetic capacity, leaf reflectance spectra, and the models that link these variables has not been evaluated. To address this issue, we studied hybrid poplar (Populus spp.) during a 7-week mid-summer period to quantify seasonally-dynamic relationships between V-cmax, J(max), and leaf spectra. We compared in situ estimates of V-cmax and J(max) from gas exchange measurements to estimates of V-cmax and J(max) derived from partial least squares regression (PLSR) and fresh-leaf reflectance spectroscopy. PLSR models were robust despite dynamic temporal variation in V-cmax and J(max) throughout the study period. Within-population variation in plant stress modestly reduced PLSR model predictive capacity. Hyperspectral vegetation indices were well-correlated to V-cmax and J(max), including the widely-used Normalized Difference Vegetation Index. Our results show that hyperspectral estimation of plant physiological traits using PLSR may be robust to temporal variation. Additionally, hyperspectral vegetation indices may be sufficient to detect temporal changes in photosynthetic capacity in contexts similar to those studied here. Overall, our results highlight the potential for hyperspectral remote sensing to estimate determinants of photosynthetic capacity during periods with dynamic temporal variations related to seasonality and plant stress, thereby improving estimates of plant productivity and characterization of the associated carbon budget.	[Barnes, Mallory L.; Breshears, David D.; Law, Darin J.; van Leeuwen, Willem J. D.; Moore, David J. P.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Breshears, David D.; Monson, Russell K.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [van Leeuwen, Willem J. D.; Barron-Gafford, Greg A.] Univ Arizona, Sch Geog & Dev, Tucson, AZ USA; [Fojtik, Alec C.] Wheaton Coll, Dept Geol, Wheaton, IL 60187 USA	University of Arizona; University of Arizona; University of Arizona; Wheaton College	Barnes, ML (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA.	mallorybarnes@email.arizona.edu	Breshears, David D./B-9318-2009; Breshears, David D/GSN-3920-2022; van Leeuwen, Willem/ABB-6711-2020; Moore, David JP/A-6268-2013	Breshears, David D./0000-0001-6601-0058; van Leeuwen, Willem/0000-0002-3188-7172; Moore, David JP/0000-0002-6462-3288; Barnes, Mallory/0000-0001-8528-6981	National Science Foundation Research Experience for Undergraduates [EAR-1263251]	National Science Foundation Research Experience for Undergraduates(National Science Foundation (NSF))	This work was supported by the National Science Foundation Research Experience for Undergraduates: grant no. EAR-1263251 to ACF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2014, PHOTOSYNTH RES, V119, P65, DOI 10.1007/s11120-013-9837-y; ASRAR G, 1984, AGRON J, V76, P300, DOI 10.2134/agronj1984.00021962007600020029x; Barnes ML, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1339; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Bernacchi CJ, 2003, NEW PHYTOL, V159, P609, DOI 10.1046/j.1469-8137.2003.00850.x; Bonan GB, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001593; Cao MK, 1998, NATURE, V393, P249, DOI 10.1038/30460; CARTER GA, 1994, INT J REMOTE SENS, V15, P697, DOI 10.1080/01431169408954109; Datt B, 1998, REMOTE SENS ENVIRON, V66, P111, DOI 10.1016/S0034-4257(98)00046-7; Dobrowski SZ, 2005, REMOTE SENS ENVIRON, V97, P403, DOI 10.1016/j.rse.2005.05.006; Doughty CE, 2011, OECOLOGIA, V165, P289, DOI 10.1007/s00442-010-1800-4; Dreyer E, 2001, TREE PHYSIOL, V21, P223, DOI 10.1093/treephys/21.4.223; Drolet GG, 2008, REMOTE SENS ENVIRON, V112, P3064, DOI 10.1016/j.rse.2008.03.002; Duursma RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143346; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Farres M, 2015, J CHEMOMETR, V29, P528, DOI 10.1002/cem.2736; Fensholt R, 2004, REMOTE SENS ENVIRON, V91, P490, DOI 10.1016/j.rse.2004.04.009; Foley JA, 1996, GLOBAL BIOGEOCHEM CY, V10, P603, DOI 10.1029/96GB02692; Frank D, 2015, GLOBAL CHANGE BIOL, V21, P2861, DOI 10.1111/gcb.12916; Friedlingstein P, 2014, J CLIMATE, V27, P511, DOI 10.1175/JCLI-D-12-00579.1; Gamon JA, 1997, OECOLOGIA, V112, P492, DOI 10.1007/s004420050337; GAMON JA, 1992, REMOTE SENS ENVIRON, V41, P35, DOI 10.1016/0034-4257(92)90059-S; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; Gitelson AA, 1997, INT J REMOTE SENS, V18, P2691, DOI 10.1080/014311697217558; Gitelson AA, 1999, REMOTE SENS ENVIRON, V69, P296, DOI 10.1016/S0034-4257(99)00023-1; Gitelson AA, 2017, REMOTE SENS ENVIRON, V191, P110, DOI 10.1016/j.rse.2016.12.014; Gray SB, 2010, J EXP BOT, V61, P4413, DOI 10.1093/jxb/erq244; Hansen PM, 2003, REMOTE SENS ENVIRON, V86, P542, DOI 10.1016/S0034-4257(03)00131-7; Heckmann D, 2017, MOL PLANT, V10, P878, DOI 10.1016/j.molp.2017.04.009; Huete A, 2016, MONITORING PHOTOSYNT; Jenkins JP, 2007, AGR FOREST METEOROL, V143, P64, DOI 10.1016/j.agrformet.2006.11.008; Kampe TU, 2010, J APPL REMOTE SENS, V4, DOI 10.1117/1.3361375; Kattge J, 2007, PLANT CELL ENVIRON, V30, P1176, DOI 10.1111/j.1365-3040.2007.01690.x; Keenan TF, 2013, NATURE, V499, P324, DOI 10.1038/nature12291; le Maire G, 2004, REMOTE SENS ENVIRON, V89, P1, DOI 10.1016/j.rse.2003.09.004; Le Quere C, 2015, EARTH SYST SCI DATA, V7, P349, DOI 10.5194/essd-7-349-2015; Lee CM, 2015, REMOTE SENS ENVIRON, V167, P6, DOI 10.1016/j.rse.2015.06.012; Limousin JM, 2010, PLANT CELL ENVIRON, V33, P863, DOI 10.1111/j.1365-3040.2009.02112.x; Maccioni A, 2001, J PHOTOCH PHOTOBIO B, V61, P52, DOI 10.1016/S1011-1344(01)00145-2; Maia R, 2013, METHODS ECOL EVOL, V4, P906, DOI 10.1111/2041-210X.12069; Morecroft MD, 2003, INT J BIOMETEOROL, V47, P221, DOI 10.1007/s00484-003-0173-3; Nijp JJ, 2014, NEW PHYTOL, V203, P70, DOI 10.1111/nph.12792; Onoda Y, 2005, FUNCT PLANT BIOL, V32, P903, DOI 10.1071/FP05024; PENUELAS J, 1995, PHOTOSYNTHETICA, V31, P221; Rahman AF., 2001, J GEOPHYS RES-ATMOS, V106, P33579, DOI 10.1029/2001jd900157; Reich PB, 2014, NAT GEOSCI, V7, P920, DOI [10.1038/NGEO2284, 10.1038/ngeo2284]; Rogers A, 2017, NEW PHYTOL, V213, P22, DOI 10.1111/nph.14283; Rogers A, 2014, PHOTOSYNTH RES, V119, P15, DOI 10.1007/s11120-013-9818-1; Ruimy A., 1995, Advances in Ecological Research, V26, P1, DOI 10.1016/S0065-2504(08)60063-X; RUNNING SW, 1988, REMOTE SENS ENVIRON, V24, P347, DOI 10.1016/0034-4257(88)90034-X; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; Schimel D, 2015, GLOBAL CHANGE BIOL, V21, P1762, DOI 10.1111/gcb.12822; Serbin SP, 2015, REMOTE SENS ENVIRON, V167, P78, DOI 10.1016/j.rse.2015.05.024; Serbin SP, 2012, J EXP BOT, V63, P489, DOI 10.1093/jxb/err294; Shi H, 2017, ECOL INDIC, V72, P153, DOI 10.1016/j.ecolind.2016.08.022; Siegmann B, 2015, INT J REMOTE SENS, V36, P4519, DOI 10.1080/01431161.2015.1084438; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Sims DA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000162; Smith ML, 2002, ECOL APPL, V12, P1286; Stimson HC, 2005, REMOTE SENS ENVIRON, V96, P108, DOI 10.1016/j.rse.2004.12.007; Turner DP, 2003, GLOBAL CHANGE BIOL, V9, P383, DOI 10.1046/j.1365-2486.2003.00573.x; Verbeeck H, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001544; Verheijen LM, 2013, BIOGEOSCIENCES, V10, P5497, DOI 10.5194/bg-10-5497-2013; VOGELMANN JE, 1993, INT J REMOTE SENS, V14, P1563, DOI 10.1080/01431169308953986; Walker AP, 2014, ECOL EVOL, V4, P3218, DOI 10.1002/ece3.1173; Wehrens R, 2007, PLS PACKAGE PRINCIPA, V24; Wilson KB, 2000, TREE PHYSIOL, V20, P565; Xia JY, 2014, NAT GEOSCI, V7, P173, DOI [10.1038/NGEO2093, 10.1038/ngeo2093]; Xu LK, 2003, TREE PHYSIOL, V23, P865, DOI 10.1093/treephys/23.13.865; Yendrek C, 2016, PLANT PHYSIOL, V2016, P01447; Zaehle S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002395; Zaehle S, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003521; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	75	34	34	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189539	10.1371/journal.pone.0189539	http://dx.doi.org/10.1371/journal.pone.0189539			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281709	Green Published, gold			2022-12-26	WOS:000419006200033
J	Shen, MM; Qu, L; Ma, M; Dou, TC; Lu, J; Guo, J; Hu, YP; Wang, XG; Li, YF; Wang, KH; Yang, N				Shen, Manman; Qu, Liang; Ma, Meng; Dou, Taocun; Lu, Jian; Guo, Jun; Hu, Yuping; Wang, Xingguo; Li, Yongfeng; Wang, Kehua; Yang, Ning			A genome-wide study to identify genes responsible for oviduct development in chickens	PLOS ONE			English	Article							AVIAN OVIDUCT; ASSOCIATION; TRAITS; PROTEINS; GROWTH; EXPRESSION; CANDIDATE; POPULATION; SCYL1BP1; WEIGHT	Molecular genetic tools provide a method for improving the breeding selection of chickens (Gallus gallus). Although some studies have identified genes affecting egg quality, little is known about the genes responsible for oviduct development. To address this issue, here we used a genome-wide association (GWA) study to detect genes or genomic regions that are related to oviduct development in a chicken F-2 resource population by employing high-density 600 K single-nucleotide polymorphism (SNP) arrays. For oviduct length and weight, which exhibited moderate heritability estimates of 0.35 and 0.39, respectively, chromosome 1 (GGA1) explained 9.45% of the genetic variance, while GGA4 to GGA8 and GGA11 explained over 1% of the variance. Independent univariate genome-wide screens for oviduct length and weight detected 69 significant SNPs on GGA1 and 49 suggestive SNPs on GGA1, GGA4, and GGA8. One hundred and fourteen suggestive SNPs were associated with oviduct length, while 73 SNPs were associated with oviduct weight. The significant genomic regions affecting oviduct weight ranged from 167.79-174.29 Mb on GGA1, 73.16-75.70 Mb on GGA4, and 4.88-4.92 Mb on GGA8. The genes CKAP2, CCKAR, NCAPG, IGFBP3, and GORAB were shown to have potential roles in oviduct development. These genes are involved in cell survival, appetite, and growth control. Our results represent the first GWA analysis of genes controlling oviduct weight and length. The identification of genomic loci and potential candidate genes affecting oviduct development greatly increase our understanding of the genetic basis underlying oviduct development, which could have an impact on the selection of egg quality.	[Shen, Manman; Qu, Liang; Ma, Meng; Dou, Taocun; Lu, Jian; Guo, Jun; Hu, Yuping; Wang, Xingguo; Li, Yongfeng; Wang, Kehua] Chinese Acad Agr Sci, Jiangsu Inst Poultry Sci, Yangzhou, Jiangsu, Peoples R China; [Shen, Manman] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China; [Yang, Ning] China Agr Univ, Coll Anim Sci & Technol, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Yangzhou University; China Agricultural University	Wang, KH (corresponding author), Chinese Acad Agr Sci, Jiangsu Inst Poultry Sci, Yangzhou, Jiangsu, Peoples R China.; Yang, N (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Beijing, Peoples R China.	sqbreeding@126.com; nyang@cau.edu.cn	沈, 曼曼/AAL-5661-2021; wang, xingguo/AAF-3020-2020; Shen, Manman/AAC-5554-2020	Shen, Manman/0000-0003-1923-861X; Yang, Ning/0000-0001-5772-3320	China Agriculture Research Systems [CARS-41-K02]; Integration Innovation Project of Layer Research Systems in Jiangsu Province [SXGC [2017]252]; Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province [CX[16]1008]	China Agriculture Research Systems; Integration Innovation Project of Layer Research Systems in Jiangsu Province; Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province	This study was supported in part by the China Agriculture Research Systems (CARS-41-K02) to KW, Integration Innovation Project of Layer Research Systems in Jiangsu Province (SXGC [2017]252) to KW, and Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province (CX[16]1008) to LQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bakst MR, 1998, J EXP ZOOL, V282, P618, DOI 10.1002/(SICI)1097-010X(199811/12)282:4/5&lt;618::AID-JEZ11&gt;3.0.CO;2-M; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berry W, 2006, POULTRY SCI, V85, P1969, DOI 10.1093/ps/85.11.1969; Bock WJ, 2007, INTEGR COMP BIOL, V47, P793; Burger AM, 2005, EUR J CANCER, V41, P1515, DOI 10.1016/j.ejca.2005.04.023; Dougherty DC, 2005, TRENDS ENDOCRIN MET, V16, P414, DOI 10.1016/j.tem.2005.09.001; Dunn IC, 2013, AM J PHYSIOL-ENDOC M, V304, pE909, DOI 10.1152/ajpendo.00580.2012; Everaert N, 2013, BRIT J NUTR, V110, P265, DOI 10.1017/S000711451200503X; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Gu XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021872; Hennies HC, 2008, NAT GENET, V40, P1410, DOI 10.1038/ng.252; Hong KU, 2009, CELL CYCLE, V8, P314, DOI 10.4161/cc.8.2.7597; Houdebine LM, 2009, COMP IMMUNOL MICROB, V32, P107, DOI 10.1016/j.cimid.2007.11.005; Hrabia A, 2016, THERIOGENOLOGY, V85, P1590, DOI 10.1016/j.theriogenology.2016.01.022; Hwa V, 1999, ACTA PAEDIATR, V88, P37, DOI 10.1111/j.1651-2227.1999.tb14349.x; Jun G, 2017, POULT SCI, V96; KATO S, 1987, POULTRY SCI, V66, P1208, DOI 10.3382/ps.0661208; Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104; Lim W, 2012, GEN COMP ENDOCR, V175, P65, DOI 10.1016/j.ygcen.2011.09.019; Liu RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061172; Liu Y, 2016, J INVEST DERMATOL, V136, P378, DOI 10.1016/j.jid.2015.10.067; Liu YH, 2012, MOL BIOL CELL, V23, P4506, DOI 10.1091/mbc.E12-05-0362; Machado SA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101188; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Moran TH, 1998, AM J PHYSIOL-REG I, V274, pR618, DOI 10.1152/ajpregu.1998.274.3.R618; MORRIS B. A., 1967, BRIT POULTRY SCI, V8, P251, DOI 10.1080/00071666708415676; Nadaf J, 2009, PHYSIOL GENOMICS, V38, P241, DOI 10.1152/physiolgenomics.90384.2008; Ou JT, 2009, POULTRY SCI, V88, P722, DOI 10.3382/ps.2008-00497; Palmer B.D., 1991, OVIDUCTAL PROTEINS T; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rikimaru K, 2012, MOL BIOL REP, V39, P4479, DOI 10.1007/s11033-011-1237-9; Setoguchi K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-43; Shen MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159081; Sun C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/919401; Sun CJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1795-7; Tetens J, 2013, ANIM GENET, V44, P467, DOI 10.1111/age.12031; Wang W, 2015, ANIM GENET; Widmann P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124574; Williams TD, 2000, J AVIAN BIOL, V31, P87, DOI 10.1034/j.1600-048X.2000.310112.x; Williams TD, 2004, J EXP BIOL, V207, P263, DOI 10.1242/jeb.00740; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x; Xie L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030910; Xu ZQ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2861-5; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yi GQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1945-y; Yu G, 2015, MOL CANCER RES, V13, P348, DOI 10.1158/1541-7786.MCR-14-0384-T; Yuan JW, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0161-1; Yuan JW, 2015, POULTRY SCI, V94, P1470, DOI 10.3382/ps/pev122; Zhang G, 2015, ANIM REPROD SCI; Zhang H, 2010, J ANIM BREED GENET, V127, P462, DOI 10.1111/j.1439-0388.2010.00871.x; Zhang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125890; Zhao JH, 2007, GAP GENETIC ANAL PAC; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/nmeth.2848, 10.1038/NMETH.2848]	55	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189955	10.1371/journal.pone.0189955	http://dx.doi.org/10.1371/journal.pone.0189955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281706	Green Submitted, Green Published, gold			2022-12-26	WOS:000419006200055
J	Chen, X; Li, Y; Chen, GF; Wang, FJ; Qiu, LC				Chen, Xin; Li, Yong; Chen, Genfa; Wang, Fujun; Qiu, Liuchao			Instantaneous sediment transport model for asymmetric oscillatory sheet flow	PLOS ONE			English	Article							SAND TRANSPORT; GRAIN-SIZE; WAVES; UNSTEADY; UNIFORM	On the basis of advanced concentration and velocity profiles above a mobile seabed, an instantaneous analytical model is derived for sediment transport in asymmetric oscillatory flow. The applied concentration profile is obtained from the classical exponential law based on mass conservation, and asymmetric velocity profile is developed following the turbulent boundary layer theory and the asymmetric wave theory. The proposed model includes two parts: the basic part that consists of erosion depth and free stream velocity, and can be simplified to the total Shields parameter power 3/ 2 in accordance with the classical empirical models, and the extra vital part that consists of phase-lead, boundary layer thickness and erosion depth. The effects of suspended sediment, phase-lag and asymmetric boundary layer development are considered particularly in the model. The observed instantaneous transport rate proportional to different velocity exponents due to phase-lag is unified and summarised by the proposed model. Both instantaneous and half period empirical formulas are compared with the developed model, using extensive data on a wide range of flow and sediment conditions. The synchronous variation in instantaneous transport rate with free stream velocity and its decrement caused by increased sediment size are predicted correctly. Net transport rates, especially offshore transport rates with large phase-lag under velocity skewed flows, which existing instantaneous type formulas failed to predict, are predicted correctly in both direction and magnitude by the proposed model. Net sediment transport rates are affected not only by suspended sediment and phase-lag, but also by the boundary layer difference between onshore and offshore.	[Chen, Xin; Wang, Fujun; Qiu, Liuchao] China Agr Univ, Beijing Engn Res Ctr Safety & Energy Saving Techn, Beijing, Peoples R China; [Li, Yong] China Geol Survey, Tianjin Ctr, Tianjin, Peoples R China; [Chen, Genfa] China Inst Water Resources & Hydropower Res, Dept Water Resources Res, Beijing, Peoples R China	China Agricultural University; China Geological Survey; China Institute of Water Resources & Hydropower Research	Chen, X (corresponding author), China Agr Univ, Beijing Engn Res Ctr Safety & Energy Saving Techn, Beijing, Peoples R China.	chenx@cau.edu.cn		CHEN, XIN/0000-0002-6244-7866	National Naturel Science Foundation of China [51609244, 11472156, 51779258]; State Key Laboratory of Hydroscience of China [sklhse-2015-C-03]; Engineering and National Science Technology Support Plan of China [2015BAD201301]	National Naturel Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Hydroscience of China; Engineering and National Science Technology Support Plan of China	The project is supported by National Naturel Science Foundation of China (No. 51609244, 11472156 and 51779258), Open Research Fund Program of State Key Laboratory of Hydroscience of China (Grant No. sklhse-2015-C-03) and Engineering and National Science Technology Support Plan of China (Grant No. 2015BAD201301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project is supported by National Naturel Science Foundation of China (No. 51609244, 11472156 and 51779258), Open Research Fund Program of State Key Laboratory of Hydro science of China (Grant No. sklhse-2015-C-03) and Engineering and National Science-Technology Support Plan of China (Grant No. 2015BAD20B01).	Abreu T, 2010, COAST ENG, V57, P656, DOI 10.1016/j.coastaleng.2010.02.005; Ahmed ASM, 2003, COAST ENG J, V45, P321, DOI 10.1142/S0578563403000786; Al-Salem A. A., 1993, THESIS; BAILARD JA, 1981, J GEOPHYS RES-OCEANS, V86, P938, DOI 10.1029/JC086iC11p10938; Chen X., 2017, ADV WATER RESOURCES; Chen X., 2017, ACTA MECH SINCA; Chen X, 2013, J WATERW PORT C, V139, P393, DOI 10.1061/(ASCE)WW.1943-5460.0000193; Chen Z, 1993, H840 DELFT HYDR 7; da Silva PA, 2006, COAST ENG, V53, P897, DOI 10.1016/j.coastaleng.2006.06.010; Dibajnia M, 2001, COAST ENG J, V43, P1, DOI 10.1142/S0578563401000256; Dibajnia M., 1991, THESIS; DICK JE, 1992, J GEOPHYS RES-OCEANS, V97, P5745, DOI 10.1029/92JC00054; Dohmen-Janssen CM, 2005, CONT SHELF RES, V25, P333, DOI 10.1016/j.csr.2004.10.009; Dohmen-Janssen CM, 2001, J GEOPHYS RES-OCEANS, V106, P27103, DOI 10.1029/2000JC000513; Dohmen-Janssen M., 1999, THESIS DELFT U TECHN; FredsOe J., 1992, MECH COASTAL SEDIMEN, DOI 10.1142/1546 25512595; Gonzalez-Rodriguez D, 2007, COAST ENG, V54, P914, DOI 10.1016/j.coastaleng.2007.06.004; Hassan WNM, 2010, COAST ENG, V57, P19, DOI 10.1016/j.coastaleng.2009.08.009; Hassan WN, 2005, COAST ENG, V52, P745, DOI 10.1016/j.coastaleng.2005.06.002; King Jr D.B., 1991, THESIS; Kranenburg WM, 2014, ADV WATER RESOUR, V72, P57, DOI 10.1016/j.advwatres.2014.05.008; Lanckriet T, 2015, J GEOPHYS RES-OCEANS, V120, P1333, DOI 10.1002/2014JC010378; Dong LP, 2013, COAST ENG, V71, P87, DOI 10.1016/j.coastaleng.2012.08.004; Li M, 2008, COAST ENG, V55, P1159, DOI 10.1016/j.coastaleng.2008.05.003; Liu H, 2006, COAST ENG, V53, P825, DOI 10.1016/j.coastaleng.2006.04.002; Meyer-Peter E., 1948, P IAHSR 2 M STOCKH, P39; Nielsen P., 2010, P 32 INT C COAST ENG; Nielsen P, 2006, COAST ENG, V53, P749, DOI 10.1016/j.coastaleng.2006.03.006; O'Donoghue T, 2004, COAST ENG, V51, P1163, DOI 10.1016/j.coastaleng.2004.08.001; O'Donoghue T, 2004, COAST ENG, V50, P117, DOI 10.1016/j.coastaleng.2003.09.004; RIBBERINK JS, 1995, COAST ENG, V25, P205, DOI 10.1016/0378-3839(95)00003-T; Ribberink JS, 1998, COAST ENG, V34, P59, DOI 10.1016/S0378-3839(98)00013-1; RIBBERINK JS, 1994, J GEOPHYS RES-OCEANS, V99, P12707, DOI 10.1029/94JC00380; Ruessink BG, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006443; Silva PA, 2011, J HYDRAUL RES, V49, P72, DOI 10.1080/00221686.2011.592681; SLEATH JFA, 1978, J WATERW PORT C DIV, V104, P291; Suntoyo, 2008, COAST ENG, V55, P1102, DOI 10.1016/j.coastaleng.2008.04.007; TROWBRIDGE J, 1989, J GEOPHYS RES-OCEANS, V94, P10971, DOI 10.1029/JC094iC08p10971; van der A D. A., 2010, P 32 INT C COAST ENG; van der A DA, 2013, COAST ENG, V76, P26, DOI 10.1016/j.coastaleng.2013.01.007; van der A DA, 2010, COAST ENG, V57, P331, DOI 10.1016/j.coastaleng.2009.11.006; van der Zanden J, 2015, COAST ENG, V105, P47, DOI 10.1016/j.coastaleng.2015.08.009; Van Rijn L.C., 1993, PRINCIPLES SEDIMENT; Wang YH, 2007, ADV WATER RESOUR, V30, P1355, DOI 10.1016/j.advwatres.2006.11.012; Watanabe A, 2005, Coastal Engineering 2004, Vols 1-4, P1703; WILSON KC, 1995, COAST ENG, V25, P191, DOI 10.1016/0378-3839(95)00006-W; Zala-Flores N., 1998, J GEOPHYS RES, V103, P783	47	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190034	10.1371/journal.pone.0190034	http://dx.doi.org/10.1371/journal.pone.0190034			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272317	gold, Green Submitted, Green Published			2022-12-26	WOS:000418651500027
J	Chen, KLA; Zhao, YC; Hieronymi, K; Smith, BP; Madak-Erdogan, Z				Chen, Karen Lee Ann; Zhao, Yiru Chen; Hieronymi, Kadriye; Smith, Brandi Patricia; Madak-Erdogan, Zeynep			Bazedoxifene and conjugated estrogen combination maintains metabolic homeostasis and benefits liver health	PLOS ONE			English	Article							STIMULATING REPRODUCTIVE TISSUES; IMPROVES HEPATIC STEATOSIS; NONALCOHOLIC STEATOHEPATITIS; INSULIN SENSITIVITY; CLINICAL-PRACTICE; FEMALE MICE; MENOPAUSE; DISEASE; DYSFUNCTION; SYMPTOMS	The bazedoxifene and conjugated estrogens (CE+BZA) combination has been shown to prevent visceral adiposity and weight gain after ovariectomy. However, its impact on the liver transcriptomes associated with prevention of hepatosteatosis is yet to be determined. In the present study, we use liver transcriptomics and plasma metabolomics analysis to characterize the effects of various estrogens on liver. The CE+BZA combination was very effective at preventing ovariectomy-induced weight gain in mice fed a high-fat diet (HFD). In CE+BZA treated animals, liver weight and hepatic lipid deposition were significantly lower than in Vehicle (Veh) treated animals. Additionally, CE+BZA induced unique liver transcrip-tome and plasma metabolome profiles compared to estradiol, conjugated estrogens alone, and bazedoxifene alone. Blood plasma metabolite analysis identified several metabolites similar to and distinct from other estrogen treatments. Integrated pathway analysis showed that gene networks that were associated with inflammation, reactive oxygen species pathway and lipid metabolism and their relevant metabolites were regulated significantly by CE+BZA treatment. Thus, long-term CE+BZA treatment modulated hepatic metabolic gene networks and their associated metabolites and improves hepatic health without stimulating the uterus.	[Chen, Karen Lee Ann; Madak-Erdogan, Zeynep] UIUC, Div Nutr Sci, Urbana, IL 61801 USA; [Zhao, Yiru Chen; Hieronymi, Kadriye; Smith, Brandi Patricia; Madak-Erdogan, Zeynep] UIUC, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA; [Madak-Erdogan, Zeynep] UIUC, Inst Genom Biol, Urbana, IL 61801 USA; [Madak-Erdogan, Zeynep] UIUC, Natl Ctr Supercomp Applicat, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Madak-Erdogan, Z (corresponding author), UIUC, Div Nutr Sci, Urbana, IL 61801 USA.; Madak-Erdogan, Z (corresponding author), UIUC, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA.; Madak-Erdogan, Z (corresponding author), UIUC, Inst Genom Biol, Urbana, IL 61801 USA.; Madak-Erdogan, Z (corresponding author), UIUC, Natl Ctr Supercomp Applicat, Urbana, IL 61801 USA.	zmadake2@illinois.edu		Smith, Brandi/0000-0001-7686-5105; Madak-Erdogan, Zeynep/0000-0003-2607-1643	University of Illinois, Office of the Vice Chancellor for Research [RB15150]; National Institute of Food and Agriculture, U.S. Department of Agriculture [ILLU-698-909]; Pfizer [WI196180]	University of Illinois, Office of the Vice Chancellor for Research; National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Pfizer(Pfizer)	This work was supported by grants from the University of Illinois, Office of the Vice Chancellor for Research, Arnold O. Beckman award RB15150 (to ZME), National Institute of Food and Agriculture, U.S. Department of Agriculture, award ILLU-698-909 (to ZME), and investigator initiated grant- WI196180 from Pfizer (to ZME). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adikwu E, 2013, PHARM PHARM; Barrera J, 2014, AM J PHYSIOL-ENDOC M, V307, pE345, DOI 10.1152/ajpendo.00653.2013; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; Bureau USC, 2010, 65 US, V2010, P23; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Chambliss KL, 2016, ENDOCRINOLOGY, V157, P3731, DOI 10.1210/en.2015-1629; Chambliss KL, 2010, J CLIN INVEST, V120, P2319, DOI 10.1172/JCI38291; CLIFFORD AJ, 1986, J NUTR, V116, P944, DOI 10.1093/jn/116.6.944; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Gambino R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040479; Goodman NF, 2011, ENDOCR PRACT, V17, P1, DOI 10.4158/EP.17.S6.1; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Itabashi A, 2011, J BONE MINER RES, V26, P519, DOI 10.1002/jbmr.252; Kim JH, 2014, MOL METAB, V3, P177, DOI 10.1016/j.molmet.2013.12.009; KUMAGAI S, 1993, ACTA PHYSIOL SCAND, V149, P91, DOI 10.1111/j.1748-1716.1993.tb09596.x; Li JW, 2016, INTEGR MED INSIGHTS, V11, P19, DOI 10.4137/IMI.S31451; Lindsay R, 2011, OSTEOPOROSIS INT, V22, P447, DOI 10.1007/s00198-010-1440-x; Lobo RA, 2009, FERTIL STERIL, V92, P1025, DOI 10.1016/j.fertnstert.2009.03.113; Madak-Erdogan Z, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad8170; Madak-Erdogan Z, 2016, J STEROID BIOCHEM, V158, P198, DOI 10.1016/j.jsbmb.2015.12.008; Madak-Erdogan Z, 2016, MOL NUTR FOOD RES, V60, P369, DOI 10.1002/mnfr.201500445; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; Mauvais-Jarvis F, 2011, TRENDS ENDOCRIN MET, V22, P24, DOI 10.1016/j.tem.2010.10.002; Pinkerton JV, 2017, MENOPAUSE, V24, P728, DOI 10.1097/GME.0000000000000921; Pinkerton JV, 2014, J CLIN ENDOCR METAB, V99, pE189, DOI 10.1210/jc.2013-1707; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; Santen RJ, 2013, J STEROID BIOCHEM, V137, P150, DOI 10.1016/j.jsbmb.2013.05.008; Song NJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162228; Stuenkel CA, 2015, J CLIN ENDOCR METAB, V100, P3975, DOI 10.1210/jc.2015-2236; Terashima Y, 2014, ARCH BIOCHEM BIOPHYS, V555, P55, DOI 10.1016/j.abb.2014.05.013; Wagner JD, 1998, J CLIN ENDOCR METAB, V83, P896, DOI 10.1210/jc.83.3.896; Wardell SE, 2013, CLIN CANCER RES, V19, P2420, DOI 10.1158/1078-0432.CCR-12-3771; Wei YZ, 2008, WORLD J GASTROENTERO, V14, P193, DOI 10.3748/wjg.14.193; Wrobel K, 2016, MOL ENDOCRINOL, V30, P1029, DOI 10.1210/me.2016-1101; Xu CF, 2015, J HEPATOL, V62, P1412, DOI 10.1016/j.jhep.2015.01.019; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655	37	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189911	10.1371/journal.pone.0189911	http://dx.doi.org/10.1371/journal.pone.0189911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267318	Green Submitted, gold, Green Published			2022-12-26	WOS:000418587400061
J	Lo, CY; Sung, FC; Mou, CH; Lin, TC; Tseng, CH; Tzeng, YL				Lo, Chyi; Sung, Fung-Chang; Mou, Chih-Hsin; Lin, Tzu-Chieh; Tseng, Chun-Huang; Tzeng, Ya-Ling			Population study evaluating fracture risk among patients with chronic osteomyelitis	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; HIP FRACTURE; OSTEOPOROSIS; MANAGEMENT; METAANALYSIS; WOMEN	Background Studies investigating the fracture risk in patients with chronic osteomyelitis (COM) limited to case reports. This study evaluated the association between COM and subsequent fracture risk using population-based data. Methods A subset claims data of the Taiwan National Health Insurance was used to identify 7,147 patients with COM newly diagnosed in 1999 +/- 2005 without fracture history and 28,588 general population controls, frequency matched by sex, age and diagnosis date. The incident fractures was measured by the end of 2013. Results The incidence density of fracture was 1.94-fold greater in the COM cohort than in controls (21.5 vs. 11.1 per 1000 person-years), with the adjusted hazard ratio (HR) of 1.81 (95% CI: 1.67 +/- 1.95) for COM patients compared to controls after controlling for sex, age, and comorbidities of diabetes, osteoporosis, depression and end-stage renal disease in Cox proportional hazards regression. The fracture risk increased with age and women were at greater risk than men. The fracture incidence increased substantially in those with osteoporosis, 40.2 per 1000 person-years in COM patients. Site specific analysis showed a higher portion of incident fractures for lower limbs, 52.7% in COM cohort and 46.3% in controls. Conclusion Findings in this 15-year follow-up observation support our hypothesis that patients with COM are at an elevated risk of subsequent fracture. COM patients and the elderly deserve adequate consultation and awareness for fracture prevention.	[Lo, Chyi; Tzeng, Ya-Ling] China Med Univ, Coll Hlth Care, Sch Nursing, Taichung, Taiwan; [Lo, Chyi; Tzeng, Ya-Ling] China Med Univ Hosp, Dept Nursing, Taichung, Taiwan; [Sung, Fung-Chang; Mou, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Lin, Tzu-Chieh] Taichung Vet Gen Hosp, Emergency Dept, Div Traumatol, Taichung, Taiwan; [Lin, Tzu-Chieh] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Tseng, Chun-Huang] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tzeng, YL (corresponding author), China Med Univ, Coll Hlth Care, Sch Nursing, Taichung, Taiwan.; Tzeng, YL (corresponding author), China Med Univ Hosp, Dept Nursing, Taichung, Taiwan.	tyaling@mail.cmu.edu.tw		Lin, Tzu-Chieh/0000-0002-6542-2023	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW106-TDU-B-212-113004, MOHW105-TDU-B-212-133019]; research laboratory of pediatrics, Childrens Hospital of China Medical University [DMR-105-042]; China Medical University Hospital [DMR-106-025]; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; research laboratory of pediatrics, Childrens Hospital of China Medical University; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	The present study was supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004; MOHW105-TDU-B-212-133019), the research laboratory of pediatrics, Childrens Hospital of China Medical University (grant number DMR-105-042), China Medical University Hospital (DMR-106-025), Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonge TO, 2002, INT J CLIN PRACT, V56, P353; Alswat Khaled A, 2017, J Clin Med Res, V9, P382, DOI 10.14740/jocmr2970w; Aytac S, 2014, ARCH ORTHOP TRAUM SU, V134, P159, DOI 10.1007/s00402-013-1907-2; Bardai G, 2017, OSTEOPOROS INT; Cheng BH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004655; Chihara S, 2010, DM-DIS MON, V56, P6, DOI 10.1016/j.disamonth.2009.07.001; CIERNY G, 1984, ORTHOPEDICS, V7, P1557, DOI 10.3928/0147-7447-19841001-07; Cizza G, 2009, TRENDS ENDOCRIN MET, V20, P367, DOI 10.1016/j.tem.2009.05.003; Cortes-Sancho R, 2004, J AM GERIATR SOC, V52, P1778, DOI 10.1111/j.1532-5415.2004.52479_2.x; Coughlan T, 2014, CLIN MED, V14, P187, DOI 10.7861/clinmedicine.14-2-187; Curtis E.M., 2017, BONE; DGBAS, 2011, STAT YB; Doring AC, 2016, CASE REP ORTHOP; Feydy A, 2000, EUR RADIOL, V10, P1929, DOI 10.1007/s003300000503; Hadji P, 2015, VALUE HEALTH, V18, pA641, DOI 10.1016/j.jval.2015.09.2288; Hatzenbuehler J, 2011, AM FAM PHYSICIAN, V84, P1027; Holm JP, 2016, ENDOCRINE, V54, P241, DOI 10.1007/s12020-016-0987-5; Hung YC, 2017, OSTEOPOROS INT; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P669, DOI 10.1007/s001980070064; Khazzani H, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-297; Kumar V, 2012, ROBBINS BASIC PATHOL; LEE CK, 1979, ORTHOPEDICS, V2, P46, DOI 10.3928/0147-7447-19790101-09; LERNER RK, 1993, CLIN ORTHOP RELAT R, P28; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Lin TY, 2010, AM J MED SCI, V339, P493, DOI 10.1097/MAJ.0b013e3181d94f90; Moura Diogo Lino, 2017, Rev. bras. ortop., V52, P141, DOI 10.1016/j.rboe.2017.03.005; Mwaka Erisa Sabakaki, 2013, J Med Case Rep, V7, P8, DOI 10.1186/1752-1947-7-8; NORDEN C, 1992, CLIN INFECT DIS, V15, pS177, DOI 10.1093/clind/15.Supplement_1.S177; Ottenbacher KJ, 2002, J GERONTOL A-BIOL, V57, pM648, DOI 10.1093/gerona/57.10.M648; Pawar I, 2010, J ORTHOP TRAUMATOL, V11, P129, DOI 10.1007/s10195-010-0090-2; Sozen T, 2017, EUR J RHEUMATOL, V4, P46, DOI 10.5152/eurjrheum.2016.048; Tamparo CD, 2016, DIS HUMAN BODY; Termaat MF, 2005, J BONE JOINT SURG AM, V87A, P2464, DOI 10.2106/JBJS.D.02691; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Watts NB, 2017, JAMA-J AM MED ASSOC, V317, P253, DOI 10.1001/jama.2016.19087; Williams LJ, 2016, J AFFECT DISORDERS, V192, P34, DOI 10.1016/j.jad.2015.11.048; Wu Q, 2010, OSTEOPOROSIS INT, V21, P1627, DOI 10.1007/s00198-010-1181-x; Wu ZJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168990; Yapici O, 2017, HEMATOL REP, V9, P19, DOI 10.4081/hr.2017.6981	41	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189743	10.1371/journal.pone.0189743	http://dx.doi.org/10.1371/journal.pone.0189743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8BI	29267371	Green Submitted, gold, Green Published			2022-12-26	WOS:000418587400043
J	Ren, LL; Balakrishnan, K; Luo, YQ; Schutz, S				Ren, Li Li; Balakrishnan, Karthi; Luo, You Qing; Schuetz, Stefan			EAG response and behavioral orientation of Dastarcus helophoroides (Fairmaire) (Coleoptera: Bothrideridae) to synthetic host-associated volatiles	PLOS ONE			English	Article							JAPANESE PINE SAWYER; MONOCHAMUS-ALTERNATUS; ANOPLOPHORA-GLABRIPENNIS; PLANT VOLATILES; HOPE COLEOPTERA; CERAMBYCIDAE; BEETLE; ATTRACTION; MANAGEMENT; PHEROMONE	Dastarcus helophoroides Fairmaire (Coleoptera: Bothrideridae) is an effective predatory beetle of larvae and pupae of several cerambycid beetles including Monochamus alternatus and Anoplophora glabripennis. Electroantennography (EAG) and a dynamic two-choice olfactometer were respectively used to measure the antennal and behavioral responses of both sexes to selected volatile compounds. Female and male D. helophoroides exhibited similar EAG and behavioral responses. Significant dose-dependent EAG responses in both sexes were elicited by nonanal, octanal, cis-3-hexenol, 3-carene, (R)-(+)-alpha-pinene, (S)(-)-alpha-pinene, (R)-(+)-limonene and (S)-(-)-limonene. Female and male beetles were repelled at high concentration by cis-3-hexenol and (S)-(-)-limonene, respectively. Both sexes of D. helophoroides were significantly attracted to nonanal, cis-3-hexenol, 3-carene and (R)(+)-limonene even at low concentrations. These compounds might be used either individually or in mixtures for developing biological control methods to attract this predatory beetle into forest stands threatened by cerambycid beetles.	[Ren, Li Li; Luo, You Qing] Beijing Forestry Univ, Beijing Key Lab Forest Pest Control, Beijing, Peoples R China; [Balakrishnan, Karthi; Schuetz, Stefan] Georg August Univ Gottingen, Dept Forest Zool & Forest Conservat, Gottingen, Germany	Beijing Forestry University; University of Gottingen	Luo, YQ (corresponding author), Beijing Forestry Univ, Beijing Key Lab Forest Pest Control, Beijing, Peoples R China.	youqingluo@126.com			Special Fund for Forest Scientific Research in the Public Welfare [201404401]; CSC [2009-6037]; DAAD [2009-6037]; Chinese National Natural Science Foundation [31500529]; BMBF-BEST project [FKZ033L033A-E]	Special Fund for Forest Scientific Research in the Public Welfare; CSC; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); BMBF-BEST project	This work was supported by Special Fund for Forest Scientific Research in the Public Welfare (201404401). We were also supported by the scientist exchange in the framework of the cooperation program PPP that was jointly funded by the CSC and DAAD (2009-6037), Chinese National Natural Science Foundation (31500529), and the BMBF-BEST project (FKZ033L033A-E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We greatly appreciate the scientific and technical support from Stefan Dippel and Dr. Bernhard Weissbecker of Georg-August-University, Gottingen. We thank Dr. Yi-nan Zhang of Beijing Agriculture College for providing the test beetles. This work was supported by Special Fund for Forest Scientific Research in the Public Welfare (201404401). We were also supported by the scientist exchange in the framework of the cooperation program PPP that was jointly funded by the CSC and DAAD (2009-6037), Chinese National Natural Science Foundation (31500529), and the BMBF-BEST project (FKZ033L033A-E).	Balakrishnan K, 2017, J APPL ENTOMOL, V141, P477, DOI 10.1111/jen.12366; Costello SL, 2008, J ECON ENTOMOL, V101, P409, DOI 10.1603/0022-0493(2008)101[409:TAAFWI]2.0.CO;2; de Boer JG, 2008, J CHEM ECOL, V34, P281, DOI 10.1007/s10886-007-9405-z; Fan JT, 2007, ANN FOREST SCI, V64, P67, DOI 10.1051/forest:2006089; Fan JT, 2007, ENVIRON ENTOMOL, V36, P58, DOI 10.1603/0046-225X(2007)36[58:ROHVIM]2.0.CO;2; Fan Li-qing, 2013, Shengtaixue Zazhi, V32, P142; Fournet S, 2001, J ANIM ECOL, V70, P1046, DOI 10.1046/j.0021-8790.2001.00557.x; Hu JF, 2009, AGR FOREST ENTOMOL, V11, P359, DOI 10.1111/j.1461-9563.2009.00443.x; Inoue E., 1991, B OKAYAMA PREFECTURA; KAISSLING KE, 1986, ANNU REV NEUROSCI, V9, P121, DOI 10.1146/annurev.ne.09.030186.001005; Li JG, 2003, ACTA BOT SIN, V45, P177; Li XJ, 2016, J INSECT BEHAV, V29, P108, DOI 10.1007/s10905-016-9547-3; Li Z, 2015, FLA ENTOMOL, V98, P1182; Nehme ME, 2009, ENVIRON ENTOMOL, V38, P1745, DOI 10.1603/022.038.0628; Paczkowski S, 2014, J INSECT BEHAV, V27, P228, DOI 10.1007/s10905-013-9430-4; Qin X.-x., 1988, Entomological Knowledge, V25, P109; Qiong L, 2005, CHINESE AGR SCI B, V3; Ren LL, 2012, MICRON, V43, P921, DOI 10.1016/j.micron.2012.03.005; SCHNEIDER D, 1962, J INSECT PHYSIOL, V8, P15, DOI 10.1016/0022-1910(62)90051-3; Scholz M, 2012, FORSTSCHUTZ AKTUELL, V55, P40; Staeben JC, THANASIMUS DUBIUS AP, V2; Tang H, 2007, ACTA ZOOTAXONOMICA S, V32, P1; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Wehnert M, 2012, BIOL CONTROL, V62, P16, DOI 10.1016/j.biocontrol.2012.03.003; Wei J-R, 2007, FOREST PEST DIS, V3; Wei JR, 2008, AGR FOREST ENTOMOL, V10, P323, DOI 10.1111/j.1461-9563.2008.00384.x; Wei JR, 2013, J INSECT SCI, V13; Wei JR, 2009, BIOCONTROL, V54, P733, DOI 10.1007/s10526-009-9224-y; Weissbecker Bernhard, 2006, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V15, P235; WHITE PR, 1993, J CHEM ECOL, V19, P2193, DOI 10.1007/BF00979657; Wibe A, 1998, J CHEM ECOL, V24, P273, DOI 10.1023/A:1022580308414; Wickham JD, 2012, INSECT SCI, V19, P355, DOI 10.1111/j.1744-7917.2012.01504.x; Yan Shan-Chun, 2006, Acta Entomologica Sinica, V49, P759; Yang Hua, 2010, Journal of Agricultural and Urban Entomology, V27, P20; Zhang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100673; Zhuge PP, 2010, J APPL ENTOMOL, V134, P600, DOI 10.1111/j.1439-0418.2010.01540.x	36	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190067	10.1371/journal.pone.0190067	http://dx.doi.org/10.1371/journal.pone.0190067			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267391	gold, Green Published, Green Submitted			2022-12-26	WOS:000418587400086
J	Gerlach, C; Klargaard, SK; Petersen, A; Starrfelt, R				Gerlach, Christian; Klargaard, Solja K.; Petersen, Anders; Starrfelt, Randi			Delayed processing of global shape information in developmental prosopagnosia	PLOS ONE			English	Article							VISUAL OBJECT RECOGNITION; CONGENITAL PROSOPAGNOSIA; FACE RECOGNITION; CONFIGURAL INFORMATION; PERCEPTION; IDENTIFICATION; TIME; PRECEDENCE; ATTENTION; STIMULI	There is accumulating evidence suggesting that a central deficit in developmental prosopagnosia (DP), a disorder characterized by profound and lifelong difficulties with face recognition, concerns impaired holistic processing. Some of this evidence comes from studies using Navon's paradigm where individuals with DP show a greater local or reduced global bias compared with controls. However, it has not been established what gives rise to this altered processing bias. Is it a reduced global precedence effect, changes in susceptibility to interference effects or both? By analyzing the performance of 10 individuals with DP in Navon's paradigm we find evidence of a reduced global precedence effect: The DPs are slower than controls to process global but not local shape information. Importantly, and in contrast to previous studies, we demonstrate that the DPs perform normally in a comprehensive test of visual attention, showing normal: visual short-term memory capacity, speed of visual processing, efficiency of top-down selectivity, and allocation of attentional resources. Hence, we conclude that the reduced global precedence effect reflects a perceptual rather than an attentional deficit. We further show that this reduced global precedence effect correlates both with the DPs' face recognition abilities, as well as their ability to recognize degraded (non-face) objects. We suggest that the DPs' impaired performance in all three domains (Navon, face and object recognition) may be related to the same dysfunction; delayed derivation of global relative to local shape information.	[Gerlach, Christian; Klargaard, Solja K.] Univ Southern Denmark, Dept Psychol, Odense, Denmark; [Petersen, Anders; Starrfelt, Randi] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark	University of Southern Denmark; University of Copenhagen	Gerlach, C (corresponding author), Univ Southern Denmark, Dept Psychol, Odense, Denmark.	cgerlach@health.sdu.dk	Starrfelt, Randi/O-1124-2016	Starrfelt, Randi/0000-0002-5849-5160; Gerlach, Christian/0000-0003-1261-4889; Petersen, Anders/0000-0003-3595-6275	Det Frie Forskningsrad (Danish Council for Independent Research) [DFF 4001-00115]	Det Frie Forskningsrad (Danish Council for Independent Research)	This work was supported by Det Frie Forskningsrad (Danish Council for Independent Research) (http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research?set_language=en&cl=en), Grant Number: DFF 4001-00115.	Amishav R, 2010, PSYCHON B REV, V17, P743, DOI 10.3758/PBR.17.5.743; Avidan G, 2011, NEUROPSYCHOLOGIA, V49, P2541, DOI 10.1016/j.neuropsychologia.2011.05.002; Awasthi B, 2012, COGN NEUROSCI-UK, V3, P120, DOI 10.1080/17588928.2012.673482; Behrmann M, 2005, J COGNITIVE NEUROSCI, V17, P1130, DOI 10.1162/0898929054475154; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Duchaine B, 2011, OXFORD HDB FACE PERC, P821; Duchaine B, 2007, SOC COGN AFFECT NEUR, V2, P104, DOI 10.1093/scan/nsm003; Duchaine B, 2007, COGN NEUROPSYCHOL, V24, P419, DOI 10.1080/02643290701380491; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; Dyrholm M, 2011, J MATH PSYCHOL, V55, P416, DOI 10.1016/j.jmp.2011.08.005; Freeman P, FACES EMOTION QUESTI; Garner W. R., 1974, PROCESSING INFORM ST; Gerlach C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165561; Gerlach C, 2014, ACTA PSYCHOL, V153, P28, DOI 10.1016/j.actpsy.2014.09.004; Gerlach C, 2014, VIS COGN, V22, P751, DOI 10.1080/13506285.2014.915908; Gerlach C, 2011, VIS COGN, V19, P1262, DOI 10.1080/13506285.2011.630044; Gerlach C, 2009, COGNITION, V111, P281, DOI 10.1016/j.cognition.2009.02.005; KIMCHI R, 1992, PSYCHOL BULL, V112, P24, DOI 10.1037/0033-2909.112.1.24; Kimchi R, 2012, COGN NEUROPSYCHOL, V29, P447, DOI 10.1080/02643294.2012.752723; Le Grand R, 2006, BRAIN COGNITION, V61, P139, DOI 10.1016/j.bandc.2005.11.005; Liu TT, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00750; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Navon D, 2003, ACTA PSYCHOL, V114, P273, DOI 10.1016/j.actpsy.2003.06.002; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Palermo R, 2011, NEUROPSYCHOLOGIA, V49, P1226, DOI 10.1016/j.neuropsychologia.2011.02.021; Parketny J, 2015, NEUROPSYCHOLOGIA, V75, P538, DOI 10.1016/j.neuropsychologia.2015.07.009; Poirel N, 2008, ACTA PSYCHOL, V127, P1, DOI 10.1016/j.actpsy.2006.12.001; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Richler JJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00553; Rossion B, 2008, ACTA PSYCHOL, V128, P274, DOI 10.1016/j.actpsy.2008.02.003; Rossion B, 2013, VIS COGN, V21, P139, DOI 10.1080/13506285.2013.772929; Rossion B, 2009, ACTA PSYCHOL, V132, P300, DOI 10.1016/j.actpsy.2009.08.002; SANOCKI T, 1993, J EXP PSYCHOL HUMAN, V19, P878, DOI 10.1037/0096-1523.19.4.878; Sanocki T, 2001, J EXP PSYCHOL HUMAN, V27, P290, DOI 10.1037/0096-1523.27.2.290; Schmalzl L, 2008, J NEUROPSYCHOL, V2, P99, DOI 10.1348/174866407X256554; Sorensen TA, 2015, J EXP PSYCHOL LEARN, V41, P178, DOI 10.1037/a0037268; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Susilo T, 2010, COGN NEUROPSYCHOL, V27, P636, DOI 10.1080/02643294.2011.613372; Tanaka J.W., 2011, OXFORD HDB FACE PERC, P177, DOI [DOI 10.1093/OXFORDHB/9780199559053.013.0010, 10.1093/oxfordhb/9780199559053.013.0010]; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Towler J, 2016, Q J EXP PSYCHOL, p1 , DOI DOI 10.1080/17470218.2016; Vangkilde S, 2011, PSYCHOPHARMACOLOGY, V218, P667, DOI 10.1007/s00213-011-2361-x; Williams MA, 2007, CURR BIOL, V17, P1259, DOI 10.1016/j.cub.2007.06.042; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; Yovel G, 2001, J EXP PSYCHOL HUMAN, V27, P1369, DOI 10.1037/0096-1523.27.6.1369; Zhang J, 2005, PSYCHOMETRIKA, V70, P203, DOI 10.1007/s11336-003-1119-8	48	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189253	10.1371/journal.pone.0189253	http://dx.doi.org/10.1371/journal.pone.0189253			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ7SY	29261708	Green Published, Green Submitted, gold			2022-12-26	WOS:000418564200036
J	Hanley, JA; Hannigan, A; O'Brien, KM				Hanley, James A.; Hannigan, Ailish; O'Brien, Katie M.			Mortality reductions due to mammography screening: Contemporary population-based data	PLOS ONE			English	Article							BREAST-CANCER MORTALITY; NORWAY	Our objective was to compare breast cancer mortality in two regions of the Republic of Ireland that introduced a screening programme eight years apart, and to estimate the steady-state mortality deficits the programme will produce. We carried out age-and year-matched between-region comparison of breast cancer mortality rates, and of incidence rates of stage 2-4 breast cancer, in the eligible cohorts. The regions comprised counties that, beginning in early 2000 (region 1) and late 2007 (region 2), invited women aged 50-64 to biennial mammography screening. The data were supplied by the National Cancer Registry, Central Statistics Office. As impact measures, we used age-and-year-matched mortality (from breast cancers diagnosed from 2000 onwards), rate ratios and incidence rate ratios in the compared regions from 2000 to 2013. Ratios were adjusted for between-region differences in background rates. In cohorts too old to be invited, death rates in regions 1 and 2 were 702 per 0.91 and 727 per 0.90 million women-years respectively (Ratio 0.96). In the eligible cohorts, they were 1027 per 2.9 and 1095 per 2.67 (Ratio 0.88). Thus, rates in cohorts that could have benefitted were 9% lower in region 1 than region 2: (95% CI: -20%, +4%). The incidence rates of stage 2-4 breast cancer were 7% lower in region 2 than region 1 over the entire 14 year period, and 20% lower in 2007, i.e., before the screening in region 2 began to narrow the difference. Since mortality reductions due to screening only manifest after several years, the full impact of screening has not yet been realized in region 1. The lower rate observed in that region is a conservative estimate of the steady state benefit. Additional deaths would have been averted had screening continued beyond age 64.	[Hanley, James A.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Hannigan, Ailish] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [O'Brien, Katie M.] Natl Canc Registry Ireland, Cork, Ireland	McGill University; University of Limerick	Hanley, JA (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	james.hanley@McGill.CA			CIHR	CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by CIHR (to JAH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autier P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4411; Breslow NE, 1987, IARC SCI PUBL, V82, P109; CHU KC, 1994, J CLIN EPIDEMIOL, V47, P1451, DOI 10.1016/0895-4356(94)90089-2; *COMM EUR COMM, 2003, PROP COUNC REC CANC; Hanley JA, 2005, EPIDEMIOLOGY, V16, P786, DOI 10.1097/01.ede.0000181313.61948.76; Hills, 1993, STAT MODELS EPIDEMIO; Kalager M, 2014, ANN ONCOL, V25, P1137, DOI 10.1093/annonc/mdu122; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Kelly A, 2004, NEW NATL DEPRIVATION; Liu ZH, 2013, J MED SCREEN, V20, P157, DOI 10.1177/0969141313504088; Miettinen OS, 2002, LANCET, V359, P404, DOI 10.1016/S0140-6736(02)07592-X; National Screening Service, 2015, GUID QUAL ASS MAMM S; Njor S, 2012, J MED SCREEN, V19, P33, DOI 10.1258/jms.2012.012080; Njor SH, 2015, J MED SCREEN, V22, P20, DOI 10.1177/0969141314563632; O'Brien K, 2014, IRISH J MED SCI, V183, P219, DOI 10.1007/s11845-013-0993-z; Olsen AH, 2005, BMJ-BRIT MED J, V330, P220, DOI 10.1136/bmj.38313.639236.82; Perry N., 2006, EUROPEAN GUIDELINES; Thompson SG, 2012, BRIT J SURG, V99, P1649, DOI 10.1002/bjs.8897; Tornberg S, 2005, J MED SCREEN, V12, P43, DOI 10.1258/0969141053279077; Weedon-Fekjaer H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3701	20	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0188947	10.1371/journal.pone.0188947	http://dx.doi.org/10.1371/journal.pone.0188947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261685	Green Published, Green Submitted, gold			2022-12-26	WOS:000418564200020
J	Wasfi, R; Steinmetz-Wood, M; Kestens, Y				Wasfi, Rania; Steinmetz-Wood, Madeleine; Kestens, Yan			Place matters: A longitudinal analysis measuring the association between neighbourhood walkability and walking by age group and population center size in Canada	PLOS ONE			English	Article							OBJECTIVELY MEASURED WALKABILITY; PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; OLDER-ADULTS; RESIDENTIAL RELOCATION; ACTIVE-TRANSPORT; DISEASE; EXERCISE; MODERATE; OUTCOMES	This study examined the influence of walkability on walking behaviour and assessed whether associations varied according to life-stage and population center (PC) size. Walk-ability scores were obtained for the six-digit postal codes of residential neighbourhoods of 11,200 Canadians, who participated in biennial assessments of the National Population Health Survey from 1994 to 2010. Participants were stratified by age-group. Mixed-effects logistic regression models were used to estimate the influence of cumulative exposure to neighborhood walkability on utilitarian and exercise walking by PC size and life-stage. Associations of neighbourhood walkability with utilitarian and exercise walking varied according to age-group and PC size. Exposure to high walkable neighborhoods was associated with utilitarian walking in younger and older adults in all PC sizes, except for older adults living in a medium PC. Living in a highly walkable neighborhood in a large PC was associated with walking for exercise in younger (OR: 1.42; 95% CI: 1.20-1.67) and older adults (OR: 2.09; 95% CI: 1.51-2.89). Living in highly walkable neighbourhood in a medium PC was associated with walking for exercise in older adults (OR: 1.62; 95% CI: 1.15-2.29). These results emphasize the need to consider the size and nature of every community, and the age-group of a population when implementing strategies to promote walking.	[Wasfi, Rania; Kestens, Yan] Univ Montreal, ESPUM, Dept Social & Prevent Med, Montreal, PQ, Canada; [Wasfi, Rania; Steinmetz-Wood, Madeleine; Kestens, Yan] Univ Montreal, CRCHUM, Univ Montreal Hosp, Res Ctr, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Wasfi, R (corresponding author), Univ Montreal, ESPUM, Dept Social & Prevent Med, Montreal, PQ, Canada.; Wasfi, R (corresponding author), Univ Montreal, CRCHUM, Univ Montreal Hosp, Res Ctr, Montreal, PQ, Canada.	rania.wasfi@umontreal.ca	Kestens, Yan/D-1631-2012	Kestens, Yan/0000-0003-2619-5750	Fonds de Recherche du Quebec - Societe et culture (FRQ-SC); Social Sciences and Humanities Research Council (SSHRC); Canadian Institutes of Health Research (CIHR); Canada Foundation for Innovation (CFI), Statistics Canada; Fonds de recherche du Quebec-Societe et culture (FRQSC); Quebec universities; Research Data Center (RDC) [16-SSH-MCG-4651]	Fonds de Recherche du Quebec - Societe et culture (FRQ-SC); Social Sciences and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI), Statistics Canada; Fonds de recherche du Quebec-Societe et culture (FRQSC); Quebec universities; Research Data Center (RDC)	RW holds a post-doctoral fellowship from the Fonds de Recherche du Quebec - Societe et culture (FRQ-SC). YK holds a Canadian Institutes of Health Research Applied Public Health Chair in Urban Interventions and Population Health.; We would like to thank Benoit Thierry at CRCHUM for his help in database structuration. The analysis presented in this paper was conducted at the Quebec Interuniversity Centre for Social Statistics, which is part of the Canadian Research Data Centre Network (CRDCN). The services and activities provided by the QICSS are made possible by the financial or in-kind support of the Social Sciences and Humanities Research Council (SSHRC), the Canadian Institutes of Health Research (CIHR), the Canada Foundation for Innovation (CFI), Statistics Canada, the Fonds de recherche du Quebec-Societe et culture (FRQSC), and the Quebec universities. We acknowledge the Research Data Center (RDC) employees who have supported our project (#16-SSH-MCG-4651). Wasfi signed oaths of confidentiality under the Statistics Act of Canada. RDCs are extensions of the Canadian statistical agency's offices located in Canadian universities. Each site has a full time employee of Statistics Canada who screens results to ensure respondent confidentiality (see http://www.statcan.gc.ca/rdc-cdr/faq-rdc-cdr-eng.htm).	Aune D, 2016, EUR J EPIDEMIOL, V31, P967, DOI 10.1007/s10654-016-0176-0; Barnes R, 2013, ANN BEHAV MED, V45, pS86, DOI 10.1007/s12160-012-9429-7; Barnes R, 2016, J TRANSPORT HLTH; Berke EM, 2007, AM J PUBLIC HEALTH, V97, P486, DOI 10.2105/AJPH.2006.085837; Boyle T, 2012, JNCI-J NATL CANCER I, V104, P1548, DOI 10.1093/jnci/djs354; Chiu M, 2015, HLTH REPORTS, P2; Christiansen LB, 2014, J TRANSP HEALTH, V1, P316, DOI 10.1016/j.jth.2014.10.002; Colley R, 2011, PHYS ACTIVITY CANADI; Duncan DT, 2013, GEOJOURNAL, V78, P407, DOI 10.1007/s10708-011-9444-4; Flint E, 2015, LANCET, V386, pS8, DOI 10.1016/S0140-6736(15)00846-6; Gebel K, 2011, AM J HEALTH PROMOT, V26, P45, DOI 10.4278/ajhp.081104-ARB-269; Giles-Corti B, 2013, SOC SCI MED, V77, P20, DOI 10.1016/j.socscimed.2012.10.016; Grasser G, 2013, INT J PUBLIC HEALTH, V58, P615, DOI 10.1007/s00038-012-0435-0; Hajna S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008964; Hillsdon M, 1996, BRIT J SPORT MED, V30, P84, DOI 10.1136/bjsm.30.2.84; Hirsch JA, 2014, AM J EPIDEMIOL, V180, P799, DOI 10.1093/aje/kwu218; Hirsch JA, 2014, AM J PUBLIC HEALTH, V104, pE49, DOI 10.2105/AJPH.2013.301773; Hosler AS, 2014, J ENVIRON PUBLIC HEA, V2014, DOI 10.1155/2014/542123; Kerr J, 2012, J PLAN LIT, V27, P43, DOI 10.1177/0885412211415283; Knuiman MW, 2014, AM J EPIDEMIOL; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Levinson D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029721; Manaugh K, 2011, TRANSPORT RES D-TR E, V16, P309, DOI 10.1016/j.trd.2011.01.009; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; McCormack G.R., 2011, INT J BEHAV NUTR PHY, V8; Merom D, 2009, ANN BEHAV MED, V38, P137, DOI 10.1007/s12160-009-9138-z; Owen N, 2004, AM J PREV MED, V27, P67, DOI 10.1016/j.amepre.2004.03.006; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4; Sallis JF, 2016, LANCET, V387, P2207, DOI 10.1016/S0140-6736(15)01284-2; Shimura H, 2012, J PHYS ACT HEALTH, V9, P1004, DOI 10.1123/jpah.9.7.1004; Smith TC, 2007, J CLIN EPIDEMIOL, V60, P309, DOI 10.1016/j.jclinepi.2006.06.013; Stewart OT, 2016, ENVIRON BEHAV, V48, P13, DOI 10.1177/0013916515612253; Sugiyama T, 2014, HEALTH PLACE, V28, P22, DOI 10.1016/j.healthplace.2014.03.003; Thielman J, 2015, PREV MED, V77, P174, DOI 10.1016/j.ypmed.2015.05.011; Todd M, 2016, PREV MED, V93, P57, DOI 10.1016/j.ypmed.2016.09.019; Van Cauwenberg J, 2016, HEALTH PLACE, V37, P16, DOI 10.1016/j.healthplace.2015.11.003; van de Coevering P, 2015, TRANSPORT REV, V35, P512, DOI 10.1080/01441647.2015.1025455; Van Holle V, 2014, INT J BEHAV NUTR PHY, V11; Villanueva K, 2014, HEALTH PLACE, V25, P43, DOI 10.1016/j.healthplace.2013.10.005; Wasfi RA, 2015, JOURNAL OF TRANSPORT; Wasfi Rania, 2012, J. Transp. Lit., V6, P08, DOI 10.1590/S2238-10312012000200002; Wasfi RA, 2013, HEALTH PLACE, V23, P18, DOI 10.1016/j.healthplace.2013.04.006; Wu YL, 2013, BREAST CANCER RES TR, V137, P869, DOI 10.1007/s10549-012-2396-7	43	16	16	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189472	10.1371/journal.pone.0189472	http://dx.doi.org/10.1371/journal.pone.0189472			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ7PP	29261706	gold, Green Submitted, Green Published			2022-12-26	WOS:000418554900021
J	Bombi, P; D'Andrea, E; Rezaie, N; Cammarano, M; Matteucci, G				Bombi, Pierluigi; D'Andrea, Ettore; Rezaie, Negar; Cammarano, Mario; Matteucci, Giorgio			Which climate change path are we following? Bad news from Scots pine	PLOS ONE			English	Article							CHANGE IMPACTS; RANGE; MODELS; EDGE; MIGRATION; RESPONSES; FORESTS; EUROPE; SHIFTS; WELL	Current expectations on future climate derive from coordinated experiments, which compile many climate models for sampling the entire uncertainty related to emission scenarios, initial conditions, and modelling process. Quantifying this uncertainty is important for taking decisions that are robust under a wide range of possible future conditions. Nevertheless, if uncertainty is too large, it can prevent from planning specific and effective measures. For this reason, reducing the spectrum of the possible scenarios to a small number of one or a few models that actually represent the climate pathway influencing natural ecosystems would substantially increase our planning capacity. Here we adopt a multidisciplinary approach based on the comparison of observed and expected spatial patterns of response to climate change in order to identify which specific models, among those included in the CMIP5, catch the real climate variation driving the response of natural ecosystems. We used dendrochronological analyses for determining the geographic pattern of recent growth trends for three European species of trees. At the same time, we modelled the climatic niche for the same species and forecasted the suitability variation expected across Europe under each different GCM. Finally, we estimated how well each GCM explains the real response of ecosystems, by comparing the expected variation with the observed growth trends. Doing this, we identified four climatic models that are coherent with the observed trends. These models are close to the highest range limit of the climatic variations expected by the ensemble of the CMIP5 models, suggesting that current predictions of climate change impacts on ecosystems could be underestimated.	[Bombi, Pierluigi; D'Andrea, Ettore; Rezaie, Negar; Cammarano, Mario; Matteucci, Giorgio] Natl Res Council Italy CNR IBAF, Inst Agroenvironm & Forest Biol, Monterotondo, Italy; [Bombi, Pierluigi] Natl Res Council Italy, Mediterranean Themat Ctr, LifeWatch ITA, Rome, Italy; [Matteucci, Giorgio] Natl Res Council Italy CNR ISAFOM, Inst Agr & Forestry Syst Mediterranean, Ercolano, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Agroambientale e Forestale (IBAF-CNR); Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per i Sistemi Agricoli e Forestali del Mediterraneo (ISAFoM-CNR)	Bombi, P (corresponding author), Natl Res Council Italy CNR IBAF, Inst Agroenvironm & Forest Biol, Monterotondo, Italy.; Bombi, P (corresponding author), Natl Res Council Italy, Mediterranean Themat Ctr, LifeWatch ITA, Rome, Italy.	pierluigi.bombi@ibaf.cnr.it	Matteucci, Giorgio/N-3526-2015; D'Andrea, Ettore/AAE-9113-2019; Matteucci, Giorgio/AAB-7022-2021	Matteucci, Giorgio/0000-0002-4790-9540; D'Andrea, Ettore/0000-0002-5884-210X; Rezaie, Negar/0000-0002-8487-2345; Bombi, Pierluigi/0000-0002-7322-5724	Project LIFE+ ManFor C.BD [LIFE09 ENV/IT/000078]; ExpeER project CC-Imp; LifeWatch-ITA European infrastructure	Project LIFE+ ManFor C.BD; ExpeER project CC-Imp; LifeWatch-ITA European infrastructure	This work was supported by Project LIFE+ ManFor C.BD. (LIFE09 ENV/IT/000078), http://www.manfor.eu; ExpeER project CC-Imp, http://www.expeeronline.eu/accepted-projects.html; LifeWatch-ITA European infrastructure, http://www.servicecentrelifewatch.eu/it/web/lifewatch-italia.	Ahlstrom A, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044008; Alagador D, 2014, J APPL ECOL, V51, P703, DOI 10.1111/1365-2664.12230; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson K, 2012, NAT CLIM CHANGE, V2, P639, DOI 10.1038/nclimate1646; [Anonymous], 2005, WORLDCLIM GLOBAL CLI; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2009, DISTR MAPS; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Batllori E, 2009, GLOBAL ECOL BIOGEOGR, V18, P460, DOI 10.1111/j.1466-8238.2009.00464.x; Bolte A, 2009, SCAND J FOREST RES, V24, P473, DOI 10.1080/02827580903418224; Brands S, 2013, CLIM DYNAM, V41, P803, DOI 10.1007/s00382-013-1742-8; Breiman L., 1984, CLASSIFICATION REGRE; Bunn A., 2015, DPLR DENDROCHRONOLOG; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cook ER, 1990, METHODS DENDROCHRONO, P101; D'Amen M, 2009, BIOL CONSERV, V142, P3060, DOI 10.1016/j.biocon.2009.08.004; Delzon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080443; Dubuis A, 2013, ECOGRAPHY, V36, P1158, DOI 10.1111/j.1600-0587.2013.00237.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Flato G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P741; Fritts H. C., 1976, TREE RINGS CLIMATE; Ge QS, 2015, GLOBAL CHANGE BIOL, V21, P265, DOI 10.1111/gcb.12648; Gleckler PJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008972; Goring SJ, 2017, ECOL LETT, V20, P461, DOI 10.1111/ele.12747; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Grimm NB, 2013, FRONT ECOL ENVIRON, V11, P474, DOI 10.1890/120282; GRISSINO-MAYER H., 1993, INT TREE RING DATA B; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hansen J, 2016, ATMOS CHEM PHYS, V16, P3761, DOI 10.5194/acp-16-3761-2016; Harley GL, 2012, BERKSH ENCY SUSTAIN, V6, P359; HARVEY PH, 1983, ANNU REV ECOL SYST, V14, P189, DOI 10.1146/annurev.es.14.110183.001201; Hastie T., 1986, STAT SCI, V1, P297; Hernandez L, 2017, EUR J FOR RES; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOFFMANN AA, 1994, TRENDS ECOL EVOL, V9, P223, DOI 10.1016/0169-5347(94)90248-8; Holthaus E., 2016, OUR PLANETS TEMPERAT; ICP Forests Coordination, 2011, INT COOP PROGR ASS M; ILTER coordination, 2016, INT LONG TERM EC RES; Jump AS, 2006, GLOBAL CHANGE BIOL, V12, P2163, DOI 10.1111/j.1365-2486.2006.01250.x; Koskela J., 2013, EUROPEAN FOREST GENE; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Lawton John H., 1995, P147; Lindner M, 2014, J ENVIRON MANAGE, V146, P69, DOI 10.1016/j.jenvman.2014.07.030; Loehle C, 1998, J BIOGEOGR, V25, P735, DOI 10.1046/j.1365-2699.1998.2540735.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; McCullagh P, 1989, GEN LINEAR MODELS; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; Murphy HT, 2010, ECOL LETT, V13, P1233, DOI 10.1111/j.1461-0248.2010.01526.x; Office M, 2015, WARMEST YEAR RECORD; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Rehfeldt GE, 2002, GLOBAL CHANGE BIOL, V8, P912, DOI 10.1046/j.1365-2486.2002.00516.x; Reichler T, 2008, B AM METEOROL SOC, V89, P303, DOI 10.1175/BAMS-89-3-303; Ridgeway G., 1999, COMPUT SCI STAT, P172; Rogelj J, 2011, NAT CLIM CHANGE, V1, P413, DOI 10.1038/NCLIMATE1258; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; de Dios RS, 2016, PERSPECT PLANT ECOL, V20, P11, DOI 10.1016/j.ppees.2016.03.001; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Thuiller W, 2015, PACKAGE BIOMOD2; van Vuuren DP, 2011, CLIMATIC CHANGE, V104, P255, DOI 10.1007/s10584-009-9764-2; Voldoire A, 2013, CLIM DYNAM, V40, P2091, DOI 10.1007/s00382-011-1259-y; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Watanabe M, 2010, J CLIMATE, V23, P6312, DOI 10.1175/2010JCLI3679.1; Watanabe S., 2011, GEOSCI MODEL DEV DIS, V4, P1063, DOI DOI 10.5194/GMDD-4-1063-2011; Welsch R, 1980, REGRESSION DIAGNOSTI; Woodall CW, 2009, FOREST ECOL MANAG, V257, P1434, DOI 10.1016/j.foreco.2008.12.013; Xin XG, 2013, ATMOS OCEAN SCI LETT, V6, P21, DOI 10.1080/16742834.2013.11447053	75	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189468	10.1371/journal.pone.0189468	http://dx.doi.org/10.1371/journal.pone.0189468			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29252985	Green Published, Green Submitted, gold			2022-12-26	WOS:000418389500030
J	Hafstrand, I; Badia-Martinez, D; Josey, BJ; Norstrom, M; Buratto, J; Pellegrino, S; Duru, AD; Sandalova, T; Achour, A				Hafstrand, Ida; Badia-Martinez, Daniel; Josey, Benjamin John; Norstrom, Melissa; Buratto, Jeremie; Pellegrino, Sara; Duru, Adil Doganay; Sandalova, Tatyana; Achour, Adnane			Crystal structures of H-2D(b) in complex with the LCMV-derived peptides GP92 and GP392 explain pleiotropic effects of glycosylation on antigen presentation and immunogenicity	PLOS ONE			English	Article							MHC CLASS-I; COLLAGEN-INDUCED ARTHRITIS; N-LINKED GLYCOSYLATION; T-CELL; POSTTRANSLATIONAL MODIFICATION; TRANSFERRIN GLYCOPEPTIDES; PHOSPHORYLATED PEPTIDES; RECOGNITION; IDENTIFICATION; MURINE	Post-translational modifications significantly broaden the epitope repertoire for major histocompatibility class I complexes (MHC-I) and may allow viruses to escape immune recognition. Lymphocytic choriomeningitis virus (LCMV) infection of H-2(b) mice generates CD8(+) CTL responses directed towards several MHC-I-restricted epitopes including the peptides GP92 (CSANNSHHYI) and GP392 (WLVTNGSYL), both with a N-glycosylation site. Interestingly, glycosylation has different effects on the immunogenicity and association capacity of these two epitopes to H-2D(b). To assess the structural bases underlying these functional results, we determined the crystal structures of H-2D(b) in complex with GP92 (CSANNSHHYI) and GP392 (WLVTNGSYL) to 2.4 and 2.5 angstrom resolution, respectively. The structures reveal that while glycosylation of GP392 most probably impairs binding, the glycosylation of the asparagine residue in GP92, which protrudes towards the solvent, possibly allows for immune escape and/or forms a neo-epitope that may select for a different set of CD8 T cells. Altogether, the presented results provide a structural platform underlying the effects of post-translational modifications on epitope binding and/or immunogenicity, resulting in viral immune escape.	[Hafstrand, Ida; Badia-Martinez, Daniel; Norstrom, Melissa; Buratto, Jeremie; Sandalova, Tatyana; Achour, Adnane] Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Sci Life Lab, Stockholm, Sweden; [Hafstrand, Ida; Badia-Martinez, Daniel; Norstrom, Melissa; Buratto, Jeremie; Sandalova, Tatyana; Achour, Adnane] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Josey, Benjamin John; Duru, Adil Doganay] Nova Southeastern Univ, NSU Cell Therapy Inst, Ft Lauderdale, FL 33314 USA; [Josey, Benjamin John; Duru, Adil Doganay] Nova Southeastern Univ, Coll Allopath Med, Ft Lauderdale, FL 33314 USA; [Pellegrino, Sara] Univ Milan, Dipartimento Sci Farmaceut Sez Chim Gen & Organ, DISFARM, Milan, Italy	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Nova Southeastern University; Nova Southeastern University; University of Milan	Achour, A (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Sci Life Lab, Stockholm, Sweden.; Achour, A (corresponding author), Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden.	adnane.achour@ki.se		Buratto, Jeremie/0000-0002-6730-336X; Hafstrand, Ida/0000-0002-1012-9532; Achour, Adnane/0000-0003-0432-710X; Duru, Adil/0000-0002-5844-913X; Sandalova, Tatyana/0000-0002-7694-6420	Swedish Research Council (Vetenskapsradet); Swedish Cancer Society (Cancerfonden)	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society)	This work was supported by the Swedish Research Council (Vetenskapsradet, https://www.vr.se/) and the Swedish Cancer Society (Cancerfonden, https://www.cancerfonden.se/) to AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour A, 1998, IMMUNITY, V9, P199, DOI 10.1016/S1074-7613(00)80602-0; Achour A, 2006, J MOL BIOL, V356, P382, DOI 10.1016/j.jmb.2005.11.068; Achour A, 2002, IMMUNITY, V17, P757, DOI 10.1016/S1074-7613(02)00478-8; Achour A, 1999, ACTA CRYSTALLOGR D, V55, P260, DOI 10.1107/S0907444998005265; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen MH, 1999, J IMMUNOL, V163, P3812; Barroso A, 2016, TALANTA, V160, P614, DOI 10.1016/j.talanta.2016.07.055; Barroso A, 2013, ANAL CHIM ACTA, V804, P167, DOI 10.1016/j.aca.2013.09.044; Baumgartner L., 2017, GLYCOBIOLOGY, P1; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Cerliani JP, 2017, TRENDS BIOCHEM SCI, V42, P255, DOI 10.1016/j.tibs.2016.11.003; Chiritoiu GN, 2016, ELECTROPHORESIS, V37, P1448, DOI 10.1002/elps.201500449; Corthay A, 2001, ANN MED, V33, P456, DOI 10.3109/07853890109002094; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Glithero A, 1999, IMMUNITY, V10, P63, DOI 10.1016/S1074-7613(00)80007-2; Hafstrand I, 2016, J IMMUNOL, V196, P2327, DOI 10.4049/jimmunol.1502249; Hanisch FG, 2006, CURR PROTEIN PEPT SC, V7, P307, DOI 10.2174/138920306778018034; Hardy LL, 2008, J IMMUNOL, V180, P5956, DOI 10.4049/jimmunol.180.9.5956; Hastie KM, 2016, NAT STRUCT MOL BIOL, V23, P513, DOI 10.1038/nsmb.3210; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HUDRISIER D, 1995, MOL IMMUNOL, V32, P895, DOI 10.1016/0161-5890(95)00043-E; Hudrisier D, 1999, J BIOL CHEM, V274, P36274, DOI 10.1074/jbc.274.51.36274; Hudrisier D, 2001, J BIOL CHEM, V276, P38255; Kario E, 2008, J BIOL CHEM, V283, P244, DOI 10.1074/jbc.M706237200; Lakshminarayanan V, 2016, PLOS ONE, V11, P1; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li HL, 2008, J IMMUNOL, V180, P4011, DOI 10.4049/jimmunol.180.6.4011; Madhurantakam C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032805; Madsen CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050139; Malaker SA, 2016, J PROTEOME RES; MALAKER SA, 2017, CANCER IMMUNOL RES, V5; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meadows L, 1997, IMMUNITY, V6, P273, DOI 10.1016/S1074-7613(00)80330-1; Pellegrino S, 2012, AMINO ACIDS, V43, P1995, DOI 10.1007/s00726-012-1274-2; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Rock KL, 2016, TRENDS IMMUNOL, V37, P724, DOI 10.1016/j.it.2016.08.010; Rosal-Vela A, 2016, J PROTEOMICS, V134, P127, DOI 10.1016/j.jprot.2015.11.023; Rosal-Vela A, 2016, DATA BRIEF, V6, P587, DOI 10.1016/j.dib.2015.12.045; Sandalova T, 2005, ACTA CRYSTALLOGR F, V61, P1090, DOI 10.1107/S1744309105037942; Sandalova T, 2005, J BIOL CHEM, V280, P27069, DOI 10.1074/jbc.M500927200; Skipper JCA, 1996, J EXP MED, V183, P527, DOI 10.1084/jem.183.2.527; Speir JA, 1999, IMMUNITY, V10, P51, DOI 10.1016/S1074-7613(00)80006-0; SUZUKI T, 1993, BIOCHEM BIOPH RES CO, V194, P1124, DOI 10.1006/bbrc.1993.1938; Tate MD, 2014, VIRUSES-BASEL, V6, P1294, DOI 10.3390/v6031294; Unanue ER, 2016, ANNU REV IMMUNOL, V34, P265, DOI 10.1146/annurev-immunol-041015-055420; Valkenburg SA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3663; van der Most RG, 1998, VIROLOGY, V240, P158, DOI 10.1006/viro.1997.8934; van Stipdonk MJB, 2009, CANCER RES, V69, P7784, DOI 10.1158/0008-5472.CAN-09-1724; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Velloso LM, 2004, J IMMUNOL, V172, P5504, DOI 10.4049/jimmunol.172.9.5504; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolfert MA, 2013, NAT CHEM BIOL, V9, P776, DOI [10.1038/NCHEMBIO.1403, 10.1038/nchembio.1403]; WRIGHT KE, 1990, VIROLOGY, V177, P175, DOI 10.1016/0042-6822(90)90471-3; Yewdell JW, 2011, TRENDS IMMUNOL, V32, P548, DOI 10.1016/j.it.2011.08.001; Yewdell JW, 1996, J IMMUNOL, V157, P1823; Zarling AL, 2000, J EXP MED, V192, P1755, DOI 10.1084/jem.192.12.1755; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	63	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189584	10.1371/journal.pone.0189584	http://dx.doi.org/10.1371/journal.pone.0189584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253009	Green Published, Green Submitted, gold			2022-12-26	WOS:000418389500040
J	Hindriks, R; Schmiedt, J; Arsiwalla, XD; Peter, A; Verschure, PFMJ; Fries, P; Schmid, MC; Deco, G				Hindriks, Rikkert; Schmiedt, Joscha; Arsiwalla, Xerxes D.; Peter, Alina; Verschure, Paul F. M. J.; Fries, Pascal; Schmid, Michael C.; Deco, Gustavo			Linear distributed source modeling of local field potentials recorded with intra-cortical electrode arrays	PLOS ONE			English	Article							SPATIOTEMPORAL DYNAMICS; NEURONAL-ACTIVITY; IN-VIVO; MEG; OSCILLATIONS; ACTIVATION; NOISE; RESPONSES; CORTEX; EEG	Planar intra-cortical electrode (Utah) arrays provide a unique window into the spatial organization of cortical activity. Reconstruction of the current source density (CSD) underlying such recordings, however, requires "inverting" Poisson's equation. For inter-laminar recordings, this is commonly done by the CSD method, which consists in taking the second-order spatial derivative of the recorded local field potentials (LFPs). Although the CSD method has been tremendously successful in mapping the current generators underlying inter-laminar LFPs, its application to planar recordings is more challenging. While for inter-laminar recordings the CSD method seems reasonably robust against violations of its assumptions, is it unclear as to what extent this holds for planar recordings. One of the objectives of this study is to characterize the conditions under which the CSD method can be successfully applied to Utah array data. Using forward modeling, we find that for spatially coherent CSDs, the CSD method yields inaccurate reconstructions due to volume-conducted contamination from currents in deeper cortical layers. An alternative approach is to "invert" a constructed forward model. The advantage of this approach is that any a priori knowledge about the geometrical and electrical properties of the tissue can be taken into account. Although several inverse methods have been proposed for LFP data, the applicability of existing electroencephalographic (EEG) and magnetoencephalographic (MEG) inverse methods to LFP data is largely unexplored. Another objective of our study therefore, is to assess the applicability of the most commonly used EEG/MEG inverse methods to Utah array data. Our main conclusion is that these inverse methods provide more accurate CSD reconstructions than the CSD method. We illustrate the inverse methods using event-related potentials recorded from primary visual cortex of a macaque monkey during a motion discrimination task.	[Hindriks, Rikkert; Deco, Gustavo] Univ Pompeu Fabra, Dept Informat & Commun Technol, Computat Neurosci Grp, Ctr Brain & Cognit, Barcelona, Spain; [Schmiedt, Joscha; Peter, Alina; Fries, Pascal; Schmid, Michael C.] Max Planck Gesell, ESI Neurosci, D-60528 Frankfurt, Germany; [Arsiwalla, Xerxes D.; Verschure, Paul F. M. J.] Univ Pompeu Fabra, SPECS Lab, Ctr Autonomous Syst & Neurorobot, Barcelona, Spain; [Schmid, Michael C.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Verschure, Paul F. M. J.; Deco, Gustavo] Univ Pompeu Fabra, ICREA, Barcelona, Spain; [Verschure, Paul F. M. J.] Inst Bioengn Catalonia, Barcelona 08028, Spain; [Verschure, Paul F. M. J.] Barcelona Inst Sci & Technol, Barcelona, Spain	Pompeu Fabra University; University of Barcelona; Max Planck Society; Pompeu Fabra University; Newcastle University - UK; ICREA; Pompeu Fabra University; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; Barcelona Institute of Science & Technology	Hindriks, R (corresponding author), Univ Pompeu Fabra, Dept Informat & Commun Technol, Computat Neurosci Grp, Ctr Brain & Cognit, Barcelona, Spain.	rikkert.hindriks@upf.edu	Fries, Pascal/E-3196-2010; Schmiedt, Joscha T/F-4152-2012; Schmid, Michael Christoph/AAH-4835-2020; Deco, Gustavo/A-6341-2008	Fries, Pascal/0000-0002-4270-1468; Schmid, Michael Christoph/0000-0003-1424-130X; Arsiwalla, Xerxes/0000-0003-1485-1853; Schmiedt, Joscha Tapani/0000-0001-6233-1866; Deco, Gustavo/0000-0002-8995-7583; Hindriks, Rikkert/0000-0003-3575-186X	European Research Council (Advanced Grant DYSTRUCTURE) [295129]; Spanish Research Project [PSI2013-42091-P]; CONSOLIDER-INGENIO Program [CSD2007-00012]; ICT Brainscales [269921]; Deutsche Forschungsgemeinschaft (DFG) [Schm2806]; DFG [Schm2806/1]; European Research Council's CDAC project [ERC-2013- ADG 341196]	European Research Council (Advanced Grant DYSTRUCTURE); Spanish Research Project(Spanish Government); CONSOLIDER-INGENIO Program(Spanish Government); ICT Brainscales; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); European Research Council's CDAC project	RH and GD were funded by the European Research Council (Advanced Grant DYSTRUCTURE No. 295129), the Spanish Research Project PSI2013-42091-P, the CONSOLIDER-INGENIO 2010 Program CSD2007-00012, and the FP7-ICT Brainscales (269921) awarded to GD (website: https://erc.europa.eu/.) JS and MCS were funded by an Emmy Noether Program grant of the Deutsche Forschungsgemeinschaft (DFG) awarded to MCS (Grant number Schm2806) (website: http://www.dfg.de/.) Data were recorded in the Schmid lab at ESI Frankfurt, supported by DFG Emmy Noether grant Schm2806/1 to MCS. XDA and PFMJV were supported by the European Research Council's CDAC project: The Role of Consciousness in Adaptive Behavior: A Combined Empirical, Computational and Robot based Approach (ERC-2013- ADG 341196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RH and GD were funded by the European Research Council (Advanced Grant DYSTRUCTURE No.295129), the Spanish Research Project 13512013-42091-P, the CONSOLIDER-INGENIO 2010 Program CSD2007-00012, and the FP7-ICT Brainscales (269921) awarded to GD. JS and MCS were funded by an Emmy Noether Program grant of the Deutsche Forschungsgemeinschaft (DFG) awarded to MCS (Grant number Schm2806). Data were recorded in the Schmid lab at ESI Frankfurt, supported by DFG Emmy Noether grant Schm2806/1 to MCS. XDA and PFMJV were supported by the European Research Council's CDAC project: "The Role of Consciousness in Adaptive Behavior: A Combined Empirical, Computational and Robot based Approach" (ERC-2013- ADG 341196).	Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Bedard C, 2009, BIOPHYS J, V96, P2589, DOI 10.1016/j.bpj.2008.12.3951; Besserve M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002257; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2033, DOI 10.1152/jn.1995.73.5.2033; Contreras D, 2001, J NEUROSCI, V21, P9403, DOI 10.1523/JNEUROSCI.21-23-09403.2001; Csercsa R, 2010, BRAIN, V133, P2814, DOI 10.1093/brain/awq169; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Di S, 1990, LAMINAR ANAL EXTRACE, V63; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; Fourcaud-Trocme N, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00088; Goto T, 2010, EVALUATION CONDUCTIV, P3388; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Greenblatt RE, 2005, IEEE T SIGNAL PROCES, V53, P3403, DOI 10.1109/TSP.2005.853201; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hansen P. C., 2010, DISCRETE INVERSE PRO; Hauk O, 2011, NEUROIMAGE, V54, P1966, DOI 10.1016/j.neuroimage.2010.09.053; Hillebrand A, 2005, INT REV NEUROBIOL, V68, P149, DOI 10.1016/S0074-7742(05)68006-3; Hindriks R, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00051; Hummer G, 1996, J ELECTROSTAT, V36, P285, DOI 10.1016/0304-3886(95)00052-6; Kajikawa Y, 2015, J NEUROPHYSIOL, V113, P339, DOI 10.1152/jn.00914.2013; Kajikawa Y, 2011, NEURON, V72, P847, DOI 10.1016/j.neuron.2011.09.029; Kim HB, 2016, J NEUROSCI METH, V264, P1, DOI 10.1016/j.jneumeth.2016.02.011; Kropf P, 2016, NEURAL COMPUT, V28, P1305, DOI 10.1162/NECO_a_00846; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Leski S, 2011, NEUROINFORMATICS, V9, P401, DOI 10.1007/s12021-011-9111-4; Lin B, 2002, BRAIN RES, V955, P164, DOI 10.1016/S0006-8993(02)03429-7; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Lippert MT, 2007, J NEUROPHYSIOL, V98, P502, DOI 10.1152/jn.01169.2006; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Maynard EM, 1997, ELECTROEN CLIN NEURO, V102, P228, DOI 10.1016/S0013-4694(96)95176-0; Menzel RR, 2005, CEREB CORTEX, V15, P1690, DOI 10.1093/cercor/bhi045; Mitsdorf U., 1985, PHYSL REV, V65; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; Pascual-Marqui R.D., 1999, INT J BIOELECTROMAGN, V1, P75; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Petersen CCH, 2003, P NATL ACAD SCI, V100; Pettersen KH, 2006, J NEUROSCI METH, V154, P116, DOI 10.1016/j.jneumeth.2005.12.005; Phongphanphanee P, 2008, J NEUROSCI, V28, P9309, DOI 10.1523/JNEUROSCI.1905-08.2008; Potworowski J, 2012, NEURAL COMPUT, V24, P541, DOI 10.1162/NECO_a_00236; Riehle A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00048; Riera JJ, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00004; Riera JJ, 2012, J NEUROPHYSIOL, V108, P956, DOI 10.1152/jn.00098.2011; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; Shimono K, 2000, J NEUROSCI, V20, P8462, DOI 10.1523/JNEUROSCI.20-22-08462.2000; Takahashi K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8169; Van Veen B. D., 1988, IEEE ASSP Magazine, V5, P4, DOI 10.1109/53.665; Wirth C, 2004, J NEUROPHYSIOL, V91, P1635, DOI 10.1152/jn.00950.2003; Xing DJ, 2009, J NEUROSCI, V29, P11540, DOI 10.1523/JNEUROSCI.2573-09.2009	52	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0187490	10.1371/journal.pone.0187490	http://dx.doi.org/10.1371/journal.pone.0187490			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253006	Green Published, Green Submitted, gold			2022-12-26	WOS:000418389500003
J	Kang, J; Hong, JH; Jang, MU; Choi, NC; Lee, JS; Kim, BJ; Han, MK; Bae, HJ				Kang, Jihoon; Hong, Jeong-Ho; Jang, Min Uk; Choi, Nack Cheon; Lee, Ji Sung; Kim, Beom Joon; Han, Moon-Ku; Bae, Hee-Joon			Change in blood pressure variability in patients with acute ischemic stroke and its effect on early neurologic outcome	PLOS ONE			English	Article							HEALTH-CARE PROFESSIONALS; VASCULAR FUNCTION; DETERIORATION; HYPERTENSION; MANAGEMENT; THROMBOLYSIS; ASSOCIATION; DEFINITION; PREDICTORS; REGISTRY	Background How short-term blood pressure variability (BPV) is affected in the acute stage of ischemic stroke and whether BPV is associated with early neurologic outcomes remains unclear. Methods Patients who admitted for ischemic stroke within 24 h of symptom onset were consecutively identified between January 2010 and January 2015. BP profiles measured in real-time were summarized into short-term, 24-h time intervals, based on standard deviation (SD) and mean of systolic BP (SBPSD) during the first 3 days. The primary outcome was daily assessment of early neurological deterioration (END). The associations between short-term SBPSD values and the secular trend for primary outcome were examined. Results A total of 2,545 subjects (mean age, 67.1 +/- 13.5 years old and median baseline National Institutes of Health Stroke Scale score, 3) arrived at the hospital an average of 6.1 +/- 6.6 h after symptom onset. SBPSD values at day 1 (SD#D1), SD#D2, and SD#D3 were 14.4 +/- 5.0, 12.5 +/- 4.5, and 12.2 +/- 4.6 mmHg, respectively. Multivariable analyses showed that SD#D2 was independently associated with onset of END at day 2 (adjusted odds ratio, 1.08; 95% confidence interval, 1.03-1.13), and SD#D3 was independently associated with END#D3 (1.07, 1.01-1.14), with adjustments for predetermined covariates, SBPmean, and interactions with daily SBPSD. Conclusion Short-term BPV changed and stabilized from the first day of ischemic stroke. Daily high BPV may be associated with neurological deterioration independent of BPV on the previous day.	[Kang, Jihoon; Kim, Beom Joon; Han, Moon-Ku; Bae, Hee-Joon] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Seongnam, South Korea; [Hong, Jeong-Ho] Keimyung Univ, Sch Med, Dongsan Med Ctr, Dept Neurol, Daegu, South Korea; [Jang, Min Uk] Hallym Univ, Sch Med, Dongtan Sacred Heart Hosp, Dept Neurol, Dongtan, South Korea; [Choi, Nack Cheon] Gyengsang Natl Univ, Coll Med, Gyneongsang Inst Neurosci, Dept Neurol, Jinju, South Korea; [Lee, Ji Sung] Ulsan Univ, Sch Med, Asan Med Ctr, Clin Res Ctr, Seoul, South Korea	Seoul National University (SNU); Keimyung University; Hallym University; Gyeongsang National University; Samsung; University of Ulsan; Asan Medical Center	Kang, J (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Neurol, Seongnam, South Korea.	rheizer@naver.com	Hong, Jeong-Ho/T-8099-2018; Kim, Beom Joon/C-2904-2011; Hong, Jeong-Ho/AAE-1002-2022	Hong, Jeong-Ho/0000-0002-8235-9855; Kim, Beom Joon/0000-0002-2719-3012; Hong, Jeong-Ho/0000-0002-8235-9855; Kang, Jihoon/0000-0001-5715-6610				BROTT TG, 1992, STROKE, V23, P632, DOI 10.1161/01.STR.23.5.632; Christensen H, 2002, ACTA NEUROL SCAND, V106, P142, DOI 10.1034/j.1600-0404.2002.01356.x; Chung JW, 2015, J HYPERTENS, V33, P2099, DOI 10.1097/HJH.0000000000000675; Churpek MM, 2014, CRIT CARE MED, V42, P841, DOI 10.1097/CCM.0000000000000038; Cuthbertson BH, 2007, CRIT CARE MED, V35, P402, DOI 10.1097/01.CCM.0000254826.10520.87; Davalos A, 1999, STROKE, V30, P2631, DOI 10.1161/01.STR.30.12.2631; Dawson SL, 2000, STROKE, V31, P463, DOI 10.1161/01.STR.31.2.463; Delgado-Mederos R, 2008, NEUROLOGY, V71, P552, DOI 10.1212/01.wnl.0000318294.36223.69; Diaz KM, 2012, HYPERTENS RES, V35, P55, DOI 10.1038/hr.2011.135; Endo K, 2013, STROKE, V44, P816, DOI 10.1161/STROKEAHA.112.681007; Fukuda K, 2015, STROKE, V46, P1832, DOI 10.1161/STROKEAHA.115.009076; Fukui M, 2013, HYPERTENS RES, V36, P219, DOI 10.1038/hr.2012.177; Goldstein LB, 2004, HYPERTENSION, V43, P137, DOI 10.1161/01.HYP.0000113297.76013.51; Hodgson JM, 2014, ATHEROSCLEROSIS, V233, P48, DOI 10.1016/j.atherosclerosis.2013.12.026; Hong KS, 2008, EUR J NEUROL, V15, P1324, DOI 10.1111/j.1468-1331.2008.02310.x; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kang J, 2014, J STROKE CEREBROVASC, V23, pE347, DOI 10.1016/j.jstrokecerebrovasdis.2013.12.028; Ko Y, 2010, STROKE, V41, P2512, DOI 10.1161/STROKEAHA.110.595561; Manning LS, 2015, STROKE, V46, P1518, DOI 10.1161/STROKEAHA.115.009078; Parati G, 2005, J HYPERTENS, V23, pS19, DOI 10.1097/01.hjh.0000165624.79933.d3; Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Schutte R, 2012, HYPERTENSION, V60, P1138, DOI 10.1161/HYPERTENSIONAHA.112.202143; Seners P, 2015, J NEUROL NEUROSUR PS, V86, P87, DOI 10.1136/jnnp-2014-308327; Siegler JE, 2013, J STROKE CEREBROVASC, V22, pE207, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.006; Siegler JE, 2011, INT J STROKE, V6, P211, DOI 10.1111/j.1747-4949.2011.00596.x; Stergiou GS, 2014, HYPERTENS RES, V37, P565, DOI 10.1038/hr.2014.2; Tatasciore A, 2013, J HYPERTENS, V31, P1653, DOI 10.1097/HJH.0b013e328361e4a6; Toyoda K, 2009, STROKE, V40, P2585, DOI 10.1161/STROKEAHA.108.543587; Weimar C, 2005, ARCH NEUROL-CHICAGO, V62, P393, DOI 10.1001/archneur.62.3.393; Willmot M, 2004, HYPERTENSION, V43, P18, DOI 10.1161/01.HYP.0000105052.65787.35; Yoo S, 2013, INT J MED INFORM, V82, P387, DOI 10.1016/j.ijmedinf.2012.08.004	33	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189216	10.1371/journal.pone.0189216	http://dx.doi.org/10.1371/journal.pone.0189216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29252991	Green Published, gold, Green Submitted			2022-12-26	WOS:000418389500016
J	Yang, S; Whang, WJ; Joo, CK				Yang, Soonwon; Whang, Woong-Joo; Joo, Choun-Ki			Effect of anterior chamber depth on the choice of intraocular lens calculation formula	PLOS ONE			English	Article							POWER CALCULATION; HOFFER-Q; AXIAL LENGTH; ACCURACY; EYES; LONG; BIOMETRY; SRK/T	Purpose To investigate the effect of anterior chamber depth (ACD) on the refractive outcomes of the SRK/T, Holladay 1, Hoffer Q and Haigis formulae in short, normal, long and extremely long eyes. Methods This retrospective study involved patients who had uncomplicated cataract surgery. Preoperative axial length (AL) was divided into four subgroups: short (< 22.00 mm), normal (22.00-24.49 mm), long (24.50-25.99 mm), extremely long (>= 26.00 mm). Preoperative ACD was divided into three subgroups: < 2.5, 2.50 +/- 3.49, and >= 3.5 mm. Median absolute errors (MedAEs) predicted by the SRK/T, Holladay 1, Hoffer Q and Haigis formulae were compared with the Friedman test. Post-hoc analysis involved the Wilcoxon signed rank test with a Bonferroni adjustment. Correlations between ACD and the predictive refractive errors of the four formulas were analyzed. Results In short eyes with an ACD < 2.5 mm, the Haigis formula revealed the highest MedAE. The difference in MedAE with the Hoffer Q formula (which had the lowest MedAE) was statistically significant (P = 0.002). In normal eyes, the Haigis formula significantly differed from the Holladay 1 (P = 0.002) and Hoffer Q (P = 0.005) formulae in the ACD < 2.5 mm group. In long eyes and extremely long eyes with an ACD >= 3.5 mm, the differences in MedAEs were statistically significant (P = 0.018, P = 0.001, respectively) and the Haigis formula had the lowest MedAEs in both subgroups (0.29 D, 0.30 D, respectively). In the total of 1,123 eyes, refractive errors predicted by the Haigis formula showed a significant negative correlation with the ACD (R-2 = 0.002, P = 0.047). Conclusions The Hoffer Q formula is preferred over other formulae in short eyes with an ACD shallower than 2.5 mm. In short and normal eyes with an ACD < 2.5 mm the Haigis formula might underestimate ELP. The Haigis formula is the preferred choice in eyes with an AL >= 24.5 mm and an ACD >= 3.5 mm.	[Yang, Soonwon; Whang, Woong-Joo; Joo, Choun-Ki] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Whang, Woong-Joo; Joo, Choun-Ki] Catholic Univ Korea, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Whang, Woong-Joo; Joo, Choun-Ki] Catholic Univ Korea, Coll Med, Catholic Inst Visual Sci, Seoul, South Korea; [Yang, Soonwon] Chungju Publ Hlth Ctr, Dept Med Examinat, Div Hlth Promot, Chungju, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea	Joo, CK (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.; Joo, CK (corresponding author), Catholic Univ Korea, Coll Med, Dept Ophthalmol, Seoul, South Korea.; Joo, CK (corresponding author), Catholic Univ Korea, Coll Med, Catholic Inst Visual Sci, Seoul, South Korea.	ckjoo@catholic.ac.kr						Aramberri J, 2011, IOL POWER, P199; Aristodemou P, 2011, J CATARACT REFR SURG, V37, P63, DOI 10.1016/j.jcrs.2010.07.032; Bang S, 2011, OPHTHALMOLOGY, V118, P503, DOI 10.1016/j.ophtha.2010.07.008; Chang JSM, 2012, ASIA-PAC J OPHTHALMO, V1, P213, DOI 10.1097/APO.0b013e31825f8cb6; Chen C, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/976847; Chong EW, 2016, CURR OPIN OPHTHALMOL, V27, P45, DOI 10.1097/ICU.0000000000000217; Connors R, 2002, J CATARACT REFR SURG, V28, P235, DOI 10.1016/S0886-3350(01)01179-8; Eom Y, 2014, AM J OPHTHALMOL, V157, P818, DOI 10.1016/j.ajo.2013.12.017; Gavin EA, 2008, EYE, V22, P935, DOI 10.1038/sj.eye.6702774; Haigis W, 2004, INTRAOCULAR LENS POW, P41; Hoffer KJ, 2015, AM J OPHTHALMOL, V160, P403, DOI 10.1016/j.ajo.2015.05.029; Hoffer KJ, 2000, J CATARACT REFR SURG, V26, P1233, DOI 10.1016/S0886-3350(00)00376-X; HOFFER KJ, 1993, J CATARACT REFR SURG, V19, P700, DOI 10.1016/S0886-3350(13)80338-0; Holladay JT, 1996, OPHTHALMOLOGY, V103, P1118, DOI 10.1016/S0161-6420(96)30558-7; Jeong J, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0454-y; Miraftab M, 2014, MIDDLE EAST AFR J OP, V21, P307, DOI 10.4103/0974-9233.142266; Muzyka-Wozniak M, 2016, J CATARACT REFR SURG, V42, P563, DOI 10.1016/j.jcrs.2015.12.050; Narvaez J, 2006, J CATARACT REFR SURG, V32, P2050, DOI 10.1016/j.jcrs.2006.09.009; Norrby S, 2008, J CATARACT REFR SURG, V34, P368, DOI 10.1016/j.jcrs.2007.10.031; OLSEN T, 1991, J CATARACT REFR SURG, V17, P187, DOI 10.1016/S0886-3350(13)80249-0; Olsen T, 2005, J CATARACT REFR SURG, V31, P1345, DOI 10.1016/j.jcrs.2004.12.066; Olsen T, 2007, ACTA OPHTHALMOL SCAN, V85, P472, DOI 10.1111/j.1600-0420.2007.00879.x; Preussner PR, 2008, J CATARACT REFR SURG, V34, P802, DOI 10.1016/j.jcrs.2008.01.015; Sedaghat Mohammad Reza, 2016, Electron Physician, V8, P3127; Wang JK, 2008, J CATARACT REFR SURG, V34, P262, DOI 10.1016/j.jcrs.2007.10.017	25	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189868	10.1371/journal.pone.0189868	http://dx.doi.org/10.1371/journal.pone.0189868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253884	gold, Green Submitted, Green Published			2022-12-26	WOS:000418389500071
J	Prohl, A; Ostermann, CH; Rummell, CD; Rothe, J; Reinholdl, P				Prohl, Annette; Ostermann, Carole H.; Rummell, Christoph D.; Rothe, Joachim; Reinholdl, Petra			Circulating and broncho-alveolar interleukin-6 in relation to body temperature in an experimental model of bovine Chlamydia psittaci infection	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; FEBRILE RESPONSE; GUINEA-PIGS; LOCALIZED INFLAMMATION; SYSTEMIC INFLAMMATION; PSYCHOLOGICAL STRESS; ENDOTHELIAL-CELLS; INDUCED FEVER; BRAIN; RATS	In rodent models of experimentally induced fever, the important role of interleukin-6 (IL-6) as a circulating endogenous pyrogen is well established. Studies employing larger animal species and real infections are scarce. Therefore, we assessed bioactive IL-6 in peripheral blood and in broncho-alveolar lavage fluid (BALF) of calves after intra-bronchial inoculation with vital Chlamydia psittaci (Cp), with inactivated Cp, or with BGM cells. Only calves inoculated with vital Cp developed fever (peak at 2-3 days after challenge) and significantly increased IL-6 activity. Controls inoculated with either inactivated Cp or BGM cells also expressed increased bioactive IL-6, but no fever developed. Activity of IL-6 in BALF was significantly higher compared to blood serum. This experimental model of Cp infection revealed no apparent relation between IL-6 in blood and body temperature, but did reveal a relation between IL-6 and other markers of inflammation in BALF. We conclude that a local inflammatory response in the lungs of infected calves caused fever, which developed by mechanisms including other mediators besides IL-6.	[Prohl, Annette; Ostermann, Carole H.; Reinholdl, Petra] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Jena, Germany; [Rummell, Christoph D.; Rothe, Joachim] Justus Liebig Univ, Inst Vet Physiol & Biochem, Giessen, Germany; [Prohl, Annette] Agro Prax GmbH, Ankum, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; Justus Liebig University Giessen	Reinholdl, P (corresponding author), Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Jena, Germany.	petra.reinhold@fli.de		Rummel, Christoph/0000-0001-5457-4390	Federal Ministry of Education and Research (BMBF) of Germany [01 KI 0720]; European Regional Development Fund (EFRE); Thuringer Aufbaubank [2013 VF 0024, 2013 FE 9077]	Federal Ministry of Education and Research (BMBF) of Germany(Federal Ministry of Education & Research (BMBF)); European Regional Development Fund (EFRE)(European Commission); Thuringer Aufbaubank	This study was financially supported by the Federal Ministry of Education and Research (BMBF) of Germany under Grant no. 01 KI 0720 "Zoonotic chlamydiae-Models of chronic and persistent infections in humans and animals" and the European Regional Development Fund (EFRE) and the Thuringer Aufbaubank (Grant no 2013 VF 0024, Project no. 2013 FE 9077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Blatteis CM, 2004, FRONT BIOSCI-LANDMRK, V9, P915, DOI 10.2741/1297; Bode J, 2014, PLOS ONE, V7; Bode JG, 2012, EUR J CELL BIOL, V91, P496, DOI 10.1016/j.ejcb.2011.09.008; Campisi J, 1985, J APPL PHYSIOL, V95, P1873; Cartmell T, 2000, J PHYSIOL-LONDON, V526, P653, DOI 10.1111/j.1469-7793.2000.00653.x; Chai Z, 1996, J EXP MED, V183, P311, DOI 10.1084/jem.183.1.311; Chi LQ, 2001, J INTERF CYTOK RES, V21, P231, DOI 10.1089/107999001750169871; Dutow P, 2014, J INFECT DIS, V209, P1269, DOI 10.1093/infdis/jit640; Eskilsson A, 2014, J NEUROSCI, V34, P15957, DOI 10.1523/JNEUROSCI.3520-14.2014; Fuchs F, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-140; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; Harden LM, 2011, PSYCHONEUROENDOCRINO, V36, P608, DOI 10.1016/j.psyneuen.2010.09.003; Harre EM, 2002, J APPL PHYSIOL, V92, P2657, DOI 10.1152/japplphysiol.00822.2001; HOLT I, 1991, EUR J CLIN INVEST, V21, P479, DOI 10.1111/j.1365-2362.1991.tb01398.x; Hothorn T, 2008, J STAT SOFTW, V28, P1; Knittler MR, 2014, INT J MED MICROBIOL, V304, P877, DOI 10.1016/j.ijmm.2014.06.010; Kozak W, 1998, ANN NY ACAD SCI, V856, P33, DOI 10.1111/j.1749-6632.1998.tb08310.x; LEMAY LG, 1990, PHYSIOL BEHAV, V47, P957, DOI 10.1016/0031-9384(90)90024-X; Li S, 2005, NEUROIMMUNOMODULAT, V12, P67, DOI 10.1159/000083578; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Navarro VP, 2006, PFLUG ARCH EUR J PHY, V453, P73, DOI 10.1007/s00424-006-0113-2; Ostermann C, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-10; Ostermann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064066; Ostermann C, 2013, VET J, V196, P351, DOI 10.1016/j.tvjl.2012.10.035; Ott D, 2015, NEUROSCI LETT, V597, P159, DOI 10.1016/j.neulet.2015.04.031; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reinhold P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030125; Ross G, 2000, PHYSIOL BEHAV, V71, P305, DOI 10.1016/S0031-9384(00)00358-9; ROTH J, 1994, J PHYSIOL-LONDON, V477, P177, DOI 10.1113/jphysiol.1994.sp020182; Roth J, 2014, COMPR PHYSIOL, V4, P1563, DOI 10.1002/cphy.c130033; Rummel C, 2005, AM J PHYSIOL-REG I, V289, pR340, DOI 10.1152/ajpregu.00104.2005; Rummel C, 2004, J PHYSIOL-LONDON, V557, P671, DOI 10.1113/jphysiol.2003.058834; Rummel C, 2006, AM J PHYSIOL-REG I, V291, pR1316, DOI 10.1152/ajpregu.00301.2006; Rummel C, 2016, BRAIN BEHAV IMMUN, V54, P1, DOI 10.1016/j.bbi.2015.09.003; Schrodl W, 2016, PROTEOM CLIN APPL, V10, P1077, DOI 10.1002/prca.201600028; Soares DM, 2012, MED MICROBIOL IMMUN, V201, P47, DOI 10.1007/s00430-011-0204-3; Trevisi E, 2012, RES VET SCI, V93, P695, DOI 10.1016/j.rvsc.2011.11.008	39	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189321	10.1371/journal.pone.0189321	http://dx.doi.org/10.1371/journal.pone.0189321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281663	Green Submitted, Green Published, gold			2022-12-26	WOS:000419006200022
J	Berman, D; Golomb, JD; Walther, DB				Berman, Daniel; Golomb, Julie D.; Walther, Dirk B.			Scene content is predominantly conveyed by high spatial frequencies in scene-selective visual cortex	PLOS ONE			English	Article							OCCIPITAL PLACE AREA; PARAHIPPOCAMPAL; CATEGORIZATION; REPRESENTATION; PATTERNS; ORGANIZATION; COMPLEX; BRAIN	In complex real-world scenes, image content is conveyed by a large collection of intertwined visual features. The visual system disentangles these features in order to extract information about image content. Here, we investigate the role of one integral component: the content of spatial frequencies in an image. Specifically, we measure the amount of image content carried by low versus high spatial frequencies for the representation of real-world scenes in scene-selective regions of human visual cortex. To this end, we attempted to decode scene categories from the brain activity patterns of participants viewing scene images that contained the full spatial frequency spectrum, only low spatial frequencies, or only high spatial frequencies, all carefully controlled for contrast and luminance. Contrary to the findings from numerous behavioral studies and computational models that have highlighted how low spatial frequencies preferentially encode image content, decoding of scene categories from the scene-selective brain regions, including the parahippocampal place area (PPA), was significantly more accurate for high than low spatial frequency images. In fact, decoding accuracy was just as high for high spatial frequency images as for images containing the full spatial frequency spectrum in scene-selective areas PPA, RSC, OPA and object selective area LOC. We also found an interesting dissociation between the posterior and anterior subdivisions of PPA: categories were decodable from both high and low spatial frequency scenes in posterior PPA but only from high spatial frequency scenes in anterior PPA; and spatial frequency was explicitly decodable from posterior but not anterior PPA. Our results are consistent with recent findings that line drawings, which consist almost entirely of high spatial frequencies, elicit a neural representation of scene categories that is equivalent to that of full-spectrum color photographs. Collectively, these findings demonstrate the importance of high spatial frequencies for conveying the content of complex real-world scenes.	[Berman, Daniel; Golomb, Julie D.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Walther, Dirk B.] Univ Toronto, Dept Psychol, Toronto, ON, Canada	University System of Ohio; Ohio State University; University of Toronto	Walther, DB (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON, Canada.	bernhardt-walther@psych.utoronto.ca		Walther, Dirk/0000-0001-8585-9858	Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-06696]; Canadian Foundation for Innovation [32896]; Connaught Fund, New Researcher Award; National Eye Institute [R01-EY025648]; Alfred P. Sloan Foundation [BR-2014-098]; NATIONAL EYE INSTITUTE [R01EY025648] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Connaught Fund, New Researcher Award; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by: Natural Sciences and Engineering Research Council of Canada, RGPIN-2015-06696, to DBW; Canadian Foundation for Innovation, 32896, to DBW; Connaught Fund, New Researcher Award, to DBW; National Eye Institute, R01-EY025648, to JDG; Alfred P. Sloan Foundation, BR-2014-098, to JDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaro MJ, 2009, J NEUROSCI, V29, P10638, DOI 10.1523/JNEUROSCI.2807-09.2009; Baldassano C, 2013, NEUROIMAGE, V75, P228, DOI 10.1016/j.neuroimage.2013.02.073; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Bryan PB, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00137; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Choo H, 2016, NEUROIMAGE, V135, P32, DOI 10.1016/j.neuroimage.2016.04.021; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dilks DD, 2013, J NEUROSCI, V33, P1331, DOI 10.1523/JNEUROSCI.4081-12.2013; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Ferrara K, 2016, NEUROPSYCHOLOGIA, V89, P180, DOI 10.1016/j.neuropsychologia.2016.05.012; Goffaux V, 2005, VIS COGN, V12, P878, DOI 10.1080/13506280444000562; Gorno-Tempini ML, 2002, NEUROIMAGE, V15, P136, DOI 10.1006/nimg.2001.0967; Greene MR, 2009, PSYCHOL SCI, V20, P464, DOI 10.1111/j.1467-9280.2009.02316.x; Groen IIA, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0102; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Julian JB, 2016, CURR BIOL, V26, P1104, DOI 10.1016/j.cub.2016.02.066; Kamps FS, 2016, NEUROIMAGE, V132, P417, DOI 10.1016/j.neuroimage.2016.02.062; Kauffmann L, 2015, NEUROIMAGE, V112, P86, DOI 10.1016/j.neuroimage.2015.02.058; KINGSMITH PE, 1994, VISION RES, V34, P885, DOI 10.1016/0042-6989(94)90039-6; Kravitz DJ, 2011, J NEUROSCI, V31, P7322, DOI 10.1523/JNEUROSCI.4588-10.2011; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Maguire EA, 2001, SCAND J PSYCHOL, V42, P225, DOI 10.1111/1467-9450.00233; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Musel B, 2014, J COGNITIVE NEUROSCI, V26, P2287, DOI 10.1162/jocn_a_00643; Nasr S, 2014, J NEUROSCI, V34, P6721, DOI 10.1523/JNEUROSCI.4802-13.2014; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Oliva A, 2000, COGNITIVE PSYCHOL, V41, P176, DOI 10.1006/cogp.1999.0728; Park S, 2011, J NEUROSCI, V31, P1333, DOI 10.1523/JNEUROSCI.3885-10.2011; Rajimehr R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000608; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; Straw Andrew D, 2008, Front Neuroinform, V2, P4, DOI 10.3389/neuro.11.004.2008; THIBOS LN, 1987, J OPT SOC AM A, V4, P1524, DOI 10.1364/JOSAA.4.001524; Walther DB, 2014, PSYCHOL SCI, V25, P851, DOI 10.1177/0956797613512662; Walther DB, 2011, P NATL ACAD SCI USA, V108, P9661, DOI 10.1073/pnas.1015666108; Walther DB, 2009, J NEUROSCI, V29, P10573, DOI 10.1523/JNEUROSCI.0559-09.2009; Watson DM, 2016, NEUROIMAGE, V124, P107, DOI 10.1016/j.neuroimage.2015.08.058; Watson DM, 2014, NEUROIMAGE, V99, P402, DOI 10.1016/j.neuroimage.2014.05.045; Zeidman P, 2012, NEUROREPORT, V23, P503, DOI 10.1097/WNR.0b013e328353766a	42	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0189828	10.1371/journal.pone.0189828	http://dx.doi.org/10.1371/journal.pone.0189828			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8ZJ	29272283	gold, Green Published, Green Submitted			2022-12-26	WOS:000418651500014
J	Du, B; Zielinski, DC; Palsson, BO				Du, Bin; Zielinski, Daniel C.; Palsson, Bernhard O.			Topological and kinetic determinants of the modal matrices of dynamic models of metabolism	PLOS ONE			English	Article							STABILITY; PHENOTYPE	Large-scale kinetic models of metabolism are becoming increasingly comprehensive and accurate. A key challenge is to understand the biochemical basis of the dynamic properties of these models. Linear analysis methods are well-established as useful tools for characterizing the dynamic response of metabolic networks. Central to linear analysis methods are two key matrices: the Jacobian matrix (J) and the modal matrix (M-1) arising from its eigen-decomposition. The modal matrix M-1 contains dynamically independent motions of the kinetic model near a reference state, and it is sparse in practice for metabolic networks. However, connecting the structure of M-1 to the kinetic properties of the underlying reactions is non-trivial. In this study, we analyze the relationship between J, M-1, and the kinetic properties of the underlying network for kinetic models of metabolism. Specifically, we describe the origin of mode sparsity structure based on features of the network stoichiometric matrix S and the reaction kinetic gradient matrix G. First, we show that due to the scaling of kinetic parameters in real networks, diagonal dominance occurs in a substantial fraction of the rows of J, resulting in simple modal structures with clear biological interpretations. Then, we show that more complicated modes originate from topologically-connected reactions that have similar reaction elasticities in G. These elasticities represent dynamic equilibrium balances within reactions and are key determinants of modal structure. The work presented should prove useful towards obtaining an understanding of the dynamics of kinetic models of metabolism, which are rooted in the network structure and the kinetic properties of reactions.	[Du, Bin; Zielinski, Daniel C.; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Palsson, BO (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	palsson@ucsd.edu		Palsson, Bernhard/0000-0003-2357-6785	Novo Nordisk Foundation [NNF10CC1016517]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work is funded by The Novo Nordisk Foundation Grant Number NNF10CC1016517.	Almquist J, 2014, METAB ENG, V24, P38, DOI 10.1016/j.ymben.2014.03.007; Barua D, 2007, BIOPHYS J, V92, P2290, DOI 10.1529/biophysj.106.093484; Bier M, 2000, BIOPHYS J, V78, P1087, DOI 10.1016/S0006-3495(00)76667-7; Blair RH, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00227; Bordbar A, 2015, CELL SYST, V1, P283, DOI 10.1016/j.cels.2015.10.003; Canelas AB, 2011, METAB ENG, V13, P294, DOI 10.1016/j.ymben.2011.02.005; Du B, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0283-2; Flach EH, 2010, MATH BIOSCI, V228, P147, DOI 10.1016/j.mbs.2010.09.002; Heuett WJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-44; Heuett WJ, 2008, PLOS COMPUT BIOL, V4; Hofmeyr JHS, 2001, P ICSB 2001, P291; Ivanov O, 2014, P 21 INT S MATH THEO, P890; Jamshidi N, 2002, GENOME RES, V12, P1687, DOI 10.1101/gr.329302; Jamshidi N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100077; Jamshidi N, 2010, BIOPHYS J, V98, P175, DOI 10.1016/j.bpj.2009.09.064; Jamshidi N, 2009, BIOPHYS J, V97, pL11, DOI 10.1016/j.bpj.2009.06.049; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Khodayari A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13806; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Mackey L., 2009, P ADV NEUR INF PROC, V21, P1017; Mannan AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139507; Qian H, 2003, EUR J BIOCHEM, V270, P415, DOI 10.1046/j.1432-1033.2003.03357.x; REDER C, 1988, J THEOR BIOL, V135, P175, DOI 10.1016/S0022-5193(88)80073-0; Smallbone K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-6; Steuer R, 2007, PHYTOCHEMISTRY, V68, P2139, DOI 10.1016/j.phytochem.2007.04.041; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Takahashi K, 2003, BIOINFORMATICS, V19, P1727, DOI 10.1093/bioinformatics/btg221; Varga R.S., 2004, GERSGORIN HIS CIRCLE; Villaverde AF, 2016, J BIOTECHNOL, V222, P1, DOI 10.1016/j.jbiotec.2016.01.005; Wilkinson J. H., 1988, ALGEBRAIC EIGENVALUE	31	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189880	10.1371/journal.pone.0189880	http://dx.doi.org/10.1371/journal.pone.0189880			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267329	Green Submitted, Green Published, gold			2022-12-26	WOS:000418587400056
J	Murakami, M; Suzuki, M; Yamaguchi, T				Murakami, Michio; Suzuki, Mai; Yamaguchi, Tomiko			Presenting information on regulation values improves the public's sense of safety: Perceived mercury risk in fish and shellfish and its effects on consumption intention	PLOS ONE			English	Article							HEALTH MANAGEMENT SURVEY; EAST JAPAN EARTHQUAKE; PSYCHOLOGICAL DISTRESS; SEAFOOD CONSUMPTION; FUKUSHIMA DISASTER; PERCEPTION; KNOWLEDGE; COMMUNICATION; DETERMINANTS; MORTALITY	Risk communication aims to promote health and understanding through information exchange; however, explanations regarding the basis of regulation values for the public are insufficient. Moreover, it is unclear how information presentation affects the public's sense of safety and their consumption intentions. We first investigated the relationship between perception of mercury-risk in fish and shellfish and individual attributes and knowledge. We then examined how presenting information on regulation values and primary factors regarding perception affected sense of safety toward regulations and food-consumption intentions. An online survey was conducted with Japanese individuals (N = 1148). Respondents were randomly assigned to one of three groups based on the presentation level of regulation values. People who frequently consumed tuna had a high perception of dread risk of mercury. This suggests that the dread risk perception of mercury does not determine tuna-type consumption behavior; rather, individuals' consumption behavior determines dread risk perception of mercury. Among those with high tuna-type consumption, those receiving information that a safety factor of 10 times had been considered showed a significantly greater sense of safety than did the group that was not presented with information on regulation values (odds ratio (95% confidence interval): 2.04 (1.18-3.53), p < 0.05). However, presentation of regulation values showed a weak but significantly positive correlation with excessive intake of tuna-type fish (odds ratio: 2.95 (0.93-9.32), p < 0.10). Presenting the information on regulation values increases sense of safety; however, it may also lead to excessive intake.	[Murakami, Michio] Fukushima Med Univ, Sch Med, Dept Hlth Risk Commun, Fukushima, Fukushima, Japan; [Suzuki, Mai] Int Christian Univ, Res Support Grp, Mitaka, Tokyo, Japan; [Yamaguchi, Tomiko] Int Christian Univ, Coll Liberal Arts, Mitaka, Tokyo, Japan	Fukushima Medical University; International Christian University; International Christian University	Murakami, M (corresponding author), Fukushima Med Univ, Sch Med, Dept Hlth Risk Commun, Fukushima, Fukushima, Japan.	michio@fmu.ac.jp			JSPS KAKENHI grant [JP 15H01774]	JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI grant number JP 15H01774, https://www.jsps.go.jp/english/index.html. MM, MS, TY have received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batty GD, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j108; Covello V.T., 1988, RISK COMMUNICATION R; Food and Agriculture Organization of the United Nations World Health Organization, 2016, RISK COMM APPL FOOD; Gigerenzer G, 2006, RISK ANAL, V26, P347, DOI 10.1111/j.1539-6924.2006.00753.x; Ha E, 2017, ENVIRON RES, V152, P419, DOI 10.1016/j.envres.2016.06.042; Hayano RS, 2015, P JPN ACAD B-PHYS, V91, P440, DOI 10.2183/pjab.91.440; Hino Y, 2016, TOHOKU J EXP MED, V239, P333, DOI 10.1620/tjem.239.333; Hommerich C, 2012, INT J JPN SOCIOL, V21, P46, DOI 10.1111/j.1475-6781.2012.01169.x; Hori K, 2001, PARALLEL ANAL; Imai H, 2015, PSYCHIAT RES, V227, P27, DOI 10.1016/j.psychres.2015.03.002; Kahan D. M., 2007, J EMPIR LEGAL STUD, V4, P465, DOI DOI 10.1111/J.1740-1461.2007.00097.X; Karimi R, 2014, INT J HYG ENVIR HEAL, V217, P758, DOI 10.1016/j.ijheh.2014.03.007; Kuttschreuter M, 2006, RISK ANAL, V26, P1045, DOI 10.1111/j.1539-6924.2006.00799.x; Mattisson C, 2015, J AFFECT DISORDERS, V178, P98, DOI 10.1016/j.jad.2015.02.028; MCNEIL BJ, 1982, NEW ENGL J MED, V306, P1259, DOI 10.1056/NEJM198205273062103; Ministry of Health Labour and Welfare, 1973, PROV REG MERC FISH P; Ministry of Health Labour and Welfare, 2010, MERC FISH PROD; Murakami M, 2017, ASIA-PAC J PUBLIC HE, V29, p193S, DOI 10.1177/1010539517691338; Murakami M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165594; Murakami M, 2016, RADIAT PROT DOSIM, V171, P156, DOI 10.1093/rpd/ncw211; National Research Council, 1987, IMPR RISK COMM; Niiyama Y, 2011, JPN J RISK ANAL, V21, p295 ; Oki S, 2012, INT J DISAST RISK RE, V2, P37, DOI 10.1016/j.ijdrr.2012.07.002; Orita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129227; Perko T, 2012, HEALTH PHYS, V102, P614, DOI 10.1097/HP.0b013e31823fb5a5; Pratt LA, 2009, ANN EPIDEMIOL, V19, P202, DOI 10.1016/j.annepidem.2008.12.005; ROTH E, 1990, RISK ANAL, V10, P375, DOI 10.1111/j.1539-6924.1990.tb00520.x; Setbon M, 2005, RISK ANAL, V25, P813, DOI 10.1111/j.1539-6924.2005.00634.x; Sheehan MC, 2014, B WORLD HEALTH ORGAN, V92, P254, DOI 10.2471/BLT.12.116152; Sjoberg L, 2000, RISK ANAL, V20, P1, DOI 10.1111/0272-4332.00001; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Suzuki Y, 2015, B WORLD HEALTH ORGAN, V93, P598, DOI 10.2471/BLT.14.146498; The Food Safety Commission Japan The Contaminant Expert Committee, 2005, FOOD SAF COMM JAP CO; U. S. Food & Drug Administration, 2017, EAT FISH WHAT PREGN; Vandermoere F, 2008, RISK ANAL, V28, P387, DOI 10.1111/j.1539-6924.2008.01025.x; Visschers VHM, 2013, RISK ANAL, V33, P333, DOI 10.1111/j.1539-6924.2012.01861.x	36	4	4	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0188758	10.1371/journal.pone.0188758	http://dx.doi.org/10.1371/journal.pone.0188758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8BI	29267301	Green Submitted, gold, Green Published			2022-12-26	WOS:000418587400015
J	Featherstone, AM; Butler, PG; Peharda, M; Chauvaud, L; Thebault, J				Featherstone, Amy M.; Butler, Paul G.; Peharda, Melita; Chauvaud, Laurent; Thebault, Julien			Influence of riverine input on the growth of Glycymeris glycymeris in the Bay of Brest, North-West France	PLOS ONE			English	Article							FILTER-FEEDING BIVALVES; CLIMATE VARIABILITY; PECTEN-MAXIMUS; SHELL GROWTH; DOG COCKLE; CRASSOSTREA-GIGAS; COASTAL WATERS; ATLANTIC; MARINE; TREE	A crossdated, replicated, chronology of 114 years (1901-2014) was developed from internal growth increments in the shells of Glycymeris glycymeris samples collected monthly from the Bay of Brest, France. Bivalve sampling was undertaken between 2014 and 2015 using a dredge. In total 401 live specimens and 243 articulated paired valves from dead specimens were collected, of which 38 individuals were used to build the chronology. Chronology strength, assessed as the Expressed Population Signal, was above 0.7 throughout, falling below the generally accepted threshold of 0.85 before 1975 because of reduced sample depth. Significant positive correlations were identified between the shell growth and the annual averages of rainfall (1975-2008; r = 0.34) and inflow from the river Elorn (1989-2009; r = 0.60). A significant negative correlation was identified between shell growth and the annual average salinity (1998-2014; r = -0.62). Analysis of the monthly averages indicates that these correlations are associated with the winter months (November-February) preceding the G. glycymeris growth season suggesting that winter conditions predispose the benthic environment for later shell growth. Concentration of suspended particulate matter within the river in February is also positively correlated with shell growth, leading to the conclusion that food availability is also important to the growth of G. glycymeris in the Bay of Brest. With the addition of principle components analysis, we were able to determine that inflow from the River Elorn, nitrite levels and salinity were the fundamental drivers of G. glycymeris growth and that these environmental parameters were all linked.	[Featherstone, Amy M.; Chauvaud, Laurent; Thebault, Julien] Univ Bretagne Occidentale, Inst Univ Europeen Mer, Lab Sci Environm Marin, LEMAR,UMR 6539,CNRS,UBO,IRD,Ifremer, Plouzane, France; [Butler, Paul G.] Univ Exeter, Coll Life & Environm Sci, Penryn, Cornwall, England; [Peharda, Melita] Inst Oceanog & Fisheries, Split, Croatia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); University of Exeter; Croatian Institute of Oceanography & Fisheries (IZOR)	Featherstone, AM (corresponding author), Univ Bretagne Occidentale, Inst Univ Europeen Mer, Lab Sci Environm Marin, LEMAR,UMR 6539,CNRS,UBO,IRD,Ifremer, Plouzane, France.	amy.featherstone1@gmail.com	Thébault, Julien/F-6198-2011; Butler, Paul G/D-1905-2012; Peharda, Melita/G-9426-2017	Thébault, Julien/0000-0002-3111-4428; Butler, Paul G/0000-0002-9924-0316; Peharda, Melita/0000-0002-9486-9633; Featherstone, Amy/0000-0001-6368-3820	European Union Seventh Framework Programme [604802]	European Union Seventh Framework Programme(European Commission)	AMF was funded by the European Union Seventh Framework Programme (FP7-PEOPLE-2013-ITN, http://ec.europa.eu/rea/index_en.htm, grant agreement number: 604802, ARAMACC "Annually Resolved Archives of Marine Climate Change," http://aramacc.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2000, AQUAT LIVING RESOUR, V13, P173, DOI 10.1016/S0990-7440(00)00150-9; Atkins D, 1936, Q J MICROSC SCI, V79, P181; BARNES R S K, 1973, Proceedings of the Malacological Society of London, V40, P253; Black BA, 2009, PALAEOGEOGR PALAEOCL, V278, P40, DOI 10.1016/j.palaeo.2009.04.010; Black BA, 2009, MAR ECOL PROG SER, V378, P37, DOI 10.3354/meps07854; Black BA, 2008, CAN J FISH AQUAT SCI, V65, P2572, DOI 10.1139/F08-158; Bond-Lamberty B, 2014, GLOBAL CHANGE BIOL, V20, P216, DOI 10.1111/gcb.12404; Brocas WM, 2013, PALAEOGEOGR PALAEOCL, V373, P133, DOI 10.1016/j.palaeo.2012.03.030; Buselic I, 2015, J SEA RES, V95, P139, DOI 10.1016/j.seares.2014.07.011; Butler PG, 2013, PALAEOGEOGR PALAEOCL, V373, P141, DOI 10.1016/j.palaeo.2012.01.016; Butler PG, 2010, QUATERNARY SCI REV, V29, P1614, DOI 10.1016/j.quascirev.2009.07.010; Caragnano A, 2017, J PHYCOL, V53, P381, DOI 10.1111/jpy.12509; Chauvand L, 2000, MAR ECOL PROG SER, V200, P35, DOI 10.3354/meps200035; Chauvaud L, 1998, J EXP MAR BIOL ECOL, V227, P83, DOI 10.1016/S0022-0981(97)00263-3; Colonese AC, 2017, PALEOGEOGR PAELEOCLI; Cook E.R., 1990, METHODS DENDROCHRONO, P97, DOI [10.2307/1551446, DOI 10.1007/978-94-015-7879-0_3, 10.1007/978-94-015-7879-0_3]; Cook ER, 1997, HOLOCENE, V7, P361, DOI 10.1177/095968369700700314; Cook ER, 2006, TREE RING STANDARDIZ; Dawson AG, 2002, HOLOCENE, V12, P363, DOI 10.1191/0959683602hl552rr; de Vries AJ, 1984, NETH J SEA RES, V18, P221; Del Amo Y, 1997, MAR ECOL PROG SER, V161, P213, DOI 10.3354/meps161213; Dridi S, 2007, AQUACULTURE, V263, P238, DOI 10.1016/j.aquaculture.2006.10.028; Dunca E, 2005, PALAEOGEOGR PALAEOCL, V228, P43, DOI 10.1016/j.palaeo.2005.03.050; Ellis J, 2002, J EXP MAR BIOL ECOL, V267, P147, DOI 10.1016/S0022-0981(01)00355-0; EPIFANIO CE, 1975, MAR BIOL, V33, P241, DOI 10.1007/BF00390928; Fritts H. C., 1976, TREE RINGS CLIMATE; Galap C, 1999, COMP BIOCHEM PHYS A, V122, P241, DOI 10.1016/S1095-6433(99)00006-9; Grall J, 1997, ESTUAR COAST SHELF S, V44, P43, DOI 10.1016/S0272-7714(97)80006-6; Grissino-Mayer, 2001, TREE-RING RES, V57, P205, DOI DOI 10.1016/J.DENDRO.2010.12.002; Gutierrez-Mas JM, 2011, ESTUAR COAST SHELF S, V92, P546, DOI 10.1016/j.ecss.2011.02.010; Helama S, 2007, MAR ENVIRON RES, V63, P185, DOI 10.1016/j.marenvres.2006.08.003; Holland HA, 2014, HOLOCENE, V24, P771, DOI 10.1177/0959683614530438; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Hurrell JW, 2001, SCIENCE, V291, P603, DOI 10.1126/science.1058761; Jennerjahn TC, 2002, NATURWISSENSCHAFTEN, V89, P23, DOI 10.1007/s00114-001-0283-x; Kubota K, 2017, PALAEOGEOGR PALAEOCL, V465, P307, DOI 10.1016/j.palaeo.2016.05.016; LePape O, 1996, CONT SHELF RES, V16, P1885, DOI 10.1016/0278-4343(95)00068-2; Lorrain A, 2000, J MAR BIOL ASSOC UK, V80, P667, DOI 10.1017/S0025315400002496; MALLIN MA, 1993, MAR ECOL PROG SER, V93, P199, DOI 10.3354/meps093199; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Marali S, 2015, PALAEOGEOGR PALAEOCL, V420, P138, DOI 10.1016/j.palaeo.2014.12.016; Melott AL, 2016, J GEOPHYS RES-ATMOS, V121, P3017, DOI 10.1002/2015JD024064; Mette MJ, 2016, LIMNOL OCEANOGR, V61, P748, DOI 10.1002/lno.10252; Milano S, 2017, PALAEOGEOGR PALAEOCL, V465, P395, DOI 10.1016/j.palaeo.2015.09.051; Moss DK, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1364; Najdek M, 2016, SCI MAR, V80, P123, DOI 10.3989/scimar.04267.23A; Peharda M, 2016, MAR ENVIRON RES, V119, P79, DOI 10.1016/j.marenvres.2016.05.022; Ragueneau O, 2002, LIMNOL OCEANOGR, V161, P213; Raimonet M, 2013, ESTUAR COAST SHELF S, V119, P31, DOI 10.1016/j.ecss.2012.12.008; Ramsay K, 2000, J SEA RES, V43, P167, DOI 10.1016/S1385-1101(00)00006-X; Ramsay K, 2001, J SEA RES, V45, P131, DOI 10.1016/S1385-1101(01)00050-8; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Reynolds DJ, 2017, PALAEOGEOGR PALAEOCL, V465, P333, DOI 10.1016/j.palaeo.2016.08.006; Reynolds DJ, 2013, PALAEOGEOGR PALAEOCL, V386, P275, DOI 10.1016/j.palaeo.2013.05.029; Richardson CA, 2001, OCEANOGR MAR BIOL, V39, P103; Roman-Gonzalez A, 2017, PALAEOGEOGR PALAEOCL, V465, P300, DOI 10.1016/j.palaeo.2016.05.004; Rombouts I, 2012, ESTUAR COAST SHELF S, V99, P153, DOI 10.1016/j.ecss.2011.12.026; Royer C, 2013, PALAEOGEOGR PALAEOCL, V373, P123, DOI 10.1016/j.palaeo.2012.01.033; Salt LA, 2016, MAR CHEM, V187, P1, DOI 10.1016/j.marchem.2016.09.003; Savina M, 2004, AQUACULTURE, V239, P289, DOI 10.1016/j.aquaculture.2004.05.029; Schone BR, 2013, PALAEOGEOGR PALAEOCL, V373, P1, DOI 10.1016/j.palaeo.2012.11.026; Schone BR, 2003, GEOLOGY, V31, P1037, DOI 10.1130/G20013.1; Schone BR, 2002, VELIGER, V45, P45; Scourse JD, 2012, RADIOCARBON, V54, P165, DOI 10.2458/azu_js_rc.v54i2.16026; Seiler R, 2017, PLOS ONE, V12; Silva LCR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501302; STEELEPETROVIC HM, 1975, J PALEONTOL, V49, P552; Steiger NJ, 2017, J GEOPHYS RES-ATMOS, V122, P1545, DOI 10.1002/2016JD026011; Stocker BD, 2017, P NATL ACAD SCI USA, V114, P1492, DOI 10.1073/pnas.1613889114; STUIVER M, 1993, RADIOCARBON, V35, P1, DOI 10.1017/S0033822200013874; Sugimoto R, 2016, ESTUAR COAST, V39, P13, DOI 10.1007/s12237-015-9986-7; Tank AMGK, 2002, INT J CLIMATOL, V22, P1441, DOI 10.1002/joc.773; Thebault J, 2013, PALAEOGEOGR PALAEOCL, V373, P108, DOI 10.1016/j.palaeo.2011.12.014; TREGUER P, 1989, OCEANOL ACTA, V12, P371; Treguer P, 2014, J MARINE SYST, V139, P79, DOI 10.1016/j.jmarsys.2014.05.019; Trigo RM, 2002, CLIMATE RES, V20, P9, DOI 10.3354/cr020009; Wanamaker AD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1901; Wanamaker AD, 2011, PALAEOGEOGR PALAEOCL, V302, P1, DOI 10.1016/j.palaeo.2010.12.024; Watanabe K, 2017, ESTUAR COAST SHELF S, V184, P126, DOI 10.1016/j.ecss.2016.10.031; Widman JC, 2008, ARCH ENVIRON CON TOX, V54, P460, DOI 10.1007/s00244-007-9051-z; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; YAMAGUCHI DK, 1991, CAN J FOREST RES, V21, P414, DOI 10.1139/x91-053; Zhao LQ, 2017, HYDROBIOLOGIA, V790, P259, DOI 10.1007/s10750-016-3037-7	83	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189782	10.1371/journal.pone.0189782	http://dx.doi.org/10.1371/journal.pone.0189782			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261749	Green Published, gold, Green Submitted			2022-12-26	WOS:000418564200065
J	Itouga, M; Hayatsu, M; Sato, M; Tsuboi, Y; Kato, Y; Toyooka, K; Suzuki, S; Nakatsuka, S; Kawakami, S; Kikuchi, J; Sakakibara, H				Itouga, Misao; Hayatsu, Manabu; Sato, Mayuko; Tsuboi, Yuuri; Kato, Yukari; Toyooka, Kiminori; Suzuki, Suechika; Nakatsuka, Seiji; Kawakami, Satoshi; Kikuchi, Jun; Sakakibara, Hitoshi			Protonema of the moss Funaria hygrometrica can function as a lead (Pb) adsorbent	PLOS ONE			English	Article							NMR-BASED METABOLOMICS; SCOPELOPHILA-CATARACTAE; ARABIDOPSIS-THALIANA; DIVALENT-CATIONS; BRYO-FILTRATION; GENE-EXPRESSION; AQUEOUS STREAMS; HEAVY-METALS; WASTE-WATER; PLANTS	Water contamination by heavy metals from industrial activities is a serious environmental concern. To mitigate heavy metal toxicity and to recover heavy metals for recycling, biomaterials used in phytoremediation and bio-sorbent filtration have recently drawn renewed attention. The filamentous protonemal cells of the moss Funaria hygrometrica can hyperaccumulate lead (Pb) up to 74% of their dry weight when exposed to solutions containing divalent Pb. Energy-dispersive X-ray spectroscopy revealed that Pb is localized to the cell walls, endoplasmic reticulum-like membrane structures, and chloroplast thylakoids, suggesting that multiple Pb retention mechanisms are operating in living F. hygrometrica. The main Pb-accumulating compartment was the cell wall, and prepared cell-wall fractions could also adsorb Pb. Nuclear magnetic resonance analysis showed that polysaccharides composed of polygalacturonic acid and cellulose probably serve as the most effective Pb-binding components. The adsorption abilities were retained throughout a wide range of pH values, and bound Pb was not desorbed under conditions of high ionic strength. In addition, the moss is highly tolerant to Pb. These results suggest that the moss F. hygrometrica could be a useful tool for the mitigation of Pb-toxicity in wastewater.	[Itouga, Misao; Sato, Mayuko; Tsuboi, Yuuri; Kato, Yukari; Toyooka, Kiminori; Nakatsuka, Seiji; Kikuchi, Jun; Sakakibara, Hitoshi] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan; [Hayatsu, Manabu; Suzuki, Suechika] Kanagawa Univ, Fac Sci, Dept Biol Sci, Hiratsuka, Kanagawa, Japan; [Hayatsu, Manabu; Suzuki, Suechika] Kanagawa Univ, Res Inst Integrated Sci, Hiratsuka, Kanagawa, Japan; [Nakatsuka, Seiji] DOWA Technol Co Ltd, Chiyoda Ku, Tokyo, Japan; [Kawakami, Satoshi] DOWA Ecosyst Co Ltd, Chiyoda Ku, Tokyo, Japan; [Sakakibara, Hitoshi] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi, Japan; [Hayatsu, Manabu] Niigata Univ, Grad Sch Med & Dent Sci, Div Microscop Anat, Niigata, Japan	RIKEN; Kanagawa University; Kanagawa University; Nagoya University; Niigata University	Itouga, M; Sakakibara, H (corresponding author), RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan.; Sakakibara, H (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi, Japan.	misao.itouga@riken.jp; sakaki@riken.jp	Sakakibara, Hitoshi/A-6040-2010; Kikuchi, Jun/M-5512-2015; Kikuchi, Jun/O-4725-2019; Toyooka, Kiminori/B-5027-2011; Itouga, Misao/C-8282-2017	Sakakibara, Hitoshi/0000-0001-5449-6492; Kikuchi, Jun/0000-0002-6809-394X; Kikuchi, Jun/0000-0002-6809-394X; Itouga, Misao/0000-0001-8001-6843	DOWA Techno Fund of DOWA Holdings	DOWA Techno Fund of DOWA Holdings	This study was funded by the DOWA Techno Fund of DOWA Holdings. The funder provided financial support for research and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. S.N. and S.K. are employees of DOWA Technology Co. Ltd and DOWA Eco-System Co. Ltd. The specific roles of these authors are articulated in the 'author contributions' section.	Amarasinghe BMWPK, 2007, CHEM ENG J, V132, P299, DOI 10.1016/j.cej.2007.01.016; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Chikayama E, 2010, ANAL CHEM, V82, P1653, DOI 10.1021/ac9022023; Clemens S, 2016, ANNU REV PLANT BIOL, V67, P489, DOI 10.1146/annurev-arplant-043015-112301; Date Y, 2012, POLYM J, V44, P888, DOI 10.1038/pj.2012.105; Dushenkov S, 2000, PHYTOREMEDIATION OF TOXIC METALS, P89; DUSHENKOV V, 1995, ENVIRON SCI TECHNOL, V29, P1239, DOI 10.1021/es00005a015; Feng NC, 2011, J HAZARD MATER, V185, P49, DOI 10.1016/j.jhazmat.2010.08.114; GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7; Hayatsu M, 2012, J ELECTRON MICROSC, V61, P57, DOI 10.1093/jmicro/dfr095; HOFFMAN GR, 1966, ECOL MONOGR, V36, P157, DOI 10.2307/1942153; Itouga M, 2011, OYO BUTURI, V80, P710; Itouga Misao, 2006, Hikobia, V14, P413; Kikuchi J, 2004, PLANT CELL PHYSIOL, V45, P1099, DOI 10.1093/pcp/pch117; KIKUCHI J., 2011, J ECOSYSTEM ECOGRA S, VS2, P1, DOI DOI 10.4172/2157-7625.S2-001; Kikuchi Jun, 2007, V358, P273, DOI 10.1007/978-1-59745-244-1_15; Kobayashi F, 2006, BIOCHEM ENG J, V28, P295, DOI 10.1016/j.bej.2005.11.013; Koch I, 1999, SCI TOTAL ENVIRON, V236, P101, DOI 10.1016/S0048-9697(99)00273-9; Komatsu T, 2013, ANAL CHEM, V85, P8857, DOI 10.1021/ac402197h; Konno H, 2010, J PLANT PHYSIOL, V167, P358, DOI 10.1016/j.jplph.2009.09.011; Kuhnlenz T, 2016, PLANT CELL PHYSIOL, V57, P2342, DOI 10.1093/pcp/pcw148; Lee M, 2010, J HAZARD MATER, V173, P589, DOI 10.1016/j.jhazmat.2009.08.127; Lee SH, 1998, PROCESS BIOCHEM, V33, P205; Li JR, 2016, PLANT CELL PHYSIOL, V57, P1720, DOI 10.1093/pcp/pcw093; Matsunaga T, 2004, PLANT PHYSIOL, V134, P339, DOI 10.1104/pp.103.030072; Nomura T, 2015, J EXP BOT, V66, P1205, DOI 10.1093/jxb/eru470; Nomura T, 2011, J PLANT RES, V124, P631, DOI 10.1007/s10265-010-0389-3; Nourimand M, 2016, PLANT CELL PHYSIOL, V57, P2485, DOI 10.1093/pcp/pcw162; Ogata Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030263; Park D, 2008, BIORESOURCE TECHNOL, V99, P8810, DOI 10.1016/j.biortech.2008.04.042; Perner-Nochta I, 2007, ENG LIFE SCI, V7, P127, DOI 10.1002/elsc.200620178; PERSSON HERMAN, 1956, JOUR HATTORI BOT LAB, V17, P1; Prasad MNV, 2003, ELECTRON J BIOTECHN, V6, P285, DOI 10.2225/vol6-issue3-fulltext-6; Puche F, 2000, NOVA HEDWIGIA, V70, P523; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Riaz M, 2009, J HAZARD MATER, V161, P88, DOI 10.1016/j.jhazmat.2008.03.096; Sarkar B., 2002, HEAVY METALS ENV; SATAKE K, 1988, J BRYOL, V15, P353, DOI 10.1179/jbr.1988.15.2.353; Sekiyama Y, 2010, ANAL CHEM, V82, P1643, DOI 10.1021/ac9019076; SHAW J, 1987, AM J BOT, V74, P1466, DOI 10.2307/2444041; Sohrin Y, 2008, ANAL CHEM, V80, P6267, DOI 10.1021/ac800500f; Song WY, 2010, P NATL ACAD SCI USA, V107, P21187, DOI 10.1073/pnas.1013964107; Sudo Emi, 2006, Hikobia, V14, P419; Sudo E, 2008, J EXP BOT, V59, P3465, DOI 10.1093/jxb/ern196; Tansel Berrin, 2008, Recent Patents on Chemical Engineering, V1, P17; Volland S, 2014, J PLANT PHYSIOL, V171, P154, DOI 10.1016/j.jplph.2013.10.002; Watanabe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106893; Wellner N, 1998, CARBOHYD RES, V308, P123, DOI 10.1016/S0008-6215(98)00065-2	48	14	14	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189726	10.1371/journal.pone.0189726	http://dx.doi.org/10.1371/journal.pone.0189726			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261745	gold, Green Submitted, Green Published			2022-12-26	WOS:000418564200059
J	Liu, XJ; Cao, YL; Xue, TT; Wu, RW; Zhou, Y; Zhou, CH; Zanatta, DT; Ouyang, S; Wu, XP				Liu, Xiongjun; Cao, Yanling; Xue, Taotao; Wu, Ruiwen; Zhou, Yu; Zhou, Chunhua; Zanatta, David T.; Ouyang, Shan; Wu, Xiaoping			Genetic structure and diversity of Nodularia douglasiae (Bivalvia: Unionida) from the middle and lower Yangtze River drainage	PLOS ONE			English	Article							FRESH-WATER MUSSELS; MICROSATELLITE NULL ALLELES; POPULATION-STRUCTURE; QUADRULA-QUADRULA; COMPUTER-PROGRAM; POYANG LAKE; SOFTWARE; CONSERVATION; BIODIVERSITY; INFERENCE	The Yangtze River drainage in China is among the most species rich rivers for freshwater mussels (order Unionida) on Earth with at least 68 species known. The freshwater mussels of the Yangtze River face a variety of threats with indications that species are declining in abundance and area of occupancy. This study represents the first analyses of the genetic structure and diversity for the common and widespread freshwater mussel Nodularia douglasiae based on microsatellite DNA genotypes and mitochondrial DNA sequences. Phylogenetic analysis a fragment of the COI mitochondrial gene indicated that N. douglasiae collected from across the middle and lower Yangtze River drainage are monophyletic with N. douglasiae from Japan, Russia, and South Korea. The results of the analysis of both the mtDNA and microsatellite datasets indicated that the seven collection locations of N. douglasiae in the middle and lower Yangtze River drainage showed high genetic diversity, significant genetic differentiation and genetic structure, and stable population dynamics over time. Moreover, we found that the connections among tributaries rivers and lakes in the Yangtze River drainage were important in maintaining gene flow among locations that N. douglasiae inhabits. An understanding of the genetic structure and diversity of a widespread species like N. douglasiae could be used as a surrogate to better understand the populations of other freshwater mussel species that are more rare in the Yangtze River drainage. At the same time, these results could provide a basis for the protection of genetic diversity and management of unionid mussels diversity and other aquatic organisms in the system.	[Liu, Xiongjun; Wu, Xiaoping] Nanchang Univ, Minist Educ, Poyang Lake Key Lab Environm & Resource Utilizat, Nanchang, Jiangxi, Peoples R China; [Liu, Xiongjun; Wu, Xiaoping] Nanchang Univ, Sch Resource Environm & Chem Engn, Nanchang, Jiangxi, Peoples R China; [Cao, Yanling; Xue, Taotao; Wu, Ruiwen; Zhou, Yu; Zhou, Chunhua; Ouyang, Shan; Wu, Xiaoping] Nanchang Univ, Sch Life Sci, Nanchang, Jiangxi, Peoples R China; [Zanatta, David T.] Cent Michigan Univ, Dept Biol, Inst Great Lakes Res, Biosci 2408, Mt Pleasant, MI 48859 USA	Nanchang University; Nanchang University; Nanchang University; Central Michigan University	Wu, XP (corresponding author), Nanchang Univ, Minist Educ, Poyang Lake Key Lab Environm & Resource Utilizat, Nanchang, Jiangxi, Peoples R China.; Wu, XP (corresponding author), Nanchang Univ, Sch Resource Environm & Chem Engn, Nanchang, Jiangxi, Peoples R China.; Ouyang, S; Wu, XP (corresponding author), Nanchang Univ, Sch Life Sci, Nanchang, Jiangxi, Peoples R China.; Zanatta, DT (corresponding author), Cent Michigan Univ, Dept Biol, Inst Great Lakes Res, Biosci 2408, Mt Pleasant, MI 48859 USA.	zanat1d@cmich.edu; ouys1963@ncu.edu.cn; xpwu@ncu.edu.cn	Wu, Ruiwen/AAT-4849-2020; Zanatta, David/AAR-6797-2020	Wu, Ruiwen/0000-0002-8936-6054; Zanatta, David/0000-0002-3174-071X	Central Michigan University Poyang Lake Research Investment Fund; Central Michigan University; Key Laboratory of Poyang Lake Wetland and Watershed Research Director's Open Fund; Nanchang University; National Nature Science Foundation of China [31260515, 81460318]; Leading Talent Training Plan of the GanPo Outstanding Talents 555 Project [18000041]	Central Michigan University Poyang Lake Research Investment Fund; Central Michigan University; Key Laboratory of Poyang Lake Wetland and Watershed Research Director's Open Fund; Nanchang University; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leading Talent Training Plan of the GanPo Outstanding Talents 555 Project	This work received support from: the Central Michigan University Poyang Lake Research Investment Fund. Central Michigan University; the Key Laboratory of Poyang Lake Wetland and Watershed Research Director's Open Fund. Central Michigan University and Nanchang University; the National Nature Science Foundation of China (No. 31260515, No.81460318). Nanchang University; the Leading Talent Training Plan of the GanPo Outstanding Talents 555 Project (No. 18000041). Nanchang University. This article is contribution 92 of the Central Michigan University Institute for Great Lakes Research.r Funding for this research project came from the Central Michigan University Poyang Lake Research Investment Fund, the Key Laboratory of Poyang Lake Wetland and Watershed Research Director's Open Fund, the National Nature Science Foundation of China (No. 31260515; No.81460318), and the Leading Talent Training Plan of the GanPo Outstanding Talents 555 Project (No. 18000041). This article is contribution 92 of the Central Michigan University Institute for Great Lakes Research.	Abbas K, 2010, BIOCHEM SYST ECOL, V38, P806, DOI 10.1016/j.bse.2010.08.003; Astanei I, 2005, MOL ECOL, V14, P1655, DOI 10.1111/j.1365-294X.2005.02530.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barnhart MC, 2008, J N AM BENTHOL SOC, V27, P370, DOI 10.1899/07-093.1; Barton NH, 2010, EVOLUTION, V64, P2701, DOI 10.1111/j.1558-5646.2010.01019.x; Berg DJ, 1998, J SHELLFISH RES, V17, P1365; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Clement M., 2002, P 16 INT PARALLEL DI, P7; Collier KJ, 2016, AQUAT CONSERV, V26, P817, DOI 10.1002/aqc.2710; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; DeWoody JA, 2004, BIOTECHNIQUES, V37, P348, DOI 10.2144/04373BM02; Doucet-Beaupre H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-50; Douda K, 2013, DIVERS DISTRIB, V19, P933, DOI 10.1111/ddi.12044; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elderkin CL, 2007, CONSERV GENET, V8, P355, DOI 10.1007/s10592-006-9175-0; Elderkin CL, 2008, MOL ECOL, V17, P2149, DOI 10.1111/j.1365-294X.2008.03745.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferguson CD, 2013, FRESHW SCI, V32, P267, DOI 10.1899/12-028.1; Fraser DJ, 2008, EVOL APPL, V1, P535, DOI 10.1111/j.1752-4571.2008.00036.x; Freeland J. R., 2011, MOL ECOLOGY; Fu CZ, 2003, BIODIVERS CONSERV, V12, P1649, DOI 10.1023/A:1023697714517; Galbraith HS, 2015, CONSERV GENET, V16, P845, DOI 10.1007/s10592-015-0705-5; Geist J, 2010, CONSERV GENET, V11, P1103, DOI 10.1007/s10592-009-9889-x; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Graf DL, 2007, J MOLLUS STUD, V73, P291, DOI 10.1093/mollus/eym029; Haag WR, 2014, HYDROBIOLOGIA, V735, P45, DOI 10.1007/s10750-013-1524-7; Haag WR, 2012, NORTH AMERICAN FRESHWATER MUSSELS: NATURAL HISTORY, ECOLOGY, AND CONSERVATION, P1, DOI 10.1017/CBO9781139048217; Han SQ, 1998, J CHINESE HIST GEOGR, V2, P61; He J., 2013, FRESHWATER BIVALVES; Hoftyzer E, 2008, CAN J FISH AQUAT SCI, V65, P1217, DOI 10.1139/F08-024; Hong X, 1991, MARINE GEOLOGY QUATE, V11, P87; Husemann M, 2012, BIOL J LINN SOC, V107, P867, DOI 10.1111/j.1095-8312.2012.01973.x; IUCN, 2020, IUCN RED LIST THREAT; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jing CY, 1989, SCI GEOGRAPHICA SINI, V9, P378; Jones JW, 2006, J SHELLFISH RES, V25, P527, DOI 10.2983/0730-8000(2006)25[527:GMGFCP]2.0.CO;2; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Klishko OK, 2018, SYST BIODIVERS, V16, P287, DOI 10.1080/14772000.2017.1383527; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Li G, 2003, MOL ECOL NOTES, V3, P228, DOI 10.1046/j.1471-8286.2003.00406.x; Li Wen-hao, 2016, Changjiang Liuyu Ziyuan Yu Huanjing, V25, P1218; Li ZH, 2009, STUDY ECOLOGICAL ENV; Liao XL, 2006, HYDROBIOLOGIA, V568, P445, DOI 10.1007/s10750-006-0222-0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JL, 1996, ACTA PALAEONTOLOGICA, V35, P129; Liu Xiao-Hong, 2013, Zoological Research, V34, pE62, DOI 10.3724/SP.J.1141.2013.E02E62; Liu YY, 1979, EC FAUNA CHINA FRESH, P116; Lopes-Lima M, 2017, BIOL REV, V92, P572, DOI 10.1111/brv.12244; Luo YM, 2006, GENETIC DIVERSITY 4; Mathias PT, 2017, HYDROBIOLOG IN PRESS; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Paterson WL, 2015, J GREAT LAKES RES, V41, P1123, DOI 10.1016/j.jglr.2015.09.006; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2007, TRACER V1 5; Scott M.W., 2014, WALKERANA, V17, P60; Shu Feng-Yue, 2009, Acta Hydrobiologica Sinica, V33, P1051, DOI 10.3724/SP.J.0000.2009.61051; Stoger I, 2013, MOL PHYLOGENET EVOL, V69, P376, DOI 10.1016/j.ympev.2012.11.017; Strayer DL, 2008, FRESHW ECOL SER, V1, P1; Sun TT, 2017, AQUATIC CON IN PRESS; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vaughn CC, 2017, HYDROBIOLOGIA IN PRE; Wang CY, 2007, HYDROBIOLOGIA, V586, P321, DOI 10.1007/s10750-007-0702-x; Wang Q., 1999, J LAKE SCI, V11, P237, DOI DOI 10.18307/1999.0308; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wu SZ, 2013, J WORLD AQUACULT SOC, V44, P600, DOI 10.1111/jwas.12057; Wu Xiaoping, 2000, Hupo Kexue, V12, P111; Wu XP, 1998, THESIS; Xiong LF, 2012, CHIN J OCEANOL LIMN, V30, P124, DOI 10.1007/s00343-012-1070-6; Xu Y., 2014, ISOLATION MICROSATEL; Yeh F. C., 2000, POPGENE32 MICROSOFT; Zanatta DT, 2011, BIOL J LINN SOC, V102, P669, DOI 10.1111/j.1095-8312.2010.01596.x; Zanatta DT, 2008, BIOL J LINN SOC, V93, P371, DOI 10.1111/j.1095-8312.2007.00936.x; Zhang Ming-hua, 2013, Marine Sciences (Beijing), V37, P114; Zhang Q, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053431; Zhang Qinghui, 2016, Hupo Kexue, V28, P545, DOI 10.18307/2016.0310; Zhang X, 1959, B BIOL FR BELG, P14; Zhu B, 2009, CHINESE FISHERIES EC, V27, P74; Zieritz A, 2017, HYDROBIOLOG IN PRESS	87	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189737	10.1371/journal.pone.0189737	http://dx.doi.org/10.1371/journal.pone.0189737			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261733	Green Published, gold, Green Submitted			2022-12-26	WOS:000418564200062
J	Psylla, I; Sapiezynski, P; Mones, E; Lehmann, S				Psylla, Ioanna; Sapiezynski, Piotr; Mones, Enys; Lehmann, Sune			The role of gender in social network organization	PLOS ONE			English	Article							SEX-DIFFERENCES; PERSONALITY-TRAITS; SELF-ESTEEM; LIFE SCALE; SAME-SEX; PATTERNS; NARCISSISM; SATISFACTION; LONELINESS; VALIDITY	The digital traces we leave behind when engaging with the modern world offer an interesting lens through which we study behavioral patterns as expression of gender. Although gender differentiation has been observed in a number of settings, the majority of studies focus on a single data stream in isolation. Here we use a dataset of high resolution data collected using mobile phones, as well as detailed questionnaires, to study gender differences in a large cohort. We consider mobility behavior and individual personality traits among a group of more than 800 university students. We also investigate interactions among them expressed via person-to-person contacts, interactions on online social networks, and telecommunication. Thus, we are able to study the differences between male and female behavior captured through a multitude of channels for a single cohort. We find that while the two genders are similar in a number of aspects, there are robust deviations that include multiple facets of social interactions, suggesting the existence of inherent behavioral differences. Finally, we quantify how aspects of an individual's characteristics and social behavior reveals their gender by posing it as a classification problem. We ask: How well can we distinguish between male and female study participants based on behavior alone? Which behavioral features are most predictive?	[Psylla, Ioanna; Sapiezynski, Piotr; Mones, Enys; Lehmann, Sune] Tech Univ Denmark, DTU Compute, Lyngby, Denmark; [Sapiezynski, Piotr] Northeastern Univ, Coll Comp & Informat Sci, Boston, MA 02115 USA; [Lehmann, Sune] Univ Copenhagen, Niels Bohr Inst, Copenhagen, Denmark	Technical University of Denmark; Northeastern University; University of Copenhagen; Niels Bohr Institute	Lehmann, S (corresponding author), Tech Univ Denmark, DTU Compute, Lyngby, Denmark.; Lehmann, S (corresponding author), Univ Copenhagen, Niels Bohr Inst, Copenhagen, Denmark.	sljo@dtu.dk		Lehmann, Sune/0000-0001-6099-2345; Mones, Enys/0000-0001-7724-0094	Villum Foundation; Young Investigator programme, High Resolution Networks; University of Copenhagen [UCPH2016]; Villum Fonden [00007192] Funding Source: researchfish	Villum Foundation(Villum Fonden); Young Investigator programme, High Resolution Networks; University of Copenhagen; Villum Fonden(Villum Fonden)	This work was supported by Villum Foundation, http://villumfoundation.dk/C12576AB0041F11B/0/4F7615B6F43A8EA5C1257AEF003D9930?OpenDocument, Young Investigator programme 2012, High Resolution Networks (SL) and University of Copenhagen, http://dsin.ku.dk/news/ucph_funds/, through the UCPH2016 Social Fabric grant (SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar A., 2008, J WEBSITE PROMOTION, DOI [10.1080/15533610802052654, DOI 10.1080/15533610802052654]; Aledavood T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138098; Back MD, 2013, J PERS SOC PSYCHOL, V105, P1013, DOI 10.1037/a0034431; BORYS S, 1985, PERS SOC PSYCHOL B, V11, P63, DOI 10.1177/0146167285111006; BRASS DJ, 1985, ACAD MANAGE J, V28, P327, DOI 10.2307/256204; Bushman BJ, 1998, J PERS SOC PSYCHOL, V75, P219, DOI 10.1037/0022-3514.75.1.219; CALDWELL MA, 1982, SEX ROLES, V8, P721; Camstra R, 1996, URBAN STUD, V33, P283, DOI 10.1080/00420989650012013; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; CLARK EJ, 1986, J MED EDUC, V61, P32; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI [10.1037/0022-3514.81.2.322, 10.1037//0022-3514.81.2.322]; Cramer KM, 1998, SEX ROLES, V38, P645, DOI 10.1023/A:1018850711372; Cuttone A, 2014, PROCEEDINGS OF THE 2014 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING (UBICOMP'14 ADJUNCT), P995, DOI 10.1145/2638728.2641283; Dahlin M, 2005, MED EDUC, V39, P594, DOI 10.1111/j.1365-2929.2005.02176.x; de Montjoye Yves-Alexandre, 2013, Social Computing, Behavioral-Cultural Modeling and Prediction. 6th International Conference, SBP 2013. Proceedings, P48, DOI 10.1007/978-3-642-37210-0_6; DEAUX K, 1987, PSYCHOL REV, V94, P369, DOI 10.1037/0033-295X.94.3.369; DEBRABANDER B, 1990, J SOC PSYCHOL, V130, P271, DOI 10.1080/00224545.1990.9924580; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; DUNBAR RIM, 1995, HUM NATURE-INT BIOS, V6, P273, DOI 10.1007/BF02734142; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; EMMONS RA, 1984, J PERS ASSESS, V48, P291, DOI 10.1207/s15327752jpa4803_11; Fano R M, 1961, AM J PHYS, V29, P793, DOI DOI 10.1119/1.1937609; Farwell L, 1998, J PERS, V66, P65, DOI 10.1111/1467-6494.00003; FEINGOLD A, 1994, PSYCHOL BULL, V116, P429, DOI 10.1037/0033-2909.116.3.429; Foster JD, 2003, J RES PERS, V37, P469, DOI 10.1016/S0092-6566(03)00026-6; Frias-Martinez V., 2010, AAAI SPRING S ART IN; Goldberg L.R., 1981, REV PERSONAL SOC PSY, V2, P141, DOI DOI 10.1037/0022-3514.59.6.1216; Goodreau SM, 2009, DEMOGRAPHY, V46, P103, DOI 10.1353/dem.0.0045; Grijalva E, 2015, PSYCHOL BULL, V141, P261, DOI 10.1037/a0038231; HANSON S, 1980, GEOGR REV, V70, P291, DOI 10.2307/214257; John O.P., 1999, HDB PERSONALITY THEO, V1999, P102, DOI DOI 10.1037/A0019265; Kalish Y, 2006, SOC NETWORKS, V28, P56, DOI 10.1016/j.socnet.2005.04.004; Kang C., 2010, 2010 35th International Conference on Infrared, Millimeter, and Terahertz Waves (IRMMW-THz 2010), DOI 10.1109/ICIMW.2010.5612960; Kling KC, 1999, PSYCHOL BULL, V125, P470, DOI 10.1037/0033-2909.125.4.470; Kossinets G, 2009, AM J SOCIOL, V115, P405, DOI 10.1086/599247; Kovanen L, 2013, P NATL ACAD SCI USA, V110, P18070, DOI 10.1073/pnas.1307941110; Kwan MP, 2000, TRANSPORT RES C-EMER, V8, P185, DOI 10.1016/S0968-090X(00)00017-6; Laniado D, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0080-6; Law R, 1999, PROG HUM GEOG, V23, P567, DOI 10.1191/030913299666161864; Lefcourt H.M., 2013, RES LOCUS CONTROL CO; Leskovec J., 2008, P 17 INT C WORLD WID, P915, DOI [10.1145/1367497.1367620, DOI 10.1145/1367497.1367620]; Lewis K, 2008, SOC NETWORKS, V30, P330, DOI 10.1016/j.socnet.2008.07.002; Lurie I., 1995, BRIT J GUID COUNS, V23, P231, DOI [DOI 10.1080/03069889508253008, https://doi.org/10.1080/03069889508253008]; Maccoby EE, 1974, PSYCHOL SEX DIFFEREN, VI; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Misra R., 2000, AM J HLTH STUDIES, V16, P41, DOI DOI 10.4236/CE.2015.61007; Misra R., 2000, COLL STUDENT J, V34, P236; NETO F, 1993, J YOUTH ADOLESCENCE, V22, P125, DOI 10.1007/BF01536648; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Onnela JP, 2014, SCI REPORTS, V4; Palchykov Vasyl, 2012, Sci Rep, V2, P370, DOI 10.1038/srep00370; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pentland A, 2015, ARXIV151106660; Polk M, P 2 NAT C WOM TRAV I; Rakow L., 1992, GENDER LINE WOMEN TE; Reeder HM, 2003, SEX ROLES, V49, P143, DOI 10.1023/A:1024408913880; Reisberg D., 1997, COGNITION EXPLORING; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1515/9781400876136; Rosenbloom S, 2000, WOM TRAV ISS 2 NAT C; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Rubinstein G, 2005, PERS INDIV DIFFER, V38, P1495, DOI 10.1016/j.paid.2004.09.012; RUSSELL D, 1978, J PERS ASSESS, V42, P290, DOI 10.1207/s15327752jpa4203_11; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168; Schmitt DP, 2007, J CROSS CULT PSYCHOL, V38, P173, DOI 10.1177/0022022106297299; Schultz D. P., 2016, THEORIES PERSONALITY; Sekara V., 2015, ARXIV150604704; Sheldon P., 2008, J MEDIA PSYCHOL-GER, V20, P67, DOI [https://doi.org/10.1027/1864-1105.20.2.67, DOI 10.1027/1864-1105.20.2.67]; Smoreda Z, 2000, SOC PSYCHOL QUART, V63, P238, DOI 10.2307/2695871; Stoicaa A, 2010, AGE GENDER COMMUNICA; STRICKLAND BR, 1980, J PERS SOC PSYCHOL, V39, P930, DOI 10.1037/0022-3514.39.5.930; Szell M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01214; Thelwall M, 2008, J AM SOC INF SCI TEC, V59, P1321, DOI 10.1002/asi.20835; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Twenge JM, 2003, PERS SOC PSYCHOL B, V29, P261, DOI 10.1177/0146167202239051; Wang SS, 2013, SOC SCI COMPUT REV, V31, P437, DOI 10.1177/0894439313481424; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Williams JE, 1999, SEX ROLES, V40, P513, DOI 10.1023/A:1018831928829; Wilson RE, 2012, PERSPECT PSYCHOL SCI, V7, P203, DOI 10.1177/1745691612442904; Wind DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149105; Wood J., 2012, GENDERED LIVES	88	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189873	10.1371/journal.pone.0189873	http://dx.doi.org/10.1371/journal.pone.0189873			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ7SY	29261767	Green Published, Green Submitted, gold			2022-12-26	WOS:000418564200070
J	Bright, T; Mulwafu, W; Thindwa, R; Zuurmond, M; Polack, S				Bright, Tess; Mulwafu, Wakisa; Thindwa, Richard; Zuurmond, Maria; Polack, Sarah			Reasons for low uptake of referrals to ear and hearing services for children in Malawi	PLOS ONE			English	Article							HEALTH-SERVICES; BARRIERS; IMPAIRMENT; EMPLOYMENT; CLUBFOOT; ACCESS; IMPACT; CARE	Background Early detection and appropriate intervention for children with hearing impairment is important for maximizing functioning and quality of life. The lack of ear and hearing services in low income countries is a significant challenge, however, evidence suggests that even where such services are available, and children are referred to them, uptake is low. The aim of this study was to assess uptake of and barriers to referrals to ear and hearing services for children in Thyolo District, Malawi. Methods This was a mixed methods study. A survey was conducted with 170 caregivers of children who were referred for ear and hearing services during community-based screening camps to assess whether they had attended their referral and reasons for non-attendance. Semistructured interviews were conducted with 23 caregivers of children who did not take up their referral to explore in-depth the reasons for non-uptake. In addition, 15 stakeholders were interviewed. Thematic analysis of the interview data was conducted and emerging trends were analysed. Results Referral uptake was very low with only 5 out of 150 (3%) children attending. Seven main interacting themes for non-uptake of referral were identified in the semi-structured interviews: location of the hospital, lack of transport, other indirect costs of seeking care, fear and uncertainty about the referral hospital, procedural problems within the camps, awareness and understanding of hearing loss, and lack of visibility and availability of services. Conclusion This study has highlighted a range of interacting challenges faced by families in accessing ear and hearing services in this setting. Understanding these context specific barriers to non-uptake of ear and hearing services is important for designing appropriate interventions to increase uptake.	[Bright, Tess; Zuurmond, Maria; Polack, Sarah] London Sch Hyg & Trop Med, London, England; [Mulwafu, Wakisa; Thindwa, Richard] Queen Elizabeth Cent Hosp, Ear Nose & Throat Dept, Blantyre, Malawi	University of London; London School of Hygiene & Tropical Medicine; University of Malawi	Bright, T (corresponding author), London Sch Hyg & Trop Med, London, England.	tess.bright@lshtm.ac.uk			Christoffel Blinden Mission	Christoffel Blinden Mission	This study was funded by Christoffel Blinden Mission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajibode Ha, 2012, J West Afr Coll Surg, V2, P38; Al Habashneh R, 2012, INT J DENT HYG, V10, P259, DOI 10.1111/j.1601-5037.2012.00545.x; Angama L, 2015, PHYSIOTHERAPY UK, V101, peS77; Bedford KJA, 2011, TROP DOCT, V41, P211, DOI 10.1258/td.2011.110121; Boyer CA, 2010, J HEALTH SOC BEHAV, V51, pS80, DOI 10.1177/0022146510383489; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bright T, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2180-9; Garramiola-Bilbao I, 2016, PUBLIC HEALTH, V141, P130, DOI 10.1016/j.puhe.2016.09.013; Gourlay A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106325; Islam SMS, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0081-9; Jackson CW, 2004, TOP EARLY CHILD SPEC, V24, P15, DOI 10.1177/02711214040240010201; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; KALUA K, 2014, HUM RESOUR HEALTH S1, V12; Kazibwe H, 2009, TROP DOCT, V39, P15, DOI 10.1258/td.2008.080178; Marmamula S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005125; Murthy GVS, 2014, ARCH DIS CHILDHOOD; Olusanya BO, 2014, B WORLD HEALTH ORGAN, V92, P367, DOI 10.2471/BLT.13.128728; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Schwering MS, 2014, OPHTHAL EPIDEMIOL, V21, P138, DOI 10.3109/09286586.2014.892139; Seidenberg PD, 2012, AM J TROP MED HYG, V87, P105, DOI 10.4269/ajtmh.2012.11-0799; Smith E, 2004, DISABIL REHABIL, V26, P121, DOI 10.1080/09638280310001629651; Stevens G, 2013, EUR J PUBLIC HEALTH, V23, P146, DOI 10.1093/eurpub/ckr176; The DHS Program, 2017, MAL DEM HLTH SURV 20; The World Bank, MAL 2015; Venail F, 2010, ARCH OTOLARYNGOL, V136, P366, DOI 10.1001/archoto.2010.31; World Health Organization, CHILDH HEAR LOSS 201; World Health Organization, PRIM EAR HEAR CAR TR; World Health Organization, MULT COUNTR ASS NAT; World Health Organization, MULTICOUNTRY ASSESSM; World Health Organization, DEAFN HEAR LOSS 2015; World Health Organization, 2017, PRIM EAR HEAR CAR 20; Zhang XJ, 2014, OPHTHAL EPIDEMIOL, V21, P153, DOI 10.3109/09286586.2014.903981	32	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0188703	10.1371/journal.pone.0188703	http://dx.doi.org/10.1371/journal.pone.0188703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ7PP	29261683	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000418554900011
J	Jeffery, HC; McDowell, P; Lutz, P; Wawman, RE; Roberts, S; Bagnall, C; Birtwistle, J; Adams, DH; Oo, YH				Jeffery, Hannah C.; McDowell, Patrick; Lutz, Philipp; Wawman, Rebecca E.; Roberts, Sheree; Bagnall, Chris; Birtwistle, Jane; Adams, David H.; Oo, Ye Htun			Human intrahepatic ILC2 are IL-13(positive) amphiregulin(positive) and their frequency correlates with model of end stage liver disease score	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; PROSTAGLANDIN D-2 RECEPTOR; GROWTH-FACTOR-RECEPTOR; T-CELLS; CRTH2; ACTIVATION; PROMOTES; SURVIVAL; T(H)2; INFLAMMATION	Introduction Innate lymphoid cells (ILC) have been implicated in the initiation of inflammation and fibrosis in mice. However, ILC have not been characterized in inflamed human liver tissue. Methods Human intrahepatic lymphocytes were isolated by mechanical digestion and phenotyped by flow cytometry. Conditioned medium from cultures of primary human biliary epithelial cells, stellate cells, fibroblasts and inflamed human liver tissue was used to model the effects of the inflammatory liver environment of ILC phenotype and function. Results All three ILC subsets were present in the human liver, with the ILC1 (CRTH2(neg)CD117(neg)) subset constituting around 70% of intrahepatic ILCs. Both NCRpos (NKp44(+)) and NCRneg ILC3 (CRTH2(neg) CD117(pos)) subsets were also detected. ILC2 (CRTH2(pos)) frequency correlated with disease severity measured by model of end stage liver disease (MELD) scoring leading us to study this subset in more detail. ILC2 displayed a tissue resident CD69(+) CD161(++) phenotype and expressed chemokine receptor CCR6 allowing them to respond to CCL20 secreted by cholangiocytes and stellate cells. ILC2 expressed integrins VLA-5 and VLA-6 and the IL-2 and IL-7 cytokine receptors CD25 and CD127 although IL-2 and IL-7 were barely detectable in inflamed liver tissue. Although biliary epithelial cells secrete IL-33, intrahepatic ILC2 had low expression of the ST2 receptor. Intrahepatic ILC2 secreted the immunoregulatory and repair cytokines IL-13 and amphiregulin. Conclusions Intrahepatic ILC2 express receptors allowing them to be recruited to bile ducts in inflamed portal tracts. Their frequencies increased with worsening liver function. Their secretion of IL-13 and amphiregulin suggests they may be recruited to promote resolution and repair and thereby they may contribute to ongoing fibrogenesis in liver disease.	[Jeffery, Hannah C.; McDowell, Patrick; Lutz, Philipp; Wawman, Rebecca E.; Roberts, Sheree; Adams, David H.; Oo, Ye Htun] Univ Birmingham, Ctr Liver Res, Birmingham, W Midlands, England; [Jeffery, Hannah C.; McDowell, Patrick; Lutz, Philipp; Wawman, Rebecca E.; Roberts, Sheree; Adams, David H.; Oo, Ye Htun] Univ Birmingham, Birmingham Biomed Res Ctr, Natl Inst Hlth Res, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England; [Lutz, Philipp] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Wawman, Rebecca E.] Coventry Univ, Fac Hlth & Life Sci, Sch Life Sci, Coventry, W Midlands, England; [Bagnall, Chris] Univ Birmingham, Human Biomat Resource Ctr, Birmingham, W Midlands, England; [Birtwistle, Jane] Univ Birmingham NHS Fdn Trust, Clin Immunol Dept, Birmingham, W Midlands, England; [Adams, David H.; Oo, Ye Htun] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Bonn; Coventry University; University of Birmingham; University of Birmingham; University of Birmingham	Oo, YH (corresponding author), Univ Birmingham, Ctr Liver Res, Birmingham, W Midlands, England.; Oo, YH (corresponding author), Univ Birmingham, Birmingham Biomed Res Ctr, Natl Inst Hlth Res, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England.; Oo, YH (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England.	y.h.oo@bham.ac.uk	Adams, David H/C-9092-2009; Oo, Ye Htun/AFC-8888-2022	Adams, David H/0000-0001-6776-0336; Oo, Ye Htun/0000-0002-0495-6734	Clinician Scientist Award from the Medical Research Council [G1002552]; Queen Elizabeth Hospital Charity; National Institute for Health Research Birmingham Biomedical Research Unit, Birmingham; NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust; University of Birmingham; MRC [G0400496, MR/M009157/1, G0700301, G0300102, G1002552, G0300101, G0802577, MC_PC_14123] Funding Source: UKRI; Medical Research Council [G0300101, G0300102, MR/M009157/1, MC_PC_14123, G1002552, G0400496, G0802577, G0700301] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10080, NF-SI-0616-10012] Funding Source: researchfish	Clinician Scientist Award from the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Queen Elizabeth Hospital Charity; National Institute for Health Research Birmingham Biomedical Research Unit, Birmingham; NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust; University of Birmingham; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Y. H. O and H. C. J. are funded by Clinician Scientist Award from the Medical Research Council (G1002552), Queen Elizabeth Hospital Charity and National Institute for Health Research Birmingham Biomedical Research Unit, Birmingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This paper presents independent research supported by the NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham.	Afford SC, 2001, FASEB J, V15, P2345, DOI 10.1096/fj.01-0088com; Balmer ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008618; Berasain C, 2005, GASTROENTEROLOGY, V128, P424, DOI 10.1053/j.gastro.2004.11.006; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Chen YY, 2016, HEPATOLOGY, V64, P138, DOI 10.1002/hep.28517; Duerr CU, 2016, NAT IMMUNOL, V17, P65, DOI 10.1038/ni.3308; Forkel M, 2017, EUR J IMMUNOL, V47, P1280, DOI 10.1002/eji.201646890; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gervais FG, 2001, J ALLERGY CLIN IMMUN, V108, P982, DOI 10.1067/mai.2001.119919; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Hirai H, 2002, J IMMUNOL, V168, P981, DOI 10.4049/jimmunol.168.3.981; Holt AP, 2009, GASTROENTEROLOGY, V136, P705, DOI 10.1053/j.gastro.2008.10.020; Ito H, 2012, J AM SOC NEPHROL, V23, P1797, DOI 10.1681/ASN.2012020126; Jeffery HC, 2015, J HEPATOL; Kim MH, 2015, IMMUNITY, V43, P107, DOI 10.1016/j.immuni.2015.06.009; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Lam EPS, 2016, J ALLERGY CLIN IMMUN, V137, P1514, DOI 10.1016/j.jaci.2015.10.019; LEWIS RA, 1982, J IMMUNOL, V129, P1627; Li J, 2014, J CLIN INVEST, V124, P3241, DOI 10.1172/JCI73742; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Maruyama T, 2008, EUR J PHARMACOL, V591, P237, DOI 10.1016/j.ejphar.2008.06.037; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mohapatra A, 2016, MUCOSAL IMMUNOL, V9, P275, DOI 10.1038/mi.2015.59; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; Monticelli LA, 2012, CURR OPIN IMMUNOL, V24, P284, DOI 10.1016/j.coi.2012.03.012; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nakazawa K, 2005, J PATHOL, V206, P356, DOI 10.1002/path.1779; Neumann K, 2017, J IMMUNOL, V198, P128, DOI 10.4049/jimmunol.1600418; NOWAK D, 1993, EUR RESPIR J, V6, P405; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oo YH, 2010, J AUTOIMMUN, V34, P45, DOI 10.1016/j.jaut.2009.07.011; Oo YH, 2010, J IMMUNOL, V184, P2886, DOI 10.4049/jimmunol.0901216; Oo YH, 2012, J HEPATOL, V57, P1044, DOI 10.1016/j.jhep.2012.07.008; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Sonnenberg Gregory F, 2013, Immunity, V39, P622, DOI 10.1016/j.immuni.2013.08.021; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Sugita K., 2017, J ALLERGY CLIN IMMUN; Thome JJC, 2015, TRENDS IMMUNOL, V36, P428, DOI 10.1016/j.it.2015.05.003; Trussoni CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125793; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553; Vinall SL, 2007, IMMUNOLOGY, V121, P577, DOI 10.1111/j.1365-2567.2007.02606.x; Wills-Karp M, 2011, NAT IMMUNOL, V12, P1025, DOI 10.1038/ni.2142; Wohlfahrt T, 2016, ANN RHEUM DIS, V75, P623, DOI 10.1136/annrheumdis-2015-207388; Wojno EDT, 2015, MUCOSAL IMMUNOL, V8, P1313, DOI 10.1038/mi.2015.21; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056; Zhou Y, 2012, J BIOL CHEM, V287, P41991, DOI 10.1074/jbc.M112.356824	58	34	36	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0188649	10.1371/journal.pone.0188649	http://dx.doi.org/10.1371/journal.pone.0188649			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261670	Green Published, Green Submitted, gold			2022-12-26	WOS:000418554900008
J	Ndenga, BA; Mutuku, FM; Ngugi, HN; Mbakaya, JO; Aswani, P; Musunzaji, PS; Vulule, J; Mukoko, D; Kitron, U; LaBeaud, AD				Ndenga, Bryson Alberto; Mutuku, Francis Maluki; Ngugi, Harun Njenga; Mbakaya, Joel Omari; Aswani, Peter; Musunzaji, Peter Siema; Vulule, John; Mukoko, Dunstan; Kitron, Uriel; LaBeaud, Angelle Desiree			Characteristics of Aedes aegypti adult mosquitoes in rural and urban areas of western and coastal Kenya	PLOS ONE			English	Article							LANDING PERIODICITY; DENGUE; DIPTERA; HUMANS; VIRUS; TRANSMISSION; ALBOPICTUS; DIVERSITY; ABUNDANCE; TRINIDAD	Aedes aegypti is the main vector for yellow fever, dengue, chikungunya and Zika viruses. Recent outbreaks of dengue and chikungunya have been reported in Kenya. Presence and abundance of this vector is associated with the risk for the occurrence and transmission of these diseases. This study aimed to characterize the presence and abundance of Ae. aegypti adult mosquitoes from rural and urban sites in western and coastal regions of Kenya. Presence and abundance of Ae. aegypti adult mosquitoes were determined indoors and outdoors in two western (urban Kisumu and rural Chulaimbo) and two coastal (urban Ukunda and rural Msambweni) sites in Kenya. Sampling was performed using quarterly human landing catches, monthly Prokopack automated aspirators and monthly Biogents-sentinel traps. A total of 2,229 adult Ae. aegypti mosquitoes were collected: 785 (35.2%) by human landing catches, 459 (20.6%) by Prokopack aspiration and 985 (44.2%) by Biogents-sentinel traps. About three times as many Ae. aegypti mosquitoes were collected in urban than rural sites (1,650 versus 579). Comparable numbers were collected in western (1,196) and coastal (1,033) sites. Over 80% were collected outdoors through human landing catches and Prokopack aspiration. The probability of collecting Ae. aegypti mosquitoes by human landing catches was significantly higher in the afternoon than morning hours (P<0.001), outdoors than indoors (P<0.001) and in urban than rural sites (P = 0.008). Significantly more Ae. aegypti mosquitoes were collected using Prokopack aspiration outdoors than indoors (P<0.001) and in urban than rural areas (P<0.001). Significantly more mosquitoes were collected using Biogents-sentinel traps in urban than rural areas (P = 0.008) and in western than coastal sites (P = 0.006). The probability of exposure to Ae. aegypti bites was highest in urban areas, outdoors and in the afternoon hours. These characteristics have major implications for the possible transmission of arboviral diseases and for the planning of surveillance and control programs.	[Ndenga, Bryson Alberto; Mbakaya, Joel Omari; Aswani, Peter] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Mutuku, Francis Maluki] Tech Univ Mombasa, Dept Environm & Hlth Sci, Mombasa, Kenya; [Ngugi, Harun Njenga] Chuka Univ, Dept Biol Sci, Chuka, Kenya; [Ngugi, Harun Njenga] Univ Nairobi, Dept Zool, Nairobi, Kenya; [Musunzaji, Peter Siema] Minist Hlth, Vector Borne Dis Control Unit, Msambweni, Kenya; [Vulule, John] Kenya Govt Med Res Ctr, Ctr Infect & Parasit Dis Control Res, Busia, Kenya; [Mukoko, Dunstan] Minist Hlth, Vector Borne Dis Control Unit, Nairobi, Kenya; [Kitron, Uriel] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA; [LaBeaud, Angelle Desiree] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Kenya Medical Research Institute; Technical University of Mombasa; University of Nairobi; Kenya Medical Research Institute; Emory University; Stanford University	Ndenga, BA (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya.	bndenga@yahoo.com	Ngugi, Harun N/I-3863-2015	Ngugi, Harun N/0000-0002-0077-1775; Kitron, Uriel/0000-0003-0493-2043	National Institutes of Health, USA [RO1 AI102918]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102918] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a program award RO1 AI102918 from the National Institutes of Health, USA to Dr. Angelle Desiree LaBeaud. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhwale W., 2013, E AFR PUBLIC HLTH LA, V7, P1; [Anonymous], 2016, DIS OUTBREAK NE 0208; Bhat M. A., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P253; Blaylock JM, 2011, TRAVEL MED INFECT DI, V9, P246, DOI 10.1016/j.tmaid.2011.06.005; Bos R, 1988, PARASIT TODAY, V4; CDC, 2016, MOSQ BIT PREV US; CHADEE DD, 1988, MED VET ENTOMOL, V2, P189, DOI 10.1111/j.1365-2915.1988.tb00071.x; Chadee DD, 2000, J VECTOR ECOL, V25, P158; Chen B, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070712; Chepkorir E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-435; Cigarroa-Toledo N, 2016, EMERG INFECT DIS, V22, P1804, DOI 10.3201/eid2210.152087; Edman JD, 1998, J MED ENTOMOL, V35, P578, DOI 10.1093/jmedent/35.4.578; Ellis EM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003733; Farraudiere L, 2017, REV PANAM SALUD PUBL, V41; Favaro EA, 2006, J VECTOR ECOL, V31, P285, DOI 10.3376/1081-1710(2006)31[285:PSOASA]2.0.CO;2; Ferreira DdaCruz, 2017, PARASIT VECTORS, V1; Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332; Freire M.E., 2014, 7 GROWTH DIAL; Getachew D, 2015, INTERDISCIP PERSPECT; Gillett J. D., 1972, COMMON AFRICAN MOSQU; GOUCK H. K., 1962, FLORIDA ENTOMOL, V45, P93, DOI 10.2307/3492224; Harburguer L, 2011, J MED ENTOMOL, V48, P577, DOI 10.1603/ME10074; Harrington LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003048; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411; Hertz JT, 2016, PATHOG GLOB HEALTH, V110, P108, DOI 10.1080/20477724.2016.1182719; Heydari N, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020196; Higa Yukiko, 2015, Tropical Medicine and Health, V43, P107, DOI 10.2149/tmh.2014-29; Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04; Huang Y, 2004, SUBGENUS STEGOMYIA A; Konongoi L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0641-0; Kraemer M, 2015, ECOL EPID GLOB HLTH; LaBeaud A, 2015, PLOS NEGL TROP DIS, V9; Leisnham P. T., 2014, PLOS ONE, V9; Lounibos LP, 2016, J INFECT DIS, V214, pS453, DOI 10.1093/infdis/jiw285; Lutomiah J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004981; Lutomiah J, 2013, J VECTOR ECOL, V38, P134, DOI 10.1111/j.1948-7134.2013.12019.x; McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964; Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175; Mwangangi JM, 2012, PARASITOL RES, V110, P61, DOI 10.1007/s00436-011-2449-6; Ngugi HN, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2271-9; Ochieng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132645; Orsborne J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152805; Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2; Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395; Saifur RGM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030919; Sanga B, 2017, STANDARD NEWSPAPER; Siriyasatien P, 2010, SE ASIAN J TROP MED, V41, P43; STRAUSS W. G., 1965, MOSQUITO NEWS, V25, P272; Sutherland LJ, 2011, AM J TROP MED HYG, V85, P158, DOI 10.4269/ajtmh.2011.10-0203; Thonnon J, 1998, AM J TROP MED HYG, V59, P108, DOI 10.4269/ajtmh.1998.59.108; United Nations, 2014, DEMOGR RES; Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602; Vu DM, 2017, AM J TROP MED HYG, V96, P141, DOI 10.4269/ajtmh.16-0562; Waggoner J, 2017, MALARIA CHIKUNGUNYA; Wan-Norafikah O, 2012, SAINS MALAYS, V41, P1309; Webb CM, 2012, BRIT J SOC WORK, V42, P1235, DOI 10.1093/bjsw/bcr144; Yalwala S, 2015, J VECTOR ECOL, V40, P301, DOI 10.1111/jvec.12168	58	36	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189971	10.1371/journal.pone.0189971	http://dx.doi.org/10.1371/journal.pone.0189971			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261766	Green Submitted, Green Published, gold			2022-12-26	WOS:000418554900045
J	Arime, Y; Akiyama, K				Arime, Yosefu; Akiyama, Kazufumi			Abnormal neural activation patterns underlying working memory impairment in chronic phencyclidine-treated mice	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; MATCHING-TO-POSITION; NEUROPSYCHOLOGICAL DEFICITS; ANIMAL-MODELS; MOUSE MODEL; SCHIZOPHRENIA; RAT; HIPPOCAMPUS; PERFORMANCE; TASK	Working memory impairment is a hallmark feature of schizophrenia and is thought be caused by dysfunctions in the prefrontal cortex (PFC) and associated brain regions. However, the neural circuit anomalies underlying this impairment are poorly understood. The aim of this study is to assess working memory performance in the chronic phencyclidine (PCP) mouse model of schizophrenia, and to identify the neural substrates of working memory. To address this issue, we conducted the following experiments for mice after withdrawal from chronic administration (14 days) of either saline or PCP (10 mg/kg): (1) a discrete paired-trial variable-delay task in T-maze to assess working memory, and (2) brain-wide c-Fos mapping to identify activated brain regions relevant to this task performance either 90 min or 0 min after the completion of the task, with each time point examined under working memory effort and basal conditions. Correct responses in the test phase of the task were significantly reduced across delays (5, 15, and 30 s) in chronic PCP-treated mice compared with chronic saline-treated controls, suggesting delay-independent impairments in working memory in the PCP group. In layer 2-3 of the prelimbic cortex, the number of working memory effort-elicited c-Fos+ cells was significantly higher in the chronic PCP group than in the chronic saline group. The main effect of working memory effort relative to basal conditions was to induce significantly increased c-Fos+ cells in the other layers of prelimbic cortex and the anterior cingulate and infralimbic cortex regardless of the different chronic regimens. Conversely, this working memory effort had a negative effect (fewer c-Fos+ cells) in the ventral hippocampus. These results shed light on some putative neural networks relevant to working memory impairments in mice chronically treated with PCP, and emphasize the importance of the layer 2-3 of the prelimbic cortex of the PFC.	[Arime, Yosefu; Akiyama, Kazufumi] Dokkyo Med Univ, Sch Med, Dept Biol Psychiat & Neurosci, Mibu, Tochigi, Japan	Dokkyo Medical University	Arime, Y (corresponding author), Dokkyo Med Univ, Sch Med, Dept Biol Psychiat & Neurosci, Mibu, Tochigi, Japan.	yarime@dokkyomed.ac.jp			JSPS KAKENHI [23890200, 26860942, 17K16397]; Dokkyo Medical University [2012-01-3, 2015-04]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Dokkyo Medical University	This work was supported by JSPS KAKENHI (Grant Numbers 23890200, 26860942, and 17K16397 to YA) and Dokkyo Medical University Investigator-Initiated Research Grant (No. 2012-01-3 and 2015-04 to YA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhlaghpour H, 2016, ELIFE, V5, DOI 10.7554/eLife.19507; Arnsten AFT, 2014, PROG MOL BIOL TRANSL, V122, P211, DOI 10.1016/B978-0-12-420170-5.00008-8; Artigas F, 2016, NAT REV DRUG DISCOV; Aultman JM, 2001, PSYCHOPHARMACOLOGY, V153, P353, DOI 10.1007/s002130000590; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; BREIER A, 1991, ARCH GEN PSYCHIAT, V48, P239; Castane A, 2015, PSYCHOPHARMACOLOGY, V232, P4085, DOI 10.1007/s00213-015-3946-6; Chaudhuri A, 1997, NEUROREPORT, V8, pR3, DOI 10.1097/00001756-199709080-00002; Chaudhuri A, 2000, ACTA NEUROBIOL EXP, V60, P403; Chudasama Y, 1997, PSYCHOPHARMACOLOGY, V134, P73, DOI 10.1007/s002130050427; Davidson M, 1999, AM J PSYCHIAT, V156, P1328; Dudchenko PA, 2013, NEUROSCI BIOBEHAV R, V37, P2111, DOI 10.1016/j.neubiorev.2012.03.003; Fritts ME, 1998, PHYSIOL BEHAV, V64, P373, DOI 10.1016/S0031-9384(98)00096-1; Fujisawa S, 2011, NEURON, V72, P153, DOI 10.1016/j.neuron.2011.08.018; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Green MF, 1996, AM J PSYCHIAT, V153, P321; Griffin AL, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00029; Hart G, 2014, NEUROBIOL LEARN MEM, V108, P104, DOI 10.1016/j.nlm.2013.11.003; Harvey PD, 1998, AM J PSYCHIAT, V155, P1080, DOI 10.1176/ajp.155.8.1080; HEATON R, 1994, ARCH GEN PSYCHIAT, V51, P469; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Hembrook JR, 2012, HIPPOCAMPUS, V22, P853, DOI 10.1002/hipo.20945; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Huang H, 2006, J NEUROPHYSIOL, V95, P1656, DOI 10.1152/jn.00927.2005; Hyman SE, 2003, SCIENCE, V299, P350, DOI 10.1126/science.1077141; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Jentsch J D, 1998, Adv Pharmacol, V42, P810; Jentsch JD, 1997, NEUROPSYCHOPHARMACOL, V17, P92, DOI 10.1016/S0893-133X(97)00034-1; Jin JJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00170; Jones CA, 2011, BRIT J PHARMACOL, V164, P1162, DOI 10.1111/j.1476-5381.2011.01386.x; Kristiansen LV, 2007, CURR OPIN PHARMACOL, V7, P48, DOI 10.1016/j.coph.2006.08.013; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Lee JH, 2005, J ABNORM PSYCHOL, V114, P599, DOI 10.1037/0021-843X.114.4.599; LUBY ED, 1959, ARCH NEURO PSYCHIATR, V81, P363, DOI 10.1001/archneurpsyc.1959.02340150095011; Mailly P, 2013, J NEUROSCI, V33, P5718, DOI 10.1523/JNEUROSCI.5248-12.2013; Mair RG, 2002, J NEUROSCI, V22, P6756; Malhotra AK, 1996, NEUROPSYCHOPHARMACOL, V14, P301, DOI 10.1016/0893-133X(95)00137-3; Mao JB, 1998, BRAIN RES, V784, P139, DOI 10.1016/S0006-8993(97)01324-3; Marquis JP, 2007, PROG NEURO-PSYCHOPH, V31, P1108, DOI 10.1016/j.pnpbp.2007.03.017; Matsuo N, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.003.2009; Moghaddam B, 2012, NEUROPSYCHOPHARMACOL, V37, P4, DOI 10.1038/npp.2011.181; Mouri A, 2007, NEUROCHEM INT, V51, P173, DOI 10.1016/j.neuint.2007.06.019; O'Neill PK, 2013, J NEUROSCI, V33, P14211, DOI 10.1523/JNEUROSCI.2378-13.2013; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pratt J, 2012, NAT REV DRUG DISCOV, V11, P560, DOI 10.1038/nrd3649; Qiao H, 2001, NEUROREPORT, V12, P11, DOI 10.1097/00001756-200101220-00010; Robinson JK, 1997, BRAIN RES, V765, P51, DOI 10.1016/S0006-8993(97)00426-5; Romanides AJ, 1999, NEUROSCIENCE, V92, P97, DOI 10.1016/S0306-4522(98)00747-7; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; Scheggia D, 2014, BIOL PSYCHIAT, V75, P660, DOI 10.1016/j.biopsych.2013.05.021; Schobel SA, 2013, NEURON, V78, P81, DOI 10.1016/j.neuron.2013.02.011; Seillier A, 2009, BEHAV BRAIN RES, V204, P410, DOI 10.1016/j.bbr.2009.02.007; Sigurdsson T, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00190; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Stefani MR, 2002, BEHAV BRAIN RES, V134, P267, DOI 10.1016/S0166-4328(02)00040-2; Tamura M, 2016, NEURON, V89, P1100, DOI 10.1016/j.neuron.2016.01.025; Vertes RP, 2015, NEUROSCI BIOBEHAV R, V54, P89, DOI 10.1016/j.neubiorev.2015.01.014; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Yang ST, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0061-2; Yoon T, 2008, LEARN MEMORY, V15, P97, DOI 10.1101/lm.850808; Zangenehpour S, 2002, MOL BRAIN RES, V109, P221, DOI 10.1016/S0169-328X(02)00556-9	62	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189287	10.1371/journal.pone.0189287	http://dx.doi.org/10.1371/journal.pone.0189287			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253020	Green Submitted, Green Published, gold			2022-12-26	WOS:000418389500020
J	Bohman, A; Juodakis, J; Oscarsson, M; Bacelis, J; Bende, M; Naluai, AT				Bohman, Anton; Juodakis, Julius; Oscarsson, Martin; Bacelis, Jonas; Bende, Mats; Naluai, Asa Torinsson			A family-based genome-wide association study of chronic rhinosinusitis with nasal polyps implicates several genes in the disease pathogenesis	PLOS ONE			English	Article							EXACERBATED RESPIRATORY-DISEASE; CYSTIC-FIBROSIS; ASTHMATIC-PATIENTS; POPULATION; POLYMORPHISMS; PREVALENCE; SINUSITIS; CELLS; CFTR; IDENTIFICATION	Background The pathogenesis of chronic rhinosinusitis with nasal polyps is largely unknown. Previous studies have given valuable information about genetic variants associated with this disease but much is still unexplained. Our goal was to identify genetic markers and genes associated with susceptibility to chronic rhinosinusitis with nasal polyps using a family-based genome-wide association study. Methods 427 patients (293 males and 134 females) with CRSwNP and 393 controls (175 males and 218 females) were recruited from several Swedish hospitals. SNP association values were generated using DFAM (implemented in PLINK) and Efficient Mixed Model Association eXpedited (EMMAX). Analyses of pathway enrichment, gene expression levels and expression quantitative trait loci were then performed in turn. Results None of the analysed SNPs reached genome wide significant association of 5.0 x 10-(8). Pathway analyses using our top 1000 markers with the most significant association p-values resulted in 138 target genes. A comparison between our target genes and gene expression data from the NCBI Gene Expression Omnibus database showed significant overlap for 36 of these genes. Comparisons with data from expression quantitative trait loci showed the most skewed allelic distributions in cases with chronic rhinosinusitis with nasal polyps compared with controls for the genes HLCS, HLA-DRA, BICD2, VSIR and SLC5A1. Conclusion Our study indicates that HLCS, HLA-DRA, BICD2, VSIR and SLC5A1 could be involved in the pathogenesis of chronic rhinosinusitis with nasal polyps. HLA-DRA has been associated with chronic rhinosinusitis with nasal polyps in previous studies and HLCS, BICD2, VSIR and SLC5A1 may be new targets for future research.	[Bohman, Anton] Uppsala Univ Hosp, Dept Otorhinolaryngol, Uppsala, Sweden; [Juodakis, Julius; Bacelis, Jonas] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden; [Oscarsson, Martin; Bende, Mats] Skaraborg Hosp, Dept Otorhinolaryngol, Skovde, Sweden; [Naluai, Asa Torinsson] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden	Uppsala University; Uppsala University Hospital; University of Gothenburg; University of Gothenburg	Bohman, A (corresponding author), Uppsala Univ Hosp, Dept Otorhinolaryngol, Uppsala, Sweden.	anton.bohman@gmail.com	Naluai, Åsa Torinsson/AAB-2166-2021; Naluai, Åsa Torinsson/P-3269-2015	Naluai, Åsa Torinsson/0000-0002-0504-6492; Naluai, Åsa Torinsson/0000-0002-0504-6492; Juodakis, Julius/0000-0001-5600-974X	Hospital of Skaraborg [VGSKAS 257221, VGSKAS 478801, VGSKAS 386021]; Health and Medical Care Committee of the Regional Executive board, Region Vastra Gotaland [VGFOUREG-373761, VGFOUREG-73101]; Foundation of Acta Oto-Laryngologica; ENT Foundation; VBG Group Centre for Asthma and Allergy Research; Gothenburg Genomic Core Facility; Science for Life Laboratory SNP&SEQ Technology Platform in Uppsala; Biobanking and Molecular Resource Infrastructure (BBMRI.se)	Hospital of Skaraborg; Health and Medical Care Committee of the Regional Executive board, Region Vastra Gotaland; Foundation of Acta Oto-Laryngologica; ENT Foundation; VBG Group Centre for Asthma and Allergy Research; Gothenburg Genomic Core Facility; Science for Life Laboratory SNP&SEQ Technology Platform in Uppsala; Biobanking and Molecular Resource Infrastructure (BBMRI.se)	This work was supported by: The Hospital of Skaraborg (http://www.vgregion./se/Skaraborgs-sjukhus/Skaraborgssjukhus/Welcome-to-Skaraborg-Hospital/), numbers VGSKAS 257221, VGSKAS 478801 and VGSKAS 386021 (MB); The Health and Medical Care Committee of the Regional Executive board, Region Vastra Gotaland (http://www.vgregion.se/en/VastraGotalandsregionen/Home/Governance/Namnder-och-styrelser/The-RegionalExecutive-Board/), numbers VGFOUREG-373761 and VGFOUREG-73101 (MB); The Foundation of Acta Oto-Laryngologica (http://www.ibohlin.se/acta/), no number available, grant issued 14th Dec 2010 (MB); The ENT Foundation, no number or website available, grant issued 2012 (MB); and VBG Group Centre for Asthma and Allergy Research (http://krefting.gu.se/KRC), no grant number available, grant issued 2009 (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Gothenburg Genomic Core Facility, the Science for Life Laboratory SNP&SEQ Technology Platform in Uppsala and the Biobanking and Molecular Resource Infrastructure (BBMRI.se) for support. Furthermore, the authors are grateful to Christel Larson for organizing the meetings with all of the test subjects. This study would not be possible without the generous participation of all the families and patients who contributed to the study.	Alexiou A, 2011, J OTOLARYNGOL-HEAD N, V40, P58, DOI 10.2310/7070.2010.100056; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Beck LA, 1996, J ALLERGY CLIN IMMUN, V98, P766, DOI 10.1016/S0091-6749(96)70126-4; Bernstein JM, 2009, LARYNGOSCOPE, V119, P1258, DOI 10.1002/lary.20239; Bohman A, 2015, RHINOLOGY, V53, P25, DOI [10.4193/Rhin14.032, 10.4193/Rhino14.032]; Bosse Y, 2009, HUM GENET, V125, P305, DOI 10.1007/s00439-009-0626-9; Burdett T, 2015, NHGRI EBI CATALOG PU; Chao PZ, 2012, EUR ARCH OTO-RHINO-L, V269, P2343, DOI 10.1007/s00405-012-1927-5; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Cohen NA, 2006, OTOLARYNG HEAD NECK, V134, P601, DOI 10.1016/j.otohns.2005.11.042; Esmaeilzadeh H, 2015, AM J RHINOL ALLERGY, V29, pE63, DOI 10.2500/ajra.2015.29.4154; Fajardo-Dolci G, 2006, OTOLARYNG HEAD NECK, V135, P243, DOI 10.1016/j.otohns.2006.03.034; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hedman J, 1999, INT J EPIDEMIOL, V28, P717, DOI 10.1093/ije/28.4.717; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Hopkins C, 2009, CLIN OTOLARYNGOL, V34, P447, DOI 10.1111/j.1749-4486.2009.01995.x; Hsu J, 2013, J ALLERGY CLIN IMMUN, V131, P977, DOI 10.1016/j.jaci.2013.01.028; Imboden M, 2012, J ALLERGY CLIN IMMUN, V129, P1218, DOI 10.1016/j.jaci.2012.01.074; Johansson L, 2004, ACTA OTO-LARYNGOL, V124, P77, DOI 10.1080/00016480310016037; Johansson L, 2003, ANN OTO RHINOL LARYN, V112, P625, DOI 10.1177/000348940311200709; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Keles B, 2008, OTOLARYNG HEAD NECK, V139, P580, DOI 10.1016/j.otohns.2008.07.002; Kim JH, 2012, AM J RHINOL ALLERGY, V26, P12, DOI 10.2500/ajra.2012.26.3692; Klossek JM, 2005, ALLERGY, V60, P233, DOI 10.1111/j.1398-9995.2005.00688.x; Kuchynkova Z, 1995, Cas Lek Cesk, V134, P212; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Lines JL, 2014, CANCER RES, V74, P1924, DOI 10.1158/0008-5472.CAN-13-1504; Mailleau C, 1998, J CELL PHYSIOL, V176, P472, DOI 10.1002/(SICI)1097-4652(199809)176:3<472::AID-JCP4>3.3.CO;2-2; Meth MJ, 2009, J ALLERGY CLIN IMMUN, V123, pS159, DOI 10.1016/j.jaci.2008.12.598; Molnar-Gabor E, 2000, LARYNGOSCOPE, V110, P422, DOI 10.1097/00005537-200003000-00017; MOLONEY JR, 1980, CLIN OTOLARYNGOL, V5, P183, DOI 10.1111/j.1365-2273.1980.tb01645.x; OAKLEY GM, 2015, INT FORUM ALLERGY RH; Oates EC, 2013, AM J HUM GENET, V92, P965, DOI 10.1016/j.ajhg.2013.04.018; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; Palikhe NS, 2010, ALLERGY ASTHMA IMMUN, V2, P134, DOI 10.4168/aair.2010.2.2.134; Pinto JM, 2008, LARYNGOSCOPE, V118, P2067, DOI 10.1097/MLG.0b013e3181805147; Plager DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011450; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rajan JP, 2015, J ALLERGY CLIN IMMUN, V135, P676, DOI 10.1016/j.jaci.2014.08.020; Ramasamy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044008; RAMSEY B, 1992, J ALLERGY CLIN IMMUN, V90, P547, DOI 10.1016/0091-6749(92)90183-3; Sahlstrand-Johnson P, 2011, RHINOLOGY, V49, P420, DOI 10.4193/Rhino11.101; Sakr MA, 2010, CANCER SCI, V101, P2368, DOI 10.1111/j.1349-7006.2010.01675.x; Schubert MS, 2004, J ALLERGY CLIN IMMUN, V114, P1376, DOI 10.1016/j.jaci.2004.08.029; Sitarek P, 2012, DNA CELL BIOL, V31, P1258, DOI 10.1089/dna.2011.1453; Munoz AT, 2008, ACTA OTORRINOLAR ESP, V59, P438; VARON R, 1995, HUM MOL GENET, V4, P1463, DOI 10.1093/hmg/4.8.1463; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wilson KF, 2014, INT FORUM ALLERGY RH, V4, P93, DOI 10.1002/alr.21258; Xue J, 2013, AM J PHYSIOL-CELL PH, V305, pC1240, DOI 10.1152/ajpcell.00279.2013; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zielinska-Blizniewska H, 2012, MOL BIOL REP, V39, P5449, DOI 10.1007/s11033-011-1345-6	53	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0185244	10.1371/journal.pone.0185244	http://dx.doi.org/10.1371/journal.pone.0185244			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253858	Green Published, gold, Green Submitted			2022-12-26	WOS:000418389500002
J	Chen, JA; Liu, XX; Li, FF; Li, YX; Yuan, DB				Chen, Jiao; Liu, Xixia; Li, Fenfang; Li, Yixing; Yuan, Debao			Cold shock treatment extends shelf life of naturally ripened or ethylene-ripened avocado fruits	PLOS ONE			English	Article							PERSEA-AMERICANA MILL.; CHILLING INJURY; HASS AVOCADOS; QUALITY; 1-METHYLCYCLOPROPENE; STORAGE; POLYGALACTURONASE; CELLULASE	Avocado is an important tropical fruit with high commercial value, but has a relatively short storage life. In this study, the effects of cold shock treatment (CST) on shelf life of naturally ripened and ethylene-ripened avocado fruits were investigated. Fruits were immersed in ice water for 30 min, then subjected to natural or ethylene-induced ripening. Fruit color; firmness; respiration rate; ethylene production; and the activities of polygalacturonase (PG), pectin methylesterase (PME), and endo-beta-1,4-glucanase were measured. Immersion in ice water for 30 min effectively delayed ripening-associated processes, including peel discoloration, pulp softening, respiration rate, and ethylene production during shelf life. The delay in fruit softening by CST was associated with decreased PG and endo-beta-1,4-glucanase activities, but not PME activity. This method could potentially be a useful postharvest technology to extend shelf life of avocado fruits.	[Chen, Jiao; Li, Fenfang; Li, Yixing; Yuan, Debao] Chinese Acad Trop Agr Sci, Hainan Key Lab Banana Genet Improvement, Haikou Expt Stn, Haikou, Hainan, Peoples R China; [Liu, Xixia] Hubei Normal Univ, Hubei Key Lab Edible Wild Plants Conservat & Util, Huangshi, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Hubei Normal University	Yuan, DB (corresponding author), Chinese Acad Trop Agr Sci, Hainan Key Lab Banana Genet Improvement, Haikou Expt Stn, Haikou, Hainan, Peoples R China.	yuandebao@163.com			Chinese Academy of Tropical Agricultural Sciences [1630062015024, 17CXTD-20]; Foundation of Key Laboratory of Plant Resources Conservation and Sustainable Utilization in South China Botanical Garden of Chinese Academy of Science; open foundation of Edible Wild Plants Conservation and Utilization of Hubei Key Laboratory [EWPL201506]	Chinese Academy of Tropical Agricultural Sciences; Foundation of Key Laboratory of Plant Resources Conservation and Sustainable Utilization in South China Botanical Garden of Chinese Academy of Science; open foundation of Edible Wild Plants Conservation and Utilization of Hubei Key Laboratory	This work was supported by the Fund of the Chinese Academy of Tropical Agricultural Sciences (Grant No. 1630062015024) to JC and (Grant No. 17CXTD-20) to DY, the Foundation of Key Laboratory of Plant Resources Conservation and Sustainable Utilization in South China Botanical Garden of Chinese Academy of Science to DY, and the open foundation of Edible Wild Plants Conservation and Utilization of Hubei Key Laboratory (Grant No. EWPL201506) to DY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins ME, 2005, POSTHARVEST BIOL TEC, V35, P33, DOI 10.1016/j.postharvbio.2004.05.021; Ahmed DM, 2010, AGR BIOL J N AM, V1, P878, DOI DOI 10.5251/ABJNA.2010.1.5.878.885; Alique R, 2005, POSTHARVEST BIOL TEC, V35, P153, DOI 10.1016/j.postharvbio.2004.07.003; Arpaia ML, 2015, POSTHARVEST BIOL TEC, V110, P149, DOI 10.1016/j.postharvbio.2015.07.016; AWAD M, 1979, PLANT PHYSIOL, V64, P306, DOI 10.1104/pp.64.2.306; Barry GH, 2006, POSTHARVEST BIOL TEC, V40, P82, DOI 10.1016/j.postharvbio.2005.12.003; Bennett AB, 2008, PLANT SCI, V175, P130, DOI 10.1016/j.plantsci.2008.03.004; Bhalerao P. P., 2010, International Journal of Processing and Post Harvest Technology, V1, P111; Bill M, 2014, FOOD REV INT, V30, P169, DOI 10.1080/87559129.2014.907304; Chen AQ, 2015, SCI HORTIC-AMSTERDAM, V197, P420, DOI 10.1016/j.scienta.2015.09.056; Cox KA, 2004, POSTHARVEST BIOL TEC, V31, P287, DOI 10.1016/j.postharvbio.2003.09.008; DMeyer M, 2017, J SCI FOOD AGR, V97, P3656, DOI 10.1002/jsfa.8225; DURBIN ML, 1988, METHOD ENZYMOL, V160, P342; Evans EA, 2009, ACTA HORTIC, V831, P247; Gaffney J. J., 1975, Proceedings of the Florida State Horticultural Society, V88, P490; HAGERMAN AE, 1986, J AGR FOOD CHEM, V34, P440, DOI 10.1021/jf00069a015; Harpster MH, 1997, PLANT MOL BIOL, V33, P47, DOI 10.1023/A:1005795028489; Hiwasa K, 2003, J EXP BOT, V54, P771, DOI 10.1093/jxb/erg073; Hofman PJ, 2003, POSTHARVEST BIOL TEC, V28, P123, DOI 10.1016/S0925-5214(02)00175-8; Hofman PJ, 2001, AUST J EXP AGR, V41, P567, DOI 10.1071/EA00152; Inaba M., 1986, Proceedings of the Florida State Horticultural Society, V99, P143; Kitinoja L, 2012, ACTA HORTIC, V934, P31; Lu QY, 2009, J AGR FOOD CHEM, V57, P10408, DOI 10.1021/jf901839h; Moya-Leon MA, 2004, POSTHARVEST BIOL TEC, V34, P211, DOI 10.1016/j.postharvbio.2004.05.005; Pacetti D, 2007, J CHROMATOGR A, V1150, P241, DOI 10.1016/j.chroma.2006.10.022; Pathak N, 1998, PHYTOCHEMISTRY, V48, P249, DOI 10.1016/S0031-9422(98)00005-3; Pesis E, 2002, POSTHARVEST BIOL TEC, V24, P171, DOI 10.1016/S0925-5214(01)00134-X; PESIS E, 1978, PLANT PHYSIOL, V61, P416, DOI 10.1104/pp.61.3.416; Sivankalyani V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140522; Vorster L. L., 1987, Yearbook, South African Avocado Growers' Association, V10, P146; Wang DD, 2013, INT J MOL SCI, V14, P23356, DOI 10.3390/ijms141223356; Weinberger Katinka, 2008, International Journal of Postharvest Technology and Innovation, V1, P288, DOI 10.1504/IJPTI.2008.021463; Woolf AB, 2003, POSTHARVEST BIOL TEC, V28, P113, DOI 10.1016/S0925-5214(02)00178-3; Zhang HY, 2010, POSTHARVEST BIOL TEC, V55, P154, DOI 10.1016/j.postharvbio.2009.11.006; Zhang ZK, 2013, POSTHARVEST BIOL TEC, V76, P58, DOI 10.1016/j.postharvbio.2012.09.003; Zhang ZK, 2011, POSTHARVEST BIOL TEC, V60, P83, DOI 10.1016/j.postharvbio.2011.01.001; Zhao Y, 2017, INT J FOOD ENG, V13	37	11	12	8	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189991	10.1371/journal.pone.0189991	http://dx.doi.org/10.1371/journal.pone.0189991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253879	gold, Green Submitted, Green Published			2022-12-26	WOS:000418389500084
J	Dingenouts, CKE; Bakker, W; Lodder, K; Wiesmeijer, KC; Moerkamp, AT; Maring, JA; Arthur, HM; Smits, AM; Goumans, MJ				Dingenouts, Calinda K. E.; Bakker, Wineke; Lodder, Kirsten; Wiesmeijer, Karien C.; Moerkamp, Asja T.; Maring, Janita A.; Arthur, Helen M.; Smits, Anke M.; Goumans, Marie-Jose			Inhibiting DPP4 in a mouse model of HHT1 results in a shift towards regenerative macrophages and reduces fibrosis after myocardial infarction	PLOS ONE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; COLONY-STIMULATING FACTOR; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; ENDOGLIN HETEROZYGOUS MICE; TO-MESENCHYMAL TRANSITION; STEM-CELL THERAPY; TGF-BETA RECEPTOR; E-DEFICIENT MICE; PROGENITOR CELLS; CARDIAC-FUNCTION	Aims Hereditary Hemorrhagic Telangiectasia type-1 (HHT1) is a genetic vascular disorder caused by haploinsufficiency of the TGF beta co-receptor endoglin. Dysfunctional homing of HHT1 mononuclear cells (MNCs) towards the infarcted myocardium hampers cardiac recovery. HHT1-MNCs have elevated expression of dipeptidyl peptidase-4 (DPP4/CD26), which inhibits recruitment of CXCR4-expressing MNCs by inactivation of stromal cell-derived factor 1 (SDF1). We hypothesize that inhibiting DPP4 will restore homing of HHT1-MNCs to the infarcted heart and improve cardiac recovery. Methods and results After inducing myocardial infarction (MI), wild type (WT) and endoglin heterozygous (Eng(+/-)) mice were treated for 5 days with the DPP4 inhibitor Diprotin A (DipA). DipA increased the number of CXCR4(+) MNCs residing in the infarcted Eng(+/-) hearts (Eng(+/-) 73.17 +/- 12.67 vs. Eng(+/-) treated 157.00 +/- 11.61, P = 0.0003) and significantly reduced infarct size (Eng(+/-) 46.60 +/- 9.33% vs. Eng(+/-) treated 27.02 +/- 3.04%, P = 0.03). Echocardiography demonstrated that DipA treatment slightly deteriorated heart function in Eng(+/-) mice. An increased number of capillaries (Eng(+/-) 61.63 +/- 1.43 vs. Eng(+/-) treated 74.30 +/- 1.74, P = 0.001) were detected in the infarct border zone whereas the number of arteries was reduced (Eng(+/-) 11.88 +/- 0.63 vs. Eng(+/-) treated 6.38 +/- 0.97, P = 0.003). Interestingly, while less M2 regenerative macrophages were present in Eng(+/-) hearts prior to DipA treatment, (WT 29.88 +/- 1.52% vs. Eng(+/-) 12.34 +/- 1.64%, P<0.0001), DPP4 inhibition restored the number of M2 macrophages to wild type levels. Conclusions In this study, we demonstrate that systemic DPP4 inhibition restores the impaired MNC homing in Eng(+/-) animals post-MI, and enhances cardiac repair, which might be explained by restoring the balance between the inflammatory and regenerative macrophages present in the heart.	[Dingenouts, Calinda K. E.; Bakker, Wineke; Lodder, Kirsten; Wiesmeijer, Karien C.; Moerkamp, Asja T.; Maring, Janita A.; Smits, Anke M.; Goumans, Marie-Jose] Leiden Univ, Dept Mol Cell Biol, Med Ctr, Leiden, Netherlands; [Arthur, Helen M.] Newcastle Univ, Inst Genet Med, Int Ctr Life, Newcastle Upon Tyne, Tyne & Wear, England; [Maring, Janita A.] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Newcastle University - UK; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Goumans, MJ (corresponding author), Leiden Univ, Dept Mol Cell Biol, Med Ctr, Leiden, Netherlands.	m.j.goumans@lumc.nl	Smits, Anke/AAC-2321-2022; Goumans, Marie Jose/U-1455-2019; Goumans, Marie-José/AAG-4994-2021	Smits, Anke/0000-0002-2443-8547; Goumans, Marie Jose/0000-0001-9344-6746; Dingenouts, Calinda/0000-0003-3889-9907; Arthur, Helen/0000-0001-6522-1363	Netherlands Institute for Regenerative Medicine (NIRM) [NIRM-1.7]; Dutch Heart Foundation [NHS200913063]	Netherlands Institute for Regenerative Medicine (NIRM); Dutch Heart Foundation(Netherlands Heart Foundation)	This work was supported by the Netherlands Institute for Regenerative Medicine (NIRM) [project NIRM-1.7]; and the Dutch Heart Foundation [project NHS200913063]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristorena M, 2014, J CELL SCI, V127, P2723, DOI 10.1242/jcs.143644; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Ben-Mordechai T, 2013, J AM COLL CARDIOL, V62, P1890, DOI 10.1016/j.jacc.2013.07.057; Best JH, 2011, DIABETES CARE, V34, P90, DOI 10.2337/dc10-1393; Bourdeau A, 2001, AM J PATHOL, V158, P2011, DOI 10.1016/S0002-9440(10)64673-1; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Brenner C, 2015, INT J CARDIOL, V199, P163, DOI 10.1016/j.ijcard.2015.07.044; Brenner C, 2016, INT J CARDIOL, V205, P23, DOI 10.1016/j.ijcard.2015.11.180; Brenner C, 2014, INT J CARDIOL, V177, P266, DOI 10.1016/j.ijcard.2014.09.016; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Choi EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088511; Choi H., 2015, J NURSING CARE, V4, P1, DOI [10.4172/2167-1168.1000233, DOI 10.4172/2167-1168.1000233]; Choi SH, 2015, VASC PHARMACOL, V73, P11, DOI 10.1016/j.vph.2015.07.005; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cobble ME, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-6; Docherty NG, 2006, NEPHROL DIAL TRANSPL, V21, P2106, DOI 10.1093/ndt/gfl179; Duim SN, 2015, J MOL CELL CARDIOL, V81, P127, DOI 10.1016/j.yjmcc.2015.02.007; Ervinna N, 2013, ENDOCRINOLOGY, V154, P1260, DOI 10.1210/en.2012-1855; Fadini GP, 2010, DIABETES CARE, V33, P1607, DOI 10.2337/dc10-0187; Frantz S, 2014, CARDIOVASC RES, V102, P240, DOI 10.1093/cvr/cvu025; Frederich R, 2010, POSTGRAD MED, V122, P16, DOI 10.3810/pgm.2010.05.2138; Garrido-Martin EM, 2014, ARTERIOSCL THROM VAS, V34, P2232, DOI 10.1161/ATVBAHA.114.303984; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Grilo GA, 2016, J MOL CELL CARDIOL, V93, P44, DOI 10.1016/j.yjmcc.2016.01.021; Gross L, 2016, INT J CARDIOL, V215, P441, DOI 10.1016/j.ijcard.2016.04.134; Guilhem A, 2013, IMMUNOLOGICAL ABNORM, P351; Jerkic M, 2006, CARDIOVASC RES, V69, P845, DOI 10.1016/j.cardiores.2005.11.020; Kanasaki K, 2014, DIABETES, V63, P2120, DOI 10.2337/db13-1029; Kapur NK, 2013, VASC HEALTH RISK MAN, V9, P195, DOI 10.2147/VHRM.S29144; Komala MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141143; Koska J, 2015, DIABETES VASC DIS RE, V12, P154, DOI 10.1177/1479164114562411; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lebrin F, 2010, NAT MED, V16, P420, DOI 10.1038/nm.2131; Liu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086273; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Mancini ML, 2009, DEV DYNAM, V238, P2479, DOI 10.1002/dvdy.22066; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Ojeda-Fernandez L, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005935; Panchapakesan U, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.S9-007; Patil HR, 2012, AM J CARDIOL, V110, P826, DOI 10.1016/j.amjcard.2012.04.061; Peter MR, 2014, MEDIAT INFLAMM, V2014, P1; Post S, 2012, J MOL CELL CARDIOL, V53, P899, DOI 10.1016/j.yjmcc.2012.08.026; Post S, 2010, CARDIOVASC RES, V85, P494, DOI 10.1093/cvr/cvp313; Read PA, 2010, CIRC-CARDIOVASC IMAG, V3, P195, DOI 10.1161/CIRCIMAGING.109.899377; Rinkevich Y, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2151; Rohrborn D, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00386; Rossi E, 2016, CELL MOL LIFE SCI, V73, P1715, DOI 10.1007/s00018-015-2099-4; Rossi E, 2013, BLOOD, V121, P403, DOI 10.1182/blood-2012-06-435347; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001; Sanz-Rodriguez F, 2004, CLIN CHEM, V50, P2003, DOI 10.1373/clinchem.2004.035287; Sauve M, 2010, GENETIC DELETION PHA, P59; Savarese G, 2015, INT J CARDIOL, V181, P239, DOI 10.1016/j.ijcard.2014.12.017; Seghers L, 2012, J CELL MOL MED, V16, P2440, DOI 10.1111/j.1582-4934.2012.01561.x; Shah Z, 2011, CIRCULATION, V124, P2339, DOI 10.1161/CIRCULATIONAHA.111.041418; Shi S, 2015, KIDNEY INT, V88, P479, DOI 10.1038/ki.2015.103; Shinjo T, 2015, AM J PHYSIOL-ENDOC M, V309, pE214, DOI 10.1152/ajpendo.00553.2014; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Ta NN, 2011, J CARDIOVASC PHARM, V58, P157, DOI 10.1097/FJC.0b013e31821e5626; Theiss HD, 2011, STEM CELL RES, V7, P244, DOI 10.1016/j.scr.2011.05.003; Thielitz A, 2008, J INVEST DERMATOL, V128, P855, DOI 10.1038/sj.jid.5701104; Tricco AC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005752; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; van Laake LW, 2006, CIRCULATION, V114, P2288, DOI 10.1161/CIRCULATIONAHA.106.639161; Waumans Y, 2016, INFLAMMATION, V39, P413, DOI 10.1007/s10753-015-0263-5; Zaruba MM, 2012, EUR HEART J, V33, P129, DOI 10.1093/eurheartj/ehr302; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013; Zhong JX, 2015, CIRC RES, V116, P1491, DOI 10.1161/CIRCRESAHA.116.305665; Zhu X, 2015, AM J PHYSIOL-HEART C, V309, pH1528, DOI 10.1152/ajpheart.00070.2015	70	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189805	10.1371/journal.pone.0189805	http://dx.doi.org/10.1371/journal.pone.0189805			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253907	Green Published, gold, Green Submitted			2022-12-26	WOS:000418389500062
J	Jensen, R				Jensen, Ralph			Effects of GABACR and mGluR1 antagonists on contrast response functions of Sprague-Dawley and P23H rat retinal ganglion cells	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; RETINITIS-PIGMENTOSA; ROYAL-COLLEGE; PHOTORECEPTOR DEGENERATION; MACULAR DEGENERATION; SPATIAL VISION; MACAQUE MONKEY; SURGEONS RAT; HOODED RAT; SENSITIVITY	The GABA(C)R antagonist TPMPA and the mGluR1 antagonist JNJ16259685 have been shown previously to alter the sensitivity of retinal ganglion cells (RGCs) in the Sprague-Dawley (SD) rat and P23H rat (animal model of retinitis pigmentosa) to brief flashes of light. In order to better understand the effects of these antagonists on the visual responses of SD and P23H rat RGCs, I examined the responses of RGCs to a drifting sinusoidal grating of various contrasts. Multielectrode array recordings were made from RGCs to a drifting sinusoidal grating of a spatial frequency of 1 cycle/mm and a temporal frequency of 2 cycles/s. In both SD and P23H rat retinas, contrast response functions were found to have a variable shape across cells. Some cells showed saturation of responses at high contrast levels while others did not. Whereas 49% of SD rat RGCs exhibited response saturation, only 14% of P23H rat RGCs showed response saturation. TPMPA decreased the responses of saturating SD rat RGCs to low (6% to 13%) grating contrasts but increased the response to the highest contrast (83%) tested. JNJ16259685 did not significantly affect the contrast response functions of either saturating or non-saturating SD rat RGCs. In contrast, both TPMPA and JNJ16259685 increased the responses of saturating and non-saturating P23H rat RGCs to all grating contrasts. Neither TPMPA nor JNJ16259685 affected the contrast thresholds of SD rat RGCs, but both antagonists lowered the contrast thresholds of P23H rat RGCs. Overall, the findings show that GABACR and mGluR1 antagonists have differential effects on the contrast response functions of SD and P23H rat RGCs. Notably, these receptor antagonists increase the responsiveness of P23H rat RGCs to both low and high contrast visual stimuli.	[Jensen, Ralph] VA Boston Healthcare Syst, Res Serv, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jensen, R (corresponding author), VA Boston Healthcare Syst, Res Serv, Boston, MA USA.	ralph.jensen@va.gov			Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service [1I0RX000341-01]	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service (1I0RX000341-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; ALEXANDER KR, 1992, INVEST OPHTH VIS SCI, V33, P1846; Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; Cuenca N, 2004, NEUROSCIENCE, V127, P301, DOI 10.1016/j.neuroscience.2004.04.042; Cuenca N, 2005, EUR J NEUROSCI, V22, P1057, DOI 10.1111/j.1460-9568.2005.04300.x; Dagar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090250; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Furtak SC, 2009, J NEUROSCI METH, V181, P82, DOI 10.1016/j.jneumeth.2009.04.023; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Gayet-Primo J, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.00436, 10.3389/fncel.2015.00486]; Grunder T, 2001, VISUAL NEUROSCI, V18, P781, DOI 10.1017/S0952523801185111; Ivanova E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00390; Jensen RJ, 2012, EXP EYE RES, V105, P21, DOI 10.1016/j.exer.2012.10.005; Jensen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056868; JENSEN RJ, 1995, J NEUROPHYSIOL, V74, P12, DOI 10.1152/jn.1995.74.1.12; Jones BW, 2016, EXP EYE RES, V150, P149, DOI 10.1016/j.exer.2016.03.018; Jones BW, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00103; KAPLAN E, 1986, P NATL ACAD SCI USA, V83, P2755, DOI 10.1073/pnas.83.8.2755; Keller J, 2000, J NEUROSCI METH, V97, P103, DOI 10.1016/S0165-0270(00)00173-4; KLEINER RC, 1988, ARCH OPHTHALMOL-CHIC, V106, P55; Koulen P, 1997, J NEUROSCI, V17, P2200; Koulen P, 1998, EUR J NEUROSCI, V10, P115, DOI 10.1046/j.1460-9568.1998.00005.x; LINDBERG CR, 1981, BRIT J OPHTHALMOL, V65, P855, DOI 10.1136/bjo.65.12.855; LINDEN R, 1983, BRAIN RES, V272, P145, DOI 10.1016/0006-8993(83)90371-2; MARTIN PR, 1986, EXP BRAIN RES, V62, P77; McGill TJ, 2004, INVEST OPHTH VIS SCI, V45, P932, DOI 10.1167/iovs.03-0964; McGill TJ, 2007, INVEST OPHTH VIS SCI, V48, P5756, DOI 10.1167/iovs.07-0054; Midena E, 1997, INVEST OPHTH VIS SCI, V38, P469; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; PERRY VH, 1984, NEUROSCIENCE, V12, P1125, DOI 10.1016/0306-4522(84)90007-1; PERRY VH, 1984, NEUROSCIENCE, V12, P1101, DOI 10.1016/0306-4522(84)90006-X; Pu ML, 2006, INVEST OPHTH VIS SCI, V47, P3579, DOI 10.1167/iovs.05-1450; PURPURA K, 1988, P NATL ACAD SCI USA, V85, P4534, DOI 10.1073/pnas.85.12.4534; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Srivastava P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123896; Strettoi E, 2002, J NEUROSCI, V22, P5492; Sunness JS, 1997, OPHTHALMOLOGY, V104, P1677, DOI 10.1016/S0161-6420(97)30079-7; Wang SM, 2005, J COMP NEUROL, V491, P400, DOI 10.1002/cne.20695	38	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189980	10.1371/journal.pone.0189980	http://dx.doi.org/10.1371/journal.pone.0189980			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253887	gold, Green Published, Green Submitted			2022-12-26	WOS:000418389500083
J	Semvua, SK; Orrell, C; Mmbaga, BT; Semvua, HH; Bartlett, JA; Boulle, AA				Semvua, Seleman Khamis; Orrell, Catherine; Mmbaga, Blandina Theophil; Semvua, Hadija Hamis; Bartlett, John A.; Boulle, Andrew A.			Predictors of non-adherence to antiretroviral therapy among HIV infected patients in northern Tanzania	PLOS ONE			English	Article							SELF-REPORTED ADHERENCE; RESOURCE-LIMITED SETTINGS; VIROLOGICAL FAILURE; INCOME COUNTRIES; DRUG-RESISTANCE; CLINICAL-TRIALS; UNITED-STATES; VIRAL LOAD; ADULTS; METAANALYSIS	Background Antiretroviral therapy (ART) has been shown to reduce HIV-related morbidity and mortality amongst those living with HIV and reduce transmission of the virus to those who are yet to be infected. However, these outcomes depend on maximum ART adherence, and HIV programs around the world make efforts to ensure optimal adherence. Predictors of ART non-adherence vary considerably across populations and settings with respect to demographic, psychological, behavioral and economic factors. The objective of this study is to investigate risk factors that predict non-adherence to antiretroviral treatment among HIV-infected individuals in northern Tanzania. Methods At Kilimanjaro Christian Medical Centre (KCMC), a tertiary and referral hospital in northern Tanzania, we used an existing ART database to randomly select HIV-infected patients above 18 years of age who have been on triple ART for at least two years. We used interviewer administered structured questionnaires to cross-sectionally determine predictors of ART non-adherence. We determined non-adherence through retrospective review of pharmacy drug refill (PDR) records of the interviewed participants using a pharmacy database. Results Non-adherence was defined as collecting less than 95% of expected monthly refills in the previous 2 years. Multivariable logistic regression model was used to determine the predictors of non-adherence. Of the 256 patients enrolled mean age was 44 years (SD +/- 11) and median CD4 count was 499 cells per microliter (IQR 332-690). Median PDR adherence was 71% (IQR 58%-75%). Non-adherence was associated with younger age and unemployment. Conclusion In this setting, adherence strategies could be adapted to address issues facing young adults, and those with household challenges such as unemployment. Further research is required to better understand the potential roles of these factors in suboptimal adherence.	[Semvua, Seleman Khamis; Mmbaga, Blandina Theophil] Duke Res Collaborat, Kilimanjaro Christian Med Centre, Moshi, Tanzania; [Semvua, Seleman Khamis; Orrell, Catherine; Boulle, Andrew A.] Univ Cape Town, Desmond Tutu HIV Ctr, Cape Town, South Africa; [Semvua, Seleman Khamis; Mmbaga, Blandina Theophil; Semvua, Hadija Hamis; Bartlett, John A.] Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Mmbaga, Blandina Theophil; Bartlett, John A.] Duke Global Hlth Inst, Durham, NC USA; [Mmbaga, Blandina Theophil; Semvua, Hadija Hamis] Kilimanjaro Christian Med Ctr, Kilimanjaro Clin Res Inst, Moshi, Tanzania	Kilimanjaro Christian Medical Centre; University of Cape Town; Duke University; Kilimanjaro Christian Medical Centre	Semvua, SK (corresponding author), Duke Res Collaborat, Kilimanjaro Christian Med Centre, Moshi, Tanzania.; Semvua, SK (corresponding author), Univ Cape Town, Desmond Tutu HIV Ctr, Cape Town, South Africa.; Semvua, SK (corresponding author), Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania.	semvua006@yahoo.co.uk	Orrell, Catherine/AAF-3405-2019; Mmbaga, Blandina Theophil/AAR-8707-2021; Boulle, Andrew/C-1413-2008	Orrell, Catherine/0000-0003-1134-7475; Mmbaga, Blandina Theophil/0000-0002-5550-1916; Boulle, Andrew/0000-0002-7713-8062	National Institutes of Health (US), Fogarty International Center through the Socionbehavioral Sciences Research Training Program for Low- and Middle-Income Country Institutions [D43TW009595]; Sociobehavioral Sciences Training and Research (SBS) [D43TW009595]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER	National Institutes of Health (US), Fogarty International Center through the Socionbehavioral Sciences Research Training Program for Low- and Middle-Income Country Institutions; Sociobehavioral Sciences Training and Research (SBS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding received from National Institutes of Health (US), Fogarty International Center through the Socionbehavioral Sciences Research Training Program for Low- and Middle-Income Country Institutions, Grant number D43TW009595, URL http://grantome.com/search?q=4D43TW009595-04. John A Bartlett who is part of the funding team offered a nummber of comments to the work as a mentor; however, he had no role in the decision making regarding the work.; I would like to express my sincere appreciation to the Sociobehavioral Sciences Training and Research (SBS)-grant number D43TW009595 for funding my MPH studies at UCT and also supporting this research as part of MPH dissertation.	Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; AVERT, 2015, HIV AIDS TANZ; Bam K, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0846-8; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Berg KM, 2006, JAIDS-J ACQ IMM DEF, V43, pS79, DOI 10.1097/01.qai.0000248337.97814.66; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Carrieri P, 2001, J ACQ IMMUN DEF SYND, V28, P232, DOI 10.1097/00042560-200111010-00005; Chalker J, 2010, JAIDS-J ACQ IMM DEF, V53, P159, DOI 10.1097/QAI.0b013e3181befa12; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Chesney MA, 2006, JAIDS-J ACQ IMM DEF, V43, pS149, DOI 10.1097/01.qai.0000243112.91293.26; Falagas ME, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-13; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Gao X, 2000, ANN PHARMACOTHER, V34, P1117; Goldman JD, 2008, AIDS RES HUM RETROV, V24, P1031, DOI 10.1089/aid.2008.0035; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Haubrich RH, 1999, AIDS, V13, P1099, DOI 10.1097/00002030-199906180-00014; Health TMo, 2012, NAT GUID MAN HIV AID; Health TMo, 2015, NAT GUID MAN HIV AID; HIV/AIDS JUNPo, 2016, GLOB AIDS UPD 2016; Hodgson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111421; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Kapiga SH, 1998, AIDS, V12, P75, DOI 10.1097/00002030-199801000-00009; Li L, 2010, NURS HEALTH SCI, V12, P212, DOI 10.1111/j.1442-2018.2010.00521.x; Lyimo RA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-716; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Muya Aisa N, 2015, J Int Assoc Provid AIDS Care, V14, P163, DOI 10.1177/2325957414539193; Nachega JB, 2004, AIDS RES HUM RETROV, V20, P1053, DOI 10.1089/aid.2004.20.1053; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Nachega JB, 2015, B WORLD HEALTH ORGAN, V93, P29, DOI 10.2471/BLT.14.138149; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Ohl ME, 2013, AIDS BEHAV, V17, P174, DOI 10.1007/s10461-012-0325-8; Peltzer K, 2013, J HEALTH POPUL NUTR, V31, P150; Ramadhani HO, 2007, CLIN INFECT DIS, V45, P1492, DOI 10.1086/522991; Rambura M, 2007, JAIDS-J ACQ IMM DEF, V46, P616, DOI 10.1097/QAI.0b013e31815a571a; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Reynolds NR, 2007, JAIDS-J ACQ IMM DEF, V46, P402, DOI 10.1097/QAI.0b013e318158a44f; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Shigdel R, 2014, HIV AIDS-RES PALLIAT, V6, P109, DOI 10.2147/HIV.S55816; Simoni JM, 2006, JAIDS-J ACQ IMM DEF, V43, pS23, DOI 10.1097/01.qai.0000248342.05438.52; Talam N, 2008, FACTORS AFFECTING AN; UR T, 2014, GLOB AIDS RESP COUNT; Uthman OA, 2014, CURR HIV-AIDS REP, V11, P291, DOI 10.1007/s11904-014-0220-1; Venkatesh KK, 2010, AIDS PATIENT CARE ST, V24, P795, DOI 10.1089/apc.2010.0153; Vitoria M, 2013, CURR OPIN HIV AIDS, V8, P12, DOI 10.1097/COH.0b013e32835b8123; Watt MH, 2010, AIDS CARE, V22, P381, DOI 10.1080/09540120903193708; Watt MH, 2009, SOC SCI MED, V68, P1793, DOI 10.1016/j.socscimed.2009.02.037; *WHO, 2006, SCAL ANT THER RES LT; WHO/ UNAIDS, 2014, GLOB AIDS RESP PROGR; World Health Organisation, 2003, ADHERENCE LONG TERM; Yaya I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1308	55	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189460	10.1371/journal.pone.0189460	http://dx.doi.org/10.1371/journal.pone.0189460			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ5HM	29252984	Green Published, Green Submitted, gold			2022-12-26	WOS:000418389500029
J	Bailey, SS; Payne, KAP; Fisher, K; Marshall, SA; Cliff, MJ; Spiess, R; Parker, DA; Rigby, SEJ; Leys, D				Bailey, Samuel S.; Payne, Karl A. P.; Fisher, Karl; Marshall, Stephen A.; Cliff, Matthew J.; Spiess, Reynard; Parker, David A.; Rigby, Stephen E. J.; Leys, David			The role of conserved residues in Fdc decarboxylase in prenylated flavin mononucleotide oxidative maturation, cofactor isomerization, and catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERULIC ACID DECARBOXYLASE; BACTERIAL UBIQUINONE BIOSYNTHESIS; 1,3-DIPOLAR CYCLOADDITION; MECHANISM; SYSTEM; UBIX	The UbiD family of reversible decarboxylases act on aromatic, heteroaromatic, and unsaturated aliphatic acids and utilize a prenylated flavin mononucleotide (prFMN) as cofactor, bound adjacent to a conserved Glu-Arg-Glu/Asp ionic network in the enzyme's active site. It is proposed that UbiD activation requires oxidative maturation of the cofactor, for which two distinct isomers, prFMN(ketimine) and prFMN(iminium), have been observed. It also has been suggested that only the prFMN(iminium) form is relevant to catalysis, which requires transient cycloaddition between substrate and cofactor. Using Aspergillus niger Fdc1 as a model system, we reveal that isomerization ofprFMN(iminium) to prFMN(ketimine) is a light-dependent process that is largely independent of the Glu(277)-Arg(173)-Glu(282) network and accompanied by irreversible loss of activity. On the other hand, efficient catalysis was highly dependent on an intact Glu-Arg-Glu network, as only Glu -> Asp substitutions retain activity. Surprisingly, oxidative maturation to form the prFMN(iminium) species is severely affected only for the R173A variant. In summary, the unusual irreversible isomerization of prFMN is light-dependent and probably proceeds via high-energy intermediates but is independent of the Glu-Arg-Glu network. Our results from mutagenesis, crystallographic, spectroscopic, and kinetic experiments indicate a clear role for the Glu-Arg-Glu network in both catalysis and oxidative maturation.	[Bailey, Samuel S.; Payne, Karl A. P.; Fisher, Karl; Marshall, Stephen A.; Cliff, Matthew J.; Spiess, Reynard; Rigby, Stephen E. J.; Leys, David] Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England; [Parker, David A.] Westhollow Technol Ctr, Innovat Biodomain Shell Int Explorat & Prod, Houston, TX 77082 USA	University of Manchester	Leys, D (corresponding author), Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.	david.leys@manchester.ac.uk	Fisher, Karl/A-5956-2013	Fisher, Karl/0000-0003-3539-8939; Cliff, Matthew/0000-0002-7482-0234; Marshall, Stephen/0000-0001-7678-4989; payne, karl/0000-0002-6331-6374	BBSRC [BB/K017802/1, BB/P000622/1]; ERC [ADG_695013]; BBSRC iCASE studentship; Biotechnology and Biological Sciences Research Council [BB/K017802/1, 1482350, BB/P000622/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); BBSRC iCASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC Grants BB/K017802/1 and BB/P000622/1, ERC Grant ADG_695013, and a BBSRC iCASE studentship (to S. S. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Clennan EL, 2005, TETRAHEDRON, V61, P6665, DOI 10.1016/j.tet.2005.04.017; Ebenau-Jehle C, 2017, ISME J, V11, P224, DOI 10.1038/ismej.2016.91; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson KL, 2017, J AM CHEM SOC, V139, P10972, DOI 10.1021/jacs.7b05060; Ferguson KL, 2016, BIOCHEMISTRY-US, V55, P2857, DOI 10.1021/acs.biochem.6b00170; He ZQ, 1996, J BACTERIOL, V178, P3539, DOI 10.1128/jb.178.12.3539-3543.1996; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Jordan F, 2013, ACS CATAL, V3, P1601, DOI 10.1021/cs400272x; KEMAL C, 1977, P NATL ACAD SCI USA, V74, P405, DOI 10.1073/pnas.74.2.405; Lan CL, 2016, J ORG CHEM, V81, P9289, DOI 10.1021/acs.joc.6b01872; Li TF, 2012, BIOORG CHEM, V43, P2, DOI 10.1016/j.bioorg.2012.03.001; Long F, 2017, ACTA CRYSTALLOGR D, V73, P112, DOI 10.1107/S2059798317000067; Marshall SA, 2017, ARCH BIOCHEM BIOPHYS, V632, P209, DOI 10.1016/j.abb.2017.07.014; Marshall SA, 2017, J BIOL CHEM, V292, P4623, DOI 10.1074/jbc.M116.762732; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Payer SE, 2017, ANGEW CHEM INT EDIT, V56, P13893, DOI 10.1002/anie.201708091; Payne KAP, 2015, NATURE, V522, P497, DOI 10.1038/nature14560; Sorigue D, 2017, SCIENCE, V357, P903, DOI 10.1126/science.aan6349; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d; White MD, 2015, NATURE, V522, P502, DOI 10.1038/nature14559; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoshida T, 2002, BIOSCI BIOTECH BIOCH, V66, P2388, DOI 10.1271/bbb.66.2388	23	28	28	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2272	2287		10.1074/jbc.RA117.000881	http://dx.doi.org/10.1074/jbc.RA117.000881			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29259125	hybrid, Green Published			2022-12-26	WOS:000425308300004
J	Huang, BS; Li, X; Tu, XM; Zhao, W; Zhu, D; Feng, Y; Si, X; Chen, JG				Huang, Baoshan; Li, Xue; Tu, Xiaomeng; Zhao, Wei; Zhu, Dan; Feng, Yue; Si, Xiang; Chen, Jie-Guang			OTX1 regulates cell cycle progression of neural progenitors in the developing cerebral cortex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; neurogenesis; proliferation; gene expression; mouse; cerebral cortex; gliogenesis; in utero electroporation; OTX1; progenitors	CORTICAL-NEURONS; GENE-TRANSFER; BRAIN; DIFFERENTIATION; EXPRESSION; NEOCORTEX; STEM; ELECTROPORATION; NEUROGENESIS; TRANSGENES	The progenitor cells in the cerebral cortex coordinate proliferation and mitotic exit to generate the correct number of neurons and glial cells during development. However, mechanisms for regulating the mitotic cycle of cortical progenitors are not fully understood. Otx1 is one of the homeobox-containing transcription factors frequently implicated in the development of the central nervous system. Mice bearing a targeted deletion of Otx1 exhibit brain hypoplasia and a decrease in the number of cortical neurons. We hypothesized that Otx1 might be crucial to the proliferation and differentiation of cortical progenitors. Otx1 knockdown by in utero electroporation in the mouse brain reduced the proportion of the G(1) phase while increasing the S and M phases of progenitor cells. The knockdown diminished Tbr1+ neurons but increased GFAP+ astrocytes in the early postnatal cortex as revealed by lineage tracing study. Tbr2+ basal progenitors lacking Otx1 were held at the transit-amplifying stage. In contrast, overexpression of wildtype Otx1 but not an astrocytoma-related mutant Y320C inhibited proliferation of the progenitor cells in embryonic cortex. This study demonstrates that Otx1 is one of the key elements regulating cortical neurogenesis, and a loss-of-function in Otx1 may contribute to the overproduction of astrocytes in vivo.	[Huang, Baoshan; Li, Xue; Tu, Xiaomeng; Zhao, Wei; Zhu, Dan; Feng, Yue; Si, Xiang; Chen, Jie-Guang] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou 325027, Zhejiang, Peoples R China; [Huang, Baoshan; Li, Xue; Tu, Xiaomeng; Zhao, Wei; Zhu, Dan; Feng, Yue; Si, Xiang; Chen, Jie-Guang] Wenzhou Med Univ, Hosp Eye, Wenzhou 325027, Zhejiang, Peoples R China; [Huang, Baoshan; Li, Xue; Tu, Xiaomeng; Zhao, Wei; Zhu, Dan; Feng, Yue; Si, Xiang; Chen, Jie-Guang] Wenzhou Med Univ, State Key Lab Optometry Ophthalmol & Vis Sci, Wenzhou 325027, Zhejiang, Peoples R China; [Huang, Baoshan; Li, Xue; Tu, Xiaomeng; Zhao, Wei; Zhu, Dan; Feng, Yue; Si, Xiang; Chen, Jie-Guang] Wenzhou Med Univ, Zhejiang Prov Key Lab Optometry & Ophthalmol, Wenzhou 325027, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Chen, JG (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou 325027, Zhejiang, Peoples R China.; Chen, JG (corresponding author), Wenzhou Med Univ, Hosp Eye, Wenzhou 325027, Zhejiang, Peoples R China.; Chen, JG (corresponding author), Wenzhou Med Univ, State Key Lab Optometry Ophthalmol & Vis Sci, Wenzhou 325027, Zhejiang, Peoples R China.; Chen, JG (corresponding author), Wenzhou Med Univ, Zhejiang Prov Key Lab Optometry & Ophthalmol, Wenzhou 325027, Zhejiang, Peoples R China.	jgchen@mail.eye.ac.cn			National Natural Science Foundation of China [81571096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 81571096 (to J. G. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Acampora D, 1996, NAT GENET, V14, P218, DOI 10.1038/ng1096-218; Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Beatty J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-16; Bellipanni G, 2010, J CELL PHYSIOL, V222, P286, DOI 10.1002/jcp.21944; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Gao P, 2014, CELL, V159, P775, DOI 10.1016/j.cell.2014.10.027; Ge WP, 2016, NEUROSCIENCE, V323, P3, DOI 10.1016/j.neuroscience.2015.08.057; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Kohwi M, 2013, NAT REV NEUROSCI, V14, P823, DOI 10.1038/nrn3618; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kwan KY, 2012, DEVELOPMENT, V139, P1535, DOI 10.1242/dev.069963; Larsen KB, 2010, J HISTOCHEM CYTOCHEM, V58, P669, DOI 10.1369/jhc.2010.955757; Liu XD, 2011, EUR J HUM GENET, V19, P1264, DOI 10.1038/ejhg.2011.112; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Panto MR, 2004, EUR J NEUROSCI, V19, P2893, DOI 10.1111/j.0953-816X.2004.03326.x; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sato Y, 2007, DEV BIOL, V305, P616, DOI 10.1016/j.ydbio.2007.01.043; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Xu DR, 2015, BIOINFORMATICS, V31, P1357, DOI 10.1093/bioinformatics/btu826; Yang YWJ, 2012, CELL, V151, P1097, DOI 10.1016/j.cell.2012.10.043; Yoshida A, 2010, GENES CELLS, V15, P501, DOI 10.1111/j.1365-2443.2010.01397.x; Zhang YA, 2002, MOL CELL NEUROSCI, V19, P430, DOI 10.1006/mcne.2001.1076	32	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2137	2148		10.1074/jbc.RA117.001249	http://dx.doi.org/10.1074/jbc.RA117.001249			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29273633	Green Published, hybrid			2022-12-26	WOS:000424948000025
J	Beshai, S; Mishra, S; Mishra, S; Carleton, RN				Beshai, Shadi; Mishra, Sanju; Mishra, Sandeep; Carleton, R. Nicholas			Personal relative deprivation associated with functional disorders via stress: An examination of fibromyalgia and gastrointestinal symptoms	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; MENTAL-HEALTH; PSYCHOLOGICAL STRESS; COGNITIVE THERAPY; GLOBAL BURDEN; DEPRESSION; ANXIETY; SCALES; COMORBIDITY; DASS-21	Background Personal relative deprivation is a negative social comparison process typified by self-comparison, negative appraisal, and resultant negative emotionality. Personal relative deprivation has been associated with poorer physical and mental health in several domains. It has been hypothesized that the deprivation-health link operates through a stress pathway. Stress has been specifically implicated in the onset and maintenance of functional disorders, including fibromyalgia and functional gastrointestinal disorders. Despite the theoretical links between personal deprivation, stress, and functional disorders, researchers have not assessed relationships between these variables. Methods We recruited community participants (n = 517; 54.9% female) to examine whether personal relative deprivation can account for variance in fibromyalgia and functional gastrointestinal symptoms beyond known demographic correlates of physical health. We also examined whether the relationships between personal relative deprivation and functional disorder symptoms are mediated by stress. Results Consistent with our hypotheses, personal relative deprivation accounted for symptom variance in fibromyalgia and functional gastrointestinal disorders beyond that accounted for by demographic variables alone. Further, self-reported stress was found to mediate relationships between personal relative deprivation and fibromyalgia and gastrointestinal symptoms. Conclusions The current results support biopsychosocial models of physical health and suggest that, for patients presenting with functional disorders symptoms, a combination of biological and psychosocial interventions may be warranted.	[Beshai, Shadi; Carleton, R. Nicholas] Univ Regina, Dept Psychol, Regina, SK, Canada; [Mishra, Sanju] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Mishra, Sanju] Western Univ, Div Clin Immunol & Allergy, Dept Med, London, ON, Canada; [Mishra, Sandeep] Univ Regina, Fac Business Adm, Regina, SK, Canada	University of Regina; Dalhousie University; Western University (University of Western Ontario); University of Regina	Beshai, S (corresponding author), Univ Regina, Dept Psychol, Regina, SK, Canada.	shadi.beshai@uregina.ca	Beshai, Shadi/C-7287-2016	Beshai, Shadi/0000-0001-7119-0129	Social Sciences and Humanities Research Council of Canada (SSHRC); Canadian Institute of Health Research (CIHR)	Social Sciences and Humanities Research Council of Canada (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)CGIAR); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding for this project was obtained from the Social Sciences and Humanities Research Council of Canada (SSHRC), and the Canadian Institute of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron LA, 1996, ARTHRITIS RHEUM-US, V39, P436, DOI 10.1002/art.1780390311; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Bennett EJ, 1998, GUT, V43, P256, DOI 10.1136/gut.43.2.256; Bennett R, 2006, NAT CLIN PRACT RHEUM, V2, P416, DOI 10.1038/ncprheum0245; Bennett RM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2783; Bennett RM, 2009, J RHEUMATOL, V36, P1304, DOI 10.3899/jrheum.081090; Beshai S, 2017, SOC SCI MED, V173, P18, DOI 10.1016/j.socscimed.2016.11.021; Beshai S, 2016, J PSYCHOL, V150, P250, DOI 10.1080/00223980.2015.1087376; Callan MJ, 2015, ADDICT BEHAV, V45, P146, DOI 10.1016/j.addbeh.2015.01.031; Callan MJ, 2011, J PERS SOC PSYCHOL, V101, P955, DOI 10.1037/a0024778; Callan MJ, 2015, FRONT PSYCHOL, V6, P82; Chandler J, 2016, ANNU REV CLIN PSYCHO, V12, P53, DOI 10.1146/annurev-clinpsy-021815-093623; Crawford J, 2011, AUST PSYCHOL, V46, P3, DOI 10.1111/j.1742-9544.2010.00003.x; Dadabhoy D, 2006, NAT CLIN PRACT RHEUM, V2, P364, DOI 10.1038/ncprheum0221; de Winter JCF, 2015, PROCEDIA MANUF, V3, P2518, DOI 10.1016/j.promfg.2015.07.514; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Drossman DA., 2000, ROME 2 FUNCTIONAL GA, P157; Eibner C, 2005, J HUM RESOUR, V40, P591; Fadgyas-Stanculete Mihaela, 2014, J Mol Psychiatry, V2, P4, DOI 10.1186/2049-9256-2-4; Fond G, 2014, EUR ARCH PSY CLIN N, V264, P651, DOI 10.1007/s00406-014-0502-z; Gatchel RJ, 2004, AM PSYCHOL, V59, P795, DOI 10.1037/0003-066X.59.8.795; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Gupta A, 2004, ARTHRITIS RES THER, V6, P98, DOI 10.1186/ar1176; Guyonnet D, 2009, J DIGEST DIS, V10, P61, DOI 10.1111/j.1751-2980.2008.00366.x; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Herschbach P, 1999, PSYCHOSOM MED, V61, P148, DOI 10.1097/00006842-199903000-00005; HUDSON JI, 1992, AM J MED, V92, P363, DOI 10.1016/0002-9343(92)90265-D; Jones AM, 2008, J HEALTH ECON, V27, P308, DOI 10.1016/j.jhealeco.2007.05.007; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Kroenke K, 1994, Arch Fam Med, V3, P774; Lackner JM, 2006, BEHAV RES THER, V44, P621, DOI 10.1016/j.brat.2005.05.002; Lacy BE, 2016, GASTROENTEROLOGY, V150, P1393, DOI 10.1053/j.gastro.2016.02.031; Le J., 2010, P SIGIR 2010 WORKSH, P22; Leibbrand R, 2002, INT J BEHAV MED, V9, P155, DOI 10.1207/S15327558IJBM0902_06; Lembo A, 2016, GASTROENTEROLOGY, V151, P1113, DOI 10.1053/j.gastro.2016.08.003; Maes M, 1998, CYTOKINE, V10, P313, DOI 10.1006/cyto.1997.0290; MATHIAS JR, 1995, POSTGRAD MED, V97, P95, DOI 10.1080/00325481.1995.11945972; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; Mishra S, 2016, PERS INDIV DIFFER, V90, P22, DOI 10.1016/j.paid.2015.10.031; Mishra S, 2015, SOC SCI MED, V147, P144, DOI 10.1016/j.socscimed.2015.10.030; Monnikes H, 2001, DIGEST DIS, V19, P201, DOI 10.1159/000050681; Nimnuan C, 2001, J PSYCHOSOM RES, V51, P361, DOI 10.1016/S0022-3999(01)00223-9; Osman A, 2012, J CLIN PSYCHOL, V68, P1322, DOI 10.1002/jclp.21908; PAYNE A, 1995, J CONSULT CLIN PSYCH, V63, P779, DOI 10.1037/0022-006X.63.5.779; Pickett KE, 2015, SOC SCI MED, V128, P316, DOI 10.1016/j.socscimed.2014.12.031; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Pridgen WL, 2017, J PAIN RES, V10, P451, DOI 10.2147/JPR.S127288; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Ramirez AJ, 1996, LANCET, V347, P724, DOI 10.1016/S0140-6736(96)90077-X; Riedl A, 2008, J PSYCHOSOM RES, V64, P573, DOI 10.1016/j.jpsychores.2008.02.021; Schmidt-Wilcke T, 2011, NAT REV RHEUMATOL, V7, P518, DOI 10.1038/nrrheum.2011.98; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Sluka KA, 2016, NEUROSCIENCE, V338, P114, DOI 10.1016/j.neuroscience.2016.06.006; Stone J, 2010, CLIN NEUROL NEUROSUR, V112, P747, DOI 10.1016/j.clineuro.2010.05.011; Tack J, 2016, CLIN GASTROENTEROL H, V14, P385, DOI 10.1016/j.cgh.2015.09.043; Tran TD, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-24; Van Houdenhove B, 2004, PSYCHOTHER PSYCHOSOM, V73, P267, DOI 10.1159/000078843; Van Houdenhove Boudewijn, 2005, Curr Rheumatol Rep, V7, P365; Vigo D, 2016, LANCET PSYCHIAT, V3, P171, DOI 10.1016/S2215-0366(15)00505-2; Walker EA, 1997, PSYCHOSOM MED, V59, P572, DOI 10.1097/00006842-199711000-00003; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Whitehead WE, 2002, GASTROENTEROLOGY, V122, P1140, DOI 10.1053/gast.2002.32392; Wilkinson R., 2009, SPIRIT LEVEL; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140	68	10	10	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189666	10.1371/journal.pone.0189666	http://dx.doi.org/10.1371/journal.pone.0189666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR3ZV	29281686	Green Published, Green Submitted, gold			2022-12-26	WOS:000419006200038
J	Poorghasamians, E; Aggabao, PC; Wren, TAL; Ponrartana, S; Gilsanz, V				Poorghasamians, Ervin; Aggabao, Patricia C.; Wren, Tishya A. L.; Ponrartana, Skorn; Gilsanz, Vicente			Vertebral cross-sectional growth: A predictor of vertebral wedging in the immature skeleton	PLOS ONE			English	Article							ADOLESCENT IDIOPATHIC SCOLIOSIS; ACUTE LYMPHOBLASTIC-LEUKEMIA; GENDER-DIFFERENCES; LUMBAR LORDOSIS; CHILDREN; BONE; FRACTURES; DEFORMITIES; SPINE; AGE	The degree of vertebral wedging, a key structural characteristic of spinal curvatures, has recently been found to be negatively related to vertebral cross-sectional area (CSA). The purpose of this longitudinal study was to examine the relation between vertebral cross-sectional growth and vertebral wedging progression within the immature lumbar spine. Using magnetic resonance imaging (MRI), we analyzed the potential association between increases in lumbar vertebral CSA and changes in L5 vertebral wedging in 27 healthy adolescent girls (ages 9-13 years) twice within a two-year period. Vertebral CSA growth was negatively associated with changes in posteroanterior vertebral wedging (r = -0.61; p = 0.001). Multiple regression analysis showed that this relation was independent of gains in age, height, and weight. When compared to the 14 girls whose vertebral wedging progressed, the 13 subjects whose vertebral wedging decreased had significantly greater vertebral cross-sectional growth (0.39-0.25 vs. 0.75-0.23 cm(2); p = 0.001); in contrast, there were no significant differences in increases in age, height, or weight between the two groups. Changes in posteroanterior vertebral wedging and the degree of lumbar lordosis (LL) positively correlated (r = 0.56, p = 0.002)-an association that persisted even after adjusting for gains in age, height, and weight. We concluded that in the immature skeleton, vertebral cross-sectional growth is an important determinant of the plasticity of the vertebral body; regression of L5 vertebral wedging is associated with greater lumbar vertebral cross-sectional growth, while progression is the consequence of lesser cross-sectional growth.	[Poorghasamians, Ervin; Aggabao, Patricia C.; Ponrartana, Skorn; Gilsanz, Vicente] Univ Southern Calif, Keck Sch Med, Dept Radiol, Childrens Hosp Los Angeles, Los Angeles, CA 90033 USA; [Wren, Tishya A. L.; Gilsanz, Vicente] Univ Southern Calif, Keck Sch Med, Div Orthopaed Surg, Childrens Hosp Los Angeles, Los Angeles, CA 90033 USA; [Gilsanz, Vicente] Univ Southern Calif, Keck Sch Med, Dept Pediat, Childrens Hosp Los Angeles, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California	Gilsanz, V (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Radiol, Childrens Hosp Los Angeles, Los Angeles, CA 90033 USA.; Gilsanz, V (corresponding author), Univ Southern Calif, Keck Sch Med, Div Orthopaed Surg, Childrens Hosp Los Angeles, Los Angeles, CA 90033 USA.; Gilsanz, V (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Pediat, Childrens Hosp Los Angeles, Los Angeles, CA 90033 USA.	vgilsanz@chla.usc.edu	Wren, Tishya/AAS-4196-2021					Alos N, 2012, J CLIN ONCOL, V30, P2760, DOI 10.1200/JCO.2011.40.4830; Arfai K, 2002, RADIOLOGY, V224, P338, DOI 10.1148/radiol.2242011369; Bailey JF, 2016, J ANAT, V229, P82, DOI 10.1111/joa.12451; Been E, 2010, CLIN ORTHOP RELAT R, V468, P1822, DOI 10.1007/s11999-009-1153-7; Bouxsein ML, 2006, J BONE MINER RES, V21, P1475, DOI 10.1359/JBMR.060606; Bruno AG, 2014, J BONE MINER RES, V29, P562, DOI 10.1002/jbmr.2067; Bruno AG, 2012, J BONE MINER RES, V27, P2144, DOI 10.1002/jbmr.1658; Cummings EA, 2015, J CLIN ENDOCR METAB, V100, P3408, DOI 10.1210/JC.2015-2176; Dal Osto LC, 2016, PEDIATR BLOOD CANCER, V63, P1107, DOI 10.1002/pbc.25942; de Seze M., 2012, Annals of Physical and Rehabilitation Medicine, V55, P128, DOI 10.1016/j.rehab.2012.01.003; Dolphens M, 2013, J ANAT, V223, P629, DOI 10.1111/joa.12119; Duan YB, 2001, J BONE MINER RES, V16, P2276, DOI 10.1359/jbmr.2001.16.12.2276; FERNAND R, 1985, SPINE, V10, P799, DOI 10.1097/00007632-198511000-00003; Giacomini F, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/11/113026; GILSANZ V, 1994, RADIOLOGY, V190, P678, DOI 10.1148/radiology.190.3.8115610; GILSANZ V, 1994, RADIOLOGY, V190, P673, DOI 10.1148/radiology.190.3.8115609; Goswami R, 1995, Australas Radiol, V39, P195, DOI 10.1111/j.1440-1673.1995.tb00272.x; Halton J, 2009, J BONE MINER RES, V24, P1326, DOI [10.1359/JBMR.090202, 10.1359/jbmr.090202]; IPPOLITO E, 1984, J BONE JOINT SURG AM, V66A, P1364, DOI 10.2106/00004623-198466090-00006; Kachanov LM, 2004, FUNDAMENTALS THEORY, P1; Lee SW, 2017, INT J HEMATOL; Andreasen ML, 2007, J MANIP PHYSIOL THER, V30, P26, DOI 10.1016/j.jmpt.2006.11.009; Loro ML, 2000, J CLIN ENDOCR METAB, V85, P3908; Makino T, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1287-1; Masharawi Y, 2010, EUR SPINE J, V19, P768, DOI 10.1007/s00586-009-1256-6; Middleditch A, 2005, FUNCTIONAL ANATOMY S, P173; Middleditch A, 2005, FUNCTIONAL ANATOMY S, P1; Modi HN, 2008, SCOLIOSIS SPINAL DIS, V3, DOI 10.1186/1748-7161-3-11; Mostoufi-Moab S, 2014, CURR OSTEOPOROS REP, V12, P300, DOI 10.1007/s11914-014-0222-3; NISSINEN M, 1995, ACTA PAEDIATR, V84, P308, DOI 10.1111/j.1651-2227.1995.tb13634.x; Pandya NA, 2001, ARCH DIS CHILD, V85, P492, DOI 10.1136/adc.85.6.492; Ruyssen-Witrand A, 2007, OSTEOPOROSIS INT, V18, P1271, DOI 10.1007/s00198-007-0356-6; Sarwark J, 2007, J BONE JOINT SURG AM, V89A, P8, DOI 10.2106/JBJS.F.00314; Scherrer SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071504; Shefi S, 2013, SPINE, V38, pE602, DOI 10.1097/BRS.0b013e31828b666b; Smith AJ, 2011, INT J PEDIATR OBES, V6, pE97, DOI 10.3109/17477166.2010.530664; Stokes I. A. F., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P277; Stokes IAF, 2007, EUR SPINE J, V16, P1621, DOI 10.1007/s00586-007-0442-7; Tauchmanova L, 2006, J CLIN ENDOCR METAB, V91, P1779, DOI 10.1210/jc.2005-0582; Trementino L, 2014, OSTEOPOROSIS INT, V25, P913, DOI 10.1007/s00198-013-2520-5; Tsai PY, 2012, NEW ENGL J MED, V366, pE30, DOI 10.1056/NEJMicm1101582; Villemure I, 2002, J BIOMECH ENG-T ASME, V124, P784, DOI 10.1115/1.1516198; Villemure I, 2001, SPINE, V26, P2244, DOI 10.1097/00007632-200110150-00016; Whitcome KK, 2007, NATURE, V450, P1075, DOI 10.1038/nature06342; Wren TAL, 2017, J BONE MINER RES; Wren TAL., 2017, SPINE DEFORM, V2017, P225, DOI 10.1016/j.jspd.2017.01.007; Wren TAL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172844	47	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190225	10.1371/journal.pone.0190225	http://dx.doi.org/10.1371/journal.pone.0190225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281728	Green Published, gold, Green Submitted			2022-12-26	WOS:000419006200074
J	Urban, JA; Urban, JM; Kuzu, G; Larschan, EN				Urban, Jennifer A.; Urban, John M.; Kuzu, Guray; Larschan, Erica N.			The Drosophila CLAMP protein associates with diverse proteins on chromatin	PLOS ONE			English	Article							DOSAGE COMPENSATION; RNA-POLYMERASE; GAGA FACTOR; MASS-SPECTROMETRY; BINDING; DNA; COMPLEX; NELF; GENES; IDENTIFICATION	Gaining new insights into gene regulation involves an in-depth understanding of protein-protein interactions on chromatin. A powerful model for studying mechanisms of gene regulation is dosage compensation, a process that targets the X-chromosome to equalize gene expression between XY males and XX females. We previously identified a zinc finger protein in Drosophila melanogaster that plays a sex-specific role in targeting the Male-specific lethal (MSL) dosage compensation complex to the male X-chromosome, called the Chromatin-Linked Adapter for MSL Proteins (CLAMP). More recently, we established that CLAMP has non-sex-specific roles as an essential protein that regulates chromatin accessibility at promoters genome-wide. To identify associations between CLAMP and other factors in both male and female cells, we used two complementary mass spectrometry approaches. We demonstrate that CLAMP associates with the transcriptional regulator complex Negative Elongation Factor (NELF) in both sexes and determine that CLAMP reduces NELF recruitment to several target genes. In sum, we have identified many new CLAMP-associated factors and provide a resource for further study of this little understood essential protein.	[Urban, Jennifer A.; Urban, John M.; Kuzu, Guray; Larschan, Erica N.] Brown Univ, Dept Mol Biol Cellular Biol & Biochem, Providence, RI 02912 USA; [Kuzu, Guray] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Brown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Larschan, EN (corresponding author), Brown Univ, Dept Mol Biol Cellular Biol & Biochem, Providence, RI 02912 USA.	Erica_Larschan@Brown.edu		Urban, Jennifer/0000-0002-6621-8358; Urban, John/0000-0001-9270-6569	National Institutes of Health [F31GM10842, R01GM098461-1]; American Cancer Society Research Scholar [123682-RSG-13-040-01-DMC]; Pew Biomedical Scholars program grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar(American Cancer Society); Pew Biomedical Scholars program grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a National Institutes of Health grant awarded to J.A.U. (F31GM10842). Additional funding was received from the National Institutes of Health R01GM098461-1, American Cancer Society Research Scholar 123682-RSG-13-040-01-DMC, and a Pew Biomedical Scholars program grant awarded to ENL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko Artyom A, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2130s109; Appocher C, 2017, NUCLEIC ACIDS RES, V45, P8026, DOI 10.1093/nar/gkx477; BELOTE JM, 1980, GENETICS, V96, P165; Blanchette M, 2009, MOL CELL, V33, P438, DOI 10.1016/j.molcel.2009.01.022; Fauth T, 2010, NUCLEIC ACIDS RES, V38, P3209, DOI 10.1093/nar/gkq026; Fay A, 2011, CURR BIOL, V21, P1624, DOI 10.1016/j.cub.2011.08.036; Fuda NJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005108; GARZINO V, 1992, EMBO J, V11, P4471, DOI 10.1002/j.1460-2075.1992.tb05548.x; Ghosh SKB, 2011, MOL CELL BIOL, V31, P4232, DOI 10.1128/MCB.05930-11; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Kaye EG, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00253-17; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kuzu G, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006120; Larschan E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002830; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Li J, 2013, MOL CELL, V50, P711, DOI 10.1016/j.molcel.2013.05.016; Lomaev D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173602; LUCCHESI JC, 1978, SCIENCE, V202, P711, DOI 10.1126/science.715437; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; Matzat LH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003069; McDermott SM, 2012, BIOL OPEN, V1, P488, DOI 10.1242/bio.2012885; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Norvell A, 1999, GENE DEV, V13, P864, DOI 10.1101/gad.13.7.864; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perrin L, 1999, J BIOL CHEM, V274, P6315, DOI 10.1074/jbc.274.10.6315; Quinn JJ, 2014, NAT BIOTECHNOL, V32, P933, DOI 10.1038/nbt.2943; Rieder LE, 2017, GENES DEV; SHOPLAND LS, 1995, GENE DEV, V9, P2756, DOI 10.1101/gad.9.22.2756; Soruco MML, 2013, GENE DEV, V27, P1551, DOI 10.1101/gad.214585.113; Syed MH, 2017, ELIFE, V6, DOI 10.7554/eLife.26287; Urban J, 2017, PLOS GENET; Urban JA, 2016, CHROMOSOME RES, P1; Wang CI, 2013, NAT STRUCT MOL BIOL, V20, P202, DOI 10.1038/nsmb.2477; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Wierer M, 2016, HUM MOL GENET, V25, pR106, DOI 10.1093/hmg/ddw208; Wu CH, 2005, NUCLEIC ACIDS RES, V33, P1269, DOI 10.1093/nar/gki274	42	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189772	10.1371/journal.pone.0189772	http://dx.doi.org/10.1371/journal.pone.0189772			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281702	gold, Green Published, Green Submitted			2022-12-26	WOS:000419006200041
J	Muhumuza, S; Akello, E; Kyomugisha-Nuwagaba, C; Baryamutuma, R; Sebuliba, I; Lutalo, IM; Kansiime, E; Kisaakye, LN; Kiragga, AN; King, R; Bazeyo, W; Lindan, C				Muhumuza, Simon; Akello, Evelyn; Kyomugisha-Nuwagaba, Charity; Baryamutuma, Rose; Sebuliba, Isaac; Lutalo, Ibrahim M.; Kansiime, Edgar; Kisaakye, Linda N.; Kiragga, Agnes N.; King, Rachel; Bazeyo, William; Lindan, Christina			Retention in care among HIV-infected pregnant and breastfeeding women on lifelong antiretroviral therapy in Uganda: A retrospective cohort study	PLOS ONE			English	Article							OPTION B PLUS; TO-CHILD TRANSMISSION; SUB-SAHARAN AFRICA; FOLLOW-UP; IMPROVE ADHERENCE; PMTCT PROGRAM; OUTCOMES; MORTALITY; REASONS; ADULTS	Background In 2013, Uganda updated its prevention of maternal-to-child transmission of HIV program to Option B+, which requires that all HIV-infected pregnant and breastfeeding women be started on lifelong antiretroviral therapy (ART) regardless of CD4 count. We describe retention in care and factors associated with loss to follow-up (LTFU) among women initiated on Option B+ as part of an evaluation of the effectiveness of the national program. Methods We conducted a retrospective cohort analysis of data abstracted from records of 2,169 women enrolled on Option B+ between January and March 2013 from a representative sample of 145 health facilities in all 24 districts of the Central region of Uganda. We defined retention as "being alive and receiving ART at the last clinic visit". We used Kaplan-Meier analysis to estimate retention in care and compared differences between women retained in care and those LTFU using the chi-squared test for dichotomized or categorical variables. Results The median follow-up time was 20.2 months (IQR 4.2-22.5). The proportion of women retained in HIV care at 6, 12 and 18 months post-ART initiation was 74.2%, 66.7% and 62.0%, respectively. Retention at 18 months varied significantly by level of health facility and ranged from 70.0% among those seen at hospitals to 56.6% among those seen at lower level health facilities. LTFU was higher among women aged less than 25 years, 59.3% compared to those aged 25 years and above, 40.7% (p = 0.02); among those attending care at lower level facilities, 44.0% compared to those attending care at hospitals, 34.1% (p = 0.01), and among those who were not tested for CD4 cell count at ART initiation, 69.4% compared to those who were tested, 30.9% (p = 0.002). Conclusion Retention of women who were initiated on Option B+ during the early phases of roll-out was only moderate, and could undermine the effectiveness of the program. Identifying reasons why women drop out and designing targeted interventions for improved retention should be a priority.	[Muhumuza, Simon; Akello, Evelyn; Kyomugisha-Nuwagaba, Charity; Baryamutuma, Rose; Sebuliba, Isaac; Lutalo, Ibrahim M.; Kansiime, Edgar; Bazeyo, William] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Kisaakye, Linda N.] Minist Hlth, AIDS Control Program, Kampala, Uganda; [Kiragga, Agnes N.] Makerere Univ, Sch Med, Infect Dis Inst, Kampala, Uganda; [King, Rachel; Lindan, Christina] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA	Makerere University; Makerere University; University of California System; University of California San Francisco	Muhumuza, S (corresponding author), Makerere Univ, Sch Publ Hlth, Kampala, Uganda.	smuhumuza@musph.ac.ug			US Centers for Disease and Prevention (CDC) [GH001370-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH064712] Funding Source: NIH RePORTER	US Centers for Disease and Prevention (CDC); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the US Centers for Disease and Prevention (CDC)-Cooperative agreement GH001370-02.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; [Anonymous], 2012, NATL BUSINESS REV; Baroncelli S, 2015, AIDS RES HUM RETROV, V31, P673, DOI [10.1089/aid.2014.0288, 10.1089/AID.2014.0288]; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Donner A, 1998, J R STAT SOC C-APPL, V47, P95, DOI 10.1111/1467-9876.00100; Dzangare J, 2016, TROP MED INT HEALTH, V21, P202, DOI 10.1111/tmi.12637; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; G.O.U, 2013, UG HIV AIDS COUNTR P; G.O.U, 2014, UG POV STAT REP; Geng EH, 2015, LANCET HIV, V2, pE107, DOI 10.1016/S2352-3018(15)00002-8; Geng EH, 2012, AM J EPIDEMIOL, V175, P1080, DOI 10.1093/aje/kwr444; Geng EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021797; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Mangwiro AZ, 2014, JAIDS-J ACQ IMM DEF, V67, pS139, DOI 10.1097/QAI.0000000000000326; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; McCoy SI, 2017, AIDS, V31, P815, DOI 10.1097/QAD.0000000000001406; Mitiku I, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20662; MoH, 2016, CONS GUID PREV TREAT; MOH, 2011, UG AID IND SURV; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, pS127, DOI 10.1097/01.qai.0000248349.25630.3d; Namusobya J., 2013, CLIN INFECT DIS; Navario P, 2009, LANCET, V374, P184, DOI 10.1016/S0140-6736(09)61312-X; NUMAT, 2009, RET HIV POS PERS ANT; Organization WH, 2012, RET HIV PROGR DEF CH; Republic of Uganda, 2010, HLTH SECT STRAT INV; Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Sanjobo N, 2008, SAHARA J-J SOC ASP H, V5, P136, DOI 10.1080/17290376.2008.9724912; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; Taha TE, 2011, LIFE SCI, V88, P917, DOI 10.1016/j.lfs.2010.09.031; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; UNAIDS, 2014, 90 90 90 AMB TREATM, P40; UNAIDS, 2014, GAP REP; UNAIDS, 2014, PROGR REP GLOB PLAN; UNAIDS, 2011, COUNTD ZER GLOB PLAN; Wanyama J, 2007, AIDS, V21, P1486, DOI 10.1097/QAD.0b013e32823ecf7f; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 2015, GLOB SUMM AIDS EP; World Health Organization, 2010, PMTCT STRAT VIS 2010	43	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0187605	10.1371/journal.pone.0187605	http://dx.doi.org/10.1371/journal.pone.0187605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272268	Green Published, Green Submitted, gold			2022-12-26	WOS:000418651500001
J	Glynn, MT; Kinahan, DJ; McArdle, NA; Kendlin, JL; O'Connell, TM; Ducree, J				Glynn, Macdara T.; Kinahan, David J.; McArdle, Niamh A.; Kendlin, Jane L.; O'Connell, Triona M.; Ducree, Jens			A portable optical reader and wall projector towards enumeration of bio-conjugated beads or cells	PLOS ONE			English	Article							CENTRIFUGO-MAGNETOPHORETIC PURIFICATION; DEFICIENCY-SYNDROME AIDS; CIRCULATING TUMOR-CELLS; RESOURCE-POOR SETTINGS; WHOLE-BLOOD; ANTIRETROVIRAL THERAPY; HIV CARE; MICROFLUIDICS; DIAGNOSTICS; ENGAGEMENT	Measurement of the height of a packed column of cells or beads, which can be direclty related to the number of cells or beads present in a chamber, is an important step in a number of diagnostic assays. For example, haematocrit measurements may rapidly identify anemia or polycthemia. Recently, user-friendly and cost-efficient Lab-on-a-Chip devices have been developed towards isolating and counting cell sub-populations for diagnostic purposes. In this work, we present a low-cost optical module for estimating the filling level of packed magnetic beads within a Lab-on-a-Chip device. The module is compatible with a previously introduced, disposable microfluidic chip for rapid determination of CD4+ cell counts. The device is a simple optical microscope module is manufactured by 3D printing. An objective lens directly interrogates the height of packed beads which are efficiently isolated on the finger-actuated chip. Optionally, an inexpensive, battery-powered Light Emitting Diode may project a shadow of the microfluidic chip at approximately 50-fold magnification onto a nearby surface. The reader is calibrated with the filling levels of known concentrations of paramagnetic beads within the finger actuated chip. Results in direct and projector mode are compared to measurements from a conventional, inverted white-light microscope. All three read-out methods indicate a maximum variation of 6.5% between methods.	[Glynn, Macdara T.; Kinahan, David J.; McArdle, Niamh A.; Kendlin, Jane L.; Ducree, Jens] Dublin City Univ, Fraunhofer Project Ctr, Dublin 9, Ireland; [Glynn, Macdara T.; Kinahan, David J.; McArdle, Niamh A.; Kendlin, Jane L.; Ducree, Jens] Dublin City Univ, Sch Phys Sci, Dublin 9, Ireland; [Kendlin, Jane L.; O'Connell, Triona M.] Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland	Dublin City University; Dublin City University; Dublin City University	Kinahan, DJ; Ducree, J (corresponding author), Dublin City Univ, Fraunhofer Project Ctr, Dublin 9, Ireland.; Kinahan, DJ; Ducree, J (corresponding author), Dublin City Univ, Sch Phys Sci, Dublin 9, Ireland.	david.kinahan@dcu.ie; jens.ducree@dcu.ie	Glynn, Macdara/J-9809-2019; Ducrée, Jens/M-4264-2014; Ducrée, Jens/AAL-4994-2021	Glynn, Macdara/0000-0002-6347-4348; Ducrée, Jens/0000-0002-0366-1897; Kinahan, David/0000-0003-1968-2016	Science Foundation Ireland [10/CE/B1821]; Enterprise Ireland [CF/2011/1317]; Science Foundation Ireland (SFI); Fraunhofer Gesellschaft [16/SPP/3321]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Enterprise Ireland; Science Foundation Ireland (SFI)(Science Foundation Ireland); Fraunhofer Gesellschaft	This work was supported in part by Science Foundation Ireland under Grant No 10/CE/B1821, Enterprise Ireland under Grant No CF/2011/1317, and Science Foundation Ireland (SFI) and Fraunhofer Gesellschaft under Grant No 16/SPP/3321.; This work was supported in part by Science Foundation Ireland under Grant No 10/CE/B1821, Enterprise Ireland under Grant No CF/2011/1317, and Science Foundation Ireland (SFI) and Fraunhofer Gesellschaft under Grant No 16/SPP/3321.	Adams AA, 2008, J AM CHEM SOC, V130, P8633, DOI 10.1021/ja8015022; Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Balic M, 2012, EXPERT REV MOL DIAGN, V12, P303, DOI [10.1586/ERM.12.12, 10.1586/erm.12.12]; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Burger R, 2012, MICROFLUID NANOFLUID, V13, P675, DOI 10.1007/s10404-012-0994-7; Burger R, 2012, CURR OPIN CHEM BIOL, V16, P409, DOI 10.1016/j.cbpa.2012.06.002; Chang WS, 2008, ANALYST, V133, P233, DOI 10.1039/b710997k; Cheng XH, 2007, LAB CHIP, V7, P170, DOI 10.1039/b612966h; Chin CD, 2011, NAT MED, V17, P1015, DOI 10.1038/nm.2408; Dimov IK, 2011, LAB CHIP, V11, P845, DOI [10.1039/c0lc00403k, 10.1039/c01c00403k]; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Glynn M, 2014, JALA-J LAB AUTOM, V19, P285, DOI 10.1177/2211068213504759; Glynn MT, 2014, LAB CHIP, V14, P2844, DOI 10.1039/c4lc00264d; Glynn MT, 2013, LAB CHIP, V13, P2731, DOI 10.1039/c3lc50213a; HIV/AIDS JUNPo, 2013, GLOBAL REPORT UNAIDS; HIV/ AIDS JUNPo, 2016, GLOB AIDS UPD 2016 J; Holmes D, 2009, LAB CHIP, V9, P2881, DOI 10.1039/b910053a; Hyun KA, 2014, LAB CHIP, V14, P45, DOI [10.1039/c3lc50582k, 10.1039/c3lc50582]; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Kinahan DJ, 2014, LAB CHIP, V14, P2249, DOI 10.1039/c4lc00380b; Kirby D, 2015, CYTOM PART A, V87A, P74, DOI 10.1002/cyto.a.22588; Kirby D, 2012, MICROFLUID NANOFLUID, V13, P899, DOI 10.1007/s10404-012-1007-6; Liu Q, 2016, LAB CHIP, V16, P506, DOI 10.1039/c5lc01153a; Losina E, 2010, ART LINKAGE PRETREAT; Mair C, 2008, CLIN EXP IMMUNOL, V151, P432, DOI 10.1111/j.1365-2249.2007.03573.x; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Organization WH, GUIDELINE ON WHEN TO; Pamme N, 2006, LAB CHIP, V6, P974, DOI 10.1039/b604542a; Rao JVRP, 2015, REPORT OF THE SPECIA; Riegger L, 2007, BIOMED MICRODEVICES, V9, P795, DOI 10.1007/s10544-007-9091-1; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Watkins NN, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006870; Zhu HY, 2011, LAB CHIP, V11, P315, DOI [10.1039/c0lc00358a, 10.1039/c01c00358a]	36	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189923	10.1371/journal.pone.0189923	http://dx.doi.org/10.1371/journal.pone.0189923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267367	Green Submitted, Green Published, gold			2022-12-26	WOS:000418587400065
J	Kashiwagi, K; Inoue, N; Yoshida, T; Bessho, R; Yoneno, K; Imaeda, H; Ogata, H; Kanai, T; Sugino, Y; Iwao, Y				Kashiwagi, Kazuhiro; Inoue, Nagamu; Yoshida, Toshifumi; Bessho, Rieko; Yoneno, Kazuaki; Imaeda, Hiroyuki; Ogata, Haruhiko; Kanai, Takanori; Sugino, Yoshinori; Iwao, Yasushi			The impact of visceral adipose tissue as best predictor for difficult colonoscopy and the clinical utility of a long small-caliber scope as rescue	PLOS ONE			English	Article							INCOMPLETE COLONOSCOPY; CECAL INSERTION; TOMOGRAPHY; QUALITY; CANCER; TIME	Background There have been many reports about a variety of factors associated with incomplete colonoscopy or difficult colonoscopy with long cecal intubation time (CIT). The aim of this retrospective study was to analyze the factors related to difficult colonoscopy under conscious sedation and demonstrate the clinical utility of a small-caliber scope as rescue by using the data from a large number of subjects who underwent health check-ups. Methods Consecutive 1036 cases over a 12-month period (April 2015 to March 2016) were enrolled and 619 subjects were divided into two groups: Easy colonoscopy (CS) Group (CIT <= 10 min); Difficult CS Group (CIT > 10 min or incomplete colonoscopy by a standard scope). The two groups were compared by subjects and colonoscopy characteristics with univariate analysis followed by multivariate logistic regression analysis. Reasons for incomplete colonoscopy were also assessed. Results Cecal intubation rate increased from 97.9% to 99.9% (1007/1008) by the rescue scope. Main reasons for incomplete colonoscopy were tortuosity in the left hemicolon (38%), redundancy in the right hemicolon (29%), pain (19%) and fixation (14%). Moreover, 95% (20/21) of rescue colonoscopies were completed without additional sedation. Higher BMI (21 kg/m(2) <= BMI) and intermediate visceral adipose tissue (VAT) (75 cm(2) <= VAT < 150 cm(2)) were significantly associated with easy CS (80.7% vs 19.3%, P = 0.004; 56.3% vs 43.7%, P = 0.001) by univariate analysis. Age, gender, and VAT, not BMI, were independently associated with difficult colonoscopy by multivariate analysis (OR (95% CI), P: 0.964 (0.942, 0.985), 0.001; 1.845 (1.101, 3.091), 0.020; 2.347 (1.395, 3.951), 0.001). Subgroup analysis by gender also showed VAT as the best predictor for both genders. Conclusion Difficult colonoscopy was significantly associated with advancing age, female gender and, lower (< 75 cm(2)) or higher (150 cm(2) <=) VAT. These subjects may benefit from having complete and more comfortable colonoscopy examinations by using the small-caliber scope rather than the standard scope.	[Kashiwagi, Kazuhiro; Inoue, Nagamu; Yoshida, Toshifumi; Bessho, Rieko; Sugino, Yoshinori; Iwao, Yasushi] Keio Univ Hosp, Ctr Prevent Med, Tokyo, Japan; [Yoneno, Kazuaki; Kanai, Takanori] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Imaeda, Hiroyuki] Saitama Med Univ, Sch Med, Dept Gen Med, Saitama, Japan; [Ogata, Haruhiko] Keio Univ, Ctr Diagnost & Therapeut Endoscopy, Sch Med, Tokyo, Japan	Keio University; Keio University; Saitama Medical University; Keio University	Kashiwagi, K (corresponding author), Keio Univ Hosp, Ctr Prevent Med, Tokyo, Japan.	kazuuk075@gmail.com		Kanai, Takanori/0000-0002-1466-4532	 [16K09290]		KK received funding from Grants-in-Aid for Scientific Research (grant number: 16K09290; URL: htto://www.isps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2000, AM J GASTROENTEROL, V95, P2784, DOI 10.1016/S0002-9270(00)01979-1; Anderson JC, 2001, GASTROINTEST ENDOSC, V54, P558, DOI 10.1067/mge.2001.118950; Arcovedo R, 2007, SURG ENDOSC, V21, P885, DOI 10.1007/s00464-006-9116-5; Aronchick CA, 2000, GASTROINTEST ENDOSC, V52, P346, DOI 10.1067/mge.2000.108480; Chung GE, 2014, SCAND J GASTROENTERO, V49, P1261, DOI 10.3109/00365521.2014.950695; CHURCH JM, 1994, AM J GASTROENTEROL, V89, P556; CIROCCO WC, 1995, DIS COLON RECTUM, V38, P964, DOI 10.1007/BF02049733; Corporaal S, 2010, SCAND J GASTROENTERO, V45, P1380, DOI 10.3109/00365521003734158; Dafnis G, 2005, DIGEST LIVER DIS, V37, P113, DOI 10.1016/j.dld.2004.09.015; Jia H, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0273-7; Kashiwagi K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174155; Lee SK, 2006, J CLIN GASTROENTEROL, V40, P711, DOI 10.1097/00004836-200609000-00010; Lee TJW, 2012, GUT, V61, P1050, DOI 10.1136/gutjnl-2011-300651; Lee YH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40389; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Moon SY, 2017, WORLD J GASTROENTERO, V23, P2346, DOI 10.3748/wjg.v23.i13.2346; Nagata N, 2014, DIS COLON RECTUM, V57, P1213, DOI 10.1097/DCR.0000000000000203; Obesity, 1997, PREV MAN GLOB EP REP; Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; SADAHIRO S, 1992, SURG RADIOL ANAT, V14, P251, DOI 10.1007/BF01794949; Sato K, 2012, ENDOSCOPY, V44, P746, DOI 10.1055/s-0032-1310063; Shah HA, 2007, GASTROENTEROLOGY, V132, P2297, DOI 10.1053/j.gastro.2007.03.032; Takahashi Y, 2005, DIS COLON RECTUM, V48, P1295, DOI 10.1007/s10350-004-0940-1	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189817	10.1371/journal.pone.0189817	http://dx.doi.org/10.1371/journal.pone.0189817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267320	Green Published, gold, Green Submitted			2022-12-26	WOS:000418587400051
J	Paul, B; Royston, KJ; Li, YY; Stoll, ML; Skibola, CF; Wilson, LS; Barnes, S; Morrow, CD; Tollefsbol, TO				Paul, Bidisha; Royston, Kendra J.; Li, Yuanyuan; Stoll, Matthew L.; Skibola, Christine F.; Wilson, Landon S.; Barnes, Stephen; Morrow, Casey D.; Tollefsbol, Trygve O.			Impact of genistein on the gut microbiome of humanized mice and its role in breast tumor inhibition	PLOS ONE			English	Article							CELL-CYCLE ARREST; SOY ISOFLAVONES; CANCER-CELLS; ESTROGEN-RECEPTOR; DIVERSITY; METABOLITE; SEQUENCES; EQUOL	Since dietary polyphenols can have beneficial effects in prevention and treatment of cancer, we tested the hypothesis that breast cancer patients' intestinal microbiota is modulated by genistein (GE), an isoflavone found in soy, and that microbial alterations may offset the side effects brought about by chemotherapy. We demonstrated successful humanization of germ-free mice by transplanting fecal samples from breast cancer patients before and after chemotherapy. Mice were then grouped based on chemotherapy status and GE or control diet. We did not find any significant differences between pre-chemotherapy and post-chemotherapy bacterial composition and abundances. Germ-free mice on a GE diet showed differences in microbial composition as compared to mice on control diet. Four weeks after introduction of the customized GE diet, there was distinct clustering of GE-fed mice as compared to the control-fed group. In the gut microbiome of GE-treated humanized mice, there was an increase in abundance of genera Lactococcus and Eubacterium. Phylum Verrucomi-crobia showed statistically significant (p = 0.02) differences in abundances between the GE-fed and control-fed groups. There was an increase in bacteria belonging to family Lachnospiraceae and Ruminococcaceae in GE-fed mice. Marked changes were observed in GE catabolism in mice humanized with fecal material from two of three patients' post-chemotherapy with complete disappearance of 4-ethylphenol and 2-(4-hydroxyphenol) propionic acid conjugates. The post-tumor samples did not show any distinct clustering of the gut microbiota between the two diet groups. There was an increase in latency of about 25% for tumor growth of the humanized mice that were on a GE diet as compared to humanized mice on a control diet. The average tumor size for the GE group was significantly decreased compared to the non-GE group. Collectively, our results suggest that the intestinal microbiota becomes altered with a GE diet before induction of tumor. Our findings indicate that GE modulates the microbiome in humanized mice that may contribute to its effects on increasing the latency of breast tumor and reducing tumor growth.	[Paul, Bidisha; Royston, Kendra J.; Li, Yuanyuan; Tollefsbol, Trygve O.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Royston, Kendra J.; Li, Yuanyuan; Barnes, Stephen; Tollefsbol, Trygve O.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Stoll, Matthew L.] Univ Alabama Birmingham, Div Pediat Rheumatol, Birmingham, AL USA; [Skibola, Christine F.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Wilson, Landon S.; Barnes, Stephen] Univ Alabama Birmingham, Targeted Metabol & Prote Lab, Birmingham, AL USA; [Barnes, Stephen] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL USA; [Barnes, Stephen; Tollefsbol, Trygve O.] Univ Alabama Birmingham, Comprehens Ctr Hlth Aging, Birmingham, AL 35294 USA; [Barnes, Stephen; Tollefsbol, Trygve O.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL 35294 USA; [Morrow, Casey D.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Tollefsbol, TO (corresponding author), Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA.; Tollefsbol, TO (corresponding author), Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA.; Tollefsbol, TO (corresponding author), Univ Alabama Birmingham, Comprehens Ctr Hlth Aging, Birmingham, AL 35294 USA.; Tollefsbol, TO (corresponding author), Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL 35294 USA.; Tollefsbol, TO (corresponding author), Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA.	trygve@uab.edu	Paul, Bidisha/AAB-8948-2022	Paul, Bidisha/0000-0002-0101-8187; Tollefsbol, Trygve/0000-0002-0284-1511	UAB Comprehensive Cancer Center; NIH [R01 CA178441, R01 CA2044346]; American institute for Cancer Research; NIN Shared Instrumentation Grant [S10 RR027822]; NIH P30 Core Grant [P30 DK079337]; Microbiome Resource at the University of Alabama at Birmingham: Comprehensive Cancer Center [P30AR050948]; Center for Clinical Translational Science [UL1TR001417]; University Wide Institutional Core, Microbiome Center; Heflin Center for Genomic Sciences; NATIONAL CANCER INSTITUTE [R01CA204346, R03CA176766] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K01AT009373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER	UAB Comprehensive Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American institute for Cancer Research; NIN Shared Instrumentation Grant; NIH P30 Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microbiome Resource at the University of Alabama at Birmingham: Comprehensive Cancer Center; Center for Clinical Translational Science; University Wide Institutional Core, Microbiome Center; Heflin Center for Genomic Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a pilot grant from the UAB Comprehensive Cancer Center to SB and in part by grants from the NIH (R01 CA178441 and R01 CA2044346) and the American institute for Cancer Research to TT. The mass spectrometer used in these experiments was purchased with a NIN Shared Instrumentation Grant (S10 RR027822 to SB). The operation of the Targeted Metabolomics and Proteomics Laboratory is supported in part by NIH P30 Core Grant (P30 DK079337 to Anupam Agarwal) to the George OBrien UAB/UCSD Acute Kidney Injury Center. The following are acknowledged for their support of the Microbiome Resource at the University of Alabama at Birmingham: Comprehensive Cancer Center (P30AR050948), Center for Clinical Translational Science (UL1TR001417), University Wide Institutional Core, Microbiome Center and Heflin Center for Genomic Sciences.	Andres S, 2011, CRIT REV TOXICOL, V41, P463, DOI 10.3109/10408444.2010.541900; Arcamone F, 2000, BIOTECHNOL BIOENG, V67, P704, DOI 10.1002/(SICI)1097-0290(20000320)67:6<704::AID-BIT8>3.0.CO;2-L; Baker JM, 2017, MATURITAS, V103, P45, DOI 10.1016/j.maturitas.2017.06.025; BEALS EW, 1984, ADV ECOL RES, V14, P1, DOI 10.1016/S0065-2504(08)60168-3; Camacho L, 2016, FOOD CHEM TOXICOL, V94, P39, DOI 10.1016/j.fct.2016.05.014; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CARY SG, 1964, J BACTERIOL, V88, P96, DOI 10.1128/JB.88.1.96-98.1964; Chao A, 2009, ECOLOGY, V90, P1125, DOI 10.1890/07-2147.1; Chen HP, 2013, J ONCOL, V2013, DOI 10.1155/2013/872957; Clavel T, 2016, INT J MED MICROBIOL, V306, P316, DOI 10.1016/j.ijmm.2016.03.002; Coldham NG, 1999, J STEROID BIOCHEM, V70, P169, DOI 10.1016/S0960-0760(99)00104-1; Crown J, 2004, ONCOLOGIST, V9, P24, DOI 10.1634/theoncologist.9-suppl_2-24; de Cremoux P, 2015, BREAST CANCER RES TR, V149, P81, DOI 10.1007/s10549-014-3233-y; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Faith DP, 2006, EVOL BIOINFORM, V2, P121; Fernandes A, 2014, 9 EUR C MATH THEOR B; Gho SA, 2013, CANCER CAUSE CONTROL, V24, P517, DOI 10.1007/s10552-012-0142-4; Goedert JJ, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv147; Guadamuro L, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1001-y; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Huang H, 2016, FASEB J S, V30, P1176; Kertesz MA, 2000, FEMS MICROBIOL REV, V24, P135, DOI 10.1016/S0168-6445(99)00033-9; Keylock CJ, 2005, OIKOS, V109, P203, DOI 10.1111/j.0030-1299.2005.13735.x; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Kim SY, 2009, ANN NY ACAD SCI, V1171, P270, DOI 10.1111/j.1749-6632.2009.04721.x; Kumar R, 2014, CURRENT PROTOCOLS HU; Kumar R, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-015-0622-2; Landete JM, 2016, CRIT REV FOOD SCI, V56, P1826, DOI 10.1080/10408398.2013.789823; Lee SA, 2009, AM J CLIN NUTR, V89, P1920, DOI 10.3945/ajcn.2008.27361; Li YY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-9; Li YY, 2009, INT J CANCER, V125, P286, DOI 10.1002/ijc.24398; Liang QY, 2017, CLIN CANCER RES, V23, P2061, DOI 10.1158/1078-0432.CCR-16-1599; Lindheim L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168390; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mahmoud AM, 2014, J STEROID BIOCHEM, V140, P116, DOI 10.1016/j.jsbmb.2013.12.010; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mondot S, 2016, ANN NY ACAD SCI, V1372, P9, DOI 10.1111/nyas.13033; Muthyala RS, 2004, BIOORGAN MED CHEM, V12, P1559, DOI 10.1016/j.bmc.2003.11.035; Nguyen DT, 2006, FREE RADICAL BIO MED, V41, P1225, DOI 10.1016/j.freeradbiomed.2006.06.026; Panasevich MR, 2017, J NUTR BIOCH; Paul B, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0144-7; Saghatchian M, 2014, BREAST, V23, P279, DOI 10.1016/j.breast.2014.01.009; Saldanha SN, 2014, EXP CELL RES, V324, P40, DOI 10.1016/j.yexcr.2014.01.024; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soukup ST, 2016, ARCH TOXICOL, V90, P1335, DOI 10.1007/s00204-016-1663-5; Spagnuolo C, 2015, ADV NUTR, V6, P408, DOI 10.3945/an.114.008052; Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14; Wilson ID, 2017, TRANSL RES, V179, P204, DOI 10.1016/j.trsl.2016.08.002; Xie Q, 2014, GENE CHROMOSOME CANC, V53, P422, DOI 10.1002/gcc.22154; Xiong T, 2020, SENSOR ACTUAT B-CHEM, V304, DOI [10.1016/j.snb.2019.127310, 10.1126/scitranslmed.3009124]	55	44	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189756	10.1371/journal.pone.0189756	http://dx.doi.org/10.1371/journal.pone.0189756			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267377	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400046
J	Attoff, K; Gliga, A; Lundqvist, J; Norinder, U; Forsby, A				Attoff, Kristina; Gliga, Anda; Lundqvist, Jessica; Norinder, Ulf; Forsby, Anna			Whole genome microarray analysis of neural progenitor C17.2 cells during differentiation and validation of 30 neural mRNA biomarkers for estimation of developmental neurotoxicity	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; METHYLMERCURY TOXICITY; EPIGENETIC CHANGES; METHYL MERCURY; SELF-RENEWAL; EXPOSURE; MODEL; TRANSCRIPTOMICS; ASTROCYTES	Despite its high relevance, developmental neurotoxicity (DNT) is one of the least studied forms of toxicity. Current guidelines for DNT testing are based on in vivo testing and they require extensive resources. Transcriptomic approaches using relevant in vitro models have been suggested as a useful tool for identifying possible DNT-generating compounds. In this study, we performed whole genome microarray analysis on the murine progenitor cell line C17.2 following 5 and 10 days of differentiation. We identified 30 genes that are strongly associated with neural differentiation. The C17.2 cell line can be differentiated into a co-culture of both neurons and neuroglial cells, giving a more relevant picture of the brain than using neuronal cells alone. Among the most highly upregulated genes were genes involved in neurogenesis (CHRDL1), axonal guidance (BMP4), neuronal connectivity (PLXDC2), axonogenesis (RTN4R) and astrocyte differentiation (S100B). The 30 biomarkers were further validated by exposure to non-cytotoxic concentrations of two DNT-inducing compounds (valproic acid and methylmercury) and one neurotoxic chemical possessing a possible DNT activity (acrylamide). Twenty-eight of the 30 biomarkers were altered by at least one of the neurotoxic substances, proving the importance of these biomarkers during differentiation. These results suggest that gene expression profiling using a predefined set of biomarkers could be used as a sensitive tool for initial DNT screening of chemicals. Using a predefined set of mRNA biomarkers, instead of the whole genome, makes this model affordable and high-throughput. The use of such models could help speed up the initial screening of substances, possibly indicating alerts that need to be further studied in more sophisticated models.	[Attoff, Kristina; Lundqvist, Jessica; Forsby, Anna] Stockholm Univ, Dept Neurochem, Stockholm, Sweden; [Gliga, Anda] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Lundqvist, Jessica; Norinder, Ulf; Forsby, Anna] Karolinska Inst, Unit Toxicol Sci, Swetox, Sodertalje, Sweden	Stockholm University; Karolinska Institutet; Karolinska Institutet	Attoff, K (corresponding author), Stockholm Univ, Dept Neurochem, Stockholm, Sweden.	kristina.attoff@neurochem.su.se		Forsby, Anna/0000-0001-6298-201X; Attoff, Kristina/0000-0002-6611-0785; Norinder, Ulf/0000-0003-3107-331X	Swedish research council [K2013-79X-21373-05-3]; Stockholm County Council; Knut & Alice Wallenberg Foundation; Swedish Research Council FORMAS; Swedish Fund for Research without Animal Experiments	Swedish research council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Fund for Research without Animal Experiments	The research at Stockholm University (KA, JL, AF) was funded by the Swedish research council (K2013-79X-21373-05-3). The research at Swetox (UN, AF) was supported by Stockholm County Council, Knut & Alice Wallenberg Foundation, and Swedish Research Council FORMAS and the Swedish Fund for Research without Animal Experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2007, DERMATOTOXICOLOGY, DOI DOI 10.1201/9781420009774.CH33; Attoff K, 2016, TOXICOL IN VITRO, V35, P100, DOI 10.1016/j.tiv.2016.05.014; Bal-Price A, 2015, ARCH TOXICOL, V89, P269, DOI 10.1007/s00204-015-1464-2; Bal-Price AK, 2010, NEUROTOXICOLOGY, V31, P545, DOI 10.1016/j.neuro.2009.11.006; Balmer NV, 2014, BASIC CLIN PHARMACOL, V115, P59, DOI 10.1111/bcpt.12203; Balmer NV, 2012, HUM MOL GENET, V21, P4104, DOI 10.1093/hmg/dds239; Barnes AP, 2008, CURR OPIN NEUROBIOL, V18, P44, DOI 10.1016/j.conb.2008.05.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CAGIANO R, 1990, NEUROTOXICOL TERATOL, V12, P23, DOI 10.1016/0892-0362(90)90108-O; Chen MJ, 2012, TOXICOL SCI, V130, P217, DOI 10.1093/toxsci/kfs223; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Ciani L, 2011, P NATL ACAD SCI USA, V108, P10732, DOI 10.1073/pnas.1018132108; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Colleoni S, 2011, TOXICOL SCI, V124, P370, DOI 10.1093/toxsci/kfr245; Crofton KM, 2012, CONGENIT ANOM, V52, P140, DOI 10.1111/j.1741-4520.2012.00377.x; Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Foster WR, 2007, TOXICOL PATHOL, V35, P621, DOI 10.1080/01926230701419063; Fritsche E, 2017, ALTEX-ALTERN ANIM EX, V34, P311, DOI 10.14573/altex.1701171; Harrill JA, 2010, NEUROTOXICOLOGY, V31, P277, DOI 10.1016/j.neuro.2010.02.003; Herbert MR, 2010, CURR OPIN NEUROL, V23, P103, DOI 10.1097/WCO.0b013e328336a01f; Hogberg HT, 2011, NEUROTOXICOLOGY, V32, P158, DOI 10.1016/j.neuro.2010.10.007; Hogberg HT, 2010, TOXICOL SCI, V113, P95, DOI 10.1093/toxsci/kfp175; Hogberg HT, 2009, TOXICOL APPL PHARM, V235, P268, DOI 10.1016/j.taap.2008.12.014; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jagtap S, 2011, BRIT J PHARMACOL, V162, P1743, DOI 10.1111/j.1476-5381.2010.01197.x; Jones EV, 2011, J NEUROSCI, V31, P4154, DOI 10.1523/JNEUROSCI.4757-10.2011; Kadereit S, 2012, FRONT BIOSCI-LANDMRK, V17, P2442, DOI 10.2741/4064; Kalia M, 2008, METABOLISM, V57, pS2, DOI 10.1016/j.metabol.2008.07.009; Kaur P, 2006, NEUROTOXICOLOGY, V27, P492, DOI 10.1016/j.neuro.2006.01.010; Kennedy KAM, 2012, CELL MOL LIFE SCI, V69, P215, DOI 10.1007/s00018-011-0807-2; Krug AK, 2013, ARCH TOXICOL, V87, P123, DOI 10.1007/s00204-012-0967-3; Kuegler PB, 2010, ALTEX-ALTERN ANIM EX, V27, P17; Laurenza I, 2013, INT J DEV NEUROSCI, V31, P679, DOI 10.1016/j.ijdevneu.2013.03.002; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Leist M, 2010, ALTEX-ALTERN ANIM EX, V27, P309; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lively S, 2008, NEUROCHEM RES, V33, P1692, DOI 10.1007/s11064-008-9606-z; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; LoPachin RM, 2002, NEUROTOXICOLOGY, V23, P253, DOI 10.1016/S0161-813X(02)00024-4; Lundqvist J, 2013, TOXICOL IN VITRO, V27, P1565, DOI 10.1016/j.tiv.2012.04.020; Luo J, 2017, IMMUNOL CELL BIOL; Mateo JL, 2015, GENOME RES, V25, P41, DOI 10.1101/gr.173435.114; Mundy WR, 2010, TOXICOLOGY, V270, P121, DOI 10.1016/j.tox.2010.02.004; National Research Council (NRC), 2007, J TOXICOL ENV HEAL B, DOI [DOI 10.1080/10937404.2010.483176, 10.1080/10937404.2010.483176]; Onishchenko N, 2008, J NEUROCHEM, V106, P1378, DOI 10.1111/j.1471-4159.2008.05484.x; Parran DK, 2004, DEV BRAIN RES, V149, P53, DOI 10.1016/j.devbrainres.2003.10.017; Parran DK, 2001, TOXICOL SCI, V59, P278, DOI 10.1093/toxsci/59.2.278; Rempel E, 2015, ARCH TOXICOL, V89, P1599, DOI 10.1007/s00204-015-1573-y; Rocha RA, 2011, TOXICOL LETT, V203, P237, DOI 10.1016/j.toxlet.2011.03.023; Schulpen SHW, 2015, TOXICOL SCI, V146, P311, DOI 10.1093/toxsci/kfv094; Shi LM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S12; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Smirnova L, 2014, ALTEX-ALTERN ANIM EX, V31, P129, DOI 10.14573/altex.1403271; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Stringari J, 2008, TOXICOL APPL PHARM, V227, P147, DOI 10.1016/j.taap.2007.10.010; Stummanna TC, 2009, TOXICOLOGY, V257, P117, DOI 10.1016/j.tox.2008.12.018; Tamm C, 2006, J NEUROCHEM, V97, P69, DOI 10.1111/j.1471-4159.2006.03718.x; Tamm C, 2008, TOXICOL SCI, V101, P310, DOI 10.1093/toxsci/kfm267; Theunissen PT, 2011, TOXICOL SCI, V122, P437, DOI 10.1093/toxsci/kfr134; Tsuji R, 2012, CONGENIT ANOM, V52, P122, DOI 10.1111/j.1741-4520.2012.00374.x; US EPA, 1998, EPA712C96239 US; van Thriel C, 2012, NEUROTOXICOLOGY, V33, P911, DOI 10.1016/j.neuro.2011.10.002; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verrotti A, 2014, REPROD TOXICOL, V48, P72, DOI 10.1016/j.reprotox.2014.04.005; Vieira HLA, 2011, PROG NEUROBIOL, V93, P444, DOI 10.1016/j.pneurobio.2011.01.007; Waldmann T, 2014, CHEM RES TOXICOL, V27, P408, DOI 10.1021/tx400402j; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang L, 2009, TOXICOL SCI, V107, P135, DOI 10.1093/toxsci/kfn201; WISE LD, 1995, NEUROTOXICOL TERATOL, V17, P189, DOI 10.1016/0892-0362(94)00071-K; Zeller KS, 2017, ALTEX; Zurich MG, 2004, TOXICOL APPL PHARM, V201, P97, DOI 10.1016/j.taap.2004.05.003	75	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0190066	10.1371/journal.pone.0190066	http://dx.doi.org/10.1371/journal.pone.0190066			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261810	Green Published, gold			2022-12-26	WOS:000418564200086
J	Buckert, M; Stroe-Kunold, E; Friederich, HC; Wesche, D; Walter, C; Kopf, S; Simon, JJ; Herzog, W; Wild, B				Buckert, Magdalena; Stroe-Kunold, Esther; Friederich, Hans-Christoph; Wesche, Daniela; Walter, Christiane; Kopf, Stefan; Simon, Joe J.; Herzog, Wolfgang; Wild, Beate			Time course of adiponectin and its relationship to psychological aspects in patients with anorexia nervosa during inpatient treatment	PLOS ONE			English	Article							PROTEIN; GLUCOCORTICOIDS; ADIPOCYTOKINES; ADIPOKINES; CORTISOL; DECREASE; OBESITY; LEPTIN; WOMEN	Objective The protein hormone adiponectin promotes metabolic and psychological health. The aim of the study was to track changes in adiponectin levels in response to weight gain and to assess associations between adiponectin and psychological aspects in patients with anorexia nervosa (AN). Methods To investigate if adiponectin levels depend on AN severity, data were assessed from 11 inpatients with a very low body mass index (BMI) and a high chronicity (high severity group; HSS), and nine with less severe symptoms (LSS). During the course of treatment, serum adiponectin concentrations were assessed on a weekly basis along with BMI. Psychological variables (i.e., depression, anxiety, stress, and AN-specific symptoms) were obtained by means of electronic diaries. Longitudinal regressions and correlations were calculated to evaluate the temporal course of adiponectin and its relationship with psychological self-ratings. Results At the beginning adiponectin was not increased in HSS patients (p = .56), and only marginally elevated in LSS patients (p = 0.07) compared with controls. In HSS patients, adiponectin increased along with BMI during the first treatment phase (i.e., when the BMI of patients was below 16 kg/m(2)) and thereafter decreased with further weight gain. In LSS patients, adiponectin was not associated with BMI increase. Furthermore, adiponectin was strongly negatively correlated with psychological self-ratings when the BMI of patients was above 16 kg/m(2), i.e., higher levels of adiponectin were related to lower ratings of depression, anxiety, and AN-specific symptoms. Discussion The study connects previous varying results by indicating that the course of adiponectin is dependent on BMI and symptom severity. Similarly, associations of adiponectin and psychological health depended on BMI.	[Buckert, Magdalena; Stroe-Kunold, Esther; Wesche, Daniela; Walter, Christiane; Simon, Joe J.; Herzog, Wolfgang; Wild, Beate] Med Univ Hosp, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany; [Friederich, Hans-Christoph; Simon, Joe J.] Univ Dusseldorf, LVR Clin, Dept Psychosomat Med & Psychotherapy, Dusseldorf, Germany; [Kopf, Stefan] Med Univ Hosp, Dept Endocrinol & Clin Chem, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Wild, B (corresponding author), Med Univ Hosp, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany.	beate.wild@med.uni-heidelberg.de	Simon, Joe/ABA-6896-2021	Simon, Joe/0000-0001-7407-1344; Hellwig-Walter, Christiane/0000-0002-4524-117X	Medical Faculty of the University of Heidelberg (Olympia Morata Programme) [F.206808]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Medical Faculty of the University of Heidelberg (Olympia Morata Programme); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	This study was supported by the Medical Faculty of the University of Heidelberg (Olympia Morata Programme, F.206808; Postdoctoral Fellowship Programme). This study also received funding from the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg, within the funding programme for Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitani H, 2013, NUTRITION, V29, P203, DOI 10.1016/j.nut.2012.07.011; Arita Y, 2012, BIOCHEM BIOPH RES CO, V425, P560, DOI 10.1016/j.bbrc.2012.08.024; Baranowska-Bik A, 2017, ENDOKRYNOL POL, V68, P422, DOI 10.5603/EP.a2017.0035; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Bosy-Westphal A, 2005, EUR J NUTR, V44, P355, DOI 10.1007/s00394-005-0533-3; Brichard SM, 2003, HORM METAB RES, V35, P337, DOI 10.1055/s-2003-41353; Brockmeyer T, 2012, COMPR PSYCHIAT, V53, P496, DOI 10.1016/j.comppsych.2011.09.003; Carvalho AF, 2014, J PSYCHIATR RES, V59, P28, DOI 10.1016/j.jpsychires.2014.08.002; Cawthorn WP, 2014, CELL METAB, V20, P368, DOI 10.1016/j.cmet.2014.06.003; Degawa-Yamauchi M, 2005, OBES RES, V13, P662, DOI 10.1038/oby.2005.74; Diniz BS, 2012, J PSYCHIATR RES, V46, P1081, DOI 10.1016/j.jpsychires.2012.04.028; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fallo F, 2004, EUR J ENDOCRINOL, V150, P339, DOI 10.1530/eje.0.1500339; Hilbert A, 2007, DIAGNOSTICA, V53, P144, DOI 10.1026/0012-1924.53.3.144; Hofmann T, 2017, APPETITE, V108, P141, DOI 10.1016/j.appet.2016.09.032; Hofmann T, 2015, PSYCHONEUROENDOCRINO, V60, P130, DOI 10.1016/j.psyneuen.2015.06.014; Hofmann T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132058; Hofmann T, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2013.00202; Iwahashi H, 2003, HORM METAB RES, V35, P537, DOI 10.1055/s-2003-42655; Khalil RB, 2014, EAT WEIGHT DISORD-ST, V19, P3, DOI 10.1007/s40519-013-0094-z; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Liu J, 2012, P NATL ACAD SCI USA, V109, P12248, DOI 10.1073/pnas.1202835109; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Mansur RB, 2016, J PSYCHIATR RES, V74, P63, DOI 10.1016/j.jpsychires.2015.12.003; Modan-Moses D, 2007, J CLIN ENDOCR METAB, V92, P1843, DOI 10.1210/jc.2006-1683; Nishida M, 2007, MED MOL MORPHOL, V40, P55, DOI 10.1007/s00795-007-0366-7; Nogueira JP, 2010, EUR J CLIN NUTR, V64, P840, DOI 10.1038/ejcn.2010.66; Oldershaw A, 2011, NEUROSCI BIOBEHAV R, V35, P970, DOI 10.1016/j.neubiorev.2010.11.001; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Scharner S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00475; Serpell L, 2004, INT J EAT DISORDER, V36, P416, DOI 10.1002/eat.20040; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Stengel A, 2014, PEPTIDES, V61, P75, DOI 10.1016/j.peptides.2014.09.006; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Stroe-Kunold E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166843; Stroe-Kunold E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154701; Tagami T, 2004, J CLIN ENDOCR METAB, V89, P1833, DOI 10.1210/jc.2003-031260; Taylor VH, 2010, J OBES, V2010, DOI 10.1155/2010/748048; Terra X, 2013, INT J EAT DISORDER, V46, P855, DOI 10.1002/eat.22166; Thundyil J, 2012, BRIT J PHARMACOL, V165, P313, DOI 10.1111/j.1476-5381.2011.01560.x; Tomasik PJ, 2014, WORLD J PSYCHIATR, V4, P103; Treasure J, 2012, EUR EAT DISORD REV, V20, P431, DOI 10.1002/erv.2181; Unsal C, 2012, J AFFECT DISORDERS, V139, P302, DOI 10.1016/j.jad.2012.03.022; Wild B, 2016, INT J PSYCHOPHYSIOL, V102, P25, DOI 10.1016/j.ijpsycho.2016.03.002; Wild B, 2014, INT J PSYCHOPHYSIOL, V94, P272, DOI 10.1016/j.ijpsycho.2014.09.010; Yau SY, 2014, P NATL ACAD SCI USA, V111, P15810, DOI 10.1073/pnas.1415219111	46	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189500	10.1371/journal.pone.0189500	http://dx.doi.org/10.1371/journal.pone.0189500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ7SY	29261731	gold, Green Submitted, Green Published			2022-12-26	WOS:000418564200044
J	Drew, AJ; Izykowski, MT; Bachus, KN; Henninger, HB; Foreman, KB				Drew, Alex J.; Izykowski, Morgan T.; Bachus, Kent N.; Henninger, Heath B.; Foreman, K. Bo			Transhumeral loading during advanced upper extremity activities of daily living	PLOS ONE			English	Article							UPPER-LIMB; ELBOW; PROSTHETICS; SHOULDER	Percutaneous osseointegrated (OI) implants for direct skeletal attachment of upper extremity prosthetics represent an alternative to traditional socket suspension that may yield improved patient function and satisfaction. This is especially true in high-level, transhumeral amputees where prosthetic fitting is challenging and abandonment rates remain high. However, maintaining mechanical integrity of the bone-implant interface is crucial for safe clinical introduction of this technology. The collection of population data on the transhumeral loading environment will aid in the design of compliance and overload protection devices that mitigate the risk of periprosthetic fracture. We collected marker-based upper extremity kinematic data from non-amputee volunteers during advanced activities of daily living (AADLs) that applied dynamic loading to the humerus. Inverse dynamic analysis was applied to calculate the axial force, bending and torsional moments at three virtual amputation levels representing 25, 50, and 75% residual humeral length. The influences of amputation level, elbow flexion constraint, gender and anthropometric scaling were assessed. Results indicate that the proximal (25%) amputation level experienced significantly higher axial forces and bending moments across all subjects when compared to distal amputation levels (p <= 0.030). Constraining elbow flexion had a limited influence on peak transhumeral loads. Male subjects experienced higher axial forces during all evaluated activities (p <= 0.023). Peak axial force for all activities occurred during jumping jacks (174.5N). Peak bending (57.6Nm) and torsional (57.2Nm) moments occurred during jumping jacks and rapid internal humeral rotation, respectively. Calculated loads fall within the range of implant fixation failure loads reported in cadaveric investigations of humeral stem fixation; indicating that periprosthetic fracture may occur during non-contact AADLs. These kinematic data, collected over a range of AADLs, will aid in the development of overload protection devices and appropriate post-operative rehabilitation protocols that balance return to an active lifestyle with patient safety.	[Drew, Alex J.; Izykowski, Morgan T.; Bachus, Kent N.; Henninger, Heath B.; Foreman, K. Bo] Univ Utah, Dept Orthopaed, Salt Lake City, UT 84112 USA; [Drew, Alex J.; Izykowski, Morgan T.; Bachus, Kent N.; Henninger, Heath B.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Bachus, Kent N.; Foreman, K. Bo] Dept Vet Affairs, Salt Lake City, UT USA; [Foreman, K. Bo] Univ Utah, Dept Phys Therapy & Athlet Training, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah	Henninger, HB (corresponding author), Univ Utah, Dept Orthopaed, Salt Lake City, UT 84112 USA.; Henninger, HB (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.; Foreman, KB (corresponding author), Dept Vet Affairs, Salt Lake City, UT USA.; Foreman, KB (corresponding author), Univ Utah, Dept Phys Therapy & Athlet Training, Salt Lake City, UT USA.	heath.henninger@utah.edu; bo.foreman@hsc.utah.edu	Henninger, Heath B/I-1488-2019	Henninger, Heath B/0000-0002-3635-1289	Medical Research and Materiel Command [W81XWH-15-C-0058]; National Institutes of Health [R01 AR067196]; United States Department of Veterans Affairs Rehabilitation Research and Development Service: Merit Review Award [I01RX001246]; University of Utah Undergraduate Research Opportunity Program; US Army Medical Research and Materiel Command [W81XWH-15-C-0058]; United States Department of Veterans Affairs Rehabilitation Research and Development Service [I01RX001246]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067196] Funding Source: NIH RePORTER; Veterans Affairs [I01RX001246] Funding Source: NIH RePORTER	Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs Rehabilitation Research and Development Service: Merit Review Award; University of Utah Undergraduate Research Opportunity Program; US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); United States Department of Veterans Affairs Rehabilitation Research and Development Service; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the Medical Research and Materiel Command, award number: #W81XWH-15-C-0058, recipient: KNB; National Institutes of Health, award number: R01 AR067196, recipient: HBH; United States Department of Veterans Affairs Rehabilitation Research and Development Service: Merit Review Award, award number: #I01RX001246, recipient: KNB; and University of Utah Undergraduate Research Opportunity Program, award number: None, recipient: MTI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the US Army Medical Research and Materiel Command under Contract #W81XWH-15-C-0058, the National Institutes of Health (R01 AR067196), a Merit Review Award #I01RX001246 from the United States Department of Veterans Affairs Rehabilitation Research and Development Service, and the University of Utah Undergraduate Research Opportunity Program. The views, opinions and/or findings contained in this report are those of the authors and should not be construed as an official Department of the Army or National Institutes of Health position, policy or decision unless so designated by other documentation. Furthermore, the contents do not represent the views of either the U.S. Department of Veterans Affairs, or the United States Government.	Aguinaldo AL, 2009, AM J SPORT MED, V37, P2043, DOI 10.1177/0363546509336721; Barker TM, 1997, P I MECH ENG H, V211, P483, DOI 10.1243/0954411981534619; Biddiss E, 2007, AM J PHYS MED REHAB, V86, P977, DOI 10.1097/PHM.0b013e3181587f6c; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; DEQUEKER J, 1971, INVEST RADIOL, V6, P260, DOI 10.1097/00004424-197107000-00005; Flury MP, 2011, ARCH ORTHOP TRAUM SU, V131, P267, DOI 10.1007/s00402-010-1170-8; Hansen RL, 2015, 6TH INTERNATIONAL CO; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Jonsson S, 2011, PROSTHET ORTHOT INT, V35, P190, DOI 10.1177/0309364611409003; Kang NV, 2010, J HAND SURG-AM, V35A, P1130, DOI 10.1016/j.jhsa.2010.03.037; Keyak JH, 2009, BONE, V44, P449, DOI 10.1016/j.bone.2008.11.014; Masjedi M, 2013, P I MECH ENG H, V227, P1275, DOI 10.1177/0954411913502330; Matsen FA, 1993, PRACTICAL TOOL EVALU; McCarthy ID, 2012, SPINAL CORD, V50, P333, DOI 10.1038/sc.2011.143; McFarland LV, 2010, J REHABIL RES DEV, V47, P299, DOI 10.1682/JRRD.2009.03.0027; Murray IA, 2004, CLIN BIOMECH, V19, P586, DOI 10.1016/j.clinbiomech.2004.03.004; Rab G, 2002, GAIT POSTURE, V15, P113, DOI 10.1016/S0966-6362(01)00155-2; Richards R R, 1994, J Shoulder Elbow Surg, V3, P347, DOI 10.1016/S1058-2746(09)80019-0; van der Lugt JCT, 2010, INT ORTHOP, V34, P1213, DOI 10.1007/s00264-009-0910-2; Welke B, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-70; WERNER SL, 1993, J ORTHOP SPORT PHYS, V17, P274, DOI 10.2519/jospt.1993.17.6.274; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Zatsiorsky V, 1983, MASS INERTIA CHARACT	23	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189418	10.1371/journal.pone.0189418	http://dx.doi.org/10.1371/journal.pone.0189418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261703	Green Published, Green Submitted, gold			2022-12-26	WOS:000418554900018
J	Osman, M; Benamrouz, S; Guyot, K; Baydoun, M; Frealle, E; Chabe, M; Gantois, N; Delaire, B; Goffard, A; Aoun, A; Jurdi, N; Dabboussi, F; Even, G; Slomianny, C; Gosset, P; Hamze, M; Creusy, C; Viscogliosi, E; Certad, G				Osman, Marwan; Benamrouz, Sadia; Guyot, Karine; Baydoun, Martha; Frealle, Emilie; Chabe, Magali; Gantois, Nausicaa; Delaire, Baptiste; Goffard, Anne; Aoun, Albert; Jurdi, Nawaf; Dabboussi, Fouad; Even, Gael; Slomianny, Christian; Gosset, Pierre; Hamze, Monzer; Creusy, Colette; Viscogliosi, Eric; Certad, Gabriela			High association of Cryptosporidium spp. infection with colon adenocarcinoma in Lebanese patients	PLOS ONE			English	Article							CELL APOPTOSIS; PARVUM; PARASITES; CANCER; MODEL; TIME	Background The association between Cryptosporidium and human colon cancer has been reported in different populations. However, this association has not been well studied. In order to add new strong arguments for a probable link between cryptosporidiosis and colon human cancer, the aim of this study was to determine prevalence and to identify species of Cryptosporidium among Lebanese patients. Methodology and principal findings Overall, 218 digestive biopsies were collected in Tripoli, Lebanon, from three groups of patients: (i) patients with recently diagnosed colon intraepithelial neoplasia/adenocarcinoma before any treatment (n = 72); (ii) patients with recently diagnosed stomach intraepithelial neoplasia/adenocarcinoma before any treatment (n = 21); and (iii) patients without digestive intraepithelial neoplasia/adenocarcinoma but with persistent digestive symptoms (n = 125). DNA extraction was performed from paraffin-embedded tissue. The presence of the parasite in tissues was confirmed by PCR, microscopic observation and immunofluorescence analysis. We identified a high rate (21%) of Cryptosporidium presence in biopsies from Lebanese patients with recently diagnosed colonic neoplasia/adenocarcinoma before any treatment. This prevalence was significantly higher compared to 7% of Cryptosporidium prevalence among patients without colon neoplasia but with persistent gastrointestinal symptoms (OR: 4, CI: 1.65-9.6, P = 0.001). When the comparison was done against normal biopsies, the risk of infection increased 11-fold in the group of patients with colon adenocarcinoma (OR: 11.315, CI: 1.44-89.02, P = 0.003). Conclusions This is the first study performed in Lebanon reporting the prevalence of Cryptosporidium among patients with digestive cancer. These results show that Cryptosporidium is strongly associated with human colon cancer being maybe a potential etiological agent of this disease.	[Osman, Marwan; Benamrouz, Sadia; Guyot, Karine; Baydoun, Martha; Frealle, Emilie; Chabe, Magali; Gantois, Nausicaa; Viscogliosi, Eric; Certad, Gabriela] Univ Lille, CHU Lille, BDPEE, UMR CNRS 8204,INSERM U1019,Inst Pasteur Lille,CII, Lille, France; [Osman, Marwan; Dabboussi, Fouad; Hamze, Monzer] Univ Libanaise, Fac Sante Publ, Ecole Doctorale Sci & Technol, LMSE, Tripoli, Lebanon; [Benamrouz, Sadia] Univ Catholique Lille, FGES, Ecol & Biodiversite, Lille, France; [Baydoun, Martha] Univ Lille, CNRS, ISEN, IEMN,BioMEMS,UMR 8520, Lille, France; [Baydoun, Martha] BioGAP, Grp HEI ISA ISEN, Lille, France; [Frealle, Emilie] Ctr Hosp Reg, Lille, France; [Frealle, Emilie] Univ Lille, Lille, France; [Frealle, Emilie] Univ Lille Nord France, Lab Parasitol Mycol, Ctr Biol & Pathol, Fac Med Lille, Lille, France; [Chabe, Magali] Univ Lille Nord France, Dept Parasitol Mycol, Fac Sci Pharmaceut & Biol, Lille, France; [Delaire, Baptiste; Gosset, Pierre; Creusy, Colette] Grp Hop Univ Catholique Lille, Serv Anat & Cytol Pathol, Lille, France; [Goffard, Anne] Univ Lille, CNRS, INSERM, Mol & Cellular Virol,Inst Pasteur Lille,CHU Lille, Lille, France; [Aoun, Albert; Jurdi, Nawaf] Amer Univ Beirut, Fac Med, Pathol Dept, Beirut, Lebanon; [Even, Gael] France PEGASE Biosci, Lille, France; [Slomianny, Christian] Univ Lille, INSERM U 1003, Lab Cell Physiol, Villeneuve Dascq, France; [Certad, Gabriela] Univ Catholique Lille, Fac Med & Maieut, Inst Catholique Lille, Dept Rech Med, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Lebanese University; Universite Catholique de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lille - ISITE; Centrale Lille; Universite de Lille; Universite Polytechnique Hauts-de-France; Centre Hospitalier Annecy Genevois; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; American University of Beirut; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite Catholique de Lille	Certad, G (corresponding author), Univ Lille, CHU Lille, BDPEE, UMR CNRS 8204,INSERM U1019,Inst Pasteur Lille,CII, Lille, France.; Certad, G (corresponding author), Univ Catholique Lille, Fac Med & Maieut, Inst Catholique Lille, Dept Rech Med, Lille, France.	gabriela.certad@pasteur-lille.fr	Osman, Marwan/AAD-3784-2021; Fréalle, Emilie/AAF-5162-2020; GOFFARD, Anne/GXG-6242-2022; Slomianny, Christian/L-8285-2018; B, S/HGC-3038-2022; Chabe, Magali/H-6045-2017	Osman, Marwan/0000-0002-6235-2760; B, S/0000-0003-1791-4389; Chabe, Magali/0000-0002-6732-6772; Frealle, Emilie/0000-0003-3129-979X	Programme Orientations Strategiques of the University of Lille 2; Institut Pasteur de Lille; Centre National de la Recherche Scientifique; Conseil National de la Recherche Scientifique; Azm & Saade Association of Lebanon	Programme Orientations Strategiques of the University of Lille 2; Institut Pasteur de Lille; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Conseil National de la Recherche Scientifique; Azm & Saade Association of Lebanon	This work was supported by the Programme Orientations Strategiques of the University of Lille 2. It was also supported by the Institut Pasteur de Lille and the Centre National de la Recherche Scientifique. MO was supported by a Ph.D. fellowship from the Conseil National de la Recherche Scientifique and the Azm & Saade Association of Lebanon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banuls AL, 2013, INFECT GENET EVOL, V20, P61, DOI 10.1016/j.meegid.2013.08.005; Benamrouz S, 2012, PARASITE, V19, P101, DOI 10.1051/parasite/2012192101; Benamrouz S, 2014, DIS MODEL MECH, V7, P693, DOI 10.1242/dmm.013292; Benamrouz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051232; Certad G, 2017, TRENDS PARASITOL; Certad G, 2012, APPL ENVIRON MICROB, V78, P1746, DOI 10.1128/AEM.06457-11; Certad G, 2010, AM J TROP MED HYG, V82, P257, DOI 10.4269/ajtmh.2010.09-0309; Certad Gabriela, 2007, Infect Agent Cancer, V2, P22, DOI 10.1186/1750-9378-2-22; Cheeseman K, 2016, M S-MED SCI, V32, P867, DOI 10.1051/medsci/20163210020; Chen XM, 2001, GASTROENTEROLOGY, V120, P1774, DOI 10.1053/gast.2001.24850; Fiorina L, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-18; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Leven EA, 2016, J CLIN IMMUNOL, V36, P490, DOI 10.1007/s10875-016-0291-4; Liu J, 2009, INFECT IMMUN, V77, P837, DOI 10.1128/IAI.00955-08; Mary C, 2013, J CLIN MICROBIOL, V51, P2556, DOI 10.1128/JCM.03458-12; Mele R, 2004, INFECT IMMUN, V72, P6061, DOI 10.1128/IAI.72.10.6061-6067.2004; Osman M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004496; Osman M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125129; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Shebl FM, 2012, AIDS RES HUM RETROV, V28, P794, DOI [10.1089/aid.2011.0185, 10.1089/AID.2011.0185]; Sow SO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004729; Striepen B, 2013, NATURE, V503, P189, DOI 10.1038/503189a; Sulzyc-Bielicka V, 2007, J PARASITOL, V93, P722, DOI 10.1645/GE-1025R1.1; Sulzyc-Bielicka Violetta, 2012, Pol Przegl Chir, V84, P348, DOI 10.2478/v10035-012-0058-4; Viennois Emilie, 2013, Transl Gastrointest Cancer, V2, P21	25	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189422	10.1371/journal.pone.0189422	http://dx.doi.org/10.1371/journal.pone.0189422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261714	gold, Green Published, Green Submitted			2022-12-26	WOS:000418554900019
J	Bando, SY; Iamashita, P; Guth, BE; dos Santos, LF; Fujita, A; Abe, CM; Ferreira, LR; Moreira, CA				Bando, Silvia Yumi; Iamashita, Priscila; Guth, Beatriz E.; dos Santos, Luis F.; Fujita, Andre; Abe, Cecilia M.; Ferreira, Leandro R.; Moreira-Filho, Carlos Alberto			A hemolytic-uremic syndrome-associated strain O113:H21 Shiga toxin-producing Escherichia coli specifically expresses a transcriptional module containing dicA and is related to gene network dysregulation in Caco-2 cells	PLOS ONE			English	Article							NF-KAPPA-B; EPITHELIAL-CELLS; SALMONELLA-TYPHIMURIUM; COLORECTAL-CANCER; BINDING-PROTEIN; MESSENGER-RNA; VIRULENCE; REGULATOR; INFECTION; APOPTOSIS	Shiga toxin-producing (Stx) Escherichia coli (STEC) O113:H21 strains are associated with human diarrhea and some of these strains may cause hemolytic uremic syndrome (HUS). The molecular mechanism underlying this capacity and the differential host cell response to HUS-causing strains are not yet completely understood. In Brazil O113:H21 strains are commonly found in cattle but, so far, were not isolated from HUS patients. Here we conducted comparative gene co-expression network (GCN) analyses of two O113:H21 STEC strains:EH41, reference strain, isolated from HUS patient in Australia, and Ec472/01, isolated from cattle feces in Brazil. These strains were cultured in fresh or in Caco-2 cell conditioned media. GCN analyses were also accomplished for cultured Caco-2 cells exposed to EH41 or Ec472/01. Differential transcriptome profiles for EH41 and Ec472/01 were not significantly changed by exposure to fresh or Caco-2 conditioned media. Conversely, global gene expression comparison of both strains cultured in conditioned medium revealed a gene set exclusively expressed in EH41, which includes the dicA putative virulence factor regulator. Network analysis showed that this set of genes constitutes an EH41 specific transcriptional module. PCR analysis in Ec472/01 and in other 10 Brazilian cattle-isolated STEC strains revealed absence of dicA in all these strains. The GCNs of Caco-2 cells exposed to EH41 or to Ec472/01 presented a major transcriptional module containing many hubs related to inflammatory response that was not found in the GCN of control cells. Moreover, EH41 seems to cause gene network dysregulation in Caco-2 as evidenced by the large number of genes with high positive and negative covariance interactions. EH41 grows slowly than Ec472/01 when cultured in Caco-2 conditioned medium and fitness-related genes are hypoexpressed in that strain. Therefore, EH41 virulence may be derived from its capacity for dysregulating enterocyte genome functioning and its enhanced enteric survival due to slow growth.	[Bando, Silvia Yumi; Iamashita, Priscila; Ferreira, Leandro R.; Moreira-Filho, Carlos Alberto] Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, SP, Brazil; [Guth, Beatriz E.; dos Santos, Luis F.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Immunol & Parasitol, Sao Paulo, SP, Brazil; [Fujita, Andre] Univ Sao Paulo, Inst Matemat & Estat, Dept Comp Sci, Sao Paulo, SP, Brazil; [Abe, Cecilia M.] Butantan Inst, Bacteriol Lab, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Instituto Butantan	Moreira, CA (corresponding author), Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, SP, Brazil.	carlos.moreira@hc.fm.usp.br	Guth, Beatriz E/D-8218-2015; Fujita, Andre/Q-1271-2019; moreira-filho, carlos alberto/J-2551-2014; dos Santos, Luís Fernando/AAW-3013-2021; Abe, Cecilia/AAM-6374-2021	Guth, Beatriz E/0000-0003-1689-3213; Fujita, Andre/0000-0002-7756-7051; moreira-filho, carlos alberto/0000-0003-3433-4714; Bando, Silvia Yumi/0000-0003-3794-2440	Programa de Apoio a Nucleos de Excelencia (PRONEX)/Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/50761-2]; FAPESP [2015/22308-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305635/2009-3]	Programa de Apoio a Nucleos de Excelencia (PRONEX)/Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Programa de Apoio a Nucleos de Excelencia (PRONEX)/Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grant no. 2011/50761-2, by FAPESP grant no. 2015/22308-2 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grant no. 305635/2009-3 to CAM-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, WORLD BEEF EXPORTS R; [Anonymous], 2017, WORD BEEF PRODUCTION; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Bando SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079913; Bansal T, 2012, FEMS IMMUNOL MED MIC, V66, P399, DOI 10.1111/1574-695X.12004; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Basavanna S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049638; Bearson BL, 2009, MICROBIOL-SGM, V155, P805, DOI 10.1099/mic.0.022905-0; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; BEJAR S, 1988, MOL GEN GENET, V212, P11, DOI 10.1007/BF00322439; BEJAR S, 1986, NUCLEIC ACIDS RES, V14, P6821, DOI 10.1093/nar/14.17.6821; Bennett KM, 2014, INFECT IMMUN, V82, P2860, DOI 10.1128/IAI.01681-14; Bergholz TM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-97; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bielaszewska M, 2006, CLIN INFECT DIS, V43, P1160, DOI 10.1086/508195; Bradford EM, 2010, AM J PHYSIOL-REG I, V298, pR1531, DOI 10.1152/ajpregu.00849.2009; Braun V, 2007, J BACTERIOL, V189, P6913, DOI 10.1128/JB.00884-07; Chapman SJ, 2007, AM J RESP CRIT CARE, V176, P181, DOI 10.1164/rccm.200702-169OC; Cosgriff S, 2010, MOL MICROBIOL, V77, P1289, DOI 10.1111/j.1365-2958.2010.07292.x; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Cui SH, 2001, APPL ENVIRON MICROB, V67, P4914, DOI 10.1128/AEM.67.10.4914-4918.2001; Dach K, 2009, INFECT IMMUN, V77, P5583, DOI 10.1128/IAI.00121-09; Daniels JJD, 1996, INFECT IMMUN, V64, P5075, DOI 10.1128/IAI.64.12.5075-5084.1996; De Biase D, 2012, MOL MICROBIOL, V86, P770, DOI 10.1111/mmi.12020; dos Santos LF, 2017, J APPL MICROBIOL, V122, P1101, DOI 10.1111/jam.13409; dos Santos LF, 2010, J MED MICROBIOL, V59, P634, DOI 10.1099/jmm.0.015263-0; Doughty S, 2002, INFECT IMMUN, V70, P6761, DOI 10.1128/IAI.70.12.6761-6769.2002; Elewaut D, 1999, J IMMUNOL, V163, P1457; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Feighner SD, 1999, SCIENCE, V284, P2184, DOI 10.1126/science.284.5423.2184; Feng P, 2017, J FOOD PROTECT, V80, P383, DOI [10.4315/0362-028X.JFP-16-325, 10.4315/0362-028x.jfp-16-325]; Feng PCH, 2014, APPL ENVIRON MICROB, V80, P4757, DOI 10.1128/AEM.01182-14; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fogg PCM, 2011, NUCLEIC ACIDS RES, V39, P2116, DOI 10.1093/nar/gkq923; Follows SA, 2009, INFECT IMMUN, V77, P3602, DOI 10.1128/IAI.01366-08; Franz E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120353; Gao N, 2010, J BIOL CHEM, V285, P28097, DOI 10.1074/jbc.M110.116566; Gerhardt A, 2004, CANCER LETT, V208, P197, DOI 10.1016/j.canlet.2003.11.021; Gonzalez AGM, 2016, J APPL MICROBIOL, V121, P1130, DOI 10.1111/jam.13230; Grimaldi S, 2010, J BIOL CHEM, V285, P179, DOI 10.1074/jbc.M109.060251; Haneburger I, 2012, J MOL BIOL, V424, P15, DOI 10.1016/j.jmb.2012.08.023; Hankins JS, 2010, J BACTERIOL, V192, P2482, DOI 10.1128/JB.01619-09; Hattori T, 2015, FEBS OPEN BIO, V5, P605, DOI 10.1016/j.fob.2015.06.005; Higgins SE, 2011, POULTRY SCI, V90, P901, DOI 10.3382/ps.2010-00907; Houghton FJ, 2012, EXP CELL RES, V318, P464, DOI 10.1016/j.yexcr.2011.12.023; Hu WL, 2013, CELL MICROBIOL, V15, P1624, DOI 10.1111/cmi.12141; Huang GTJ, 1996, J CLIN INVEST, V98, P572, DOI 10.1172/JCI118825; Imamovic L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032393; Jandhyala DM, 2016, INFECT IMMUN, V84, P138, DOI 10.1128/IAI.00977-15; Kaleem A, 2008, J CELL BIOCHEM, V103, P835, DOI 10.1002/jcb.21454; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; Konar M, 2012, FEMS IMMUNOL MED MIC, V66, P177, DOI 10.1111/j.1574-695X.2012.00998.x; Kulsantiwong P, 2016, MED MICROBIOL IMMUN, V205, P255, DOI 10.1007/s00430-015-0440-z; Lanciano P, 2007, J BIOL CHEM, V282, P17468, DOI 10.1074/jbc.M700994200; Lemire S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002149; Li QM, 2013, TUMOR BIOL, V34, P505, DOI 10.1007/s13277-012-0575-0; Li ZY, 2011, ANAT REC, V294, P1015, DOI 10.1002/ar.21395; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Liu Y, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-65; Loebel DAF, 2011, DEVELOPMENT, V138, P4511, DOI 10.1242/dev.063867; M'Bika JP, 2010, J GEN VIROL, V91, P1346, DOI 10.1099/vir.0.016030-0; Macmaster R, 2006, NUCLEIC ACIDS RES, V34, P5577, DOI 10.1093/nar/gkl447; Martinsohn JT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000065; Massrieh W, 2006, BIOL REPROD, V74, P699, DOI 10.1095/biolreprod.105.045450; Matsutani S, 1997, J MOL BIOL, V267, P548, DOI 10.1006/jmbi.1996.0894; Matussek A, 2016, J PEDIAT INF DIS SOC, V5, P147, DOI 10.1093/jpids/piv003; McMaken S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019654; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Miyamoto Y, 2006, CELL MICROBIOL, V8, P869, DOI 10.1111/j.1462-5822.2005.00673.x; Miyazaki H, 2012, FEMS IMMUNOL MED MIC, V65, P481, DOI 10.1111/j.1574-695X.2012.00979.x; Miyoshi Y, 2016, AM J PHYSIOL-GASTR L, V311, pG105, DOI 10.1152/ajpgi.00405.2015; Monaghan AM, 2012, FOODBORNE PATHOG DIS, V9, P1088, DOI 10.1089/fpd.2012.1257; Moreira CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128174; Morett E, 2008, J MOL BIOL, V376, P839, DOI 10.1016/j.jmb.2007.12.017; Murthi P, 2012, PLACENTA, V33, P741, DOI 10.1016/j.placenta.2012.06.011; Nishino Kunihiko, 2008, Journal of Infection and Chemotherapy, V14, P23, DOI 10.1007/s10156-007-0575-y; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Paton AW, 1999, J CLIN MICROBIOL, V37, P3357, DOI 10.1128/JCM.37.10.3357-3361.1999; Petruzziello-Pellegrini TN, 2012, CURR OPIN NEPHROL HY, V21, P433, DOI 10.1097/MNH.0b013e328354a62e; Pinske C, 2011, ARCH MICROBIOL, V193, P893, DOI 10.1007/s00203-011-0726-5; Qi SQ, 2014, J BIOL CHEM, V289, P4743, DOI 10.1074/jbc.M113.527473; Qian QY, 2014, BIOCHEM BIOPH RES CO, V443, P1041, DOI 10.1016/j.bbrc.2013.12.090; Roche JK, 2007, AM J PATHOL, V170, P526, DOI 10.2353/ajpath.2007.060366; Rosenberger CM, 2012, J IMMUNOL, V189, P5965, DOI 10.4049/jimmunol.1201437; Ryan KR, 2012, J CELL SCI, V125, P3202, DOI 10.1242/jcs.101931; Sanchez-Torres V, 2009, APPL ENVIRON MICROB, V75, P5639, DOI 10.1128/AEM.00638-09; Satoh-Takayama N, 2011, EUR J IMMUNOL, V41, P780, DOI 10.1002/eji.201040851; Schaer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018495; Scott DW, 2005, J CELL PHYSIOL, V202, P295, DOI 10.1002/jcp.20135; Selvik LKM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112485; Sheikh SZ, 2011, J BIOL CHEM, V286, P1174, DOI 10.1074/jbc.M110.147884; Shimizu M, 2012, CYTOKINE, V60, P694, DOI 10.1016/j.cyto.2012.07.038; Singh VK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117594; Spory A, 2002, J BACTERIOL, V184, P3549, DOI 10.1128/JB.184.13.3549-3559.2002; Staege MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089577; Stenstedt K, 2012, ANTICANCER RES, V32, P3869; Stummeyer K, 2006, MOL MICROBIOL, V60, P1123, DOI 10.1111/j.1365-2958.2006.05173.x; Taka N, 2009, BIOORG MED CHEM LETT, V19, P3426, DOI 10.1016/j.bmcl.2009.05.059; Terasaki H, 2002, INT J MOL MED, V9, P107; Tran HJ, 2005, J BIOL CHEM, V280, P42423, DOI 10.1074/jbc.M504464200; Trivedi RN, 2015, IMMUNOBIOLOGY, V220, P1322, DOI 10.1016/j.imbio.2015.07.011; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Ueda K, 2003, ONCOGENE, V22, P5586, DOI 10.1038/sj.onc.1206845; Uehata T, 2013, BBA-GENE REGUL MECH, V1829, P708, DOI 10.1016/j.bbagrm.2013.03.001; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Vinayagam A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001699; Vonberg RP, 2013, CLIN INFECT DIS, V56, P1132, DOI 10.1093/cid/cis1218; Wang LS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-215; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Wu F, 2007, J IMMUNOL, V179, P6988, DOI 10.4049/jimmunol.179.10.6988; Xu JW, 2012, NUCLEIC ACIDS RES, V40, P6957, DOI 10.1093/nar/gks359; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yang SK, 1997, GASTROENTEROLOGY, V113, P1214, DOI 10.1053/gast.1997.v113.pm9322516; Yun S., 2012, INT J ADV ROBOT SYST, V2012, P9, DOI DOI 10.1371/J0URNAL.P0NE.0045236; Zhang JS, 2011, MOL BIOL CELL, V22, P2119, DOI 10.1091/mbc.E10-12-0969; Zhang ZG, 2003, ARCH MICROBIOL, V180, P88, DOI 10.1007/s00203-003-0561-4; Zhou Q, 2012, BRIT J PHARMACOL, V166, P1756, DOI 10.1111/j.1476-5381.2012.01875.x	117	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189613	10.1371/journal.pone.0189613	http://dx.doi.org/10.1371/journal.pone.0189613			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253906	Green Published, Green Submitted, gold			2022-12-26	WOS:000418389500042
J	Kim, S; Kim, GH				Kim, Sua; Kim, Gheun-Ho			Roles of claudin-2, ZO-1 and occludin in leaky HK-2 cells	PLOS ONE			English	Article							TIGHT JUNCTION PROTEINS; PROXIMAL TUBULE; BARRIER; KIDNEY; EXPRESSION; PERMEABILITY	Background Claudin-2, ZO-1, and occludin are major components of tight junctions (TJs) in the proximal tubule. However, their roles in maintaining paracellular permeability as leaky epithelia have yet to be defined. Methods To investigate the contributory role of TJ proteins in the leaky proximal tubule, we xamined the effect of inhibiting claudin-2, occludin, and ZO-1 expression on transepithelial electrical resistance (TER) and paracellular permeability using the immortalized human proximal tubule epithelial cell line HK-2. For this, small-interfering RNAs (siRNAs) against claudin-2, occludin and ZO-1 were transfected into HK-2 cells. TER and transepithelial flux rates of dextrans (4 and 70 kDa) were determined after 24 h. Results Transfection of siRNAs (25 nM) knocked down TJ protein expression. Control HK-2 mono-layers achieved a steady-state TER of 6 +/- 8 Omega.cm(2) when grown in 12-well Transwell filters, which are compatible with leaky epithelia. Knockdown of claudin-2 decreased in TER and increased occludin expression. Transfection with siRNA against either occludin or ZO-1 increased TER and decreased claudin-2 expression. TER was decreased by co-inhibition of claudin-2 and ZO-1 but increased by co-inhibition of claudin-2 and occludin. TER was suppressed when claudin-2, occludin, and ZO-1 were all inhibited. Dextran flux rate was increased by claudin-2, occludin, or ZO-1 siRNA transfection. Increased dextran flux was enhanced by co-transfection of claudin-2, ZO-1, and occludin siRNA. Conclusions The depletion of claudin-2, occludin and ZO-1 in HK-2 cells had differential effects on TER and macromolecule flux. We demonstrated that integration of claudin-2, occludin and ZO-1 is necessary for maintaining the function of the proximal tubular epithelium.	[Kim, Sua; Kim, Gheun-Ho] Hanyang Univ, Coll Med, Inst Biomed Sci, Seoul, South Korea; [Kim, Gheun-Ho] Hanyang Univ, Coll Med, Dept Internal Med, Div Nephrol, Seoul, South Korea	Hanyang University; Hanyang University	Kim, GH (corresponding author), Hanyang Univ, Coll Med, Inst Biomed Sci, Seoul, South Korea.; Kim, GH (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Div Nephrol, Seoul, South Korea.	kimgh@hanyang.ac.kr		Kim, Gheun-Ho/0000-0002-8445-9892	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2008924, NRF-2016R1A6A3A01009353]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2008924, Gheun-Ho Kim; NRF-2016R1A6A3A01009353, Sua Kim). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Angelow S, 2007, CURR OPIN NEPHROL HY, V16, P459, DOI 10.1097/MNH.0b013e32820ac97d; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Denker BM, 2011, J AM SOC NEPHROL, V22, P622, DOI 10.1681/ASN.2010090922; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Hou JH, 2006, J BIOL CHEM, V281, P36117, DOI 10.1074/jbc.M608853200; Hou JH, 2013, ANNU REV PHYSIOL, V75, P479, DOI 10.1146/annurev-physiol-030212-183705; Kim S, 2015, AM J PHYSIOL-RENAL, V309, pF474, DOI 10.1152/ajprenal.00477.2014; Kirk A, 2010, NEPHROL DIAL TRANSPL, V25, P2107, DOI 10.1093/ndt/gfq006; Krug SM, 2014, SEMIN CELL DEV BIOL, V36, P166, DOI 10.1016/j.semcdb.2014.09.002; Lee CH, 2011, AM J NEPHROL, V33, P7, DOI 10.1159/000322445; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Neunlist M, 2003, AM J PHYSIOL-GASTR L, V285, pG1028, DOI 10.1152/ajpgi.00066.2003; Prozialeck WC, 2006, TOXICOL IN VITRO, V20, P942, DOI 10.1016/j.tiv.2005.11.006; Raleigh DR, 2011, J CELL BIOL, V193, P565, DOI 10.1083/jcb.201010065; RECTOR FC, 1983, AM J PHYSIOL, V244, pF461, DOI 10.1152/ajprenal.1983.244.5.F461; Rosenthal R, 2017, ACTA PHYSIOL, V219, P521, DOI 10.1111/apha.12742; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Shen L, 2012, ANN NY ACAD SCI, V1258, P9, DOI 10.1111/j.1749-6632.2012.06613.x; Van Itallie CM, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.25247; Van Itallie CM, 2011, J BIOL CHEM, V286, P3442, DOI 10.1074/jbc.M110.195578; Van Itallie CM, 2010, J CELL SCI, V123, P2844, DOI 10.1242/jcs.065581	23	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189221	10.1371/journal.pone.0189221	http://dx.doi.org/10.1371/journal.pone.0189221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29252987	Green Published, gold, Green Submitted			2022-12-26	WOS:000418389500017
J	Alshaer, W; Ababneh, N; Hatmal, M; Izmirli, H; Choukeife, M; Shraim, A; Sharar, N; Abu-Shiekah, A; Odeh, F; Al Bawab, A; Awidi, A; Ismail, S				Alshaer, Walhan; Ababneh, Nida; Hatmal, Mamon; Izmirli, Heba; Choukeife, Moujab; Shraim, Alaa; Sharar, Nour; Abu-Shiekah, Aya; Odeh, Fadwa; Al Bawab, Abeer; Awidi, Abdalla; Ismail, Said			Selection and targeting of EpCAM protein by ssDNA aptamer	PLOS ONE			English	Article							CELL-ADHESION-MOLECULE; CANCER STEM-CELLS; EPITHELIAL OVARIAN-CANCER; IN-VITRO SELECTION; POTENTIAL ROLE; RNA MOLECULES; SOLID TUMORS; EP-CAM; THERAPEUTICS; MARKER	Aptamers are molecules that reveal highly complex and refined molecular recognition properties. These molecules are capable of binding with high affinity and selectivity to targets, ranging from small molecules to whole living cells. Several aptamers have been selected for targeting cellular proteins and they have also used in developing therapeutics and diagnostic strategies. Epithelial cell adhesion molecule (EpCAM) is considered as a cancer stem cell (CSC) biomarker and one of the most promising targets for aptamer selection against CSCs. In this study, we have developed a ssDNA aptamer with high affinity and selectivity of targeting the EpCAM protein extracellular domain. The SELEX technique was applied and the resulted sequences were tested on EpCAM-positive human gastric cancer cell line, KATO III, and the EpCAM-negative mouse embryonic fibroblast, NIH/3T3 cells. Ep1 aptamer was successfully isolated and showed selective binding on EpCAM-positive KATO III cells when compared to EpCAM-negative NIH/3T3 cells, as observed by the flow cytometry and the confocal imaging results. Additionally, the binding of Ep1 to EpCAM protein was assessed using mobility shifting assay and aptamers-protein docking. Furthermore, the binding affinity of Ep1 was measured against EpCAM protein using EpCAM-immobilized on magnetic beads and showed apparent affinity of 118 nM. The results of this study could suggest that Ep1 aptamer can bind specifically to the cellular EpCAM protein, making it an attractive ligand for targeted drug delivery and as an imaging agent for the identification of cancer	[Alshaer, Walhan; Ababneh, Nida; Sharar, Nour; Abu-Shiekah, Aya; Awidi, Abdalla] Univ Jordan, Cell Therapy Ctr, Amman, Jordan; [Alshaer, Walhan; Ababneh, Nida; Izmirli, Heba; Choukeife, Moujab; Shraim, Alaa; Ismail, Said] Univ Jordan, Fac Med, Mol Biol Res Lab, Amma, Jordan; [Hatmal, Mamon] Hashemite Univ, Fac Allied Hlth Sci, Dept Med Lab Sci, Zarqa, Jordan; [Odeh, Fadwa; Al Bawab, Abeer] Univ Jordan, Sch Sci, Dept Chem, Amman, Jordan; [Al Bawab, Abeer] Univ Jordan, HMCSR, Amman, Jordan	University of Jordan; University of Jordan; Hashemite University; University of Jordan; University of Jordan	Alshaer, W; Awidi, A (corresponding author), Univ Jordan, Cell Therapy Ctr, Amman, Jordan.; Alshaer, W (corresponding author), Univ Jordan, Fac Med, Mol Biol Res Lab, Amma, Jordan.	walhan.alshaer@ju.edu.jo; ctc-ceo@ju.edu.jo	Hatmal, Ma'mon M./AAF-7164-2020; Odeh, Fadwa/U-7078-2019; Ababneh, Nidaa/D-1553-2019; Alshaer, Walhan/A-7403-2018	Ababneh, Nidaa/0000-0002-2155-3013; Alshaer, Walhan/0000-0003-2946-7328; Odeh, Fadwa/0000-0002-9341-2359; Shraim, Ala'a/0000-0001-7021-8847; ismail, said/0000-0002-8425-4010; M. Hatmal, Ma'mon/0000-0003-1745-8985	Scientific Research Support Fund (SRF) [MPH/2/08/2013]	Scientific Research Support Fund (SRF)	This work was supported by research grant MPH/2/08/2013 from Scientific Research Support Fund (SRF) to MB, SI, and FO. http://www.srf.gov.jo/.; This work was supported by research grant MPH/2/08/2013 from Scientific Research Support Fund (SRF). The authors appreciate Bara'a Qaqish, Fatima Akhras, and Duaa Abuarqoub for providing technical advice and support for performing experiments during project.	Ababneh N, 2013, NUCLEIC ACID THER, V23, P401, DOI 10.1089/nat.2013.0423; Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Alshaer W, 2015, BIOCONJUGATE CHEM, V26, P1307, DOI 10.1021/bc5004313; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Bellone S, 2009, INT J GYNECOL CANCER, V19, P860, DOI 10.1111/IGC.0b013e3181a8331f; Bohl SR, 2011, ONKOLOGIE, V34, P269, DOI 10.1159/000327815; Burmeister PE, 2006, OLIGONUCLEOTIDES, V16, P337, DOI 10.1089/oli.2006.16.337; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Groff K, 2015, BIOTECHNOLOGY ADV; Grotenhuis BA, 2012, J SURG ONCOL, V106, P209, DOI 10.1002/jso.23069; Guo W, 2006, PEDIATR RES, V59, p59R, DOI 10.1203/01.pdr.0000203592.04530.06; Heiat M, 2016, J BIOTECHNOL, V230, P34, DOI 10.1016/j.jbiotec.2016.05.021; Hernandez LI, 2015, CURR TOP MED CHEM, V15, P1066, DOI 10.2174/1568026615666150413153717; Iida J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088712; Imrich S, 2012, CELL ADHES MIGR, V6, P30, DOI 10.4161/cam.18953; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Linke R, 2010, MABS-AUSTIN, V2, P129, DOI 10.4161/mabs.2.2.11221; Lupold SE, 2002, CANCER RES, V62, P4029; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Munz M, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-44; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Nimjee SM, 2017, ANNU REV PHARMACOL, V57, P61, DOI 10.1146/annurev-pharmtox-010716-104558; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Schnell U, 2013, BBA-BIOMEMBRANES, V1828, P1989, DOI 10.1016/j.bbamem.2013.04.018; Shigdar S, 2013, CANCER LETT, V330, P84, DOI 10.1016/j.canlet.2012.11.032; Shigdar S, 2011, CANCER SCI, V102, P991, DOI 10.1111/j.1349-7006.2011.01897.x; Shum Ka-To, 2013, J Cancer Ther, V4, P872; Somasunderam A, 2010, BIOCHEMISTRY-US, V49, P9106, DOI 10.1021/bi1009503; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; Song YL, 2013, ANAL CHEM, V85, P4141, DOI 10.1021/ac400366b; Spizzo G, 2006, GYNECOL ONCOL, V103, P483, DOI 10.1016/j.ygyno.2006.03.035; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Xiang DX, 2015, THERANOSTICS, V5, P1083, DOI 10.7150/thno.11711	37	29	30	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189558	10.1371/journal.pone.0189558	http://dx.doi.org/10.1371/journal.pone.0189558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29245156	Green Published, gold, Green Submitted			2022-12-26	WOS:000418184700039
J	Jahan, S; Strezov, V				Jahan, Sayka; Strezov, Vladimir			Water quality assessment of Australian ports using water quality evaluation indices	PLOS ONE			English	Article							JACKSON ESTUARY; HEAVY-METAL; POLLUTION; COASTAL; HARBOR; VARIABILITY; MANAGEMENT; SEDIMENTS	Australian ports serve diverse and extensive activities, such as shipping, tourism and fisheries, which may all impact the quality of port water. In this work water quality monitoring at different ports using a range of water quality evaluation indices was applied to assess the port water quality. Seawater samples at 30 stations in the year 2016-2017 from six ports in NSW, Australia, namely Port Jackson, Botany, Kembla, Newcastle, Yamba and Eden, were investigated to determine the physicochemical and biological variables that affect the port water quality. The large datasets obtained were designed to determine the Water Quality Index, Heavy metal Evaluation Index, Contamination Index and newly developed Environmental Water Quality Index. The study revealed medium water quality index and high and medium heavy metal evaluation index at three of the study ports and high contamination index in almost all study ports. Low level dissolved oxygen and higher level of total dissolved solids, turbidity, fecal coliforms, copper, iron, lead, zinc, manganese, cadmium and cobalt are mainly responsible for the poor water qualities of the port areas. Good water quality at the background samples indicated that various port activities are the likely cause for poor water quality inside the port area.	[Jahan, Sayka; Strezov, Vladimir] Macquarie Univ NSW, Dept Environm Sci, Fac Sci & Engn, Sydney, NSW, Australia	Macquarie University	Strezov, V (corresponding author), Macquarie Univ NSW, Dept Environm Sci, Fac Sci & Engn, Sydney, NSW, Australia.	vladimir.strezov@mq.edu.au	Strezov, Vladimir/J-4827-2019	Strezov, Vladimir/0000-0002-9129-9284				Abbasi T, 2012, WATER QUALITY INDICES, P1; Ali A, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-6110-4; [Anonymous], 2015, ENV WAT TEST LAB SYD; ANZECC/ARMCANZ, 2000, AUSTR NZ GUID FRESH; ATSDR, 2015, PRIOR LIST HAZ SUBST; Backman B, 1998, ENVIRON GEOL, V36, P55, DOI 10.1007/s002540050320; Bateman S, 1996, OCEAN COAST MANAGE, V33, P229, DOI 10.1016/S0964-5691(96)00053-1; Croteau AJ, 1997, Patent No. [US5700655, 5700655]; Darbra RM, 2005, MAR POLLUT BULL, V50, P866, DOI 10.1016/j.marpolbul.2005.04.037; DEFRA, 2014, WAT FRAM DIR IMPL EN; Edet A. E., 2002, GeoJournal, V57, P295, DOI 10.1023/B:GEJO.0000007250.92458.de; Gomez AG, 2015, J ENVIRON MANAGE, V155, P77, DOI 10.1016/j.jenvman.2015.01.042; Goonetilleke A, 2009, MAR POLLUT BULL, V58, P213, DOI 10.1016/j.marpolbul.2008.09.025; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Guerra-Garcia JM, 2005, J ENVIRON MANAGE, V77, P1, DOI 10.1016/j.jenvman.2005.01.023; Gupta AK, 2003, J ENVIRON SCI HEAL A, V38, P2711, DOI 10.1081/ESE-120024458; Harris P, 1998, ANTIMICROBIAL RESIST, P1; Hatje V, 2003, MAR POLLUT BULL, V46, P719, DOI 10.1016/S0025-326X(03)00061-4; Hatje V, 2001, ESTUAR COAST SHELF S, V53, P63, DOI 10.1006/ecss.2001.0792; Haynes D, 2000, MAR POLLUT BULL, V41, P267, DOI 10.1016/S0025-326X(00)00134-X; IMO, 2013, OC LAW SEA; Islam MS, 2004, MAR POLLUT BULL, V48, P624, DOI 10.1016/j.marpolbul.2003.12.004; Jonathan MP, 2011, MAR POLLUT BULL, V62, P845, DOI 10.1016/j.marpolbul.2011.02.042; NATA, 2009, 33 NATA; NATA, 2012, 17 NATA; National Ports Strategy, 2010, IRR BOW SYNDR CAM GL, P1; Ng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143123; Nikoo MR, 2011, ENVIRON MONIT ASSESS, V181, P465, DOI 10.1007/s10661-010-1842-4; Orpin AR, 2004, MAR POLLUT BULL, V49, P602, DOI 10.1016/j.marpolbul.2004.03.020; Pollard DA, 2003, PORT EDEN INTRO MARI; Prasanna MV, 2012, ENVIRON EARTH SCI, V67, P1987, DOI 10.1007/s12665-012-1639-6; REVELANTE N, 1978, AUST J MAR FRESH RES, V29, P9; Rice EW, 2012, STANDARD METHODS EXA; Sanchez E, 2007, ECOL INDIC, V7, P315, DOI 10.1016/j.ecolind.2006.02.005; Swain R, 2017, J ENVIRON MANAGE, V192, P1, DOI 10.1016/j.jenvman.2017.01.034; Trozzi C, 2000, WAT STUD SER, V9, P151; USEPA, 2013, HUM HLTH RISK ASS; Yogendra K, 2008, P 12 WORLD LAK C KAR	38	28	28	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189284	10.1371/journal.pone.0189284	http://dx.doi.org/10.1371/journal.pone.0189284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244876	Green Submitted, gold, Green Published			2022-12-26	WOS:000418184700026
J	McClenaghan, C; Hanson, A; Sala-Rabanal, M; Roessler, HI; Josifova, D; Grange, DK; van Haaften, G; Nichols, CG				McClenaghan, Conor; Hanson, Alex; Sala-Rabanal, Monica; Roessler, Helen I.; Josifova, Dragana; Grange, Dorothy K.; van Haaften, Gijs; Nichols, Colin G.			Cantu syndrome-associated SUR2 (ABCC9) mutations in distinct structural domains result in K-ATP channel gain-of-function by differential mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						potassium channel; ABC transporter; cardiovascular disease; electrophysiology; nucleotide	SENSITIVE POTASSIUM CHANNELS; VASCULAR SMOOTH-MUSCLE; SULFONYLUREA RECEPTOR; PHYSIOLOGICAL ROLES; HIGH-AFFINITY; NUCLEOTIDES; DOMINANT; SUBUNITS; MANIFESTATIONS; IDENTIFICATION	The complex disorder Cantu syndrome (CS) arises from gain-of-function mutations in either KCNJ8 or ABCC9, the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (K-ATP) channels, respectively. Recent reports indicate that such mutations can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which K-ATP function is altered by several substitutions in distinct structural domains of SUR2: D207E in the intracellular L0-linker and Y985S, G989E, M1060I, and R1154Q/R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium (Rb-86(+)) efflux assays and patch-clamp electrophysiology. Our results indicate that D207E increases K-ATP channel activity by increasing intrinsic stability of the open state, whereas the cluster of Y981S/G985E/M1056I substitutions, as well as R1150Q/R1150W, augmented Mg-nucleotide activation. We also tested the responses of these channel variants to inhibition by the sulfonylurea drug glibenclamide, a potential pharmacotherapy for CS. None of the D207E, Y981S, G985E, or M1056I substitutions had a significant effect on glibenclamide sensitivity. However, Gln and Trp substitution at Arg-1150 significantly decreased glibenclamide potency. In summary, these results provide additional confirmation that mutations in CS-associated SUR2 mutations result in K-ATP gain-of-function. They help link CS genotypes to phenotypes and shed light on the underlying molecular mechanisms, including consequences for inhibitory drug sensitivity, insights that may inform the development of therapeutic approaches to manage CS.	[McClenaghan, Conor; Hanson, Alex; Sala-Rabanal, Monica; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Grange, Dorothy K.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, Dept Pediat, St Louis, MO 63110 USA; [Roessler, Helen I.; van Haaften, Gijs] Univ Med Ctr Utrecht, Dept Med Genet, Postbus 85500, NL-3508 GA Utrecht, Netherlands; [Josifova, Dragana] Guys & St Thomas NHS Trust, Dept Clin Genet, Great Maze Pond, London SE1 9RT, England	Washington University (WUSTL); Washington University (WUSTL); Utrecht University; Utrecht University Medical Center; Guy's & St Thomas' NHS Foundation Trust	Nichols, CG (corresponding author), Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	cnichols@wustl.edu	van Haaften, Gijs/G-7832-2012; Sala-Rabanal, Monica/AAU-2383-2021	van Haaften, Gijs/0000-0003-3033-0329; McClenaghan, Conor/0000-0002-0859-3854; Hanson, Alex/0000-0002-4931-0590	National Institutes of Health from NHLBI [HL140024]; E-Rare Joint Transnational Cantu Treat Program [I-2101-B26]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL140024] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); E-Rare Joint Transnational Cantu Treat Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL140024 from NHLBI (to C. G. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the E-Rare Joint Transnational Cantu Treat Program Grant I-2101-B26 (to G. v. H.).	Afifi HH, 2016, PEDIATR DERMATOL, V33, pE109, DOI 10.1111/pde.12821; Ashfield R, 1999, DIABETES, V48, P1341, DOI 10.2337/diabetes.48.6.1341; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; BONEV AD, 1993, AM J PHYSIOL, V264, pC1190, DOI 10.1152/ajpcell.1993.264.5.C1190; Brownstein CA, 2013, EUR J MED GENET, V56, P678, DOI 10.1016/j.ejmg.2013.09.009; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Cooper PE, 2017, J BIOL CHEM, V292, P17387, DOI 10.1074/jbc.M117.804971; Cooper PE, 2015, J GEN PHYSIOL, V146, P527, DOI 10.1085/jgp.201511495; Cooper PE, 2014, HUM MUTAT, V35, P809, DOI 10.1002/humu.22555; Ellard S, 2007, AM J HUM GENET, V81, P375, DOI 10.1086/519174; Fang K, 2006, J PHYSIOL-LONDON, V576, P379, DOI 10.1113/jphysiol.2006.112748; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Flagg TP, 2008, CIRC RES, V103, P1458, DOI 10.1161/CIRCRESAHA.108.178186; Foster MN, 2016, PHYSIOL REV, V96, P177, DOI 10.1152/physrev.00003.2015; Grange DK, 2006, AM J MED GENET A, V140A, P1673, DOI 10.1002/ajmg.a.31348; Gribble FM, 2003, DIABETOLOGIA, V46, P875, DOI 10.1007/s00125-003-1143-3; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; Guerrero CRL, 2016, NEUROLOGY, V87, P270, DOI 10.1212/WNL.0000000000002861; Hambrock A, 2002, BRIT J PHARMACOL, V136, P995, DOI 10.1038/sj.bjp.0704801; Hambrock A, 2001, MOL PHARMACOL, V60, P190, DOI 10.1124/mol.60.1.190; Harakalova M, 2012, NAT GENET, V44, P793, DOI 10.1038/ng.2324; Ko Eun A., 2008, Journal of Smooth Muscle Research, V44, P65, DOI 10.1540/jsmr.44.65; Koster JC, 2005, DIABETES, V54, P2645, DOI 10.2337/diabetes.54.9.2645; Levin MD, 2016, P NATL ACAD SCI USA, V113, P6773, DOI 10.1073/pnas.1606465113; Levin MD, 2015, HEART RHYTHM, V12, P2316, DOI 10.1016/j.hrthm.2015.06.042; Li AL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000365; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.24149; Matsuoka T, 2000, CIRC RES, V87, P873, DOI 10.1161/01.RES.87.10.873; NAKASHIMA M, 1995, J PHARMACOL EXP THER, V272, P379; NELSON MT, 1990, NATURE, V344, P770, DOI 10.1038/344770a0; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nichols CG, 2013, CIRC RES, V112, P1059, DOI 10.1161/CIRCRESAHA.112.300514; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Proks P, 2014, J GEN PHYSIOL, V144, P469, DOI 10.1085/jgp.201411222; Proks P, 2013, DIABETES METAB J, V37, P157, DOI 10.4093/dmj.2013.37.3.157; QUAMME GA, 1990, BIOCHEM BIOPH RES CO, V167, P1406, DOI 10.1016/0006-291X(90)90679-H; Reimann F, 2000, MOL PHARMACOL, V58, P1318, DOI 10.1124/mol.58.6.1318; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Swaminathan R, 2003, Clin Biochem Rev, V24, P47; Teramoto N, 2006, J PHYSIOL-LONDON, V572, P617, DOI 10.1113/jphysiol.2006.105973; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Ueda K, 1999, P NATL ACAD SCI USA, V96, P1268, DOI 10.1073/pnas.96.4.1268; van Bon BWM, 2012, AM J HUM GENET, V90, P1094, DOI 10.1016/j.ajhg.2012.04.014; Vedovato N, 2016, DIABETOLOGIA, V59, P1430, DOI 10.1007/s00125-016-3964-x; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7	47	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2041	2052		10.1074/jbc.RA117.000351	http://dx.doi.org/10.1074/jbc.RA117.000351			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29275331	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000424948000017
J	Cuthbertson, L; Craven, V; Bingle, L; Cookson, WOCM; Everard, ML; Moffatt, MF				Cuthbertson, Leah; Craven, Vanessa; Bingle, Lynne; Cookson, William O. C. M.; Everard, Mark L.; Moffatt, Miriam F.			The impact of persistent bacterial bronchitis on the pulmonary microbiome of children	PLOS ONE			English	Article							LUNG MICROBIOME; BRONCHIECTASIS; DISEASE	Introduction Persistent bacterial bronchitis (PBB) is a leading cause of chronic wet cough in young children. This study aimed to characterise the respiratory bacterial microbiota of healthy children and to assess the impact of the changes associated with the development of PBB. Blind, protected brushings were obtained from 20 healthy controls and 24 children with PBB, with an additional directed sample obtained from PBB patients. DNA was extracted, quantified using a 16S rRNA gene quantitative PCR assay prior to microbial community analysis by 16S rRNA gene sequencing. Results No significant difference in bacterial diversity or community composition (R-2 = 0.01, P = 0.36) was observed between paired blind and non-blind brushes, showing that blind brushings are a valid means of accessing the airway microbiota. This has important implications for collecting lower respiratory samples from healthy children. A significant decrease in bacterial diversity (P < 0.001) and change in community composition (R-2 = 0.08, P = 0.004) was observed among controls, in comparison with patients. Bacterial communities within patients with PBB were dominated by Proteobacteria, and indicator species analysis showed that Haemophilus and Neisseria were significantly associated with the patient group. In 15 (52.9%) cases the dominant organism by sequencing was not identified by standard routine clinical culture. Conclusion The bacteria present in the lungs of patients with PBB were less diverse in terms of richness and evenness. The results validate the clinical diagnosis, and suggest that more attention to bacterial communities in children with chronic cough may lead to more rapid recognition of this condition with earlier treatment and reduction in disease burden.	[Cuthbertson, Leah; Cookson, William O. C. M.; Moffatt, Miriam F.] Imperial Coll, Natl Heart & Lung Inst, London, England; [Cuthbertson, Leah; Cookson, William O. C. M.] Royal Brompton & Harefield NHS Fdn Trust, Sydney St, London, England; [Craven, Vanessa] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England; [Bingle, Lynne] Univ Sheffield, Sch Dent, Sheffield, S Yorkshire, England; [Everard, Mark L.] Univ Western Australia, Sch Paediat, Perth, WA, Australia	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Sheffield; University of Western Australia	Cuthbertson, L (corresponding author), Imperial Coll, Natl Heart & Lung Inst, London, England.; Cuthbertson, L (corresponding author), Royal Brompton & Harefield NHS Fdn Trust, Sydney St, London, England.; Everard, ML (corresponding author), Univ Western Australia, Sch Paediat, Perth, WA, Australia.	l.cuthbertson@imperial.ac.uk; mark.everard@uwa.edu.au	Cookson, William/HHC-1790-2022	Cookson, William/0000-0001-9551-4677; Moffatt, Miriam/0000-0001-7623-5840; Cuthbertson, Leah/0000-0002-9604-2269; Everard, Mark/0000-0003-1571-261X	Wellcome Trust [WT097117, WT096964]; NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust; Imperial College London; Sheffield Children's Hospital Charity Research Fund	Wellcome Trust(Wellcome Trust); NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust; Imperial College London(General Electric); Sheffield Children's Hospital Charity Research Fund	The study was funded by the Wellcome Trust under WT097117 and WT096964. This project was funded and supported by the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London and the Sheffield Children's Hospital Charity Research Fund. M.F. Moffatt and W.O.C.M. Cookson are Joint Wellcome Trust Senior Investigators.	Auguie B, 2017, GRIDEXTRA MISCELLANE; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang AB, 2016, PEDIATR PULM, V51, P225, DOI 10.1002/ppul.23351; Craven V, 2013, ARCH DIS CHILD, V98, P72, DOI 10.1136/archdischild-2012-302760; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; Dickson RP, 2015, ANN AM THORAC SOC, V12, P821, DOI 10.1513/AnnalsATS.201501-029OC; Dickson RP, 2014, J CLIN MICROBIOL, V52, P3605, DOI 10.1128/JCM.01028-14; Dickson RP, 2014, LANCET, V384, P691, DOI 10.1016/S0140-6736(14)61136-3; Dickson RP, 2015, ANNU REV PHYSIOL, P1; Donnelly D, 2007, THORAX, V62, P80, DOI 10.1136/thx.2006.058933; Duff RM, 2013, EUR RESPIR J, V41, P991, DOI 10.1183/09031936.00052712; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Ishak A, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00019; Kompare M, 2012, J PEDIATR-US, V160, P88, DOI 10.1016/j.jpeds.2011.06.049; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mammen MJ, 2016, RESPIROLOGY, V21, P590, DOI 10.1111/resp.12732; Marsh RL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0182-1; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Rogers GB, 2015, ISME J, V9, P217, DOI 10.1038/ismej.2014.124; Rogers GB, 2013, THORAX, V68, P731, DOI 10.1136/thoraxjnl-2012-203105; Sze MA, 2015, AM J RESP CRIT CARE, V192, P438, DOI 10.1164/rccm.201502-0223OC; van der Gast Christopher J, 2014, Ann Am Thorac Soc, V11, P1039, DOI 10.1513/AnnalsATS.201312-456OC; Colombo APV, 2016, MICROB PATHOGENESIS, V94, P27, DOI 10.1016/j.micpath.2015.09.009; Vienne P, 2003, CLIN INFECT DIS, V37, P1639, DOI 10.1086/379719	26	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190075	10.1371/journal.pone.0190075	http://dx.doi.org/10.1371/journal.pone.0190075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281698	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000419006200060
J	Finne, M; Holmgren, K; Shen, CC; Hu, HM; Boyd, M; Stocker, S				Finne, Martin; Holmgren, Karin; Shen, Chuan-Chou; Hu, Hsun-Ming; Boyd, Meighan; Stocker, Sharon			Late Bronze Age climate change and the destruction of the Mycenaean Palace of Nestor at Pylos	PLOS ONE			English	Article							EASTERN MEDITERRANEAN REGION; SOREQ CAVE; ENVIRONMENTAL HISTORY; RESOLUTION RECORD; NORTHEAST TURKEY; MAYA LOWLANDS; DRY EVENTS; HOLOCENE; SPELEOTHEM; COLLAPSE	This paper offers new high-resolution oxygen and carbon isotope data from Stalagmite S1 from Mavri Trypa Cave, SW Peloponnese. Our data provide the climate background to the destruction of the nearby Mycenaean Palace of Nestor at Pylos at the transition from Late Helladic (LH) IIIB to LH IIIC, similar to 3150-3130 years before present (before AD 1950, hereafter yrs BP) and the subsequent period. S1 is dated by 24 U-Th dates with an averaged precision of +/- 26 yrs (2s), providing one of the most robust paleoclimate records from the eastern Mediterranean for the end of the Late Bronze Age (LBA). The delta O-18 record shows generally wetter conditions at the time when the Palace of Nestor at Pylos was destroyed, but a brief period of drier conditions around 3200 yrs BP may have disrupted the Mycenaean agricultural system that at the time was likely operating close to its limit. Gradually developing aridity after 3150 yrs BP, i.e. subsequent to the destruction, probably reduced crop yields and helped to erode the basis for the reinstitution of a central authority and the Palace itself.	[Finne, Martin] Uppsala Univ, Dept Archaeol & Ancient Hist, Uppsala, Sweden; [Finne, Martin; Holmgren, Karin; Boyd, Meighan] Stockholm Univ, Dept Phys Geog, Stockholm, Sweden; [Finne, Martin; Holmgren, Karin; Boyd, Meighan] Navarino Environm Observ, Costa Navarino, Messinia, Greece; [Holmgren, Karin] Swedish Univ Agr Sci, Uppsala, Sweden; [Shen, Chuan-Chou; Hu, Hsun-Ming] Natl Taiwan Univ, High Precis Mass Spectrometry & Environm Change L, Dept Geosci, Taipei, Taiwan; [Boyd, Meighan] Royal Holloway Univ London, Dept Earth Sci, Egham, Surrey, England; [Stocker, Sharon] Univ Cincinnati, Dept Class, 410 Blegen Lib, Cincinnati, OH USA	Uppsala University; Stockholm University; Swedish University of Agricultural Sciences; National Taiwan University; University of London; Royal Holloway University London; University System of Ohio; University of Cincinnati	Finne, M (corresponding author), Uppsala Univ, Dept Archaeol & Ancient Hist, Uppsala, Sweden.; Finne, M (corresponding author), Stockholm Univ, Dept Phys Geog, Stockholm, Sweden.; Finne, M (corresponding author), Navarino Environm Observ, Costa Navarino, Messinia, Greece.	martin.finne@antiken.uu.se	Shen, Chuan-Chou/H-9642-2013; lin, ke/GZM-8300-2022; Finné, Martin/O-4768-2019	Shen, Chuan-Chou/0000-0003-2833-2771; Finné, Martin/0000-0001-7433-268X	Institute for Aegean Prehistory; Swedish Research Council [421-2014-1181, 621-2012-4344]; Taiwan ROC MOST [104-2119-M-002-003, 105-2119-M-002-001]; National Taiwan University [105R7625]	Institute for Aegean Prehistory; Swedish Research Council(Swedish Research CouncilEuropean Commission); Taiwan ROC MOST; National Taiwan University(National Taiwan University)	This work was funded by the Institute for Aegean Prehistory (http://www.aegeanprehistory.net/), and the Swedish Research Council (www.vr.se), grant numbers: 421-2014-1181 (M.F.) and 621-2012-4344 (K.H.). Funding was also provided by grants from Taiwan ROC MOST (104-2119-M-002-003, 105-2119-M-002-001 to C.-C.S.) and the National Taiwan University (105R7625 to C.-C.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal PK, 2016, NAT GEOSCI, V9, P624, DOI [10.1038/ngeo2739, 10.1038/NGEO2739]; Akers PD, 2016, PALAEOGEOGR PALAEOCL, V459, P268, DOI 10.1016/j.palaeo.2016.07.007; [Anonymous], 2009, SCI DELLANTICHITA, V15, P241; Argiriou AA, 2006, J HYDROL, V327, P486, DOI 10.1016/j.jhydrol.2005.11.053; Bajo P, 2017, GEOCHIM COSMOCHIM AC, V210, P208, DOI 10.1016/j.gca.2017.04.038; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Bar-Matthews M, 2011, HOLOCENE, V21, P163, DOI 10.1177/0959683610384165; BarMatthews M, 1997, QUATERNARY RES, V47, P155, DOI 10.1006/qres.1997.1883; Bennet J., 2007, CAMBRIDGE EC HIST GR; Bintliff J., 2012, COMPLETE ARCHAEOLOGY; Boyd M., 2015, SPELEOTHEMS WARM CLI; Cheng H, 2015, GEOPHYS RES LETT, V42, P8641, DOI 10.1002/2015GL065397; Cheng H, 2013, EARTH PLANET SC LETT, V371, P82, DOI 10.1016/j.epsl.2013.04.006; Cline E. H., 2014, 1177 B C YEAR CIVIL; Cullen HM, 2000, GEOLOGY, V28, P379, DOI 10.1130/0091-7613(2000)28<379:CCATCO>2.0.CO;2; Cullen T., 2001, AEGEAN PREHISTORY RE; Cullen T., 2001, AEGEAN PREHISTORY RE, P329; Davis J. L., 2010, OXFORD HDB BRONZE AG, P680; Dean JR, 2015, QUATERNARY SCI REV, V124, P162, DOI 10.1016/j.quascirev.2015.07.023; Deger-Jalkotzy S, 2008, CAMBRIDGE COMPANION TO THE AEGEAN BRONZE AGE, P387; DORALE JA, 1992, SCIENCE, V258, P1626, DOI 10.1126/science.258.5088.1626; Douglas PMJ, 2015, P NATL ACAD SCI USA, V112, P5607, DOI 10.1073/pnas.1419133112; Drake BL, 2012, J ARCHAEOL SCI, V39, P1862, DOI 10.1016/j.jas.2012.01.029; Drysdale R, 2006, GEOLOGY, V34, P101, DOI 10.1130/G22103.1; Fairchild I.J., 2012, SPELEOTHEM SCI PROCE; Fairchild IJ, 2006, EARTH-SCI REV, V75, P105, DOI 10.1016/j.earscirev.2005.08.003; Finne M, 2014, CLIMATE E MEDITERRAN; Finne M, 2014, QUATERNARY RES, V81, P213, DOI 10.1016/j.yqres.2013.12.009; Finne M, 2011, J ARCHAEOL SCI, V38, P3153, DOI 10.1016/j.jas.2011.05.007; Fleitmann D, 2004, QUATERNARY SCI REV, V23, P935, DOI 10.1016/j.quascirev.2003.06.019; Fleitmann D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040050; Flohr P, 2017, GEOPHYS RES LETT, V44, P1528, DOI 10.1002/2016GL071786; Foxhall L., 1995, ANNU BRIT SCH ATHENS, V90, P239; Frisia S, 2006, QUATERNARY RES, V66, P388, DOI 10.1016/j.yqres.2006.05.003; Frumkin A, 1999, HOLOCENE, V9, P677, DOI 10.1191/095968399669422210; Giosan L, 2012, P NATL ACAD SCI USA, V109, pE1688, DOI 10.1073/pnas.1112743109; Gokturk OM, 2011, QUATERNARY SCI REV, V30, P2433, DOI 10.1016/j.quascirev.2011.05.007; Halstead P., 2007, RETHINKING MYCENAEAN, P66; Halstead P., 1989, BAD YEAR EC CULTURAL; Harrison AB, 1998, SANDY PYLOS ARCHAEOL, P147; Hellstrom J, 2006, QUAT GEOCHRONOL, V1, P289, DOI 10.1016/j.quageo.2007.01.004; Hodell DA, 2005, QUATERNARY SCI REV, V24, P1413, DOI 10.1016/j.quascirev.2004.10.013; Hoflmayer F, 2017, COMMENTS CLIMATE INT, P451; Jazwa CS, 2017, J ANTHROPOL ARCHAEOL, V45, P157, DOI 10.1016/j.jaa.2016.12.003; Jex CN, 2011, QUATERNARY RES, V75, P399, DOI 10.1016/j.yqres.2011.01.005; Jex CN, 2010, GLOBAL PLANET CHANGE, V71, P207, DOI 10.1016/j.gloplacha.2009.08.004; Jones MD, 2006, GEOLOGY, V34, P361, DOI 10.1130/G22407.1; Kaniewski D, 2010, QUATERNARY RES, V74, P207, DOI 10.1016/j.yqres.2010.07.010; Kaniewski D, 2015, WIRES CLIM CHANGE, V6, P369, DOI 10.1002/wcc.345; Kaniewski D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071004; Katrantsiotis C, 2016, HOLOCENE, V26, P188, DOI 10.1177/0959683615596838; Kennett DJ, 2012, SCIENCE, V338, P788, DOI 10.1126/science.1226299; Killen J, 2007, RETHINKING MYCENAEAN, VII, P114; Killen J.T., 1985, LINEAR B 1984 SURVEY, P241; Knapp AB, 2016, AM J ARCHAEOL, V120, P99, DOI 10.3764/aja.120.1.0099; Knauss J., 1991, Irrigation and Drainage Systems, V5, P363, DOI 10.1007/BF01102833; Lachniet MS, 2009, QUATERNARY SCI REV, V28, P412, DOI 10.1016/j.quascirev.2008.10.021; Langgut D, 2015, RADIOCARBON, V57, P217, DOI 10.2458/azu_rc.57.18555; Langgut D, 2013, TEL AVIV, V40, P149, DOI 10.1179/033443513X13753505864205; MacDonald G, 2011, QUATERN INT, V229, P140, DOI 10.1016/j.quaint.2009.11.012; MANNING SW, 1992, ANTIQUITY, V66, P636, DOI 10.1017/S0003598X00039351; Manning SW, 2010, OXFORD HDB BRONZE AG, P11; Maran J., 2010, OXFORD HDB BRONZE AG, P722; Mattey DP, 2016, GEOCHIM COSMOCHIM AC, V184, P88, DOI 10.1016/j.gca.2016.01.041; McDermott F, 2004, QUATERNARY SCI REV, V23, P901, DOI 10.1016/j.quascirev.2003.06.021; Middleton G, 2012, J ARCHAEOL RES, V20, P257, DOI 10.1007/s10814-011-9054-1; Moore K.M., 2011, SUSTAINABLE LIFEWAYS; Narayana Rao T., 2008, GEOPHYS RES LETT, V35; Nur A, 2000, J ARCHAEOL SCI, V27, P43, DOI 10.1006/jasc.1999.0431; Nur A., 2008, APOCALYPSE EARTHQUAK; Oppenheim A., 2015, B EGYPTOLOGICAL SEMI, V19, P649; Orland IJ, 2009, QUATERNARY RES, V71, P27, DOI 10.1016/j.yqres.2008.08.005; Roberts N, 2011, HOLOCENE, V21, P147, DOI 10.1177/0959683610386819; Rowe PJ, 2012, QUATERNARY SCI REV, V45, P60, DOI 10.1016/j.quascirev.2012.04.013; Rozanski K., 1993, CLIMATE CHANGE CONTI, V78, P1, DOI DOI 10.1029/GM078P0001; Scholz D, 2011, QUAT GEOCHRONOL, V6, P369, DOI 10.1016/j.quageo.2011.02.002; Shelmerdine C.W., 2011, BICS, V54, P19, DOI DOI 10.1111/J.2041-5370.2011.00014.X; Shen CC, 2012, GEOCHIM COSMOCHIM AC, V99, P71, DOI 10.1016/j.gca.2012.09.018; Staubwasser M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016822; Tomas H, 2010, OXFORD HDB BRONZE AG, P340; Unkel I, 2014, Z GEOMORPHOL, V58, P89, DOI 10.1127/0372-8854/2014/S-00160; Verheyden S, 2008, QUATERNARY RES, V70, P368, DOI 10.1016/j.yqres.2008.05.004; Weiberg E, 2016, QUATERNARY SCI REV, V136, P40, DOI 10.1016/j.quascirev.2015.10.042; Weiberg E, 2013, AM J ARCHAEOL, V117, P1; WEISS H, 1993, SCIENCE, V261, P995, DOI 10.1126/science.261.5124.995; Wiener M.H., 2013, AM J ARCHAEOL, V117, P581; Wiener MH, 2014, RADIOCARBON, V56, pS1, DOI 10.2458/azu_rc.56.18325; Wright J., 1984, PYLOS COMES ALIVE IN; Zanchetta G, 2007, QUATERNARY SCI REV, V26, P279, DOI 10.1016/j.quascirev.2006.12.003; Zanchetta G, 2014, GLOBAL PLANET CHANGE, V122, P130, DOI 10.1016/j.gloplacha.2014.07.013; ZANCHETTA G, 2016, ALP MEDITERR QUAT, V29, P5; Zanchetta G, 2012, J QUATERNARY SCI, V27, P780, DOI 10.1002/jqs.2563	92	60	60	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189447	10.1371/journal.pone.0189447	http://dx.doi.org/10.1371/journal.pone.0189447			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR3ZV	29281669	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000419006200028
J	Hornberg, K; Sundstrom, B; Innala, L; Rantapaa-Dahlqvist, S; Wallberg-Jonsson, S				Hornberg, Kristina; Sundstrom, Bjorn; Innala, Lena; Rantapaa-Dahlqvist, Solbritt; Wallberg-Jonsson, Solveig			Aerobic capacity over 16 years in patients with rheumatoid arthritis: Relationship to disease activity and risk factors for cardiovascular disease	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; ARTERIAL STIFFNESS; HEALTHY CONTROLS; FITNESS; VALIDATION; WOMEN; METAANALYSIS; DISABILITY; TRENDS	The aim of this study was to analyse the change in aerobic capacity from disease onset of rheumatoid arthritis (RA) over 16.2 years, and its associations with disease activity and cardiovascular risk factors. Twenty-five patients (20 f/5 m), diagnosed with RA 1995-2002 were tested at disease onset and after mean 16.2 years. Parameters measured were: sub-maximal ergometer test for aerobic capacity, functional ability, self-efficacy, ESR, CRP and DAS28. At follow-up, cardiovascular risk factors were assessed as blood lipids, glucose concentrations, waist circumference, body mass index (BMI), body composition, pulse wave analysis and carotid intima-media thickness. Aerobic capacity [median (IQR)] was 32.3 (27.9-42.1) ml O-2/kg x min at disease onset, and 33.2 (28.4-38.9) at follow-up (p>0.05). Baseline aerobic capacity was associated with follow-up values of: BMI (r(s) = -.401, p = .047), waist circumference (r(s) = -.498, p = .011), peripheral pulse pressure (r(s) = -.415, p = .039) self-efficacy (r(s) = .420, p = .037) and aerobic capacity (rs = .557, p = .004). In multiple regression models adjusted for baseline aerobic capacity, disease activity at baseline and over time predicted aerobic capacity at follow-up (AUC DAS28, 0-24 months; beta = -.14, p = .004). At follow-up, aerobic capacity was inversely associated with blood glucose levels (r(s) = -.508, p = .016), BMI (r(s) = -.434, p = .030), body fat% (r(s) = -.419, p = .037), aortic pulse pressure (r(s) = -.405, p = .044), resting heart rate (r(s) = -.424, p = .034) and self-efficacy (r(s) = .464, p = .020) at follow-up. We conclude that the aerobic capacity was maintained over 16 years. High baseline aerobic capacity associated with favourable measures of cardiovascular risk factors at follow-up. Higher disease activity in early stages of RA predicted lower aerobic capacity after 16.2 years.	[Hornberg, Kristina; Sundstrom, Bjorn; Innala, Lena; Rantapaa-Dahlqvist, Solbritt; Wallberg-Jonsson, Solveig] Univ Umea, Dept Publ Hlth & Clin Med Rheumatol, Umea, Sweden	Umea University	Hornberg, K (corresponding author), Univ Umea, Dept Publ Hlth & Clin Med Rheumatol, Umea, Sweden.	kristina.hornberg@umu.se			County Council of Vasterbotten; Swedish Rheumatism Association; Medical Faculty of Umea University; King Gustav V's 80-Year Fund; Sweden	County Council of Vasterbotten; Swedish Rheumatism Association; Medical Faculty of Umea University; King Gustav V's 80-Year Fund; Sweden	This work received support from the County Council of Vasterbotten, www.vll.se; the Swedish Rheumatism Association, www. reumatikerforbundet.org; the Medical Faculty of Umea University, http://www.medfak.umu.se/english/; and The King Gustav V's 80-Year Fund; Sweden, kungahuset.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Astrand PO, 2003, TXB WORK PHYSL PHYSL, P287; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Baillet A, 2009, RHEUMATOLOGY, V48, P410, DOI 10.1093/rheumatology/ken511; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cimen OB, 2001, CLIN RHEUMATOL, V20, P168, DOI 10.1007/s100670170058; Douketis JD, 2005, CAN MED ASSOC J, V172, P995, DOI 10.1503/cmaj.045170; Ekblom B, 2007, SCAND J MED SCI SPOR, V17, P267, DOI 10.1111/j.1600-0838.2006.00531.x; EKDAHL C, 1988, SCAND J RHEUMATOL, V17, P263, DOI 10.3109/03009748809098795; EKDAHL C, 1992, ANN RHEUM DIS, V51, P35, DOI 10.1136/ard.51.1.35; Eurenius E, 2005, ARTHRIT RHEUM-ARTHR, V53, P48, DOI 10.1002/art.20924; Hakkinen A, 2002, SCAND J RHEUMATOL, V31, P345; Hornberg K., 2014, CARDIOPULM PHYS THER, V25, P68; Hornberg K, 2007, EUR J PHYSIOTHER, V9, P144, DOI 10.1080/14038190701433274; Hurkmans EJ, 2011, ACTA REUMATOL PORT, V36, P146; Ikdahl E, 2016, J RHEUMATOL, V43, P1622, DOI 10.3899/jrheum.160053; Iversen MD, 2004, PHYS THER, V84, P706, DOI 10.1093/ptj/84.8.706; Kiebzak GM, 2000, J CLIN DENSITOM, V3, P35, DOI 10.1385/JCD:3:1:035; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Kokkinos P, 2008, ANGIOLOGY, V59, p26S, DOI 10.1177/0003319708318582; Kurtais Y, 2006, J RHEUMATOL, V33, P1530; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lomi C, 1992, Scand J Caring Sci, V6, P131; Mancuso CA, 2007, ARTHRIT RHEUM-ARTHR, V57, P672, DOI 10.1002/art.22689; Metsios GS, 2014, ANN RHEUM DIS, V73, P748, DOI 10.1136/annrheumdis-2013-203291; Metsios GS, 2015, RHEUMATOLOGY OXFORD; Munsterman T, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-202; Munsterman T, 2013, J REHABIL MED, V45, P164, DOI 10.2340/16501977-1073; Nordgren B, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-305; O'Rourke MF, 2001, BRIT J CLIN PHARMACO, V51, P507, DOI 10.1046/j.0306-5251.2001.01400.x; Pedersen AB, 2015, J RHEUMATOL, V42, P2247, DOI 10.3899/jrheum.141297; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Sodergren A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3116; Solomon DH, 2010, ANN RHEUM DIS, V69, P1920, DOI 10.1136/ard.2009.122226; Stavropoulos-Kalinoglou A, 2013, ANN RHEUM DIS, V72, P1819, DOI 10.1136/annrheumdis-2012-202075; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; van Rensburg DCJ, 2012, CLIN RHEUMATOL, V31, P1155, DOI 10.1007/s10067-012-1985-5; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Veldhuijzen van Zanten JJ, 2015, SPORTS MED; WallbergJonsson S, 1997, J RHEUMATOL, V24, P445	42	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190211	10.1371/journal.pone.0190211	http://dx.doi.org/10.1371/journal.pone.0190211			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272303	Green Submitted, Green Published, gold			2022-12-26	WOS:000418651500042
J	Mastren, T; Radchenko, V; Hopkins, PD; Engle, JW; Weidner, JW; Copping, R; Brugh, M; Nortier, FM; Birnbaum, ER; John, KD; Fassbender, MEH				Mastren, Tara; Radchenko, Valery; Hopkins, Philip D.; Engle, Jonathan W.; Weidner, John W.; Copping, Roy; Brugh, Mark; Nortier, F. Meiring; Birnbaum, Eva R.; John, Kevin D.; Fassbender, Michael Ernst-Heinrich			Separation of Ru-103 from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide Rh-103m	PLOS ONE			English	Article							ANION-EXCHANGE BEHAVIOR; CHROMATOGRAPHIC-SEPARATION; EXTRACTION PROCESS; PUREX RAFFINATE; ION-EXCHANGE; NITRIC-ACID; GENERATOR; ELEMENTS; FISSION; TARGETS	Ruthenium-103 is the parent isotope of Rh-103m (t(1/2) 56.1 min), an isotope of interest for Auger electron therapy. During the proton irradiation of thorium targets, large amounts of Ru-103 are generated through proton induced fission. The development of a two part chemical separation process to isolate Ru-103 in high yield and purity from a proton irradiated thorium matrix on an analytical scale is described herein. The first part employed an anion exchange column to remove cationic actinide/lanthanide impurities along with the majority of the transition metal fission products. Secondly, an extraction chromatographic column utilizing diglycolamide functional groups was used to decontaminate Ru-103 from the remaining impurities. This method resulted in a final radiochemical yield of 83 +/- 5% of Ru-103 with a purity of 99.9%. Additionally, measured nuclear reaction cross sections for the formation of Ru-103 and Ru-106 via the Th-232(p,f) Ru-103,Ru-106 reactions are reported within.	[Mastren, Tara; Radchenko, Valery; Hopkins, Philip D.; Engle, Jonathan W.; Weidner, John W.; Brugh, Mark; Nortier, F. Meiring; Birnbaum, Eva R.; John, Kevin D.; Fassbender, Michael Ernst-Heinrich] Los Alamos Natl Lab, Chem Div, Los Alamos, NM 87545 USA; [Copping, Roy] Oak Ridge Natl Lab, Nucl Secur & Isotope Technol Div, Oak Ridge, TN USA; [Radchenko, Valery] TRIUMF, Vancouver, BC, Canada; [Engle, Jonathan W.] Univ Wisconsin Madison, Madison, WI 53706 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of British Columbia; University of Wisconsin System; University of Wisconsin Madison	Fassbender, MEH (corresponding author), Los Alamos Natl Lab, Chem Div, Los Alamos, NM 87545 USA.	mifa@lanl.gov	John, Kevin D./R-3752-2019; Fassbender, Michael/Q-5478-2017	John, Kevin D./0000-0002-6181-9330; Forssell-Aronsson, Eva/0000-0002-7558-4368; Hopkins, Philip/0000-0002-0430-7398; Fassbender, Michael/0000-0003-3784-0276; Engle, Jonathan W/0000-0002-3399-7228	United States Department of Energy, Office of Science, Isotope Development and Production for Research and Application subprogram within Office of Nuclear Physics; LANL LDRD program [LDRD 20160439ER]	United States Department of Energy, Office of Science, Isotope Development and Production for Research and Application subprogram within Office of Nuclear Physics; LANL LDRD program(United States Department of Energy (DOE)Los Alamos National Laboratory)	This work was supported by the United States Department of Energy, Office of Science, Isotope Development and Production for Research and Application subprogram within Office of Nuclear Physics and the LANL LDRD program (LDRD 20160439ER) for financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully recognize the United States Department of Energy, Office of Science, Isotope Development and Production for Research and Application subprogram within Office of Nuclear Physics and the LANL LDRD program (LDRD 20160439ER) for financial support.	[Anonymous], 1961, RADIOCHEMISTRY RUTHE; Ballard B, 2012, APPL RADIAT ISOTOPES, V70, P595, DOI 10.1016/j.apradiso.2012.01.018; Bartos B, 2009, J RADIOANAL NUCL CH, V279, P655, DOI 10.1007/s10967-008-7346-9; Bernhardt P, 2001, ACTA ONCOL, V40, P602; BUNNEY LR, 1959, ANAL CHEM, V31, P324, DOI 10.1021/ac60147a001; Cornelissen Bart, 2010, Curr Drug Discov Technol, V7, P263, DOI 10.2174/157016310793360657; Duijvestijn MC, 1999, PHYS REV C, V59, P776, DOI 10.1103/PhysRevC.59.776; Engle JW, 2014, RADIOCHIM ACTA, V102, P569, DOI 10.1515/ract-2013-2179; Engle JW, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.014604; EPPERSON CE, 1976, ANAL CHEM, V48, P979, DOI 10.1021/ac60371a031; Filosofov DV, 2013, RADIOCHEMISTRY+, V55, P410, DOI 10.1134/S1066362213040127; Guin R, 1998, J RADIOANAL NUCL CH, V230, P269, DOI 10.1007/BF02387477; Hermanne A, 2002, NUCL INSTRUM METH B, V187, P3, DOI 10.1016/S0168-583X(01)00851-5; Hermanne A, 2000, NUCL INSTRUM METH B, V170, P281, DOI 10.1016/S0168-583X(00)00190-7; ICHIKAWA F, 1961, B CHEM SOC JPN, V34, P952, DOI 10.1246/bcsj.34.952; Knapp FF., 2016, RADIOPHARMACEUTICALS, P131, DOI [10.1007/978-81-322-2607-9_7, DOI 10.1007/978-81-322-2607-9_7]; KUDO H, 1982, PHYS REV C, V25, P3011, DOI 10.1103/PhysRevC.25.3011; Magnusson D, 2009, SOLVENT EXTR ION EXC, V27, P26, DOI 10.1080/07366290802544726; Mastren T, 2018, ANAL CHIM ACTA, V998, P75, DOI 10.1016/j.aca.2017.10.020; Mastren T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08506-9; Modolo G, 2008, SOLVENT EXTR ION EXC, V26, P62, DOI 10.1080/07366290701784175; Nortier FM, 2010, ISOTOPE PRODUCTION F; Pereira E, 2017, SCI REP-UK, V7, DOI 10.1038/srep42544; Pourmand A, 2010, TALANTA, V81, P741, DOI 10.1016/j.talanta.2010.01.008; Radchenko V, 2015, J CHROMATOGR A, V1380, P55, DOI 10.1016/j.chroma.2014.12.045; Radchenko V, 2017, TALANTA, V175, P318, DOI 10.1016/j.talanta.2017.07.057; Skarnemark G, 2009, J RADIOANAL NUCL CH, V280, P371, DOI 10.1007/s10967-009-0529-1; STEYN GF, 1990, APPL RADIAT ISOTOPES, V41, P315, DOI 10.1016/0883-2889(90)90197-O; Sudar S, 2002, APPL RADIAT ISOTOPES, V56, P821, DOI 10.1016/S0969-8043(02)00054-4; Thisgaard H, 2016, THERANOSTICS, V6, P2278, DOI 10.7150/thno.15898; Titarenko YE, 2003, EXPT THEORETICAL STU; van Rooyen J, 2008, APPL RADIAT ISOTOPES, V66, P1346, DOI 10.1016/j.apradiso.2008.02.088; Weidner JW, 2012, APPL RADIAT ISOTOPES, V70, P2602, DOI 10.1016/j.apradiso.2012.07.006; Weidner JW, 2012, APPL RADIAT ISOTOPES, V70, P2590, DOI 10.1016/j.apradiso.2012.07.003; Zhang AY, 2005, SOLVENT EXTR ION EXC, V23, P231, DOI 10.1081/SEI-200049894; Zweit J, 1996, PHYS MED BIOL, V41, P1905, DOI 10.1088/0031-9155/41/10/004	36	4	4	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190308	10.1371/journal.pone.0190308	http://dx.doi.org/10.1371/journal.pone.0190308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272318	Green Published, gold, Green Submitted			2022-12-26	WOS:000418651500049
J	Mortensen, LM; Lundbye-Christensen, S; Schmidt, EB; Calder, PC; Schierup, MH; Tjonneland, A; Parner, ET; Overvad, K				Mortensen, Lotte Maxild; Lundbye-Christensen, Soren; Schmidt, Erik Berg; Calder, Philip C.; Schierup, Mikkel Heide; Tjonneland, Anne; Parner, Erik T.; Overvad, Kim			Long-chain n-3 and n-6 polyunsaturated fatty acids and risk of atrial fibrillation: Results from a Danish cohort study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; REGRESSION-ANALYSIS; PSEUDO-OBSERVATIONS; GENE-CLUSTER; FISH; OMEGA-3-FATTY-ACIDS; INFLAMMATION; ASSOCIATION; VARIANTS; PATHWAYS	Background Studies of the relation between polyunsaturated fatty acids and risk of atrial fibrillation have been inconclusive. The risk of atrial fibrillation may depend on the interaction between n-3 and n-6 polyunsaturated fatty acids as both types of fatty acids are involved in the regulation of systemic inflammation. Objective We investigated the association between dietary intake of long chain polyunsaturated fatty acids (individually and in combination) and the risk of atrial fibrillation with focus on potential interaction between the two types of polyunsaturated fatty acids. Design The risk of atrial fibrillation in the Diet, Cancer and Health Cohort was analyzed using the pseudo-observation method to explore cumulative risks on an additive scale providing risk differences. Dietary intake of long chain polyunsaturated fatty acids was assessed by food frequency questionnaires. The main analyses were adjusted for the dietary intake of n-3 alinolenic acid and n-6 linoleic acid to account for endogenous synthesis of long chain polyunsaturated fatty acids. Interaction was assessed as deviation from additivity of absolute association measures (risk differences). Results Cumulative risks in 15-year age periods were estimated in three strata of the cohort (N = 54,737). No associations between intake of n-3 or n-6 long chain polyunsaturated fatty acids and atrial fibrillation were found, neither when analyzed separately as primary exposures nor when interaction between n-3 and n-6 long chain polyunsaturated fatty acids was explored. Conclusion This study suggests no association between intake of long chain polyunsaturated fatty acids and risk of atrial fibrillation.	[Mortensen, Lotte Maxild; Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, Aarhus, Denmark; [Mortensen, Lotte Maxild; Lundbye-Christensen, Soren; Schmidt, Erik Berg; Overvad, Kim] Aalborg Univ Hosp, Dept Cardiol, Aalborg AF Study Grp, Aalborg, Denmark; [Calder, Philip C.] Univ Southampton, Fac Med, Human Dev & Hlth Acad Unit, Southampton, Hants, England; [Calder, Philip C.] Univ Southampton, Natl Inst Hlth Res Southampton Biomed Res Ctr, Southampton, Hants, England; [Calder, Philip C.] Univ Southampton, Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Schierup, Mikkel Heide] Univ Aarhus, Bioinformat Res Ctr, Aarhus, Denmark; [Tjonneland, Anne] Danish Canc Soc Res Ctr, Unit Diet Genes & Environm, Copenhagen, Denmark; [Parner, Erik T.] Aarhus Univ, Dept Publ Hlth, Sect Biostat, Aarhus, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Aarhus University; Danish Cancer Society; Aarhus University	Mortensen, LM (corresponding author), Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, Aarhus, Denmark.; Mortensen, LM (corresponding author), Aalborg Univ Hosp, Dept Cardiol, Aalborg AF Study Grp, Aalborg, Denmark.	lmm@ph.au.dk	Parner, Erik Thorlund/F-5532-2010; Calder, Philip C/E-9739-2013; Schierup, Mikkel Heide/AAM-4997-2020	Parner, Erik Thorlund/0000-0003-3661-1922; Calder, Philip C/0000-0002-6038-710X; Schierup, Mikkel Heide/0000-0002-5028-1790; Tjonneland, Anne/0000-0003-4385-2097; Overvad, Kim/0000-0001-6429-7921	Danish Council for Strategic Research [09-066965]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by a research grant from the Danish Council for Strategic Research, grant number 09-066965 (http://ufm.dk/en/research-and-innovation/councils-and- commissions/former-councils-and-commissions/ the-danish-council-for-strategic-researcli). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 2005, EUR J EPIDEMIOL, V20, P563, DOI 10.1007/s10654-005-4410-4; Al-Khudairy L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011094.pub2; Andersen PK, 2015, LIFETIME DATA ANAL, V21, P300, DOI 10.1007/s10985-015-9318-z; Andersen PK, 2010, STAT METHODS MED RES, V19, P71, DOI 10.1177/0962280209105020; [Anonymous], 2013, STATA STAT SOFTW REL; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Bellavia A, 2016, EPIDEMIOLOGY, V27, P360, DOI 10.1097/EDE.0000000000000449; Berry JD, 2010, AM J CARDIOL, V105, P844, DOI 10.1016/j.amjcard.2009.11.039; Billman GE, 2013, PHARMACOL THERAPEUT, V140, P53, DOI 10.1016/j.pharmthera.2013.05.011; Brouwer IA, 2006, AM HEART J, V151, P857, DOI 10.1016/j.ahj.2005.07.029; Calder PC, 2010, NUTRIENTS, V2, P355, DOI 10.3390/nu2030355; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; Estes NAM, 2011, CIRCULATION, V124, P363, DOI 10.1161/CIR.0b013e318224b037; Fuster V, 2011, CIRCULATION, V123, pE269, DOI 10.1161/CIR.0b013e318214876d; Greenland S., 2008, MODERN EPIDEMIOLOGY; Gronroos NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036686; Harrell F.E, 2001, REGRESSION MODELING, P53, DOI DOI 10.1007/978-1-4757-3462-1_4; Larsson SC, 2017, CLIN NUTR, V36, P537, DOI 10.1016/j.clnu.2016.01.019; Lauritsen J, FOODCALC; Madden J, 2011, ANNU REV NUTR, V31, P203, DOI 10.1146/annurev-nutr-010411-095239; Malerba G, 2008, LIPIDS, V43, P289, DOI 10.1007/s11745-008-3158-5; Menezes AR, 2013, MAYO CLIN PROC, V88, P394, DOI 10.1016/j.mayocp.2013.01.022; Mozaffarian D, 2004, CIRCULATION, V110, P368, DOI 10.1161/01.CIR.0000138154.00779.A5; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Overgaard M, 2015, STATA J, V15, P809, DOI 10.1177/1536867X1501500313; Parner ET, 2010, STATA J, V10, P408, DOI 10.1177/1536867X1001000308; Ralston JC, 2015, OBESITY, V23, P725, DOI 10.1002/oby.21035; Rix TA, 2014, EUROPACE EUROPEAN PA; Rix TA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00152; Rix TA, 2012, SCAND CARDIOVASC J, V46, P149, DOI 10.3109/14017431.2012.673728; ROTHMAN KJ, 1980, AM J EPIDEMIOL, V112, P467, DOI 10.1093/oxfordjournals.aje.a113015; Sata N, 2004, JPN HEART J, V45, P441, DOI 10.1536/jhj.45.441; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Shen JA, 2011, AM J CLIN NUTR, V93, P261, DOI 10.3945/ajcn.110.001305; Spector AA, 1999, LIPIDS, V34, pS1, DOI 10.1007/BF02562220; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; THRALL G, 2006, AM J MED, V119, P448, DOI DOI 10.1016/J.AMJMED.2005.10.057; Tjonneland A, 2007, SCANDJPUBLIC HLTH, V35; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P863, DOI 10.1097/EDE.0b013e3181ba333c; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Wood KE, 2015, PROSTAG LEUKOTR ESS, V95, P47, DOI 10.1016/j.plefa.2015.01.001; Wood KE, 2014, PROSTAG LEUKOTR ESS, V90, P133, DOI 10.1016/j.plefa.2013.12.010; Wu N, 2013, INT J CARDIOL, V169, P62, DOI 10.1016/j.ijcard.2013.08.078	45	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190262	10.1371/journal.pone.0190262	http://dx.doi.org/10.1371/journal.pone.0190262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272310	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000418651500047
J	Ghnenis, AB; Odhiambo, JF; McCormick, RJ; Nathanielsz, PW; Ford, SP				Ghnenis, Adel B.; Odhiambo, John F.; McCormick, Richard J.; Nathanielsz, Peter W.; Ford, Stephen P.			Maternal obesity in the ewe increases cardiac ventricular expression of glucocorticoid receptors, proinflammatory cytokines and fibrosis in adult male offspring	PLOS ONE			English	Article							HIGH-FAT DIET; ADIPOSE-TISSUE; GENE-EXPRESSION; TRANSGENIC MICE; INFLAMMATION; HEART; DYSFUNCTION; IDENTIFICATION; OVERNUTRITION; DYSREGULATION	Obesity during human pregnancy predisposes offspring to obesity and cardiovascular disease in postnatal life. In a sheep model of maternal overnutrition/obesity we have previously reported myocardial inflammation and fibrosis, as well as cardiac dysfunction in late term fetuses, in association with chronically elevated blood cortisol. Significant research has suggested a link between elevated glucocorticoid exposure in utero and hypertension and cardiovascular disease postnatally. Here we examined the effects of maternal obesity on myocardial inflammation and fibrosis of their adult offspring. Adult male offspring from control (CON) mothers fed 100% of National Research Council (NRC) recommendations (n = 6) and male offspring from obese mothers (MO) fed 150% NRC (n = 6), were put on a 12-week ad libitum feeding challenge then necropsied. At necropsy, plasma cortisol and left and right ventricular thickness were markedly increased (P<0.05) in adult male MO offspring. Myocardial collagen content and collagen-crosslinking were greater (P<0.05) in MO offspring compared to CON offspring in association with increased mRNA and protein expression of glucocorticoid receptors (GR). No group difference was found in myocardial mineralocorticoids receptor (MR) protein expression. Further, mRNA expression for the proinflammatory cytokines: cluster of differentiation (CD)-68, transforming growth factor (TGF)-beta 1, and tumor necrosis factor (TNF)-alpha were increased (P <0.05), and protein expression of CD-68, TGF-beta 1, and TNF-alpha tended to increase (P<0.10) in MO vs. CON offspring. These data provide evidence for MO-induced programming of elevated plasma cortisol and myocardial inflammation and fibrosis in adult offspring potentially through increased GR.	[Ghnenis, Adel B.; Odhiambo, John F.; McCormick, Richard J.; Nathanielsz, Peter W.; Ford, Stephen P.] Univ Wyoming, Dept Anim Sci, Ctr Study Fetal Programming, Laramie, WY 82071 USA	University of Wyoming	Ford, SP (corresponding author), Univ Wyoming, Dept Anim Sci, Ctr Study Fetal Programming, Laramie, WY 82071 USA.	spford@uwyo.edu	odhiambo, john/AAC-2444-2020	odhiambo, john/0000-0002-1005-3486; Nathanielsz, Peter/0000-0001-8410-6280	National Institutes of Health (NIH) [HD070096-01A1]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The present work was supported by the National Institutes of Health (NIH) HD070096-01A1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; [Anonymous], 2010, J STEROID BIOCHEM, V119, P56; Bryant D, 1998, CIRCULATION, V97, P1375, DOI 10.1161/01.CIR.97.14.1375; Craft Jennifer, 2004, Proc (Bayl Univ Med Cent), V17, P217; Decologne N, 2007, J IMMUNOL, V179, P6043, DOI 10.4049/jimmunol.179.9.6043; Devaux B, 1997, EUR HEART J, V18, P470; Dong ML, 2013, J MOL CELL CARDIOL, V55, P111, DOI 10.1016/j.yjmcc.2012.08.023; ETXABE J, 1994, CLIN ENDOCRINOL, V40, P479, DOI 10.1111/j.1365-2265.1994.tb02486.x; Fan XJ, 2011, J NUTR BIOCHEM, V22, P30, DOI 10.1016/j.jnutbio.2009.11.006; Feng XD, 2013, AM J PHYSIOL-REG I, V305, pR343, DOI 10.1152/ajpregu.00112.2013; Fernandez-Twinn DS, 2012, ENDOCRINOLOGY, V153, P5961, DOI 10.1210/en.2012-1508; Ford SP, 2013, EXPERT REV ENDOCRINO; Ford SP, 2009, AM J PHYSIOL-REG I, V297, pR835, DOI 10.1152/ajpregu.00072.2009; Garg R, 2015, CURRENT HYPERTENSION, V17, p1 ; Ge W, 2013, J NUTR BIOCHEM, V24, P1258, DOI 10.1016/j.jnutbio.2012.10.001; Ghnenis AB, 2016, MATERNAL OBESITY MO; Gray GA, 2017, J MOL ENDOCRINOL, V58, pR1, DOI 10.1530/JME-16-0128; Hattori T, 2013, NAGOYA J MED SCI, V75, P81; Heslehurst N, 2007, BJOG-INT J OBSTET GY, V114, P187, DOI 10.1111/j.1471-0528.2006.01180.x; Huang Y, 2010, AM J PHYSIOL-ENDOC M, V299, pE968, DOI 10.1152/ajpendo.00434.2010; Ingvorsen C, 2015, ACTA PHYSIOL, V214, P440, DOI 10.1111/apha.12533; Johanssen S, 2007, EUR J ENDOCRINOL, V157, P561, DOI 10.1530/EJE-07-0458; Johnson A, 2013, FASEB J, V27, P3893, DOI 10.1096/fj.12-214189; Kai H, 2005, HYPERTENS RES, V28, P483, DOI 10.1291/hypres.28.483; Kandadi MR, 2013, J NUTR BIOCHEM, V24, P1982, DOI 10.1016/j.jnutbio.2013.07.003; Kaya Z, 2008, CIRCULATION, V118, P2063, DOI 10.1161/CIRCULATIONAHA.108.788711; Khan IY, 2005, AM J PHYSIOL-REG I, V288, pR127, DOI 10.1152/ajpregu.00354.2004; Kubota T, 1997, CIRC RES, V81, P627, DOI 10.1161/01.RES.81.4.627; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOMBES M, 1995, CIRCULATION, V92, P175, DOI 10.1161/01.CIR.92.2.175; Long NM, 2012, DOMEST ANIM ENDOCRIN, V42, P195, DOI 10.1016/j.domaniend.2011.12.002; Long NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122152; Maloyan A, 2013, PHYSIOL GENOMICS, V45, P889, DOI 10.1152/physiolgenomics.00050.2013; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; Mills JL, 2010, AM J CLIN NUTR, V91, P1543, DOI 10.3945/ajcn.2009.28865; Mingrone G, 2008, DIABETES CARE, V31, P1872, DOI 10.2337/dc08-0432; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ohtake M, 2014, NAGOYA J MED SCI, V76, P59; Pantham P, 2015, PLACENTA, V36, P709, DOI 10.1016/j.placenta.2015.04.006; Pardo Annie, 2006, Proc Am Thorac Soc, V3, P383, DOI 10.1513/pats.200601-012TK; Ponten A, 2005, CIRC RES, V97, P1036, DOI 10.1161/01.RES.0000190590.31545.d4; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Reini SA, 2008, J ENDOCRINOL, V198, P419, DOI 10.1677/JOE-08-0022; Ren J, 2009, OBESITY, V17, P1114, DOI 10.1038/oby.2009.8; Ren RQ, 2012, ENDOCRINOLOGY, V153, P5346, DOI 10.1210/en.2012-1563; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Richardson RV, 2016, TRENDS ENDOCRIN MET, V27, P35, DOI 10.1016/j.tem.2015.10.001; Roberts VHJ, 2015, PHYSIOLOGY, V30, P224, DOI 10.1152/physiol.00021.2014; Rog-Zielinska EA, 2013, HUM MOL GENET, V22, P3269, DOI 10.1093/hmg/ddt182; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Segovia Stephanie A, 2014, Biomed Res Int, V2014, P418975, DOI 10.1155/2014/418975; Smith AM, 2016, MATERNAL OBESITY IND; Souverein PC, 2004, HEART, V90, P859, DOI 10.1136/hrt.2003.020180; Spencer M, 2010, AM J PHYSIOL-ENDOC M, V299, pE1016, DOI 10.1152/ajpendo.00329.2010; Takeshita Y, 2015, HYPERTENS RES, V38, P741, DOI 10.1038/hr.2015.77; Tuersunjiang N, 2013, AM J PHYSIOL-ENDOC M, V305, pE868, DOI 10.1152/ajpendo.00117.2013; Turdi S, 2013, J MOL CELL CARDIOL, V55, P117, DOI 10.1016/j.yjmcc.2012.12.007; Walker BR, 2007, EUR J ENDOCRINOL, V157, P545, DOI 10.1530/EJE-07-0455; Wang JY, 2010, FASEB J, V24, P2066, DOI 10.1096/fj.09-142315; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zanchi NE, 2010, J CELL PHYSIOL, V224, P311, DOI 10.1002/jcp.22141; Zhu MJ, 2010, AM J PHYSIOL-REG I, V299, pR1224, DOI 10.1152/ajpregu.00309.2010	65	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189977	10.1371/journal.pone.0189977	http://dx.doi.org/10.1371/journal.pone.0189977			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267325	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400072
J	Mahmood, ASMA; Rao, S; McGarvey, P; Wu, C; Madhavan, S; Vijay-Shanker, K				Mahmood, A. S. M. Ashique; Rao, Shruti; McGarvey, Peter; Wu, Cathy; Madhavan, Subha; Vijay-Shanker, K.			eGARD: Extracting associations between genomic anomalies and drug responses from text	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; ADJUVANT CHEMOTHERAPY; SEQUENCE VARIANTS; MINING TOOL; FOLLOW-UP; CANCER; TRASTUZUMAB; KNOWLEDGE; EFFICACY; DATABASE	Tumor molecular profiling plays an integral role in identifying genomic anomalies which may help in personalizing cancer treatments, improving patient outcomes and minimizing risks associated with different therapies. However, critical information regarding the evidence of clinical utility of such anomalies is largely buried in biomedical literature. It is becoming prohibitive for biocurators, clinical researchers and oncologists to keep up with the rapidly growing volume and breadth of information, especially those that describe therapeutic implications of biomarkers and therefore relevant for treatment selection. In an effort to improve and speed up the process of manually reviewing and extracting relevant information from literature, we have developed a natural language processing (NLP)-based text mining (TM) system called eGARD (extracting Genomic Anomalies association with Response to Drugs). This system relies on the syntactic nature of sentences coupled with various textual features to extract relations between genomic anomalies and drug response from MEDLINE abstracts. Our system achieved high precision, recall and F-measure of up to 0.95, 0.86 and 0.90, respectively, on annotated evaluation datasets created in-house and obtained externally from PharmGKB. Additionally, the system extracted information that helps determine the confidence level of extraction to support prioritization of curation. Such a system will enable clinical researchers to explore the use of published markers to stratify patients upfront for 'best-fit' therapies and readily generate hypotheses for new clinical trials.	[Mahmood, A. S. M. Ashique; Wu, Cathy; Vijay-Shanker, K.] Univ Delaware, Dept Comp & Informat Sci, Newark, DE 19716 USA; [Rao, Shruti; McGarvey, Peter; Madhavan, Subha] Georgetown Univ, Innovat Ctr Biomed Informat, Washington, DC USA; [McGarvey, Peter; Wu, Cathy] Georgetown Univ, Med Ctr, Prot Informat Resource, Washington, DC 20007 USA; [Wu, Cathy] Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DC USA; [Madhavan, Subha] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA	University of Delaware; Georgetown University; Georgetown University; University of Delaware; Georgetown University	Mahmood, ASMA (corresponding author), Univ Delaware, Dept Comp & Informat Sci, Newark, DE 19716 USA.	ashique@udel.edu	McGarvey, Peter/AAE-9351-2019	Rao, Shruti/0000-0002-7235-0777; Wu, Cathy/0000-0001-6379-8601; McGarvey, Peter/0000-0002-8312-6017	National Institutes of Health BD2K Data Wrangling Awards [1 U01 HG008390-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008390] Funding Source: NIH RePORTER	National Institutes of Health BD2K Data Wrangling Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Institutes of Health BD2K Data Wrangling Awards Grant Number: 1 U01 HG008390-01. https://commonfund.nih.gov/bd2k. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Beroud C, 2005, HUM MUTAT, V26, P184, DOI 10.1002/humu.20210; Cameron D, 2017, LANCET, V389, P1195, DOI 10.1016/S0140-6736(16)32616-2; Carr TH, 2016, NAT REV CANCER, V16, P319, DOI 10.1038/nrc.2016.35; Coulet A, 2012, J BIOMED INFORM, V45, P825, DOI 10.1016/j.jbi.2012.08.001; Ding PN, 2017, J THORAC ONCOL, V12, P633, DOI 10.1016/j.jtho.2016.11.2236; Ding R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139961; Fleuren WWM, 2015, METHODS, V74, P97, DOI 10.1016/j.ymeth.2015.01.015; Garten Y, 2010, PHARMACOGENOMICS, V11, P1467, DOI [10.2217/pgs.10.136, 10.2217/PGS.10.136]; Garten Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S2-S6; Griffith M, 2017, NAT GENET, V49, P170, DOI 10.1038/ng.3774; Gupta S, 2016, J BIOMED SEMANT, V7, DOI 10.1186/s13326-015-0044-y; Hakenberg J, 2012, J BIOMED INFORM, V45, P842, DOI 10.1016/j.jbi.2012.04.006; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kibbe WA, 2015, NUCLEIC ACIDS RES, V43, pD1071, DOI 10.1093/nar/gku1011; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Leaman R, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/1758-2946-7-S1-S3; Leaman R, 2013, BIOINFORMATICS, V29, P2909, DOI 10.1093/bioinformatics/btt474; Levy MA, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.7576; Li MM, 2017, J MOL DIAGN, V19, P4, DOI 10.1016/j.jmoldx.2016.10.002; Mahmood ASMA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152725; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; McArthur GA, 2014, LANCET ONCOL, V15, P323, DOI 10.1016/S1470-2045(14)70012-9; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Narayanaswamy Meenakshi, 2003, Pac Symp Biocomput, P427; Pakhomov S, 2012, J BIOMED INFORM, V45, P862, DOI 10.1016/j.jbi.2012.04.007; Peng Y., 2012, P 2012 IEEE INT C BI; Rance B, 2012, J BIOMED INFORM, V45, P835, DOI 10.1016/j.jbi.2012.05.003; Rao S, 2016, ONCOTARGET; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Rinaldi F, 2012, J BIOMED INFORM, V45, P851, DOI 10.1016/j.jbi.2012.04.014; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Schwartz Ariel S, 2003, Pac Symp Biocomput, P451; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singh A, 2008, NUCLEIC ACIDS RES, V36, pD815, DOI 10.1093/nar/gkm659; Singhal A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005017; Singhal A, 2016, J AM MED INFORM ASSN, V23, P766, DOI 10.1093/jamia/ocw041; Sullivan I, 2017, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00076; Thorisson GA, 2009, NUCLEIC ACIDS RES, V37, pD797, DOI 10.1093/nar/gkn748; Uemura M, 2016, MOL CLIN ONCOL, V5, P375, DOI 10.3892/mco.2016.938; Wei CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041056; Wei CH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/918710; Wei CH, 2013, NUCLEIC ACIDS RES, V41, pW518, DOI 10.1093/nar/gkt441; Wei CH, 2013, BIOINFORMATICS, V29, P1433, DOI 10.1093/bioinformatics/btt156; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Wu TJ, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau022; Xu R, 2012, J BIOMED INFORM, V45, P827, DOI 10.1016/j.jbi.2012.04.011; Zhu F, 2013, J BIOMED INFORM, V46, P200, DOI 10.1016/j.jbi.2012.10.007	51	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189663	10.1371/journal.pone.0189663	http://dx.doi.org/10.1371/journal.pone.0189663			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261751	Green Published, Green Submitted, gold			2022-12-26	WOS:000418564200054
J	Velez, EJ; Azizi, S; Verheyden, D; Salmeron, C; Lutfi, E; Sanchez-Moya, A; Navarro, I; Gutierrez, J; Capilla, E				Velez, Emilio J.; Azizi, Sheida; Verheyden, Dorothy; Salmeron, Cristina; Lutfi, Esmail; Sanchez-Moya, Albert; Navarro, Isabel; Gutierrez, Joaquim; Capilla, Encarnacion			Proteolytic systems' expression during myogenesis and transcriptional regulation by amino acids in gilthead sea bream cultured muscle cells	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; E3 UBIQUITIN LIGASES; IN-VITRO DEVELOPMENT; SKELETAL-MUSCLE; RAINBOW-TROUT; SPARUS-AURATA; IGF-I; ATLANTIC SALMON; GENE-EXPRESSION; GROWTH	Proteolytic systems exert an important role in vertebrate muscle controlling protein turnover, recycling of amino acids (AA) or its use for energy production, as well as other functions like myogenesis. In fish, proteolytic systems are crucial for the relatively high muscle somatic index they possess, and because protein is the most important dietary component. Thus in this study, the molecular profile of proteolytic markers (calpains, cathepsins and ubiquitin-proteasome system (UbP) members) were analyzed during gilthead sea bream (Sparus aurata) myogenesis in vitro and under different AA treatments. The gene expression of calpains (capn1, capn3 and capns1b) decreased progressively during myogenesis together with the proteasome member n3; whereas capn2, capns1a, capns1b and ubiquitin (ub) remained stable. Contrarily, the cathepsin D (ctsd) paralogs and E3 ubiquitin ligases mafbx and murf1, showed a significant peak in gene expression at day 8 of culture that slightly decreased afterwards. Moreover, the protein expression analyzed for selected molecules presented in general the same profile of the mRNA levels, which was confirmed by correlation analysis. These data suggest that calpains seem to be more important during proliferation, while cathepsins and the UbP system appear to be required for myogenic differentiation. Concerning the transcriptional regulation by AA, the recovery of their levels after a short starvation period did not show effects on cathepsins expression, whereas it down-regulated the expression of capn3, capns1b, mafbx, murf1 and up-regulated n3. With regards to AA deficiencies, the major changes occurred at day 2, when leucine limitation suppressed ctsb and ctsl expression. Besides at the same time, both leucine and lysine deficiencies increased the expression of mafbx and murf1 and decreased that of n3. Overall, the opposite nutritional regulation observed, especially for the UbP members, points out an efficient and complementary role of these factors that could be useful in gilthead sea bream diets optimization.	[Velez, Emilio J.; Azizi, Sheida; Verheyden, Dorothy; Salmeron, Cristina; Lutfi, Esmail; Sanchez-Moya, Albert; Navarro, Isabel; Gutierrez, Joaquim; Capilla, Encarnacion] Univ Barcelona, Fac Biol, Dept Biol Cellular Fisiol & Immunol, Barcelona, Spain	University of Barcelona	Capilla, E (corresponding author), Univ Barcelona, Fac Biol, Dept Biol Cellular Fisiol & Immunol, Barcelona, Spain.	ecapilla@ub.edu	Salmeron, Cristina/CAG-8357-2022; Azizi, Sheida/F-2085-2017; Vélez, Emilio J/M-7661-2015; Capilla, Encarnación/L-6143-2014; Gutierrez, Joaquim/H-2836-2015; Sánchez-Moya, Albert/J-3515-2017; Lutfi, Esmail/J-3529-2017; NAVARRO ALVAREZ, ISABEL/L-9318-2014	Vélez, Emilio J/0000-0002-6363-0697; Capilla, Encarnación/0000-0002-0863-9728; Gutierrez, Joaquim/0000-0002-3126-2236; Sánchez-Moya, Albert/0000-0002-5749-5978; Lutfi, Esmail/0000-0002-0208-9075; Salmeron, Cristina/0000-0003-2259-3807; NAVARRO ALVAREZ, ISABEL/0000-0002-2641-0361	"Ministerio de Economia y Competitividad" (MINECO) [BES-2013-062949, BES-2012-061867]; MINECO [AGL2014-57974-R, AGL2012-39768, AGL2015-70679-R]; Xarxa de Referenda d'R+D+I en Aguicultura; Generalitat de Catalunya [2014SGR-01371]; European Union through the project LIFECYCLE [EU-FP7 222719]	"Ministerio de Economia y Competitividad" (MINECO)(Spanish Government); MINECO(Spanish Government); Xarxa de Referenda d'R+D+I en Aguicultura; Generalitat de Catalunya(Generalitat de Catalunya); European Union through the project LIFECYCLE	E.J.V. and E.L. are supported by predoctoral fellowships (BES-2013-062949 and BES-2012-061867) from the "Ministerio de Economia y Competitividad" (MINECO). This study was supported by the projects from the MINECO AGL2014-57974-R to I.N. and E.G., AGL2012-39768 and AGL2015-70679-R to J.G., the "Xarxa de Referenda d'R+D+I en Aguicultura" and 2014SGR-01371 from the "Generalitat de Catalunya", and by funds from the European Union through the project LIFECYCLE (EU-FP7 222719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attaix D, 2010, CURR OPIN CLIN NUTR, V13, P223, DOI 10.1097/MCO.0b013e328338b9a6; Azizi Sh, 2016, PLOS ONE, V1; Bell RAV, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0086-6; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Bower NI, 2010, PHYSIOL GENOMICS, V42A, P114, DOI 10.1152/physiolgenomics.00065.2010; Bower NI, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-80; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai DQ, 2004, ARCH BIOCHEM BIOPHYS, V425, P42, DOI 10.1016/j.abb.2004.02.027; Castillo J, 2002, AM J PHYSIOL-REG I, V283, pR647, DOI 10.1152/ajpregu.00121.2002; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Cleveland BM, 2012, AQUACULTURE, V338, P228, DOI 10.1016/j.aquaculture.2012.01.032; Cleveland BM, 2010, AM J PHYSIOL-REG I, V298, pR341, DOI 10.1152/ajpregu.00516.2009; COLELLA R, 1986, BIOMED BIOCHIM ACTA, V45, P1413; de la Serrana DG, 2017, GEN COMP ENDOCR, V247, P53, DOI 10.1016/j.ygcen.2017.01.017; Delbarre-Ladrat C, 2006, CRIT REV FOOD SCI, V46, P409, DOI 10.1080/10408390591000929; EBISUI C, 1995, J BIOCHEM-TOKYO, V117, P1088, DOI 10.1093/oxfordjournals.jbchem.a124811; Froehlich JM, 2014, JOVE-J VIS EXP, DOI 10.3791/51354; Froehlich JM, 2013, IN VITRO CELL DEV-AN, V49, P371, DOI 10.1007/s11626-013-9616-2; Fuentes EN, 2013, GEN COMP ENDOCR, V192, P136, DOI 10.1016/j.ygcen.2013.06.009; de la Serrana DG, 2014, COMP BIOCHEM PHYS A, V167, P90, DOI 10.1016/j.cbpa.2013.10.020; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Honda M, 2008, AM J PHYSIOL-CELL PH, V294, pC957, DOI 10.1152/ajpcell.00505.2007; Ilian MA, 2001, J ANIM SCI, V79, P122; Jogo M, 2009, FEBS LETT, V583, P2715, DOI 10.1016/j.febslet.2009.07.033; Johnston IA, 2011, J EXP BIOL, V214, P1617, DOI 10.1242/jeb.038620; Kaminskyy V, 2012, BBA-PROTEINS PROTEOM, V1824, P44, DOI 10.1016/j.bbapap.2011.05.013; Kimura Y, 2010, J BIOCHEM, V147, P793, DOI 10.1093/jb/mvq044; Macqueen DJ, 2010, GENE, V453, P45, DOI 10.1016/j.gene.2010.01.002; Mairinger FD, 2014, J CANCER, V5, P646, DOI 10.7150/jca.9955; Martin SAM, 2002, PFLUG ARCH EUR J PHY, V445, P257, DOI 10.1007/s00424-002-0916-8; Montserrat N, 2007, CELL TISSUE RES, V330, P503, DOI 10.1007/s00441-007-0507-2; Moyen C, 2004, INT J BIOCHEM CELL B, V36, P728, DOI 10.1016/S1357-2725(03)00265-6; Murton AJ, 2008, BBA-MOL BASIS DIS, V1782, P730, DOI 10.1016/j.bbadis.2008.10.011; Nakashima K, 2011, J POULT SCI, V48, P51, DOI 10.2141/jpsa.010049; Perera S, 2012, J MUSCLE RES CELL M, V33, P107, DOI 10.1007/s10974-012-9288-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Preziosa E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059404; Rius-Francino M, 2011, GEN COMP ENDOCR, V172, P44, DOI 10.1016/j.ygcen.2011.03.024; Sadiq F, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-23; Salem M, 2005, COMP BIOCHEM PHYS B, V140, P63, DOI 10.1016/j.cbpc.2004.09.007; Salmeron Cristina, 2015, BMC Research Notes, V8, P149, DOI 10.1186/s13104-015-1121-0; Salmeron C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075349; Sato T, 2014, MOL CELL BIOCHEM, V391, P37, DOI 10.1007/s11010-014-1984-8; Seiliez I, 2014, AM J PHYSIOL-REG I, V307, pR1330, DOI 10.1152/ajpregu.00370.2014; Seiliez I, 2012, AUTOPHAGY, V8, P364, DOI 10.4161/auto.18863; Seiliez I, 2010, COMP BIOCHEM PHYS B, V157, P258, DOI 10.1016/j.cbpb.2010.06.011; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Stockholm D, 1999, EXP CELL RES, V252, P392, DOI 10.1006/excr.1999.4628; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Velez EJ, 2017, AQUACULTURE, V467, P28, DOI 10.1016/j.aquaculture.2016.07.004; Velez EJ, 2017, AM J PHYSIOL-REG I, V312, pR643, DOI 10.1152/ajpregu.00308.2016; Velez EJ, 2014, GEN COMP ENDOCR, V205, P296, DOI 10.1016/j.ygcen.2014.05.024; Wang J, 2013, GEOMECH GEOENGIN, V8, P1, DOI 10.1080/17486025.2012.759281	55	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0187339	10.1371/journal.pone.0187339	http://dx.doi.org/10.1371/journal.pone.0187339			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261652	gold, Green Published, Green Submitted			2022-12-26	WOS:000418564200004
J	Bharani, KL; Derex, R; Granholm, AC; Ledreux, A				Bharani, Krishna L.; Derex, Rebecca; Granholm, Ann-Charlotte; Ledreux, Aurelie			A noradrenergic lesion aggravates the effects of systemic inflammation on the hippocampus of aged rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; BLOOD-BRAIN-BARRIER; LOCUS-COERULEUS; ALZHEIMERS-DISEASE; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; CHRONIC NEUROINFLAMMATION; COGNITIVE DYSFUNCTION; SELECTIVE NEUROTOXIN	Neuroinflammation is potentiated by early degeneration of the locus coeruleus noradrenergic pathway (LC-NE) commonly seen in aging-related neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. In animal models, lipopolysaccharide (LPS) induces strong peripheral immune responses that can cause cognitive changes secondary to neuroinflammation. The influence of the peripheral immune response on cognition might be exacerbated by LC-NE degeneration, but this has not been well characterized previously. In this study, we investigated how systemic inflammation affects neuroinflammation and cognition in aged rats that have had either normal or damaged LC-NE transmitter systems. Rats were first exposed to the selective noradrenergic (NE) neurotoxin N-(2-chloroethyl)-Nethyl-2-bromobenzylamine (DSP4) to induce degeneration of central NE pathways. Two weeks later, the rats received a low dose of LPS. This resulted in 3 treatment groups (Control, LPS-, and DSP4+LPS-treated rats) studied at 4 hours (short-term subgroup) and 7 days (long-term subgroup) following the LPS injection. DSP4+LPS-treated rats exhibited increased serum levels of several pro-inflammatory cytokines, increased astroglial and microglial activation in the hippocampus, and poorer performance in the novel object recognition task (NORT) compared to controls and LPS-treated rats. Additionally, serum and brain tissue levels of brain-derived neurotrophic factor (BDNF) were modulated over time in the DSP4+LPS group compared to the other two groups. Specifically, DSP4+LPS-treated rats in the short-term subgroup had lower hippocampal BDNF levels (similar to 25%) than controls and LPS-treated rats, which negatively correlated with hippocampal astrogliosis and positively correlated with hippocampal IL-1 beta levels. Serum and hippocampal BDNF levels in the DSP4+LPS-treated rats in the long-term subgroup returned to levels similar to the control group. These results show that systemic inflammation in LC-NE-lesioned aged rats promotes an exacerbated systemic and central inflammatory response compared to LC-NE-intact rats and alters BDNF levels, indicating the important role of this neurotransmitter system in response to neuroinflammation.	[Bharani, Krishna L.; Derex, Rebecca; Granholm, Ann-Charlotte] Med Univ South Carolina, BSB, Dept Neurosci, Charleston, SC USA; [Granholm, Ann-Charlotte; Ledreux, Aurelie] Univ Denver, Knoebel Inst Hlth Aging, Denver, CO 80208 USA	Medical University of South Carolina; University of Denver	Ledreux, A (corresponding author), Univ Denver, Knoebel Inst Hlth Aging, Denver, CO 80208 USA.	Aurelie.Ledreux@du.edu	Ledreux, Aurélie/M-3967-2018; Bharani, Krishna/CAH-1586-2022	Ledreux, Aurélie/0000-0001-6232-7672; Bharani, Krishna/0000-0002-5441-4423	National Institute on Aging [R01 AG044920]; NATIONAL INSTITUTE ON AGING [R01AG044920] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the National Institute on Aging (R01 AG044920) to ACG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1997, EUR J PHARMACOL, V321, P149, DOI 10.1016/S0014-2999(96)00934-X; Amor S, 2014, IMMUNOLOGY, V142, P151, DOI 10.1111/imm.12233; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Banks WA, 1995, NEUROIMMUNOMODULAT, V2, P241, DOI 10.1159/000097202; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; Banks WA, 2010, NEUROBIOL DIS, V37, P26, DOI 10.1016/j.nbd.2009.07.031; Bardou I, 2014, NEUROBIOL AGING, V35, P1065, DOI 10.1016/j.neurobiolaging.2013.11.006; Barrientos RM, 2004, J NEUROIMMUNOL, V155, P119, DOI 10.1016/j.jneuroim.2004.06.009; Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P46, DOI 10.1016/j.bbi.2008.07.002; Begni V, 2017, CLIN SCI, V131, P123, DOI 10.1042/CS20160009; Bettcher BM, 2014, CLIN PHARMACOL THER, V96, P464, DOI 10.1038/clpt.2014.147; Bilbo SD, 2005, BEHAV NEUROSCI, V119, P293, DOI 10.1037/0735-7044.119.1.293; Bortel A., 2014, HDB NEUROTOXICITY, P219, DOI [10.1007/978-1-4614-5836-4_75, DOI 10.1007/978-1-4614-5836-4_75]; Counts SE, 2010, J NEUROCHEM, V113, P649, DOI 10.1111/j.1471-4159.2010.06622.x; Culley DJ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00107; Cunningham C, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0117-2; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Czerniawski J, 2015, BRAIN BEHAV IMMUN, V44, P159, DOI 10.1016/j.bbi.2014.09.014; Donoso V, 2008, MECH AGEING DEV, V129, P728, DOI 10.1016/j.mad.2008.09.018; Duarte PD, 2017, AGING CLIN EXP RES, V29, P411, DOI 10.1007/s40520-016-0603-9; Feinstein DL, 2016, J NEUROCHEM, V139, P154, DOI 10.1111/jnc.13447; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Fu HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106331; GRANHOLM AC, 1992, EXP NEUROL, V118, P7, DOI 10.1016/0014-4886(92)90017-K; Grudzien A, 2007, NEUROBIOL AGING, V28, P327, DOI 10.1016/j.neurobiolaging.2006.02.007; Guan ZW, 2006, BRAIN BEHAV IMMUN, V20, P64, DOI 10.1016/j.bbi.2005.04.005; Haba R, 2012, BEHAV BRAIN RES, V228, P423, DOI 10.1016/j.bbr.2011.12.027; Handing EP, 2017, J GERONTOL B-PSYCHOL, P1; Hauser J, 2012, ADHD-ATTEND DEFICIT, V4, P93, DOI 10.1007/s12402-012-0076-4; Hauss-Wegrzyniak B, 1998, BRAIN RES, V780, P294, DOI 10.1016/S0006-8993(97)01215-8; Hauss-Wegrzyniak B, 2002, EXP NEUROL, V176, P336, DOI 10.1006/exnr.2002.7966; Hauss-Wegrzyniak B, 1999, NEUROBIOL AGING, V20, P305, DOI 10.1016/S0197-4580(99)00028-7; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107; Heneka MT, 2002, J NEUROSCI, V22, P2434, DOI 10.1523/JNEUROSCI.22-07-02434.2002; Holmes C, 2013, NEUROPATH APPL NEURO, V39, P51, DOI 10.1111/j.1365-2990.2012.01307.x; Iyer SS, 2010, J IMMUNOL, V185, P6599, DOI 10.4049/jimmunol.1002041; Jeong HK, 2010, EXP MOL MED, V42, P823, DOI 10.3858/emm.2010.42.12.085; Kalinin S, 2006, EUR J NEUROSCI, V24, P3393, DOI 10.1111/j.1460-9568.2006.05223.x; Kawano T, 2014, J ANESTH, V28, P780, DOI 10.1007/s00540-013-1786-2; Kelly SC, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0411-2; Kesse-Guyot E, 2017, EUR J NUTR, V56, P1647, DOI 10.1007/s00394-016-1211-3; Kohman RA, 2007, BRAIN BEHAV IMMUN, V21, P824, DOI 10.1016/j.bbi.2007.01.009; Laflamme N, 1999, J NEUROCHEM, V73, P309, DOI 10.1046/j.1471-4159.1999.0730309.x; Lapiz MDS, 2001, PSYCHOPHARMACOLOGY, V155, P251, DOI 10.1007/s002130100702; Ledreux A, 2016, BRAIN RES, V1631, P34, DOI 10.1016/j.brainres.2015.11.028; Li YX, 2001, NEUROSCIENCE, V106, P385, DOI 10.1016/S0306-4522(01)00194-4; Liu X, 2015, J ALZHEIMERS DIS, V44, P251, DOI 10.3233/JAD-141062; Lockrow J, 2011, J ALZHEIMERS DIS, V23, P471, DOI 10.3233/JAD-2010-101218; MANN DMA, 1983, MECH AGEING DEV, V23, P73, DOI 10.1016/0047-6374(83)90100-8; Marien MR, 2004, BRAIN RES REV, V45, P38, DOI 10.1016/j.brainresrev.2004.02.002; Mello-Carpes PB, 2016, NEUROBIOL LEARN MEM, V127, P84, DOI 10.1016/j.nlm.2015.11.014; Murray CA, 1998, J NEUROSCI, V18, P2974; Nakai S, 2006, NEUROSCI RES, V54, P213, DOI 10.1016/j.neures.2005.12.001; Nolan Y, 2005, J BIOL CHEM, V280, P9354, DOI 10.1074/jbc.M412170200; Patterson SL, 2015, NEUROPHARMACOLOGY, V96, P11, DOI 10.1016/j.neuropharm.2014.12.020; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x; Pugh CR, 1999, BEHAV BRAIN RES, V106, P109, DOI 10.1016/S0166-4328(99)00098-4; Pugh CR, 1998, BRAIN BEHAV IMMUN, V12, P212, DOI 10.1006/brbi.1998.0524; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Rengo G, 2016, EUR J NUCL MED MOL I, V43, P2392, DOI 10.1007/s00259-016-3432-3; Roggero E, 2016, BRAIN BEHAV IMMUN, V58, P228, DOI 10.1016/j.bbi.2016.07.163; Ross JA, 2015, NEUROBIOL STRESS, V2, P73, DOI 10.1016/j.ynstr.2015.09.002; Ross SB, 2015, NEUROTOX RES, V27, P15, DOI 10.1007/s12640-014-9482-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schreuder L, 2017, BRAIN BEHAV IMMUN, V62, P362, DOI 10.1016/j.bbi.2017.01.010; Shaw KN, 2001, BEHAV BRAIN RES, V124, P47, DOI 10.1016/S0166-4328(01)00232-7; Simen AA, 2011, THER ADV CHRONIC DIS, V2, P175, DOI 10.1177/2040622311399145; Srinivasan J, 2004, BEHAV BRAIN RES, V151, P191, DOI 10.1016/j.bbr.2003.08.016; Sun J, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0394-5; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; TOMLINSON BE, 1981, J NEUROL SCI, V49, P419, DOI 10.1016/0022-510X(81)90031-9; Tong LQ, 2008, NEUROBIOL AGING, V29, P1380, DOI 10.1016/j.neurobiolaging.2007.02.027; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Trager U, 2013, J MOL MED, V91, P673, DOI 10.1007/s00109-013-1026-0; Uematsu A, 2015, LEARN MEMORY, V22, P444, DOI 10.1101/lm.037283.114; Vereker E, 2000, J BIOL CHEM, V275, P26252, DOI 10.1074/jbc.M002226200; Vermeiren Y, 2017, NEUROCHEM INT, V102, P22, DOI 10.1016/j.neuint.2016.11.009; Willis L, 2005, CELL TRANSPLANT, V14, P21, DOI 10.3727/000000005783983313; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Zhu B, 2014, EXP THER MED, V7, P750, DOI 10.3892/etm.2014.1479	83	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189821	10.1371/journal.pone.0189821	http://dx.doi.org/10.1371/journal.pone.0189821			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261743	Green Submitted, gold, Green Published			2022-12-26	WOS:000418554900032
J	Elia, M; Blancato, G; Picchi, L; Lucas, C; Bagneres, AG; Lorenzi, MC				Elia, Marta; Blancato, Giuliano; Picchi, Laura; Lucas, Christophe; Bagneres, Anne-Genevieve; Lorenzi, Maria Cristina			Nest signature changes throughout colony cycle and after social parasite invasion in social wasps	PLOS ONE			English	Article							POLISTES-BIGLUMIS-BIMACULATUS; DOMINULUS CHRIST HYMENOPTERA; CUTICULAR HYDROCARBONS; SULCOPOLISTES-ATRIMANDIBULARIS; RECOGNITION SYSTEMS; CHEMICAL SIGNATURE; GUARD HONEYBEES; SURFACE-LIPIDS; METRICUS SAY; HOST NESTS	Social insects recognize their nestmates by means of a cuticular hydrocarbon signature shared by colony members, but how nest signature changes across time has been rarely tested in longitudinal studies and in the field. In social wasps, the chemical signature is also deposited on the nest surface, where it is used by newly emerged wasps as a reference to learn their colony odor. Here, we investigate the temporal variations of the chemical signature that wasps have deposited on their nests. We followed the fate of the colonies of the social paper wasp Polistes biglumis in their natural environment from colony foundation to decline. Because some colonies were invaded by the social parasite Polistes atrimandibularis, we also tested the effects of social parasites on the nest signature. We observed that, as the season progresses, the nest signature changed; the overall abundance of hydrocarbons as well as the proportion of longer-chain and branched hydrocarbons increased. Where present, social parasites altered the host-nest signature qualitatively (adding parasite-specific alkenes) and quantitatively (by interfering with the increase in overall hydrocarbon abundance). Our results show that 1) colony odor is highly dynamic both in colonies controlled by legitimate foundresses and in those controlled by social parasites; 2) emerged offspring contribute little to colony signature, if at all, in comparison to foundresses; and 3) social parasites, that later mimic host signature, initially mark host nests with species-specific hydrocarbons. This study implies that important updating of the neural template used in nestmate recognition should occur in social insects.	[Elia, Marta; Blancato, Giuliano; Picchi, Laura; Lorenzi, Maria Cristina] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [Elia, Marta; Lucas, Christophe; Bagneres, Anne-Genevieve] Univ Tours, Fac Sci, CNRS, IRBI,UMR 7261, Parc Grandmont, Tours, France; [Bagneres, Anne-Genevieve] Univ Paul Valery Montpellier, Univ Montpellier, EPHE, CNRS,CEFE UMR 5175, Montpellier, France; [Lorenzi, Maria Cristina] Univ Paris 13, Sorbonne Paris Cite, LEEC, Villetaneuse, France	University of Turin; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; Universite Paul-Valery; Universite Paris 13	Elia, M (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.; Elia, M (corresponding author), Univ Tours, Fac Sci, CNRS, IRBI,UMR 7261, Parc Grandmont, Tours, France.	marta.elia@outlook.com	Bagneres, Anne-Genevieve/A-6075-2009; Bagneres, Anne-Genevieve/P-9764-2019; Lucas, Christophe/A-4186-2011; Lorenzi, Maria Cristina/D-5193-2013	Bagneres, Anne-Genevieve/0000-0002-1729-379X; Bagneres, Anne-Genevieve/0000-0002-1729-379X; Lucas, Christophe/0000-0003-2839-7583; Lorenzi, Maria Cristina/0000-0002-7364-729X	UNIVERSITY OF TURIN; FRANCO-ITALIAN UNIVERSITY	UNIVERSITY OF TURIN; FRANCO-ITALIAN UNIVERSITY	This work was made possible thanks to a PhD grant provided by the UNIVERSITY OF TURIN to Marta Elia. We thank the FRANCO-ITALIAN UNIVERSITY for the "Vinci 2014" grant supporting the PhD project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; Bagneres AG, 1996, SCIENCE, V272, P889, DOI 10.1126/science.272.5263.889; BAGNERES AG, 1990, J CHEM ECOL, V16, P3213, DOI 10.1007/BF00982094; Bagneres AG, 2011, ANN SOC ENTOMOL FR, V47, P202, DOI 10.1080/00379271.2011.10697712; Bagneres AG, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P121, DOI 10.1017/CBO9780511711909.008; Baracchi D, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2750; Baracchi D, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1406-8; Blomquist G.J., 2016, EXTRACELLULAR COMPOS; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P19, DOI 10.1017/CBO9780511711909.003; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Bonelli M., 2015, THESIS; Bonelli M, 2015, J CHEM ECOL, V41, P22, DOI 10.1007/s10886-014-0531-0; Bos N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00083; Bos N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019435; Braga MV, 2013, ACTA TROP, V128, P479, DOI 10.1016/j.actatropica.2013.07.014; Brown WV, 1993, COMP BIOCH PHYSL B, V99B, P553; Buczkowski G, 2005, J CHEM ECOL, V31, P829, DOI 10.1007/s10886-005-3547-7; Cervo R, 1996, ETHOLOGY, V102, P1042; CERVO R, 1990, INSECT SOC, V37, P333, DOI 10.1007/BF02225996; CERVO R, 1990, ETHOLOGY, V86, P71, DOI 10.1111/j.1439-0310.1990.tb00419.x; Costanzi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065107; Couvillon MJ, 2007, BIOL LETTERS, V3, P228, DOI 10.1098/rsbl.2006.0612; D'Ettorre P, 2006, ANIM BEHAV, V71, P773, DOI 10.1016/j.anbehav.2005.05.014; DANI FR, 1992, BEHAV PROCESS, V28, P51, DOI 10.1016/0376-6357(92)90048-I; Dapporto L, 2004, INSECT SOC, V51, P279, DOI 10.1007/s00040-004-0738-0; ESPELIE KE, 1990, J CHEM ECOL, V16, P1841, DOI 10.1007/BF01020498; ESPELIE KE, 1990, J CHEM ECOL, V16, P2229, DOI 10.1007/BF01026933; Fucini S, 2014, J INSECT BEHAV, V27, P403, DOI 10.1007/s10905-013-9436-y; GAMBOA GJ, 1986, ANIM BEHAV, V34, P685, DOI 10.1016/S0003-3472(86)80053-7; Gamboa GJ, 2004, ANN ZOOL FENN, V41, P789; Gibbs AG, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P100, DOI 10.1017/CBO9780511711909.007; Lahav S, 2001, J CHEM ECOL, V27, P927, DOI 10.1023/A:1010382919227; Lambardi D, 2007, BEHAV ECOL SOCIOBIOL, V61, P843, DOI 10.1007/s00265-006-0313-y; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Lenoir A, 2009, J CHEM ECOL, V35, P913, DOI 10.1007/s10886-009-9669-6; Leonhardt SD, 2007, J COMP PHYSIOL A, V193, P993, DOI 10.1007/s00359-007-0252-8; Lhomme P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043053; Lorenzi MC, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00008; Lorenzi MC, 2011, EVOLUTION, V65, P3527, DOI 10.1111/j.1558-5646.2011.01403.x; Lorenzi MC, 2011, ANIM BEHAV, V82, P1143, DOI 10.1016/j.anbehav.2011.08.011; Lorenzi MC, 2014, CURR ZOOL, V60, P137, DOI 10.1093/czoolo/60.1.137; Lorenzi Maria Cristina, 1996, P178; Lorenzi MC, 2000, J ETHOL, V18, P65, DOI 10.1007/s101640070001; LORENZI MC, 1992, B ZOOL, V59, P267, DOI 10.1080/11250009209386681; Lorenzi MC, 2004, J INSECT PHYSIOL, V50, P935, DOI 10.1016/j.jinsphys.2004.07.005; Lorenzi MC, 2003, INSECT SOC, V50, P82, DOI 10.1007/s000400300013; Lorenzi MC, 2002, PARASITOLOGY, V125, P507, DOI 10.1017/S003118200200238X; Lorenzi MC, 1997, INSECT SOC, V44, P123, DOI 10.1007/s000400050035; LORENZI MC, 1986, ECOL ENTOMOL, V11, P199, DOI 10.1111/j.1365-2311.1986.tb00295.x; Lorenzi MC, 1999, J INSECT BEHAV, V12, P147, DOI 10.1023/A:1020906631121; Lorenzi MC, 1982, THESIS; Martin SJ, 2009, BIOL J LINN SOC, V96, P732, DOI 10.1111/j.1095-8312.2008.01158.x; Michener C.D., 1987, P209; Mori A, 2000, ETHOL ECOL EVOL, V12, P315; Newey PS, 2009, ANIM BEHAV, V77, P481, DOI 10.1016/j.anbehav.2008.11.003; PAGE M, 1990, J CHEM ECOL, V16, P1173, DOI 10.1007/BF01021018; Panek LM, 2001, ETHOLOGY, V107, P55, DOI 10.1046/j.1439-0310.2001.00633.x; Pekkarinen A, 1999, ENTOMOL FENNICA, V10, P191, DOI 10.33338/ef.84021; PROVOST E, 1993, INSECT BIOCHEM MOLEC, V23, P945, DOI 10.1016/0965-1748(93)90112-6; ROSS NM, 1981, BEHAV ECOL SOCIOBIOL, V9, P163, DOI 10.1007/BF00302933; Rottler-Hoermann AM, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150599; Signorotti L, 2015, INSECT SOC, V62, P433, DOI 10.1007/s00040-015-0422-6; Signorotti L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097024; Singer TL, 1998, AM ZOOL, V38, P394; Singer TL, 1997, INSECT SOC, V44, P245, DOI 10.1007/s000400050045; Steiger S, 2007, P R SOC B, V274, P2211, DOI 10.1098/rspb.2007.0656; TURILLAZZI S, 1990, ETHOLOGY, V84, P47, DOI 10.1111/j.1439-0310.1990.tb00784.x; Turillazzi S, 2000, NATURWISSENSCHAFTEN, V87, P172, DOI 10.1007/s001140050697; Uboni A, 2012, J INSECT PHYSIOL, V58, P1259, DOI 10.1016/j.jinsphys.2012.06.013; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; van Zweden JS, 2009, J INSECT PHYSIOL, V55, P158, DOI 10.1016/j.jinsphys.2008.11.001; Wyatt TD, 2010, J COMP PHYSIOL A, V196, P685, DOI 10.1007/s00359-010-0564-y	72	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0190018	10.1371/journal.pone.0190018	http://dx.doi.org/10.1371/journal.pone.0190018			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ7PP	29261775	Green Published, gold, Green Submitted			2022-12-26	WOS:000418554900049
J	Yeh, CC; Lussier, EC; Sun, YT; Lan, TY; Yu, HY; Chang, TY				Yeh, Chang Ching; Lussier, Eric C.; Sun, Yi-Ting; Lan, Tzuo-Yun; Yu, Hsiang-Yu; Chang, Tung-Yao			Antiepileptic drug use among women from the Taiwanese Registry of Epilepsy and Pregnancy: Obstetric complications and fetal malformation outcomes	PLOS ONE			English	Article							EURAP EPILEPSY; TRENDS; RISK; METAANALYSIS; POPULATION; MANAGEMENT; DELIVERY; SEIZURES; MEDICINE; PROGRAM	To investigate antiepileptic drugs (AEDs) prescription and pregnancy outcomes in pregnancies with epilepsy in Taiwan between 2004 and 2015. We retrospectively reviewed data from the Taiwanese Registry of Epilepsy and Pregnancy (TREP). The TREP registry is a voluntary prospective cohort registry, which tracks pregnant women with epilepsy and AED prescription throughout pregnancy, delivery, and early childhood development. All TREP pregnancies (n = 318) that had completed questionnaires up until delivery or had had an unsuccessful pregnancy were analyzed. Over 94.7% of women had been prescribed AEDs during pregnancy, with 69.0% and 25.7% having received monotherapy, or polytherapy, respectively. Among live births, 12 (3.9%) reported malformation. Cesarean section rate was reported higher than usual (54.5%). In 2004, 73.3% of AEDs prescribed were 1st generation, with 1 st generation prescription rates falling to only 8.3% of total prescribed in 2015. AED polytherapy also fell during the study period (40.0% to 20.0%). Cesarean sections were found to be higher for women over 35 years, who had generalized epilepsy, or had experienced an obstetric complication during pregnancy term. Binary logistic regression revealed that Cesarean section was associated with maternal complications (OR = 5.11, CI 95% = 1.11-23.51, p = 0.036), while malformations were associated with obstetric complication (OR = 20.46, CI 95% = 4.80-87.21, p<0.001). Both AED risk types were not associated with complications or malformations. Our sample provides a unique insight into the women with epilepsy with AED use during pregnancy. Cesarean section rate was observed to be higher than usual, but malformation rates remained low. Results indicate a decrease in both 1 st generation AEDs and proportion of patients receiving polytherapy over the study period. Obstetric complications were associated with Cesarean section. Fetal malformations were significantly associated with obstetric complications. AED risk factors were not significantly associated with either complications or malformations.	[Yeh, Chang Ching] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Yeh, Chang Ching] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Yeh, Chang Ching] Natl Yang Ming Univ, Dept Obstet & Gynecol, Taipei, Taiwan; [Lussier, Eric C.; Sun, Yi-Ting; Chang, Tung-Yao] Taiji Clin, Taipei, Taiwan; [Lan, Tzuo-Yun] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan; [Lan, Tzuo-Yun] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Yu, Hsiang-Yu] Taipei Vet Gen Hosp, Neurol Dept, Taipei, Taiwan; [Yu, Hsiang-Yu] Natl Yang Ming Univ, Neurol Dept, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; China Medical University Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chang, TY (corresponding author), Taiji Clin, Taipei, Taiwan.	tychang@fetalmedicine.tw		YEH, CHANG-CHING/0000-0003-0690-7503; Lussier, Eric/0000-0001-8137-9953; Yu, Hsiang-Yu/0000-0002-8183-1863				Bansal R., 2016, INT J EPILEPSY, V3, P80; Battino D, 2013, EPILEPSIA, V54, P1621, DOI 10.1111/epi.12302; Bobo WV, 2012, PAEDIATR PERINAT EP, V26, P578, DOI 10.1111/ppe.12004; Borthen I, 2011, BJOG-INT J OBSTET GY, V118, P956, DOI 10.1111/j.1471-0528.2011.03004.x; Cassina M, 2013, REPROD TOXICOL, V39, P50, DOI 10.1016/j.reprotox.2013.04.002; Chang Tung-Yao, 2007, Taiwan J Obstet Gynecol, V46, P47, DOI 10.1016/S1028-4559(08)60106-0; Chen YH, 2009, ARCH NEUROL-CHICAGO, V66, P979, DOI 10.1001/archneurol.2009.142; CHUNG MY, 1995, EPILEPSIA, V36, P488, DOI 10.1111/j.1528-1157.1995.tb00491.x; D'Alton ME, 2013, AM J OBSTET GYNECOL, V208, P442, DOI 10.1016/j.ajog.2012.11.041; de Boer HM, 2008, EPILEPSY BEHAV, V12, P540, DOI 10.1016/j.yebeh.2007.12.019; Ecker JL, 2001, AM J OBSTET GYNECOL, V185, P883, DOI 10.1067/mob.2001.117364; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; Hsieh LP, 2008, EPILEPSY RES, V80, P114, DOI 10.1016/j.eplepsyres.2008.03.016; Hsieh LP, 2011, EPILEPSY RES, V96, P81, DOI 10.1016/j.eplepsyres.2011.05.003; Jadhav SV, 2013, INDIAN MED GAZ, V147, P352; Kaplan PW, 2007, EPILEPSY BEHAV, V11, P283, DOI 10.1016/j.yebeh.2007.08.012; Kinney MO, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2880; Lee Myeong-Su, 2010, [The Journal of The Korea Institute of Intelligent Transportation Systems, 한국ITS학회 논문지], V9, P1; Lin HL, 2009, J NEUROL, V256, P1742, DOI 10.1007/s00415-009-5222-3; Liu CM, 2013, J FORMOS MED ASSOC, V112, P93, DOI 10.1016/j.jfma.2011.12.005; MacDonald SC, 2015, JAMA NEUROL, V72, P981, DOI 10.1001/jamaneurol.2015.1017; Meador K, 2008, EPILEPSY RES, V81, P1, DOI 10.1016/j.eplepsyres.2008.04.022; Nicholas JM, 2012, SEIZURE-EUR J EPILEP, V21, P466, DOI 10.1016/j.seizure.2012.04.014; Nisenblat V, 2006, OBSTET GYNECOL, V108, P21, DOI 10.1097/01.AOG.0000222380.11069.11; Patel SI, 2016, THER ADV NEUROL DISO, V9, P118, DOI 10.1177/1756285615623934; Perucca E, 2005, EPILEPSIA, V46, P31, DOI 10.1111/j.1528-1167.2005.463007.x; Razaz N, 2017, JAMA NEUROL, V74, P983, DOI 10.1001/jamaneurol.2017.1310; Thomas SV, 2012, EPILEPSIA, V53, pe85, DOI 10.1111/j.1528-1167.2012.03439.x; Tomson T, 2004, EPILEPSIA, V45, P1463, DOI 10.1111/j.0013-9580.2004.451101.x; Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7; Tomson T, 2010, EPILEPSIA, V51, P909, DOI 10.1111/j.1528-1167.2010.02525.x; Viale L, 2015, LANCET, V386, P1845, DOI 10.1016/S0140-6736(15)00045-8; WHO, 2015, 2015 WORLD POP DAT S	33	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189497	10.1371/journal.pone.0189497	http://dx.doi.org/10.1371/journal.pone.0189497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253023	Green Submitted, Green Published, gold			2022-12-26	WOS:000418389500034
J	Lentini, G; El Hajj, H; Papoin, J; Fall, G; Pfaff, AW; Tawil, N; Braun-Breton, C; Lebrun, M				Lentini, Gaelle; El Hajj, Hiba; Papoin, Julien; Fall, Gamou; Pfaff, Alexander W.; Tawil, Nadim; Braun-Breton, Catherine; Lebrun, Maryse			Characterization of Toxoplasma DegP, a rhoptry serine protease crucial for lethal infection in mice	PLOS ONE			English	Article							DENSE GRANULE PROTEIN; GONDII; VIRULENCE; REVEALS; STRESS; IDENTIFICATION; TRAFFICKING; COMPRISE; STRAINS; BINDING	During the infection process, Apicomplexa discharge their secretory organelles called micronemes, rhoptries and dense granules to sustain host cell invasion, intracellular replication and to modulate host cell pathways and immune responses. Herein, we describe the Toxoplasma gondii Deg-like serine protein (TgDegP), a rhoptry protein homologous to High temperature requirement A (HtrA) or Deg-like family of serine proteases. TgDegP undergoes processing in both types I and II strains as most of the rhoptries proteins. We show that genetic disruption of the degP gene does not impact the parasite lytic cycle in vitro but affects virulence in mice. While in a type I strain DegP I appears dispensable for the establishment of an infection, removal of DegP II in a type II strain dramatically impairs the virulence. Finally, we show that KO-DegP II parasites kill immunodeficient mice as efficiently as the wild-type strain indicating that the protease might be involved in the complex crosstalk that the parasite engaged with the host immune response. Thus, this study unravels a novel rhoptry protein in T. gondii important for the establishment of lethal infection.	[Lentini, Gaelle; Papoin, Julien; Fall, Gamou; Braun-Breton, Catherine; Lebrun, Maryse] Univ Montpellier, CNRS, UMR 5235, Montpellier, France; [El Hajj, Hiba; Tawil, Nadim] Amer Univ Beirut, Expt Pathol Immunol & Microbiol, Dept Internal Med & Expt Pathol, Immunol & Microbiol, Beirut, Lebanon; [Pfaff, Alexander W.] Univ Strasbourg, Inst Parasitol & Pathol Trop, Federat Med Translat, EA 7292, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; American University of Beirut; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lebrun, M (corresponding author), Univ Montpellier, CNRS, UMR 5235, Montpellier, France.	mylebrun@univ-montp2.fr	Lebrun, Maryse/I-7728-2016	TAWIL, NADIM/0000-0003-2396-6679; Lebrun, Maryse/0000-0002-0962-0156; Lentini, Gaelle/0000-0003-0836-9972	Laboratoire d'Excellence (LabEx) [ParaFrap ANR-11-LABX-0024]; Fondation pour la Recherche Medicale [Equipe FRM DEQ20130326508]; Cedre France-Lebanon program [N2177, N21774]; American University of Beirut Medical Practice Plan; National Council for Scientific Research (CNRS-L); American University of Beirut Faculty of Medicine Medical Practice Plan; Centre National de Recherche Scientifique Libanais (CNRS-L); FRM [FDT20140931002]; Fonds Inkerman Fondation de France	Laboratoire d'Excellence (LabEx); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Cedre France-Lebanon program; American University of Beirut Medical Practice Plan; National Council for Scientific Research (CNRS-L); American University of Beirut Faculty of Medicine Medical Practice Plan; Centre National de Recherche Scientifique Libanais (CNRS-L); FRM(Fondation pour la Recherche Medicale); Fonds Inkerman Fondation de France	This research was supported by the Laboratoire d'Excellence (LabEx) (ParaFrap ANR-11-LABX-0024), by the Fondation pour la Recherche Medicale (Equipe FRM DEQ20130326508) and The Cedre France-Lebanon program (Project N2177) to M.L., by the Cedre France-Lebanon program (Project N21774) and the American University of Beirut Medical Practice Plan and the National Council for Scientific Research (CNRS-L) to H.E.H and M.L. Hiba El Hajj (H.E.H.) is funded by the American University of Beirut Faculty of Medicine Medical Practice Plan and the Centre National de Recherche Scientifique Libanais (CNRS-L) and The Cedre France-Lebanon program (Project N2177) and The Centre National de Recherche Scientifique Libanais (CNRS-L). Gaelle Lentini received a fellowship through the FRM FDT20140931002. Gamou Fall was supported by a fellowship from the Fonds Inkerman Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Bougdour A, 2013, CELL HOST MICROBE, V13, P489, DOI 10.1016/j.chom.2013.03.002; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Bradley PJ, 1999, MOL BIOCHEM PARASIT, V100, P103, DOI 10.1016/S0166-6851(99)00035-3; Braun L, 2013, J EXP MED, V210, P2071, DOI 10.1084/jem.20130103; Cerede O, 2005, J EXP MED, V201, P453, DOI 10.1084/jem.20041672; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; COUVREUR G, 1988, PARASITOLOGY, V97, P1, DOI 10.1017/S0031182000066695; Daher W, 2012, EUKARYOT CELL, V11, P343, DOI 10.1128/EC.05192-11; El Hajj H, 2008, EUKARYOT CELL, V7, P1019, DOI 10.1128/EC.00413-07; El Hajj H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079474; Farid Arenas Aylan, 2010, Genomics Proteomics & Bioinformatics, V8, P103, DOI 10.1016/S1672-0229(10)60011-3; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; Fox BA, 2011, EUKARYOT CELL, V10, P1193, DOI 10.1128/EC.00297-10; Hajagos BE, 2012, TRAFFIC, V13, P292, DOI 10.1111/j.1600-0854.2011.01308.x; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Lamarque MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5098; Lebrun M, 2014, TOXOPLASMA GONDII: THE MODEL APICOMPLEXAN - PERSPECTIVES AND METHODS, 2ND EDITION, P389, DOI 10.1016/B978-0-12-396481-6.00012-X; Lentini G, 2015, CELL MICROBIOL, V17, P62, DOI 10.1111/cmi.12337; Lodoen MB, 2010, CELL MICROBIOL, V12, P55, DOI 10.1111/j.1462-5822.2009.01378.x; Lorenzi H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10147; Melo MB, 2011, TRENDS PARASITOL, V27, P487, DOI 10.1016/j.pt.2011.08.001; Miller SA, 2003, MOL MICROBIOL, V49, P883, DOI 10.1046/j.1365-2958.2003.03604.x; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Sharma S, 2014, FEBS J, V281, P1679, DOI 10.1111/febs.12732; Shastri AJ, 2014, INFECT IMMUN, V82, P2595, DOI 10.1128/IAI.01339-13; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Wilson RL, 2006, INFECT IMMUN, V74, P765, DOI 10.1128/IAI.74.1.765-768.2006; Yamamoto T, 1997, INFECT IMMUN, V65, P2190, DOI 10.1128/IAI.65.6.2190-2196.1997	45	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189556	10.1371/journal.pone.0189556	http://dx.doi.org/10.1371/journal.pone.0189556			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244879	Green Submitted, Green Published, gold			2022-12-26	WOS:000418184700038
J	McCarthy, MT; Moncayo, G; Hiron, TK; Jakobsen, NA; Valli, A; Soga, T; Adam, J; O'Callaghan, CA				McCarthy, Michael T.; Moncayo, Gerard; Hiron, Thomas K.; Jakobsen, Niels A.; Valli, Alessandro; Soga, Tomoyoshi; Adam, Julie; O'Callaghan, Christopher A.			Purine nucleotide metabolism regulates expression of the human immune ligand MICA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-LYMPHOCYTES; NKG2D LIGANDS; NK CELLS; RECEPTOR; GLUCOSE; BLOCKADE; COSTIMULATION; CYTOTOXICITY; ACTIVATION; ENGAGEMENT	Expression of the cell-surface glycoprotein MHC class I poly-peptide-related sequence A (MICA) is induced in dangerous, abnormal, or "stressed" cells, including cancer cells, virus-infected cells, and rapidly proliferating cells. MICA is recognized by the activating immune cell receptor natural killer group 2D (NKG2D), providing a mechanism by which immune cells can identify and potentially eliminate pathological cells. Immune recognition through NKG2D is implicated in cancer, atherosclerosis, transplant rejection, and inflammatory diseases, such as rheumatoid arthritis. Despite the wide range of potential therapeutic applications of MICA manipulation, the factors that control MICA expression are unclear. Here we use metabolic interventions and metabolomic analyses to show that the transition from quiescent cellular metabolism to a "Warburg" or biosynthetic metabolic state induces MICA expression. Specifically, we show that glucose transport into the cell and active glycolytic metabolism are necessary to up-regulate MICA expression. Active purine synthesis is necessary to support this effect of glucose, and increases in purine nucleotide levels are sufficient to induce MICA expression. Metabolic induction of MICA expression directly influences NKG2D-dependent cytotoxicity by immune cells. These findings support a model of MICA regulation where by the purine metabolic activity of individual cells is reflected by cell-surface MICA expression and is the subject of surveillance by NKG2D receptor-expressing immune cells.	[McCarthy, Michael T.; Moncayo, Gerard; Hiron, Thomas K.; Jakobsen, Niels A.; Adam, Julie; O'Callaghan, Christopher A.] Univ Oxford, Nuffield Dept Med, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Valli, Alessandro; Adam, Julie] Nuffield Dept Med, Target Discovery Inst, Oxford OX3 7FZ, England; [Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, 246-2 Mizukami, Tsuruoka, Yamagata 9970052, Japan	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Keio University	O'Callaghan, CA (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Henry Wellcome Bldg Mol Physiol,Roosevelt Dr, Oxford OX3 7BN, England.	chris.ocallaghan@ndm.ox.ac.uk		Hiron, Thomas/0000-0001-9062-8472; Adam, Julie/0000-0002-7980-7151; McCarthy, Michael/0000-0001-7148-7096; Jakobsen, Niels Asger/0000-0002-5776-5085	Medical Research Council Grants [G116/165, G0901998]; National Institute for Health Research Oxford Comprehensive Biomedical Research Centre Program; Novo Nordisk Foundation Grant [NNF15CC0018346]; Medical Research Council [G0901998, G116/165] Funding Source: researchfish; Novo Nordisk Fonden [NNF15SA0018346] Funding Source: researchfish; MRC [G0901998, G116/165] Funding Source: UKRI	Medical Research Council Grants(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Oxford Comprehensive Biomedical Research Centre Program; Novo Nordisk Foundation Grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council Grants G116/165 and G0901998, the National Institute for Health Research Oxford Comprehensive Biomedical Research Centre Program, and Novo Nordisk Foundation Grant NNF15CC0018346. The authors declare that they have no conflicts of interest with the contents of this article.	Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Andersson AK, 2011, ARTHRITIS RHEUM-US, V63, P2617, DOI 10.1002/art.30460; Andre P, 2004, EUR J IMMUNOL, V34, P961, DOI 10.1002/eji.200324705; Andresen L, 2007, J IMMUNOL, V179, P8235, DOI 10.4049/jimmunol.179.12.8235; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cerboni C, 2007, BLOOD, V110, P606, DOI 10.1182/blood-2006-10-052720; Cerboni C, 2009, BLOOD, V113, P2955, DOI 10.1182/blood-2008-06-165944; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Eagle RA, 2006, HUM IMMUNOL, V67, P159, DOI 10.1016/j.humimm.2006.02.015; Ehrlich LIR, 2005, J IMMUNOL, V174, P1922, DOI 10.4049/jimmunol.174.4.1922; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Freckmann Guido, 2007, J Diabetes Sci Technol, V1, P695; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Hirschey MD, 2015, SEMIN CANCER BIOL, V35, pS129, DOI 10.1016/j.semcancer.2015.10.002; Ito Y, 2008, AM J PHYSIOL-GASTR L, V294, pG199, DOI 10.1152/ajpgi.00286.2007; Kim JY, 2006, EXP MOL MED, V38, P474, DOI 10.1038/emm.2006.56; Kloss M, 2008, J IMMUNOL, V181, P6711, DOI 10.4049/jimmunol.181.10.6711; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; LANDINI MP, 1984, J GEN VIROL, V65, P1229, DOI 10.1099/0022-1317-65-7-1229; Li MV, 2010, BIOCHEM BIOPH RES CO, V395, P395, DOI 10.1016/j.bbrc.2010.04.028; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Lin D, 2012, J BIOL CHEM, V287, P4299, DOI 10.1074/jbc.M111.282152; McGilvray RW, 2009, CLIN CANCER RES, V15, P6993, DOI 10.1158/1078-0432.CCR-09-0991; Rajasekaran K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012635; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Reinicke K, 2012, J CELL BIOCHEM, V113, P553, DOI 10.1002/jcb.23379; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Suarez-Alvarez B, 2009, AM J TRANSPLANT, V9, P251, DOI 10.1111/j.1600-6143.2008.02526.x; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Valli A, 2015, ONCOTARGET, V6, P1920, DOI 10.18632/oncotarget.3058; Vantourout P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007579; Venkataraman GM, 2007, J IMMUNOL, V178, P961, DOI 10.4049/jimmunol.178.2.961; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yu YJ, 2011, TRENDS MICROBIOL, V19, P360, DOI 10.1016/j.tim.2011.04.002; Yu YJ, 2011, J VIROL, V85, P1573, DOI 10.1128/JVI.01967-10	50	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3913	3924		10.1074/jbc.M117.809459	http://dx.doi.org/10.1074/jbc.M117.809459			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29279329	Green Published, hybrid			2022-12-26	WOS:000427587500006
J	Aminiaghdam, S; Blickhan, R; Muller, R; Rode, C				Aminiaghdam, Soran; Blickhan, Reinhard; Muller, Roy; Rode, Christian			Posture alteration as a measure to accommodate uneven ground in able-bodied gait	PLOS ONE			English	Article							CENTER-OF-MASS; LEG ADJUSTMENTS; TRUNK FLEXION; FLATBACK DEFORMITY; PERTURBED WALKING; CEREBRAL-PALSY; ERECT POSTURE; LEVEL; LOCOMOTION; STABILITY	Though the effects of imposed trunk posture on human walking have been studied, less is known about such locomotion while accommodating changes in ground level. For twelve able participants, we analyzed kinematic parameters mainly at touchdown and toe-off in walking across a 10-cm visible drop in ground level (level step, pre-perturbation step, step-down, step-up) with three postures (regular erect, similar to 30 degrees and similar to 50 degrees of trunk flexion from the vertical). Two-way repeated measures ANOVAs revealed step-specific effects of posture on the kinematic behavior of gait mostly at toe-off of the pre-perturbation step and the step-down as well as at touchdown of the step-up. In preparation to step-down, with increasing trunk flexion the discrepancy in hip-center of pressure distance, i.e. effective leg length, (shorter at toe-off versus touchdown), compared with level steps increased largely due to a greater knee flexion at toe-off. Participants rotated their trunk backwards during step-down (2- to 3-fold backwards rotation compared with level steps regardless of trunk posture) likely to control the angular momentum of their whole body. The more pronounced trunk backwards rotation in trunk-flexed walking contributed to the observed elevated center of mass (CoM) trajectories during the step-down which may have facilitated drop negotiation. Able-bodied individuals were found to recover almost all assessed kinematic parameters comprising the vertical position of the CoM, effective leg length and angle as well as hip, knee and ankle joint angles at the end of the step-up, suggesting an adaptive capacity and hence a robustness of human walking with respect to imposed trunk orientations. Our findings may provide clinicians with insight into a kinematic interaction between posture and locomotion in uneven ground. Moreover, a backward rotation of the trunk for negotiating step-down may be incorporated into exercise-based interventions to enhance gait stability in individuals who exhibit trunk-flexed postures during walking.	[Aminiaghdam, Soran; Blickhan, Reinhard; Muller, Roy; Rode, Christian] Friedrich Schiller Univ Jena, Inst Sport Sci, Dept Mot Sci, Jena, Thuringia, Germany	Friedrich Schiller University of Jena	Aminiaghdam, S (corresponding author), Friedrich Schiller Univ Jena, Inst Sport Sci, Dept Mot Sci, Jena, Thuringia, Germany.	soran.aminiaghdam@uni-jena.com	Rode, Christian/P-7340-2018; Müller, Roy/AAH-6372-2020	Rode, Christian/0000-0003-1938-2478; Müller, Roy/0000-0002-4688-1515; AminiAghdam, Soran/0000-0001-9310-6768				Aminiaghdam S, 2017, BIOL OPEN; Aminiaghdam S, 2017, J EXP BIOL, V220, P478, DOI 10.1242/jeb.148312; Andrada E, 2014, P BIOL SCI, V281, P1797; Birn-Jeffery AV, 2012, J EXP BIOL, V215, P2117, DOI 10.1242/jeb.065557; Blickhan R, 2015, J THEOR BIOL, V382, P187, DOI 10.1016/j.jtbi.2015.06.036; Blickhan R, 2013, HUM MOVEMENT SCI, V32, P971, DOI 10.1016/j.humov.2013.02.009; Blum Y, 2011, J THEOR BIOL, V281, P97, DOI 10.1016/j.jtbi.2011.04.029; Byl K, 2009, INT J ROBOT RES, V28, P1040, DOI 10.1177/0278364909340446; COREN S, 1978, BRIT J PSYCHOL, V69, P207, DOI 10.1111/j.2044-8295.1978.tb01649.x; de Groot MH, 2014, GAIT POSTURE, V39, P767, DOI 10.1016/j.gaitpost.2013.10.015; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; DIETZ V, 1987, J PHYSIOL-LONDON, V386, P149, DOI 10.1113/jphysiol.1987.sp016527; Farcy JPC, 1997, SPINE, V22, P2452, DOI 10.1097/00007632-199710150-00025; Ferris DP, 1999, J BIOMECH, V32, P787, DOI 10.1016/S0021-9290(99)00078-0; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Gard SA, 2004, HUM MOVEMENT SCI, V22, P597, DOI 10.1016/j.humov.2003.11.002; Gillet A, 2003, AM J PHYS MED REHAB, V82, P101, DOI 10.1097/01.PHM.0000046629.78324.28; Grasso R, 2000, J NEUROPHYSIOL, V83, P288, DOI 10.1152/jn.2000.83.1.288; Grimmer S, 2008, J EXP BIOL, V211, P2989, DOI 10.1242/jeb.014357; Halliday SE, 1998, GAIT POSTURE, V8, P8, DOI 10.1016/S0966-6362(98)00020-4; Hirose D, 2004, CLIN BIOMECH, V19, P57, DOI 10.1016/j.clinbiomech.2003.08.005; HIRSCHFELD H, 1991, J NEUROPHYSIOL, V66, P12, DOI 10.1152/jn.1991.66.1.12; Hohne A, 2011, J BIOMECH, V44, P2194, DOI 10.1016/j.jbiomech.2011.06.012; Kluger D, 2014, HUM MOVEMENT SCI, V33, P395, DOI 10.1016/j.humov.2013.12.006; Leroux A, 2002, GAIT POSTURE, V15, P64, DOI 10.1016/S0966-6362(01)00181-3; Leteneur S, 2009, CLIN BIOMECH, V24, P190, DOI 10.1016/j.clinbiomech.2008.10.005; Leteneur S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055256; Lin CJ, 2000, GAIT POSTURE, V11, P224, DOI 10.1016/S0966-6362(00)00049-7; MAGARIAN EO, 1987, J CLIN PHARMACOL, V27, P756, DOI 10.1002/j.1552-4604.1987.tb02992.x; Malone A, 2015, GAIT POSTURE, V41, P716, DOI 10.1016/j.gaitpost.2015.02.001; Marigold DS, 2005, J NEUROPHYSIOL, V94, P1733, DOI 10.1152/jn.00019.2005; Massion J, 1997, EXP BRAIN RES, V114, P384, DOI 10.1007/PL00005647; Maus HM, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1073; McGibbon CA, 2001, J NEUROPHYSIOL, V85, P1923, DOI 10.1152/jn.2001.85.5.1923; MOUCHNINO L, 1993, NEUROREPORT, V4, P125, DOI 10.1097/00001756-199302000-00002; Muller R, 2015, J BIOMECH, V48, P1009, DOI 10.1016/j.jbiomech.2015.01.042; Muller R, 2014, J BIOMECH, V47, P2286, DOI 10.1016/j.jbiomech.2014.04.041; Muller R, 2012, J APPL BIOMECH, V28, P718, DOI 10.1123/jab.28.6.718; Muller R, 2012, J EXP BIOL, V215, P3072, DOI 10.1242/jeb.072314; Muller R, 2010, HUM MOVEMENT SCI, V29, P578, DOI 10.1016/j.humov.2010.04.007; Muller R, 2010, HUM MOVEMENT SCI, V29, P299, DOI 10.1016/j.humov.2010.01.003; Muller R, 2017, P ROYAL SOC A; Potter BK, 2004, J BONE JOINT SURG AM, V86A, P1793, DOI 10.2106/00004623-200408000-00027; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Saha D, 2008, GAIT POSTURE, V27, P653, DOI 10.1016/j.gaitpost.2007.08.009; Sarwahi V, 2002, SPINE, V27, P2328, DOI 10.1097/00007632-200211010-00005; Shinya M, 2009, GAIT POSTURE, V29, P483, DOI 10.1016/j.gaitpost.2008.11.009; Tang PF, 1998, EXP BRAIN RES, V119, P141, DOI 10.1007/s002210050327; van der Linden MH, 2009, GAIT POSTURE, V29, P255, DOI 10.1016/j.gaitpost.2008.08.017; van Dieen JH, 2007, J BIOMECH, V40, P3641, DOI 10.1016/j.jbiomech.2007.06.009; Wisse M, 2005, IEEE T ROBOT, V21, P393, DOI 10.1109/TRO.2004.838030	51	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190135	10.1371/journal.pone.0190135	http://dx.doi.org/10.1371/journal.pone.0190135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR3ZV	29281712	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000419006200069
J	Luebbert, CC; Clarke, TM; Pointet, R; Frahm, GE; Tam, S; Lorbetskie, B; Sauve, S; Johnston, MJW				Luebbert, Christian C.; Clarke, Tessa M.; Pointet, Roberta; Frahm, Grant E.; Tam, Sharon; Lorbetskie, Barry; Sauve, Simon; Johnston, Michael J. W.			Nanoparticle size and production efficiency are affected by the presence of fatty acids during albumin nanoparticle fabrication	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; DRUG-DELIVERY SYSTEMS; OF-THE-ART; HSA NANOPARTICLES; BOUND PACLITAXEL; ORYZA-SATIVA; DOXORUBICIN; BINDING; CANCER; DOMAIN	We have previously identified extensive glycation, bound fatty acids and increased quantities of protein aggregates in commercially available recombinant HSA (rHSA) expressed in Oryza sativa (Asian rice) (OsrHSA) when compared to rHSA from other expression systems. We propose these differences may alter some attributes of nanoparticles fabricated with OsrHSA, as studies have associated greater quantities of aggregates with increased nanoparticle diameters. To determine if this is the case, nanoparticles were fabricated with OsrHSA from various suppliers using ethanol desolvation and subsequent glutaraldehyde cross-linking. All nanoparticles fabricated with OsrHSA showed larger diameters of approximately 20 to 90 nm than particles fabricated with either defatted bovine serum albumin (DF-BSA) (100.9 +/- 2.8nm) or human plasma albumin (pHSA) (112.0 +/- 4.0nm). It was hypothesized that the larger nanoparticle diameters were due to the presence of bound fatty acids and this was confirmed through defatting OsrHSA prior to particle fabrication which yielded particles with diameters similar to those fabricated with pHSA. For additional conformation, DF-BSA was incubated with dodecanoic acid prior to desolvation yielding particles with significantly larger diameters. Further studies showed the increased nanoparticle diameters were due to the bound fatty acids modulating electrostatic interactions between albumin nanoparticles during the desolvation and not changes in protein structure, stability or generation of additional albumin oligomers. Finally the presence of dodecanoic acid was shown to improve doxorubicin loading efficiency onto preformed albumin nanoparticles.	[Luebbert, Christian C.; Clarke, Tessa M.; Pointet, Roberta; Frahm, Grant E.; Tam, Sharon; Lorbetskie, Barry; Sauve, Simon; Johnston, Michael J. W.] Hlth Canada, Biol & Genet Therapies Directorate, Ctr Biol Evaluat, Ottawa, ON, Canada	Health Canada	Luebbert, CC (corresponding author), Hlth Canada, Biol & Genet Therapies Directorate, Ctr Biol Evaluat, Ottawa, ON, Canada.	michael.johnston@hc-sc.gc.ca			Government of Canada	Government of Canada(CGIAR)	The work was supported by the Government of Canada.	Agudelo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043814; Ahmad B, 2005, BBA-PROTEINS PROTEOM, V1750, P93, DOI 10.1016/j.bbapap.2005.04.001; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blair HA, 2015, DRUGS, V75, P2017, DOI 10.1007/s40265-015-0484-9; Choi JK, 2002, J LIPID RES, V43, P1000, DOI 10.1194/jlr.M200041-JLR200; Dawidczyk CM, 2014, J CONTROL RELEASE, V187, P133, DOI 10.1016/j.jconrel.2014.05.036; DEWOLF FA, 1993, BIOCHEMISTRY-US, V32, P6688, DOI 10.1021/bi00077a023; Dreis S, 2007, INT J PHARM, V341, P207, DOI 10.1016/j.ijpharm.2007.03.036; Frahm GE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109893; Frahm GE, 2012, J PHYS CHEM B, V116, P4661, DOI 10.1021/jp2125729; Galisteo-Gonzalez F, 2014, COLLOID SURFACE B, V123, P286, DOI 10.1016/j.colsurfb.2014.09.028; Hawkins MJ, 2008, ADV DRUG DELIVER REV, V60, P876, DOI 10.1016/j.addr.2007.08.044; He Y, 2011, P NATL ACAD SCI USA, V108, P19078, DOI 10.1073/pnas.1109736108; Jin SE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/814208; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Karimi M, 2016, EXPERT OPIN DRUG DEL, V13, P1609, DOI 10.1080/17425247.2016.1193149; Karukstis KK, 1998, BIOPHYS CHEM, V73, P249, DOI 10.1016/S0301-4622(98)00150-1; Kobayashi K, 2006, BIOLOGICALS, V34, P55, DOI 10.1016/j.biologicals.2005.08.021; Kuo YC, 2013, INT J MOL SCI, V14, P8719, DOI 10.3390/ijms14058719; Langer K, 2008, INT J PHARMACEUT, V347, P109, DOI 10.1016/j.ijpharm.2007.06.028; Langer K, 2003, INT J PHARM, V257, P169, DOI 10.1016/S0378-5173(03)00134-0; Leggio C, 2009, J PHYS CHEM B, V113, P12590, DOI 10.1021/jp904330v; Mehta SB, 2014, BIOCHEMISTRY-US, V53, P3367, DOI 10.1021/bi5002163; Moriyama Y, 2008, J PHYS CHEM B, V112, P16585, DOI 10.1021/jp8067624; Nichols JW, 2014, J CONTROL RELEASE, V190, P451, DOI 10.1016/j.jconrel.2014.03.057; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sercombe L, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00286; Shrake A, 2006, BIOPOLYMERS, V81, P235, DOI 10.1002/bip.20406; Sofias AM, 2017, ADV DRUG DELIV REV; Steere AN, 2012, J INORG BIOCHEM, V116, P37, DOI 10.1016/j.jinorgbio.2012.07.005; Stinchcombe TE, 2007, NANOMEDICINE-UK, V2, P415, DOI 10.2217/17435889.2.4.415; Suzuki R, 2016, METHOD PHARMACOL TOX, P457, DOI 10.1007/978-1-4939-3121-7_23; Varshney A, 2008, INT J BIOL MACROMOL, V42, P483, DOI 10.1016/j.ijbiomac.2008.03.004; Wu D, 2017, INT J NANOMED, V12, P5879, DOI 10.2147/IJN.S123437; Yoshikawa H, 2012, INT J BIOL MACROMOL, V50, P1286, DOI 10.1016/j.ijbiomac.2012.03.014; Zhigaltsev IV, 2010, J CONTROL RELEASE, V144, P332, DOI 10.1016/j.jconrel.2010.02.029; Zsila F, 2013, MOL PHARMACEUT, V10, P1668, DOI 10.1021/mp400027q; Zylberberg C, 2016, DRUG DELIV, V23, P3319, DOI 10.1080/10717544.2016.1177136	41	6	6	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189814	10.1371/journal.pone.0189814	http://dx.doi.org/10.1371/journal.pone.0189814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281685	Green Published, gold, Green Submitted			2022-12-26	WOS:000419006200044
J	Pecenka, C; Munthali, S; Chunga, P; Levin, A; Morgan, W; Lambach, P; Bhat, N; Neuzil, KM; Ortiz, JR; Hutubessy, R				Pecenka, Clint; Munthali, Spy; Chunga, Paul; Levin, Ann; Morgan, Win; Lambach, Philipp; Bhat, Niranjan; Neuzil, Kathleen M.; Ortiz, Justin R.; Hutubessy, Raymond			Maternal influenza immunization in Malawi: Piloting a maternal influenza immunization program costing tool by examining a prospective program	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; ROUTINE IMMUNIZATION; VACCINES; UGANDA; GHANA	Background This costing study in Malawi is a first evaluation of a Maternal Influenza Immunization Program Costing Tool (Costing Tool) for maternal immunization. The tool was designed to help low-and middle-income countries plan for maternal influenza immunization programs that differ from infant vaccination programs because of differences in the target population and potential differences in delivery strategy or venue. Methods This analysis examines the incremental costs of a prospective seasonal maternal influenza immunization program that is added to a successful routine childhood immunization and antenatal care program. The Costing Tool estimates financial and economic costs for different vaccine delivery scenarios for each of the major components of the expanded immunization program. Results In our base scenario, which specifies a donated single dose pre-filled vaccine formulation, the total financial cost of a program that would reach 2.3 million women is approximately $1.2 million over five years. The economic cost of the program, including the donated vaccine, is $10.4 million over the same period. The financial and economic costs per immunized pregnancy are $0.52 and $4.58, respectively. Other scenarios examine lower vaccine uptake, reaching 1.2 million women, and a vaccine purchased at $2.80 per dose with an alternative presentation. Conclusion This study estimates the financial and economic costs associated with a prospective maternal influenza immunization program in a low-income country. In some scenarios, the incremental delivery cost of a maternal influenza immunization program may be as low as some estimates of childhood vaccination programs, assuming the routine childhood immunization and antenatal care systems are capable of serving as the platform for an additional vaccination program. However, purchasing influenza vaccines at the prices assumed in this analysis, instead of having them donated, is likely to be challenging for lower-income countries. This result should be considered as a starting point to understanding the costs of maternal immunization programs in low-and middle-income countries.	[Pecenka, Clint; Bhat, Niranjan] PATH, Ctr Vaccine Innovat & Access, Seattle, WA USA; [Munthali, Spy] Chancellors Coll, Zomba, Malawi; [Chunga, Paul] Minist Hlth, Lilongwe, Malawi; [Levin, Ann; Morgan, Win] Levin & Morgan, Washington, DC USA; [Lambach, Philipp; Ortiz, Justin R.; Hutubessy, Raymond] World Hlth Org, Initiat Vaccine Res, Geneva, Switzerland; [Neuzil, Kathleen M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA	World Health Organization; University System of Maryland; University of Maryland Baltimore	Hutubessy, R (corresponding author), World Hlth Org, Initiat Vaccine Res, Geneva, Switzerland.	hutubessyr@who.int		Ortiz, Justin/0000-0002-3138-5965	Centers for Disease Control and Prevention (CDC) [U50 CK000431]; Bill and Melinda Gates Foundation (BMGF) [OPP 1084288]; World Health Organization's Initiative for Vaccine Research	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); World Health Organization's Initiative for Vaccine Research	The authors would like to acknowledge the contributions of the Centers for Disease Control and Prevention (CDC) and the Bill and Melinda Gates Foundation (BMGF), which provide financial support to the World Health Organization Initiative for Vaccine Research (U50 CK000431) and (OPP 1084288) respectively. The development of the Influenza Vaccine Program Costing Tool was funded by a grant from the World Health Organization's Initiative for Vaccine Research. The development of the Influenza Vaccine Program Costing Tool was undertaken with Levin and Morgan, a commercial entity. Levin and Morgan contributed to the development of the Influenza Vaccine Program Costing Tool, its piloting, data collection, analysis and writing. The funders (BMGF and CDC) provided support in the form of salaries for authors [CP, PL, NB, KMN, JRO, RH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Abramson JS, 2016, LANCET, V388, P2562, DOI 10.1016/S0140-6736(16)30882-0; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P261; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2010, PERF QUAL SAF PQS CA; [Anonymous], 2016, ESBJ DENM VESTFR SOL; Brenzel L, 2015, VACCINE, V33, pA93, DOI 10.1016/j.vaccine.2014.12.076; de Francisco N, 2015, VACCINE, V33, P6537, DOI 10.1016/j.vaccine.2015.10.066; Galactionova K, 2015, VACCINE, V33, P6710, DOI 10.1016/j.vaccine.2015.10.079; Hutubessy R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-136; ICRC, 2011, EM MED IT CAT REFR 1; Janusz CB, 2015, VACCINE, V33, pA53, DOI 10.1016/j.vaccine.2015.01.016; Keller-Stanislawski B, 2014, VACCINE, V32, P7057, DOI 10.1016/j.vaccine.2014.09.052; Le Gargasson JB, 2015, VACCINE, V33, pA40, DOI 10.1016/j.vaccine.2014.12.081; Levin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101114; Levin C, 2011, CONVENING IMMUNIZATI; Levin CE, 2013, B WORLD HEALTH ORGAN, V91, P585, DOI 10.2471/BLT.12.113837; Malawi Expanded Programme on Immunisation, 2011, MAL COMPR EPI MULT Y; Malawi Ministry of Health, 2011, COLD CHAIN ASS INV C; Malawi NSO, 2008, POPULATION PROJECTIO; National Statistical Office, 2011, MAL DEM HLTH SURV 20; Ngabo F, 2015, VACCINE, V33, P7357, DOI 10.1016/j.vaccine.2015.10.022; Orenstein E, 2017, PLOS ONE, V12, P1; Ortiz JR, 2016, VACCINE, V34, P5400, DOI 10.1016/j.vaccine.2016.07.045; Ott JJ, 2013, HUM VACC IMMUNOTHER, V9, P1500, DOI 10.4161/hv.24704; PATH, 2016, MAT INFL IMM PERC DE; PATH, 2011, VACC REG DISTR CTR C; Peasah SK, 2013, VACCINE, V31, P5339, DOI 10.1016/j.vaccine.2013.09.013; Schutte C, 2015, VACCINE, V33, pA47, DOI 10.1016/j.vaccine.2014.12.040; WHO, 2015, INFL VACC SEAS IN 10; WHO, 2016, WHO FLUT PLANN COST; WHO, 2015, VACC PROD PRIC PROC; WHO, 2016, EFF VACC MAN EVM IN; WHO, 2016, TOOL EST EC BURD ASS; World Bank, 2015, WORLD DEV INDICATORS; World Bank and GAVI Alliance, 2010, IMM FIN TOOLK RES PO; World Health Organization, 2012, WHO CERV CANC PREV C; World Health Organization, 2016, GUID EC EV INFL VACC; World Health Organization,, 2016, WHO MAN EST EC BURD; World Health Organization, 2015, MAN EST DIS BURD ASS; [World Health Organization Organization WH], 2016, IMPL INFL VACC PREGN	40	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190006	10.1371/journal.pone.0190006	http://dx.doi.org/10.1371/journal.pone.0190006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281710	Green Submitted, gold, Green Published			2022-12-26	WOS:000419006200057
J	Ikegami, T; Balogh, A; Nishiyama, S; Lokugamage, N; Saito, TB; Morrill, JC; Shivanna, V; Indran, SV; Zhang, LH; Smith, JK; Perez, D; Juelich, TL; Morozov, I; Wilson, WC; Freiberg, AN; Richt, JA				Ikegami, Tetsuro; Balogh, Aaron; Nishiyama, Shoko; Lokugamage, Nandadeva; Saito, Tais B.; Morrill, John C.; Shivanna, Vinay; Indran, Sabarish V.; Zhang, Lihong; Smith, Jennifer K.; Perez, David; Juelich, Terry L.; Morozov, Igor; Wilson, William C.; Freiberg, Alexander N.; Richt, Juergen A.			Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse model	PLOS ONE			English	Article							VIRUS; IMMUNOGENICITY; DETERMINANTS; EXPRESSION; DIVERSITY; INFECTION; REVEALS; SAFETY; CELLS; IMAGE	Rift Valley fever phlebovirus (RVFV) causes high rates of abortions and fetal malformations in ruminants, and hemorrhagic fever, encephalitis, or blindness in humans. Viral transmission occurs via mosquito vectors in endemic areas, which necessitates regular vaccination of susceptible livestock animals to prevent the RVF outbreaks. Although ZH501 strain has been used as a challenge strain for past vaccine efficacy studies, further characterization of other RVFV strains is important to optimize ruminant and nonhuman primate RVFV challenge models. This study aimed to characterize the virulence of wild-type RVFV strains belonging to different genetic lineages in outbred CD1 mice. Mice were intraperitoneally infected with 1x10(3) PFU of wild-type ZH501, Kenya 9800523, Kenya 90058, Saudi Arabia 200010911, OS1, OS7, SA75, Entebbe, or SA51 strains. Among them, mice infected with SA51, Entebbe, or OS7 strain showed rapid dissemination of virus in livers and peracute necrotic hepatitis at 2 +/- 3 dpi. Recombinant SA51 (rSA51) and Zinga (rZinga) strains were recovered by reverse genetics, and their virulence was also tested in CD1 mice. The rSA51 strain reproduced peracute RVF disease in mice, whereas the rZinga strain showed a similar virulence with that of rZH501 strain. This study showed that RVFV strains in different genetic lineages display distinct virulence in outbred mice. Importantly, since wild-type RVFV strains contain defective-interfering RNA or various genetic subpopulations during passage from original viral isolations, recombinant RVFV strains generated by reverse genetics will be better suitable for reproducible challenge studies for vaccine development as well as pathological studies.	[Ikegami, Tetsuro; Nishiyama, Shoko; Lokugamage, Nandadeva; Saito, Tais B.; Zhang, Lihong; Smith, Jennifer K.; Perez, David; Juelich, Terry L.; Freiberg, Alexander N.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Ikegami, Tetsuro; Freiberg, Alexander N.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA; [Ikegami, Tetsuro; Freiberg, Alexander N.] Univ Texas Med Branch, Ctr Biodefense & Emerging Infect Dis, Galveston, TX 77555 USA; [Balogh, Aaron; Shivanna, Vinay; Indran, Sabarish V.; Morozov, Igor; Richt, Juergen A.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Morrill, John C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Zhang, Lihong; Smith, Jennifer K.; Perez, David; Juelich, Terry L.; Freiberg, Alexander N.] Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77555 USA; [Wilson, William C.] ARS, USDA, Arthropod Borne Anim Dis Res Unit, Manhattan, KS USA; [Balogh, Aaron] Univ Wisconsin, Influenza Res Inst, Madison, WI USA; [Nishiyama, Shoko] Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Kansas State University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; Hokkaido University	Ikegami, T (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Ikegami, T (corresponding author), Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.; Ikegami, T (corresponding author), Univ Texas Med Branch, Ctr Biodefense & Emerging Infect Dis, Galveston, TX 77555 USA.	teikegam@utmb.edu	Richt, Juergen/AAL-3632-2020; Ikegami, Tetsuro/H-1329-2013; Shivanna, Vinay/AAC-9236-2019	Ikegami, Tetsuro/0000-0001-8318-2783; Shivanna, Vinay/0000-0002-4625-954X; Freiberg, Alexander N/0000-0001-8413-8960; Wilson, William/0000-0002-7877-9224	DHS Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD); Kansas Bioscience Authority [S13027]; NIH [R01 AI08764301-A1]; Sealy Center for Vaccine Development at the University of Texas Medical Branch at Galveston; James W. McLaughlin Postdoctoral Fellowship at UTMB; USDA, Agricultural Research Service CRIS project [5430-32000-009-00D]	DHS Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD); Kansas Bioscience Authority; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sealy Center for Vaccine Development at the University of Texas Medical Branch at Galveston; James W. McLaughlin Postdoctoral Fellowship at UTMB; USDA, Agricultural Research Service CRIS project	This study was supported by the DHS Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD) and the Kansas Bioscience Authority grant subcontract S13027, and also partly supported by the NIH grant R01 AI08764301-A1, and the funding from the Sealy Center for Vaccine Development at the University of Texas Medical Branch at Galveston. SN was supported by the James W. McLaughlin Postdoctoral Fellowship at UTMB. WW was supported by the USDA, Agricultural Research Service CRIS project #5430-32000-009-00D.	ANDERSON GW, 1988, MICROB PATHOGENESIS, V5, P241, DOI 10.1016/0882-4010(88)90096-4; ANDERSON GW, 1989, RES VIROLOGY, V140, P129, DOI 10.1016/S0923-2516(89)80090-1; BATTLES JK, 1988, AM J TROP MED HYG, V39, P617, DOI 10.4269/ajtmh.1988.39.617; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; BESSELAAR TG, 1991, RES VIROLOGY, V142, P469, DOI 10.1016/0923-2516(91)90069-F; Billecocq A, 1996, J GEN VIROL, V77, P3053, DOI 10.1099/0022-1317-77-12-3053; Bird BH, 2007, J VIROL, V81, P2805, DOI 10.1128/JVI.02095-06; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; Dimmock NJ, 2014, J VIROL, V88, P5217, DOI 10.1128/JVI.03193-13; do Valle TZ, 2010, J IMMUNOL, V185, P6146, DOI 10.4049/jimmunol.1000949; EASTERDAY BC, 1962, AM J VET RES, V23, P1231; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2005, J VIROL, V79, P12106, DOI 10.1128/JVI.79.18.12106-12111.2005; Ikegami T, 2017, EXPERT REV VACCINES, V16, P601, DOI 10.1080/14760584.2017.1321482; Indran SV, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00131; Ito N, 2003, MICROBIOL IMMUNOL, V47, P613, DOI 10.1111/j.1348-0421.2003.tb03424.x; Kalveram B, 2011, JOVE-J VIS EXP, DOI 10.3791/3400; KEEGAN K, 1986, J VIROL, V58, P263, DOI 10.1128/JVI.58.2.263-270.1986; Kortekaas J, 2014, ANTIVIR RES, V106, P24, DOI 10.1016/j.antiviral.2014.03.008; Mansfield KL, 2015, VACCINE, V33, P5520, DOI 10.1016/j.vaccine.2015.08.020; MEEGAN JM, 1979, T ROY SOC TROP MED H, V73, P618, DOI 10.1016/0035-9203(79)90004-X; Morrill JC, 2013, VACCINE, V31, P4988, DOI 10.1016/j.vaccine.2013.08.003; Morrill JC, 2013, VACCINE, V31, P559, DOI 10.1016/j.vaccine.2012.10.118; Morrill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009986; NIKLASSON BS, 1984, ACTA PATH MICRO IM C, V92, P197; Olaleye O D, 1996, Rev Elev Med Vet Pays Trop, V49, P6; Pepin M, 2010, VET RES, V41; PETERS CJ, 1982, J MED VIROL, V10, P45, DOI 10.1002/jmv.1890100107; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seiler P, 1997, EUR J IMMUNOL, V27, P2626, DOI 10.1002/eji.1830271023; Swanepoel R., 2004, INFECT DIS LIVESTOCK, V2, P1037; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Won S, 2006, J VIROL, V80, P8274, DOI 10.1128/JVI.00476-06	35	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189250	10.1371/journal.pone.0189250	http://dx.doi.org/10.1371/journal.pone.0189250			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267298	Green Submitted, gold, Green Published			2022-12-26	WOS:000418587400024
J	Pedrotti, ML; Mousseau, L; Marro, S; Passafiume, O; Gossaert, M; Labat, JP				Pedrotti, Maria Luiza; Mousseau, Laure; Marro, Sophie; Passafiume, Ornella; Gossaert, Marjorie; Labat, Jean-Philippe			Variability of ultraplankton composition and distribution in an oligotrophic coastal ecosystem of the NW Mediterranean Sea derived from a two-year survey at the single cell level	PLOS ONE			English	Article							NUCLEIC-ACID CONTENT; LIGURIAN SEA; VILLEFRANCHE BAY; BACTERIAL-CELLS; HYDROGRAPHIC CONDITIONS; HETEROTROPHIC BACTERIA; PLANKTONIC BACTERIA; COMMUNITY STRUCTURE; MARINE ECOSYSTEM; GROWTH-RATES	Ultraplankton [heterotrophic prokaryotes and ultraphytoplankton (< 10 mu m)] were monitored weekly over two years (2009 & 2010) in a coastal area of the NW Mediterranean Sea. Six clusters were differentiated by flow cytometry on the basis of their optical properties, two heterotrophic prokaryote (HP) subgroups labelled LNA and HNA (low and high nucleic acid content respectively), Prochlorococcus, Synechococcus, autotrophic picoeukaryotes and nanoeukaryotes. HP represented an important component of the microbial assemblage over the survey with relatively small abundance variation through seasons. The carbon biomass ratio HP/ ultraphytoplankton averaged 0.45, however this ratio exceeded 1 during spring. Ultraphytoplankton biomass made about 50% of the total autotrophic carbon estimates but this contribution increased up to 97% and 67% during the 2009 and 2010 spring periods respectively. Within ultraphytoplankton, nanoeukaryote represent the most important ultraphytoplankton group in terms of autotrophic carbon biomass (up to 70%). Picoeukaryote maximum abundance occurred in winter. Synechococcus was the most abundant population (maximum 1.2 x 10(5) cells cm(-3)) particularly in spring where it represented up to 54% of ultraphytoplankton carbon biomass. The warmer winter-spring temperatures and the lengthening of the stratification period created a favorable situation for the earlier appearance of Synechococcus and its persistence throughout summer, paralleling Prochlorococcus development. Prochlorococcus was dominant over summer and autumn with concentrations up to 1.0 x 10 (5) cells cm(-3). While the abundance of Synechococcus throughout survey was of the same order as that reported in western Mediterranean Sea, Prochlorococcus was more abundant and similar to the more typical oligotrophic and warm waters. The abundance variation of the ultraplankton components through the survey was relatable to variations in the hydrological and nutrient conditions.	[Pedrotti, Maria Luiza; Mousseau, Laure; Marro, Sophie; Passafiume, Ornella; Gossaert, Marjorie; Labat, Jean-Philippe] UPMC Univ Paris 06, Sorbonne Univ, UMR 7093, LOV, Villefranche Sur Mer, France; [Pedrotti, Maria Luiza; Mousseau, Laure; Marro, Sophie; Passafiume, Ornella; Gossaert, Marjorie; Labat, Jean-Philippe] CNRS, UMR 7093, LOV, Villefranche Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Pedrotti, ML (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, UMR 7093, LOV, Villefranche Sur Mer, France.; Pedrotti, ML (corresponding author), CNRS, UMR 7093, LOV, Villefranche Sur Mer, France.	pedrotti@obs-vlfr.fr	Marro, Sophie/B-2411-2012	pedrotti, Maria Luiza/0000-0002-9963-0402	Service d'Observation en Milieu Littoral (SOMLIT) program; Service d'Observation de la rade (SORADE) of the Observatory of Villefranche sur Mer; French Ministry of Research (CNRS-INSU)	Service d'Observation en Milieu Littoral (SOMLIT) program; Service d'Observation de la rade (SORADE) of the Observatory of Villefranche sur Mer; French Ministry of Research (CNRS-INSU)	This work was supported by the Service d'Observation en Milieu Littoral (SOMLIT) program, the Service d'Observation de la rade (SORADE) of the Observatory of Villefranche sur Mer and the French Ministry of Research (CNRS-INSU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present study was supported by Service d'Observation en Milieu Littoral (SOMLIT) French program, the Service d'Observation de la rade (SORADE) of the Observatory of Ville-franche sur Mer (OOV) and the French Ministry of Research (CNRS-INSU). We thank the Service d'Observation Rade de Villefranche (SORADE) especially A. M. Corre for hydrological sampling and analysis, M. E. Kerros for graph editing, John Dolan for English editing and the crew of the boat Sagitta 2. We thank Michel Denis for constructive comments that helped improve the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agawin NSR, 2000, LIMNOL OCEANOGR, V45, P591, DOI 10.4319/lo.2000.45.3.0591; Aminot A, 2007, QUAE; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Azam F, 2007, NAT REV MICROBIOL, V5; BAINES SB, 1991, LIMNOL OCEANOGR, V36, P1078, DOI 10.4319/lo.1991.36.6.1078; Beauvais S, 2003, MAR ECOL PROG SER, V262, P97, DOI 10.3354/meps262097; Bethoux J. P., 1988, OCEANOL ACTA, P59; Bethoux JP, 2002, DEEP-SEA RES PT II, V49, P2007, DOI 10.1016/S0967-0645(02)00024-3; Bettarel Y, 2002, FEMS MICROBIOL ECOL, V42, P451, DOI 10.1111/j.1574-6941.2002.tb01034.x; Biller SJ, 2015, NAT REV MICROBIOL, V13, P13, DOI 10.1038/nrmicro3378; Bonilla-Findji O, 2010, BIOGEOSCIENCES, V7, P3491, DOI 10.5194/bg-7-3491-2010; BUSTILLOSGUZMAN J, 1995, MAR ECOL PROG SER, V124, P247, DOI 10.3354/meps124247; Cailliau C, 1996, MAR ECOL PROG SER, V145, P209, DOI 10.3354/meps145209; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954; Casotti R, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001541; Casotti R, 2000, MAR ECOL PROG SER, V195, P15, DOI 10.3354/meps195015; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Chow CET, 2014, ISME J, V8, P816, DOI 10.1038/ismej.2013.199; Cloern JE, 1995, LIMNOL OCEANOGR, V40, P1313, DOI 10.4319/lo.1995.40.7.1313; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Del Amo Y, 1997, MAR ECOL PROG SER, V161, P225, DOI 10.3354/meps161225; DeLaRocha C. L, 2007, TREATISE GEOCHEMISTR, P1, DOI [10.1016/B0-08-043751-6/06107-7, DOI 10.1016/B0-08-043751-6/06107-7]; Denis M, 2003, J MARINE SYST, V39, P19, DOI 10.1016/S0924-7963(02)00244-0; Denis M, 2010, BIOGEOSCIENCES, V7, P2227, DOI 10.5194/bg-7-2227-2010; DOLAN JR, 1995, OPHELIA, V41, P71, DOI 10.1080/00785236.1995.10422038; DUCKLOW HW, 1992, ADV MICROB ECOL, V12, P113; Ducklow HW, 2001, DEEP SEA RES 2, V48, P4199, DOI DOI 10.1016/S0967-0645(01)00086-8; EGGE JK, 1992, MAR ECOL PROG SER, V83, P281, DOI 10.3354/meps083281; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FENCHEL T, 1988, ANNU REV ECOL SYST, V19, P19, DOI 10.1146/annurev.es.19.110188.000315; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Garcia-Comas C, 2011, J MARINE SYST, V87, P216, DOI 10.1016/j.jmarsys.2011.04.003; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Gasol JM, APPL ENV MICROBIOL; Goffart A, 2002, MAR ECOL PROG SER, V236, P45, DOI 10.3354/meps236045; Gomez F, 2003, J PLANKTON RES, V25, P323, DOI 10.1093/plankt/25.4.323; Gorsky G, 1999, J GEOPHYS RES-OCEANS, V104, P3381, DOI 10.1029/98JC01850; Gostan J, 1967, CAH OCEANOGR, V21, P1; HAGSTROM A, 1988, MAR ECOL PROG SER, V49, P171, DOI 10.3354/meps049171; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Jacquet S, 1998, AQUAT MICROB ECOL, V14, P309, DOI 10.3354/ame014309; KANA TM, 1987, DEEP-SEA RES, V34, P497, DOI 10.1016/0198-0149(87)90002-1; Lebaron P, 2001, APPL ENVIRON MICROB, V67, P1775, DOI 10.1128/AEM.67.4.1775-1782.2001; LEE S, 1987, APPL ENVIRON MICROB, V53, P1298, DOI 10.1128/AEM.53.6.1298-1303.1987; LEGENDRE L, 1989, LIFE SCI R, V44, P49; Longnecker K, 2006, AQUAT MICROB ECOL, V43, P113, DOI 10.3354/ame043113; Longnecker K, 2005, APPL ENVIRON MICROB, V71, P7737, DOI 10.1128/AEM.71.12.7737-7749.2005; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Marie D, 1999, CURR PROTOCOLS CYTOM, V11, P1, DOI [DOI 10.1002/0471142956.CY1111S10, 10.1002/0471142956.cy1111s10, 10.1002/0471142956.cy1112s11]; Marty JC, 2010, BIOGEOSCIENCES, V7, P2117, DOI 10.5194/bg-7-2117-2010; Marty JC, 2002, DEEP-SEA RES PT II, V49, P1965, DOI 10.1016/S0967-0645(02)00022-X; Mella-Flores D, 2011, BIOGEOSCIENCES, V8, P2785, DOI 10.5194/bg-8-2785-2011; MIGON C, 1993, SCI TOTAL ENVIRON, V138, P289, DOI 10.1016/0048-9697(93)90422-3; Millot C, 2005, HANDB ENVIRON CHEM, V5, P29, DOI 10.1007/b107143; Molinero JC, 2005, GLOBAL CHANGE BIOL, V14, P11; Moran XAG, 2007, AQUAT MICROB ECOL, V49, P267, DOI 10.3354/ame01151; Moutin T, 2002, LIMNOL OCEANOGR, V47, P1562, DOI 10.4319/lo.2002.47.5.1562; NIVAL P, 1976, ANN I OCEANOGR PARIS, V52, P57; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; PETERSON WT, 1987, S AFR J MARINE SCI, V5, P411, DOI 10.2989/025776187784522748; Raven JA, 1999, PLANT CELL ENVIRON, V22, P741, DOI 10.1046/j.1365-3040.1999.00419.x; Richardson TL, 2007, SCIENCE, V315, P838, DOI 10.1126/science.1133471; Romagnan JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119219; Servais P, 2003, AQUAT MICROB ECOL, V33, P41, DOI 10.3354/ame033041; SHELDON RW, 1992, HYDROBIOLOGIA, V241, P91, DOI 10.1007/BF00008262; Siokou-Frangou I, 2010, BIOGEOSCIENCES, V7, P1543, DOI 10.5194/bg-7-1543-2010; Strickland J.D.H., 1972, PRACT HDB SEAWATER A, V167, P185; Tanaka T, 2004, LIMNOL OCEANOGR, V49, P1063, DOI 10.4319/lo.2004.49.4.1063; Thingstad TF, 2005, SCIENCE, V309, P1068, DOI 10.1126/science.1112632; Thingstad TF, 1998, LIMNOL OCEANOGR, V43, P88, DOI 10.4319/lo.1998.43.1.0088; Thyssen M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00387; Tian RC, 2000, DEEP-SEA RES PT II, V47, P637, DOI 10.1016/S0967-0645(99)00121-6; Trabelsi A, 2011, J PLANKTON RES, V33, P1249, DOI 10.1093/plankt/fbr024; TROUSSELLIER M, 1995, ESTUAR COAST SHELF S, V40, P621, DOI 10.1006/ecss.1995.0042; Van Wambeke F, 2011, BIOGEOSCIENCES, V8, P1853, DOI 10.5194/bg-8-1853-2011; Van Wambeke F, 2002, MICROB ECOL, V43, P119, DOI 10.1007/s00248-001-0038-4; Vandromme P, 2011, BIOGEOSCIENCES, V8, P3143, DOI 10.5194/bg-8-3143-2011; VAULOT D, 1990, LIMNOL OCEANOGR, V35, P1156, DOI 10.4319/lo.1990.35.5.1156; Vaulot D, 1996, APPL ENVIRON MICROB, V62, P2527, DOI 10.1128/AEM.62.7.2527-2533.1996; VERITY PG, 1992, LIMNOL OCEANOGR, V37, P1434, DOI 10.4319/lo.1992.37.7.1434; Vidussi F, 2001, J GEOPHYS RES-OCEANS, V106, P19939, DOI 10.1029/1999JC000308; Weyhenmeyer GA, 2013, FRESHWATER BIOL, V58, P612, DOI 10.1111/j.1365-2427.2012.02779.x; Zubkov MV, 2003, APPL ENVIRON MICROB, V69, P1299, DOI 10.1128/AEM.69.2.1299-1304.2003; ZWEIFEL UL, 1993, MAR ECOL PROG SER, V101, P23, DOI 10.3354/meps101023	86	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190121	10.1371/journal.pone.0190121	http://dx.doi.org/10.1371/journal.pone.0190121			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267395	gold, Green Published, Green Submitted			2022-12-26	WOS:000418587400095
J	Gao, J; Wang, TT; Liu, MX; Liu, J; Zhang, ZW				Gao, Jia; Wang, Tingting; Liu, Minxuan; Liu, Jing; Zhang, Zongwen			Transcriptome analysis of filling stage seeds among three buckwheat species with emphasis on rutin accumulation	PLOS ONE			English	Article							FAGOPYRUM-TATARICUM GAERTN.; TARTARY BUCKWHEAT; FLAVONOL SYNTHASE; ARABIDOPSIS; METABOLISM; STARCH; EXPRESSION; COMMON; BIOSYNTHESIS; REVEALS	Buckwheat is an important minor crop with pharmaceutical functions due to rutin enrichment in the seed. Seeds of common buckwheat cultivars (Fagopyrum esculentum, Fes) usually have much lower rutin content than tartary buckwheat (F. tartaricum, Ft). We previously found a wild species of common buckwheat (F. esculentum ssp. ancestrale, Fea), with seeds that are high in rutin, similar to Ft. In the present study, we investigated the mechanism by which rutin production varies among different buckwheat cultivars, Fea, a Ft variety (Xide) and a Fes variety (No. 2 Pingqiao) using RNA sequencing of filling stage seeds. Sequencing data generated approximately 43.78-Gb of clean bases, all these data were pooled together and assembled 180,568 transcripts, and 109,952 unigenes. We established seed gene expression profiles of each buckwheat sample and assessed genes involved in flavonoid biosynthesis, storage proteins production, CYP450 family, starch and sucrose metabolism, and transcription factors. Differentially expressed genes between Fea and Fes were further analyzed due to their close relationship than with Ft. Expression levels of flavonoid biosynthesis gene FLS1 (Flavonol synthase 1) were similar in Fea and Ft, and much higher than in Fes, which was validated by qRT-PCR. This suggests that FLS1 transcript levels may be associated with rutin accumulation in filling stage seeds of buckwheat species. Further, we explored transcription factors by iTAK, and multiple gene families were identified as being involved in the coordinate regulation of metabolism and development. Our extensive transcriptomic data sets provide a complete description of metabolically related genes that are differentially expressed in filling stage buckwheat seeds and suggests that FLS1 is a key controller of rutin synthesis in buckwheat species. FLS1 can effectively convert dihydroflavonoids into flavonol products. These findings provide a basis for further studies of flavonoid biosynthesis in buckwheat breeding to help accelerate flavonoid metabolic engineering that would increase rutin content in cultivars of common buckwheat.	[Gao, Jia; Wang, Tingting; Liu, Minxuan; Liu, Jing; Zhang, Zongwen] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Wang, Tingting] South China Univ Technol, Sch Biol & Biol Engn, Guangzhou, Guangdong, Peoples R China; [Zhang, Zongwen] China Off Biodivers Int, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; South China University of Technology	Zhang, ZW (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.; Zhang, ZW (corresponding author), China Off Biodivers Int, Beijing, Peoples R China.	zhangzongwen@caas.cn	wang, tingting/AAK-2640-2020		Agricultural Science and Technology Innovation Program of CAAS, Chinese Academy of Agricultural Science; Crop Germplasm Conservation and Utilization Project of the Ministry of Agriculture, Chinese Ministry of Agriculture [2016NWB036-06]; Scientific Support Program of the Ministry of Science and Technology, Chinese Ministry of Science and Technology [2013BAD01B05-2]	Agricultural Science and Technology Innovation Program of CAAS, Chinese Academy of Agricultural Science; Crop Germplasm Conservation and Utilization Project of the Ministry of Agriculture, Chinese Ministry of Agriculture; Scientific Support Program of the Ministry of Science and Technology, Chinese Ministry of Science and Technology	This work was supported by grants from the Agricultural Science and Technology Innovation Program of CAAS, Chinese Academy of Agricultural Science (http://www.caas.cn/research/research_program/index. shtml); the Crop Germplasm Conservation and Utilization Project of the Ministry of Agriculture (grant number 2016NWB036-06), Chinese Ministry of Agriculture (http://www.moa.gov.cn); and the Scientific Support Program of the Ministry of Science and Technology (grant number 2013BAD01B05-2), Chinese Ministry of Science and Technology (http://www.most.gov.cn/eng/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleckmann A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00452; Bonafaccia G, 2003, FOOD CHEM, V83, P1, DOI 10.1016/S0308-8146(03)00228-0; Chen CX, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00100; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Endt DV, 2002, PHYTOCHEMISTRY, V61, P107, DOI 10.1016/S0031-9422(02)00185-1; Fabjan N, 2003, J AGR FOOD CHEM, V51, P6452, DOI 10.1021/jf034543e; Gao JF, 2016, FOOD CHEM, V190, P552, DOI 10.1016/j.foodchem.2015.05.122; Gibson SI, 2004, J EXP BOT, V55, P253, DOI 10.1093/jxb/erh048; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gupta N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-231; Kreft I, 2006, FOOD CHEM, V98, P508, DOI 10.1016/j.foodchem.2005.05.081; Lafon-Placette C, 2014, CURR OPIN PLANT BIOL, V17, P64, DOI 10.1016/j.pbi.2013.11.008; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li J, 2013, PLANT CELL PHYSIOL, V54, P282, DOI 10.1093/pcp/pcs180; Li SQ, 2001, CRIT REV FOOD SCI, V41, P451, DOI 10.1080/20014091091887; Li X, 2013, J PLANT PHYSIOL, V170, P1630, DOI 10.1016/j.jplph.2013.06.010; Liu CL, 2008, J AGR FOOD CHEM, V56, P173, DOI 10.1021/jf072347s; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; Lou Q, 2014, J EXP BOT, V65, P3157, DOI 10.1093/jxb/eru168; Luo P, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01257; Malacarne G, 2015, J EXP BOT, V66, P4441, DOI 10.1093/jxb/erv243; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Morant M, 2003, CURR OPIN BIOTECH, V14, P151, DOI 10.1016/S0958-1669(03)00024-7; Naganol M, 2000, GENOME SIZE ANAL GEN, V39, P35; Ohnishi O, 1998, ECON BOT, V52, P123, DOI 10.1007/BF02861199; Ohnishi O., 1998, Fagopyrum, V15, P18; Ohnishi O., 1991, Fagopyrum, V11, P5; Orzechowski S, 2008, ACTA BIOCHIM POL, V55, P435, DOI 10.18388/abp.2008_3049; Preuss A, 2009, FEBS LETT, V583, P1981, DOI 10.1016/j.febslet.2009.05.006; Radchuk V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00510; Radoviu E S, 2012, BUCKWHEAT MODEL PLAN, P3; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Steadman KJ, 2000, J AGR FOOD CHEM, V48, P2843, DOI 10.1021/jf990709t; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Tian J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12228; Yao HP, 2017, PROG BIOPHYS MOL BIO, V124, P49, DOI 10.1016/j.pbiomolbio.2016.11.003; Zheng Y, 2016, MOL PLANT, V9, P1667, DOI 10.1016/j.molp.2016.09.014; Zhu F, 2016, TRENDS FOOD SCI TECH, V49, P121, DOI 10.1016/j.tifs.2015.12.002; Zondlo SC, 1999, PLANT J, V19, P259, DOI 10.1046/j.1365-313X.1999.00523.x	41	12	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189672	10.1371/journal.pone.0189672	http://dx.doi.org/10.1371/journal.pone.0189672			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261741	Green Submitted, Green Published, gold			2022-12-26	WOS:000418564200055
J	Liu, CY; Lau, KY; Hsu, CC; Chen, JL; Lee, CH; Huang, TT; Chen, YT; Huang, CT; Lin, PH; Tseng, LM				Liu, Chun-Yu; Lau, Ka-Yi; Hsu, Chia-Chi; Chen, Ji-Lin; Lee, Chia-Han; Huang, Tzu-Ting; Chen, Yi-Ting; Huang, Chun-Teng; Lin, Po-Han; Tseng, Ling-Ming			Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells	PLOS ONE			English	Article							RESISTANT PROSTATE-CANCER; DEPENDENT KINASE 4/6; ANTITUMOR-ACTIVITY; SELECTIVE INHIBITOR; TUMOR-SUPPRESSOR; BASAL-LIKE; SUBTYPES; RETINOBLASTOMA; IDENTIFICATION; PD-0332991	Objectives Triple negative breast cancer (TNBC) lacks specific drug targets and remains challenging. Palbociclib, a cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitor is approved for metastatic estrogen receptor (ER)-positive and human epithermal growth factor 2 (HER2)-negative breast cancer. The nature of cell cycle inhibition by palbociclib suggests its potential in TNBC cells. Retinoblastoma (RB, a known substrate of CDK4/6) pathway deregulation is a frequent occurrence in TNBC and studies have revealed that pharmacological CDK4/6 inhibition induces a cooperative cytostatic effect with doxorubicin in RB-proficient TNBC models. In addition, recent studies reported that anti-androgen therapy shows preclinical efficacy in androgen-receptor (AR)-positive TNBC cells. Here we examined the effect of palbociclib in combination with an anti-androgen enzalutamide in TNBC cells. Method MDA-MB-453, BT-549, MDA-MB-231 and MDA-MB-468 TNBC cell lines were used for in vitro studies. Protein expressions were assessed by Western blot analysis. Cytostatic effect was examined by MTT assay. Cell cycle and apoptosis were examined by flow cytometry. Results Palbociclib showed inhibitory effect in RB-proficient TNBC cells, and enzalutamide inhibited cell viability in AR-positive TNBC cells. Enzalutamide treatment could enhance the palbociclib-induced cytostatic effect in AR-positive/RB-proficient TNBC cells. In addition, palbociclib-mediated G1 arrest in AR-positive/RB-proficient TNBC cells was attenuated by RB knockdown. Conclusion Our study provided a preclinical rationale in selecting patients who might have therapeutic benefit from combining CDK4/6 inhibitors with AR antagonists.	[Liu, Chun-Yu; Hsu, Chia-Chi; Chen, Ji-Lin; Huang, Tzu-Ting; Tseng, Ling-Ming] Taipei Vet Gen Hosp, Comprehens Breast Hlth Ctr, Taipei, Taiwan; [Liu, Chun-Yu; Huang, Chun-Teng; Tseng, Ling-Ming] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Liu, Chun-Yu; Lau, Ka-Yi; Hsu, Chia-Chi; Chen, Ji-Lin; Lee, Chia-Han; Huang, Tzu-Ting; Chen, Yi-Ting] Taipei Vet Gen Hosp, Div Med Oncol, Dept Oncol, Taipei, Taiwan; [Huang, Chun-Teng] Taipei City Hosp, Div Hematol Oncol, Dept Med, Yang Ming Branch, Taipei, Taiwan; [Lin, Po-Han] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; [Tseng, Ling-Ming] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei City Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital	Tseng, LM (corresponding author), Taipei Vet Gen Hosp, Comprehens Breast Hlth Ctr, Taipei, Taiwan.; Tseng, LM (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Tseng, LM (corresponding author), Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan.	lmtseng@vghtpe.gov.tw	Huang, Tzu-Ting/S-9455-2019; Lin, Po-Han/AEU-8550-2022; Chen, Yi/HIR-2608-2022	Lin, Po-Han/0000-0001-6066-398X; Huang, Tzu-Ting/0000-0002-3675-2760; Hsu, Chia-Chi/0000-0003-1532-7017	Taiwan Clinical Oncology Research Foundation-the Yen Tjing Ling Medical Foundation [CI-104-07]; Ministry of Science and Technology, Taiwan [MOST 104-2628-B-075-001-MY3]; Yang Ming Branch of Taipei City Hospital [10601-62-020]; Taipei Veterans General Hospital [V104C-151, V105C-067, V106C-101]; TVGH-NTUH Joint Research Program from Taipei Veterans General Hospital [VN105-09, VN106-07]; TVGH-NTUH Joint Research Program from National Taiwan-University Hospital [VN105-09, VN106-07]; Ministry of Health and Welfare, Executive Yuan, Taiwan [MOHW105-TDU-B-211-134003, MOHW106-TDU-B-211-144-003]	Taiwan Clinical Oncology Research Foundation-the Yen Tjing Ling Medical Foundation; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Yang Ming Branch of Taipei City Hospital; Taipei Veterans General Hospital(Taipei Veterans General Hospital); TVGH-NTUH Joint Research Program from Taipei Veterans General Hospital; TVGH-NTUH Joint Research Program from National Taiwan-University Hospital; Ministry of Health and Welfare, Executive Yuan, Taiwan	This work was funded by the Taiwan Clinical Oncology Research Foundation-the Yen Tjing Ling Medical Foundation (CI-104-07); Ministry of Science and Technology, Taiwan (MOST 104-2628-B-075-001-MY3) to C-YL; Yang Ming Branch of Taipei City Hospital (10601-62-020) to C-YL; Taipei Veterans General Hospital (V104C-151, V105C-067, V106C-101) to C-YL; TVGH-NTUH Joint Research Program (VN105-09, VN106-07) from Taipei Veterans General Hospital and National Taiwan-University Hospital to C-YL; Ministry of Health and Welfare, Executive Yuan, Taiwan (MOHW105-TDU-B-211-134003; MOHW106-TDU-B-211-144-003 for the Center of Excellence for Cancer Research at Taipei Veterans General) to C-YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASGHAR U, 2015, J CLIN ONC 15 SUPPL, V33; Asghar US, 2017, CLIN CANCER RES, V23, P5561, DOI 10.1158/1078-0432.CCR-17-0369; Barton VN, 2015, MOL CANCER THER, V14, P769, DOI 10.1158/1535-7163.MCT-14-0926; Beer TM, 2014, NEW ENGL J MED, V371, P1755, DOI 10.1056/NEJMc1410239; Caiazza F, 2016, ENDOCR-RELAT CANCER, V23, P323, DOI 10.1530/ERC-16-0068; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cochrane DR, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3599; Farrow JM, 2014, NAT REV UROL, V11, P508, DOI 10.1038/nrurol.2014.196; Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao S, 2016, CELL REP, V17, P966, DOI 10.1016/j.celrep.2016.09.064; Gelmon K, 2012, ANN ONCOL, V23, P2223, DOI 10.1093/annonc/mds067; Gucalp A, 2013, CLIN CANCER RES, V19, P5505, DOI 10.1158/1078-0432.CCR-12-3327; Kalimutho M, 2015, TRENDS PHARMACOL SCI, V36, P822, DOI 10.1016/j.tips.2015.08.009; Kobayashi K, 2016, SURG TODAY, V46, P821, DOI 10.1007/s00595-015-1252-x; Konecny GE, 2011, CLIN CANCER RES, V17, P1591, DOI 10.1158/1078-0432.CCR-10-2307; Lehmann BD, 2014, J PATHOL, V232, P142, DOI 10.1002/path.4280; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Logan JE, 2013, ANTICANCER RES, V33, P2997; Loriot Y, 2013, ANN ONCOL, V24, P1807, DOI 10.1093/annonc/mdt136; Loriot Y, 2015, LANCET ONCOL, V16, P509, DOI 10.1016/S1470-2045(15)70113-0; Malorni L, 2012, BREAST CANCER RES TR, V136, P795, DOI 10.1007/s10549-012-2315-y; Mayer IA, 2014, CLIN CANCER RES, V20, P782, DOI 10.1158/1078-0432.CCR-13-0583; O'Leary B, 2016, NAT REV CLIN ONCOL, V13, P417, DOI 10.1038/nrclinonc.2016.26; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Robinson TJW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078641; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Schrader AJ, 2014, EUR UROL, V65, P30, DOI 10.1016/j.eururo.2013.06.042; Subhawong AP, 2009, AM J SURG PATHOL, V33, P163, DOI 10.1097/PAS.0b013e31817f9790; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Turner NC, 2015, NEW ENGL J MED, V373, P209, DOI 10.1056/NEJMoa1505270; Witkiewicz AK, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3652; Yeh SY, 1998, BIOCHEM BIOPH RES CO, V248, P361, DOI 10.1006/bbrc.1998.8974	37	31	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189007	10.1371/journal.pone.0189007	http://dx.doi.org/10.1371/journal.pone.0189007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261702	gold, Green Published, Green Submitted			2022-12-26	WOS:000418564200021
J	Abdulkader, RCRM; Burdmann, EA; Lebrao, ML; Duarte, YAO; Zanetta, DMT				Abdulkader, Regina C. R. M.; Burdmann, Emmanuel A.; Lebrao, Maria Lucia; Duarte, Yeda A. O.; Zanetta, Dirce M. T.			Aging and decreased glomerular filtration rate: An elderly population-based study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SERUM CREATININE; CKD; PREVALENCE; COHORT	Background Although a reduced glomerular filtration rate (GFR) in old people has been attributed to physiologic aging, it may be associated with kidney disease or superimposed comorbidities. This study aims to assess the prevalence of decreased GFR in a geriatric population in a developing country and its prevalence in the absence of simultaneous diseases. Study design and methods This is a cross-sectional study of data from the Sau A de, Bem-Estar e Envelhecimento cohort study (SABE study[Health, Well-Being and Aging]), a multiple cohorts study. A multistage cluster sample composed of 1,253 individuals representative of 1,249,388 inhabitants of Sao Paulo city aged >= 60 years in 2010 was analyzed. The participants answered a survey on socio-demographic factors and health, had blood pressure measured and urine and blood samples collected. GFR was estimated and defined as decreased when <60 mL/min/1.73m(2). Kidney damage was defined as dipstick-positive hematuria or urinary protein: creatinine > 0.20 g/g. Results The prevalence of GFR <60 mL/min/1.73m(2) was 19.3%. Individuals with GFR <60 mL/min/1.73m(2) were older (75 +/- 1 versus 69 +/- 1 years, p<0.001), had lower schooling (18 versus 30% with complete 8-year basic cycle, p = 0.010), and higher prevalence of hypertension (82 versus 63%, p<0.001), diabetes (34 versus 26%, p = 0.021), cardiovascular disease (43 versus 24%, p<0.001) and kidney damage (35% versus 15%, p<0.001). Only 0.7% of the entire studied population had GFR <60 mL/min/1.73m(2) without simultaneous diseases or kidney damage. Among the individuals with GFR <60 mL/min/1.73m(2), 3.5% had neither renal damage nor associated comorbidities, whereas among those with GFR >= 60 mL/min/1.73m(2), 11.0% had none of these conditions. Logistic regression showed that older age, cardiovascular disease and hypertension were associated with GFR<60 mL/min/1.73m(2). Conclusions Decreased GFR was highly prevalent among the geriatric population in a megalopolis of a developing country. It was rarely present without simultaneous chronic comorbidities or kidney damage.	[Abdulkader, Regina C. R. M.; Burdmann, Emmanuel A.] Univ Sao Paulo, Med Sch, Sao Paulo, Brazil; [Lebrao, Maria Lucia; Duarte, Yeda A. O.; Zanetta, Dirce M. T.] Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Zanetta, DMT (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, Brazil.	dzanetta@usp.br	Zanetta, Dirce M T/G-4950-2013; Burdmann, Emmanuel/AAY-1966-2020; Burdmann, Emmanuel/B-7023-2009; Duarte, Yeda/AAT-8935-2020	Burdmann, Emmanuel/0000-0002-7644-8579; Zanetta, Dirce Maria/0000-0002-7273-5087	FAPESP [2009/53778-3]; CNPq (National Council for Scientific and Technological Development)	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was part of the SABE Project (Health, Well-being and Aging) supported by a grant from FAPESP (2009/53778-3). EAB, MLL, YAOD and DMTZ were partially supported by CNPq (National Council for Scientific and Technological Development). The funders had no role in study design; collection, analysis, and interpretation of data; writing the report; or in the decision to submit the report for publication.	Abdelhafiz AH, 2010, NEPHRON CLIN PRACT, V116, pC19, DOI 10.1159/000314545; Abreu P F, 1999, Geriatr Nephrol Urol, V9, P141, DOI 10.1023/A:1008308213377; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; American Diabetes Association (ADA), 2014, DIABETES CARE, V37, P581; Andrassy KM, 2013, KIDNEY INT, V84, P622, DOI 10.1038/ki.2013.243; ARORA P, 2013, CAN MED ASSOC J, V185, pE417, DOI DOI 10.1503/cmaj.120833; Botev R, 2011, CLIN J AM SOC NEPHRO, V6, P937, DOI 10.2215/CJN.09241010; Browne GM, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-144; Carter JL, 2011, QJM-INT J MED, V104, P839, DOI 10.1093/qjmed/hcr077; Dutra Marina Constante, 2014, Braz. J. Nephrol., V36, P297, DOI 10.5935/0101-2800.20140043; Ebert N, 2017, NEPHROL DIAL TRANSPL, V32, P997, DOI 10.1093/ndt/gfw079; Esposito C, 2012, J GERONTOL A-BIOL, V67, P1387, DOI 10.1093/gerona/gls182; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Glassock RJ, 2008, CLIN J AM SOC NEPHRO, V3, P1563, DOI 10.2215/CJN.00960208; Glassock Richard J, 2009, Trans Am Clin Climatol Assoc, V120, P419; Group K.W., 2002, AM J KIDNEY DIS, V39, pS46, DOI DOI 10.1053/AJKD.2002.30943; Icaza M G AC, 1999, MINIMENTAL STATE EXA; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Lebrao M. L., 2003, PROJETO SABE MUNICIP; Lebrão Maria Lúcia, 2005, Rev. bras. epidemiol., V8, P127, DOI 10.1590/S1415-790X2005000200005; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lima-Costa MF, 2011, INT J EPIDEMIOL, V40, P862, DOI 10.1093/ije/dyq143; Mandelli S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136039; Murthy K, 2005, KIDNEY INT, V68, P1884, DOI 10.1111/j.1523-1755.2005.00608.x; Passos VMA, 2003, BRAZ J MED BIOL RES, V36, P393, DOI 10.1590/S0100-879X2003000300015; Poggio ED, 2009, NEPHROL DIAL TRANSPL, V24, P698, DOI 10.1093/ndt/gfn704; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAO JNK, 1987, ANN STAT, V15, P385, DOI 10.1214/aos/1176350273; Sepanlou SG, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0176540, 10.1371/journal.pone.]; Sesso RC, 2012, J BRAS NEFROL, V36, P48; United States Renal Data System, 2015, 2015 USRDS ANN DAT R; Vart P, 2013, CLIN J AM SOC NEPHRO, V8, P1685, DOI 10.2215/CJN.12521212; Vassalotti JA, 2007, AM J KIDNEY DIS, V50, P169, DOI 10.1053/j.ajkd.2007.06.013; Winearls CG, 2011, NEPHRON CLIN PRACT, V119, pC2, DOI 10.1159/000328013; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	37	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189935	10.1371/journal.pone.0189935	http://dx.doi.org/10.1371/journal.pone.0189935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261774	gold, Green Published, Green Submitted			2022-12-26	WOS:000418554900040
J	Murata, M; Kanetani, S; Nara, K				Murata, Masao; Kanetani, Seiichi; Nara, Kazuhide			Ectomycorrhizal fungal communities in endangered Pinus amamiana forests	PLOS ONE			English	Article							SCALE GENETIC-STRUCTURE; SOIL PROPAGULE BANKS; PRIMARY SUCCESSION; RESISTANT PROPAGULES; SPORE BANKS; SEEDLING ESTABLISHMENT; CENOCOCCUM-GEOPHILUM; MYCORRHIZAL NETWORKS; VOLCANIC DESERT; RHIZOPOGON	Interactions between trees and ectomycorrhizal (ECM) fungi are critical for the growth and survival of both partners. However, ECM symbiosis in endangered trees has hardly been explored, complicating conservation efforts. Here, we evaluated resident ECM roots and soil spore banks of ECM fungi from endangered Pinus amamiana forests on Yakushima and Tanegashima Islands, Kagoshima Prefecture, Japan. Soil samples were collected from remaining four forests in the two islands. The resident ECM roots in soil samples were subjected to molecular identification. Soil spore banks of ECM fungi were analyzed via bio-assays using a range of host seedlings (P. amamiana, P. parviflora, P. densiflora and Castanopsis sieboldii) for 6 +/- 8 months. In all remaining P. amamiana forests, we discovered a new Rhizopogon species (Rhizopogon sp. 1), the sequence of which has no match amoung numerous Rhizopogon sequences deposited in the international sequence database. Host identification of the resident ECM roots confirmed that Rhizopogon sp. 1 was associated only with P. amamiana. Rhizopogon sp. 1 was far more dominant in soil spore banks than in resident ECM roots, and its presence was confirmed in nearly all soil samples examined across the major remaining populations. While Rhizopogon sp. 1 did not completely lose compatibility to other pine species, its infection rate in the bioassays was highest in the original host, P. amamiana, the performance of which was improved by the infection. These results indicate that Rhizopogon sp. 1 is very likely to have a close ecological relationship with endangered P. amamiana, probably due to a long co-evolutionary period on isolated islands, and to play the key role in seedling establishment after disturbance. We may need to identify and utilize such key ECM fungi to conserve endangered trees practically.	[Murata, Masao; Nara, Kazuhide] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Kanetani, Seiichi] Kyushu Res Ctr, Forestry & Forest Prod Res Inst, Chuo Ku, Kumamoto, Japan	University of Tokyo; Forestry & Forest Products Research Institute - Japan	Murata, M (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan.	muratam0209@gmail.com			Yakushima Environmental and Cultural Foundation; Japan Society for the Promotion of Science [26870163 MM, 15H02449 KN]	Yakushima Environmental and Cultural Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work received support from The biodiversity conservation research activity promotion project from the Yakushima Environmental and Cultural Foundation (URL: http://www.yakushima.or.ip/, MM, Describe the role: data collection and analysis) and a Grant-in Aid for Scientific Research from the Japan Society for the Promotion of Science (26870163 MM and 15H02449 KN, URL: https://www.jsps.go.jp/j-grantsinaid/, Describe the role: the study design, data collection and analysis, decision to publish, or preparation of the manuscript).; We are grateful to the members of the Yakushima forest ecosystem conservation center and to K. Tetsuka and T. Saito for supporting our field survey. This study was supported by the biodiversity conservation research activity promotion project from the Yakushima Environmental and Cultural Foundation.	Abe H, 2017, MYCOSCIENCE, V58, P14, DOI 10.1016/j.myc.2016.07.009; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Ashkannejhad S, 2006, NEW PHYTOL, V169, P345, DOI 10.1111/j.1469-8137.2005.01593.x; Baar J, 1999, NEW PHYTOL, V143, P409, DOI 10.1046/j.1469-8137.1999.00452.x; Bahram M, 2011, FEMS MICROBIOL ECOL, V75, P313, DOI 10.1111/j.1574-6941.2010.01000.x; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bruns TD, 2009, NEW PHYTOL, V181, P463, DOI 10.1111/j.1469-8137.2008.02652.x; Buscardo E, 2010, FUNGAL BIOL-UK, V114, P628, DOI 10.1016/j.funbio.2010.05.004; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Douhan GW, 2007, MYCOLOGIA, V99, P812, DOI 10.3852/mycologia.99.6.812; Dunham SM, 2013, MYCOLOGIA, V105, P814, DOI 10.3852/12-265; FAO, 2010, 163 FAO; Farjon A., 2005, PINES DRAWINGS DESCR; Frank JL, 2009, BOTANY, V87, P821, DOI 10.1139/B09-044; Frankham R, 2010, INTRO CONSERVATION G, Vxxiii; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Glassman SI, 2016, ISME J, V10, P1228, DOI 10.1038/ismej.2015.182; Glassman SI, 2015, NEW PHYTOL, V205, P1619, DOI 10.1111/nph.13240; Grubisha LC, 2002, MYCOLOGIA, V94, P607, DOI 10.2307/3761712; Grubisha LC, 2007, MOL ECOL, V16, P1811, DOI 10.1111/j.1365-294X.2007.03264.x; Hao ZZ, 2015, MOL PHYLOGENET EVOL, V87, P65, DOI 10.1016/j.ympev.2015.03.013; Hayashi Y., 1960, TAXONOMICAL PHYTOGEO; Hirose D, 2010, FUNGAL ECOL, V3, P255, DOI 10.1016/j.funeco.2009.11.001; Huang J, 2014, EUR J CLIN NUTR, V1, P1, DOI DOI 10.1109/TPDS.2014.2326156; Huang J, 2015, MICROB ECOL, V69, P768, DOI 10.1007/s00248-014-0484-4; Hynson NA, 2013, BIOL INVASIONS, V15, P2373, DOI 10.1007/s10530-013-0458-3; Ishida TA, 2008, NEW PHYTOL, V180, P491, DOI 10.1111/j.1469-8137.2008.02572.x; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; IUCN, IUCN RED LIST THREAT; Izzo A, 2006, MYCOL RES, V110, P196, DOI 10.1016/j.mycres.2005.08.010; Junichi Kikuchi, 2003, Journal of Forest Research, V8, P17; Kanetani S., 1997, Journal of the Japanese Forestry Society, V79, P160; KANETANI S, 2004, USDA FOREST SERVICE, V32, P188; Kanetani S, 2010, RES B KAGOSHIMA U FO, V37, P49; Kipfer T, 2011, OECOLOGIA, V167, P219, DOI 10.1007/s00442-011-1981-5; Kipfer T, 2010, FUNGAL BIOL-UK, V114, P467, DOI 10.1016/j.funbio.2010.03.008; Kjoller R, 2003, MYCOLOGIA, V95, P603, DOI 10.2307/3761936; Koizumi T, 2016, MYCOSCIENCE, V57, P287, DOI 10.1016/j.myc.2016.04.002; Liao HL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006348; Ministry of Environment, 2015, RED LIST JAP THREAT; Miyamoto Y, 2016, MYCORRHIZA, V26, P189, DOI 10.1007/s00572-015-0658-z; Molina R, 1999, ECTOMYCORRHIZAL FUNGI: KEY GENERA IN PROFILE, P129; Mujic AB, 2014, MYCOLOGIA, V106, P105, DOI 10.3852/13-055; Murata M, 2017, J JPN FOR SOC; Murata M, 2017, ECOL RES, V32, P469, DOI 10.1007/s11284-017-1456-1; Murata M, 2013, MYCORRHIZA, V23, P641, DOI 10.1007/s00572-013-0504-0; Nara K, 2006, NEW PHYTOL, V169, P169, DOI 10.1111/j.1469-8137.2005.01545.x; Nara K, 2003, NEW PHYTOL, V159, P743, DOI 10.1046/j.1469-8137.2003.00844.x; Nara K, 2009, NEW PHYTOL, V181, P245, DOI 10.1111/j.1469-8137.2008.02691.x; Nara K, 2006, NEW PHYTOL, V171, P187, DOI 10.1111/j.1469-8137.2006.01744.x; Nguyen NH, 2012, FUNGAL ECOL, V5, P741, DOI 10.1016/j.funeco.2012.05.006; Oksanen JF, 2010, VEGAN COMMUNITY ECOL; Peay KG, 2012, MOL ECOL, V21, P4122, DOI 10.1111/j.1365-294X.2012.05666.x; Peay KG, 2009, J ECOL, V97, P537, DOI 10.1111/j.1365-2745.2009.01489.x; Rusca TA, 2006, NEW PHYTOL, V170, P551, DOI 10.1111/j.1469-8137.2006.01689.x; Ryberg PE, 2012, INT J PLANT SCI, V173, P917, DOI 10.1086/667228; Simard Suzanne W., 2012, Fungal Biology Reviews, V26, P39, DOI 10.1016/j.fbr.2012.01.001; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Taylor DL, 1999, MOL ECOL, V8, P1837, DOI 10.1046/j.1365-294x.1999.00773.x; Tedersoo L, 2008, NEW PHYTOL, V180, P479, DOI 10.1111/j.1469-8137.2008.02561.x; VISSER S, 1995, NEW PHYTOL, V129, P389, DOI 10.1111/j.1469-8137.1995.tb04309.x; Watanabe A, 1996, T KYUSHU BRANCH JPN, V49, P57; Wen ZG, 2015, PLANT SOIL, V387, P189, DOI 10.1007/s11104-014-2278-3; White T.J., 1990, PCR PROTOCOLS GUIDE, P315; Wu QX, 2000, MOL PHYLOGENET EVOL, V17, P37, DOI 10.1006/mpev.2000.0812; YAMANAKA T, 1975, Memoirs of the National Science Museum (Tokyo), V8, P119; Yatoh K., 1958, B FAC AGR MIE U, V18, P105; Zhang R, 2017, MYCOLOGIA, V109, P296, DOI 10.1080/00275514.2017.1305942	68	17	18	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189957	10.1371/journal.pone.0189957	http://dx.doi.org/10.1371/journal.pone.0189957			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261780	Green Submitted, Green Published, gold			2022-12-26	WOS:000418554900042
J	Weed, MR; Polino, J; Signor, L; Bookbinder, M; Keavy, D; Benitex, Y; Morgan, DG; King, D; Macor, JE; Zaczek, R; Olson, R; Bristow, LJ				Weed, Michael R.; Polino, Joseph; Signor, Laura; Bookbinder, Mark; Keavy, Deborah; Benitex, Yulia; Morgan, Daniel G.; King, Dalton; Macor, John E.; Zaczek, Robert; Olson, Richard; Bristow, Linda J.			Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning	PLOS ONE			English	Article							INDUCED COGNITIVE DEFICITS; MEMORY PERFORMANCE; ALZHEIMERS-DISEASE; WORKING-MEMORY; BATTERY CANTAB; IMPAIRMENT; ANTAGONIST; ATTENTION; DEMENTIA; MICE	Agonists at the nicotinic acetylcholine alpha 7 receptor (nAChR alpha 7) subtype have the potential to treat cognitive deficits in patients with Alzheimer's disease (AD) or schizophrenia. Visuo-spatial paired associates learning (vsPAL) is a task that has been shown to reliably predict conversion from mild cognitive impairment to AD in humans and can also be performed by nonhuman primates. Reversal of scopolamine-induced impairment of vsPAL performance may represent a translational approach for the development of nAChR alpha 7 agonists. The present study investigated the effect of treatment with the acetylcholinesterase inhibitor, donepezil, or three nAChR alpha 7 agonists, BMS-933043, EVP-6124 and RG3487, on vsPAL performance in scopolamine-treated cynomolgus monkeys. Scopolamine administration impaired vsPAL performance accuracy in a dose-and difficulty-dependent manner. The impairment of eventual accuracy, a measure of visuo-spatial learning during the task, was significantly ameliorated by treatment with donepezil (0.3 mg/kg, i.m.), EVP-6124 (0.01 mg/kg, i.m.) or BMS-933043 (0.03, 0.1 and 0.3 mg/kg, i.m.). Both nAChR alpha 7 agonists showed inverted-U shaped dose-effect relationships with EVP-6124 effective at a single dose only whereas BMS-933043 was effective across at least a 10 fold dose/exposure range. RG3487 was not efficacious in this paradigm at the dose range examined (0.03 +/- 1 mg/kg, i.m.). These results are the first demonstration that the nAChR alpha 7 agonists, EVP-6124 and BMS-933043, can ameliorate scopolamine-induced cognitive deficits in nonhuman primates performing the vsPAL task.	[Weed, Michael R.; Polino, Joseph; Signor, Laura; Bookbinder, Mark; Keavy, Deborah; Zaczek, Robert; Bristow, Linda J.] Bristol Myers Squibb Co, Genet Defined Dis & Gen, Wallingford, CT 06492 USA; [Benitex, Yulia; Morgan, Daniel G.] Bristol Myers Squibb Co, Pharmaceut Candidate Optimizat, Wallingford, CT 06492 USA; [King, Dalton; Macor, John E.; Olson, Richard] Bristol Myers Squibb Co, Discovery Chem, Wallingford, CT 06492 USA; [Weed, Michael R.] RxGen Inc, CNS Dis & Physiol, New Haven, CT USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Weed, MR (corresponding author), Bristol Myers Squibb Co, Genet Defined Dis & Gen, Wallingford, CT 06492 USA.; Weed, MR (corresponding author), RxGen Inc, CNS Dis & Physiol, New Haven, CT USA.	mweed@rx-gen.com			BMS	BMS(Bristol-Myers Squibb)	This work was funded in full by BMS, and all authors were BMS employees during their contribution to this project. Some authors own stock in BMS. BMS only provided financial support in the form of authors' salaries and/or research materials. No other individuals employed or contracted by BMS (other than the named authors) played any role in: study design, data collection and analysis, or preparation of the manuscript. The specific roles of the authors are articulated in the author contributions section. Nonauthors at BMS were involved in the decision to publish, for instance, in vetting the manuscript material for disclosure of proprietary information and approval of the timing of submission.	Bali ZK, 2015, BEHAV BRAIN RES, V278, P404, DOI 10.1016/j.bbr.2014.10.030; Barbier AJ, 2015, CLIN THER, V37, P311, DOI 10.1016/j.clinthera.2014.09.013; Barnett JH, 2010, NEUROSCI BIOBEHAV R, V34, P1161, DOI 10.1016/j.neubiorev.2010.01.012; Beinat C, 2015, CNS DRUGS, V29, P529, DOI 10.1007/s40263-015-0260-0; Boess FG, 2013, PSYCHOPHARMACOLOGY, V227, P1, DOI 10.1007/s00213-012-2933-4; Briggs CA, 1997, PHARMACOL BIOCHEM BE, V57, P231, DOI 10.1016/S0091-3057(96)00354-1; Bristow LJ, 2016, PLOS ONE, V11; Buccafusco JJ, 2007, BIOCHEM PHARMACOL, V74, P1202, DOI 10.1016/j.bcp.2007.07.010; Buccafusco JJ, 2009, BIOCHEM PHARMACOL, V78, P852, DOI 10.1016/j.bcp.2009.06.102; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Callahan PM, 2017, NEUROPHARMACOLOGY; Callahan PM, 2006, SOC NEUROSCIENCE; Cardinal RN, 2010, BEHAV RES METHODS, V42, P1059, DOI 10.3758/BRM.42.4.1059; Castner SA, 2011, BIOL PSYCHIAT, V69, P12, DOI 10.1016/j.biopsych.2010.08.006; Chamberlain SR, 2011, J ALZHEIMERS DIS, V24, P125, DOI 10.3233/JAD-2010-100450; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; de Rover M, 2011, NEUROPSYCHOLOGIA, V49, P2060, DOI 10.1016/j.neuropsychologia.2011.03.037; Deardorff WJ, 2015, EXPERT REV NEUROTHER, V15, P7, DOI 10.1586/14737175.2015.995639; Egerhazi A, 2007, PROG NEURO-PSYCHOPH, V31, P746, DOI 10.1016/j.pnpbp.2007.01.011; Fowler KS, 2002, J INT NEUROPSYCH SOC, V8, P58, DOI 10.1017/S1355617701020069; Fray PJ, 1996, NEUROTOXICOL TERATOL, V18, P499, DOI 10.1016/0892-0362(96)00027-X; Harel BT, 2013, PSYCHOPHARMACOLOGY, V228, P673, DOI 10.1007/s00213-013-3072-2; Hashimoto K, 2008, BIOL PSYCHIAT, V63, P92, DOI 10.1016/j.biopsych.2007.04.034; Hashimoto K, 2006, EUR J PHARMACOL, V553, P191, DOI 10.1016/j.ejphar.2006.09.055; Hauser TA, 2009, BIOCHEM PHARMACOL, V78, P803, DOI 10.1016/j.bcp.2009.05.030; Hayward A, 2017, EUR NEUROPSYCHOPHARM; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Jones KM, 2014, PSYCHOPHARMACOLOGY, V231, P673, DOI 10.1007/s00213-013-3275-6; Keefe R.S., 2015, NEUROPSYCHOPHARMACOL; King D, 2017, ACS MED CHEM LETT, V8, P366, DOI 10.1021/acsmedchemlett.7b00032; Klinkenberg I, 2010, NEUROSCI BIOBEHAV R, V34, P1307, DOI 10.1016/j.neubiorev.2010.04.001; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Kuzmickiene J, 2015, MED SCI MONITOR, V21, P2572, DOI 10.12659/MSM.895381; Lange HS, 2015, J PHARMACOL EXP THER, V355, P442, DOI 10.1124/jpet.115.226712; Lewis AS, 2017, PROG NEURO-PSYCHOPH, V75, P45, DOI 10.1016/j.pnpbp.2017.01.001; Mazurov AA, 2011, J MED CHEM, V54, P7943, DOI 10.1021/jm2007672; Medeiros R, 2014, AM J PATHOL, V184, P520, DOI 10.1016/j.ajpath.2013.10.010; NRC, 2011, GUIDE FOR THE CARE A; Pichat P, 2007, NEUROPSYCHOPHARMACOL, V32, P17, DOI 10.1038/sj.npp.1301188; Preskorn SH, 2014, J PSYCHIATR PRACT, V20, P12, DOI 10.1097/01.pra.0000442935.15833.c5; Prickaerts J, 2012, NEUROPHARMACOLOGY, V62, P1099, DOI 10.1016/j.neuropharm.2011.10.024; Redrobe JR, 2009, EUR J PHARMACOL, V602, P58, DOI 10.1016/j.ejphar.2008.09.035; Rezvani AH, 2009, PROG NEURO-PSYCHOPH, V33, P269, DOI 10.1016/j.pnpbp.2008.11.018; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; Robbins TW, 1997, PSYCHOPHARMACOLOGY, V134, P95, DOI 10.1007/s002130050430; Roncarati R, 2009, J PHARMACOL EXP THER, V329, P459, DOI 10.1124/jpet.108.150094; RUSTED JM, 1988, PSYCHOPHARMACOLOGY, V96, P145; Spinelli S, 2004, COGNITIVE BRAIN RES, V19, P123, DOI 10.1016/j.cogbrainres.2003.11.007; Swainson R, 2001, DEMENT GERIATR COGN, V12, P265, DOI 10.1159/000051269; Sydserff S, 2009, BIOCHEM PHARMACOL, V78, P880, DOI 10.1016/j.bcp.2009.07.005; Taffe MA, 2004, BEHAV BRAIN RES, V149, P123, DOI 10.1016/S0166-4328(03)00214-6; Taffe MA, 2002, PSYCHOPHARMACOLOGY, V160, P253, DOI 10.1007/s00213-001-0954-5; Terry AV, 1996, NEUROREPORT, V8, P49, DOI 10.1097/00001756-199612200-00011; Thomsen MS, 2010, CURR PHARM DESIGN, V16, P323, DOI 10.2174/138161210790170094; van Goethem NP, 2015, BEHAV PHARMACOL, V26, P403, DOI 10.1097/FBP.0000000000000134; Wallace TL, 2011, J PHARMACOL EXP THER, V336, P242, DOI 10.1124/jpet.110.171892; Wallace TL, 2010, SOC NEUROSCIENCE; Wallace-Boone TL, 2009, SOC NEUROSCIENCE; Wechsler D., 1939, MEASUREMENT ADULT IN; Weed MR, 1999, COGNITIVE BRAIN RES, V8, P185, DOI 10.1016/S0926-6410(99)00020-8	60	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0187609	10.1371/journal.pone.0187609	http://dx.doi.org/10.1371/journal.pone.0187609			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261656	Green Submitted, Green Published, gold			2022-12-26	WOS:000418554900002
J	Burgueno, E; Carlos, S; Lopez-Del Burgo, C; Osorio, A; Stozek, M; Ndarabu, A; Muamba, P; Tshisuaka, P; De Lrala, J				Burgueno, Eduardo; Carlos, Silvia; Lopez-Del Burgo, Cristina; Osorio, Alfonso; Stozek, Maria; Ndarabu, Adolphe; Muamba, Philemon; Tshisuaka, Philomene; De Irala, Jokin			Forced sexual intercourse and its association with HIV status among people attending HIV Voluntary Counseling and Testing in a healthcare center in Kinshasa (DRC)	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; SUB-SAHARAN AFRICA; TRANSACTIONAL SEX; PHYSICAL VIOLENCE; RISK BEHAVIORS; POSITIVE WOMEN; PREVALENCE; EXPERIENCES; PREVENTION; VICTIMIZATION	Introduction Sexual violence, an HIV determinant, is an integrated behavior in the D.R.Congo. We aimed to analyze the prevalence of forced sexual intercourse (FSI) among people receiving HIV Voluntary Counseling and Testing in a hospital in Kinshasa, and its association with socio-demographics, behaviors and HIV status. Methodology Case-control study (2010-2012). Two-hundred and seventy-four cases with a new HIV+ test and 1,340 controls with an HIV-test were interviewed about HIV-related knowledge, attitudes and behaviors, including FSI. Results Thirty-four percent of the participants declared having had FSI (38% of women and 32% of men). Being a woman, aged 25-49 and reporting multiple sexual partners were associated with reporting FSI. For men, being single was protective against FSI; and cohabiting, having a high socioeconomic status, and alcohol consumption increased the odds. For women, being single, divorced/separated and widow was associated with reporting FSI. A significant positive association was found between FSI and an HIV positive test. Conclusion Among our Congolese population, FSI was strongly associated with HIV infection and it was also associated with alcohol consumption and multiple sexual partnerships, other key HIV determinants. These behaviors need to be identified as potential risk factors of FSI during counseling interventions. Researchers, practitioners and decision-makers should work together to get violence prevention integrated into health, social and educational policies.	[Burgueno, Eduardo] CEFA Monkole, Kinshasa, DEM REP CONGO; [Burgueno, Eduardo] Univ Mwene Ditu, Sch Med, Mwene Ditu, DEM REP CONGO; [Carlos, Silvia; Lopez-Del Burgo, Cristina; De Irala, Jokin] Univ Navarra, Prevent Med & Publ Hlth Dept, Pamplona, Spain; [Carlos, Silvia; Lopez-Del Burgo, Cristina; Osorio, Alfonso; De Irala, Jokin] Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain; [Carlos, Silvia; Lopez-Del Burgo, Cristina; Osorio, Alfonso; Stozek, Maria; De Irala, Jokin] Univ Navarra, Inst Culture & Soc, Pamplona, Spain; [Osorio, Alfonso] Univ Navarra, Sch Educ & Psychol, Pamplona, Spain; [Ndarabu, Adolphe] Monkole Hosp, Kinshasa, DEM REP CONGO; [Muamba, Philemon] Catholic Univ Congo, Sch Law & Polit, Kinshasa, DEM REP CONGO; [Tshisuaka, Philomene] ISSI Monkole Nursing Sch, Kinshasa, DEM REP CONGO	University of Navarra; University of Navarra; University of Navarra	Carlos, S (corresponding author), Univ Navarra, Prevent Med & Publ Hlth Dept, Pamplona, Spain.; Carlos, S (corresponding author), Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain.; Carlos, S (corresponding author), Univ Navarra, Inst Culture & Soc, Pamplona, Spain.	scarlos@unav.es	Burgo, Cristina Lopez-del/I-1963-2017; Osorio, Alfonso/B-4644-2011; de Irala, Jokin/H-2936-2017; CARLOS, SILVIA/L-9123-2014	Osorio, Alfonso/0000-0003-4337-5382; de Irala, Jokin/0000-0002-7249-6581; CARLOS, SILVIA/0000-0002-4968-7080; Burgueno, Eduardo/0000-0001-6898-3929	University of Navarra [PIUNA 12458071]	University of Navarra	This work was supported by the University of Navarra (PIUNA 12458071).	Abbey A, 2011, DRUG ALCOHOL REV, V30, P481, DOI 10.1111/j.1465-3362.2011.00296.x; Ayimpam S, 2015, ETUDE MASCULINITE RD; Ba I, 2017, PUBLIC HEALTH, V142, P121, DOI 10.1016/j.puhe.2016.07.019; Bernstein M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011999; Brownridge DA, 2008, VIOLENCE AGAINST WOM, V14, P809, DOI 10.1177/1077801208320368; Callands TA, 2013, CULT HEALTH SEX, V15, P680, DOI 10.1080/13691058.2013.779030; Campbell JC, 2013, AM J REPROD IMMUNOL, V69, P41, DOI 10.1111/aji.12026; Carlos S, 2017, AIDS CARE, V29, P772, DOI 10.1080/09540121.2016.1258450; Christian Mervyn, 2011, Med Confl Surviv, V27, P227, DOI 10.1080/13623699.2011.645144; Conroy AA, 2016, AIDS BEHAV, V20, P2045, DOI 10.1007/s10461-016-1385-y; Decker MR, 2016, AM J PREV MED, V51, P731, DOI 10.1016/j.amepre.2016.07.005; DeMaris A, 2001, J MARRIAGE FAM, V63, P235, DOI 10.1111/j.1741-3737.2001.00235.x; du Plan et Suivi de la Mise en oeuvre de la Revolution de la Modernite (MPSMRM),de la Sante Publique (MSP) et ICF International, 2014, DEM SANT REP DEM CON; Durevall D, 2015, LANCET GLOB HEALTH, V3, pE34, DOI 10.1016/S2214-109X(14)70343-2; Duroch F, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-5; Fleming PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118639; Gaffoor Zakir, 2013, BMC Res Notes, V6, P532, DOI 10.1186/1756-0500-6-532; Gibbs A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4223-x; Gottert A, 2017, AIDS BEHAV; Grimes DA, 2005, LANCET, V365, P1429, DOI 10.1016/S0140-6736(05)66379-9; Harling G, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20038; Hatcher AM, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19233; Helman R, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31122; Hosmer DW, 2013, WILEY SER PROBAB ST, P377; Hurley EA, 2017, J ADOLESCENT HEALTH, V60, P79, DOI 10.1016/j.jadohealth.2016.08.023; Iliyasu Z, 2016, INT J GYNECOL OBSTET, V133, P32, DOI 10.1016/j.ijgo.2015.08.010; IOM (Institute of Medicine) and NRC (National Research Council), 2015, PREV INT PARTN VIOL; Kapiga S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4119-9; Kidman R, 2015, SOC SCI MED, V133, P2, DOI 10.1016/j.socscimed.2015.03.034; Kiene SM, 2017, AIDS BEHAV, V21, P2497, DOI 10.1007/s10461-017-1817-3; Kinuthia J, 2017, JAIDS-J ACQ IMM DEF, V74, P142, DOI 10.1097/QAI.0000000000001225; Konde JNN, 2015, BASELINE QUALITATIVE; Kosia A, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.32307; Lamptey, 2016, J INTERPERS VIOLENCE; Lusey H, 2014, SAHARA J-J SOC ASP H, V11, P84, DOI 10.1080/17290376.2014.930695; MacQuarrie Kerry L.D., 2013, DHS ANAL STUDIES; Meekers D, 2013, GLOB PUBLIC HEALTH, V8, P593, DOI 10.1080/17441692.2013.776093; Miller JA, 2016, J RES ADOLESCENCE, V26, P673, DOI 10.1111/jora.12217; Ministere du Plan Macro International., 2008, ENQ DEM SANT REP DEM; Mulawa M, 2016, SOC SCI MED, V153, P35, DOI 10.1016/j.socscimed.2016.02.002; Naidoo S, 2017, J COMMUN HEALTH, V42, P1035, DOI 10.1007/s10900-017-0354-3; Nanda G, 2015, RES BRIEF BASELINE S; National Department of Health (NDoH) Statistics South Africa (Stats SA) South African Medical Research Council (SAMRC) and ICF, 2017, S AFR DEM HLTH SURV; Nguyen AH, 2017, INT J STD AIDS, V28, P1380, DOI 10.1177/0956462417705970; Niolon P., 2017, PREVENTING INTIMATE; Norris AH, 2017, SEX TRANSM INFECT, V93, P253, DOI 10.1136/sextrans-2016-052873; O'Leary A, 2015, SEX TRANSM DIS, V42, P135, DOI 10.1097/OLQ.0000000000000247; Obermeyer CM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001329; Ohene SA, 2015, SOC SCI MED, V146, P266, DOI 10.1016/j.socscimed.2015.10.019; Papas RK, 2017, AIDS BEHAV, V21, P2243, DOI 10.1007/s10461-017-1684-y; Peterman A, 2011, AM J PUBLIC HEALTH, V101, P1060, DOI 10.2105/AJPH.2010.300070; Petersen I, 2005, CHILD ABUSE NEGLECT, V29, P1233, DOI 10.1016/j.chiabu.2005.02.012; Roberts ST, 2016, JAIDS-J ACQ IMM DEF, V73, P313, DOI 10.1097/QAI.0000000000001093; Roka JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111096; Samarasekera U, 2015, LANCET, V385, P1480, DOI 10.1016/S0140-6736(14)61775-X; Sawyer S, 2016, MED EDUC, V50, P1107, DOI 10.1111/medu.13108; Schaefer R, 2017, AIDS, V31, P1461, DOI [10.1097/qad.0000000000001506, 10.1097/QAD.0000000000001506]; Semahegn A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0072-1; Shackel R, 2016, MAKING JUSTICE WORK; Shayo Elizabeth H, 2017, BMC Res Notes, V10, P140, DOI 10.1186/s13104-017-2452-9; Shisana O, 2016, AIDS CARE, V28, P234, DOI 10.1080/09540121.2015.1080790; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Stockman JK, 2013, AIDS BEHAV, V17, P832, DOI 10.1007/s10461-012-0361-4; Stoebenau K, 2016, SOC SCI MED, V168, P186, DOI 10.1016/j.socscimed.2016.09.023; Sunita Kishor, 2008, DHS COMP REPORTS; Sunita Kishor, 2012, DHS ANAL STUDIES; Tanimu Tanko S, 2016, Afr J Prim Health Care Fam Med, V8, pe1, DOI 10.4102/phcfm.v8i1.1209; Teitelman AM, 2016, HEALTH PSYCHOL, V35, P751, DOI 10.1037/hea0000351; Tran TD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167438; Tlapek SM, 2015, J INTERPERS VIOLENCE, V30, P2526, DOI 10.1177/0886260514553118; Townsend L, 2011, AIDS BEHAV, V15, P132, DOI 10.1007/s10461-010-9680-5; Tsai AC, 2011, AM J PUBLIC HEALTH, V101, P1068, DOI 10.2105/AJPH.2010.300060; UNAIDS, 2014, DEM REP CONG HIV AID; Urquia Marcelo L, 2013, Am J Public Health, V103, pe8, DOI 10.2105/AJPH.2012.301116; Valles X, 2017, EUR J CONTRACEP REPR, V22, P62, DOI 10.1080/13625187.2016.1262023; Wagman JA, 2015, LANCET GLOB HEALTH, V3, pE23, DOI 10.1016/S2214-109X(14)70344-4; Wamoyi J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20992; Wegner R, 2014, VIOLENCE AGAINST WOM, V20, P1360, DOI 10.1177/1077801214552856; Wembonyama S, 2007, REPUBLIC MED TROPICA, V67, P447; Williams JR, 2017, J ASSOC NURSE AIDS C, V28, P819, DOI 10.1016/j.jana.2017.04.010; Wilson KS, 2016, INT J STD AIDS, V27, P1194, DOI 10.1177/0956462415611514; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 2021, VIOL WOM PREV EST 20; Zembe YZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139430; Zihindula G, 2015, J COMMUN HEALTH, V40, P736, DOI 10.1007/s10900-015-9992-5	85	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189632	10.1371/journal.pone.0189632	http://dx.doi.org/10.1371/journal.pone.0189632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ5HM	29253857	Green Submitted, Green Published, gold			2022-12-26	WOS:000418389500045
J	Hu, J; Zhou, SQ; Wu, P; Qu, KJ				Hu, Jing; Zhou, Shaoqi; Wu, Pan; Qu, Kunjie			Assessment of the distribution, bioavailability and ecological risks of heavy metals in the lake water and surface sediments of the Caohai plateau wetland, China	PLOS ONE			English	Article							TRACE-ELEMENTS; SURFICIAL SEDIMENTS; CONTAMINATION; POLLUTION; BAY; SPECIATION; CARBONATE; TOXICITY; REGIONS; GUIZHOU	In this study, selected heavy metals (Hg, As, Cd, Pb, Cr, Cu and Zn) in the lake water and sediments from the Caohai wetland, which is a valuable state reserve for migrant birds in China, were investigated to assess the spatial distribution, sources, bioavailability and ecological risks. The results suggested that most of the higher concentrations were found in the eastern region of the lakeshore. The concentration factor (CF) revealed that Hg, Cd and Zn were present from moderate risk levels to considerable risk levels in this study; thus, based on the high pollution load index (PLI) values, the Caohai wetland can be considered polluted. According to the associated effects-range classification, Cd may present substantial environmental hazards. An investigation of the chemical speciation suggested that Cd and Zn were unstable across most of the sites, which implied a higher risk of quick desorption and release. Principal component analysis (PCA) indicated that the heavy metal contamination originated from both natural and anthropogenic sources.	[Hu, Jing; Zhou, Shaoqi; Wu, Pan; Qu, Kunjie] Guizhou Univ, Coll Resources & Environm Engn, Guiyang, Guizhou, Peoples R China; [Zhou, Shaoqi] South China Univ Technol, Guangzhou Higher Educ Mega Ctr, Coll Environm & Energy, Guangzhoou, Peoples R China; [Zhou, Shaoqi] Guizhou Acad Sci, Guiyang, Guizhou, Peoples R China; [Zhou, Shaoqi] South China Univ Technol, State Key Lab Subtrop Bldg Sci, Guangzhou, Guangdong, Peoples R China; [Zhou, Shaoqi] South China Univ Technol, Key Lab Environm Protect & Ecoremediat Guangdong, Guangzhou Higher Educ Mega Ctr, Guangzhou, Guangdong, Peoples R China	Guizhou University; South China University of Technology; South China University of Technology; South China University of Technology	Zhou, SQ (corresponding author), Guizhou Univ, Coll Resources & Environm Engn, Guiyang, Guizhou, Peoples R China.; Zhou, SQ (corresponding author), South China Univ Technol, Guangzhou Higher Educ Mega Ctr, Coll Environm & Energy, Guangzhoou, Peoples R China.; Zhou, SQ (corresponding author), Guizhou Acad Sci, Guiyang, Guizhou, Peoples R China.; Zhou, SQ (corresponding author), South China Univ Technol, State Key Lab Subtrop Bldg Sci, Guangzhou, Guangdong, Peoples R China.; Zhou, SQ (corresponding author), South China Univ Technol, Key Lab Environm Protect & Ecoremediat Guangdong, Guangzhou Higher Educ Mega Ctr, Guangzhou, Guangdong, Peoples R China.	fesqzhou@scut.edu.cn		zhou, shao qi/0000-0001-9838-3983	National Key Research and Development Program of China [2016YFC0400702]; National Natural Science Fund [U1612441]; Department of Science and Technology of Guizhou Province [2015-4013, 2017-5409]; State Key Laboratory of Subtropical Building Science [2015ZA07, 2016KA05]	National Key Research and Development Program of China; National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Guizhou Province(Department of Science & Technology (DOST), PhilippinesDepartment of Science & Technology (India)); State Key Laboratory of Subtropical Building Science	This study was co-supported by the National Key Research and Development Program of China (2016YFC0400702) and the National Natural Science Fund (U1612441) and the Department of Science and Technology of Guizhou Province (2015-4013; 2017-5409) and the State Key Laboratory of Subtropical Building Science (2015ZA07, 2016KA05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antizar-Ladislao B, 2015, MAR POLLUT BULL, V101, P886, DOI 10.1016/j.marpolbul.2015.11.014; Armid A, 2014, MAR POLLUT BULL, V84, P373, DOI 10.1016/j.marpolbul.2014.05.021; Bassi N, 2014, J HYDROL-REG STUD, V2, P1, DOI 10.1016/j.ejrh.2014.07.001; Bi XY, 2007, SCI TOTAL ENVIRON, V387, P257, DOI 10.1016/j.scitotenv.2007.07.059; Bing HJ, 2011, J ENVIRON SCI-CHINA, V23, P1671, DOI 10.1016/S1001-0742(10)60593-1; Cameron R.E., 1992, METALS-BASEL, V1, P288; Chaikumbung M, 2016, ECOL ECON, V124, P164, DOI 10.1016/j.ecolecon.2016.01.022; Chen HY, 2016, ECOTOX ENVIRON SAFE, V125, P85, DOI 10.1016/j.ecoenv.2015.11.042; DAVIDSON CM, 1994, ANAL CHIM ACTA, V291, P277, DOI 10.1016/0003-2670(94)80023-5; Deng B, 2010, ENVIRON MONIT ASSESS, V161, P349, DOI 10.1007/s10661-009-0751-x; Eisler R., 2007, EISLERS ENCY ENV HAZ; Fei Y., 2011, J GUIZHOU NORMAL U, V29, P39; Feng XB, 2006, SCI TOTAL ENVIRON, V368, P47, DOI 10.1016/j.scitotenv.2005.09.036; Gao XL, 2015, PLOS ONE, P10; Gao XL, 2014, ENVIRON INT, V62, P12, DOI 10.1016/j.envint.2013.09.019; Gibson BD, 2015, J SOIL SEDIMENT, V15, P1644, DOI 10.1007/s11368-015-1106-6; Gredilla A, 2015, MAR POLLUT BULL, V99, P305, DOI 10.1016/j.marpolbul.2015.07.040; Li GQ, 2016, J GUIZHOU METEOROLOG, V40, P27; Lin SX., 2012, NONG YE HUAN JING KE, V31, P2236; Liu SF, 2016, CONT SHELF RES, V117, P81, DOI 10.1016/j.csr.2016.02.002; Long ER, 2000, ENVIRON TOXICOL CHEM, V19, P2598, DOI 10.1002/etc.5620191028; Long ER, 2006, ENVIRON SCI TECHNOL, V40, P1726, DOI 10.1021/es058012d; Loska K, 1997, WATER AIR SOIL POLL, V93, P347, DOI 10.1023/A:1022121615949; Ma XL, 2016, CHEMOSPHERE, V144, P264, DOI 10.1016/j.chemosphere.2015.08.026; Pan JJ, 2014, MAR POLLUT BULL, V89, P427, DOI 10.1016/j.marpolbul.2014.10.022; Pedro S, 2015, ESTUAR COAST SHELF S, V167, P240, DOI 10.1016/j.ecss.2015.07.039; Pekey H, 2013, MICROCHEM J, V106, P233, DOI 10.1016/j.microc.2012.07.007; Perin G, 1997, ENVIRON TECHNOL, V18, P593, DOI 10.1080/09593331808616577; Ros A, 2014, CONT SHELF RES, V91, P220, DOI 10.1016/j.csr.2014.10.004; SEPA (State Environmental Protection Administration of China), 2002, 186682002 SEPA GB; Shah Eqani SA, 2016, ENVIRON POLLUT, V213, P213; Shaike MM, 2014, ECOTOX ENVIRON SAFE, V110, P246, DOI 10.1016/j.ecoenv.2014.09.007; TOMLINSON DL, 1980, HELGOLANDER MEERESUN, V33, P566, DOI 10.1007/BF02414780; Udayakumar P, 2014, ENVIRON EARTH SCI, V72, P1887, DOI 10.1007/s12665-014-3097-9; Xu FJ, 2016, MAR POLLUT BULL, V104, P371, DOI 10.1016/j.marpolbul.2016.01.019; [张珍明 Zhang Zhenming], 2013, [水土保持学报, Journal of Soil and Water Conservation], V27, P199; [赵晓韵 Zhao Xiaoyun], 2014, [地球与环境, Earth and Environment], V42, P316; [周晨 Zhou Chen], 2016, [水生态学杂志, Journal of Hydroecology], V37, P24; Zhu ZJ, 2013, QUATERN INT, V286, P85, DOI 10.1016/j.quaint.2012.06.004; Zhu Zhengjie, 2011, Hupo Kexue, V23, P681	40	25	32	7	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189295	10.1371/journal.pone.0189295	http://dx.doi.org/10.1371/journal.pone.0189295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253896	Green Submitted, gold, Green Published			2022-12-26	WOS:000418389500021
J	Lin, S; Wang, SX; Si, YL; Yang, WH; Zhu, SW; Ni, WZ				Lin, Sen; Wang, Shaoxian; Si, Yuanli; Yang, Wenhao; Zhu, Shaowei; Ni, Wuzhong			Variations in eco-enzymatic stoichiometric and microbial characteristics in paddy soil as affected by long-term integrated organic-inorganic fertilization	PLOS ONE			English	Article							ECOENZYMATIC STOICHIOMETRY; NUTRIENT MANAGEMENT; GROWTH-RATE; MANURE; PHOSPHORUS; BIODIVERSITY; PHOSPHATASE; GRASSLAND; PLANTS; MAIZE	To investigate the effects of different nutrient management regimes on the soil chemical, eco-enzymatic stoichiometric and microbial characteristics, soil samples were collected from a 30-year, long-term field experiment with six plots growing rice. The results showed that as integrated fertilization increased, so did the concentrations of soil total or available nutrients and microbial biomass carbon (MBC). Our results also found enhanced soil basal respiration and cumulative carbon mineralization compared to chemical fertilization alone at the same nutrient doses. The activities of soil protease (Pro), beta-glucosidase (beta G), N-acetyl-glucosaminidase (NAG) and acid phosphatase (AP) from the integrated fertilization treatments were significantly higher than those of the treatments without organic manure, so did the activities of soil leucyl aminopeptidase (LAP) and urease (Ure) from the treatment with organic manure in addition to farmer practise fertilization (NPKM2). The stoichiometric ratios, expressed as ln beta G/ln(NAG+LAP)/lnPro/lnUre/lnAP, ranged from 1:0.94:1.04:0.67:1.01 to 1:0.98:1.10:0.78:1.25, indicating that the acquisition of C, N and P changed consistently and synchronously under different nutrient management strategies. Integrated fertilization was more beneficial to the acquisition and utilization of soil organic carbon compared to low-molecular-weight organic nitrogen. We concluded that protease and urease should be considered in eco-enzymatic stoichiometric assessments for the hydrolysis of proteins, amino acids, carbohydrates and phosphomonoesters in soil, and integrated fertilization with chemical fertilizers and organic manure should be recommended as a preferable nutrient management system for intensive rice cultivation.	[Lin, Sen; Si, Yuanli; Yang, Wenhao; Zhu, Shaowei; Ni, Wuzhong] Zhejiang Univ, Key Lab Agr Resource & Environm Zhejiang Prov, Coll Environm & Resource Sci, Hangzhou, Zhejiang, Peoples R China; [Wang, Shaoxian] Jiangxi Acad Agr Sci, Nanchang, Jiangxi, Peoples R China; [Yang, Wenhao] Fujian Agr & Forestry Univ, Coll Resource & Environm Sci, Fuzhou, Fujian, Peoples R China	Zhejiang University; Fujian Agriculture & Forestry University	Ni, WZ (corresponding author), Zhejiang Univ, Key Lab Agr Resource & Environm Zhejiang Prov, Coll Environm & Resource Sci, Hangzhou, Zhejiang, Peoples R China.	wzni@zju.edu.cn	Yang, wenhao/GXG-5965-2022	Yang, Wenhao/0000-0003-2837-1412	National Basic Research Program of China [2013CB127403]; National Science and Technology Major Project of China from the Ministry of Science and Technology of the People's Republic of China [2014ZX07101-012]; National Science and Technology Major Project of China [2014ZX07101-012]	National Basic Research Program of China(National Basic Research Program of China); National Science and Technology Major Project of China from the Ministry of Science and Technology of the People's Republic of China; National Science and Technology Major Project of China	This study was supported by the National Basic Research Program of China (2013CB127403) and the National Science and Technology Major Project of China (2014ZX07101-012) from the Ministry of Science and Technology of the People's Republic of China (http://www.most.gov.cn/index.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Basic Research Program of China (2013CB127403) and the National Science and Technology Major Project of China (2014ZX07101-012).	Ai C, 2012, GEODERMA, V173, P330, DOI 10.1016/j.geoderma.2011.07.020; AJWA HA, 1994, BIOL FERT SOILS, V18, P175, DOI 10.1007/BF00647664; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Caldwell BA, 2005, PEDOBIOLOGIA, V49, P637, DOI 10.1016/j.pedobi.2005.06.003; Cang L, 2009, J HAZARD MATER, V172, P1602, DOI 10.1016/j.jhazmat.2009.08.033; Cao CJ, 1982, CHIN J SOIL SCI, V13, P39; Chadwick D, 2015, AGR ECOSYST ENVIRON, V209, P34, DOI 10.1016/j.agee.2015.03.025; Cheng F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067353; Cross WF, 2005, FRESHWATER BIOL, V50, P1895, DOI 10.1111/j.1365-2427.2005.01458.x; DeForest JL, 2009, SOIL BIOL BIOCHEM, V41, P1180, DOI 10.1016/j.soilbio.2009.02.029; Dinesh R, 2012, GEODERMA, V173, P192, DOI 10.1016/j.geoderma.2011.12.025; Ebhin MR, 2006, SOIL BIOL BIOCHEM, V38, P1577, DOI DOI 10.1016/j.soilbio.2005.11.012; Elfstrand S, 2007, APPL SOIL ECOL, V35, P610, DOI 10.1016/j.apsoil.2006.09.011; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Feng XM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24559; Guo P, 2011, PLANT SOIL, V338, P355, DOI 10.1007/s11104-010-0550-8; Islam MR, 2011, BIOL FERT SOILS, V47, P599, DOI 10.1007/s00374-010-0524-2; Jenkinson DS, 2004, SOIL BIOL BIOCHEM, V36, P5, DOI 10.1016/j.soilbio.2003.10.002; JOHNSTON AE, 1986, SOIL USE MANAGE, V2, P3, DOI 10.1111/j.1475-2743.1986.tb00669.x; Kaiser M, 2005, GEODERMA, V127, P196, DOI 10.1016/j.geoderma.2004.12.002; Kamimura Y, 2000, BIOL FERT SOILS, V30, P351, DOI 10.1007/s003740050015; Kato Y, 2011, FIELD CROP RES, V120, P387, DOI 10.1016/j.fcr.2010.11.015; Knicker H, 2000, SOIL BIOL BIOCHEM, V32, P241, DOI 10.1016/S0038-0717(99)00154-6; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061141; Liu EK, 2010, GEODERMA, V158, P173, DOI 10.1016/j.geoderma.2010.04.029; Lu R.K, 2000, ANAL METHOD SOIL AGR; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Makino W, 2003, FUNCT ECOL, V17, P121, DOI 10.1046/j.1365-2435.2003.00712.x; Mandal A, 2007, BIORESOURCE TECHNOL, V98, P3585, DOI 10.1016/j.biortech.2006.11.027; Matzek V, 2009, ECOL LETT, V12, P765, DOI 10.1111/j.1461-0248.2009.01310.x; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; Mugwe J, 2009, EXP AGR, V45, P47, DOI 10.1017/S0014479708007084; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Qiu QY, 2016, ENVIRON SCI-PROC IMP, V18, P330, DOI 10.1039/c5em00446b; Qu Z, 2014, GLOBAL CHANGE BIOL, V20, P1685, DOI 10.1111/gcb.12461; Roberts T. L., 2009, Better Crops with Plant Food, V93, P12; Saha S, 2008, EUR J SOIL BIOL, V44, P309, DOI 10.1016/j.ejsobi.2008.02.004; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Sinsabaugh RL, 2012, ANNU REV ECOL EVOL S, V43, P313, DOI 10.1146/annurev-ecolsys-071112-124414; Sinsabaugh RL, 2009, NATURE, V462, P795, DOI 10.1038/nature08632; Soares JR, 2012, SOIL BIOL BIOCHEM, V52, P82, DOI 10.1016/j.soilbio.2012.04.019; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Toor GS, 2003, SOIL BIOL BIOCHEM, V35, P1317, DOI 10.1016/S0038-0717(03)00202-5; Turner BL, 2011, BIOGEOCHEMISTRY, V103, P297, DOI 10.1007/s10533-010-9466-x; Turner BL, 2002, SOIL BIOL BIOCHEM, V34, P27, DOI 10.1016/S0038-0717(01)00144-4; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Xu MingGang, 2008, Agricultural Sciences in China, V7, P1245, DOI 10.1016/S1671-2927(08)60171-6; Yang N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166536; Zagal E, 2009, GEODERMA, V151, P191, DOI 10.1016/j.geoderma.2009.04.004; Zaman M, 1999, BIOL FERT SOILS, V29, P178, DOI 10.1007/s003740050542; Zhao J, 2016, APPL SOIL ECOL, V99, P1, DOI 10.1016/j.apsoil.2015.11.006; Zhao YC, 2009, EUR J AGRON, V31, P36, DOI 10.1016/j.eja.2009.03.001; Zhu ZhaoLiang, 2008, Acta Pedologica Sinica, V45, P778	53	12	14	6	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189908	10.1371/journal.pone.0189908	http://dx.doi.org/10.1371/journal.pone.0189908			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253000	gold, Green Submitted, Green Published			2022-12-26	WOS:000418389500074
J	Saxena, R; Vashist, P; Tandon, R; Pandey, RM; Bhardawaj, A; Gupta, V; Menon, V				Saxena, Rohit; Vashist, Praveen; Tandon, Radhika; Pandey, Ravindra M.; Bhardawaj, Amit; Gupta, Vivek; Menon, Vimala			Incidence and progression of myopia and associated factors in urban school children in Delhi: The North India Myopia Study (NIM Study)	PLOS ONE			English	Article							HONG-KONG; REFRACTIVE ERRORS; TIME OUTDOORS; AUSTRALIAN SCHOOLCHILDREN; VISUAL IMPAIRMENT; CHILDHOOD EYE; RISK-FACTORS; PREVALENCE; CHINA; POPULATION	Aim To evaluate the incidence and progression of myopia and factors associated with progression of myopia in school going children in Delhi. Methods Prospective longitudinal study of 10,000 school children aged 5 to 15 years screened after an interval of 1 year to identify new myopes (Spherical Equivalent <= -0.5D) and progression of myopia in previously diagnosed myopic children. Association between risk factors and progression was analyzed using adjusted odds ratio. Results Of the 9,616 children re-screened (97.3% coverage), annual incidence of myopia was 3.4% with mean dioptric change of -1.09 +/- 0.55. There was a significant higher incidence of myopia in younger children compared to older children (P = 0.012) and among girls compared to boys (P = 0.002). Progression was observed in 49.2% children with mean dioptric change of -0.27 +/- 0.42 diopters. The demographic and behavioral risk factors were analyzed for children with progression (n = 629) and adjusted odds ratio values were estimated. Hours of reading-writing/week (p<0.001), use of computers/video games (P<0.001) and watching television (P = 0.048) were significant risk factors for progression of myopia. Outdoor activities/time spent outdoors> 2 hours in a day were protective with an inverse association with progression of myopia (P<0.001). Conclusion Myopia is an important health issue in India and is associated with long hours of reading and screen time with use of computers and video games. An annual eye vision screening should be conducted, and outdoor activities be promoted to prevent the increase of myopia among school children.	[Saxena, Rohit; Tandon, Radhika; Menon, Vimala] All India Inst Med Sci, Dept Ophthalmol, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India; [Vashist, Praveen; Bhardawaj, Amit; Gupta, Vivek] All India Inst Med Sci, Dept Community Ophthalmol, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India; [Pandey, Ravindra M.] All India Inst Med Sci, Dept Biostat, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; All India Institute of Medical Sciences (AIIMS) New Delhi	Saxena, R (corresponding author), All India Inst Med Sci, Dept Ophthalmol, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India.	rohitsaxena80@yahoo.com		Saxena, Rohit/0000-0002-8660-8062; Gupta, Vivek/0000-0002-6157-3705	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	The Department of Science and Technology, Government of India provided funds for the study. The funds were for school visits, data collection and analysis. None of the authors are employed by the funding agency (www.dst.gov.in). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HB, 2001, ADOLESCENCE, V36, P305; Dandona R, 2002, INVEST OPHTH VIS SCI, V43, P615; Edwards MH, 1999, OPHTHAL PHYSL OPT, V19, P286, DOI 10.1046/j.1475-1313.1999.00445.x; Fan DSP, 2004, INVEST OPHTH VIS SCI, V45, P1071, DOI 10.1167/iovs.03-1151; French AN, 2013, OPHTHALMOLOGY, V120, P2100, DOI 10.1016/j.ophtha.2013.02.035; French AN, 2013, EXP EYE RES, V114, P58, DOI 10.1016/j.exer.2013.04.018; French AN, 2013, OPHTHALMOLOGY, V120, P1482, DOI 10.1016/j.ophtha.2012.12.018; Goldschmidt E., 1968, ACTA OPHTHALMOL, V98, P1; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2015, JAMA-J AM MED ASSOC, V314, P1142, DOI 10.1001/jama.2015.10803; Jones-Jordan LA, 2012, INVEST OPHTH VIS SCI, V53, P7169, DOI 10.1167/iovs.11-8336; Jones-Jordan LA, 2010, INVEST OPHTH VIS SCI, V51, P115, DOI 10.1167/iovs.08-3210; Lam CSY, 2012, OPHTHAL PHYSL OPT, V32, P17, DOI 10.1111/j.1475-1313.2011.00886.x; Lam CSY, 1999, OPTOMETRY VISION SCI, V76, P370, DOI 10.1097/00006324-199906000-00016; Li SM, 2015, INVEST OPHTH VIS SCI, V56, P4734, DOI 10.1167/iovs.14-15474; Lim HT, 2012, JPN J OPHTHALMOL, V56, P76, DOI 10.1007/s10384-011-0090-7; Lin LL, 2004, ANN ACAD MED SINGAP, V33, P27; Lin LLK, 2001, J FORMOS MED ASSOC, V100, P684; Matsumura H, 1999, SURV OPHTHALMOL, V44, pS109, DOI 10.1016/S0039-6257(99)00094-6; Morgan IG, 2013, OPHTHAL PHYSL OPT, V33, P329, DOI 10.1111/opo.12040; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Murthy GVS, 2002, INVEST OPHTH VIS SCI, V43, P623; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Qian YS, 2009, INVEST OPHTH VIS SCI, V50, P1598, DOI 10.1167/iovs.07-1362; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Saw SM, 2005, INVEST OPHTH VIS SCI, V46, P51, DOI 10.1167/iovs.04-0565; Saw SM, 2002, ARCH OPHTHALMOL-CHIC, V120, P620, DOI 10.1001/archopht.120.5.620; Saw SM, 2001, BRIT J OPHTHALMOL, V85, P855, DOI 10.1136/bjo.85.7.855; Saxena R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117349; Tong L, 2004, OPTOMETRY VISION SCI, V81, P684, DOI 10.1097/01.opx.0000144747.88341.b2; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Wu PC, 2016, ASIA-PAC J OPHTHALMO, V5, P386, DOI 10.1097/APO.0000000000000236; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421; You QS, 2014, ACTA OPHTHALMOL, V92, pE398, DOI 10.1111/aos.12299; Zhou WJ, 2016, J EPIDEMIOL, V26, P386, DOI 10.2188/jea.JE20140258	36	68	70	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189774	10.1371/journal.pone.0189774	http://dx.doi.org/10.1371/journal.pone.0189774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253002	Green Submitted, Green Published, gold			2022-12-26	WOS:000418389500056
J	Keeley, TP; Siow, RCM; Jacob, R; Mann, GE				Keeley, Thomas P.; Siow, Richard C. M.; Jacob, Ron; Mann, Giovanni E.			Reduced SERCA activity underlies dysregulation of Ca(2)(+ )homeostasis under atmospheric O-2 levels	FASEB JOURNAL			English	Article						Ca2+ signaling; physiological normoxia; oxygen; mitochondria; Ca2+ overload	NITRIC-OXIDE PRODUCTION; ENDOTHELIAL-CELLS; PROTEIN-KINASE; RETICULUM CA2+-ATPASE; ENDOPLASMIC-RETICULUM; CA2+ CONCENTRATION; CALCIUM; MECHANISM; ISOFORM; CULTURE	Unregulated increases in cellular Ca(2+)homeostasis are a hallmark of pathophysiological conditions and a key trigger of cell death. Endothelial cells cultured under physiologic O-2 conditions (5% O-2) exhibit a reduced cytosolic Ca(2+)response to stimulation. The mechanism for reduced plateau [Ca2+](i) upon stimulation was due to increased sarco/endoplasmic reticulum Ca(2+)ATPase (SERCA)-mediated reuptake rather than changes in Ca(2+)influx capacity. Agonist-stimulated phosphorylation of the SERCA regulatory protein phospholamban was increased in cells cultured under 5% O-2. Elevation of cytosolic and mitochondrial [Ca2+] and cell death after prolonged ionomycin treatment, as a model of Ca(2+)overload, were lower when cells were cultured long-term under 5% compared with 18% O-2. This protection was abolished by cotreatment with the SERCA inhibitor cyclopiazonic acid. Taken together, these results demonstrate that culturing cells under hyperoxic conditions reduces their ability to efficiently regulate [Ca2+](i), resulting in greater sensitivity to cytotoxic stimuli.	[Keeley, Thomas P.; Siow, Richard C. M.; Jacob, Ron; Mann, Giovanni E.] Kings Coll London, Fac Life Sci & Med, Sch Cardiovasc Med & Sci, Kings British Heart Fdn,Ctr Res Excellence, London, England	University of London; King's College London	Mann, GE (corresponding author), Kings Coll London, 150 Stamford St,Franklin Wilkins Bldg,Room 3-01, London SE1 9NH, England.	giovanni.mann@kcl.ac.uk		Keeley, Thomas/0000-0002-0334-7144; Mann, Giovanni/0000-0001-7311-2044	British Heart Foundation [FS/13/66/30445]; Heart Research UK [RG2633]	British Heart Foundation(British Heart Foundation); Heart Research UK	The authors thank Kalwant Authi (King's College London) for helpful discussions and SERCA2 and SERCA3 antibodies, and the midwives of St. Thomas' Hospital (London, United Kingdom) for collecting umbilical cords. This study was supported by British Heart Foundation Grant FS/13/66/30445 and Heart Research UK Grant RG2633. The authors declare no conflicts of interest.	Abaci HE, 2014, SCI REP-UK, V4, DOI 10.1038/srep04951; Aley PK, 2005, J BIOL CHEM, V280, P13349, DOI 10.1074/jbc.M413674200; ANGER M, 1993, FEBS LETT, V334, P45, DOI 10.1016/0014-5793(93)81677-R; Atkuri KR, 2005, P NATL ACAD SCI USA, V102, P3756, DOI 10.1073/pnas.0409910102; Berna N, 2002, J CELL BIOCHEM, V84, P115, DOI 10.1002/jcb.1271; Bhosale G, 2015, ANN NY ACAD SCI, V1350, P107, DOI 10.1111/nyas.12885; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Brocard JB, 2001, J PHYSIOL-LONDON, V531, P793, DOI 10.1111/j.1469-7793.2001.0793h.x; Camello P, 1996, J PHYSIOL-LONDON, V490, P585, DOI 10.1113/jphysiol.1996.sp021169; Chami M, 2000, ONCOGENE, V19, P2877, DOI 10.1038/sj.onc.1203605; Chandrasekera PC, 2009, AM J PHYSIOL-CELL PH, V296, pC1105, DOI 10.1152/ajpcell.00650.2008; Chapple SJ, 2016, FREE RADICAL BIO MED, V92, P152, DOI 10.1016/j.freeradbiomed.2015.12.013; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; Cohen RA, 1999, CIRC RES, V84, P210, DOI 10.1161/01.RES.84.2.210; CORNWELL TL, 1991, MOL PHARMACOL, V40, P923; El Alami M, 2014, STEM CELL REP, V3, P566, DOI 10.1016/j.stemcr.2014.08.002; Ferdek PE, 2012, CURR BIOL, V22, P1241, DOI 10.1016/j.cub.2012.05.002; Haas B, 2015, J CELL PHYSIOL, V230, P1128, DOI 10.1002/jcp.24844; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Herscher CJ, 1997, ANN NY ACAD SCI, V834, P407, DOI 10.1111/j.1749-6632.1997.tb52284.x; Kanatous SB, 2009, AM J PHYSIOL-CELL PH, V296, pC393, DOI 10.1152/ajpcell.00428.2008; Keeley TP, 2017, FASEB J, V31, P5172, DOI 10.1096/fj.201700211R; Khan I, 2000, MOL CELL BIOCHEM, V203, P11, DOI 10.1023/A:1007093516593; Lantoine F, 1998, BIOCHEM J, V330, P695, DOI 10.1042/bj3300695; Lim WS, 2008, CIRCULATION, V117, P940, DOI 10.1161/CIRCULATIONAHA.107.711275; Morgan AJ, 1998, J PHYSIOL-LONDON, V513, P83, DOI 10.1111/j.1469-7793.1998.083by.x; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Mountian I, 1999, CELL CALCIUM, V25, P371, DOI 10.1054/ceca.1999.0034; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Sahai A, 1997, AM J PHYSIOL-RENAL, V273, pF954, DOI 10.1152/ajprenal.1997.273.6.F954; Schneider H, 2015, HYPERTENSION, V66, P108, DOI 10.1161/HYPERTENSIONAHA.115.05514; Scotcher J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13187; Steinert JR, 2002, FASEB J, V16, P721, DOI 10.1096/fj.01-0916fje; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Sutliff RL, 1999, CIRC RES, V84, P360, DOI 10.1161/01.RES.84.3.360; TEPIKIN AV, 1992, J BIOL CHEM, V267, P3569; Ward JPT, 2008, BBA-BIOENERGETICS, V1777, P1, DOI 10.1016/j.bbabio.2007.10.010; WEIR EK, 1995, FASEB J, V9, P183, DOI 10.1096/fasebj.9.2.7781921; White R, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-27; Zhu J, 2012, J NEUROSCI RES, V90, P422, DOI 10.1002/jnr.22765	42	6	6	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2531	2538		10.1096/fj.201700685RRR	http://dx.doi.org/10.1096/fj.201700685RRR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29273673	Green Published			2022-12-26	WOS:000432528000018
J	Rimon-Dahari, N; Heinemann-Yerushalmi, L; Hadas, R; Kalich-Philosoph, L; Ketter, D; Nevo, N; Galiani, D; Dekel, N				Rimon-Dahari, Nitzan; Heinemann-Yerushalmi, Lia; Hadas, Ron; Kalich-Philosoph, Lital; Ketter, Dafna; Nevo, Nava; Galiani, Dalia; Dekel, Nava			Vasorin: a newly identified regulator of ovarian folliculogenesis	FASEB JOURNAL			English	Article						ovulation; TGF-beta; ovarian reserve	GROWTH-FACTOR-BETA; ANTI-MULLERIAN HORMONE; TGF-BETA; MOUSE OVARY; IN-VIVO; FOLLICLE DEVELOPMENT; SUPERFAMILY MEMBERS; GENE-EXPRESSION; GRANULOSA-CELLS; MICE	Members of the TGF-beta superfamily take part in the control of folliculogenesis. Vasorin (Vasn) is a newly identified negative regulator of TGF-beta signaling whose possible involvement in ovarian physiology has never been studied. Here, we demonstrate that Vasn is expressed in the ovary by somatic cells of follicles, and that its expression is up-regulated by LH. We established a conditional knockout (cKO) mouse model in which Vasn is deleted specifically in granulosa cells of growing follicles from the secondary stage onwards. Using this model, we show that, upon hormonal stimulation, follicle ovulation size is almost 2-fold higher. This enhanced ovulatory response is associated with overactivation of the TGF-beta signaling pathway and a lower number of atretic antral follicles. Of importance, we demonstrate that the number of primordial follicles is reduced in prepubertal cKO mouse ovaries, which suggests that the production of VASN by growing follicles protects the ovarian reserve. Finally, analysis of systemic KO mice revealed that the ovarian reserve is almost 2.5-fold higher, which implies that Vasn may also play a role in primordial follicle formation. Overall, our findings reveal that Vasn is a new regulator that exerts an effect on several key ovarian functions, including folliculogenesis, maintenance of the ovarian reserve, and ovulation.	[Rimon-Dahari, Nitzan; Heinemann-Yerushalmi, Lia; Hadas, Ron; Kalich-Philosoph, Lital; Ketter, Dafna; Nevo, Nava; Galiani, Dalia; Dekel, Nava] Weizmann Inst Sci, Dept Regulat Biol, 234 Herzl St, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Dekel, N (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, 234 Herzl St, IL-76100 Rehovot, Israel.	nava.dekel@weizmann.ac.il	DEKEL, NAVA/R-8817-2019	Heinemann-Yerushalmi, Lia/0000-0002-2488-9022	Dwek Fund for Biomedical Research; Israel Science Foundation [1115/16]	Dwek Fund for Biomedical Research; Israel Science Foundation(Israel Science Foundation)	The authors thank Calanit Raanan for histologic processing, Oz Yermiahu and Hana Stup for animal care and maintenance (all from the Weizmann Institute of Science), and Elazar Zelzer, Alon Chen, and the entire N.D. laboratory (the Weizmann Institute of Science) for fruitful discussions and insightful comments. This work was supported by the Dwek Fund for Biomedical Research (to N.D.) and the Israel Science Foundation (1115/16). The authors declare no conflicts of interest.	Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chen L, 2005, BIOCHEM BIOPH RES CO, V336, P364, DOI 10.1016/j.bbrc.2005.08.071; Choksi S, 2011, MOL CELL, V42, P597, DOI 10.1016/j.molcel.2011.03.030; DODSON WC, 1987, ENDOCRINOLOGY, V120, P512, DOI 10.1210/endo-120-2-512; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Fortin J, 2014, FASEB J, V28, P1474, DOI 10.1096/fj.13-237818; Harlow CR, 2002, ENDOCRINOLOGY, V143, P3316, DOI 10.1210/en.2001-211389; Huang AX, 2015, INT J BIOL SCI, V11, P961, DOI 10.7150/ijbs.11943; Ikeda Y, 2004, P NATL ACAD SCI USA, V101, P10732, DOI 10.1073/pnas.0404117101; Ingman WV, 2009, CYTOKINE GROWTH F R, V20, P233, DOI 10.1016/j.cytogfr.2009.05.003; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Krautzberger AM, 2012, GENE EXPR PATTERNS, V12, P167, DOI 10.1016/j.gep.2012.02.003; Kuo SW, 2011, J CELL PHYSIOL, V226, P1608, DOI 10.1002/jcp.22491; Li QL, 2008, MOL CELL BIOL, V28, P7001, DOI 10.1128/MCB.00732-08; Li SH, 2015, ONCOTARGET, V6, P10045, DOI 10.18632/oncotarget.6631; Lin SY, 2003, REPRODUCTION, V126, P133, DOI 10.1530/rep.0.1260133; Liu XW, 1999, ENDOCRINOLOGY, V140, P2480, DOI 10.1210/en.140.6.2480; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malapeira J, 2011, ONCOGENE, V30, P1912, DOI 10.1038/onc.2010.565; Mansouri-Attia N, 2014, MOL ENDOCRINOL, V28, P1887, DOI 10.1210/me.2014-1217; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Myers M, 2009, DEV BIOL, V334, P458, DOI 10.1016/j.ydbio.2009.08.001; Pangas SA, 2004, MOL CELL ENDOCRINOL, V225, P83, DOI 10.1016/j.mce.2004.02.017; Pangas SA, 2006, MOL ENDOCRINOL, V20, P1406, DOI 10.1210/me.2005-0462; Pangas SA, 2012, MOL CELL ENDOCRINOL, V356, P40, DOI 10.1016/j.mce.2011.06.021; Pepling ME, 2012, REPRODUCTION, V143, P139, DOI 10.1530/REP-11-0299; Raja-Khan N, 2014, REPROD SCI, V21, P20, DOI 10.1177/1933719113485294; Reddy P, 2010, TRENDS ENDOCRIN MET, V21, P96, DOI 10.1016/j.tem.2009.10.001; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Rimon-Dahari N, 2016, RESULTS PROBL CELL D, V58, P167, DOI 10.1007/978-3-319-31973-5_7; ROBERTS VJ, 1993, J CLIN ENDOCR METAB, V77, P1402, DOI 10.1210/jc.77.5.1402; Schindler R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012979; SHIMASAKI S, 1989, MOL ENDOCRINOL, V3, P651, DOI 10.1210/mend-3-4-651; Shwartz Y., 2014, METHODS MOL BIOL SER, V1130; Tal R, 2013, FERTIL STERIL, V100, P538, DOI 10.1016/j.fertnstert.2013.04.022; Tingen CM, 2009, BIOL REPROD, V81, P16, DOI 10.1095/biolreprod.108.074898; Tomic D, 2002, BIOL REPROD, V66, P917, DOI 10.1095/biolreprod66.4.917; Torrents E, 2003, HUM REPROD UPDATE, V9, P471, DOI 10.1093/humupd/dmg036; Trombly DJ, 2009, SEMIN REPROD MED, V27, P14, DOI 10.1055/s-0028-1108006; Wang ZP, 2014, J BIOL CHEM, V289, P8299, DOI 10.1074/jbc.M113.532952; Zamah AM, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9077-6	44	10	11	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2124	2136		10.1096/fj.201700057RRR	http://dx.doi.org/10.1096/fj.201700057RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29259033				2022-12-26	WOS:000429051400032
J	Moon, SJ; Jeong, BC; Kim, HJ; Lim, JE; Kwon, GY; Kim, JH				Moon, Sue Jin; Jeong, Byong Chang; Kim, Hwa Jin; Lim, Joung Eun; Kwon, Ghee Young; Kim, Jeong Hoon			DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7	ONCOGENE			English	Article							RECEPTOR SPLICE VARIANTS; LENGTH ANDROGEN RECEPTOR; CELL-LINES; EXPRESSION; SIRT1; TRANSCRIPTION; ACTIVATION; GENES; P53; IDENTIFICATION	Constitutively active AR-V7, one of the major androgen receptor (AR) splice variants lacking the ligand-binding domain, plays a key role in the development of castration-resistant prostate cancer (CRPC) and anti-androgen resistance. However, our understanding of the regulatory mechanisms of AR-V7-driven transcription is limited. Here we report DBC1 as a key regulator of AR-V7 transcriptional activity and stability in CRPC cells. DBC1 functions as a coactivator for AR-V7 and is required for the expression of AR-V7 target genes including CDH2, a mesenchymal marker linked to CRPC progression. DBC1 is required for recruitment of AR-V7 to its target enhancers and for long-range chromatin looping between the CDH2 enhancer and promoter. Mechanistically, DBC1 enhances DNA-binding activity of AR-V7 by direct interaction and inhibits CHIP E3 ligase-mediated ubiquitination and degradation of AR-V7 by competing with CHIP for AR-V7 binding, thereby stabilizing and activating AR-V7. Importantly, DBC1 depletion suppresses the tumorigenic and metastatic properties of CRPC cells. Our results firmly establish DBC1 as a critical AR-V7 coactivator that plays a key role in the regulation of DNA binding and stability of AR-V7 and has an important physiological role in CRPC progression.	[Moon, Sue Jin; Kim, Hwa Jin; Kim, Jeong Hoon] Sungkyunkwan Univ, Dept Hlth Sci & Technol, Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea; [Moon, Sue Jin; Kim, Hwa Jin; Kim, Jeong Hoon] Samsung Med Ctr, Samsung Biomed Res Inst, Dept Biomed Sci, Seoul, South Korea; [Jeong, Byong Chang; Lim, Joung Eun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea; [Kwon, Ghee Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, JH (corresponding author), Sungkyunkwan Univ, Dept Hlth Sci & Technol, Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea.; Kim, JH (corresponding author), Samsung Med Ctr, Samsung Biomed Res Inst, Dept Biomed Sci, Seoul, South Korea.	jeongkim@skku.edu			National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2016R1A2B4008661]; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C0117]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	We thank Dr. Robert Roeder (Rockefeller University) for HA-Ubiquitin expression plasmid. This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning [2016R1A2B4008661]; and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea [HI17C0117].	An J, 2014, CELL REP, V6, P657, DOI 10.1016/j.celrep.2014.01.013; Antonarakis ES, 2016, PROSTATE CANCER P D, V19, P231, DOI 10.1038/pcan.2016.17; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Beltran H, 2013, EUR UROL, V63, P920, DOI 10.1016/j.eururo.2012.08.053; Cardozo CP, 2003, ARCH BIOCHEM BIOPHYS, V410, P134, DOI 10.1016/S0003-9861(02)00680-X; Chini CCS, 2010, J BIOL CHEM, V285, P40830, DOI 10.1074/jbc.M110.153270; Cottard F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063466; Cronauer MV, 2004, ONCOGENE, V23, P3541, DOI 10.1038/sj.onc.1207346; DePaolo JS, 2016, ONCOTARGET, V7, P71417, DOI 10.18632/oncotarget.12163; Fu JJ, 2009, J BIOL CHEM, V284, P6832, DOI 10.1074/jbc.M808988200; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Fu MF, 2002, MOL CELL BIOL, V22, P3373, DOI 10.1128/MCB.22.10.3373-3388.2002; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Imamura Y, 2016, INT J UROL, V23, P654, DOI 10.1111/iju.13137; Jennbacken K, 2010, ENDOCR-RELAT CANCER, V17, P469, DOI 10.1677/ERC-10-0015; Kim HO, 2015, IEEE GEOSC REM SEN M, V3, P34, DOI 10.1109/MGRS.2014.2382652; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Kong DJ, 2015, PROSTATE, V75, P161, DOI 10.1002/pros.22901; Krause WC, 2014, INT J BIOCHEM CELL B, V54, P49, DOI 10.1016/j.biocel.2014.06.013; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Li ZY, 2009, J BIOL CHEM, V284, P10361, DOI 10.1074/jbc.M900956200; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Liu G, 2015, ONCOTARGET, V6, P288, DOI 10.18632/oncotarget.2672; Lu J, 2015, NAT REV UROL, V12, P137, DOI 10.1038/nrurol.2015.13; Lu J, 2015, J UROLOGY, V193, P690, DOI 10.1016/j.juro.2014.08.043; Makkonen H, 2009, NUCLEIC ACIDS RES, V37, P4135, DOI 10.1093/nar/gkp352; Masuda K, 2005, J MOL BIOL, V353, P763, DOI 10.1016/j.jmb.2005.09.009; McClurg UL, 2017, NUCLEIC ACIDS RES, V45, P1793, DOI 10.1093/nar/gkw1162; McGrath MJ, 2013, CANCER RES, V73, P5066, DOI 10.1158/0008-5472.CAN-12-4520; Noh SJ, 2013, PATHOLOGY, V45, P574, DOI 10.1097/PAT.0b013e3283652c7a; Park HS, 2013, TRANSL ONCOL, V6, P370, DOI 10.1593/tlo.13250; Portillo-Lara R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130118; Qin B, 2015, CELL REP, V10, P1324, DOI 10.1016/j.celrep.2015.01.066; Seo WY, 2013, NUCLEIC ACIDS RES, V41, P8526, DOI 10.1093/nar/gkt644; Shafi AA, 2013, PHARMACOL THERAPEUT, V140, P223, DOI 10.1016/j.pharmthera.2013.07.003; Sun YT, 2012, CANCER RES, V72, P527, DOI 10.1158/0008-5472.CAN-11-3004; Takayama K, 2007, ONCOGENE, V26, P4453, DOI 10.1038/sj.onc.1210229; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; van de Wijngaart DJ, 2012, MOL CELL ENDOCRINOL, V352, P57, DOI 10.1016/j.mce.2011.08.007; van der Steen T, 2013, INT J MOL SCI, V14, P14833, DOI 10.3390/ijms140714833; Wagle S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13144; Yu EJ, 2016, ONCOGENE, V35, P3410, DOI 10.1038/onc.2015.401; Yu EJ, 2011, NUCLEIC ACIDS RES, V39, P6932, DOI 10.1093/nar/gkr347	45	18	20	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	10					1326	1339		10.1038/s41388-017-0047-5	http://dx.doi.org/10.1038/s41388-017-0047-5			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ0RI	29249800				2022-12-26	WOS:000427279300005
J	Yaparla, A; Popovic, M; Grayfer, L				Yaparla, Amulya; Popovic, Milan; Grayfer, Leon			Differentiation-dependent antiviral capacities of amphibian (Xenopus laevis) macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antiviral agent; immunology; innate immunity; macrophage; Xenopus; interleukin-34; Frog virus 3; Interleukin-34; antiviral immunity; colony-stimulating factor-1	COLONY-STIMULATING FACTOR; FROG VIRUS 3; GENE REGULATORY NETWORKS; INTERFERON RESPONSE; IMMUNE-RESPONSES; LANGERHANS CELLS; FACTOR-I; RANAVIRUS; EXPRESSION; IL-34	Infections by ranaviruses such as Frog virus 3 (Fv3), are significantly contributing to worldwide amphibian population declines. Notably, amphibian macrophages (M phi s) are important to both the Fv3 infection strategies and the immune defense against this pathogen. However, the mechanisms underlying amphibian M phi Fv3 susceptibility and resistance remain unknown. M phi differentiation is mediated by signaling through the colony-stimulating factor-1 receptor (CSF-1R) which is now known to be bound not only by CSF-1, but also by the unrelated interleukin-34 (IL-34) cytokine. Pertinently, amphibian (Xenopus laevis) M phi s differentiated by CSF-1 and IL-34 are highly susceptible and resistant to Fv3, respectively. Accordingly, in the present work, we elucidate the facets of this M phi Fv3 susceptibility and resistance. Because cellular resistance to viral replication is marked by expression of antiviral restriction factors, it was intuitive to find that IL-34-M phi s possess significantly greater mRNA levels of select restriction factor genes than CSF-1-M phi s. Xenopodinae amphibians have highly expanded repertoires of antiviral interferon (IFN) cytokine gene families, and our results indicated that in comparison with the X. laevis CSF-1-M phi s, the IL-34-M phi s express substantially greater transcripts of representative IFN genes, belonging to distinct gene family clades, as well as their cognate receptor genes. Finally, we demonstrate that IL-34-M phi-conditioned supernatants confer IFN-mediated anti-Fv3 protection to the virally susceptible X. laevis kidney (A6) cell line. Together, this work underlines the differentiation pathways leading to Fv3-susceptible and -resistant amphibian M phi populations and defines the molecular mechanisms responsible for these differences.	[Yaparla, Amulya; Popovic, Milan; Grayfer, Leon] George Washington Univ, Dept Biol Sci, 800 22nd St NW,Suite 6000, Washington, DC 20052 USA	George Washington University	Grayfer, L (corresponding author), George Washington Univ, Dept Biol Sci, 800 22nd St NW,Suite 6000, Washington, DC 20052 USA.	leon_grayfer@gwu.edu			George Washington University	George Washington University	This work was supported by start-up funding from George Washington University (to L. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Badia R, 2016, J ANTIMICROB CHEMOTH, V71, P387, DOI 10.1093/jac/dkv363; Ballana E, 2015, TRENDS MICROBIOL, V23, P680, DOI 10.1016/j.tim.2015.08.002; Baud'Huin M, 2010, J PATHOL, V221, P77, DOI 10.1002/path.2684; Bayley AE, 2013, DIS AQUAT ORGAN, V103, P171, DOI 10.3354/dao02574; Belosevic M, 2006, FISH SHELLFISH IMMUN, V20, P152, DOI 10.1016/j.fsi.2004.10.010; Bezie S, 2015, J CLIN INVEST, V125, P3952, DOI 10.1172/JCI81227; Carey C, 1999, DEV COMP IMMUNOL, V23, P459, DOI 10.1016/S0145-305X(99)00028-2; Chemel M, 2012, ANN RHEUM DIS, V71, P150, DOI 10.1136/annrheumdis-2011-200096; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Droin N, 2010, J LEUKOCYTE BIOL, V87, P745, DOI 10.1189/jlb.1209780; Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101; Dwyer AR, 2016, J LEUKOCYTE BIOL, V100, P163, DOI 10.1189/jlb.2A0815-344RR; Gan Z, 2017, DEV COMP IMMUNOL, V67, P166, DOI 10.1016/j.dci.2016.10.007; Garceau V, 2010, J LEUKOCYTE BIOL, V87, P753, DOI 10.1189/jlb.0909624; Gramberg T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-26; Grayfer L, 2016, DEV COMP IMMUNOL, V58, P60, DOI 10.1016/j.dci.2015.12.008; Grayfer L, 2015, J LEUKOCYTE BIOL, V98, P641, DOI 10.1189/jlb.4AB0315-117RR; Grayfer L, 2015, J VIROL, V89, P5072, DOI 10.1128/JVI.00051-15; Grayfer L, 2014, J LEUKOCYTE BIOL, V96, P1143, DOI 10.1189/jlb.4A0614-295R; Grayfer L, 2014, J VIROL, V88, P5766, DOI 10.1128/JVI.00223-14; Grayfer L, 2012, VIRUSES-BASEL, V4, P1075, DOI 10.3390/v4071075; Grayfer L, 2009, FISH SHELLFISH IMMUN, V26, P406, DOI 10.1016/j.fsi.2008.12.001; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; GUILBERT LJ, 1980, J CELL BIOL, V85, P153, DOI 10.1083/jcb.85.1.153; Guillonneau C, 2017, CELL MOL LIFE SCI, V74, P2569, DOI 10.1007/s00018-017-2482-4; Hamilton TA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00554; Hanington PC, 2007, J BIOL CHEM, V282, P31865, DOI 10.1074/jbc.M706278200; Hoverman JT, 2010, DIS AQUAT ORGAN, V89, P97, DOI 10.3354/dao02200; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Landsberg JH, 2013, DIS AQUAT ORGAN, V105, P89, DOI 10.3354/dao02625; Lang FC, 2017, SCI REP-UK, V7, DOI 10.1038/srep39861; Laslo P, 2008, SEMIN IMMUNOL, V20, P228, DOI 10.1016/j.smim.2008.08.003; Li DJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003880; Lichanska AM, 1999, BLOOD, V94, P127, DOI 10.1182/blood.V94.1.127.413k07_127_138; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Morales HD, 2007, J VIROL, V81, P2240, DOI 10.1128/JVI.01104-06; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Pentland I, 2015, VIRUSES-BASEL, V7, P3574, DOI 10.3390/v7072791; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Reeve BC, 2013, ECOHEALTH, V10, P190, DOI 10.1007/s10393-013-0834-6; Robert J, 2007, J WILDLIFE DIS, V43, P645, DOI 10.7589/0090-3558-43.4.645; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sang YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29072; Shi K, 2017, NAT STRUCT MOL BIOL, V24, P131, DOI 10.1038/nsmb.3344; Singh H, 2014, TRENDS IMMUNOL, V35, P211, DOI 10.1016/j.it.2014.03.006; Trang K, 2017, VIRAL IMMUNOL, V30, P142, DOI 10.1089/vim.2016.0160; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Wang TH, 2008, J IMMUNOL, V181, P3310, DOI 10.4049/jimmunol.181.5.3310; Wang YM, 2014, EUR J IMMUNOL, V44, P1575, DOI 10.1002/eji.201344365; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; Wendel ES, 2017, VIROLOGY, V503, P12, DOI 10.1016/j.virol.2017.01.001; Wolf D, 2008, P NATL ACAD SCI USA, V105, P12521, DOI 10.1073/pnas.0805540105; Yamane F, 2014, J LEUKOCYTE BIOL, V95, P19, DOI 10.1189/jlb.0613311; Yaparla A, 2016, DEV COMP IMMUNOL, V63, P136, DOI 10.1016/j.dci.2016.05.014; Zou J, 2011, DEV COMP IMMUNOL, V35, P1376, DOI 10.1016/j.dci.2011.07.001	59	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1736	1744		10.1074/jbc.M117.794065	http://dx.doi.org/10.1074/jbc.M117.794065			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29259133	Green Published, hybrid			2022-12-26	WOS:000424201700024
J	Chatvaratthana, K; Thaworanunta, S; Seriwatanachai, D; Wongsirichat, N				Chatvaratthana, Kanthanat; Thaworanunta, Sita; Seriwatanachai, Dutmanee; Wongsirichat, Natthamet			Correlation between the thickness of the crestal and buccolingual cortical bone at varying depths and implant stability quotients	PLOS ONE			English	Article							RESONANCE FREQUENCY-ANALYSIS; BEAM COMPUTED-TOMOGRAPHY; DENSITY VALUES; LOADING PROTOCOLS; INSERTION TORQUE; TOOTH EXTRACTION; IN-VIVO; TISSUE; PERCEPTION; PLACEMENT	Background/purpose Resonance frequency analysis (RFA) is clinically used in dentistry to access the stiffness of dental implants in surrounding bone. However, the clear advantages and disadvantages of this method are still inconclusive. The aim of this study was to investigate and compare implant stability quotient (ISQ) values obtained from RFA with parameters obtained from a cone beam computed tomography (CBCT) scan of the same region. Materials and methods Nineteen implants (Conelog) were inserted in the posterior maxillary and mandibular partially edentulous regions of 16 patients. At the time of implant placement, the ISQ values were obtained using RFA (Osstell). CBCT was used to measure the thickness of the crestal, cortical, buccolingual cortical, and cancellous bone at 3, 6, and 9 mm below the crestal bone level, as indicated by radiographic markers. The ratio of the thickness of the cortical to cancellous bone at varying depths was also calculated and classified into 4 groups (Group 1-4). Results There was a strong correlation between the crestal cortical bone thickness and ISQ values (P<0.001). The thickness of the buccolingual cortical bone and ratio of the cortical to cancellous bone thickness at 3 mm were significantly related to the ISQ (P = 0.018 and P = 0.034, respectively). Furthermore, the ISQs in Group 1 were the highest compared with those in Group 2 and Group 3, whereas the CBCT parameters at 6 and 9 mm did not have any specific correlation with the ISQ values. Conclusion This study showed that the ISQ values obtained from RFA highly correlated with the quantity and quality of bone 3 mm below the crestal bone level. The correlation between the ISQ and bone surrounding the implant site was dependent on the depth of measurement. Therefore, RFA can help to predict the marginal bone level, as confirmed in this study.	[Chatvaratthana, Kanthanat] Mahidol Univ, Dent Implant Ctr, Fac Dent, Bangkok, Thailand; [Thaworanunta, Sita] Mahidol Univ, Dept Maxillofacial Prosthodont, Fac Dent, Bangkok, Thailand; [Seriwatanachai, Dutmanee] Mahidol Univ, Dept Oral Biol, Fac Dent, Bangkok, Thailand; [Wongsirichat, Natthamet] Mahidol Univ, Dept Oral & Maxillofacial Surg, Fac Dent, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University	Seriwatanachai, D (corresponding author), Mahidol Univ, Dept Oral Biol, Fac Dent, Bangkok, Thailand.	dutmanee.ser@mahidol.ac.th	Seriwatanachai, Dutmanee/K-3423-2019; Wongsirichat, Natthamet/Q-2994-2019	Seriwatanachai, Dutmanee/0000-0001-8955-1324; Wongsirichat, Natthamet/0000-0003-3005-2680	Mahidol University	Mahidol University	Funded by Mahidol University to Dutmanee Seriwatanachai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fuster-Torres MA, 2011, INT J ORAL MAX IMPL, V26, P1051; Atsumi M, 2007, INT J ORAL MAX IMPL, V22, P743; Balleri Piero, 2002, Clin Implant Dent Relat Res, V4, P128, DOI 10.1111/j.1708-8208.2002.tb00162.x; Barewal RM, 2003, INT J ORAL MAX IMPL, V18, P641; Bischof M, 2004, CLIN ORAL IMPLAN RES, V15, P529, DOI 10.1111/j.1600-0501.2004.01042.x; Buchter A, 2003, Mund Kiefer Gesichtschir, V7, P351, DOI 10.1007/s10006-003-0504-x; Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x; Chang Pei-Kun, 2012, Int J Oral Maxillofac Implants, V27, pe96; Degidi M, 2010, INT J ORAL MAX IMPL, V25, P558; Elias CN, 2012, J MECH BEHAV BIOMED, V16, P169, DOI 10.1016/j.jmbbm.2012.10.010; Friberg B, 1999, INT J ORAL MAX SURG, V28, P297; Gallucci GO, 2014, INT J ORAL MAX IMPL, V29, P287, DOI 10.11607/jomi.2013.g4; Greenstein G, 2017, COMPEND CONTIN ED DE, V38, P6; Greenstein Gary, 2017, Compend Contin Educ Dent, V38, P88; Herrero-Climent M, 2012, MED ORAL PATOL ORAL, V17, pE801, DOI 10.4317/medoral.17861; Hsu JT, 2013, CLIN IMPLANT DENT R, V15, P251, DOI 10.1111/j.1708-8208.2011.00349.x; Irinakis T, 2006, J CAN DENT ASSOC, V72, P917; Ito Y, 2008, CLIN ORAL IMPLAN RES, V19, P9, DOI 10.1111/j.1600-0501.2007.01419.x; Javed F, 2010, J DENT, V38, P612, DOI 10.1016/j.jdent.2010.05.013; Markovic A, 2013, CLIN IMPLANT DENT R, V15, P341, DOI 10.1111/j.1708-8208.2011.00415.x; Meredith N, 1997, CLIN ORAL IMPLAN RES, V8, P226, DOI 10.1034/j.1600-0501.1997.080309.x; Meredith N, 1996, CLIN ORAL IMPLAN RES, V7, P261, DOI 10.1034/j.1600-0501.1996.070308.x; Meredith N, 1998, INT J PROSTHODONT, V11, P491; Merheb J, 2010, CLIN ORAL IMPLAN RES, V21, P612, DOI 10.1111/j.1600-0501.2009.01880.x; Miyamoto I, 2005, BONE, V37, P776, DOI 10.1016/j.bone.2005.06.019; O'Sullivan D, 2000, Clin Implant Dent Relat Res, V2, P85, DOI 10.1111/j.1708-8208.2000.tb00110.x; O'Sullivan Dominic, 2004, Clin Implant Dent Relat Res, V6, P48, DOI 10.1111/j.1708-8208.2004.tb00027.x; Ostman PO, 2005, CLIN IMPLANT DENT R, V7, pS60, DOI 10.1111/j.1708-8208.2005.tb00076.x; Porter Judith A, 2005, Gen Dent, V53, P423; Rabel A, 2007, CLIN ORAL INVEST, V11, P257, DOI 10.1007/s00784-007-0115-2; Ribeiro-Rotta RF, 2014, CLIN ORAL IMPLAN RES, V25, pE47, DOI 10.1111/clr.12046; Roze J, 2009, CLIN ORAL IMPLAN RES, V20, P1140, DOI 10.1111/j.1600-0501.2009.01745.x; Schropp L, 2003, INT J PERIODONT REST, V23, P313; Sennerby L, 2008, PERIODONTOL 2000, V47, P51, DOI 10.1111/j.1600-0757.2008.00267.x; Sennerby L, 2012, CLIN IMPLANT DENT R, V14, P313, DOI 10.1111/j.1708-8208.2010.00273.x; Linck GKSB, 2016, CLIN IMPLANT DENT R, V18, P601, DOI 10.1111/cid.12341; Song YD, 2009, INT J ORAL MAX IMPL, V24, P59; Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K; T A, 1985, TISSUE INTEGRATED PR, P199, DOI DOI 10.1111/J.1708-8208.2002.TB00174.X; Tatli U, 2014, J CRANIOFAC SURG, V25, pE293, DOI 10.1097/SCS.0000000000000727; Trisi P, 2011, CLIN ORAL IMPLAN RES, V22, P567, DOI 10.1111/j.1600-0501.2010.02036.x; Turkyilmaz U, 2007, J CLIN PERIODONTOL, V34, P716, DOI 10.1111/j.1600-051X.2007.01112.x; Turkyilmaz I, 2006, CLIN ORAL IMPLAN RES, V17, P501, DOI 10.1111/j.1600-0501.2006.01261.x; Turkyilmaz Ilser, 2008, BMC Oral Health, V8, P32, DOI 10.1186/1472-6831-8-32; Valderrama P, 2007, J PERIODONTOL, V78, P262, DOI 10.1902/jop.2007.060143	45	8	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190293	10.1371/journal.pone.0190293	http://dx.doi.org/10.1371/journal.pone.0190293			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281715	gold, Green Published, Green Submitted			2022-12-26	WOS:000419006200080
J	Cichowitz, C; Maraba, N; Hamilton, R; Charalambous, S; Hoffmann, CJ				Cichowitz, Cody; Maraba, Noriah; Hamilton, Robin; Charalambous, Salome; Hoffmann, Christopher J.			Depression and alcohol use disorder at antiretroviral therapy initiation led to disengagement from care in South Africa	PLOS ONE			English	Article							QUALITY-OF-LIFE; AIDS-RELATED STIGMA; CAPE-TOWN; HIV; HIV/AIDS; RELIABILITY; VALIDITY; RETENTION; HEALTH; SCALE	We sought to assess mental health at the time of antiretroviral therapy (ART) initiation and subsequent retention in care over a six-month follow-up period. A total of 136 people living with HIV in South Africa were administered surveys measuring demographic information and mental health indicators at the time of ART initiation. Follow-up was completed via chart abstraction to assess for six-month outcomes of retention in care and viral suppression. At enrollment, 45/136 (33%), 67/136 (49%), and 45/136 (33%) participants screened positive for depression, anxiety, and alcohol use disorder, respectively. After six months of followup, 96/136 (71%) participants remained in care; 35/87 (40.2%) participants who remained in care had a level <50 copies/mL. Those with depression (49% vs. 77% retained; p < 0.01) and those with alcohol use disorder (52% vs. 76% retained; p < 0.01) were less likely to be retained in care. In multivariable logistic regression, depression OR 3.46 (95% CI: 1.33, 7.97; p < 0.01) and alcohol abuse OR 3.89 (95% CI: 1.70, 8.97; p < 0.01) were independently associated with loss from care. These results emphasize the importance of mental health on early ART outcomes and the HIV care continuum.	[Cichowitz, Cody] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Maraba, Noriah; Charalambous, Salome; Hoffmann, Christopher J.] Aurum Inst, Johannesburg, South Africa; [Charalambous, Salome; Hoffmann, Christopher J.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Hoffmann, Christopher J.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21218 USA	Johns Hopkins University; University of Witwatersrand; Johns Hopkins University	Hoffmann, CJ (corresponding author), Aurum Inst, Johannesburg, South Africa.; Hoffmann, CJ (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.; Hoffmann, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21218 USA.	choffmann@jhmi.edu		Charalambous, Salome/0000-0001-7143-1009; Cichowitz, Cody/0000-0002-9029-6508; Hoffmann, Christopher/0000-0002-9422-0519	Infectious Disease Society of America Medical Scholars Program; Aurum Institute, Johannesburg, South Africa	Infectious Disease Society of America Medical Scholars Program; Aurum Institute, Johannesburg, South Africa	Cody Cichowitz was supported by the Infectious Disease Society of America Medical Scholars Program while contributing to this paper. The study was supported by internal funds of the Aurum Institute, Johannesburg, South Africa. Neither funder had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abas M, 2014, TROP MED INT HEALTH, V19, P1392, DOI 10.1111/tmi.12382; AIDS JUNPOH, 2016, GLOB AIDS UPD 2016; [Anonymous], 2015, NHMRC STAT EV WIND H; Bauer LK, 2012, AM J CARDIOL, V109, P1266, DOI 10.1016/j.amjcard.2011.12.017; Brandt R, 2009, AJAR-AFR J AIDS RES, V8, P123, DOI 10.2989/AJAR.2009.8.2.1.853; Breuer E, 2014, AIDS BEHAV, V18, P1133, DOI 10.1007/s10461-014-0698-y; Cholera R, 2014, J AFFECT DISORDERS, V167, P160, DOI [10.1016/j.jad.2014.06.003, 10.1016/]; Claassen JN, 1999, BENEFITS CAGE SCREEN; Dhalla S, 2007, CLIN INVEST MED, V30, P33, DOI 10.25011/cim.v30i1.447; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Gonzalez JS, 2011, JAIDS-J ACQ IMM DEF, V58, P181, DOI [10.1097/QAI.0B013E31822D490A, 10.1097/QAI.0b013e31822d490a]; Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970; Holmes WC, 1998, MED CARE, V36, P138, DOI 10.1097/00005650-199802000-00004; Joska JA, 2010, AIDS BEHAV, V14, P371, DOI 10.1007/s10461-009-9538-x; Kagee A, 2017, AIDS BEHAV, V21, P1511, DOI 10.1007/s10461-016-1428-4; Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x; Kessing D, 2016, PSYCHOSOM MED, V78, P412, DOI 10.1097/PSY.0000000000000270; Mayston Rosie, 2012, AIDS, V26 Suppl 2, pS117, DOI 10.1097/QAD.0b013e32835bde0f; Monroe AK, 2016, JAIDS-J ACQ IMM DEF, V73, P419, DOI 10.1097/QAI.0000000000001083; Muller-Tasch T, 2017, EUR J CARDIOVASC NUR, V5402; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; Nakimuli-Mpungu E, 2012, AIDS BEHAV, V16, P2101, DOI 10.1007/s10461-011-0087-8; Nanni MG, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0530-4; Oparah Azuka C, 2013, Value Health Reg Issues, V2, P254, DOI 10.1016/j.vhri.2013.07.004; Pappin M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-244; Parry CD, 2005, J STUD ALCOHOL, V66, P91, DOI DOI 10.15288/jsa.2005.66.91; Reda AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016049; Rendall-Mkosi K, 2013, ADDICTION, V108, P725, DOI 10.1111/add.12081; Schinckus L, 2017, PATIENT EDUC COUNS, P1; Shah M, 2016, CLIN INFECT DIS, V62, P220, DOI 10.1093/cid/civ801; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Soares GB, 2015, CIENC SAUDE COLETIVA, V20, P1075, DOI 10.1590/1413-81232015204.00522014; Tatum AK, 2017, AIDS CARE, V29, P306, DOI 10.1080/09540121.2016.1220481; Taylor TN, 2009, AIDS CARE, V21, P598, DOI 10.1080/09540120802302574; Tsai AC, 2014, JAIDS-J ACQ IMM DEF, V66, P503, DOI 10.1097/QAI.0000000000000210; Tsai AC, 2013, AIDS BEHAV, V17, P427, DOI 10.1007/s10461-012-0281-3; Vagenas P, 2015, CURR HIV-AIDS REP, V12, P421, DOI 10.1007/s11904-015-0285-5; Williams EC, 2016, ALCOHOL CLIN EXP RES, V40, P2056, DOI 10.1111/acer.13204; Wouters E, 2016, AIDS BEHAV      0114, P1; Wouters E, 2012, PLOONE PUBLIC LIB, V7; Zuniga JA, 2016, AIDS PATIENT CARE ST, V30, P34, DOI 10.1089/apc.2015.0214	42	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189820	10.1371/journal.pone.0189820	http://dx.doi.org/10.1371/journal.pone.0189820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR3ZV	29281681	Green Submitted, gold, Green Published			2022-12-26	WOS:000419006200047
J	Jerve, A; Qu, QM; Sanchez, S; Ahlberg, PE; Haitina, T				Jerve, Anna; Qu, Qingming; Sanchez, Sophie; Ahlberg, Per Erik; Haitina, Tatjana			Vascularization and odontode structure of a dorsal ridge spine of Romundina stellina Orvig 1975	PLOS ONE			English	Article							EVOLUTIONARY ORIGIN; SHEDS LIGHT; PLACODERM; CHONDRICHTHYAN	There are two types of dermal skeletons in jawed vertebrates: placoderms and osteichthyans carry large bony plates (macromery), whereas chondrichthyans and acanthodians are covered by small scales (micromery). Fin spines are one of the last large dermal structures found on micromeric taxa and offer a potential source of histology and morphology that can be compared to those found on macromeric groups. Dermal fin spines offer a variety of morphology but aspects of their growth modes and homology are unclear. Here, we provide detailed descriptions of the microstructure and growth of a dorsal ridge spine from the acanthothoracid placoderm, Romundina stellina, using virtual three-dimensional paleohistological datasets. From these data we identify several layers of dentine ornamentation covering the lateral surfaces of the spine and reconstructed their growth pattern. We show that this spine likely grew posteriorly and proximally from a narrow portion of bone located along the leading edge of the spine. The spine is similarly constructed to the scales with a few exceptions, including the absence of polarized fibers distributed throughout the bone and the presence of a thin layer of perichondral bone. The composition of the spine (semidentine odontodes, dermal bone, perichondral bone) is identical to that of the Romundina dermal plates. These results illustrate the similarities and differences between the dermal tissues in Romundina and indicate that the spine grew differently from the dentinous fin spines from extant and fossil chondrichthyans. The morphology and histology of Romundina is most similar to the fin spine of the probable stem osteichthyan Lophosteus, with a well-developed inner cellular bony base and star-shaped odontodes on the surface. Results from these studies will undoubtedly have impact on our understanding of fossil fin spine histology and evolution, contributing to the on-going revision of early gnathostome phylogeny.	[Jerve, Anna] Imperial Coll London, Biol Dept, Silwood Pk Campus, Ascot, Berks, England; [Qu, Qingming; Ahlberg, Per Erik; Haitina, Tatjana] Uppsala Univ, Dept Organismal Biol, Uppsala, Sweden; [Qu, Qingming] Univ Ottawa, Ctr Adv Res Environm Genom, Ottawa, ON, Canada; [Sanchez, Sophie] Sci Life Lab, Uppsala, Sweden; [Sanchez, Sophie] European Synchrotron Radiat Facil, Grenoble, France	Imperial College London; Uppsala University; University of Ottawa; European Synchrotron Radiation Facility (ESRF)	Jerve, A (corresponding author), Imperial Coll London, Biol Dept, Silwood Pk Campus, Ascot, Berks, England.	a.jerve@ic.ac.uk	Sanchez, Sophie/AAE-1168-2022	Sanchez, Sophie/0000-0002-3611-6836; Ahlberg, Per/0000-0001-9054-2900	European Research Council Advance Investigator Grant [233111]; Knut and Alice Wallengberg Foundation; European Synchrotron Radiation Facility [EC688]	European Research Council Advance Investigator Grant; Knut and Alice Wallengberg Foundation; European Synchrotron Radiation Facility	This work was supported by European Research Council Advance Investigator Grant 233111 (https://erc.europa.eu) awarded to PEA and by Knut and Alice Wallengberg Foundation (http://www.wallenberg.org/en) awarded to PEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by European Synchrotron Radiation Facility EC688 (http://www.esrf.eu) awarded to AJ. This award made it possible to collect the data described in this manuscript. It had no other role in how the data were analyzed, prepared, or published.	Beck KG, 2016, ACTA PALAEONTOL POL, V61, P97, DOI 10.4202/app.00126.2014; Brazeau MD, 2014, ZOOL J LINN SOC-LOND, V170, P779, DOI 10.1111/zoj.12111; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Burrow C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0159; Burrow CJ, 1999, J VERTEBR PALEONTOL, V19, P204, DOI 10.1080/02724634.1999.10011135; Burrow CJ, 2016, PALAEONTOL ELECTRON, V19, P1; Chen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036256; Dupret V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171241; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Dupret V, 2010, CR PALEVOL, V9, P369, DOI 10.1016/j.crpv.2010.07.005; Giles S, 2015, NATURE, V520, P82, DOI 10.1038/nature14065; Giles S, 2013, J MORPHOL, V274, P627, DOI 10.1002/jmor.20119; Gillis JA, 2007, J MORPHOL, V268, P33, DOI 10.1002/jmor.10501; Goujet D, 2004, RECENT ADV ORIGIN EA, P109; GROSS W, 1969, LETHAIA, V2, P15, DOI 10.1111/j.1502-3931.1969.tb01249.x; Janvier P., 1996, EARLY VERTEBRATES, P393; Janvier Philippe, 2005, Geologica Belgica, V8, P51; Jerve A, 2017, PALAEONTOL ELECTRON, V20, DOI 10.26879/749; Jerve A, 2016, PEERJ, V4, DOI 10.7717/peerj.2521; Jerve A, 2014, EVOL DEV, V16, P339, DOI 10.1111/ede.12104; King B., 2016, SYS BIO, P1; Labiche JC, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2783112; Long John A., 1997, Geodiversitas, V19, P515; MAISEY J G, 1986, Cladistics, V2, P201, DOI 10.1111/j.1096-0031.1986.tb00462.x; MAISEY J G, 1978, Palaeontology (Oxford), V21, P657; MAISEY JG, 1979, ZOOL J LINN SOC-LOND, V66, P161, DOI 10.1111/j.1096-3642.1979.tb01907.x; Maisey John G., 2017, American Museum Novitates, V3875, P1; Martin T, 2009, IEEE T NUCL SCI, V56, P1412, DOI 10.1109/TNS.2009.2015878; Miles R.S., 1973, Zoological J Linn Soc, V53, P63; Miller RF, 2003, NATURE, V425, P501, DOI 10.1038/nature02001; Orvig T., 1975, PROBL MES ACTUELS PA, P41; PATTERSO.C, 1965, PHILOS T ROY SOC B, V249, P101, DOI 10.1098/rstb.1965.0010; Qiao T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163157; Qu QM, 2017, BIOL REV, V92, P1189, DOI 10.1111/brv.12277; Rucklin M, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0526; Rucklin M, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0326; Sanchez S, 2012, MICROSC MICROANAL, V18, P1095, DOI 10.1017/S1431927612001079; SCHULTZE H.-P., 1979, HDB PALEOICHTHYOLOGY, V5; Schultze H-P, 2004, ACTA U LATV, V674, P57; Sire JY, 2009, J ANAT, V214, P409, DOI 10.1111/j.1469-7580.2009.01046.x; Soler-Gijon R, 1999, J MORPHOL, V242, P1, DOI 10.1002/(SICI)1097-4687(199910)242:1<1::AID-JMOR2>3.0.CO;2-9; Stahl, 1999, HDB PALEOICHTHYOLOGY; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2016, SCIENCE, V354, P334, DOI 10.1126/science.aah3764; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855	46	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189833	10.1371/journal.pone.0189833	http://dx.doi.org/10.1371/journal.pone.0189833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281687	Green Published, Green Submitted, gold			2022-12-26	WOS:000419006200048
J	Kim, JE; Park, KM; Lee, SY; Seo, JH; Yoon, IS; Bae, CS; Yoo, JC; Bang, MA; Cho, SS; Park, DH				Kim, Jung-Eun; Park, Kyung-Mok; Lee, Soon-Young; Seo, Ji-Hye; Yoon, In-Soo; Bae, Chun-Sik; Yoo, Jin-Cheol; Bang, Mi-Ae; Cho, Seung-Sik; Park, Dae-Hun			Anti-inflammatory effect of Allium hookeri on carrageenan-induced air pouch mouse model	PLOS ONE			English	Article								Inflammation is a commonly observed immune reaction, and rheumatoid arthritis is a particularly severe inflammatory disease. In this study, we used an air pouch mouse model to evaluate the anti-inflammatory potential of Allium hookeri, which has both been used as a culinary material and a traditional medicine in south-eastern Asia for many years. Allium hookeri suppressed typical symptoms of inflammation, such as condensation of the air pouch membrane, and inhibited the expression of several inducible proinflammatory cytokines such as IL-1 beta, IL-6, IL-13, and TNF-alpha. In order to determine the molecules modulating the inflammatory effect of carrageenan treatment, the components in Allium hookeri were analyzed by GC-MS, and linoleic acid, which have anti-inflammatory effect, was detected. From the results, we concluded that the anti-inflammatory effect of Allium hookeri might be attributed to linoleic acid, which could be promising candidates for anti-inflammatory drugs that have no adverse effects.	[Kim, Jung-Eun; Yoon, In-Soo; Cho, Seung-Sik] Mokpo Natl Univ, Coll Pharm, Dept Pharm, Muan, Jeonnam, South Korea; [Park, Kyung-Mok] Dongshin Univ, Dept Pharmaceut Engn, Naju, Jeonnam, South Korea; [Lee, Soon-Young; Seo, Ji-Hye; Park, Dae-Hun] Dongshin Univ, Dept Nursing, Naju, Jeonnam, South Korea; [Bae, Chun-Sik] Chonnam Natl Univ, Coll Vet Med, Gwangju, South Korea; [Yoo, Jin-Cheol] Chosun Univ, Coll Pharm, Dept Pharm, Gwangju, South Korea; [Bang, Mi-Ae] Jeonnam Biofood Technol Ctr, Res Dev Team, Naju, South Korea; [Park, Kyung-Mok; Lee, Soon-Young; Seo, Ji-Hye; Park, Dae-Hun] Dongshin Univ, Coll Oriental Med, Naju, Jeonnam, South Korea; [Yoon, In-Soo] Pusan Natl Univ, Coll Pharm, Busan, South Korea	Mokpo National University; Dongshin University; Dongshin University; Chonnam National University; Chosun University; Dongshin University; Pusan National University	Cho, SS (corresponding author), Mokpo Natl Univ, Coll Pharm, Dept Pharm, Muan, Jeonnam, South Korea.; Park, DH (corresponding author), Dongshin Univ, Dept Nursing, Naju, Jeonnam, South Korea.; Park, DH (corresponding author), Dongshin Univ, Coll Oriental Med, Naju, Jeonnam, South Korea.	sscho@mokpo.ac.kr; dhj1221@hanmail.net	Yoon, In-Soo/ABG-2948-2021	Yoon, In-Soo/0000-0002-0997-5723				Adao CR, 2011, FITOTERAPIA, V82, P1175, DOI 10.1016/j.fitote.2011.08.003; Akram M, 2014, INT J IMMUNOPATH PH, V27, P313, DOI 10.1177/039463201402700301; [Anonymous], 2015, TOC ACT AD PAT MOD S; Aviello G, 2009, NAT PROD COMMUN, V4, P1785; Bae MS, 2014, SCI TOTAL ENVIRON, V466, P56, DOI 10.1016/j.scitotenv.2013.06.096; BLOCK E, 1986, J AM CHEM SOC, V108, P7045, DOI 10.1021/ja00282a033; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Carrillo C., 2016, EUR J NUTR; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Duarte Djane B, 2012, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0506s56; EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205; El-Gabalawy H, 2010, J RHEUMATOL, V37, P2, DOI 10.3899/jrheum.091461; Kim JE, 2016, NAT PROD COMMUN, V11, P237; Krejcova P, 2014, J ETHNOPHARMACOL, V154, P176, DOI 10.1016/j.jep.2014.03.066; Kyung KH, 2012, CURR OPIN BIOTECH, V23, P142, DOI 10.1016/j.copbio.2011.08.004; 김창현, 2012, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V41, P1645; Li R, 2014, NAT PROD COMMUN, V9, P863; Lopes D., 1997, Flavour and Fragrance Journal, V12, P237, DOI 10.1002/(SICI)1099-1026(199707)12:4<237::AID-FFJ644>3.3.CO;2-0; Matsuura H, 2001, J NUTR, V131, p1000S, DOI 10.1093/jn/131.3.1000S; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Merck & Co. Inc, 2009, YOU CAN CONTR YOUR C; Nolte CG, 2002, ENVIRON SCI TECHNOL, V36, P4273, DOI 10.1021/es020518y; Romano M, 1997, MEDIAT INFLAMM, V6, P32, DOI 10.1080/09629359791901; Rukaiyat M., 2015, ADV MED PLANT RES, V3, P120; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Teres S, 2008, P NATL ACAD SCI USA, V105, P13811, DOI 10.1073/pnas.0807500105; Tokayer A, 2002, J RHEUMATOL, V29, P454	27	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190305	10.1371/journal.pone.0190305	http://dx.doi.org/10.1371/journal.pone.0190305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281705	gold, Green Submitted, Green Published			2022-12-26	WOS:000419006200082
J	Wang, L; Hubbard, RA; Walker, RL; Lee, EB; Larson, EB; Crane, PK				Wang, Le; Hubbard, Rebecca A.; Walker, Rod L.; Lee, Edward B.; Larson, Eric B.; Crane, Paul K.			Assessing robustness of hazard ratio estimates to outcome misclassification in longitudinal panel studies with application to Alzheimer's disease	PLOS ONE			English	Article							LOGISTIC-REGRESSION; GLUCOSE-LEVELS; MODELS; DEMENTIA; RISK; DIAGNOSIS; CRITERIA; AUTOPSY; BIAS	Analyses of imperfectly assessed time to event outcomes give rise to biased hazard ratio estimates. This bias is a common challenge for studies of Alzheimer's Disease (AD) because AD neuropathology can only be identified through brain autopsy and is therefore not available for most study participants. Clinical AD diagnosis, although more widely available, has imperfect sensitivity and specificity relative to AD neuropathology. In this study we present a sensitivity analysis approach using a bias-adjusted discrete proportional hazards model to quantify robustness of results to misclassification of a time to event outcome and apply this method to data from a longitudinal panel study of AD. Using data on 1,955 participants from the Adult Changes in Thought study we analyzed the association between average glucose level and AD neuropathology and conducted sensitivity analyses to explore how estimated hazard ratios varied according to AD classification accuracy. Unadjusted hazard ratios were closer to the null than estimates obtained under most scenarios for misclassification investigated. Confidence interval estimates from the unadjusted model were substantially underestimated compared to adjusted estimates. This study demonstrates the importance of exploring outcome misclassification in time to event analyses and provides an approach that can be undertaken without requiring validation data.	[Wang, Le; Hubbard, Rebecca A.] Univ Penn, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Walker, Rod L.; Larson, Eric B.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Lee, Edward B.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Crane, Paul K.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Pennsylvania; Kaiser Permanente; University of Pennsylvania; University of Washington; University of Washington Seattle	Wang, L (corresponding author), Univ Penn, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA.	wangle@mail.med.upenn.edu	Lee, Edward/AAU-8436-2021; Hubbard, Rebecca/Y-6500-2019; Melief, Erica/M-6436-2019	Hubbard, Rebecca/0000-0003-0879-0994; Walker, Rod/0000-0002-8464-9805	National Institute on Aging of the National Institutes of Health [U01AG006781]; NATIONAL INSTITUTE ON AGING [P30AG010124, U01AG006781] Funding Source: NIH RePORTER	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National Institute on Aging of the National Institutes of Health under award number U01AG006781. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research reported in this publication was supported by the National Institute on Aging of the National Institutes of Health under award number U01AG006781. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Buchman AS, 2011, AM J GERIAT PSYCHIAT, V19, P571, DOI 10.1097/JGP.0b013e3181ef7a2e; Cook RJ, 2008, BIOMETRICS, V64, P1100, DOI 10.1111/j.1541-0420.2007.00978.x; Crane PK, 2016, NEUROBIOL AGING, V48, P72, DOI 10.1016/j.neurobiolaging.2016.07.021; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Edwards JK, 2013, AM J EPIDEMIOL, V177, P904, DOI 10.1093/aje/kws340; Fischer ME, 2016, J AM GERIATR SOC, V64, P1981, DOI 10.1111/jgs.14308; Gross AL, 2016, J GERONTOL A-BIOL, V71, P1624, DOI 10.1093/gerona/glw067; Haneuse S, 2009, NEUROEPIDEMIOLOGY, V32, P229, DOI 10.1159/000197389; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Letenneur L, 1999, J NEUROL NEUROSUR PS, V66, P177, DOI 10.1136/jnnp.66.2.177; Lindsey JC, 1998, STAT MED, V17, P219, DOI 10.1002/(SICI)1097-0258(19980130)17:2<219::AID-SIM735>3.0.CO;2-O; Lyles RH, 2011, EPIDEMIOLOGY, V22, P589, DOI 10.1097/EDE.0b013e3182117c85; Magder LS, 1997, AM J EPIDEMIOL, V146, P195; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meier AS, 2003, BIOMETRICS, V59, P947, DOI 10.1111/j.0006-341X.2003.00109.x; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Neuhaus JM, 1999, BIOMETRIKA, V86, P843, DOI 10.1093/biomet/86.4.843; PRENTICE RL, 1978, BIOMETRICS, V34, P57, DOI 10.2307/2529588; Richardson B A, 2000, Biostatistics, V1, P341, DOI 10.1093/biostatistics/1.3.341; Shah RC, 2011, J GERONTOL A-BIOL, V66, P82, DOI 10.1093/gerona/glq187; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Yu L, 2010, STAT MED, V29, P639, DOI 10.1002/sim.3828; Zhang Y, 2010, SCAND J STAT, V37, P338, DOI 10.1111/j.1467-9469.2009.00680.x; Zhao XB, 2008, STAT MED, V27, P1261, DOI 10.1002/sim.3018	31	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190107	10.1371/journal.pone.0190107	http://dx.doi.org/10.1371/journal.pone.0190107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272296	gold, Green Submitted, Green Published			2022-12-26	WOS:000418651500034
J	Zulu, T; Heap, M; Sinanovic, E				Zulu, Tryphine; Heap, Marion; Sinanovic, Edina			The cost and utilisation patterns of a pilot sign language interpreter service for primary health care services in South Africa	PLOS ONE			English	Article							DEAF PEOPLE	Background The World Health Organisation estimates disabling hearing loss to be around 5.3%, while a study of hearing impairment and auditory pathology in Limpopo, South Africa found a prevalence of nearly 9%. Although Sign Language Interpreters (SLIs) improve the communication challenges in health care, they are unaffordable for many signing Deaf people and people with disabling hearing loss. On the other hand, there are no legal provisions in place to ensure the provision of SLIs in the health sector in most countries including South Africa. To advocate for funding of such initiatives, reliable cost estimates are essential and such data is scarce. To bridge this gap, this study estimated the costs of providing such a service within a South African District health service based on estimates obtained from a pilot-project that initiated the first South African Sign Language Interpreter (SASLI) service in healthcare. Methods The ingredients method was used to calculate the unit cost per SASLI-assisted visit from a provider perspective. The unit costs per SASLI-assisted visit were then used in estimating the costs of scaling up this service to the District Health Services. The average annual SASLI utilisation rate per person was calculated on Stata v. 12 using the projects' registry from 2008 +/- 2013. Sensitivity analyses were carried out to determine the effect of changing the discount rate and personnel costs. Results Average Sign Language Interpreter services' utilisation rates increased from 1.66 to 3.58 per person per year, with a median of 2 visits, from 2008 +/- 2013. The cost per visit was US $189.38 in 2013 whilst the estimated costs of scaling up this service ranged from US $14.2million to US$76.5million in the Cape Metropole District. These cost estimates represented 2.3%-12.2% of the budget for the Western Cape District Health Services for 2013. Conclusions In the presence of Sign Language Interpreters, Deaf Sign language users utilise health care service to a similar extent as the hearing population. However, this service requires significant capital investment by government to enable access to healthcare for the Deaf.	[Zulu, Tryphine; Sinanovic, Edina] Univ Cape Town, Sch Publ Hlth & Family Med, Fac Hlth Sci, Hlth Econ Unit, Cape Town, South Africa; [Heap, Marion] Univ Cape Town, Sch Publ Hlth & Family Med, Fac Hlth Sci, Hlth & Human Rights Programme, Cape Town, South Africa	University of Cape Town; University of Cape Town	Zulu, T (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Fac Hlth Sci, Hlth Econ Unit, Cape Town, South Africa.	tryphinen@gmail.com	Sinanovic, Edina/AAR-2590-2020		South African medical Research Council	South African medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TZ received a bursary for her MPH degree from the South African medical Research Council, http://www.mrc.ac.za/ researchdevelopment/opportunity.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the South African Medical Research Council for funding TZ as part of the National Health Scholars Program and Prof Lesley London, head of the Health and Human Rights programme that runs the SASLI service for providing access to the dataset.	Aarons Debra, 1998, STELLENBOSCH PAPERS, V31, P1, DOI DOI 10.5774/31-0-55; Abraham D, 2006, MAKING CASE COMMUNIT, P189; Ahmad W, 1998, DEAF PEOPLE MINORITY; [Anonymous], 2018, WHO GLOB EST PREV HE; Bartlett G, 2008, CAN MED ASSOC J, V178, P5; Comhairle, 2006, REV SIGN LANG INT SE; Council SANA, 2012, NAT STRAT PLAN HIV S; Deaf Federation of South Africa, 2011, POL PROV REG S AFR S; Drennan G., 1999, INTERPRETING, V4, P169, DOI [10.1075/intp.4.2.03dre, DOI 10.1075/intp.4.2.03dre]; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Emond A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006668; Gie J, 2007, PLANNING DISTRICT PR; Gilson L, 2012, HLTH POLICY SYSTEMS; Glaser M, 2006, DISABILITY SOCIAL CH, P192; Hanass-Hancock J, 2009, J INT AIDS SOC, V12, P1; Haricharan HJ, 2012, DISABIL SOC, P37; Harmer L, 1999, J Deaf Stud Deaf Educ, V4, P73, DOI 10.1093/deafed/4.2.73; Heap M, 2006, DISABILITY SOCIAL CH, P134; Jokinen M, 2010, SUBMISSION WORLD FED; Kritzinger J, 2014, PATIENT EDUC COUNS, V94, P379, DOI 10.1016/j.pec.2013.12.006; MacLachlan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035864; McKee MM, 2011, AM J PREV MED, V41, P75, DOI 10.1016/j.amepre.2011.03.004; Newton, 2002, ACCESS PRIMARY CARE; Nilsson A, 2013, MEDISIGNS PRESCRIPTI; Pullen DL., 2015, PREVALENCE HEARING I; Rodda M, 2002, AM ANN DEAF, V147, P45, DOI 10.1353/aad.2012.0243; Scheier Donna B, 2009, J N Y State Nurses Assoc, V40, P4; Steinberg AG, 2006, J GEN INTERN MED, V21, P260, DOI 10.1111/j.1525-1497.2006.00340.x	28	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0189983	10.1371/journal.pone.0189983	http://dx.doi.org/10.1371/journal.pone.0189983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8ZJ	29272272	Green Published, gold, Green Submitted			2022-12-26	WOS:000418651500021
J	Sarmento, KMA; Sampaio, ALL; Santos, TGT; de Oliveira, CACP				Sarmento, Krishnamurti M. A., Jr.; Lopes Sampaio, Andre Luiz; Targino Santos, Tatiana Guthierre; Costa Pires de Oliveira, Carlos Augusto			High-frequency conductive hearing loss as a diagnostic test for incomplete ossicular discontinuity in non-cholesteatomatous chronic suppurative otitis media	PLOS ONE			English	Article							MIDDLE-EAR DISEASES; SAMPLE-SIZE; MALLEUS; CHAIN	Chronic suppurative otitis media, with or without cholesteatoma, may lead to erosion of the ossicles and discontinuity of the ossicular chain. In incomplete ossicular discontinuity (IOD), partial erosion of the ossicles occurs, but some sound transmission is noted throughout the ossicular chain. High-frequency conductive hearing loss (HfCHL) has been considered a hallmark of incomplete ossicular discontinuity. This study aims to evaluate the use of HfCHL as a preoperative predictor of IOD in patients with non-cholesteatomatous chronic suppurative otitis media. The HfCHL test was defined as the preoperative air-bone gap (ABG) at 4 kHz minus the average of the ABG at 0.25 and 0.5 kHz. The test was applied in 328 patients before surgery and compared to intraoperative findings as the gold standard. At surgery, 201 (61.3%) patients had an intact ossicular chain, 44 (13.4%) had a complete ossicular discontinuity, and 83 (25.3%) exhibited an IOD. The best cutoff level was calculated as 10 dB. The HfCHL test to diagnose IOD had a sensitivity of 83% and a specificity of 92% with a post-test probability of 78% and a likelihood ratio of 10.2. We concluded that the HfCHL test is highly effective in predicting IOD in patients with non-cholesteatomatous chronic suppurative otitis media and that it should be used routinely as a screening test prior to surgery.	[Sarmento, Krishnamurti M. A., Jr.] Brasilia Mil Police Hosp, Dept Otolaryngol, Brasilia, DF, Brazil; [Sarmento, Krishnamurti M. A., Jr.] Affiliated Ctr Fisch Int Microsurg Fdn FIMF, Brasilia, DF, Brazil; [Lopes Sampaio, Andre Luiz; Targino Santos, Tatiana Guthierre; Costa Pires de Oliveira, Carlos Augusto] Univ Brasilia, Dept Otolaryngol, Brasilia, DF, Brazil	Universidade de Brasilia	Sarmento, KMA (corresponding author), Brasilia Mil Police Hosp, Dept Otolaryngol, Brasilia, DF, Brazil.; Sarmento, KMA (corresponding author), Affiliated Ctr Fisch Int Microsurg Fdn FIMF, Brasilia, DF, Brazil.	krishnamurti.sarmento@gmail.com	Sarmento Jr, Krishnamurti/A-6358-2014	Sarmento Jr, Krishnamurti/0000-0002-2334-0054				ANDERSON H, 1971, ARCHIV OTOLARYNGOL, V93, P599; BEICKERT P, 1964, ARCHIV OTOLARYNGOL, V80, P383; Carrillo RJC, 2007, OTOL NEUROTOL, V28, P1034, DOI 10.1097/MAO.0b013e31815882a6; Chien W, 2008, J LARYNGOL OTOL, V122, P898, DOI 10.1017/S0022215107000990; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Farahmand RB, 2016, EAR HEARING, V37, P206, DOI 10.1097/AUD.0000000000000239; Fisch U, 2008, TYMPANOPLASTY MASTOI, P48; Fletcher RH, 2014, DIAGNOSIS CLIN EPIDE, P108; Green JO, 1895, MED SURG REPORTS BOS, V6, P95; Hajian-Tilaki K, 2014, J BIOMED INFORM, V48, P193, DOI 10.1016/j.jbi.2014.02.013; Hayden SR, 1999, ANN EMERG MED, V33, P575, DOI 10.1016/S0196-0644(99)70346-X; Jeng FC, 2003, OTOL NEUROTOL, V24, P29, DOI 10.1097/00129492-200301000-00007; KARTUSH JM, 1994, OTOLARYNG CLIN N AM, V27, P689; Malhotra RK, 2010, INDIAN J OPHTHALMOL, V58, P519, DOI 10.4103/0301-4738.71699; MUSTAIN WD, 1981, LARYNGOSCOPE, V91, P599, DOI 10.1288/00005537-198104000-00013; SADE J, 1974, J LARYNGOL OTOL, V88, P139, DOI 10.1017/S0022215100078476; Sarmento Jr KM, 2017, CLIN OTOLARYNGOL, V88, P139; Sim JH, 2013, OTOL NEUROTOL, V34, P699, DOI 10.1097/MAO.0b013e31828864a7; TOS M, 1979, J LARYNGOL OTOL, V93, P769, DOI 10.1017/S0022215100087703; Wada H, 1998, EAR HEARING, V19, P240, DOI 10.1097/00003446-199806000-00007	20	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189997	10.1371/journal.pone.0189997	http://dx.doi.org/10.1371/journal.pone.0189997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267386	Green Submitted, gold, Green Published			2022-12-26	WOS:000418587400075
J	Sobral-Leite, M; Lips, EH; Vieira-Monteiro, HD; Giacomin, LC; Freitas-Alves, DR; Cornelissen, S; Mulder, L; Wesseling, J; Schmidt, MK; Vianna-Jorge, R				Sobral-Leite, Marcelo; Lips, Esther H.; Vieira-Monteiro, Hayra de Andrade; Giacomin, Leticia Carlos; Freitas-Alves, Daniely Regina; Cornelissen, Sten; Mulder, Lennart; Wesseling, Jelle; Schmidt, Marjanka K.; Vianna-Jorge, Rosane			Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; FAVORABLE PROGNOSTIC-FACTOR; HISTOLOGICAL GRADE; GENE POLYMORPHISMS; CHEMOTHERAPY; THERAPY; PREDICTORS; RECURRENCE; EXPRESSION; CARCINOMA	Pathological response of breast cancer to neoadjuvant chemotherapy (NAC) presents great variability, and new prognostic biomarkers are needed. Our aim was to evaluate the association of the epidermal growth factor receptor gene (EGFR) polymorphism R497K (rs2227983) with prognostic features and clinical outcomes of breast cancer, including the pathological response to NAC and the recurrence-free survival (RFS). Tumoral complete response (tCR) was defined by no remaining invasive cancer in the excised breast, whereas pathological complete response (pCR) was defined by no remaining invasive cancer both in the excised breast and lymph nodes. Two independent cohorts were analyzed: one from Brazil (INCA, n = 288) and one from The Netherlands (NKI-AVL, n = 255). In the INCA cohort, the variant (Lys-containing) genotypes were significantly associated with lower proportion of tCR (ORadj = 0.92; 95% CI = 0.85 +/- 0.99), whereas in the NKI-AVL cohort they were associated with tumor grade 3 (p = 0.035) and with triple-negative subtype (p = 0.032), but not with clinical outcomes. Such distinct prognostic associations may have arisen due to different neoadjuvant protocols (p < 0.001), or to lower age at diagnosis (p < 0.001) and higher proportion of tumor grade 3 (p = 0.018) at the NKI-AVL cohort. Moreover, NKI-AVL patients achieved better proportion of pCR (21.2% vs 8.3%, p < 0.001) and better RFS (HRadj = 0.48; 95% adjCI = 0.26 +/- 0.86) than patients from INCA. In conclusion, large scale studies comprehending different populations are needed to evaluate the impact of genome variants on breast cancer outcomes.	[Sobral-Leite, Marcelo; Lips, Esther H.; Cornelissen, Sten; Mulder, Lennart; Wesseling, Jelle; Schmidt, Marjanka K.] Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands; [Sobral-Leite, Marcelo; Vieira-Monteiro, Hayra de Andrade; Giacomin, Leticia Carlos; Freitas-Alves, Daniely Regina; Vianna-Jorge, Rosane] Inst Nacl Canc, Coordenacao Pesquisa, Rio De Janeiro, RJ, Brazil; [Vieira-Monteiro, Hayra de Andrade; Freitas-Alves, Daniely Regina; Vianna-Jorge, Rosane] Fiocruz MS, Programa Posgrad Sau Publ & Meio Ambiente, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil; [Wesseling, Jelle] Netherlands Canc Inst, Div Pathol, Amsterdam, Netherlands; [Vianna-Jorge, Rosane] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Farmacol & Inflamacao, Rio De Janeiro, RJ, Brazil	Netherlands Cancer Institute; National Cancer Institute (Inca); Fundacao Oswaldo Cruz; Netherlands Cancer Institute; Universidade Federal do Rio de Janeiro	Vianna-Jorge, R (corresponding author), Inst Nacl Canc, Coordenacao Pesquisa, Rio De Janeiro, RJ, Brazil.; Vianna-Jorge, R (corresponding author), Fiocruz MS, Programa Posgrad Sau Publ & Meio Ambiente, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil.; Vianna-Jorge, R (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Farmacol & Inflamacao, Rio De Janeiro, RJ, Brazil.	rosanevj@gmail.com	Schmidt, Marjanka K/G-9058-2011; Vianna-Jorge, Rosane/A-1230-2013; Vianna-Jorge, Rosane/AAC-7301-2020	Schmidt, Marjanka K/0000-0002-2228-429X; Vianna-Jorge, Rosane/0000-0001-5407-4695; Vianna-Jorge, Rosane/0000-0001-5407-4695; Sobral-Leite, Marcelo/0000-0002-4275-8050; Giacomin, Leticia/0000-0001-6422-6795; Freitas-Alves, Daniely/0000-0002-3304-9922; Mulder, Lennart/0000-0001-8844-1481	KWF Kankerbestrijding; Center for Translational Molecular Medicine [030104]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [474522/2010-5, 573806/2008-0]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/110356/2010, E26/170.026/2008]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [1321-13-7]	KWF Kankerbestrijding(KWF Kankerbestrijding); Center for Translational Molecular Medicine; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by KWF Kankerbestrijding (MKS): https://www.kwf.nl/pages/default.aspx; Center for Translational Molecular Medicine (030104; EL and JW); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (474522/2010-5 and 573806/2008-0): http://cnpq.br/; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (E-26/110356/2010 and E26/170.026/2008): http://www.faperj.br/; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (1321-13-7; MSL): http://www.capes.gov.br/; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akay CL, 2012, ANN SURG ONCOL, V19, P901, DOI 10.1245/s10434-011-2006-7; Alaoui-Jamali M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00017; Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Amir E, 2010, CANCER TREAT REV, V36, P410, DOI 10.1016/j.ctrv.2009.12.012; Arpino G, 2004, BREAST CANCER RES, V6, pR149, DOI 10.1186/bcr767; Bandres E, 2007, ORAL ONCOL, V43, P713, DOI 10.1016/j.oraloncology.2006.09.002; Bhargava R, 2005, MODERN PATHOL, V18, P1027, DOI 10.1038/modpathol.3800438; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Davis NM, 2014, ONCOTARGET, V5, P4603, DOI 10.18632/oncotarget.2209; de Souza JA, 2016, J CLIN ONCOL, V34, P6, DOI 10.1200/JCO.2015.62.2860; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fitzal F, 2011, BREAST CANCER RES TR, V127, P121, DOI 10.1007/s10549-010-1164-9; Goncalves A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-169; Hammond ME, 2010, J CLIN ONCOLOGY OFFI, V28; Hsieh YY, 2012, CANCER SCI, V103, P791, DOI 10.1111/j.1349-7006.2012.02225.x; Jaka A, 2014, EXP DERMATOL, V23, P751, DOI 10.1111/exd.12510; Kallel I, 2009, J BIOMED BIOTECHNOL, V2009; KLIJN JGM, 1994, BREAST CANCER RES TR, V29, P73, DOI 10.1007/BF00666183; Lai CY, 2013, ANN SURG ONCOL, V20, pS599, DOI 10.1245/s10434-013-3069-4; Leite MS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-190; Lester SC, 2009, ARCH PATHOL LAB MED, V133, P1515, DOI 10.1043/1543-2165-133.10.1515; Li CI, 2005, BRIT J CANCER, V93, P1046, DOI 10.1038/sj.bjc.6602787; Li Q, 2013, ELECTRON J DIFFER EQ; Li XR, 2011, MED ONCOL, V28, pS129, DOI 10.1007/s12032-010-9742-6; Lips EH, 2013, BREAST CANCER RES TR, V140, P63, DOI 10.1007/s10549-013-2620-0; Lips EH, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0642-8; Lluch A, 2014, EXPERT OPIN EMERG DR, V19, P165, DOI 10.1517/14728214.2014.903919; Lurje G, 2008, CLIN CANCER RES, V14, P7884, DOI 10.1158/1078-0432.CCR-07-5165; Masuda H, 2012, BREAST CANCER RES TR, V136, P331, DOI 10.1007/s10549-012-2289-9; Masuda H, 2011, CANCER CHEMOTH PHARM, V67, P911, DOI 10.1007/s00280-010-1371-4; MORIAI T, 1994, P NATL ACAD SCI USA, V91, P10217, DOI 10.1073/pnas.91.21.10217; Rigter LS, 2013, BRIT J CANCER, V109, P2965, DOI 10.1038/bjc.2013.661; Rodenhuis S, 2010, ANN ONCOL, V21, P481, DOI 10.1093/annonc/mdp348; Santa-Maria CA, 2015, ONCOLOGY-NY, V29, P828; Sasaki H, 2009, J CANCER RES CLIN, V135, P313, DOI 10.1007/s00432-008-0464-5; Saxena N, 2012, WORLD J SURG, V36, P2838, DOI 10.1007/s00268-012-1746-2; Schmidt M, 2014, BREAST CARE, V9, P154, DOI 10.1159/000363755; Senkus E, 2015, ANN ONCOL, V26, pV8, DOI 10.1093/annonc/mdv298; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tang YQ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-S1-S4; Vieira-Monteiro HD, 2016, CANCER BIOL THER, V17, P674, DOI 10.1080/15384047.2016.1190486; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Wang WS, 2007, CLIN CANCER RES, V13, P3597, DOI 10.1158/1078-0432.CCR-06-2601; Wang YR, 2014, SHOCK VIB, V2014, DOI 10.1155/2014/397584; Zhang W, 2005, CLIN CANCER RES, V11, P600	47	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189750	10.1371/journal.pone.0189750	http://dx.doi.org/10.1371/journal.pone.0189750			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267323	Green Published, gold, Green Submitted			2022-12-26	WOS:000418587400044
J	Tseng, CY; Hsu, HJ				Tseng, Chen-Yuan; Hsu, Hwei-Jan			Decreased expression of lethal giant larvae causes ovarian follicle cell outgrowth in the Drosophila Scutoid mutant	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; ANTIMORPHIC MUTATION; OOCYTE POLARITY; E-CADHERIN; GENE; PROLIFERATION; MELANOGASTER; OOGENESIS; NOTCH	Snail, a zinc-finger transcription factor, controls the process of epithelial-mesenchymal transition, and ectopic expression of this protein may produce cells with stem cell properties. Because the effect of Snail expression in ovarian epithelial cells remains unclear, we generated Drosophila ovarian follicle stem cells (FSCs) with homozygous Scutoid (Sco) mutation. The Sco mutation is a reciprocal transposition that is known to induce ectopic Snail activity. We found that Sco mutant FSCs showed excess proliferation and high competitiveness for niche occupancy, and the descendants of this lineage formed outgrowths that failed to enter the endocycle. Surprisingly, such phenotypes were not rescued by suppressing Snail expression, but were completely restored by supplying Lethal giant larvae (Lgl). The lgl allele is a cell polarity gene that is often mutated in the genome. Importantly, Sco mutants survived in a complementation test with lgl. This result was probably obtained because the Sco-associated lgl allele appears to diminish, but not ablate lgl expression. While our data do not rule out the possibility that the Sco mutation disrupts a regulator of lgl transcription, our results strongly suggest that the phenotypes we found in Sco mutants are more closely associated with the lgl allele than ectopic Snail activity.	[Tseng, Chen-Yuan; Hsu, Hwei-Jan] Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan	Academia Sinica - Taiwan	Hsu, HJ (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan.	cohsu@gate.sinica.edu.tw	Hsu, Hwei-Jan/AAD-1518-2022	Hsu, Hwei-Jan/0000-0001-7892-2310; Tseng, Chen Yuan/0000-0002-0383-3660	Institute of Cellular and Organismic Biology, Academia Sinica, Taiwan; Ministry of Science and Technology, Taiwan [101-2311-B- 001 -032 -MY3]	Institute of Cellular and Organismic Biology, Academia Sinica, Taiwan(Academia Sinica - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by intramural funding from the Institute of Cellular and Organismic Biology, Academia Sinica, Taiwan, and a grant from the Ministry of Science and Technology, Taiwan (101-2311-B- 001 -032 -MY3).	Abdelilah-Seyfried S, 2003, DEVELOPMENT, V130, P1927, DOI 10.1242/dev.00420; ASHBURNER M, 1982, GENETICS, V102, P401; Bassermann F, 2005, CELL, V122, P45, DOI 10.1016/j.cell.2005.04.034; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chang YC, 2013, P NATL ACAD SCI USA, V110, pE1734, DOI 10.1073/pnas.1300725110; Deng WM, 2001, DEVELOPMENT, V128, P4737; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; Goode S, 1997, GENE DEV, V11, P2532, DOI 10.1101/gad.11.19.2532; Hartman TR, 2010, J CELL BIOL, V191, P943, DOI 10.1083/jcb.201007142; JACOB L, 1987, CELL, V50, P215, DOI 10.1016/0092-8674(87)90217-0; Jia DY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18850; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Klusza S, 2011, BIOESSAYS, V33, P124, DOI 10.1002/bies.201000089; Kronen MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101085; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Li Q, 2008, CELL RES, V18, P372, DOI 10.1038/cr.2008.25; LIN H, 1993, DEV BIOL, V159, P140, DOI 10.1006/dbio.1993.1228; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Masui T, 2014, INT J ONCOL, V44, P693, DOI 10.3892/ijo.2013.2225; MCGILL S, 1988, GENETICS, V119, P647; MECHLER BM, 1985, EMBO J, V4, P1551, DOI 10.1002/j.1460-2075.1985.tb03816.x; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Roegiers F, 2009, GENETICS, V182, P407, DOI 10.1534/genetics.109.101808; Sun JJ, 2007, DEV CELL, V12, P431, DOI 10.1016/j.devcel.2007.02.003; Sun JJ, 2005, DEVELOPMENT, V132, P4299, DOI 10.1242/dev.02015; Tian AG, 2008, DEVELOPMENT, V135, P463, DOI 10.1242/dev.016253; Tseng CY, 2016, DEV BIOL, V414, P142, DOI 10.1016/j.ydbio.2016.04.022; Tseng CY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004888; Wahlstrom G, 2006, MECH DEVELOP, V123, P801, DOI 10.1016/j.mod.2006.08.004; Wang HZ, 2013, TRANSPORT RES REC, P3, DOI 10.3141/2332-01; Wang ZA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1765; XU T, 1993, DEVELOPMENT, V117, P1223; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099; Zhou W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087409; Zhu CH, 2003, DEVELOPMENT, V130, P2579, DOI 10.1242/dev.00499	40	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0188917	10.1371/journal.pone.0188917	http://dx.doi.org/10.1371/journal.pone.0188917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261681	Green Submitted, Green Published, gold			2022-12-26	WOS:000418564200018
J	Geldreich, A; Haas, G; Kubina, J; Bouton, C; Tanguy, M; Erhardt, M; Keller, M; Ryabova, L; Dimitrova, M				Geldreich, Angele; Haas, Gabrielle; Kubina, Julie; Bouton, Clement; Tanguy, Melanie; Erhardt, Mathieu; Keller, Mario; Ryabova, Lyubov; Dimitrova, Maria			Formation of large viroplasms and virulence of Cauliflower mosaic virus in turnip plants depend on the N-terminal EKI sequence of viral protein TAV	PLOS ONE			English	Article							INCLUSION-BODY PROTEIN; GENE-VI; CAPSID PROTEIN; P6 PROTEIN; ACTIN MICROFILAMENTS; ARABIDOPSIS-THALIANA; APHID TRANSMISSION; SELF-ASSOCIATION; IN-VIVO; PRODUCT	Cauliflower mosaic virus (CaMV) TAV protein (TransActivator/Viroplasmin) plays a pivotal role during the infection cycle since it activates translation reinitiation of viral polycistronic RNAs and suppresses RNA silencing. It is also the major component of cytoplasmic electron- dense inclusion bodies (EDIBs) called viroplasms that are particularly evident in cells infected by the virulent CaMV Cabb B-JI isolate. These EDIBs are considered as virion factories, vehicles for CaMV intracellular movement and reservoirs for CaMV transmission by aphids. In this study, focused on different TAV mutants in vivo, we demonstrate that three physically separated domains collectively participate to the formation of large EDIBs: the N-terminal EKI motif, a sequence of the MAV domain involved in translation reinitiation and a C-terminal region encompassing the zinc finger. Surprisingly, EKI mutant TAVm3, corresponding to a substitution of the EKI motif at amino acids 11 - 13 by three alanines (AAA), which completely abolished the formation of large viroplasms, was not lethal for CaMV but highly reduced its virulence without affecting the rate of systemic infection. Expression of TAVm3 in a viral context led to formation of small irregularly shaped inclusion bodies, mild symptoms and low levels of viral DNA and particles accumulation, despite the production of significant amounts of mature capsid proteins. Unexpectedly, for CaMV-TAVm3 the formation of viral P2-containing electron-light inclusion body (ELIB), which is essential for CaMV aphid transmission, was also altered, thus suggesting an indirect role of the EKI tripeptide in CaMV plant-to-plant propagation. This important functional contribution of the EKI motif in CaMV biology can explain the strict conservation of this motif in the TAV sequences of all CaMV isolates.	[Geldreich, Angele; Haas, Gabrielle; Kubina, Julie; Bouton, Clement; Tanguy, Melanie; Erhardt, Mathieu; Keller, Mario; Ryabova, Lyubov; Dimitrova, Maria] Univ Strasbourg, CNRS UPR2357, Inst Biol Mol Plantes, Strasbourg, France; [Haas, Gabrielle] Univ Strasbourg, CNRS UPR9022, Inst Biol Mol & Cellulaire, Strasbourg, France; [Bouton, Clement] Rothamsted Res, Harpenden, Herts, England; [Tanguy, Melanie] NIBSC, Potters Bar, Herts, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; National Institute for Biological Standards & Control	Dimitrova, M (corresponding author), Univ Strasbourg, CNRS UPR2357, Inst Biol Mol Plantes, Strasbourg, France.	m.dimitrova@unistra.fr		Bouton, Clement/0000-0001-9607-6533; julie, Kubina/0000-0003-0938-6985; Tanguy, Melanie/0000-0003-4862-0981	Centre National de la Recherche Scientifique; Universite de Strasbourg; Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation	This work was supported by Centre National de la Recherche Scientifique and Universite de Strasbourg. Gabrielle Haas, Clement Bouton and Julie Kubina PhD were supported by fellowships from Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON EJ, 1991, VIROLOGY, V181, P647, DOI 10.1016/0042-6822(91)90898-L; Angel CA, 2013, VIROLOGY, V443, P363, DOI 10.1016/j.virol.2013.05.028; Bak A, 2013, J VIROL, V87, P12207, DOI 10.1128/JVI.01883-13; Blevins T, 2011, NUCLEIC ACIDS RES, V39, P5003, DOI 10.1093/nar/gkr119; Bouton C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132665; Bureau M, 2004, J GEN VIROL, V85, P3765, DOI 10.1099/vir.0.80242-0; Campagna M, 2013, J VIROL, V87, P807, DOI 10.1128/JVI.01578-12; Carreno-Torres JJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-350; Cecchini E, 1997, MOL PLANT MICROBE IN, V10, P1094, DOI 10.1094/MPMI.1997.10.9.1094; Champagne J, 2004, VIROLOGY, V324, P257, DOI 10.1016/j.virol.2004.04.014; DAUBERT S D, 1984, Journal of Molecular and Applied Genetics, V2, P537; DEZOETEN GA, 1989, VIROLOGY, V172, P213, DOI 10.1016/0042-6822(89)90123-2; Drucker M, 2002, P NATL ACAD SCI USA, V99, P2422, DOI 10.1073/pnas.042587799; ESPINOZA AM, 1991, VIROLOGY, V185, P337, DOI 10.1016/0042-6822(91)90781-6; Fujisawa I, 1972, Uirusu, V22, P136; Geri C, 1999, MOL PLANT MICROBE IN, V12, P377, DOI 10.1094/MPMI.1999.12.5.377; GIBAND M, 1984, J VIROL METHODS, V9, P277, DOI 10.1016/0166-0934(84)90053-3; Haas G, 2008, EMBO J, V27, P2102, DOI 10.1038/emboj.2008.129; Haas M, 2005, PLANT CELL, V17, P927, DOI 10.1105/tpc.104.029017; Haas M, 2002, MOL PLANT PATHOL, V3, P419, DOI 10.1046/j.1364-3703.2002.00136.x; Hafren A, 2017, P NATL ACAD SCI USA, V114, pE2026, DOI 10.1073/pnas.1610687114; Harries PA, 2009, PLANT PHYSIOL, V149, P1005, DOI 10.1104/pp.108.131755; Himmelbach A, 1996, VIROLOGY, V217, P147, DOI 10.1006/viro.1996.0102; Hohn T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00398; Hohn T, 2013, CURR OPIN VIROL, V3, P621, DOI 10.1016/j.coviro.2013.08.013; HULL R, 1976, J GEN VIROL, V31, P93, DOI 10.1099/0022-1317-31-1-93; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Karsies A, 2002, J GEN VIROL, V83, P1783, DOI 10.1099/0022-1317-83-7-1783; Karsies A, 2001, PLANT J, V27, P335, DOI 10.1046/j.1365-313x.2001.01093.x; Khelifa M, 2007, J GEN VIROL, V88, P2872, DOI 10.1099/vir.0.83009-0; Kiraly L, 1999, MOL PLANT MICROBE IN, V12, P919, DOI 10.1094/MPMI.1999.12.10.919; Kobayashi K, 2003, J VIROL, V77, P8577, DOI 10.1128/JVI.77.15.8577-8583.2003; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Laird J, 2013, J GEN VIROL, V94, P2777, DOI 10.1099/vir.0.057729-0; LEISNER SM, 1992, PHYTOPATHOLOGY, V82, P1042, DOI 10.1094/Phyto-82-1042; Li YZ, 2002, MOL PLANT MICROBE IN, V15, P1050, DOI 10.1094/MPMI.2002.15.10.1050; Love AJ, 2007, J GEN VIROL, V88, P3439, DOI 10.1099/vir.0.83090-0; Love AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047535; Lutz L, 2015, VIROLOGY, V476, P26, DOI 10.1016/j.virol.2014.11.017; Lutz L, 2012, VIRUS RES, V170, P150, DOI 10.1016/j.virusres.2012.08.017; Martiniere A, 2009, PLANT J, V58, P135, DOI 10.1111/j.1365-313X.2008.03768.x; MAZZOLINI L, 1985, VIROLOGY, V145, P293, DOI 10.1016/0042-6822(85)90162-X; MESNARD JM, 1993, BIOCHIMIE, V75, P645, DOI 10.1016/0300-9084(93)90094-9; Netherton CL, 2011, CURR OPIN VIROL, V1, P381, DOI 10.1016/j.coviro.2011.09.008; Patton JT, 2006, CURR TOP MICROBIOL, V309, P169; Plisson C, 2005, J MOL BIOL, V346, P267, DOI 10.1016/j.jmb.2004.11.052; Raikhy G, 2011, VIRUS RES, V159, P69, DOI 10.1016/j.virusres.2011.04.026; RICHINS RD, 1987, NUCLEIC ACIDS RES, V15, P8451, DOI 10.1093/nar/15.20.8451; Rodriguez A, 2014, PLANT PHYSIOL, V166, P1345, DOI 10.1104/pp.114.249250; Ryabova LA, 2006, VIRUS RES, V119, P52, DOI 10.1016/j.virusres.2005.10.017; Schepetilnikov M, 2011, EMBO J, V30, P1343, DOI 10.1038/emboj.2011.39; SCHOELZ J, 1986, MOL CELL BIOL, V6, P2632, DOI 10.1128/MCB.6.7.2632; Schoelz JE, 2016, J EXP BOT, V67, P2039, DOI 10.1093/jxb/erv520; SCHOELZ JE, 1988, VIROLOGY, V162, P30, DOI 10.1016/0042-6822(88)90391-1; SHALLA TA, 1980, VIROLOGY, V102, P381, DOI 10.1016/0042-6822(80)90105-1; Shivaprasad PV, 2008, NUCLEIC ACIDS RES, V36, P5896, DOI 10.1093/nar/gkn590; Thiebeauld O, 2009, EMBO J, V28, P3171, DOI 10.1038/emboj.2009.256; THOMAS CM, 1985, NUCLEIC ACIDS RES, V13, P4557, DOI 10.1093/nar/13.12.4557; TORRUELLA M, 1989, EMBO J, V8, P2819, DOI 10.1002/j.1460-2075.1989.tb08428.x; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; XIONG C, 1982, EMBO J, V1, P971, DOI 10.1002/j.1460-2075.1982.tb01280.x; XIONG C, 1984, P NATL ACAD SCI-BIOL, V81, P6608, DOI 10.1073/pnas.81.21.6608; Yu WC, 2003, MOL PLANT MICROBE IN, V16, P35, DOI 10.1094/MPMI.2003.16.1.35; Zhang CZ, 2008, J GEN VIROL, V89, P1770, DOI 10.1099/vir.0.2008/000109-0	64	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189062	10.1371/journal.pone.0189062	http://dx.doi.org/10.1371/journal.pone.0189062			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253877	Green Published, gold			2022-12-26	WOS:000418389500011
J	Lewis, JM; Savage, RS; Beeching, NJ; Beadsworth, MBJ; Feasey, N; Covington, JA				Lewis, Joseph M.; Savage, Richard S.; Beeching, Nicholas J.; Beadsworth, Mike B. J.; Feasey, Nicholas; Covington, James A.			Identifying volatile metabolite signatures for the diagnosis of bacterial respiratory tract infection using electronic nose technology: A pilot study	PLOS ONE			English	Article							DISEASE	Objectives New point of care diagnostics are urgently needed to reduce the over-prescription of antimicrobials for bacterial respiratory tract infection (RTI). We performed a pilot cross sectional study to assess the feasibility of gas-capillary column ion mobility spectrometer (GC-IMS), for the analysis of volatile organic compounds (VOC) in exhaled breath to diagnose bacterial RTI in hospital inpatients. Methods 71 patients were prospectively recruited from the Acute Medical Unit of the Royal Liverpool University Hospital between March and May 2016 and classified as confirmed or probable bacterial or viral RTI on the basis of microbiologic, biochemical and radiologic testing. Breath samples were collected at the patient's bedside directly into the electronic nose device, which recorded a VOC spectrum for each sample. Sparse principal component analysis and sparse logistic regression were used to develop a diagnostic model to classify VOC spectra as being caused by bacterial or non-bacterial RTI. Results Summary area under the receiver operator characteristic curve was 0.73 (95% CI 0.61 +/- 0.86), summary sensitivity and specificity were 62% (95% CI 41 +/- 80%) and 80% (95% CI 64 +/- 91%) respectively (p = 0.00147). Conclusions GC-IMS analysis of exhaled VOC for the diagnosis of bacterial RTI shows promise in this pilot study and further trials are warranted to assess this technique.	[Lewis, Joseph M.; Beeching, Nicholas J.; Beadsworth, Mike B. J.; Feasey, Nicholas] Royal Liverpool Univ Hosp, Trop & Infect Dis Unit, Liverpool, Merseyside, England; [Lewis, Joseph M.] Wellcome Trust Res Labs, Liverpool Glasgow Ctr Global Hlth Res, Liverpool, Merseyside, England; [Lewis, Joseph M.; Beeching, Nicholas J.; Beadsworth, Mike B. J.; Feasey, Nicholas] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Savage, Richard S.] Univ Warwick, Dept Stat, Coventry, W Midlands, England; [Covington, James A.] Univ Warwick, Sch Engn, Coventry, W Midlands, England	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Liverpool School of Tropical Medicine; University of Warwick; University of Warwick	Lewis, JM (corresponding author), Royal Liverpool Univ Hosp, Trop & Infect Dis Unit, Liverpool, Merseyside, England.; Lewis, JM (corresponding author), Wellcome Trust Res Labs, Liverpool Glasgow Ctr Global Hlth Res, Liverpool, Merseyside, England.; Lewis, JM (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England.	joseph.lewis@lstmed.ac.uk	Covington, James A./Q-1934-2018	Covington, James A./0000-0003-1307-6488; Beeching, Nicholas/0000-0002-7019-8791; Lewis, Joseph/0000-0002-3837-5188; Feasey, Nicholas/0000-0003-4041-1405	Liverpool School of Tropical Medicine; University of Warwick; Royal Liverpool University Hospital; National Institute of Health Research (NIHR) Health Protection Unit Emerging and Zoonotic Infections in the University of Liverpool; Liverpool School of Tropical Medicine and Public Health England; EPSRC [EP/M027503/1]; Wellcome Trust [109105Z/15/A]; Engineering and Physical Sciences Research Council [EP/M027503/1] Funding Source: researchfish	Liverpool School of Tropical Medicine; University of Warwick; Royal Liverpool University Hospital; National Institute of Health Research (NIHR) Health Protection Unit Emerging and Zoonotic Infections in the University of Liverpool; Liverpool School of Tropical Medicine and Public Health England; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The study was funded by the Liverpool School of Tropical Medicine and the University of Warwick and co-sponsored by the Liverpool School of Tropical Medicine and Royal Liverpool University Hospital. Dr Beeching receives partial support from the National Institute of Health Research (NIHR) Health Protection Unit Emerging and Zoonotic Infections in the University of Liverpool, in partnership with the Liverpool School of Tropical Medicine and Public Health England. Dr Beeching is based at the Liverpool School of Tropical Medicine. Dr Covington is also supported in this work by the EPSRC (grant no. EP/M027503/1). Dr Lewis is supported by a Wellcome Trust clinical PhD fellowship (109105Z/15/A). The funder and sponsors had no role in the planning, execution or analysis of the study. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health, or PHE.	Ahmed I, 2016, SCAND J GASTROENTERO, V51, P385, DOI 10.3109/00365521.2015.1105286; Arasaradnam RP, 2014, ALIMENT PHARM THER, V39, P780, DOI 10.1111/apt.12657; Bond A, 2015, J GASTROINTEST LIVER, V24, P281, DOI 10.15403/jgld.2014.1121.243.abo; Davies S. C, 2014, ANN REPORT CHIEF MED; Dragonieri S, 2017, LUNG, V195, P157, DOI 10.1007/s00408-017-9987-3; Khalid T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143283; Kramer R, 2015, EUR J CLIN MICROBIOL, V34, P745, DOI 10.1007/s10096-014-2286-5; Krilaviciute A, 2015, ONCOTARGET, V6, P38643, DOI 10.18632/oncotarget.5938; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Shafiek H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135199; Shapiro DJ, 2014, J ANTIMICROB CHEMOTH, V69, P234, DOI 10.1093/jac/dkt301; van der Meer V, 2005, BRIT MED J, V331, P26, DOI 10.1136/bmj.38483.478183.EB; van Oort PMP, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020449; Wang DC, 2016, BIOMED REP, V5, P68, DOI 10.3892/br.2016.686; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	17	28	29	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0188879	10.1371/journal.pone.0188879	http://dx.doi.org/10.1371/journal.pone.0188879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29252995	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000418389500008
J	Rasheed, SAK; Leong, HS; Lakshmanan, M; Raju, A; Dadlani, D; Chong, FT; Shannon, NB; Rajarethinam, R; Skanthakumar, T; Tan, EY; Hwang, JSG; Lim, KH; Tan, DSW; Ceppi, P; Wang, M; Tergaonkar, V; Casey, PJ; Iyer, NG				Rasheed, Suhail Ahmed Kabeer; Leong, Hui Sun; Lakshmanan, Manikandan; Raju, Anandhkumar; Dadlani, Dhivya; Chong, Fui-Teen; Shannon, Nicholas B.; Rajarethinam, Ravisankar; Skanthakumar, Thakshayeni; Tan, Ern Yu; Hwang, Jacqueline Siok Gek; Lim, Kok Hing; Tan, Daniel Shao-Weng; Ceppi, Paolo; Wang, Mei; Tergaonkar, Vinay; Casey, Patrick J.; Iyer, N. Gopalakrishna			GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers	ONCOGENE			English	Article							HETEROTRIMERIC G-PROTEINS; EPIDERMAL-GROWTH-FACTOR; BREAST-CANCER; STEM-CELLS; MESENCHYMAL TRANSITION; MICROARRAY DATA; BETA-CATENIN; LUNG-CANCER; G12 FAMILY; METASTASIS	Treatment failure in solid tumors occurs due to the survival of specific subpopulations of cells that possess tumor-initiating (TIC) phenotypes. Studies have implicated G protein-coupled-receptors (GPCRs) in cancer progression and the acquisition of TIC phenotypes. Many of the implicated GPCRs signal through the G protein GNA13. In this study, we demonstrate that GNA13 is upregulated in many solid tumors and impacts survival and metastases in patients. GNA13 levels modulate drug resistance and TIC-like phenotypes in patient-derived head and neck squamous cell carcinoma (HNSCC) cells in vitro and in vivo. Blockade of GNA13 expression, or of select downstream pathways, using small-molecule inhibitors abrogates GNA13-induced TIC phenotypes, rendering cells vulnerable to standard-of-care cytotoxic therapies. Taken together, these data indicate that GNA13 expression is a potential prognostic biomarker for tumor progression, and that interfering with GNA13-induced signaling provides a novel strategy to block TICs and drug resistance in HNSCCs.	[Rasheed, Suhail Ahmed Kabeer; Dadlani, Dhivya; Wang, Mei; Casey, Patrick J.; Iyer, N. Gopalakrishna] Duke NUS Med Sch, Programme Canc & Stem Cell Biol, Singapore, Singapore; [Leong, Hui Sun; Chong, Fui-Teen; Tan, Daniel Shao-Weng; Iyer, N. Gopalakrishna] Natl Canc Ctr, Canc Therapeut Res Lab, Singapore, Singapore; [Lakshmanan, Manikandan; Raju, Anandhkumar; Tergaonkar, Vinay] Inst Mol & Cell Biol, Mouse Models Human Canc Unit, Singapore, Singapore; [Shannon, Nicholas B.; Skanthakumar, Thakshayeni; Iyer, N. Gopalakrishna] Natl Canc Ctr, Dept Surg Oncol, Singapore, Singapore; [Rajarethinam, Ravisankar] Adv Mol Pathol Lab, Singapore, Singapore; [Tan, Ern Yu] Tan Tock Seng Hosp, Dept Gen Surg, Singapore, Singapore; [Hwang, Jacqueline Siok Gek; Lim, Kok Hing] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Ceppi, Paolo] Friedrich Alexander Univ Erlangen Nuernberg, IZKF Jr Res Grp, Erlangen, Germany; [Casey, Patrick J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	National University of Singapore; National Cancer Centre Singapore (NCCS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National Cancer Centre Singapore (NCCS); Tan Tock Seng Hospital; Singapore General Hospital; University of Erlangen Nuremberg; Duke University	Casey, PJ; Iyer, NG (corresponding author), Duke NUS Med Sch, Programme Canc & Stem Cell Biol, Singapore, Singapore.; Iyer, NG (corresponding author), Natl Canc Ctr, Canc Therapeut Res Lab, Singapore, Singapore.; Iyer, NG (corresponding author), Natl Canc Ctr, Dept Surg Oncol, Singapore, Singapore.	patrick.casey@duke-nus.edu.sg; gopaliyer@nccs.com.sg	Ceppi, Paolo/GPS-8668-2022; Rasheed, Suhail Ahmed Kabeer/P-1257-2019	Rasheed, Suhail Ahmed Kabeer/0000-0002-7674-7560; Casey, Patrick/0000-0002-7366-9309; Wang, Mei/0000-0001-6887-6840; Ceppi, Paolo/0000-0002-3632-8476; Shannon, Nicholas Brian/0000-0001-8742-8285	National Medical Research Council, Singapore [NMRC/BNIG/2041/2015, NMRC/CBRG/0044/2013, NMRC/CSA-INV/011/2016, NMRC/CIRG/1434/2015]; Inter- disciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg	National Medical Research Council, Singapore(National Medical Research Council, Singapore); Inter- disciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg	This work was supported by grants from National Medical Research Council, Singapore (NMRC/BNIG/2041/2015 to SAKR, NMRC/CBRG/0044/2013 to PJC, NMRC/CSA-INV/011/2016 and NMRC/CIRG/1434/2015 to NGI). PC was supported by the Inter- disciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chia S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00451-5; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ghosh P, 2015, AGING-US, V7, P469, DOI 10.18632/aging.100781; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hong X, 2014, EMBO J, V33, P2447, DOI 10.15252/embj.201489385; Ibrahim EE, 2012, STEM CELLS, V30, P2076, DOI 10.1002/stem.1182; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Juneja J, 2009, BRIT J PHARMACOL, V158, P32, DOI 10.1111/j.1476-5381.2009.00180.x; Kaplan DD, 2001, J BIOL CHEM, V276, P44037, DOI 10.1074/jbc.M106121200; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kuo SZ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-556; Lappano R, 2012, ACTA PHARMACOL SIN, V33, P351, DOI 10.1038/aps.2011.183; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Leong HS, 2014, STEM CELL TRANSL MED, V3, P1055, DOI 10.5966/sctm.2013-0214; Liu SC, 2009, CANCER RES, V69, P6122, DOI 10.1158/0008-5472.CAN-08-3435; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Montgomery ER, 2014, MOL PHARMACOL, V85, P586, DOI 10.1124/mol.113.088443; O'Hayre M, 2014, CURR OPIN CELL BIOL, V27, P126, DOI 10.1016/j.ceb.2014.01.005; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Prud'homme GJ, 2012, CURR PHARM DESIGN, V18, P2838; Rasheed SAK, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0337-x; Rasheed SAK, 2013, J BIOL CHEM, V288, P7986, DOI 10.1074/jbc.M112.437749; Rasheed SAK, 2010, INT J CANCER, V127, P1475, DOI 10.1002/ijc.25315; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saha S, 2016, CANCER RES, V76, P2000, DOI 10.1158/0008-5472.CAN-15-1360; Singh JK, 2013, CLIN CANCER RES, V19, P643, DOI 10.1158/1078-0432.CCR-12-1063; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Tan DSW, 2017, NAT MED, V23, P1167, DOI 10.1038/nm.4401; Teo CR, 2016, CELL SIGNAL, V28, P1479, DOI 10.1016/j.cellsig.2016.07.001; Turm H, 2010, J BIOL CHEM, V285, P15137, DOI 10.1074/jbc.M109.072843; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; von Rahden BHA, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-23; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Yi TF, 2014, P NATL ACAD SCI USA, V111, pE2182, DOI 10.1073/pnas.1404943111; Yip NC, 2011, BRIT J CANCER, V104, P1564, DOI 10.1038/bjc.2011.126; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang HH, 2013, INT J CLIN EXP PATHO, V6, P1734; Zhang JX, 2014, ANN ONCOL, V25, P2196, DOI 10.1093/annonc/mdu439; Zhang JX, 2016, ONCOTARGET, V7, P4414, DOI 10.18632/oncotarget.6780; Zhao Y, 2008, ONCOGENE, V27, P1, DOI 10.1038/sj.onc.1210625	52	26	27	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	10					1340	1353		10.1038/s41388-017-0038-6	http://dx.doi.org/10.1038/s41388-017-0038-6			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ0RI	29255247	hybrid, Green Published			2022-12-26	WOS:000427279300006
J	Strang, KH; Croft, CL; Sorrentino, ZA; Chakrabarty, P; Golde, TE; Giasson, BI				Strang, Kevin H.; Croft, Cara L.; Sorrentino, Zachary A.; Chakrabarty, Paramita; Golde, Todd E.; Giasson, Benoit I.			Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-BINDING REGION; PAIRED HELICAL FILAMENTS; FRONTOTEMPORAL DEMENTIA; TRANSGENIC MICE; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; FTDP-17 MUTATIONS; IN-VIVO; SULFATED GLYCOSAMINOGLYCANS; NEURODEGENERATIVE-DISEASES	The accumulation of aberrantly aggregated MAPT (microtubule-associated protein Tau) defines a spectrum of tauopathies, including Alzheimer's disease. Mutations in the MAPT gene cause frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), characterized by neuronal pathological Tau inclusions in the form of neurofibrillary tangles and Pick bodies and in some cases glial Tau pathology. Increasing evidence points to the importance of prion-like seeding as a mechanism for the pathological spread in tauopathy and other neurodegenerative diseases. Herein, using a cell culture model, we examined a multitude of genetic FTDP-17 Tau variants for their ability to be seeded by exogenous Tau fibrils. Our findings revealed stark differences between FTDP-17 Tau variants in their ability to be seeded, with variants at Pro(301) and Ser(320) showing robust aggregation with seeding. Similarly, we elucidated the importance of certain Tau protein regions and unique residues, including the role of Pro(301) in inhibiting Tau aggregation. We also revealed potential barriers in cross-seeding between three-repeat and four-repeat Tau isoforms. Overall, these differences alluded to potential mechanistic differences between wildtype and FTDP-17 Tau variants, as well as different Tau isoforms, in influencing Tau aggregation. Furthermore, by combining two FTDP-17 Tau variants (either P301L or P301S with S320F), we generated aggressive models of tauopathy that do not require exogenous seeding. These models will allow for rapid screening of potential therapeutics to alleviate Tau aggregation without the need for exogenous Tau fibrils. Together, these studies provide novel insights in the molecular determinants that modulate Tau aggregation.	[Strang, Kevin H.; Croft, Cara L.; Sorrentino, Zachary A.; Chakrabarty, Paramita; Golde, Todd E.; Giasson, Benoit I.] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Strang, Kevin H.; Croft, Cara L.; Sorrentino, Zachary A.; Chakrabarty, Paramita; Golde, Todd E.; Giasson, Benoit I.] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Chakrabarty, Paramita; Golde, Todd E.; Giasson, Benoit I.] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Giasson, BI (corresponding author), BMS J483 CTRND,1275 Ctr Dr, Gainesville, FL 32610 USA.	bgiasson@ufl.edu		Sorrentino, Zachary/0000-0001-8835-0432; Croft, Cara Louise/0000-0001-7969-5084	National Institutes of Health [R01NS089022]; Florida Department of Health [7AZ25]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS082168, R01NS089622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG047266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant R01NS089022 and the Florida Department of Health Grant 7AZ25. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Ayers JI, 2018, BIOL PSYCHIAT, V83, P337, DOI 10.1016/j.biopsych.2017.04.003; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Boluda S, 2015, ACTA NEUROPATHOL, V129, P221, DOI 10.1007/s00401-014-1373-0; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Crystal AS, 2003, J NEUROCHEM, V86, P1359, DOI 10.1046/j.1471-4159.2003.01949.x; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Denk F, 2009, NEUROBIOL AGING, V30, P1, DOI 10.1016/j.neurobiolaging.2007.05.010; Deramecourt V, 2012, J ALZHEIMERS DIS, V31, P741, DOI 10.3233/JAD-2012-120160; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Elbaum-Garfinkle S, 2014, P NATL ACAD SCI USA, V111, P6311, DOI 10.1073/pnas.1315983111; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Ganguly P, 2015, J PHYS CHEM B, V119, P4582, DOI 10.1021/acs.jpcb.5b00175; Ghetti B, 2015, NEUROPATH APPL NEURO, V41, P24, DOI 10.1111/nan.12213; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Goedert M, 2017, BRAIN, V140, P266, DOI 10.1093/brain/aww230; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Hasegawa M, 1997, J BIOL CHEM, V272, P33118, DOI 10.1074/jbc.272.52.33118; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hasegawa M, 1999, FEBS LETT, V443, P93, DOI 10.1016/S0014-5793(98)01696-2; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iba M, 2015, ACTA NEUROPATHOL, V130, P349, DOI 10.1007/s00401-015-1458-4; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Jackson SJ, 2016, J NEUROSCI, V36, P762, DOI 10.1523/JNEUROSCI.3542-15.2016; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2016, ACTA NEUROPATHOL, V131, P27, DOI 10.1007/s00401-015-1507-z; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Lim S, 2014, COMPUT STRUCT BIOTEC, V12, P7, DOI 10.1016/j.csbj.2014.09.011; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Magnani E, 2007, EMBO J, V26, P4546, DOI 10.1038/sj.emboj.7601878; Meyer V, 2014, ANGEW CHEM INT EDIT, V53, P1590, DOI 10.1002/anie.201308473; Miyasaka T, 2001, J NEUROPATH EXP NEUR, V60, P872, DOI 10.1093/jnen/60.9.872; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Peeraer E, 2015, NEUROBIOL DIS, V73, P83, DOI 10.1016/j.nbd.2014.08.032; Poepsel S, 2015, NAT CHEM BIOL, V11, P862, DOI [10.1038/NCHEMBIO.1931, 10.1038/nchembio.1931]; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Roberson ED, 2012, ANN NEUROL, V72, P837, DOI 10.1002/ana.23722; Rossi G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.008; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Smit FX, 2017, J PHYS CHEM B, V121, P3250, DOI 10.1021/acs.jpcb.6b07045; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Stancu IC, 2015, ACTA NEUROPATHOL, V129, P875, DOI 10.1007/s00401-015-1413-4; Steward A, 2002, J MOL BIOL, V318, P935, DOI 10.1016/S0022-2836(02)00184-5; Strang KH, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0458-0; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Waxman EA, 2010, BIOCHEM BIOPH RES CO, V391, P1415, DOI 10.1016/j.bbrc.2009.12.079; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yu X, 2012, J BIOL CHEM, V287, P14950, DOI 10.1074/jbc.M112.340794	83	55	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2408	2421		10.1074/jbc.M117.815357	http://dx.doi.org/10.1074/jbc.M117.815357			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29259137	Green Published, hybrid			2022-12-26	WOS:000425308300015
J	Campos, WF; Dressano, K; Ceciliato, PHO; Guerrero-Abad, JC; Silva, AL; Fiori, CS; do Canto, AM; Bergonci, T; Claus, LAN; Silva-Filho, MC; Moura, DS				Campos, Wellington F.; Dressano, Keini; Ceciliato, Paulo H. O.; Guerrero-Abad, Juan Carlos; Silva, Aparecida Leonir; Fiori, Celso S.; do Canto, Amanda Morato; Bergonci, Tabata; Claus, Lucas A. N.; Silva-Filho, Marcio C.; Moura, Daniel S.			Arabidopsis thaliana rapid alkalinization factor 1-mediated root growth inhibition is dependent on calmodulin-like protein 38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calmodulin (CaM); cell growth; cell signaling; development; peptide hormone; rapid alkalinization factor; root; secreted protein; secretory pathway	SUSPENSION-CULTURED CELLS; EXTRACELLULAR CALMODULIN; PEPTIDE-HORMONE; PLANT-GROWTH; POLLEN GERMINATION; BINDING-PROTEINS; HAIR DEVELOPMENT; FUSION PROTEINS; CALCIUM SENSOR; RALF PEPTIDE	Arabidopsis thaliana rapid alkalinization factor 1 (AtRALF1) is a small secreted peptide hormone that inhibits root growth by repressing cell expansion. Although it is known that AtRALF1 binds the plasma membrane receptor FERONIA and conveys its signals via phosphorylation, the AtRALF1 signaling pathway is largely unknown. Here, using a yeast two-hybrid system to search for AtRALF1-interacting proteins in Arabidopsis, we identified calmodulin-like protein 38 (CML38) as an AtRALF1-interacting partner. We also found that CML38 and AtRALF1 are both secreted proteins that physically interact in a Ca2+- and pH-dependent manner. CML38-knockout mutants generated via T-DNA insertion were insensitive to AtRALF1, and simultaneous treatment with both AtRALF1 and CML38 proteins restored sensitivity in these mutants. Hybrid plants lacking CML38 and having high accumulation of the AtRALF1 peptide did not exhibit the characteristic short-root phenotype caused by AtRALF1 overexpression. Although CML38 was essential for AtRALF1-mediated root inhibition, it appeared not to have an effect on the AtRALF1-induced alkalinization response. Moreover, acridinium-labeling of AtRALF1 indicated that the binding of AtRALF1 to intact roots is CML38-dependent. In summary, we describe a new component of the AtRALF1 response pathway. The new component is a calmodulin-like protein that binds AtRALF1, is essential for root growth inhibition, and has no role in AtRALF1 alkalinization.	[Campos, Wellington F.; Dressano, Keini; Ceciliato, Paulo H. O.; Guerrero-Abad, Juan Carlos; Silva, Aparecida Leonir; Fiori, Celso S.; do Canto, Amanda Morato; Bergonci, Tabata; Claus, Lucas A. N.; Moura, Daniel S.] Univ Sao Paulo, ESALQ, Dept Ciencias Biol, Lab Bioquim Prot, BR-13418900 Piracicaba, SP, Brazil; [Silva-Filho, Marcio C.] Univ Sao Paulo, ESALQ, Dept Genet, Lab Biol Mol Plantas, BR-13418900 Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Moura, DS (corresponding author), Univ Sao Paulo, ESALQ, Dept Ciencias Biol, Lab Bioquim Prot, BR-13418900 Piracicaba, SP, Brazil.	danielmoura@usp.br	da Silva, Aparecida Leonir/H-8398-2016; Silva, Aparecida/AAJ-9250-2020; Guerrero-Abad, Juan Carlos/I-3728-2014; Campos, Wellington/GZG-2946-2022; Silva, Aparecida/AAR-9442-2020; do Canto, Amanda Morato/A-6807-2015; Moura, Daniel S/D-6673-2012; Silva-Filho, Marcio/F-2639-2012; Bergonci, Tábata/E-3759-2014	da Silva, Aparecida Leonir/0000-0002-1887-4414; Guerrero-Abad, Juan Carlos/0000-0002-7285-9506; Silva, Aparecida/0000-0002-1887-4414; do Canto, Amanda Morato/0000-0002-3989-8351; Moura, Daniel S/0000-0003-2042-1403; Silva-Filho, Marcio/0000-0003-2129-0388; Bergonci, Tábata/0000-0001-9100-6974; Alves Neubus Claus, Lucas/0000-0001-8591-8969	FAPESP; CNPq; CAPES	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported in part by FAPESP and CNPq. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from CAPES.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ARAZI T, 1995, PLANT PHYSIOL, V108, P551, DOI 10.1104/pp.108.2.551; Atkinson NJ, 2013, PLANT PHYSIOL, V162, P2028, DOI 10.1104/pp.113.222372; Bedinger PA, 2010, PLANT SIGNAL BEHAV, V5, P1342, DOI 10.4161/psb.5.11.12954; Bender KW, 2013, PLANT J, V76, P634, DOI 10.1111/tpj.12323; Bender KW, 2013, PLANT PHYSIOL, V163, P486, DOI 10.1104/pp.113.221069; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bergonci T, 2014, J EXP BOT, V65, P2219, DOI 10.1093/jxb/eru099; Bibikova TN, 1998, DEVELOPMENT, V125, P2925; BIRO RL, 1984, PLANT PHYSIOL, V75, P382, DOI 10.1104/pp.75.2.382; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burstenbinder K, 2017, PLANT PHYSIOL, V173, P1692, DOI 10.1104/pp.16.01743; Burstenbinder K, 2013, J BIOL CHEM, V288, P1871, DOI 10.1074/jbc.M112.396200; Butenko MA, 2014, PLANT CELL, V26, P1838, DOI 10.1105/tpc.113.120071; Cao J, 2012, EVOL BIOINFORM, V8, P271, DOI 10.4137/EBO.S9652; Chen J, 2016, P NATL ACAD SCI USA, V113, pE5519, DOI 10.1073/pnas.1608449113; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Covey PA, 2010, PLANT PHYSIOL, V153, P703, DOI 10.1104/pp.110.155457; Cui SJ, 2005, J BIOL CHEM, V280, P31420, DOI 10.1074/jbc.M501349200; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; do Canto AM, 2014, PLANT PHYSIOL BIOCH, V75, P45, DOI 10.1016/j.plaphy.2013.12.005; Dressano K, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007053; Du CQ, 2016, P NATL ACAD SCI USA, V113, pE8326, DOI 10.1073/pnas.1609626113; Escobara NM, 2003, PLANT CELL, V15, P1507, DOI 10.1105/tpc.013284; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; GRIGNON C, 1991, ANNU REV PLANT PHYS, V42, P103, DOI 10.1146/annurev.pp.42.060191.000535; Haruta M, 2008, BIOCHEMISTRY-US, V47, P6311, DOI 10.1021/bi8001488; Haruta M, 2014, SCIENCE, V343, P408, DOI 10.1126/science.1244454; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Li C, 2016, PLANT PHYSIOL, V171, P2379, DOI 10.1104/pp.16.00667; Li C, 2015, ELIFE, V4, DOI [10.7554/eLife.06587, 10.1155/2015/757269]; Lokdarshi A, 2016, PLANT PHYSIOL, V170, P1046, DOI 10.1104/pp.15.01407; Ma LG, 1997, PLANTA, V202, P336, DOI 10.1007/s004250050135; Ma LG, 1999, PLANT CELL, V11, P1351, DOI 10.1105/tpc.11.7.1351; Masachis S, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.43, 10.1038/nmicrobiol.2016.43]; Matos JL, 2008, FEBS LETT, V582, P3343, DOI 10.1016/j.febslet.2008.08.025; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; Mingossi FB, 2010, PLANT MOL BIOL, V73, P271, DOI 10.1007/s11103-010-9613-8; Murphy E, 2014, TRENDS PLANT SCI, V19, P664, DOI 10.1016/j.tplants.2014.06.005; Osterrieder A, 2010, J EXP BOT, V61, P405, DOI 10.1093/jxb/erp315; Pearce G, 2001, P NATL ACAD SCI USA, V98, P12843, DOI 10.1073/pnas.201416998; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; Popescu SC, 2007, P NATL ACAD SCI USA, V104, P4730, DOI 10.1073/pnas.0611615104; Scheer JM, 2005, PLANTA, V221, P667, DOI 10.1007/s00425-004-1442-z; Scholz SS, 2014, MOL PLANT, V7, P1712, DOI 10.1093/mp/ssu102; Snedden WA, 2001, NEW PHYTOL, V151, P35, DOI 10.1046/j.1469-8137.2001.00154.x; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Srivastava R, 2009, PLANT J, V59, P930, DOI 10.1111/j.1365-313X.2009.03926.x; Stegmann M, 2017, SCIENCE, V355, P287, DOI 10.1126/science.aal2541; STINEMETZ CL, 1992, PLANT GROWTH REGUL, V11, P419, DOI 10.1007/BF00130651; SUN DY, 1995, PLANT CELL PHYSIOL, V36, P133; SUN DY, 1994, PLANT SCI, V99, P1, DOI 10.1016/0168-9452(94)90114-7; Vanderbeld B, 2007, PLANT MOL BIOL, V64, P683, DOI 10.1007/s11103-007-9189-0; Wang QL, 2009, J BIOL CHEM, V284, P12000, DOI 10.1074/jbc.M808028200; Weigel D., 2002, ARABIDOPSIS LAB MANU; Wu JS, 2007, PLANT J, V52, P877, DOI 10.1111/j.1365-313X.2007.03289.x; Yamaguchi T, 2005, P NATL ACAD SCI USA, V102, P16107, DOI 10.1073/pnas.0504437102; Zhao Q, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00807	66	25	26	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2159	2171		10.1074/jbc.M117.808881	http://dx.doi.org/10.1074/jbc.M117.808881			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29282286	hybrid, Green Published			2022-12-26	WOS:000424948000027
J	Moody, RR; Lo, MC; Meagher, JL; Lin, CC; Stevers, NO; Tinsley, SL; Jung, I; Matvekas, A; Stuckey, JA; Sun, DX				Moody, Rebecca Reed; Lo, Miao-Chia; Meagher, Jennifer L.; Lin, Chang-Ching; Stevers, Nicholas O.; Tinsley, Samantha L.; Jung, Inkyung; Matvekas, Aleksas; Stuckey, Jeanne A.; Sun, Duxin			Probing the interaction between the histone methyltransferase/deacetylase subunit RBBP4/7 and the transcription factor BCL11A in epigenetic complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; cancer stem cells; crystal structure; epigenetics; histone chaperone; protein complex; protein-protein interaction; BCL11A; RBBP4; TNBC	NEGATIVE BREAST-CANCER; FETAL-HEMOGLOBIN EXPRESSION; STEM-CELLS; REPRESSOR COMPLEX; DRUG-RESISTANCE; MAMMALIAN-CELLS; PROTEIN COMPLEX; METASTASIS; NURD; METHYLATION	The transcription factor BCL11A has recently been reported to be a driving force in triple-negative breast cancer (TNBC), contributing to the maintenance of a chemoresistant breast cancer stem cell (BCSC) population. Although BCL11A was shown to suppress -globin and p21 and to induce MDM2 expression in the hematopoietic system, its downstream targets in TNBC are still unclear. For its role in transcriptional repression, BCL11A was found to interact with several corepressor complexes; however, the mechanisms underlying these interactions remain unknown. Here, we reveal that BCL11A interacts with histone methyltransferase (PRC2) and histone deacetylase (NuRD and SIN3A) complexes through their common subunit, RBBP4/7. In fluorescence polarization assays, we show that BCL11A competes with histone H3 for binding to the negatively charged top face of RBBP4. To define that interaction, we solved the crystal structure of RBBP4 in complex with an N-terminal peptide of BCL11A (residues 2-16, BCL11A(2-16)). The crystal structure identifies novel interactions between BCL11A and the side of the -propeller of RBBP4 that are not seen with histone H3. We next show that BCL11A(2-16) pulls down RBBP4, RBBP7, and other components of PRC2, NuRD, and SIN3A from the cell lysate of the TNBC cell line SUM149. Furthermore, we demonstrate the therapeutic potential of targeting the RBBP4-BCL11A binding by showing that a BCL11A peptide can decrease aldehyde dehydrogenase-positive BCSCs and mammosphere formation capacity in SUM149. Together, our findings have uncovered a previously unidentified mechanism that BCL11A may use to recruit epigenetic complexes to regulate transcription and promote tumorigenesis.	[Moody, Rebecca Reed; Sun, Duxin] Univ Michigan, Chem Biol Program, Ann Arbor, MI 48109 USA; [Moody, Rebecca Reed; Lo, Miao-Chia; Lin, Chang-Ching; Stevers, Nicholas O.; Tinsley, Samantha L.; Jung, Inkyung; Matvekas, Aleksas; Sun, Duxin] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Meagher, Jennifer L.; Stuckey, Jeanne A.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Stuckey, Jeanne A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sun, DX (corresponding author), Univ Michigan, Chem Biol Program, Ann Arbor, MI 48109 USA.; Lo, MC; Sun, DX (corresponding author), Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA.	miaoclo@umich.edu; duxins@umich.edu	Sun, Duxin/AAA-1774-2022	Lin, Chang-Ching/0000-0001-6659-5543; Stevers, Nicholas/0000-0003-1082-6423; Tinsley, Samantha Lauren/0000-0002-8761-5504	DOE Office of Science [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; NCI, National Institutes of Health [P30CA046592]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor Grant 085P1000817. Research reported in this publication was supported by the NCI, National Institutes of Health under award number P30CA046592 (for flow cytometry).	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balboula AZ, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.128298; Bricogne G, 2017, BUSTER VERSION 2 10; Brown R, 2014, NAT REV CANCER, V14, P747, DOI 10.1038/nrc3819; Cakouros D, 2012, MOL CELL BIOL, V32, P1433, DOI 10.1128/MCB.06315-11; Cetin I, 2014, ASIAN PAC J CANCER P, V15, P2427, DOI 10.7314/APJCP.2014.15.6.2427; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Connarn JN, 2014, J BIOL CHEM, V289, P2908, DOI 10.1074/jbc.M113.519421; Davidovich C, 2014, NUCLEIC ACIDS RES, V42, P9236, DOI 10.1093/nar/gku540; Deng L, 2014, CANCER RES, V74, P6648, DOI 10.1158/0008-5472.CAN-13-3710; Dias C, 2016, AM J HUM GENET, V99, P253, DOI 10.1016/j.ajhg.2016.05.030; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fu JJ, 2011, CELL RES, V21, P275, DOI 10.1038/cr.2010.118; Gangemi R, 2009, CURR MED CHEM, V16, P1688, DOI 10.2174/092986709788186147; Gao C, 2013, BLOOD, V121, P1413, DOI 10.1182/blood-2012-04-424275; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Jene-Sanz A, 2013, MOL CELL BIOL, V33, P3951, DOI 10.1128/MCB.00426-13; Kagara N, 2012, AM J PATHOL, V181, P257, DOI 10.1016/j.ajpath.2012.03.019; Khaled WT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6987; Kloet SL, 2015, FEBS J, V282, P1774, DOI 10.1111/febs.12972; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lejon S, 2011, J BIOL CHEM, V286, P1196, DOI 10.1074/jbc.M110.195842; Liu ST, 2013, INT J PHOTOENERGY, V2013, DOI 10.1155/2013/172010; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Millard CJ, 2016, ELIFE, V5, DOI 10.7554/eLife.13941; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Munoz P, 2012, MOL ONCOL, V6, P620, DOI 10.1016/j.molonc.2012.10.006; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Saathoff H, 2015, BIOORGAN MED CHEM, V23, P960, DOI 10.1016/j.bmc.2015.01.023; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Tong ZT, 2012, ONCOGENE, V31, P583, DOI 10.1038/onc.2011.254; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110	43	32	33	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2125	2136		10.1074/jbc.M117.811463	http://dx.doi.org/10.1074/jbc.M117.811463			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29263092	hybrid, Green Published			2022-12-26	WOS:000424948000024
J	Haselier, C; Biswas, S; Rosch, S; Thumann, G; Muller, F; Walter, P				Haselier, Christine; Biswas, Sonia; Roesch, Sarah; Thumann, Gabriele; Mueller, Frank; Walter, Peter			Correlations between specific patterns of spontaneous activity and stimulation efficiency in degenerated retina	PLOS ONE			English	Article							ELECTRICALLY-EVOKED RESPONSE; PHOTORECEPTOR CELL-DEATH; RD10 MOUSE MODEL; GANGLION-CELLS; VISUAL-SYSTEM; THRESHOLDS; NETWORK; MICE; EER	Retinal prostheses that are currently used to restore vision in patients suffering from retinal degeneration are not adjusted to the changes occurring during the remodeling process of the retina. Recent studies revealed abnormal rhythmic activity in the retina of genetic mouse models of retinitis pigmentosa. Here we describe this abnormal activity also in a pharmacologically-induced (MNU) mouse model of retinal degeneration. To investigate how this abnormal activity affects the excitability of retinal ganglion cells, we recorded the electrical activity from whole mounted retinas of rd10 mice and MNU-treated mice using a microelectrode array system and applied biphasic current pulses of different amplitude and duration to stimulate ganglion cells electrically. We show that the electrical stimulation efficiency is strongly reduced in degenerated retinas, in particular when abnormal activity such as oscillations and rhythmic firing of bursts of action potentials can be observed. Using a prestimulus pulse sequence, we could abolish rhythmic retinal activity. Under these conditions, the stimulation efficiency was enhanced in a few cases but not in the majority of tested cells. Nevertheless, this approach supports the idea that modified stimulation protocols could help to improve the efficiency of retinal prostheses in the future.	[Haselier, Christine; Roesch, Sarah; Thumann, Gabriele; Walter, Peter] Rhein Westfal TH Aachen, Dept Ophthalmol, Aachen, Germany; [Biswas, Sonia; Mueller, Frank] Forschungszentrum Julich GmbH, Inst Complex Syst, Cellular Biophys, ICS 4, Julich, Germany; [Roesch, Sarah] Univ Leipzig, Clin Dept Small Animals, Leipzig, Germany; [Thumann, Gabriele] Hop Univ Geneva, Dept Neurosci Clin, Serv Ophthalmol, Geneva, Switzerland	RWTH Aachen University; Helmholtz Association; Research Center Julich; Leipzig University; University of Geneva	Walter, P (corresponding author), Rhein Westfal TH Aachen, Dept Ophthalmol, Aachen, Germany.	PWalter@ukaachen.de	Walter, Peter/L-5982-2018	Walter, Peter/0000-0001-8745-6593	Deutsche Forschungsgemeinschaft [TH 603/15-1, MU 3036/3-1, MU 3036/2-1, WA 1472/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (www.dfg.de) to GT (TH 603/15-1), FM (MU 3036/3-1 and MU 3036/2-1), and PW (WA 1472/6-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; Biswas S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099075; Bittner AK, 2009, RETINA-J RET VIT DIS, V29, P1513, DOI 10.1097/IAE.0b013e3181af0d57; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chen YY, 2014, EXP EYE RES, V121, P102, DOI 10.1016/j.exer.2013.12.019; Dagar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090250; Feucht M, 2005, OPHTHALMOLOGE, V102, P688, DOI 10.1007/s00347-005-1186-6; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Goo YS, 2011, KOREAN J PHYSIOL PHA, V15, P415, DOI 10.4196/kjpp.2011.15.6.415; Goo YS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/035003; HECKENLIVELY JR, 1988, AM J OPHTHALMOL, V105, P504, DOI 10.1016/0002-9394(88)90242-5; Humayun MS, 1999, VISION RES, V39, P2569, DOI 10.1016/S0042-6989(99)00052-8; Jae SA, 2013, KOREAN J PHYSIOL PHA, V17, P229, DOI 10.4196/kjpp.2013.17.3.229; Jensen RJ, 2008, VISION RES, V48, P1562, DOI 10.1016/j.visres.2008.04.016; Jones BW, 2012, JPN J OPHTHALMOL, V56, P289, DOI 10.1007/s10384-012-0147-2; Kanda H, 2004, INVEST OPHTH VIS SCI, V45, P560, DOI 10.1167/iovs.02-1268; Kent TL, 2008, INVEST OPHTH VIS SCI, V49, P372, DOI 10.1167/iovs.07-0952; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Marc RE, 2007, INVEST OPHTH VIS SCI, V48, P3364, DOI 10.1167/iovs.07-0032; Margalit E, 2011, VISUAL NEUROSCI, V28, P145, DOI 10.1017/S0952523810000489; Margolis DJ, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/507037; Mazzoni F, 2008, J NEUROSCI, V28, P14282, DOI 10.1523/JNEUROSCI.4968-08.2008; Menzler J, 2011, J NEUROSCI, V31, P2280, DOI 10.1523/JNEUROSCI.4238-10.2011; Nagar S, 2009, NEUROSCIENCE, V160, P517, DOI 10.1016/j.neuroscience.2009.02.056; Nambu H, 1997, PATHOL INT, V47, P377, DOI 10.1111/j.1440-1827.1997.tb04511.x; O'Hearn TM, 2006, VISION RES, V46, P3198, DOI 10.1016/j.visres.2006.03.031; Phillips MJ, 2010, J COMP NEUROL, V518, P2071, DOI 10.1002/cne.22322; POTTS AM, 1968, INVEST OPHTH VISUAL, V7, P269; POTTS AM, 1969, INVEST OPHTH VISUAL, V8, P605; POTTS AM, 1970, INVEST OPHTH VISUAL, V9, P814; Rizzo JF, 2003, INVEST OPHTH VIS SCI, V44, P5355, DOI 10.1167/iovs.02-0819; Rodriguez-Muela N, 2015, CELL DEATH DIFFER, V22, P476, DOI 10.1038/cdd.2014.203; Rosch S, 2014, INVEST OPHTH VIS SCI, V55, P1711, DOI 10.1167/iovs.13-13242; Sekirnjak C, 2009, J NEUROPHYSIOL, V102, P3260, DOI 10.1152/jn.00663.2009; Shepherd RK, 2013, TRENDS BIOTECHNOL, V31, P562, DOI 10.1016/j.tibtech.2013.07.001; Stasheff SF, 2011, J NEUROPHYSIOL, V105, P3002, DOI 10.1152/jn.00704.2010; Suzuki S, 2004, JPN J OPHTHALMOL, V48, P345, DOI 10.1007/s10384-004-0084-9; Trenholm S, 2012, J PHYSIOL-LONDON, V590, P2501, DOI 10.1113/jphysiol.2011.225060; Tsuruma K, 2012, J PHARMACOL SCI, V118, P351, DOI 10.1254/jphs.11110FP; Ye JH, 2007, PHYSIOL MEAS, V28, P1079, DOI 10.1088/0967-3334/28/9/009; Ye JH, 2010, IEEE ENG MED BIO, P6761, DOI 10.1109/IEMBS.2010.5625998; Ye JH, 2008, IEEE ENG MED BIO, P2465, DOI 10.1109/IEMBS.2008.4649699	44	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190048	10.1371/journal.pone.0190048	http://dx.doi.org/10.1371/journal.pone.0190048			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281713	Green Published, gold			2022-12-26	WOS:000419006200058
J	Kabbadj, A; Makoudi, B; Mouradi, M; Pauly, N; Frendo, P; Ghoulam, C				Kabbadj, Ablaa; Makoudi, Bouchra; Mouradi, Mohammed; Pauly, Nicolas; Frendo, Pierre; Ghoulam, Cherki			Physiological and biochemical responses involved in water deficit tolerance of nitrogen-fixing Vicia faba	PLOS ONE			English	Article							ANTIOXIDANT ENZYME-ACTIVITIES; GLYCINE BETAINE; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; BEAN GENOTYPES; DROUGHT; STRESS; PROLINE; GROWTH; PLANTS	Climate change is increasingly impacting the water deficit over the world. Because of drought and the high pressure of the rising human population, water is becoming a scarce and expensive commodity, especially in developing countries. The identification of crops presenting a higher acclimation to drought stress is thus an important objective in agriculture. The present investigation aimed to assess the adaptation of three Vicia faba genotypes, Aguadulce (AD), Luz d'Otonio (LO) and Reina Mora (RM) to water deficit. Multiple physiological and biochemical parameters were used to analyse the response of the three genotypes to two soil water contents (80% and 40% of field capacity). A significant lower decrease in shoot, root and nodule dry weight was observed for AD compared to LO and RM. The better growth performance of AD was correlated to higher carbon and nitrogen content than in LO and RM under water deficit. Leaf parameters such as relative water content, mass area, efficiency of photosystem II and chlorophyll and carotenoid content were significantly less affected in AD than in LO and RM. Significantly higher accumulation of proline was correlated to the higher performance of AD compared to LO and RM. Additionally, the better growth of AD genotype was related to an important mobilisation of antioxidant enzyme activities such as ascorbate peroxidase and catalase. Taken together, these results allow us to suggest that AD is a water deficit tolerant genotype compared to LO and RM. Our multiple physiological and biochemical analyses show that nitrogen content, leaf proline accumulation, reduced leaf hydrogen peroxide accumulation and leaf antioxidant enzymatic activities (ascorbate peroxidase, guaiacol peroxidase, catalase and polyphenol oxidase) are potential biological markers useful to screen for water deficit resistant Vicia faba genotypes.	[Kabbadj, Ablaa; Makoudi, Bouchra; Mouradi, Mohammed; Ghoulam, Cherki] Fac Sci & Tech, Unit Plant Biotechnol & Symbiosis Agrophysiol, Gueliz, Marrakesh, Morocco; [Kabbadj, Ablaa; Pauly, Nicolas; Frendo, Pierre] Univ Cote Azur, INRA, CNRS, ISA, Nice, France	Cadi Ayyad University of Marrakech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Ghoulam, C (corresponding author), Fac Sci & Tech, Unit Plant Biotechnol & Symbiosis Agrophysiol, Gueliz, Marrakesh, Morocco.	c.ghoulam@uca.ma	Pauly, Nicolas/L-1484-2015; Mouradi, Mohammed/G-2284-2014	Pauly, Nicolas/0000-0003-2990-3150; Mouradi, Mohammed/0000-0002-6216-9683; Frendo, Pierre/0000-0002-4578-3366	Franco-Moroccan Partenariat Hubert Curien (PHC) Programme de Recherche Agronomique pour le Developpement (PRAD) [28048TD]	Franco-Moroccan Partenariat Hubert Curien (PHC) Programme de Recherche Agronomique pour le Developpement (PRAD)	Our study was financially supported by the Franco-Moroccan Partenariat Hubert Curien (PHC) Programme de Recherche Agronomique pour le Developpement (PRAD; 28048TD) to NP and CG and was carried out within the framework of EnviMED program (DEMOSYM) to PF.	Abid G, 2016, ARCH AGRON SOIL SCI, V340, P1; Abid G, 2017, BIOTECHNOL AGRON SOC, V21, P146; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Alderfasi A. A., 2010, AM EURAS J AGRON, V3, P8; Annicchiarico P, 2008, CROP SCI, V48, P983, DOI 10.2135/cropsci2007.09.0501; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Berger J, 2016, PLANT SCI, V253, P58, DOI 10.1016/j.plantsci.2016.09.007; Bohnert HJ, 2006, CURR OPIN PLANT BIOL, V9, P180, DOI 10.1016/j.pbi.2006.01.003; Boncompagni E, 1999, APPL ENVIRON MICROB, V65, P2072; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brhada F, 1997, CURR MICROBIOL, V34, P167, DOI 10.1007/s002849900163; Chavan JK, 1989, HDB WORLD FOOD LEGUM, VI, P223; CHEN GX, 1992, PLANT CELL PHYSIOL, V33, P117; Coleto I, 2014, ANN BOT-LONDON, V113, P1071, DOI 10.1093/aob/mcu029; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; Dichio B, 2003, PLANT SOIL, V257, P381, DOI 10.1023/A:1027392831483; El-Tayab M. A., 2006, Acta Agronomica Hungarica, V54, P25, DOI 10.1556/AAgr.54.2006.1.3; El-Tayeb M. A., 2000, Acta Agronomica Hungarica, V48, P11, DOI 10.1556/AAgr.48.2000.1.2; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Farooq M, 2014, CRIT REV PLANT SCI, V33, P331, DOI 10.1080/07352689.2014.875291; FIELDING JL, 1978, J EXP BOT, V29, P969, DOI 10.1093/jxb/29.4.969; Fita A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00978; Gholami M, 2012, SCI HORTIC-AMSTERDAM, V143, P7, DOI 10.1016/j.scienta.2012.05.012; Ghoulam C, 2002, ENVIRON EXP BOT, V47, P39, DOI 10.1016/S0098-8472(01)00109-5; GRIEVE CM, 1983, PLANT SOIL, V70, P303, DOI 10.1007/BF02374789; HARTMANN A, 1983, CAN J MICROBIOL, V29, P916, DOI 10.1139/m83-147; HAVIR EA, 1987, PLANT PHYSIOL, V84, P450, DOI 10.1104/pp.84.2.450; Hayat S, 2012, PLANT SIGNAL BEHAV, V7, P1456, DOI 10.4161/psb.21949; Hori K, 1997, APPL ENTOMOL ZOOL, V32, P365, DOI 10.1303/aez.32.365; Horie T, 2011, PLANT CELL PHYSIOL, V52, P663, DOI 10.1093/pcp/pcr027; Jamet A, 2003, MOL PLANT MICROBE IN, V16, P217, DOI 10.1094/MPMI.2003.16.3.217; Jifon JL, 2003, TREE PHYSIOL, V23, P119, DOI 10.1093/treephys/23.2.119; Khan HR, 2010, FIELD CROP RES, V115, P279, DOI 10.1016/j.fcr.2009.09.003; Khan HUR, 2007, PLANT SOIL, V292, P205, DOI 10.1007/s11104-007-9217-5; KLAPHECK S, 1990, PLANT CELL PHYSIOL, V31, P1005; Kopke U, 2010, FIELD CROP RES, V115, P217, DOI 10.1016/j.fcr.2009.10.012; Le Thiec D, 2003, PLANT PHYSIOL BIOCH, V41, P55, DOI 10.1016/S0981-9428(02)00009-8; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Matamoros MA, 2003, PLANT PHYSIOL, V133, P499, DOI 10.1104/pp.103.025619; Mhadhbi H, 2005, PHYSIOL PLANTARUM, V124, P4, DOI 10.1111/j.1399-3054.2005.00489.x; Mhadhbi H, 2004, PLANT PHYSIOL BIOCH, V42, P717, DOI 10.1016/j.plaphy.2004.07.005; Mhadhbi H, 2009, J AGRON CROP SCI, V195, P225, DOI 10.1111/j.1439-037X.2009.00361.x; Migdadi HM, 2016, J ANIM PLANT SCI, V26, P1772; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mouradi M, 2016, ARID L RES MANAG, V30; Murchie EH, 2013, J EXP BOT, V64, P3983, DOI 10.1093/jxb/ert208; Nandwal AS, 2007, J PLANT PHYSIOL, V164, P1161, DOI 10.1016/j.jplph.2006.05.017; Noctor G, 2014, PLANT PHYSIOL, V164, P1636, DOI 10.1104/pp.113.233478; Orikasa Y, 2010, J BIOSCI BIOENG, V110, P397, DOI 10.1016/j.jbiosc.2010.04.007; Puppo A, 2013, ANTIOXID REDOX SIGN, V18, P2202, DOI 10.1089/ars.2012.5136; Rao KVM, 2000, PLANT SCI, V157, P113, DOI 10.1016/S0168-9452(00)00273-9; Ricciardi L, 2001, EUPHYTICA, V118, P39, DOI 10.1023/A:1004078017159; Sanchez-Blanco MJ, 2002, PLANT SCI, V162, P107, DOI 10.1016/S0168-9452(01)00540-4; Scheibe R, 2011, ECOL STUD-ANAL SYNTH, V215, P209, DOI 10.1007/978-3-642-19106-0_11; Siddiqui MH, 2015, INT J MOL SCI, V16, P10214, DOI 10.3390/ijms160510214; Soja G., 1988, FABIS Newsletter, Faba Bean Information Service, ICARDA, P20; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Takele A, 2010, AGR SCI CHINA, V9, P813, DOI 10.1016/S1671-2927(09)60159-0; Tejera NA, 2004, J PLANT PHYSIOL, V161, P329, DOI 10.1078/0176-1617-01050; Tilahun Amede, 2003, Sinet, Ethiopian Journal of Science, V26, P37; Toker C, 2004, HEREDITAS, V140, P222, DOI 10.1111/j.1601-5223.2004.01780.x; Velikova V, 2000, PLANT SCI, V151, P59, DOI 10.1016/S0168-9452(99)00197-1; Verdoy D, 2006, PLANT CELL ENVIRON, V29, P1913, DOI 10.1111/j.1365-3040.2006.01567.x; You J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01092; Zheng ZL, 2009, PLANT SIGNAL BEHAV, V4, P584, DOI 10.4161/psb.4.7.8540; Zlatev ZS, 2013, EMIR J FOOD AGR, V25, P1014, DOI 10.9755/ejfa.v25i12.16734	68	22	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190284	10.1371/journal.pone.0190284	http://dx.doi.org/10.1371/journal.pone.0190284			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281721	Green Published, gold, Green Submitted			2022-12-26	WOS:000419006200079
J	Mota, GS; Sartori, CJ; Miranda, I; Quilho, T; Mori, FA; Pereira, H				Mota, Graciene S.; Sartori, Caroline J.; Miranda, Isabel; Quilho, Teresa; Mori, Fabio Akira; Pereira, Helena			Bark anatomy, chemical composition and ethanol-water extract composition of Anadenanthera peregrina and Anadenanthera colubrina	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; TANNINS; CORK; VARIABILITY; GRANDIS; PHLOEM; BRAZIL; VIEW	The bark of Anadenanthera peregrina (L.) Speg and Anadenanthera colubrina (Vell.) Brenan were characterized in relation to anatomical and chemical features. The barks were similar and included a thin conducting phloem, a largely dilated and sclerified non-conducting phloem, and a rhyridome with periderms with thin phellem interspersed by cortical tissues. Only small differences between species were observed that cannot be used alone for taxonomic purposes. The summative chemical composition of A. peregrina and A. colubrina was respectively: 8.2% and 7.7% ash; 28.8% and 29.3% extractives; 2.4% and 2.6% suberin; and 18.9% lignin. The monosaccharide composition showed the predominance of glucose (on average 82% of total neutral sugars) and of xylose (9%). The ethanol-water extracts of A. peregrina and A. colubrina barks included a high content of phenolics, respectively: total phenolics 583 and 682 mg GAE/g extract; 148 and 445 mg CE/g extract; tannins 587 and 98 mg CE/g extract. The antioxidant activity was 238 and 269 mg Trolox/g extract. The barks of the Anadenanthera species are a potential source of polar extractives that will represent an important valorization and therefore contribute to improve the overall economic potential and sustainability of A. peregrina and A. colubrina	[Mota, Graciene S.] Univ Fed Lavras, Dept Ciencias Biol, Lavras, MG, Brazil; [Sartori, Caroline J.; Mori, Fabio Akira] Univ Fed Lavras, Dept Ciencias Florestais, Lavras, MG, Brazil; [Miranda, Isabel; Quilho, Teresa; Pereira, Helena] Univ Lisbon, Inst Super Agron, Ctr Estudos Florestais, Lisbon, Portugal	Universidade Federal de Lavras; Universidade Federal de Lavras; Universidade de Lisboa	Mota, GS (corresponding author), Univ Fed Lavras, Dept Ciencias Biol, Lavras, MG, Brazil.	motagraciene7@gmail.com	Mori, Fabio/AAP-8571-2021; Pereira, Helena/V-5236-2019; Quilhó, Teresa/AAM-7149-2021	Mori, Fabio/0000-0002-7468-018X; Pereira, Helena/0000-0002-5393-4443; Quilhó, Teresa/0000-0001-8353-3459; Miranda, Isabel/0000-0003-0280-5219; Mota, Graciene/0000-0002-6977-4149	Individual PhD Sandwich Scholarships of CAPES (Coordenacao de Apoio ao Pessoal de Nivel Superior, Brazil); FAPEMIG (Fundacao de Apoio a Pesquisa do Estado de Minas Gerais, Brazil); CNPq (Conselho Nacional de Pesquisa Cientifica, Brazil); FCT - Fundacao para a Ciencia e a Tecnologia, Portugal [UID/AGR/00239/2013]	Individual PhD Sandwich Scholarships of CAPES (Coordenacao de Apoio ao Pessoal de Nivel Superior, Brazil); FAPEMIG (Fundacao de Apoio a Pesquisa do Estado de Minas Gerais, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (Conselho Nacional de Pesquisa Cientifica, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FCT - Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	Graciene S. Mota and Caroline J. Sartori were supported by Individual PhD Sandwich Scholarships of CAPES (Coordenacao de Apoio ao Pessoal de Nivel Superior, Brazil), and this work was financially supported by FAPEMIG (Fundacao de Apoio a Pesquisa do Estado de Minas Gerais, Brazil) and CNPq (Conselho Nacional de Pesquisa Cientifica, Brazil). This work is part of the research activities of Centro de Estudos Florestais (CEF), a research unit supported by FCT - Fundacao para a Ciencia e a Tecnologia, Portugal, under UID/AGR/00239/2013.	Abdalla S, 2014, BIORESOURCES, V9, P3396; Altschul SVR, 1964, CONTRIBUTIONS GRAY H, V193, P3; Angyalossy V, 2016, IAWA J, V37, P517, DOI 10.1163/22941932-20160151; ARCHER RH, 1993, IAWA J, V14, P35, DOI 10.1163/22941932-90000574; Baitelo JB, 1997, SEMENTES MUDAS ARVOR; Baptista I, 2013, IND CROP PROD, V50, P166, DOI 10.1016/j.indcrop.2013.07.004; Boatwright JS, 2009, S AFR J BOT, V75, P546, DOI 10.1016/j.sajb.2009.06.001; Carvalho PER, 2003, EMBRAPA INFORMACA GI; CHATTAWAY MARGARET M., 1953, AUSTRALIAN JOUR BOT, V1, P402, DOI 10.1071/BT9530402; Costa CG, 1997, IAWA J, V18, P385, DOI 10.1163/22941932-90001504; Damascena NP, 2014, NAT PROD RES, V28, P753, DOI 10.1080/14786419.2013.877902; de Souza Sales Rocha Eveline Angelica Lira, 2013, Revista de Ciencias Farmaceuticas Basica e Aplicada, V34, P351; Valente BMDT, 2013, SCI FOR, V41, P485; Esau K, 1969, PHLOEM ENCY PLANT AN; Ferreira JPA, 2015, IND CROP PROD, V74, P998, DOI 10.1016/j.indcrop.2015.05.065; Foelkel C, 2006, CASCA ARVORE EUCALIP; Francisco TM, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22615; FURUNO T, 1990, IAWA BULL, V11, P239, DOI 10.1163/22941932-90001181; Janceva S, 2011, ENVIRONMENT, TECHNOLOGY, RESOURCES, PROCEEDINGS OF THE 8TH INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE, 2011, VOL I, P265; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kenicer G, 2005, ENDINB J BOT, V62, P195; Krishnappa P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/507851; Lima MA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-75; Lorenzi, 2009, ARVORES BRASILEIRAS; Lorenzi H, 2002, MAN ID CULT PLANT AR; Maia, 2012, CAATINGA ARVORES ARB; Metcalfe C.R., 1950, ANATOMY DICOTYLEDONS; Miranda I, 2016, IND CROP PROD, V82, P81, DOI 10.1016/j.indcrop.2015.12.003; Miranda I, 2013, IND CROP PROD, V41, P299, DOI 10.1016/j.indcrop.2012.04.024; Miranda I, 2012, IND CROP PROD, V36, P395, DOI 10.1016/j.indcrop.2011.10.035; Monteiro JM, 2006, J ETHNOPHARMACOL, V105, P173, DOI 10.1016/j.jep.2005.10.016; Mori CLSO, 2003, BRASIL FLORESTAL BRA, V77, P29; Outer RW, 1976, ACTA BOT NEERL, V25, P481; Paes JB, 2013, REV CAATINGA, V26, P22; PATEL RN, 1985, NEW ZEAL J BOT, V23, P511, DOI 10.1080/0028825X.1985.10434225; PEREIRA H, 1988, WOOD SCI TECHNOL, V22, P211, DOI 10.1007/BF00386015; Pereira H., 2011, CORK BIOL PRODUCTION; Pereira H, 2015, BIORESOURCES, V10, P6207; POTGIETER MJ, 1994, IAWA J, V15, P161, DOI 10.1163/22941932-90001358; Queiroz L. P. de, 2009, LEGUMINOSAS CAATINGA; Quilho T, 1999, IAWA J, V20, P171, DOI 10.1163/22941932-90000677; Quilho T, 2000, IAWA J, V21, P31, DOI 10.1163/22941932-90000234; ROTH I, 1981, ENCY PLANT ANATOMY 3, V9; Santos JS, 2013, J ETHNOPHARMACOL, V148, P218, DOI 10.1016/j.jep.2013.04.012; Santos SAO, 2012, IND CROP PROD, V39, P120, DOI 10.1016/j.indcrop.2012.02.003; Sartori C, 2016, HOLZFORSCHUNG, P1; Sartori CJ, 2014, FLORESTA AMBIENTE, V21, P394, DOI 10.1590/2179-8087.061113; Sartori CJ, 2014, CERNE, V20, P239, DOI 10.1590/01047760.201420021512; Sen A, 2010, IND CROP PROD, V31, P417, DOI 10.1016/j.indcrop.2010.01.002; Sharma OP, 2009, FOOD CHEM, V113, P1202, DOI 10.1016/j.foodchem.2008.08.008; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Suckow I. M. S., 2009, IF SERIE REGISTROS, V40, P131; Sulaiman CT, 2012, INDIAN J PHARM SCI, V74, P258, DOI 10.4103/0250-474X.106069; Sultana B, 2007, FOOD CHEM, V104, P1106, DOI 10.1016/j.foodchem.2007.01.019; Trentin DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066257; TROCKENBRODT M, 1995, ANN BOT-LONDON, V75, P281, DOI 10.1006/anbo.1995.1022; TROCKENBRODT M, 1986, IAWA BULL, V7, P62, DOI 10.1163/22941932-90000442	57	21	22	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189263	10.1371/journal.pone.0189263	http://dx.doi.org/10.1371/journal.pone.0189263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281656	Green Submitted, Green Published, gold			2022-12-26	WOS:000419006200018
J	Strutzenberger, P; Brehm, G; Gottsberger, B; Bodner, F; Seifert, CL; Fiedler, K				Strutzenberger, Patrick; Brehm, Gunnar; Gottsberger, Brigitte; Bodner, Florian; Seifert, Carlo Lutz; Fiedler, Konrad			Diversification rates, host plant shifts and an updated molecular phylogeny of Andean Eois moths (Lepidoptera: Geometridae)	PLOS ONE			English	Article							SPECIES RICHNESS; CLEARWING BUTTERFLIES; BIOLOGICAL DIVERSITY; EVOLUTION; GRADIENT; ORIGIN; BIODIVERSITY; LARENTIINAE; COMMUNITIES; SPECIATION	Eois is one of the best-investigated genera of tropical moths. Its close association with Piper plants has inspired numerous studies on life histories, phylogeny and evolutionary biology. This study provides an updated view on phylogeny, host plant use and temporal patterns of speciation in Eois. Using sequence data (2776 bp) from one mitochondrial (COI) and one nuclear gene (Ef1-alpha) for 221 Eois species, we confirm and reinforce previous findings regarding temporal patterns of diversification. Deep diversification within Andean Eois took place in the Miocene followed by a sustained high rate of diversification until the Pleistocene when a pronounced slowdown of speciation is evident. In South America, Eois diversification is very likely to be primarily driven by the Andean uplift which occurred concurrently with the entire evolutionary history of Eois. A massively expanded dataset enabled an in-depth look into the phylogenetic signal contained in host plant usage. This revealed several independent shifts from Piper to other host plant genera and families. Seven shifts to Peperomia, the sister genus of Piper were detected, indicating that the shift to Peperomia was an easy one compared to the singular shifts to the Chloranthaceae, Siparunaceae and the Piperacean genus Manekia. The potential for close co-evolution of Eois with Piper host plants is therefore bound to be limited to smaller subsets within Neotropical Eois instead of a frequently proposed genus-wide co-evolutionary scenario. In regards to Eois systematics we confirm the monophyly of Neotropical Eois in relation to their Old World counterparts. A tentative biogeographical hypothesis is presented suggesting that Eois originated in tropical Asia and subsequently colonized the Neotropics and Africa. Within Neotropical Eois we were able to identify the existence of six clades not recognized in previous studies and confirm and reinforce the monophyly of all 9 previously delimited infrageneric clades.	[Strutzenberger, Patrick; Gottsberger, Brigitte; Bodner, Florian; Fiedler, Konrad] Univ Vienna, Div Trop Ecol & Anim Biodivers, Dept Bot & Biodivers Res, Vienna, Austria; [Brehm, Gunnar] Friedrich Schiller Univ Jena, Inst Spezielle Zool & Evolut Biol, Phyletischem Museum, Jena, Germany; [Seifert, Carlo Lutz] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Seifert, Carlo Lutz] Czech Acad Sci, Biol Ctr, Dept Ecol, Inst Entomol, Ceske Budejovice, Czech Republic	University of Vienna; Friedrich Schiller University of Jena; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Strutzenberger, P (corresponding author), Univ Vienna, Div Trop Ecol & Anim Biodivers, Dept Bot & Biodivers Res, Vienna, Austria.	patrick.strutzenberger@univie.ac.at	Seifert, Carlo L./ABI-6483-2020; Casagrande, Mirna M/C-4590-2013; Fiedler, Konrad/H-8788-2019	Seifert, Carlo L./0000-0002-2295-2833; Casagrande, Mirna M/0000-0002-6076-8463; Fiedler, Konrad/0000-0002-4789-3753; Gottsberger, Brigitte/0000-0002-6317-306X; Strutzenberger, Patrick/0000-0003-3278-5693	Deutsche Forschungsgemeinschaft (DFG) [Fi 547/10-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funded by Deutsche Forschungsgemeinschaft (DFG) Fi 547/10-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2011, SYST BIOL, V60, P596, DOI 10.1093/sysbio/syr062; Antonelli A, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P386; Bergamini LL, 2017, OIKOS, V126, P703, DOI 10.1111/oik.03567; Blies D, 2014, THESIS, P1; Bodner F, 2012, NEOTROP ENTOMOL, V41, P375, DOI 10.1007/s13744-012-0066-4; Bodner F., 2011, THESIS; Bodner F, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.6701; Borer M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-310; Brehm Gunnar, 1999, Journal of Research on the Lepidoptera, V38, P1; Brehm G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150327; Brehm G, 2013, ECOGRAPHY, V36, P1247, DOI 10.1111/j.1600-0587.2013.00030.x; Brehm G, 2011, ANN ENTOMOL SOC AM, V104, P1091, DOI 10.1603/AN10050; Chazot N, 2016, MOL ECOL, V25, P5765, DOI 10.1111/mec.13773; Choi S.-W., 2012, INSECT FAUNA KOREA, V16; Cisneros LM, 2014, J ANIM ECOL, V83, P1124, DOI 10.1111/1365-2656.12201; Colwell RK, 2013, ESTIMATES STAT ESTIM; CONNAHS H, 2009, J INSECT SCI, V9, pNIL13; Davis CC, 2005, AM NAT, V165, pE36, DOI 10.1086/428296; De-Silva DL, 2017, SCI REP-UK, V7, DOI 10.1038/srep45966; De-Silva DL, 2016, J BIOGEOGR, V43, P44, DOI 10.1111/jbi.12611; Drummond AJ., 2015, BAYESIAN EVOLUTIONAR, DOI DOI 10.1017/CBO9781139095112; Dumont ER, 2012, P ROY SOC B-BIOL SCI, V279, P1797, DOI 10.1098/rspb.2011.2005; Dyer LA, 2004, PIPER MODEL GENUS ST; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Diniz JAF, 2007, P ROY SOC B-BIOL SCI, V274, P43, DOI 10.1098/rspb.2006.3712; Fine PVA, 2013, ECOLOGY, V94, P1764, DOI 10.1890/12-1920.1; Forbes AA, 2017, EVOLUTION, V71, P1126, DOI 10.1111/evo.13164; Fordyce JA, 2010, P ROY SOC B-BIOL SCI, V277, P3735, DOI 10.1098/rspb.2010.0211; Frenzke L, 2015, TAXON, V64, P424, DOI 10.12705/643.4; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Garzione CN, 2008, SCIENCE, V320, P1304, DOI 10.1126/science.1148615; Glassmire AE, 2016, NEW PHYTOL, V212, P208, DOI 10.1111/nph.14038; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; Groot MHM, 2013, REV PALAEOBOT PALYNO, V197, P186, DOI 10.1016/j.revpalbo.2013.04.005; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hausmann A, 2012, GEOM MOTHS EUR, V3; Hembry DH, 2014, AM NAT, V184, P425, DOI 10.1086/677928; Holloway J. D., 1997, Malayan Nature Journal, V51, P1; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hoorn C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P123; Hovikoski J, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P143; Ignatov II, 2011, ANN ENTOMOL SOC AM, V104, P68, DOI 10.1603/AN09083; JARZEMBOWSKI E. A., 1980, B BRIT MUS NAT HIST, V33, P237; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kergoat GJ, 2017, ADV BOT RES, V81, P25, DOI 10.1016/bs.abr.2016.09.005; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Long EC, 2014, MOL PHYLOGENET EVOL, V79, P69, DOI 10.1016/j.ympev.2014.06.010; Mannion PD, 2014, TRENDS ECOL EVOL, V29, P42, DOI 10.1016/j.tree.2013.09.012; Massad TJ, 2017, ECOLOGY, V98, P1750, DOI 10.1002/ecy.1875; Matos-Maravi P, 2016, EVOLUTION, V70, P1638, DOI 10.1111/evo.12960; Matos-Maravi PF, 2013, MOL PHYLOGENET EVOL, V66, P54, DOI 10.1016/j.ympev.2012.09.005; Matzke N.J., 2013, FRONT BIOGEOGR, V5, P242, DOI [DOI 10.21425/F5FBG19694, 10.21425/F5FBG19694]; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; Moreau CS, 2013, EVOLUTION, V67, P2240, DOI 10.1111/evo.12105; Mullen SP, 2011, P ROY SOC B-BIOL SCI, V278, P1777, DOI 10.1098/rspb.2010.2140; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Novotny V, 2003, ECOL ENTOMOL, V28, P704, DOI 10.1111/j.1365-2311.2003.00558.x; Ounap E, 2008, ZOOL SCR, V37, P405, DOI 10.1111/j.1463-6409.2008.00327.x; Ounap E, 2016, SYST ENTOMOL, V41, P824, DOI 10.1111/syen.12195; Palin OF, 2011, BIOTROPICA, V43, P100, DOI 10.1111/j.1744-7429.2010.00650.x; Popescu AA, 2012, BIOINFORMATICS, V28, P1536, DOI 10.1093/bioinformatics/bts184; Presley SJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P968, DOI 10.1111/j.1466-8238.2011.00738.x; Rabosky DL, 2009, ECOL LETT, V12, P735, DOI 10.1111/j.1461-0248.2009.01333.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Rodriguez-Castaneda G, 2010, ECOL LETT, V13, P1348, DOI 10.1111/j.1461-0248.2010.01525.x; Santos JC, 2009, PLOS BIOL, V7, P448, DOI 10.1371/journal.pbio.1000056; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schmidt O, 2016, BIODIVERS DATA J, V4, DOI 10.3897/BDJ.4.e7938; Seifert CL, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev098; Sihvonen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020356; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Stephens PR, 2003, AM NAT, V161, P112, DOI 10.1086/345091; Strutzenberger P, 2011, J EVOLUTION BIOL, V24, P919, DOI 10.1111/j.1420-9101.2010.02216.x; Strutzenberger P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049710; Strutzenberger P, 2010, ZOOL SCR, V39, P603, DOI 10.1111/j.1463-6409.2010.00440.x; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Tepe EJ, 2014, PHYTOKEYS, V34, P19, DOI 10.3897/phytokeys.34.6376; Thompson J. N., 2005, INTERSPEC INTERACT; Tishechkin DY, 2016, ZOOTAXA, V4121, P117, DOI 10.11646/zootaxa.4121.2.2; Viidalepp J, 2011, ZOOTAXA, P1; Volf M, 2017, J ANIM ECOL, V86, P556, DOI 10.1111/1365-2656.12646; Wilson JS, 2012, J EVOLUTION BIOL, V25, P532, DOI 10.1111/j.1420-9101.2011.02446.x; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; Xue Dayong, 2002, Bulletin of the Natural History Museum Entomology Series, V71, P77; Yamamoto S, 2007, MOL PHYLOGENET EVOL, V44, P711, DOI 10.1016/j.ympev.2006.12.027	86	13	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0188430	10.1371/journal.pone.0188430	http://dx.doi.org/10.1371/journal.pone.0188430			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281664	Green Published, Green Submitted, gold			2022-12-26	WOS:000419006200007
J	Ren, YD; Lv, JL; Guo, L; Fang, J; Guo, CC				Ren, Yudan; Lv, Jinglei; Guo, Lei; Fang, Jun; Guo, Christine Cong			Sparse coding reveals greater functional connectivity in female brains during naturalistic emotional experience	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; TEST-RETEST RELIABILITY; GENDER-DIFFERENCES; MATRIX FACTORIZATION; VIEWING CONDITIONS; SEX-DIFFERENCES; FMRI; NETWORK; REPRESENTATION; ARCHITECTURE	Functional neuroimaging is widely used to examine changes in brain function associated with age, gender or neuropsychiatric conditions. FMRI (functional magnetic resonance imaging) studies employ either laboratory-designed tasks that engage the brain with abstracted and repeated stimuli, or resting state paradigms with little behavioral constraint. Recently, novel neuroimaging paradigms using naturalistic stimuli are gaining increasing attraction, as they offer an ecologically-valid condition to approximate brain function in real life. Wider application of naturalistic paradigms in exploring individual differences in brain function, however, awaits further advances in statistical methods for modeling dynamic and complex dataset. Here, we developed a novel data-driven strategy that employs group sparse representation to assess gender differences in brain responses during naturalistic emotional experience. Comparing to independent component analysis (ICA), sparse coding algorithm considers the intrinsic sparsity of neural coding and thus could be more suitable in modeling dynamic whole-brain fMRI signals. An online dictionary learning and sparse coding algorithm was applied to the aggregated fMRI signals from both groups, which was subsequently factorized into a common time series signal dictionary matrix and the associated weight coefficient matrix. Our results demonstrate that group sparse representation can effectively identify gender differences in functional brain network during natural viewing, with improved sensitivity and reliability over ICA-based method. Group sparse representation hence offers a superior data-driven strategy for examining brain function during naturalistic conditions, with great potential for clinical application in neuropsychiatric disorders.	[Ren, Yudan; Guo, Lei; Fang, Jun] Northwestern Polytech Univ, Sch Automat, Xian, Shaanxi, Peoples R China; [Ren, Yudan; Lv, Jinglei; Guo, Christine Cong] QIMR Berghofer Med Res Inst, Herston, Qld, Australia	Northwestern Polytechnical University; QIMR Berghofer Medical Research Institute	Guo, CC (corresponding author), QIMR Berghofer Med Res Inst, Herston, Qld, Australia.	christine.cong@gmail.com	Guo, Christine/F-4006-2017	Guo, Christine/0000-0003-1530-0172; Lv, Jinglei/0000-0002-4906-2646				Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; Anderson ML, 2013, NEUROIMAGE, V73, P50, DOI 10.1016/j.neuroimage.2013.01.071; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Bartels A, 2004, NEUROIMAGE, V22, P419, DOI 10.1016/j.neuroimage.2004.01.007; Bartels A, 2005, NEUROIMAGE, V24, P339, DOI 10.1016/j.neuroimage.2004.08.044; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Bernhard S., 2007, ADV NEURAL INFORM PR, P801; Bianchin M, 2012, PHYSIOL BEHAV, V105, P925, DOI 10.1016/j.physbeh.2011.10.031; Bigler ED, 2007, DEV NEUROPSYCHOL, V31, P217, DOI 10.1080/87565640701190841; Bordier C, 2013, NEUROIMAGE, V67, P213, DOI 10.1016/j.neuroimage.2012.11.031; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; CALHOUN VD, 2009, FRONT HUM NEUROSCI, V3, DOI DOI 10.3389/NEURO.09.017.2009; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Chen SSB, 2001, SIAM REV, V43, P129, DOI 10.1137/S1064827596304010; Codispoti M, 2008, INT J PSYCHOPHYSIOL, V69, P90, DOI 10.1016/j.ijpsycho.2008.03.004; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Daubechies I, 2009, P NATL ACAD SCI USA, V106, P10415, DOI 10.1073/pnas.0903525106; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Fedorenko E, 2013, P NATL ACAD SCI USA, V110, P16616, DOI 10.1073/pnas.1315235110; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fugate JMB, 2009, BEHAV BRAIN SCI, V32, P394, DOI 10.1017/S0140525X09990203; Gazzaniga M. S., 2004, COGNITIVE NEUROSCIEN; George MS, 1996, BIOL PSYCHIAT, V40, P859, DOI 10.1016/0006-3223(95)00572-2; Griffanti L, 2014, NEUROIMAGE, V95, P232, DOI 10.1016/j.neuroimage.2014.03.034; Guo CC, 2012, NEUROIMAGE, V61, P1471, DOI 10.1016/j.neuroimage.2012.03.027; Guo CL, 2015, INT J ANAL CHEM, V2015, DOI 10.1155/2015/912631; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2010, TRENDS COGN SCI, V14, P40, DOI 10.1016/j.tics.2009.10.011; Hasson U, 2009, AUTISM RES, V2, P220, DOI 10.1002/aur.89; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Kanwisher N, 2010, P NATL ACAD SCI USA, V107, P11163, DOI 10.1073/pnas.1005062107; Kemp AH, 2004, NEUROIMAGE, V21, P632, DOI 10.1016/j.neuroimage.2003.09.055; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Lee K, 2011, IEEE T MED IMAGING, V30, P1076, DOI 10.1109/TMI.2010.2097275; Lee YB, 2016, NEUROIMAGE, V125, P1032, DOI 10.1016/j.neuroimage.2015.10.081; Lewicki MS, 2000, NEURAL COMPUT, V12, P337, DOI 10.1162/089976600300015826; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Lv JL, 2015, PSYCHIAT RES-NEUROIM, V233, P254, DOI 10.1016/j.pscychresns.2015.07.012; Lv JL, 2015, IEEE T BIO-MED ENG, V62, P1120, DOI 10.1109/TBME.2014.2369495; Lv JL, 2015, MED IMAGE ANAL, V20, P112, DOI 10.1016/j.media.2014.10.011; Mairal J, 2010, J MACH LEARN RES, V11, P19; Malinen S, 2007, NEUROIMAGE, V35, P131, DOI 10.1016/j.neuroimage.2006.11.015; McGraw KO, 1996, PSYCHOL METHODS, V1, P390, DOI 10.1037//1082-989X.1.4.390; Morita Y, 2001, NEUROSCI RES, V41, P89, DOI 10.1016/S0168-0102(01)00248-6; Naci L, 2014, P NATL ACAD SCI USA, V111, P14277, DOI 10.1073/pnas.1407007111; Nguyen HM, 2017, 2017 INTERNATIONAL CONFERENCE ON RECENT ADVANCES IN SIGNAL PROCESSING, TELECOMMUNICATIONS & COMPUTING (SIGTELCOM), P7, DOI 10.1109/SIGTELCOM.2017.7849786; Nguyen V. T., 2016, CEREB CORTEX; Nguyen VT, 2015, AUTON NEUROSCI-BASIC, V192, P81; Nielsen FA, 2005, NEUROIMAGE, V27, P520, DOI 10.1016/j.neuroimage.2005.04.034; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Pessoa L, 2012, BEHAV BRAIN SCI, V35, P158, DOI 10.1017/S0140525X11001567; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Quiroga RQ, 2008, TRENDS COGN SCI, V12, P87, DOI 10.1016/j.tics.2007.12.003; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Ren Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11324-8; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Svensen M, 2002, NEUROIMAGE, V16, P551, DOI 10.1006/nimg.2002.1122; Tosic I, 2011, IEEE SIGNAL PROC MAG, V28, P27, DOI 10.1109/MSP.2010.939537; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wang JH, 2017, HUM BRAIN MAPP, V38, P2226, DOI 10.1002/hbm.23517; Worsley KJ, 2005, PHILOS T R SOC B, V360, P913, DOI 10.1098/rstb.2005.1637; Wrase J, 2003, NEUROSCI LETT, V348, P41, DOI 10.1016/S0304-3940(03)00565-2; Xie JW, 2017, J NEUROSCI METH, V282, P81, DOI 10.1016/j.jneumeth.2017.03.008; Yang HY, 2007, BEHAV BRAIN RES, V178, P172, DOI 10.1016/j.bbr.2006.11.039; Yudan Ren, 2016, 2016 IEEE 13th International Symposium on Biomedical Imaging (ISBI). Proceedings, P1278, DOI 10.1109/ISBI.2016.7493500	74	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190097	10.1371/journal.pone.0190097	http://dx.doi.org/10.1371/journal.pone.0190097			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8ZJ	29272294	gold, Green Published			2022-12-26	WOS:000418651500033
J	Khan, SR; Kuzminov, A				Khan, Sharik R.; Kuzminov, Andrei			Degradation of RNA during lysis of Escherichia coli cells in agarose plugs breaks the chromosome	PLOS ONE			English	Article							PROTEIN H-NS; ENDONUCLEASE-I; RIBONUCLEIC-ACID; GENE-EXPRESSION; NUCLEOID STRUCTURE; OSMOTIC SHOCK; DNA; BACTERIA; REPLICATION; FRAGMENTATION	The nucleoid of Escherichia coli comprises DNA, nucleoid associated proteins (NAPs) and RNA, whose role is unclear. We found that lysing bacterial cells embedded in agarose plugs in the presence of RNases caused massive fragmentation of the chromosomal DNA. This RNase-induced chromosomal fragmentation (RiCF) was completely dependent on the presence of RNase around lysing cells, while the maximal chromosomal breakage required fast cell lysis. Cell lysis in plugs without RNAse made the chromosomal DNA resistant to subsequent RNAse treatment. RiCF was not influenced by changes in the DNA supercoiling, but was influenced by growth temperature or age of the culture. RiCF was partially dependent on H-NS, histone-like nucleoid structuring-and global transcription regulator protein. The hupAB deletion of heat-unstable nucleoid protein (HU) caused increase in spontaneous fragmentation that was further increased when combined with deletions in two non-coding RNAs, nc1 and nc5. RiCF was completely dependent upon endonuclease I, a periplasmic deoxyribonuclease that is normally found inhibited by cellular RNA. Unlike RiCF, the spontaneous fragmentation in hupAB nc1 nc5 quadruple mutant was resistant to deletion of endonuclease I. RiCF-like phenomenon was observed without addition of RNase to agarose plugs if EDTA was significantly reduced during cell lysis. Addition of RNase under this condition was synergistic, breaking chromosomes into pieces too small to be retained by the pulsed field gels. RNase-independent fragmentation was qualitatively and quantitatively comparable to RiCF and was partially mediated by endonuclease I.	[Khan, Sharik R.; Kuzminov, Andrei] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Khan, SR (corresponding author), Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA.	sharik@illinois.edu			National Institutes of Heath [GM 073115]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073115] Funding Source: NIH RePORTER	National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant #GM 073115 from the National Institutes of Heath, https://www.nigms.nih.gov/Research/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant # GM 073115 from the National Institutes of Health. We want to thank Glen Cronan from this lab for helpful discussions. The authors have no conflict of interest to declare.	Atlung T, 1997, MOL MICROBIOL, V24, P7, DOI 10.1046/j.1365-2958.1997.3151679.x; Bachmann B.J., 1987, ESCHERICHIA COLI SAL, P1190; BERNARDI G, 1965, J MOL BIOL, V11, P141, DOI 10.1016/S0022-2836(65)80180-2; Bertin P, 2001, BIOCHIMIE, V83, P235, DOI 10.1016/S0300-9084(01)01247-0; BEVERLEY SM, 1988, NUCLEIC ACIDS RES, V16, P925, DOI 10.1093/nar/16.3.925; Brescia CC, 2004, J MOL BIOL, V339, P505, DOI 10.1016/j.jmb.2004.03.067; Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031; CORDONNI.C, 1965, BIOCHEM BIOPH RES CO, V20, P555, DOI 10.1016/0006-291X(65)90434-1; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Lay N, 2011, RNA, V17, P1172, DOI 10.1261/rna.2531211; de Vries R, 2010, BIOCHIMIE, V92, P1715, DOI 10.1016/j.biochi.2010.06.024; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; DEUTSCHER MP, 1985, J BIOL CHEM, V260, P7067; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Dorman CJ, 2014, J MOL MICROB BIOTECH, V24, P316, DOI 10.1159/000368850; DWORSKY P, 1973, J BACTERIOL, V116, P1364, DOI 10.1128/JB.116.3.1364-1374.1973; FALCONI M, 1988, MOL MICROBIOL, V2, P323, DOI 10.1111/j.1365-2958.1988.tb00035.x; GOEBEL W, 1970, BIOCHEMISTRY-US, V9, P4793; GOLDSTEIN E, 1984, P NATL ACAD SCI-BIOL, V81, P4046, DOI 10.1073/pnas.81.13.4046; Hommais F, 2001, MOL MICROBIOL, V40, P20, DOI 10.1046/j.1365-2958.2001.02358.x; HSIEH LS, 1991, J BACTERIOL, V173, P3914, DOI 10.1128/JB.173.12.3914-3917.1991; JEKEL M, 1995, GENE, V154, P55, DOI 10.1016/0378-1119(94)00835-G; KAVENOFF R, 1976, CHROMOSOMA, V59, P89, DOI 10.1007/BF00328479; Khan SH, 2017, ARCH BIOCHEM BIOPHYS, V633, P40, DOI 10.1016/j.abb.2017.08.015; Khan SR, 2013, ANAL BIOCHEM, V443, P269, DOI 10.1016/j.ab.2013.06.001; Khan SR, 2012, J BIOL CHEM, V287, P6250, DOI 10.1074/jbc.M111.322990; Kim J, 2004, NUCLEIC ACIDS RES, V32, P1982, DOI 10.1093/nar/gkh512; Kouzminova EA, 2008, MOL MICROBIOL, V68, P202, DOI 10.1111/j.1365-2958.2008.06149.x; Kouzminova EA, 2012, MOL MICROBIOL, V84, P1079, DOI 10.1111/j.1365-2958.2012.08076.x; Kuong KJ, 2012, J BIOL CHEM, V287, P23958, DOI 10.1074/jbc.M112.359687; LEHMAN IR, 1962, J BIOL CHEM, V237, P819; LEHMAN IR, 1962, J BIOL CHEM, V237, P829; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; Lukas L, 2006, GENETICS, V172, P1359, DOI 10.1534/genetics.105.051144; Macvanin M, 2012, J BACTERIOL, V194, P6046, DOI 10.1128/JB.00961-12; Macvanin M, 2012, BBA-GENE REGUL MECH, V1819, P830, DOI 10.1016/j.bbagrm.2012.02.012; Mahaseth T, 2015, MOL MICROBIOL, V96, P349, DOI 10.1111/mmi.12938; Malik M, 2006, MOL MICROBIOL, V61, P810, DOI 10.1111/j.1365-2958.2006.05275.x; MCCLELLAN JA, 1990, P NATL ACAD SCI USA, V87, P8373, DOI 10.1073/pnas.87.21.8373; MCINTOSH MA, 1975, J BACTERIOL, V122, P592, DOI 10.1128/JB.122.2.592-598.1975; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Murphy LD, 1997, J STRUCT BIOL, V119, P336, DOI 10.1006/jsbi.1997.3884; NEU HC, 1964, BIOCHEM BIOPH RES CO, V17, P215, DOI 10.1016/0006-291X(64)90386-9; NEU HC, 1964, J BIOL CHEM, V239, P3893; NEU HC, 1964, BIOCHEM BIOPH RES CO, V14, P109, DOI 10.1016/0006-291X(64)90238-4; NEU HC, 1965, J BIOL CHEM, V240, P3685; Noom MC, 2007, CURR BIOL, V17, pR913, DOI 10.1016/j.cub.2007.09.005; NOSSAL NG, 1966, J BIOL CHEM, V241, P3055; Ohniwa RL, 2006, EMBO J, V25, P5591, DOI 10.1038/sj.emboj.7601414; Ohniwa RL, 2007, GENES CELLS, V12, P1141, DOI 10.1111/j.1365-2443.2007.01125.x; Ohniwa RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019172; Pettijohn D.E., 1996, ESCHERICHIA COLI SAL, P158; PETTIJOHN DE, 1970, J MOL BIOL, V52, P281, DOI 10.1016/0022-2836(70)90031-8; PETTIJOHN DE, 1973, COLD SPRING HARB SYM, V38, P31; Phadtare S, 2012, GENES CELLS, V17, P850, DOI 10.1111/gtc.12002; Qian Z, 2015, MBIO, V6, DOI 10.1128/mBio.00998-15; SCHLICK T, 1994, BIOPHYS J, V67, P2146, DOI 10.1016/S0006-3495(94)80732-5; SHORTMAN K, 1964, J BIOL CHEM, V239, P2964; SPAHR PF, 1961, J BIOL CHEM, V236, P823; STEVENS A, 1980, J BIOL CHEM, V255, P3080; STIGTER D, 1977, BIOPOLYMERS, V16, P1435, DOI 10.1002/bip.1977.360160705; STONINGT.OG, 1971, P NATL ACAD SCI USA, V68, P6, DOI 10.1073/pnas.68.1.6; STUDIER FW, 1965, J MOL BIOL, V11, P373, DOI 10.1016/S0022-2836(65)80064-X; WORCEL A, 1972, J MOL BIOL, V71, P127, DOI 10.1016/0022-2836(72)90342-7; ZHU LQ, 1990, J BACTERIOL, V172, P3146, DOI 10.1128/jb.172.6.3146-3151.1990; Zimmerman SB, 1996, FEBS LETT, V390, P245, DOI 10.1016/0014-5793(96)00725-9; Zuo YH, 1999, NUCLEIC ACIDS RES, V27, P4077, DOI 10.1093/nar/27.20.4077; ZUSMAN DR, 1973, J BACTERIOL, V115, P1167, DOI 10.1128/JB.115.3.1167-1178.1973	68	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190177	10.1371/journal.pone.0190177	http://dx.doi.org/10.1371/journal.pone.0190177			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267353	Green Submitted, Green Published, gold			2022-12-26	WOS:000418587400099
J	Chollett, I; Collin, R; Bastidas, C; Croquer, A; Gayle, PMH; Jordan-Dahlgren, E; Koltes, K; Oxenford, H; Rodriguez-Ramirez, A; Weil, E; Alemu, J; Bone, D; Buchan, KC; Ford, MC; Escalante-Mancera, E; Garzon-Ferreira, J; Guzman, HM; Kjerfve, B; Klein, E; McCoy, C; Potts, AC; Ruiz-Renteria, F; Smith, SR; Tschirky, J; Cortes, J				Chollett, Iliana; Collin, Rachel; Bastidas, Carolina; Croquer, Aldo; Gayle, Peter M. H.; Jordan-Dahlgren, Eric; Koltes, Karen; Oxenford, Hazel; Rodriguez-Ramirez, Alberto; Weil, Ernesto; Alemu, Jahson; Bone, David; Buchan, Kenneth C.; Ford, Marcia Creary; Escalante-Mancera, Edgar; Garzon-Ferreira, Jaime; Guzman, Hector M.; Kjerfve, Bjoern; Klein, Eduardo; McCoy, Croy; Potts, Arthur C.; Ruiz-Renteria, Francisco; Smith, Struan R.; Tschirky, John; Cortes, Jorge			Widespread local chronic stressors in Caribbean coastal habitats	PLOS ONE			English	Article							LONG-TERM TRENDS; BOCAS DEL TORO; CORAL-REEFS; CLIMATE-CHANGE; SPATIAL VARIABILITY; SCLERACTINIAN CORAL; CARICOMP SITE; WATER-QUALITY; HUMAN IMPACTS; TEMPERATURE	Coastal ecosystems and the livelihoods they support are threatened by stressors acting at global and local scales. Here we used the data produced by the Caribbean Coastal Marine Productivity program (CARICOMP), the longest, largest monitoring program in the wider Caribbean, to evidence local-scale (decreases in water quality) and global-scale (increases in temperature) stressors across the basin. Trend analyses showed that visibility decreased at 42% of the stations, indicating that local-scale chronic stressors are widespread. On the other hand, only 18% of the stations showed increases in water temperature that would be expected from global warming, partially reflecting the limits in detecting trends due to inherent natural variability of temperature data. Decreases in visibility were associated with increased human density. However, this link can be decoupled by environmental factors, with conditions that increase the flush of water, dampening the effects of human influence. Besides documenting environmental stressors throughout the basin, our results can be used to inform future monitoring programs, if the desire is to identify stations that provide early warning signals of anthropogenic impacts. All CARICOMP environmental data are now available, providing an invaluable baseline that can be used to strengthen research, conservation, and management of coastal ecosystems in the Caribbean basin.	[Chollett, Iliana] Smithsonian Inst, Smithsonian Marine Stn, Ft Pierce, FL 34949 USA; [Collin, Rachel] Smithsonian Inst, Smithsonian Trop Res Inst, Panama City, Panama; [Bastidas, Carolina] Univ Simon Bolivar, Dept Biol Organismos, Caracas, Venezuela; [Bastidas, Carolina] MIT, Sea Grant Program, Cambridge, MA 02139 USA; [Croquer, Aldo] Univ Simon Bolivar, Dept Estudios Ambientales, Caracas, Venezuela; [Gayle, Peter M. H.] Univ West Indies, Ctr Marine Sci, Discovery Bay Marine Lab, St Ann, Jamaica; [Jordan-Dahlgren, Eric; Escalante-Mancera, Edgar] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Puerto Morelos, Mexico; [Koltes, Karen] US Dept Interior, Off Insular Affairs, Washington, DC USA; [Oxenford, Hazel] Univ West Indies, Ctr Resource Management & Environm Studies, Cave Hill, Barbados; [Rodriguez-Ramirez, Alberto] Univ Queensland, Global Change Inst, Brisbane, Qld, Australia; [Weil, Ernesto] Univ Puerto Rico, Mayaguez, PR USA; [Alemu, Jahson] Univ West Indies, Port of Spain, Trinidad Tobago; [Bone, David] Univ Simon Bolivar, Inst Tecnol & Ciencias Marinas, Caracas, Venezuela; [Buchan, Kenneth C.] Dorset Cty Council, Environm & Econ Directorate, Dorchester, Dorset, England; [Ford, Marcia Creary] Univ West Indies, Ctr Marine Sci, St Ann, Jamaica; [Garzon-Ferreira, Jaime] Brewster Acad, Wolfeboro, NH USA; [Kjerfve, Bjoern] Amer Univ Sharjah, Sharjah, U Arab Emirates; [McCoy, Croy] Cayman Islands Govt, Dept Environm, Georgetown, Cayman Islands; [McCoy, Croy] Bangor Univ, Sch Ocean Sci, Gwyneth, England; [Potts, Arthur C.] Univ Trinidad & Tobago, Chaguaramas, Trinidad Tobago; [Smith, Struan R.] Bermuda Aquarium Museum & Zoo, Flatts, Bermuda; [Tschirky, John] Amer Bird Conservancy, Int Program, Washington, DC USA; [Cortes, Jorge] Univ Costa Rica, Ctr Invest Ciencias Mar & Limnol, San Jose, Costa Rica	Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian Tropical Research Institute; Simon Bolivar University; Massachusetts Institute of Technology (MIT); Simon Bolivar University; University West Indies Mona Jamaica; Universidad Nacional Autonoma de Mexico; United States Department of the Interior; University West Indies Mona Jamaica; University West Indies Cave Hill Campus; University of Queensland; University of Puerto Rico; University of Puerto Rico Mayaguez; University West Indies Mona Jamaica; University West Indies Saint Augustine; Simon Bolivar University; University West Indies Mona Jamaica; American University of Sharjah; Bangor University; Universidad Costa Rica	Chollett, I (corresponding author), Smithsonian Inst, Smithsonian Marine Stn, Ft Pierce, FL 34949 USA.	iliana.chollett@gmail.com	Croquer, Aldo/ABE-6554-2021; Weil, Ernesto/ABF-1290-2020; Weil, Ernesto/AAI-3591-2020; Kjerfve, Björn/X-9027-2019; Collin, Rachel/Q-7100-2019; Cortés, Jorge/AAC-9782-2020	Croquer, Aldo/0000-0001-8880-9338; Weil, Ernesto/0000-0001-5275-1584; Kjerfve, Björn/0000-0002-3867-3281; Collin, Rachel/0000-0001-5103-4460; Cortés, Jorge/0000-0001-7004-8649; Rodriguez-Ramirez, Alberto/0000-0003-4855-7345; Chollett, Iliana/0000-0003-0536-499X; Guzman, Hector M./0000-0001-9928-8523; Alemu I, Jahson/0000-0002-6936-2857	MacArthur Foundation; Coral Reef Initiative of the US Department of State; UNESCO's Environment and Development in Coastal Regions and Small Islands; US National Science Foundation; Summit Foundation; Vicerrectoria de Investigacion, Universidad de Costa Rica; UNEP; Universidad Nacional Autonoma de Mexico; Institute for Marine and Coastal Research (INVE-MAR)	MacArthur Foundation; Coral Reef Initiative of the US Department of State; UNESCO's Environment and Development in Coastal Regions and Small Islands; US National Science Foundation(National Science Foundation (NSF)); Summit Foundation; Vicerrectoria de Investigacion, Universidad de Costa Rica; UNEP; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Institute for Marine and Coastal Research (INVE-MAR)	Through the years the CARICOMP program was supported by the MacArthur Foundation, the Coral Reef Initiative of the US Department of State, UNESCO's Environment and Development in Coastal Regions and Small Islands and the US National Science Foundation. Each participating institution and national agency from each CARICOMP country have also provided individual financial and logistical support. IC was supported by the Summit Foundation. JC thanks the Vicerrectoria de Investigacion, Universidad de Costa Rica and UNEP for funding the monitoring in Costa Rica. FRR, EEM and EJD thank the Universidad Nacional Autonoma de Mexico for funding the monitoring in Mexico.; Through the years the CARICOMP program was supported by the MacArthur Foundation, the Coral Reef Initiative of the US Department of State, UNESCO's Environment and Development in Coastal Regions and Small Islands and the US National Science Foundation. Each participating institution and national agency from each CARICOMP country have also provided individual financial and logistical support. IC was supported by the Summit Foundation. JC thanks the Vicerrectoria de Investigacion, Universidad de Costa Rica and UNEP for funding the monitoring in Costa Rica. FRR, EEM and EJD thank the Universidad Nacional Autonoma de Mexico for funding the monitoring in Mexico. The authors are thankful to all the researchers, students and volunteers who are too many to name but who have participated willingly and selflessly in collecting data at the CARICOMP stations. We are grateful to John Ogden and his staff at FIO (USF) for his leadership and their dedication in support of the CARICOMP program throughout the years. Thanks to Rosa Rodriguez-Martinez, site director, for running the station in Puerto Morelos. Monitoring activities in Colombia have been possible thanks to the support of the Institute for Marine and Coastal Research (INVE-MAR) and particularly Raul Navas. Thanks to the Bermuda Institute of Oceans Sciences for access to the data. This is the contribution Number 1076 from the Smithsonian Marine Station at Fort Pierce, Florida, and 990 of the Smithsonian Institution's Caribbean Coral Reef Ecosystem program.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Alcolado PM, 2001, B MAR SCI, V69, P819; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Beaulieu C, 2013, BIOGEOSCIENCES, V10, P2711, DOI 10.5194/bg-10-2711-2013; Bivand, 2016, RGEOS INTERFACE GEOM; Bivand R., 2016, MAPTOOLS TOOLS READI; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; Bleck R, 2002, OCEAN MODEL, V4, P55, DOI 10.1016/S1463-5003(01)00012-9; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Burke L., 2011, REEFS RISK REVISITED, P114; CARICOMP, 1997, P 8 INT COR REEF S, P673; CARICOMP, 1997, P 8 INT COR REEF S, V1, P641; Chassignet EP, 2007, J MARINE SYST, V65, P60, DOI 10.1016/j.jmarsys.2005.09.016; Chen ZQ, 2007, REMOTE SENS ENVIRON, V109, P207, DOI 10.1016/j.rse.2006.12.019; Chollett I, 2012, LIMNOL OCEANOGR, V57, P1233, DOI 10.4319/lo.2012.57.4.1233; Chollett I, 2012, MAR POLLUT BULL, V64, P956, DOI 10.1016/j.marpolbul.2012.02.016; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Collin Rachel, 2009, Smithsonian Contributions to the Marine Sciences, P323; Cortes J, 2010, REV BIOL TROP, V58, P1; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Croquer A, 2010, REV BIOL TROP, V58, P51; Croquer A, 2009, DIS AQUAT ORGAN, V83, P209, DOI 10.3354/dao02012; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Ehrlich PR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2845; Fabricius KE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P493, DOI 10.1007/978-94-007-0114-4_28; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Grottoli AG, 2007, EARTH-SCI REV, V81, P67, DOI 10.1016/j.earscirev.2006.10.001; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Hedley JD, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020118; Henson SA, 2010, BIOGEOSCIENCES, V7, P621, DOI 10.5194/bg-7-621-2010; Henson SA, 2016, GLOBAL CHANGE BIOL, V22, P1561, DOI 10.1111/gcb.13152; Hijmans RJ., 2015, PACKAGE RASTER R PAC; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoffman RN, 2005, WEATHER FORECAST, V20, P476, DOI 10.1175/WAF841.1; Huffman GJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040000; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Kennedy EV, 2013, CURR BIOL, V23, P912, DOI 10.1016/j.cub.2013.04.020; Kjerve B., 1998, CARICOMP CARIBBEAN C, P347; Koltes KH, 1997, P 8 INT CO REEF S, P651; Kuznetsova A., 2016, LMERTEST TESTS LINEA; Leichter JJ, 2006, J MAR RES, V64, P563, DOI 10.1357/002224006778715711; Levitus S., 2013, DATA SCI J, V12, pWDS229; Lima FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1713; Lopez-Calderon JM, 2013, REV BIOL TROP, V61, P1815; Lough JM, 2010, WIRES CLIM CHANGE, V1, P318, DOI 10.1002/wcc.39; Miller R.L., 2005, REMOTE SENSING COAST; MILLER RL, 1995, REMOTE SENS ENVIRON, V53, P177, DOI 10.1016/0034-4257(95)00081-B; Purkis SJ, 2011, REMOTE SENSING AND GLOBAL ENVIRONMENTAL CHANGE, P204; Rauscher SA, 2011, J CLIMATE, V24, P2003, DOI 10.1175/2010JCLI3536.1; Rodriguez-Martinez RE, 2010, REV BIOL TROP, V58, P23; Rodriguez-Ramirez A, 2010, REV BIOL TROP, V58, P45; Sanden P, 1996, LIMNOL OCEANOGR, V41, P346, DOI 10.4319/lo.1996.41.2.0346; Schaeffer BA, 2013, INT J REMOTE SENS, V34, P7534, DOI 10.1080/01431161.2013.823524; SCHLUESSEL P, 1990, J GEOPHYS RES-OCEANS, V95, P13341, DOI 10.1029/JC095iC08p13341; Seemann J, 2014, ENVIRON MONIT ASSESS, V186, P1747, DOI 10.1007/s10661-013-3490-y; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Taylor MA, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001097; Taylor MA, 2013, INT J CLIMATOL, V33, P784, DOI 10.1002/joc.3461; van Tussenbroek BI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090600; Venables WN., 2002, MODERN APPL STAT S 4; Weatherhead EC, 1998, J GEOPHYS RES-ATMOS, V103, P17149, DOI 10.1029/98JD00995; Weatherhead EC, 2002, PHYS CHEM EARTH, V27, P399, DOI 10.1016/S1474-7065(02)00019-0; Weil E, 2009, DIS AQUAT ORGAN, V83, P195, DOI 10.3354/dao02011; Werdell PJ, 2002, SEAWIFS BIO OPTICAL; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wooldridge SA, 2009, ECOL APPL, V19, P1492, DOI 10.1890/08-0963.1	71	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0188564	10.1371/journal.pone.0188564	http://dx.doi.org/10.1371/journal.pone.0188564			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261694	Green Published, gold, Green Submitted			2022-12-26	WOS:000418564200013
J	Schuster, M; Foxall, E; Finch, D; Smith, H; De Leenheer, P				Schuster, Martin; Foxall, Eric; Finch, David; Smith, Hal; De Leenheer, Patrick			Tragedy of the commons in the chemostat	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BACTERIAL-POPULATIONS; COOPERATION; EVOLUTION; CONFLICT; CHEATERS; YEAST; COMPETITION; ADAPTATION; MECHANISM	We present a proof of principle for the phenomenon of the tragedy of the commons that is at the center of many theories on the evolution of cooperation. Whereas the tragedy is commonly set in a game theoretical context, and attributed to an underlying Prisoner's Dilemma, we take an alternative approach based on basic mechanistic principles of species growth that does not rely on the specification of payoffs which may be difficult to determine in practice. We establish the tragedy in the context of a general chemostat model with two species, the cooperator and the cheater. Both species have the same growth rate function and yield constant, but the cooperator allocates a portion of the nutrient uptake towards the production of a public good-the "Commons" in the Tragedy- which is needed to digest the externally supplied nutrient. The cheater on the other hand does not produce this enzyme, and allocates all nutrient uptake towards its own growth. We prove that when the cheater is present initially, both the cooperator and the cheater will eventually go extinct, hereby confirming the occurrence of the tragedy. We also show that without the cheater, the cooperator can survive indefinitely, provided that at least a low level of public good or processed nutrient is available initially. Our results provide a predictive framework for the analysis of cooperator cheater dynamics in a powerful model system of experimental evolution.	[Schuster, Martin] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Foxall, Eric; Smith, Hal] Arizona State Univ, Sch Math & Stat Sci, Tempe, AZ USA; [Finch, David; De Leenheer, Patrick] Oregon State Univ, Dept Math, Corvallis, OR 97331 USA	Oregon State University; Arizona State University; Arizona State University-Tempe; Oregon State University	De Leenheer, P (corresponding author), Oregon State Univ, Dept Math, Corvallis, OR 97331 USA.	deleenhp@math.oregonstate.edu	Smith, Hal L./A-2545-2008	Smith, Hal L./0000-0002-9010-5003	National Science Foundation [NSF-MCB-1158553, NSF-MCB-1616967, NSF-DMS-1411853]; Simons Foundation [355819]	National Science Foundation(National Science Foundation (NSF)); Simons Foundation	This work was supported by National Science Foundation: NSF-MCB-1158553 and NSF-MCB-1616967 (to MS) and NSF-DMS-1411853; https://www.nsf.gov/ (to PDL) and Simons Foundation: 355819 (to HS); https://www.simonsfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Martin Schuster acknowledges support from NSF-MCB-1158553 and NSF-MCB-1616967, Hal Smith from Simons Foundation Grant 355819, and Patrick De Leenheer from NSF-DMS-1411853.	Asfahl KL, 2017, FEMS MICROBIOL REV, V41, P92, DOI 10.1093/femsre/fuw038; Asfahl KL, 2015, ISME J, V9, P1734, DOI 10.1038/ismej.2014.259; Chuang JS, 2009, SCIENCE, V323, P272, DOI 10.1126/science.1166739; Cremer J, SCI REP, V2, P28; Dandekar AA, 2012, SCIENCE, V338, P264, DOI 10.1126/science.1227289; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Fiegna F, 2006, NATURE, V441, P310, DOI 10.1038/nature04677; Fiegna F, 2003, P ROY SOC B-BIOL SCI, V270, P1527, DOI 10.1098/rspb.2003.2387; Foster KR, 2007, TRENDS GENET, V23, P74, DOI 10.1016/j.tig.2006.12.003; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; Frank, 1998, FDN SOCIAL EVOLUTION; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Greig D, 2004, P ROY SOC B-BIOL SCI, V271, pS25, DOI 10.1098/rsbl.2003.0083; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; HARDIN R, 1971, BEHAV SCI, V16, P472, DOI 10.1002/bs.3830160507; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Kummerli R, 2010, P NATL ACAD SCI USA, V107, P18921, DOI 10.1073/pnas.1011154107; Kummerli R, 2010, P BIOL SCI, V276, P3531; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Lloyd William Forster, 1833, 2 LECT CHECKS POPULA; MacLean RC, 2006, NATURE, V441, P498, DOI 10.1038/nature04624; Moreno-Fenoll C, 2017, SCI REP-UK, V7, DOI 10.1038/srep42561; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Oliveira NM, 2014, P NATL ACAD SCI USA, V111, P17941, DOI 10.1073/pnas.1412673111; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Rauch J, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2016.0967; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Waite AJ, 2012, P NATL ACAD SCI USA, V109, P19079, DOI 10.1073/pnas.1210190109; Wakano JY, 2009, P NATL ACAD SCI USA, V106, P7910, DOI 10.1073/pnas.0812644106; Wang MZ, 2015, P NATL ACAD SCI USA, V112, P2187, DOI 10.1073/pnas.1500704112; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Xavier JB, 2011, MOL MICROBIOL, V79, P166, DOI 10.1111/j.1365-2958.2010.07436.x	38	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0186119	10.1371/journal.pone.0186119	http://dx.doi.org/10.1371/journal.pone.0186119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261671	Green Published, gold, Green Submitted			2022-12-26	WOS:000418564200001
J	Smith, DW; Gardiner, BS				Smith, David W.; Gardiner, Bruce S.			Estimating outflow facility through pressure dependent pathways of the human eye	PLOS ONE			English	Article							AQUEOUS-HUMOR DYNAMICS; EPISCLERAL VENOUS-PRESSURE; RETINAL-PIGMENT EPITHELIUM; OCULAR PULSE AMPLITUDE; PRIMARY OPEN-ANGLE; INTRAOCULAR-PRESSURE; BLOOD-FLOW; HYDROSTATIC-PRESSURE; FLUID ABSORPTION; SUBRETINAL FLUID	We develop and test a new theory for pressure dependent outflow from the eye. The theory comprises three main parameters: (i) a constant hydraulic conductivity, (ii) an exponential decay constant and (iii) a no-flow intraocular pressure, from which the total pressure dependent outflow, average outflow facilities and local outflow facilities for the whole eye may be evaluated. We use a new notation to specify precisely the meaning of model parameters and so model outputs. Drawing on a range of published data, we apply the theory to animal eyes, enucleated eyes and in vivo human eyes, and demonstrate how to evaluate model parameters. It is shown that the theory can fit high quality experimental data remarkably well. The new theory predicts that outflow facilities and total pressure dependent outflow for the whole eye are more than twice as large as estimates based on the Goldman equation and fluorometric analysis of anterior aqueous outflow. It appears likely that this discrepancy can be largely explained by pseudofacility and aqueous flow through the retinal pigmented epithelium, while any residual discrepancy may be due to pathological processes in aged eyes. The model predicts that if the hydraulic conductivity is too small, or the exponential decay constant is too large, then intraocular eye pressure may become unstable when subjected to normal circadian changes in aqueous production. The model also predicts relationships between variables that may be helpful when planning future experiments, and the model generates many novel testable hypotheses. With additional research, the analysis described here may find application in the differential diagnosis, prognosis and monitoring of glaucoma.	[Smith, David W.] Univ Western Australia, Fac Engn & Math Sci, Perth, WA, Australia; [Gardiner, Bruce S.] Murdoch Univ, Sch Engn & Informat Technol, Murdoch, WA, Australia	University of Western Australia; Murdoch University	Smith, DW (corresponding author), Univ Western Australia, Fac Engn & Math Sci, Perth, WA, Australia.	david.smith@uwa.edu.au	Gardiner, Bruce/C-8593-2012; Smith, David W/H-5856-2014	Smith, David W/0000-0003-4864-0288; Gardiner, Bruce/0000-0001-8770-5908				Acott TS, 2014, J OCUL PHARMACOL TH, V30, P94, DOI 10.1089/jop.2013.0185; Agnifili L, 2015, ACTA OPHTHALMOL, V93, pE14, DOI 10.1111/aos.12408; Amoaku WMK, 2015, EYE, V29, P1115, DOI 10.1038/eye.2015.110; Arora N, 2017, INVEST OPHTH VIS SCI, V58, P5151, DOI 10.1167/iovs.17-22154; Ascaso FJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/432685; Balachandran RK, 2008, PHARM RES-DORDR, V25, P2685, DOI 10.1007/s11095-008-9691-3; Balaratnasingam C, 2007, INVEST OPHTH VIS SCI, V48, P3632, DOI 10.1167/iovs.06-1002; Band LR, 2009, INVEST OPHTH VIS SCI, V50, P3750, DOI 10.1167/iovs.08-2396; BARANY EH, 1964, INVEST OPHTH VISUAL, V3, P135; BARANY EH, 1963, INVEST OPHTH VISUAL, V2, P584; Beaton L, 2015, BIOMED OPT EXPRESS, V6, P1694, DOI 10.1364/BOE.6.001694; BECKER B, 1953, AMA ARCH OPHTHALMOL, V50, P557; Berdahl JP, 2012, MED HYPOTHESES, V79, P719, DOI 10.1016/j.mehy.2012.08.009; BILL A, 1962, EXP EYE RES, V1, P193, DOI 10.1016/S0014-4835(62)80001-3; BILL A, 1966, ARCH OPHTHALMOL-CHIC, V75, P665, DOI 10.1001/archopht.1966.00970050667017; BRUBAKER RF, 1975, INVEST OPHTH VISUAL, V14, P286; Brubaker RF, 2004, EXP EYE RES, V78, P633, DOI 10.1016/j.exer.2003.07.002; BRUBAKER RF, 1991, INVEST OPHTH VIS SCI, V32, P3145; BRUBAKER RF, 1970, INVEST OPHTH VISUAL, V9, P42; Cagatay HH, 2014, CASE REP OPHTHALMOL, V2014, DOI 10.1155/2014/897928; CANTRILL HL, 1984, ARCH OPHTHALMOL-CHIC, V102, P747, DOI 10.1001/archopht.1984.01040030595029; CARLSON KH, 1987, INVEST OPHTH VIS SCI, V28, P1346; Carreon T, 2017, PROG RETIN EYE RES, V57, P108, DOI 10.1016/j.preteyeres.2016.12.004; Cheng JY, 2016, ACTA OPHTHALMOL, V94, pE460, DOI 10.1111/aos.12963; CHIHARA E, 1985, GRAEF ARCH CLIN EXP, V223, P202, DOI 10.1007/BF02174060; Choi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081499; Dastiridou AI, 2013, INVEST OPHTH VIS SCI, V54, P4571, DOI 10.1167/iovs.13-12303; Dastiridou AI, 2009, INVEST OPHTH VIS SCI, V50, P5718, DOI 10.1167/iovs.09-3760; Day RE, 2014, BBA-GEN SUBJECTS, V1840, P1492, DOI 10.1016/j.bbagen.2013.09.033; del Amo EM, 2015, EXP EYE RES, V137, P111, DOI 10.1016/j.exer.2015.05.003; Detorakis Efstathios T, 2015, Acta Medica (Hradec Kralove), V58, P92, DOI 10.14712/18059694.2015.99; Detorakis ET, 2013, CLIN EXP OPHTHALMOL, V41, P73, DOI 10.1111/j.1442-9071.2012.02809.x; EDELMAN JL, 1992, INVEST OPHTH VIS SCI, V33, P1111; EDELMAN JL, 1991, INVEST OPHTH VIS SCI, V32, P3033; Eisenlohr J E, 1962, Br J Ophthalmol, V46, P536, DOI 10.1136/bjo.46.9.536; EMI K, 1989, INVEST OPHTH VIS SCI, V30, P233; FATT I, 1975, B MATH BIOL, V37, P85, DOI 10.1007/BF02463495; Fatt I., 1992, PHYSL EYE INTRO VEGE; Fautsch MP, 2006, INVEST OPHTH VIS SCI, V47, P4181, DOI 10.1167/iovs.06-0830; FOWLKS WL, 1963, INVEST OPHTH VISUAL, V2, P63; FRIBERG TR, 1987, AM J OPHTHALMOL, V103, P523, DOI 10.1016/S0002-9394(14)74275-8; Friedenwald JS, 1937, AM J OPHTHALMOL, V20, P39; Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052; GOLDINGER JM, 1980, J APPL PHYSIOL, V49, P224, DOI 10.1152/jappl.1980.49.2.224; GREEN K, 1985, Q J EXP PHYSIOL CMS, V70, P271, DOI 10.1113/expphysiol.1985.sp002908; Hall AC, 1999, J CELL PHYSIOL, V178, P197, DOI 10.1002/(SICI)1097-4652(199902)178:2<197::AID-JCP9>3.0.CO;2-3; HASHIMOTO JM, 1980, INVEST OPHTH VIS SCI, V19, P1483; HAYASHI M, 1989, EXP EYE RES, V48, P621, DOI 10.1016/0014-4835(89)90004-3; Hollborn M, 2015, MOL VIS, V21, P360; Hommer A, 2008, INVEST OPHTH VIS SCI, V49, P4046, DOI 10.1167/iovs.07-1342; HUGHES BA, 1984, J GEN PHYSIOL, V83, P875, DOI 10.1085/jgp.83.6.875; Johnstone MA, 2014, J OCUL PHARMACOL TH, V30, P88, DOI 10.1089/jop.2013.0224; Karyotakis NG, 2009, ARVO ANN M ABSTR INV; Karyotakis NG, 2015, ACTA OPHTHALMOL, V93, pE343, DOI 10.1111/aos.12652; Kazemi A, 2017, INVEST OPHTH VIS SCI, V58, P204, DOI 10.1167/iovs.16-20754; Kiel JW, 2011, PROG RETIN EYE RES, V30, P1, DOI 10.1016/j.preteyeres.2010.08.001; KIEL JW, 1995, INVEST OPHTH VIS SCI, V36, P579; Kim H, 2005, ANN BIOMED ENG, V33, P150, DOI 10.1007/s10439-005-8974-7; Kuchel PW, 2006, CELL MOL BIOL, V52, P2, DOI 10.1170/T741; KUPFER C, 1971, INVEST OPHTH VISUAL, V10, P518; Lange C, 2016, NAT REV NEUROL, V12, P439, DOI 10.1038/nrneurol.2016.88; LANGHAM ME, 1977, EXP EYE RES, V25, P311, DOI 10.1016/S0014-4835(77)80028-6; LANGHAM ME, 1963, INVEST OPHTH VISUAL, V2, P72; Lavery WJ, 2013, EXP EYE RES, V111, P88, DOI 10.1016/j.exer.2013.03.020; Le YZ, 2015, INVEST OPHTH VIS SCI, V56; Lei YA, 2011, INVEST OPHTH VIS SCI, V52, P1865, DOI 10.1167/iovs.10-6019; Levick JR, 2010, CARDIOVASC RES, V87, P198, DOI 10.1093/cvr/cvq062; Malihi M, 2015, INVEST OPHTH VIS SCI, V56, P2968, DOI 10.1167/iovs.14-16325; MARMOR MF, 1990, EYE, V4, P340, DOI 10.1038/eye.1990.46; MARMOR MF, 1980, INVEST OPHTH VIS SCI, V19, P893; Morgan WH, 2009, J GLAUCOMA, V18, P172, DOI 10.1097/IJG.0b013e31819aa524; MOSES RA, 1977, SURV OPHTHALMOL, V22, P88, DOI 10.1016/0039-6257(77)90088-1; Motulsky E, 2010, MOL VIS, V16, P602; Nau CB, 2013, INVEST OPHTH VIS SCI, V54, P7623, DOI [10.1167/iovs.13-12690, 10.1167/iovs.12-12690]; NEGI A, 1986, INVEST OPHTH VIS SCI, V27, P1564; Nilsson SFE, 1997, EYE, V11, P149, DOI 10.1038/eye.1997.43; OLD SE, 1995, INVEST OPHTH VIS SCI, V36, P88; OLVER JM, 1990, EYE, V4, P262, DOI 10.1038/eye.1990.38; Overby DR, 2009, EXP EYE RES, V88, P656, DOI 10.1016/j.exer.2008.11.033; Pallikaris IG, 2005, INVEST OPHTH VIS SCI, V46, P409, DOI 10.1167/iovs.04-0162; Pallikaris IG, 2010, EXPERT REV OPHTHALMO, V5, P343, DOI 10.1586/EOP.10.30; Pizzirani S, 2015, VET CLIN N AM-SMALL, V45, P1101, DOI 10.1016/j.cvsm.2015.06.005; Praetorius J, 2017, AM J PHYSIOL-CELL PH, V312, pC673, DOI 10.1152/ajpcell.00041.2017; Quintyn JC, 2004, SURV OPHTHALMOL, V49, P96, DOI 10.1016/j.survophthal.2003.10.003; Reitsamer HA, 2002, INVEST OPHTH VIS SCI, V43, P3728; Ren RY, 2016, INVEST OPHTH VIS SCI, V57, P6197, DOI 10.1167/iovs.16-20189; ROSENQUIST R, 1989, CURR EYE RES, V8, P1233, DOI 10.3109/02713688909013902; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Schey KL, 2014, BBA-GEN SUBJECTS, V1840, P1513, DOI 10.1016/j.bbagen.2013.10.037; Schuman JS, 1999, INVEST OPHTH VIS SCI, V40, P1676; Sherwood JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150694; Silver DM, 2000, CURR EYE RES, V20, P115, DOI 10.1076/0271-3683(200002)20:2;1-D;FT115; Sit AJ, 2011, EXP EYE RES, V93, P291, DOI 10.1016/j.exer.2011.05.003; Song YK, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-127; Sparrrow JR, 2011, CURR MOL MED, V11, P802; Strauss O, 1995, WEBVISION ORG RETINA; Sutherland IA, 2007, CURR OPIN DRUG DISC, V10, P540; Tran TL, 2013, ACTA OPHTHALMOL, V91, P557, DOI 10.1111/j.1755-3768.2012.02547.x; Tian BH, 2006, EXP EYE RES, V83, P1515, DOI 10.1016/j.exer.2006.08.008; To Chi-ho, 2002, Clin Exp Optom, V85, P335; TORIS CB, 1990, INVEST OPHTH VIS SCI, V31, P43; Toris CB, 1999, AM J OPHTHALMOL, V127, P407, DOI 10.1016/S0002-9394(98)00436-X; Tran T, 2012, ACTA OPHTHALMOLOGICA; TSUBOI S, 1987, INVEST OPHTH VIS SCI, V28, P96; TSUBOI S, 1987, INVEST OPHTH VIS SCI, V28, P1776; VANBUSKIRK EM, 1982, INVEST OPHTH VIS SCI, V22, P625; Wang J, 2013, INVEST OPHTH VIS SCI, V54, P1706, DOI 10.1167/iovs.12-9841; Ward DA, 2001, AM J VET RES, V62, P853, DOI 10.2460/ajvr.2001.62.853; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Willermain F, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00199; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002; Wolfensberger TJ, 2010, DEV OPHTHALMOL, V47, P49, DOI 10.1159/000320073; Xin C, 2017, EXP EYE RES, V158, P171, DOI 10.1016/j.exer.2016.06.007; Xu J, 2000, PHARMACEUT RES, V17, P664, DOI 10.1023/A:1007517912927; YABLONSKI ME, 1987, INVEST OPHTH VIS SCI, V28, P2076; Zhu JY, 2013, CHINESE MED J-PEKING, V126, P1451, DOI 10.3760/cma.j.issn.0366-6999.20123656	116	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0188769	10.1371/journal.pone.0188769	http://dx.doi.org/10.1371/journal.pone.0188769			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261696	Green Published, gold			2022-12-26	WOS:000418564200016
J	Wang, BL; Liu, D; Wang, C; Wang, QQ; Zhang, H; Liu, GY; He, Q; Zhang, LM				Wang, Beilei; Liu, Dan; Wang, Chao; Wang, Qianqian; Zhang, Hui; Liu, Guoyan; He, Qian; Zhang, Liming			Tentacle extract from the jellyfish Cyanea capillata increases proliferation and migration of human umbilical vein endothelial cells through the ERK1/2 signaling pathway	PLOS ONE			English	Article							NF-KAPPA-B; WOUND REPAIR; REVERSE DEVELOPMENT; OXIDATIVE STRESS; GROWTH-FACTOR; REGENERATION; INVERTEBRATES; ANGIOGENESIS; APOPTOSIS	Wound healing is a complex biological process, and current research finds that jellyfish have a great capacity for promoting growth and healing. However, the underlying mechanisms remain unclear. Thus, this study was conducted to investigate the molecular mechanisms and effects of a tentacle extract (TE) from the jellyfish Cyanea capillata (C. capillata) on cell proliferation and migration in human umbilical vein endothelial cells (HUVECs). First, our results showed that TE at the concentration of 1 mu g/ml could promote cell proliferation over various durations, induce a transition of the cells from the G1-phase to the S/G2-phase of the cell cycle, and increase the expression of cell cycle proteins (CyclinB1 and CyclinD1). Second, we found that TE could activate the PI3K/Akt, ERK1/2 and JNK MAPK signaling pathways but not the NF-kappa B signaling pathway or the apoptosis signaling cascade. Finally, we demonstrated that the TE-induced expression of cell cycle proteins was decreased by ERK1/2 inhibitor PD98059 but not by PI3K inhibitor LY294002 or JNK inhibitor SP600125. Similarly, the TE-enhanced migration ability of HUVECs was also markedly attenuated by PD98059. Taken together, our findings indicate that TE-induced proliferation and migration in HUVECs mainly occurred through the ERK1/2 MAPK signaling pathway. These results are instructively important for further research on the isolation and purification of growth-promoting factors from C. capillata and are hopeful as a means to improve human wound repair in unfavorable conditions.	[Wang, Beilei; Wang, Qianqian; Liu, Guoyan; Zhang, Liming] Second Mil Med Univ, Marine Biopharmaceut Inst, Shanghai, Peoples R China; [Wang, Beilei; Wang, Chao; Wang, Qianqian; Zhang, Hui; Liu, Guoyan; Zhang, Liming] Second Mil Med Univ, Fac Naval Med, Dept Marine Biotechnol, Shanghai, Peoples R China; [Liu, Dan] Second Mil Med Univ, Shanghai Changhai Hosp, Dept Urol, Shanghai, Peoples R China; [He, Qian] Second Mil Med Univ, Affiliated Hosp 3, Dept Gynecol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University	Zhang, LM (corresponding author), Second Mil Med Univ, Marine Biopharmaceut Inst, Shanghai, Peoples R China.; Zhang, LM (corresponding author), Second Mil Med Univ, Fac Naval Med, Dept Marine Biotechnol, Shanghai, Peoples R China.; He, Q (corresponding author), Second Mil Med Univ, Affiliated Hosp 3, Dept Gynecol, Shanghai, Peoples R China.	heqian@smmu.edu.cn; lmzhang@smmu.edu.cn			Young Scientists Fund of the National Natural Science Foundation of China [41506178]; National Natural Science Foundation of China [81673348]; National Major Scientific and Technological Special Project for "Significant New Drugs Development" (Ministry of Science and Technology) [2013ZX09J13110-07B]	Young Scientists Fund of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific and Technological Special Project for "Significant New Drugs Development" (Ministry of Science and Technology)	This work was supported by the Young Scientists Fund of the National Natural Science Foundation of China (41506178), the National Natural Science Foundation of China (81673348) and the National Major Scientific and Technological Special Project for "Significant New Drugs Development" (Ministry of Science and Technology) (2013ZX09J13110-07B).	Abrams MJ, 2015, P NATL ACAD SCI USA, V112, pE3365, DOI 10.1073/pnas.1502497112; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Chandika P, 2015, INT J BIOL MACROMOL, V77, P24, DOI 10.1016/j.ijbiomac.2015.02.050; Chen J, 2014, RECHARGEABLE SENSOR NETWORKS: TECHNOLOGY, THEORY, AND: APPLICATION: INTRODUCING ENERGY HARVESTING TO SENSOR NETWORKS, P1, DOI 10.1142/8911; Chen WL, 2009, CURR EYE RES, V34, P103, DOI 10.1080/02713680802621741; Cui PL, 2008, J PINEAL RES, V44, P107, DOI 10.1111/j.1600-079X.2007.00496.x; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Gong YQ, 2015, ONCOTARGET, V6, P25856, DOI 10.18632/oncotarget.4624; Gordon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031277; Gurska D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102628; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Haines DD, 2013, J CELL MOL MED, V17, P936, DOI 10.1111/jcmm.12074; Johnson KE, 2014, ADV WOUND CARE, V3, P647, DOI 10.1089/wound.2013.0517; Kim GD, 2013, MAR DRUGS, V11, P1087, DOI 10.3390/md11041087; Kipryushina YO, 2015, CYTOKINE GROWTH F R, V26, P687, DOI 10.1016/j.cytogfr.2015.04.001; Lin YCJ, 2000, DEV BIOL, V225, P87, DOI 10.1006/dbio.2000.9807; Lindsay SM, 2010, INTEGR COMP BIOL, V50, P479, DOI 10.1093/icb/icq099; Liu GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142680; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; McDaniel JC, 2008, WOUND REPAIR REGEN, V16, P337, DOI 10.1111/j.1524-475X.2008.00388.x; Osaki LH, 2013, INT J MOL SCI, V14, P10143, DOI 10.3390/ijms140510143; Piraino S, 2004, CAN J ZOOL, V82, P1748, DOI 10.1139/Z04-174; Pitt KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072683; Primo AL, 2012, MAR ENVIRON RES, V79, P152, DOI 10.1016/j.marenvres.2012.06.009; Ranzato E, 2010, J CELL BIOCHEM, V110, P783, DOI 10.1002/jcb.22591; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Schmich J, 2007, INT J DEV BIOL, V51, P45, DOI 10.1387/ijdb.062152js; Seipel K, 2004, DEV DYNAM, V231, P303, DOI 10.1002/dvdy.20139; Shingyochi Y, 2015, EXPERT OPIN BIOL TH, V15, P1285, DOI 10.1517/14712598.2015.1053867; Shono T, 1996, MOL CELL BIOL, V16, P4231; Wang BL, 2014, TOXICON, V81, P48, DOI 10.1016/j.toxicon.2014.01.017; Wang T, 2013, MAR DRUGS, V11, P67, DOI 10.3390/md11010067; Yoshida A, 1999, INVEST OPHTH VIS SCI, V40, P1624	34	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189920	10.1371/journal.pone.0189920	http://dx.doi.org/10.1371/journal.pone.0189920			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261770	Green Submitted, Green Published, gold			2022-12-26	WOS:000418564200075
J	Bradford, EL; Christie, CR; Campbell, EM; Bowman, AS				Bradford, Emma L.; Christie, Craig R.; Campbell, Ewan M.; Bowman, Alan S.			A real-time PCR method for quantification of the total and major variant strains of the deformed wing virus	PLOS ONE			English	Article							HONEYBEES APIS-MELLIFERA; QUANTITATIVE PCR; VIRAL LOAD; BEES; VARROA-DESTRUCTOR-VIRUS-1; REPLICATION; POLLINATION; PREVALENCE; VALIDATION; VARROIDAE	European honey bees (Apis mellifera) are critically important to global food production by virtue of their pollination services but are severely threatened by deformed wing virus (DWV) especially in the presence of the external parasite Varroa destructor. DWV exists as many viral strains with the two major variants (DWV-A and DWV-B) varying in virulence. A single plasmid standard was constructed containing three sections for the specific determination of DWV-A (VP2 capsid region), DWV-B (IRES) and a conserved region suitable for total DWV (helicase region). The assays were confirmed as specific and discriminatory with limits of detections of 25, 25 and 50 genome equivalents for DWV-A, DWV-B and total-DWV, respectively. The methods were successfully tested on Apis mellifera and V. destructor samples with varying DWV profiles. The new method determined a more accurate total DWV titre in samples with substantial DWV-B than the method currently described in the COLOSS Beebook. The proposed assays could be utilized for the screening of large quantities of bee material for both a total DWV load overview along with more detailed investigations into DWV-A and DWV-B profiles.	[Bradford, Emma L.; Christie, Craig R.; Campbell, Ewan M.; Bowman, Alan S.] Univ Aberdeen, Sch Biol Sci, Inst Biol & Environm Sci, Aberdeen, Scotland	University of Aberdeen	Bowman, AS (corresponding author), Univ Aberdeen, Sch Biol Sci, Inst Biol & Environm Sci, Aberdeen, Scotland.	a.bowman@abdn.ac.uk		Campbell, Ewan/0000-0002-5573-8243; Bradford, Emma/0000-0002-3591-4748; Bowman, Alan/0000-0002-0306-9033	Biotechnology and Biological Sciences Research Council (BBSRC) EASTBIO Doctoral Training Partnership [BB/J01446X/1]; Eastern Association Regional Studentship (EARS); Morley Agricultural Foundation; KTN BBSRC CASE studentship [BB/M503526/1]; Scottish Beekeeping Association; Animal Health - Disease Prevention, Scottish Government; European Union's Seventh Framework Programme for research, technological development and demonstration [613960]; Biotechnology and Biological Sciences Research Council [1523973, 1658520] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) EASTBIO Doctoral Training Partnership(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Eastern Association Regional Studentship (EARS); Morley Agricultural Foundation; KTN BBSRC CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Beekeeping Association; Animal Health - Disease Prevention, Scottish Government; European Union's Seventh Framework Programme for research, technological development and demonstration; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	ELB was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) EASTBIO Doctoral Training Partnership (http://www.bbsrc.ac.uk) [grant number BB/J01446X/1] and an Eastern Association Regional Studentship (EARS) and The Morley Agricultural Foundation awarded to ASB. CRC was supported by a KTN BBSRC CASE studentship (BB/M503526/1) (http://www.bbsrc.ac.uk), part-funded by the Scottish Beekeeping Association (https://www.scottishbeekeepers.org.uk/) and the Animal Health - Disease Prevention, Scottish Government awarded to ASB CRC. This project received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 613960 (SMARTBEES) (http://www.smartbees-fp7eu/) awarded to ASB. The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Barriga GP, 2012, VIRUS GENES, V45, P606, DOI 10.1007/s11262-012-0791-0; Beckmann JF, 2012, J MED ENTOMOL, V49, P1103, DOI 10.1603/ME12049; Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; Blanchard P, 2014, J VIROL METHODS, V197, P7, DOI 10.1016/j.jviromet.2013.09.012; Blanchard P, 2012, J VIROL METHODS, V180, P26, DOI 10.1016/j.jviromet.2011.12.005; Boncristiani H, 2011, APIDOLOGIE, V42, P457, DOI 10.1007/s13592-011-0009-9; Boncristiani HF, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-221; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Campbell EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155640; Carrillo-Tripp J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22265; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Cornman RS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-154; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; de Miranda JR, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.22; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; DEJONG D, 1982, ANNU REV ENTOMOL, V27, P229, DOI 10.1146/annurev.en.27.010182.001305; Duay P, 2003, APIDOLOGIE, V34, P61, DOI 10.1051/apido:2002052; Evans JD, 2013, J APIC RES, V52; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gauthier L, 2007, APIDOLOGIE, V38, P426, DOI 10.1051/apido:2007026; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Genersch E, 2005, VET J, V169, P121, DOI 10.1016/j.tvjl.2004.01.004; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Kukielka D, 2008, J VIROL METHODS, V147, P275, DOI 10.1016/j.jviromet.2007.09.008; Kukielka D, 2009, J VIROL METHODS, V161, P240, DOI 10.1016/j.jviromet.2009.06.014; Lee KV, 2015, APIDOLOGIE, V46, P292, DOI 10.1007/s13592-015-0356-z; Leonhardt SD, 2013, BASIC APPL ECOL, V14, P461, DOI 10.1016/j.baae.2013.06.003; Li X, 2000, BRAIN RES PROTOC, V5, P211, DOI 10.1016/S1385-299X(00)00015-5; Locke B, 2012, APPL ENVIRON MICROB, V78, P2073, DOI 10.1128/AEM.00086-12; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Martin SJ, 2010, J APICULT RES, V49, P72, DOI 10.3896/IBRA.1.49.1.10; Mazzei M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113448; McMahon DP, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0811; Mengelle C, 2003, J MED VIROL, V69, P225, DOI 10.1002/jmv.10277; Mondet F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004323; Moore J, 2011, J GEN VIROL, V92, P156, DOI 10.1099/vir.0.025965-0; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Ongus JR, 2006, J GEN VIROL, V87, P3397, DOI 10.1099/vir.0.82122-0; Polanco JC, 2002, EXP PARASITOL, V100, P131, DOI 10.1016/S0014-4894(02)00010-3; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Shah KS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-182; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sunderland S, 2013, 2012 SCOTTISH HONEY; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; WATANABE ME, 1994, SCIENCE, V265, P1170, DOI 10.1126/science.265.5176.1170; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, P6718, DOI 10.1093/nar/gkl1020; Zioni N, 2011, VIROLOGY, V417, P106, DOI 10.1016/j.virol.2011.05.009	61	11	11	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0190017	10.1371/journal.pone.0190017	http://dx.doi.org/10.1371/journal.pone.0190017			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261772	Green Published, gold, Green Submitted			2022-12-26	WOS:000418554900048
J	Danaee, H; Kalebic, T; Currency, TW; Fassan, M; Mescoli, C; Currency, FG; Trepicchio, WL; Rugge, M				Danaee, Hadi; Kalebic, Thea; Currency, Timothy Wyant; Fassan, Matteo; Mescoli, Claudia; Currency, Feng Gao; Trepicchio, William L.; Rugge, Massimo			Consistent expression of guanylyl cyclase-C in primary and metastatic gastrointestinal cancers	PLOS ONE			English	Article							COLORECTAL-CANCER; ECTOPIC EXPRESSION; MARKER; ADENOCARCINOMAS; ESOPHAGUS; THERAPY; CELLS; AXIS	Background The transmembrane receptor guanylate cyclase-C (GCC) has been found to be expressed in colorectal cancers. However, limited data are available on GCC protein expression in non-colorectal gastrointestinal tumors and few studies have reported whether GCC protein expression was consistently preserved in synchronous primary and metastatic cancer tissues. Methods GCC protein status was assessed by immunohistochemistry in tumor specimens from individuals (n = 627) with gastrointestinal tumors, including esophageal (n = 130), gastric (n = 276), pancreatic (n = 136), and colorectal (n = 85) primary and metastatic tumors. Tissue specimens consisted of tissue microarrays containing esophageal, gastric, pancreatic tumors, and whole-slide tissue sections from colorectal cancer patients with matching primary and metastatic tumors Result Among the evaluated esophageal, gastric, and pancreatic tumors, the frequency of GCC positivity at the protein level ranged from 59% to 68%. GCC was consistently expressed in primary and matched/synchronous metastatic lesions of colorectal cancer tissues derived from the same patients. Conclusion This observational study demonstrated the protein expression of GCC across various gastrointestinal malignancies. In all cancer histotypes, GCC protein localization was observed predominantly in the cytoplasm compared to the membrane region of tumor cells. Consistent immunohistochemistry detection of GCC protein expression in primary colorectal cancers and in their matched liver metastases suggests that the expression of GCC is maintained throughout the process of tumor progression and formation of metastatic disease.	[Danaee, Hadi; Kalebic, Thea; Currency, Timothy Wyant; Currency, Feng Gao; Trepicchio, William L.] Millennium Pharmaceut Inc, Cambridge, MA 02139 USA; [Fassan, Matteo; Mescoli, Claudia; Rugge, Massimo] Univ Padua, Dept Med DIMED, Surg Pathol & Cytopathol Unit, Padua, Italy; [Currency, Timothy Wyant] Curis Inc, Lexington, MA USA; [Currency, Feng Gao] Biogen, Cambridge, MA USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; University of Padua; Biogen	Kalebic, T (corresponding author), Millennium Pharmaceut Inc, Cambridge, MA 02139 USA.	Thea.Kalebic@takeda.com	; Fassan, Matteo/F-5152-2012	RUGGE, MASSIMO/0000-0002-0679-0563; Fassan, Matteo/0000-0001-6515-5482	Takeda Pharmaceuticals International Co	Takeda Pharmaceuticals International Co	This study was funded by Takeda Pharmaceuticals International Co (URL: https://www.takeda.com/). Moreover, Takeda Pharmaceuticals provided support in the form of salaries for authors (HD, TK, TW, FG, and WLT) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almhanna K, 2016, CLIN CANC RES; Almhanna K, 2017, INVEST NEW DRUGS; Birbe R, 2005, HUM PATHOL, V36, P170, DOI 10.1016/j.humpath.2004.12.002; Blomain ES, 2016, CANC BIOL THER; Brierley SM, 2012, CURR OPIN PHARMACOL, V12, P632, DOI 10.1016/j.coph.2012.10.005; Carrithers SL, 1996, DIS COLON RECTUM, V39, P171, DOI 10.1007/BF02068072; Chen XX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00650-0; Debruyne PR, 2006, GASTROENTEROLOGY, V130, P1191, DOI 10.1053/j.gastro.2005.12.032; Frick GS, 2005, EXPERT REV MOL DIAGN, V5, P701, DOI 10.1586/14737159.5.5.701; Gong L, 2009, CTS-CLIN TRANSL SCI, V2, P286, DOI 10.1111/j.1752-8062.2009.00131.x; Hyslop T, 2013, BIOMARK MED, V7, P159, DOI [10.2217/BMM.12.90, 10.2217/bmm.12.90]; Kloeters O, 2008, SCAND J GASTROENTERO, V43, P447, DOI 10.1080/00365520701746378; Lagisetty KH, 2017, J THORAC CARDIOV SUR, V154, P1446, DOI 10.1016/j.jtcvs.2017.04.074; Lucas KA, 2000, PHARMACOL REV, V52, P375; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Nakazato M, 2001, J GASTROENTEROL, V36, P219, DOI 10.1007/s005350170106; Park J, 2002, CANCER EPIDEM BIOMAR, V11, P739; Pattison AM, 2016, WORLD J GASTROENTERO, V22, P8070, DOI 10.3748/wjg.v22.i36.8070; Sargent DJ, 2011, ANN SURG ONCOL, V18, P3261, DOI 10.1245/s10434-011-1731-2; Smaglo BG, 2014, NAT REV CLIN ONCOL, V11, P637, DOI 10.1038/nrclinonc.2014.159; Snook AE, 2007, BIOMARK MED, V1, P187, DOI 10.2217/17520363.1.1.187; Vaandrager AB, 2002, MOL CELL BIOCHEM, V230, P73, DOI 10.1023/A:1014231722696; Waldman SA, 1998, CANCER EPIDEM BIOMAR, V7, P505; Wilson C, 2014, CANCER EPIDEM BIOMAR, V23, P2328, DOI 10.1158/1055-9965.EPI-14-0440; Zhang YW, 2013, WORLD J GASTROENTERO, V19, P5598, DOI 10.3748/wjg.v19.i34.5598	25	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189953	10.1371/journal.pone.0189953	http://dx.doi.org/10.1371/journal.pone.0189953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261789	gold, Green Submitted, Green Published			2022-12-26	WOS:000418554900041
J	Knudsen, JG; Gudiksen, A; Bertholdt, L; Overby, P; Villesen, I; Schwartz, CL; Pilegaard, H				Knudsen, Jakob G.; Gudiksen, Anders; Bertholdt, Laerke; Overby, Peter; Villesen, Ida; Schwartz, Camilla L.; Pilegaard, Henriette			Skeletal muscle IL-6 regulates muscle substrate utilization and adipose tissue metabolism during recovery from an acute bout of exercise	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GLUCOSE-METABOLISM; INTERLEUKIN-6; INSULIN; ADIPOCYTES; EXPRESSION; HUMANS; FAT; SENSITIVITY; OXIDATION	An acute bout of exercise imposes a major challenge on whole-body metabolism and metabolic adjustments are needed in multiple tissues during recovery to reestablish metabolic homeostasis. It is currently unresolved how this regulation is orchestrated between tissues. This study was undertaken to clarify the role of skeletal muscle derived interleukin 6 (IL-6) in the coordination of the metabolic responses during recovery from acute exercise. Skeletal muscle specific IL-6 knockout (IL-6 MKO) and littermate Control mice were rested or ran on a treadmill for 2h. Plasma, skeletal muscle, liver and adipose tissue were obtained after 6 and 10h of recovery. Non-exercised IL-6 MKO mice had higher plasma lactate and lower plasma non-esterified fatty acids than Controls. The activity of pyruvate dehydrogenase in the active form was, in skeletal muscle, higher in IL-6 MKO mice than Controls in non-exercised mice and 6h after exercise. IL-6 MKO mice had lower glucose transporter 4 protein content in inguinal adipose tissue (WAT) than Control in non-exercised mice and 10h after treadmill running. Epididymal WAT hormone sensitive lipase phosphorylation and inguinal WAT mitogen activated kinase P38 phosphorylation were higher in IL-6 MKO than Control mice 6h after exercise. These findings indicate that skeletal muscle IL-6 may play an important role in the regulation of substrate utilization in skeletal muscle, basal and exercise-induced adaptations in adipose tissue glucose uptake and lipolysis during recovery from exercise. Together this indicates that skeletal muscle IL-6 contributes to reestablishing metabolic homeostasis during recovery from exercise by regulating WAT and skeletal muscle metabolism.	[Knudsen, Jakob G.; Gudiksen, Anders; Bertholdt, Laerke; Overby, Peter; Villesen, Ida; Schwartz, Camilla L.; Pilegaard, Henriette] Univ Copenhagen, Dept Biol, Sect Cell Biol & Physiol, Copenhagen, Denmark; [Knudsen, Jakob G.] Univ Oxford, Radcliffe Dept Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England	University of Copenhagen; University of Oxford	Knudsen, JG; Pilegaard, H (corresponding author), Univ Copenhagen, Dept Biol, Sect Cell Biol & Physiol, Copenhagen, Denmark.; Knudsen, JG (corresponding author), Univ Oxford, Radcliffe Dept Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.	Jakob.Knudsen@Ocdem.ox.ac.uk; hpilegaard@bio.ku.dk	Knudsen, Jakob G/Q-2227-2018; Pilegaard, Henriette/M-2315-2014	Knudsen, Jakob G/0000-0001-7237-8457; Schwartz, Camilla Lindgren/0000-0002-2352-7396; Pilegaard, Henriette/0000-0002-1071-0327	Lundbeckfonden [R93-2011-8974]; Danish Agency for Science, Technology and Innovation [DFF-1323-00317]; Danish Diabetes Association; Agustinus Foundation	Lundbeckfonden(Lundbeckfonden); Danish Agency for Science, Technology and Innovation; Danish Diabetes Association; Agustinus Foundation	This work was supported by Lundbeckfonden: R93-2011-8974, www.lundbeckfonden.com/; Danish Agency for Science, Technology and Innovation, DFF-1323-00317, http://ufm.dk/en/the-minister-and-the-ministry/organisation/the-danish-agency-for-science-technology-andinnovation/contact (to HP); The Danish Diabetes Association, (http://www.diabetes.dk/diabetesforeningen/in-english/the-danish-diabetes-association.aspx) (to LB); the Agustinus Foundation (http://augustinusfonden.dk/) (to JGK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalili L, 2006, MOL ENDOCRINOL, V20, P3364, DOI 10.1210/me.2005-0490; Bertholdt L, 2017, AM J PHYSIOL-REG I, V312, pR626, DOI 10.1152/ajpregu.00373.2016; Bienso R, 2013, PFLUG ARCH EUR J PHY, P1; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Carlson CJ, 2003, DIABETES, V52, P634, DOI 10.2337/diabetes.52.3.634; Castellani L, 2015, J APPL PHYSIOL, V119, P1347, DOI 10.1152/japplphysiol.00551.2015; CEDERBLAD G, 1990, ANAL BIOCHEM, V185, P274, DOI 10.1016/0003-2697(90)90292-H; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CONSTANTINTEODOSIU D, 1991, ANAL BIOCHEM, V198, P347, DOI 10.1016/0003-2697(91)90437-X; Dalen KT, 2003, J BIOL CHEM, V278, P48283, DOI 10.1074/jbc.M302287200; Dyar KA, 2014, MOL METAB, V3, P29, DOI 10.1016/j.molmet.2013.10.005; DYCK DJ, 1993, AM J PHYSIOL, V265, pE852, DOI 10.1152/ajpendo.1993.265.6.E852; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Febbraio MA, 2004, DIABETES, V53, P1643, DOI 10.2337/diabetes.53.7.1643; Ferrer B, 2014, BRAIN BEHAV IMMUN, V40, P121, DOI 10.1016/j.bbi.2014.03.001; Fritsche L, 2010, DIABETOLOGIA, V53, P1732, DOI 10.1007/s00125-010-1754-4; GERRITS PM, 1993, J BIOL CHEM, V268, P640; Gudiksen A, 2017, AM J PHYSIOL-ENDOC M, V312, pE204, DOI 10.1152/ajpendo.00291.2016; Gudiksen A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156460; Haase TN, 2011, AM J PHYSIOL-REG I, V301, pR1501, DOI 10.1152/ajpregu.00775.2010; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Kelly M, 2009, DIABETES, V58, P1953, DOI 10.2337/db08-1293; Knudsen JG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084910, 10.1371/journal.pone.0086457]; Knudsen JG, 2015, OBESITY; Langberg H, 2002, J PHYSIOL-LONDON, V542, P985, DOI 10.1113/jphysiol.2002.019141; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Neufer PD, 1993, EXERCISE INDUCES TRA; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; Pilegaard H, 2006, EFFECT INTRALIPID IN, V55, P3020; Pilegaard H, 2000, AJP ENDOCRINOLOGY ME, V279; PUTMAN CT, 1993, AM J PHYSIOL, V265, pE752, DOI 10.1152/ajpendo.1993.265.5.E752; RICHTER EA, 1982, J CLIN INVEST, V69, P785, DOI 10.1172/JCI110517; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; Wan Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051233; Watt MJ, 2005, DIABETOLOGIA, V48, P105, DOI 10.1007/s00125-004-1598-x; Wolfe RR, 1990, ROLE TRIGLYCERIDE FA; Wolsk E, 2010, AJP ENDOCRINOLOGY ME; Wu Y, 2015, NAT MED, V21, P373, DOI 10.1038/nm.3826; Wueest S, 2014, AM J PHYSIOL-REG I, V306, pR861, DOI 10.1152/ajpregu.00533.2013	40	19	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189301	10.1371/journal.pone.0189301	http://dx.doi.org/10.1371/journal.pone.0189301			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253016	Green Published, Green Submitted, gold			2022-12-26	WOS:000418389500022
J	Sasidhar, MV; Chevooru, SK; Eickelberg, O; Hartung, HP; Neuhaus, O				Sasidhar, Manda V.; Chevooru, Sai Krishnaveni; Eickelberg, Oliver; Hartung, Hans-Peter; Neuhaus, Oliver			Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INDUCER; CELL-SURFACE EXPRESSION; N-LINKED GLYCOSYLATION; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; PROINFLAMMATORY CYTOKINES; AUTOIMMUNE-DISEASES; CONTROLLED-TRIAL; MEVALONIC ACID; NITRIC-OXIDE	CD147 is an activation induced glycoprotein that promotes the secretion and activation of matrix metalloproteinases (MMPs) and is upregulated during the differentiation of macrophages. Interestingly, some of the molecular functions of CD147 rely on its glycosylation status: the highly glycosylated forms of CD147 induce MMPs whereas the lowly glycosylated forms inhibit MMP activation. Statins are hydroxy-methylglutaryl coenzyme A reductase inhibitors that block the synthesis of mevalonate, thereby inhibiting all mevalonate-dependent pathways, including isoprenylation, N-glycosylation and cholesterol synthesis. In this study, we investigated the role of statins in the inhibition of macrophage differentiation and the associated process of MMP secretion through modulation of CD147. We observed that differentiation of the human monocytic cell line THP-1 to a macrophage phenotype led to upregulation of CD147 and CD14 and that this effect was inhibited by statins. At the molecular level, statins altered CD147 expression, structure and function by inhibiting isoprenylation and N-glycosylation. In addition, statins induced a shift of CD147 from its highly glycosylated form to its lowly glycosylated form. This shift in N-glycosylation status was accompanied by a decrease in the production and functional activity of MMP-2 and MMP-9. In conclusion, these findings describe a novel molecular mechanism of immune regulation by statins, making them interesting candidates for autoimmune disease therapy.	[Sasidhar, Manda V.; Hartung, Hans-Peter; Neuhaus, Oliver] Heinrich Heine Univ, Dept Neurol, Dusseldorf, Germany; [Sasidhar, Manda V.] Apollo Hosp Educ & Res Fdn, Hyderabad, Andhra Pradesh, India; [Chevooru, Sai Krishnaveni; Eickelberg, Oliver] Justus Liebig Univ, Dept Internal Med Mol Biol & Med Lung 2, Giessen, Germany; [Chevooru, Sai Krishnaveni] Wockhardt Res Ctr, Aurangabad, Maharashtra, India; [Eickelberg, Oliver] Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, Aurora, CO USA; [Neuhaus, Oliver] SRH Kliniken Landkreis Sigmaringen, Dept Neurol, Sigmaringen, Germany	Heinrich Heine University Dusseldorf; Justus Liebig University Giessen; University of Colorado System; University of Colorado Anschutz Medical Campus	Neuhaus, O (corresponding author), Heinrich Heine Univ, Dept Neurol, Dusseldorf, Germany.; Neuhaus, O (corresponding author), SRH Kliniken Landkreis Sigmaringen, Dept Neurol, Sigmaringen, Germany.	o.neuhaus@klksig.de	Manda, Sasidhar/AAH-8620-2019	Manda, Sasidhar/0000-0002-5981-5277	Graduate College of the German Research Foundation; International Graduate Program of the Justus Liebig University of Giessen, "Molecular Biology and Medicine of the Lung"	Graduate College of the German Research Foundation; International Graduate Program of the Justus Liebig University of Giessen, "Molecular Biology and Medicine of the Lung"	This work was supported in part by grants from the Graduate College of the German Research Foundation, "Pathological processes of the nervous system: from gene to behaviour" (to MVS), and from the International Graduate Program of the Justus Liebig University of Giessen, "Molecular Biology and Medicine of the Lung" (to SKC).	Abe N, 2006, LIFE SCI, V78, P1021, DOI 10.1016/j.lfs.2005.06.015; Archelos JJ, 1997, MOL MED TODAY, V3, P310, DOI 10.1016/S1357-4310(97)01066-6; Arnaud Claire, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P127, DOI 10.2174/1568006043586198; Avolio C, 2003, J NEUROIMMUNOL, V136, P46, DOI 10.1016/S0165-5728(03)00006-7; Bigg Heather F., 2001, Current Opinion in Pharmacology, V1, P314, DOI 10.1016/S1471-4892(01)00055-8; Bose M, 1995, IMMUNOL LETT, V48, P59, DOI 10.1016/0165-2478(95)02444-1; Bruck W, 1996, IMMUNOBIOLOGY, V195, P588; Bruck W, 2005, J NEUROL, V252, pV3, DOI 10.1007/s00415-005-5002-7; Carlberg M, 1996, J BIOL CHEM, V271, P17453, DOI 10.1074/jbc.271.29.17453; Chan KKW, 2003, CLIN CANCER RES, V9, P10; Chen ZN, 2005, J INFECT DIS, V191, P755, DOI 10.1086/427811; Cho JY, 2001, BLOOD, V98, P374, DOI 10.1182/blood.V98.2.374; Colin S, 2014, IMMUNOL REV, V262, P153, DOI 10.1111/imr.12218; COLLIER E, 1993, BIOCHEMISTRY-US, V32, P7818, DOI 10.1021/bi00081a029; Dreier R, 2004, EXP CELL RES, V297, P303, DOI 10.1016/j.yexcr.2004.02.027; Ferro D, 2000, J AM COLL CARDIOL, V36, P427, DOI 10.1016/S0735-1097(00)00771-3; Friesen JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-248; Garshick M, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0685-7; Ge H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117463; Guo HM, 1997, J BIOL CHEM, V272, P24; Huang JL, 2011, EUR J PHARMACOL, V670, P304, DOI 10.1016/j.ejphar.2011.07.045; Jia L, 2006, IUBMB LIFE, V58, P209, DOI 10.1080/15216540600719580; Kaushik DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163802; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Kirsch C, 2003, BIOCHEM PHARMACOL, V65, P843, DOI 10.1016/S0006-2952(02)01654-4; Kuipers HF, 2005, HUM IMMUNOL, V66, P653, DOI 10.1016/j.humimm.2005.04.004; Lanzillo R, 2010, MULT SCLER J, V16, P450, DOI 10.1177/1352458509358909; Lin JT, 2014, CURR DRUG TARGETS, V15, P442, DOI 10.2174/1389450115666140211115805; Lu YB, 2005, J LEUKOCYTE BIOL, V78, P259, DOI 10.1189/jlb.0904498; Ma YY, 2005, CURR PHARM DESIGN, V11, P569, DOI 10.2174/1381612053381927; McCarey DW, 2004, LANCET, V363, P2015, DOI 10.1016/S0140-6736(04)16449-0; McCarty MF, 2001, MED HYPOTHESES, V56, P12, DOI 10.1054/mehy.2000.1073; McInnes IB, 2004, ANN RHEUM DIS, V63, P1535, DOI 10.1136/ard.2004.022061; Neuhaus O, 2004, LANCET NEUROL, V3, P369, DOI 10.1016/S1474-4422(04)00770-7; Nicholson LB, 2009, CURR MOL MED, V9, P23, DOI 10.2174/156652409787314499; Noda I, 1999, INT J CANCER, V80, P279, DOI 10.1002/(SICI)1097-0215(19990118)80:2<279::AID-IJC18>3.3.CO;2-E; Okamoto H, 2007, J RHEUMATOL, V34, P964; Paul F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001928; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Riboldi P, 2005, LUPUS, V14, P765, DOI 10.1191/0961203305lu2217oa; Ridnour LA, 2007, P NATL ACAD SCI USA, V104, P16898, DOI 10.1073/pnas.0702761104; Shirinsky IV, 2009, SCAND J RHEUMATOL, V38, P23, DOI 10.1080/03009740802363776; Siddals KW, 2004, J BIOL CHEM, V279, P38353, DOI 10.1074/jbc.M404838200; Sun JX, 2001, CANCER RES, V61, P2276; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; Tang W, 2004, J BIOL CHEM, V279, P11112, DOI 10.1074/jbc.M312947200; Vamvakopoulos JE, 2003, BMC CARDIOVASC DISOR, V3, DOI 10.1186/1471-2261-3-6; Verrey F, 1999, J MEMBRANE BIOL, V172, P181, DOI 10.1007/s002329900595; Waas ET, 2002, BRIT J CANCER, V86, P1876, DOI 10.1038/sj.bjc.6600366; Wang QM, 2016, CELL PHYSIOL BIOCHEM, V39, P2308, DOI 10.1159/000447923; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Wong BM, 2001, J LEUKOCYTE BIOL, V69, P959; Xu DS, 2005, MOL CELL PROTEOMICS, V4, P1061, DOI 10.1074/mcp.M400207-MCP200; Yu XL, 2006, INT J BIOCHEM CELL B, V38, P1939, DOI 10.1016/j.biocel.2006.05.008; Yue HH, 2009, ARCH BIOCHEM BIOPHYS, V485, P30, DOI 10.1016/j.abb.2009.01.023; Zhou J, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-25; Zhu P, 2005, ARTHRITIS RES THER, V7, pR1023, DOI 10.1186/ar1778; Zucker S, 2001, AM J PATHOL, V158, P1921, DOI 10.1016/S0002-9440(10)64660-3	60	16	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189701	10.1371/journal.pone.0189701	http://dx.doi.org/10.1371/journal.pone.0189701			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253870	Green Published, gold, Green Submitted			2022-12-26	WOS:000418389500052
J	de Almeida, MMS; Guimaraes, RA; Jardim, PCBV; Sousa, ALL; de Souza, MM				Souza de Almeida, Mayara Maria; Guimaraes, Rafael Alves; Veiga Jardim, Paulo Cesar Brandao; Lima Sousa, Ana Luiza; de Souza, Marcia Maria			Association between arterial hypertension and nutritional status in adolescents from Goiania, Goias, Brazil	PLOS ONE			English	Article							BLOOD-PRESSURE; YOUNG-ADULTS; CHILDREN; OBESITY; PREHYPERTENSION; SCHOOLCHILDREN; PREVALENCE; SCHOOL	Introduction Adolescents are a population with unique lifestyle challenges, including physical inactivity, inadequate nutrition, and obesity, all of which increase the risk of developing hypertension (HTN). The objective of this study has been to estimate the prevalence of factors associated with hypertension in adolescents in the city of Goiania City, Central Brazil. Methods Between 2013and2014, a cross-sectional population study on cardiovascular risk in adolescents, was conducted with the participation of 1,586 adolescents in 108 classes at 36 schools (public and private) in Goiania city. All of the adolescents were interviewed to establish their sociodemographic and behavioral characteristics related to hypertension and nutritional status. Anthropometric and blood pressure data were collected following a protocol. A Poisson regression, stratified by gender, was used to verify the factors associated with HTN. Results In this mixed-gender group of 1,586 students, the prevalence of HTN was 6.2% (95% CI: 4.6 +/- 8.2%) in girls and 14.0% (95% CI: 10.2 +/- 18.8%) in boys - about twice as high in boys as in girls (p < 0.001). Obesity was independently associated with HTN in both genders. Being overweight was a risk factor for HTN. In addition, there was a positive correlation between the SBP/SBP percentile and the BMI Z-score/Nutritional status (NS) in both genders. A high prevalence of physical inactivity was also observed in the adolescents investigated, especially in the girls. On the other hand, more boys than girls were found to be obese. Conclusion The results of this investigation revealed the need for strategies to prevent and control HTN and its risk factors, especially in Brazil's schools. In addition to the constant surveillance of HTN prevalence and risk factors (in particular, being overweight or obese), information should be distributed to promote beneficial health behaviors among adolescents.	[Souza de Almeida, Mayara Maria; Lima Sousa, Ana Luiza; de Souza, Marcia Maria] Univ Fed Goias, Fac Nursing, Goiania, Go, Brazil; [Guimaraes, Rafael Alves] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil; [Veiga Jardim, Paulo Cesar Brandao] Univ Fed Goias, Fac Med, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias	de Almeida, MMS (corresponding author), Univ Fed Goias, Fac Nursing, Goiania, Go, Brazil.	maymsalmeida@hotmail.com	Sousa, Ana Luiza L/G-2936-2017; Sousa, Ana Luiza/AAO-4239-2020	Sousa, Ana Luiza L/0000-0002-7566-3541; Almeida, Mayara Maria/0000-0001-8870-0922	FINEP [01090421]; CNPq [565037/2010-2, 405.009/2012-7]	FINEP(Financiadora de Inovacao e Pesquisa (Finep)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FINEP (01090421) and CNPq (565037/2010-2 and 405.009/2012-7).	Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; [Anonymous], 2014, GLOBAL STATUS REPORT; [Anonymous], 2006, CAD SAUDE PUBLICA 20, V25, P375; Ashraf MS, 2006, CURR HYPERTENS REP, V8, P368, DOI 10.1007/s11906-006-0080-1; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016; Bibiloni M, 2013, ISRN OBES; Bloch KV, 2016, REV SAUDE PUBL, V50, DOI 10.1590/S01518-8787.2016050006685; Bloch KV, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1442-x; Bucher VS, 2013, CURR HYPERTENS REP, V15; Burgos MS, 2010, ARQ BRAS CARDIOL, V94, P788, DOI 10.1590/S0066-782X2010005000046; Campos Wd, 2010, ARQ BRAS CARDIOL, V94; Candido APC, 2009, EUR J PEDIATR, V168, P1373, DOI 10.1007/s00431-009-0940-1; Christofaro DGD, 2010, REV PAUL PEDIAT, V28; Courtney KE, 2009, PSYCHOL BULL, V135, P142, DOI 10.1037/a0014414; Coutinho LMS, 2008, REV SAUDE PUBL, V42; Cureau Felipe Vogt, 2016, Rev Saude Publica, V50 Suppl 1, p4s, DOI 10.1590/S01518-8787.2016050006683; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Diedenhofen D, 2015, PLOS ONE, V10; Dubey RK, 2002, CARDIOVASC RES, V53, P688, DOI 10.1016/S0008-6363(01)00527-2; Everett B, 2015, BIODEMOGR SOC BIOL, V61, P1, DOI 10.1080/19485565.2014.929488; Ewald DR, 2016, GLOB PEDIAT HLTH, P3; Falkner B, 2010, PEDIATR NEPHROL, V25, P1219, DOI 10.1007/s00467-009-1200-3; Ferreira HS, 2015, HIGH BLOOD PRESSURE; Figueiredo VC, 2016, REV SAUDE PUBL, V50, DOI 10.1590/S01518-8787.2016050006741; Coutinho ESF, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S01518-8787.2016050006684, 10.1590/s01518-8787.2016050006684]; Grossman E, 2013, DIABETES CARE, V36, pS307, DOI 10.2337/dcS13-2039; HAUKE J, 2011, QUEST GEOGR, V30, P2, DOI DOI 10.2478/V10117-011-0021-1; Instituto Brasileiro de Geografia e Estatostica, 2010, PESQ ORC FAM 2008 20, P930; Kotsis V, 2010, HYPERTENS RES, V33, P386, DOI 10.1038/hr.2010.9; Kukull WA, 2012, NEUROLOGY, V78, P1886, DOI 10.1212/WNL.0b013e318258f812; de Vasconcellos MTL, 2015, CAD SAUDE PUBLICA, V31, P921, DOI 10.1590/0102-311X00043214; Leung LCK, 2011, ARCH DIS CHILD; Magliano ES, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-833; McNiece KL, 2007, J PEDIATR-US, V150, P640, DOI 10.1016/j.jpeds.2007.01.052; Monego ET, 2006, ARQUIVOS BRASILEIROS, V87; Morais ACFd, 2014, MEDICINE, V93; Moreira NF, 2013, ARQ BRAS ENDOCRINOL, V57, P520, DOI 10.1590/S0004-27302013000700004; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Neto VG, CIENC SAUDE COLETIVA; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pinto SL, 2011, CAD SAUDE PUBLICA, V27, P1065, DOI 10.1590/S0102-311X2011000600004; Prasad Senthamizh, 2017, Indian J Community Med, V42, P155, DOI 10.4103/ijcm.IJCM_106_16; Goncalves VSS, 2016, REV SAUDE PUBL, V50, DOI 10.1590/S1518-8787.2016050006236; Schommer VA, 2014, ARQ BRAS CARDIOL, V102, P312, DOI 10.5935/abc.20140038; Silva Kelly Samara da, 2007, Rev Bras Med Esporte, V13, P237, DOI 10.1590/S1517-86922007000400005; Silva MCP, 2008, ESTADO NUTR NIVEIS P, V18; StataCorp, 2015, STAT STAT SOFTW REL; Steene-Johannessen J, 2016, MED SCI SPORT EXER, V48, P235, DOI 10.1249/MSS.0000000000000760; Stergiou GS, 2006, BLOOD PRESS MONIT, V11, P229, DOI 10.1097/01.mbp.0000209074.38331.16; Theme Filha Mariza Miranda, 2015, Rev. bras. epidemiol., V18, P83, DOI 10.1590/1980-5497201500060008; VIGITEL Brasil, 2016, VIG FAT RISC PROT DO; Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/radiol.2273011499	53	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0188782	10.1371/journal.pone.0188782	http://dx.doi.org/10.1371/journal.pone.0188782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ5HM	29253900	Green Submitted, Green Published, gold			2022-12-26	WOS:000418389500007
J	Rivera-Valdes, JJ; Garcia-Banuelos, J; Salazar-Montes, A; Garcia-Benavides, L; Rosales-Dominguez, A; Armendariz-Borunda, J; Sandoval-Rodriguez, A				Jose Rivera-Valdes, Juan; Garcia-Banuelos, Jesus; Salazar-Montes, Adriana; Garcia-Benavides, Leonel; Rosales-Dominguez, Alfredo; Armendariz-Borunda, Juan; Sandoval-Rodriguez, Ana			Human adipose derived stem cells regress fibrosis in a chronic renal fibrotic model induced by adenine	PLOS ONE			English	Article							ACUTE TUBULAR INJURY; LIVER FIBROSIS; STROMAL CELLS; RAT MODEL; KIDNEY; INJECTION; 2,8-DIHYDROXYADENINE; FAILURE; VIVO	Background and aims ADSCs transplantation had been shown in some experimental models of kidney damage that it improves kidney function and reduces fibrosis. In this study we evaluated the effect of human adipose tissue-derived stem cell (hADSC) therapy in a chronic kidney damage experimental model. Methods A chronic kidney injury was induced by daily orogastric administration of adenine (100mg/kg) to male Wistar rats for 28 days. hADSCs were isolated, expanded and characterized before transplantation. hADSC administration was performed in a tail vein at a dose of 2 x10(6) cells/animal. Animals were sacrificed at 7 days post-treatment. The percentage of fibrotic tissue, serum and urine levels of urea, creatinine, total protein and renal mRNA of COL1A1, TGFB1, CTGF, ACTA2, IL6, IL10, TNF were analyzed. Results hADSCs treatment significantly reduces kidney fibrosis, improves urea and creatinine serum and urine levels, and diminishes COL1A1, TGFB1, CTGF, ACTA2 mRNA kidney levels. Conclusions These results showed that cell therapy using hADSCs improves renal function and reduces fibrosis.	[Jose Rivera-Valdes, Juan; Garcia-Banuelos, Jesus; Salazar-Montes, Adriana; Armendariz-Borunda, Juan; Sandoval-Rodriguez, Ana] Univ Guadalajara, Hlth Sci Univ Ctr, Dept Mol Biol & Genom, Inst Mol Biol Med & Gene Therapy, Guadalajara, Jalisco, Mexico; [Garcia-Benavides, Leonel] Univ Guadalajara, Tonala Univ Ctr, Dept Biomed Sci, Tonala, Jalisco, Mexico; [Rosales-Dominguez, Alfredo] Univ Guadalajara, Hlth Sci Univ Ctr, Chron Degenerat Dis Inst, Guadalajara, Jalisco, Mexico; [Armendariz-Borunda, Juan] Tecnol Monterrey, Guadalajara, Jalisco, Mexico	Universidad de Guadalajara; Universidad de Guadalajara; Universidad de Guadalajara; Tecnologico de Monterrey	Sandoval-Rodriguez, A (corresponding author), Univ Guadalajara, Hlth Sci Univ Ctr, Dept Mol Biol & Genom, Inst Mol Biol Med & Gene Therapy, Guadalajara, Jalisco, Mexico.	anasol44@hotmail.com	Armendáriz-Borunda, Juan/AAU-1471-2021; Garcia-Banuelos, Jesus/W-2927-2019; Garcia Benavides, Leonel/GPP-7463-2022; garcia, leonel/V-9040-2017	Garcia Benavides, Leonel/0000-0001-8087-3597; garcia, leonel/0000-0001-8087-3597; Sandoval-Rodriguez, Ana/0000-0003-1708-1495	CONACYT	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	JJRV received a scholarship from CONACYT to obtain his PhD as part of this project. The specific role of this author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev V, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt411; Alfarano C, 2012, CELL TRANSPLANT, V21, P2009, DOI 10.3727/096368912X640448; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Bian XH, 2013, KIDNEY BLOOD PRESS R, V38, P11, DOI 10.1159/000355749; Burgos-Silva M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142183; Castiglione F, 2016, EUR UROL; Castiglione F, 2013, EUR UROL, V63, P551, DOI 10.1016/j.eururo.2012.09.034; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Claramunt D, 2015, AM J PHYSIOL-RENAL, V309, pF57, DOI 10.1152/ajprenal.00051.2015; de Vries A, 1977, Ciba Found Symp, P179; Engle SJ, 1996, P NATL ACAD SCI USA, V93, P5307, DOI 10.1073/pnas.93.11.5307; Ezquer F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/164703; Furuichi K, 2012, CLIN EXP NEPHROL, V16, P679, DOI 10.1007/s10157-012-0614-6; Harn HJ, 2012, CELL TRANSPLANT, V21, P2753, DOI 10.3727/096368912X652959; Herrera MB, 2007, KIDNEY INT, V72, P430, DOI 10.1038/sj.ki.5002334; Hong SJ, 2011, ACTA OTO-LARYNGOL, V131, P1198, DOI 10.3109/00016489.2011.599816; Kamada Y, 2008, AM J PHYSIOL-GASTR L, V296, pG157; Kunter U, 2007, J AM SOC NEPHROL, V18, P1754, DOI 10.1681/ASN.2007010044; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Mias C, 2008, STEM CELLS, V26, P1749, DOI 10.1634/stemcells.2007-1000; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Okabe C, 2013, AM J PHYSIOL-RENAL, V305, pF155, DOI 10.1152/ajprenal.00491.2012; Parekkadan B, 2007, BIOCHEM BIOPH RES CO, V363, P247, DOI 10.1016/j.bbrc.2007.05.150; Park HJ, 2016, BIOMACROMOLECULES, V17, P1939, DOI 10.1021/acs.biomac.5b01670; Peired AJ, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/8342625; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Sangkum P, 2016, CUAJ-CAN UROL ASSOC, V10, pE175, DOI 10.5489/cuaj.3435; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seki A, 2013, HEPATOLOGY, V58, P1133, DOI 10.1002/hep.26470; Sheashaa H, 2016, EXP THER MED, V11, P1573, DOI 10.3892/etm.2016.3109; Togel F, 2009, STEM CELLS DEV, V18, P475, DOI 10.1089/scd.2008.0092; Tomasoni S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0266; Vigneau C, 2007, J AM SOC NEPHROL, V18, P1709, DOI 10.1681/ASN.2006101078; Villanueva S, 2013, CLIN SCI, V125, P199, DOI 10.1042/CS20120644; Wang K, 2015, ACTA BIOMATER, V15, P65, DOI 10.1016/j.actbio.2014.12.025; Webster AC, 2016, LANCET LOND ENGL; WYNGAARDEN JB, 1957, ARCH BIOCHEM BIOPHYS, V70, P150, DOI 10.1016/0003-9861(57)90088-7; YOKOZAWA T, 1986, NEPHRON, V44, P230, DOI 10.1159/000183992; Yong KW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33067; Zhao W, 2012, WORLD J GASTROENTERO, V18, P1048, DOI 10.3748/wjg.v18.i10.1048; Zuk, 2013, ISRN STEM CELLS, DOI [10.1155/2013/713959, DOI 10.1155/2013/713959]	42	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0187907	10.1371/journal.pone.0187907	http://dx.doi.org/10.1371/journal.pone.0187907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281649	Green Submitted, Green Published, gold			2022-12-26	WOS:000419006200005
J	Mwape, I; Bosomprah, S; Mwaba, J; Mwila-Kazimbaya, K; Laban, NM; Chisenga, CC; Sijumbila, G; Simuyandi, M; Chilengi, R				Mwape, Innocent; Bosomprah, Samuel; Mwaba, John; Mwila-Kazimbaya, Katayi; Laban, Natasha Makabilo; Chisenga, Caroline Cleopatra; Sijumbila, Gibson; Simuyandi, Michelo; Chilengi, Roma			Immunogenicity of rotavirus vaccine (Rotarix (TM)) in infants with environmental enteric dysfunction	PLOS ONE			English	Article							ORAL POLIOVIRUS VACCINE; INTESTINAL PERMEABILITY; TIGHT JUNCTIONS; HUMAN ZONULIN; MALNUTRITION; DIARRHEA; DISEASE; LIPOPOLYSACCHARIDE; ENTEROPATHY; MODULATOR	Introduction Deployment of rotavirus vaccines has contributed to significant declines in diarrheal morbidity and mortality globally. Unfortunately, vaccine performance in low-middle income countries (LMICs) is generally lower than in developed countries. The cause for this has been associated with several host and maternal factors including poor water sanitation and hygiene (WASH) status, which are predominant in LMICs. More recently, environmental enteric dysfunction (EED) has specifically been hypothesized to contribute to poor vaccine uptake and response. The aim of this study was to examine the association between serological biomarkers of EED and seroconversion to rotavirus vaccine in Zambian infants. Methods This was a retrospective cohort study of 142 infants who had been fully immunized with Rotarix (TM), and had known seroconversion status. Seroconversion was defined as 4-fold or more increase in rotavirus-specific IgA titres between pre-vaccination and one month post-dose two vaccination. We performed ELISA assays to assess soluble CD14 (sCD14), Endotoxin Core IgG Antibodies (EndoCAb), intestinal fatty acid binding protein (i-FABP) and Zonulin according to the manufacturers protocols. Generalised linear model with family-poisson, link-log and robust standard error was used to estimate the independent effects of biomarkers on seroconversion adjusting for important cofounders. Results The median concentration of Zonulin, Soluble CD14, EndoCaB, and IFABP were 209.3 (IQR = 39.7, 395.1), 21.5 (IQR = 21.5, 21.5), 0.3 (IQR = 0.3, 0.3), and 107.7 (IQR = 6.4, 1141.4) respectively. In multivariable analyses adjusting for the independent effect of other biomarkers and confounders (i.e. age of child at vaccination, breast-milk anti-rotavirus IgA, infant serum anti-rotavirus IgG, and IgA seropositivity at baseline), there was strong evidence of about 24% increase in seroconversion due to doubling Zonulin concentration (Adjusted risk ratio (aRR) = 1.24; 95% CI = 1.12 to1.37; p<0.0001). Similarly, we found about 7% increase in seroconversion due to doubling IFABP concentration (aRR = 1.07; 95% CI = 1.02 to 1.13; p = 0.006). Conclusion We found that high levels of zonulin and IFABP played a role in seroconversion. It is plausible that increased gut permeability in EED allows greater uptake of the live virus within the vaccine, but later consequences result in deleterious local structural distortions and malabsorption syndromes.	[Mwape, Innocent; Bosomprah, Samuel; Mwaba, John; Mwila-Kazimbaya, Katayi; Laban, Natasha Makabilo; Chisenga, Caroline Cleopatra; Simuyandi, Michelo; Chilengi, Roma] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Mwape, Innocent; Sijumbila, Gibson] Univ Zambia, Dept Physiol Sci, Lusaka, Zambia; [Bosomprah, Samuel] Univ Ghana, Sch Publ Hlth, Dept Biostat, Legon, Accra, Ghana; [Chilengi, Roma] Univ N Carolina, Chapel Hill, NC USA	University of Zambia; University of Ghana; University of North Carolina; University of North Carolina Chapel Hill	Mwape, I (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.; Mwape, I (corresponding author), Univ Zambia, Dept Physiol Sci, Lusaka, Zambia.	Innocent.Mwape@cidrz.org	Simuyandi, Michelo/I-5598-2018	Simuyandi, Michelo/0000-0002-7348-2835; Bosomprah, PhD, Prof. Samuel/0000-0002-2826-3887; Mwila Kazimbaya, Katayi/0000-0002-8482-4693	NIH R01 grant [1R01AI099601]; DfID through the SHARE Consortium [ITDCHA23-5]	NIH R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DfID through the SHARE Consortium	This work was supported with funding from an NIH R01 grant #1R01AI099601 and DfID through the SHARE Consortium through grant # ITDCHA23-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristo V., 2013, ALTERNATIVE THERAPIE, V19; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Barclay G R, 1995, Prog Clin Biol Res, V392, P263; Chilengi R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150100; Denno D, ENV ENTERIC DYSFUNCT; DURIEUX JJ, 1994, EUR J IMMUNOL, V24, P2006, DOI 10.1002/eji.1830240911; Fasano A, 2012, CLIN GASTROENTEROL H, V10, P1096, DOI 10.1016/j.cgh.2012.08.012; FORD RPK, 1985, J PEDIATR GASTR NUTR, V4, P568, DOI 10.1097/00005176-198508000-00012; Gajda A, 2014, PROSTAGLANDINS LEUKO, V93, P9; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Huda MN, 2014, PEDIATRICS, V134, pE362, DOI 10.1542/peds.2013-3937; JUVONEN P, 1991, ARCH DIS CHILD, V66, P300, DOI 10.1136/adc.66.3.300; Kelly P, 2004, AM J TROP MED HYG, V70, P412; Keusch GT, 2014, CLIN INFECT DIS, V59, pS207, DOI 10.1093/cid/ciu485; Kitchens RL, 2000, CHEM IMMUNOL, V74, P61; Korpe PS, 2012, TRENDS MOL MED, V18, P328, DOI 10.1016/j.molmed.2012.04.007; Kosek M, 2013, AM J TROP MED HYG, V88, P390, DOI 10.4269/ajtmh.2012.12-0549; Lammers KM, 2008, GASTROENTEROLOGY, V135, P194, DOI 10.1053/j.gastro.2008.03.023; Lau E, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0089-7; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Mondal D, 2012, CLIN INFECT DIS, V54, P185, DOI 10.1093/cid/cir807; Mwila K, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00405-16; Parker EPK, 2014, J INFECT DIS, V210, P853, DOI 10.1093/infdis/jiu182; PATH, ROT DIS VACC ZAMB; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1; Petri WA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0187-1; Prendergast A, 2012, AM J TROP MED HYG, V86, P756, DOI 10.4269/ajtmh.2012.11-0743; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rudd C, 2015, VACCINE, V33, P3263, DOI 10.1016/j.vaccine.2015.04.002; Salinas M, 2005, PEDIATR INFECT DIS J, V24, P807, DOI 10.1097/01.inf.0000178294.13954.a1; Soares-Weiser K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008521.pub3; Soderholm JD, 2004, GUT, V53, P1817, DOI 10.1136/gut.2004.041426; SULLIVAN PB, 1991, J PEDIATR GASTR NUTR, V12, P195, DOI 10.1097/00005176-199102000-00010; SULLIVAN PB, 1992, J PEDIATR GASTR NUTR, V14, P208, DOI 10.1097/00005176-199202000-00016; Tapping RI, 2000, CHEM IMMUNOL, V74, P108; Tarko A, 2017, HINDAWI DIS MARKERS; Tate JE, 2016, CID S2, V62; Tennant S, 2013, MOL VACCINES, V1, P61; Tripathi A, 2009, P NATL ACAD SCI USA, V106, P16799, DOI 10.1073/pnas.0906773106; Uddin MI, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005039; United Nations Children's Fund World Health Organization, 2009, DIARRH WHY CHILDR AR; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2004, PEDIAT INFECT DIS J, V23; Wang WL, 2000, J CELL SCI, V113, P4435; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	47	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0187761	10.1371/journal.pone.0187761	http://dx.doi.org/10.1371/journal.pone.0187761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281659	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000419006200003
J	Chen, WJ; HolcDorf, D; McCusker, MW; Gaillard, F; Howe, PDL				Chen, Weijia; HolcDorf, David; McCusker, Mark W.; Gaillard, Frank; Howe, Piers D. L.			Perceptual training to improve hip fracture identification in conventional radiographs	PLOS ONE			English	Article							VISUAL-SEARCH; FACE GENDER; DIFFERENCE; FEATURES; IMAGES	Diagnosing certain fractures in conventional radiographs can be a difficult task, usually taking years to master. Typically, students are trained ad-hoc, in a primarily-rule based fashion. Our study investigated whether students can more rapidly learn to diagnose proximal neck of femur fractures via perceptual training, without having to learn an explicit set of rules. One hundred and thirty-nine students with no prior medical or radiology training were shown a sequence of plain film X-ray images of the right hip and for each image were asked to indicate whether a fracture was present. Students were told if they were correct and the location of any fracture, if present. No other feedback was given. The more able students achieved the same level of accuracy as board certified radiologists at identifying hip fractures in less than an hour of training. Surprisingly, perceptual learning was reduced when the training set was constructed to over-represent the types of images participants found more difficult to categorise. Conversely, repeating training images did not reduce post-training performance relative to showing an equivalent number of unique images. Perceptual training is an effective way of helping novices learn to identify hip fractures in X-ray images and should supplement the current education programme for students.	[Chen, Weijia; Howe, Piers D. L.] Univ Melbourne, Sch Psychol Sci, Parkville, Vic, Australia; [HolcDorf, David; McCusker, Mark W.; Gaillard, Frank] Royal Melbourne Hosp, Radiol Dept, Parkville, Vic, Australia; [Gaillard, Frank] Univ Melbourne, Radiol Dept, Parkville, Vic, Australia	University of Melbourne; Royal Melbourne Hospital; University of Melbourne	Chen, WJ (corresponding author), Univ Melbourne, Sch Psychol Sci, Parkville, Vic, Australia.	weijiacelinachen@gmail.com		Howe, Piers/0000-0001-6171-1381; Chen, Weijia/0000-0001-5723-2484	Royal Australian and New Zealand College of Radiology (RANZCR); University of Melbourne Engagement Grants Scheme	Royal Australian and New Zealand College of Radiology (RANZCR); University of Melbourne Engagement Grants Scheme	This study was supported by a Royal Australian and New Zealand College of Radiology (RANZCR) research grant in 2015 to FG and PDLH (no grant number available, URL https://www.ranzcr.com/college/awards-and-prizes/research-awards-and-grants), and the University of Melbourne Engagement Grants Scheme 2015 to FG (no available grant number or URL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Biggs AT, 2013, VIS COGN, V21, P330, DOI 10.1080/13506285.2013.790329; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BURTON AM, 1993, PERCEPTION, V22, P153, DOI 10.1068/p220153; Drew T, 2013, RADIOGRAPHICS, V33, P263, DOI 10.1148/rg.331125023; ENFRON B, 1993, INTRO BOOTSTRAP; Gale AG, 1997, HUMAN RESPONSE VISUA, P127; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Gibson Eleanor Jack, 1969, PRINCIPLES PERCEPTUA; Green DM, 1966, SIGNAL DETECTION THE; Haykin S, 1999, P842; Kellman PJ, 2009, PHYS LIFE REV, V6, P53, DOI 10.1016/j.plrev.2008.12.001; Kellman PJ, 2002, STEVENS HDB EXPT PSY, V3; Komori M, 2011, J EXP PSYCHOL HUMAN, V37, P626, DOI 10.1037/a0020369; Krasne Sally, 2013, J Pathol Inform, V4, P34, DOI 10.4103/2153-3539.123991; LeCun Y., 1993, EFFICIENT LEARNING 2, V93; Macrae CN, 2007, EUR J SOC PSYCHOL, V37, P793, DOI 10.1002/ejsp.406; Newell A., 1981, COGNITIVE SKILLS THE, P1; O'Toole AJ, 1998, MEM COGNITION, V26, P146, DOI 10.3758/BF03211378; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petrov AA, 2005, PSYCHOL REV, V112, P715, DOI 10.1037/0033-295X.112.4.715; Russell R, 2009, PERCEPTION, V38, P1211, DOI 10.1068/p6331; Sowden PT, 2000, J EXP PSYCHOL HUMAN, V26, P379, DOI 10.1037/0096-1523.26.1.379; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Xu B, 2016, APPL COGNITIVE PSYCH, V30, P750, DOI 10.1002/acp.3250; YOUNG KG, 2005, INVEST OPHTHALNIOL V, V46, P5631	25	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189192	10.1371/journal.pone.0189192	http://dx.doi.org/10.1371/journal.pone.0189192			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8BI	29267344	Green Published, gold			2022-12-26	WOS:000418587400022
J	De Franciscis, P; Barbieri, M; Leo, S; Dalise, AM; Sardu, C; Marfella, R; Colacurci, N; Paolisso, G; Rizzo, MR				De Franciscis, Pasquale; Barbieri, Michelangela; Leo, Stefania; Dalise, Anna Maria; Sardu, Celestino; Marfella, Raffaele; Colacurci, Nicola; Paolisso, Giuseppe; Rizzo, Maria Rosaria			Serum adiponectin levels are associated with worse cognitive function in postmenopausal women	PLOS ONE			English	Article							METABOLIC SYNDROME; ADIPOSE-TISSUE; IMPAIRMENT; ESTROGENS; OBESITY; MENOPAUSE; HORMONES; RISK; INFLAMMATION; METAANALYSIS	Introduction Adiponectin may be a biomarker of cognitive impairment stage, and its clinical progression. In this study we aimed to evaluate the relationship between serum adiponectin levels and cognitive performances in menopausal women, and whether serum adiponectin levels may be differently associated with cognitive performances as compared to overweight/obese subjects. Methods We enrolled 188 post-menopausal women, divided into two groups: obese/overweight group (n = 96) and normal weight group (n = 92). After a clinical examination, and laboratory measurements, we assessed cognitive functions by Montreal Cognitive Assessment test (MoCA). Results A significant and greater decrease in executive/visuo-spatial and in attention functions occurred in obese/overweight group as compared to normal weight group (p< 0.001). A significant positive relationship between serum adiponectin levels, and MoCA Global cognitive function was found. MoCA executive, and MoCA attention functions significantly and positively correlated with serum adiponectin levels. BMI, WHR, and serum adiponectin levels were independently associated with MoCA Global cognitive function, but only serum adiponectin levels were independently associated with MoCA attention. Conclusion A significant positive association may exist between serum adiponectin levels, and better cognitive function in postmenopausal status. The major determinant of attentional capacity was just serum adiponectin levels, and dosage of serum adiponectin levels may be early serum marker of cognitive decline. Therefore, serum adiponectin level has to be used, as early biomarker, to detect cognitive decline, and to support an early prevention.	[De Franciscis, Pasquale; Leo, Stefania; Colacurci, Nicola] Univ Campania Luigi Vanvitelli, Dept Woman Child & Gen & Specialized Surg, Naples, Italy; [Barbieri, Michelangela; Dalise, Anna Maria; Sardu, Celestino; Marfella, Raffaele; Paolisso, Giuseppe; Rizzo, Maria Rosaria] Univ Campania Luigi Vanvitelli, Dept Med Surg Neurol Metab & Geriatr Sci, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Rizzo, MR (corresponding author), Univ Campania Luigi Vanvitelli, Dept Med Surg Neurol Metab & Geriatr Sci, Naples, Italy.	mariarosaria.rizzo@unicampania2.it	Barbieri, Michelangela/K-2192-2016; Sardu, Celestino/AAA-7451-2019; Rizzo, Maria/HGD-6576-2022; paolisso, giuseppe/AAP-8516-2020; Rizzo, Maria Rosaria/AHH-3649-2022; Marfella, Raffaele/AAH-2595-2019	Barbieri, Michelangela/0000-0002-9223-5792; Sardu, Celestino/0000-0001-5099-3790; paolisso, giuseppe/0000-0002-2137-455X; Rizzo, Maria Rosaria/0000-0002-1023-4260; Marfella, Raffaele/0000-0003-3960-9270; De Franciscis, Pasquale/0000-0002-5607-3562				[Anonymous], 1995, PHYS STAT US INT ANT; Au A, 2016, FRONT NEUROENDOCRIN, V40, P87, DOI 10.1016/j.yfrne.2016.01.002; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Chan KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052354; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Cohen RA, 2010, NEUROEPIDEMIOLOGY, V34, P230, DOI 10.1159/000297745; Fisman EZ, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-103; Fry M, 2006, J NEUROSCI, V26, P9695, DOI 10.1523/JNEUROSCI.2014-06.2006; Gottesman RF, 2014, JAMA NEUROL, V71, P1218, DOI 10.1001/jamaneurol.2014.1646; Gunstad J, 2010, NEUROEPIDEMIOLOGY, V34, P222, DOI 10.1159/000297742; Gurka MJ, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003609; Henderson VW, 2014, J STEROID BIOCHEM, V142, P99, DOI 10.1016/j.jsbmb.2013.05.010; Hogervorst E, 2013, J NEUROENDOCRINOL, V25, P1182, DOI 10.1111/jne.12080; Janssen I, 2008, ARCH INTERN MED, V168, P1568, DOI 10.1001/archinte.168.14.1568; Kelley BJ, 2007, NEUROL CLIN, V25, P577, DOI 10.1016/j.ncl.2007.03.008; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Laughlin GA, 2010, CLIN ENDOCRINOL, V72, P99, DOI 10.1111/j.1365-2265.2009.03599.x; Lawson RA, 2016, PARKINSONISM RELAT D, V27, P47, DOI 10.1016/j.parkreldis.2016.04.009; Lebrun CEI, 2005, CLIN ENDOCRINOL, V63, P50, DOI 10.1111/j.1365-2265.2005.02297.x; Lobo RA, 2008, MATURITAS, V60, P10, DOI 10.1016/j.maturitas.2008.02.008; Mattsson C, 2007, CURR MED CHEM, V14, P2918, DOI 10.2174/092986707782359972; Ohashi K, 2015, ENDOCR METAB IMMUNE, V15, P145; Palin MF, 2012, VITAM HORM, V90, P239, DOI 10.1016/B978-0-12-398313-8.00010-5; Phipps AI, 2010, MATURITAS, V67, P60, DOI 10.1016/j.maturitas.2010.04.015; Rettberg JR, 2016, NEUROBIOL AGING, V40, P155, DOI 10.1016/j.neurobiolaging.2016.01.011; Roberts RO, 2009, ALZHEIMERS DEMENT, V5, P398, DOI 10.1016/j.jalz.2009.01.025; Ryan CM, 2006, DIABETES CARE, V29, P345, DOI 10.2337/diacare.29.02.06.dc05-1626; Sahakyan KR, 2015, ANN INTERN MED, V163, P827, DOI 10.7326/M14-2525; Siervo M, 2014, J ALZHEIMERS DIS, V41, P151, DOI 10.3233/JAD-132279; Soni AC, 2011, MENOPAUSE, V18, P296, DOI 10.1097/gme.0b013e3181f2e611; Sowers MR, 2008, MATURITAS, V59, P149, DOI 10.1016/j.maturitas.2007.12.006; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Teixeira AL, 2013, NEUROMOL MED, V15, P115, DOI 10.1007/s12017-012-8201-2; Trzepacz PT, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0103-3; Wan Z, 2014, BIOCH BIOPHYS RES CO; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	36	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0186205	10.1371/journal.pone.0186205	http://dx.doi.org/10.1371/journal.pone.0186205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267309	gold, Green Published, Green Submitted			2022-12-26	WOS:000418587400001
J	Hunt, L; Mulwafu, W; Knott, V; Ndamala, CB; Naunje, AW; Dewhurst, S; Hall, A; Mortimer, K				Hunt, Luke; Mulwafu, Wakisa; Knott, Victoria; Ndamala, Chifundo B.; Naunje, Andrew W.; Dewhurst, Sam; Hall, Andrew; Mortimer, Kevin			Prevalence of paediatric chronic suppurative otitis media and hearing impairment in rural Malawi: A cross-sectional survey	PLOS ONE			English	Article							PRIMARY-SCHOOL CHILDREN; VIDEO-OTOSCOPY; EAR; SCHOOLCHILDREN; PERFORMANCE; DISORDERS; DISTRICT; TANZANIA; DISEASE; KENYA	Objective To estimate the prevalence of World Health Organization-defined chronic suppurative otitis media (CSOM) and mild hearing impairment in a population representative sample of school-entry age children in rural Malawi. A secondary objective was to explore factors associated with CSOM in this population. Methods We performed a community-based cross-sectional study of children aged 4-6 years in Chikhwawa District, Southern Malawi, utilising a village-level cluster design. Participants underwent a structured clinical assessment, including video-otoscopy and screening audiometry. Diagnoses were made remotely by two otolaryngologists who independently reviewed clinical data and images collected in the field. Hearing impairment was classified as failure to hear a pure tone of 25dB or greater at 1, 2 or 4kHz. Results We recruited 281 children across 10 clusters. The prevalence estimates of CSOM, unilateral hearing impairment and bilateral hearing impairment were 5.4% (95% CI 2.2-8.6), 24.5% (95% CI 16.3-30.0), and 12.5% (95% CI 6.2-16.9) respectively. Middle ear disease was seen in 46.9% of children with hearing impairment. A trend towards increased risk of CSOM was observed with sleeping in a house with >2 other children. Interpretation We found a high burden of middle ear disease and preventable hearing impairment in our sample of school-entry age children in rural Malawi. There are important public health implications of these findings as CSOM and hearing impairment can affect educational outcomes, and may impact subsequent development. The identification and management of middle ear disease and hearing impairment represent major unmet needs in this population.	[Hunt, Luke; Mortimer, Kevin] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Mulwafu, Wakisa] Coll Med, Blantyre, Malawi; [Knott, Victoria] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England; [Ndamala, Chifundo B.; Naunje, Andrew W.] Malawi Liverpool Wellcome Trust Clin Res Program, Blantyre, Malawi; [Dewhurst, Sam] Univ Hosp Leicester NHS Fdn Trust, Leicester, Leics, England	Liverpool School of Tropical Medicine; University of Malawi; University of Sheffield; University of Malawi; University Hospitals of Leicester NHS Trust	Hunt, L (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.	luke.hunt@doctors.org.uk	Hunt, Luke/AAQ-1949-2020	Mortimer, Kevin/0000-0002-8118-8871; Hall, Andrew/0000-0003-1165-706X	Joint Global Health Trials Grant from the Medical Research Council; UK Department for International Development; Wellcome Trust [MR/K006533/1]; New Investigator Research Grant from the Medical Research Council [MR/L002515/1]; Malawi-Liverpool-Wellcome trust; MRC [MR/L002515/1] Funding Source: UKRI	Joint Global Health Trials Grant from the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development; Wellcome Trust(Wellcome TrustEuropean Commission); New Investigator Research Grant from the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Malawi-Liverpool-Wellcome trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was conducted in the context of the Cooking and Pneumonia Study (CAPS) which was funded by a Joint Global Health Trials Grant from the Medical Research Council, UK Department for International Development and Wellcome Trust (Ref: MR/K006533/1) and a New Investigator Research Grant from the Medical Research Council (Ref: MR/L002515/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Otolaryngology department at Queen Elizabeth Community Hospital in Blantyre, Malawi for ongoing management of participants with CSOM and other ear disease, and the Malawi-Liverpool-Wellcome trust for providing support with logistics and planning. We also thank Dino-LiteTM Europe for donating otoscopy equipment and HearScreenTM for providing audiometry equipment used in this study.	Adebola SO, 2013, INT J PEDIATR OTORHI, V77, P1987, DOI 10.1016/j.ijporl.2013.09.019; Aduda DSO, 2013, INT J PEDIATR OTORHI, V77, P1107, DOI 10.1016/j.ijporl.2013.04.011; Amusa Y B, 2005, West Afr J Med, V24, P227; BASTOS I, 1995, INT J PEDIATR OTORHI, V32, P1, DOI 10.1016/0165-5876(94)01904-C; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; Biagio L, 2012, ASYNCHRONOUS VIDEO O, P1; Biagio L, 2013, TELEMED E-HEALTH, V19, P252, DOI 10.1089/tmj.2012.0161; BLAIR JC, 1985, VOLTA REV, V87, P87; da Costa JL, 2004, INT J EPIDEMIOL, V33, P573, DOI 10.1093/ije/dyh071; Daud MKM, 2010, INT J PEDIATR OTORHI, V74, P67, DOI 10.1016/j.ijporl.2009.10.013; Dubey SP, 2007, LARYNGOSCOPE, V117, P264, DOI 10.1097/01.mlg.0000249728.48588.22; Famine early warning systems network, 2016, MAL FOOD SEC OUTL JU; HALDANE JBS, 1956, ANN HUM GENET, V20, P309; HATCHER J, 1995, INT J PEDIATR OTORHI, V33, P197, DOI 10.1016/0165-5876(95)01209-5; Lasisi AO, 2007, INT J PEDIATR OTORHI, V71, P1549, DOI 10.1016/j.ijporl.2007.06.005; Lundberg T, 2014, INT J PEDIATR OTORHI, V78, P1489, DOI 10.1016/j.ijporl.2014.06.018; Mahomed-Asmail F, EAR HEAR, V37, pe11; Mahomed-Asmail F, 2016, EAR HEARING, V37, pe11, DOI 10.1097/AUD.0000000000000223; Minja BM, 1996, INT J PEDIATR OTORHI, V37, P29, DOI 10.1016/0165-5876(96)01363-8; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; Mortimer K, 2017, LANCET, V389, P167, DOI 10.1016/S0140-6736(16)32507-7; Mulwafu W, 2016, TROP MED INT HEALTH, V21, P158, DOI 10.1111/tmi.12640; Mulwafu W, 2014, TROP DOCT, V44, P135, DOI 10.1177/0049475514524393; National Statistical Office, 2010, MAL DEM HLTH SURV; National Statistics Office, 2008, MAL POP HOUS CENS; Olatoke Fatai, 2008, Ear Nose Throat J, V87, pE19; Ologe FE, 2004, E AFR MED J, V80, P12; PRESCOTT CAJ, 1991, S AFR MED J, V79, P90; Shekelle P, 2003, AHRQ EVIDENCE REPORT; Simoes A. E, 2015, J PEDIAT INFECT DIS, P1; SITTER RR, 1992, CAN J STAT, V20, P135, DOI 10.2307/3315464; Smith A., 1999, WHO EAR HEARING DISO; Swanepoel DW, 2014, INT J AUDIOL; SWART SM, 1995, INT J PEDIATR OTORHI, V32, P23, DOI 10.1016/0165-5876(94)01109-B; Thornton D, 2011, J LARYNGOL OTOL, V125, P22, DOI 10.1017/S0022215110001878; Wathore R, 2017, ENVIRON SCI TECHNOL, V51, P1929, DOI 10.1021/acs.est.6b05557; Westerberg BD, 2005, INT J PEDIATR OTORHI, V69, P517, DOI 10.1016/j.ijporl.2004.11.020; World Health Organization, 2004, CHRON SUPP OT MED BU	38	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0188950	10.1371/journal.pone.0188950	http://dx.doi.org/10.1371/journal.pone.0188950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267304	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000418587400019
J	Liu, SY; Xing, ZC; Wang, ZF; Tian, SB; Jahun, FR				Liu, Siyao; Xing, Zuochang; Wang, Zifan; Tian, Subo; Jahun, Falalu Rabiu			Development of machine-vision system for gap inspection of muskmelon grafted seedlings	PLOS ONE			English	Article								Grafting robots have been developed in the world, but some auxiliary works such as gap-inspecting for grafted seedlings still need to be done by human. An machine-vision system of gap inspection for grafted muskmelon seedlings was developed in this study. The image acquiring system consists of a CCD camera, a lens and a front white lighting source. The image of inspected gap was processed and analyzed by software of HALCON 12.0. The recognition algorithm for the system is based on principle of deformable template matching. A template should be created from an image of qualified grafted seedling gap. Then the gap image of the grafted seedling will be compared with the created template to determine their matching degree. Based on the similarity between the gap image of grafted seedling and the template, the matching degree will be 0 to 1. The less similar for the grafted seedling gap with the template the smaller of matching degree. Thirdly, the gap will be output as qualified or unqualified. If the matching degree of grafted seedling gap and the template is less than 0.58, or there is no match is found, the gap will be judged as unqualified; otherwise the gap will be qualified. Finally, 100 muskmelon seedlings were grafted and inspected to test the gap inspection system. Results showed that the gap inspection machine-vision system could recognize the gap qualification correctly as 98% of human vision. And the inspection speed of this system can reach 15 seedlings.min(-1). The gap inspection process in grafting can be fully automated with this developed machine-vision system, and the gap inspection system will be a key step of a fully-automatic grafting robots.	[Liu, Siyao; Xing, Zuochang; Wang, Zifan; Tian, Subo; Jahun, Falalu Rabiu] Shenyang Agr Univ, Coll Engn, Shenyang, Liaoning, Peoples R China; [Jahun, Falalu Rabiu] Bayero Univ, Dept Agr Engn, Kano, Nigeria	Shenyang Agricultural University; Bayero University	Tian, SB (corresponding author), Shenyang Agr Univ, Coll Engn, Shenyang, Liaoning, Peoples R China.	tiansubo@163.com	wang, zifan/HHS-5709-2022	Liu, Siyao/0000-0003-3399-1640; Tian, Subo/0000-0001-9190-407X	Nation Natural Science Foundation of China [31101076]; Tianzhu Mountain Scholar in Shenyang Agricultural University	Nation Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianzhu Mountain Scholar in Shenyang Agricultural University	This work was supported by the Nation Natural Science Foundation of China (31101076) whose URLs are "http://www.nsfc.gov.cn/", and the Tianzhu Mountain Scholar in Shenyang Agricultural University (2014) whoes URLs are "http://www.syau.edu.cn/". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (31101076) and Tianzhu Mountain Scholar in Shenyang Agricultural University(2014).	Ahmadi R, 2017, ARAB J GEOSCI, V10, DOI 10.1007/s12517-017-2901-8; Barbedo JGA, 2014, J ASIA-PAC ENTOMOL, V17, P685, DOI 10.1016/j.aspen.2014.06.014; Ashraf Muhammad Ali, 2011, Engineering in Agriculture, Environment and Food, V4, P119; Ebrahimi E, 2014, MEASUREMENT, V55, P196, DOI 10.1016/j.measurement.2014.05.003; [辜松 GU Song], 2007, [东北农业大学学报, Journal of Northeast Agricultural University], V38, P847; Jenkins MD, 2016, PATTERN RECOGN LETT, V69, P82, DOI 10.1016/j.patrec.2015.10.014; Kartikey T, 2016, OPTIK, V130, P935; Kubota C, 2008, ACTA HORTIC, V770, P21, DOI 10.17660/ActaHortic.2008.770.2; Lee JM, 2010, SCI HORTIC-AMSTERDAM, V127, P93, DOI 10.1016/j.scienta.2010.08.003; Liming X, 2010, COMPUT ELECTRON AGR, V71, pS32, DOI 10.1016/j.compag.2009.09.013; Ling PP, 1996, J AGR ENG RES, V65, P85, DOI 10.1006/jaer.1996.0082; Luo J, 2010, HUMAN AGR MACHINERY, V37, P1; Manickavasagan A, 2014, SCI HORTIC-AMSTERDAM, V175, P87, DOI 10.1016/j.scienta.2014.06.003; Mizushima A, 2013, COMPUT ELECTRON AGR, V94, P29, DOI 10.1016/j.compag.2013.02.009; Sun CM, 2014, J CEREAL SCI, V60, P426, DOI 10.1016/j.jcs.2014.04.009; Tian SB, 2017, ADV MECH ENG, V9, DOI 10.1177/1687814016686265; Tian SuBo, 2015, Journal of Shenyang Agricultural University, V46, P329; Tian SuBo, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P9; Wu Y, 2014, INF PROCESS AGR, V1, P2, DOI DOI 10.3969/j.issn.1674-6082; Zhang D, 2014, COMPUT ELECTRON AGR, V100, P116, DOI 10.1016/j.compag.2013.11.009; Zhang TieZhong, 1999, Journal of China Agricultural University, V4, P45	21	2	2	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189732	10.1371/journal.pone.0189732	http://dx.doi.org/10.1371/journal.pone.0189732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267293	gold, Green Published, Green Submitted			2022-12-26	WOS:000418587400041
J	Prado, FP; dos Santos, DO; Blefari, V; Silva, CA; Machado, J; Kettelhut, ID; Ramos, SG; Baruffi, MD; Salgado, HC; Prado, CM				Prado, Fernanda P.; dos Santos, Daniele O.; Blefari, Valdecir; Silva, Carlos A.; Machado, Juliano; Kettelhut, Isis do Carmo; Ramos, Simone G.; Baruffi, Marcelo Dias; Salgado, Helio C.; Prado, Cibele M.			Early dystrophin loss is coincident with the transition of compensated cardiac hypertrophy to heart failure	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; PRESSURE-OVERLOAD HYPERTROPHY; RENIN-ANGIOTENSIN SYSTEM; MYOCARDIAL FIBROSIS; SKELETAL-MUSCLE; PATHOLOGICAL HYPERTROPHY; CONTRACTILE DYSFUNCTION; AORTIC CONSTRICTION; PROTEIN-KINASE; FAILING HEART	Hypertension causes cardiac hypertrophy, one of the most important risk factors for heart failure (HF). Despite the importance of cardiac hypertrophy as a risk factor for the development of HF, not all hypertrophied hearts will ultimately fail. Alterations of cytoskeletal and sarcolemma-associated proteins are considered markers cardiac remodeling during HF. Dystrophin provides mechanical stability to the plasma membrane through its interactions with the actin cytoskeleton and, indirectly, to extracellular matrix proteins. This study was undertaken to evaluate dystrophin and calpain-1 in the transition from compensated cardiac hypertrophy to HF. Wistar rats were subjected to abdominal aorta constriction and killed at 30, 60 and 90 days post surgery (dps). Cardiac function and blood pressure were evaluated. The hearts were collected and Western blotting and immunofluorescence performed for dystrophin, calpain-1, alpha-fodrin and calpastatin. Statistical analyses were performed and considered significant when p<0.05. After 90 dps, 70% of the animals showed hypertrophic hearts (HH) and 30% hypertrophic+dilated hearts (HD). Systolic and diastolic functions were preserved at 30 and 60 dps, however, decreased in the HD group. Blood pressure, cardiomyocyte diameter and collagen content were increased at all time points. Dystrophin expression was lightly increased at 30 and 60 dps and HH group. HD group showed decreased expression of dystrophin and calpastatin and increased expression of calpain-1 and alpha-fodrin fragments. The first signals of dystrophin reduction were observed as early as 60 dps. In conclusion, some hearts present a distinct molecular pattern at an early stage of the disease; this pattern could provide an opportunity to identify these failure-prone hearts during the development of the cardiac disease. We showed that decreased expression of dystrophin and increased expression of calpains are coincident and could work as possible therapeutic targets to prevent heart failure as a consequence of cardiac hypertrophy.	[Prado, Fernanda P.; dos Santos, Daniele O.; Blefari, Valdecir; Ramos, Simone G.; Prado, Cibele M.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pathol, Ribeirao Preto, SP, Brazil; [Silva, Carlos A.; Salgado, Helio C.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Phisiol, Ribeirao Preto, SP, Brazil; [Machado, Juliano; Kettelhut, Isis do Carmo] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Biochem Immunol, Ribeirao Preto, SP, Brazil; [Baruffi, Marcelo Dias] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Clin Anal Toxicol & Food Sci, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Prado, CM (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pathol, Ribeirao Preto, SP, Brazil.	cibeleprado@usp.br	dos Santos, Daniele O/L-5646-2016; dos Santos, Daniele Oliveira/M-4038-2019; Kettelhut, Isis/I-4839-2012; Ramos, Simone G./C-4720-2012; Baruffi, Marcelo D/I-7199-2015; Prado, Cibele/P-5773-2016	dos Santos, Daniele O/0000-0002-4066-4448; dos Santos, Daniele Oliveira/0000-0002-4066-4448; Kettelhut, Isis/0000-0002-9034-5357; Ramos, Simone G./0000-0002-1981-5248; Baruffi, Marcelo D/0000-0002-2039-1884; Prado, Cibele/0000-0003-4321-0879	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [09/17787-8, 10/19216-5, 09/54010-1, 13/20549-7, 12/23649-0, 16/21710-4, 15/21112-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: 09/17787-8 CMP; 10/19216-5 CMP; 09/54010-1 HCS; 13/20549-7 HCS; 12/23649-0 SGR; 16/21710-4 SGR; 15/21112-7 JM.	Akers WS, 2000, AM J PHYSIOL-HEART C, V279, pH2797, DOI 10.1152/ajpheart.2000.279.6.H2797; Badorff C, 1999, NAT MED, V5, P320, DOI 10.1038/6543; BAKER KM, 1990, AM J PHYSIOL, V259, pH324, DOI 10.1152/ajpheart.1990.259.2.H324; BEZNAK M, 1955, CAN J BIOCHEM PHYS, V33, P985; BROWN SC, 1993, BIOESSAYS, V15, P413, DOI 10.1002/bies.950150608; Campos EC, 2008, INT J EXP PATHOL, V89, P367, DOI 10.1111/j.1365-2613.2008.00604.x; Campos EC, 2011, EUR J PHARMACOL, V670, P541, DOI 10.1016/j.ejphar.2011.09.021; Cantor EJF, 2005, J MOL CELL CARDIOL, V38, P777, DOI 10.1016/j.yjmcc.2005.02.012; Celes MRN, 2010, LAB INVEST, V90, P531, DOI 10.1038/labinvest.2010.3; CONRAD CH, 1995, CIRCULATION, V91, P161, DOI 10.1161/01.CIR.91.1.161; COOPER G, 1985, J CLIN INVEST, V75, P1403, DOI 10.1172/JCI111842; COTTIN P, 1992, BIOCHIMIE, V74, P565, DOI 10.1016/0300-9084(92)90156-9; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Derumeaux G, 2002, CIRCULATION, V105, P1602, DOI 10.1161/01.CIR.0000012943.91101.D7; Dhalla NS, 2009, CARDIOVASC RES, V81, P429, DOI 10.1093/cvr/cvn281; Dhalla NS, 2006, J CARDIOVASC PHARM T, V11, P31, DOI 10.1177/107424840601100103; dos Santos DO, 2016, EXP MOL PATHOL, V100, P167, DOI 10.1016/j.yexmp.2015.12.009; Ervasti J M, 1993, Mol Cell Biol Hum Dis Ser, V3, P139; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Greyson CR, 2008, J MOL CELL CARDIOL, V44, P59, DOI 10.1016/j.yjmcc.2007.10.010; Han F, 2010, J PHARMACOL EXP THER, V332, P421, DOI 10.1124/jpet.109.161646; Hein S, 2000, CARDIOVASC RES, V45, P273, DOI 10.1016/S0008-6363(99)00268-0; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Higuchi MD, 1999, J CARDIAC SURG, V14, P401; Kawada T, 2005, BBA-PROTEINS PROTEOM, V1751, P73, DOI 10.1016/j.bbapap.2005.01.001; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Khairallah M, 2007, J MOL CELL CARDIOL, V43, P119, DOI 10.1016/j.yjmcc.2007.05.015; KIRA Y, 1984, AM J PHYSIOL, V246, pC247, DOI 10.1152/ajpcell.1984.246.3.C247; KOMURO I, 1991, JPN CIRC J, V55, P1149, DOI 10.1253/jcj.55.1149; Kudoh S, 2003, PROG BIOPHYS MOL BIO, V82, P57, DOI 10.1016/S0079-6107(03)00005-1; KWAK KB, 1993, FEBS LETT, V323, P151, DOI 10.1016/0014-5793(93)81468-F; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; Liao YL, 2002, AM J PHYSIOL-HEART C, V282, pH1703, DOI 10.1152/ajpheart.00238.2001; LITWIN SE, 1995, CIRCULATION, V91, P2642, DOI 10.1161/01.CIR.91.10.2642; Londono JEC, 2015, EUR HEART J, V36, P2257, DOI 10.1093/eurheartj/ehv250; Lorell BH, 2000, CIRCULATION, V102, P470; Maeda M, 2003, CELL MOTIL CYTOSKEL, V55, P26, DOI 10.1002/cm.10110; Malvestio LM, 2017, PARASITOL RES, V116, P429, DOI 10.1007/s00436-016-5281-1; Malvestio LM, 2014, MICROBES INFECT, V16, P768, DOI 10.1016/j.micinf.2014.07.010; MANN DL, 1989, CIRC RES, V64, P1079, DOI 10.1161/01.RES.64.6.1079; McNally E, 2003, J MOL CELL CARDIOL, V35, P231, DOI 10.1016/S0022-2828(03)00018-X; Moinudin G, 2013, CARDIOVASC J AFR, V24, P58, DOI 10.5830/CVJA-2012-080; Monreal G, 2008, LIFE SCI, V83, P786, DOI 10.1016/j.lfs.2008.09.026; Muller AL, 2012, HEART FAIL REV, V17, P395, DOI 10.1007/s10741-011-9269-8; Nishida K, 2015, J MOL CELL CARDIOL, V84, P212, DOI 10.1016/j.yjmcc.2015.05.004; Norton GR, 2002, J AM COLL CARDIOL, V39, P664, DOI 10.1016/S0735-1097(01)01792-2; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Prado CM, 2012, MICROBES INFECT, V14, P59, DOI 10.1016/j.micinf.2011.08.010; Prado CM, 2006, J HYPERTENS, V24, P503, DOI 10.1097/01.hjh.0000209987.51606.23; Purintrapiban J, 2003, COMP BIOCHEM PHYS B, V136, P393, DOI 10.1016/S1096-4959(03)00201-X; Reddy DS, 1996, MOL CELL BIOCHEM, V155, P1, DOI 10.1007/BF00714327; ROSSI MA, 1992, AM HEART J, V124, P700, DOI 10.1016/0002-8703(92)90281-Y; Ruppert M, 2016, AM J PHYSIOL-HEART C, V311, pH592, DOI 10.1152/ajpheart.00085.2016; Ruwhof C, 2001, CELL CALCIUM, V29, P73, DOI 10.1054/ceca.2000.0158; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; SAVAGE DD, 1987, CIRCULATION, V75, P26; Schroen B, 2004, CIRC RES, V95, P515, DOI 10.1161/01.RES.0000141019.20332.3e; SIGURDSON W, 1992, AM J PHYSIOL, V262, pH1110, DOI 10.1152/ajpheart.1992.262.4.H1110; Stilli D, 2006, EXP PHYSIOL, V91, P571, DOI 10.1113/expphysiol.2005.032607; SWYNGHEDAUW B, 1982, PATHOBIOL ANN, V12, P137; Takahashi M, 2005, CARDIOVASC RES, V65, P356, DOI 10.1016/j.cardiores.2004.09.022; Tatsukawa Y, 1997, HEART VESSELS, V12, P128, DOI 10.1007/BF02767130; Toyo-Oka T, 2004, P NATL ACAD SCI USA, V101, P7381, DOI 10.1073/pnas.0401944101; Tsuji T, 2001, AM J PHYSIOL-HEART C, V281, pH1286, DOI 10.1152/ajpheart.2001.281.3.H1286; UNVERFERTH DV, 1986, AM J CARDIOL, V57, P816, DOI 10.1016/0002-9149(86)90620-X; Vanderklish PW, 2000, INT J EXP PATHOL, V81, P323, DOI 10.1046/j.1365-2613.2000.00169.x; Weber K T, 1992, Blood Press, V1, P75, DOI 10.3109/08037059209077497; Weber KT, 2000, CURR OPIN CARDIOL, V15, P264, DOI 10.1097/00001573-200007000-00010; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; WEBER KT, 1992, CARDIOLOGY, V81, P266, DOI 10.1159/000175816; WEBER KT, 1990, AM J CARDIOL, V65, pG1; Wu B, 2008, P NATL ACAD SCI USA, V105, P14814, DOI 10.1073/pnas.0805676105; Xiao YY, 2003, COMP BIOCHEM PHYS C, V134, P439, DOI 10.1016/S1532-0456(03)00026-7; YAMAZAKI T, 1993, J BIOL CHEM, V268, P12069; Yoshida H, 2003, CARDIOVASC RES, V59, P419, DOI 10.1016/S0008-6363(03)00385-7	76	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189469	10.1371/journal.pone.0189469	http://dx.doi.org/10.1371/journal.pone.0189469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267303	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400032
J	Al-Sabahi, J; Bora, T; Al-Abri, M; Dutta, J				Al-Sabahi, Jamal; Bora, Tanujjal; Al-Abri, Mohammed; Dutta, Joydeep			Efficient visible light photocatalysis of benzene, toluene, ethylbenzene and xylene (BTEX) in aqueous solutions using supported zinc oxide nanorods	PLOS ONE			English	Article							WATER-TREATMENT; GAS-PHASE; TITANIUM-DIOXIDE; ZNO; DEGRADATION; OXIDATION; OIL; NANOPARTICLES; GROUNDWATER; DEFECTS	Benzene, toluene, ethylbenzene and xylenes (BTEX) are some of the common environmental pollutants originating mainly from oil and gas industries, which are toxic to human as well as other living organisms in the ecosystem. Here we investigate photocatalytic degradation of BTEX under visible light irradiation using supported zinc oxide (ZnO) nanorods grown on glass substrates using a microwave assisted hydrothermal method. ZnO nanorods were characterized by electron microscopy, X-ray diffraction (XRD), specific surface area, UV/visible absorption and photoluminescence spectroscopy. Visible light photocatalytic degradation products of BTEX are studied for individual components using gas chromatograph/mass spectrometer (GC/MS). ZnO nanorods with significant amount of electronic defect states, due to the fast crystallization of the nanorods under microwave irradiation, exhibited efficient degradation of BTEX under visible light, degrading more than 80% of the individual BTEX components in 180 minutes. Effect of initial concentration of BTEX as individual components is also probed and the photocatalytic activity of the ZnO nanorods in different conditions is explored. Formation of intermediate byproducts such as phenol, benzyl alcohol, benzaldehyde and benzoic acid were confirmed by our HPLC analysis which could be due to the photocatalytic degradation of BTEX. Carbon dioxide was evaluated and showed an increasing pattern over time indicating the mineralization process confirming the conversion of toxic organic compounds into benign products.	[Al-Sabahi, Jamal; Al-Abri, Mohammed] Sultan Qaboos Univ, Dept Petr & Chem Engn, Coll Engn, Al Khoud, Oman; [Al-Sabahi, Jamal; Al-Abri, Mohammed] Sultan Qaboos Univ, Water Res Ctr, Chair Nanotechnol Water Desalinat, Al Khoud, Oman; [Bora, Tanujjal] Asian Inst Technol, Ctr Excellence Nanotechnol, Klongluang, Pathumthani, Thailand; [Dutta, Joydeep] KTH Royal Inst Technol, Sch Engn Sci, Dept Appl Phys, Funct Mat, Stockholm, Sweden	Sultan Qaboos University; Sultan Qaboos University; Asian Institute of Technology; Royal Institute of Technology	Al-Abri, M (corresponding author), Sultan Qaboos Univ, Dept Petr & Chem Engn, Coll Engn, Al Khoud, Oman.; Al-Abri, M (corresponding author), Sultan Qaboos Univ, Water Res Ctr, Chair Nanotechnol Water Desalinat, Al Khoud, Oman.; Dutta, J (corresponding author), KTH Royal Inst Technol, Sch Engn Sci, Dept Appl Phys, Funct Mat, Stockholm, Sweden.	alabri@squ.edu.om; joydeep@kth.se	Dutta, Joydeep/B-4675-2011; Al-Sabahi, Jamal/AAU-3490-2020; Bora, Tanujjal/GQR-2418-2022	Dutta, Joydeep/0000-0002-0074-3504; Bora, Tanujjal/0000-0003-0358-4040	The Research Center (TRC); Chair in Nano technology for Water Desalination; Research Council (TRC) of Oman; College of Agricultural and Marine Sciences (Central instrument laboratory); Department of Petroleum and Chemical Engineering, College of Engineering, Sultan Qaboos University, Oman	The Research Center (TRC); Chair in Nano technology for Water Desalination; Research Council (TRC) of Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman); College of Agricultural and Marine Sciences (Central instrument laboratory); Department of Petroleum and Chemical Engineering, College of Engineering, Sultan Qaboos University, Oman	This work was supported by The Research Center (TRC) represented by the Chair in Nanotechnology Sultanate of Oman.; Authors would like to acknowledge financial and technical support from the Chair in Nano technology for Water Desalination, the Research Council (TRC) of Oman; College of Agricultural and Marine Sciences (Central instrument laboratory) and the Department of Petroleum and Chemical Engineering, College of Engineering, Sultan Qaboos University, Oman.	Ahmadun FR, 2009, J HAZARD MATER, V170, P530, DOI 10.1016/j.jhazmat.2009.05.044; Al-Sabahi J, 2016, MATERIALS, V9, DOI 10.3390/ma9040238; Allen EW, 2008, J ENVIRON ENG SCI, V7, P499, DOI 10.1139/S08-020; Appavoo K, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868534; Ardizzone S, 2008, ENVIRON SCI TECHNOL, V42, P6671, DOI 10.1021/es8009327; Bamberger M, 2015, J ENVIRON SCI HEAL A, V50, P447, DOI 10.1080/10934529.2015.992655; Baruah S, 2010, BEILSTEIN J NANOTECH, V1, P14, DOI 10.3762/bjnano.1.3; Baruah S, 2009, J CRYST GROWTH, V311, P2549, DOI 10.1016/j.jcrysgro.2009.01.135; Baruah S, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/1/013001; Baruah S, 2008, NANO, V3, P399, DOI 10.1142/S179329200800126X; Bora T, 2011, BEILSTEIN J NANOTECH, V2, P681, DOI 10.3762/bjnano.2.73; Chakrabarti S, 2004, J HAZARD MATER, V112, P269, DOI 10.1016/j.jhazmat.2004.05.013; Chen DM, 2014, J PHYS CHEM C, V118, P15300, DOI 10.1021/jp5033349; Coelho A, 2006, J HAZARD MATER, V137, P178, DOI 10.1016/j.jhazmat.2006.01.051; Colborn T, 2011, HUM ECOL RISK ASSESS, V17, P1039, DOI 10.1080/10807039.2011.605662; d'Hennezel O, 1998, J PHOTOCH PHOTOBIO A, V118, P197, DOI 10.1016/S1010-6030(98)00366-9; Danwittayakul S, 2015, APPL CATAL B-ENVIRON, V163, P1, DOI 10.1016/j.apcatb.2014.07.042; Das D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182823; do Rego ECP, 2007, B ENVIRON CONTAM TOX, V79, P660, DOI 10.1007/s00128-007-9300-x; Dorea HS, 2007, MICROCHEM J, V85, P234, DOI 10.1016/j.microc.2006.06.002; Fang JW, 2015, APPL SURF SCI, V332, P47, DOI 10.1016/j.apsusc.2015.01.139; Fernandez-Lima FA, 2009, ANAL CHEM, V81, P9941, DOI 10.1021/ac901594f; Foo KL, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-429; Fulekar MH, 2014, ENV SUSTAINABLE DEV, P87, DOI DOI 10.1007/978-3-319-58538-3_96-1; Gaya UI, 2008, J PHOTOCH PHOTOBIO C, V9, P1, DOI 10.1016/j.jphotochemrev.2007.12.003; Goto T, 2016, RSC ADV, V6, P23794, DOI 10.1039/c5ra25430b; HAGFELDT A, 1995, CHEM REV, V95, P49, DOI 10.1021/cr00033a003; Hickey RF, 1990, 4 NAT OUTD ACT C AQ; Hughey CA, 2002, ANAL CHEM, V74, P4145, DOI 10.1021/ac020146b; Ishak S, 2012, J SCI IND RES INDIA, V71, P251; Jabeen M, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/1/018504; Janotti A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121201; Jing YQ, 2017, ACS SUSTAIN CHEM ENG, V5, P3641, DOI 10.1021/acssuschemeng.6b02650; Kang DW, 2012, ECS SOLID STATE LETT, V1, pP15, DOI 10.1149/2.007201ssl; Khan MN, 2014, CERAM INT, V40, P8743, DOI 10.1016/j.ceramint.2014.01.094; Khezrianjoo S., 2012, CHEM SCI J, V85, P1; Klein GC, 2006, ENERG FUEL, V20, P668, DOI 10.1021/ef050353p; Krishnakumar B, 2011, SPECTROCHIM ACTA A, V81, P739, DOI 10.1016/j.saa.2011.07.019; Kumar KV, 2008, CATAL COMMUN, V9, P82, DOI 10.1016/j.catcom.2007.05.019; Kumar KV, 2007, DYES PIGMENTS, V75, P246, DOI 10.1016/j.dyepig.2006.05.035; Lazar MA, 2012, CATALYSTS, V2, P572, DOI 10.3390/catal2040572; Li HS, 2016, WATER RES, V88, P458, DOI 10.1016/j.watres.2015.10.031; Liu SW, 2011, CRYSTENGCOMM, V13, P2533, DOI 10.1039/c0ce00295j; Mahmood MA, 2012, ENVIRON CHEM LETT, V10, P145, DOI 10.1007/s10311-011-0347-x; Mandal T, 2010, DESALINATION, V250, P87, DOI 10.1016/j.desal.2009.04.012; Mao Y, 1996, J PHYS CHEM-US, V100, P4219, DOI 10.1021/jp9529376; Meenakshi G, 2017, ECOTOX ENVIRON SAFE, V135, P243, DOI 10.1016/j.ecoenv.2016.10.010; Mishra YK, 2013, PART PART SYST CHAR, V30, P775, DOI 10.1002/ppsc.201300197; Mishra YK, 2015, ACS APPL MATER INTER, V7, P14303, DOI 10.1021/acsami.5b02816; Mohan R, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-503; Munter R., 2001, P EST ACAD SCI, V50, P59, DOI DOI 10.1002/CHIN.200141291; Osborn SG, 2011, METHANE CONTAMINATIO, P8172; Park JH, 2011, KOREAN J CHEM ENG, V28, P1693, DOI 10.1007/s11814-011-0021-9; Raizada P, 2016, J TAIBAH UNIV SCI, P1; Reimer T, 2014, ACS APPL MATER INTER, V6, P7806, DOI 10.1021/am5010877; Saenz-Trevizoa A, 2016, MATER RES-IBERO-AM J, V19, P33, DOI [10.1590/1980-5373-mr-2015-0612, 10.1590/1980-5373-MR-2015-0612]; Saien J, 2008, J HAZARD MATER, V157, P269, DOI 10.1016/j.jhazmat.2007.12.094; Saoud K, 2015, MATER RES BULL, V63, P134, DOI 10.1016/j.materresbull.2014.12.001; Sathe P, 2016, BIOFOULING, V32, P383, DOI 10.1080/08927014.2016.1146256; Singh P, 2016, POLLUTION, V2, P199, DOI 10.7508/pj.2016.02.008; Soltani T, 2017, PHOTOCH PHOTOBIO SCI, V16, P86, DOI 10.1039/c6pp00212a; Tang YW, 2015, CHEM ENG J, V262, P260, DOI 10.1016/j.cej.2014.09.095; Tao Y., 2013, J CATALYSTS, V2013, DOI DOI 10.1155/2013/364275; Tiburtius ERL, 2005, J HAZARD MATER, V126, P86, DOI 10.1016/j.jhazmat.2005.06.003; Tripathi KM, 2017, ACS SUSTAIN CHEM ENG, V5, P3982, DOI 10.1021/acssuschemeng.6b03182; Tyagi A, 2016, RSC ADV, V6, P72423, DOI 10.1039/c6ra10488f; Ullah R, 2007, THIRD INTERNATIONAL CONFERENCE ON EMERGING TECHNOLOGIES 2007, PROCEEDINGS, P307; Umang VD, 2012, NANOTECHNOLOGY, V23; Vinoth R, 2017, ULTRASON SONOCHEM, V35, P655, DOI 10.1016/j.ultsonch.2016.03.005; VOICE TC, 1992, WATER RES, V26, P1389, DOI 10.1016/0043-1354(92)90132-N; Wahab R, 2016, RSC ADV, V6, P32328, DOI 10.1039/c6ra05297e; Wahab R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19950; Wahab R, 2014, COLLOID SURFACE B, V117, P267, DOI 10.1016/j.colsurfb.2014.02.038; Wang JL, 2012, CRIT REV ENV SCI TEC, V42, P251, DOI 10.1080/10643389.2010.507698; Wang M, 2015, SCI REPORTS, V5; Ye JD, 2005, APPL PHYS A-MATER, V81, P759, DOI 10.1007/s00339-004-2996-0; Yoon TP, 2010, NAT CHEM, V2, P527, DOI [10.1038/NCHEM.687, 10.1038/nchem.687]; Yuan Z., 2010, NANOTECHNOLOGY, V21; Zhang HJ, 2009, J MATER CHEM, V19, P5089, DOI 10.1039/b821991e; Zhao Z, 2014, T NONFERR METAL SOC, V24, P1434, DOI 10.1016/S1003-6326(14)63209-X	80	29	29	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189276	10.1371/journal.pone.0189276	http://dx.doi.org/10.1371/journal.pone.0189276			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261711	Green Published, Green Submitted, gold			2022-12-26	WOS:000418564200040
J	Caro, JC; Ng, SW; Bonilla, R; Tovar, J; Popkin, BM				Caro, Juan Carlos; Ng, Shu Wen; Bonilla, Ricardo; Tovar, Jorge; Popkin, Barry M.			Sugary drinks taxation, projected consumption and fiscal revenues in Colombia: Evidence from a QUAIDS model	PLOS ONE			English	Article							SNACKING DIETARY PATTERN; SWEETENED BEVERAGES; SOCIOECONOMIC-STATUS; 2-STEP ESTIMATION; PRICE ELASTICITY; FOOD; OBESITY; DEMAND; TAX; PRODUCTS	The global shift towards diets high in sugar-sweetened beverages (SSBs) is linked to higher prevalence of obesity, diabetes and most other non-communicable diseases. In Colombia, one out of every two people was overweight or obese by 2010. This study estimates price-elasticities from a Quadratic Almost Ideal Demand System model, using the 2006 +/- 2007 Colombian Income and Expenditure survey. The food groups that were jointly considered were: unsweetened unflavored milks; coffee and tea; sugar sweetened beverages (SSBs); sweets and candies (including sugar); dairy products; meats and animal-based products; grains based staples; fruits and vegetables; and condiments and snacks. We take into account the high proportion of households not purchasing specific food and beverage groups (censored data) and endogeneity on both prices (as unit values) and total expenditure. Unhealthy beverages are price-elastic (-1.61 for SSBs) meaning that the change in consumption is proportionally larger with respect to a change in price. Also, there is a high complementarity among SSBs and major food groups (grains, meats and fruits and vegetables). In Colombia, the design of a meaningful tax to influence healthier diets is a next critical step. This study also shows that a tax of 20% on SSBs should prove to be effective, and can yield revenues of about 1% of the Colombian government's total annual fiscal revenue, which can potentially be directed towards public health promotion and investments.	[Caro, Juan Carlos] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA; [Ng, Shu Wen; Popkin, Barry M.] Univ N Carolina, Gillings Sch Global Publ Hlth, Carolina Populat Ctr, Chapel Hill, NC 27599 USA; [Ng, Shu Wen; Popkin, Barry M.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA; [Bonilla, Ricardo] Univ Nacl Colombia, Ctr Invest Desarrollo, Bogota, Colombia; [Tovar, Jorge] Univ Los Andes, Fac Econ CEDE, Bogota, Colombia	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Universidad Nacional de Colombia; Universidad de los Andes (Colombia)	Popkin, BM (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Carolina Populat Ctr, Chapel Hill, NC 27599 USA.; Popkin, BM (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA.	popkin@unc.edu	Popkin, Barry/T-6633-2019		Bloomberg Philanthropies; International Development Research Center (IDRC); NIH via the Carolina Population Center grant [P2C HD050924]; NIH via CPC grant [P2C HD050924]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER	Bloomberg Philanthropies; International Development Research Center (IDRC); NIH via the Carolina Population Center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH via CPC grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this research comes predominantly from Bloomberg Philanthropies with added funding from the International Development Research Center (IDRC) and NIH via the Carolina Population Center grant P2C HD050924. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this research comes predominantly from Bloomberg Philanthropies with added funding from NIH via CPC grant P2C HD050924. We also wish to thank Ms. Frances D. Burton for administrative assistance and Luis Gomez for assistance in arranging this collaboration.	Anand SS, 2015, J AM COLL CARDIOL, V66, P1590, DOI 10.1016/j.jacc.2015.07.050; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704; Banks J, 1997, REV ECON STAT, V79, P527, DOI 10.1162/003465397557015; Batis C, 2015, PLOS MED IN PRESS; Biro A, 2015, FOOD POLICY, V54, P107, DOI 10.1016/j.foodpol.2015.05.003; Bonnet C, SUGAR POLICY REFORM; Boysen O, 2016, S AFR J ECON, V84, P260, DOI 10.1111/saje.12093; Capacci S, 2011, J HEALTH ECON, V30, P87, DOI 10.1016/j.jhealeco.2010.10.006; Caro JC, 2017, FOOD POLICY, V71, P86, DOI 10.1016/j.foodpol.2017.08.001; Cawley J, 2017, J POLICY ANAL MANAG, V36, P303, DOI 10.1002/pam.21960; Colchero MA, 2015, ECON HUM BIOL, V19, P129, DOI 10.1016/j.ehb.2015.08.007; Crovetto M, 2014, REV MED CHILE, V142, P1530, DOI 10.4067/S0034-98872014001200006; DEATON A, 1980, AM ECON REV, V70, P312; DEATON A, 1988, AM ECON REV, V78, P418; Departamento Administrativo Nacional de Estadistica, 2016, 200620072009 DEP ADM; Departamento de Impuestos y Aduanas Nacionales, 2016, 2015 DIAN; Dharmasena S, 2014, J AGR RESOUR ECON, V39, P157; Euromonitor, EUR INT 2015; Food and Agriculture Organization of the United Nations United Nations University Organization WH, 2001, HUM EN REQ REP JOINT, pix; Haag BR, 2009, J ECONOMETRICS, V153, P33, DOI 10.1016/j.jeconom.2009.04.003; Haag BR, 2009, WORKING PAPERS; Harding M, WORKING PAPERS, V2014; Hawkes C, 2007, AM J PUBLIC HEALTH, V97, P1962, DOI 10.2105/AJPH.2006.101162; Instituto Colombiano de Bienestar Familiar, 2016, 20102010 I COL BIEN; Jaacks LM, 2015, J NUTR, V145, P352, DOI 10.3945/jn.114.203562; Jensen J., 2015, P IEEE ULTR S, P1; Jou J, 2012, HEALTH POLICY, V107, P83, DOI 10.1016/j.healthpol.2012.05.011; Kasper NM, 2014, PUBLIC HEALTH NUTR, V17, P2398, DOI 10.1017/S1368980013003418; Kwan GF, 2016, CIRCULATION, V133, P2561, DOI 10.1161/CIRCULATIONAHA.116.008731; Lazaridis P, 2004, APPL ECON LETT, V11, P523, DOI 10.1080/1350485042000207234; Lin BH, 2011, ECON HUM BIOL, V9, P329, DOI 10.1016/j.ehb.2011.08.007; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; McDonald CM, 2009, J NUTR, V139, P370, DOI 10.3945/jn.108.098111; Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107; MORENGA LT, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.E7492; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Paraje G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152260; Paris Q, 2014, EAAE 2014 C AGR FOOD; Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Poti JM, 2014, AM J CLIN NUTR, V99, P162, DOI 10.3945/ajcn.113.071928; Pries AM, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12412; Pries AM, 2016, MATERN CHILD NUTR, V12, P22, DOI 10.1111/mcn.12267; Pudney S, 1989, MODELLING INDIVIDUAL; Rodriguez-Ramirez S, 2016, J NUTR, V146, P1916, DOI 10.3945/jn.115.220145; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Saha A, 1997, APPL ECON LETT, V4, P181, DOI 10.1080/135048597355474; Sarmiento OL, 2014, AM J CLIN NUTR, V100, p1628S, DOI 10.3945/ajcn.114.083816; Shonkwiler JS, 1999, AM J AGR ECON, V81, P972, DOI 10.2307/1244339; Shroff MR, 2014, PUBLIC HEALTH NUTR, V17, P1507, DOI 10.1017/S136898001300133X; Smed S, 2016, EUR J CLIN NUTR, V70, P681, DOI 10.1038/ejcn.2016.6; Snowdon W, 2013, OBES REV, V14, P150, DOI 10.1111/obr.12090; StataCorp, 2015, STAT STAT SOFTW REL; Tavares LF, 2012, PUBLIC HEALTH NUTR, V15, P82, DOI 10.1017/S1368980011001571; Thow AM, 2014, NUTR REV, V72, P551, DOI 10.1111/nure.12123; Trujillo-Hernández Benjamín, 2010, Rev. salud pública, V12, P197; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; World Health Organization, 2016, FISC POL DIET PREV N; Yen ST, 2002, APPL ECON, V34, P1799, DOI 10.1080/00036840210125008; Zhen C, 2014, AM J AGR ECON, V96, P1, DOI 10.1093/ajae/aat049	62	11	11	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189026	10.1371/journal.pone.0189026	http://dx.doi.org/10.1371/journal.pone.0189026			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ7SY	29261699	Green Submitted, gold, Green Published			2022-12-26	WOS:000418564200024
J	Titulaer, M; Melgoza-Castillo, A; Panjabi, AO; Sanchez-Flores, A; Martinez-Guerrero, JH; Macias-Duarte, A; Fernandez, JA				Titulaer, Mieke; Melgoza-Castillo, Alicia; Panjabi, Arvind O.; Sanchez-Flores, Alejandro; Hugo Martinez-Guerrero, Jose; Macias-Duarte, Alberto; Fernandez, Jesus A.			Molecular analysis of stomach contents reveals important grass seeds in the winter diet of Baird's and Grasshopper sparrows, two declining grassland bird species	PLOS ONE			English	Article							HOME-RANGE SIZE; GRANIVOROUS BIRDS; EATING BIRDS; MONTE DESERT; BILL STRUCTURE; SELECTION; DNA; MEXICO; CONSERVATION; TIME	We analyzed the diet of Baird's Sparrow (Ammodramus bairdii) and Grasshopper Sparrow (A. savannarum) in three different sites and sampling periods across the Chihuahuan Desert in northern Mexico. DNA from seeds in regurgitated stomach contents was sequenced using NGS technology and identified with a barcoding approach using the P6 loop of the trnL intron as genetic marker. During each sampling period, we collected random soil samples to estimate seed availability in the soil seed bank. Due to the variability and size of the genetic marker, the resolution was limited to a family level resolution for taxonomic classification of seeds, but in several cases a genus level was achieved. Diets contained a high diversity of seeds but were dominated by a limited number of genera/families. Seeds from Panicoideae (from the genera Panicum, Setaria, Eriochloa, Botriochloa, and Hackelochloa) contributed for the largest part to the diets (53 +/- 19%), followed by Bouteloua (10 +/- 12%). Depending on the site and sampling period, other important seeds in the diets were Eragrostideae, Pleuraphis, Asteraceae, Verbena, and Amaranthus. The most abundant seeds were not always preferred. Aristida and Chloris were common in the soil seed bank but these seeds were avoided by both bird species. Baird's and Grasshopper sparrows did not differ in seed preferences. This work highlights the importance of range management practices that favor seed production of Panicoideae and Bouteloua grasses to enhance winter habitat use and survival of Baird's and Grasshopper sparrows in the Chihuahuan Desert.	[Titulaer, Mieke; Melgoza-Castillo, Alicia; Fernandez, Jesus A.] Univ Autonoma Chihuahua, Fac Zootecnia & Ecol, Chihuahua, Mexico; [Panjabi, Arvind O.] Bird Conservancy Rockies, Ft Collins, CO USA; [Sanchez-Flores, Alejandro] Univ Nacl Autonoma Mexico, Inst Biotechnol, Cuernavaca, Morelos, Mexico; [Hugo Martinez-Guerrero, Jose] Univ Juarez Estado Durango, Fac Med Vet & Zootecnia, Durango, Mexico; [Macias-Duarte, Alberto] Univ Estatal Sonora, Hermosillo, Sonora, Mexico; [Titulaer, Mieke] Sul Ross State Univ, Borderlands Res Inst, Alpine, TX 79830 USA	Universidad Nacional Autonoma de Mexico; Universidad Juarez del Estado de Durango; Texas State University System	Titulaer, M (corresponding author), Univ Autonoma Chihuahua, Fac Zootecnia & Ecol, Chihuahua, Mexico.; Titulaer, M (corresponding author), Sul Ross State Univ, Borderlands Res Inst, Alpine, TX 79830 USA.	mieke.titulaer@sulross.edu	Macías-Duarte, Alberto/GQP-7682-2022; Fernandez, Jesus A/AAH-8774-2020; Sanchez-Flores, Alejandro/L-9454-2016	Macías-Duarte, Alberto/0000-0001-5571-5810; Melgoza, Alicia/0000-0001-9467-1902; Sanchez-Flores, Alejandro/0000-0003-0476-3139	National Park Service (Desert Southwest Cooperative Ecosystem Studies Unit Cooperative Agreement) [H1200-10-0001]; T&E Inc. Conservation Award; CONACyT [441029]; "Unidad de Secuenciacion Masiva y Bioinformatica" of the "Laboratorio Nacional de Apoyo Tecnologico a las Ciencias Genomicas," CONACyT at the Instituto de Biotecnologia/UNAM [260481]	National Park Service (Desert Southwest Cooperative Ecosystem Studies Unit Cooperative Agreement); T&E Inc. Conservation Award; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); "Unidad de Secuenciacion Masiva y Bioinformatica" of the "Laboratorio Nacional de Apoyo Tecnologico a las Ciencias Genomicas," CONACyT at the Instituto de Biotecnologia/UNAM	Research was funded by National Park Service (Desert Southwest Cooperative Ecosystem Studies Unit Cooperative Agreement Number H1200-10-0001) granted to AOP and a T&E Inc. Conservation Award 2012 received by MT. MT is thankful to CONACyT for a three-year doctorate scholarship (grant number 441029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Cesar Mendez Gonzalez for teaching the regurgitation technique to MT. We thank Erin Strasser, Greg Levandoski, Jorge Gonzalez-Villalba, and many volunteers who participated during field work and assisted the seed lab. We are very grateful to Ricardo Grande and the "Unidad de Secuenciacion Masiva y Bioinformatica" of the "Laboratorio Nacional de Apoyo Tecnologico a las Ciencias Genomicas," CONACyT #260481, at the Instituto de Biotecnologia/UNAM. We also thank Eduviges Burrola, Agustin Corral, Ana Karen Torres, and Beatriz Castro for their support in the laboratory. We would like to thank Eero Vesterinen and Pierre Taberlet for their willingness to discuss molecular procedures, and Felipe Alonso Rodriguez-Almeida for statistical advice. Finally, we are thankful to the The Nature Conservancy and managers and landowners of Santa Teresa and Teseachi for allowing us to conduct field work in their ranches. MT is thankful to CONACyT for a three-year doctorate scholarship (grant number 441029).	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; [Anonymous], 2021, LANG ENV STAT COMP; Bechtoldt CL, 2005, WILSON BULL, V117, P211, DOI 10.1676/04-110.1; BENKMAN CW, 1988, ECOLOGY, V69, P1195, DOI 10.2307/1941274; Block G, 2010, WEST N AM NATURALIST, V70, P19, DOI 10.3398/064.070.0103; Brennan LA, 2005, J WILDLIFE MANAGE, V69, P1, DOI 10.2193/0022-541X(2005)069&lt;0001:NAGBAU&gt;2.0.CO;2; Carrillo CM, 2007, ANN ZOOL FENN, V44, P377; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cowan Robyn S, 2012, Methods Mol Biol, V862, P23, DOI 10.1007/978-1-61779-609-8_3; Cueto VR, 2006, AUK, V123, P358, DOI 10.1642/0004-8038(2006)123[358:SPISSO]2.0.CO;2; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Desmond M, 2004, BIOL CONSERV, V116, P235, DOI 10.1016/S0006-3207(03)00194-0; Desmond Martha J., 2005, P439; Desmond Martha J., 2008, Studies in Avian Biology, V37, P101; DIAZ M, 1994, OECOLOGIA, V99, P1, DOI 10.1007/BF00317076; Diaz M, 1996, COMP BIOCHEM PHYS A, V113, P239, DOI 10.1016/0300-9629(95)02093-4; DUNNING JB, 1982, AUK, V99, P123, DOI 10.2307/4086028; Gerwing TG, 2016, AUK, V133, P168, DOI 10.1642/AUK-15-176.1; Ginter DL, 2005, WILSON BULL, V117, P63, DOI 10.1676/04-017; GRZYBOWSKI JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P211, DOI 10.1007/BF00299925; Henderson AE, 2014, RANGELAND ECOL MANAG, V67, P88, DOI 10.2111/REM-D-12-00140.1; Herrick JE, 2009, MONITORING MANUAL GR, VII; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hrabar HDK, 2002, AFR ZOOL, V37, P67; Hugo Martinez-Guerrero Jose, 2014, Open Journal of Ecology, V4, P281, DOI 10.4236/oje.2014.45026; Hutto R.L., 1985, P455; IUCN, IUCN RED LIST THREAT; Johansen SM, 2014, WILSON J ORNITHOL, V126, P374, DOI 10.1676/13-066.1; KEATING JF, 1992, AUK, V109, P863; Larson JA, 2012, SOUTHWEST NAT, V57, P319, DOI 10.1894/0038-4909-57.3.319; Macias-Duarte A, 2013, AUK, V130, P141, DOI 10.1525/auk.2012.12047; Macoas-Duarte A, 2009, FACTORS INFLUENCING, P126; Maier M. J, 2014, DIRICHLETREG DIRICHL; Rios JM, 2012, CONDOR, V114, P44, DOI 10.1525/cond.2012.110043; Marone L, 2008, OIKOS, V117, P611, DOI 10.1111/j.0030-1299.2008.16506.x; Mendez-Gonzalez CE, 2010, THESIS; Molokwu MN, 2011, BEHAV ECOL, V22, P639, DOI 10.1093/beheco/arr025; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Pellant M., 2005, 17346 US DEP INT BUR; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Pool DB, 2014, BIOL CONSERV, V170, P274, DOI 10.1016/j.biocon.2013.12.019; PULLIAM HR, 1979, FORTS ZOOL, V25, P137; PULLIAM HR, 1980, ARDEA, V68, P75; PULLIAM HR, 1985, ECOLOGY, V66, P1829, DOI 10.2307/2937378; PULLIAM HR, 1975, ECOLOGY, V56, P1158, DOI 10.2307/1936155; PULLIAM HR, 1986, AM ZOOL, V26, P71; Pyle P, 1997, IDENTIFICATION GUIDE; Rio Grande Joint Venture, 2017, PRIOR BIRDS CHIH DES; Rosenberg K. V., 2016, PARTNERS FLIGHT LAND; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sauer J.R., 2017, N AM BREEDING BIRD S; Soininen EM, 2013, POLAR BIOL, V36, P1069, DOI 10.1007/s00300-013-1328-2; Soobramoney S, 2007, EMU, V107, P169, DOI 10.1071/MU05018; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; THOMPSON DB, 1987, OECOLOGIA, V74, P106, DOI 10.1007/BF00377353; Titulaer M., 2015, THESIS; US Fish and Wildlife Service, 2008, BIRDS CONS CONC 2008; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Valera F, 2005, CONDOR, V107, P29, DOI 10.1650/7599; Van der Meij MAA, 2004, ANIM BIOL, V54, P195, DOI 10.1163/1570756041445164; Vickery PD, 1999, STUD AVIAN BIOL, P2	62	7	7	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189695	10.1371/journal.pone.0189695	http://dx.doi.org/10.1371/journal.pone.0189695			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261732	gold, Green Published, Green Submitted			2022-12-26	WOS:000418564200057
J	Toledo, MZ; Baez, GM; Garcia-Guerra, A; Lobos, NE; Guenther, JN; Trevisol, E; Luchini, D; Shaver, RD; Wiltbank, MC				Toledo, Mateus Z.; Baez, Giovanni M.; Garcia-Guerra, Alvaro; Lobos, Nelson E.; Guenther, Jerry N.; Trevisol, Eduardo; Luchini, Daniel; Shaver, Randy D.; Wiltbank, Milo C.			Effect of feeding rumen-protected methionine on productive and reproductive performance of dairy cows	PLOS ONE			English	Article							TIMED ARTIFICIAL-INSEMINATION; PREGNANCY-ASSOCIATED GLYCOPROTEINS; MILK PROTEIN YIELD; AMINO-ACIDS; OVSYNCH PROTOCOL; SELECT NUTRIENTS; HOLSTEIN COWS; LACTATIONAL PERFORMANCE; PREIMPLANTATION EMBRYO; FETAL-DEVELOPMENT	The objectives of this study were to evaluate the effects of daily top-dressing (individually feeding on the top of the total mixed ration) with rumen-protected methionine (RPM) from 30 +/- 3 until 126 +/- 3 Days in milk on productive and reproductive performance in lactating dairy cows. A total of 309 lactating dairy Holstein cows (138 primiparous and 171 multiparous) were randomly assigned to treatment diets containing either RPM (21.2 g of RPM + 38.8 g of dried distillers grain; 2.34% Methionine [Met] of metabolizable protein [MP]) or Control (CON; 60 g of dried distillers grain; 1.87% Met of MP). Plasma amino acids were evaluated at the time of artificial insemination (AI) and near pregnancy diagnosis. Milk production and milk composition were evaluated monthly. Pregnancy was diagnosed on Day 28 (by Pregnancy- specific protein B [PSPB]), 32, 47, and 61 (by ultrasound) and sizes of embryonic and amniotic vesicle were determined by ultrasound on Day 33 after AI. Feeding RPM increased plasma Met at 6, 9, 12, and 18 hours after top-dressing with a peak at 12 hours (52.4 vs 26.0 mu M; P < 0.001) and returned to basal by 24 hours. Cows fed RPM had a small increase in milk protein percentage (3.08 vs 3.00%; P = 0.04) with no differences on milk yield and milk protein yield. Additionally, in multiparous cows, RPM feeding increased milk protein (3.03 vs 2.95%; P = 0.05) and fat (3.45 vs 3.14%; P = 0.01) percentages, although no effects were observed in primiparous cows. In multiparous cows fed RPM, pregnancy loss was lower between Days 28 to 61 (19.6 [10/51] vs. 6.1% [3/49]; P = 0.03) or between Days 32 to 61 (8.9 [4/45] vs. 0 [0/0] %; P = 0.03), although, there was no effect of treatment on pregnancy loss in primiparous cows. Consistent with data on pregnancy loss, RPM feeding increased embryonic abdominal diameter (P = 0.01) and volume (P = 0.009) and amniotic vesicle volume (P = 0.04) on Day 33 of pregnancy in multiparous cows but had no effect on embryonic size in primiparous cows. Thus, the increase in plasma Met concentrations after feeding RPM was sufficient to produce a small increase in milk protein percentage and to improve embryonic size and pregnancy maintenance in multiparous cows. Further studies are needed to confirm these responses and understand the biological mechanisms that underlie these responses as well as the timing and concentrations of circulating Met that are needed to produce this effect.	[Toledo, Mateus Z.; Baez, Giovanni M.; Garcia-Guerra, Alvaro; Lobos, Nelson E.; Guenther, Jerry N.; Trevisol, Eduardo; Shaver, Randy D.; Wiltbank, Milo C.] Univ Wisconsin Madison, Dept Dairy Sci, Madison, WI 53706 USA; [Garcia-Guerra, Alvaro; Wiltbank, Milo C.] Univ Wisconsin Madison, Endocrinol & Reprod Physiol Program, Madison, WI 53706 USA; [Luchini, Daniel] Adisseo USA Inc, Alpharetta, GA USA; [Baez, Giovanni M.] Univ Francisco Paula Santander, Cucuta, Colombia; [Garcia-Guerra, Alvaro] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Universidad Francisco de Paula Santander; University System of Ohio; Ohio State University	Wiltbank, MC (corresponding author), Univ Wisconsin Madison, Dept Dairy Sci, Madison, WI 53706 USA.; Wiltbank, MC (corresponding author), Univ Wisconsin Madison, Endocrinol & Reprod Physiol Program, Madison, WI 53706 USA.	wiltbank@wisc.edu	Garcia-Guerra, Alvaro/F-9796-2013; Baez, Giovanni/AAM-3359-2021; Wiltbank, Milo C/B-1506-2010; Garcia-Guerra, Alvaro/P-2580-2015	Wiltbank, Milo C/0000-0001-8188-0991; Garcia-Guerra, Alvaro/0000-0002-4114-5965; Zucato Toledo, Mateus/0000-0003-3050-3007; LOBOS, NELSON/0000-0002-3491-069X	Research Foundation of the State of Sao Paulo (FAPESP) from Sao Paulo, Brazil; Colombian government [497/2009]; Adisseo USA Inc. (Alpharetta, GA); WI Experiment Station as Hatch Project [WIS01240]; BARD grant [IS-478815]; Parnell Pharmaceutical, USA	Research Foundation of the State of Sao Paulo (FAPESP) from Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Colombian government; Adisseo USA Inc. (Alpharetta, GA); WI Experiment Station as Hatch Project; BARD grant; Parnell Pharmaceutical, USA	ET was supported by the Research Foundation of the State of Sao Paulo (FAPESP; fapesp.br/en) from Sao Paulo, Brazil. GMB was supported by the Colombian government (Scholarship Colciencias-497/2009). This research was supported by Adisseo USA Inc. (Alpharetta, GA; adisseo.corn), WI Experiment Station as Hatch Project WIS01240 to MCW, BARD grant IS-478815 (www.bard-isus.com), and Parnell Pharmaceutical, USA. Dr. Daniel Luchini helped with designing the diets and was involved in discussion of results. Other than that, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta DAV, 2016, THERIOGENOLOGY, V85, P1669, DOI 10.1016/j.theriogenology.2016.01.024; [Anonymous], 2000, NON TRADITIONAL REF; Armentano LE, 1997, J DAIRY SCI, V80, P1194, DOI 10.3168/jds.S0022-0302(97)76047-8; Ayres H, 2013, THERIOGENOLOGY, V79, P159, DOI 10.1016/j.theriogenology.2012.10.001; Bach A, 2000, ANIM FEED SCI TECH, V84, P23, DOI 10.1016/S0377-8401(00)00113-9; Baez GM, 2016, THERIOGENOLOGY, V85, P1357, DOI 10.1016/j.theriogenology.2015.04.022; Baez GM, 2015, ANN M SOC STUD REP T; Bazer FW, 2011, BIOL REPROD, V85, P1094, DOI 10.1095/biolreprod.111.094722; Bertolini M, 2002, THERIOGENOLOGY, V58, P973, DOI 10.1016/S0093-691X(02)00935-4; Bisinotto RS, 2012, ANIM REPROD, V9, P260; Bistulfi G, 2009, FASEB J, V23, P2888, DOI 10.1096/fj.09-130708; Bonilla L, 2010, J REPROD DEVELOP, V56, P527, DOI 10.1262/jrd.10-037H; Britt J.H., 1992, BOVINE P, V24, P39; Brosnan JT, 2007, LIVEST SCI, V112, P2, DOI 10.1016/j.livsci.2007.07.005; Carvalho PD, 2015, J DAIRY SCI, V98, P8800, DOI 10.3168/jds.2015-9968; Carvalho PD, 2014, J DAIRY SCI, V97, P6305, DOI 10.3168/jds.2014-8222; Carvalho PD, 2014, J DAIRY SCI, V97, P3666, DOI 10.3168/jds.2013-7809; Chapinal N, 2012, J DAIRY SCI, V95, P5676, DOI 10.3168/jds.2011-5132; Chen ZH, 2011, J DAIRY SCI, V94, P1978, DOI 10.3168/jds.2010-3578; FERGUSON JD, 1994, J DAIRY SCI, V77, P2695, DOI 10.3168/jds.S0022-0302(94)77212-X; Gao HJ, 2009, BIOL REPROD, V80, P1196, DOI 10.1095/biolreprod.108.075440; Gao HJ, 2009, BIOL REPROD, V81, P67, DOI 10.1095/biolreprod.108.075473; Gao HJ, 2009, BIOL REPROD, V80, P602, DOI 10.1095/biolreprod.108.073890; Gao HJ, 2009, BIOL REPROD, V80, P86, DOI 10.1095/biolreprod.108.071597; Green JA, 2005, THERIOGENOLOGY, V63, P1481, DOI 10.1016/j.theriogenology.2004.07.011; Green JA, 2000, BIOL REPROD, V62, P1624, DOI 10.1095/biolreprod62.6.1624; Groebner AE, 2011, REPRODUCTION, V141, P685, DOI 10.1530/REP-10-0533; Hansen PJ, 2014, TURK J VET ANIM SCI, V38, P589, DOI 10.3906/vet-1405-96; Herlihy MM, 2012, J DAIRY SCI, V95, P7003, DOI 10.3168/jds.2011-5260; Hugentobler SA, 2007, MOL REPROD DEV, V74, P445, DOI 10.1002/mrd.20607; HUSEK P, 1991, J CHROMATOGR, V552, P289, DOI 10.1016/S0021-9673(01)95945-X; Hutchinson IA, 2012, J DAIRY SCI, V95, P2442, DOI 10.3168/jds.2011-4632; Ikeda S, 2012, J REPROD DEVELOP, V58, P91, DOI 10.1262/jrd.11-096H; Knudsen KEB, 1997, ANIM FEED SCI TECH, V67, P319, DOI 10.1016/S0377-8401(97)00009-6; Koenig KM, 2001, J DAIRY SCI, V84, P1480, DOI 10.3168/jds.S0022-0302(01)70181-6; Lefevre PLC, 2011, ENDOCR REV, V32, P694, DOI 10.1210/er.2011-0012; Leonardi C, 2003, J DAIRY SCI, V86, P4033, DOI 10.3168/jds.S0022-0302(03)74014-4; Lima FS, 2012, VET J, V193, P140, DOI 10.1016/j.tvjl.2011.09.019; Lobos NE, 2014, J DAIRY SCI, V97, P759; Lopes-da-Costa L, 2011, THERIOGENOLOGY, V76, P522, DOI 10.1016/j.theriogenology.2011.03.004; Lopez-Garcia C, 2008, ENDOCRINOLOGY, V149, P5012, DOI 10.1210/en.2008-0084; Lopez-Gatius F, 2004, REPROD DOMEST ANIM, V39, P429, DOI 10.1111/j.1439-0531.2004.00533.x; Lucy MC, 2014, ANIMAL, V8, P82, DOI 10.1017/S1751731114000482; Mercadante PM, 2013, J ANIM SCI, V91, P3693, DOI 10.2527/jas.2012-6130; Metayer S, 2008, J NUTR BIOCHEM, V19, P207, DOI 10.1016/j.jnutbio.2007.05.006; Mohabbat T, 2008, J CHROMATOGR B, V862, P86, DOI 10.1016/j.jchromb.2007.11.003; Ordway RS, 2009, J DAIRY SCI, V92, P5154, DOI 10.3168/jds.2009-2259; Patton RA, 2010, J DAIRY SCI, V93, P2105, DOI 10.3168/jds.2009-2693; Penagaricano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072302; Pohler KG, 2016, J DAIRY SCI, V99, P1584, DOI 10.3168/jds.2015-10192; Ribeiro ES, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114694; Ricci A, 2015, J DAIRY SCI, V98, P2502, DOI 10.3168/jds.2014-8974; Roche JR, 2011, ANIM PROD SCI, V51, P1045, DOI 10.1071/AN10162; Rulquin H, 2006, J DAIRY SCI, V89, P4387, DOI 10.3168/jds.S0022-0302(06)72485-7; Santos JEP, 2009, ANIM REPROD SCI, V110, P207, DOI 10.1016/j.anireprosci.2008.01.014; Santos JEP, 2004, ANIM REPROD SCI, V82-3, P513, DOI 10.1016/j.anireprosci.2004.04.015; Schwab C.G., 1995, PROTECTED PROTEINS A; SIGLER PB, 1975, ANNU REV BIOPHYS BIO, V4, P477, DOI 10.1146/annurev.bb.04.060175.002401; Silva E, 2007, J DAIRY SCI, V90, P4612, DOI 10.3168/jds.2007-0276; Socha MT, 2005, J DAIRY SCI, V88, P1113, DOI 10.3168/jds.S0022-0302(05)72778-8; Souza AH, 2008, THERIOGENOLOGY, V70, P208, DOI 10.1016/j.theriogenology.2008.03.014; Souza AH, 2012, J DAIRY SCI S1, V95, pT288; Souza AH., 2012, J DAIRY SCI, V95, pT181; Van Amburgh M, 2010, P CORN NUTR C DEPT A; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Vyas D, 2009, J DAIRY SCI, V92, P5011, DOI 10.3168/jds.2008-1769; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Wiltbank MC, 2015, J DAIRY SCI, V98, P8644, DOI 10.3168/jds.2015-9353; Zanton GI, 2014, J DAIRY SCI, V97, P7085, DOI 10.3168/jds.2014-8220	69	32	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189117	10.1371/journal.pone.0189117	http://dx.doi.org/10.1371/journal.pone.0189117			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261700	Green Published, Green Submitted, gold			2022-12-26	WOS:000418564200028
J	Yoo, W; Gjuka, D; Stevenson, HL; Song, XL; Shen, H; Yoo, SY; Wang, J; Fallon, M; Ioannou, GN; Harrison, SA; Beretta, L				Yoo, Wonbeak; Gjuka, Donjeta; Stevenson, Heather L.; Song, Xiaoling; Shen, Hong; Yoo, Suk Young; Wang, Jing; Fallon, Michael; Ioannou, George N.; Harrison, Stephen A.; Beretta, Laura			Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid	PLOS ONE			English	Article							LIVER-DISEASE; NONINVASIVE DIAGNOSIS; LIPID-METABOLISM; ODD-CHAIN; NASH; BIOMARKERS; ASSOCIATION; MARKERS	Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease and ranges from isolated steatosis to NASH. To determine whether circulating fatty acids could serve as diagnostic markers of NAFLD severity and whether specific fatty acids could contribute to the pathogenesis of NASH, we analyzed two independent NAFLD patient cohorts and used the methionine-and choline-deficient diet (MCD) NASH mouse model. We identified six fatty acids that could serve as non-invasive markers of NASH in patients with NAFLD. Serum levels of 15:0, 17:0 and 16:1n7t negatively correlated with NAFLD activity scores and hepatocyte ballooning scores, while 18:1n7c serum levels strongly correlated with fibrosis stage and liver inflammation. Serum levels of 15:0 and 17:0 also negatively correlated with fasting glucose and AST, while 16:1n7c and 18:1n7c levels positively correlated with AST and ferritin, respectively. Inclusion of demographic and clinical parameters improved the performance of the fatty acid panels in detecting NASH in NAFLD patients. The panel [15:0, 16:1n7t, 18:1n7c, 22:5n3, age, ferritin and APRI] predicted intermediate or advanced fibrosis in NAFLD patients, with 82% sensitivity at 90% specificity [AUROC = 0.92]. 15:0 and 18:1n7c were further selected for functional studies in vivo. Mice treated with 15:0-supplemented MCD diet showed reduced AST levels and hepatic infiltration of ceroidladen macrophages compared to MCD-treated mice, suggesting that 15:0 deficiency contributes to liver injury in NASH. In contrast, 18:1n7c-supplemented MCD diet didn't affect liver pathology. In conclusion, 15:0 may serve as a promising biomarker or therapeutic target in NASH, opening avenues for the integration of diagnosis and treatment.	[Yoo, Wonbeak; Gjuka, Donjeta; Shen, Hong; Beretta, Laura] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Stevenson, Heather L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Song, Xiaoling] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Yoo, Suk Young; Wang, Jing] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Fallon, Michael] Univ Texas Hlth Sci Ctr Houston, Div Gastroenterol, Houston, TX 77030 USA; [Ioannou, George N.] Vet Affairs Puget Sound Hlth Care Syst, Div Gastroenterol, Seattle, WA USA; [Ioannou, George N.] Univ Washington, Seattle, WA 98195 USA; [Harrison, Stephen A.] Brooke Army Med Ctr, Dept Med, San Antonio, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Medical Branch Galveston; Fred Hutchinson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; San Antonio Military Medical Center; United States Department of Defense; United States Army	Beretta, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	lberetta@mdanderson.org		Stevenson, Heather/0000-0002-0645-7621; Yoo, Wonbeak/0000-0001-5803-0577; Laura, Beretta/0000-0002-2054-684X	National Institutes of Health [R01 CA120719]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health, R01 CA120719 (to LB).	Adams LA, 2011, J DIGEST DIS, V12, P10, DOI 10.1111/j.1751-2980.2010.00471.x; Argo CK, 2015, J HEPATOL, V62, P190, DOI 10.1016/j.jhep.2014.08.036; Arndt S, 2015, GUT, V64, P973, DOI 10.1136/gutjnl-2014-306968; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Clarke JD, 2014, J APPL TOXICOL, V34, P726, DOI 10.1002/jat.2960; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Feldstein AE, 2010, J LIPID RES, V51, P3046, DOI 10.1194/jlr.M007096; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9; Gorden DL, 2015, J LIPID RES, V56, P722, DOI 10.1194/jlr.P056002; Grandison GA, 2012, CLIN LIVER DIS, V16, P567, DOI 10.1016/j.cld.2012.05.001; Jenkins B, 2015, MOLECULES, V20, P2425, DOI 10.3390/molecules20022425; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; Khaw KT, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001255; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706; Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049; Leite NC, 2013, HEPATOL RES, V43, P508, DOI 10.1111/j.1872-034X.2012.01106.x; LEPAGE G, 1986, J LIPID RES, V27, P114; Loomba R, 2015, J LIPID RES, V56, P185, DOI 10.1194/jlr.P055640; Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991; Machado MV, 2011, EXPERT REV GASTROENT, V5, P213, DOI [10.1586/egh.11.16, 10.1586/EGH.11.16]; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; Meikle PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074341; Muir K, 2013, CANCER RES, V73, P4722, DOI 10.1158/0008-5472.CAN-12-3797; Nobili V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088005; Paredes AH, 2012, CLIN LIVER DIS, V16, P397, DOI 10.1016/j.cld.2012.03.005; Parker HM, 2012, J HEPATOL, V56, P944, DOI 10.1016/j.jhep.2011.08.018; Pearce SG, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-7; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; Sanyal AJ, 2014, GASTROENTEROLOGY, V147, P377, DOI 10.1053/j.gastro.2014.04.046; Schattenberg JM, 2011, CURR OPIN LIPIDOL, V22, P479, DOI 10.1097/MOL.0b013e32834c7cfc; SCHLIERF G, 1965, J LIPID RES, V6, P317; Scorletti E, 2013, ANNU REV NUTR, V33, P231, DOI 10.1146/annurev-nutr-071812-161230; Scorletti E, 2014, HEPATOLOGY, V60, P1211, DOI 10.1002/hep.27289; Shen JY, 2012, J HEPATOL, V56, P1363, DOI 10.1016/j.jhep.2011.12.025; Sookoian S, 2014, NAT REV GASTRO HEPAT, V11, P205, DOI 10.1038/nrgastro.2014.25; Sumida Y, 2014, WORLD J GASTROENTERO, V20, P475, DOI 10.3748/wjg.v20.i2.475; Sutti S, 2014, HEPATOLOGY, V59, P886, DOI 10.1002/hep.26749; Verhaegh P, 2017, CLIN GASTROENTEROL H; Vlaeminck B, 2006, ANIM FEED SCI TECH, V131, P389, DOI 10.1016/j.anifeedsci.2006.06.017; Yamada K, 2015, LIVER INT, V35, P582, DOI 10.1111/liv.12685; Yamasaki Y, 2015, J GASTROEN HEPATOL, V30, P528, DOI 10.1111/jgh.12726; Zhou Y, 2016, CLIN GASTROENTEROL H, V14, P1463, DOI 10.1016/j.cgh.2016.05.046	45	20	21	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189965	10.1371/journal.pone.0189965	http://dx.doi.org/10.1371/journal.pone.0189965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244873	gold, Green Published, Green Submitted			2022-12-26	WOS:000418184700072
J	Martinez-Sanchez, A; Nguyen-Tu, MS; Cebola, I; Yavari, A; Marchetti, P; Piemonti, L; de Koning, E; Shapiro, AMJ; Johnson, P; Sakamoto, K; Smith, DM; Leclerc, I; Ashrafian, H; Ferrer, J; Rutter, GA				Martinez-Sanchez, Aida; Nguyen-Tu, Marie-Sophie; Cebola, Ines; Yavari, Arash; Marchetti, Piero; Piemonti, Lorenzo; de Koning, Eelco; Shapiro, A. M. James; Johnson, Paul; Sakamoto, Kei; Smith, David M.; Leclerc, Isabelle; Ashrafian, Houman; Ferrer, Jorge; Rutter, Guy A.			MiR-184 expression is regulated by AMPK in pancreatic islets	FASEB JOURNAL			English	Article						miRNAs; glucose; beta cell; diabetes	STIMULATED INSULIN-SECRETION; BETA-CELL FUNCTION; GLUCOSE-METABOLISM; PROTEIN-KINASE; MICRORNAS; CANCER; MICE; IDENTITY; MIRNAS; MODELS	AMPK is a critical energy sensor and target for widely used antidiabetic drugs. In beta cells, elevated glucose concentrations lower AMPK activity, and the ablation of both catalytic subunits[beta-cell-specific AMPK double-knockout (beta AMPKdKO) mice] impairs insulin secretion in vivo and beta-cell identity. MicroRNAs (miRNAs) are small RNAs that silence gene expression that are essential for pancreatic beta-cell function and identity and altered in diabetes. Here, we have explored the miRNAs acting downstream of AMPK in mouse and human beta cells. We identified 14 down-regulated and 9 up-regulated miRNAs in beta AMPKdKOvs. control islets. Gene ontology analysis of targeted transcripts revealed enrichment in pathways important for beta-cell function and identity. The most downregulated miRNA was miR-184 (miR-184-3p), an important regulator of beta-cell function and compensatory expansion that is controlled by glucose and reduced in diabetes. We demonstrate that AMPK is a potent regulator and an important mediator of the negative effects of glucose on miR-184 expression. Additionally, we reveal sexual dimorphism in miR-184 expression in mouse and human islets. Collectively, these data demonstrate that glucose-mediated changes in AMPK activity are central for the regulation of miR-184 and other miRNAs in islets and provide a link between energy status and gene expression in beta cells.	[Martinez-Sanchez, Aida; Nguyen-Tu, Marie-Sophie; Leclerc, Isabelle; Rutter, Guy A.] Imperial Coll London, Sect Cell Biol & Funct Genom, London, England; [Cebola, Ines; Ferrer, Jorge] Imperial Coll London, Beta Cell Genome Regulat Lab, Div Diabet Endocrinol & Metab, Dept Med, London, England; [Yavari, Arash; Ashrafian, Houman] Univ Oxford, Radcliffe Dept Med, Oxford, England; [Johnson, Paul] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, Pisa, Italy; [Piemonti, Lorenzo] Ist Sci San Raffaele, IRCCS, SR DRI, Milan, Italy; [Piemonti, Lorenzo] Univ Vita Salute San Raffaele, Milan, Italy; [de Koning, Eelco] Hubrecht Inst, Utrecht, Netherlands; [de Koning, Eelco] Leiden Univ, Med Ctr, Dept Med, Leiden, Netherlands; [Shapiro, A. M. James] Univ Alberta, Clin Islet Lab, Edmonton, AB, Canada; [Shapiro, A. M. James] Univ Alberta, Clin Islet Transplant Program, Edmonton, AB, Canada; [Sakamoto, Kei] Nestle Inst Hlth Sci, Lausanne, Switzerland; [Smith, David M.] Discovery Sci, Innovat Med & Early Dev, AstraZeneca Res & Dev, Cambridge, England	Imperial College London; Imperial College London; University of Oxford; University of Oxford; University of Pisa; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Alberta; University of Alberta; Nestle SA; AstraZeneca	Martinez-Sanchez, A; Rutter, GA (corresponding author), Imperial Coll London, Du Cane Rd, London W12 0NN, England.	a.martinez-sanchez@imperial.ac.uk; g.rutter@imperial.ac.uk	de Koning, Eelco JP/H-6030-2011; Cebola, Inês/AAG-9652-2020; Ferrer, Jorge/A-3176-2012; Piemonti, Lorenzo/P-7605-2017; Sanchez, Aida Martinez/ABH-5957-2020; sakamoto, kei/C-8806-2019	de Koning, Eelco JP/0000-0002-1232-7022; Cebola, Inês/0000-0003-3528-4982; Ferrer, Jorge/0000-0002-5959-5729; Piemonti, Lorenzo/0000-0002-2172-2198; Sanchez, Aida Martinez/0000-0001-5142-2527; sakamoto, kei/0000-0001-8839-5980; Smith, David/0000-0001-6831-280X; Leclerc, Isabelle/0000-0003-0044-7921; Rutter, Guy/0000-0001-6360-0343	Wellcome Trust Senior Investigator Grant [WT098424AIA]; Medical Research Council (MRC) [MR/J0003042/1, MR/N00275X/1, MR/L020149/1]; Royal Society Wolfson Research Merit Awards; Diabetes UK Project [BDA11/0004210, BDA/15/0005275]; Society for Endocrinology; New Research Investigator Grant [MR/P023223/1]; Juvenile Diabetes Research Foundation [3-RSC-2016-160-I-X]; Academy of Medical Sciences (AMS) [SGL015\\1031] Funding Source: researchfish; Medical Research Council [MR/L02036X/1, MR/K019023/1, MR/K001981/1, MR/P023223/1] Funding Source: researchfish; National Institute for Health Research [CL-2013-13-004] Funding Source: researchfish; Alberta Innovates [201201154] Funding Source: researchfish; MRC [MR/L02036X/1, MR/N00275X/1, MR/P023223/1, MR/L020149/1, MR/K001981/1, MR/K019023/1] Funding Source: UKRI	Wellcome Trust Senior Investigator Grant; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society Wolfson Research Merit Awards(Royal Society of London); Diabetes UK Project(Diabetes UK); Society for Endocrinology; New Research Investigator Grant; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Alberta Innovates; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Delphine Rolando (Imperial College London) for helping with computational analysis, the Centre for Genomic Regulation (Barcelona, Spain) for the generation of the high-throughput sequencing data, Exiqon (Vedbaek, Denmark) for the miRNA detection using qPCR panels, and Patrick MacDonald (Alberta Diabetes Institute, University of Alberta) for providing human islets. G.A.R. was supported by Wellcome Trust Senior Investigator Grant WT098424AIA, Medical Research Council (MRC) Programme Grants MR/J0003042/1, MR/N00275X/1, and MR/L020149/1 (DIVA), and by Royal Society Wolfson Research Merit Awards and Diabetes UK Project Grants BDA11/0004210 and BDA/15/0005275. This work was also supported by an Early Career Research grant from the Society for Endocrinology, and by New Research Investigator Grant MR/P023223/1 to A.M.-S. Human islet preparations (Milan, Italy) were obtained from the European Consortium for Islet Transplantation; the Human Islet Distribution program is supported by Juvenile Diabetes Research Foundation Grant 3-RSC-2016-160-I-X. The authors declare no conflicts of interest.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andersson SA, 2012, MOL CELL ENDOCRINOL, V364, P36, DOI 10.1016/j.mce.2012.08.009; Bolmeson C, 2011, BIOCHEM BIOPH RES CO, V404, P16, DOI 10.1016/j.bbrc.2010.11.024; Bouzakri K, 2008, DIABETES, V57, P1195, DOI 10.2337/db07-1469; Casimir M, 2009, J BIOL CHEM, V284, P25004, DOI 10.1074/jbc.M109.015495; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Cunningham KA, 2012, CELL METAB, V16, P113, DOI 10.1016/j.cmet.2012.05.014; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Franconi F, 2008, PHARMACOL RES, V57, P6, DOI 10.1016/j.phrs.2007.11.007; Fu A, 2013, MOL CELL ENDOCRINOL, V366, P127, DOI 10.1016/j.mce.2012.06.020; Gendron CM, 2017, AGING CELL, V16, P1434, DOI 10.1111/acel.12673; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hall E, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0522-z; Hunter RW, 2014, CHEM BIOL, V21, P866, DOI 10.1016/j.chembiol.2014.05.014; Iguchi H, 2005, J BIOL CHEM, V280, P37669, DOI 10.1074/jbc.M505392200; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kameswaran V, 2014, CELL METAB, V19, P135, DOI 10.1016/j.cmet.2013.11.016; Kanji MS, 2013, DIABETES, V62, P1602, DOI 10.2337/db12-0841; Kaspi H, 2014, TRENDS ENDOCRIN MET, V25, P285, DOI 10.1016/j.tem.2014.01.003; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kone M, 2014, FASEB J, V28, P4972, DOI 10.1096/fj.14-257667; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Leclerc I, 2004, AM J PHYSIOL-ENDOC M, V286, pE1023, DOI 10.1152/ajpendo.00532.2003; Li Z, 2017, BIOCH CELL BIOL; Locke JM, 2014, DIABETOLOGIA, V57, P122, DOI 10.1007/s00125-013-3089-4; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Maj M, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1964634; Marco A, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140024; Martinez-Sanchez A, 2017, FRONT GENET, V7, DOI 10.3389/fgene.2016.00226; Martinez-Sanchez A, 2015, MOL ENDOCRINOL, V29, P1067, DOI 10.1210/me.2015; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Nesca V, 2013, DIABETOLOGIA, V56, P2203, DOI 10.1007/s00125-013-2993-y; Nomura T, 2008, HUM MOL GENET, V17, P1192, DOI 10.1093/hmg/ddn011; Pepin E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153017; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Rajman M, 2017, DEVELOPMENT, V144, P2310, DOI 10.1242/dev.144337; Ramalingam L, 2014, BIOCHEM J, V464, P251, DOI 10.1042/BJ20140845; Richards OC, 2010, ENDOCR REV, V31, P343, DOI 10.1210/er.2009-0035; Rutter GA, 2015, BIOCHEM J, V466, P203, DOI 10.1042/BJ20141384; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sorensen H, 2006, DIABETES, V55, P3463, DOI 10.2337/db06-0307; Sun G, 2010, DIABETOLOGIA, V53, P924, DOI 10.1007/s00125-010-1692-1; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tajima K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064633; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Tattikota SG, 2015, J BIOL CHEM, V290, P20284, DOI 10.1074/jbc.M115.658625; Tattikota SG, 2014, CELL METAB, V19, P122, DOI 10.1016/j.cmet.2013.11.015; Tiano JP, 2012, ENDOCRINOLOGY, V153, P2997, DOI 10.1210/en.2011-1980; Tohyama D, 2010, BIOCHEM BIOPH RES CO, V394, P112, DOI 10.1016/j.bbrc.2010.02.126; Varlamov O, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00241; Vazquez P, 2014, DIABETOLOGIA, V57, P2339, DOI 10.1007/s00125-014-3341-6; Wang FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139241; Wang J, 2015, ONCOTARGET, V6, P19456, DOI 10.18632/oncotarget.3318; Wang M, 2014, INT J ONCOL, V45, P362, DOI 10.3892/ijo.2014.2413; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xiao XS, 2016, SCI REP-UK, V6, DOI 10.1038/srep21735; Yang SY, 2016, BIOCHEM J, V473, P1791, DOI 10.1042/BCJ20160137; Yavari A, 2016, CELL METAB, V23, P821, DOI 10.1016/j.cmet.2016.04.003; Zhang J, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.11; Zhang L, 1999, NEUROSCIENCE, V94, P251, DOI 10.1016/S0306-4522(99)00234-1; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	64	23	25	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2587	2600		10.1096/fj.201701100R	http://dx.doi.org/10.1096/fj.201701100R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29269398	hybrid, Green Published			2022-12-26	WOS:000432528000023
J	Goins, CM; Schreidah, CM; Dajnowicz, S; Ronning, DR				Goins, Christopher M.; Schreidah, Celine M.; Dajnowicz, Steven; Ronning, Donald R.			Structural basis for lipid binding and mechanism of the Mycobacterium tuberculosis Rv3802 phospholipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; phospholipase A; hydrolase; drug discovery; phosphatidylinositol; alpha; beta-Hydrolase; Rv3802	PHOSPHATIDYLINOSITOL MANNOSIDE; INHIBITION; MEMBRANE; PROTEINS; GROWTH; GENES; MODEL; A(2)	The Mycobacterium tuberculosis rv3802c gene encodes an essential enzyme with thioesterase and phospholipase A activity. Overexpression of Rv3802 orthologs in Mycobacterium smegmatis and Corynebacterium glutamicum increases mycolate content and decreases glycerophospholipids. Although a role in modulating the lipid composition of the unique mycomembrane has been proposed, the true biological function of Rv3802 remains uncertain. In this study, we present the first M. tuberculosis Rv3802 X-ray crystal structure, solved to 1.7 resolution. On the basis of the binding of PEG molecules to Rv3802, we identified its lipid-binding site and the structural basis for phosphatidyl-based substrate binding and phospholipase A activity. We found that movement of the 8-helix affords lipid binding and is required for catalytic turnover through covalent tethering. We gained insights into the mechanism of acyl hydrolysis by observing differing arrangements of PEG and water molecules within the active site. This study provides structural insights into biological function and facilitates future structure-based drug design toward Rv3802.	[Goins, Christopher M.; Schreidah, Celine M.; Dajnowicz, Steven; Ronning, Donald R.] Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft, Toledo, OH 43606 USA; [Dajnowicz, Steven] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA	University System of Ohio; University of Toledo; United States Department of Energy (DOE); Oak Ridge National Laboratory	Ronning, DR (corresponding author), Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft, Toledo, OH 43606 USA.	Donald.Ronning@utoledo.edu	Schreidah, Celine/GSI-6761-2022	Schreidah, Celine/0000-0002-4967-5880; Ronning, Donald/0000-0003-2583-8849	National Institutes of Health [AI105084]; Office of Undergraduate Research at the University of Toledo; First Year Summer Research Experience; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Undergraduate Research at the University of Toledo; First Year Summer Research Experience; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI105084. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of funding from the First Year Summer Research Experience, awarded by the Office of Undergraduate Research at the University of Toledo.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albesa-Jove D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10906; Bansal-Mutalik R, 2011, P NATL ACAD SCI USA, V108, P15360, DOI 10.1073/pnas.1112572108; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crellin PK, 2010, J BIOL CHEM, V285, P30050, DOI 10.1074/jbc.M110.150094; DeLano W. L., 2013, THE PYMOL MOLECULAR; Dennis EA, 2015, J LIPID RES, V56, P1245, DOI 10.1194/jlr.E061101; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Jackson M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a021105; Jackson M, 2013, FUTURE MICROBIOL, V8, P855, DOI 10.2217/fmb.13.52; Jochens H, 2011, CHEMBIOCHEM, V12, P1508, DOI 10.1002/cbic.201000771; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Marsh D, 2003, PROTEIN SCI, V12, P2109, DOI 10.1110/ps.0396803; Meniche X, 2009, J BACTERIOL, V191, P7323, DOI 10.1128/JB.01042-09; Miltner E, 2005, INFECT IMMUN, V73, P4214, DOI 10.1128/IAI.73.7.4214-4221.2005; Mitchison D, 2012, INT J TUBERC LUNG D, V16, P724, DOI 10.5588/ijtld.12.0083; Morita YS, 2005, J BIOL CHEM, V280, P21645, DOI 10.1074/jbc.m414181200; Mouchlis VD, 2015, P NATL ACAD SCI USA, V112, pE516, DOI 10.1073/pnas.1424651112; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pai M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.76; Parish T, 1997, J BACTERIOL, V179, P7827, DOI 10.1128/jb.179.24.7827-7833.1997; Parker SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004281; Ravindran MS, 2014, MOL CELL PROTEOMICS, V13, P435, DOI 10.1074/mcp.M113.029942; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; West NP, 2011, CHEM COMMUN, V47, P5166, DOI 10.1039/c0cc05635a; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; WHO U, 2016, 2016 GLOB TUB REP	39	4	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1363	1372		10.1074/jbc.RA117.000240	http://dx.doi.org/10.1074/jbc.RA117.000240			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29247008	Green Published, hybrid			2022-12-26	WOS:000423515000022
J	Druszczynska, M; Wlodarczyk, M; Kielnierowski, G; Seweryn, M; Wawrocki, S; Rudnicka, W				Druszczynska, Magdalena; Wlodarczyk, Marcin; Kielnierowski, Grzegorz; Seweryn, Michel; Wawrocki, Sebastian; Rudnicka, Wieslawa			CD14-159C/T polymorphism in the development of delayed skin hypersensitivity to tuberculin	PLOS ONE			English	Article							SOLUBLE CD14 LEVELS; MYCOBACTERIUM-TUBERCULOSIS; PROMOTER POLYMORPHISM; IMMUNE-RESPONSES; PLASMA-LEVELS; GENE; SUSCEPTIBILITY; REGION; BCG; ASSOCIATION	The skin tuberculin test (TST), an example of a delayed-type hypersensitivity (DTH) reaction, is based on measuring the extent of skin induration to mycobacterial tuberculin (PPD). Little is known about the genetic basis of TST reactivity, widely used for diagnosing TB infection. The study investigated the relationship of the single base change polymorphic variants in CD14 gene (CD14(-159C/T)) with the development of DTH to PPD in BCG-vaccinated Polish Caucasian individuals. We found persistent lack of TST reactivity in about 40% of healthy subjects despite receiving more than one dose of BCG. The TST size was negatively correlated with the number of BCG inoculations. The distribution of C/T genotype was significantly more frequent among TST-negative compared with TST-positive individuals. The concentration of serum sCD14 was positively associated with mCD14 expression, but not with the TST status or CD14(-159C/T) polymorphism. A significant increase in mCD14 expression and serum sCD14 levels was found in TB group. We hypothesize that CD14 (-159C/T) polymorphic variants might be one of genetic components in the response to attenuated M. bovis BCG bacilli.	[Druszczynska, Magdalena; Wlodarczyk, Marcin; Wawrocki, Sebastian; Rudnicka, Wieslawa] Univ Lodz, Fac Biol & Environm Protect, Inst Microbiol Biotechnol & Immunol, Dept Immunol & Infect Biol,Div Cell Immunol, Lodz, Poland; [Kielnierowski, Grzegorz] Reg Specialized Hosp TB Lung Dis & Rehabil, Tuszyn, Poland; [Seweryn, Michel] Jagiellonian Univ, Med Coll, Ctr Med Genom OMICRON, Krakow, Poland	University of Lodz; Jagiellonian University; Collegium Medicum Jagiellonian University	Druszczynska, M (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Inst Microbiol Biotechnol & Immunol, Dept Immunol & Infect Biol,Div Cell Immunol, Lodz, Poland.	magdalena.druszczynska@biol.uni.lodz.pl	Wawrocki, Sebastian/J-5811-2017	Wawrocki, Sebastian/0000-0002-1834-4739; Wlodarczyk, Marcin/0000-0002-3323-7093; Druszczynska, Magdalena/0000-0001-9386-4809; Seweryn, Michal/0000-0002-9090-3435	Polish Ministry of Science and Higher Education [N N402 098539]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the grant from the Polish Ministry of Science and Higher Education (N N402 098539). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Augustynowicz-Kopec E, 2013, ADV RESPIR MED, V81, P323; Ayaslioglu E, 2005, JPN J INFECT DIS, V58, P11; Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Barreto Mauricio L., 2006, J. Pediatr. (Rio J.), V82, ps45, DOI 10.1590/S0021-75572006000400006; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; CHU CQ, 1992, CLIN EXP IMMUNOL, V90, P522; Cobat A, 2015, J INFECT DIS, V211, P317, DOI 10.1093/infdis/jiu446; Cobat A, 2012, CLIN INFECT DIS, V54, P968, DOI 10.1093/cid/cir972; Cobat A, 2010, J INFECT DIS, V201, P15, DOI 10.1086/648611; Cobat A, 2009, J EXP MED, V206, P2583, DOI 10.1084/jem.20090892; Collin M, 2013, IMMUNOLOGY, V140, P22, DOI 10.1111/imm.12117; DANNENBERG AM, 1991, IMMUNOL TODAY, V12, P228, DOI 10.1016/0167-5699(91)90035-R; dos Santos PL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004375; Druszczynska M, 2016, INDIAN J MICROBIOL, V56, P205, DOI 10.1007/s12088-016-0571-y; Druszczynska M, 2015, ACTA BIOCHIM POL, V62, P913, DOI 10.18388/abp.2015_1160; Druszczynska M, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/851452; Dye C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0365; Fol M, 2015, ACTA BIOCHIM POL, V62, P633, DOI 10.18388/abp.2015_1130; Ganachari M, 2012, GENES IMMUN, V13, P605, DOI 10.1038/gene.2012.39; Griga T, 2005, HEPATO-GASTROENTEROL, V52, P808; Hartel C, 2008, HUM IMMUNOL, V69, P338, DOI 10.1016/j.humimm.2008.04.011; Haidari M, 2006, IMMUNOL INVEST, V35, P239, DOI 10.1080/08820130600634568; Han D, 2010, AM J RHINOL ALLERGY, V24, P1; Holla LI, 2002, J MED GENET, V39, P844, DOI 10.1136/jmg.39.11.844; Kang YA, 2009, FEMS IMMUNOL MED MIC, V57, P229, DOI 10.1111/j.1574-695X.2009.00602.x; Karhukorpi J, 2002, EUR J IMMUNOGENET, V29, P57, DOI 10.1046/j.0960-7420.2001.00282.x; Katial RK, 2001, CLIN DIAGN LAB IMMUN, V8, P339, DOI 10.1128/CDLI.8.2.339-345.2001; Kobayashi K, 2001, MICROSC RES TECHNIQ, V53, P241, DOI 10.1002/jemt.1090; Koppelman GH, 2003, CURR OPIN ALLERGY CL, V3, P347, DOI 10.1097/01.all.0000092604.76804.2a; Kowalewicz-Kulbat M, 2016, J IMMUNOL METHODS, V439, P79, DOI 10.1016/j.jim.2016.10.004; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838; LeVan TT, 2006, GENES IMMUN, V7, P77, DOI 10.1038/sj.gene.6364276; Lewthwaite JC, 2001, INFECT IMMUN, V69, P7349, DOI 10.1128/IAI.69.12.7349-7355.2001; Leynaert B, 2006, J ALLERGY CLIN IMMUN, V118, P658, DOI 10.1016/j.jaci.2006.06.015; Li N, 2016, TUMOR BIOL, V37, P6607, DOI 10.1007/s13277-015-4423-x; Liang XH, 2006, PHARMACOGENET GENOM, V16, P229; LUE KH, 1991, J IMMUNOL, V147, P1134; Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Medhat E, 2015, J INTERF CYTOK RES, V35, P563, DOI 10.1089/jir.2014.0155; Nayak Surajit, 2012, Indian Dermatol Online J, V3, P2, DOI 10.4103/2229-5178.93479; Nores JER, 1999, EUR J IMMUNOL, V29, P265, DOI 10.1002/(SICI)1521-4141(199901)29:01<265::AID-IMMU265>3.3.CO;2-7; Pacheco E, 2004, FEMS IMMUNOL MED MIC, V40, P207, DOI 10.1016/S0928-8244(03)00369-9; PETERSON PK, 1995, INFECT IMMUN, V63, P1598, DOI 10.1128/IAI.63.4.1598-1602.1995; Rosas-Taraco AG, 2007, J INFECT DIS, V196, P1698, DOI 10.1086/522147; ROSE DN, 1995, J GEN INTERN MED, V10, P635, DOI 10.1007/BF02602749; Rupp J, 2004, GENES IMMUN, V5, P435, DOI 10.1038/sj.gene.6364112; Schmitz G, 2002, CURR OPIN LIPIDOL, V13, P513, DOI 10.1097/00041433-200210000-00007; Seiffert M, 2010, BLOOD, V116, P4223, DOI 10.1182/blood-2010-05-284505; SEPULVEDA RL, 1994, AM J RESP CRIT CARE, V149, P620, DOI 10.1164/ajrccm.149.3.8118628; Strapagiel D, 2008, FOLIA HISTOCHEM CYTO, V46, P353, DOI 10.2478/v10042-008-0044-1; Thye T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005420; Tomlinson GS, 2011, EUR J IMMUNOL, V41, P3253, DOI 10.1002/eji.201141841; Vallinoto ACR, 2010, HUM IMMUNOL, V71, P692, DOI 10.1016/j.humimm.2010.03.008; van Pinxteren LAH, 2000, CLIN DIAGN LAB IMMUN, V7, P155, DOI 10.1128/CDLI.7.2.155-160.2000; von Aulock S, 2005, CLIN DIAGN LAB IMMUN, V12, P1254, DOI 10.1128/CDLI.12.10.1254-1256.2005; Wlodarczyk M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107208; World Health Organization, 2020, GLOBAL TUBERCULOSIS; WRIGHT SD, 1995, J IMMUNOL, V155, P6; Yuan Q, 2014, MOL BIOL REP, V41, P7623, DOI 10.1007/s11033-014-3652-1; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	63	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190106	10.1371/journal.pone.0190106	http://dx.doi.org/10.1371/journal.pone.0190106			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281719	Green Published, gold, Green Submitted			2022-12-26	WOS:000419006200063
J	Hongoh, V; Gosselin, P; Michel, P; Ravel, A; Waaub, JP; Campagna, C; Samoura, K				Hongoh, Valerie; Gosselin, Pierre; Michel, Pascal; Ravel, Andre; Waaub, Jean-Philippe; Campagna, Celine; Samoura, Karim			Criteria for the prioritization of public health interventions for climate-sensitive vector-borne diseases in Quebec	PLOS ONE			English	Article							MULTICRITERIA DECISION-ANALYSIS; PIG INDUSTRY; CANADA; PERCEPTION; RISK; SURVEILLANCE; MANAGEMENT; AUSTRALIA; ZOONOSES	Prioritizing resources for optimal responses to an ever growing list of existing and emerging infectious diseases represents an important challenge to public health. In the context of climate change, there is increasing anticipated variability in the occurrence of infectious diseases, notably climate-sensitive vector-borne diseases. An essential step in prioritizing efforts is to identify what considerations and concerns to take into account to guide decisions and thus set disease priorities. This study was designed to perform a comprehensive review of criteria for vector-borne disease prioritization, assess their applicability in a context of climate change with a diverse cross-section of stakeholders in order to produce a baseline list of considerations to use in this decision-making context. Differences in stakeholder choices were examined with regards to prioritization of these criteria for research, surveillance and disease prevention and control objectives. A preliminary list of criteria was identified following a review of the literature. Discussions with stakeholders were held to consolidate and validate this list of criteria and examine their effects on disease prioritization. After this validation phase, a total of 21 criteria were retained. A pilot vector-borne disease prioritization exercise was conducted using PROMETHEE to examine the effects of the retained criteria on prioritization in different intervention domains. Overall, concerns expressed by stakeholders for prioritization were well aligned with categories of criteria identified in previous prioritization studies. Weighting by category was consistent between stakeholders overall, though some significant differences were found between public health and non-public health stakeholders. From this exercise, a general model for climate-sensitive vector-borne disease prioritization has been developed that can be used as a starting point for further public health prioritization exercises relating to research, surveillance, and prevention and control interventions in a context of climate change. Multi-stakeholder engagement in prioritization can help broaden the range of criteria taken into account, offer opportunities for early identification of potential challenges and may facilitate acceptability of any resulting decisions.	[Hongoh, Valerie; Michel, Pascal; Ravel, Andre] Univ Montreal, Fac Vet Med, Res Grp Epidemiol Zoonoses & Publ Hlth GREZOSP, St Hyacinthe, PQ, Canada; [Hongoh, Valerie; Ravel, Andre] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ, Canada; [Gosselin, Pierre; Campagna, Celine] INSPQ, Quebec City, PQ, Canada; [Gosselin, Pierre] Ouranos, Consortium Reg Climatol & Adaptat Climate Change, Montreal, PQ, Canada; [Michel, Pascal] Natl Microbiol Lab St Hyacinthe, Publ Hlth Agcy Canada, St Hyacinthe, PQ, Canada; Univ Quebec Montreal, Montreal, PQ, Canada; [Waaub, Jean-Philippe] McGill, McGill, Polytech Montreal, HEC Montreal,Grp Res Decision Anal GERAD, Montreal, PQ, Canada; [Campagna, Celine] Univ Laval, Dept Social & Prevent Med, Laval, PQ, Canada; [Samoura, Karim] Univ Aube Nouvelle, Ouagadougou, Burkina Faso	Universite de Montreal; Universite de Montreal; Institut national de sante publique du Quebec (INSPQ); Ouranos Consortium; Public Health Agency of Canada; University of Quebec; University of Quebec Montreal; Universite de Montreal; HEC Montreal; Polytechnique Montreal; Laval University	Hongoh, V (corresponding author), Univ Montreal, Fac Vet Med, Res Grp Epidemiol Zoonoses & Publ Hlth GREZOSP, St Hyacinthe, PQ, Canada.; Hongoh, V (corresponding author), Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ, Canada.	valeriehongoh@umontreal.ca			Public Health Agency of Canada; Canadian Institutes of Health Research; Ouranos Consortium for research in climatology and adaptation to climate change; Strategic Training Program in Global Health Research; Quebec Population Health Research Network; International Development Research Centre; Natural Sciences and Engineering Research Council of Canada; Social Sciences and Humanities Research Council from Canada	Public Health Agency of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ouranos Consortium for research in climatology and adaptation to climate change; Strategic Training Program in Global Health Research; Quebec Population Health Research Network; International Development Research Centre; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Social Sciences and Humanities Research Council from Canada	The Quebec institute for Public Health research provided facilities for stakeholder meetings. The Public Health Agency of Canada provided funding to cover meeting facility and travel cost of participants for focus group discussions in the context of a separate, concurrent study on West Nile virus. VH is funded by the Canadian Institutes of Health Research, Ouranos Consortium for research in climatology and adaptation to climate change and the Strategic Training Program in Global Health Research, a partnership of the Canadian Institutes of Health Research and the Quebec Population Health Research Network. This project is also nested within the Initiative de Recherche Internationale sur l'Adaptation aux Changements Climatiques - Faire-face Aux Changements Ensemble program funded by the International Development Research Centre, Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada and Social Sciences and Humanities Research Council from Canada. The funding sources had no involvement in the actual research or preparation of the paper.	Abelson J, 2007, HEALTH POLICY, V82, P37, DOI 10.1016/j.healthpol.2006.07.009; Aenishaenslin C, 2016, TICKS TICK-BORNE DIS, V7, P1067, DOI 10.1016/j.ttbdis.2016.09.007; Aenishaenslin C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-015-2629-x; [Anonymous], COMMUN DIS REP CDR S; Balabanova Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025691; Baltussen Rob, 2006, Cost Eff Resour Alloc, V4, P14, DOI 10.1186/1478-7547-4-14; Belton V., 2002, MULTIPLE CRITERIA DE, DOI DOI 10.1007/978-1-4615-1495-4; Berrang-Ford L, 2009, INTERDISCIP PERSPECT, V2009, P13; Brans J. P., 2005, PROMETHEE METHODS MU, P163; Brans J-P, 2002, PROMETHEE GAIA UNE M; BRANS JP, 1985, MANAGE SCI, V31, P647, DOI 10.1287/mnsc.31.6.647; Brookes VJ, 2015, EPIDEMIOL INFECT, V143, P2911, DOI [10.1017/S0950268815000801, 10.1017/S0950268]; Brookes VJ, 2014, PREV VET MED, V113, P118, DOI 10.1016/j.prevetmed.2013.10.016; Brookes VJ, 2014, PREV VET MED, V113, P103, DOI 10.1016/j.prevetmed.2013.10.014; Capek I, 2010, DEFINITIN PRIORITES; Cardoen S, 2009, FOODBORNE PATHOG DIS, V6, P1083, DOI 10.1089/fpd.2009.0291; Carter A, 1991, Can J Infect Dis, V2, P37; Cediel N, 2013, REV PANAM SALUD PUBL, V33, P316, DOI 10.1590/S1020-49892013000500002; Confalonieri U, 2007, CLIMATE CHANGE 2007, P391, DOI DOI 10.1016/J.JHYDR0L.2011.05.013; Cox RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041679; Cox R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068338; Doherty J A, 2000, Can J Infect Dis, V11, P21; Doherty J-A, 2006, CAN COMMUN DIS REP, V32; Drebot Michael A, 2003, Can J Infect Dis, V14, P105; Ebi KL, 2006, ENVIRON HEALTH PERSP, V114, P1930, DOI 10.1289/ehp.8430; Gilsdorf A, 2011, EURO SURVEILL, V16; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; Greenhalgh T, 2005, BRIT MED J, V331, P1064, DOI 10.1136/bmj.38636.593461.68; Gubler DJ, 2001, ENV HLTH PERSPECT, V109; Havelaar AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013965; Horby PW, 2014, CONFRONTING EMERGING, P13, DOI [10.1007/978-4-431-55120-1_2, DOI 10.1007/978-4-431-55120-1_2]; Humblet M.F., 2012, EMERG INFECT DIS, V18; Institut de Veille Sanitaire, 2010, DEF PRIOR DOM ZOON A; Institut de Veille Sanitaire, 2002, DEF PRIOR DOM ZOON A; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kadohira M, 2015, EPIDEMIOL INFECT, V143, P1477, DOI 10.1017/S0950268814002246; Kiker GA, 2005, INTEGR ENVIRON ASSES, V1, P95, DOI 10.1897/IEAM_2004a-015.1; Krause G, 2008, EUROSURVEILLANCE, V13; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Krewski D, 2006, HUM ECOL RISK ASSESS, V12, P626, DOI 10.1080/10807030600561832; Linkov I, 2006, RISK ANAL, V26, P61, DOI 10.1111/j.1539-6924.2006.00713.x; McGregor S, 2014, PLOS ONE, V9; Ng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072172; Ng V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048519; Ng V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029752; Ogden NH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0532-4; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Pavlin BI, 2010, ASIA-PAC J PUBLIC HE, V22, P279, DOI 10.1177/1010539509342748; Paz S, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0561; Sawford K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-182; Schwartz KL, 2014, CAN MED ASSOC J, V186, P772, DOI 10.1503/cmaj.130680; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; Vilas VJD, 2013, PREV VET MED, V108, P94, DOI 10.1016/j.prevetmed.2012.08.007; WHO, 2003, REP WHO M BUCH, P27; WILDAVSKY A, 1990, DAEDALUS, V119, P41	56	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190049	10.1371/journal.pone.0190049	http://dx.doi.org/10.1371/journal.pone.0190049			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR3ZV	29281726	Green Submitted, Green Published, gold			2022-12-26	WOS:000419006200059
J	Le Berre, JY; Gourgues, M; Samans, B; Keller, H; Panabieres, F; Attard, A				Le Berre, Jo-Yanne; Gourgues, Mathieu; Samans, Birgit; Keller, Harald; Panabieres, Franck; Attard, Agnes			Transcriptome dynamic of Arabidopsis roots infected with Phytophthora parasitica identifies VQ29, a gene induced during the penetration and involved in the restriction of infection	PLOS ONE			English	Article							MOTIF-CONTAINING PROTEINS; PLANT DEFENSE RESPONSES; FUSARIUM-OXYSPORUM; MAGNAPORTHE-ORYZAE; SALICYLIC-ACID; COMPREHENSIVE ANALYSIS; SIGNAL-TRANSDUCTION; DISEASE RESISTANCE; IMMUNE-RESPONSES; MICROARRAY DATA	Little is known about the responses of plant roots to filamentous pathogens, particularly to oomycetes. To assess the molecular dialog established between the host and the pathogen during early stages of infection, we investigated the overall changes in gene expression in A. thaliana roots challenged with P. parasitica. We analyzed various infection stages, from penetration and establishment of the interaction to the switch from biotrophy to necrotrophy. We identified 3390 genes for which expression was modulated during the infection. The A. thaliana transcriptome displays a dynamic response to P. parasitica infection, from penetration onwards. Some genes were specifically coregulated during penetration and biotrophic growth of the pathogen. Many of these genes have functions relating to primary metabolism, plant growth, and defense responses. In addition, many genes encoding VQ motif-containing proteins were found to be upregulated in plant roots, early in infection. Inactivation of VQ29 gene significantly increased susceptibility to P. parasitica during the late stages of infection. This finding suggests that the gene contributes to restricting oomycete development within plant tissues. Furthermore, the vq29 mutant phenotype was not associated with an impairment of plant defenses involving SA-, JA-, and ET-dependent signaling pathways, camalexin biosynthesis, or PTI signaling. Collectively, the data presented here thus show that infection triggers a specific genetic program in roots, beginning as soon as the pathogen penetrates the first cells.	[Le Berre, Jo-Yanne; Gourgues, Mathieu; Keller, Harald; Panabieres, Franck; Attard, Agnes] Univ Cote dAzur, CNRS, INRA, ISA, Nice, France; [Samans, Birgit] Inst Agron & Plant Breeding, Dept Plant Breeding, Giessen, Germany	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Attard, A (corresponding author), Univ Cote dAzur, CNRS, INRA, ISA, Nice, France.	agnes.attard@inra.fr	Panabieres, Franck/ABE-2515-2021; , Attard/AAG-6607-2020	attard, agnes/0000-0002-6416-7032	INRA; French Ministry for education; SIGNALIFE-LABEX [ANR-11-LABX-0028-01]	INRA; French Ministry for education; SIGNALIFE-LABEX	This work was funded by INRA and the French Ministry for education and was supported by the "SIGNALIFE-LABEX" (ANR-11-LABX-0028-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuqamar S, 2013, MOL PLANT PATHOL, V14, P813, DOI 10.1111/mpp.12049; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Andreasson E, 2005, EMBO J, V24, P2579, DOI 10.1038/sj.emboj.7600737; Attard A, 2010, NEW PHYTOL; Attard A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-538; Badri DV, 2008, NEW PHYTOL, V179, P209, DOI 10.1111/j.1469-8137.2008.02458.x; Balmer D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00256; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Berrocal-Lobo M, 2004, MOL PLANT MICROBE IN, V17, P763, DOI 10.1094/MPMI.2004.17.7.763; Berrocal-Lobo M, 2008, TRENDS PLANT SCI, V13, P145, DOI 10.1016/j.tplants.2007.12.004; Bonardi V, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00237; Buhtz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138242; Buscaill P, 2014, CURR OPIN PLANT BIOL, V20, P35, DOI 10.1016/j.pbi.2014.04.004; CHEN QHG, 1995, PLANT PHYSIOL, V108, P597, DOI 10.1104/pp.108.2.597; Chen YC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05584; Cheng Y, 2012, PLANT PHYSIOL, V159, P810, DOI 10.1104/pp.112.196816; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; De Coninck B, 2015, TRENDS PLANT SCI, V20, P91, DOI 10.1016/j.tplants.2014.09.007; Divon HH, 2007, FEMS MICROBIOL LETT, V266, P65, DOI 10.1111/j.1574-6968.2006.00504.x; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Evangelisti E, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0379-1; Galiana E, 2005, CELL MICROBIOL, V7, P1365, DOI 10.1111/j.1462-5822.2005.00565.x; Geraats BPJ, 2002, MOL PLANT MICROBE IN, V15, P1078, DOI 10.1094/MPMI.2002.15.10.1078; GIBSON S, 1994, PLANT PHYSIOL, V106, P1615, DOI 10.1104/pp.106.4.1615; Glawischnig E, 2004, P NATL ACAD SCI USA, V101, P8245, DOI 10.1073/pnas.0305876101; GOMEZLIM MA, 1993, GENE, V134, P217, DOI 10.1016/0378-1119(93)90096-L; Hardham AR, 2007, CELL MICROBIOL, V9, P31, DOI 10.1111/j.1462-5822.2006.00833.x; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hermanns M, 2003, MOL PLANT MICROBE IN, V16, P752, DOI 10.1094/MPMI.2003.16.9.752; Higaki T, 2011, J PLANT RES, V124, P315, DOI 10.1007/s10265-011-0408-z; Hoffman T, 1999, PLANT PHYSIOL, V119, P935, DOI 10.1104/pp.119.3.935; Hok S, 2011, PLANT CELL ENVIRON, V34, P1944, DOI 10.1111/j.1365-3040.2011.02390.x; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002589; Huibers RP, 2009, MOL PLANT MICROBE IN, V22, P1104, DOI 10.1094/MPMI-22-9-1104; Hwang IS, 2013, NEW PHYTOL; Iven T, 2012, MOL PLANT, V5, P1389, DOI 10.1093/mp/sss044; Jansen M, 2006, MOL PLANT PATHOL, V7, P191, DOI [10.1111/j.1364-3703.2006.00331.x, 10.1111/J.1364-3703.2006.00331.X]; Jing YJ, 2015, PLANT PHYSIOL, V169, P371, DOI 10.1104/pp.15.00788; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Journot-Catalino N, 2006, PLANT CELL, V18, P3289, DOI 10.1105/tpc.106.044149; Jupe J, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r63; Kamoun S, 2015, MOL PLANT PATHOL, V16, P413, DOI 10.1111/mpp.12190; Katari MS, 2010, PLANT PHYSIOL, V152, P500, DOI 10.1104/pp.109.147025; Kazan K, 2012, TRENDS PLANT SCI, V17, P22, DOI 10.1016/j.tplants.2011.10.006; Kebdani N, 2010, NEW PHYTOL, V185, P248, DOI 10.1111/j.1469-8137.2009.03048.x; Kim KC, 2008, PLANT CELL, V20, P2357, DOI 10.1105/tpc.107.055566; LAROCHERAYNAL M, 1984, PLANT SCI LETT, V35, P139, DOI 10.1016/0304-4211(84)90187-1; Larroque M, 2013, J EXP BOT, V64, P3615, DOI 10.1093/jxb/ert195; Leivar P, 2012, PLANT CELL, V24, P1398, DOI 10.1105/tpc.112.095711; Less H, 2011, PLANT CELL, V23, P1264, DOI 10.1105/tpc.110.082867; Li N, 2014, PLANT CELL REP, V33, P1493, DOI 10.1007/s00299-014-1633-4; Li YL, 2014, PLANT PHYSIOL, V164, P2068, DOI 10.1104/pp.113.234492; Liljeroth E, 2001, J PHYTOPATHOL, V149, P447, DOI 10.1046/j.1439-0434.2001.00660.x; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; LYONS R, 2015, PLOS ONE, V10; Marcel S, 2010, PLANT CELL, V22, P3177, DOI 10.1105/tpc.110.078048; Meng Yuling, 2014, Mycology, V5, P43, DOI 10.1080/21501203.2014.917734; Millet YA, 2010, PLANT CELL, V22, P973, DOI 10.1105/tpc.109.069658; Okubara PA, 2005, PLANT SOIL, V274, P215, DOI 10.1007/s11104-004-7328-9; Panabieres F, 2016, PHYTOPATHOL MEDITERR, V55, P20, DOI 10.14601/Phytopathol_Mediterr-16423; Pecher P, 2014, NEW PHYTOL, V203, P592, DOI 10.1111/nph.12817; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; POTTER S, 1993, MOL PLANT MICROBE IN, V6, P680, DOI 10.1094/MPMI-6-680; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Qiu JL, 2008, PLANT PHYSIOL, V148, P212, DOI 10.1104/pp.108.120006; Quentin M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000264; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Rovenich H, 2014, CURR OPIN PLANT BIOL, V20, P96, DOI 10.1016/j.pbi.2014.05.001; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Schenk G, 2000, GENE, V250, P117, DOI 10.1016/S0378-1119(00)00186-4; Schlink K, 2009, FUNCT INTEGR GENOMIC; Schlink K, 2009, PLANT CELL REP, V28, P873, DOI 10.1007/s00299-009-0694-2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schreiber C, 2011, MOL PLANT PATHOL, V12, P397, DOI 10.1111/j.1364-3703.2010.00682.x; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Shinya T, 2007, PLANT CELL PHYSIOL, V48, P1404, DOI 10.1093/pcp/pcm115; Sokal R.R., 2012, BIOMETRY; Staswick PE, 1998, PLANT J, V15, P747, DOI 10.1046/j.1365-313X.1998.00265.x; Stokstad E, 2006, SCIENCE, V313, P1217; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; Tjamos SE, 2005, MOL PLANT MICROBE IN, V18, P555, DOI 10.1094/MPMI-18-0555; van der Fits L, 2001, PLANT J, V25, P43, DOI 10.1046/j.1365-313x.2001.00932.x; VAN DER STRAETEN D, 1992, P NATL ACAD SCI USA, V89, P9969, DOI 10.1073/pnas.89.20.9969; Vijayan P, 1998, P NATL ACAD SCI USA, V95, P7209, DOI 10.1073/pnas.95.12.7209; Wang HP, 2015, SCI REP-UK, V5, DOI 10.1038/srep14185; Wang Y, 2011, MOL PLANT PATHOL, V12, P187, DOI 10.1111/j.1364-3703.2010.00659.x; Ward JL, 2010, PLANT J, V63, P443, DOI 10.1111/j.1365-313X.2010.04254.x; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xie YD, 2010, PLANT CELL ENVIRON, V33, P828, DOI 10.1111/j.1365-3040.2009.02109.x; Zhang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-637; Zhao MR, 2012, PLANT CELL REP, V31, P671, DOI 10.1007/s00299-011-1185-9; Zhu ZQ, 2014, J EXP BOT, V65, P5743, DOI 10.1093/jxb/eru349	102	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190341	10.1371/journal.pone.0190341	http://dx.doi.org/10.1371/journal.pone.0190341			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281727	gold, Green Published, Green Submitted			2022-12-26	WOS:000419006200086
J	Andersson, S; Belkic, K; Demirbuker, SS; Mints, M; Ostensson, E				Andersson, Sonia; Belkic, Karen; Demirbuker, Selin Safer; Mints, Miriam; Ostensson, Ellinor			Perceived cervical cancer risk among women treated for high-grade cervical intraepithelial neoplasia: The importance of specific knowledge	PLOS ONE			English	Article							MINORITY WOMEN; SCREENING-PROGRAM; LOW-INCOME; FOLLOW-UP; HPV; BREAST; PARTICIPATION; DISPARITIES; IMMIGRANTS; MORTALITY	Objective Women with high-grade cervical intraepithelial neoplasia (CIN) are at increased risk for developing cervical cancer. We examine how women with high-grade CIN perceive their own risk, and about pertinent knowledge concerning human high-risk papillomavirus (HPV), CIN and cervical cancer. Methods All patients who underwent first-time treatment of high-grade CIN (grade 2+) were followed-up at 6-months at the Karolinska University Hospital, Stockholm, Sweden and were invited to participate in the present study. This included completion of a questionnaire examining sociodemographic characteristics, self-perceived risk of cervical cancer without regular gynecologic follow-up, and 14 queries about HPV, CIN and cervical cancer knowledge, inter alia. Results The participation rate was 96.6%, with 479 women enrolled in this study. Over 75% were age 40 or younger, over half had completed university education. Most were married or coliving with their partner and were gainfully employed. On a scale scored from 10 (highest self-perceived risk of cervical cancer without regular gynecologic follow-up) to 1 (lowest self-perceived risk), 64% rated their risk >= 7; almost 30% viewed their risk <= 6 and 7.5% did not rate their risk. A Specific Knowledge Scale with six of the queries explained 58.3% of the total variance. Nearly 30% of the women answered four or fewer of the six queries correctly. The Specific Knowledge Scale predicted self-perceived cervical cancer risk (Odds ratio = 11.3, 95% Confidence Interval 5.6 - 22.6) after adjusting for age, income and education. Most of the women with low self-perceived cervical cancer risk did not rate their HPV-related knowledge as good. However, 32 predominantly university-educated women, with low self-perceived cervical cancer risk, considered their HPV-related knowledge good. Conclusion It is vital to effectively convey accurate information about these patients' cervical cancer risk, needed preventive and follow-up measures, together with the relevant specific knowledge, for these women at increased risk for developing cervical cancer. Tailored programming to address these knowledge gaps is needed.	[Andersson, Sonia; Demirbuker, Selin Safer; Mints, Miriam; Ostensson, Ellinor] Karolinska Inst, Karolinska Univ Hosp Solna, Div Obstet & Gynecol, Dept Childrens & Womens Hlth, Stockholm, Sweden; [Belkic, Karen] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Belkic, Karen] Claremont Grad Univ, Sch Community & Global Hlth, Claremont, CA USA; [Belkic, Karen] Univ Southern Calif, Keck Sch Med, Inst Prevent Res, Alhambra, CA USA; [Ostensson, Ellinor] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Claremont Colleges; Claremont Graduate School; University of Southern California; Karolinska Institutet	Ostensson, E (corresponding author), Karolinska Inst, Karolinska Univ Hosp Solna, Div Obstet & Gynecol, Dept Childrens & Womens Hlth, Stockholm, Sweden.; Ostensson, E (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	ellinor.ostensson@ki.se		Ostensson, Ellinor/0000-0003-0668-088X	Swedish Cancer Foundation [11 0544, CAN 2011/471]; Karolinska Institutet Cancer Strategic Grants [5888/05-722]; Swedish Research Council [521-2008-2899]; Stockholm County Council [20130097, 20160155]; Gustaf V Jubilee Fund [154022]	Swedish Cancer Foundation; Karolinska Institutet Cancer Strategic Grants; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Gustaf V Jubilee Fund	The Swedish Cancer Foundation (11 0544, CAN 2011/471) URL: www.cancerfonden.se, SA; Karolinska Institutet Cancer Strategic Grants (5888/05-722) URL: www.ki.se, SA; The Swedish Research Council (521-2008-2899), URL: www.vr.se, SA; Stockholm County Council (20130097, 20160155) URL: www.skl.se, SA; The Gustaf V Jubilee Fund (154022) URL: www.rahfo.se, SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoli G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093174; Altobelli E, 2015, INT J GYNECOL CANCER, V25, P474, DOI 10.1097/IGC.0000000000000374; Asciutto KC, 2016, ACTA OBSTET GYN SCAN, V95, P1251, DOI 10.1111/aogs.12960; Azerkan F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107624; Azerkan F, 2012, INT J CANCER, V130, P937, DOI 10.1002/ijc.26084; Baezconde-Garbanati L, 1999, HISPANIC J BEHAV SCI, V21, P302, DOI 10.1177/0739986399213007; Barnoy S, 2003, CANCER NURS, V26, P363, DOI 10.1097/00002820-200310000-00004; Bethune G R, 2009, Public Health, V123 Suppl 1, pe17, DOI 10.1016/j.puhe.2009.06.006; Brismar S, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.01.005; Brown DR, 2000, ANN EPIDEMIOL, V10, pS13, DOI 10.1016/S1047-2797(00)00197-6; Davis M, 2015, CURR TREAT OPTION ON, V16, DOI 10.1007/s11864-015-0373-1; Ebisch RMF, 2017, J CLIN ONCOL, V35, P2542, DOI 10.1200/JCO.2016.71.4543; Elfstrom KM, 2015, EUR J CANCER, V51, P950, DOI 10.1016/j.ejca.2015.03.008; Fortner Kimberly B, 2007, J Low Genit Tract Dis, V11, P251, DOI 10.1097/LGT.0b013e318033999f; Galbraith KV, 2014, J COMMUN HEALTH, V39, P849, DOI 10.1007/s10900-014-9931-x; Garutti P, 2017, EUR J OBSTET GYN R B, V210, P236, DOI 10.1016/j.ejogrb.2016.12.018; Goel MS, 2003, J GEN INTERN MED, V18, P1028, DOI 10.1111/j.1525-1497.2003.20807.x; Gottvall M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014255; Harper DM, 2017, GYNECOL ONCOL, V146, P196, DOI 10.1016/j.ygyno.2017.04.004; Jibaja-Weiss ML, 2003, PATIENT EDUC COUNS, V50, P123; Lamb R, 2017, J CANCER EDUC; Marlow LAV, 2015, BRIT J CANCER, V113, P833, DOI 10.1038/bjc.2015.248; McBride KR, 2017, HEALTH EDUC BEHAV; Mousavi SM, 2012, INT J CANCER, V131, P497, DOI 10.1002/ijc.26395; Mueller NT, 2012, J IMMIGR MINOR HEALT, V14, P183, DOI 10.1007/s10903-011-9501-6; Navalpakam A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155955; Navarro AM, 1998, AM J PREV MED, V15, P32, DOI 10.1016/S0749-3797(98)00023-3; Nuno VL, 2016, J LOW GENIT TRACT DI, V20, P131, DOI 10.1097/LGT.0000000000000174; O'Connor M, 2014, BJOG-INT J OBSTET GY, V121, P1421, DOI 10.1111/1471-0528.12741; O'Connor M, 2015, WOMEN HEALTH ISS, V25, P528, DOI 10.1016/j.whi.2015.05.009; OSTENSSON E, 2015, PLOS ONE, V10; Ostensson E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179520; Otero-Sabogal R, 2003, HEALTH EDUC BEHAV, V30, P337, DOI 10.1177/1090198103030003008; Persson M, 2012, ONCOL REP, V28, P346, DOI 10.3892/or.2012.1755; Pimple S, 2016, CURR OPIN OBSTET GYN, V28, P4, DOI 10.1097/GCO.0000000000000241; Prigge ES, 2017, MUTAT RES-REV MUTAT, V772, P51, DOI 10.1016/j.mrrev.2016.06.005; Pruitt SL, 2009, CANCER EPIDEM BIOMAR, V18, P2579, DOI 10.1158/1055-9965.EPI-09-0135; Remennick Larissa, 2003, J Immigr Health, V5, P153, DOI 10.1023/A:1026163008336; Rodvall Y, 2005, EUR J CANCER PREV, V14, P459, DOI 10.1097/01.cej.0000178078.21910.da; Singh GK, 2004, CANCER, V101, P1051, DOI 10.1002/cncr.20467; Smith RA, 2017, CA-CANCER J CLIN, V67, P100, DOI 10.3322/caac.21392; Statistics Sweden, 2016, WOM MEN SWED FACTS F; Strander B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7361; Teran L, 2007, ANTICANCER RES, V27, P4325; Torre LA, 2017, CANCER EPIDEM BIOMAR, V26, P444, DOI 10.1158/1055-9965.EPI-16-0858; Wentzensen N, 2017, PREV MED, V98, P33, DOI 10.1016/j.ypmed.2016.12.040; Wilson KL, 2016, J CANCER EDUC	47	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190156	10.1371/journal.pone.0190156	http://dx.doi.org/10.1371/journal.pone.0190156			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8ZJ	29272293	gold, Green Published			2022-12-26	WOS:000418651500038
J	Yang, F; Wu, DZ; Lin, LM; Yang, J; Yang, TH; Zhao, J				Yang, Fan; Wu, Duzhi; Lin, Limei; Yang, Jian; Yang, Tinghong; Zhao, Jing			The integration of weighted gene association networks based on information entropy	PLOS ONE			English	Article							COMPLEX DISEASES; ONTOLOGY; COEXPRESSION; DATABASE	Constructing genome scale weighted gene association networks (WGAN) from multiple data sources is one of research hot spots in systems biology. In this paper, we employ information entropy to describe the uncertain degree of gene-gene links and propose a strategy for data integration of weighted networks. We use this method to integrate four existing human weighted gene association networks and construct a much larger WGAN, which includes richer biology information while still keeps high functional relevance between linked gene pairs. The new WGAN shows satisfactory performance in disease gene prediction, which suggests the reliability of our integration strategy. Compared with existing integration methods, our method takes the advantage of the inherent characteristics of the component networks and pays less attention to the biology background of the data. It can make full use of existing biological networks with low computational effort.	[Yang, Fan; Lin, Limei; Yang, Tinghong] Army Logist Univ PLA, Dept Math, Chongqing, Peoples R China; [Wu, Duzhi] Rongzhi Coll Chongqing Technol & Business, Chongqing, Peoples R China; [Yang, Jian] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Zhao, Jing] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Complex Res, Shanghai, Peoples R China	Naval Medical University; Shanghai University of Traditional Chinese Medicine	Wu, DZ (corresponding author), Rongzhi Coll Chongqing Technol & Business, Chongqing, Peoples R China.; Zhao, J (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Complex Res, Shanghai, Peoples R China.	wwwdz63@163.com; zhaojanne@gmail.com	Zhao, Jing/S-3581-2019	Zhao, Jing/0000-0002-2439-2876	National Natural Science Foundation of China [61372194, 81260672]; Chongqing Education Reform Project of Graduate [yjg152017]; National Science and Technology Major Project of China [2015ZX09101043-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Education Reform Project of Graduate; National Science and Technology Major Project of China	This work was supported by National Natural Science Foundation of China under Grant Nos. 61372194, 81260672 to JZ, http://www.nsfc.gov.cn/; Chongqing Education Reform Project of Graduate (yjg152017) to JZ, http://www.cqjw.gov. cn/; National Science and Technology Major Project of China (2015ZX09101043-008) to JZ, http.//www.nmp.gov.cn/. The funders had no role in study design, data collection and analysis,	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Al-Harazi O, 2016, J GENET GENOMICS, V43, P349, DOI 10.1016/j.jgg.2015.11.002; Alexeyenko A, 2009, GENOME RES, V19, P1107, DOI 10.1101/gr.087528.108; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Association As, 2017, ALZH DIS FACTS FIG; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cao S, 2017, NETWORK ENTROPIES BA, P265; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Chasman D, 2016, CURR OPIN BIOTECH, V39, P157, DOI 10.1016/j.copbio.2016.04.007; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chen ZQ, 2014, APPL MATH COMPUT, V242, P462, DOI 10.1016/j.amc.2014.05.105; Dehmer M, 2016, MATH FDN APPL GRAPH; Duc-Hau Le, 2016, Vietnam Journal of Computer Science, V3, P197, DOI 10.1007/s40595-016-0063-3; Emmert-Streib F, 2016, 50 YEARS GRAPH MATCH, p180 ; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gao B, 2016, INT J ONCOL, V49, P1108, DOI 10.3892/ijo.2016.3591; Gray RM, 2011, ENTROPY AND INFORMATION THEORY , SECOND EDITION, P395, DOI 10.1007/978-1-4419-7970-4; Gromiha MM, 2017, CURR OPIN STRUC BIOL, V44, P31, DOI 10.1016/j.sbi.2016.10.016; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Gupta S, 2017, BIOINFORMATICS; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Hobbs ET, 2016, ALGORITHM MOL BIOL, V11, DOI 10.1186/s13015-016-0082-8; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Kerrien Samuel, 2011, NUCLEIC ACIDS RES; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Liu ZP, 2012, IET SYST BIOL, V6, P22, DOI 10.1049/iet-syb.2010.0052; Mattick JS, 2016, FUTURE MOL PATHOLOGY, P349; Peng JJ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3263-4; Peng JJ, 2016, BIOINFORMATICS, V32, P1185, DOI 10.1093/bioinformatics/btv712; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Specht AT, 2017, BIOINFORMATICS, V33, P764, DOI 10.1093/bioinformatics/btw729; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sun JC, 2005, BIOINFORMATICS, V21, P3409, DOI 10.1093/bioinformatics/bti532; Sun Y, 2017, MICROBIAL PATHOGENES; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Yang J, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0398-0; Yin T, 2017, SCI REPORTS, P7; Yu JK, 2009, BIOINFORMATICS, V25, P105, DOI 10.1093/bioinformatics/btn597; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang QS, 2016, MOL BIOSYST, V12, P1082, DOI 10.1039/c5mb00815h	51	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190029	10.1371/journal.pone.0190029	http://dx.doi.org/10.1371/journal.pone.0190029			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272314	gold, Green Submitted, Green Published			2022-12-26	WOS:000418651500025
J	Bennett, TM; M'Hamdi, O; Hejtmancik, JF; Shiels, A				Bennett, Thomas M.; M'Hamdi, Oussama; Hejtmancik, J. Fielding; Shiels, Alan			Germ-line and somatic EPHA2 coding variants in lens aging and cataract	PLOS ONE			English	Article							AGE-RELATED CATARACT; CONGENITAL CATARACT; ULTRAVIOLET-RADIATION; PEDIATRIC CATARACT; TYROSINE KINASE; GENE-MUTATIONS; RISK-FACTORS; DNA-DAMAGE; EPIDEMIOLOGY; POLYMORPHISMS	Rare germ-line mutations in the coding regions of the human EPHA2 gene (EPHA2) have been associated with inherited forms of pediatric cataract, whereas, frequent, non-coding, single nucleotide variants (SNVs) have been associated with age-related cataract. Here we sought to determine if germ-line EPHA2 coding SNVs were associated with age-related cataract in a case-control DNA panel (> 50 years) and if somatic EPHA2 coding SNVs were associated with lens aging and/or cataract in a post-mortem lens DNA panel (> 48 years). Micro-fluidic PCR amplification followed by targeted amplicon (exon) next-generation (deep) sequencing of EPHA2 (17-exons) afforded high read-depth coverage (1000x) for > 82% of reads in the cataract case-control panel (161 cases, 64 controls) and > 70% of reads in the post-mortem lens panel (35 clear lens pairs, 22 cataract lens pairs). Novel and reference (known) missense SNVs in EPHA2 that were predicted in silico to be functionally damaging were found in both cases and controls from the age-related cataract panel at variant allele frequencies (VAFs) consistent with germ-line transmission (VAF > 20%). Similarly, both novel and reference missense SNVs in EPHA2 were found in the post-mortem lens panel at VAFs consistent with a somatic origin (VAF > 3%). The majority of SNVs found in the cataract case-control panel and post-mortem lens panel were transitions and many occurred at di-pyrimidine sites that are susceptible to ultraviolet (UV) radiation induced mutation. These data suggest that novel germ-line (blood) and somatic (lens) coding SNVs in EPHA2 that are predicted to be functionally deleterious occur in adults over 50 years of age. However, both types of EPHA2 coding variants were present at comparable levels in individuals with or without age-related cataract making simple genotype-phenotype correlations inconclusive.	[Bennett, Thomas M.; Shiels, Alan] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [M'Hamdi, Oussama; Hejtmancik, J. Fielding] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA	Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Shiels, A (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	shiels@vision.wustl.edu			NIH/NEI [EY012284, EY023549, P30 EY02687]; Research to Prevent Blindness (RPB); NIH [P30 CA91842, UL1 TR000448]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002687, R01EY023549, R01EY012284] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH/NEI grants EY012284 and EY023549 (to A.S.) and P30 EY02687 (Core Grant for Vision Research), and an unrestricted grant to the Department of Ophthalmology and Visual Sciences from Research to Prevent Blindness (RPB). The Genome Technology Access Center (GTAC) at Washington University School of Medicine is partially supported by NIH grants P30 CA91842 and UL1 TR000448. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AG, 2010, INVEST OPHTH VIS SCI, V51, P3919, DOI 10.1167/iovs.09-4557; Aldahmesh MA, 2012, GENET MED, V14, P955, DOI 10.1038/gim.2012.86; Barquilla A, 2015, ANNU REV PHARMACOL, V55, P465, DOI 10.1146/annurev-pharmtox-011112-140226; Bassnett S, 2009, MOL VIS, V15, P2448; Besaratinia A, 2011, FASEB J, V25, P3079, DOI 10.1096/fj.11-187336; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; Bu J, 2016, INDIAN J OPHTHALMOL, V64, P364, DOI 10.4103/0301-4738.185597; Celojevic D, 2016, OPHTHALMIC GENET, V37, P14, DOI 10.3109/13816810.2014.902080; Chen JJ, 2017, INVEST OPHTH VIS SCI, V58, P2207, DOI 10.1167/iovs.17-21469; Cheng C, 2013, DEVELOPMENT, V140, P4237, DOI 10.1242/dev.100727; Cheng C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028147; Dave A, 2016, MOL VIS, V22, P18; Dave A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072518; Foster A, 1997, J CATARACT REFR SURG, V23, P601, DOI 10.1016/S0886-3350(97)80040-5; Gillespie RL, 2014, OPHTHALMOLOGY, V121, P2124, DOI 10.1016/j.ophtha.2014.06.006; Haargaard B, 2004, OPHTHALMOLOGY, V111, P2292, DOI 10.1016/j.ophtha.2004.06.024; Hodge WG, 1995, EPIDEMIOL REV, V17, P336, DOI 10.1093/oxfordjournals.epirev.a036197; Jun G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000584; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Kassoff A, 2001, AM J OPHTHALMOL, V131, P167; Kaul H, 2010, MOL VIS, V16, P511; Khairallah M, 2015, INVEST OPHTH VIS SCI, V56, P6762, DOI 10.1167/iovs.15-17201; Koboldt Daniel C, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi1504s44; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kong LK, 2012, J AAPOS, V16, P501, DOI 10.1016/j.jaapos.2012.09.004; Lee HJ, 2012, STRUCTURE, V20, P41, DOI 10.1016/j.str.2011.11.013; Li D, 2016, MOL VIS, V22, P589; Lim Z, 2010, AM J OPHTHALMOL, V149, P887, DOI 10.1016/j.ajo.2010.01.012; LINDBERG RA, 1990, MOL CELL BIOL, V10, P6316, DOI 10.1128/MCB.10.12.6316; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Lombardo M, 2015, J CATARACT REFR SURG, V41, P446, DOI 10.1016/j.jcrs.2014.12.013; Maraini G, 2003, MOL VIS, V9, P397; Maraini G, 2008, OPHTHALMOLOGY, V115, P599, DOI 10.1016/j.ophtha.2008.01.005; Masoodi TA, 2012, BIOINFORMATION, V8, P562, DOI 10.6026/97320630008562; McCarty CA, 2002, DEV OPHTHALMOL, V35, P21; McCarty CA, 2001, INVEST OPHTH VIS SCI, V42, P1677; Mesa R, 2016, INVEST OPHTH VIS SCI, V57, P4063, DOI 10.1167/iovs.16-19726; Musleh M, 2016, EYE, V30, P1175, DOI 10.1038/eye.2016.105; Osnes-Ringen O, 2013, ACTA OPHTHALMOL, V91, P652, DOI 10.1111/j.1755-3768.2012.02500.x; Park JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036564; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Patel N, 2017, HUM GENET, V136, P205, DOI 10.1007/s00439-016-1747-6; Rahi JS, 2000, INVEST OPHTH VIS SCI, V41, P2108; Reis LM, 2014, MOL VIS, V20, P836; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sanfilippo PG, 2010, SURV OPHTHALMOL, V55, P561, DOI 10.1016/j.survophthal.2010.07.003; Shentu XC, 2013, INT J OPHTHALMOL-CHI, V6, P34, DOI 10.3980/j.issn.2222-3959.2013.01.07; Shi YR, 2012, INVEST OPHTH VIS SCI, V53, P551, DOI 10.1167/iovs.11-8568; Shiels A, 2017, EXP EYE RES, V156, P95, DOI 10.1016/j.exer.2016.06.011; Shiels A, 2010, MOL VIS, V16, P2007; Shiels A, 2008, MOL VIS, V14, P2042; SPECTOR A, 1995, FASEB J, V9, P1173, DOI 10.1096/fasebj.9.12.7672510; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Sulman EP, 1997, GENOMICS, V40, P371, DOI 10.1006/geno.1996.4569; Sun WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100455; Sundaresan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033001; Tan W, 2011, MOL VIS, V17, P1553; Taylor HR, 1999, EYE, V13, P445, DOI 10.1038/eye.1999.119; Wang Z, 2013, INVEST OPHTH VIS SCI, V54, P1135, DOI 10.1167/iovs.12-11168; Weiss JS, 2016, JAMA OPHTHALMOL, V134, P776, DOI 10.1001/jamaophthalmol.2015.5101; WEST SK, 1995, SURV OPHTHALMOL, V39, P323; Yang J, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/401894; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071003; Zhang HX, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0341-y; Zhang TX, 2009, HUM MUTAT, V30, pE603, DOI 10.1002/humu.20995	68	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189881	10.1371/journal.pone.0189881	http://dx.doi.org/10.1371/journal.pone.0189881			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267365	Green Published, gold, Green Submitted			2022-12-26	WOS:000418587400057
J	Meneghine, AK; Nielsen, S; Varani, AM; Thomas, T; Alves, LMC				Meneghine, Aylan K.; Nielsen, Shaun; Varani, Alessandro M.; Thomas, Torsten; Carareto Alves, Lucia Maria			Metagenomic analysis of soil and freshwater from zoo agricultural area with organic fertilization	PLOS ONE			English	Article							IRRIGATION WATER; MICROBIAL QUALITY; ESCHERICHIA-COLI; NITROGEN; PAENIBACILLUS; COMMUNITIES; COMPOST; ISLANDS; PROJECT; WASTES	Microbial communities drive biogeochemical cycles in agricultural areas by decomposing organic materials and converting essential nutrients. Organic amendments improve soil quality by increasing the load of essential nutrients and enhancing the productivity. Additionally, fresh water used for irrigation can affect soil quality of agricultural soils, mainly due to the presence of microbial contaminants and pathogens. In this study, we investigated how microbial communities in irrigation water might contribute to the microbial diversity and function of soil. Whole-metagenomic sequencing approaches were used to investigate the taxonomic and the functional profiles of microbial communities present in fresh water used for irrigation, and in soil from a vegetable crop, which received fertilization with organic compost made from animal carcasses. The taxonomic analysis revealed that the most abundant genera were Polynucleobacter (similar to 8% relative abundance) and Bacillus (similar to 10%) in fresh water and soil from the vegetable crop, respectively. Low abundance (0.38%) of cyanobacterial groups were identified. Based on functional gene prediction, denitrification appears to be an important process in the soil community analysed here. Conversely, genes for nitrogen fixation were abundant in freshwater, indicating that the N-fixation plays a crucial role in this particular ecosystem. Moreover, pathogenicity islands, antibiotic resistance and potential virulence related genes were identified in both samples, but no toxigenic genes were detected. This study provides a better understanding of the community structure of an area under strong agricultural activity with regular irrigation and fertilization with an organic compost made from animal carcasses. Additionally, the use of a metagenomic approach to investigate fresh water quality proved to be a relevant method to evaluate its use in an agricultural ecosystem.	[Meneghine, Aylan K.; Varani, Alessandro M.; Carareto Alves, Lucia Maria] Sao Paulo State Univ Unesp, Dept Technol, Sch Agr & Veterinarian Sci, Jaboticabal, SP, Brazil; [Nielsen, Shaun; Thomas, Torsten] Univ New South Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Thomas, Torsten] Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	Universidade Estadual Paulista; University of New South Wales Sydney; University of New South Wales Sydney	Alves, LMC (corresponding author), Sao Paulo State Univ Unesp, Dept Technol, Sch Agr & Veterinarian Sci, Jaboticabal, SP, Brazil.	lmcalves@fcav.unesp.br	Varani, Alessandro M/F-6887-2011; Meneghine, Aylan K/M-9515-2016; alves, lucia maria carareto/AAH-6555-2020	Varani, Alessandro M/0000-0002-8876-3269; Meneghine, Aylan K/0000-0002-9834-5984; Thomas, Torsten/0000-0001-9557-3001	CAPES Foundation [BEX 9552/14-6]; Foundation for Research Support of the Sao Paulo State (FAPESP) [2013/08729-0]; National Counsel for Technological and Scientific Development (CNPq) [478347/2013-8]	CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Foundation for Research Support of the Sao Paulo State (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel for Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funded by CAPES Foundation, scholarship granted [Process n. BEX 9552/14-6] to AKM. Foundation for Research Support of the Sao Paulo State (FAPESP) [Grant number: 2013/08729-0] to LMCA). National Counsel for Technological and Scientific Development (CNPq) [Grant number: 478347/2013-8] to LMCA.	Abdulla HM, 2007, WASTE MANAGE, V27, P850, DOI 10.1016/j.wasman.2006.06.006; Andreote FD, 2012, PLOS ONE, P7; Andrews S., 2010, FASTQC QUALITY CONTR; APHA, 2012, 3120 APHA, V22nd; Aw Y-K, 2016, FRONT MICROBIOL, P7; Banerjee S, 2010, AUST J CROP SCI, V4, P378; Bent E, 2001, CAN J MICROBIOL, V47, P793, DOI 10.1139/cjm-47-9-793; Berge ACB, 2009, JAVMA-J AM VET MED A, V234, P47, DOI 10.2460/javma.234.1.47; Bhardwaj D, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-66; Braker G, 2003, APPL ENVIRON MICROB, V69, P3476, DOI 10.1128/AEM.69.6.3476-3483.2003; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Lopes FAC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148296; Chaudhry V, 2012, MICROB ECOL, V64, P450, DOI 10.1007/s00248-012-0025-y; Chavez-Romero Y, 2016, SOIL TILL RES, V159, P1, DOI 10.1016/j.still.2016.01.007; Dahan O, 2014, HYDROL EARTH SYST SC, V18, P333, DOI 10.5194/hess-18-333-2014; Decol LT, 2017, FOOD MICROBIOL, V65, P105, DOI 10.1016/j.fm.2017.02.003; Diaz E, 2013, CURR OPIN BIOTECH, V24, P431, DOI 10.1016/j.copbio.2012.10.010; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Durso LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048325; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fanigliulo A, 2008, Commun Agric Appl Biol Sci, V73, P651; Foerstner KU, 2005, EMBO REP, V6, P1208, DOI 10.1038/sj.embor.7400538; Fremaux B, 2009, J APPL MICROBIOL, V106, P442, DOI 10.1111/j.1365-2672.2008.04012.x; Gal-Mor O, 2006, CELL MICROBIOL, V8, P1707, DOI 10.1111/j.1462-5822.2006.00794.x; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; Gomez-Alvarez V, 2012, APPL ENVIRON MICROB, V78, P6095, DOI 10.1128/AEM.01018-12; Grady EN, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0603-7; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hahn MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032772; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P112, DOI 10.1099/ijs.0.001743-0; Hamm AC, 2016, APPL SOIL ECOL, V103, P61, DOI 10.1016/j.apsoil.2016.02.015; Ibekwe AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079490; Ikunaga Y, 2011, APPL MICROBIOL BIOT, V89, P419, DOI 10.1007/s00253-010-2857-z; Ishii S, 2008, MICROBES ENVIRON, V23, P101, DOI 10.1264/jsme2.23.101; Jezbera J, 2012, FEMS MICROBIOL ECOL, V81, P467, DOI 10.1111/j.1574-6941.2012.01372.x; Jezbera J, 2011, ENVIRON MICROBIOL, V13, P922, DOI 10.1111/j.1462-2920.2010.02396.x; Jongman M, 2017, J FOOD SAFETY, V37, DOI 10.1111/jfs.12324; Jorquera MA, 2011, FEMS MICROBIOL ECOL, V75, P163, DOI 10.1111/j.1574-6941.2010.00995.x; Jung J, 2016, SCI REP, P1; Kalbasi A, 2005, COMPOST SCI UTIL, V13, P180; Kasalicky V, 2010, INT J SYST EVOL MICR, V60, P2710, DOI 10.1099/ijs.0.018952-0; Keraita B, 2008, J ENVIRON SCI HEAL A, V43, P749, DOI 10.1080/10934520801959948; Madsen EL, 2011, CURR OPIN BIOTECH, V22, P456, DOI 10.1016/j.copbio.2011.01.008; Marschner P, 2011, SOIL BIOL BIOCHEM, V43, P883, DOI 10.1016/j.soilbio.2011.01.005; Martins Layla Farage, 2013, PLoS One, V8, pe61928, DOI 10.1371/journal.pone.0061928; Medeiros JD, 2016, BRAZ J MICROBIOL, V47, P835, DOI 10.1016/j.bjm.2016.06.011; Medina J, 2015, WASTE MANAGE, V42, P41, DOI 10.1016/j.wasman.2015.04.002; Mendes LW, 2014, ISME J, V8, P1577, DOI 10.1038/ismej.2014.17; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mou XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061890; Newton RJ, 2013, MICROB ECOL, V65, P1011, DOI 10.1007/s00248-013-0200-9; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Nielsen S, 2014, AGR ECOSYST ENVIRON, V191, P73, DOI 10.1016/j.agee.2014.04.006; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Raza W, 2008, J PLANT PATHOL, V90, P419; Rodriguez H, 2007, DEV PLANT SOIL SCI, P15, DOI DOI 10.1007/978-1-4020-5765-6; Ruiz-Gonzalez C, 2015, ECOL LETT, V18, P1198, DOI 10.1111/ele.12499; Salcher MM, 2014, J LIMNOL, V73, P74, DOI 10.4081/jlimnol.2014.813; Saran LM, 2017, CIENC AGROTEC, V41, P263, DOI 10.1590/1413-70542017413037616; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Scotti R, 2016, APPL SOIL ECOL, V107, P13, DOI 10.1016/j.apsoil.2016.05.004; Semenov AV, 2009, APPL ENVIRON MICROB, V75, P3206, DOI 10.1128/AEM.01791-08; Sharma SB, 2013, SPRINGERPLUS, V2, DOI [10.1186/2193-1801-2-587, 10.1186/2193-1801-2-41]; Steele M, 2005, J FOOD PROTECT, V68, P1388, DOI 10.4315/0362-028X-68.7.1388; Steele M, 2004, J FOOD PROTECT, V67, P2839, DOI 10.4315/0362-028X-67.12.2839; Steffen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044002; Takai K, 2004, PEST MANAG SCI, V60, P42, DOI 10.1002/ps.777; Tan B, 2015, FRONT MICROBIOL, P6; van Raij B., 2001, CHEM ANAL EVALUATION; Vary PS, 2007, APPL MICROBIOL BIOT, V76, P957, DOI 10.1007/s00253-007-1089-3; Wang R., 2017, SCI REP, V7; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Wei YQ, 2015, BIORESOURCE TECHNOL, V189, P349, DOI 10.1016/j.biortech.2015.04.031; Ye J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00372; Zhang YL, 2008, EUR J SOIL BIOL, V44, P84, DOI 10.1016/j.ejsobi.2007.10.003; Zhao J, 2015, LANDSCAPE URBAN PLAN, V137, P20, DOI 10.1016/j.landurbplan.2014.12.010	79	13	13	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190178	10.1371/journal.pone.0190178	http://dx.doi.org/10.1371/journal.pone.0190178			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267397	gold, Green Published, Green Submitted			2022-12-26	WOS:000418587400100
J	Morihara, H; Obana, M; Tanaka, S; Kawakatsu, I; Tsuchiyama, D; Mori, S; Suizu, H; Ishida, A; Kimura, R; Tsuchimochi, I; Maeda, M; Yoshimitsu, T; Fujio, Y; Nakayama, H				Morihara, Hirofumi; Obana, Masanori; Tanaka, Shota; Kawakatsu, Ikki; Tsuchiyama, Daisuke; Mori, Shota; Suizu, Hiroshi; Ishida, Akiko; Kimura, Rumi; Tsuchimochi, Izuru; Maeda, Makiko; Yoshimitsu, Takehiko; Fujio, Yasushi; Nakayama, Hiroyuki			2-aminoethoxydiphenyl borate provides an anti-oxidative effect and mediates cardioprotection during ischemia reperfusion in mice	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION; OPERATED CA2+ ENTRY; OXIDATIVE STRESS; CELL-DEATH; POTENTIAL CHANNELS; N-ACETYLCYSTEINE; ISCHEMIA/REPERFUSION INJURY; INDUCED APOPTOSIS	Excessive levels of reactive oxygen species (ROS) and impaired Ca2+ homeostasis play central roles in the development of multiple cardiac pathologies, including cell death during ischemia-reperfusion (I/R) injury. In several organs, treatment with 2-aminoethoxydiphenyl borate (2-APB) was shown to have protective effects, generally believed to be due to Ca2+ channel inhibition. However, the mechanism of 2-APB-induced cardioprotection has not been fully investigated. Herein we investigated the protective effects of 2-APB treatment against cardiac pathogenesis and deciphered the underlying mechanisms. In neonatal rat cardiomyocytes, treatment with 2-APB was shown to prevent hydrogen peroxide (H2O2)-induced cell death by inhibiting the increase in intracellular Ca2+ levels. However, no 2-APB-sensitive channel blocker inhibited H2O2-induced cell death and a direct reaction between 2-APB and H2O2 was detected by 1 H-NMR, suggesting that 2-APB chemically scavenges extracellular ROS and provides cytoprotection. In a mouse I/R model, treatment with 2-APB led to a considerable reduction in the infarct size after I/R, which was accompanied by the reduction in ROS levels and neutrophil infiltration, indicating that the anti-oxidative properties of 2-APB plays an important role in the prevention of I/R injury in vivo as well. Taken together, present results indicate that 2-APB treatment induces cardioprotection and prevents ROS-induced cardiomyocyte death, at least partially, by the direct scavenging of extracellular ROS. Therefore, administration of 2-APB may represent a promising therapeutic strategy for the treatment of ROS-related cardiac pathology including I/R injury.	[Morihara, Hirofumi; Obana, Masanori; Tanaka, Shota; Kawakatsu, Ikki; Tsuchiyama, Daisuke; Mori, Shota; Ishida, Akiko; Kimura, Rumi; Fujio, Yasushi; Nakayama, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Clin Sci & Biomed, Suita, Osaka, Japan; [Suizu, Hiroshi; Tsuchimochi, Izuru] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Synthet Med Chem, Suita, Osaka, Japan; [Maeda, Makiko] Osaka Univ, Pharm Grad Sch Pharmaceut Sci D, Educ & Res Unit, Suita, Osaka, Japan; [Yoshimitsu, Takehiko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Lab Synthet Organ & Med Chem, Okayama, Japan; [Morihara, Hirofumi] Osaka Med Coll, Pharmacol, Takatsuki, Osaka, Japan	Osaka University; Osaka University; Osaka University; Okayama University; Osaka Medical College	Nakayama, H (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Clin Sci & Biomed, Suita, Osaka, Japan.	nakayama@phs.osaka-u.ac.jp	Fujio, Yasushi/H-3421-2017	Fujio, Yasushi/0000-0003-0828-2930	Smoking Research Foundation; MEXT/JSPS KAKENHI [17K09576]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [15K14977] Funding Source: KAKEN	Smoking Research Foundation; MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is partially supported by Smoking Research Foundation (http://www.srf.or.jp/index.html) and MEXT/JSPS KAKENHI (Grant Number 17K09576) (https://www.jsps.go.jp/english/e-grants/) to H.N. This work is also partially supported by Takeda Science Foundation to M.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Wakako Okamoto and Chiharu Tottori for their excellent secretarial work. This work is partially supported by Smoking Research Foundation and MEXT/JSPS KAKENHI (Grant Number 17K09576) to H.N. This work is also partially supported by Takeda Science Foundation to M.O.	Abe M, 2008, J PHARMACOL SCI, V106, P571, DOI 10.1254/jphs.FP0071664; Aikawa R, 2000, CIRCULATION, V102, P2873; Akao M, 2001, CIRC RES, V88, P1267, DOI 10.1161/hh1201.092094; Ali MAM, 2013, TOXICOL IN VITRO, V27, P1686, DOI 10.1016/j.tiv.2013.04.013; Bilmen JG, 2002, CELL SIGNAL, V14, P955, DOI 10.1016/S0898-6568(02)00042-6; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; Callera GE, 2009, J HYPERTENS, V27, P155, DOI 10.1097/HJH.0b013e3283190582; Calvo M, 2015, METHODS MOL BIOL, V1254, P73, DOI 10.1007/978-1-4939-2152-2_6; Chen HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011161; Conejeros I, 2012, VET IMMUNOL IMMUNOP, V145, P540, DOI 10.1016/j.vetimm.2011.12.006; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Dobryndeva Y, 2001, MOL PHARMACOL, V60, P541; Du K, 2013, TOXICOL APPL PHARM, V273, P484, DOI 10.1016/j.taap.2013.09.010; Ekelof S, 2014, CARDIOVASC DRUG THER, V28, P173, DOI 10.1007/s10557-014-6511-3; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; Fukui T, 2011, HYPERTENS RES, V34, P1041, DOI 10.1038/hr.2011.76; Gao GF, 2014, J CLIN INVEST, V124, P4989, DOI 10.1172/JCI76042; Gao H, 2012, J MOL CELL CARDIOL, V53, P657, DOI 10.1016/j.yjmcc.2012.08.005; Garcia-Dorado D, 2012, CARDIOVASC RES, V94, P168, DOI 10.1093/cvr/cvs116; Granger DN, 2015, REDOX BIOL, V6, P524, DOI 10.1016/j.redox.2015.08.020; Gysembergh A, 1999, AM J PHYSIOL-HEART C, V277, pH2458, DOI 10.1152/ajpheart.1999.277.6.H2458; Hahn NE, 2014, CELL SIGNAL, V26, P1818, DOI 10.1016/j.cellsig.2014.04.018; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Ibanez B, 2015, J AM COLL CARDIOL, V65, P1455, DOI 10.1016/j.jacc.2015.02.032; Itagaki K, 2004, J IMMUNOL, V172, P601, DOI 10.4049/jimmunol.172.1.601; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kevin LG, 2003, AM J PHYSIOL-HEART C, V284, pH566, DOI 10.1152/ajpheart.00711.2002; Klose C, 2011, BRIT J PHARMACOL, V162, P1757, DOI 10.1111/j.1476-5381.2010.01186.x; Kurian GA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1656450; Lemonnier L, 2004, FEBS LETT, V556, P121, DOI 10.1016/S0014-5793(03)01387-5; Lewis Harry W., 1989, EXPT ORGANIC CHEM PR, P159; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Lin L, 2015, OTOLARYNG HEAD NECK, V153, P461, DOI 10.1177/0194599815589582; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Ma HT, 2001, J BIOL CHEM, V276, P18888, DOI 10.1074/jbc.M100944200; Ma KT, 2011, AM J PHYSIOL-HEART C, V300, pH335, DOI 10.1152/ajpheart.00737.2010; Marshall KD, 2014, AM J PHYSIOL-CELL PH, V306, pC639, DOI 10.1152/ajpcell.00167.2013; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Matsuo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111097; Mortadza SAS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00407; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Nicoud IB, 2007, AM J PHYSIOL-GASTR L, V293, pG623, DOI 10.1152/ajpgi.00521.2006; Obana M, 2012, AM J PHYSIOL-HEART C, V303, pH569, DOI 10.1152/ajpheart.00060.2012; Pasupathy S, 2017, CIRCULATION, V136, P894, DOI 10.1161/CIRCULATIONAHA.117.027575; Patel SJ, 2012, NAT BIOTECHNOL, V30, P179, DOI 10.1038/nbt.2089; Pell VR, 2016, CIRC RES, V118, P898, DOI 10.1161/CIRCRESAHA.115.306569; Schindl R, 2002, J BIOL CHEM, V277, P26950, DOI 10.1074/jbc.M203700200; Siddiqui T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106087; Silverstein R. M., 2014, SPECTROMETRIC IDENTI, P126; Takada M, 2011, BIOL PHARM BULL, V34, P954, DOI 10.1248/bpb.34.954; Tanaki K, 2001, J AM COLL CARDIOL, V37, P676, DOI 10.1016/S0735-1097(00)01123-2; Taskin MI, 2014, EUR J OBSTET GYN R B, V178, P74, DOI 10.1016/j.ejogrb.2014.03.049; Thiele H, 2010, J AM COLL CARDIOL, V55, P2201, DOI 10.1016/j.jacc.2009.08.091; Togashi K, 2008, BRIT J PHARMACOL, V153, P1324, DOI 10.1038/sj.bjp.0707675; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Xu SZ, 2005, BRIT J PHARMACOL, V145, P405, DOI 10.1038/sj.bjp.0706197; Yan Y, 2006, ACTA PHARMACOL SIN, V27, P821, DOI 10.1111/j.1745-7254.2006.00390.x; Yang KT, 2006, CELL DEATH DIFFER, V13, P1815, DOI 10.1038/sj.cdd.4401813; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yildar M, 2014, J SURG RES, V187, P683, DOI 10.1016/j.jss.2013.11.009; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404	64	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189948	10.1371/journal.pone.0189948	http://dx.doi.org/10.1371/journal.pone.0189948			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267336	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400070
J	Zhang, XM; Azhar, G; Wei, JY				Zhang, Xiaomin; Azhar, Gohar; Wei, Jeanne Y.			SIRT2 gene has a classic SRE element, is a downstream target of serum response factor and is likely activated during serum stimulation	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TRANSCRIPTION FACTOR; SIR2-LIKE PROTEINS; STEM-CELLS; EXPRESSION; NAD; IDENTIFICATION; COACTIVATORS; ACETYLATION; FIBROBLASTS	The sirtuin proteins are an evolutionarily conserved family of NAD(+)-dependent deacetylases that regulate various cellular functions. Among the seven sirtuins, SIRT2 is predominantly found in the cytoplasm, and is present in a wide range of tissues. Recent studies indicate that SIRT2 plays an important role in metabolic homeostasis. Several studies indicate that SIRT2 is upregulated under serum deprivation conditions. Since the serum response factor gene usually responds rapidly to serum deprivation and/or serum restoration following deprivation, we hypothesized that a common mechanism may serve to regulate both SIRT2 and SRF during serum stimulation. Using a bioinformatics approach, we searched the SRF binding motif in the SIRT2 gene, and found one classic CArG element (CCATAATAGG) in the SIRT2 gene promoter, which was bound to SRF in the electrophoretic mobility shift assay (EMSA). Serum deprivation induced SIRT2 expression, while SRF and the SRF binding protein, p49/STRAP, repressed SIRT2 gene expression. SIRT2 gene expression was also repressed by the Rho/SRF inhibitor, CCG-1423. These data demonstrate that the classic SRE element in the SIRT2 gene promoter region is functional and therefore, SIRT2 gene is a downstream target of the Rho/SRF signaling pathway. The increased expression of SRF that was observed in the aged heart may affect SIRT2 gene expression and contribute to altered metabolic status in senescence.	[Zhang, Xiaomin; Azhar, Gohar; Wei, Jeanne Y.] Univ Arkansas Med Sci, Donald W Reynolds Inst Aging, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Wei, JY (corresponding author), Univ Arkansas Med Sci, Donald W Reynolds Inst Aging, Little Rock, AR 72205 USA.	weijeanne@uams.edu	Zhang, Xiaomin/GVT-8927-2022	Wei, Jeanne/0000-0002-1861-3329	Claude D. Pepper Older American Independence Center grant [P30AG28718]; NATIONAL INSTITUTE ON AGING [P30AG028718] Funding Source: NIH RePORTER	Claude D. Pepper Older American Independence Center grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the P30AG28718 (Claude D. Pepper Older American Independence Center grant). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the P30AG28718 (Claude D. Pepper Older American Independence Center grant). We thank Y. Zhong for technical assistance.	Benson CC, 2011, PHYSIOL GENOMICS, V43, P1038, DOI 10.1152/physiolgenomics.00098.2011; Bonkowski MS, 2016, NAT REV MOL CELL BIO, V17, P679, DOI 10.1038/nrm.2016.93; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Cha Y, 2017, NAT CELL BIOL, V19, P445, DOI 10.1038/ncb3517; Coletti D, 2016, EUR J TRANSL MYOL, V26, P87, DOI 10.4081/ejtm.2016.6008; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Esnault C, 2017, MOL CELL, V65, P1081, DOI 10.1016/j.molcel.2017.02.005; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gualdrini F, 2016, MOL CELL, V64, P1048, DOI 10.1016/j.molcel.2016.10.016; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; IVY JM, 1986, MOL CELL BIOL, V6, P688, DOI 10.1128/MCB.6.2.688; Jeon ES, 2008, CIRC RES, V103, P635, DOI 10.1161/CIRCRESAHA.108.180885; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Lacolley P, 2017, CARDIOVASC RES, V113, P120, DOI 10.1093/cvr/cvw253; Liu TM, 2017, NAT CELL BIOL, V19, P412, DOI 10.1038/ncb3522; Mericskay M, 2000, DEV BIOL, V226, P192, DOI 10.1006/dbio.2000.9865; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; TAYLOR M, 1989, DEVELOPMENT, V106, P67; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994; Zhang X, 2007, GENE, V400, P131, DOI 10.1016/j.gene.2007.06.008; Zhang XM, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-32; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034688; Zhang XM, 2011, GENE REGUL SYST BIO, V5, P41, DOI 10.4137/GRSB.S7457; Zhang XM, 2004, J BIOL CHEM, V279, P55626, DOI 10.1074/jbc.M405945200; Zhang XM, 2003, AM J PHYSIOL-REG I, V285, pR552, DOI 10.1152/ajpregu.00631.2002; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190011	10.1371/journal.pone.0190011	http://dx.doi.org/10.1371/journal.pone.0190011			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267359	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400077
J	Llewellyn, AC; Lucas, CE; Roberts, SE; Brown, EW; Nayak, BS; Raphael, BH; Winchell, JM				Llewellyn, Anna C.; Lucas, Claressa E.; Roberts, Sarah E.; Brown, Ellen W.; Nayak, Bina S.; Raphael, Brian H.; Winchell, Jonas M.			Distribution of Legionella and bacterial community composition among regionally diverse US cooling towers	PLOS ONE			English	Article							LEGIONNAIRES-DISEASE; UNITED-STATES; WATER; OUTBREAKS; IDENTIFICATION; AGGLUTINATION; PNEUMOPHILA; DYNAMICS; SPP.	Cooling towers (CTs) are a leading source of outbreaks of Legionnaires' disease (LD), a severe form of pneumonia caused by inhalation of aerosols containing Legionella bacteria. Accordingly, proper maintenance of CTs is vital for the prevention of LD. The aim of this study was to determine the distribution of Legionella in a subset of regionally diverse US CTs and characterize the associated microbial communities. Between July and September of 2016, we obtained aliquots from water samples collected for routine Legionella testing from 196 CTs located in eight of the nine continental US climate regions. After screening for Legionella by PCR, positive samples were cultured and the resulting Legionella isolates were further characterized. Overall, 84% (164) were PCR-positive, including samples from every region studied. Of the PCR-positive samples, Legionella spp were isolated from 47% (78), L. pneumophila was isolated from 32% (53), and L. pneumophila serogroup 1 (Lp1) was isolated from 24% (40). Overall, 144 unique Legionella isolates were identified; 53% (76) of these were Legionella pneumophila. Of the 76 L. pneumophila isolates, 51% (39) were Lp1. Legionella were isolated from CTs in seven of the eight US regions examined. 16S rRNA amplicon sequencing was used to compare the bacterial communities of CT waters with and without detectable Legionella as well as the microbiomes of waters from different climate regions. Interestingly, the microbial communities were homogenous across climate regions. When a subset of seven CTs sampled in April and July were compared, there was no association with changes in corresponding CT microbiomes over time in the samples that became culture-positive for Legionella. Legionella species and Lp1 were detected frequently among the samples examined in this first large-scale study of Legionella in US CTs. Our findings highlight that, under the right conditions, there is the potential for CT-related LD outbreaks to occur throughout the US.	[Llewellyn, Anna C.] Ctr Dis Control & Prevent, Lab Leadership Serv, Atlanta, GA USA; [Llewellyn, Anna C.; Lucas, Claressa E.; Roberts, Sarah E.; Brown, Ellen W.; Raphael, Brian H.; Winchell, Jonas M.] Ctr Dis Control & Prevent, Resp Dis Branch, Pneumonia Response & Surveillance Lab, Atlanta, GA 30333 USA; [Nayak, Bina S.] Pinellas Cty Util, Water Qual Div, Largo, FL USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Winchell, JM (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Pneumonia Response & Surveillance Lab, Atlanta, GA 30333 USA.	zdx2@cdc.gov		Llewellyn, Anna/0000-0001-6712-7477; Raphael, Brian/0000-0003-2778-2623	CDC Office of Advance Molecular Detection	CDC Office of Advance Molecular Detection	This study was supported by funds made available by the CDC Office of Advance Molecular Detection.	Adams Deborah, 2015, MMWR Morb Mortal Wkly Rep, V62, P1, DOI 10.15585/mmwr.mm6253a1; [Anonymous], 2015, MMWR-MORBID MORTAL W, V64, P1019; Baron JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102679; Bassett MT, 2017, PUBLIC HEALTH REP, V132, P133, DOI 10.1177/0033354916689612; Bentham RH, 2000, CURR MICROBIOL, V41, P271, DOI 10.1007/s002840010133; Burillo A, 2017, INFECT DIS CLIN N AM, V31, P7, DOI 10.1016/j.idc.2016.10.002; CHERRY WB, 1978, J CLIN MICROBIOL, V8, P329; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Garrison Laurel E, 2016, MMWR Morb Mortal Wkly Rep, V65, P576, DOI 10.15585/mmwr.mm6522e1; Hilborn ED, 2013, MMWR-MORBID MORTAL W, V62, P714; Karl T.R., 1984, HIST CLIMATOLOGY SER, V4-3; Kozak Natalia A, 2013, Methods Mol Biol, V954, P3, DOI 10.1007/978-1-62703-161-5_1; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; LEE TLC, 1993, J CLIN MICROBIOL, V31, P2764, DOI 10.1128/JCM.31.10.2764-2768.1993; Leung MHY, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0165-2; Lucas CE, 2011, WATER RES, V45, P4428, DOI 10.1016/j.watres.2011.05.030; Merault N, 2011, APPL ENVIRON MICROB, V77, P1708, DOI 10.1128/AEM.02261-10; Mercante JW, 2015, CLIN MICROBIOL REV, V28, P95, DOI 10.1128/CMR.00029-14; Mouchtouri VA, 2010, AM J INFECT CONTROL, V38, P50, DOI 10.1016/j.ajic.2009.04.285; Nazanian EJ, 2008, DIAGN MICR INFEC DIS, V62, P125, DOI 10.1016/j.diagmicrobio.2008.05.004; Neil K, 2008, CLIN INFECT DIS, V47, P591, DOI 10.1086/590557; Nguyen TMN, 2006, J INFECT DIS, V193, P102, DOI 10.1086/498575; Pagnier I, 2009, FUTURE MICROBIOL, V4, P615, DOI 10.2217/FMB.09.25; Palmer A, 2016, MICROBIOL IMMUNOL, V60, P694, DOI 10.1111/1348-0421.12439; Pereira RPA, 2017, WATER RES, V122, P363, DOI 10.1016/j.watres.2017.06.011; Ragull S, 2007, APPL ENVIRON MICROB, V73, P5382, DOI 10.1128/AEM.00066-07; Ratcliff RM, 1998, J CLIN MICROBIOL, V36, P1560, DOI 10.1128/JCM.36.6.1560-1567.1998; Sharmin F, 2013, SCI REP-UK, V3, DOI 10.1038/srep03107; THACKER WL, 1983, J CLIN MICROBIOL, V18, P1113, DOI 10.1128/JCM.18.5.1113-1118.1983; van der Mee-Marquet N, 2006, J CLIN MICROBIOL, V44, P56, DOI 10.1128/JCM.44.1.56-59.2006; van Heijnsbergen E, 2015, ENVIRON SCI TECHNOL, V49, P4797, DOI 10.1021/acs.est.5b00142; Weiss D, 2017, PUBLIC HEALTH REP, V132, P241, DOI 10.1177/0033354916689620; Wery N, 2008, APPL ENVIRON MICROB, V74, P3030, DOI 10.1128/AEM.02760-07; YAMAMOTO H, 1992, APPL ENVIRON MICROB, V58, P1394, DOI 10.1128/AEM.58.4.1394-1397.1992; Yong SFY, 2010, J WATER HEALTH, V8, P92, DOI 10.2166/wh.2009.002; Zhang LY, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030222	36	35	36	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189937	10.1371/journal.pone.0189937	http://dx.doi.org/10.1371/journal.pone.0189937			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261791	Green Submitted, Green Published, gold			2022-12-26	WOS:000418564200077
J	Raccanello, D; Burro, R; Hall, R				Raccanello, Daniela; Burro, Roberto; Hall, Rob			Children's emotional experience two years after an earthquake: An exploration of knowledge of earthquakes and associated emotions	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; INTERNAL STATES LANGUAGE; YOUNG-CHILDREN; DISASTERS; NARRATIVES; IMPACT; AGE; SYMPTOMATOLOGY; VALIDATION; MOTHERS	A major earthquake has a potentially highly traumatic impact on children's psychological functioning. However, while many studies on children describe negative consequences in terms of mental health and psychiatric disorders, little is known regarding how the developmental processes of emotions can be affected following exposure to disasters. Objectives We explored whether and how the exposure to a natural disaster such as the 2012 Emilia Romagna earthquake affected the development of children's emotional competence in terms of understanding, regulating, and expressing emotions, after two years, when compared with a control group not exposed to the earthquake. We also examined the role of class level and gender. Method The sample included two groups of children (n = 127) attending primary school: The experimental group (n = 65) experienced the 2012 Emilia Romagna earthquake, while the control group (n = 62) did not. The data collection took place two years after the earthquake, when children were seven or ten-year-olds. Beyond assessing the children's understanding of emotions and regulating abilities with standardized instruments, we employed semi-structured interviews to explore their knowledge of earthquakes and associated emotions, and a structured task on the intensity of some target emotions. Results We applied Generalized Linear Mixed Models. Exposure to the earthquake did not influence the understanding and regulation of emotions. The understanding of emotions varied according to class level and gender. Knowledge of earthquakes, emotional language, and emotions associated with earthquakes were, respectively, more complex, frequent, and intense for children who had experienced the earthquake, and at increasing ages. Conclusions Our data extend the generalizability of theoretical models on children's psychological functioning following disasters, such as the dose-response model and the organizational-developmental model for child resilience, and provide further knowledge on children's emotional resources related to natural disasters, as a basis for planning educational prevention programs.	[Raccanello, Daniela; Burro, Roberto] Univ Verona, Dept Human Sci, Verona, Italy; [Hall, Rob] Environmetrics Ltd, Pymble, Australia	University of Verona	Raccanello, D (corresponding author), Univ Verona, Dept Human Sci, Verona, Italy.	daniela.raccanello@univr.it	RACCANELLO, DANIELA/ABD-7577-2020; Hall, Rob/AAE-5942-2019	RACCANELLO, DANIELA/0000-0002-2810-7630; Hall, Rob/0000-0003-1709-363X	Environmetrics Ltd	Environmetrics Ltd	One of the authors [R.H.] is employed by a commercial company: Environmetrics Ltd. Environmetrics Ltd provided support in the form of salary for author R.H., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Albanese O., 2008, SVILUPPO COMPRENSION; Barr DJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00328; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bartsch K., 1995, CHILDREN TALK MIND; Bates D, 2015, PARSIMONIOUS MIXED M, DOI DOI 10.1177/0146167220913363; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bauer PJ, 2005, J COGN DEV, V6, P463, DOI 10.1207/s15327647jcd0604_2; Brondino M, 2015, ADV INTELL SYST, V374, P1, DOI 10.1007/978-3-319-19632-9_1; Burro R, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3418-4; Cadamuro A, 2016, EUR J DEV PSYCHOL, V13, P52, DOI 10.1080/17405629.2015.1055240; Denham S.A., 1998, EMOTIONAL DEV YOUNG; Fergusson DM, 2014, AUST NZ J PSYCHIAT, V48, P597, DOI 10.1177/0004867414538677; Fivush R, 2000, SEX ROLES, V42, P233, DOI 10.1023/A:1007091207068; Fivush R, 2003, APPL COGNITIVE PSYCH, V17, P1, DOI 10.1002/acp.854; Fivush R, 2008, MEMORY, V16, P579, DOI 10.1080/09658210802150681; Fivush R, 2005, J COGN DEV, V6, P489, DOI 10.1207/s15327647jcd0604_3; Flynn BW, 2004, PSYCHIAT ANN, V34, P597, DOI 10.3928/0048-5713-20040801-13; Furr JM, 2010, J CONSULT CLIN PSYCH, V78, P765, DOI 10.1037/a0021482; Galambos CM, 2005, HEALTH SOC WORK, V30, P83, DOI 10.1093/hsw/30.2.83; Gennari R, 2017, INT J HUM-COMPUT ST, V101, P45, DOI 10.1016/j.ijhcs.2017.01.006; Gobbo C, 2007, APPL COGNITIVE PSYCH, V21, P1173, DOI 10.1002/acp.1324; Gobbo C, 2011, APPL COGNITIVE PSYCH, V25, P386, DOI 10.1002/acp.1703; Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582; Gokcen C, 2013, EUR CHILD ADOLES PSY, V22, P295, DOI 10.1007/s00787-012-0348-8; Hurnen F, 1997, AUSTRALASIAN J DISAS; Ioannou I, 2012, EPIFO290512 UCL EPI; Jones RT, 2009, LIFESPAN PERSPECTIVES ON NATURAL DISASTERS: COPING WITH KATRINA, RITA, AND OTHER STORMS, P65, DOI 10.1007/978-1-4419-0393-8_4; Kar N, 2009, WORLD J PEDIATR, V5, P5, DOI 10.1007/s12519-009-0001-x; Kim-Spoon J, 2013, CHILD DEV, V84, P512, DOI 10.1111/j.1467-8624.2012.01857.x; King TA, 2013, AUSTRALASIAN J DISAS, V1, P17; La Greca AM, 2002, HELPING CHILDREN COP; Lac E, 2007, INT J ENV SCI ED, V2, p14 ; Legerski JP, 2015, APPL COGNITIVE PSYCH, V29, P91, DOI 10.1002/acp.3081; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Masten AS, 2010, CHILD DEV, V81, P1029, DOI 10.1111/j.1467-8624.2010.01452.x; Molina P, 2014, EUR J DEV PSYCHOL, V11, P624, DOI 10.1080/17405629.2014.898581; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Nolen SB, 2007, COGNITION INSTRUCT, V25, P219, DOI 10.1080/07370000701301174; Oncu EC, 2010, CHILD DEV, V81, P1161, DOI 10.1111/j.1467-8624.2010.01460.x; Perlman SB, 2008, COGNITION EMOTION, V22, P651, DOI 10.1080/02699930701461154; Pons F, 2004, EUR J DEV PSYCHOL, V1, P127, DOI 10.1080/17405620344000022; Raccanello D., 2014, ADV INTELLIGENT SOFT, V292, P127, DOI DOI 10.1007/978-3-319-07698-0; Raccanello D, 2012, PSICOL CLIN SVILUPP, V16, P507, DOI 10.1449/38837; Raccanello D, 2014, INTERACT DES ARCHIT, P68; Raccanello D, 2015, EUR J DEV PSYCHOL, V12, P158, DOI 10.1080/17405629.2014.972358; ROSS KEK, 1993, SCI EDUC, V77, P191, DOI 10.1002/sce.3730770207; Rossetto T, 2012, EPIFO200512 UCL EPI; Rutter M, 1996, INT J BEHAV DEV, V19, P603, DOI 10.1177/016502549601900309; Sales JM, 2005, J COGN DEV, V6, P529, DOI 10.1207/s15327647jcd0604_5; Schulz LE, 2004, DEV PSYCHOL, V40, P162, DOI 10.1037/0012-1649.40.2.162; Shapiro L., 1991, DEV NARRATIVE STRUCT, P89; Shapiro LR, 2016, MULTIDISCIPLINARY IN, p199 ; Shields A, 1997, DEV PSYCHOL, V33, P906, DOI 10.1037/0012-1649.33.6.906; Tang CM, 2007, J EXP CHILD PSYCHOL, V97, P149, DOI 10.1016/j.jecp.2007.01.003; Tatsuta N, 2015, J PEDIATR-US, V167, P745, DOI 10.1016/j.jpeds.2015.06.033; Tekeli-Yesil S, 2010, RISK ANAL, V30, P1181, DOI 10.1111/j.1539-6924.2010.01424.x; Vezzali L, 2016, GROUP PROCESS INTERG, V19, P314, DOI 10.1177/1368430215590492; Vizek-Vidovic V, 2000, SCAND J PSYCHOL, V41, P297, DOI 10.1111/1467-9450.00202; WELLMAN HM, 1992, ANNU REV PSYCHOL, V43, P337, DOI 10.1146/annurev.ps.43.020192.002005; Winje D, 1998, J CHILD PSYCHOL PSYC, V39, P635, DOI 10.1017/S0021963098002479; Wyman PA, 1999, CHILD DEV, V70, P645, DOI 10.1111/1467-8624.00047; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; Zimmer-Gembeck MJ, 2011, INT J BEHAV DEV, V35, P1, DOI 10.1177/0165025410384923	64	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189633	10.1371/journal.pone.0189633	http://dx.doi.org/10.1371/journal.pone.0189633			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ7SY	29261748	gold, Green Published, Green Submitted			2022-12-26	WOS:000418564200049
J	Jensen, KV; Cseh, O; Aman, A; Weiss, S; Luchman, HA				Jensen, Katharine Victoria; Cseh, Orsolya; Aman, Ahmed; Weiss, Samuel; Luchman, Hema Artee			The JAK2/STAT3 inhibitor pacritinib effectively inhibits patient-derived GBM brain tumor initiating cells in vitro and when used in combination with temozolomide increases survival in an orthotopic xenograft model	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; HUMAN GLIOBLASTOMA; DRUG-METABOLISM; STAT3; MYELOFIBROSIS; MULTIFORME; CANCER; CLASSIFICATION; PROLIFERATION	Purpose The prognosis for patients diagnosed with glioblastoma multiforme (GBM) remains dismal, with current treatment prolonging survival only modestly. As such, there remains a strong need for novel therapeutic strategies. The janus kinase (JAK) 2/signal transducer and activator of transcription (STAT) 3 pathway regulates many cellular processes in GBM, including survival, proliferation, invasion, anti-apoptosis, and immune evasion. Here, we evaluated the preclinical efficacy of pacritinib, a novel compound targeting JAK2, using a collection of diverse patient-derived brain tumor initiating cells (BTICs). Experimental design The effects of pacritinib on BTIC viability and sphere forming capacity were evaluated in vitro using the alamarBlue and neurosphere assays, respectively. On-target inhibition of JAK2/STAT3 signaling was investigated using western blotting. The efficacy of pacritinib was tested in vivo in pharmacokinetic analyses, liver microsome analyses, and Kaplan-Meier survival studies. Results In vitro, pacritinib decreased BTIC viability and sphere forming potential at low micromolar doses and demonstrated on-target inhibition of STAT3 signaling. Additionally, pacritinib was found to improve the response to temozolomide (TMZ) in TMZ-resistant BTICs. In vivo, systemic treatment with pacritinib demonstrated blood-brain barrier penetration and led to improved overall median survival in combination with TMZ, in mice orthotopically xeno-grafted with an aggressive recurrent GBM BTIC culture. Conclusion This preclinical study demonstrates the efficacy of pacritinib and supports the feasibility of testing pacritinib for the treatment of GBM, in combination with the standard of care TMZ.	[Jensen, Katharine Victoria; Cseh, Orsolya; Weiss, Samuel; Luchman, Hema Artee] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Jensen, Katharine Victoria; Cseh, Orsolya; Weiss, Samuel; Luchman, Hema Artee] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada; [Aman, Ahmed] Ontario Inst Canc Res, Drug Discovery Program, Toronto, ON, Canada	University of Calgary; University of Calgary; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Luchman, HA (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.; Luchman, HA (corresponding author), Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada.	aluchman@ucalgary.ca		Jensen, Katharine/0000-0002-8914-0039	Terry Fox Research Institute; Stem Cell Network of Canada; Cell Therapeutics Inc Biopharma; Canadian Institutes of Health Research; Alberta Cancer Foundation; Stem Cell Networks of Canada	Terry Fox Research Institute; Stem Cell Network of Canada; Cell Therapeutics Inc Biopharma; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; Stem Cell Networks of Canada	This work was supported by Terry Fox Research Institute to HAL and SW, http://www.tfri.ca/; Stem Cell Network of Canada to HAL and SW, http://stemcellnetwork.ca/; Cell Therapeutics Inc Biopharma to HAL and SW, http://www.ctibiopharma.com/; Canadian Institutes of Health Research (Scholarship to KVJ), http://www.cihr-irsc.gc.ca/e/193.html; Alberta Cancer Foundation (Scholarship to KVJ), http://albertacancer.ca/. Please note that we do not have grant numbers in Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Rozina Hassam, Jiqing Zhang, and Xiaoguang Hao for technical support. This research project was supported in part by grants from the Terry Fox Research Institute (H.A.L and S.W), Stem Cell Networks of Canada (H.A.L and S.W), Cell Therapeutics Inc Biopharma (H.A.L and S.W), the Canadian Institutes of Health Research (Scholarship to K.V.J), and the Alberta Cancer Foundation (Scholarship to K.V.J).	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; 2017, BRAIN TUM STAT; Birner P, 2010, J NEURO-ONCOL, V100, P339, DOI 10.1007/s11060-010-0195-8; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cusulin C, 2015, STEM CELL REP, V5, P1, DOI 10.1016/j.stemcr.2015.05.010; de Groot J., 2022, CNS ONCOL, V11, DOI [10.2217/cns-2022-0005, DOI 10.2217/CNS-2022-0005]; De-Fraja C, 1998, J NEUROSCI RES, V54, P320, DOI 10.1002/(SICI)1097-4547(19981101)54:3<320::AID-JNR3>3.0.CO;2-R; Duenas-Perez AB, 2015, THER ADV HEMATOL, V6, P186, DOI 10.1177/2040620715586527; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gu F, 2005, J NEUROSCI RES, V81, P163, DOI 10.1002/jnr.20561; Haan C, 2011, CHEM BIOL, V18, P314, DOI 10.1016/j.chembiol.2011.01.012; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jain Rekha, 2012, Current Pharmacogenomics & Personalized Medicine, V10, P54; Kelly JJP, 2009, STEM CELLS, V27, P1722, DOI 10.1002/stem.98; Kohsaka S, 2012, MOL CANCER THER, V11, P1289, DOI 10.1158/1535-7163.MCT-11-0801; Komrokji RS, 2015, BLOOD, V125, P2649, DOI 10.1182/blood-2013-02-484832; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Luchman HA, 2014, CLIN CANCER RES, V20, P5756, DOI 10.1158/1078-0432.CCR-13-3389; Luchman HA, 2012, NEURO-ONCOLOGY, V14, P184, DOI 10.1093/neuonc/nor207; Luwor RB, 2013, J CLIN NEUROSCI, V20, P907, DOI 10.1016/j.jocn.2013.03.006; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Mascarenhas J, 2016, BLOOD, V128, pLBA; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ostermann S, 2004, CLIN CANCER RES, V10, P3728, DOI 10.1158/1078-0432.CCR-03-0807; Rahaman SO, 2002, ONCOGENE, V21, P8404, DOI 10.1038/sj.onc.1206047; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; REMMER H, 1970, AM J MED, V49, P617, DOI 10.1016/S0002-9343(70)80129-2; Sakai C, 2014, J DRUG METABOLISM TO; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; Singer J, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.1874.1874; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stechishin OD, 2013, NEURO-ONCOLOGY, V15, P198, DOI 10.1093/neuonc/nos302; Verstovsek S, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0367-x; Weaver JL, 2012, TOXICOL PATHOL, V40, P267, DOI 10.1177/0192623311427711; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhao W, 2014, J BIOMOL SCREEN, V19, P817, DOI 10.1177/1087057114521867	42	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189670	10.1371/journal.pone.0189670	http://dx.doi.org/10.1371/journal.pone.0189670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253028	Green Submitted, Green Published, gold			2022-12-26	WOS:000418389500046
J	Klauke, B; Gaertner-Rommel, A; Schulz, U; Kassner, A; zu Knyphausen, E; Laser, T; Kececioglu, D; Paluszkiewicz, L; Blanz, U; Sandica, E; van den Bogaerdt, AJ; van Tintelen, JP; Gummert, J; Milting, H				Klauke, Baerbel; Gaertner-Rommel, Anna; Schulz, Uwe; Kassner, Astrid; zu Knyphausen, Edzard; Laser, Thorsten; Kececioglu, Deniz; Paluszkiewicz, Lech; Blanz, Ute; Sandica, Eugen; van den Bogaerdt, Antoon J.; van Tintelen, J. Peter; Gummert, Jan; Milting, Hendrik			High proportion of genetic cases in patients with advanced cardiomyopathy including a novel homozygous Plakophilin 2-gene mutation	PLOS ONE			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY; AMINO-ACID SUBSTITUTIONS; DILATED CARDIOMYOPATHY; PERICARDIAL DISEASES; POSITION STATEMENT; MISSENSE MUTATIONS; VARIANTS DATABASE; WORKING GROUP; WOOLLY HAIR; TASK-FORCE	Cardiomyopathies might lead to end-stage heart disease with the requirement of drastic treatments like bridging up to transplant or heart transplantation. A not precisely known proportion of these diseases are genetically determined. We genotyped 43 index-patients (30 DCM, 10 ARVC, 3 RCM) with advanced or end stage cardiomyopathy using a gene panel which covered 46 known cardiomyopathy disease genes. Fifty-three variants with possible impact on disease in 33 patients were identified. Of these 27 (51%) were classified as likely pathogenic or pathogenic in the MYH7, MYL2, MYL3, NEXN, TNNC1, TNNI3, DES, LMNA, PKP2, PLN, RBM20, TTN, and CRYAB genes. Fifty-six percent (n = 24) of index-patients carried a likely pathogenic or pathogenic mutation. Of these 75% (n = 18) were familial and 25% (n = 6) sporadic cases. However, severe cardiomyopathy seemed to be not characterized by a specific mutation profile. Remarkably, we identified a novel homozygous PKP2-missense variant in a large consanguineous family with sudden death in early childhood and several members with heart transplantation in adolescent age.	[Klauke, Baerbel; Gaertner-Rommel, Anna; Kassner, Astrid; Gummert, Jan; Milting, Hendrik] Ruhr Univ Bochum, Heart & Diabet Ctr NRW, Clin Thorac & Cardiovasc Surg, Erich & Hanna Klessmann Inst Cardiovasc Res & Dev, Bad Oeynhausen, Germany; [Schulz, Uwe; Paluszkiewicz, Lech; Gummert, Jan; Milting, Hendrik] Ruhr Univ Bochum, Heart & Diabet Ctr NRW, Clin Thorac & Cardiovasc Surg, Bad Oeynhausen, Germany; [zu Knyphausen, Edzard; Laser, Thorsten; Kececioglu, Deniz] Ruhr Univ Bochum, Ctr Congenital Heart Defects, Heart & Diabet Ctr NRW, Bad Oeynhausen, Germany; [Blanz, Ute; Sandica, Eugen] Ruhr Univ Bochum, Dept Surg Congenital Heart, Heart & Diabet Ctr NRW, Bad Oeynhausen, Germany; [van den Bogaerdt, Antoon J.] Erasmus MC, Dept Thorac Surg, Euro Heart Valve Bank, Ca Rotterdam, Netherlands; [van Tintelen, J. Peter] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [van Tintelen, J. Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Gz Groningen, Netherlands	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Groningen	Milting, H (corresponding author), Ruhr Univ Bochum, Heart & Diabet Ctr NRW, Clin Thorac & Cardiovasc Surg, Erich & Hanna Klessmann Inst Cardiovasc Res & Dev, Bad Oeynhausen, Germany.; Milting, H (corresponding author), Ruhr Univ Bochum, Heart & Diabet Ctr NRW, Clin Thorac & Cardiovasc Surg, Bad Oeynhausen, Germany.	hmilting@hdz-nrw.de	van Tintelen, J. Peter/AAJ-9962-2021; Paluszkiewicz, Lech/AAT-9523-2020; Gärtner, Anna/X-6863-2019	Paluszkiewicz, Lech/0000-0002-9095-1277; Gärtner, Anna/0000-0001-6899-7693	Erich and Hanna Klessmann Foundation, Gutersloh, Germany; Deutsche Forschungsgemeinschaft (DFG) [MI 1146/2-1]; Netherlands Cardiovascular Research Initiative; Dutch Heart Foundation [CVON2012-10 PREDICT, CVON2014-40 DOSIS]	Erich and Hanna Klessmann Foundation, Gutersloh, Germany; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Netherlands Cardiovascular Research Initiative; Dutch Heart Foundation(Netherlands Heart Foundation)	This work was supported by a grant of the Erich and Hanna Klessmann Foundation, Gutersloh, Germany to HM; the Deutsche Forschungsgemeinschaft (DFG) [grant No. MI 1146/2-1 to HM]; and The Netherlands Cardiovascular Research Initiative: An initiative with support of the Dutch Heart Foundation [CVON2012-10 PREDICT and CVON2014-40 DOSIS to JPvT]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2011, EUROPACE, V13, P1077, DOI 10.1093/europace/eur245; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alcalai R, 2003, J AM COLL CARDIOL, V42, P319, DOI 10.1016/S0735-1097(03)00628-4; [Anonymous], 2000, NON TRADITIONAL REF; Begay RL, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002645; Bogomolovas J, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160114; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S4-S3; Carmignac V, 2007, ANN NEUROL, V61, P340, DOI 10.1002/ana.21089; Cuenca S, 2016, J HEART LUNG TRANSPL; Ng D, 2013, CIRC-CARDIOVASC GENE, V6, P337, DOI 10.1161/CIRCGENETICS.113.000039; Deo RC, 2016, CIRC-CARDIOVASC GENE, V9, P419, DOI 10.1161/CIRCGENETICS.116.001513; Deshpande SR, 2016, PEDIATR CARDIOL, V37, P646, DOI 10.1007/s00246-015-1327-x; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Golbus JR, 2014, CIRC-CARDIOVASC GENE, V7, P751, DOI 10.1161/CIRCGENETICS.113.000578; Gramlich M, 2009, J MOL CELL CARDIOL, V47, P352, DOI 10.1016/j.yjmcc.2009.04.014; Groeneweg JA, 2015, CIRC CARDIOVASC GENE; Haas J, 2014, EUR HEART J; Hall C, 2009, CELL COMMUN ADHES, V16, P15, DOI 10.1080/15419060903009329; Hassel D, 2009, NAT MED, V15, P1281, DOI 10.1038/nm.2037; Hastings R, 2016, CIRC-CARDIOVASC GENE, V9, P426, DOI 10.1161/CIRCGENETICS.116.001431; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hershberger RE, 2011, J AM COLL CARDIOL, V57, P1641, DOI 10.1016/j.jacc.2011.01.015; Hinson JT, 2015, SCIENCE, V349, P982, DOI 10.1126/science.aaa5458; Jansweijer JA, 2016, EUR J HEART FAIL; Joshi-Mukherjee R, 2008, HEART RHYTHM, V5, P1715, DOI 10.1016/j.hrthm.2008.09.009; Kirchner F, 2012, CIRC-CARDIOVASC GENE, V5, P400, DOI 10.1161/CIRCGENETICS.111.961854; Lazzarini E, 2015, HUM MUTAT, V36, P403, DOI 10.1002/humu.22765; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marcus FI, 2010, EUR HEART J, V31, P806, DOI [10.1093/eurheartj/ehq025, 10.1161/CIRCULATIONAHA.108.840827]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Ortiz-Genga MF, 2016, J AM COLL CARDIOL, V68, P2440, DOI 10.1016/j.jacc.2016.09.927; Peled Y, 2014, INT J CARDIOL, V171, P24, DOI 10.1016/j.ijcard.2013.11.037; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Pinto YM, 2016, EUR HEART J, V37, P1850, DOI 10.1093/eurheartj/ehv727; Pugh TJ, 2014, GENET MED, V16, P601, DOI 10.1038/gim.2013.204; Quarta G, 2011, CIRCULATION, V123, P2701, DOI 10.1161/CIRCULATIONAHA.110.976936; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Rigato I, 2013, CIRC-CARDIOVASC GENE, V6, P533, DOI 10.1161/CIRCGENETICS.113.000288; Roberts AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010134; Schafer S, 2017, NAT GENET, V49, P46, DOI 10.1038/ng.3719; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; te Riele ASJM, 2017, CARDIOVASC RES, V113, P102, DOI 10.1093/cvr/cvw234; Teekakirikul P, 2013, J MOL DIAGN, V15, P158, DOI 10.1016/j.jmoldx.2012.09.002; Towbin J.A., 2015, LANCET; Towbin JA, 2015, LANCET, V386, P813, DOI 10.1016/S0140-6736(14)61282-4; van der Zwaag PA, 2009, HUM MUTAT, V30, P1278, DOI 10.1002/humu.21064; van Spaendonck-Zwarts KY, 2013, EUR J HEART FAIL, V15, P628, DOI 10.1093/eurjhf/hft013; Xu TH, 2010, J AM COLL CARDIOL, V55, P587, DOI 10.1016/j.jacc.2009.11.020; Zou J, 2015, ELIFE, V4, DOI 10.7554/eLife.09406	55	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189489	10.1371/journal.pone.0189489	http://dx.doi.org/10.1371/journal.pone.0189489			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253866	Green Published, Green Submitted, gold			2022-12-26	WOS:000418389500032
J	Danza, F; Storelli, N; Roman, S; Ludin, S; Tonolla, M				Danza, Francesco; Storelli, Nicola; Roman, Samuele; Ludin, Samuel; Tonolla, Mauro			Dynamic cellular complexity of anoxygenic phototrophic sulfur bacteria in the chemocline of meromictic Lake Cadagno	PLOS ONE			English	Article							DARK CARBON FIXATION; IN-SITU ANALYSIS; FLOW-CYTOMETRY; CHLOROBIUM-TEPIDUM; PURPLE; COMMUNITY; IDENTIFICATION; POPULATION; MICROSCOPY; OXIDATION	The meromictic Lake Cadagno is characterized by a compact chemocline with high concentrations of anoxygenic phototrophic purple sulfur bacteria (PSB) and green sulfur bacteria (GSB). The co-occurrence of phylogenetically distant bacterial groups such as PSB and GSB in the same ecological niche, makes the chemocline of Lake Cadagno an ideal system for studying the conditions and consequences of coexistence of photosynthetic bacteria populations. In this study, we applied flow cytometry (FCM) as a fast tool to identify metabolic changes due to the production and consumption of inclusion bodies such as sulfur globules (SGBs), and follow population dynamics of closely related anoxygenic photosynthetic sulfur bacteria in their natural environment. Large-celled PSB Chromatium okenii and GSB Chlorobium populations were reliably separated and identified due to differences in auto-fluorescence and cell size. Moreover, we showed that these dominant taxa share the same ecological niche over seasonal periods. Taking advantage of FCM detection of dynamic cellular complexity variation during phases of photosynthetic activity, we identified an unexpected alternation in PSB versus GSB metabolic activity, indicating dynamic interspecific interactions between these two populations.	[Danza, Francesco; Storelli, Nicola; Roman, Samuele; Ludin, Samuel; Tonolla, Mauro] Univ Appl Sci & Arts Southern Switzerland SUPSI, Dept Environm Construct & Design DACD, Lab Appl Microbiol LMA, Via Mirasole 22a, Bellinzona, Switzerland; [Danza, Francesco; Ludin, Samuel; Tonolla, Mauro] Univ Geneva, Dept Bot & Plant Biol, Microbiol Unit, Geneva, Switzerland; [Roman, Samuele; Tonolla, Mauro] Alpine Biol Ctr Fdn, Via Mirasole 22a, Bellinzona, Switzerland; [Ludin, Samuel] Fed Off Civil Protect, Spiez Lab, Div Biol, Spiez, Switzerland	University of Geneva	Tonolla, M (corresponding author), Univ Appl Sci & Arts Southern Switzerland SUPSI, Dept Environm Construct & Design DACD, Lab Appl Microbiol LMA, Via Mirasole 22a, Bellinzona, Switzerland.; Tonolla, M (corresponding author), Univ Geneva, Dept Bot & Plant Biol, Microbiol Unit, Geneva, Switzerland.; Tonolla, M (corresponding author), Alpine Biol Ctr Fdn, Via Mirasole 22a, Bellinzona, Switzerland.	mauro.tonolla@supsi.ch	Storelli, Nicola/AAP-5061-2021	Storelli, Nicola/0000-0002-1318-115X; Ludin, Samuel/0000-0002-2803-2536	Scuola Universitaria Professionale della Svizzera Italiana	Scuola Universitaria Professionale della Svizzera Italiana	This work was supported by Scuola Universitaria Professionale della Svizzera Italiana.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; BLANKENSHIP RE, 1995, ADV PHOTOSYNTH, V2, P399; Camacho A, 2001, AQUAT SCI, V63, P91, DOI 10.1007/PL00001346; Casamayor EO, 2007, ENVIRON MICROBIOL, V9, P1969, DOI 10.1111/j.1462-2920.2007.01313.x; Casamayor EO, 2000, APPL ENVIRON MICROB, V66, P499, DOI 10.1128/AEM.66.2.499-508.2000; Dahl Christiane, 2006, V1, P21, DOI 10.1007/7171_002; Decristophoris PMA, 2009, J LIMNOL, V68, P16, DOI 10.4081/jlimnol.2009.16; Dvornyk V, 2003, P NATL ACAD SCI USA, V100, P2495, DOI 10.1073/pnas.0130099100; Dyksma S, 2016, ISME J, V10, P1939, DOI [10.1038/ISMEJ.2015.257, 10.1038/ismej.2015.257]; EICHLER B, 1988, ARCH MICROBIOL, V149, P395, DOI 10.1007/BF00425577; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Felip M, 2007, APPL ENVIRON MICROB, V73, P4508, DOI 10.1128/AEM.00733-07; FISCHER K, 1995, CAN J MICROBIOL, V41, P666, DOI 10.1139/m95-092; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Frigaard NU, 2003, PHOTOSYNTH RES, V78, P93, DOI 10.1023/B:PRES.0000004310.96189.b4; Gasol JM, 1999, APPL ENVIRON MICROB, V65, P4475; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Gregersen LH, 2009, FEMS MICROBIOL ECOL, V70, P30, DOI 10.1111/j.1574-6941.2009.00737.x; GUERRERO R, 1985, LIMNOL OCEANOGR, V30, P919, DOI 10.4319/lo.1985.30.5.0919; Gulati RD, ECOLOGICAL STUDIES, V228; Habicht KS, 2011, ENVIRON MICROBIOL, V13, P203, DOI 10.1111/j.1462-2920.2010.02321.x; Hammes F, 2010, ANAL BIOANAL CHEM, V397, P1083, DOI 10.1007/s00216-010-3646-3; Holkenbrink C, 2011, MICROBIOL-SGM, V157, P1229, DOI 10.1099/mic.0.044669-0; Imhoff JF, 2010, PHOTOSYNTH RES, V104, P123, DOI 10.1007/s11120-009-9510-7; Luthy L, 2000, SITU DETERMINATION S, V66, P712; Mas J., 2004, ANOXYGENIC PHOTOSYNT, V2, P973; Masse A, 2002, APPL ENVIRON MICROB, V68, P2972, DOI 10.1128/AEM.68.6.2972-2981.2002; Min HT, 2005, FEBS LETT, V579, P808, DOI 10.1016/j.febslet.2005.01.003; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; OVERMANN J, 1992, LIMNOL OCEANOGR, V37, P150, DOI 10.4319/lo.1992.37.1.0150; Overmann J., 2013, PROKARYOTES, P203, DOI DOI 10.1007/978-3-642-30123-0_51; Overmann Joerg, 2008, V27, P375; Peduzzi S, 2012, SYST APPL MICROBIOL, V35, P139, DOI 10.1016/j.syapm.2012.01.001; Peduzzi S, 2011, INT J SYST EVOL MICR, V61, P1682, DOI 10.1099/ijs.0.010397-0; Pjevac P, 2015, APPL ENVIRON MICROB, V81, P298, DOI 10.1128/AEM.02435-14; SHIVELY JM, 1974, ANNU REV MICROBIOL, V28, P167, DOI 10.1146/annurev.mi.28.100174.001123; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sommer T, 2017, GEOPHYS RES LETT, V44, P9424, DOI 10.1002/2017GL074868; SRIENC F, 1984, BIOTECHNOL BIOENG, V26, P982, DOI 10.1002/bit.260260824; Storelli N, 2013, FEMS MICROBIOL ECOL, V84, P421, DOI 10.1111/1574-6941.12074; Tonolla M, 1999, APPL ENVIRON MICROB, V65, P1325; Tonolla M, 2005, APPL ENVIRON MICROB, V71, P3544, DOI 10.1128/AEM.71.7.3544-3550.2005; Tonolla M, 2003, FEMS MICROBIOL ECOL, V43, P89, DOI 10.1111/j.1574-6941.2003.tb01048.x; Tonolla Mauro, 2004, Journal of Limnology, V63, P161; Tonolla M, 2017, ECOL STUD-ANAL SYNTH, V228, P155, DOI 10.1007/978-3-319-49143-1_7; Veldhuis MJW, 2000, SCI MAR, V64, P121, DOI 10.3989/scimar.2000.64n2121; Vila-Costa M, 2006, SCIENCE, V314, P652, DOI 10.1126/science.1131043; Vives-Rego J, 2000, FEMS MICROBIOL REV, V24, P429, DOI 10.1111/j.1574-6976.2000.tb00549.x; von Bodman SB, 2008, J BACTERIOL, V190, P4377, DOI 10.1128/JB.00486-08; Wang YY, 2010, TRENDS BIOTECHNOL, V28, P416, DOI 10.1016/j.tibtech.2010.04.006; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; WIDDEL F, 1993, NATURE, V362, P834, DOI 10.1038/362834a0; Widdel F, 1992, PROKARYOTES, P3352, DOI DOI 10.1007/978-1-4757-2191-1_; Zarda B, 1997, ARCH MICROBIOL, V168, P185, DOI 10.1007/s002030050486; Zimmermann M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00243	56	14	14	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189510	10.1371/journal.pone.0189510	http://dx.doi.org/10.1371/journal.pone.0189510			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29245157	Green Published, Green Submitted, gold			2022-12-26	WOS:000418184700035
J	Triska, C; Karsten, B; Heidegger, B; Koller-Zeisler, B; Prinz, B; Nimmerichter, A; Tschan, H				Triska, Christoph; Karsten, Bettina; Heidegger, Bernd; Koller-Zeisler, Bernhard; Prinz, Bernhard; Nimmerichter, Alfred; Tschan, Harald			Reliability of the parameters of the power-duration relationship using maximal effort time-trials under laboratory conditions	PLOS ONE			English	Article							IV MUSCLE AFFERENTS; VISIT FIELD-TEST; TO-EXHAUSTION; STATISTICAL-METHODS; GROUP-III; PERFORMANCE; EXERCISE; PERCEPTION; AGREEMENT; VALIDITY	The purpose of this study was to assess the reliability of critical power (CP) and the total amount of work accomplished above CP (W A) across repeated tests using ecologically valid maximal effort time-trials (TT) under laboratory conditions. After an initial incremental exercise test, ten well-trained male triathletes (age: 28.5 +/- 4.7 years; body mass: 73.3 +/- 7.9 kg; height: 1.80 +/- 0.07 m; maximal aerobic power [ MAP]: 329 +/- 41 W) performed three testing sessions (Familiarization, Test I and Test II) each comprising three TT (12, 7, and 3 min with a passive recovery of 60 min between trials). CP and W A were determined using a linear regression of power vs. the inverse of time (1/t) (P = WA'.1/t+ CP). A repeated-measures ANOVA was used to detect differences in CP and W A and reliability was assessed using the intra-class correlation coefficient (ICC) and the coefficient of variation (CoV). CP and W A values were not significantly different between repeated tests (P = 0.171 and P = 0.078 for CP and W A, respectively). The ICC between Familiarization and Test I was r = 0.86 (CP) and r = 0.58 (W A) and between Tests I and II it was r = 0.94 (CP) and r = 0.95 (W A). The CoV notably decreased from 4.1% to 2.6% and from 25.3% to 8.2% for CP and W A, respectively. Despite the non-significant differences for both parameter estimates between Familiarization, Test I, and Test II, ICC and CoV values improved notably after the familiarization trial. Our novel findings indicate that for both, CP and W A a familiarization trial increased reliability. It is therefore advisable to familiarize well-trained athletes when determining the power-duration relationship using TT under laboratory conditions.	[Triska, Christoph; Heidegger, Bernd; Koller-Zeisler, Bernhard; Tschan, Harald] Univ Vienna, Ctr Sport Sci & Univ Sports, Vienna, Austria; [Karsten, Bettina] Univ Greenwich, Dept Life & Sport Sci, Chatham, Kent, England; [Karsten, Bettina] LUNEX Int Univ Hlth Exercise & Sports, Dept Exercise & Sport Sci, Differdingen, Luxembourg; [Koller-Zeisler, Bernhard] Austrian Inst Sports Med, Vienna, Austria; [Prinz, Bernhard; Nimmerichter, Alfred] Univ Appl Sci, Training & Sports Sci, Wr Neustadt, Austria	University of Vienna; University of Greenwich	Triska, C (corresponding author), Univ Vienna, Ctr Sport Sci & Univ Sports, Vienna, Austria.	christoph.triska@univie.ac.at	Triska, Christoph/ABF-3481-2020; Nimmerichter, Alfred/AAW-7593-2021	Triska, Christoph/0000-0003-2506-8282; Nimmerichter, Alfred/0000-0001-8275-2166; Karsten, Bettina/0000-0001-7336-9472	University of Vienna	University of Vienna	Open access funding provided by University of Vienna.; Open access funding provided by University of Vienna. The corresponding author wants to express his sincere thanks to the Austrian Institute of Sports Medicine and the University of Applied Science Wr. Neustadt for providing equipment of their laboratories.	Amann M, 2010, J APPL PHYSIOL, V109, P966, DOI 10.1152/japplphysiol.00462.2010; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Black MI, 2015, APPL PHYSIOL NUTR ME, V40, P662, DOI 10.1139/apnm-2014-0442; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Buchheit M, 2016, INT J SPORT PHYSIOL, V11, P551, DOI 10.1123/IJSPP.2016-0214; Coakley S, 2017, J SPORTS SCI, V11, P1; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Dekerle J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138428; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferguson C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076420; GAESSER GA, 1988, INT J SPORTS MED, V9, P417, DOI 10.1055/s-2007-1025043; Galbraith A, 2015, INT J SPORTS MED, V36, P365, DOI 10.1055/s-0034-1394465; Galbraith A, 2011, J SPORTS MED DOPING, V1, P1, DOI [10.4172/2161-0673.1000101, DOI 10.4172/2161-0673.1000101]; Galbraith A, 2014, INT J SPORT PHYSIOL, V9, P931, DOI 10.1123/ijspp.2013-0507; Hampson DB, 2001, SPORTS MED, V31, P935, DOI 10.2165/00007256-200131130-00004; HILL DW, 1993, SPORTS MED, V16, P237, DOI 10.2165/00007256-199316040-00003; Hinckson EA, 2005, MED SCI SPORT EXER, V37, P696, DOI 10.1249/01.MSS.0000159023.06934.53; Hopkins W.G., 2000, SPORTSCIENCE, P1; Hopkins WG, 2001, SPORTS MED, V31, P211, DOI 10.2165/00007256-200131030-00005; JENKINS DG, 1992, MED SCI SPORT EXER, V24, P1283; Jeukendrup A, 1996, MED SCI SPORT EXER, V28, P266, DOI 10.1097/00005768-199602000-00017; Jeukendrup AE, 2005, MED SCI SPORT EXER, V37, P1820, DOI 10.1249/01.mss.0000175095.56646.4b; Jones AM, 2008, AM J PHYSIOL-REG I, V294, pR585, DOI 10.1152/ajpregu.00731.2007; Karsten B, 2015, EUR J APPL PHYSIOL, V115, P197, DOI 10.1007/s00421-014-3001-z; Karsten B, 2014, INT J SPORTS MED, V35, P298, DOI 10.1055/s-0033-1349844; Karsten B, 2018, INT J SPORT PHYSIOL, V13, P183, DOI 10.1123/ijspp.2016-0761; Karsten B, 2017, J SPORT SCI, V35, P1420, DOI 10.1080/02640414.2016.1215500; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Laursen PB, 2007, MED SCI SPORT EXER, V39, P1374, DOI 10.1249/mss.0b013e31806010f5; Marcora SM, 2011, J APPL PHYSIOL, V110, P1499, DOI 10.1152/japplphysiol.00146.2011; MORITANI T, 1981, ERGONOMICS, V24, P339, DOI 10.1080/00140138108924856; NEBELSICKGULLETT LJ, 1988, ERGONOMICS, V31, P1413, DOI 10.1080/00140138808966785; Nimmerichter A, 2015, SPORTS, V3, P358, DOI 10.3390/sports3040358; Parker Simpson L, 2016, INT J SPORT PHYSIOL, P1; SMITH JC, 1993, CAN J APPL PHYSIOL, V18, P43, DOI 10.1139/h93-005; Triska C, 2015, INT J SPORTS MED, V36, P1063, DOI 10.1055/s-0035-1549958; Triska C, 2017, INT J SPORTS MED, V38, P527, DOI 10.1055/s-0043-102943; Vandewalle H, 1997, J SPORT MED PHYS FIT, V37, P89; Wright J, 2017, INT J SPORTS MED, V38, P462, DOI 10.1055/s-0043-102944	39	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189776	10.1371/journal.pone.0189776	http://dx.doi.org/10.1371/journal.pone.0189776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244861	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000418184700062
J	Huynh, M; Pak, C; Markovina, S; Callander, NS; Chng, KS; Wuerzberger-Davis, SM; Bakshi, DD; Kink, JA; Hematti, P; Hope, C; Asimakopoulos, F; Rui, LX; Miyamoto, S				Huynh, Mailee; Pak, Chorom; Markovina, Stephanie; Callander, Natalie S.; Chng, Kenneth S.; Wuerzberger-Davis, Shelly M.; Bakshi, Debayan D.; Kink, John A.; Hematti, Peiman; Hope, Chelsea; Asimakopoulos, Fotis; Rui, Lixin; Miyamoto, Shigeki			Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-kappa B activity and increases drug resistance in multiple myeloma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEDD8-ACTIVATING ENZYME-INHIBITOR; EXTRACELLULAR-MATRIX; ALPHA DEGRADATION; CELLS; PATHWAY; UBIQUITINATION; MATRIKINES; THERAPY; DOMAINS; BINDING	Nuclear factor-kappa B (NF-kappa B) is a family of transcription factors that play a key role in cell survival and proliferation in many hematological malignancies, including multiple myeloma (MM). Bortezomib, a proteasome inhibitor used in the management of MM, can inhibit both canonical and noncanonical activation of NF-kappa B in MM cells. However, we previously reported that a significant fraction of freshly isolated MM cells harbor bortezomib-resistant NF-kappa B activity. Here, we report that hyaluronan and proteoglycan link protein 1 (HAPLN1) is produced in bone marrow stromal cells from MM patients, is detected in patients' bone marrow plasma, and can activate an atypical bortezomib-resistant NF-kappa B pathway in MM cells. We found that this pathway involves bortezomib-resistant degradation of the inhibitor of NF-kappa B (I kappa B alpha), despite efficient bortezomib-mediated inhibition of proteasome activity. Moreover, HAPLN1 can also confer bortezomib-resistant survival of MM cells. We propose that HAPLN1 is a novel pathogenic factor in MM that induces an atypical NF-kappa B activation and thereby promotes bortezomib resistance in MM cells.	[Huynh, Mailee] Univ Wisconsin, Canc Biol Grad Program, Madison, WI 53705 USA; [Pak, Chorom] Univ Wisconsin, Mol & Cellular Pharmacol Grad Program, Madison, WI 53705 USA; [Markovina, Stephanie; Bakshi, Debayan D.] Univ Wisconsin, Cellular & Mol Biol Grad Program, Madison, WI 53705 USA; [Markovina, Stephanie] Univ Wisconsin, Med Sci Training Program, Madison, WI 53705 USA; [Callander, Natalie S.; Kink, John A.; Hematti, Peiman; Hope, Chelsea; Asimakopoulos, Fotis; Rui, Lixin] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53705 USA; [Callander, Natalie S.; Hematti, Peiman; Hope, Chelsea; Asimakopoulos, Fotis; Rui, Lixin; Miyamoto, Shigeki] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; [Chng, Kenneth S.; Wuerzberger-Davis, Shelly M.; Miyamoto, Shigeki] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53705 USA; [Chng, Kenneth S.; Wuerzberger-Davis, Shelly M.; Miyamoto, Shigeki] Univ Wisconsin, Dept Oncol, Madison, WI 53705 USA; [Pak, Chorom] Lynx Biosci, Madison, WI 53714 USA; [Markovina, Stephanie] Washington Univ, Sch Med, Siteman Canc Ctr, Dept Radiat Oncol, St Louis, MO 63110 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Siteman Cancer Center; Washington University (WUSTL)	Miyamoto, S (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, 6159 Wisconsin Inst Med Res,1111 Highland Ave, Madison, WI 53705 USA.	smiyamot@wisc.edu	li, rui/GSD-4367-2022; rui, li/GYR-3791-2022	De Bakshi, Debayan/0000-0002-8429-2965	National Institutes of Health (NIH) [R01 CA155192, RO1 CA077474-14S1, R21 CA194868]; Multiple Myeloma Research Foundation Senior Investigator Awards; University of Wisconsin Carbone Cancer Center Grant [P30 CA014520]; Trillium Fund; NIH [T32 CA009135, R01 CA077474-14S1, T32 GM008688, F30 AG029714-02]; University of Wisconsin-Madison; NATIONAL CANCER INSTITUTE [R01CA155192, R01CA187299, T32CA009135, R21CA194868, R01CA077474, P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688, T32GM008692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG029714] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Research Foundation Senior Investigator Awards; University of Wisconsin Carbone Cancer Center Grant; Trillium Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health (NIH) Grants R01 CA155192, RO1 CA077474-14S1, and R21 CA194868 and Multiple Myeloma Research Foundation Senior Investigator Awards (to S. Miyamoto); University of Wisconsin Carbone Cancer Center Grant P30 CA014520 and the Trillium Fund (to S. Miyamoto, N. S. C., F. A., and P. H.); NIH Grant T32 CA009135 (to M. H. and C. P); NIH Grant R01 CA077474-14S1 (to M. H.); the SciMed Graduate Research Scholars Fellowship at the University of Wisconsin-Madison (to M. H.); NIH Grant T32 GM008688 (C. P.); and NIH Grant F30 AG029714-02 (to S. Markovina). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bharti AC, 2004, BLOOD, V103, P3175, DOI 10.1182/blood-2003-06-2151; Bianchi G, 2014, CA-CANCER J CLIN, V64, P422, DOI 10.3322/caac.21252; BINETTE F, 1994, J BIOL CHEM, V269, P19116; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Demchenko YN, 2010, ONCOTARGET, V1, P59, DOI 10.18632/oncotarget.109; Di Marzo L, 2016, ONCOTARGET, V7, P60698, DOI 10.18632/oncotarget.10849; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; Dingli D, 2017, MAYO CLIN PROC, V92, P578, DOI 10.1016/j.mayocp.2017.01.003; Dong HJ, 2009, LEUKEMIA LYMPHOMA, V50, P974, DOI 10.1080/10428190902895780; Gilmore TD, 2007, CANCER CELL, V12, P95, DOI 10.1016/j.ccr.2007.07.010; Glavey SV, 2017, LEUKEMIA, V31, P2426, DOI 10.1038/leu.2017.102; Godbersen JC, 2014, CLIN CANCER RES, V20, P1576, DOI 10.1158/1078-0432.CCR-13-0987; HARDINGHAM TE, 1979, BIOCHEM J, V177, P237, DOI 10.1042/bj1770237; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Hooper C, 2014, J BIOL CHEM, V289, P33161, DOI 10.1074/jbc.M114.582478; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kim J, 2012, BRIT J HAEMATOL, V158, P336, DOI 10.1111/j.1365-2141.2012.09154.x; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Laubach J, 2016, LEUKEMIA, V30, P1005, DOI 10.1038/leu.2015.356; Lohr JG, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac7037; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Maki CG, 1996, CANCER RES, V56, P2649; Maquart F, 2005, BIOCHIMIE, V87, P353, DOI 10.1016/j.biochi.2004.10.006; Maquart FX, 2004, CRIT REV ONCOL HEMAT, V49, P199, DOI 10.1016/j.critrevonc.2003.06.007; Markovina S, 2008, MOL CANCER RES, V6, P1356, DOI 10.1158/1541-7786.MCR-08-0108; Markovina S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-176; Mebarki S, 2016, ONCOTARGET, V7, P39026, DOI 10.18632/oncotarget.9346; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Mishima Y, 2017, CELL REP, V19, P218, DOI 10.1016/j.celrep.2017.03.025; Misra S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00201; Miyamoto S, 1998, MOL CELL BIOL, V18, P19, DOI 10.1128/MCB.18.1.19; Monboisse J.C., 2013, J CARCINOG MUTAGEN, V4, P148; Murray MY, 2014, BIOCHEM SOC T, V42, P804, DOI 10.1042/BST20140126; NGUYEN Q, 1993, BIOCHEM J, V295, P595, DOI 10.1042/bj2950595; Nikesitch N, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.40; O'Connor S, 2004, MOL CELL BIOL, V24, P4895, DOI 10.1128/MCB.24.11.4895-4908.2004; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Papadas A., 2017, HDB EXP PHA IN PRESS; PERIN JP, 1987, J BIOL CHEM, V262, P13269; PERKINS SJ, 1989, J MOL BIOL, V206, P737, DOI 10.1016/0022-2836(89)90580-9; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Ricard-Blum S, 2014, EXP DERMATOL, V23, P457, DOI 10.1111/exd.12435; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Seyfried NT, 2005, J BIOL CHEM, V280, P5435, DOI 10.1074/jbc.M411297200; Shumway SD, 2004, BIOCHEM J, V380, P173, DOI 10.1042/BJ20031796; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wiita AP, 2013, ELIFE, V2, DOI 10.7554/eLife.01236; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753	59	20	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2452	2465		10.1074/jbc.RA117.000667	http://dx.doi.org/10.1074/jbc.RA117.000667			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29279332	Green Published, hybrid			2022-12-26	WOS:000425308300018
J	Yangyuoru, PM; Bradburn, DA; Liu, ZH; Xiao, TS; Russell, R				Yangyuoru, Philip M.; Bradburn, Devin A.; Liu, Zhonghua; Xiao, Tsan Sam; Russell, Rick			The G-quadruplex (G4) resolvase DHX36 efficiently and specifically disrupts DNA G4s via a translocation-based helicase mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; enzyme mechanism; G-quadruplex; pre-steady-state kinetics; RNA folding; RNA helicase	DEAH-BOX HELICASE; TETRAMOLECULAR QUADRUPLEX; RNA TETRAPLEX; MAJOR SOURCE; HUMAN GENOME; LOOP-LENGTH; RHAU; RECOGNITION; G4-DNA; UNWINDS	Single-stranded DNA (ssDNA) and RNA regions that include at least four closely spaced runs of three or more consecutive guanosines strongly tend to fold into stable G-quadruplexes (G4s). G4s play key roles as DNA regulatory sites and as kinetic traps that can inhibit biological processes, but how G4s are regulated in cells remains largely unknown. Here, we developed a kinetic framework for G4 disruption by DEAH-box helicase 36 (DHX36), the dominant G4 resolvase in human cells. Using tetramolecular DNA and RNA G4s with four to six G-quartets, we found that DHX36-mediated disruption is highly efficient, with rates that depend on G4 length under saturating conditions (k(cat)) but not under subsaturating conditions (k(cat)/K-m). These results suggest that a step during G4 disruption limits the k(cat) value and that DHX36 binding limits k(cat)/K-m. Similar results were obtained for unimolecular DNA G4s. DHX36 activity depended on a 3 ssDNA extension and was blocked by a polyethylene glycol linker, indicating that DHX36 loads onto the extension and translocates 3-5 toward the G4. DHX36 unwound dsDNA poorly compared with G4s of comparable intrinsic lifetime. Interestingly, we observed that DHX36 has striking 3-extension sequence preferences that differ for G4 disruption and dsDNA unwinding, most likely arising from differences in the rate-limiting step for the two activities. Our results indicate that DHX36 disrupts G4s with a conventional helicase mechanism that is tuned for great efficiency and specificity for G4s. The dependence of DHX36 on the 3-extension sequence suggests that the extent of formation of genomic G4s may not track directly with G4 stability.	[Yangyuoru, Philip M.; Bradburn, Devin A.; Russell, Rick] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Yangyuoru, Philip M.; Bradburn, Devin A.; Russell, Rick] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Liu, Zhonghua; Xiao, Tsan Sam] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Case Western Reserve University	Russell, R (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.; Russell, R (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	rick_russell@cm.utexas.edu	Xiao, Tsan Sam/A-8590-2010	Xiao, Tsan Sam/0000-0001-9688-475X	National Institutes of Health [GM070456]; Welch Foundation [F-1563]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant GM070456 (to R. R.) and Welch Foundation Grant F-1563 (to R. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Booy EP, 2014, NUCLEIC ACIDS RES, V42, P3346, DOI 10.1093/nar/gkt1340; Bugaut A, 2008, BIOCHEMISTRY-US, V47, P689, DOI 10.1021/bi701873c; Chakraborty P, 2011, DNA REPAIR, V10, P654, DOI 10.1016/j.dnarep.2011.04.013; Chatterjee S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6556; Chen MC, 2015, NUCLEIC ACIDS RES, V43, P2223, DOI 10.1093/nar/gkv051; CHEONG CJ, 1992, BIOCHEMISTRY-US, V31, P8406, DOI 10.1021/bi00151a003; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; Deng JP, 2001, P NATL ACAD SCI USA, V98, P13665, DOI 10.1073/pnas.241374798; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Gao X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.571; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Guo JU, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5371; Hansel-Hertsch R, 2017, NAT REV MOL CELL BIO, V18, P279, DOI 10.1038/nrm.2017.3; Harrington C, 1997, J BIOL CHEM, V272, P24631, DOI 10.1074/jbc.272.39.24631; Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j; Heddi B, 2015, P NATL ACAD SCI USA, V112, P9608, DOI 10.1073/pnas.1422605112; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hilbert M, 2009, BIOL CHEM, V390, P1237, DOI 10.1515/BC.2009.135; Huang WW, 2012, NUCLEIC ACIDS RES, V40, P1033, DOI 10.1093/nar/gkr849; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511; Jarmoskaite I, 2014, ANNU REV BIOCHEM, V83, P697, DOI 10.1146/annurev-biochem-060713-035546; Lai JC, 2012, BLOOD, V119, P4291, DOI 10.1182/blood-2011-08-362954; Lattmann S, 2010, NUCLEIC ACIDS RES, V38, P6219, DOI 10.1093/nar/gkq372; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Meier M, 2013, J BIOL CHEM, V288, P35014, DOI 10.1074/jbc.M113.512970; Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, P81, DOI 10.1093/nar/gki148; Mullen MA, 2010, NUCLEIC ACIDS RES, V38, P8149, DOI 10.1093/nar/gkq804; Newman M, 2017, J MOL BIOL, V429, P3121, DOI 10.1016/j.jmb.2016.11.033; Nie JW, 2015, CELL REP, V13, P723, DOI 10.1016/j.celrep.2015.09.043; Piazza A, 2015, EMBO J, V34, P1718, DOI 10.15252/embj.201490702; Prabu JR, 2015, MOL CELL, V60, P487, DOI 10.1016/j.molcel.2015.10.011; Rachwal PA, 2007, NUCLEIC ACIDS RES, V35, P4214, DOI 10.1093/nar/gkm316; Russell R, 2013, RNA BIOL, V10, P44, DOI 10.4161/rna.22210; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Sexton AN, 2011, MOL CELL BIOL, V31, P736, DOI 10.1128/MCB.01033-10; Smaldino PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132668; Tauchert MJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21510; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; Wu CG, 2016, NUCLEIC ACIDS RES, V44, P8742, DOI 10.1093/nar/gkw574; You HJ, 2017, NUCLEIC ACIDS RES, V45, P206, DOI 10.1093/nar/gkw881	49	22	22	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1924	1932		10.1074/jbc.M117.815076	http://dx.doi.org/10.1074/jbc.M117.815076			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29269411	Green Published, hybrid			2022-12-26	WOS:000424948000008
J	Clow, KM; Leighton, PA; Ogden, NH; Lindsay, LR; Michel, P; Pearl, DL; Jardine, CM				Clow, Katie M.; Leighton, Patrick A.; Ogden, Nicholas H.; Lindsay, L. Robbin; Michel, Pascal; Pearl, David L.; Jardine, Claire M.			Northward range expansion of Ixodes scapularis evident over a short timescale in Ontario, Canada	PLOS ONE			English	Article							EASTERN UNITED-STATES; BORRELIA-BURGDORFERI; LYME-DISEASE; ANAPLASMA-PHAGOCYTOPHILUM; LONG POINT; INVASION; IXODIDAE; ACARI; HABITAT; AGENT	The invasion of the blacklegged tick, Ixodes scapularis into Ontario, Canada poses a significant risk to public health because it is a vector for numerous pathogens, including Borrelia burgdorferi sensu stricto, the causative agent of Lyme disease. Baseline field sampling in 2014 and 2015 detected I. scapularis and B. burgdorferi at sites across southern, eastern and central Ontario, including a hot spot in eastern Ontario. A "speed of spread" model for I. scapularis developed by Leighton and colleagues (2012) estimated that the tick's range was expanding northward at 46 km/year. In 2016, we revisited a subset of sites sampled in 2014 and 2015 to understand the changing nature of risk, and assess whether the rate of tick invasion is consistent with the speed of spread estimate. Ticks were collected via tick dragging at 17 out of 36 sites, 5 of which were new sites for I. scapularis. Samples were positive for B. burgdorferi at 8 sites. No other I. scapularis-borne pathogens were detected. Centrographic statistics revealed an increase in the dispersion of I. scapularis positive sites in eastern Ontario. Field data for each site were then compared to the model's predicted year of establishment for each census subdivision. Our findings illustrate that the range expansion of I. scapularis and the emergence of B. burgdorferi is ongoing, and provide short timescale evidence of the processes associated with I. scapularis spread. The range front appears to be moving at a rate of similar to 46 km/year, with colonization of the tick behind this range front occurring at a slower and heterogeneous rate. Assessment of site-level ecological factors did not provide any insight into the underlying processes that may be influencing the colonization of I. scapularis in specific areas. Ongoing field sampling is needed to monitor this dynamic process. This study highlights the current geographic risk associated with Lyme disease, which can be used to target public health interventions to the areas of greatest risk.	[Clow, Katie M.; Jardine, Claire M.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada; [Leighton, Patrick A.] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ, Canada; [Ogden, Nicholas H.] Publ Hlth Agcy Canada, Natl Microbiol Lab, St Hyacinthe, PQ, Canada; [Lindsay, L. Robbin] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Michel, Pascal] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Pearl, David L.] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada; [Jardine, Claire M.] Univ Guelph, Ontario Vet Coll, Canadian Wildlife Hlth Cooperat, Guelph, ON, Canada	University of Guelph; Universite de Montreal; Public Health Agency of Canada; Public Health Agency of Canada; Public Health Agency of Canada; University of Guelph; University of Guelph	Clow, KM (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada.	kclow@uoguelph.ca		Lindsay, Robbin/0000-0001-7236-2930	Natural Sciences and Engineering Research Council; Blake Graham Fellowship; Ontario Veterinary College Fellowship; Public Health Agency of Canada; Natural Sciences and Engineering Research Council Discovery Grant; Canadian Wildlife Health Cooperative	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Blake Graham Fellowship; Ontario Veterinary College Fellowship; Public Health Agency of Canada; Natural Sciences and Engineering Research Council Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Wildlife Health Cooperative	KMC was provided with stipend support from the Natural Sciences and Engineering Research Council through a post-graduate scholarship-doctoral (http://www.nserc-crsng.gc.ca), the Blake Graham Fellowship, and the Ontario Veterinary College Fellowship. Project funding was provided by the Public Health Agency of Canada, the Natural Sciences and Engineering Research Council Discovery Grant and the Canadian Wildlife Health Cooperative. No funders, except researchers from the Public Health Agency of Canada, had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Clow KM, 2017, TICKS TICK-BORNE DIS, V8, P554, DOI 10.1016/j.ttbdis.2017.03.003; Clow KM, 2016, VECTOR-BORNE ZOONOT, V16, P215, DOI 10.1089/vbz.2015.1890; Courtney JW, 2004, J CLIN MICROBIOL, V42, P3164, DOI 10.1128/JCM.42.7.3164-3168.2004; Dibernardo A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-183; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Dobson ADM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-344; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Estrada-Pena A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00029; FALCO RC, 1991, J MED ENTOMOL, V28, P726, DOI 10.1093/jmedent/28.5.726; Hamer SA, 2010, ECOHEALTH, V7, P47, DOI 10.1007/s10393-010-0287-0; Hoen AG, 2009, P NATL ACAD SCI USA, V106, P15013, DOI 10.1073/pnas.0903810106; Kulkarni MA, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.33; Langley R.B., 1998, GPSWORLD, V9, P46; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Levine N., 2010, CRIMESTAT SPATIAL ST; Levine N, 2010, CRIMESTAT 3 USER MAN, P1; Lindsay LR, 1999, J MED ENTOMOL, V36, P255, DOI 10.1093/jmedent/36.3.255; Lindsay LR, 1999, J MED ENTOMOL, V36, P243, DOI 10.1093/jmedent/36.3.243; Madhav NK, 2004, J MED ENTOMOL, V41, P842, DOI 10.1603/0022-2585-41.5.842; Margos G, 2012, APPL ENVIRON MICROB, V78, P6059, DOI 10.1128/AEM.00231-12; May RM, 2001, PHILOS T R SOC B, V356, P901, DOI 10.1098/rstb.2001.0866; McPherson M, ENV HLTH PE IN PRESS; Nakajima R, 2009, J VET MED SCI, V71, P55, DOI 10.1292/jvms.71.55; Nelder MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105358; Ogden N, 2014, CANADA COMMUN DIS RE, V40; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07; Ogden NH, 2006, J MED ENTOMOL, V43, P600, DOI 10.1603/0022-2585(2006)43[600:ISTCBP]2.0.CO;2; Ogden N. H., 2015, CANADA COMMUN DIS RE, V41, P2009; Ogden NH, 2006, J MED ENTOMOL, V43, P403, DOI 10.1603/0022-2585(2006)043[0403:IOGLAR]2.0.CO;2; Ogden NH, 2013, J APPL ECOL, V50, P510, DOI [10.1111/1365-2664.12050, 10.1111/]; Ogden NH, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-24; SCHOLTEN T, 1977, CAN J PUBLIC HEALTH, V68, P494; Sider D, 2012, TECHNICAL REPORT UPD; SPIELMAN A, 1985, ANNU REV ENTOMOL, V30, P439, DOI 10.1146/annurev.en.30.010185.002255; Watkins L., 2011, FOREST RESOURCES ONT, P1; Werden L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085640	38	54	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189393	10.1371/journal.pone.0189393	http://dx.doi.org/10.1371/journal.pone.0189393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281675	Green Submitted, Green Published, gold			2022-12-26	WOS:000419006200025
J	Konini, S; Janse Van Rensburg, EJ				Konini, S.; Janse van Rensburg, E. J.			Mean field analysis of algorithms for scale-free networks in molecular biology	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; DUPLICATION; EVOLUTION; DIVERGENCE; TOPOLOGY; GENES	The sampling of scale-free networks in Molecular Biology is usually achieved by growing networks from a seed using recursive algorithms with elementary moves which include the addition and deletion of nodes and bonds. These algorithms include the Baraba A si-Albert algorithm. Later algorithms, such as the Duplication-Divergence algorithm, the Sole A algorithm and the iSite algorithm, were inspired by biological processes underlying the evolution of protein networks, and the networks they produce differ essentially from networks grown by the Baraba A si-Albert algorithm. In this paper the mean field analysis of these algorithms is reconsidered, and extended to variant and modified implementations of the algorithms. The degree sequences of scale-free networks decay according to a powerlaw distribution, namely P(k) similar to k(-Upsilon), where. is a scaling exponent. We derive mean field expressions for., and test these by numerical simulations. Generally, good agreement is obtained. We also found that some algorithms do not produce scale-free networks (for example some variant Baraba A si-Albert and Sole A networks).	[Konini, S.; Janse van Rensburg, E. J.] York Univ, Math & Stat, Toronto, ON M3J 1P3, Canada	York University - Canada	Janse Van Rensburg, EJ (corresponding author), York Univ, Math & Stat, Toronto, ON M3J 1P3, Canada.	rensburg@yorku.ca		Janse van Rensburg, Esaias J/0000-0003-4366-634X	NSERC (Canada) [RGPIN-04731-2014]; NSERC (Canada)	NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by NSERC (Canada) grant number RGPIN-04731-2014 to EJJvR (http://www.nserc-crsng.gc.ca/index_eng.asp).r EJJvR is grateful to NSERC (Canada) for support in the form of a Discovery Grant. Data produced by our simulations can be downloaded as ancilliary files from http://arxiv.org_identifier_1702.00239.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], 2016, CVTOSC 3 4 0; Barabasi AL, 2000, PHYSICA A, V281, P69, DOI 10.1016/S0378-4371(00)00018-2; Barabasi AL, 1999, PHYSICA A, V272, P173, DOI 10.1016/S0378-4371(99)00291-5; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Cormen T., 2009, INTRO ALGORITHMS; Eisenberg E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.138701; Estrada E, 2006, PROTEOMICS, V6, P35, DOI 10.1002/pmic.200500209; Evlampiev K, 2008, P NATL ACAD SCI USA, V105, P9863, DOI 10.1073/pnas.0804119105; Gibson TA, 2015, LECT N BIOINFORMAT, V9289, P40, DOI 10.1007/978-3-662-48221-6_3; Gibson TA, 2011, BIOINFORMATICS, V27, P376, DOI 10.1093/bioinformatics/btq623; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Khanin R, 2006, J COMPUT BIOL, V13, P810, DOI 10.1089/cmb.2006.13.810; Knuth D. E., 1973, ART COMPUTER PROGRAM, V3; Nasvall J, 2012, SCIENCE, V338, P384, DOI 10.1126/science.1226521; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Smith E D, 2002, ADV COMPLEX SYST, V5, P43, DOI DOI 10.1142/S021952590200047X; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Wright H., 1961, TABLES INTEGRALS OTH	29	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0189866	10.1371/journal.pone.0189866	http://dx.doi.org/10.1371/journal.pone.0189866			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272285	Green Submitted, Green Published, gold			2022-12-26	WOS:000418651500015
J	Kuga, N; Tanioka, A; Hagihara, K; Kawai, T				Kuga, Nahoko; Tanioka, Asao; Hagihara, Koichiro; Kawai, Tomoyuki			Fiber type-specific afferent nerve activity induced by transient contractions of rat bladder smooth muscle in pathological states	PLOS ONE			English	Article							CYCLOPHOSPHAMIDE-INDUCED CYSTITIS; PIG URINARY-BLADDER; PROSTAGLANDIN E-2; CONSCIOUS RATS; IN-VITRO; VISCERAL PAIN; UROTHELIUM; MODEL; HYPERACTIVITY; INFLAMMATION	Bladder smooth muscle shows spontaneous phasic contractions, which undergo a variety of abnormal changes depending on pathological conditions. How abnormal contractions affect the activity of bladder afferent nerves remains to be fully tested. In this study, we examined the relationship between transient increases in bladder pressure, representing transient contraction of bladder smooth muscle, and spiking patterns of bladder afferent fibers of the L6 dorsal root, in rat pathological models. All recordings were performed at a bladder pressure of approximately 10 cmH(2)O by maintaining the degree of bladder filling. In the cyclo-phosphamide-induced model, both A delta and C fibers showed increased sensitivity to transient bladder pressure increases. In the prostaglandin E2-induced model, Ad fibers, but not C fibers, specifically showed overexcitation that was time-locked with transient bladder pressure increases. These fiber type-specific changes in nerve spike patterns may underlie the symptoms of urinary bladder diseases.	[Kuga, Nahoko; Tanioka, Asao; Hagihara, Koichiro; Kawai, Tomoyuki] Kyorin Pharmaceut Co Ltd, Watarase Res Ctr, Pharmacol Res Lab, Nogi, Tochigi, Japan	Kyorin Pharmaceutical Co Ltd	Kawai, T (corresponding author), Kyorin Pharmaceut Co Ltd, Watarase Res Ctr, Pharmacol Res Lab, Nogi, Tochigi, Japan.	tomoyuki.kawai@mb.kyorin-pharm.co.jp			Kyorin Pharmaceutical Co., Ltd.	Kyorin Pharmaceutical Co., Ltd.	This study was funded by Kyorin Pharmaceutical Co., Ltd. The funder provided support in the form of salaries for NK, AT, KH and TK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aizawa N, 2015, NEUROUROL URODYNAM, V34, P368, DOI 10.1002/nau.22571; Aizawa N, 2012, EUR UROL, V62, P1165, DOI 10.1016/j.eururo.2012.08.056; Aizawa N, 2010, NEUROUROL URODYNAM, V29, P771, DOI 10.1002/nau.20826; Akino H, 2008, BJU INT, V102, P1168, DOI 10.1111/j.1464-410X.2008.07782.x; Auge C, 2013, EUR J PHARMACOL, V707, P32, DOI 10.1016/j.ejphar.2013.03.008; Boucher M, 2000, J UROLOGY, V164, P203, DOI 10.1016/S0022-5347(05)67495-2; Boudes M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069550; Chopra B, 2005, J PHYSIOL-LONDON, V562, P859, DOI 10.1113/jphysiol.2004.071159; Collins VM, 2013, BJU INT, V112, P1018, DOI 10.1111/bju.12266; de Groat William C, 2009, Handb Exp Pharmacol, P91, DOI 10.1007/978-3-540-79090-7_4; Drake MJ, 2005, BJU INT, V95, P1002, DOI 10.1111/j.1464-410X.2005.05455.x; Drake MJ, 2003, EXP PHYSIOL, V88, P19, DOI 10.1113/eph8802473; Fowler CJ, 2002, UROLOGY, V59, P37, DOI 10.1016/S0090-4295(02)01544-3; Gabella G, 1998, J NEUROCYTOL, V27, P141, DOI 10.1023/A:1006903507321; Gillespie JI, 2005, BJU INT, V95, P149, DOI 10.1111/j.1464-410X.2005.05268.x; Gillespie JI, 2004, BJU INT, V93, P478, DOI 10.1111/j.1464-410X.2003.04667.x; Granato C, 2015, N-S ARCH PHARMACOL, V388, P727, DOI 10.1007/s00210-015-1139-9; Heppner TJ, 2016, J GEN PHYSIOL, V147, P323, DOI 10.1085/jgp.201511550; Iijima K, 2009, J UROLOGY, V182, P2504, DOI 10.1016/j.juro.2009.07.012; ISHIZUKA O, 1995, J UROLOGY, V153, P2034, DOI 10.1016/S0022-5347(01)67397-X; Kanai A, 2007, AM J PHYSIOL-RENAL, V292, pF1065, DOI 10.1152/ajprenal.00229.2006; Kuga N, 2016, EXP PHYSIOL, V101, P577, DOI 10.1113/EP085418; LANTERIMINET M, 1995, EXP BRAIN RES, V105, P220, DOI 10.1007/BF00240958; Lee T, 2008, NEUROUROL URODYNAM, V27, P88, DOI 10.1002/nau.20460; Malley SE, 2002, PHYSIOL GENOMICS, V9, P5, DOI 10.1152/physiolgenomics.00117.2001; McCarthy CJ, 2009, J UROLOGY, V181, P1459, DOI 10.1016/j.juro.2008.10.139; Munoz A, 2010, BMC UROL, V10, DOI 10.1186/1471-2490-10-10; Nile CJ, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.08.029; Okinami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104216; Ozawa H, 1999, J UROLOGY, V162, P2211, DOI 10.1016/S0022-5347(05)68161-X; Parajuli SP, 2014, EUR J PHARMACOL, V738, P179, DOI 10.1016/j.ejphar.2014.05.042; Quinn T, 2004, BJU INT, V94, P651, DOI 10.1111/j.1464-410X.2004.05017.x; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; SCHUSSLER B, 1990, UROL RES, V18, P349, DOI 10.1007/BF00300786; Takeda H, 2002, NEUROUROL URODYNAM, V21, P558, DOI 10.1002/nau.10034; Van Os-Bossagh P, 2001, INT UROGYNECOL J PEL, V12, P89, DOI 10.1007/s001920170071; Wang XJ, 2008, BIOMED RES-TOKYO, V29, P105, DOI 10.2220/biomedres.29.105; Yoshimura N, 1999, J NEUROSCI, V19, P4644; Yu YB, 2013, BRAIN RES, V1490, P83, DOI 10.1016/j.brainres.2012.10.007; Yu YB, 2010, BRAIN RES, V1361, P43, DOI 10.1016/j.brainres.2010.09.018; Zvara Peter, 2010, Front Neurol, V1, P127, DOI 10.3389/fneur.2010.00127	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189941	10.1371/journal.pone.0189941	http://dx.doi.org/10.1371/journal.pone.0189941			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267380	gold, Green Submitted, Green Published			2022-12-26	WOS:000418587400068
J	Pinichka, C; Makka, N; Sukkumnoed, D; Chariyalertsak, S; Inchai, P; Bundhamcharoen, K				Pinichka, Chayut; Makka, Nuttapat; Sukkumnoed, Decharut; Chariyalertsak, Suwat; Inchai, Puchong; Bundhamcharoen, Kanitta			Burden of disease attributed to ambient air pollution in Thailand: A GIS-based approach	PLOS ONE			English	Article							COMPARATIVE RISK-ASSESSMENT; LONG-TERM EXPOSURE; GLOBAL BURDEN; PARTICULATE MATTER; CARDIOVASCULAR-DISEASE; SYSTEMATIC ANALYSIS; FINE PARTICLES; LUNG-CANCER; MORTALITY; ASSOCIATION	Background Growing urbanisation and population requiring enhanced electricity generation as well as the increasing numbers of fossil fuel in Thailand pose important challenges to air quality management which impacts on the health of the population. Mortality attributed to ambient air pollution is one of the sustainable development goals (SDGs). We estimated the spatial pattern of mortality burden attributable to selected ambient air pollution in 2009 based on the empirical evidence in Thailand. Methods We estimated the burden of disease attributable to ambient air pollution based on the comparative risk assessment (CRA) framework developed by the World Health Organization (WHO) and the Global Burden of Disease study (GBD). We integrated geographical information systems (GIS)-based exposure assessments into spatial interpolation models to estimate ambient air pollutant concentrations, the population distribution of exposure and the concentration-response (CR) relationship to quantify ambient air pollution exposure and associated mortality. We obtained air quality data from the Pollution Control Department (PCD) of Thailand surface air pollution monitoring network sources and estimated the CR relationship between relative risk (RR) and concentration of air pollutants from the epidemiological literature. Results We estimated 650-38,410 ambient air pollution-related fatalities and 160-5,982 fatalities that could have been avoided with a 20 reduction in ambient air pollutant concentrations. The summation of population-attributable fraction (PAF) of the disease burden for all-causes mortality in adults due to NO2 and PM2.5 were the highest among all air pollutants at 10% and 7.5%, respectively. The PAF summation of PM2.5 for lung cancer and cardiovascular disease were 16.8% and 14.6% respectively and the PAF summations of mortality attributable to PM10 was 3.4% for all-causes mortality, 1.7% for respiratory and 3.8% for cardiovascular mortality, while the PAF summation of mortality attributable to NO2 was 7.8% for respiratory mortality in Thailand. Conclusion Mortality due to ambient air pollution in Thailand varies across the country. Geographical distribution estimates can identify high exposure areas for planners and policy-makers. Our results suggest that the benefits of a 20% reduction in ambient air pollution concentration could prevent up to 25% of avoidable fatalities each year in all-causes, respiratory and cardiovascular categories. Furthermore, our findings can provide guidelines for future epidemiological investigations and policy decisions to achieve the SDGs.	[Pinichka, Chayut; Makka, Nuttapat; Inchai, Puchong; Bundhamcharoen, Kanitta] Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi, Thailand; [Sukkumnoed, Decharut] Hlth Syst Res Inst, Res & Dev Program Hlth Publ Policy & Hlth Impact, Nonthaburi, Thailand; [Chariyalertsak, Suwat] Chiang Mai Univ, Res Inst Hlth Sci, Sriphum, Muang Chiang Ma, Thailand	Ministry of Public Health - Thailand; Chiang Mai University	Bundhamcharoen, K (corresponding author), Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi, Thailand.	kanitta@ihpp.thaigov.net		Bundhamcharoen, Kanitta/0000-0002-6318-0497	Thai Health Promotion Foundation [ThaiHealth 58-03229]	Thai Health Promotion Foundation	This work was supported by the Thai Health Promotion Foundation (ThaiHealth 58-03229).	An Jun-lin, 2007, Huanjing Kexue, V28, P706; Anderson HR, 1997, EUR RESPIR J, V10, P1064, DOI 10.1183/09031936.97.10051064; Anenberg SC, 2010, ENVIRON HEALTH PERSP, V118, P1189, DOI 10.1289/ehp.0901220; [Anonymous], 1981, POPULATION STUDIES, V84; [Anonymous], 2005, CIESIN GRIDD POP WOR; Barnett AG, 2006, ENVIRON HEALTH PERSP, V114, P1018, DOI 10.1289/ehp.8674; Bartier PM, 1996, COMPUT GEOSCI, V22, P795, DOI 10.1016/0098-3004(96)00021-0; Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752; Bundhamcharoen K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-53; CESAR H, 2002, IMPROVING AIR QUALIT; Chen CC, 2015, INT J ENV RES PUB HE, V12, P4697, DOI 10.3390/ijerph120504697; Cho HS, 2014, SUSTAINABILITY-BASEL, V6, P5968, DOI 10.3390/su6095968; Cohen A.J., 2017, LANCET; Dashtpagerdi MM, 2014, J INDIAN SOC REMOTE, V42, P179, DOI 10.1007/s12524-013-0288-x; Dennis RL, 1996, ATMOS ENVIRON, V30, P1925, DOI 10.1016/1352-2310(95)00174-3; Department of Provincial Administration, 2009, OFF STAT REG SYST; Department of Public Health, 2017, PUBLIC HLTH STAT 201, P43; Dijkema MBA, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-76; Dockery D W, 1993, N Engl J Med, V329, P1753, DOI 10.1056/NEJM199312093292401; Dockery DW, 2009, ANN EPIDEMIOL, V19, P257, DOI 10.1016/j.annepidem.2009.01.018; Environment Canterbury NZ, 2005, ANN AMB AIR QUAL MON; Evans J, 2013, ENVIRON RES, V120, P33, DOI 10.1016/j.envres.2012.08.005; Fann N, 2012, RISK ANAL, V32, P81, DOI 10.1111/j.1539-6924.2011.01630.x; Faustini A, 2014, EUR RESPIR J, V44, P744, DOI 10.1183/09031936.00114713; Forouzanfar MH, 2013, LANCET, P386; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Garcia-Llamas P, 2016, INT J APPL EARTH OBS, V50, P95, DOI 10.1016/j.jag.2016.03.010; Gong G, 2014, ENVIRON RES, V130, P59, DOI 10.1016/j.envres.2013.12.005; Gorai AK, 2014, INT J ENV RES PUB HE, V11, P4845, DOI 10.3390/ijerph110504845; Guo YM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05509; Hill K, 1987, Asian Pac Popul Forum, V1, P8; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; Horowitz LW, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002853; Ivina O, 2012, PROG ARTIF INTELL, V1, P235, DOI 10.1007/s13748-012-0018-6; Kim E, 2014, SCI TOTAL ENVIRON, V481, P439, DOI 10.1016/j.scitotenv.2014.01.107; Kim YM, 2011, SCI TOTAL ENVIRON, V409, P2019, DOI 10.1016/j.scitotenv.2011.02.032; Kirubagaran R, 2011, UNIVERS J ENV, V1, P301; Kloog I, 2013, EPIDEMIOLOGY, V24, P555, DOI 10.1097/EDE.0b013e318294beaa; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Li Y, 2010, SCI TOTAL ENVIRON, V408, P5784, DOI 10.1016/j.scitotenv.2010.08.017; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu Y, 2005, ENVIRON SCI TECHNOL, V39, P3269, DOI 10.1021/es049352m; Makka N, 2009, J HLTH SCI 2016, V25; Mathers CD, 2005, B WORLD HLTH ORG 200; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Nuckols JR, 2004, ENVIRON HEALTH PERSP, V112, P1007, DOI 10.1289/ehp.6738; Office NS, 2006, REP 2005 2006 NAT SU; Ostro B., 2004, OUTDOOR AIR POLLUTIO; Ostro BD, 2000, J EXPO ANAL ENV EPID, V10, P412, DOI 10.1038/sj.jea.7500094; Pinichka Chayut, 2015, Glob J Health Sci, V8, P1, DOI 10.5539/gjhs.v8n1p1; Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Prasartkul Pramote, 2006, World Health Popul, V8, P43; Puangthongthub S, 2007, ATMOS ENVIRON, V41, P7788, DOI 10.1016/j.atmosenv.2007.06.051; Qian ZM, 2001, J EXPO ANAL ENV EPID, V11, P341, DOI 10.1038/sj.jea.7500170; RAO C, 2010, POPUL HEALTH METR, V8; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Services MoHaS, 2010, NAT HLTH FRAM 2010 2; Simachaya W, 2007, OVERVIEW AIR QUALITY; Tangcharoensathien V, 2006, B WORLD HEALTH ORGAN, V84, P233, DOI 10.2471/BLT.05.026310; Teegavarapu RSV, 2012, COMPUT GEOSCI-UK, V40, P28, DOI 10.1016/j.cageo.2011.07.004; Thailand BoD, 2009, INT HLTH POL PROGR; Thailand Go, 1992, ENH CONS NAT ENV QUA, V2535; Valari M, 2011, J AIR WASTE MANAGE, V61, P164, DOI 10.3155/1047-3289.61.2.164; van Donkelaar A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006996; Vichit-Vadakan N, 2001, ENVIRON HEALTH PERSP, V109, P381, DOI 10.2307/3434785; Vichit-Vadakan N, 2008, ENVIRON HEALTH PERSP, V116, P1179, DOI 10.1289/ehp.10849; Vichit-Vadakan N, 2011, ENVIRON HEALTH PERSP, V119, pA197, DOI 10.1289/ehp.1103728; Vichit-Vadakan Nuntavarn, 2010, Res Rep Health Eff Inst, P231; Wang WQ, 2015, RESP MED, V109, P372, DOI 10.1016/j.rmed.2015.01.006; Wanida Jinsart KT, 2002, J AIR WASTE MANAGEME, V52, P1102; WEBER D, 1992, MATH GEOL, V24, P381, DOI 10.1007/BF00891270; Wickramasinghe CH, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8110932; Wilson WE, 1997, J AIR WASTE MANAGE, V47, P1238, DOI 10.1080/10473289.1997.10464074; World Bank, 2003, THAIL ENV MON 2002 A; World Health Organization, 2006, AIR QUAL GUID GLOB U; Xing YF, 2016, J THORAC DIS, V8, pE69, DOI 10.3978/j.issn.2072-1439.2016.01.19; Zhang K, 2013, SCI TOTAL ENVIRON, V450, P307, DOI 10.1016/j.scitotenv.2013.01.074; Zhao H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131878	81	30	30	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189909	10.1371/journal.pone.0189909	http://dx.doi.org/10.1371/journal.pone.0189909			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267319	Green Submitted, gold, Green Published			2022-12-26	WOS:000418587400060
J	Robergs, RA				Robergs, Robert Andrew			Competitive cation binding computations of proton balance for reactions of the phosphagen and glycolytic energy systems within skeletal muscle	PLOS ONE			English	Article							INDUCED METABOLIC-ACIDOSIS; ELECTRICAL-STIMULATION; EXERCISING MUSCLE; LACTIC-ACIDOSIS; ATP SYNTHESIS; PH CHANGE; GLYCOGENOLYSIS; EQUILIBRIA; RECOVERY; KINETICS	Limited research and data has been published for the H+ coefficients for the metabolites and reactions involved in non-mitochondrial energy metabolism. The purpose of this investigation was to compute the fractional binding of H+, K+, Na+ and Mg2+ to 21 metabolites of skeletal muscle non-mitochondrial energy metabolism, resulting in 104 different metabolitecation complexes. Fractional binding of H+ to these metabolite-cation complexes were applied to 17 reactions of skeletal muscle non-mitochondrial energy metabolism, and 8 conditions of the glycolytic pathway based on the source of substrate (glycogen vs. glucose), completeness of glycolytic flux, and the end-point of pyruvate vs. lactate. For pH conditions of 6.0 and 7.0, respectively, H+ coefficients (-'ve values = H+ release) for the creatine kinase, adenylate kinase, AMP deaminase and ATPase reactions were 0.8 and 0.97, -0.13 and -0.02, 1.2 and 1.09, and -0.01 and -0.66, respectively. The glycolytic pathway is net H+ releasing, regardless of lactate production, which consumes 1 H+. For glycolysis fueled by glycogen and ending in either pyruvate or lactate, H+ coefficients for pH 6.0 and 7.0 were -3.97 and -2.01 (pyruvate), and -1.96 and -0.01 (lactate), respectively. When starting with glucose, the same conditions result in H+ coefficients of -3.98 and -2.67, and -1.97 and -0.67, respectively. The most H+ releasing reaction of glycolysis is the glyceraldehyde-3-phosphate dehydrogenase reaction, with H+ coefficients for pH 6.0 and 7.0 of -1.58 and -0.76, respectively. Incomplete flux of substrate through glycolysis would increase net H+ release due to the absence of the pyruvate kinase and lactate dehydrogenase reactions, which collectively result in H+ coefficients for pH 6.0 and 7.0 of 1.35 and 1.88, respectively. The data presented provide an extensive reference source for academics and researchers to accurately profile the balance of protons for all metabolites and reactions of non-mitochondrial energy metabolism, and reveal the greater role of glycolysis in net H+ release than previously assumed. The data can also be used to improve the understanding of the cause of metabolic acidosis, and reveal mechanistic connections between H+ release within and from muscle and the electrochemical neutrality concepts that further refine acid-base balance in biological solutions.	[Robergs, Robert Andrew] Queensland Univ Technol, Fac Hlth, Sch Exercise & Nutr Sci, Kelvin Grove, Qld, Australia	Queensland University of Technology (QUT)	Robergs, RA (corresponding author), Queensland Univ Technol, Fac Hlth, Sch Exercise & Nutr Sci, Kelvin Grove, Qld, Australia.	rob.robergs@qut.edu.au		Robergs, Robert/0000-0002-7741-8136				Alberty R. A., 2003, THERMODYNAMICS BIOCH; BANGSBO J, 1990, J PHYSIOL-LONDON, V422, P539, DOI 10.1113/jphysiol.1990.sp018000; Bendahan D, 2003, J APPL PHYSIOL, V94, P2391, DOI 10.1152/japplphysiol.00589.2002; Boning D, 2005, AM J PHYSIOL-REG I, V289, pR902, DOI 10.1152/ajpregu.00069.2005; Kemp G, 2006, AM J PHYSIOL-REG I, V291, pR235, DOI 10.1152/ajpregu.00662.2005; Kemp G, 2005, AM J PHYSIOL-REG I, V289, pR895, DOI 10.1152/ajpregu.00641.2004; Kemp GJ, 2001, J PHYSIOL-LONDON, V535, P901, DOI 10.1111/j.1469-7793.2001.00901.x; Kushmerick MJ, 1997, AM J PHYSIOL-CELL PH, V272, pC1739, DOI 10.1152/ajpcell.1997.272.5.C1739; Layec G, 2013, NMR BIOMED, V26, P1403, DOI 10.1002/nbm.2966; MEDBO JI, 1993, J APPL PHYSIOL, V75, P1654, DOI 10.1152/jappl.1993.75.4.1654; Moll K, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3723; NIST, 1994, NIST STAND REF DAT; Robergs R. A., 2001, SPORTSCIENCE, V5; Robergs RA, 2006, AM J PHYSIOL-REG I, V291, pR238, DOI 10.1152/ajpregu.00081.2006; Robergs RA, 2005, AM J PHYSIOL-REG I, V289, pR904, DOI 10.1152/ajpregu.00117.2005; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; SPRIET LL, 1987, J APPL PHYSIOL, V62, P611, DOI 10.1152/jappl.1987.62.2.611; SPRIET LL, 1987, J APPL PHYSIOL, V62, P616, DOI 10.1152/jappl.1987.62.2.616; SPRIET LL, 1992, CAN J PHYSIOL PHARM, V70, P157, DOI 10.1139/y92-023; Vinnakota K, 2006, BIOPHYS J, V91, P1264, DOI 10.1529/biophysj.105.073296; Xu Shukai, 2011, NANFANG DIANWANG JIS, V5, P10, DOI DOI 10.1093/DATABASE/BAR005	21	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189822	10.1371/journal.pone.0189822	http://dx.doi.org/10.1371/journal.pone.0189822			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267370	gold, Green Published			2022-12-26	WOS:000418587400052
J	Nehete, PN; Shelton, KA; Nehete, BP; Chitta, S; Williams, LE; Schapiro, SJ; Abee, CR				Nehete, Pramod N.; Shelton, Kathryn A.; Nehete, Bharti P.; Chitta, Sriram; Williams, Lawrence E.; Schapiro, Steven J.; Abee, Christian R.			Effects of transportation, relocation, and acclimation on phenotypes and functional characteristics of peripheral blood lymphocytes in rhesus monkeys (Macaca mulatta)	PLOS ONE			English	Article							CELL-MEDIATED-IMMUNITY; PSYCHOLOGICAL STRESS; COLORIMETRIC ASSAY; MEDICAL-STUDENTS; RESPONSES; IMMUNIZATION; MICE; PROLIFERATION; ENHANCEMENT; ENRICHMENT	Nonhuman primates from domestic sources constitute a small, but critical, proportion of animals studied in research laboratories. Many of these nonhuman primates are raised at one facility and subsequently transported/relocated to another facility for research purposes. We examined the effects of transport, relocation, and acclimation on the phenotype and function of peripheral blood mononuclear cells (PBMCs) in a group of rhesus monkeys that were transported by road for approximately 21 hours from one facility to another. Using a panel of human antibodies and a set of standardized human immune assays, we evaluated the phenotype of lymphocyte subsets by flow, mitogen-specific immune responses of PBMCs in vitro, and levels of circulating cytokines and cortisol in plasma at various time points including immediately before transport, immediately upon arrival, and after approximately 30 days of acclimation. Analyses of blood samples revealed that CD3(+) T-cell and CD20(+) B-cell populations had decreased significantly immediately after relocation but had recovered within 30 days after arrival at the new facility. Similarly, circulating cortisol and cytokine levels in plasma were significantly higher immediately after relocation; and by the 30-day time point, these differences were no longer significant. However, immune assays of PBMCs indicated that mitogen-specific responses for proliferation, interferon. (IFN-gamma), and perforin were significantly higher after relocation and 30 days of acclimation. These findings have implications on the research participation of transported and relocated nonhuman primates in immunologic research studies, suggesting that 30 days is not sufficient to ensure return to baseline immune homeostasis. These data should be considered when planning research studies in order to minimize potential confounding factors associated with relocation and to maximize study validity.	[Nehete, Pramod N.; Shelton, Kathryn A.; Nehete, Bharti P.; Chitta, Sriram; Williams, Lawrence E.; Schapiro, Steven J.; Abee, Christian R.] Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Bastrop, TX 78602 USA; [Nehete, Pramod N.; Williams, Lawrence E.] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Schapiro, Steven J.] Univ Copenhagen, Dept Expt Med, Copenhagen, Denmark	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Copenhagen	Nehete, PN (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Bastrop, TX 78602 USA.; Nehete, PN (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA.	pnehete@mdanderson.org	Williams, Lawrence/AAD-6685-2020	Williams, Lawrence/0000-0003-2267-9918; Nehete, Pramod/0000-0002-2815-2677				[Anonymous], 2010, GUIDE USE SUGARCANE; BLECHA F, 1982, P SOC EXP BIOL MED, V169, P239; Cacioppo JT, 1998, ANN NY ACAD SCI, V840, P664, DOI 10.1111/j.1749-6632.1998.tb09605.x; Calcagni E, 2006, ANN NY ACAD SCI, V1069, P62, DOI 10.1196/annals.1351.006; Capitanio JP, 1998, AM J PRIMATOL, V44, P29, DOI 10.1002/(SICI)1098-2345(1998)44:1<29::AID-AJP3>3.0.CO;2-Z; Chavan SS, 2017, IMMUNITY, V46, P927, DOI 10.1016/j.immuni.2017.06.008; COCKE R, 1993, BRAIN BEHAV IMMUN, V7, P36, DOI 10.1006/brbi.1993.1004; Cohen S, 2001, PSYCHOSOM MED, V63, P7, DOI 10.1097/00006842-200101000-00002; Dhabhar FS, 2014, IMMUNOL RES, V58, P193, DOI 10.1007/s12026-014-8517-0; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Dhabhar FS, 2005, AM J PHYSIOL-REG I, V289, pR738, DOI 10.1152/ajpregu.00145.2005; Dhabhar FS, 1996, J IMMUNOL, V156, P2608; DOBBIN JP, 1991, BRAIN BEHAV IMMUN, V5, P339, DOI 10.1016/0889-1591(91)90029-A; Elenkov IJ, 2002, ANN NY ACAD SCI, V966, P290, DOI 10.1111/j.1749-6632.2002.tb04229.x; Fries E, 2009, INT J PSYCHOPHYSIOL, V72, P67, DOI 10.1016/j.ijpsycho.2008.03.014; GLASER R, 1985, PSYCHIAT RES, V16, P233; GLASER R, 1985, J BEHAV MED, V8, P249, DOI 10.1007/BF00870312; Groer MW, 2007, PSYCHONEUROENDOCRINO, V32, P133, DOI 10.1016/j.psyneuen.2006.11.007; GUST DA, 1994, PHYSIOL BEHAV, V55, P681, DOI 10.1016/0031-9384(94)90044-2; He H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019607; HERBERT TB, 1993, PSYCHOSOM MED, V55, P364, DOI 10.1097/00006842-199307000-00004; HOBBS MV, 1993, J IMMUNOL, V150, P3602; Keller S, 1991, PSYCHONEUROIMMUNOLOG, P771; KIECOLTGLASER JK, 1986, J BEHAV MED, V9, P5, DOI 10.1007/BF00844640; KIECOLTGLASER JK, 1984, PSYCHOSOM MED, V46, P7, DOI 10.1097/00006842-198401000-00003; KiecoltGlaser JK, 1996, P NATL ACAD SCI USA, V93, P3043, DOI 10.1073/pnas.93.7.3043; Kim CY, 2005, J MED PRIMATOL, V34, P188, DOI 10.1111/j.1600-0684.2005.00116.x; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; MAIER SF, 1994, AM PSYCHOL, V49, P1004, DOI 10.1037/0003-066X.49.12.1004; Miller GE, 2005, PSYCHOSOM MED, V67, P679, DOI 10.1097/01.psy.0000174172.82428.ce; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munck A., 1991, PSYCHONEUROIMMUNOLOG, P447; Murasko DM, 2002, EXP GERONTOL, V37, P427, DOI 10.1016/S0531-5565(01)00210-8; Nehete PN, 2003, J MED PRIMATOL, V32, P67, DOI 10.1034/j.1600-0684.2003.00011.x; Nehete PN, 2017, COMPARATIVE MED, V67, P67; Nehete PN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079836; Ochi T, 2016, J VET MED SCI, V78, P889, DOI 10.1292/jvms.15-0502; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Pavlov VA, 2015, IMMUNOL RES, V63, P38, DOI 10.1007/s12026-015-8718-1; Phillips KA, 2014, AM J PRIMATOL, V76, P801, DOI 10.1002/ajp.22281; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; SACKETT GP, 1981, J MED PRIMATOL, V10, P149; Sastry K Jagannadha, 2005, Methods Mol Biol, V302, P153; Schapiro SJ, 1996, APPL ANIM BEHAV SCI, V48, P159, DOI 10.1016/0168-1591(96)01038-6; Schapiro SJ, 2000, APPL ANIM BEHAV SCI, V68, P67, DOI 10.1016/S0168-1591(00)00090-3; Schapiro SJ, 1996, AM J PRIMATOL, V40, P247, DOI 10.1002/(SICI)1098-2345(1996)40:3<247::AID-AJP3>3.0.CO;2-Y; Schapiro SJ, 2012, APPL ANIM BEHAV SCI, V137, P183, DOI 10.1016/j.applanim.2011.11.004; Shearer GM, 1997, MECH AGEING DEV, V94, P1; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Weaver EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067574; WOOD PG, 1993, BRAIN BEHAV IMMUN, V7, P121, DOI 10.1006/brbi.1993.1014; Wust S, 2000, NOISE HLTH, V2	54	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0188694	10.1371/journal.pone.0188694	http://dx.doi.org/10.1371/journal.pone.0188694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ7PP	29261698	Green Published, Green Submitted, gold			2022-12-26	WOS:000418554900010
J	Alvarez, LD; Presman, DM; Pecci, A				Damia Alvarez, Lautaro; Martin Presman, Diego; Pecci, Adali			Molecular dynamics simulations of the glucocorticoid receptor DNA-binding domain suggest a role of the lever-arm mobility in transcriptional output	PLOS ONE			English	Article							FORCE-FIELD; DIMER; SOFTWARE; PROTEINS; MONOMERS; GENE	One of the first and essential steps in gene expression regulation involves the recruitment of transcription factors (TFs) to specific response elements located at enhancers and/or promoters of targeted genes. These DNA elements have a certain variability in both sequence and length, which may affect the final transcriptional output. The molecular mechanisms in which TFs integrate the subtle differences within specific recognition sequences to offer different transcriptional responses is still largely unknown. Here we used molecular dynamics simulations to study the DNA binding behavior of the glucocorticoid receptor (GR), a ligandregulated TF with pleiotropic effects in almost all cells. By comparing the behavior of the wild type receptor and a well characterized Ala477Thr substitution within the rat GR DNA binding domain, we found that the region that connects the two-zinc fingers (i.e. the lever arm) would likely play a key role in GR transcriptional output.	[Damia Alvarez, Lautaro] Univ Buenos Aires, CONICET, UMYMFOR, Buenos Aires, DF, Argentina; [Damia Alvarez, Lautaro] Univ Buenos Aires, CONICET, Fac Ciencias Exactas & Nat, Dept Quim Organ, Buenos Aires, DF, Argentina; [Martin Presman, Diego] NCI, Lab Receptor Biol & Gene Express, NIH, Bldg 41,41 Lib Dr, Bethesda, MD USA; [Pecci, Adali] Univ Buenos Aires, CONICET, IFIBYNE, Buenos Aires, DF, Argentina; [Pecci, Adali] Univ Buenos Aires, CONICET, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Alvarez, LD (corresponding author), Univ Buenos Aires, CONICET, UMYMFOR, Buenos Aires, DF, Argentina.; Alvarez, LD (corresponding author), Univ Buenos Aires, CONICET, Fac Ciencias Exactas & Nat, Dept Quim Organ, Buenos Aires, DF, Argentina.	lalvarez@qo.fcen.uba.ar	Presman, Diego Martín/Y-6750-2019	Presman, Diego Martín/0000-0003-4515-8058; Alvarez, Lautaro Damian/0000-0001-8841-2330	University of Buenos Aires [20020130100363BA]; National Agency of Scientific Promotion of Argentina [BID-2014 PICT 0630]	University of Buenos Aires(University of Buenos Aires); National Agency of Scientific Promotion of Argentina(ANPCyT)	This work was supported by grants from the University of Buenos Aires [20020130100363BA] and the National Agency of Scientific Promotion of Argentina [BID-2014 PICT 0630] to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2003, MOL ENDOCRINOL, V17, P2583, DOI 10.1210/me.2002-0305; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Case DA., 2015, AMBER 2015; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; DAHLMANWRIGHT K, 1991, J BIOL CHEM, V266, P3107; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; Frijters R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-359; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; Helsen C, 2012, MOL CELL ENDOCRINOL, V348, P411, DOI 10.1016/j.mce.2011.07.025; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivani I, 2016, NAT METHODS, V13, P55, DOI [10.1038/NMETH.3658, 10.1038/nmeth.3658]; Jewell CM, 2012, MOL ENDOCRINOL, V26, P244, DOI 10.1210/me.2011-1116; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lim HW, 2015, GENOME RES, V25, P836, DOI 10.1101/gr.188581.114; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Peters MB, 2010, J CHEM THEORY COMPUT, V6, P2935, DOI 10.1021/ct1002626; Presman DM, 2017, TRANSCR-AUSTIN, V8, P32, DOI 10.1080/21541264.2016.1249045; Presman DM, 2016, P NATL ACAD SCI USA, V113, P8236, DOI 10.1073/pnas.1606774113; Presman DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001813; Ramamoorthy S, 2013, ENDOCR DEV, V24, P41, DOI 10.1159/000342502; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Ribeiro AAST, 2014, J CHEM THEORY COMPUT, V10, P1762, DOI 10.1021/ct400977r; Robertson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064831; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Schiller BJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0418-y; Stortz M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06676-0; VanWart AT, 2012, J CHEM THEORY COMPUT, V8, P2949, DOI 10.1021/ct300377a; Watson LC, 2013, NAT STRUCT MOL BIOL, V20, P876, DOI 10.1038/nsmb.2595; Weikum ER, 2017, NAT REV MOL CELL BIO, V18, P159, DOI 10.1038/nrm.2016.152; Zhou P, 2009, PROTEINS, V76, P151, DOI 10.1002/prot.22327	40	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189588	10.1371/journal.pone.0189588	http://dx.doi.org/10.1371/journal.pone.0189588			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244866	Green Submitted, Green Published, gold			2022-12-26	WOS:000418184700040
J	Shekhar, M; Singh, N; Dutta, R; Kumar, S; Mahajan, V				Shekhar, Meena; Singh, Nirupma; Dutta, Ram; Kumar, Shrvan; Mahajan, Vinay			Comparative study of qualitative and quantitative methods to determine toxicity level of Aspergillus flavus isolates in maize	PLOS ONE			English	Article							3 AGROECOLOGICAL ZONES; SECTION FLAVI; AFLATOXIN; GRAINS; VARIABILITY; HEPATITIS; NIGERIA; INDIA; SOILS	An attempt was made to compare between easy and inexpensive qualitative method (ammonia vapour test) and analytical methods (thin layer chromatography and enzymelinked immunosorbent assay) for identification of aflatoxigenic isolates of Aspergillus flavus in maize. In this comparative study the toxicity level of A. flavus isolates exhibited 100% agreement among ammonia vapour test, ELISA and TLC for highly toxigenic (> 2000 ppb) and toxigenic (501 +/- 2000 ppb) isolates while 88.5% agreement observed for least toxic (< 20 ppb) isolates. In ammonia vapour test 51% of A. flavus isolates showed creamish or no colour change corresponding to least toxic/atoxic (< 20ppb) category estimated by ELISA. Similarly 22% highly toxic isolates exhibited plum red colour, 12% moderately toxic indicated pink colour and 10% toxic isolates showed red colour. However, 11.5% isolates were found to be false positive in cream colour category (least toxic) and 28.5% false negatives in pink colour (moderately toxic) category. The isolates from different agroclimatic zones of maize in India showed high variability for aflatoxin B-1 (AFB(1)) production potential ranging from 0.214 +/- 8116.61 ppb. Toxigenic potential of Aspergillus flavus isolates in culture was further validated by inoculating maize grain sample with four different isolates with varied toxin producing ability. With good agreement percentage between cultural and analytical methods the study concludes the ammonia vapour test to be easy, inexpensive, reliable and time saving method that can be used for segregating or pre-screening of contaminated samples from bulk food/feed stock.	[Shekhar, Meena; Singh, Nirupma; Kumar, Shrvan; Mahajan, Vinay] ICAR Res Complex, IIMR, Pusa Campus, New Delhi, India; [Dutta, Ram] ICAR Res Complex, DGR, Junagadh, Gujarat, India; [Singh, Nirupma] Indian Agr Res Inst, Div Genet, New Delhi, India; [Kumar, Shrvan] Banaras Hindu Univ, Inst Agr Sci, Dept Mycol & Plant Pathol, Varanasi, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Directorate of Groundnut Research; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Banaras Hindu University (BHU)	Shekhar, M (corresponding author), ICAR Res Complex, IIMR, Pusa Campus, New Delhi, India.	shekhar.meena@gmail.com	Research, ICAR-Indian Institute of Maize/ABC-7039-2020; Dutta, Ram/AAA-4197-2021		Indian Council of Agricultural Research and Indian Institute of Maize Research, New Delhi, India	Indian Council of Agricultural Research and Indian Institute of Maize Research, New Delhi, India	This work was supported by the Indian Council of Agricultural Research and Indian Institute of Maize Research, New Delhi, India.	Amaike S, 2011, ANNU REV PHYTOPATHOL, V49, P107, DOI 10.1146/annurev-phyto-072910-095221; Atehrikeng J, 2008, INT J FOOD MICROBIOL, V122, P74, DOI 10.1016/j.ijfoodmicro.2007.11.062; CAST (Council for Agricultural Science and Technology), 2003, MYCOTOXINS RISKS PLA; Chauhan YS, 2008, AUST J EXP AGR, V48, P358, DOI 10.1071/EA06101; Cheraghali AM, 2007, FOOD CHEM TOXICOL, V45, P812, DOI 10.1016/j.fct.2006.10.026; Cornea C P, 2001, ROM BIOTECH LETT, V16, P5863; Cotty P. J., 2008, Mycotoxins: detection methods, management, public health and agricultural trade, P287, DOI 10.1079/9781845930820.0287; Cotty PJ, 1997, MYCOL RES, V101, P698, DOI 10.1017/S0953756296003139; Davis N. D., 1987, Food and beverage mycology., P517; Dini A, 2013, FOOD CONTROL, V30, P540, DOI 10.1016/j.foodcont.2012.08.012; Donner M, 2009, SOIL BIOL BIOCHEM, V41, P37, DOI 10.1016/j.soilbio.2008.09.013; Ghadarijani MM, 2006, ACTA HORTIC, P431, DOI 10.17660/ActaHortic.2006.726.69; Groopman John D., 2005, Cancer Biomarkers, V1, P5; Hsieh D., 1988, MYCOTOXINS PHYTOTOXI, P69; Hussein HS, 2001, TOXICOLOGY, V167, P101, DOI 10.1016/S0300-483X(01)00471-1; Idris YMA, 2010, FOOD CHEM TOXICOL, V48, P2539, DOI 10.1016/j.fct.2010.05.021; Jaime-Garcia R, 2006, PHYTOPATHOLOGY, V96, P599, DOI 10.1094/PHYTO-96-0599; Kelley RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036892; Klich M. A., 2002, IDENTIFICATION COMMO; KRISHNAMACHARI KAVR, 1975, LANCET, V1, P1061; Kumar S., 2009, DMR TECHNICAL B, V1, P22; Lai XW, 2015, SAUDI J BIOL SCI, V22, P176, DOI 10.1016/j.sjbs.2014.09.013; Muthusamy Karthikeyan, 2013, African Journal of Biotechnology, V12, P5839; Nasir MS, 2002, J AGR FOOD CHEM, V50, P3116, DOI 10.1021/jf011638c; OBrian GR, 2007, MYCOLOGIA, V99, P232, DOI 10.3852/mycologia.99.2.232; Probst C, 2012, FUNGAL BIOL-UK, V116, P503, DOI 10.1016/j.funbio.2012.02.001; Reddy KRN, 2009, WORLD J MICROB BIOT, V25, P33, DOI 10.1007/s11274-008-9857-5; Saito Michihiko, 1999, Mycoscience, V40, P205, DOI 10.1007/BF02464300; Shekhar M, 2017, QUAL ASSUR SAF CROP, V9, P171, DOI 10.3920/QAS2015.0720; Solorzano Cesar D, 2014, ScientificWorldJournal, V2014, P356059, DOI 10.1155/2014/356059; Stroka J, 2002, TRAC-TREND ANAL CHEM, V21, P90, DOI 10.1016/S0165-9936(01)00133-9; Waliyar Farid, 2009, Peanut Science, V36, P54, DOI 10.3146/AT07-007.1; Whitlow L. W., 2004, Feedstuffs, V76, P66; Williams JH, 2004, AM J CLIN NUTR, V80, P1106, DOI 10.1093/ajcn/80.5.1106; Zablotowicz RM, 2007, FOOD ADDIT CONTAM A, V24, P1102, DOI 10.1080/02652030701546198	35	9	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189760	10.1371/journal.pone.0189760	http://dx.doi.org/10.1371/journal.pone.0189760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	29244880	Green Published, Green Submitted, gold			2022-12-26	WOS:000418184700060
J	Yun, JH; Jeong, HS; Kim, KJ; Han, MH; Lee, EH; Lee, K; Cho, CH				Yun, Jang-Hyuk; Jeong, Han-Seok; Kim, Kyung-Jin; Han, Man Hyup; Lee, Eun Hui; Lee, Kihwang; Cho, Chung-Hyun			beta-Adrenergic receptor agonists attenuate pericyte loss in diabetic retinas through Akt activation	FASEB JOURNAL			English	Article						diabetic retinopathy; pericyte apoptosis; vascular leakage; tight junction protein	CAPILLARY ENDOTHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; TIGHT JUNCTION; BCL-2 EXPRESSION; GENE-EXPRESSION; RAT RETINA; IN-VITRO; KAPPA-B; RETINOPATHY; APOPTOSIS	Pericytes (PCs) are crucial in maintaining the quiescence of endothelial cells (ECs) and the integrity of EC tight junctions. Especially in diabetic retinopathy (DR), PC loss is one of the early pathologic changes in capillaries of diabetic retinas. Thus, preventing PC loss is beneficial for attenuating vision impairment in patients with DR. Although many studies have revealed the mechanism of PC loss in retinas, little is known about the mechanisms that increase PC survival. We focused on the effect of beta-adrenergic receptor agonists (beta-agonists) on PC loss in diabetic retinas. In this study, beta-agonists increased the cell viability of PCs by increasing PC survival and proliferation. Mechanistically, beta-agonist-induced protein kinase B activation in PCs reduced PC apoptosis in response to various stimuli. beta 2-agonists more potently increased PC survival than beta 1-agonists. beta 2-Agonist reduced vascular leakage and PC loss in retinas of mice with streptozotocin-induced diabetes. In cocultures of PCs and ECs, beta 2-agonists restored the altered permeability and ZO-1 expression in ECs induced by PC loss. We concluded that beta-agonists, especially beta 2-agonists, increase PC survival, thereby preventing diabetes-induced PC loss in retinas. These results provide a potential therapeutic benefit of beta-agonists for preventing PC loss in DR.	[Yun, Jang-Hyuk; Jeong, Han-Seok; Kim, Kyung-Jin; Han, Man Hyup; Cho, Chung-Hyun] Seoul Natl Univ, Coll Med, Dept Pharmacol, Vasc Microenvironm Lab, 103 Daehakro Dong, Seoul 110799, South Korea; [Cho, Chung-Hyun] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul, South Korea; [Cho, Chung-Hyun] Seoul Natl Univ, Coll Med, Canc Reseach Inst, Seoul, South Korea; [Lee, Eun Hui] Catholic Univ Korea, Coll Med, Dept Physiol, Seoul, South Korea; [Lee, Kihwang] Ajou Univ, Sch Med, Dept Ophthalmol, Suwon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Catholic University of Korea; Ajou University	Cho, CH (corresponding author), Seoul Natl Univ, Coll Med, Dept Pharmacol, Vasc Microenvironm Lab, 103 Daehakro Dong, Seoul 110799, South Korea.	iam-hyun@snu.ac.kr		Lee, Eun Hui/0000-0003-4555-1730	National Research Foundation of Korea - Korean government [2014R1A2A1A11050981, 2012R1A5A2A44671346]; Seoul National University Hospital Research Fund [0420160230]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government); Seoul National University Hospital Research Fund	This work was supported by National Research Foundation of Korea Grants 2014R1A2A1A11050981 and 2012R1A5A2A44671346 (to C.-H.C.), funded by the Korean government), and by Grant 0420160230 from the Seoul National University Hospital Research Fund (to C.-H.C.). The authors declare no conflicts of interest.	Alikhani M, 2005, J BIOL CHEM, V280, P12096, DOI 10.1074/jbc.M412171200; Alikhani M, 2010, MOL VIS, V16, P408; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Barisione G, 2010, PHARMACEUTICALS-BASE, V3, P1016, DOI 10.3390/ph3041016; Cai J, 2008, INVEST OPHTH VIS SCI, V49, P2163, DOI 10.1167/iovs.07-1206; Chintalgattu V, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005066; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Dohgu S, 2004, CELL MOL NEUROBIOL, V24, P491, DOI 10.1023/B:CEMN.0000022776.47302.ce; Du XL, 2003, J CLIN INVEST, V112, P1049, DOI 10.1172/JCI200318127; Feng YX, 2007, THROMB HAEMOSTASIS, V97, P99, DOI 10.1160/TH06-05-0277; Flusberg DA, 2001, MOL BIOL CELL, V12, P3087, DOI 10.1091/mbc.12.10.3087; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Hammes HP, 2011, DIABETES, V60, P9, DOI 10.2337/db10-0454; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Iaccarino G, 2005, CIRC RES, V97, P1182, DOI 10.1161/01.RES.0000191541.06788.bb; Ji Y, 2013, CELL DIV, V8, DOI 10.1186/1747-1028-8-1; Jiang YD, 2010, EXP EYE RES, V91, P171, DOI 10.1016/j.exer.2010.04.014; Jo DH, 2013, MOL CELLS, V36, P465, DOI 10.1007/s10059-013-0228-1; Kowluru RA, 2005, ANTIOXID REDOX SIGN, V7, P1581, DOI 10.1089/ars.2005.7.1581; Kowluru RA, 2004, BRIT J OPHTHALMOL, V88, P1343, DOI 10.1136/bjo.2003.038133; Machida K, 2005, AM J PHYSIOL-LUNG C, V288, pL860, DOI 10.1152/ajplung.00131.2004; McDonald DM, 2001, AM J RESP CRIT CARE, V164, pS39, DOI 10.1164/ajrccm.164.supplement_2.2106065; MINNEAR FL, 1989, AM J PHYSIOL, V257, pH1613, DOI 10.1152/ajpheart.1989.257.5.H1613; Naruse K, 2000, EXP EYE RES, V71, P309, DOI 10.1006/exer.2000.0882; Nishioku T, 2009, CELL MOL NEUROBIOL, V29, P309, DOI 10.1007/s10571-008-9322-x; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455; Park SW, 2014, DIABETES, V63, P3057, DOI 10.2337/db13-1942; Pfister F, 2008, DIABETES, V57, pA234, DOI 10.2337/db08-0325; Pfister F, 2010, ACTA DIABETOL, V47, P59, DOI 10.1007/s00592-009-0099-2; PHILLIPS PJ, 1980, BRIT J CLIN PHARMACO, V9, P483, DOI 10.1111/j.1365-2125.1980.tb05844.x; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Rangasamy S, 2011, INVEST OPHTH VIS SCI, V52, P3784, DOI 10.1167/iovs.10-6386; Romeo G, 2002, DIABETES, V51, P2241, DOI 10.2337/diabetes.51.7.2241; SATO Y, 1989, J CELL BIOL, V109, P309, DOI 10.1083/jcb.109.1.309; Schuller HM, 2010, ONCOTARGET, V1, P466; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Shin ES, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.517; Steinle JJ, 2009, EXP EYE RES, V88, P1014, DOI 10.1016/j.exer.2008.12.015; Takashima S, 2005, J SURG RES, V126, P114, DOI 10.1016/j.jss.2005.01.017; Walshe TE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005149; Wiley LA, 2005, INVEST OPHTH VIS SCI, V46, P744, DOI 10.1167/iovs.04-1023; Yuan AH, 2010, ONCOL REP, V23, P151, DOI 10.3892/or_00000616; Yun J., 2016, J OPEN INNOV-TECHNOL, V2, P7, DOI [10.1186/s40852-016-0033-0, DOI 10.1186/S40852-016-0033-0]; Yun JH, 2017, J CELL PHYSIOL, V232, P1123, DOI 10.1002/jcp.25575; Zeng H, 2016, SCI REP-UK, V6, DOI 10.1038/srep20931; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010	55	23	23	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2324	2338		10.1096/fj.201700570RR	http://dx.doi.org/10.1096/fj.201700570RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29269397				2022-12-26	WOS:000432528000003
J	Kim, SH; Zhong, X; Kim, W; Kim, K; Suh, YG; Kim, C; Joe, Y; Chung, HT; Cha, YN; Surh, YJ				Kim, Seung Hyeon; Zhong, Xiancai; Kim, Wonki; Kim, Kyeojin; Suh, Young-Ger; Kim, Chaekyun; Joe, Yeonsoo; Chung, Hun Taeg; Cha, Young-Nam; Surh, Young-Joon			Taurine chloramine potentiates phagocytic activity of peritoneal macrophages through up-regulation of dectin-1 mediated by heme oxygenase-1-derived carbon monoxide	FASEB JOURNAL			English	Article						curdlan; fungal infection; phagocytosis; resolution	PPAR-GAMMA; MURINE MACROPHAGES; PATTERN-RECOGNITION; BACTERIAL CLEARANCE; FUNGAL-INFECTIONS; HOST-DEFENSE; BETA-GLUCAN; INFLAMMATION; ACTIVATION; RECEPTOR	Resolution of inflammation that occurs after microbial infection or tissue damage is an important physiologic process in maintaining or restoring host homeostasis. Taurine chloramine (TauCl) is formed by a reaction between taurine and hypochlorite in leukocytes, and it is especially abundant in activated neutrophils that encounter an oxidative burst. As neutrophils undergo apoptosis, TauCl is released to the extracellular matrix at the inflamed sites, thereby affecting coexisting macrophages in the inflammatory microenvironment. In this study, we investigated the role of TauCl in phagocytosis by macrophages during resolution of fungal infection-induced inflammation. We found that exogenous TauCl substantially increased the phagocytic efficiency of macrophages through up-regulation of dectin-1, a receptor for fungal beta-1,3-glucans, which is present on the membrane of macrophages. Our previous studies demonstrated the induction of heme oxygenase-1 (HO-1) expression in murine peritoneal macrophages treated with TauCl. In the present study, knocking out HO-1 or pharmacologic inhibition of HO-1 with zinc protoporphyrin IX attenuated the TauCl-induced expression of dectin-1 and subsequent phagocytosis. Furthermore, carbon monoxide (CO), a by-product of the HO-1-catalyzed reaction, induced expression of dectin-1 and potentiated phagocytic capability of the macrophages, which appeared to be mediated through up-regulation of peroxisome proliferator-activated receptor . Taken together, induction of HO-1 expression and subsequent CO production by TauCl are essential for phagocytosis of fungi by macrophages. Our results suggest that TauCl has important roles in host defense against fungal infection and has therapeutic potential in the management of inflammatory diseases.	[Kim, Seung Hyeon; Zhong, Xiancai; Kim, Wonki; Kim, Kyeojin; Suh, Young-Ger; Surh, Young-Joon] Seoul Natl Univ, Pharmaceut Sci Res Inst, Tumor Microenvironm Global Core Res Ctr, Seoul, South Korea; [Kim, Seung Hyeon; Surh, Young-Joon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Canc Res Inst, Seoul, South Korea; [Surh, Young-Joon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Kim, Chaekyun; Cha, Young-Nam] Inha Univ, Dept Pharmacol & Toxicol, Coll Med, Incheon, South Korea; [Joe, Yeonsoo; Chung, Hun Taeg] Univ Ulsan, Dept Biol Sci, Ulsan, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Inha University; University of Ulsan	Surh, YJ (corresponding author), Seoul Natl Univ, Coll Pharm, Bldg 142,Room 507,1 Gwanak Ro, Seoul 08826, South Korea.	surh@snu.ac.kr	Zhong, Xiancai/AAM-3069-2020; Zhong, Xiancai/AAV-2761-2020	Zhong, Xiancai/0000-0001-8312-4057; Zhong, Xiancai/0000-0001-8312-4057; Kim, Seung Hyeon/0000-0001-9197-5978	Global Core Research Center (GCRC) from the Korean National Research Foundation (NRF) [2011-003-0001]	Global Core Research Center (GCRC) from the Korean National Research Foundation (NRF)	This work was supported by the Global Core Research Center (GCRC; Grant 2011-003-0001) from the Korean National Research Foundation (NRF). The authors declare no conflicts of interest.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Bilban M, 2006, IMMUNITY, V24, P601, DOI 10.1016/j.immuni.2006.03.012; Billings EA, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac6250; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Chiang N, 2017, J IMMUNOL, V198, P842, DOI 10.4049/jimmunol.1601650; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Coste A, 2003, IMMUNITY, V19, P329, DOI 10.1016/S1074-7613(03)00229-2; Coste A, 2008, J IMMUNOL, V180, P4939, DOI 10.4049/jimmunol.180.7.4939; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; Erwig LP, 2016, NAT REV MICROBIOL, V14, P163, DOI 10.1038/nrmicro.2015.21; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Gales A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000714; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gottardi W, 2005, J ANTIMICROB CHEMOTH, V55, P475, DOI 10.1093/jac/dki054; Gottardi W, 2002, ARCH PHARM, V335, P411, DOI 10.1002/1521-4184(200212)335:9<411::AID-ARDP411>3.0.CO;2-D; Gottardi W, 2013, ANTIMICROB AGENTS CH, V57, P1107, DOI 10.1128/AAC.02132-12; Greenblatt MB, 2010, J EXP MED, V207, P923, DOI 10.1084/jem.20092531; Hoetzel A, 2008, AM J RESP CRIT CARE, V177, P1223, DOI 10.1164/rccm.200708-1265OC; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim C, 2014, AMINO ACIDS, V46, P89, DOI 10.1007/s00726-013-1545-6; Kim C, 2010, INT IMMUNOPHARMACOL, V10, P440, DOI 10.1016/j.intimp.2009.12.018; Kim HJ, 2017, FREE RADICAL BIO MED, V110, P81, DOI 10.1016/j.freeradbiomed.2017.05.026; Kim W, 2015, ANTIOXID REDOX SIGN, V23, P163, DOI 10.1089/ars.2013.5825; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Lackner M, 2015, ANTIMICROB AGENTS CH, V59, P6454, DOI 10.1128/AAC.00957-15; Lee S, 2014, ANTIOXID REDOX SIGN, V20, P432, DOI 10.1089/ars.2013.5368; Lefevre L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7801; Lefevre L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012828; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Liu M, 2015, J IMMUNOL, V195, P5055, DOI 10.4049/jimmunol.1501158; Marcinkiewicz J, 1995, J LEUKOCYTE BIOL, V58, P667, DOI 10.1002/jlb.58.6.667; Marcinkiewicz J, 2014, AMINO ACIDS, V46, P7, DOI 10.1007/s00726-012-1361-4; Maruyama Naho, 2005, J Inflamm (Lond), V2, P1, DOI 10.1186/1476-9255-2-1; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Onyiah JC, 2013, GASTROENTEROLOGY, V144, P789, DOI 10.1053/j.gastro.2012.12.025; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Ryter SW, 2016, TRANSL RES, V167, P7, DOI 10.1016/j.trsl.2015.06.011; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672, DOI 10.1002/jlb.56.6.672; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; Tam JM, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5020034; Trinath J, 2014, MOL CELL BIOL, V34, P4301, DOI 10.1128/MCB.00641-14; Tsoyi K, 2016, CRIT CARE MED, V44, pE1236, DOI 10.1097/CCM.0000000000001999; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Vernon PJ, 2013, ANTIOXID REDOX SIGN, V18, P677, DOI 10.1089/ars.2012.4810; Wegiel B, 2014, J CLIN INVEST, V124, P4926, DOI 10.1172/JCI72853; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Winkler JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep18972; Yun N, 2014, FREE RADICAL BIO MED, V68, P168, DOI 10.1016/j.freeradbiomed.2013.12.014	59	8	9	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2246	2257		10.1096/fj.201700817R	http://dx.doi.org/10.1096/fj.201700817R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29247123				2022-12-26	WOS:000429051400042
J	Chorba, JS; Galvan, AM; Shokat, KM				Chorba, John S.; Galvan, Adri M.; Shokat, Kevan M.			Stepwise processing analyses of the single-turnover PCSK9 protease reveal its substrate sequence specificity and link clinical genotype to lipid phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proprotein convertase subtilisin; kexin type 9 (PCSK9); substrate specificity; serine protease; single-nucleotide polymorphism (SNP); atherosclerosis; low-density lipoprotein (LDL); high-throughput screening (HTS); protein secretion; active site	SUBTILISIN/KEXIN TYPE 9; PLASMA LDL-CHOLESTEROL; PROPROTEIN CONVERTASE; SECRETED PCSK9; FAMILIAL HYPERCHOLESTEROLEMIA; FUNCTION MUTATIONS; HEPG2 CELLS; RECEPTOR; REPORTER; VARIANTS	Proprotein convertase subtilisin/kexin type 9 (PCSK9) down-regulates the low-density lipoprotein (LDL) receptor, elevating LDL cholesterol and accelerating atherosclerotic heart disease, making it a promising cardiovascular drug target. To achieve its maximal effect on the LDL receptor, PCSK9 requires autoproteolysis. After cleavage, PCSK9 retains its prodomain in the active site as a self-inhibitor. Unlike other proprotein convertases, however, this retention is permanent, inhibiting any further protease activity for the remainder of its life cycle. Such inhibition has proven a major challenge toward a complete biochemical characterization of PCSK9's proteolytic function, which could inform therapeutic approaches against its hypercholesterolemic effects. To address this challenge, we employed a cell-based, high-throughput method using a luciferase readout to evaluate the single-turnover PCSK9 proteolytic event. We combined this method with saturation mutagenesis libraries to interrogate the sequence specificities of PCSK9 cleavage and proteolysis-independent secretion. Our results highlight several key differences in sequence identity between these two steps, complement known structural data, and suggest that PCSK9 self-proteolysis is the rate-limiting step of secretion. Additionally, we found that for missense SNPs within PCSK9, alterations in both proteolysis and secretion are common. Last, we show that some SNPs allosterically modulate PCSK9's substrate sequence specificity. Our findings indicate that PCSK9 proteolysis acts as a commonly perturbed but critical switch in controlling lipid homeostasis and provide a new hope for the development of small-molecule PCSK9 inhibitors.	[Chorba, John S.] Zuckerberg San Francisco Gen, Div Cardiol, Dept Med, San Francisco, CA 94110 USA; [Chorba, John S.] Univ Calif San Francisco, San Francisco, CA 94110 USA; [Chorba, John S.; Galvan, Adri M.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Chorba, John S.; Galvan, Adri M.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Chorba, JS (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen, Div Cardiol, Dept Med, 1001 Potrero Ave,Bldg 100 Rm 261, San Francisco, CA 94110 USA.	john.chorba@ucsf.edu			NHLBI, National Institutes of Health (NIH) [K08 HL124068, LRP HMOT1243]; NCATS, NIH, through the University of California San Francisco Clinical and Translational Science Institute Catalyst Program [UL1 TR000004]; University of California San Francisco Academic Senate; Hellman Foundation; Gilead Sciences Research Scholar Award; Pfizer ASPIRE Cardiovascular Award; Howard Hughes Medical Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL124068] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCATS, NIH, through the University of California San Francisco Clinical and Translational Science Institute Catalyst Program; University of California San Francisco Academic Senate(University of California System); Hellman Foundation; Gilead Sciences Research Scholar Award; Pfizer ASPIRE Cardiovascular Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health (NIH), Grants K08 HL124068 and LRP HMOT1243; NCATS, NIH, through the University of California San Francisco Clinical and Translational Science Institute Catalyst Program (Grant UL1 TR000004); the University of California San Francisco Academic Senate; the Hellman Foundation; a Gilead Sciences Research Scholar Award; a Pfizer ASPIRE Cardiovascular Award (all to J. S. C.); and the Howard Hughes Medical Institute (to A. M. G. and K. M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ai X., 2016, BIOCHEM MOL BIOL J, V2, P17, DOI [10.21767/2471-8084.100026, DOI 10.21767/2471-8084.100026]; Bartok E, 2013, NAT METHODS, V10, P147, DOI [10.1038/NMETH.2327, 10.1038/nmeth.2327]; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Benjannet S, 2012, J BIOL CHEM, V287, P33745, DOI 10.1074/jbc.M112.399725; Browning JD, 2010, J LIPID RES, V51, P3359, DOI 10.1194/jlr.P009860; Cameron J, 2008, J INTERN MED, V263, P420, DOI 10.1111/j.1365-2796.2007.01915.x; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Cameron J, 2008, FEBS J, V275, P4121, DOI 10.1111/j.1742-4658.2008.06553.x; Cameron J, 2009, ATHEROSCLEROSIS, V203, P161, DOI 10.1016/j.atherosclerosis.2008.10.007; Cariou B, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-4; Chorba JS, 2014, J BIOL CHEM, V289, P29030, DOI 10.1074/jbc.M114.594861; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Du F, 2011, J BIOL CHEM, V286, P43054, DOI 10.1074/jbc.M111.273474; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; FOOTE J, 1985, J BIOL CHEM, V260, P9624; Garvie CW, 2016, PROTEIN SCI, V25, P2018, DOI 10.1002/pro.3019; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Hasson SA, 2015, ACS CHEM BIOL, V10, P1188, DOI 10.1021/cb5010417; Homer VM, 2008, ATHEROSCLEROSIS, V196, P659, DOI 10.1016/j.atherosclerosis.2007.07.022; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Joshi N, 2013, BIOCHEMISTRY-US, V52, P8026, DOI 10.1021/bi4010649; Ketteler R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r64; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Leigha SEA, 2009, ATHEROSCLEROSIS, V203, P32, DOI 10.1016/j.atherosclerosis.2009.02.006; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayne J, 2011, CLIN CHEM, V57, P1415, DOI 10.1373/clinchem.2011.165191; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Miyake Y, 2008, ATHEROSCLEROSIS, V196, P29, DOI 10.1016/j.atherosclerosis.2006.12.035; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Niers JM, 2011, MOL THER, V19, P1090, DOI 10.1038/mt.2011.17; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Persson L, 2010, ARTERIOSCL THROM VAS, V30, P2666, DOI 10.1161/ATVBAHA.110.214130; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Qu L, 2014, J VIROL, V88, P10312, DOI 10.1128/JVI.01111-14; Ridker PM, 2017, NEW ENGL J MED, V376, P1527, DOI 10.1056/NEJMoa1701488; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Seidah NG, 2016, CURR OPIN LIPIDOL, V27, P274, DOI 10.1097/MOL.0000000000000295; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Shelton CC, 2009, P NATL ACAD SCI USA, V106, P20228, DOI 10.1073/pnas.0910757106; Wanneh E, 2017, J CLIN LIPIDOL, V11, P55, DOI 10.1016/j.jacl.2016.09.015; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 2017, NAT STRUCT MOL BIOL, V24, P611, DOI 10.1038/nsmb.3435; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	63	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1875	1886		10.1074/jbc.RA117.000754	http://dx.doi.org/10.1074/jbc.RA117.000754			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29259136	Green Published, hybrid			2022-12-26	WOS:000424948000002
J	Wushouer, H; Tian, Y; Guan, XD; Han, S; Shi, LW				Wushouer, Haishaerjiang; Tian, Ye; Guan, Xiao-Dong; Han, Sheng; Shi, Lu-Wen			Trends and patterns of antibiotic consumption in China's tertiary hospitals: Based on a 5 year surveillance with sales records, 2011-2015	PLOS ONE			English	Article							EUROPEAN SURVEILLANCE; RESISTANCE; ESAC	The consumption of antibiotics is a major driver in the development of antimicrobial resistance. This study aims to identify the trends and patterns of the total antibiotic consumption in China's tertiary hospitals from 2011 to 2015 by retrospectively analyzing aggregated monthly surveillance data on antibiotic sales made to 468 hospitals from 28 provinces. Antibiotic consumption was expressed in DDD per 1,000 inhabitants per day (DID). We compared population weighted antibiotic consumption patterns in China with European countries using indicators from the European Surveillance of Antimicrobial Consumption (ESAC). Total antibiotic consumption, including all the specific antibiotic class except for aminoglycoside antibacterials, were significantly increased during the study period from an average of 7.97 DID in 2011 to 10.08 DID in 2015. In 2015, the eastern regions of China consumed the most antibiotics using population denominator while the western regions consumed the most using inpatient denominator. Cephalosporins accounted for 28.6% of total DID, followed by beta-lactam-beta-lactamase inhibitor combinations (20.0%), macrolides (17.4%), and fluoroquinolones (10.5%). Antibiotic in parenteral form accounted for nearly half of all antibiotics. Although over the past few years major efforts had been made to reduce the risks of excessive antibiotic use through antibiotic stewardship, total antibiotic consumption showed a significant upward trend during the study period. A consistent preference for cephalosporins, macrolides, beta-lactam-beta-lactamase inhibitor combinations, as well as parenteral preparations was observed.	[Wushouer, Haishaerjiang; Tian, Ye; Guan, Xiao-Dong; Han, Sheng; Shi, Lu-Wen] Peking Univ, Sch Pharmaceut Sci, Dept Pharm Adm & Clin Pharm, Beijing, Peoples R China; [Guan, Xiao-Dong; Han, Sheng; Shi, Lu-Wen] Peking Univ, IRCMA, Beijing, Peoples R China	Peking University; Peking University	Shi, LW (corresponding author), Peking Univ, Sch Pharmaceut Sci, Dept Pharm Adm & Clin Pharm, Beijing, Peoples R China.; Shi, LW (corresponding author), Peking Univ, IRCMA, Beijing, Peoples R China.	shiluwen211@163.com	Shi, Lu/AAG-5414-2021	GUAN, Xiaodong/0000-0002-1290-3827; Shi, Luwen/0000-0003-2683-6685; Wushouer, Haishaerjiang/0000-0003-1466-9840				Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; [Anonymous], 2016, SUMM LAT DAT ANT CON; [Anonymous], 2015, PROG PHARM SCI, V39, P501; Bao L., 2015, PLOS ONE, V10; Centers for Disease Control and Prevention, OUTP ANT PRESCR US; Coenen S, 2007, QUAL SAF HEALTH CARE, V16, P440, DOI 10.1136/qshc.2006.021121; de Sande-Bruinsma NV, 2008, EMERG INFECT DIS, V14, P1722, DOI 10.3201/eid1411.070467; Department of Medical Administration and Committee of Experts on Rational Drug Use National Health and Family Planning Commission of the People's Republic of China, 2012, NAT ANT THER GUID; Earnshaw S, 2013, LANCET INFECT DIS, V13, P1003, DOI 10.1016/S1473-3099(13)70315-3; European Centre for Disease Prevention and Control, 2014, SURV ANT CONS EUR 20; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P401, DOI 10.1093/jac/dkl188; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hicks LA, 2015, CLIN INFECT DIS, V60, P1308, DOI 10.1093/cid/civ076; Lin H, 2016, J ANTIMICROB CHEMOTH, V71, P1723, DOI 10.1093/jac/dkw013; Ma XD, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2051-8; Meyer E, 2013, INT J MED MICROBIOL, V303, P388, DOI 10.1016/j.ijmm.2013.04.004; Ministry of Health, 2005, NOT EST CHIN ANT RES; Ministry of Health, 2004, NAT GUID PRINC ANT C; National Health and Family Planning Commission, 2016, 2016 CHIN HLTH STAT; National Health and Family Planning Commission of the People's Republic of China, 2016, ADM CLIN US ANT AG S; Public Health England, ENGL SURV PROGR ANT; Public Health England, 2019, ENGL SURV PROGR ANT; State Council of China, 2009, OP DEEP REF MED HLTH; Sun J., 2015, BIOMED RES INT, V2015, P1, DOI [DOI 10.1016/J.JGAR.2015.03.001, DOI 10.1038/SREP14235]; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Vander Stichele RH, 2004, BRIT J CLIN PHARMACO, V58, P419, DOI 10.1111/j.1365-2125.2004.02164.x; WHO Collaborating Centre for Drug Statistics Methodology, 2005, GUIDELINES ATC CLASS; World Health Organization, 2014, ANT RES GLOB REP SUR; Wushouer H, 2011, TRENDS PATTERNS ANTI; Xiao YH, 2016, LANCET INFECT DIS, V16, P1216, DOI 10.1016/S1473-3099(16)30388-7; Xiao YH, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001556; Xiao YH, 2013, LANCET INFECT DIS, V13, P189, DOI 10.1016/S1473-3099(13)70011-2; Zhang QQ, 2015, ENVIRON SCI TECHNOL, V49, P6772, DOI 10.1021/acs.est.5b00729	33	30	33	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190314	10.1371/journal.pone.0190314	http://dx.doi.org/10.1371/journal.pone.0190314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281716	gold, Green Published, Green Submitted			2022-12-26	WOS:000419006200084
J	Adamson, PC; Tafuma, TA; Davis, SM; Xaba, S; Herman-Roloff, A				Adamson, Paul C.; Tafuma, Taurayi A.; Davis, Stephanie M.; Xaba, Sinokuthemba; Herman-Roloff, Amy			A systems-based assessment of the PrePex device adverse events active surveillance system in Zimbabwe	PLOS ONE			English	Article							CIRCUMCISION	Background Voluntary Medical Male Circumcision (VMMC) is an effective method for HIV prevention and the World Health Organization (WHO) has recommended its expansion in 14 African countries with a high prevalence of HIV and low prevalence of male circumcision. The WHO has recently pre-qualified the PrePex device, a non-surgical male circumcision device, which reduces procedure time, can increase acceptability of VMMC, and can expand the set of potential provider cadres. The PrePex device was introduced in Zimbabwe as a way to scale-up VMMC services in the country. With the rapid scale-up of the PrePex device, as well as other similar devices, a strong surveillance system to detect adverse events (AE) is needed to monitor the safety profile of these devices. We performed a systems-based evaluation of the PrePex device AE active surveillance system in Zimbabwe. Methods The evaluation was based on the Centers for Disease Control and Prevention's Updated Guidelines for Evaluating Public Health Surveillance Systems. We adapted these guidelines to fit our local context. The evaluation incorporated the review of the standard operating procedures and surveillance system documents. Additionally, structured, in-person interviews were performed with key stakeholders who were users of the surveillance system at various levels. These key stakeholders were from the Ministry of Health, implementing partners, and health facilities in Harare. Results Clients were requested to return to the facility for follow-up on days 7, 14 and 49 after placement of the device. In the event of a severe AE, a standard report was generated by the health facility and relayed to the Ministry of Health Child and Care and donor agencies through predefined channels within 24 hours of diagnosis. Clinic staff reported difficulties with the amount of documentation required to follow up with clients and to report AEs. The surveillance system's acceptability among users interviewed was high, and users were motivated to identify all possible AEs related to this device. The surveillance system was purely paper-based and both duplicate and discrepant reporting forms between sites were identified. Conclusion The PrePex AE active surveillance system was well accepted among participants in the health system. However, the amount of documentation which was required to follow-up with patients was a major barrier within the system, and might lead to decreased timeliness and quality of reporting. A passive surveillance system supported by electronic reporting would improve acceptance of the program.	[Adamson, Paul C.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Adamson, Paul C.] Ctr Dis Control & Prevent, CDC Hubert Global Hlth Fellowship, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA; [Tafuma, Taurayi A.; Herman-Roloff, Amy] US Ctr Dis Control & Prevent, Harare, Zimbabwe; [Davis, Stephanie M.] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Xaba, Sinokuthemba] Minist Hlth & Child Care, AIDS & TB Programme, Harare, Zimbabwe; [Adamson, Paul C.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Herman-Roloff, Amy] US Ctr Dis Control & Prevent, Pretoria, South Africa	University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Yale University	Adamson, PC (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.; Adamson, PC (corresponding author), Ctr Dis Control & Prevent, CDC Hubert Global Hlth Fellowship, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.; Adamson, PC (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	paul.adamson@yale.edu	Adamson, Paul/AAR-1405-2020	Adamson, Paul/0000-0002-2776-6458	Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [U2GGH000972]; CDC Foundation; health care workers in the PrePex clinics; Ministry of Health Child and Care	Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)); CDC Foundation(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); health care workers in the PrePex clinics; Ministry of Health Child and Care	This work has been supported by the Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of Cooperative Agreement #: U2GGH000972. PCA was a CDC-Hubert Global Health Fellow and supported by a stipend from the CDC Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the following people and organisations: health care workers in the PrePex clinics, VMMC Implementing Partners, and Ministry of Health Child and Care.	[Anonymous], M CONV GEN SWITZ 9 1; Feldblum PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095357; Ford N, 2012, AIDS, V26, P559, DOI 10.1097/QAD.0b013e32834f3264; Galukande M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086631; German R R, 2001, MMWR Recomm Rep, V50, P1; Grund JM, 2016, MMWR-MORBID MORTAL W, V65, P36, DOI DOI 10.15585/MMWR.MM6502A5.PMID:26797167; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Heidebrecht CL, 2011, INT J TUBERC LUNG D, V15, P912, DOI 10.5588/ijtld.10.0296; Maponga BA, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.278.5202; PSI/COSECSA, 2013, ADV EV ACT GUID MAL; Samuelson J, 2013, JAIDS-J ACQ IMM DEF, V64, P127, DOI 10.1097/QAI.0b013e3182a61dd3; Sgaier SK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001641; VOGT RL, 1983, AM J PUBLIC HEALTH, V73, P795, DOI 10.2105/AJPH.73.7.795; WHO, 2016, WHO MARCH 2015 M; WHO, 2013, GUID US DEV AD MAL C; WHO, 2013, EV 2 AD DEV; Zimbabwe Ministry of Health and Child Care, 2014, ACC STRAT OP PLAN 20	17	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0190055	10.1371/journal.pone.0190055	http://dx.doi.org/10.1371/journal.pone.0190055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272320	Green Published, Green Submitted, gold			2022-12-26	WOS:000418651500029
J	Garcia-Martin, E; Ruiz-de Gopegui, E; Leon-Latre, M; Otin, S; Altemir, I; Polo, V; Larrosa, JM; Cipres, M; Casasnovas, JA; Pablo, LE				Garcia-Martin, Elena; Ruiz-de Gopegui, Erika; Leon-Latre, Montserrat; Otin, Sofia; Altemir, Irene; Polo, Vicente; Larrosa, Jose M.; Cipres, Marta; Casasnovas, Jose A.; Pablo, Luis E.			Influence of cardiovascular condition on retinal and retinal nerve fiber layer measurements	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; LINEAR DISCRIMINANT FUNCTION; MULTIPLE-SCLEROSIS; NEURODEGENERATIVE DISEASES; CHOROIDAL THICKNESS; ALZHEIMERS-DISEASE; RISK-FACTORS; DEGENERATION; INFARCTION; ISCHEMIA	Objective To assess changes in the retinal nerve fiber layer (RNFL) and macula in subjects with cardiovascular risk factors or subclinical ischemia. Design Prospective and observational study. Methods A total of 152 healthy men underwent cardiovascular examination, including quantification of subclinical atheroma plaques by artery ultrasound scans, blood analysis, and a complete ophthalmic evaluation, including spectral-domain optical coherence tomography. The variables registered in cardiovascular examination were quantification of classic major risk factors, subclinical atheroma plaques by artery ultrasound scans, and analytical records. The ophthalmic evaluation registered RNFL and macular thickness. Results Mean subject age was 51.27 +/- 3.71 years. The 40 subjects without classic cardiovascular risk factors did not show differences in RNFL and macular thicknesses compared with the 112 subjects with at least one risk factor (except in sector 9 that showed higher thicknesses in subjects with >= 1 risk factor). Comparison between the group of subjects with and without atheroma plaques revealed no differences in RNFL and macular thicknesses. The sub-analysis of subjects with subclinical atheroma plaques in the common carotid artery revealed a significant reduction in central macular thickness in the left eye compared with the right eye (p = 0.016), RNFL in the superior quadrant (p = 0.007), and the 11 o'clock sector (p = 0.020). Comparison between smokers and nonsmokers revealed that smokers had significant thinning of the central macular thickness (p = 0.034), the nasal RNFL quadrant (p = 0.006), and the 3 and 5 o'clock sectors (p = 0.016 and 0.009). Conclusions Classic cardiovascular risk factors do not cause RNFL or macular thickness reduction, but tobacco smoking habit reduces nasal RNFL thickness. Subclinical atherosclerosis in the common carotid artery associates a reduction in central macular and nasal RNFL quadrant thicknesses in the left eye compared with the right eye.	[Garcia-Martin, Elena; Ruiz-de Gopegui, Erika; Otin, Sofia; Altemir, Irene; Polo, Vicente; Larrosa, Jose M.; Cipres, Marta; Pablo, Luis E.] Miguel Servet Univ Hosp, Ophthalmol Dept, Zaragoza, Spain; [Garcia-Martin, Elena; Ruiz-de Gopegui, Erika; Leon-Latre, Montserrat; Otin, Sofia; Altemir, Irene; Polo, Vicente; Larrosa, Jose M.; Cipres, Marta; Casasnovas, Jose A.; Pablo, Luis E.] Aragon Hlth Res Inst IACS IIS Aragon, Zaragoza, Spain; [Leon-Latre, Montserrat] Aragon Hlth Serv, Hlth Ctr La Jota, Zaragoza, Spain; [Casasnovas, Jose A.] Univ Zaragoza, Dept Med, Zaragoza, Spain	Miguel Servet University Hospital; University of Zaragoza	Garcia-Martin, E (corresponding author), Miguel Servet Univ Hosp, Ophthalmol Dept, Zaragoza, Spain.; Garcia-Martin, E (corresponding author), Aragon Hlth Res Inst IACS IIS Aragon, Zaragoza, Spain.	egmvivax@yahoo.com	Lenguas, José Antonio Casasnovas/F-4038-2010	Lenguas, José Antonio Casasnovas/0000-0002-9887-2629; Ruiz de Gopegui, Erika/0000-0001-7106-1378; Pablo, Luis/0000-0003-2389-8282; Otin Mallada, Sofia Zaira/0000-0002-6591-0801; Polo Llorens, Vicente/0000-0002-1402-3129; Larrosa Poves, Jose Manuel/0000-0002-6745-7668; GARCIA-MARTIN, ELENA/0000-0001-6258-2489	National Center for Cardiovascular Research (Carlos III Health Institute, Madrid); Aragon Institute of Health Sciences	National Center for Cardiovascular Research (Carlos III Health Institute, Madrid); Aragon Institute of Health Sciences	The AWHS is funded by the National Center for Cardiovascular Research (Carlos III Health Institute, Madrid) and the Aragon Institute of Health Sciences. There are no other financial disclosures.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Akay F, 2016, EUR J OPHTHALMOL, V26, P152, DOI 10.5301/ejo.5000675; Casasnovas JA, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-45; Ewering C, 2015, CEPHALALGIA, V35, P946, DOI 10.1177/0333102414560632; Garcia-Martin E, 2014, RETINA-J RET VIT DIS, V34, P971, DOI 10.1097/IAE.0000000000000028; Garcia-Martin E, 2013, INVEST OPHTH VIS SCI, V54, P7137, DOI 10.1167/iovs.13-12726; Garcia-Martin E, 2012, OPHTHALMOLOGY, V119, P1705, DOI 10.1016/j.ophtha.2012.01.046; Garcia-Martin E, 2011, BRIT J OPHTHALMOL, V95, P1577, DOI 10.1136/bjo.2010.199232; Hwang YH, 2015, J GLAUCOMA, V24, P503, DOI 10.1097/IJG.0000000000000015; Jones-Odeh E, 2015, EYE, V29, P1270, DOI 10.1038/eye.2015.158; Kalesnykas G, 2008, NEUROSCIENCE, V155, P937, DOI 10.1016/j.neuroscience.2008.06.038; Kersten HM, 2015, J NEUROL, V262, P2457, DOI 10.1007/s00415-015-7869-2; Kim M, 2011, INVEST OPHTH VIS SCI, V52, P6882, DOI 10.1167/iovs.11-7276; Kure CE, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2015-000356; Laclaustra M, 2016, J AM COLL CARDIOL, V67, P1263, DOI 10.1016/j.jacc.2015.12.056; Larrosa JM, 2014, INVEST OPHTH VIS SCI, V55, P3043, DOI 10.1167/iovs.13-13629; Liu Qing Yan, 2016, Am J Neurodegener Dis, V5, P74; Lyons-Wait VA, 2002, OPTOMETRY VISION SCI, V79, P353, DOI 10.1097/00006324-200206000-00008; Martinez-Lapiscina EH, 2016, LANCET NEUROL, V15, P574, DOI 10.1016/S1474-4422(16)00068-5; Ozge G, 2016, POSTGRAD MED, V128, P317, DOI 10.1080/00325481.2016.1159118; Park HYL, 2013, OPHTHALMOLOGY, V120, P1292, DOI 10.1016/j.ophtha.2012.11.021; Petrov AM, 2016, ACTA NATURAE, V8, P58, DOI 10.32607/20758251-2016-8-1-58-73; Salobrar-Garcia E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/636548; Satue S, 2016, J OPHTHALMO IN PRESS; Schuman JS, 1996, OPHTHALMOLOGY, V103, P1889, DOI 10.1016/S0161-6420(96)30410-7; Shariati MA, 2015, INVEST OPHTH VIS SCI, V56, P2790, DOI 10.1167/iovs.14-15145; SMITH SC, 1995, CIRCULATION, V92, P2; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yamashita T, 2012, JPN J OPHTHALMOL, V56, P502, DOI 10.1007/s10384-012-0146-3	30	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0189929	10.1371/journal.pone.0189929	http://dx.doi.org/10.1371/journal.pone.0189929			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272287	gold, Green Published, Green Submitted			2022-12-26	WOS:000418651500018
J	Hassan, T; Thiberville, L; Hermant, C; Lachkar, S; Piton, N; Guisier, F; Salaun, M				Hassan, Tidi; Thiberville, Luc; Hermant, Christophe; Lachkar, Samy; Piton, Nicolas; Guisier, Florian; Salaun, Mathieu			Assessing the feasibility of confocal laser endomicroscopy in solitary pulmonary nodules for different part of the lungs, using either 0.6 or 1.4 mm probes	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; CANCER; PROBABILITY; BRONCHOSCOPY; DIAGNOSIS; CT	Background Malignant solitary pulmonary nodules (SPN) have become more prevalent, with upper lobes predilection. Probe-based confocal laser endomicroscopy (pCLE) provides in-vivo imaging of SPN. However, the stiffness of the 1mm confocal probe (AlveoFlex) causes difficult accessibility to the upper lobes. A thinner 600 mu m probe designed for bile duct exploration (CholangioFlex) has the potential to reach the upper lobes. Objectives To examine the accessibility of malignant SPNs in all segments of the lungs using either the 0.6mm or 1.4 mm probe and to assess the quality and inter observer interpretation of SPN confocal imaging obtained from either miniprobes. Methods Radial(r)-EBUS was used to locate and sample the SPN. In-vivo pCLE analysis of the SPN was performed using either CholangioFlex (apical and posterior segments of the upper lobes) or AlveoFlex (other segments) introduced into the guide sheath before sampling. pCLE features were compared between the two probes. Results Fourty-eight patients with malignant SPN were included (NCT01931579). The diagnostic accuracy for lung cancer using r-EBUS coupled with pCLE imaging was 79.2%. All the SPNs were successfully explored with either one of the probes (19 and 29 subjects for CholangioFlex and AlveoFlex, respectively). A specific solid pattern in the SPN was found in 30 pCLE explorations. Comparison between the two probes found no differences in the axial fibers thickness, cell size and specific solid pattern in the nodules. Extra-alveolar microvessel size appeared larger using CholangioFlex suggesting less compression effect. The kappa test for interobserver agreement for the identification of solid pattern was 0.74 (p = 0.001). Conclusion This study demonstrates that pCLE imaging of SPNs is achievable in all segments of both lungs using either the 0.6mm or 1.4mm miniprobe.	[Hassan, Tidi; Thiberville, Luc; Lachkar, Samy; Guisier, Florian; Salaun, Mathieu] Rouen Univ Hosp, Thorac Oncol & Resp Intens Care, Dept Resp Care, Rouen, France; [Hassan, Tidi; Thiberville, Luc; Lachkar, Samy; Guisier, Florian; Salaun, Mathieu] Rouen Univ Hosp, CIC, CRB, U1404, Rouen, France; [Hassan, Tidi] Univ Kebangsaan Malaysia, Fac Med, Dept Med, Cheras, Malaysia; [Thiberville, Luc; Guisier, Florian; Salaun, Mathieu] Normandie Univ, UNIROUEN, LITIS, Quant IF, Rouen, France; [Hermant, Christophe] Univ Toulouse III Paul Sabatier, CHU Toulouse, Hop Larrey, Serv Pneumol Allergol, Toulouse, France; [Piton, Nicolas] Rouen Univ Hosp, Dept Pathol & Cytol, Rouen, France	CHU de Rouen; CHU de Rouen; Universiti Kebangsaan Malaysia; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Rouen	Salaun, M (corresponding author), Rouen Univ Hosp, Thorac Oncol & Resp Intens Care, Dept Resp Care, Rouen, France.; Salaun, M (corresponding author), Rouen Univ Hosp, CIC, CRB, U1404, Rouen, France.; Salaun, M (corresponding author), Normandie Univ, UNIROUEN, LITIS, Quant IF, Rouen, France.	mathieu.salaun@univ-rouen.fr	SALAUN, Mathieu/M-3914-2019	SALAUN, Mathieu/0000-0003-1430-6396; Guisier, Florian/0000-0002-8166-7303; Piton, Nicolas/0000-0001-8779-586X	European Respiratory Society [STRTF-2014-5440]; French Ministry of Health / Institut National du Cancer, programme hospitalier de recherche clinique "Cancer" [PHRC11-192]	European Respiratory Society; French Ministry of Health / Institut National du Cancer, programme hospitalier de recherche clinique "Cancer"	This work was supported by the European Respiratory Society, Fellowship STRTF-2014-5440; French Ministry of Health / Institut National du Cancer, programme hospitalier de recherche clinique "Cancer", 2011 (# PHRC11-192).	Arenberg DA, 2011, AM J RESP CRIT CARE, V83, pA6097; Asano F, 2008, LUNG CANCER, V60, P366, DOI 10.1016/j.lungcan.2007.10.022; BYERS TE, 1984, JNCI-J NATL CANCER I, V72, P1271; Filner JJ, 2011, J BRONCHOL INTERN PU, V18, P23, DOI 10.1097/LBR.0b013e318203da1c; Hassan T, 2015, LUNG, V193, P773, DOI 10.1007/s00408-015-9769-8; Horeweg N, 2014, LANCET ONCOL, V15, P1332, DOI 10.1016/S1470-2045(14)70389-4; LIBBY DM, 1995, AM J MED, V99, P491, DOI 10.1016/S0002-9343(99)80225-3; McWilliams A, 2013, NEW ENGL J MED, V369, P910, DOI 10.1056/NEJMoa1214726; Mery CM, 2004, CHEST, V125, P2175, DOI 10.1378/chest.125.6.2175; Newton RC, 2012, RESP MED, V106, P127, DOI 10.1016/j.rmed.2011.09.009; Patel VK, 2013, CHEST, V143, P825, DOI 10.1378/chest.12-0960; Pelosi G, 2008, LUNG CANCER, V62, P202, DOI 10.1016/j.lungcan.2008.03.012; Salaun M, 2010, EUR RESPIR J, V36, P451, DOI 10.1183/09031936.00194509; Salaun M, 2013, EUR RESPIR J, V42, P1646, DOI 10.1183/09031936.00191911; Thiberville L, 2009, EUR RESPIR J, V33, P974, DOI 10.1183/09031936.00083708; Thiberville L, 2008, EUR RESP J; Thiberville L, 2007, AM J RESP CRIT CARE, V175, P22, DOI 10.1164/rccm.200605-684OC; Thiberville L, 2010, RESPIRATION, V79, P441, DOI 10.1159/000313495; Thiberville Luc, 2009, Proc Am Thorac Soc, V6, P444, DOI 10.1513/pats.200902-009AW; Yserbyt J, 2014, J HEART LUNG TRANSPL, V33, P492, DOI 10.1016/j.healun.2014.01.857	20	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189846	10.1371/journal.pone.0189846	http://dx.doi.org/10.1371/journal.pone.0189846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267317	Green Submitted, Green Published, gold			2022-12-26	WOS:000418587400053
J	Kido, D; Mizutani, K; Takeda, K; Mikami, R; Matsuura, T; Iwasaki, K; Izumi, Y				Kido, Daisuke; Mizutani, Koji; Takeda, Kohei; Mikami, Risako; Matsuura, Takanori; Iwasaki, Kengo; Izumi, Yuichi			Impact of diabetes on gingival wound healing via oxidative stress	PLOS ONE			English	Article							PROTEIN-KINASE-C; NONSURGICAL PERIODONTAL THERAPY; HIGH-GLUCOSE-CONCENTRATIONS; GLYCATION END-PRODUCTS; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; FIBROBLASTS; EXPRESSION; DYSFUNCTION; MELLITUS	The aim of this study is to investigate the mechanisms linking high glucose to gingival wound healing. Bilateral wounds were created in the palatal gingiva adjacent to maxillary molars of control rats and rats with streptozotocin-induced diabetes. After evaluating postsurgical wound closure by digital imaging, the maxillae including wounds were resected for histological examinations. mRNA expressions of angiogenesis, inflammation, and oxidative stress markers in the surgical sites were quantified by real-time polymerase chain reaction. Primary fibroblast culture from the gingiva of both rats was performed in high glucose and normal medium. In vitro wound healing and cell proliferation assays were performed. Oxidative stress marker mRNA expressions and reactive oxygen species production were measured. Insulin resistance was evaluated via PI3K/Akt and MAPK/Erk signaling following insulin stimulation using Western blotting. To clarify oxidative stress involvement in high glucose culture and cells of diabetic rats, cells underwent N-acetyl-L-cysteine treatment; subsequent Akt activity was measured. Wound healing in diabetic rats was significantly delayed compared with that in control rats. Nox1, Nox2, Nox4, p-47, and tumor necrosis factor-a mRNA levels were significantly higher at baseline in diabetic rats than in control rats. In vitro study showed that cell proliferation and migration significantly decreased in diabetic and high glucose culture groups compared with control groups. Nox1, Nox2, Nox4, and p47 expressions and reactive oxygen species production were significantly higher in diabetic and high glucose culture groups than in control groups. Akt phosphorylation decreased in the high glucose groups compared with the control groups. Erk1/2 phosphorylation increased in the high glucose groups, with or without insulin treatment, compared with the control groups. Impaired Akt phosphorylation partially normalized after antioxidant N-acetyl-L-cysteine treatment. Thus, delayed gingival wound healing in diabetic rats occurred because of impaired fibroblast proliferation and migration. Fibroblast dysfunction may occur owing to high glucose-induced insulin resistance via oxidative stress.	[Kido, Daisuke; Mizutani, Koji; Takeda, Kohei; Mikami, Risako; Matsuura, Takanori; Izumi, Yuichi] TMDU, Grad Sch Med & Dent Sci, Dept Periodontol, Tokyo, Japan; [Iwasaki, Kengo] TMDU, Grad Sch Med & Dent Sci, Dept Nanomed, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Mizutani, K (corresponding author), TMDU, Grad Sch Med & Dent Sci, Dept Periodontol, Tokyo, Japan.	mizuperi@tmd.ac.jp	Takeda, Kohei/AAN-3401-2021; Iwasaki, Kengo/AAG-7902-2021	Takeda, Kohei/0000-0002-9063-2532; 	Japan Society for the promotion of Science [25862043, 16K20666]; Grants-in-Aid for Scientific Research [16K20666] Funding Source: KAKEN	Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the promotion of Science (16K20666 and 25862043), https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-16K20666/.; This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the promotion of Science (25862043). The authors would like to thanks to Dr. Mayu Hasegawa, Dr. Masahiro Noda, Dr. Prima Buranasin, and Dr. Yujin Ohsugi in department of periodontology, TMDU, for technical advice. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	BATEMAN DN, 1984, HUM TOXICOL, V3, P393, DOI 10.1177/096032718400300504; Benazzoug Y, 1998, EXP GERONTOL, V33, P445, DOI 10.1016/S0531-5565(98)00015-1; Borgnakke WS, 2013, J CLIN PERIODONTOL, V40, pS135, DOI [10.1111/jcpe.12080, 10.1902/jop.2013.1340013]; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chang PC, 2014, J DENT RES, V93, P388, DOI 10.1177/0022034514523785; Chang PC, 2012, J PERIODONTOL, V83, P644, DOI 10.1902/jop.2011.110325; Christgau M, 1998, J CLIN PERIODONTOL, V25, P112, DOI 10.1111/j.1600-051X.1998.tb02417.x; Du SC, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/743798; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; GANDA OP, 1976, DIABETES, V25, P595, DOI 10.2337/diabetes.25.7.595; GIARDINO I, 1994, J CLIN INVEST, V94, P110, DOI 10.1172/JCI117296; GOPAUL NK, 1995, FEBS LETT, V368, P225, DOI 10.1016/0014-5793(95)00649-T; Hamburg NM, 2007, ARTERIOSCL THROM VAS, V27, P2650, DOI 10.1161/ATVBAHA.107.153288; Hehenberger K, 1997, CELL BIOCHEM FUNCT, V15, P197; Hehenberger Karin, 1998, Wound Repair and Regeneration, V6, P135, DOI 10.1046/j.1524-475X.1998.60207.x; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; HUE L, 1975, BIOCHEM J, V152, P105, DOI 10.1042/bj1520105; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kamal A, 2000, DIABETOLOGIA, V43, P500, DOI 10.1007/s001250051335; Kardesler L, 2011, INFLAMM RES, V60, P143, DOI 10.1007/s00011-010-0248-7; Karima M, 2005, J LEUKOCYTE BIOL, V78, P862, DOI 10.1189/jlb.1004583; Katagiri S, 2016, DIABETES, V65, P2760, DOI 10.2337/db15-1721; Katz J, 2005, J CLIN PERIODONTOL, V32, P40, DOI 10.1111/j.1600-051X.2004.00623.x; Kiji M, 2007, CLIN EXP IMMUNOL, V149, P327, DOI 10.1111/j.1365-2249.2007.03414.x; King GL, 2008, J PERIODONTOL, V79, P1527, DOI 10.1902/jop.2008.080246; Lalla E, 2000, J CLIN INVEST, V105, P1117, DOI 10.1172/JCI8942; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Lantuejoul S, 1998, AM J SURG PATHOL, V22, P1267, DOI 10.1097/00000478-199810000-00012; Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7; Loots MAM, 1999, ARCH DERMATOL RES, V291, P93, DOI 10.1007/s004030050389; LORENZI M, 1985, DIABETES, V34, P621, DOI 10.2337/diabetes.34.7.621; MARK EJ, 1993, VIRCHOWS ARCH A, V422, P445, DOI 10.1007/BF01606452; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mattson John S, 2002, Compend Contin Educ Dent, V23, P1135; Mealey BL, 2006, J PERIODONTOL, V77, P1289, DOI 10.1902/jop.2006.050459; Mima A, 2012, DIABETES, V61, P2967, DOI 10.2337/db11-1824; Miyamoto T, 2002, AVIAN DIS, V46, P10, DOI 10.1637/0005-2086(2002)046[0010:LPRDET]2.0.CO;2; Mizutani K, 2014, J DENT RES, V93, P596, DOI 10.1177/0022034514532102; Navarro-Sanchez AB, 2007, J CLIN PERIODONTOL, V34, P835, DOI 10.1111/j.1600-051X.2007.01127.x; Nishikawa T, 2012, J CLIN PERIODONTOL, V39, P342, DOI 10.1111/j.1600-051X.2011.01848.x; Noguchi K, 2001, INFLAMMATION, V25, P75, DOI 10.1023/A:1007110304044; Ogita M, 2015, LASER MED SCI, V30, P1855, DOI 10.1007/s10103-014-1691-4; OHSHIMA M, 1995, J PERIODONTAL RES, V30, P220, DOI 10.1111/j.1600-0765.1995.tb01277.x; Paoletti R, 2006, VASC HEALTH RISK MAN, V2, P145, DOI 10.2147/vhrm.2006.2.2.145; Park K, 2013, MOL CELL BIOL, V33, P3227, DOI 10.1128/MCB.00506-13; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; PORTA M, 1988, DIABETES RES CLIN EX, V7, P59; Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366; Reddy MA, 2015, DIABETOLOGIA, V58, P443, DOI 10.1007/s00125-014-3462-y; ROSS R, 1968, BIOL REV, V43, P51, DOI 10.1111/j.1469-185X.1968.tb01109.x; Simpson TC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004714.pub3; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stehouwer CDA, 2002, DIABETES, V51, P1157, DOI 10.2337/diabetes.51.4.1157; Tominaga H, 1999, ANAL COMMUN, V36, P47, DOI 10.1039/a809656b; VANDEBERG JS, 1984, AM J PATHOL, V114, P187; WIERUSZWYSOCKA B, 1995, DIABETES RES CLIN PR, V27, P193, DOI 10.1016/0168-8227(95)01043-D; WILLERSHAUSENZONNCHEN B, 1991, J CLIN PERIODONTOL, V18, P190, DOI 10.1111/j.1600-051X.1991.tb01132.x; Xuan YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108182; Yokota S, 2010, INFECT IMMUN, V78, P468, DOI 10.1128/IAI.00903-09; YOUNG IS, 1995, FREE RADICAL BIO MED, V18, P833, DOI 10.1016/0891-5849(94)00202-U	60	43	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189601	10.1371/journal.pone.0189601	http://dx.doi.org/10.1371/journal.pone.0189601			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267310	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400034
J	Knapen, JEP; Blaker, NM; Pollet, TV				Knapen, Jill E. P.; Blaker, Nancy M.; Pollet, Thomas V.			Size, skills, and suffrage: Motivated distortions in perceived formidability of political leaders	PLOS ONE			English	Article							ENVISIONED PHYSICAL FORMIDABILITY; US PRESIDENTS; HEIGHT; PERCEPTION; DOMINANCE; MEN; POWER; EVOLUTION; COGNITION; STRENGTH	Research shows that perception of physical size and status are positively associated. The current study was developed to replicate and extend earlier research on height perceptions of political leaders, indicating that supporters perceive their leaders as taller than non-supporters do, and winners are perceived as taller after the elections, while losers are perceived as shorter after the elections (winner/loser effects). Individuals use greater height and strength as indications of greater physical formidability. We hypothesized that in-group leaders' height and strength, but not weight, would be overestimated more compared to out-group leaders', and that this status-size association is not only driven by dominance, but also by prestige. We also tested whether previously found gender effects in estimates were due to using one's own height as an anchor, and we used an improved methodological approach by relying on multiple measurements of physical formidability and a within-subject design for testing winner/loser effects. The results of a two-part longitudinal study (self-selected sample via voting advice website; N-Wave1 = 2,011; N-Wave2 = 322) suggest that estimated physical formidability of political leaders is affected by motivated perception, as prestige was positively associated with estimated formidability, and in-group leaders were estimated more formidable than out-group leaders. We conclude that distortions in judged formidability related to social status are the result of motivated social perception in order to promote group functioning and leadership. Although we did not replicate a winner-effect (greater estimations of formidability after winning the elections), we did find some evidence for a loser-effect. Earlier suggestions that men make larger estimations than women because of their own larger body size are not supported. Implications for theory and future research are discussed.	[Knapen, Jill E. P.; Blaker, Nancy M.] Vrije Univ Amsterdam, Sect Social & Org Psychol, Dept Expt & Appl Psychol, Amsterdam, Netherlands; [Knapen, Jill E. P.] Univ Amsterdam, Dept Work & Org Psychol, Amsterdam, Netherlands; [Blaker, Nancy M.] Univ Otago, Dept Management, Dunedin, New Zealand; [Pollet, Thomas V.] Northumbria Univ, Dept Psychol, Newcastle Upon Tyne, Tyne & Wear, England	Vrije Universiteit Amsterdam; University of Amsterdam; University of Otago; Northumbria University	Knapen, JEP (corresponding author), Vrije Univ Amsterdam, Sect Social & Org Psychol, Dept Expt & Appl Psychol, Amsterdam, Netherlands.; Knapen, JEP (corresponding author), Univ Amsterdam, Dept Work & Org Psychol, Amsterdam, Netherlands.	j.e.p.knapen@uva.nl	Pollet, Thomas/M-6346-2019	Pollet, Thomas/0000-0002-4210-935X; Knapen, Jill/0000-0002-4876-5008	NWO (de Nederlandse Organisatie voor Wetenschappelijk Onderzoek) [451.10.032]; NIAS fellowship (Netherlands Institute for Advanced Study)	NWO (de Nederlandse Organisatie voor Wetenschappelijk Onderzoek)(Netherlands Organization for Scientific Research (NWO)); NIAS fellowship (Netherlands Institute for Advanced Study)	TVP is supported by an NWO (de Nederlandse Organisatie voor Wetenschappelijk Onderzoek; www.nwo.nl) Veni grant (451.10.032), and NIAS fellowship (Netherlands Institute for Advanced Study; http://www.nias.knaw.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Archer J, 2007, PERS INDIV DIFFER, V43, P627, DOI 10.1016/j.paid.2007.01.005; Bernard J, 1928, AM J SOCIOL, V34, P296, DOI 10.1086/214670; Blaker N.M., 2014, PSYCHOL SOCIAL STATU, P119; Blaker NM, 2013, GROUP PROCESS INTERG, V16, P17, DOI 10.1177/1368430212437211; Brown DE, BIG MAN U PERSPECTIV; Carrier DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019630; Cesario J, 2014, SOC PSYCHOL PERS SCI, V5, P12, DOI 10.1177/1948550613485605; Cheng JT, 2013, J PERS SOC PSYCHOL, V104, P103, DOI 10.1037/a0030398; DANNENMAIER WD, 1964, J SOC PSYCHOL, V63, P361, DOI 10.1080/00224545.1964.9922246; DARLEY JM, 1967, HUM RELAT, V20, P29, DOI 10.1177/001872676702000103; EGOLF DB, 1991, SEX ROLES, V24, P365, DOI 10.1007/BF00288309; Ellian A., 2014, DIEDERIK SAMSOM HEEF; Ellis BJ, 1995, ADAPTED MIND EVOLUTI, P267; Ellis L., 1994, SOCIAL STRATIFICATIO, P93; Fessler DMT, 2013, PSYCHOL SCI, V24, P797, DOI 10.1177/0956797612461508; Fessler DMT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032751; Gawley T, 2009, SEX ROLES, V60, P208, DOI 10.1007/s11199-008-9520-5; Giessner SR, 2007, ORGAN BEHAV HUM DEC, V104, P30, DOI 10.1016/j.obhdp.2006.10.001; Gilovich T., 2002, HEURISTICS BIASES PS, DOI [DOI 10.1017/CBO9780511808098.004, DOI 10.1017/CBO9780511808098]; Hamstra MRW, 2014, PERS INDIV DIFFER, V56, P190, DOI 10.1016/j.paid.2013.08.014; HANDWERKER WP, 1982, AM ANTHROPOL, V84, P97, DOI 10.1525/aa.1982.84.1.02a00070; Haselton M. G., 2006, EVOLUTION SOCIAL PSY, P15, DOI [DOI 10.4324/9780203782965, 10.4324/9780203782965]; Haselton MG, 2000, J PERS SOC PSYCHOL, V78, P81, DOI 10.1037/0022-3514.78.1.81; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; HIGHAM PA, 1992, CAN J BEHAV SCI, V24, P404, DOI 10.1037/h0078723; Holbrook C, 2013, COGNITION, V127, P46, DOI 10.1016/j.cognition.2012.12.002; IBM Corp, 2013, IBM SPSS STAT WINDOW; JACKSON LA, 1992, J SOC PSYCHOL, V132, P433, DOI 10.1080/00224545.1992.9924723; Judge TA, 2004, J APPL PSYCHOL, V89, P428, DOI 10.1037/0021-9010.89.3.428; KLEIN WM, 1992, J EXP SOC PSYCHOL, V28, P145, DOI 10.1016/0022-1031(92)90036-J; Korsten A., 2012, WAT VALT OP AAN VERK; KOULACK D, 1972, CAN J BEH SCI, V4, P50, DOI 10.1037/h0082289; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Landau MJ, 2010, PSYCHOL BULL, V136, P1045, DOI 10.1037/a0020970; Lemay EP, 2015, CURR OPIN PSYCHOL, V1, P72, DOI 10.1016/j.copsyc.2014.11.002; Littell RC, 2000, STAT MED, V19, P1793, DOI 10.1002/1097-0258(20000715)19:13<1793::AID-SIM482>3.3.CO;2-H; Lopez AC, 2011, INT SECURITY, V36, P48, DOI 10.1162/ISEC_a_00056; Lukaszewski AW, 2016, J PERS SOC PSYCHOL, V110, P385, DOI 10.1037/pspi0000042; Maner JK, 2005, J PERS SOC PSYCHOL, V88, P63, DOI 10.1037/0022-3514.88.1.63; Marsh AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005707; Meerhof R., 2012, STEMBUSDUEL RUTTE VE; MELAMED T, 1992, PSYCHOL REP, V71, P587, DOI 10.2466/PR0.71.6.587-593; MELAMED T, 1994, PERS INDIV DIFFER, V17, P689, DOI 10.1016/0191-8869(94)90143-0; MONTEPARE JM, 1995, J NONVERBAL BEHAV, V19, P31, DOI 10.1007/BF02173411; Murray Gregg R, 2014, Politics Life Sci, V33, P33, DOI 10.2990/33_1_33; Murray GR, 2011, SOC SCI QUART, V92, P1215, DOI 10.1111/j.1540-6237.2011.00815.x; Murray SL, 1999, PSYCHOL INQ, V10, P23, DOI 10.1207/s15327965pli1001_3; Re DE, 2012, PERCEPTION, V41, P1477, DOI 10.1068/p7342; Roberts Julian V., 1986, PHYSICAL APPEARANCE, P113; SAHLINS MD, 1963, COMP STUD SOC HIST, V5, P285, DOI 10.1017/S0010417500001729; Schubert TW, 2009, SOC COGNITION, V27, P1, DOI 10.1521/soco.2009.27.1.1; Schubert TW, 2005, J PERS SOC PSYCHOL, V89, P1, DOI 10.1037/0022-3514.89.1.1; Sear R, 2009, BIOL LETTERS, V5, P606, DOI 10.1098/rsbl.2009.0342; Sell A, 2012, HUM NATURE-INT BIOS, V23, P30, DOI 10.1007/s12110-012-9131-2; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Sorokowski P, 2015, PERS INDIV DIFFER, V74, P220, DOI 10.1016/j.paid.2014.10.034; Sorokowski P, 2010, EUR J SOC PSYCHOL, V40, P1302, DOI 10.1002/ejsp.710; Spisak BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036945; Stillman TF, 2009, EVOL HUM BEHAV, V30, P124, DOI 10.1016/j.evolhumbehav.2008.09.005; Stulp G, 2013, LEADERSHIP QUART, V24, P159, DOI 10.1016/j.leaqua.2012.09.002; Stulp G, 2012, EVOL PSYCHOL-US, V10, P588, DOI 10.1177/147470491201000314; Thomsen L, 2011, SCIENCE, V331, P477, DOI 10.1126/science.1199198; Tiedens LZ, 2007, J PERS SOC PSYCHOL, V93, P402, DOI 10.1037/0022-3514.93.3.402; Trebicky V, 2013, PSYCHOL SCI, V24, P1664, DOI 10.1177/0956797613477117; Van Vugt M., 2010, SELECTED WHY SOME PE; Von Rueden C., 2014, PSYCHOL SOCIAL STATU, P179; Watkins CD, 2013, EVOL HUM BEHAV, V34, P366, DOI 10.1016/j.evolhumbehav.2013.06.004; WERNER D, 1982, ETHOS, V10, P136, DOI 10.1525/eth.1982.10.2.02a00030; WILSON M, 1985, ETHOL SOCIOBIOL, V6, P59, DOI 10.1016/0162-3095(85)90041-X; WILSON PR, 1968, J SOC PSYCHOL, V74, P97, DOI 10.1080/00224545.1968.9919806; Wrangham RW, 1999, YEARB PHYS ANTHROPOL, V42, P1; Young TJ, 1996, PERCEPT MOTOR SKILL, V82, P1002, DOI 10.1177/003151259608200301; Zanolie K, 2012, BRAIN COGNITION, V78, P50, DOI 10.1016/j.bandc.2011.10.006; Zebrowitz L.A., 2006, EVOLUTION SOCIAL PSY, P81, DOI 10.4324/9780203782965	76	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0188485	10.1371/journal.pone.0188485	http://dx.doi.org/10.1371/journal.pone.0188485			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8BI	29267275	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000418587400009
J	Manchego, CE; Hildebrandt, P; Cueva, J; Espinosa, CI; Stimm, B; Gunter, S				Manchego, Carlos E.; Hildebrandt, Patrick; Cueva, Jorge; Espinosa, Carlos Ivan; Stimm, Bernd; Guenter, Sven			Climate change versus deforestation: Implications for tree species distribution in the dry forests of southern Ecuador	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; DISTRIBUTION MODELS; RANGE SHIFTS; RISK; PERFORMANCE; PRIORITIES; DIVERSITY; SCENARIOS; MIGRATION; PATTERNS	Seasonally dry forests in the neotropics are heavily threatened by a combination of human disturbances and climate change; however, the severity of these threats is seldom contrasted. This study aims to quantify and compare the effects of deforestation and climate change on the natural spatial ranges of 17 characteristic tree species of southern Ecuador dry deciduous forests, which are heavily fragmented and support high levels of endemism as part of the Tumbesian ecoregion. We used 660 plant records to generate species distribution models and land-cover data to project species ranges for two time frames: a simulated deforestation scenario from 2008 to 2014 with native forest to anthropogenic land-use conversion, and an extreme climate change scenario (CCSM4.0, RCP 8.5) for 2050, which assumed zero change from human activities. To assess both potential threats, we compared the estimated annual rates of species loss (i.e., range shifts) affecting each species. Deforestation loss for all species averaged approximately 71 km 2/year, while potential climate-attributed loss was almost 21 km 2/year. Moreover, annual area loss rates due to deforestation were significantly higher than those attributed to climate-change (P < 0.01). However, projections into the future scenario show evidence of diverging displacement patterns, indicating the potential formation of novel ecosystems, which is consistent with other species assemblage predictions as result of climate change. Furthermore, we provide recommendations for management and conservation, prioritizing the most threatened species such as Albizia multiflora, Ceiba trichistandra, and Cochlospermum vitifolium.	[Manchego, Carlos E.; Hildebrandt, Patrick; Cueva, Jorge; Stimm, Bernd; Guenter, Sven] Tech Univ Munich, Res Dept Ecol & Ecosyst Management, Freising Weihenstephan, Germany; [Manchego, Carlos E.; Cueva, Jorge; Espinosa, Carlos Ivan] Univ Tecn Particular Loja, Dept Ciencias Nat, Loja, Ecuador; [Guenter, Sven] Thunen Inst Int Forestry & Forest Econ, Sect Forestry Worldwide, Hamburg, Germany	Technical University of Munich; Universidad Tecnica Particular de Loja; Johann Heinrich von Thunen Institute	Manchego, CE (corresponding author), Tech Univ Munich, Res Dept Ecol & Ecosyst Management, Freising Weihenstephan, Germany.; Manchego, CE (corresponding author), Univ Tecn Particular Loja, Dept Ciencias Nat, Loja, Ecuador.	carlos.manchego@tum.de	Espinosa, Carlos Ivan/AAI-1305-2019; Ortiz, Jorge Cueva/AAE-2572-2020; Stimm, Bernd/O-7865-2014	Espinosa, Carlos Ivan/0000-0002-5330-4505; Ortiz, Jorge Cueva/0000-0002-7920-8343; Stimm, Bernd/0000-0003-4808-1893	German Research Foundation (DFG) [PAK 824/B3 STI 191/2-1]; Catholic Academic Exchange Service (KAAD); Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT); Technical University of Munich (TUM)	German Research Foundation (DFG)(German Research Foundation (DFG)); Catholic Academic Exchange Service (KAAD); Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT); Technical University of Munich (TUM)	This research, CEM, PH, JC were financially supported by the German Research Foundation (DFG - http://www.dfg.de/en/) project PAK 824/B3 STI 191/2-1. CEM received a scholarship from the Catholic Academic Exchange Service (KAAD - http://www.kaad.de/en/) during the completion of the manuscript. JC was financially supported by the the Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT - http://www.educacionsuperior.gob.ec/). This work was supported by the German Research Foundation (DFG - http://www.dfg.de/en/) and the Technical University of Munich (TUM - https://www.tem.de/en/) in the framework of the Open Access Publishing Program. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Aguirre M.Z., 2006, BOT EC ANDES CENTRAL, P162; Aguirre Z, 2015, ESPECIES FORESTALES; Aguirre Z, 2005, LYONIA, V8; Aguirre Z., 2012, GUIA DENDROLOGICA ID; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2010, MAPPING SPECIES DIST; Baez S., 2010, PROPUESTA METODOLOGI; Banda-R K, 2016, SCIENCE, V353, P1383, DOI 10.1126/science.aaf5080; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Blackie R, 2014, TROPICAL DRY FORESTS; Booth TH, 2017, CLIMATIC CHANGE, V145, P259, DOI 10.1007/s10584-017-2107-9; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cobben MMP, 2015, PLANT GENET RESOUR-C, V13, P153, DOI 10.1017/S1479262114000847; Condom T, 2012, WATER INT, V37, P442, DOI 10.1080/02508060.2012.706773; Convention on Biological Diversity, 2011, QUICK GUID AICH BIOD; Cuesta Francisco, 2017, Neotropical Biodiversity, V3, P93, DOI 10.1080/23766808.2017.1295705; Espinosa C. I., 2012, Ecosistemas, V21, P167; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Tapia-Armijos MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133701; Franklin J, 2013, DIVERS DISTRIB, V19, P1217, DOI 10.1111/ddi.12125; GBIF, 2019, GBIF OCC DOWNL, DOI [10.15468/dl.yn92aj, DOI 10.15468/DL.V84N8J]; Geist HJ, 2004, BIOSCIENCE, V54, P817, DOI 10.1641/0006-3568(2004)054[0817:DCPOD]2.0.CO;2; Giorgi F, 2008, CLIM RES, V36, P141, DOI 10.3354/cr00728; Giovanelli JGR, 2010, ECOL MODEL, V221, P215, DOI 10.1016/j.ecolmodel.2009.10.009; HANNAH L, 1994, AMBIO, V23, P246; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hengl T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169748; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobbs R.J., 2013, NOVEL ECOSYSTEMS INT, V1st ed.; Jorgensen P.M., 1999, MONOGRAPHS SYSTEMATI, V75, P1; Jung M, 2016, ECOL INFORM, V31, P18, DOI 10.1016/j.ecoinf.2015.11.006; Linares-Palomino R., 2004, ARNALDOA, V11, P103; Linares-Palomino R, 2010, BIODIVERS CONSERV, V19, P169, DOI 10.1007/s10531-009-9713-4; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lozano P., 2002, BOT AUSTROECUATORIAN, P29; Lugo AE, 2009, BIOTROPICA, V41, P589, DOI 10.1111/j.1744-7429.2009.00550.x; Magrin GO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1499; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Marengo JA, 2010, CLIM DYNAM, V35, P1089, DOI 10.1007/s00382-009-0721-6; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Ministeno de Ambiente del Ecuador, 2015, MAP INT AMB; Ministerio de Ambiente del Ecuador, 2015, EST PATR NAT DAT BOS; Muenchow J, 2013, ERDKUNDE, V67, P241, DOI 10.3112/erdkunde.2013.03.03; Ochoa PA, 2016, CATENA, V140, P31, DOI 10.1016/j.catena.2016.01.011; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Ordonez A, 2016, NAT CLIM CHANGE, V6, P1104, DOI [10.1038/nclimate3127, 10.1038/NCLIMATE3127]; Pachauri R.K., 2014, CONTRIBUTION WORKING; Parker TA, 1992, STATUS FOREST REMNAN; Pecl GT, 2017, SCIENCE, V355, DOI 10.1126/science.aai9214; Pennington R.T., 2006, NEOTROPICAL SAVANNAS; Peters T, 2013, ECOSYSTEM SERVICES B, V221, P19, DOI [10.1007/978-3-642-38137-9_2, DOI 10.1007/978-3-642-38137-9_2]; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Portillo-Quintero CA, 2010, BIOL CONSERV, V143, P144, DOI 10.1016/j.biocon.2009.09.020; Ramirez-Villegas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013497; Rehm EM, 2013, FOREST ECOL MANAG, V305, P204, DOI 10.1016/j.foreco.2013.05.041; Reid W, 1989, SCI BASIS CONSERVING; RodriguezMahecha J. V, 2004, HOTSPOTS REVISITED E, P80; Rykiel EJ, 1996, ECOL MODEL, V90, P229, DOI 10.1016/0304-3800(95)00152-2; Saenz M, 2005, INDICADORES BIODIVER; Sakschewski B, 2016, NAT CLIM CHANGE, V6, P1032, DOI [10.1038/nclimate3109, 10.1038/NCLIMATE3109]; Sanchez-Azofeifa A, 2014, TROPICAL DRY FORESTS IN THE AMERICAS: ECOLOGY, CONSERVATION, AND MANAGEMENT, P1; Sanchez-Azofeifa GA, 2005, BIOTROPICA, V37, P477, DOI 10.1111/j.1744-7429.2005.00066.x; SARMIENTO G, 1992, NATURE AND DYNAMICS OF FOREST-SAVANNA BOUNDARIES, P583; Secretariat of the Convention on Biological Diversity, 2001, GLOB BIOD OUTL 1 ANN; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sierra R, 2002, LANDSCAPE URBAN PLAN, V59, P95, DOI 10.1016/S0169-2046(02)00006-3; Sierra R., 2013, PATRONES FACTORES DE; Sierra R, 1999, PROPUESTA PRELIMINAR; Smith AB, 2012, ELIMCELLDUPS ELIMINA; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; The Plant List, 2013, VERS 1 1 PUBL INT; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; van der Sleen P, 2015, NAT GEOSCI, V8, P24, DOI [10.1038/ngeo2313, 10.1038/NGEO2313]; Villacis M., 2008, RESSOURCES EAU GLACI; Wei SG, 2017, J ADV MODEL EARTH SY, V9, P65, DOI 10.1002/2016MS000686; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; World Wildlife Fund, 2001, TROP SUBTR DRY BROAD; Wunder S, 2000, EC DEF EX EC	82	20	20	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190092	10.1371/journal.pone.0190092	http://dx.doi.org/10.1371/journal.pone.0190092			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267357	gold, Green Published, Green Submitted			2022-12-26	WOS:000418587400090
J	Shiode, Y; Morizane, Y; Matoba, R; Hirano, M; Doi, S; Toshima, S; Araki, R; Hosogi, M; Takahashi, K; Kanzaki, Y; Yonezawa, T; Shiraga, F				Shiode, Yusuke; Morizane, Yuki; Matoba, Ryo; Hirano, Masayuki; Doi, Shinichiro; Toshima, Shinji; Araki, Ryoichi; Hosogi, Mika; Takahashi, Kosuke; Kanzaki, Yuki; Yonezawa, Tomoko; Shiraga, Fumio			A novel cell exclusion zone assay with a barrier made from room temperature vulcanizing silicone rubber	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; MIGRATION; INVASION	Objective To examine the usefulness of room temperature vulcanizing (RTV) silicone rubber as a barrier material for cell exclusion zone assays. Methods We created barriers using three types of RTV silicone rubber with differing viscosities. We then assessed the adherence of these barriers to culture dishes and their ease of removal from the dishes. We tested the effect of the newly created barriers on the extracellular matrix (ECM) protein fibronectin by attaching and then removing them from fibronectin-coated culture dishes. We also conducted cell exclusion zone assays with MIO-M1 cells using this new barrier in order to measure cell migration. We used real time reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemical staining to measure the effect of fibronectin on MIO-M1 cell migration and the effect of migration (with fibronectin coating) on basic fibroblast growth factor (bFGF) expression in MIO-M1 cells. Results Of the three types of RTV silicon rubber tested, KE-3495-T was the best in terms of adherence to the dish and ease of removal from the dish. When barrier attachment and removal tests were performed, this rubber type did not have an effect on the fibronectin that coated the dish. In the cell exclusion assay, removal of the barrier revealed that a cell-free area with a distinct margin had been created, which allowed us to conduct a quantitative assessment of migration. Fibronectin significantly promoted the migration of MIO-M1 cells (P = 0.02). In addition, both real time RT-PCR and immunohistological staining indicated that bFGF expression in migrating MIO-M1 cells was significantly higher than that in non-migrating cells (P = 0.03). Conclusions RTV silicone rubber can be used to create an effective barrier in cell exclusion zone assays and allows simple and low-cost multi-parametric analysis of cell migration.	[Shiode, Yusuke; Morizane, Yuki; Matoba, Ryo; Hirano, Masayuki; Doi, Shinichiro; Toshima, Shinji; Araki, Ryoichi; Hosogi, Mika; Takahashi, Kosuke; Kanzaki, Yuki; Shiraga, Fumio] Okayama Univ, Dept Ophthalmol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Yonezawa, Tomoko] Okayama Univ, Dept Mol Biol & Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Okayama University; Okayama University	Morizane, Y (corresponding author), Okayama Univ, Dept Ophthalmol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	moriza-y@okayama-u.ac.jp	Kanzaki, Yuki/HGU-6189-2022	YONEZAWA, Tomoko/0000-0002-3380-8298				BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Chen Hui, 2014, BMC Res Notes, V7, P183, DOI 10.1186/1756-0500-7-183; Eccles SA, 2005, BIOTECHNOL ANN REV, V11, P391, DOI 10.1016/S1387-2656(05)11013-8; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gough W, 2011, J BIOMOL SCREEN, V16, P155, DOI 10.1177/1087057110393340; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hulkower Keren I, 2011, Pharmaceutics, V3, P107, DOI 10.3390/pharmaceutics3010107; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Kramer N, 2013, MUTAT RES-REV MUTAT, V752, P10, DOI 10.1016/j.mrrev.2012.08.001; Kroening S, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3126pl1; Ungefroren H, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-18	13	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190198	10.1371/journal.pone.0190198	http://dx.doi.org/10.1371/journal.pone.0190198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267369	Green Published, gold, Green Submitted			2022-12-26	WOS:000418587400103
J	Smythe, T; Wainwright, A; Foster, A; Lavy, C				Smythe, Tracey; Wainwright, Andrew; Foster, Allen; Lavy, Christopher			What is a good result after clubfoot treatment? A Delphi-based consensus on success by regional clubfoot trainers from across Africa	PLOS ONE			English	Article							PONSETI TREATMENT; EXPERIENCE; CHILDREN; SURGERY	Background Congenital talipes equino-varus (CTEV), also known as clubfoot, is one of the most common congenital musculoskeletal malformations. Despite this, considerable variation exists in the measurement of deformity correction and outcome evaluation. This study aims to determine the criteria for successful clubfoot correction using the Ponseti technique in low resource settings through Africa. Methods Using the Delphi method, 18 experienced clubfoot practitioners and trainers from ten countries in Africa ranked the importance of 22 criteria to define an 'acceptable or good clubfoot correction' at the end of bracing with the Ponseti technique. A 10cm visual analogue scale was used. They repeated the rating with the results of the mean scores and standard deviation of the first test provided. The consistency among trainers was determined with the intra-class correlation coefficient (ICC). From the original 22 criteria, ten criteria with a mean score > 7 and SD < 2 were identified and were rated through a second Delphi round by 17 different clubfoot treatment trainers from 11 countries in Africa. The final definition consisted of all statements that achieved strong agreement, a mean score of > 9 and SD<1.5. Results The consensus definition of a successfully treated clubfoot includes: (1) a plantigrade foot, (2) the ability to wear a normal shoe, (3) no pain, and (4) the parent is satisfied. Participants demonstrated good consistency in rating these final criteria (ICC 0.88; 0.74,0.97). Conclusions The consistency of Ponseti technique trainers from Africa in rating criteria for a successful outcome of clubfoot management was good. The consensus definition includes basic physical assessment, footwear use, pain and parent satisfaction.	[Smythe, Tracey; Foster, Allen] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London, England; [Wainwright, Andrew; Lavy, Christopher] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Headington, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Smythe, T (corresponding author), London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London, England.	tracey.smythe@lshtm.ac.uk	Wainwright, Andrew/AAO-7698-2021; Smythe, Tracey/N-7699-2017	Foster, Allen/0000-0003-2368-4436; Smythe, Tracey/0000-0003-3408-7362	Beit Trust; CBM	Beit Trust; CBM	This work was supported by Beit Trust (TS) and CBM (TS).	Adegbehingbe O., 2012, INT SOC ORTH SURG TR; Adewole O, 2014, E CENTRAL AFRICAN J, V19, P72; Andriesse H, 2005, BMC MUSCULOSKEL DIS, P6; Ayana B, 2014, ACTA ORTHOP, V85, P641, DOI 10.3109/17453674.2014.957085; Barker S, 2003, J PEDIATR ORTHOPED, V23, P265, DOI 10.1097/00004694-200303000-00025; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Campbell SM, 1999, MED CARE, V37, P964, DOI 10.1097/00005650-199909000-00012; Dietz FR, 2009, CLIN ORTHOP RELAT R, P467; Evans AM, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/1757-1146-7-27; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; GOODMAN CM, 1987, J ADV NURS, V12, P729, DOI 10.1111/j.1365-2648.1987.tb01376.x; Graham B, 2003, J CLIN EPIDEMIOL, V56, P1150, DOI 10.1016/S0895-4356(03)00211-7; Jones J., 1995, BMJ-BRIT MED J, P311; Keeley T, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1356-7; Laaveg S, 1980, J BONE JOINT SURG, P62; Lavy CBD, 2007, DISABIL REHABIL, V29, P857, DOI 10.1080/09638280701240169; Malagelada F, 2016, J CHILD ORTHOP, V10, P101, DOI 10.1007/s11832-016-0719-7; Mang'oli P, 2014, PAED CHILD HEALT-CAN, V19, P513, DOI 10.1093/pch/19.10.513; Morcuende JA, 2004, PEDIATRICS, V113, P376, DOI 10.1542/peds.113.2.376; Owen RM, 2012, J PEDIATR ORTHOP B, V21, P59, DOI 10.1097/BPB.0b013e3283499264; Portney L., 2009, FDN CLIN RES, V(3rd ed.); Roye BD, 2001, J PEDIATR ORTHOPED, V21, P42, DOI 10.1097/01241398-200101000-00010; Shabtai L, 2014, WORLD J ORTHOP, V5, P585, DOI 10.5312/wjo.v5.i5.585; Sinha IP, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-103; Smythe T, 2016, TROP MED INT HEALTH, V21, P1311, DOI 10.1111/tmi.12750	26	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190056	10.1371/journal.pone.0190056	http://dx.doi.org/10.1371/journal.pone.0190056			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8BI	29267350	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000418587400085
J	Yi, LX; Gao, FY; Siqin, B; Zhou, Y; Li, Q; Zhao, XQ; Jia, XY; Zhang, H				Yi, Liuxi; Gao, Fengyun; Siqin, Bateer; Zhou, Yu; Li, Qiang; Zhao, Xiaoqing; Jia, Xiaoyun; Zhang, Hui			Construction of an SNP-based high-density linkage map for flax (Linum usitatissimum L.) using specific length amplified fragment sequencing (SLAF-seq) technology	PLOS ONE			English	Article							IDENTIFICATION; COMPONENTS; ALIGNMENT; MARKERS	Flax is an important crop for oil and fiber, however, no high-density genetic maps have been reported for this species. Specific length amplified fragment sequencing (SLAF-seq) is a high-resolution strategy for large scale de novo discovery and genotyping of single nucleotide polymorphisms. In this study, SLAF-seq was employed to develop SNP markers in an F-2 population to construct a high-density genetic map for flax. In total, 196.29 million paired-end reads were obtained. The average sequencing depth was 25.08 in male parent, 32.17 in the female parent, and 9.64 in each F-2 progeny. In total, 389,288 polymorphic SLAFs were detected, from which 260,380 polymorphic SNPs were developed. After filtering, 4,638 SNPs were found suitable for genetic map construction. The final genetic map included 4,145 SNP markers on 15 linkage groups and was 2,632.94 cM in length, with an average distance of 0.64 cM between adjacent markers. To our knowledge, this map is the densest SNP-based genetic map for flax. The SNP markers and genetic map reported in here will serve as a foundation for the fine mapping of quantitative trait loci (QTLs), map-based gene cloning and marker assisted selection (MAS) for flax.	[Yi, Liuxi; Siqin, Bateer; Zhao, Xiaoqing] Inner Mongolia Acad Agr & Husb Sci, Biotechnol Res Ctr, Hohhot, Inner Mongolia, Peoples R China; [Gao, Fengyun; Zhou, Yu; Jia, Xiaoyun; Zhang, Hui] Inner Mongolia Acad Agr & Husb Sci, Special Crops Inst, Hohhot, Inner Mongolia, Peoples R China; [Li, Qiang] Inner Mongolia Acad Agr & Husb Sci, Corn Inst, Hohhot, Inner Mongolia, Peoples R China		Siqin, B (corresponding author), Inner Mongolia Acad Agr & Husb Sci, Biotechnol Res Ctr, Hohhot, Inner Mongolia, Peoples R China.	nmgbaater@163.com		Siqin, Bateer/0000-0001-8828-9141	Fund for Innovation of Agricultural and Husbandry Sciences in Inner Mongolia [2011CXJJM01]; Inner Mongolia Science and Technology Department; Fund for the China Agriculture Research System [CARS-17-GW-3]; China's Ministry of Agriculture	Fund for Innovation of Agricultural and Husbandry Sciences in Inner Mongolia; Inner Mongolia Science and Technology Department; Fund for the China Agriculture Research System; China's Ministry of Agriculture	This work was supported by 1) the Fund for Innovation of Agricultural and Husbandry Sciences in Inner Mongolia, Grant number: 2011CXJJM01; funding institution: Inner Mongolia Science and Technology Department; http://www.nmkjt.gov.cn/; BS; and 2) the Fund for the China Agriculture Research System, CARS-17-GW-3; China's Ministry of Agriculture; http://www.moa.gov.cn/; XY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Cloutier S, 2012, THEOR APPL GENET, V125, P685, DOI 10.1007/s00122-012-1860-4; Cloutier S, 2011, MOL BREEDING, V28, P437, DOI 10.1007/s11032-010-9494-1; Cullis C. A., 2007, Oilseeds, P275; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Guo YS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00393; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Jansen J, 2001, THEOR APPL GENET, V102, P1113, DOI 10.1007/s001220000489; Ken WJ., 2002, GENOME RES, V12, P656, DOI DOI 10.1101/GR.229202; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liu DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098855; Luo C, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01310; Ma JL, 2015, PROCEEDINGS OF 2015 INTERNATIONAL CONFERENCE ON ORANGE TECHNOLOGIES (ICOT), P10, DOI 10.1109/ICOT.2015.7498477; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Oh TJ, 2000, THEOR APPL GENET, V101, P590, DOI 10.1007/s001220051520; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Qi ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104871; Ragupathy R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-217; Simopoulos AP, 2000, POULTRY SCI, V79, P961, DOI 10.1093/ps/79.7.961; Singh KK, 2011, CRIT REV FOOD SCI, V51, P210, DOI 10.1080/10408390903537241; Spielmeyer W, 1998, THEOR APPL GENET, V97, P633, DOI 10.1007/s001220050939; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Toure A, 2010, COMPR REV FOOD SCI F, V9, P261, DOI 10.1111/j.1541-4337.2009.00105.x; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; van Os H, 2005, THEOR APPL GENET, V112, P187, DOI 10.1007/s00122-005-0124-y; Vision TJ, 2000, GENETICS, V155, P407; Wang ZW, 2012, PLANT J, V72, P461, DOI 10.1111/j.1365-313X.2012.05093.x; West MAL, 2006, GENOME RES, V16, P787, DOI 10.1101/gr.5011206; Woodhead M, 2005, MOL ECOL, V14, P1681, DOI 10.1111/j.1365-294X.2005.02543.x; Wu JianZhong, 2013, Acta Agronomica Sinica, V39, P1134, DOI 10.3724/SP.J.1006.2013.01134; Xu XW, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00768; Zhang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157777; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141; Zhu WY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00437; Zohary D, 1999, GENET RESOUR CROP EV, V46, P133, DOI 10.1023/A:1008692912820	41	12	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189785	10.1371/journal.pone.0189785	http://dx.doi.org/10.1371/journal.pone.0189785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267332	Green Submitted, Green Published, gold			2022-12-26	WOS:000418587400050
J	Leistner, R; Kola, A; Gastmeier, P; Kruger, R; Hoppe, PA; Schneider-Burrus, S; Zuschneid, I; Wischnewski, N; Bender, J; Layer, F; Niebank, M; Scheibenbogen, C; Hanitsch, LG				Leistner, Rasmus; Kola, Axel; Gastmeier, Petra; Krueger, Renate; Hoppe, Pia-Alice; Schneider-Burrus, Sylke; Zuschneid, Irina; Wischnewski, Nicoletta; Bender, Jennifer; Layer, Franziska; Niebank, Michaela; Scheibenbogen, Carmen; Hanitsch, Leif G.			Pyoderma outbreak among kindergarten families: Association with a Panton-Valentine leukocidin (PVL)-producing S. aureus strain	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; INFECTION; DISEASE; TOXIN; SKIN	Objectives We report on an outbreak of skin and soft tissue infections (SSTI) among kindergarten families. We analyzed the transmission route and aimed to control the outbreak. Methods The transmission route was investigated by nasal screening for Panton-Valentine leukocidin (PVL)-producing Staphylococcus aureus (PVL-SA), subsequent microbiological investigation including whole genome sequencing and a questionnaire-based analysis of epidemiological information. The control measures included distribution of outbreak information to all individuals at risk and implementation of a Staphylococcus aureus decontamination protocol. Results Individuals from 7 of 19 families were either colonized or showed signs of SSTI such as massive abscesses or eye lid infections. We found 10 PVL-SA isolates in 9 individuals. In the WGS-analysis all isolates were found identical with a maximum of 17 allele difference. The clones were methicillin-susceptible but cotrimoxazole resistant. In comparison to PVL-SAs from an international strain collection, the outbreak clone showed close genetical relatedness to PVL-SAs from a non-European country. The questionnaire results showed frequent travels of one family to this area. The results also demonstrated likely transmission via direct contact between families. After initiation of Staphylococcus aureus decontamination no further case was detected. Conclusions Our outbreak investigation showed the introduction of a PVL-SA strain into a kindergarten likely as a result of international travel and further transmission by direct contact. The implementation of a Staphylococcus aureus decontamination protocol was able to control the outbreak.	[Leistner, Rasmus; Kola, Axel; Gastmeier, Petra] Charite Univ Med Berlin, Inst Hyg & Environm Med, Berlin, Germany; [Leistner, Rasmus; Krueger, Renate; Hoppe, Pia-Alice; Schneider-Burrus, Sylke; Layer, Franziska; Niebank, Michaela; Hanitsch, Leif G.] Charite Univ Med Berlin, PVL Workgrp, Berlin, Germany; [Krueger, Renate; Hoppe, Pia-Alice] Charite Univ Med Berlin, Dept Pediat Pulmonol & Immunol, Berlin, Germany; [Schneider-Burrus, Sylke] Charite Univ Med Berlin, Dept Dermatol & Allergy, Berlin, Germany; [Zuschneid, Irina; Wischnewski, Nicoletta] Charlottenburg Wilmersdorf Hlth Dept, Berlin, Germany; [Bender, Jennifer; Layer, Franziska] Robert Koch Inst, Wernigerode, Germany; [Niebank, Michaela] Charite Univ Med Berlin, Dept Internal Med Infect Dis & Pulm Med, Berlin, Germany; [Scheibenbogen, Carmen; Hanitsch, Leif G.] Charite Univ Med Berlin, Inst Med Immunol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Leistner, R (corresponding author), Charite Univ Med Berlin, Inst Hyg & Environm Med, Berlin, Germany.; Leistner, R (corresponding author), Charite Univ Med Berlin, PVL Workgrp, Berlin, Germany.	rasmus.leistner@charite.de		Layer, Franziska/0000-0002-4613-6478; Scheibenbogen, Carmen/0000-0002-8554-9638; Hanitsch, Leif G./0000-0002-8181-0093; Gastmeier, Petra/0000-0001-5520-4287; Leistner, Rasmus/0000-0002-1225-9023				Ali H, 2012, J HOSP INFECT, V80, P293, DOI 10.1016/j.jhin.2011.12.019; Gillet Y, 2011, INT J ANTIMICROB AG, V38, P457, DOI 10.1016/j.ijantimicag.2011.05.003; Hermos CR, 2010, CLIN INFECT DIS, V51, P1138, DOI 10.1086/656742; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Krishna S, 2012, CURR OPIN MICROBIOL, V15, P28, DOI 10.1016/j.mib.2011.11.003; Nurjadi D, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.08.021; Panton PN, 1932, LANCET, V1, P506; Rasigade JP, 2010, J INFECT DIS, V201, P1589, DOI 10.1086/652008; Shallcross LJ, 2013, LANCET INFECT DIS, V13, P43, DOI 10.1016/S1473-3099(12)70238-4	9	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189961	10.1371/journal.pone.0189961	http://dx.doi.org/10.1371/journal.pone.0189961			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261764	Green Published, gold, Green Submitted			2022-12-26	WOS:000418554900043
J	Norris, MH; Heacock-Kang, Y; Zarzycki-Siek, J; Bluhm, AP; McMillan, IA; Schweizer, HP; Hoang, TT				Norris, Michael H.; Heacock-Kang, Yun; Zarzycki-Siek, Jan; Bluhm, Andrew P.; McMillan, Ian A.; Schweizer, Herbert P.; Hoang, Tung T.			Burkholderia pseudomallei natural competency and DNA catabolism: Identification and characterization of relevant genes from a constructed fosmid library	PLOS ONE			English	Article							WIDE EXPRESSION ANALYSIS; SELECT-AGENT-COMPLIANT; BACTERIAL TRANSFORMATION; THAILANDENSIS; TOOLS; MUTAGENESIS	Burkholderia spp. are genetically and physiologically diverse. Some strains are naturally transformable and capable of DNA catabolism. Burkholderia pseudomallei (Bp) strains 1026b and K96243 and B. thailandensis strain E264 are able to utilize DNA as a sole carbon source for growth, while only strains 1026b and E264 are naturally transformable. In this study, we constructed low-copy broad-host-range fosmid library, containing Bp strain 1026b chromosomal DNA fragments, and employed a novel positive selection approach to identify genes responsible for DNA uptake and DNA catabolism. The library was transferred to non-competent Bp K96243 and B. cenocepacia (Bc) K56-2, harboring chromosomally-inserted FRT-flanked sacB and pheS counter-selection markers. The library was incubated with DNA encoding Flp recombinase, followed by counter-selection on sucrose and chlorinated phenylalanine, to select for clones that took up flp-DNA, transiently expressed Flp, and excised the sacB-pheS cassette. Putative clones that survived the counter-selection were subsequently incubated with gfp-DNA and bacteria were visualized via fluorescent microscopy to confirm natural competency. Fosmid sequencing identified several 1026b genes implicated in DNA uptake, which were validated using chromosomal mutants. One of the naturally competent clones selected in Bc K56-2 enabled Bc, Bp and B. mallei to utilize DNA as a sole carbon source, and all fosmids were used to successfully create mutations in non-naturally-competent B. mallei and Bp strains.	[Norris, Michael H.; Heacock-Kang, Yun; Zarzycki-Siek, Jan; Bluhm, Andrew P.; McMillan, Ian A.; Hoang, Tung T.] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA; [Norris, Michael H.; McMillan, Ian A.; Hoang, Tung T.] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Norris, Michael H.] Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL USA; [Schweizer, Herbert P.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Schweizer, Herbert P.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Hoang, TT (corresponding author), Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA.; Hoang, TT (corresponding author), Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA.	tongh@hawaii.edu	Heacock-Kang, Yun/O-9767-2016	Heacock-Kang, Yun/0000-0002-7304-9687; McMillan, Ian/0000-0002-8934-172X; Norris, Michael/0000-0002-5285-0432	US National Institutes of Health (NIH) [R01GM103580, R21A1123913, P20GM103516, U54 AI065359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359, R21AI123913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516, R01GM103580] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported in parts by the US National Institutes of Health (NIH) grants R01GM103580, R21A1123913, P20GM103516, U54 AI065359. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported in parts by the US National Institutes of Health (NIH) grants R01GM103580, P20GM103516, U54 AI065359.	Averhoff B, 2004, J BIOENERG BIOMEMBR, V36, P25, DOI 10.1023/B:JOBB.0000019595.66733.fa; Barrett AR, 2008, APPL ENVIRON MICROB, V74, P4498, DOI 10.1128/AEM.00531-08; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Choi KH, 2008, APPL ENVIRON MICROB, V74, P1064, DOI 10.1128/AEM.02430-07; Facius D, 1996, FEMS MICROBIOL LETT, V137, P159; Graupner S, 2001, RES MICROBIOL, V152, P451, DOI 10.1016/S0923-2508(01)01218-9; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Kang Y, 2011, NAT PROTOC, V6, P1085, DOI 10.1038/nprot.2011.346; Kang Y, 2009, APPL ENVIRON MICROB, V75, P4015, DOI 10.1128/AEM.02733-08; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Nandi T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000845; Norris MH, 2009, APPL ENVIRON MICROB, V75, P6062, DOI 10.1128/AEM.00820-09; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Stingl K, 2010, P NATL ACAD SCI USA, V107, P1184, DOI 10.1073/pnas.0909955107; SUZUKI T, 1994, MOL MICROBIOL, V11, P31, DOI 10.1111/j.1365-2958.1994.tb00287.x; Thongdee M, 2008, APPL ENVIRON MICROB, V74, P2985, DOI 10.1128/AEM.00030-08; Tuanyok A, 2005, FEMS MICROBIOL LETT, V252, P327, DOI 10.1016/j.femsle.2005.09.043; Tuanyok A, 2006, INFECT IMMUN, V74, P5465, DOI 10.1128/IAI.00737-06	18	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189018	10.1371/journal.pone.0189018	http://dx.doi.org/10.1371/journal.pone.0189018			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253888	Green Published, Green Submitted, gold			2022-12-26	WOS:000418389500009
J	Han, BC; Zhou, B; Qu, Y; Gao, BW; Xu, YL; Chung, S; Tanaka, H; Yang, W; Giuliano, AE; Cui, XJ				Han, Bingchen; Zhou, Bo; Qu, Ying; Gao, Bowen; Xu, Yali; Chung, Stacey; Tanaka, Hisashi; Yang, Wei; Giuliano, Armando E.; Cui, Xiaojiang			FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer	ONCOGENE			English	Article							NF-KAPPA-B; MESENCHYMAL TRANSITION; CELL MOTILITY; DNA-BINDING; INVASION; PROTEIN; IDENTIFICATION; SUBTYPES; METASTASIS; EXPRESSION	Triple-negative breast cancer (TNBC) has high rates of local recurrence and distant metastasis, partially due to its high invasiveness. The Forkhead box C1 (FOXC1) transcription factor has been shown to be specifically overexpressed in TNBC and associated with poor clinical outcome. How TNBC's high invasiveness is driven by FOXC1 and its downstream targets remains poorly understood. In the present study, pathway-specific PCR array assays revealed that WNT5A and matrix metalloproteinase-7 (MMP7) were upregulated by FOXC1 in TNBC cells. Interestingly, WNT5A mediates the upregulation of MMP7 by FOXC1 and the WNT5A-MMP7 axis is essential for FOXC1-induced invasiveness of TNBC cells in vitro. Xenograft models showed that the lung extravasation and metastasis of FOXC1-overexpressing TNBC cells were attenuated by knocking out WNT5A, but could be restored by MMP7 overexpression. Mechanistically, FOXC1 can bind directly to the WNT5A promoter region to activate its expression. Engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP), coupled with mass spectrometry, identified FOXC1-interacting proteins including a group of heterogeneous nuclear ribonucleoproteins involved in WNT5A transcription induction. Finally, we found that WNT5A activates NF-kappa B signaling to induce MMP7 expression. Collectively, these data demonstrate a FOXC1-elicited noncanonical WNT5A signaling mechanism comprising NF-kappa B and MMP7 that is essential for TNBC cell invasiveness, thereby providing implications toward developing an effective therapy for TNBC.	[Han, Bingchen; Zhou, Bo; Qu, Ying; Gao, Bowen; Chung, Stacey; Tanaka, Hisashi; Yang, Wei; Giuliano, Armando E.; Cui, Xiaojiang] Cedars Sinai Med Ctr, Dept Surg, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Xu, Yali] Beijing Union Med Coll Hosp, Dept Breast Surg, Beijing, Peoples R China	Cedars Sinai Medical Center; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Cui, XJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA.	Xiaojiang.cui@cshs.org	Yang, Wei/C-3047-2008; Yang, Wei/ABA-5268-2020; Tanaka, Hisashi/ABE-7637-2020	Yang, Wei/0000-0003-2575-3570; Tanaka, Hisashi/0000-0001-9223-4186	National Institutes of Health [CA151610]; Avon Foundation for Women [02-2014-063]; David Salomon Translational Breast Cancer Research Fund; Fashion Footwear Charitable Foundation of New York, Inc.; Entertainment Industry Foundation; Margie and Robert E. Petersen Foundation; Linda and Jim Lippman Research Fund; NATIONAL CANCER INSTITUTE [R01CA151610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avon Foundation for Women; David Salomon Translational Breast Cancer Research Fund; Fashion Footwear Charitable Foundation of New York, Inc.; Entertainment Industry Foundation; Margie and Robert E. Petersen Foundation; Linda and Jim Lippman Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (CA151610), the Avon Foundation for Women (02-2014-063), and David Salomon Translational Breast Cancer Research Fund to Xiaojiang Cui, and the Fashion Footwear Charitable Foundation of New York, Inc., the Entertainment Industry Foundation, the Margie and Robert E. Petersen Foundation, and the Linda and Jim Lippman Research Fund to Armando Giuliano.	Bunch H, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0040-x; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Fujita T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103084; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Guan PP, 2015, ONCOTARGET, V6, P9140, DOI 10.18632/oncotarget.3274; Gujral TS, 2014, CELL, V159, P844, DOI 10.1016/j.cell.2014.10.032; Han B, 2013, MOL BIOL BREAST CANC, P91; Han BC, 2015, CELL REP, V13, P1046, DOI 10.1016/j.celrep.2015.09.063; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Honda K, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0031-0; Jang M, 2009, ONCOGENE, V28, P1529, DOI 10.1038/onc.2009.11; Jensen TW, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv148; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim GE, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-959; Klemm F, 2011, CARCINOGENESIS, V32, P434, DOI 10.1093/carcin/bgq269; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Mazurek A, 2012, CANCER DISCOV, V2, P812, DOI 10.1158/2159-8290.CD-12-0116; Morley S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12136; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; Phoomak C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27853; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Sizemore ST, 2012, J BIOL CHEM, V287, P24631, DOI 10.1074/jbc.M112.375865; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Wang J, 2012, ONCOGENE, V31, P4798, DOI 10.1038/onc.2011.635; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Weng MT, 2013, PROTEIN CELL, V4, P807, DOI 10.1007/s13238-013-3056-3; Xu JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117097; Zhao Y, 2014, J BIOL CHEM, V289, P21028, DOI 10.1074/jbc.M113.546523	39	51	56	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	10					1399	1408		10.1038/s41388-017-0021-2	http://dx.doi.org/10.1038/s41388-017-0021-2			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ0RI	29249801	Green Accepted			2022-12-26	WOS:000427279300010
J	Lv, SD; Ji, LY; Chen, B; Liu, SQ; Lei, CY; Liu, X; Qi, XX; Wang, Y; Leung, ELH; Wang, HY; Zhang, L; Yu, XM; Liu, ZQ; Wei, Q; Lu, LL				Lv, Shidong; Ji, Liyan; Chen, Bin; Liu, Shuqiang; Lei, Chengyong; Liu, Xi; Qi, Xiaoxiao; Wang, Ying; Leung, Elaine Lai-Han; Wang, Hongyi; Zhang, Lin; Yu, Xiaoming; Liu, Zhongqiu; Wei, Qiang; Lu, Linlin			Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4	ONCOGENE			English	Article							ESTROGEN-RECEPTOR; CANCER STATISTICS; GENE; EXPRESSION; MUTATIONS; IDENTIFICATION; PROLIFERATION; PROGRESSION; LEUKEMIA	Abnormalities in epigenetic modifiers are emerging as driving events in prostate cancer (PCa). The histone methyltransferase KMT2D, a frequently aberrant epigenetic modifier in various tumors, has an undefined role in PCa. Moreover, little is known regarding KMT2D's mutation in Chinese patients or its downstream signaling pathways and targets. Here, we profiled the mutational spectrum of 32 significantly PCa-associated genes by using disease-targeted sequencing, and found that KMT2D was highly mutated (63.04%, 29/46) in Chinese patients. Moreover, high KMT2D transcription was also associated with poor prognosis in an independent cohort (n = 51). In KMT2D-knockdown PC-3 and DU145 cells, cell proliferation (P < 0.01), invasion (P < 0.001), and migration (P < 0.01) were consequently suppressed. KMT2D depletion effectively suppressed tumor growth by 92.21% in vivo. Notably, integrative analyses of RNAseq and ChIPseq characterized two crucial genes downregulated by KMT2D, leukemia inhibitory factor receptor (LIFR) and Kruppel-like factor-4 (KLF4), which are regulators in PI3K/Akt and EMT, respectively. Our present study revealed that KMT2D epigenetically activates PI3K/Akt pathway and EMT by targeting LIFR and KLF4 and thus serves as a putative epigenetic-based target for treating PCa.	[Lv, Shidong; Lei, Chengyong; Wang, Hongyi; Zhang, Lin; Yu, Xiaoming; Wei, Qiang] Southern Med Univ, Nanfang Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Lv, Shidong; Ji, Liyan; Liu, Shuqiang; Liu, Xi; Qi, Xiaoxiao; Wang, Ying; Liu, Zhongqiu; Lu, Linlin] Guangzhou Univ Chinese Med, Int Inst Translat Chinese Med, Guangzhou, Guangdong, Peoples R China; [Chen, Bin] Peoples Liberat Army, Guangzhou Mil Command, Gen Hosp, Dept Sci & Training, Guangzhou, Guangdong, Peoples R China; [Leung, Elaine Lai-Han; Liu, Zhongqiu; Lu, Linlin] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Macau, Peoples R China	Southern Medical University - China; Guangzhou University of Chinese Medicine; Southern Theater Command General Hospital; Macau University of Science & Technology	Wei, Q (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China.; Liu, ZQ; Lu, LL (corresponding author), Guangzhou Univ Chinese Med, Int Inst Translat Chinese Med, Guangzhou, Guangdong, Peoples R China.; Liu, ZQ; Lu, LL (corresponding author), Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Macau, Peoples R China.	liuzq@gzucm.edu.cn; qwei@smu.edu.cn; lllu@gzucm.edu.cn	Liu, Zhongqiu/ABB-8204-2021; Liu, Zhongqiu/AHC-9661-2022; lu, Linlin/K-6600-2016	Liu, Zhongqiu/0000-0001-6986-9677; lu, Linlin/0000-0002-9943-2422; Lv, Shidong/0000-0002-6875-7697	National Natural Science Foundation of China [81720108033]; Natural Science Foundation of Guangdong Province [2015A030312012, 2016A050502052, 2015B020233015]; Science and Technology Planning Project of Guangdong Province [2016A020215122]; Bureau for Science and Information Technology of Guangzhou Municipality [201509010004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; Bureau for Science and Information Technology of Guangzhou Municipality	This work was mainly supported by National Natural Science Foundation of China (81720108033), Natural Science Foundation of Guangdong Province (2015A030312012, 2016A050502052, and 2015B020233015), the Science and Technology Planning Project of Guangdong Province (2016A020215122), Bureau for Science and Information Technology of Guangzhou Municipality (201509010004).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Ansari KI, 2011, J MOL BIOL, V411, P334, DOI 10.1016/j.jmb.2011.05.050; Augert A, 2017, J THORAC ONCOL, V12, P704, DOI 10.1016/j.jtho.2016.12.011; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Carlin Bruce I., 2000, Cancer, V88, P2989, DOI 10.1002/1097-0142(20000615)88:12+<2989::AID-CNCR14>3.3.CO;2-H; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Dawkins JBN, 2016, CANCER RES, V76, P4861, DOI 10.1158/0008-5472.CAN-16-0481; Ferraldeschi R, 2015, EUR UROL, V67, P795, DOI 10.1016/j.eururo.2014.10.027; Ford DJ, 2015, CANCER GENET-NY, V208, P178, DOI 10.1016/j.cancergen.2015.01.005; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Fukagai T, 2006, BJU INT, V97, P1190, DOI 10.1111/j.1464-410X.2006.06201.x; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Grasso C, 2015, J MOL DIAGN, V17, P53, DOI 10.1016/j.jmoldx.2014.09.008; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guo CC, 2013, ONCOTARGET, V4, P2144, DOI 10.18632/oncotarget.1555; Guo CC, 2012, P NATL ACAD SCI USA, V109, P17603, DOI 10.1073/pnas.1208807109; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ito K, 2014, NAT REV UROL, V11, P197, DOI 10.1038/nrurol.2014.42; Jiang YM, 2018, ANN SURG, V267, P504, DOI 10.1097/SLA.0000000000002116; Jung SH, 2016, EUR UROL, V69, P823, DOI 10.1016/j.eururo.2015.10.031; Kantidakis T, 2016, GENE DEV, V30, P408, DOI 10.1101/gad.275453.115; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Komai Y, 2014, UROLOGY, V83, P500, DOI 10.1016/j.urology.2013.09.053; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu SC, 2013, J CLIN INVEST, V123, P5269, DOI 10.1172/JCI63428; Mao XY, 2010, CANCER RES, V70, P5207, DOI 10.1158/0008-5472.CAN-09-4074; Mathelier A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0648-7; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Ortega-Molina A, 2015, NAT MED, V21, P1199, DOI 10.1038/nm.3943; Preudhomme C, 2000, BLOOD, V96, P2862, DOI 10.1182/blood.V96.8.2862.h8002862_2862_2869; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Roychowdhury S, 2013, J CLIN ONCOL, V31, P1866, DOI 10.1200/JCO.2012.45.3662; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; Shin SH, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.34; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun C, 2010, HUM MUTAT, V31, P99, DOI 10.1002/humu.21145; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang B, 2016, INSECT BIOCHEM MOLEC, V79, P108, DOI 10.1016/j.ibmb.2016.11.001; Zhang JY, 2015, NAT MED, V21, P1190, DOI 10.1038/nm.3940; Zhao MH, 2016, IN VITRO CELL DEV-AN, V52, P699, DOI 10.1007/s11626-016-0017-1	50	68	68	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	10					1354	1368		10.1038/s41388-017-0026-x	http://dx.doi.org/10.1038/s41388-017-0026-x			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ0RI	29269867	Green Published, hybrid			2022-12-26	WOS:000427279300007
J	Segawa, K; Kurata, S; Nagata, S				Segawa, Katsumori; Kurata, Sachiko; Nagata, Shigekazu			The CDC50A extracellular domain is required for forming a functional complex with and chaperoning phospholipid flippases to the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; chaperone; membrane protein; mutagenesis; phospholipid; ATP11C; CDC50A; error-prone PCR; flippase	NA,K-ATPASE BETA-SUBUNIT; P-TYPE ATPASES; PHOSPHATIDYLSERINE; PROTEINS; GLYCOSYLATION; MUTAGENESIS; EXPRESSION; ASYMMETRY; P4-ATPASE; RESIDUES	Flippases are enzymes that translocate phosphatidylserine (PtdSer) and phosphatidylethanolamine (PtdEtn) from the outer to the inner leaflet in the lipid bilayer of the plasma membrane, leading to the asymmetric distribution of aminophospholipids in the membrane. One mammalian phospholipid flippase at the plasma membrane is ATP11C, a type IV P-type ATPase (P4-ATPase) that forms a heterocomplex with the transmembrane protein CDC50A. However, the structural features in CDC50A that support the function of ATP11C and other P4-ATPases have not been characterized. Here, using error-prone PCR-mediated mutagenesis of human CDC50A cDNA followed by functional screening and deep sequencing, we identified 14 amino acid residues that affect ATP11C's flippase activity. These residues were all located in CDC50A's extracellular domain and were evolutionarily well-conserved. Most of the mutations decreased CDC50A's ability to chaperone ATP11C and other P4-ATPases to their destinations. The CDC50A mutants failed to form a stable complex with ATP11C and could not induce ATP11C's PtdSer-dependent ATPase activity. Notably, one mutant variant could form a stable complex with ATP11C and transfer ATP11C to the plasma membrane, yet the ATP11C complexed with this CDC50A variant had very weak or little PtdSer- or PtdEtn-dependent ATPase activity. These results indicated that the extracellular domain of CDC50A has important roles both in CDC50A's ability to chaperone ATP11C to the plasma membrane and in inducing ATP11C's ATP hydrolysis-coupled flippase activity.	[Segawa, Katsumori; Kurata, Sachiko; Nagata, Shigekazu] Osaka Univ, Immunol Frontier Res Ctr, Lab Biochem & Immunol, Suita, Osaka 5650871, Japan	Osaka University	Nagata, S (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Lab Biochem & Immunol, Suita, Osaka 5650871, Japan.	snagata@ifrec.osaka-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Japan Society for the Promotion of Science [16H01360, 17H05506, 15H05785]; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency [JPMJCR14M4]; Grants-in-Aid for Scientific Research [15K08266] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas 16H01360 and 17H05506 from the Japan Society for the Promotion of Science (to K. S.), Grant-in-Aid for Specially Promoted Research 15H05785 from the Japan Society for the Promotion of Science (to S. N.), and Grant-in-Aid JPMJCR14M4 from Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (to S. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; Arashiki N, 2016, HAEMATOLOGICA, V101, P559, DOI 10.3324/haematol.2016.142273; Bevers EM, 2016, PHYSIOL REV, V96, P605, DOI 10.1152/physrev.00020.2015; Borgese N, 2016, J CELL SCI, V129, P1537, DOI 10.1242/jcs.183335; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Costa SR, 2016, BIOCHEM J, V473, P1605, DOI 10.1042/BCJ20160207; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; Fowler DM, 2014, NAT PROTOC, V9, P2267, DOI 10.1038/nprot.2014.153; Garcia-Sanchez S, 2014, BIOCHEM J, V459, P83, DOI 10.1042/BJ20131318; HAMRICK M, 1993, J BIOL CHEM, V268, P24367; Hankins HM, 2015, TRAFFIC, V16, P35, DOI 10.1111/tra.12233; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KORNBERG RD, 1971, BIOCHEMISTRY-US, V10, P1111; Labrou NE, 2010, CURR PROTEIN PEPT SC, V11, P91, DOI 10.2174/138920310790274617; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lhermusier T, 2011, J THROMB HAEMOST, V9, P1883, DOI 10.1111/j.1538-7836.2011.04478.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lopez-Marques RL, 2010, MOL BIOL CELL, V21, P791, DOI 10.1091/mbc.E09-08-0656; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Puts CF, 2012, J BIOL CHEM, V287, P30529, DOI 10.1074/jbc.M112.371088; Raymond C, 2011, METHODS, V55, P44, DOI 10.1016/j.ymeth.2011.04.002; RENAUD KJ, 1991, J BIOL CHEM, V266, P20491; Robins WP, 2013, P NATL ACAD SCI USA, V110, pE848, DOI 10.1073/pnas.1222538110; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Segawa K, 2016, J BIOL CHEM, V291, P762, DOI 10.1074/jbc.M115.690727; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Shin H, 2015, INT J MOL SCI, V16, P23094, DOI 10.3390/ijms160923094; Stanley P., 2011, COLD SPRING HARB PER, V3; Suzuki J, 2016, P NATL ACAD SCI USA, V113, P9509, DOI 10.1073/pnas.1610403113; Takahashi Y, 2011, J BIOCHEM, V149, P423, DOI 10.1093/jb/mvq155; Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Toyoshima C, 2013, CURR OPIN STRUC BIOL, V23, P507, DOI 10.1016/j.sbi.2013.06.005; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vestergaard AL, 2015, FEBS LETT, V589, P3908, DOI 10.1016/j.febslet.2015.11.031; Yabas M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146774; Yabas M, 2014, J BIOL CHEM, V289, P19531, DOI 10.1074/jbc.C114.570267; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09506-5	45	27	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2172	2182		10.1074/jbc.RA117.000289	http://dx.doi.org/10.1074/jbc.RA117.000289			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29276178	Green Published, hybrid			2022-12-26	WOS:000424948000028
J	Seok, SH; Ma, ZX; Feltenberger, JB; Chen, HB; Chen, H; Scarlett, C; Lin, ZQ; Satyshur, KA; Cortopassi, M; Jefcoate, CR; Ge, Y; Tang, WP; Bradfield, CA; Xing, YN				Seok, Seung-Hyeon; Ma, Zhi-Xiong; Feltenberger, John B.; Chen, Hongbo; Chen, Hui; Scarlett, Cameron; Lin, Ziqing; Satyshur, Kenneth A.; Cortopassi, Marissa; Jefcoate, Colin R.; Ge, Ying; Tang, Weiping; Bradfield, Christopher A.; Xing, Yongna			Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aryl hydrocarbon receptor (AhR) (AHR); structure-function; dioxin; ligand-binding protein; chemical biology; Ah receptor; dioxin; kynurenine; pro-ligand; structural determinants	TRYPTOPHAN-METABOLISM; HIGH-AFFINITY; LIGAND; RECOGNITION; EXPRESSION; PATHWAY; DISEASE	Cellular metabolites act as important signaling cues, but are subject to complex unknown chemistry. Kynurenine is a tryptophan metabolite that plays a crucial role in cancer and the immune system. Despite its atypical, non-ligand-like, highly polar structure, kynurenine activates the aryl hydrocarbon receptor (AHR), a PER, ARNT, SIM (PAS) family transcription factor that responds to diverse environmental and cellular ligands. The activity of kynurenine is increased 100-1000-fold by incubation or long-term storage and relies on the hydrophobic ligand-binding pocket of AHR, with identical structural signatures for AHR induction before and after activation. We purified trace-active derivatives of kynurenine and identified two novel, closely related condensation products, named trace-extended aromatic condensation products (TEACOPs), which are active at low picomolar levels. The synthesized compound for one of the predicted structures matched the purified compound in both chemical structure and AHR pharmacology. Our study provides evidence that kynurenine acts as an AHR pro-ligand, which requires novel chemical conversions to act as a receptor agonist.	[Seok, Seung-Hyeon; Chen, Hongbo; Chen, Hui; Satyshur, Kenneth A.; Cortopassi, Marissa; Bradfield, Christopher A.; Xing, Yongna] Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab Canc Res, Madison, WI 53705 USA; [Ma, Zhi-Xiong; Feltenberger, John B.; Tang, Weiping] Univ Wisconsin, Sch Pharm, Med Chem Ctr, Madison, WI 53705 USA; [Scarlett, Cameron] Univ Wisconsin, Sch Pharm, Analyt Instrumentat Ctr, Mass Spectrometry Facil, Madison, WI 53705 USA; [Chen, Hongbo; Xing, Yongna] Univ Wisconsin, Biophys Grad Program, Madison, WI 53706 USA; [Lin, Ziqing; Ge, Ying] Univ Wisconsin, Human Prote Program, Madison, WI 53705 USA; [Jefcoate, Colin R.; Bradfield, Christopher A.; Xing, Yongna] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Xing, YN (corresponding author), McArdle Lab Canc Res, 1111 Highland Ave, Madison, WI 53705 USA.	xing@oncology.wisc.edu		Chen, Hongbo/0000-0001-8005-5658; Satyshur, Kenneth/0000-0001-9371-2493	National Institutes of Health [R01 GM096060, R35028377, P30CA014520, UL1TR000427]; McArdle New Direction Fund; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R35ES028377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096060] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McArdle New Direction Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01 GM096060 (to Y. X.), R35028377 (to C. A. B.), P30CA014520, and UL1TR000427, as well as the McArdle New Direction Fund. All authors have intellectual property associated with this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bergander L, 2004, CHEM-BIOL INTERACT, V149, P151, DOI 10.1016/j.cbi.2004.08.005; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Bisson WH, 2009, J MED CHEM, V52, P5635, DOI 10.1021/jm900199u; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Bohar Z, 2015, INT J MOL SCI, V16, P9772, DOI 10.3390/ijms16059772; BROWN KS, 1967, TETRAHEDRON LETT, P1721; CHANG CY, 1993, PHARMACOGENETICS, V3, P312, DOI 10.1097/00008571-199312000-00005; Changsirivathanathamrong D, 2011, CRIT CARE MED, V39, P2678, DOI 10.1097/CCM.0b013e31822827f2; DOLWICK KM, 1993, P NATL ACAD SCI USA, V90, P8566, DOI 10.1073/pnas.90.18.8566; EMA M, 1994, J BIOL CHEM, V269, P27337; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Han D, 2004, BIOFACTORS, V20, P11, DOI 10.1002/biof.5520200102; HELFERICH WG, 1991, MOL PHARMACOL, V40, P674; Hubbard TD, 2015, DRUG METAB DISPOS, V43, P1522, DOI 10.1124/dmd.115.064246; Hubbard TD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12689; Jasiewicz M, 2016, HEART, V102, P230, DOI 10.1136/heartjnl-2015-308581; Korashy HM, 2006, DRUG METAB REV, V38, P411, DOI 10.1080/03602530600632063; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Lanis JM, 2017, MUCOSAL IMMUNOL, V10, P1133, DOI 10.1038/mi.2016.133; LEKLEM JE, 1971, AM J CLIN NUTR, V24, P659; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Oxenkrug GF, 2010, ANN NY ACAD SCI, V1199, P1, DOI 10.1111/j.1749-6632.2009.05356.x; Pandini A, 2009, BIOCHEMISTRY-US, V48, P5972, DOI 10.1021/bi900259z; POLAND A, 1994, MOL PHARMACOL, V46, P915; POLAND A, 1991, MOL PHARMACOL, V39, P20; Polyzos KA, 2015, HAMOSTASEOLOGIE, V35, P128, DOI 10.5482/HAMO-14-10-0052; Procopio M, 2002, EUR J BIOCHEM, V269, P13, DOI 10.1046/j.0014-2956.2002.02619.x; RANNUG A, 1987, J BIOL CHEM, V262, P15422; Rannug U, 1995, CHEM BIOL, V2, P841, DOI 10.1016/1074-5521(95)90090-X; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; RUDZITE V, 1991, ADV EXP MED BIOL, V294, P663; Savouret JF, 2003, NUTR METAB CARDIOVAS, V13, P104, DOI 10.1016/S0939-4753(03)80026-1; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Seok SH, 2017, P NATL ACAD SCI USA, V114, P5431, DOI 10.1073/pnas.1617035114; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; TOKUYAMA T, 1967, J AM CHEM SOC, V89, P1017, DOI 10.1021/ja00980a046; Wei YD, 2000, ARCH BIOCHEM BIOPHYS, V383, P99, DOI 10.1006/abbi.2000.2037; Wei YD, 1998, CHEM-BIOL INTERACT, V110, P39, DOI 10.1016/S0009-2797(97)00111-7; Xing YN, 2012, TOXICOL SCI, V129, P86, DOI 10.1093/toxsci/kfs194; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zelentsova EA, 2013, PHOTOCH PHOTOBIO SCI, V12, P546, DOI 10.1039/c2pp25357g	47	68	70	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1994	2005		10.1074/jbc.RA117.000631	http://dx.doi.org/10.1074/jbc.RA117.000631			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29279331	hybrid, Green Published			2022-12-26	WOS:000424948000013
J	Finlayson-Trick, ECL; Getz, LJ; Elaine, PD; Thornbury, M; Lamoureux, E; Cook, J; Langille, MGI; Murray, LE; McCormick, C; Rohde, JR; Cheng, ZY				Finlayson-Trick, Emma C. L.; Getz, Landon J.; Elaine, Patrick D.; Thornbury, Mackenzie; Lamoureux, Emily; Cook, Jamie; Langille, Morgan G. I.; Murray, Lois E.; McCormick, Craig; Rohde, John R.; Cheng, Zhenyu			Taxonomic differences of gut microbiomes drive cellulolytic enzymatic potential within hind-gut fermenting mammals	PLOS ONE			English	Article							GENE; KEGG; CONVERGENCE; ALIGNMENT; HEALTHY; HOST; DIET	Host diet influences the diversity and metabolic activities of the gut microbiome. Previous studies have shown that the gut microbiome provides a wide array of enzymes that enable processing of diverse dietary components. Because the primary diet of the porcupine, Erethizon dorsatum, is lignified plant material, we reasoned that the porcupine microbiome would be replete with enzymes required to degrade lignocellulose. Here, we report on the bacterial composition in the porcupine microbiome using 16S rRNA sequencing and bioinformatics analysis. We extended this analysis to the microbiomes of 20 additional mammals located in Shubenacadie Wildlife Park (Nova Scotia, Canada), enabling the comparison of bacterial diversity amongst three mammalian taxonomic orders (Rodentia, Carnivora, and Artiodactyla). 16S rRNA sequencing was validated using metagenomic shotgun sequencing on selected herbivores (porcupine, beaver) and carnivores (coyote, Arctic wolf). In the microbiome, functionality is more conserved than bacterial composition, thus we mined microbiome data sets to identify conserved microbial functions across species in each order. We measured the relative gene abundances for cellobiose phosphorylase, endoglucanase, and beta-glucosidase to evaluate the cellulose-degrading potential of select mammals. The porcupine and beaver had higher proportions of genes encoding cellulose-degrading enzymes than the Artic wolf and coyote. These findings provide further evidence that gut microbiome diversity and metabolic capacity are influenced by host diet.	[Finlayson-Trick, Emma C. L.; Getz, Landon J.; Elaine, Patrick D.; Thornbury, Mackenzie; Cook, Jamie; Murray, Lois E.; McCormick, Craig; Rohde, John R.; Cheng, Zhenyu] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Lamoureux, Emily; Langille, Morgan G. I.] Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Cheng, ZY (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	zhenyu.cheng@dal.ca	Getz, Landon/ABC-1692-2020; McCormick, Craig/AAH-9069-2019	Getz, Landon/0000-0002-3841-1062; McCormick, Craig/0000-0003-2794-3722; Cheng, Zhenyu/0000-0002-7240-9126; Langille, Morgan/0000-0002-6604-3009	Dalhousie University Office of the President, Dalhousie Student Union, Academic Innovation Fund, Faculty of Medicine, Faculty of Science; Department of Microbiology and Immunology; Integrated Microbiome Resource	Dalhousie University Office of the President, Dalhousie Student Union, Academic Innovation Fund, Faculty of Medicine, Faculty of Science; Department of Microbiology and Immunology; Integrated Microbiome Resource	Dalhousie University Office of the President, Dalhousie Student Union, Academic Innovation Fund, Faculty of Medicine, Faculty of Science, and the Department of Microbiology and Immunology, and the Integrated Microbiome Resource provided financial support for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cheng JJ, 2014, J MICROBIOL METH, V99, P27, DOI 10.1016/j.mimet.2014.01.015; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Choo JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16350; Clavel T., 2014, PROKARYOTES ACTINOBA, P201, DOI DOI 10.1007/978-3-642-30138-4_343; Clayton JB, 2016, P NATL ACAD SCI USA, V113, P10376, DOI 10.1073/pnas.1521835113; Comeau AM, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00127-16; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; Culligan EP, 2014, VIRULENCE, V5, P399, DOI 10.4161/viru.27208; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Delsuc F, 2014, MOL ECOL, V23, P1301, DOI 10.1111/mec.12501; Dunn KA, 2016, INFLAMM BOWEL DIS, V22, P2607, DOI 10.1097/MIB.0000000000000949; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Fulton TL, 2006, MOL PHYLOGENET EVOL, V41, P165, DOI 10.1016/j.ympev.2006.05.025; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Gruninger RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156457; Gruninger RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089682; Gu H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140715; Gulino LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061463; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; Kanehisa Laboratories, 2017, STARCH SUCR MET; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Karasov WH, 2013, COMPR PHYSIOL, V3, P741, DOI 10.1002/cphy.c110054; Karlin S, 2000, J BACTERIOL, V182, P5238, DOI 10.1128/JB.182.18.5238-5250.2000; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pourramezan Z, 2012, Mikrobiologiia, V81, P796; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Ravindran Rajeev, 2016, Bioengineering-Basel, V3, P30, DOI 10.3390/bioengineering3040030; Ren Z, 2007, J APPL MICROBIOL, V103, P2258, DOI 10.1111/j.1365-2672.2007.03477.x; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Sanders JG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9285; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Tremblay Julien, 2015, Front Microbiol, V6, P771, DOI 10.3389/fmicb.2015.00771; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; VISPO C, 1995, CAN J ZOOL, V73, P967, DOI 10.1139/z95-113; Wesley-Hunt GD, 2005, J SYST PALAEONTOL, V3, P1; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108	59	12	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0189404	10.1371/journal.pone.0189404	http://dx.doi.org/10.1371/journal.pone.0189404			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281673	gold, Green Submitted, Green Published			2022-12-26	WOS:000419006200026
J	Wolford, E; Lahti, M; Tuovinen, S; Lahti, J; Lipsanen, J; Savolainen, K; Heinonen, K; Hamalainen, E; Kajantie, E; Pesonen, AK; Villa, PM; Laivuori, H; Reynolds, RM; Raikkonen, K				Wolford, Elina; Lahti, Marius; Tuovinen, Soile; Lahti, Jari; Lipsanen, Jari; Savolainen, Katri; Heinonen, Kati; Hamalainen, Esa; Kajantie, Eero; Pesonen, Anu-Katriina; Villa, Pia M.; Laivuori, Hannele; Reynolds, Rebecca M.; Raikkonen, Katri			Maternal depressive symptoms during and after pregnancy are associated with attention-deficit/hyperactivity disorder symptoms in their 3-to 6-year-old children	PLOS ONE			English	Article							BEHAVIORAL SYMPTOMS; BIRTH; POPULATION; PREVALENCE; EXPOSURE; STRESS; HEALTH; ADHD	Maternal depressive symptoms during pregnancy have been associated with child behavioural symptoms of attention-deficit/hyperactivity disorder (ADHD) in early childhood. However, it remains unclear if depressive symptoms throughout pregnancy are more harmful to the child than depressive symptoms only during certain times, and if maternal depressive symptoms after pregnancy add to or mediate any prenatal effects. 1,779 mother-child dyads participated in the Prediction and Prevention of Pre-eclampsia and Intrauterine Growth Restriction (PREDO) study. Mothers filled in the Center of Epidemiological Studies Depression Scale biweekly from 12+0-13+ 6 to 38+0-39+6 weeks+days of gestation or delivery, and the Beck Depression Inventory-II and the Conners' Hyperactivity Index at the child's age of 3 to 6 years (mean 3.8 years, standard deviation [SD] 0.5). Maternal depressive symptoms were highly stable throughout pregnancy, and children of mothers with consistently high depressive symptoms showed higher average levels (mean difference = 0.46 SD units, 95% Confidence Interval [CI] 0.36, 0.56, p < 0.001 compared to the low group), and proportion (32.1% vs. 14.7%) and odds (odds ratio = 2.80, 95% CI 2.20, 3.57, p < 0.001) of clinically significant ADHD symptoms. These associations were not explained by the effects of maternal depressive symptoms after pregnancy, which both added to and partially mediated the prenatal effects. Maternal depressive symptoms throughout pregnancy are associated with increased ADHD symptomatology in young children. Maternal depressive symptoms after pregnancy add to, but only partially mediate, the prenatal effects. Preventive interventions suited for the pregnancy period may benefit both maternal and offspring mental health.	[Wolford, Elina; Lahti, Marius; Tuovinen, Soile; Lahti, Jari; Lipsanen, Jari; Savolainen, Katri; Heinonen, Kati; Pesonen, Anu-Katriina; Raikkonen, Katri] Univ Helsinki, Fac Med, Dept Psychol & Logoped, Helsinki, Finland; [Lahti, Marius; Reynolds, Rebecca M.] Univ Edinburgh, Univ British Heart Fdn, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Lahti, Jari] Univ Helsinki, Helsinki Collegium Adv Studies, Helsinki, Finland; [Lahti, Jari] Folkhalsan Res Ctr, Helsinki, Finland; [Hamalainen, Esa] Univ Helsinki, Dept Clin Chem, Helsinki, Finland; [Kajantie, Eero] Natl Inst Hlth & Welf, Helsinki, Finland; [Kajantie, Eero] Helsinki Univ Hosp, Childrens Hosp, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Helsinki, Finland; [Kajantie, Eero] Oulu Univ Hosp, PEDEGO Res Unit, MRC Oulu, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland; [Villa, Pia M.] Univ Helsinki, Obstet & Gynaecol, Helsinki, Finland; [Villa, Pia M.; Laivuori, Hannele] Helsinki Univ Hosp, Helsinki, Finland; [Laivuori, Hannele] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Laivuori, Hannele] Tampere Univ Hosp, Dept Obstet & Gynecol, Tampere, Finland; [Laivuori, Hannele] Univ Helsinki, Med & Clin Genet, Helsinki, Finland; [Laivuori, Hannele] Univ Helsinki, Helsinki Inst Life Sci, Inst Mol Med Finland, Helsinki, Finland	University of Helsinki; University of Edinburgh; University of Helsinki; Folkhalsan Research Center; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Oulu; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; University of Helsinki	Wolford, E (corresponding author), Univ Helsinki, Fac Med, Dept Psychol & Logoped, Helsinki, Finland.	elina.wolford@helsinki.fi	Reynolds, Rebecca M/C-3044-2008; Lahti, Jari/P-2283-2019; Lahti, Jari/P-7987-2018; Laivuori, Hannele/F-2953-2011; Lahti-Pulkkinen, Marius/Q-2472-2017	Reynolds, Rebecca M/0000-0001-6226-8270; Lahti, Jari/0000-0002-4310-5297; Lahti, Jari/0000-0002-4310-5297; Pesonen, Anu-Katriina/0000-0002-0662-6261; Wolford, Elina/0000-0003-4461-6256; Laivuori, Hannele/0000-0003-3212-7826; Savolainen, Katri/0000-0002-1875-800X; Lipsanen, Jari Olavi/0000-0003-0746-2745; Heinonen, Kati/0000-0002-1262-5599; Raikkonen, Katri/0000-0003-3124-3470; Lahti-Pulkkinen, Marius/0000-0002-5244-5525	Academy of Finland; EraNet; EVO; University of Helsinki Research Funds; Signe and Ane Gyllenberg Foundation; Emil Aaltonen Foundation; Finnish Medical Foundation; Jane and Aatos Erkko Foundation; Novo Nordisk Foundation; Paivikki and Sakari Sohlberg Foundation; Sigrid Juselius Foundation; Sir Jules Thorn Charitable Trust; Novo Nordisk Fonden [NNF15OC0016362] Funding Source: researchfish	Academy of Finland(Academy of Finland); EraNet; EVO; University of Helsinki Research Funds; Signe and Ane Gyllenberg Foundation; Emil Aaltonen Foundation; Finnish Medical Foundation; Jane and Aatos Erkko Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Sir Jules Thorn Charitable Trust; Novo Nordisk Fonden(Novo Nordisk Foundation)	The PREDO study is funded by the Academy of Finland, EraNet, EVO (a special state subsidy for health science research), University of Helsinki Research Funds, the Signe and Ane Gyllenberg Foundation, the Emil Aaltonen Foundation, the Finnish Medical Foundation, the Jane and Aatos Erkko Foundation, the Novo Nordisk Foundation, the Paivikki and Sakari Sohlberg Foundation, the Sigrid Juselius Foundation, and the Sir Jules Thorn Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Achenbach TM, 2003, MANUAL ASEBA ADULT F; Atladottir HO, 2015, EUR CHILD ADOLES PSY, V24, P173, DOI 10.1007/s00787-014-0553-8; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Buss C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037758; Center for Disease Control and Prevention, 2010, MMWR-MORBID MORTAL W, V59, P2006; Conners C.K., 2001, CONNERS RATING SCALE; D'Onofrio BM, 2013, JAMA PSYCHIAT, V70, P1231, DOI 10.1001/jamapsychiatry.2013.2107; Dalsgaard S, 2015, LANCET, V385, P2190, DOI 10.1016/S0140-6736(14)61684-6; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Erskine HE, 2016, J AM ACAD CHILD PSY, V55, P841, DOI 10.1016/j.jaac.2016.06.016; Fontein-Kuipers YJ, 2014, BJOG-INT J OBSTET GY, V121, P389, DOI 10.1111/1471-0528.12500; Getahun D, 2013, PEDIATRICS, V131, pE53, DOI 10.1542/peds.2012-1298; Girchenko P, 2017, INT J EPIDEMIOL, V46, P1380, DOI 10.1093/ije/dyw154; Glover V, 2014, BEST PRACT RES CL OB, V28, P25, DOI 10.1016/j.bpobgyn.2013.08.017; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Lahti J, 2006, J CHILD PSYCHOL PSYC, V47, P1167, DOI 10.1111/j.1469-7610.2006.01661.x; Lahti M, 2017, J AM ACAD CHILD PSY, V56, P30, DOI 10.1016/j.jaac.2016.10.007; Landgren M, 1996, DEV MED CHILD NEUROL, V38, P891; Leis JA, 2014, J ABNORM CHILD PSYCH, V42, P161, DOI 10.1007/s10802-013-9766-4; Molyneaux E, 2014, OBSTET GYNECOL, V123, P857, DOI 10.1097/AOG.0000000000000170; Nast I, 2013, PAEDIATR PERINAT EP, V27, P313, DOI 10.1111/ppe.12051; Nomura Y, 2012, ARCH PEDIAT ADOL MED, V166, P337, DOI 10.1001/archpediatrics.2011.784; Parker J., 1996, J ATTEN DISORD, V1, P55, DOI [10.1177/108705479600100105, DOI 10.1177/108705479600100105]; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raikkonen K., 2017, AM J EPIDEMIOL, V185, P1; Ray GT, 2009, MED CARE, V47, P105, DOI 10.1097/MLR.0b013e31817e18c0; Reynolds R. M., 2015, PSYCHOL MED, P1; Rodriguez A, 2008, INT J OBESITY, V32, P550, DOI 10.1038/sj.ijo.0803741; Schellong D., 2016, P ECIS, P1; Shelton M, 2014, BIOL RES NURS, V17, P1; Strang-Karlsson S, 2008, AM J PSYCHIAT, V165, P1345, DOI 10.1176/appi.ajp.2008.08010085; Thomas R, 2015, PEDIATRICS, V135, pE994, DOI 10.1542/peds.2014-3482; Van Batenburg-Eddes T, 2013, J CHILD PSYCHOL PSYC, V54, P591, DOI 10.1111/jcpp.12023; Van den Bergh B. R. H., 2017, NEUROSCI BIOBEHAV RE; Westerlund J, 2009, ACTA PAEDIATR, V98, P828, DOI 10.1111/j.1651-2227.2008.01214.x; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8	40	51	54	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190248	10.1371/journal.pone.0190248	http://dx.doi.org/10.1371/journal.pone.0190248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8BI	29267405	Green Published, gold			2022-12-26	WOS:000418587400108
J	Achkar, T; Arjunan, A; Wang, H; Saul, M; Davar, D; Appleman, LJ; Friedland, D; Parikh, RA				Achkar, Tala; Arjunan, Ananth; Wang, Hong; Saul, Melissa; Davar, Diwakar; Appleman, Leonard J.; Friedland, David; Parikh, Rahul A.			High-dose interleukin 2 in patients with metastatic renal cell carcinoma with sarcomatoid features	PLOS ONE			English	Article							THERAPY; TRIAL; IMMUNOTHERAPY; NIVOLUMAB; SURVIVAL; ANTIBODY; PD-1	Background High-dose interleukin-2 (HD IL-2) is used in the treatment of metastatic renal cell carcinoma (mRCC) and has an overall response rate (ORR) of 12 +/- 20% and a complete response rate (CR) of 8% in unselected populations with predominantly clear cell type renal cell carcinoma. Nearly 10 +/- 15% of patients with renal cell carcinoma exhibit sarcomatoid differentiation, a feature which correlates with a median overall survival (OS) of 9 months and overall poor prognosis. We report a single institution experience with 21 patients with mRCC with sarcomatoid features post-nephrectomy who were treated with HD IL-2. Methods Twenty one patients with mRCC with sarcomatoid features post-nephrectomy who underwent therapy with HD IL-2 were identified at the University of Pittsburgh Medical Center from 2004 to 2016. Baseline patient characteristics, HD IL-2 cycles, time to progression, and subsequent therapies were evaluated. OS and progression-free survival (PFS) in the cohort were calculated using the Kaplan-Meier method. Disease characteristics were evaluated for significance using the Fischer's exact test and Wilcoxon rank sum test. Results Patients were predominantly Caucasian males with a median age of 54 years. A majority, 86% of these patients, had metastatic disease at time of initial presentation, primarily with lung and lymph node involvement. The ORR and CR with HD IL-2 was 10% and 5%, respectively. Initial localized disease presentation is the only variable that was significantly associated with response to HD IL-2 (p = 0.0158). Number of HD IL-2 doses did not correlate with response with a mean of 16.5 and 15.0 total doses in responders and non-responders, respectively (p = 0.53). Median PFS with HD IL-2 was 7.9 months (95% CI, 5.0 +/- 21.3). Median OS was 30.5 months (95% CI 13.3 +/- 57.66). Within the subset of patients who had progression on IL-2, median OS was 19.4 months (95% CI, 13.3 +/- 35.3). In patients who received second-line therapy, median PFS was 7.9 months (95% CI 2.4 +/- 10.2). Conclusion In patients with mRCC with sarcomatoid features, use of HD IL-2 was associated with a modest ORR and a higher survival compared to historical controls (patients with mRCC and sarcomatoid features). Thus, HD IL-2 may have a role in treating selected patients with mRCC with sarcomatoid features.	[Achkar, Tala; Arjunan, Ananth; Davar, Diwakar; Appleman, Leonard J.] Univ Pittsburgh, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15260 USA; [Wang, Hong] Univ Pittsburgh, Dept Publ Hlth, Biostat, Pittsburgh, PA USA; [Saul, Melissa] Univ Pittsburgh, Dept Hlth Informat Management, Pittsburgh, PA USA; [Friedland, David] Univ Pittsburgh, Med Ctr, Hillman Canc Ctr, Pittsburgh, PA USA; [Parikh, Rahul A.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Kansas; University of Kansas Medical Center	Achkar, T (corresponding author), Univ Pittsburgh, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15260 USA.	achkart@upmc.edu	Davar, Diwakar/AAC-3785-2020; Davar, Diwakar/AAL-9592-2021	Davar, Diwakar/0000-0002-7846-8055; Wang, Hong/0000-0003-0477-2908				Cangiano T, 1999, J CLIN ONCOL, V17, P523, DOI 10.1200/JCO.1999.17.2.523; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Cheville JC, 2004, AM J SURG PATHOL, V28, P435, DOI 10.1097/00000478-200404000-00002; CHITTORIA N, 2013, J CLIN ONCOL S, V31; FYFE G, 1995, J CLIN ONCOL, V13, P688, DOI 10.1200/JCO.1995.13.3.688; Fyfe GA, 1996, J CLIN ONCOL, V14, P2410, DOI 10.1200/JCO.1996.14.8.2410; Geynisman DM, 2015, EUR UROL, V68, P912, DOI 10.1016/j.eururo.2015.07.008; Golshayan AR, 2009, J CLIN ONCOL, V27, P235, DOI 10.1200/JCO.2008.18.0000; Joseph RW, 2015, CANCER IMMUNOL RES, V3, P1303, DOI 10.1158/2326-6066.CIR-15-0150; Klapper JA, 2008, CANCER-AM CANCER SOC, V113, P293, DOI 10.1002/cncr.23552; Leibovich BC, 2003, CANCER-AM CANCER SOC, V98, P2566, DOI 10.1002/cncr.11851; McDermott DF, 2016, J CLIN ONCOL, V34, P833, DOI 10.1200/JCO.2015.63.7421; McDermott DF, 2015, CLIN CANCER RES, V21, P561, DOI 10.1158/1078-0432.CCR-14-1520; McDermott DF, 2005, J CLIN ONCOL, V23, P133, DOI 10.1200/JCO.2005.03.206; Michaelson MD, 2015, CANCER-AM CANCER SOC, V121, P3435, DOI 10.1002/cncr.29503; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 2015, J CLIN ONCOL, V33, P1430, DOI 10.1200/JCO.2014.59.0703; Shuch B, 2012, ONCOLOGIST, V17, P46, DOI 10.1634/theoncologist.2011-0227; Upton MP, 2005, J IMMUNOTHER, V28, P488, DOI 10.1097/01.cji.0000170357.14962.9b; Zhang BY, 2015, BJU INT, V115, P405, DOI 10.1111/bju.12781	20	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0190084	10.1371/journal.pone.0190084	http://dx.doi.org/10.1371/journal.pone.0190084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261796	Green Submitted, Green Published, gold			2022-12-26	WOS:000418564200088
J	Deng, L; Li, W; Zhong, ZJ; Liu, XH; Chai, YJ; Luo, X; Song, Y; Wang, WY; Gong, C; Huang, XM; Hu, YC; Fu, HL; He, M; Wang, Y; Zhang, Y; Wu, KJ; Cao, SZ; Peng, GN				Deng, Lei; Li, Wei; Zhong, Zhijun; Liu, Xuehan; Chai, Yijun; Luo, Xue; Song, Yuan; Wang, Wuyou; Gong, Chao; Huang, Xiangming; Hu, Yanchun; Fu, Hualin; He, Min; Wang, Ya; Zhang, Yue; Wu, Kongju; Cao, Suizhong; Peng, Guangneng			Prevalence and molecular characterization of Giardia intestinalis in racehorses from the Sichuan province of southwestern China	PLOS ONE			English	Article							EQUINE CRYPTOSPORIDIUM; DUODENALIS; HORSES; EPIDEMIOLOGY; GENOTYPES; IDENTIFICATION; TRANSMISSION; PERSPECTIVE; INFECTIONS; ASSEMBLAGE	Giardia intestinalis, a cosmopolitan zoonotic parasite, is one of the most common causes of protozoal diarrhea in both humans and animals worldwide. Although G. intestinalis has been detected in many animals, information regarding its prevalence and genotype in Chinese racehorses is scarce. In the present study, we investigated the prevalence of G. intestinalis in racehorses and performed molecular characterization of the pathogen to assess its zoonotic potential. Two hundred and sixty-four racehorse fecal samples from six equestrian clubs located in different regions of the Sichuan province of southwestern China were examined. Nested polymerase chain reaction (PCR) analysis of the gene encoding triose-phosphate isomerase (tpi) showed the prevalence of G. intestinalis to be 8.3% (22/264), and the prevalence in different clubs varied from 3.6% to 13.5%. Three assemblages were identified in the successfully sequenced samples, including the potentially zoonotic assemblages A (n = 5) and B (n = 14), the mouse-specific assemblage G (n = 3), and a mixed A and B assemblage. Sequence analysis of tpi, glutamate dehydrogenase (gdh), and beta giardin (bg) loci revealed that the majority of sequences isolated from assemblage A were identical to the subtype AIV and assemblage B isolates showed variability among the nucleotide sequences of the subtype BIV. Using the nomenclature for the multilocus genotype (MLG) model, one each of multilocus genotypes A (MLG1) and B (MLG2) were identified, with MLG2 being a novel genotype. To the best of our knowledge, this is the first study to investigate G. intestinalis in Chinese racehorses. The presence of both animal and human assemblages of G. intestinalis in racehorses indicated that these animals might constitute a potential zoonotic risk to human beings.	[Deng, Lei; Li, Wei; Zhong, Zhijun; Chai, Yijun; Luo, Xue; Song, Yuan; Wang, Wuyou; Gong, Chao; Hu, Yanchun; Fu, Hualin; He, Min; Wang, Ya; Cao, Suizhong; Peng, Guangneng] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Liu, Xuehan] Henan Inst Sci & Technol, Coll Anim Sci & Vet Med, Xinxiang, Henan, Peoples R China; [Huang, Xiangming; Zhang, Yue; Wu, Kongju] Chengdu Giant Panda Breeding Res Base, Chengdu, Sichuan, Peoples R China	Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University; Henan Institute of Science & Technology	Peng, GN (corresponding author), Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan, Peoples R China.	pgn.sicau@163.com	LUO, XUEFENG/AAX-3762-2021; Deng, Lei/AAB-5622-2020	Deng, Lei/0000-0003-0391-6180	Chengdu Giant Panda Breeding Research Foundation [CPF2014-10]	Chengdu Giant Panda Breeding Research Foundation	The study was financially supported by the Chengdu Giant Panda Breeding Research Foundation CPF2014-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, GUANGZHOU CHEM IND, DOI DOI 10.1016/J.C0MP0SITESB.2013.09.020; Atwill ER, 2000, EQUINE VET J, V32, P247, DOI 10.2746/042516400776563545; Ballweber LR, 2010, TRENDS PARASITOL, V26, P180, DOI 10.1016/j.pt.2010.02.005; Beelitz P, 1996, Tierarztl Prax, V24, P48; Caccio SM, 2008, INT J PARASITOL, V38, P1523, DOI 10.1016/j.ijpara.2008.04.008; Caccio SA, 2002, INT J PARASITOL, V32, P1023, DOI 10.1016/S0020-7519(02)00068-1; Caccio SM, 2008, MOL BIOCHEM PARASIT, V160, P75, DOI 10.1016/j.molbiopara.2008.04.006; De Souza PNB, 2009, VET PARASITOL, V160, P327, DOI 10.1016/j.vetpar.2008.10.103; Fantham HB, 1924, S AFR J SCI, P164; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Fernandez-Alvarez A, 2014, PARASITOLOGY, V141, P206, DOI 10.1017/S003118201300139X; Fletcher SM, 2012, CLIN MICROBIOL REV, V25, P420, DOI 10.1128/CMR.05038-11; Garcia-Cervantes PC, 2017, J INFECT DEV COUNTR, V11, P180, DOI 10.3855/jidc.8223; Gomes AD, 2008, CIENC RURAL, V38, P2662, DOI 10.1590/S0103-84782008000900045; Johnson E, 1997, J VET DIAGN INVEST, V9, P56, DOI 10.1177/104063879700900110; Karanis P, 2007, J WATER HEALTH, V5, P1, DOI 10.2166/wh.2006.002; KIRKPATRICK CE, 1985, J AM VET MED ASSOC, V187, P163; Koehler AV, 2014, BIOTECHNOL ADV, V32, P280, DOI 10.1016/j.biotechadv.2013.10.009; Kostopoulou D, 2015, VET PARASITOL, V211, P170, DOI 10.1016/j.vetpar.2015.04.018; Lebbad M, 2010, VET PARASITOL, V168, P231, DOI 10.1016/j.vetpar.2009.11.003; Li J, 2012, VET PARASITOL, V188, P368, DOI 10.1016/j.vetpar.2012.04.004; Liu AQ, 2012, PARASITOL RES, V111, P655, DOI 10.1007/s00436-012-2883-0; Liu AQ, 2011, PARASITOL RES, V109, P913, DOI 10.1007/s00436-011-2333-4; Liu D., 2013, MOL DETECTION HUMAN, P295; MANAHAN FF, 1970, AUST VET J, V46, P231, DOI 10.1111/j.1751-0813.1970.tb02014.x; PAVLASEK I, 1995, VET MED-CZECH, V40, P81; Qi M, 2015, VET PARASITOL, V209, P169, DOI 10.1016/j.vetpar.2015.02.030; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; Santin M, 2013, VET PARASITOL, V196, P31, DOI 10.1016/j.vetpar.2013.02.006; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558; Traub R, 2005, VET PARASITOL, V130, P317, DOI 10.1016/j.vetpar.2005.02.011; Traversa D, 2012, INFECT GENET EVOL, V12, P1642, DOI 10.1016/j.meegid.2012.06.014; Veronesi F, 2010, ZOONOSES PUBLIC HLTH, V57, P510, DOI 10.1111/j.1863-2378.2009.01261.x; XIAO LH, 1994, EQUINE VET J, V26, P14, DOI 10.1111/j.2042-3306.1994.tb04323.x; Xiao LH, 2008, INT J PARASITOL, V38, P1239, DOI 10.1016/j.ijpara.2008.03.006; Ye JB, 2014, PARASITOL INT, V63, P132, DOI 10.1016/j.parint.2013.10.007; Zhang WC, 2012, CHIN CONT DECIS CONF, P2012, DOI 10.1109/CCDC.2012.6244324; Zhang WZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001826; Zhang X, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2529-2; Zhang XX, 2016, J EUKARYOT MICROBIOL, V63, P498, DOI 10.1111/jeu.12293	41	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189728	10.1371/journal.pone.0189728	http://dx.doi.org/10.1371/journal.pone.0189728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261753	gold, Green Published, Green Submitted			2022-12-26	WOS:000418564200060
J	Passannanti, F; Nigro, F; Gallo, M; Tornatore, F; Frasso, A; Saccone, G; Budelli, A; Barone, MV; Nigro, R				Passannanti, Francesca; Nigro, Federica; Gallo, Marianna; Tornatore, Fabio; Frasso, Annalisa; Saccone, Giulia; Budelli, Andrea; Barone, Maria V.; Nigro, Roberto			In vitro dynamic model simulating the digestive tract of 6-month-old infants	PLOS ONE			English	Article							STARCH DIGESTIBILITY; PEARL-MILLET; FERMENTATION; PROTEIN; CHILDREN; FOOD; PREVALENCE; ANIMALS; HUMANS; SALIVA	Background In vivo assays cannot always be conducted because of ethical reasons, technical constraints or costs, but a better understanding of the digestive process, especially in infants, could be of great help in preventing food-related pathologies and in developing new formulas with health benefits. In this context, in vitro dynamic systems to simulate human digestion and, in particular, infant digestion could become increasingly valuable. Objective To simulate the digestive process through the use of a dynamic model of the infant gastroenteric apparatus to study the digestibility of starch-based infant foods. Design Using M.I.D.A (Model of an Infant Digestive Apparatus), the oral, gastric and intestinal digestibility of two starch-based products were measured: 1) rice starch mixed with distilled water and treated using two different sterilization methods (the classical method with a holding temperature of 121 degrees C for 37 min and the HTST method with a holding temperature of 137 degrees C for 70 sec) and 2) a rice cream with (premium product) or without (basic product) an aliquot of rice flour fermented by Lactobacillus paracasei CBA L74. After the digestion the foods were analyzed for the starch concentration, the amount of D-glucose released and the percentage of hydrolyzed starch. Results An in vitro dynamic system, which was referred to as M.I.D.A., was obtained. Using this system, the starch digestion occurred only during the oral and intestinal phase, as expected. The D-glucose released during the intestinal phase was different between the classical and HTST methods (0.795 grams for the HTST versus 0.512 for the classical product). The same analysis was performed for the basic and premium products. In this case, the premium product had a significant difference in terms of the starch hydrolysis percentage during the entire process. Conclusions The M.I.D.A. system was able to digest simple starches and a more complex food in the correct compartments. In this study, better digestibility of the premium product was revealed.	[Passannanti, Francesca; Gallo, Marianna; Tornatore, Fabio; Frasso, Annalisa; Saccone, Giulia; Nigro, Roberto] Univ Naples Federico II, DICMAPI, Naples, Italy; [Nigro, Federica] Univ Rome Niccolo Cusano, Engn Dept, Rome, Italy; [Budelli, Andrea] Heinz Innovat Ctr, Nijmegen, Netherlands; [Barone, Maria V.] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Barone, Maria V.] European Lab Invest Food Induced Dis ELFID, Naples, Italy	University of Naples Federico II; Niccolo Cusano Online University; University of Naples Federico II	Nigro, R (corresponding author), Univ Naples Federico II, DICMAPI, Naples, Italy.	rnigro@unina.it	Nigro, Roberto/M-7315-2016; Gallo, Marianna/AAA-7730-2020; Marianna, Gallo/AAR-8112-2020	Nigro, Roberto/0000-0002-9459-2128; Marianna, Gallo/0000-0002-7919-7971; Passannanti, Francesca/0000-0003-4773-3466; Budelli, Andrea/0000-0003-1866-1301	AIC (Associazione Italiana Celiachia) Project [N.053_FC_2013]	AIC (Associazione Italiana Celiachia) Project	Grant support: AIC (Associazione Italiana Celiachia) Project N.053_FC_2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding Statement: Dr. Andrea Budelli provided the raw materials. Heinz BV and Dr. Andrea Budelli did not provide any financial support to the authors and to the project.	ARNOLD JG, 1983, DIGEST DIS SCI, V28, P737, DOI 10.1007/BF01312565; Bao J., 2004, STARCH FOOD STRUCTUR; Bernfeld P, 1962, COMP BIOCHEM, VIII, P355; Blanquet S., 2004, PHARM RES; Borowitz D, 2009, J PEDIAT, V155; Coles LT, 2005, ANIM FEED SCI TECH, V123, P421, DOI 10.1016/j.anifeedsci.2005.04.021; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; Deglaire A, 2009, BRIT J NUTR, V102, P1752, DOI 10.1017/S0007114509991267; Desai BB, 2000, HDB NUTR DIET; ELASHOFF JD, 1982, GASTROENTEROLOGY, V83, P1306; Eliasson A. -C., 2004, STARCH FOOD STRUCTUR; FALLINGBORG J, 1990, J PEDIATR GASTR NUTR, V11, P211, DOI 10.1097/00005176-199008000-00010; Giz-Izquierdo, 2002, EUROPEAN FOOD RES TE, P155; Guerra A, 2012, TRENDS BIOTECHNOL, V30, P591, DOI 10.1016/j.tibtech.2012.08.001; Hansen J., 2014, NETTERS CLIN ANATOMY; Havenaar R, 2013, INT J PHARMACEUT, V457, P327, DOI 10.1016/j.ijpharm.2013.07.053; Hoebler C, 2002, INT J FOOD SCI NUTR, V53, P389, DOI 10.1080/0963748021000044732; HUNT JN, 1975, J PHYSIOL-LONDON, V245, P209, DOI 10.1113/jphysiol.1975.sp010841; Kaye JL, 2011, INT J CLIN PHARM-NET, V33, P20, DOI 10.1007/s11096-010-9455-0; KNUCKLES BE, 1985, J FOOD SCI, V50, P1080, DOI 10.1111/j.1365-2621.1985.tb13016.x; Lohi S, 2007, ALIMENT PHARM THERAP, V26, P1217, DOI 10.1111/j.1365-2036.2007.03502.x; López María Elena, 2003, Braz. Dent. J., V14, P26, DOI 10.1590/S0103-64402003000100005; Mattila-Sandholm T, 1999, INT DAIRY J, V9, P25, DOI 10.1016/S0958-6946(99)00041-2; Menard O, 2014, FOOD CHEM, V145, P1039, DOI 10.1016/j.foodchem.2013.09.036; MINEKUS M, 1995, ATLA-ALTERN LAB ANIM, V23, P197; Minekus M, 2014, FOOD FUNCT, V5, P1113, DOI 10.1039/c3fo60702j; MOLLY K, 1993, APPL MICROBIOL BIOT, V39, P254, DOI 10.1007/BF00228615; Moules T, 1998, TXB CHILDRENS NURS 1; Niba LL, 2005, HDB FOOD SCI TECHNOL; Patterson M, 2000, J PEDIATR SURG, V35, P59, DOI 10.1016/S0022-3468(00)80014-7; Pinto MF, 2002, MEAT SCI, V61, P187, DOI 10.1016/S0309-1740(01)00184-X; Ross RP, 2002, INT J FOOD MICROBIOL, V79, P3, DOI 10.1016/S0168-1605(02)00174-5; ROSSITER MA, 1974, ACTA PAEDIATR SCAND, V63, P389, DOI 10.1111/j.1651-2227.1974.tb04815.x; Sarno M, 2014, INT J FOOD SCI NUTR, V65, P953, DOI 10.3109/09637486.2014.940283; Seidel BM, 2001, EARLY HUM DEV, V62, P159, DOI 10.1016/S0378-3782(01)00130-X; Sharma A, 1996, PLANT FOOD HUM NUTR, V49, P241, DOI 10.1007/BF01093221; Sharma A, 1996, NAHRUNG, V40, P142, DOI 10.1002/food.19960400309; Sindhu SC, 2001, J FOOD COMPOS ANAL, V14, P601, DOI 10.1006/jfca.2001.1022; Singh J, 2010, TRENDS FOOD SCI TECH, V21, P168, DOI 10.1016/j.tifs.2009.12.001; Tamura M., 2015, Agricultural Engineering International: CIGR Journal, V17, P268; Tavares AMP, 2014, INVESTIGATING EFFECT; THOMPSON LU, 1984, J FOOD SCI, V49, P1228, DOI 10.1111/j.1365-2621.1984.tb10443.x; Verwei M, 2005, TRENDS FOOD SCI TECH, V16, P307, DOI 10.1016/j.tifs.2005.03.015; WEAVER LT, 1991, GUT, V32, P1321, DOI 10.1136/gut.32.11.1321; Yoo J. Y., 2006, INT J FOOD ENGR; Zagato E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087615; ZOPPI G, 1972, PEDIATR RES, V6, P880, DOI 10.1203/00006450-197212000-00005	48	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189807	10.1371/journal.pone.0189807	http://dx.doi.org/10.1371/journal.pone.0189807			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261742	gold, Green Published, Green Submitted			2022-12-26	WOS:000418564200067
J	Shan, GG; Gerstenberger, S				Shan, Guogen; Gerstenberger, Shawn			Fisher's exact approach for post hoc analysis of a chi-squared test	PLOS ONE			English	Article							EXACT CONFIDENCE-INTERVALS; ADAPTIVE 2-STAGE DESIGNS; C CONTINGENCY-TABLES; II CLINICAL-TRIALS; UNCONDITIONAL TESTS; EFFICIENT; ERROR	This research is motivated by one of our survey studies to assess the potential influence of introducing zebra mussels to the Lake Mead National Recreation Area, Nevada. One research question in this study is to investigate the association between the boating activity type and the awareness of zebra mussels. A chi-squared test is often used for testing independence between two factors with nominal levels. When the null hypothesis of independence between two factors is rejected, we are often left wondering where does the significance come from. Cell residuals, including standardized residuals and adjusted residuals, are traditionally used in testing for cell significance, which is often known as a post hoc test after a statistically significant chi-squared test. In practice, the limiting distributions of these residuals are utilized for statistical inference. However, they may lead to different conclusions based on the calculated p-values, and their p-values could be over-o6r under-estimated due to the unsatisfactory performance of asymptotic approaches with regards to type I error control. In this article, we propose new exact p-values by using Fisher's approach based on three commonly used test statistics to order the sample space. We theoretically prove that the proposed new exact p-values based on these test statistics are the same. Based on our extensive simulation studies, we show that the existing asymptotic approach based on adjusted residual is often more likely to reject the null hypothesis as compared to the exact approach due to the inflated family-wise error rates as observed. We would recommend the proposed exact p-value for use in practice as a valuable post hoc analysis technique for chi-squared analysis.	[Shan, Guogen; Gerstenberger, Shawn] Univ Nevada Las Vegas, Sch Community Hlth Sci, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Shan, GG (corresponding author), Univ Nevada Las Vegas, Sch Community Hlth Sci, Las Vegas, NV 89154 USA.	guogen.shan@unlv.edu	Shan, Guogen/GQI-3293-2022	Shan, Guogen/0000-0001-8690-6599	National Institute of General Medical Sciences from the National Institutes of Health [P20GM109025, P20GM103440, 5U54GM104944]	National Institute of General Medical Sciences from the National Institutes of Health(General Electric)	GS's research is partially supported by grants from the National Institute of General Medical Sciences from the National Institutes of Health: P20GM109025, P20GM103440, and 5U54GM104944. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are very grateful to the Editor, and two reviewers for their insightful comments that help improve the manuscript. Shan's research is partially supported by grants from the National Institute of General Medical Sciences from the National Institutes of Health: P20GM109025, P20GM103440, and 5U54GM104944.	[Anonymous], 2012, CATEGORICAL DATA ANA; COX MK, 1993, EDUC PSYCHOL MEAS, V53, P951, DOI 10.1177/0013164493053004008; Demirhan H, 2016, R J, V8, P48; Dobson AJ, 2008, INTRO GEN LINEAR MOD; Everitt B.S., 1992, ANAL CONTINGENCY TAB; Fisher RA, 1935, DESIGN EXPT; FREEMAN GH, 1951, BIOMETRIKA, V38, P141, DOI 10.2307/2332323; Gerstenberger S, 2003, 100 MERIDIAN INITIAT; HABERMAN SJ, 1973, BIOMETRICS, V29, P205, DOI 10.2307/2529686; HEBERT PDN, 1989, CAN J FISH AQUAT SCI, V46, P1587, DOI 10.1139/f89-202; Jin M, 2014, IMPLEMENTING MULTIPL, P1544; LANCASTER HO, 1949, BIOMETRIKA, V36, P117, DOI 10.2307/2332535; MacDonald PL, 2000, EDUC PSYCHOL MEAS, V60, P735, DOI 10.1177/00131640021970871; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; Patefield W. M., 1981, APPL STAT, V30, P91, DOI DOI 10.2307/2346669; ROBERTS G, 1981, PATHOLOGY, V13, P763, DOI 10.3109/00313028109086650; Shan G., 2015, EXACT STAT INFERENCE; SHAN G, 2013, THE R J, V5, P62; Shan G, 2017, BRIT J MATH STAT PSY; Shan G, 2015, J CLIN EPIDEMIOL, V68, P733; Shan GG, 2017, STAT MED, V36, P3437, DOI 10.1002/sim.7359; Shan GG, 2017, STAT METHODS MED RES, V26, P615, DOI 10.1177/0962280214552881; Shan GG, 2016, STAT BIOSCI, V8, P351, DOI 10.1007/s12561-016-9152-1; Shan GG, 2016, COMPUTATION STAT, V31, P1633, DOI 10.1007/s00180-016-0654-6; Shan GG, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0194-3; Shan GG, 2016, J APPL STAT, V43, P1279, DOI 10.1080/02664763.2015.1094454; Shan GG, 2016, STAT MED, V35, P1257, DOI 10.1002/sim.6794; Shan GG, 2016, STAT METHODS MED RES, V25, P241, DOI 10.1177/0962280212450957; Shan GG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097386; Shan GG, 2013, HUM HERED, V76, P10, DOI 10.1159/000353205; Shan GG, 2013, STAT PROBABIL LETT, V83, P644, DOI 10.1016/j.spl.2012.11.014; Shan GG, 2012, STAT MED, V31, P155, DOI 10.1002/sim.4411; Sharpe D., 2015, PRACT ASSESS RES EVA, V20, P8; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Wang WZ, 2015, BIOMETRICS, V71, P985, DOI 10.1111/biom.12360	35	84	86	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0188709	10.1371/journal.pone.0188709	http://dx.doi.org/10.1371/journal.pone.0188709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261690	Green Published, Green Submitted, gold			2022-12-26	WOS:000418564200014
J	Singletary, M; Hagerty, S; Muramoto, S; Daniels, Y; MacCrehan, WA; Stan, G; Lau, JW; Pustovyy, O; Globa, L; Morrison, EE; Sorokulova, I; Vodyanoy, V				Singletary, Melissa; Hagerty, Samantha; Muramoto, Shin; Daniels, Yasmine; MacCrehan, William A.; Stan, Gheorghe; Lau, June W.; Pustovyy, Oleg; Globa, Ludmila; Morrison, Edward E.; Sorokulova, Iryna; Vodyanoy, Vitaly			PEGylation of zinc nanoparticles amplifies their ability to enhance olfactory responses to odorant	PLOS ONE			English	Article							ELECTRON-TRANSFER; VISCOSITY; OXIDATION; KINETICS; GROWTH	Olfactory responses are intensely enhanced with the addition of endogenous and engineered primarily-elemental small zinc nanoparticles (NPs). With aging, oxidation of these Zn nanoparticles eliminated the observed enhancement. The design of a polyethylene glycol coating to meet storage requirements of engineered zinc nanoparticles is evaluated to achieve maximal olfactory benefit. The zinc nanoparticles were covered with 1000 g/mol or 400 g/mol molecular weight polyethylene glycol (PEG). Non-PEGylated and PEGylated zinc nanoparticles were tested by electroolfactogram with isolated rat olfactory epithelium and odorant responses evoked by the mixture of eugenol, ethyl butyrate and (+/-) carvone after storage at 278 K (5 degrees C), 303 K (30 degrees C) and 323 K (50 degrees C). The particles were analyzed by atomic force microscopy, transmission electron microscopy, X-ray photoelectron spectroscopy, and laser Doppler velocimetry. Our data indicate that stored ZnPEG400 nanoparticles maintain physiologically-consistent olfactory enhancement for over 300 days. These engineered Nanoparticles support future applications in olfactory research, sensitive detection, and medicine.	[Singletary, Melissa; Hagerty, Samantha; Pustovyy, Oleg; Globa, Ludmila; Morrison, Edward E.; Sorokulova, Iryna; Vodyanoy, Vitaly] Auburn Univ, Coll Vet Med, Dept Anat Physiol & Pharmacol, Auburn, AL 36849 USA; [Muramoto, Shin; Daniels, Yasmine; MacCrehan, William A.; Stan, Gheorghe; Lau, June W.] NIST, Mat Measurement Lab, Gaithersburg, MD 20899 USA	Auburn University System; Auburn University; National Institute of Standards & Technology (NIST) - USA	Vodyanoy, V (corresponding author), Auburn Univ, Coll Vet Med, Dept Anat Physiol & Pharmacol, Auburn, AL 36849 USA.	vodyavi@auburn.edu		HASSIN, SAMANTHA/0000-0003-4932-1633; Lau, June/0000-0002-5233-4956	National Institute of Science and Technology (NIST) [70NANB14H324]	National Institute of Science and Technology (NIST)(National Institute of Standards & Technology (NIST) - USA)	The work was supported by the grant from the National Institute of Science and Technology (NIST) grant 70NANB14H324. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, 2017, ALZHEIMERS DEMENT, V13, P325, DOI [DOI 10.1016/J.JALZ.2017.02.001, 10.1016/j.jalz.2017.02.001]; Anand AS, 2017, J HAZARD MATER, V327, P180, DOI 10.1016/j.jhazmat.2016.12.040; Bahuleyan B, 2012, J CLIN DIAGN RES, V6, P1437, DOI 10.7860/JCDR/2012/3408.2382; Banks FR, 1941, PHYS REV, V59, P376, DOI 10.1103/PhysRev.59.376; Boldyreva L.B., 2014, SPIN SUPERCURR NANOM, V2, P1; Brookes JC, 2012, SENSORS-BASEL, V12, P15709, DOI 10.3390/s121115709; Butterworth MD, 2001, COLLOID SURFACE A, V179, P93, DOI 10.1016/S0927-7757(00)00633-6; Chen YJ, 2007, MATER LETT, V61, P144, DOI 10.1016/j.matlet.2006.04.044; COPE JO, 1961, T FARADAY SOC, V57, P493, DOI 10.1039/tf9615700493; DEROUBAIX G, 1992, SURF INTERFACE ANAL, V18, P39, DOI 10.1002/sia.740180107; Doneux T, 2016, ELECTROCHIM ACTA, V219, P412, DOI 10.1016/j.electacta.2016.10.005; Doneux T, 2016, J PHYS CHEM C, V120, P15915, DOI 10.1021/acs.jpcc.5b12260; Duan CH, 2016, J MATER CHEM A, V4, P1855, DOI 10.1039/c5ta09483f; Feng W, 2015, SCI REP-UK, V5, DOI 10.1038/srep17422; Ferro S, 2005, CARBON, V43, P1191, DOI 10.1016/j.carbon.2004.12.012; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; Fukutani Y, 2012, BIOTECHNOL BIOENG, V109, P3143, DOI 10.1002/bit.24589; Gaarenstroom S.W., 2012, NIST XRAY PHOTOELECT; Gidwani M, 2013, CURR PHARM BIOTECHNO, V14, P1201, DOI 10.2174/1389201015666140508122558; Gomes R, 2003, ETHYLENE GLYCOL HUMA; Gu X-F, 2016, J APPL CRYSTALLOGR, V49, P1; Guay-Begin AA, 2012, LANGMUIR, V28, P774, DOI 10.1021/la202780x; Hagerty S, 2016, BIOMETALS, V29, P1005, DOI 10.1007/s10534-016-9972-y; Hassan S, 2014, J NANOSCI NANOTECHNO, V14, P402, DOI 10.1166/jnn.2014.8747; Hideo W, 1965, JPN J APPL PHYS, V4, P945; Hoshino A, 2009, IEEE T NANOBIOSCI, V8, P51, DOI 10.1109/TNB.2009.2016550; Hotchen CE, 2015, PHYS CHEM CHEM PHYS, V17, P11260, DOI 10.1039/c5cp01244a; Jachimska B, 2008, LANGMUIR, V24, P6866, DOI 10.1021/la800548p; Jia H, 2016, CHEM SENSES, V41, P53, DOI 10.1093/chemse/bjv054; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/NNM.11.19, 10.2217/nnm.11.19]; Karakoti AS, 2011, ANGEW CHEM INT EDIT, V50, P1980, DOI 10.1002/anie.201002969; Kaushik NK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103349; Kogan MJ, 2007, NANOMEDICINE-UK, V2, P287, DOI 10.2217/17435889.2.3.287; Kruyt HR, 1952, COLLOID SCI; Lu CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep19870; Mai NT, 2013, CRYSTENGCOMM, V15, P6606, DOI 10.1039/c3ce40801a; Mapping Nanotech Drugs' Landscape, 2012, CHEM ENG NEWS, V90, P46; MASON MG, 1983, PHYS REV B, V27, P748, DOI 10.1103/PhysRevB.27.748; McKone JR, 2013, ACS CATAL, V3, P166, DOI 10.1021/cs300691m; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; MOORE WJ, 1951, T FARADAY SOC, V47, P501, DOI 10.1039/tf9514700501; Mu QX, 2014, CHEM REV, V114, P7740, DOI 10.1021/cr400295a; Nasajpour A, ADV FUNCTIONAL MAT; Nekoueian K, 2015, ACS APPL MATER INTER, V7, P15458, DOI 10.1021/acsami.5b03654; Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0; OTTOSON D, 1956, ACTA PHYSIOL SCAND, V35, P7; Ottoson D, 1971, HDB SENSORY PHYSIO 1, V4, P95; Qiu LM, 2006, LANGMUIR, V22, P4480, DOI 10.1021/la053071q; Roldan Cuenya B, 2010, THIN SOLID FILMS, V518, P3127, DOI 10.1016/j.tsf.2010.01.018; Samoylov AM, 2005, CELLS TISSUES ORGANS, V179, P115, DOI 10.1159/000085003; Scott JW, 2002, MICROSC RES TECHNIQ, V58, P152, DOI 10.1002/jemt.10133; Segel IH., 1975, BIOCH CALCULATIONS; Sirelkhatim A, 2015, NANO-MICRO LETT, V7, P219, DOI 10.1007/s40820-015-0040-x; Suk JS, 2016, ADV DRUG DELIVER REV, V99, P28, DOI 10.1016/j.addr.2015.09.012; Thierry B, 2009, CHEM COMMUN, P1724, DOI 10.1039/b820137d; Turin L, 1996, CHEM SENSES, V21, P773, DOI 10.1093/chemse/21.6.773; Viswaprakash N, 2010, CELLS TISSUES ORGANS, V192, P361, DOI 10.1159/000319468; Viswaprakash N, 2009, CHEM SENSES, V34, P547, DOI 10.1093/chemse/bjp031; Vodyanoy V, 2010, BIOMETALS, V23, P1097, DOI 10.1007/s10534-010-9355-8; Wang P, 2009, J PHYS CHEM C, V113, P13793, DOI 10.1021/jp903060q; Wang SG, 2015, BIOMATERIALS, V39, P206, DOI 10.1016/j.biomaterials.2014.11.009; Wang XY, 2015, J TAIWAN INST CHEM E, V50, P297, DOI 10.1016/j.jtice.2014.12.030; Xie J, 2015, J BIOL CHEM, V290, P11591, DOI 10.1074/jbc.M114.623264	63	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189273	10.1371/journal.pone.0189273	http://dx.doi.org/10.1371/journal.pone.0189273			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261701	Green Submitted, Green Published, gold			2022-12-26	WOS:000418564200039
J	Couttenier, A; Lacroix, O; Vaes, E; Cardwell, CR; De Schutter, H; Robert, A				Couttenier, Alexandra; Lacroix, Olivia; Vaes, Evelien; Cardwell, Chris R.; De Schutter, Harlinde; Robert, Annie			Statin use is associated with improved survival in ovarian cancer: A retrospective population-based study	PLOS ONE			English	Article							BREAST-CANCER; RELATIVE SURVIVAL; APOPTOSIS; MORTALITY; COHORT; TRENDS; DRUGS	Background Preclinical in vitro and in vivo studies suggest that statins could exhibit anticancer properties in ovarian cancer. Similar effects have also been reported in observational studies but their results remain inconsistent and could be impaired by methodological limitations. This study aimed to investigate whether statin use is associated with improved survival in ovarian cancer patients at the Belgian population-level. Methods All patients with invasive epithelial ovarian cancer diagnosed between 2004 and 2012 were identified from the Belgian Cancer Registry. Vital statuses were obtained from the Crossroads Bank for Social Security and ovarian cancer-specific deaths were identified from death certificates provided by regional administrations. Information on cancer treatments and statin use were retrieved from health insurance databases. Statin use was modelled as a time-varying covariate in Cox regression models to calculate adjusted hazards ratios (HR) and 95% confidence intervals (95% CI) for the association between postdiagnostic exposure to statins and overall-or ovarian cancer-specific mortality within three years after diagnosis. Adjustments were made for age at diagnosis, year of diagnosis, comorbidities, cancer stage, and cancer treatments. Results A total of 5,416 patients with epithelial ovarian cancer met the inclusion criteria. Of these 1,255 (23%) had at least one statin prescription within three years after diagnosis. Postdiagnostic use of statins was associated with a reduced risk of overall mortality (adjusted HR = 0.81, 95% CI: 0.72-0.90, p<0.001). In analyses by statin type, this association was only significant for simvastatin (adjusted HR = 0.86, 95% CI: 0.74-0.99, p = 0.05) or rosuvastatin (adjusted HR = 0.71, 95% CI: 0.55-0.92, p = 0.01). In subgroup analyses by statin prediagnostic use, the protective association for postdiagnostic statin use was only observed in patients who were also using statins before diagnosis (adjusted HR = 0.73, 95% CI: 0.64-0.83, p<0.001). Similar results were observed for ovarian cancer-specific mortality. Conclusion In this large nation-wide cohort of ovarian cancer patients postdiagnostic use of statins was associated with improved survival.	[Couttenier, Alexandra; Lacroix, Olivia; Robert, Annie] Catholic Univ Louvain, Pole Epidemiol & Biostat, Inst Rech Expt & Clin, Brussels, Belgium; [Vaes, Evelien; De Schutter, Harlinde] Belgian Canc Registry, Res Dept, Brussels, Belgium; [Cardwell, Chris R.] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland	Universite Catholique Louvain; Queens University Belfast	Couttenier, A (corresponding author), Catholic Univ Louvain, Pole Epidemiol & Biostat, Inst Rech Expt & Clin, Brussels, Belgium.	alexandra.couttenier@uclouvain.be		Cardwell, Chris/0000-0002-2689-4335; couttenier, alexandra/0000-0003-3713-2624; Lacroix, Olivia/0000-0003-2774-2226	Universite catholique de Louvain - Institut de Recherche Experimentale et Clinique - Pole d'Epidemiologie et Biostatistique [UCL-2015-EPID-2022, UCL-2015-EPID-2019]	Universite catholique de Louvain - Institut de Recherche Experimentale et Clinique - Pole d'Epidemiologie et Biostatistique	Alexandra Couttenier and Olivia Lacroix are fully funded by grants of Universite catholique de Louvain - Institut de Recherche Experimentale et Clinique - Pole d'Epidemiologie et Biostatistique, via grant numbers UCL-2015-EPID-2022 and UCL-2015-EPID-2019, respectively. We confirm that we did not receive any additional funding for this study.	Baldwin LA, 2012, OBSTET GYNECOL, V120, P612, DOI 10.1097/AOG.0b013e318264f794; Banno K, 2015, SCI WORLD J; Cancer survival in Belgium, 2012, BELGIAN CANCER REGIS; Cardwell CR, 2015, EPIDEMIOLOGY, V26, P68, DOI 10.1097/EDE.0000000000000189; Chubak J, 2013, JNCI-J NATL CANCER I, V105, P1456, DOI 10.1093/jnci/djt211; Desai P, 2015, CANCER CAUSE CONTROL, V26, P529, DOI 10.1007/s10552-015-0530-7; Elmore RG, 2008, GYNECOL ONCOL, V111, P102, DOI 10.1016/j.ygyno.2008.06.007; Gbelcova H, 2008, INT J CANCER, V122, P1214, DOI 10.1002/ijc.23242; Habis M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104521; Henau K, 2015, CANCER EPIDEMIOL, V39, P55, DOI 10.1016/j.canep.2014.10.009; Horiuchi A, 2008, CANCER SCI, V99, P2532, DOI 10.1111/j.1349-7006.2008.00977.x; Kaitin KI, 2011, CLIN PHARMACOL THER, V89, P183, DOI 10.1038/clpt.2010.286; Lavie O, 2013, GYNECOL ONCOL, V130, P615, DOI 10.1016/j.ygyno.2013.05.025; Levesque LE, 2010, BMJ; Liu HL, 2009, CANCER CHEMOTH PHARM, V63, P997, DOI 10.1007/s00280-008-0830-7; Martirosyan A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-103; Matsuura M, 2011, ONCOL REP, V25, P41, DOI 10.3892/or_00001039; Mc Menamin UC, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2651-0; Mueck AO, 2003, MENOPAUSE, V10, P332, DOI 10.1097/01.GME.0000055485.06076.00; Murtola TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110231; Nickels S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075088; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Padhy BM, 2011, J POSTGRAD MED, V57, P153, DOI 10.4103/0022-3859.81870; Pantziarka P, 2015, FUTURE ONCOL, V11, P181, DOI [10.2217/fon.14.244, 10.2217/FON.14.244]; Robinson E, 2014, BIOCHEM SOC T, V42, P125, DOI 10.1042/BST20130203; Robinson E, 2013, GYNECOL ONCOL, V129, P417, DOI 10.1016/j.ygyno.2013.02.003; Taylor-Harding B, 2010, GYNECOL ONCOL, V119, P549, DOI 10.1016/j.ygyno.2010.08.017; Tretarre B, 2015, GYNECOL ONCOL, V139, P324, DOI 10.1016/j.ygyno.2015.09.013; Vikas V.P, 2014, ECANCERMEDICALSCIENC, V8; Vrijens F, 2016, QUALITY INDICATORS M; Wright JD, 2015, OBSTET GYNECOL, V125, P1345, DOI 10.1097/AOG.0000000000000854	31	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189233	10.1371/journal.pone.0189233	http://dx.doi.org/10.1371/journal.pone.0189233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261726	Green Published, Green Submitted, gold			2022-12-26	WOS:000418554900014
J	Li, LL; Wagner, B; Freer, H; Schilling, M; Bannantine, JP; Campo, JJ; Katani, R; Grohn, YT; Radzio-Basu, J; Kapur, V				Li, Lingling; Wagner, Bettina; Freer, Heather; Schilling, Megan; Bannantine, John P.; Campo, Joseph J.; Katani, Robab; Grohn, Yrjo T.; Radzio-Basu, Jessica; Kapur, Vivek			Early detection of Mycobacterium avium subsp paratuberculosis infection in cattle with multiplex-bead based immunoassays	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSES; MALTOSE-BINDING PROTEIN; JOHNES-DISEASE; FECAL CULTURE; SECRETED ANTIGENS; DIAGNOSIS; ANTIBODY; ELISA; ASSAY; MILK	Johne's Disease (JD), caused by Mycobacterium avium subspecies paratuberculosis (MAP), results in significant economic loss to livestock production. The early detection of MAP infection in animals with extant serological assays has remained challenging due to the low sensitivity of commercially available ELISA tests, a fact that has hampered the development of effective JD control programs. Our recent protein microarray-based studies identified several promising candidate antigens that are immunogenic during different stages of MAP infection. To evaluate these antigens for use in diagnostic assays and reliably identify animals with MAP infection, a multiplex (Luminex (R)) assay was developed using color-coded flourescent beads coupled to 6 MAP recombinant proteins and applied to screen 180 serum and 90 milk samples from cows at different stages of MAP infection including negative (NL), fecal test positive/ELISA negative (F+E-), and fecal positive/ELISA positive (F+E+). The results show that while serum antibody reactivities to each of the 6 antigens were highest in F+E+ group, antibody reactivity to three of the six antigens were identified in the F+E- group, suggesting that these three antigens are expressed and provoke antibody responses during the early infection stages with MAP. Further, antibodies against all six antigens were elevated in milk samples from both the F+E- and F+E+ groups in comparison to the NL group (p<0.01). Taken together, the results of our investigation suggest that multiplex bead-based assays are able to reliably identify MAP infection, even during early stages when antibody responses in animals are undetectable with widely used commercial ELISA tests.	[Li, Lingling; Schilling, Megan; Katani, Robab; Kapur, Vivek] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA; [Li, Lingling; Schilling, Megan; Katani, Robab; Kapur, Vivek] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Wagner, Bettina; Freer, Heather; Grohn, Yrjo T.] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Bannantine, John P.] USDA ARS, Natl Anim Dis Ctr, POB 70, Ames, IA 50010 USA; [Campo, Joseph J.] Antigen Discovery Inc, Irvine, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cornell University; United States Department of Agriculture (USDA)	Kapur, V (corresponding author), Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA.; Kapur, V (corresponding author), Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.	vkapur@psu.edu	Katani, Robab/AAS-1292-2020	Kapur, Vivek/0000-0002-9648-0138; Bannantine, John/0000-0002-5692-7898	United States Department of Agriculture, National institute of Food and Agriculture [2015-67015-23177]	United States Department of Agriculture, National institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by the United States Department of Agriculture, National institute of Food and Agriculture (https://nifa.usda.gov/), 2015-67015-23177. The funder provided support in the form of salaries for author jjc, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Andrade DC, 2014, J IMMUNOL METHODS, V405, P130, DOI 10.1016/j.jim.2014.02.002; Bannantine JP, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00081-17; Bannantine JP, 2004, J CLIN MICROBIOL, V42, P106, DOI 10.1128/JCM.42.1.106-114.2004; Baud D, 2014, DIAGN MICR INFEC DIS, V78, P217, DOI 10.1016/j.diagmicrobio.2013.11.022; Cho D, 2007, PROTEIN EXPRES PURIF, V53, P411, DOI 10.1016/j.pep.2006.12.022; Christopher-Hennings J, 2013, J VET DIAGN INVEST, V25, P671, DOI 10.1177/1040638713507256; Clarke CJ, 1997, J COMP PATHOL, V116, P217, DOI 10.1016/S0021-9975(97)80001-1; COCITO C, 1994, CLIN MICROBIOL REV, V7, P328, DOI 10.1128/CMR.7.3.328-345.1994; Collins MT, 2005, CLIN DIAGN LAB IMMUN, V12, P685, DOI 10.1128/CDLI.12.6.685-692.2005; Eisenberg SWF, 2015, J DAIRY SCI, V98, P2345, DOI 10.3168/jds.2014-8380; Facciuolo A, 2013, CLIN VACCINE IMMUNOL, V20, P1783, DOI 10.1128/CVI.00380-13; Gapper LW, 2007, ANAL BIOANAL CHEM, V389, P93, DOI 10.1007/s00216-007-1391-z; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Gumber S, 2009, VET MICROBIOL, V137, P290, DOI 10.1016/j.vetmic.2009.01.012; Gurung RB, 2013, CLIN VACCINE IMMUNOL, V20, P1817, DOI 10.1128/CVI.00596-13; Hurley WL, 2011, NUTRIENTS, V3, P442, DOI 10.3390/nu3040442; Khol JL, 2014, VET MICROBIOL, V172, P301, DOI 10.1016/j.vetmic.2014.05.022; Leite FL, 2015, VET MICROBIOL, V175, P275, DOI 10.1016/j.vetmic.2014.11.009; Leroy B, 2007, PROTEOMICS, V7, P1164, DOI 10.1002/pmic.200600988; Li L, 2017, GEOTECH SP, P12; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; McKenna SLB, 2005, VET MICROBIOL, V110, P105, DOI 10.1016/j.vetmic.2005.07.010; Nagata R, 2013, VET IMMUNOL IMMUNOP, V155, P253, DOI 10.1016/j.vetimm.2013.06.020; Nielsen SS, 2002, J DAIRY SCI, V85, P2795, DOI 10.3168/jds.S0022-0302(02)74366-X; Ott SL, 1999, PREV VET MED, V40, P179, DOI 10.1016/S0167-5877(99)00037-9; Paustian ML, 2004, J CLIN MICROBIOL, V42, P2675, DOI 10.1128/JCM.42.6.2675-2681.2004; Pribylova R, 2011, INT J FOOD MICROBIOL, V151, P314, DOI 10.1016/j.ijfoodmicro.2011.09.025; Sachdev D, 2000, METHOD ENZYMOL, V326, P312; Shin Sung Jae, 2004, J Vet Sci, V5, P111; Stewart DJ, 2004, VET MICROBIOL, V104, P165, DOI 10.1016/j.vetmic.2004.09.007; Sweeney RW, 2006, J VET DIAGN INVEST, V18, P2, DOI 10.1177/104063870601800102; Wagner B, 2015, VACCINE, V33, P5588, DOI 10.1016/j.vaccine.2015.09.009; Wagner B, 2011, VET IMMUNOL IMMUNOP, V144, P374, DOI 10.1016/j.vetimm.2011.08.005; Wagner B, 2009, VET IMMUNOL IMMUNOP, V127, P242, DOI 10.1016/j.vetimm.2008.10.313; Waters WR, 2003, INFECT IMMUN, V71, P5130, DOI 10.1128/IAI.71.9.5130-5138.2003; Whitlock RH, 2000, VET MICROBIOL, V77, P387, DOI 10.1016/S0378-1135(00)00324-2; Willemsen PTJ, 2006, VET MICROBIOL, V114, P337, DOI 10.1016/j.vetmic.2005.12.005; YOKOMIZO Y, 1985, JPN J VET SCI, V47, P111, DOI 10.1292/jvms1939.47.111	38	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189783	10.1371/journal.pone.0189783	http://dx.doi.org/10.1371/journal.pone.0189783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7PP	29261761	Green Published, gold, Green Submitted			2022-12-26	WOS:000418554900029
J	Vergara-Asenjo, G; Mateo-Vega, J; Alvarado, A; Potvin, C				Vergara-Asenjo, Gerardo; Mateo-Vega, Javier; Alvarado, Alexis; Potvin, Catherine			A participatory approach to elucidate the consequences of land invasions on REDD plus initiatives: A case study with Indigenous communities in Panama	PLOS ONE			English	Article							TROPICAL FOREST; CARBON; TENURE; DEFORESTATION; COVER	Land tenure and tenure security are among the most important factors determining the viability and success of Reducing Emissions from Deforestation and Forest Degradation (REDD+) initiatives. The premise of the present paper is that territorial conflicts lead to forest loss and compromise the successful implementation of REDD+. Within this context, the main objectives of this paper are to (i) document, relying on participatory methods, the extent to which land conflicts drive deforestation and (ii) reflect on the legal context of REDD+ examining if, from an Indigenous perspective, it offers tools to resolve such conflicts. We used the Upper Bayano Watershed in eastern Panama as a case study of complex land tenure dynamics, and their effects on forest conservation in the context of REDD+. Combining a range of participatory methods including participatory mapping and forest carbon stock assessment, we estimated the consequences of land invasions on forest carbon stocks. Our analysis shows that invasions of Indigenous territories amounted to 27.6% of the total deforestation for the period of 2001-2014. The situation is of paramount concern in the Embera territory of Maje A where 95.4% of total deforestation was caused by colonist invaders. Using and validating the maps made freely available by the Global Forest Change initiative of the University of Maryland, we then developed a reference level for the watershed and carried out a back of the envelop estimation of likely REDD+ revenue, showing its potential to bring much needed income to Indigenous communities striving to protect their forest estate. Our analysis of current legislation in Panama highlights confusion and important legal voids and emphasizes the strong links between land tenure, carbon ownership, and territorial invasions. The options and shortcoming of implementing REDD+ in Indigenous territories is discussed in the conclusion taking our legal review into account.	[Vergara-Asenjo, Gerardo; Mateo-Vega, Javier; Potvin, Catherine] McGill Univ, Dept Biol, Montreal, PQ, Canada; [Vergara-Asenjo, Gerardo] Forest Res Inst INFOR, Valdivia, Chile; [Mateo-Vega, Javier; Potvin, Catherine] Smithsonian Trop Res Inst, Panama City, Panama; [Alvarado, Alexis] Fdn Dobbo Yala, Panama City, Panama	McGill University; Smithsonian Institution; Smithsonian Tropical Research Institute	Vergara-Asenjo, G (corresponding author), McGill Univ, Dept Biol, Montreal, PQ, Canada.; Vergara-Asenjo, G (corresponding author), Forest Res Inst INFOR, Valdivia, Chile.	gevergara@gmail.com			David and Lucile Packard Foundation [2009-35009]; Margaret A. Cargill Foundation [504473]; Natural Sciences and Engineering Research Council of Canada [223445]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Margaret A. Cargill Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was made possible thanks to support from the David and Lucile Packard Foundation (Grant No.2009-35009;https://www.packard.org), the Margaret A. Cargill Foundation (Designated Code: 504473; http://www.macphilanthropies.org), as well as a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (Grant No. 223445; http://www.nserc-crsng.gc.ca), all made to CP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado A, 2014, EXPERIENCIAS LATINOA; American Convention on Human Rights, 1969, PACT SAN JOS COST RI; ANAM (Autoridad Nacional del Ambiente), 2010, CUART INF NAC PAN AN; [Anonymous], 2012, SCIENCE, DOI DOI 10.1126/science.1215904; Araujo C, 2009, ECOL ECON, V68, P2461, DOI 10.1016/j.ecolecon.2008.12.015; Benavides M, 2009, ENC INT PUEBL IND LI, V500, P400; CAMPANA FS., 2013, IURIS DICTIO, V13, P9; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Coomes OT, 2008, ECOL ECON, V65, P207, DOI 10.1016/j.ecolecon.2007.12.028; Cotula L., 2009, NATURAL RESOURCE ISS, V15; Cuellar N, 2003, PRISMA REPORT INDIGE; Eastman JR, 2009, INT J REMOTE SENS, V30, P2721, DOI 10.1080/01431160902755338; Eastman JR, 2015, TERRSET GUIDE GIS IM; FAO, 2021, FAOSTAT AN BRIEF SER; Fearnside PM, 2001, WORLD DEV, V29, P1361, DOI 10.1016/S0305-750X(01)00039-0; Feiring B., 2013, PRELIMINARY NOTE FIN; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; Foro y Observatorio de Sostenibilidad, 2015, REC CONS CONS RES CO; Gray E., 2015, EC COSTS BENEFITS SE; Green K., 2002, ASSESSING ACCURACY R; Griess VC, 2011, NEW FOREST, V41, P13, DOI 10.1007/s11056-010-9207-y; Guillemette M, 2017, FACETS, V2, P195, DOI 10.1139/facets-2016-0010; Hamrick K, 2015, AHEAD CURVE STATE VO; Herold Martin, 2011, Carbon Balance Manag, V6, P13, DOI 10.1186/1750-0680-6-13; Holmes I, 2017, FORESTS, V8, DOI 10.3390/f8030067; Holmes I, 2014, CONSERV BIOL, V28, P1380, DOI 10.1111/cobi.12301; IACHR, 2014, CAS PUEBL IND KUN MA; Karsenty A, 2012, FOREST POLICY ECON, V18, P38, DOI [10.1016/j.forpol.2011.05.006, 10.1016/j.forpol.2012.03.001]; KELSEN Hans, 1967, PURE THEORY LAW; Kirby KR, 2007, FOREST ECOL MANAG, V246, P208, DOI 10.1016/j.foreco.2007.03.072; Kossoy A., 2015, STATE TRENDS CARBON; Larson AM, 2013, GLOBAL ENVIRON CHANG, V23, P678, DOI 10.1016/j.gloenvcha.2013.02.014; Mateo-Vega J, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1635; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Naughton-Treves L, 2014, WORLD DEV, V55, P1, DOI 10.1016/j.worlddev.2013.01.010; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Ongolo S, 2015, INT FOREST REV, V17, P195, DOI 10.1505/146554815815500561; Ostrom E, 2012, GLOBAL ENV COMMONS A, P105, DOI DOI 10.1093/ACPROF:OSO/9780199656202.001.0001; Potvin C., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P1341, DOI 10.1007/s11027-006-9056-3; Potvin C, 2013, NATURE, V500, P400, DOI 10.1038/500400e; Robinson B. E., 2011, CCAFS Policy Brief; Sharma D, 2015, ECOL SOC, V20, DOI 10.5751/ES-07897-200437; Sloan S, 2008, GLOBAL ENVIRON CHANG, V18, P425, DOI 10.1016/j.gloenvcha.2008.04.009; Smithsonian Tropical Research Institute, 2013, ZON VID HOLDR DIG MA; St-Laurent GP, 2013, LAND USE POLICY, V31, P516, DOI [10.1016/j.landusepol.2012.08.0, 10.1016/j.landusepol.2012.08.017]; Sunderlin W.D., 2009, REALISING REDD NATL, P139; Thomlinson JR, 1999, REMOTE SENS ENVIRON, V70, P16, DOI 10.1016/S0034-4257(99)00055-3; Vergara-Asenjo G, 2015, CONSERV LETT; Vergara-Asenjo G, 2014, GLOBAL ENVIRON CHANG, V28, P205, DOI 10.1016/j.gloenvcha.2014.07.002; Viana V.M., 2009, 2159 IIED; Wali A, 1989, KILOWATTS CRISIS HYD; Wright S Joseph, 2010, Ecology, V91, P3664, DOI 10.1890/09-2335.1	52	5	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2017	12	12							e0189463	10.1371/journal.pone.0189463	http://dx.doi.org/10.1371/journal.pone.0189463			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ7PP	29261704	Green Submitted, Green Published, gold			2022-12-26	WOS:000418554900020
J	Asam, K; Staniszewski, A; Zhang, H; Melideo, SL; Mazzeo, A; Voronkov, M; Huber, KL; Perez, E; Stock, M; Stock, JB; Arancio, O; Nicholls, RE				Asam, Kesava; Staniszewski, Agnieszka; Zhang, Hong; Melideo, Scott L.; Mazzeo, Adolfo; Voronkov, Michael; Huber, Kristen L.; Perez, Eduardo; Stock, Maxwell; Stock, Jeffry B.; Arancio, Ottavio; Nicholls, Russell E.			Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer's disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; E-BASED PEPTIDE; TAU HYPERPHOSPHORYLATION; APOLIPOPROTEIN-E; SODIUM SELENATE; A-BETA; SYNAPTIC PLASTICITY; MEMORY; METHYLATION; INJURY	Soluble forms of oligomeric beta-amyloid (A beta) are thought to play a central role in Alzheimer's disease (AD). Transgenic manipulation of methylation of the serine/threonine protein phosphatase, PP2A, was recently shown to alter the sensitivity of mice to AD-related impairments resulting from acute exposure to elevated levels of A beta. In addition, eicosanoyl-5-hydroxytryptamide (EHT), a naturally occurring component from coffee beans that modulates PP2A methylation, was shown to confer therapeutic benefits in rodent models of AD and Parkinson's disease. Here, we tested the hypothesis that EHT protects animals from the pathological effects of exposure to elevated levels of soluble oligomeric A beta. We treated mice with EHT-containing food at two different doses and assessed the sensitivity of these animals to A beta-induced behavioral and electrophysiological impairments. We found that EHT administration protected animals from A beta-induced cognitive impairments in both a radial-arm water maze and contextual fear conditioning task. We also found that both chronic and acute EHT administration prevented A beta-induced impairments in long-term potentiation. These data add to the accumulating evidence suggesting that interventions with pharmacological agents, such as EHT, that target PP2A activity may be therapeutically beneficial for AD and other neurological conditions.	[Asam, Kesava; Staniszewski, Agnieszka; Zhang, Hong; Mazzeo, Adolfo; Arancio, Ottavio; Nicholls, Russell E.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Asam, Kesava; Staniszewski, Agnieszka; Zhang, Hong; Mazzeo, Adolfo; Arancio, Ottavio; Nicholls, Russell E.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Melideo, Scott L.; Stock, Jeffry B.] Princeton Univ, Dept Mol Biol, Princeton, NJ USA; [Voronkov, Michael; Huber, Kristen L.; Perez, Eduardo; Stock, Maxwell; Stock, Jeffry B.] Signum Biosci, 133 Wall St, Princeton, NJ USA; [Arancio, Ottavio] Columbia Univ, Dept Med, New York, NY USA	Columbia University; Columbia University; Princeton University; Columbia University	Nicholls, RE (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.; Nicholls, RE (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.	rn95@columbia.edu	arancio, ottavio/AAB-7959-2019	Mazzeo, Adolfo/0000-0002-7014-6617; Asam, Kesava/0000-0002-6247-9905; arancio, ottavio/0000-0001-6335-164X	Signum Biosciences; National Institutes of Health [NS092045]; National Center for Complementary & Integrative Health [R01AT006868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092045, R01NS101134] Funding Source: NIH RePORTER	Signum Biosciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from Signum Biosciences to REN. and by National Institutes of Health grant NS092045 to REN. and OA. Employees of Signum Biosciences participated in the design, execution, analysis of experiments and manuscript preparation as indicated in the author contributions section.	Ahmed T, 2015, NEUROBIOL AGING, V36, P730, DOI 10.1016/j.neurobiolaging.2014.09.015; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Aleksis R, 2017, BIOCHIMIE; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Basurto-Islas G, 2014, NEUROBIOL AGING, V35, P2701, DOI 10.1016/j.neurobiolaging.2014.06.012; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Bolognin S, 2012, ACTA NEUROPATHOL, V123, P133, DOI 10.1007/s00401-011-0908-x; Christensen DJ, 2011, J IMMUNOL, V186, P2535, DOI 10.4049/jimmunol.1002847; Chu DD, 2016, J ALZHEIMERS DIS, V49, P365, DOI 10.3233/JAD-150497; Corcoran NM, 2010, J CLIN NEUROSCI, V17, P1025, DOI 10.1016/j.jocn.2010.04.020; Fa M, 2010, J VIS EXP; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; Guntupalli S, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/3204519; Hoane MR, 2007, J NEUROTRAUM, V24, P1108, DOI 10.1089/neu.2006.0254; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kaufman NA, 2010, BEHAV BRAIN RES, V214, P395, DOI 10.1016/j.bbr.2010.06.017; Kins S, 2001, J BIOL CHEM, V276, P38193; Kremer A, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00017; Lang R, 2005, EUR FOOD RES TECHNOL, V220, P638, DOI 10.1007/s00217-004-1123-y; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Lee KW, 2013, NEUROTHERAPEUTICS, V10, P143, DOI 10.1007/s13311-012-0165-2; Lee KW, 2011, J NEUROSCI, V31, P6963, DOI 10.1523/JNEUROSCI.6513-10.2011; Lee L, 2014, J ALZHEIMERS DIS, V38, P49, DOI 10.3233/JAD-130740; Louis JV, 2011, P NATL ACAD SCI USA, V108, P6957, DOI 10.1073/pnas.1018777108; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Mairet-Coello G, 2013, NEURON, V78, P94, DOI 10.1016/j.neuron.2013.02.003; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Martin L, 2013, AGEING RES REV, V12, P39, DOI 10.1016/j.arr.2012.06.008; Mauna JC, 2011, HIPPOCAMPUS, V21, P1093, DOI 10.1002/hipo.20823; Nicholls RE, 2016, P NATL ACAD SCI USA, V113, P3347, DOI 10.1073/pnas.1521018113; Ondrejcak T, 2010, NEUROMOL MED, V12, P13, DOI 10.1007/s12017-009-8091-0; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Paxinos G, 2013, PAXINOS FRANKLINS MO; Pujol-Pina R, 2015, SCI REP-UK, V5, DOI 10.1038/srep14809; Puzzo D, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.020; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Schild A, 2006, BIOCHEM BIOPH RES CO, V343, P1171, DOI 10.1016/j.bbrc.2006.03.066; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sents W, 2013, FEBS J, V280, P644, DOI 10.1111/j.1742-4658.2012.08579.x; Shipton OA, 2011, J NEUROSCI, V31, P1688, DOI 10.1523/JNEUROSCI.2610-10.2011; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Silva DFF, 2011, J ALZHEIMERS DIS, V26, P565, DOI 10.3233/JAD-2011-110423; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P287, DOI 10.1093/jnen/63.4.287; Sontag JM, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00016; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Sun L, 2003, NEUROSCIENCE, V118, P1175, DOI 10.1016/S0306-4522(02)00697-8; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Teich AF, 2015, NEUROTHERAPEUTICS, V12, P29, DOI 10.1007/s13311-014-0327-5; Thal DR, 2015, ACTA NEUROPATHOL, V129, P167, DOI 10.1007/s00401-014-1375-y; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; Vogelsberg-Ragaglia V, 2001, EXP NEUROL, V168, P402, DOI 10.1006/exnr.2001.7630; Wang XC, 2010, FASEB J, V24, P4420, DOI 10.1096/fj.10-158477; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yin YY, 2010, J ALZHEIMERS DIS, V19, P735, DOI 10.3233/JAD-2010-1272; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhuo JM, 2011, TRENDS PHARMACOL SCI, V32, P562, DOI 10.1016/j.tips.2011.05.003	60	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189413	10.1371/journal.pone.0189413	http://dx.doi.org/10.1371/journal.pone.0189413			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253878	Green Published, gold, Green Submitted			2022-12-26	WOS:000418389500026
J	Chen, YF; Zhen, W; Guo, T; Zhao, YG; Liu, AL; Rubio, JP; Krull, D; Richardson, JC; Lu, HT; Wang, R				Chen, Yongfeng; Zhen, Wei; Guo, Tony; Zhao, Yonggang; Liu, Ailian; Rubio, Justin P.; Krull, David; Richardson, Jill C.; Lu, Hongtao; Wang, Ryan			Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination	PLOS ONE			English	Article							MODERATE ALZHEIMERS-DISEASE; MULTIPLE-SCLEROSIS; H-3 RECEPTOR; PRECURSOR CELLS; CYCLIC-AMP; ANTAGONIST; GSK239512; NEUROPROTECTION; SUSCEPTIBILITY; THERAPY	Background Agents promoting oligodendrocyte precursor cell differentiation have the potential to restore halted and/or delayed remyelination in patients with multiple sclerosis. However, few therapeutic targets have been identified. The objective of this study was to identify novel targets for promotion of remyelination and characterize their activity in vitro and in vivo. Methods A high-content screening assay with differentiation of primary rat oligodendrocyte precursor cells was used to screen GSK-proprietary annotated libraries for remyelination-promoting compounds. Compounds were further validated in vitro and in vivo models; clinical relevance of target was confirmed in human post-mortem brain sections from patients with MS. Results Of similar to 1000 compounds screened, 36 promoted oligodendrocyte precursor cell differentiation in a concentration-dependent manner; seven were histamine receptor-3 (H3R) antagonists. Inverse agonists of H3R but not neutral antagonists promoted oligodendrocyte precursor cell (OPC) differentiation. H3R was expressed throughout OPC differentiation; H3R expression was transiently upregulated on Days 3-5 and subsequently downregulated. H3R gene knockdown in OPCs increased the expression of differentiation markers and the number of mature oligodendrocytes. Overexpression of full-length H3R reduced differentiation marker expression and the number of mature cells. H3R inverse agonist GSK247246 reduced intracellular cyclic AMP (cAMP) and downstream cAMP response element-binding protein (CREB) phosphorylation in a dose-dependent manner. Histone deacetylase (HDAC-1) and Hes-5 were identified as key downstream targets of H3R during OPC differentiation. In the mouse cuprizone/rapamycin model of demyelination, systemic administration of brain-penetrable GSK247246 enhanced remyelination and subsequently protected axons. Finally, we detected high H3R expression in oligodendroglial cells from demyelination lesions in human samples of patients with MS, and validated a genetic association between an exonic single nucleotide polymorphism in HRH3 and susceptibility to multiple sclerosis. Conclusions From phenotypic screening to human genetics, we provide evidence for H3R as a novel therapeutic target to promote remyelination in patients with multiple sclerosis.	[Chen, Yongfeng; Lu, Hongtao; Wang, Ryan] GSK, Neuroimmunol Discovery Performance Unit, Shanghai, Peoples R China; [Zhen, Wei; Guo, Tony; Liu, Ailian] GSK, RD Platform Technol & Sci, Shanghai, Peoples R China; [Zhao, Yonggang; Rubio, Justin P.] GSK, Projects Clin Platforms & Sci, Genet, Stevenage, Herts, England; [Krull, David] GSK, RD Platform Technol & Sci, Pathol, Res Triangle Pk, NC USA; [Richardson, Jill C.] GSK, Neurosci TAU, Neuroinflammat DPU, Stevenage, Herts, England; [Guo, Tony] Roche Holding Ltd, Shanghai, Peoples R China; [Zhao, Yonggang] Suzhou Finder Therapeut Inc, Suzhou, Peoples R China; [Rubio, Justin P.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Richardson, Jill C.] GSK, Neurosci Virtual Proof Concept Discovery Performa, Stevenage, Herts, England; [Lu, Hongtao] Zai Lab Inc, Shanghai, Peoples R China	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; University of Melbourne; GlaxoSmithKline	Wang, R (corresponding author), GSK, Neuroimmunol Discovery Performance Unit, Shanghai, Peoples R China.	ryan.r.wang@gsk.com		Richardson, Jill/0000-0001-6564-3187	GlaxoSmithKline; GSK	GlaxoSmithKline(GlaxoSmithKline); GSK(GlaxoSmithKline)	The study was funded by GlaxoSmithKline. The study was funded by GlaxoSmithKline. The funder provided support in the form of salaries for authors [RW, YC, WZ, TG, DK, JPR, YZ, AL, JCR, HL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge GSK personnel, Drs Pamela St Jean and Meg Ehm, for their assistance with the genetic analysis. The authors would also like to thank ANZgene for the use of their data. The authors wish to thank Alex Lowe, PhD, and Chris Tan, PhD of Fishawack Indicia Ltd, UK, who provided editorial support with developing this manuscript (in the form of writing assistance, including development of the first full draft and further drafts based on author input, assembling tables and figures, collating authors comments, grammatical editing and referencing), funded by GSK.	Armstrong RC, 2002, J NEUROSCI, V22, P8574; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Browne P, 2014, NEUROLOGY, V83, P1022, DOI 10.1212/WNL.0000000000000768; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chamberlain KA, 2016, NEUROPHARMACOLOGY, V110, P633, DOI 10.1016/j.neuropharm.2015.10.010; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Deshmukh VA, 2013, NATURE, V502, P327, DOI 10.1038/nature12647; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Dutta R, 2013, ANN NEUROL, V73, P637, DOI 10.1002/ana.23860; Franklin K., 2007, MOUSE BRAIN STEREOTA; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Franklin RJM, 2012, NAT REV NEUROL, V8, P624, DOI 10.1038/nrneurol.2012.200; Grove RA, 2014, CURR ALZHEIMER RES, V11, P47, DOI 10.2174/1567205010666131212110148; Jadidi-Niaragh F, 2010, NEUROPHARMACOLOGY, V59, P180, DOI 10.1016/j.neuropharm.2010.05.005; Jarskog LF, 2015, SCHIZOPHR RES, V164, P136, DOI 10.1016/j.schres.2015.01.041; Kieseier BC, 2003, CURR OPIN NEUROL, V16, P247, DOI 10.1097/00019052-200306000-00001; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Leurs R, 2005, NAT REV DRUG DISCOV, V4, P107, DOI 10.1038/nrd1631; Morisset S, 2000, NATURE, V408, P860, DOI 10.1038/35048583; Nathan PJ, 2013, CURR ALZHEIMER RES, V10, P240; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Passani MB, 2011, TRENDS PHARMACOL SCI, V32, P242, DOI 10.1016/j.tips.2011.01.003; RAIBLE DW, 1993, J NEUROSCI RES, V34, P287, DOI 10.1002/jnr.490340305; SatoBigbee C, 1996, J NEUROSCI RES, V46, P98, DOI 10.1002/(SICI)1097-4547(19961001)46:1<98::AID-JNR12>3.0.CO;2-8; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schwartzbach CJ, 2016, J NEUROL; Skaper Stephen D, 2012, Methods Mol Biol, V846, P67, DOI 10.1007/978-1-61779-536-7_7; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tanaka Tatsuhide, 2014, Biomol Concepts, V5, P289, DOI 10.1515/bmc-2014-0015; Tao Yanmei, 2013, Methods Mol Biol, V1018, P93, DOI 10.1007/978-1-62703-444-9_9; Teuscher C, 2007, P NATL ACAD SCI USA, V104, P10146, DOI 10.1073/pnas.0702291104; The Australia and New Zealand Multiple Sclerosis Genetics Consortium, 2009, Nature Genetics, V41, P824, DOI 10.1038/ng.396; Wolswijk G, 1998, J NEUROSCI, V18, P601	34	35	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189380	10.1371/journal.pone.0189380	http://dx.doi.org/10.1371/journal.pone.0189380			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253893	Green Published, gold, Green Submitted			2022-12-26	WOS:000418389500024
J	Hoedjes, M; de Kruif, A; Mols, F; Bours, M; Beijer, S; Winkels, R; Westerman, MJ; Seidell, JC; Kampman, E				Hoedjes, Meeke; de Kruif, Anja; Mols, Floortje; Bours, Martijn; Beijer, Sandra; Winkels, Renate; Westerman, Marjan J.; Seidell, Jaap C.; Kampman, Ellen			An exploration of needs and preferences for dietary support in colorectal cancer survivors: A mixed-methods study	PLOS ONE			English	Article							QUALITY-OF-LIFE; LONG-TERM EVALUATION; PHYSICAL-ACTIVITY; HEALTH BEHAVIORS; WEIGHT-LOSS; SELF-DETERMINATION; INITIAL TREATMENT; OUTCOMES; RISK; INTERVENTION	Purpose To describe the proportion of colorectal cancer (CRC) survivors who perceive a need for dietary support; to examine which socio-demographic, cancer-related, and health-related characteristics are associated with this need; to explore reasons for (not) needing support; and to explore CRC survivors' specific needs and preferences with regard to lifestyle (i.e., dietary, exercise, and/or weight management) support. Methods This mixed-methods study comprised a cross-sectional survey among 1774 Dutch CRC survivors and three focus groups (n = 16). To examine associations, logistic regression analyses were conducted. Focus groups were audio-taped, transcribed verbatim, and analyzed using a thematic approach. Results Of 1458 respondents (82%), 1198 (67.5%) were included for analyses. 17.5% reported a need for dietary support. Characteristics associated with this need were: being younger, living without a partner, having a stoma, having diabetes, and being overweight or obese. The main reason for needing support was being unable to initiate and maintain lifestyle changes without support. CRC survivors preferred receiving information soon after diagnosis to make an autonomous, informed decision on improving their lifestyle. They preferred to receive individually-tailored lifestyle support in an autonomy-supportive environment, preferably with involvement of their family and fellow-sufferers. Conclusions This study has provided knowledge on appropriate support for CRC survivors in need for dietary support to improve health outcomes by promoting adherence to lifestyle and body weight recommendations. Findings can be used to better identify CRC survivors in need for dietary support, and to tailor lifestyle support to their needs and preferences in order to promote uptake, adherence, and effectiveness.	[Hoedjes, Meeke; de Kruif, Anja; Westerman, Marjan J.; Seidell, Jaap C.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Hoedjes, Meeke; de Kruif, Anja; Westerman, Marjan J.; Seidell, Jaap C.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Hoedjes, Meeke; Mols, Floortje] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis, Tilburg, Netherlands; [de Kruif, Anja; Winkels, Renate; Kampman, Ellen] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Mols, Floortje; Beijer, Sandra] Netherlands Comprehens Canc Org IKNL, Utrecht, Netherlands; [Bours, Martijn] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, Maastricht, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Tilburg University; Wageningen University & Research; Maastricht University	Hoedjes, M (corresponding author), Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands.; Hoedjes, M (corresponding author), Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.; Hoedjes, M (corresponding author), Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis, Tilburg, Netherlands.	m.hoedjes@uvt.nl	Beijer, Sandra/AAU-9936-2020; Winkels, Renate M./AAB-2619-2019; seidell, jacob/AAF-5362-2019	Winkels, Renate M./0000-0002-0376-8811; seidell, jacob/0000-0002-9262-9062; Kruif, de;Kruif, de, Anja;Anja/0000-0002-1801-0798; Hoedjes, Meeke/0000-0001-6887-2882; Westerman, Marjan J./0000-0002-9827-6958; Mols, Floortje/0000-0003-0818-2913	Dutch Cancer Society/Alpe D'HuZes [VUL 2011-5234, UM 2012-5653]; Netherlands Organization for Scientific Research, The Hague, The Netherlands [451-10-041]	Dutch Cancer Society/Alpe D'HuZes; Netherlands Organization for Scientific Research, The Hague, The Netherlands(Netherlands Organization for Scientific Research (NWO)Netherlands Government)	This study was funded by a grant from the Dutch Cancer Society/Alpe D'HuZes (http://www.kwf.nl: VUL 2011-5234, received by EK), and was based on studies supported by the Dutch Cancer Society/Alpe D'HuZes (UM 2012-5653) and a VENI grant (#451-10-041) from the Netherlands Organization for Scientific Research, The Hague, The Netherlands received by FM: http:// www.nwo.nl/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2013, SUPPORT CARE CANCER, V21, P35, DOI 10.1007/s00520-012-1487-7; Arthur AE, 2016, J CANCER SURVIV, V10, P981, DOI 10.1007/s11764-016-0544-5; Badr H, 2013, J CANCER SURVIV, V7, P523, DOI 10.1007/s11764-013-0289-3; Bartholomew LK, 1998, HEALTH EDUC BEHAV, V25, P545, DOI 10.1177/109019819802500502; Bellizzi KM, 2005, J CLIN ONCOL, V23, P8884, DOI 10.1200/JCO.2005.02.2343; Blanchard CM, 2008, J CLIN ONCOL, V26, P2198, DOI 10.1200/JCO.2007.14.6217; Boeije H., 2009, ANAL QUALITATIVE RES; Bours MJ, 2015, BRIT J NUTR, V114, P286, DOI 10.1017/S0007114515001798; Breitkopf CR, 2014, SUPPORT CARE CANCER, V22, P2517, DOI 10.1007/s00520-014-2245-9; Buffart LM, 2014, CANCER TREAT REV, V40, P327, DOI 10.1016/j.ctrv.2013.06.007; Buffart LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036164; Cha R, 2012, NEW ZEAL MED J, V125, P38; Coups EJ, 2005, PREV MED, V40, P702, DOI 10.1016/j.ypmed.2004.09.011; Deci EL, 2008, CAN PSYCHOL, V49, P182, DOI 10.1037/a0012801; Demark-Wahnefried W, 2005, J CLIN ONCOL, V23, P5814, DOI 10.1200/JCO.2005.01.230; Denlinger CS, 2009, J NATL COMPR CANC NE, V7, P883, DOI 10.6004/jnccn.2009.0058; Dennis DL, 2013, CURR ONCOL, V20, pE493, DOI 10.3747/co.20.1514; Duijn C, 2002, MAANDSTATISTIEK BEVO, V50, P32; Eakin EG, 2007, CANCER CAUSE CONTROL, V18, P881, DOI 10.1007/s10552-007-9033-5; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Greaves CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-119; Green HJ, 2014, EUR J CANCER CARE, V23, P640, DOI 10.1111/ecc.12190; Grimmett C, 2011, QUAL LIFE RES, V20, P1237, DOI 10.1007/s11136-011-9855-1; Heim N, 2011, AM J EPIDEMIOL, V174, P479, DOI 10.1093/aje/kwr093; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Mata J, 2009, HEALTH PSYCHOL, V28, P709, DOI 10.1037/a0016764; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Michie S, 2009, HEALTH PSYCHOL, V28, P690, DOI 10.1037/a0016136; Moroshko I, 2011, OBES REV, V12, P912, DOI 10.1111/j.1467-789X.2011.00915.x; Mosher CE, 2008, PSYCHO-ONCOLOGY, V17, P1014, DOI 10.1002/pon.1327; Mosher CE, 2013, PSYCHO-ONCOLOGY, V22, P876, DOI 10.1002/pon.3089; Patella MN, 2009, MEDITERR J NUTR META, V1, P171, DOI 10.1007/s12349-008-0026-z; Pullar JM, 2012, NEW ZEAL MED J, V125, P27; Rippe JM, 2007, AM J LIFESTYLE MED, V1, P79, DOI 10.1177/1559827606297759; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; Silva MN, 2011, MED SCI SPORT EXER, V43, P728, DOI 10.1249/MSS.0b013e3181f3818f; Soerjomataram I, 2012, J GASTROENTEROL, V47, P999, DOI 10.1007/s00535-012-0567-2; Sprangers MAG, 1999, EUR J CANCER, V35, P238, DOI 10.1016/S0959-8049(98)00357-8; Tabachnick B. G., 2001, USING MULTIVARIATE S; Teixeira PJ, 2010, OBESITY, V18, P725, DOI 10.1038/oby.2009.281; Thompson MS, 2013, QUANT METH EDUC BEHA, P163; Underwood J. Michael, 2012, Morbidity and Mortality Weekly Report, V61, P1; van de Poll-Franse LV, 2011, EUR J CANCER, V47, P2188, DOI 10.1016/j.ejca.2011.04.034; WCRF/AICR, 2007, FOOD NUTR PHYS ACT P; Winkels RM, 2016, CANCER MED-US, V5, P2587, DOI 10.1002/cam4.791; Winkels RM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-374	47	10	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189178	10.1371/journal.pone.0189178	http://dx.doi.org/10.1371/journal.pone.0189178			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ5HM	29253011	Green Submitted, Green Published, gold			2022-12-26	WOS:000418389500014
J	Malik, NA				Malik, Nadeem A.			Residual sweeping errors in turbulent particle pair diffusion in a Lagrangian diffusion model	PLOS ONE			English	Article							HOMOGENEOUS TURBULENCE; 2-PARTICLE DISPERSION; SIMULATION	Thomson, D.J. & Devenish, B.J. [J. Fluid Mech. 526, 277 (2005)] and others have suggested that sweeping effects make Lagrangian properties in Kinematic Simulations (KS), Fung et al [Fung J. C. H., Hunt J. C. R., Malik N. A. & Perkins R. J. J. Fluid Mech. 236, 281 (1992)], unreliable. However, such a conclusion can only be drawn under the assumption of locality. The major aim here is to quantify the sweeping errors in KS without assuming locality. Through a novel analysis based upon analysing pairs of particle trajectories in a frame of reference moving with the large energy containing scales of motion it is shown that the normalized integrated error e(K)(I) in the turbulent pair diffusivity (K) due to the sweeping effect decreases with increasing pair separation (sigma(l)), such that e(K)(I) -> 0 as sigma(l)/eta -> infinity; and e(K)(I) -> infinity as sigma(l)/eta -> 0. eta is the Kolmogorov turbulence microscale. There is an intermediate range of separations 1 < sigma(l)/eta < infinity in which the error e(K)(I) remains negligible. Simulations using KS shows that in the swept frame of reference, this intermediate range is large covering almost the entire inertial subrange simulated, 1 < sigma(l)/eta < 10(5), implying that the deviation from locality observed in KS cannot be atributed to sweeping errors. This is important for pair diffusion theory and modeling. PACS numbers: 47.27.E?, 47.27.Gs, 47.27.jv, 47.27.Ak, 47.27. tb, 47.27.eb, 47.11.-j.	[Malik, Nadeem A.] King Fahd Univ Petr & Minerals, Dept Math & Stat, POB 5046, Dhahran 31261, Saudi Arabia	King Fahd University of Petroleum & Minerals	Malik, NA (corresponding author), King Fahd Univ Petr & Minerals, Dept Math & Stat, POB 5046, Dhahran 31261, Saudi Arabia.	namalik@kfupm.edu.sa	Malik, Nadeem/D-4883-2015	Malik, Nadeem/0000-0001-5053-9360	Saudi Arabia Basic Industries Corporation (SABIC) [SB101011]; SABIC [SB101011]	Saudi Arabia Basic Industries Corporation (SABIC); SABIC	This work was supported by Saudi Arabia Basic Industries Corporation (SABIC), grant number SB101011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author would like to thank SABIC for funding this work through project number SB101011, and the ITC Department at KFUPM for making available the High Performance Computing facility for this project.	BATCHELOR GK, 1952, P CAMB PHILOS SOC, V48, P345, DOI 10.1017/S0305004100027687; Biferale L, 2014, SPRINGER PROC PHYS, V149, P9, DOI 10.1007/978-3-319-01860-7_2; Bourgoin M, 2015, J FLUID MECH, V772, P678, DOI 10.1017/jfm.2015.206; Eyink GL, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.023011; Farhan M, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.043021; Fung JCH, 1998, PHYS REV E, V57, P1677, DOI 10.1103/PhysRevE.57.1677; FUNG JCH, 1992, J FLUID MECH, V236, P281, DOI 10.1017/S0022112092001423; Hinze J. O., 1975, TURBULENCE; KLAFTER J, 1987, PHYS REV A, V35, P3081, DOI 10.1103/PhysRevA.35.3081; KRAICHNAN RH, 1970, PHYS FLUIDS, V13, P22, DOI 10.1063/1.1692799; Malik NA, 1999, PHYS FLUIDS, V11, P1572, DOI 10.1063/1.870019; Malik NA, 1996, FLUID MEC A, V36, P619; MAXEY MR, 1987, J FLUID MECH, V174, P441, DOI 10.1017/S0022112087000193; Meneguz E, 2011, J FLUID MECH, V686, P338, DOI 10.1017/jfm.2011.333; MOREL P, 1974, J ATMOS SCI, V31, P2189, DOI 10.1175/1520-0469(1974)031<2189:RDOCBI>2.0.CO;2; Murray S, 2016, PHYS FLUIDS, V28, DOI 10.1063/1.4942815; Nicolleau FCGA, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056317; Obukhov A., 1941, DOKL AKAD NAUK SSSR, V5, P453; Richardson LF, 1926, P R SOC LOND A-CONTA, V110, P709, DOI 10.1098/rspa.1926.0043; Salazar JPLC, 2009, ANNU REV FLUID MECH, V41, P405, DOI 10.1146/annurev.fluid.40.111406.102224; Thalabard S., 2014, J FUID MECH, V755, P1; Thomson DJ, 2005, J FLUID MECH, V526, P277, DOI 10.1017/S0022112004002915; Turfus C., 1987, Advances in Turbulence. Proceedings of the First European Turbulence Conference, P191	24	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189917	10.1371/journal.pone.0189917	http://dx.doi.org/10.1371/journal.pone.0189917			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253875	Green Published, gold			2022-12-26	WOS:000418389500075
J	Ebert, K; Ewers, M; Bisha, I; Sander, S; Rasputniac, T; Daniel, H; Antes, I; Witt, H				Ebert, Karolin; Ewers, Maren; Bisha, Ina; Sander, Simone; Rasputniac, Tanja; Daniel, Hannelore; Antes, Iris; Witt, Heiko			Identification of essential amino acids for glucose transporter 5 (GLUT5)-mediated fructose transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose transport; fructose; protein chimera; molecular dynamics; membrane protein; GLUT5; GLUT7; transporter	FORCE-FIELD; PROTEIN; GLUT2; EFFICIENT; DOMAINS; SERVER	Intestinal fructose uptake is mainly mediated by glucose transporter 5 (GLUT5/SLC2A5). Its closest relative, GLUT7, is also expressed in the intestine but does not transport fructose. For rat Glut5, a change of glutamine to glutamic acid at codon 166 (p.Q166E) has been reported to alter the substrate-binding specificity by shifting Glut5-mediated transport from fructose to glucose. Using chimeric proteins of GLUT5 and GLUT7, here we identified amino acid residues of GLUT5 that define its substrate specificity. The proteins were expressed in NIH-3T3 fibroblasts, and their activities were determined by fructose radiotracer flux. We divided the human GLUT5 sequence into 26 fragments and then replaced each fragment with the corresponding region in GLUT7. All fragments that yielded reduced fructose uptake were analyzed further by assessing the role of individual amino acid residues. Various positions in the first extracellular loop, in the fifth, seventh, eighth, ninth, and tenth transmembrane domains (TMDs), and in the regions between the ninth and tenth TMDs and tenth and 11th TMDs were identified as being important for proper fructose uptake. Although the p.Q167E change did not render the human protein into a glucose transporter, molecular dynamics simulations revealed a drastic change in the dynamics and a movement of the intracellular loop connecting the sixth and seventh TMDs, which covers the exit of the ligand. Finally, we generated a GLUT7-GLUT5 chimera consisting of the N-terminal part of GLUT7 and the C-terminal part of GLUT5. Although this chimera was inactive, we demonstrate fructose transport after introduction of four amino acids derived from GLUT5.	[Ebert, Karolin; Ewers, Maren; Sander, Simone; Rasputniac, Tanja; Witt, Heiko] Tech Univ Munich, Else Kroner Fresenius Zentrum Ernahrungsmed, Klinikum Rechts Isar MRI, Pediat Nutr Med, D-85354 Freising Weihenstephan, Germany; [Bisha, Ina; Antes, Iris] Tech Univ Munich, Dept Biosci, Emil Erlenmeyer Forum 8 Geb 4264, D-85354 Freising Weihenstephan, Germany; [Bisha, Ina; Antes, Iris] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Emil Erlenmeyer Forum 8 Geb 4264, D-85354 Freising Weihenstephan, Germany; [Daniel, Hannelore] Tech Univ Munich, Nutr Physiol, D-85354 Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich	Antes, I (corresponding author), Tech Univ Munich, Dept Biosci, Emil Erlenmeyer Forum 8 Geb 4264, D-85354 Freising Weihenstephan, Germany.; Antes, I (corresponding author), Tech Univ Munich, Ctr Integrated Prot Sci Munich, Emil Erlenmeyer Forum 8 Geb 4264, D-85354 Freising Weihenstephan, Germany.; Witt, H (corresponding author), Tech Univ Munich, Padiatr Ernahrungsmed, Gregor Mendel Str 2, D-85354 Freising Weihenstephan, Germany.	antes@tum.de; heiko.witt@tum.de		Ewers, Maren/0000-0002-9029-2240; Ebert, Karolin/0000-0002-6657-0191; Sander, Simone/0000-0001-8255-7096	TUM University Foundation; Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft [GRK 1482, SFB1035/A10]	TUM University Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants GRK 1482 (to H. W.) and SFB1035/A10 (to I. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the TUM University Foundation and the Alexander von Humboldt Foundation.	Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Bisha I, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1004017; Buchs AE, 1998, ENDOCRINOLOGY, V139, P827, DOI 10.1210/en.139.3.827; BURANT CF, 1992, J BIOL CHEM, V267, P14523; CHEESEMAN CI, 1993, GASTROENTEROLOGY, V105, P1050, DOI 10.1016/0016-5085(93)90948-C; Clemencon B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108852; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ebert K, 2017, J MEMBRANE BIOL, V250, P171, DOI 10.1007/s00232-016-9945-7; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; INUKAI K, 1995, ENDOCRINOLOGY, V136, P4850, DOI 10.1210/en.136.11.4850; Jojart B, 2007, J COMPUT CHEM, V28, P2051, DOI 10.1002/jcc.20748; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Napolitano LMR, 2015, P NATL ACAD SCI USA, V112, pE3619, DOI 10.1073/pnas.1503334112; Nomura N, 2015, NATURE, V526, P397, DOI 10.1038/nature14909; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Patel C, 2015, FASEB J, V29, P4046, DOI 10.1096/fj.15-272195; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wilder-Smith CH, 2014, UNITED EUR GASTROENT, V2, P14, DOI 10.1177/2050640613505279; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Wu L, 1998, ENDOCRINOLOGY, V139, P4205, DOI 10.1210/en.139.10.4205	25	6	8	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2115	2124		10.1074/jbc.RA117.001442	http://dx.doi.org/10.1074/jbc.RA117.001442			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29259131	Green Published, hybrid			2022-12-26	WOS:000424948000023
J	Amorim, CF; Galina, L; Carvalho, NB; Sperotto, NDM; Pissinate, K; Machado, P; Campos, MM; Basso, LA; Rodrigues, VS; Carvalho, EM; Santos, DS				Amorim, Camila F.; Galina, Luiza; Carvalho, Natalia B.; Sperotto, Nathalia D. M.; Pissinate, Kenia; Machado, Pablo; Campos, Maria M.; Basso, Luiz A.; Rodrigues-Junior, Valnes S.; Carvalho, Edgar M.; Santos, Diogenes Santiago			Inhibitory activity of pentacyano(isoniazid) ferrate(II), IQG-607, against promastigotes and amastigotes forms of Leishmania braziliensis	PLOS ONE			English	Article							AMERICAN CUTANEOUS LEISHMANIASIS; LIPOSOMAL AMPHOTERICIN-B; 2-TRANS-ENOYL-ACP COA REDUCTASE; MYCOBACTERIUM-TUBERCULOSIS; TEGUMENTARY LEISHMANIASIS; MUCOSAL LEISHMANIASIS; NORTHEASTERN BRAZIL; INORGANIC COMPLEX; ENOYL REDUCTASE; DNA-DAMAGE	M. tuberculosis and parasites of the genus Leishmania present the type II fatty acid biosynthesis system (FASII). The pentacyano(isoniazid) ferrate(II) compound, named IQG-607, inhibits the enzyme 2-trans-enoyl-ACP(CoA) reductase from M. tuberculosis, a key component in the FASII system. Here, we aimed to evaluate the inhibitory activity of IQG-607 against promastigote and amastigote forms of Leishmania (Viannia) braziliensis isolated from patients with different clinical forms of L. braziliensis infection, including cutaneous, mucosal and disseminated leishmaniasis. Importantly, IQG-607 inhibited the proliferation of three different isolates of L. braziliensis promastigotes associated with cutaneous, mucosal and disseminated leishmaniasis. The IC50 values for IQG-607 ranged from 32 to 75 mu M, for these forms. Additionally, IQG-607 treatment decreased the proliferation of intracellular amastigotes in infected macrophages, after an analysis of the percentage of infected cells and the number of intracellular parasites/100 cells. IQG-607 reduced from 58% to 98% the proliferation of L. braziliensis from cutaneous, mucosal and disseminated strains. Moreover, IQG-607 was also evaluated regarding its potential toxic profile, by using different cell lines. Cell viability of the lineages Vero, HaCat and HepG2 was significantly reduced after incubation with concentrations of IQG-607 higher than 2 mM. Importantly, IQG-607, in a concentration of 1 mM, did not induce DNA damage in HepG2 cells, when compared to the untreated control group. Future studies will confirm the mechanism of action of IQG-607 against L. braziliensis.	[Amorim, Camila F.; Carvalho, Natalia B.; Carvalho, Edgar M.] Univ Fed Bahia, Complexo Hosp Univ Prof Edgard Santos, Serv Immunol, Salvador, BA, Brazil; [Galina, Luiza; Sperotto, Nathalia D. M.; Pissinate, Kenia; Machado, Pablo; Basso, Luiz A.; Rodrigues-Junior, Valnes S.; Santos, Diogenes Santiago] Pontificia Univ Catolica Rio Grande Sul PUCRS, Ctr Pesquisas Biol Mol & Func, Porto Alegre, RS, Brazil; [Galina, Luiza; Machado, Pablo; Basso, Luiz A.; Santos, Diogenes Santiago] Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil; [Sperotto, Nathalia D. M.; Campos, Maria M.; Basso, Luiz A.; Rodrigues-Junior, Valnes S.] Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Med & Ciencias Saude, Porto Alegre, RS, Brazil; [Campos, Maria M.] Pontificia Univ Catolica Rio Grande do Sul, Inst Toxicol Farmacol, Porto Alegre, RS, Brazil; [Carvalho, Edgar M.] Inst Nacl Ciencia & Tecnol Doencas Trop, Salvador, BA, Brazil; [Carvalho, Edgar M.] Fundacao Oswaldo Cruz, Inst Pesquisa Goncalo Muniz, Salvador, BA, Brazil	Universidade Federal da Bahia; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Fundacao Oswaldo Cruz	Carvalho, EM (corresponding author), Univ Fed Bahia, Complexo Hosp Univ Prof Edgard Santos, Serv Immunol, Salvador, BA, Brazil.; Rodrigues, VS (corresponding author), Pontificia Univ Catolica Rio Grande Sul PUCRS, Ctr Pesquisas Biol Mol & Func, Porto Alegre, RS, Brazil.; Rodrigues, VS (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Med & Ciencias Saude, Porto Alegre, RS, Brazil.; Carvalho, EM (corresponding author), Inst Nacl Ciencia & Tecnol Doencas Trop, Salvador, BA, Brazil.; Carvalho, EM (corresponding author), Fundacao Oswaldo Cruz, Inst Pesquisa Goncalo Muniz, Salvador, BA, Brazil.	valnes.junior@pucrs.br; edgar@ufba.br	Farias Amorim, Camila/ABD-4444-2021; Campos, Maria Martha M/J-8829-2015; Sperotto, Nathalia D. M./L-3313-2015; Machado, Pablo/M-4356-2013; Carvalho, Natalia/H-3977-2015	Farias Amorim, Camila/0000-0001-8249-7265; Campos, Maria Martha M/0000-0002-1153-3633; Sperotto, Nathalia D. M./0000-0002-0095-4504; Machado, Pablo/0000-0001-5616-9583; Pissinate, Kenia/0000-0001-7433-8811; Campos, Maria/0000-0001-7738-9892; S. Rodrigues-Junior, Valnes/0000-0002-4849-2249; Carvalho, Natalia/0000-0003-2586-7877	MCT/CNPq; Decit/SCTIE/MS-MCT-CNPq-FNDTC-CAPES	MCT/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Decit/SCTIE/MS-MCT-CNPq-FNDTC-CAPES	This work was supported by research grants to the National Institute of Science and Technology on Tropical Diseases (INCT-DT), MCT/CNPq and to the National Institute of Science and Technology on Tuberculosis, Decit/SCTIE/MS-MCT-CNPq-FNDTC-CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by research grants to the National Institute of Science and Technology on Tropical Diseases (INCT-DT), MCT/CNPq and to the National Institute of Science and Technology on Tuberculosis (INCT-TB), Decit/SCTIE/MS-MCT-CNPq-FNDTC-CAPES.	Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Andrews KT, 2014, INT J PARASITOL-DRUG, V4, P95, DOI 10.1016/j.ijpddr.2014.02.002; Azeredo-Coutinho RBG, 2007, J PARASITOL, V93, P688, DOI 10.1645/GE-1031R.1; Basso LA, 1998, J INFECT DIS, V178, P769, DOI 10.1086/515362; Basso LA, 2010, J BRAZIL CHEM SOC, V21, P1384, DOI 10.1590/S0103-50532010000700026; BITTENCOURT AL, 1991, MEM I OSWALDO CRUZ, V86, P51, DOI 10.1590/S0074-02761991000100009; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; COLLINS AR, 1995, MUTAT RES-DNA REPAIR, V336, P69, DOI 10.1016/0921-8777(94)00043-6; COSTA JML, 1986, J TROP MED HYG, V89, P319; Costa S, 2016, PARASITOL RES, V115, P3881, DOI 10.1007/s00436-016-5153-8; de Oliveira CI, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00145; Feasey N, 2010, BRIT MED BULL, V93, P179, DOI 10.1093/bmb/ldp046; Gurvitz A, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/950864; Handman E, 2002, TRENDS PARASITOL, V18, P332, DOI 10.1016/S1471-4922(02)02352-8; Jirmanus L, 2012, AM J TROP MED HYG, V86, P426, DOI 10.4269/ajtmh.2012.11-0378; JONES TC, 1987, J INFECT DIS, V156, P73, DOI 10.1093/infdis/156.1.73; Kaur J, 2011, MOL BIOL INT, V2011; Lessa HA, 2012, T ROY SOC TROP MED H, V106, P376, DOI 10.1016/j.trstmh.2012.03.007; Machado PRL, 2015, CLIN INFECT DIS, V61, P945, DOI 10.1093/cid/civ416; Machado PRL, 2012, CURR OPIN INFECT DIS, V25, P141, DOI 10.1097/QCO.0b013e3283509cac; Motta JOC, 2012, J EUR ACAD DERMATOL, V26, P331, DOI 10.1111/j.1468-3083.2011.04070.x; Oliveira JS, 2006, CURR PHARM DESIGN, V12, P2409, DOI 10.2174/138161206777698927; Oliveira JS, 2004, CHEM COMMUN, P312, DOI 10.1039/b313592f; Patterson S, 2016, ELIFE, V5, DOI 10.7554/eLife.09744; Paul KS, 2001, TRENDS PARASITOL, V17, P381, DOI 10.1016/S1471-4922(01)01984-5; Queiroz A, 2012, J CLIN MICROBIOL, V50, P4028, DOI 10.1128/JCM.02064-12; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Roberts CW, 2003, MOL BIOCHEM PARASIT, V126, P129, DOI 10.1016/S0166-6851(02)00280-3; Rodrigues VS, 2017, REGUL TOXICOL PHARM, V90, P78, DOI 10.1016/j.yrtph.2017.08.015; Rodrigues VS, 2017, REGUL TOXICOL PHARM, V86, P11, DOI 10.1016/j.yrtph.2017.02.016; Rodrigues VS, 2014, INT J ANTIMICROB AG, V43, P82, DOI 10.1016/j.ijantimicag.2013.08.021; Rodrigues VS, 2012, INT J ANTIMICROB AG, V40, P182, DOI 10.1016/j.ijantimicag.2012.04.019; Schriefer A, 2008, CURR OPIN INFECT DIS, V21, P483, DOI 10.1097/QCO.0b013e32830d0ee8; Sousa EHS, 2012, J BIOL INORG CHEM, V17, P275, DOI 10.1007/s00775-011-0848-x; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Solomon M, 2007, J AM ACAD DERMATOL, V56, P612, DOI 10.1016/j.jaad.2006.06.044; Soto J, 2007, CLIN INFECT DIS, V44, P350, DOI 10.1086/510588; Turetz ML, 2002, J INFECT DIS, V186, P1829, DOI 10.1086/345772; Unger A, 2009, AM J TROP MED HYG, V80, P574, DOI 10.4269/ajtmh.2009.80.574; Valentin-Severin I, 2003, MUTAT RES-GEN TOX EN, V536, P79, DOI 10.1016/S1383-5718(03)00031-7; Von Stebut E, 2015, J DTSCH DERMATOL GES, V13, P191, DOI 10.1111/ddg.12595; Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176	43	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190294	10.1371/journal.pone.0190294	http://dx.doi.org/10.1371/journal.pone.0190294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281707	Green Published, gold, Green Submitted			2022-12-26	WOS:000419006200081
J	Lee, JL; Gliem, M; Gerdes, G; Turowski, B; Kaschner, M; Kraus, B; Hartung, HP; Jander, S				Lee, John-lh; Gliem, Michael; Gerdes, Gebke; Turowski, Bernd; Kaschner, Marius; Kraus, Bastian; Hartung, Hans-Peter; Jander, Sebastian			Safety of bridging antiplatelet therapy with the gpIIb-IIIa inhibitor tirofiban after emergency stenting in stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; MODIFIED RANKIN SCALE; THROMBECTOMY; TRIAL	Background In a proportion of stroke patients with acute large vessel occlusion permanent stent implantation is mandatory to achieve successful recanalization. The optimum platelet inhibition strategy after such emergency stenting is unknown. We therefore analyzed the outcome of early glycoprotein (gp) IIb/IIIa inhibitor treatment after emergency stenting in acute stroke. Methods Sixty patients with emergency stenting were identified in our stroke unit registry from 12/2010-06/2014 and analyzed retrospectively. All patients were bridged intravenously with the gpIIb/IIIa antagonist tirofiban immediately after the acute procedure until switching to oral aspirin and clopidogrel was performed. For comparison we studied 135 patients with M1 occlusion undergoing thrombectomy without stent implantation or tirofiban treatment in a propensity score-adjusted analysis. Results In the acute stenting group receiving tirofiban complications with 6 deaths during the hospital stay (10%), 2 reinfarctions (3%), 12 intracerebral hemorrhages (ICH; 20%) and 5 symptomatic ICH (8%) occurred. Thirty-seven patients (62%) reached a moderate outcome of mRS 0-3 after 90 days. In the thrombectomy group without tirofiban administration the rate of deaths within hospital stay, the rate of ICH and outcome at day 90 were not different. Conclusion In our retrospective study acute stenting with subsequent gpIIb/IIIa inhibition was not associated with an increased risk of ICH or in-hospital death.	[Lee, John-lh; Gliem, Michael; Gerdes, Gebke; Hartung, Hans-Peter; Jander, Sebastian] Heinrich Heine Univ, Dept Neurol, Med Fac, Dusseldorf, Germany; [Turowski, Bernd; Kaschner, Marius; Kraus, Bastian] Heinrich Heine Univ, Dept Diagnost & Intervent Radiol, Med Fac, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Gliem, M (corresponding author), Heinrich Heine Univ, Dept Neurol, Med Fac, Dusseldorf, Germany.	michael.gliem@uni-duesseldorf.de	Riscado, Lorrane/AAN-6266-2021		B. Braun Foundation [BBST-D-14-00005]	B. Braun Foundation	This work was supported by B. Braun Foundation BBST-D-14-00005 to Michael Gliem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Bruno A, 2010, STROKE, V41, P1048, DOI 10.1161/STROKEAHA.109.571562; Ciccone A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005208.pub3; Fiorelli M, 1999, STROKE, V30, P2280, DOI 10.1161/01.STR.30.11.2280; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Kellert L, 2013, STROKE, V44, P1453, DOI 10.1161/STROKEAHA.111.000502; Kraft P, 2015, STROKE, V46, P3502, DOI 10.1161/STROKEAHA.115.011114; Malik AM, 2011, STROKE, V42, P1653, DOI 10.1161/STROKEAHA.110.595520; Siebler M, 2011, STROKE, V42, P2388, DOI 10.1161/STROKEAHA.110.599662; Stampfl S, 2014, AM J NEURORADIOL, V35, P741, DOI 10.3174/ajnr.A3763; Steglich-Arnholm H, 2015, J NEUROL, V262, P2668, DOI 10.1007/s00415-015-7895-0; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD	13	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190218	10.1371/journal.pone.0190218	http://dx.doi.org/10.1371/journal.pone.0190218			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281734	Green Published, gold, Green Submitted			2022-12-26	WOS:000419006200073
J	Nyari, S; Waugh, CA; Dong, JB; Quigley, BL; Hanger, J; Loader, J; Polkinghorne, A; Timms, P				Nyari, Sharon; Waugh, Courtney A.; Dong, Jianbao; Quigley, Bonnie L.; Hanger, Jonathan; Loader, Joanne; Polkinghorne, Adam; Timms, Peter			Epidemiology of chlamydial infection and disease in a free-ranging koala (Phascolarctos cinereus) population	PLOS ONE			English	Article							SOUTH-EAST QUEENSLAND; WILD KOALAS; PECORUM; AUSTRALIA; MORTALITY; WALES; PREVALENCE; MORBIDITY; VICTORIA; ISLAND	Chlamydial disease continues to be one of the main factors threatening the long-term survival of the koala (Phascolarctos cinereus). Despite this, large epidemiological studies of chlamydial infection and disease in wild koala populations are lacking. A better understanding of the prevalence, transmission and pathogenesis is needed to improve control measures, such as the development of vaccines. We investigated the prevalence of Chlamydia pecorum infection and disease in 160 koalas in a peri-urban wild population in Queensland, Australia and found that 31% of koalas were Chlamydia PCR positive and 28% had clinically detectable chlamydial disease. Most infections were at the urogenital site (27%; both males and females) with only 14% at the ocular site. Interestingly, we found that 27% (4/15) of koalas considered to be sexually immature (9-13 months) were already infected with C. pecorum, suggesting that a significant percentage of animals are infected directly from their mother. Ocular infection levels were less prevalent with increasing age (8% in koalas older than 4 years), whereas the prevalence of urogenital tract infections remained high into older age (26% in koalas older than 4 years), suggesting that, after mother-to-young transmission, C. pecorum is predominantly a sexually transmitted infection. While 28% of koalas in this population had clinically detectable chlamydial disease (primarily urogenital tract disease), many PCR positive koalas had no detectable disease and importantly, not all diseased animals were PCR positive. We also observed higher chlamydial loads in koalas who were C. pecorum infected without clinical disease than in koalas who were C. pecorum infected with clinical disease. These results shed light on the potential mechanisms of transmission of C. pecorum in koalas and also guide future control measures, such as vaccination.	[Nyari, Sharon; Waugh, Courtney A.; Dong, Jianbao; Quigley, Bonnie L.; Polkinghorne, Adam; Timms, Peter] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Ctr Anim Hlth Innovat, Sippy Downs, Qld, Australia; [Hanger, Jonathan; Loader, Joanne] Endeavour Vet Ecol, Toorbul, Qld, Australia; [Waugh, Courtney A.] Norwegian Univ Sci & Technol, Dept Biol, Trondheim, Norway	University of the Sunshine Coast; Norwegian University of Science & Technology (NTNU)	Timms, P (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Ctr Anim Hlth Innovat, Sippy Downs, Qld, Australia.	ptimms@usc.edu.au		Polkinghorne, Adam/0000-0002-6567-2962; Timms, Peter/0000-0002-1682-0025; Quigley, Bonnie/0000-0003-3787-0993; Waugh, Courtney/0000-0001-5234-4137	Australian Research Council (ARC) [LP160100138]; Queensland Government (Department of Transport and Main Roads); EVE	Australian Research Council (ARC)(Australian Research Council); Queensland Government (Department of Transport and Main Roads); EVE	This project was financially supported by Australian Research Council (ARC, Linkage Scheme LP160100138) to PT and AP. This project was significantly supported by the Queensland Government (Department of Transport and Main Roads) and specifically the Moreton Bay Rail Link project team. JH and JL were employed by Endeavour Veterinary Ecology (EVE). EVE provided support in the form of salaries for JH and JL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Australian Research Council also did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and research materials.	Bodetti TJ, 2002, VET REC, V151, P147, DOI 10.1136/vr.151.5.147; Bodley K., 2008, MED AUSTR MAMMALS; Burach F, 2014, VET MICROBIOL, V172, P230, DOI 10.1016/j.vetmic.2014.04.022; Burton E, 2016, RESCUE REHABILITATIO; CANFIELD PJ, 1987, AUST VET J, V64, P325, DOI 10.1111/j.1751-0813.1987.tb06059.x; CANFIELD PJ, 1991, J WILDLIFE DIS, V27, P657, DOI 10.7589/0090-3558-27.4.657; Crawley MJ, 2005, STAT INTRO USING R; Darville Toni, 2005, Semin Pediatr Infect Dis, V16, P235, DOI 10.1053/j.spid.2005.06.004; Devereaux LN, 2003, SYST APPL MICROBIOL, V26, P245, DOI 10.1078/072320203322346092; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; Gonzalez-Astudillo V, 2017, SCI REP-UK, V7, DOI 10.1038/srep42587; GORDON G, 1991, Australian Mammalogy, V14, P5; Griffith JE, 2013, J WILDLIFE DIS, V49, P18, DOI 10.7589/2012-05-135; Hanger Jon J., 2014, Technical Reports of the Australian Museum Online, V24, P19, DOI 10.3853/j.1835-4211.24.2014.1609; Jackson M, 1999, VET MICROBIOL, V65, P225; Jain S, 1999, J Matern Fetal Med, V8, P130; Johnston SD, 2015, VET PATHOL, V52, P1254, DOI 10.1177/0300985815570069; Kollipara A, 2013, VET MICROBIOL, V167, P513, DOI 10.1016/j.vetmic.2013.08.009; Legione AR, 2016, J MED MICROBIOL, V65, P420, DOI 10.1099/jmm.0.000241; Legione AR, 2016, J WILDLIFE DIS, V52, P426, DOI 10.7589/2015-10-276; Lunney Daniel, 2007, Pacific Conservation Biology, V13, P189; Mackie JT, 2016, J COMP PATHOL, V155, P356, DOI 10.1016/j.jcpa.2016.07.011; Marsh J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-77; McColl K A, 1984, VET REC, V115, P25; MCKENZIE RA, 1981, AUST VET J, V57, P243, DOI 10.1111/j.1751-0813.1981.tb02670.x; Melzer A, 2000, CONSERV BIOL, V14, P619, DOI 10.1046/j.1523-1739.2000.99383.x; OBENDORF DL, 1983, J WILDLIFE DIS, V19, P123, DOI 10.7589/0090-3558-19.2.123; Patterson JLS, 2015, J WILDLIFE DIS, V51, P309, DOI 10.7589/2014-07-176; Plumber M, P 3 INT WORKSH DISTR, P20; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Ratelle S, 1997, AM J PREV MED, V13, P221, DOI 10.1016/S0749-3797(18)30197-1; Speight KN, 2016, J WILDLIFE DIS, V52, P301, DOI 10.7589/2015-05-120; Su YSaY M., R2JAGS PACCKAGE RUNN; Tarlinton R, 2005, J GEN VIROL, V86, P783, DOI 10.1099/vir.0.80547-0; Timms Peter, 2014, Technical Reports of the Australian Museum Online, V24; Wan C, 2011, AUST VET J, V89, P409, DOI 10.1111/j.1751-0813.2011.00827.x; Waugh CA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00137-4; WHITE NA, 1994, WILDLIFE RES, V21, P41, DOI 10.1071/WR9940041; Zuur AF, 2016, METHODS ECOL EVOL, V7, P636, DOI 10.1111/2041-210X.12577	39	30	30	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2017	12	12							e0190114	10.1371/journal.pone.0190114	http://dx.doi.org/10.1371/journal.pone.0190114			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR3ZV	29281731	Green Submitted, Green Published, gold			2022-12-26	WOS:000419006200066
J	Moss, DJH; Robertson, N; Farmer, R; Scahill, RI; Haider, S; Tessari, MA; Flynn, G; Fischer, DF; Wild, EJ; Macdonald, D; Tabrizi, SJ				Moss, Davina J. Hensman; Robertson, Nicola; Farmer, Ruth; Scahill, Rachael I.; Haider, Salman; Tessari, Michela A.; Flynn, Geraldine; Fischer, David F.; Wild, Edward J.; Macdonald, Douglas; Tabrizi, Sarah J.			Quantification of huntingtin protein species in Huntington's disease patient leukocytes using optimised electrochemiluminescence immunoassays	PLOS ONE			English	Article							MUTANT HUNTINGTIN; SEX-DIFFERENCES; CAG REPEAT; SERIAL MRI; LIFE-SPAN; TRACK-HD; PROGRESSION; PREMANIFEST; PATTERNS; ATROPHY	Background Huntington's disease (HD) is an autosomal dominant neurodegenerative condition caused by an expanded CAG repeat in the gene encoding huntingtin (HTT). Optimizing peripheral quantification of huntingtin throughout the course of HD is valuable not only to illuminate the natural history and pathogenesis of disease, but also to detect peripheral effects of drugs in clinical trial. Rationale We previously demonstrated that mutant HTT (mHTT) was significantly elevated in purified HD patient leukocytes compared with controls and that these levels track disease progression. Our present study investigates whether the same result can be achieved with a simpler and more scalable collection technique that is more suitable for clinical trials. Methods We collected whole blood at 133 patient visits in two sample sets and generated peripheral blood mononuclear cells (PBMCs). Levels of mHTT, as well as N-, and C-terminal and midregion huntingtin were measured in the PBMCs using ELISA-based Meso Scale Discovery (MSD) electrochemiluminescence immunoassay platforms, and we evaluated the relationship between different HTT species, disease stage, and brain atrophy on magnetic resonance imaging. Conclusions The assays were sensitive and accurate. We confirm our previous findings that mHTT increases with advancing disease stage in patient PBMCs, this time using a simple collection protocol and scalable assay.	[Moss, Davina J. Hensman; Robertson, Nicola; Scahill, Rachael I.; Haider, Salman; Wild, Edward J.; Tabrizi, Sarah J.] UCL Inst Neurol, Huntingtons Dis Ctr, Dept Neurodegenerat Dis, London, England; [Farmer, Ruth] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Tessari, Michela A.] Galapagos BV, Leiden, Netherlands; [Flynn, Geraldine; Fischer, David F.] Charles River, Leiden, Netherlands; [Macdonald, Douglas] CHDI Fdn, CHDI Management, Los Angeles, CA USA	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Galapagos NV	Tabrizi, SJ (corresponding author), UCL Inst Neurol, Huntingtons Dis Ctr, Dept Neurodegenerat Dis, London, England.	s.tabrizi@ucl.ac.uk	Wild, Edward/G-1436-2016	Wild, Edward/0000-0002-6921-7887; Hensman Moss, Davina/0000-0003-2467-0917; Fischer, David/0000-0002-6690-0197; Tabrizi, Sarah/0000-0003-2716-2045; Scahill, Rachael/0000-0002-1832-106X	European Union PADDINGTON project [HEALTHF2-2010-261358]; CHDI Foundation; Guarantors of Brain; MRC [MR/M008592/1] Funding Source: UKRI; Medical Research Council [MR/M008592/1, MR/P007015/1] Funding Source: researchfish; National Institute for Health Research [ACF-2009-18-016] Funding Source: researchfish; Rosetrees Trust [M574] Funding Source: researchfish; Wellcome Trust [200181/Z/15/Z] Funding Source: researchfish	European Union PADDINGTON project; CHDI Foundation; Guarantors of Brain; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); Wellcome Trust(Wellcome TrustEuropean Commission)	This work has been supported by the European Union PADDINGTON project, contract no. HEALTHF2-2010-261358. This work has also been supported by CHDI Foundation which is a privately-funded not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. CHDI Foundation conducts research in a number of different ways; for the purposes of this manuscript, research was conducted at the contract research organization Charles River, under fee-for-service agreements. DHM has received funding from the Guarantors of Brain. URLs: European Commission PADDINGTON, http://cordis.europa.eu/project/rcn/97130_en.html; CHDI, http://chdfoundation.org/. DFF and GF are employed by Charles River. MAT is employed by Galapagos B. V. Charles River provided support in the form of salaries for authors DFF and GF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Galapagos B. V. provided support in the form of salary for author MAT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 1987, J IMMUNOL METHODS, V99, P283; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; Cannella M, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-11; ClinicalTrials.gov, SAF TOL PHARM PHARM; Cong SY, 2005, HYBRIDOMA, V24, P231, DOI 10.1089/hyb.2005.24.231; de Almeida LP, 2002, J NEUROSCI, V22, P3473; Fox NC, 1997, J MAGN RESON IMAGING, V7, P1069, DOI 10.1002/jmri.1880070620; Fulcher DA, 1997, IMMUNOL CELL BIOL, V75, P446, DOI 10.1038/icb.1997.69; GERSTEN DM, 1980, BIOCHEM J, V191, P869, DOI 10.1042/bj1910869; Hellerstein M, 1999, NAT MED, V5, P83, DOI 10.1038/4772; Hobbs NZ, 2013, NEUROIMAGE-CLIN, V2, P204, DOI 10.1016/j.nicl.2012.12.001; Hobbs NZ, 2009, NEUROIMAGE, V47, P1659, DOI 10.1016/j.neuroimage.2009.06.003; Hughes A., 2014, HUNTINGTONS DIS, V4th 4th ed., P323; Iyer RR, 2015, ANN REV BIOCH; Kwan W, 2012, J CLIN INVEST, V122, P4737, DOI 10.1172/JCI64484; Li PW, 2007, NAT STRUCT MOL BIOL, V14, P381, DOI 10.1038/nsmb1234; Macdonald D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096854; MACDONALD ME, 1993, J MED GENET, V30, P982, DOI 10.1136/jmg.30.12.982; MAHANY T, 1984, COMPUT BIOL MED, V14, P345, DOI 10.1016/0010-4825(84)90034-9; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Orth Michael, 2010, PLoS Curr, V2, DOI 10.1371/currents.RRN1184; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; Penney JBV J-PM MEG JPM RH, 1997, ANN NEUROLOGY, V41; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; Trager U, 2015, NEUROBIOL DIS, V73, P388, DOI 10.1016/j.nbd.2014.10.012; Weiss A, 2012, J CLIN INVEST, V122, P3731, DOI 10.1172/JCI64565; WHITELAW DM, 1966, BLOOD-J HEMATOL, V28, P455, DOI 10.1182/blood.V28.3.455.455; Wild Edward, 2008, Expert Rev Neurother, V8, P1779, DOI 10.1586/14737175.8.12.1779; Zielonka D, 2013, PARKINSONISM RELAT D, V19, P192, DOI 10.1016/j.parkreldis.2012.09.012	37	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2017	12	12							e0189891	10.1371/journal.pone.0189891	http://dx.doi.org/10.1371/journal.pone.0189891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8ZJ	29272284	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000418651500016
J	Feng, C; Ji, T; Liu, Y; Chen, DF; Dai, J; Ni, XS; Zhu, JQ; Liu, XB; Zhao, XX				Feng, Can; Ji, Tao; Liu, Yu; Chen, Danfeng; Dai, Jia; Ni, Xiushi; Zhu, Jiaqi; Liu, Xuebo; Zhao, Xianxian			Role of depression in secondary prevention of Chinese coronary heart disease patients receiving percutaneous coronary intervention	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; PREDICTORS; PREVALENCE; SYMPTOMS	Introduction Coronary heart disease (CHD) patients who have undergone percutaneous coronary intervention (PCI) have higher rates of depression than the general population. However, few researchers have assessed the impact of depression on the secondary prevention of CHD in China. Objective The main purpose of this investigation was to explore the relationship between depression and secondary prevention of CHD in Chinese patients after PCI. Methods This descriptive, cross-sectional one-site study recruited both elective and emergency PCI patients one year after discharge. Data from 1934 patients were collected in the clinic using questionnaires and medical history records between August 2013 and September 2015. Depression was evaluated by the 9-item Patient Health Questionnaire. Secondary prevention of CHD was compared between depression and non-depression groups. Results We found that depression affected secondary prevention of CHD in the following aspects: lipid levels, blood glucose levels, smoking status, physical activity, BMI, and rates of medication use. Conclusions Depressive patients with CHD are at increased risk of not achieving the lifestyle and risk factor control goals recommended in the 2006 AHA guidelines. Screening should focus on patients after PCI because treating depression can improve outcomes by improving secondary prevention of CHD.	[Feng, Can] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Shanghai, Peoples R China; [Ji, Tao] Tongji Univ, Affiliated Hosp 10, Dept Neurosurg, Shanghai, Peoples R China; [Liu, Yu] Nanjing Univ, Dept Cardiol, Gulou Hosp, Nanjing, Jiangsu, Peoples R China; [Chen, Danfeng; Zhu, Jiaqi; Zhao, Xianxian] Second Mil Med Univ, Changhai Hosp, Dept Cardiol, Shanghai, Peoples R China; [Dai, Jia; Ni, Xiushi] Shanghai Jiao Tong Univ, Dept Geriatr, Shanghai Peoples Hosp 1, Shanghai, Peoples R China; [Liu, Xuebo] Tongji Univ, Shanghai Tongji Hosp, Dept Cardiol, Sch Med, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Tongji University; Nanjing University; Naval Medical University; Shanghai Jiao Tong University; Tongji University	Zhao, XX (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Cardiol, Shanghai, Peoples R China.; Liu, XB (corresponding author), Tongji Univ, Shanghai Tongji Hosp, Dept Cardiol, Sch Med, Shanghai, Peoples R China.	Lxb70@hotmail.com; 13601713431@163.com		Feng, Can/0000-0002-8437-9606				[Anonymous], 2011, NATL VITAL STAT SYST; Blumenthal JA, 2012, J AM COLL CARDIOL, V60, P1053, DOI 10.1016/j.jacc.2012.04.040; Damen NL, 2013, INT J CARDIOL, V167, P2496, DOI 10.1016/j.ijcard.2012.04.028; Hare DL, 2014, EUR HEART J, V35, P1365, DOI 10.1093/eurheartj/eht462; Jaffery Z, 2011, PATIENT-RELAT OUTCOM, V2, P161, DOI 10.2147/PROM.S24796; Lee S, 2009, PSYCHOL MED, V39, P735, DOI 10.1017/S0033291708004091; Liu SI, 2011, COMPR PSYCHIAT, V52, P96, DOI 10.1016/j.comppsych.2010.04.013; Park HW, 2013, INT J CARDIOL, V169, P254, DOI 10.1016/j.ijcard.2013.08.132; Park JH, 2015, J CARDIOVASC NURS, V30, P351, DOI 10.1097/JCN.0000000000000143; Pedersen SS, 2007, J PSYCHOSOM RES, V62, P455, DOI 10.1016/j.jpsychores.2006.12.018; Ren YP, 2014, CHINESE MED J-PEKING, V127, P2991, DOI 10.3760/cma.j.issn.0366-6999.20140036; Richards SH, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002902.pub4; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; Watkins LL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000068; Whalley B, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002902.pub3, 10.1002/14651858.CD002902]; Whooley MA, 2013, ANNU REV CLIN PSYCHO, V9, P327, DOI 10.1146/annurev-clinpsy-050212-185526; Zhang WJ, 2013, INT J MENT HEALTH SY, V7, DOI 10.1186/1752-4458-7-22	19	9	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0187016	10.1371/journal.pone.0187016	http://dx.doi.org/10.1371/journal.pone.0187016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ8BI	29267269	Green Published, gold, Green Submitted			2022-12-26	WOS:000418587400003
J	Hu, BY; Deng, JC; Yang, CQ; Hu, Y; Zhang, J; Yang, WY; Liu, J				Hu, Bao-yu; Deng, Jun-cai; Yang, Cai-qiong; Hu, Yao; Zhang, Jing; Yang, Wen-yu; Liu, Jiang			Extraction optimization, purification and characterization of polysaccharides from the seed coat of black soybean	PLOS ONE			English	Article							GLYCINE-MAX L.; WATER-SOLUBLE POLYSACCHARIDES; RESPONSE-SURFACE METHODOLOGY; PANAX-GINSENG; FIELD MOLD; FRUITS; ANTHOCYANINS; MERR.; FILM; DIFFERENTIATION	In this study, the extraction of water-soluble polysaccharides from the seed coat of black soybean (BSCP) was investigated and optimized. A response surface methodology based on a Box-Behnken design (BBD) was used to optimize the extraction conditions as follows: extraction temperature, 100 degrees C;ratio of water to material, 22.3 mL/g; and extraction time, 133.2 min. Under these conditions, the experimental yield of polysaccharides was 10.56%, which was consistent with the predictive yield. A novel galactomannan, BSCP-1, with a molecular weight of 7.55 x 10(5) Da determined by high-performance gel permeation chromatography, was isolated from the black soybean seed coat. Through gas chromatographymass spectrometry analysis, BSCP-1 was identified as a galactomannan consisting of galactose, mannose and rhamnose in a molar ratio of 6.01: 3.56: 1.00. Cytotoxicity against the human gastric carcinoma cancer cell line was also determined.	[Hu, Bao-yu; Deng, Jun-cai; Yang, Cai-qiong; Hu, Yao; Zhang, Jing; Yang, Wen-yu; Liu, Jiang] Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Peoples R China; [Hu, Bao-yu; Yang, Cai-qiong; Liu, Jiang] Sichuan Agr Univ, Inst Ecol Agr, Chengdu, Sichuan, Peoples R China	Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University	Yang, WY; Liu, J (corresponding author), Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Peoples R China.; Liu, J (corresponding author), Sichuan Agr Univ, Inst Ecol Agr, Chengdu, Sichuan, Peoples R China.	mssiyangwy@sicau.edu.cn; jiangliu@sicau.edu.cn		Liu, Jiang/0000-0001-8791-3053	National Natural Science Foundation of China [31401329]; China Postdoctoral Science Foundation [2014M560724, 2017T100707]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was supported by the National Natural Science Foundation of China (Grant No. 31401329) and the China Postdoctoral Science Foundation (Grant No. 2014M560724 & 2017T100707).	China TSPCoPsRo, 2015, PHARM PEOPL REP CHIN; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Han YL, 2016, CARBOHYD POLYM, V151, P381, DOI 10.1016/j.carbpol.2016.05.085; He ZC, 2014, CARBOHYD RES, V388, P100, DOI 10.1016/j.carres.2013.12.020; Jia XJ, 2015, RSC ADV, V5, P73525, DOI 10.1039/c5ra12421b; Lee JH, 2009, FOOD CHEM, V112, P226, DOI 10.1016/j.foodchem.2008.05.056; Li C, 2014, CARBOHYD POLYM, V102, P103, DOI 10.1016/j.carbpol.2013.11.016; Li C, 2012, INT J BIOL MACROMOL, V51, P968, DOI 10.1016/j.ijbiomac.2012.06.031; Liao HF, 2001, ANTI-CANCER DRUG, V12, P841, DOI 10.1097/00001813-200111000-00008; Liu J, 2017, FRONTIERS IN MICROBI, V8; Liu J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00779; Liu J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42478; Liu J, 2016, J AGR FOOD CHEM, V64, P9135, DOI 10.1021/acs.jafc.6b03561; Liu J, 2016, FOOD CHEM, V207, P107, DOI 10.1016/j.foodchem.2016.03.059; Liu J, 2015, J AGR FOOD CHEM, V63, P225, DOI 10.1021/jf505172m; Liu J, 2015, INT J BIOL MACROMOL, V72, P1182, DOI 10.1016/j.ijbiomac.2014.08.058; Salarbashi D, 2014, FOOD CHEM, V146, P614, DOI 10.1016/j.foodchem.2013.09.014; Salarbashi D, 2013, CARBOHYD POLYM, V98, P1127, DOI 10.1016/j.carbpol.2013.07.031; Tajik S, 2013, CARBOHYD POLYM, V97, P817, DOI 10.1016/j.carbpol.2013.05.037; Wang YY, 2015, CARBOHYD POLYM, V127, P215, DOI 10.1016/j.carbpol.2015.03.070; Wu HJ, 2017, ANAL METHODS-UK, V9, P792, DOI 10.1039/c6ay02970a; Wu SB, 2011, PLANTA MED, V77, P922, DOI 10.1055/s-0030-1250673; Xu BJ, 2008, J AGR FOOD CHEM, V56, P8365, DOI 10.1021/jf801196d; Zhang W, 2007, SOIL BIOL BIOCHEM, V39, P2665, DOI 10.1016/j.soilbio.2007.04.003; Zhao ZY, 2015, CARBOHYD POLYM, V119, P101, DOI 10.1016/j.carbpol.2014.11.052; Zou YF, 2011, CARBOHYD POLYM, V84, P503, DOI 10.1016/j.carbpol.2010.12.013	26	3	3	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190202	10.1371/journal.pone.0190202	http://dx.doi.org/10.1371/journal.pone.0190202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267349	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400105
J	Karatolios, K; Holzendorf, V; Hatzis, G; Tousoulis, D; Richter, A; Schieffer, B; Pankuweit, S				Karatolios, Konstantinos; Holzendorf, Volker; Hatzis, George; Tousoulis, Dimitrios; Richter, Anette; Schieffer, Bernhard; Pankuweit, Sabine			Clinical predictors of outcome in patients with inflammatory dilated cardiomyopathy	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; VENTRICULAR EJECTION FRACTION; MORBIDITY CHARM PROGRAM; ATRIAL-FIBRILLATION; SUSPECTED MYOCARDITIS; PERICARDIAL DISEASES; POSITION STATEMENT; EUROPEAN-SOCIETY; RENAL-FUNCTION; WORKING GROUP	Objectives The study objectives were to identify predictors of outcome in patients with inflammatory dilated cardiomyopathy (DCMi). Methods From 2004 to 2008, 55 patients with biopsy-proven DCMi were identified and followed up for 58.2 +/- 19.8 months. Predictors of outcome were identified in a multivariable analysis with a Cox proportional hazards analysis. The primary endpoint was a composite of death, heart transplantation and hospitalization for heart failure or ventricular arrhythmias. Results For the primary endpoint, a QTc interval > 440msec (HR 2.84; 95% CI 1.03-7.87; p = 0.044), a glomerular filtration rate (GFR) <60ml/min/1.73m(2) (HR 3.19; 95% CI 1.35-7.51; p = 0.008) and worsening of NYHA classification during follow-up (HR 2.48; 95% CI 1.01-6.10; p = 0.048) were univariate predictors, whereas left ventricular ejection fraction at baseline, NYHA class at entry, atrial fibrillation, treatment with digitalis or viral genome detection were not significantly related to outcome. After multivariable analysis, a GFR < 60ml/min/1.73m(2) (HR 3.04; 95% CI 1.21-7.66; p = 0.018) remained a predictor of adverse outcome. Conclusions In patients with DCMi, a prolonged QTc interval > 440msec, a GFR <60ml/min/1.73m(2) and worsening of NYHA classification during follow-up were univariate predictors of adverse prognosis. In contrast, NYHA classification at baseline, left ventricular ejection fraction, atrial fibrillation, treatment with digitalis or viral genome detection were not related to outcome. After multivariable analysis, a GFR < 60ml/min/1.73m(2) remained independently associated with adverse outcome.	[Karatolios, Konstantinos; Hatzis, George; Richter, Anette; Schieffer, Bernhard; Pankuweit, Sabine] Philipps Univ Marburg, Dept Cardiol Angiol & Intens Care, Marburg, Germany; [Holzendorf, Volker] Univ Leipzig, Clin Trial Ctr Leipzig, Fac Med, Leipzig, Germany; [Hatzis, George; Tousoulis, Dimitrios] Univ Athens, Hippokration Gen Hosp, Dept Cardiol, Med Sch, Athens, Greece	Philipps University Marburg; Leipzig University; National & Kapodistrian University of Athens	Karatolios, K (corresponding author), Philipps Univ Marburg, Dept Cardiol Angiol & Intens Care, Marburg, Germany.	konstantinos.karatolios@med.uni-marburg.de			Competence Network Heart Failure Germany	Competence Network Heart Failure Germany	This study was funded by the Competence Network Heart Failure Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Competence Network Heart Failure Germany and especially Prof. Dr. Georg Ertl (University Hospital Wuerzburg, Germany) and Prof. Dr. Stefan Stoerck (University Hospital Wuerzburg, Germany) for excellent assistance and support.	Al-Ahmad A, 2001, J AM COLL CARDIOL, V38, P955, DOI 10.1016/S0735-1097(01)01470-X; Basso C, 2001, CARDIOVASC RES, V50, P290, DOI 10.1016/S0008-6363(01)00261-9; Besler C, 2016, EUR J HEART FAIL, V18, P1442, DOI 10.1002/ejhf.579; Brooksby P, 1999, EUR HEART J, V20, P1335, DOI 10.1053/euhj.1999.1542; Caforio ALP, 2007, EUR HEART J, V28, P1326, DOI 10.1093/eurheartj/ehm076; Caforio ALP, 2013, EUROPEAN SOCIETY OF; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Curtis JP, 2003, J AM COLL CARDIOL, V42, P736, DOI 10.1016/S0735-1097(03)00789-7; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Ertas G, 2012, J CARDIOVASC MED, V13, P554, DOI 10.2459/JCM.0b013e328356a2fd; Felker GM, 2000, NEW ENGL J MED, V342, P1077, DOI 10.1056/NEJM200004133421502; Hillege HL, 2006, CIRCULATION, V113, P671, DOI 10.1161/CIRCULATIONAHA.105.580506; Hombach V, 2009, EUR HEART J, V30, P2011, DOI 10.1093/eurheartj/ehp293; Kan H, 2003, J CELL PHYSIOL, V195, P1, DOI 10.1002/jcp.10213; Karatolios K, 2016, INT J CARDIOL, V220, P608, DOI 10.1016/j.ijcard.2016.06.167; Kindermann I, 2008, CIRCULATION, V118, P639, DOI 10.1161/CIRCULATIONAHA.108.769489; Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074; Krejci J, 2016, HEART VESSELS, V31, P416, DOI 10.1007/s00380-014-0618-0; Kuhl U, 2005, CIRCULATION, V112, P1965, DOI 10.1161/CIRCULATIONAHA.105.548156; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Linssen GCM, 2011, EUR J HEART FAIL, V13, P1111, DOI 10.1093/eurjhf/hfr066; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; Matsumori A, 1999, JPN CIRC J, V63, P934, DOI 10.1253/jcj.63.934; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Odutayo A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4482; Ohshima K, 2011, INT HEART J, V52, P366, DOI 10.1536/ihj.52.366; Olsson LG, 2006, J AM COLL CARDIOL, V47, P1997, DOI 10.1016/j.jacc.2006.01.060; Pankuweit S, 2003, HUM PATHOL, V34, P497, DOI 10.1016/S0046-8177(03)00078-9; Parker AB, 2002, AM HEART J, V144, P941, DOI 10.1067/mhj.2002.126446; Pedersen OD, 2006, EUR HEART J, V27, P2866, DOI 10.1093/eurheartj/ehl359; Perry G, 1997, NEW ENGL J MED, V336, P525; Pinto YM, 2016, EUR HEART J, V37, P1850, DOI 10.1093/eurheartj/ehv727; Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555; Solomon SD, 2004, CIRCULATION, V110, P2180, DOI 10.1161/01.CIR.0000144474.65922.AA; Stehlik J, 2010, J HEART LUNG TRANSPL, V29, P1089, DOI 10.1016/j.healun.2010.08.007; Ukena C, 2011, EUR J HEART FAIL, V13, P398, DOI 10.1093/eurjhf/hfq229; Vrtovec B, 2003, CIRCULATION, V107, P1764, DOI 10.1161/01.CIR.0000057980.84624.95; Youn JC, 2014, CARDIOVASC PATHOL, V23, P139, DOI 10.1016/j.carpath.2014.01.004	38	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0188491	10.1371/journal.pone.0188491	http://dx.doi.org/10.1371/journal.pone.0188491			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267340	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400010
J	Kindie, E; Anteneh, ZA; Worku, E				Kindie, Etsegenet; Anteneh, Zelalem Alamrew; Worku, Endalkachew			Time to development of adverse drug reactions and associated factors among adult HIV positive patients on antiretroviral treatment in Bahir Dar City, Northwest Ethiopia	PLOS ONE			English	Article							FOLLOW-UP; PREDICTORS; UNIVERSITY; THERAPY; REGIMEN	Background Adverse drug reactions (ADRs) are harmful and unintended reactions to medicines given at standard doses. Although the antiretroviral treatment (ART) changed the global HIV epidemic significantly, it's associated adverse events is huge. Therefore, investigating the rate and development of ADRs of ART provides vital information for monitoring risks. Methods Retrospective study was conducted among patients on ART from July1/2011 D June 30/2016 at Felege Hiwot referral hospital. Data were collected using checklist and document review. The p-value and hazard ratio with its confidence interval was used to show presence and strength of association. Results A total of 602 subjects were studied. The rate of occurrence of major ADRs was 4.3/100PY. Patients with no formal and completed primary education were at higher risk of developing ADRs compared to those with higher level education [AHR = 8, 95% CI: 2.53 +/- 25.20, AHR = 4.9, 95% CI: 1.65 +/- 14.44]. The risks of ADRs among patients working in NGOs were more than four times compared to those in governmental organizations [AHR = 4.3, 95% CI: 1.42 +/- 13.31]. The risks of ADRs in WHO clinical stage II, III and IV were much higher than in stage I [AHR = 4, 95% CI: 1.33 +/- 11.93, AHR = 5.3, 95% CI: 2.02 +/- 13.79 and AHR = 7, 95% CI: 2.51 +/- 20.10] respectively. Moreover, patients didn't receive OI prophylaxis were more three times at risk of ADRs compared to those received [AHR = 3.2, 95% CI: 1.47 +/- 7.08]. Conclusions Most of the ADRs cases were occurred within a year after initiation of ART. Educational status, occupation, advanced clinical stage and OI prophylaxis therapy were predictors ADRs. Continuous counseling for non-educated patients and clients in clinical stage II and above, and patients didn't take OI prophylaxis need to get close follow up to prevent the associated ADRs by the concerned parties.	[Kindie, Etsegenet] Yinesa Hlth Ctr, Bahir Dar Dist, Bahir Dar, Ethiopia; [Anteneh, Zelalem Alamrew; Worku, Endalkachew] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia	Bahir Dar University	Anteneh, ZA (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia.	kzolam@gmail.com	Anteneh, Zelalem Alamrew/AAD-1052-2022	Anteneh, Zelalem Alamrew/0000-0003-4879-675X; Mengesha, Endalkachew Worku/0000-0002-0147-5513				Alem D., 2014, KNOWLEDGE ATTITUDE P; Anlay DZ, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0095-x; [Anonymous], 2014, PROGR AETC GUID HIV; Berheto TM, 2014, N AM J MED SCI, V6, P453, DOI 10.4103/1947-2714.141636; Bhatnagar S, 2013, ASIAN J PHARM CLIN R, V6, P122; Bhuvana K., 2017, INT J BASIC CLIN PHA, V3, P380; Constance A., 2004, TREATING OPPORTUNIST; Hicks CB, 2006, LANCET, V368, P466, DOI 10.1016/S0140-6736(06)69154-X; Inzaule S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093106; Kauffman Y, 2014, RETROSPECTIVE EVALUA, V4; Masenyetse LJ, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0044-0; Mudzviti T., 2015, Pharmacology and Pharmacy, V6, P201, DOI 10.4236/pp.2015.63021; Nemaura T, 2013, J AIDS CLIN RES, V2013; Obiako OR., 2012, J ANTIVIRALS ANTIRET, V4, P006; Organization WH, 2013, CONGUID UANT DRU, V2015; Shet A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091028; Shet Anita A J, 2014, PLOS ONE, V9; Sood Atal P H, 2017, INT J RES MED SCI, V5; Teklay G, 2014, J PHARMACOVIGILANCE; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Velen Kavindhran L JJ, 2013, PLOS ONE, V8; Weldegebreal F, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.255.8356; WHO, ESS MED HLTH PROD; WHO, 2013, GLOB UPD HIV TREATM; World Health Organization, 2013, CONGUID UANT DRU	25	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189322	10.1371/journal.pone.0189322	http://dx.doi.org/10.1371/journal.pone.0189322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267292	Green Published, gold			2022-12-26	WOS:000418587400026
J	Munoz, R; Aguilar-Sandoval, F; Bellon, L; Melo, F				Munoz, Romina; Aguilar-Sandoval, Felipe; Bellon, Ludovic; Melo, Francisco			Detecting protein folding by thermal fluctuations of microcantilevers	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPE; BOVINE SERUM-ALBUMIN; VISCOUS FLUIDS; VISCOSITY; CANTILEVERS; FLOW; HYDRODYNAMICS; KINETICS; MOTION	The accurate characterization of proteins in both their native and denatured states is essential to effectively understand protein function, folding and stability. As a proof of concept, a micro rheological method is applied, based on the characterization of thermal fluctuations of a micro cantilever immersed in a bovine serum albumin solution, to assess changes in the viscosity associated with modifications in the protein's structure under the denaturant effect of urea. Through modeling the power spectrum density of the cantilever's fluctuations over a broad frequency band, it is possible to implement a fitting procedure to accurately determine the viscosity of the fluid, even at low volumes. Increases in viscosity during the denaturant process are identified using the assumption that the protein is a hard sphere, with a hydrodynamic radius that increases during unfolding. This is modeled accordingly through the Einstein-Batchelor formula. The Einstein-Batchelor formula estimates are verified through dynamic light scattering, which measures the hydrodynamic radius of proteins. Thus, this methodology is proven to be suitable for the study of protein folding in samples of small size at vanishing shear stresses.	[Munoz, Romina; Bellon, Ludovic] Univ Santiago Chile, Fac Ciencia, Dept Fis, Santiago, Chile; [Aguilar-Sandoval, Felipe] Univ Chile, Fac Ciencias Fis & Matemat, Dept Fis, Santiago, Chile; [Bellon, Ludovic] Univ Lyon, Univ Claude Bernard Lyon 1, ENS Lyon, Lab Phys,CNRS, Lyon, France	Universidad de Santiago de Chile; Universidad de Chile; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Munoz, R (corresponding author), Univ Santiago Chile, Fac Ciencia, Dept Fis, Santiago, Chile.	romina.munoz@usach.cl	Bellon, Ludovic/B-5213-2008	Bellon, Ludovic/0000-0002-2499-8106	Fondecyt [1161010]; Proyecto Basal [USA1555]; Conicyt-Chile through Fondecyt [1161010]; Universidad de Santiago de Chile through Proyecto Basal [USA1555]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Proyecto Basal(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Conicyt-Chile through Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Universidad de Santiago de Chile through Proyecto Basal	This work was supported by Fondecyt grant 1161010 (http://www.conicyt.cl/fondecyt/) and Proyecto Basal USA1555 (http://usach.cl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel A, 2008, MAT SCI ENG C-BIO S, V28, P594, DOI 10.1016/j.msec.2007.10.004; Ashton L, 2010, BIOPHYS J, V98, P707, DOI 10.1016/j.bpj.2009.10.010; BATCHELOR GK, 1977, J FLUID MECH, V83, P97, DOI 10.1017/S0022112077001062; Bekard IB, 2012, SOFT MATTER, V8, P385, DOI 10.1039/c1sm06704d; Berg RF, 1999, PHYS REV E, V60, P4079, DOI 10.1103/PhysRevE.60.4079; Bergaud C, 2000, REV SCI INSTRUM, V71, P2487, DOI 10.1063/1.1150640; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; Calero-Rubio C, 2016, J PHYS CHEM B, V120, P6592, DOI 10.1021/acs.jpcb.6b04907; FRENSDORFF HK, 1953, J AM CHEM SOC, V75, P5157, DOI 10.1021/ja01117a004; Hennemeyer M, 2008, SENSORS-BASEL, V8, P10, DOI 10.3390/s8010010; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; Jaspe J, 2006, BIOPHYS J, V91, P3415, DOI 10.1529/biophysj.106.089367; Josephson LL, 2016, J RHEOL, V60, P531, DOI 10.1122/1.4948427; KUWAJIMA K, 1990, BIOCHEMISTRY-US, V29, P8240, DOI 10.1021/bi00488a007; Maali A, 2005, J APPL PHYS, V97, DOI 10.1063/1.1873060; McLoughlin N, 2007, LAB CHIP, V7, P1057, DOI 10.1039/b705787c; Medda L, 2015, CHEM COMMUN, V51, P6663, DOI 10.1039/c5cc01538c; Nayak RK, 2012, J AM CHEM SOC, V134, P2453, DOI 10.1021/ja208490w; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pang YJ, 2012, NANO LETT, V12, P402, DOI 10.1021/nl203719v; Paolino P, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4819743; Papi M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2200588; Sader JE, 1998, J APPL PHYS, V84, P64, DOI 10.1063/1.368002; Sandoval FA, 2015, SENSORS-BASEL, V15, P27905, DOI 10.3390/s151127905; Sarangapani PS, 2013, BIOPHYS J, V105, P2418, DOI 10.1016/j.bpj.2013.10.012; Spector S, 1999, J MOL BIOL, V293, P763, DOI 10.1006/jmbi.1999.3189; Tu RS, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041914; Vandebril S, 2010, RHEOL ACTA, V49, P131, DOI 10.1007/s00397-009-0407-3; VANDERWERFF JC, 1989, PHYS REV A, V39, P795, DOI 10.1103/PhysRevA.39.795	29	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189979	10.1371/journal.pone.0189979	http://dx.doi.org/10.1371/journal.pone.0189979			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267316	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400073
J	Ping, JH; Yan, SY; Gu, P; Wu, ZN; Hu, CH				Ping, Jianhua; Yan, Shiyan; Gu, Pan; Wu, Zening; Hu, Caihong			Application of MIKE SHE to study the impact of coal mining on river runoff in Gujiao mining area, Shanxi, China	PLOS ONE			English	Article							ENVIRONMENTAL-IMPACT; WATER-BALANCE; BASE-FLOW; CALIBRATION; CATCHMENT; MODEL; HYDROLOGY; VALIDATION; SUBSIDENCE; REGIME	Coal mining is one of the core industries that contribute to the economic development of a country but deteriorate the environment. Being the primary source of energy, coal has become essential to meet the energy demand of a country. It is excavated by both opencast and underground mining methods and affects the environment, especially hydrological cycle, by discharging huge amounts of mine water. Natural hydrological processes have been well known to be vulnerable to human activities, especially large scale mining activities, which inevitably generate surface cracks and subsidence. It is therefore valuable to assess the impact of mining on river runoff for the sustainable development of regional economy. In this paper, the impact of coal mining on river runoff is assessed in one of the national key coal mining sites, Gujiao mining area, Shanxi Province, China. The characteristics of water cycle are described, the similarities and differences of runoff formation are analyzed in both coal mining and pre-mining periods. The integrated distributed hydrological model named MIKE SHE is employed to simulate and evaluate the influence of coal mining on river runoff. The study shows that mining one ton of raw coal leads to the reduction of river runoff by 2.87 m(3) between 1981 and 2008, of which the surface runoff decreases by 0.24 m(3) and the baseflow by 2.63 m(3). The reduction degree of river runoff for mining one ton of raw coal shows an increasing trend over years. The current study also reveals that large scale coal mining initiates the formation of surface cracks and subsidence, which intercepts overland flow and enhances precipitation infiltration. Together with mine drainage, the natural hydrological processes and the stream flows have been altered and the river run off has been greatly reduced.	[Ping, Jianhua; Yan, Shiyan; Gu, Pan; Wu, Zening; Hu, Caihong] Zhengzhou Univ, Sch Water Conservancy & Environm Engn, Zhengzhou, Henan, Peoples R China	Zhengzhou University	Ping, JH (corresponding author), Zhengzhou Univ, Sch Water Conservancy & Environm Engn, Zhengzhou, Henan, Peoples R China.	pingjianhua@126.com			Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period of China [2012BAB02B04-07]; National Natural Science Foundation of China [51379191]; Joint Research of National Natural Science Foundation of China-Henan Province [U1504404]; Scientific Research Foundation for Returned Scholars, Ministry of Education of China	Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Joint Research of National Natural Science Foundation of China-Henan Province(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for Returned Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This work has been supported by the "Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period of China (Grant No.2012BAB02B04-07)", "National Natural Science Foundation of China (Grant No. 51379191), "Joint Research of National Natural Science Foundation of China-Henan Province (Grant No.U1504404)", "Scientific Research Foundation for Returned Scholars, Ministry of Education of China".	Abu El-Nasr A, 2005, HYDROL PROCESS, V19, P573, DOI 10.1002/hyp.5610; [Anonymous], 1995, COMPUTER MODELS WATE; Arkoc O, 2016, ENVIRON EARTH SCI, V75, P1; Beaulieu M, 2012, HYDROL PROCESS, V26, P2672, DOI 10.1002/hyp.9404; Cartwright I, 2014, HYDROL EARTH SYST SC, V10, P5943; CHOUBEY VD, 1991, ENVIRON GEOL WATER S, V17, P185, DOI 10.1007/BF01701698; Clapcott JE, 2016, ENVIRON MANAGE, V57, P1; Danish Hydraulic Institute, 1999, MIKE SHE WM US MAN W; Fan L, 2000, SHANXI COAL, V1, P7; Gomes CJB, 2011, MINE WATER ENVIRON, V30, P159, DOI 10.1007/s10230-011-0139-3; Graham DN, 2006, WATERSHED MODELS, P245; Gu P., 2015, THESIS; Hossain M. M., 2015, Open Journal of Modern Hydrology, V5, P32, DOI 10.4236/ojmh.2015.52004; Howladar MF, 2013, ENVIRON EARTH SCI, V70, P215, DOI 10.1007/s12665-012-2117-x; Huang ZQ, 2006, W CHINA EXPLOR ENG, V18, P95; Krasny J, 2002, NATO SCI S SS IV EAR, V8, P381; Larsen MAD, 2016, AGR FOREST METEOROL, V217, P74, DOI 10.1016/j.agrformet.2015.11.012; Lee CH, 2006, ENVIRON GEOL, V51, P73, DOI 10.1007/s00254-006-0305-2; [雷通文 Lei Tongwen], 2005, [矿冶工程, Mining and Metallurgical Engineering], V25, P15; Li GY, 2006, ENVIRON GEOL, V49, P449, DOI 10.1007/s00254-005-0102-3; Liu Z, 2005, THESIS; Madsen H, 2003, ADV WATER RESOUR, V26, P205, DOI 10.1016/S0309-1708(02)00092-1; McMichael CE, 2006, J HYDROL, V317, P307, DOI 10.1016/j.jhydrol.2005.05.023; Miller MP, 2015, J HYDROL, V522, P203, DOI 10.1016/j.jhydrol.2014.12.039; Obiadi II, 2016, SUSTAIN WATER RESOUR, V2, P1, DOI DOI 10.4172/2472-0518.1000118; Oda T, 2013, HYDROL PROCESS, V27, P3864, DOI 10.1002/hyp.9497; POWELL JD, 1988, ENVIRON GEOL WATER S, V11, P141, DOI 10.1007/BF02580450; Qiao W, 2017, MINE WATER ENVIRON, V36, P104, DOI 10.1007/s10230-016-0414-4; Sahoo GB, 2006, J HYDROL, V327, P94, DOI 10.1016/j.jhydrol.2005.11.012; Sandu MA, 2015, AGRIC AGRIC SCI PROC, V6, P517, DOI 10.1016/j.aaspro.2015.08.135; Shepley MG, 2008, Q J ENG GEOL HYDROGE, V41, P425, DOI 10.1144/1470-9236/07-210; Sidle RC, 2000, ENVIRON GEOL, V39, P279, DOI 10.1007/s002540050007; SIMONS DB, 1984, MINER ENVIRON, V6, P133, DOI 10.1007/BF02043995; Stisen S, 2012, HYDROL EARTH SYST SC, V16, P4157, DOI 10.5194/hess-16-4157-2012; Thompson JR, 2004, J HYDROL, V293, P151, DOI 10.1016/j.jhydrol.2004.01.017; Tiwary RK, 2001, WATER AIR SOIL POLL, V132, P185, DOI 10.1023/A:1012083519667; Wan Z., 2011, SCI TECHN ASS FOR, V5, P99; Wang Q, 2010, SHANXI HYDROTECHNICS, V175, P14; Wang X., 2008, SHANXI WATER RESOURC, V24, P26; Whitfield L., 1988, PREDICTION VERSUS PE, P78; Xevi E, 1997, WATER RESOUR MANAG, V11, P219, DOI 10.1023/A:1007977521604; Xu J, 2016, DATABASE, V2016, P1, DOI DOI 10.3390/PHARMACEUTICS8010008; [张发旺 ZHANG Fawang], 2007, [地球学报, Acta Geoscientia Sinica], V28, P521; [张念龙 ZHANG Nianlong], 2008, [煤田地质与勘探, Coal Geology & Exploration], V36, P50; Zhang Y, 2004, WATER RESOUR RES, V40, P114; Zhou H, 2012, NEW DEV HYDROLOGICAL, V12, P256; Zipper C, 1997, ENVIRON GEOL, V29, P84, DOI 10.1007/s002540050107	47	11	12	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0188949	10.1371/journal.pone.0188949	http://dx.doi.org/10.1371/journal.pone.0188949			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267313	Green Submitted, Green Published, gold			2022-12-26	WOS:000418587400018
J	van Haren, H; Hanz, U; de Stigter, H; Mienis, F; Duineveld, G				van Haren, Hans; Hanz, Ulrike; de Stigter, Henko; Mienis, Furu; Duineveld, Gerard			Internal wave turbulence at a biologically rich Mid-Atlantic seamount	PLOS ONE			English	Article							CORAL LOPHELIA-PERTUSA; SHETLAND CHANNEL; NE ATLANTIC; TEMPERATURE; OCEAN; DISSIPATION; AZORES; HYDRODYNAMICS; RESUSPENSION; OVERTURNS	The turbulence regime near the crest of a biologically rich seamount of the Mid-Atlantic Ridge southwest of the Azores was registered in high spatial and temporal resolution. Internal tides and their higher harmonics dominate the internal wave motions, producing considerable shear-induced turbulent mixing in layers of 10-50 m thickness. This interior mixing of about 100 times open-ocean interior values is observed both at a high-resolution temperature sensor mooring-site at the crest, 770 m water depth being nearly 400 m below the top of the seamount, and a CTD-yoyo site at the slope off the crest 400 m horizontally away, 880 m water depth. Only at the mooring site, additionally two times higher turbulence is observed near the bottom, associated with highly non-linear wave breaking. The highest abundance of epifauna, notably sponges, are observed just below the crest and 100 m down the eastern slope (700-800 m) in a cross-ridge video-camera transect. This sponge belt is located in a water layer of depressed oxygen levels (saturation 63 +/- 2%) with a local minimum centered around 700 m. Turbulent mixing supplies oxygen to this region from above and below and is expected to mix nutrients away from this biodegraded layer towards the depth of highest abundance of macrofauna.	[van Haren, Hans] Royal Netherlands Inst Sea Res NIOZ, Den Burg, Netherlands; Univ Utrecht, Den Burg, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University	van Haren, H (corresponding author), Royal Netherlands Inst Sea Res NIOZ, Den Burg, Netherlands.	hans.van.haren@nioz.nl	de Stigter, Henko/ABC-8757-2021; Mienis, Furu/L-1934-2015	Mienis, Furu/0000-0002-7370-0652; de Stigter, Hendrik Corstiaan/0000-0002-4878-6546	NWO, the Netherlands Organization for Scientific Research; SponGES project from the European Union's Horizon research and innovation programme [679849]; Technology Foundation STW of the Netherlands Organisation for Scientific Research (NWO) [13273]; Dutch maritime industry; Topsector Water programme, a collaborative effort of Dutch industry, academia and government; Innovational Research Incentives Scheme of the Netherlands Organisation for Scientific Research (NWO-VIDI grant) [016.161.366]	NWO, the Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); SponGES project from the European Union's Horizon research and innovation programme; Technology Foundation STW of the Netherlands Organisation for Scientific Research (NWO); Dutch maritime industry; Topsector Water programme, a collaborative effort of Dutch industry, academia and government; Innovational Research Incentives Scheme of the Netherlands Organisation for Scientific Research (NWO-VIDI grant)	The construction of the NIOZ temperature sensors has been financed in part by NWO, the Netherlands Organization for Scientific Research. UH is funded by the SponGES project, which received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 679849. RV Pelagia cruise 64PE412 was carried out in the framework of the TREASURE (Towards Responsible ExtrAction of Submarine Resources) project, supported under grant No 13273 by the Technology Foundation STW of the Netherlands Organisation for Scientific Research (NWO), and partners from the Dutch maritime industry. Shiptime was funded by the Topsector Water programme, a collaborative effort of Dutch industry, academia and government. FM is supported financially by the Innovational Research Incentives Scheme of the Netherlands Organisation for Scientific Research (NWO-VIDI grant 016.161.366).	Bak RPM, 1998, MAR ECOL PROG SER, V175, P285, DOI 10.3354/meps175285; Bashmachnikov I, SEARIE ESTUDOS; Bongiorni L, 2013, DEEP-SEA RES PT II, V98, P75, DOI 10.1016/j.dsr2.2013.08.006; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Colaco A, 2013, DEEP-SEA RES PT II, V98, P178, DOI 10.1016/j.dsr2.2013.01.010; Consalvey Mireille, 2010, P123, DOI 10.1002/9781444325508.ch7; Cyr F, 2016, GEOPHYS RES LETT, V43, P775, DOI 10.1002/2015GL067038; DILLON TM, 1982, J GEOPHYS RES-OCEANS, V87, P9601, DOI 10.1029/JC087iC12p09601; Dodds LA, 2007, J EXP MAR BIOL ECOL, V349, P205, DOI 10.1016/j.jembe.2007.05.013; FREDERIKSEN R, 1992, SARSIA, V77, P157, DOI 10.1080/00364827.1992.10413502; Gemmrich JR, 2002, J SEA RES, V47, P209, DOI 10.1016/S1385-1101(02)00119-3; GREGG MC, 1989, J GEOPHYS RES-OCEANS, V94, P9686, DOI 10.1029/JC094iC07p09686; Guinotte JM, 2015, THE STATE OF DEEP SE; Hosegood P, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019544; Ishizu M, 2013, J GEOPHYS RES-OCEANS, V118, P3586, DOI 10.1002/jgrc.20249; Kirchman DL, 2000, MICROBIAL ECOLOGY OC; Klymak JM, 2010, J PHYS OCEANOGR, V40, P2059, DOI 10.1175/2010JPO4396.1; Korotenko K, 2013, CONT SHELF RES, V58, P21, DOI 10.1016/j.csr.2013.03.001; LAMPITT RS, 1985, DEEP-SEA RES, V32, P885, DOI 10.1016/0198-0149(85)90034-2; Lawler SN, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00458; Middelburg JJ, 2000, MAR ECOL PROG SER, V203, P13, DOI 10.3354/meps203013; Mohn C, 2014, PROG OCEANOGR, V122, P92, DOI 10.1016/j.pocean.2013.12.003; Morato T, 2008, MAR ECOL PROG SER, V357, P17, DOI 10.3354/meps07268; MUNK WH, 1980, J PHYS OCEANOGR, V10, P1718, DOI 10.1175/1520-0485(1980)010<1718:IWSATB>2.0.CO;2; OAKEY NS, 1982, J PHYS OCEANOGR, V12, P256, DOI 10.1175/1520-0485(1982)012<0256:DOTROD>2.0.CO;2; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; RICE AL, 1990, PROG OCEANOGR, V24, P179, DOI 10.1016/0079-6611(90)90029-2; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Stansfield K, 2001, J PHYS OCEANOGR, V31, P3421, DOI 10.1175/1520-0485(2001)031<3421:TPDOTT>2.0.CO;2; Tempera F, 2011, SEARIE ESTUDOS, P100; Tennekes H., 1972, 1 COURSE TURBULENCE; THORPE SA, 1977, PHILOS T R SOC A, V286, P125, DOI 10.1098/rsta.1977.0112; TSUCHIYA M, 1992, DEEP-SEA RES, V39, P1885, DOI 10.1016/0198-0149(92)90004-D; UNESCO IOC SCOR and IAPSO, 2010, INT THERM EQ SEAW 20; van Haren H, 2016, GEOPHYS RES LETT, V43, P4483, DOI 10.1002/2016GL068032; van Haren H, 2012, J MAR RES, V70, P173, DOI 10.1357/002224012800502363; van Haren H, 2009, IEEE J OCEANIC ENG, V34, P315, DOI 10.1109/JOE.2009.2021237; Wehrl M, 2007, MICROB ECOL, V53, P355, DOI 10.1007/s00248-006-9090-4; White M., 2004, SEAMOUNTS REV PHYS P, V2004, P7; Winters KB, 2015, GEOPHYS RES LETT, V42, P7123, DOI 10.1002/2015GL064676; Witbaard R, 2005, MAR BIOL RES, V1, P186, DOI 10.1080/17451000510018935; Yahel G, 2006, AQUAT MICROB ECOL, V45, P181, DOI 10.3354/ame045181; Zeppilli D, 2013, DEEP-SEA RES PT II, V98, P87, DOI 10.1016/j.dsr2.2013.08.009	43	18	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189720	10.1371/journal.pone.0189720	http://dx.doi.org/10.1371/journal.pone.0189720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267294	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400040
J	Wu, K; Camargo, C; Fishilevich, E; Narva, KE; Chen, XP; Taylor, CE; Siegfried, BD				Wu, Ke; Camargo, Carolina; Fishilevich, Elane; Narva, Kenneth E.; Chen, Xiuping; Taylor, Caitlin E.; Siegfried, Blair D.			Distinct fitness costs associated with the knockdown of RNAi pathway genes in western corn rootworm adults	PLOS ONE			English	Article							VIRGIFERA-VIRGIFERA LECONTE; NOVO DNA METHYLATION; COLEOPTERA-CHRYSOMELIDAE; ARGONAUTE PROTEINS; ANTIVIRAL DEFENSE; DROSOPHILA; INTERFERENCE; VIRUS; ROLES; EVOLUTION	RNA interference (RNAi) based approaches can potentially be used to control insect pests. These approaches may depend on the usage of microRNA (miRNA) or double stranded RNA (dsRNA) mediated gene knockdown, which likely involves proteins that regulate these pathways, such as Argonaute 1 (Ago1), Argonaute 2 (Ago2), Dicer 1 (Dcr1), Dicer 2 (Dcr2), and Drosha in insects. We previously performed functional characterization of Ago2 and Dcr2 of western corn rootworm (WCR), Diabrotica virgifera virgifera (Coleoptera: Chrysomelidae) and observed that knockdown of Ago2 and Dcr2 ameliorated the lethal effect induced by the dsRNA-mediated knockdown of an essential gene in WCR, thereby confirming the involvement of Ago2 and Dcr2 in the dsRNA pathway. In the current study, we identified and characterized additional members of the Argonaute and Dicer gene families, namely Ago1, Ago3, Aubergine, and Dcr1, in a previously developed WCR transcriptome. We also identified a Drosha homolog in the same transcriptome. We evaluated the impacts on WCR adult fitness associated with the dsRNA-mediated knockdown of Ago1, Ago2, Dcr1, Dcr2, and Drosha genes. Among these putative RNAi pathway genes, only the knockdown of Ago1 incurred significant fitness costs such as reduced survival and oviposition rate, as well as decreased egg viability. The present study, to our knowledge, represents the first report showing that Ago1 is critical to the survival of insect adults. Our findings suggest that Ago1 plays an essential role in broader life stages of an insect than previously thought. Importantly, since fitness costs were not observed, downregulation or loss of function of RNAi pathway genes such as Ago2 or Dcr2 may confer resistance to pest control measures that rely on the normal functions of these genes. However, the precise roles of these genes under field conditions (i.e., in the presence of possible viral pathogens) requires further investigation.	[Wu, Ke; Camargo, Carolina; Taylor, Caitlin E.; Siegfried, Blair D.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Fishilevich, Elane; Narva, Kenneth E.] Dow AgroSci LLC, Indianapolis, IN USA; [Chen, Xiuping] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing, Peoples R China; [Camargo, Carolina] Max Planck Univ, Antioquia Tandem Grp, Mosquito Reprod Biol, Medellin, Colombia	State University System of Florida; University of Florida; Dow Chemical Company; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wu, K (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.	kewu@ufl.edu		Narva, Kenneth/0000-0001-8094-6418; Wu, Ke/0000-0002-4438-1517; Camargo, Carolina/0000-0001-8958-9410	Dow AgroSciences [AGR00004305]	Dow AgroSciences	This study was funded under a Collaborative Research Agreement AGR00004305 from Dow AgroSciences. Dow AgroSciences (through coauthors EF and KEN) had roles in the design of the experiments, interpretation of results, and the preparation of the manuscript. Dow AgroSciences had no role in the data collection and analysis.; We want to thank Joyce Morales and Liyun Kong for technical assistance. This research was supported by Dow AgroSciences through Agreement AGR00004305 with B.D. Siegfried at the University of Florida.	Agrawal A, 2015, TRANSGENIC RES, V24, P791, DOI 10.1007/s11248-015-9880-x; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Azzam G, 2012, DEV BIOL, V365, P384, DOI 10.1016/j.ydbio.2012.03.005; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BRANSON TF, 1973, J ECON ENTOMOL, V66, P417, DOI 10.1093/jee/66.2.417; Bronkhorst AW, 2014, CURR OPIN VIROL, V7, P19, DOI 10.1016/j.coviro.2014.03.010; BURROUGHS AM, 2013, BIOL DIRECT, V8; Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425; Campbell LA, 2010, ANN ENTOMOL SOC AM, V103, P925, DOI 10.1603/AN10031; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; De N, 2013, MOL CELL, V50, P344, DOI 10.1016/j.molcel.2013.04.001; Dowling D, 2017, GENOME BIOL EVOL; Eyun SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094052; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Gassmann AJ, 2012, J INVERTEBR PATHOL, V110, P287, DOI 10.1016/j.jip.2012.04.006; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Huang V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003821; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khajuria C, 2015, INSECT BIOCHEM MOLEC, V63, P54, DOI 10.1016/j.ibmb.2015.05.011; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Lin YT, 2011, P NATL ACAD SCI USA, V108, P11229, DOI 10.1073/pnas.1105799108; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu S., 2017, GENOME ANNOUNC, V5; Liu SJ, 2014, J GEN VIROL, V95, P2809, DOI 10.1099/vir.0.069765-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miyata K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101661; Nayak A, 2010, NAT STRUCT MOL BIOL, V17, P547, DOI 10.1038/nsmb.1810; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Pepin G, 2012, NUCLEIC ACIDS RES, V40, P11603, DOI 10.1093/nar/gks903; Rangasamy M, 2012, PEST MANAG SCI, V68, P587, DOI 10.1002/ps.2301; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Rodrigues TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109825; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Siegfried BD., 2012, GENE CONTAINMENT; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Song JJ, 2006, CURR OPIN STRUC BIOL, V16, P5, DOI 10.1016/j.sbi.2006.01.010; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Spradling AC, 1999, GENETICS, V153, P135; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Van Rij RP, 2006, TRENDS BIOTECHNOL, V24, P186, DOI 10.1016/j.tibtech.2006.02.006; Velez AM, 2016, GENES, V8; Velez AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157520; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Wu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144291; Wu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110874; Yang LL, 2007, DEVELOPMENT, V134, P4265, DOI 10.1242/dev.009159; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x	71	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0190208	10.1371/journal.pone.0190208	http://dx.doi.org/10.1371/journal.pone.0190208			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267401	Green Published, gold			2022-12-26	WOS:000418587400106
J	Yeh, DM; Chen, CY; Tang, JF; Pan, LK				Yeh, Da-Ming; Chen, Ching-Yuan; Tang, Jing-Fa; Pan, Lung-Kwang			A quantitative evaluation of multiple biokinetic models using an assembled water phantom: A feasibility study	PLOS ONE			English	Article							IODINE	This study examined the feasibility of quantitatively evaluating multiple biokinetic models and established the validity of the different compartment models using an assembled water phantom. Most commercialized phantoms are made to survey the imaging system since this is essential to increase the diagnostic accuracy for quality assurance. In contrast, few customized phantoms are specifically made to represent multi-compartment biokinetic models. This is because the complicated calculations as defined to solve the biokinetic models and the time-consuming verifications of the obtained solutions are impeded greatly the progress over the past decade. Nevertheless, in this work, five biokinetic models were separately defined by five groups of simultaneous differential equations to obtain the time-dependent radioactive concentration changes inside the water phantom. The water phantom was assembled by seven acrylic boxes in four different sizes, and the boxes were linked to varying combinations of hoses to signify the multiple biokinetic models from the biomedical perspective. The boxes that were connected by hoses were then regarded as a closed water loop with only one infusion and drain. 129.1 +/- 24.2 MBq of Tc-99m labeled methylene diphosphonate (MDP) solution was thoroughly infused into the water boxes before gamma scanning; then the water was replaced with de-ionized water to simulate the biological removal rate among the boxes. The water was driven by an automatic infusion pump at 6.7 c.c./min, while the biological half-life of the four different-sized boxes (64, 144, 252, and 612 c.c.) was 4.8, 10.7, 18.8, and 45.5 min, respectively. The five models of derived time-dependent concentrations for the boxes were estimated either by a self-developed program run in MATLAB or by scanning via a gamma camera facility. Either agreement or disagreement between the practical scanning and the theoretical prediction in five models was thoroughly discussed. The derived biokinetic model represented the metabolic mechanism in the human body and helped to solidify the internal circulatory system into concert with numerical verification.	[Yeh, Da-Ming] Chung Shan Med Univ Hosp, Dept Diagnost Radiol, Taichung, Taiwan; [Yeh, Da-Ming] Chung Shan Med Univ, Sch Med Imaging & Radiol Sci, Taichung, Taiwan; [Chen, Ching-Yuan; Tang, Jing-Fa; Pan, Lung-Kwang] Cent Taiwan Univ Sci & Technol, Grad Inst Radiol Sci, Taichung, Taiwan; [Chen, Ching-Yuan] Buddhist Tzu Chi Gen Hosp, Taichung Branch, Dept Nucl Med, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Central Taiwan University Science & Technology; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital	Pan, LK (corresponding author), Cent Taiwan Univ Sci & Technol, Grad Inst Radiol Sci, Taichung, Taiwan.	lkpan@ctust.edu.tw			Chung Shan Medical University Hospital [CSH-2011-C-003]; Ministry of Science and Technology of the Republic of China [MOST 106-2221-E-166-002]	Chung Shan Medical University Hospital; Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	The authors would like to thank the Chung Shan Medical University Hospital under contract No. CSH-2011-C-003 to D-MY and the Ministry of Science and Technology of the Republic of China under contract No. MOST 106-2221-E-166-002 to L-KP for the financial support of this research	Chen CY, 2007, J RADIAT RES, V48, P485, DOI 10.1269/jrr.07031; Chen CY, 2001, FOOD CHEM, V72, P255, DOI 10.1016/S0308-8146(00)00241-7; Chiang FT, 2016, BIOENGINEERED, V7, P304, DOI 10.1080/21655979.2016.1197738; Chiribiri A, 2013, MAGN RESON MED, V69, P698, DOI 10.1002/mrm.24299; Cho GY, 2012, MAGN RESON MED, V67, P1710, DOI 10.1002/mrm.23193; Chu KH, 2012, J RADIAT RES, V53, P989, DOI 10.1093/jrr/rrs050; Giussani A, 2012, J NUCL MED, V53, P985, DOI 10.2967/jnumed.111.099408; Hsu CC, 2012, RADIAT PROT DOSIM, V150, P405, DOI 10.1093/rpd/ncr425; ICRP-30, 1978, ICRP30; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/nmat4014, 10.1038/NMAT4014]; Knoll G. F., 1989, RAD DETECTION MEASUR; Simunovic G, 2013, INT J SIMUL MODEL, V12, P141, DOI 10.2507/IJSIMM12(3)1.219; Tani K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12426; Turner J.E., 2000, ATOMS RAD RAD PROTEC, V2nd ed.; Unice KM, 2012, FOOD CHEM TOXICOL, V50, P2456, DOI 10.1016/j.fct.2012.04.009	15	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2017	12	12							e0189244	10.1371/journal.pone.0189244	http://dx.doi.org/10.1371/journal.pone.0189244			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ8BI	29267305	Green Published, Green Submitted, gold			2022-12-26	WOS:000418587400023
J	Batiro, B; Demissie, T; Halala, Y; Anjulo, AA				Batiro, Bancha; Demissie, Tsegaye; Halala, Yoseph; Anjulo, Antehun Alemayehu			Determinants of stunting among children aged 6-59 months at Kindo Didaye woreda, Wolaita Zone, Southern Ethiopia: Unmatched case control study	PLOS ONE			English	Article								Background Stunting is a well-established risk marker of poor child development. Globally in 2017, 155 million children under 5 were estimated to be stunted. While different activities are being done to reduce the burden of stunted growth, the problem is overwhelming in Africa; it was increased by 24%. Therefore, identifying determinants of stunting among children aged 6 +/- 59 would help to set priorities for action and to the design of stunting reduction plan at a grassroots level. Methods The unmatched case-control study was conducted in randomly selected 8 rural kebeles of Kindo Didaye woreda, Ethiopia from February to April, 2016 to identify the determinants of stunting among children aged 6 +/- 59 months. The sampling frame was identified by enumeration of 6 +/- 59 months of age children in the entire households of the study area. From which 155 as cases and 310 as controls were chosen using anthropometric measurement based on the median of WHO 2006 reference population. The anthropometric data were analyzed by WHO Anthro 2010 software to generate Z-score values. Odds Ratio along with 95% confidence interval was estimated to identify determinants of stunting using the multivariable logistic regression. Results Drinking water from unsafe source (AOR = 7.06, 95% CI; 4.40 +/- 20.42), occasionally eating animal source food (AOR = 0.51, 95% CI; 0.02 +/- 0.68), ARI in the past two weeks (AOR = 3.04, (95% CI; 1.04 +/- 13.35), late initiation of breastfeeding after one hours after birth (AOR = 5.16, 95% CI; 2.24 +/- 15.90) and lack of vaccination (AOR = 6.38, 95% CI; 2.54 +/- 17.10) were significantly associated with stunting. Conclusions Factors like exposure to diarrhea disease, exposure to acute respiratory infection, late initiation of breast milk after child breath, squeeze out of 1 st breast milk, lack of vaccination, animal source of food, and unsafe source of water for drinking could be used to set priorities for action and to the design of Kindo Didaye woreda plan for stunting reduction down to grassroots level. Therefore, zonal health department and Kindo Didaye woreda health office should promote the importance of colostrums feeding. Drinking water should be decontaminated. Expansion of vaccination program to enhance herd immunity at the community level is important.	[Batiro, Bancha] Kindo Didaye Woreda Hlth Off, Halale, Ethiopia; [Demissie, Tsegaye; Halala, Yoseph] Wolaita Sodo Univ, Coll Hlth Sci & Med, Sch Publ Hlth, Wolaita Sodo, Ethiopia; [Anjulo, Antehun Alemayehu] Wolaita Sodo Univ, Dept Lab Med, Coll Hlth Sci & Med, Wolaita Sodo, Ethiopia		Anjulo, AA (corresponding author), Wolaita Sodo Univ, Dept Lab Med, Coll Hlth Sci & Med, Wolaita Sodo, Ethiopia.	Antehunalemayehu@gmail.com		Anjulo, Antehun/0000-0002-6083-5857	Norwegian Project for the Research, Higher Education and Development-South Ethiopia Network Universities in Public Health	Norwegian Project for the Research, Higher Education and Development-South Ethiopia Network Universities in Public Health	This work was supported by the Norwegian Project for the Research, Higher Education and Development-South Ethiopia Network Universities in Public Health, to BB.	Agency E. C. S. and O. Macro, 2006, ETH DEM HLTH SURV; Akombi BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177338; Alemayehu M., 2014, INT J NUTR FOOD SCI, V3, P579; [Anonymous], 2013, APPL LOGISTIC REGRES; [Anonymous], 2011, J AGR SCI, P3; [Anonymous], 2007, PREVALENCE DETERMINA; Ayana AB., 2015, BMC NUTR, V1, P34, DOI [10.1186/s40795-015-0031-9, DOI 10.1186/S40795-015-0031-9]; Bantamen GB, 2014, J NUTR FOOD SCI, V4, P1, DOI DOI 10.4172/2155-9600.1000256; Basit A, 2012, AUSTRALAS MED J, V5, P163, DOI [10.4066/AMJ.2012.102, 10.4066/AMJ.20121022]; Beka T, 2009, ETHIOP J HEALTH DEV, V23, P2; Chirande L, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0482-9; De Onis M, 2006, WHO CHILD GROWTH STA; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Demissie S., 2013, SCI J PUBLIC HLTH, V1, P175, DOI [10.11648/j.sjph.20130104.12, DOI 10.11648/J.SJPH.20130104.12]; Dereje N, 2014, J NUTR FOOD SCI, V4, P5, DOI DOI 10.4172/2155-9600.100030021; Egata G, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-91; Fentahun W, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3180-0; Frozanfar MK, 2016, NAGOYA J MED SCI, V78, P41; Getabil F., 2012, PREVALENCE FACTORS A; Hagos S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170785; Maalin A, 2016, BMC NUTR, V2, P44; Mekides WT., 2015, INT J NUTR FOOD SCI, V4, P278, DOI [10.11648/j.ijnfs.20150403.15, DOI 10.11648/J.IJNFS.20150403.15]; Mengistu K, 2013, J NUTR DISORDERS THE, VT1, DOI DOI 10.4172/2161-0509.T1-001; Office K. D. W. A. R. D, 2014, ANN REPORT; Onis D., 2006, WHO CHILD GROWTH STA; Semali IA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2507-6; Solomon Amsalu, 2008, Ethiopian Journal of Health Development, V22, P21; Soto A, 2014, J PEDIATR GASTR NUTR, V59, P78, DOI 10.1097/MPG.0000000000000347; UN, 2015, MILLENNIUM DEV GOALS; UNICEF; WHO, 2012, JOINT CHILD MALN EST; UNICEF WHO and World Bank, 2014, JOINT CHILD MALN EST; WHO, 2014, PROM HLTH GROWTH PRE; WHO, 2021, INF YOUNG CHILD FEED; Woldie Y. T., 2015, INT J MED HLTH SCI R, V2, P36; Wong HJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-785; Yisak H, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0535-0	36	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189106	10.1371/journal.pone.0189106	http://dx.doi.org/10.1371/journal.pone.0189106			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261680	gold, Green Published, Green Submitted			2022-12-26	WOS:000418564200026
J	Zubrzycki, JE; Maringolo, CA; Filippi, CV; Quiroz, FJ; Nishinakamasu, V; Puebla, AF; Di Rienzo, JA; Escande, A; Lia, VV; Heinz, RA; Hopp, HE; Cervigni, GDL; Paniego, NB				Enrique Zubrzycki, Jeremias; Andrea Maringolo, Carla; Valeria Filippi, Carla; Jose Quiroz, Facundo; Nishinakamasu, Veronica; Fabiana Puebla, Andrea; Di Rienzo, Julio A.; Escande, Alberto; Viviana Lia, Veronica; Amalia Heinz, Ruth; Esteban Hopp, Horacio; Cervigni, Gerardo D. L.; Beatriz Paniego, Norma			Main and epistatic QTL analyses for Sclerotinia Head Rot resistance in sunflower	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; HELIANTHUS-ANNUUS L.; COMPARATIVE GENETIC-ANALYSIS; DISEASE RESISTANCE; COMPLEX TRAITS; MULTIPLE LOCI; LINKAGE MAP; IDENTIFICATION; ARCHITECTURE; SELECTION	Sclerotinia Head Rot (SHR), a disease caused by Sclerotinia sclerotiorum, is one of the most limiting factors in sunflower production. In this study, we identified genomic loci associated with resistance to SHR to support the development of assisted breeding strategies. We genotyped 114 Recombinant Inbred Lines (RILs) along with their parental lines (PAC2 -partially resistant-and RHA266 -susceptible-) by using a 384 single nucleotide polymorphism (SNP) Illumina Oligo Pool Assay to saturate a sunflower genetic map. Subsequently, we tested these lines for SHR resistance using assisted inoculations with S. sclerotiorum ascospores. We also conducted a randomized complete-block assays with three replicates to visually score disease incidence (DI), disease severity (DS), disease intensity (DInt) and incubation period (IP) through four field trials (2010-2014). We finally assessed main effect quantitative trait loci (M-QTLs) and epistatic QTLs (E-QTLs) by composite interval mapping (CIM) and mixed-model-based composite interval mapping (MCIM), respectively. As a result of this study, the improved map incorporates 61 new SNPs over candidate genes. We detected a broad range of narrow sense heritability (h(2)) values (1.86-59.9%) as well as 36 M-QTLs and 13 E-QTLs along 14 linkage groups (LGs). On LG1, LG10, and LG15, we repeatedly detected QTLs across field trials; which emphasizes their putative effectiveness against SHR. In all selected variables, most of the identified QTLs showed high determination coefficients, associated with moderate to high heritability values. Using markers shared with previous Sclerotinia resistance studies, we compared the QTL locations in LG1, LG2, LG8, LG10, LG11, LG15 and LG16. This study constitutes the largest report of QTLs for SHR resistance in sunflower. Further studies focusing on the regions in LG1, LG10, and LG15 harboring the detected QTLs are necessary to identify causal alleles and contribute to unraveling the complex genetic basis governing the resistance.	[Enrique Zubrzycki, Jeremias; Valeria Filippi, Carla; Nishinakamasu, Veronica; Fabiana Puebla, Andrea; Viviana Lia, Veronica; Amalia Heinz, Ruth; Esteban Hopp, Horacio; Beatriz Paniego, Norma] Inst Nacl Tecnol Agr, Ctr Invest Ciencias Agron & Vet, Inst Biotecnol, Buenos Aires, DF, Argentina; [Andrea Maringolo, Carla; Jose Quiroz, Facundo; Escande, Alberto] Univ Nacl Mar del Plata, Unidad Integrada, Lab Patol Vegetal, Estn Expt Agr INTA Balcarce, Buenos Aires, DF, Argentina; [Valeria Filippi, Carla; Viviana Lia, Veronica; Amalia Heinz, Ruth; Cervigni, Gerardo D. L.; Beatriz Paniego, Norma] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Di Rienzo, Julio A.] Univ Nacl Cordoba, Fac Ciencias Agr, Catedra Estadist & Biometr, Cordoba, Argentina; [Viviana Lia, Veronica; Amalia Heinz, Ruth; Esteban Hopp, Horacio] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Cervigni, Gerardo D. L.] Ctr Estudios Fotosintet & Bioquim, Rosario, Santa Fe, Argentina; [Enrique Zubrzycki, Jeremias] Biocodices, Buenos Aires, DF, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA); National University of Mar del Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; University of Buenos Aires	Paniego, NB (corresponding author), Inst Nacl Tecnol Agr, Ctr Invest Ciencias Agron & Vet, Inst Biotecnol, Buenos Aires, DF, Argentina.; Paniego, NB (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	paniego.norma@inta.gob.ar	Paniego, Norma/AAK-6140-2021	Lia, Veronica Viviana/0000-0001-8849-8349; Hopp, H. Esteban/0000-0002-2230-641X; Puebla, Andrea Fabiana/0000-0002-5181-1378; Filippi, Carla/0000-0002-5564-7480; Paniego, Norma/0000-0003-3906-5330	Institute Nacional de Tecnologia Agropecuaria [PNBIO-1131042, 1131043]; Agencia Nacional de Promocion Cientifica y Tecnica [PICT 2011 1365, PICT 2014 0701, PICT 2015 1799]; Agencia Espanola de Cooperacion Internacional y Desarrollo [D/016099/08, D/024562/09]	Institute Nacional de Tecnologia Agropecuaria; Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT); Agencia Espanola de Cooperacion Internacional y Desarrollo	This research was supported by Institute Nacional de Tecnologia Agropecuaria (PNBIO-1131042, 1131043) and Agencia Nacional de Promocion Cientifica y Tecnica (PICT 2011 1365; PICT 2014 0701; PICT 2015 1799), and the Agencia Espanola de Cooperacion Internacional y Desarrollo (D/016099/08; D/024562/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Instituto Nacional de Tecnologia Agropecuaria (PNBIO-1131042, 1131043) and Agencia Nacional de Promocion Cientifica y Tecnica (PICT 2011 1365; PICT 2014 0701; PICT 2015 1799), and the Agencia Espanola de CooperaciOn Internacional y Desarrollo (D/016099/08; D/024562/09). The authors are grateful to Silvio Giuliano and Carlos Antonelli for their support in field experiments at INTA Balcarce, Dr. Julia Sabio y Garcia for her critical reading of this manuscript, and to the editor and reviewer for their valuable comments and suggestions.	ABAWI GS, 1979, PHYTOPATHOLOGY, V69, P899, DOI 10.1094/Phyto-69-899; Al-Chaarani GR, 2004, THEOR APPL GENET, V109, P1353, DOI 10.1007/s00122-004-1770-1; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BEAVIS WD, 1994, CROP SCI, V34, P882, DOI 10.2135/cropsci1994.0011183X003400040010x; Becelaere G. van, 2004, Helia, V27, P137, DOI 10.2298/HEL0441137V; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berrios EF, 2000, THEOR APPL GENET, V101, P1299, DOI 10.1007/s001220051610; Bert PF, 2004, THEOR APPL GENET, V109, P865, DOI 10.1007/s00122-004-1701-1; Bert PF, 2002, THEOR APPL GENET, V105, P985, DOI 10.1007/s00122-002-1004-3; Bioley JP, 1987, INFS TECH CETIOM, P7; Bowers JE, 2012, G3-GENES GENOM GENET, V2, P721, DOI 10.1534/g3.112.002659; Castano F., 2009, Helia, V32, P59, DOI 10.2298/HEL0950059C; Castano F, 2001, EUPHYTICA, V122, P373, DOI 10.1023/A:1012970101508; Darvishzadeh R, 2007, PLANT PATHOL, V56, P855, DOI 10.1111/j.1365-3059.2007.01620.x; Davar R, 2010, PHYTOPATHOL MEDITERR, V49, P330; Desgroux A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2429-4; Desta ZA, 2014, TRENDS PLANT SCI, V19, P592, DOI 10.1016/j.tplants.2014.05.006; Doerge RW, 1996, GENETICS, V142, P285; Escande AR, 2002, PLANT PATHOL, V51, P346, DOI 10.1046/j.1365-3059.2002.00723.x; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Fernandez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045899; Filippi C, 2015, THESIS; Filippi CV, 2017, PLANT DIS, V101, P1941, DOI 10.1094/PDIS-12-16-1784-RE; Filippi CV, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0360-x; Fusari CM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-7; Fusari CM, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-93; Fusari CM, 2011, MOL BREEDING, V28, P73, DOI 10.1007/s11032-010-9462-9; GENTZBITTEL L, 1995, THEOR APPL GENET, V90, P1079, DOI 10.1007/BF00222925; Gentzbittel L, 1998, THEOR APPL GENET, V96, P519, DOI 10.1007/s001220050769; Gentzbittel L, 1999, THEOR APPL GENET, V99, P218, DOI 10.1007/s001220051228; Giussani A, 2008, P 17 INT SUNFL C COR, P539; Goncalves E, 2013, EUPHYTICA, V189, P379, DOI 10.1007/s10681-012-0787-9; Gulya Thomas, 1997, Agronomy (Madison), V35, P263; Haldane JBS, 1931, GENETICS, V16, P0357; Hulke BS, 2015, CROP SCI, V55, P1696, DOI 10.2135/cropsci2014.11.0752; Ingvarsson PK, 2011, NEW PHYTOL, V189, P909, DOI 10.1111/j.1469-8137.2010.03593.x; Jannink JL, 2007, GENETICS, V176, P553, DOI 10.1534/genetics.106.062992; JANSEN RC, 1994, GENETICS, V136, P1447; Jouan I, 2000, P 15 INT SUNFL C TOU, pK54; Kiani SP, 2008, PLANT SCI, V175, P565, DOI 10.1016/j.plantsci.2008.06.002; Kiani SP, 2007, PLANT SCI, V172, P773, DOI 10.1016/j.plantsci.2006.12.007; Kolkman JM, 2007, GENETICS, V177, P457, DOI 10.1534/genetics.107.074054; Koric D., 2016, RECENT ADV FUTURE PE; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Lepoittevin C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011034; Livaja M, 2016, THEOR APPL GENET, V129, P317, DOI 10.1007/s00122-015-2629-3; Mandel JR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003378; Maringolo C., 2007, POSGRADO PRODUCCION; Markell S.G., 2015, SUNFLOWER CHEM PRODU, P93, DOI [10.1016/B978-1-893997-94-3.50010-6, DOI 10.1016/B978-1-893997-94-3.50010-6]; McCouch SR, 1997, RICE GENET NEWSLETT, V14, P11, DOI [DOI 10.1007/S10142-013-0328-1, DOI 10.1007/S10681-005-0449-2]; Mestries E, 1998, MOL BREEDING, V4, P215, DOI 10.1023/A:1009694626992; Micic Z, 2005, THEOR APPL GENET, V111, P233, DOI 10.1007/s00122-005-2004-x; Micic Z, 2004, THEOR APPL GENET, V109, P1474, DOI 10.1007/s00122-004-1764-z; Moschini RC, 2002, REV ARG AGROMETEOROL, V2, P51; Pedraza M. V., 2004, Helia, V27, P171, DOI 10.2298/HEL0440171P; Pinheiro J., 2019, NLME LINEAR NONLINEA; Qi LL, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0380-8; R Core Team, 2021, R LANGUAGE ENV STAT; Robledo C., 2018, INFOSTAT VERSION 201; Ronicke S, 2005, PHYTOPATHOLOGY, V95, P834, DOI 10.1094/PHYTO-95-0834; Roorkiwal M, 2013, PLANT GEN, V6, P1, DOI DOI 10.3835/PLANTGENOME2013.05.0017; Roux F, 2014, MOL PLANT PATHOL, V15, P427, DOI 10.1111/mpp.12138; SCHNEITER AA, 1981, CROP SCI, V21, P901, DOI 10.2135/cropsci1981.0011183X002100060024x; Schuster I, 2004, ESTATISTICA GENOMICA; Sebastian RL, 2000, THEOR APPL GENET, V100, P75, DOI 10.1007/s001220050011; Talia P, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue6-fulltext-14; Talukder ZI, 2014, THEOR APPL GENET, V127, P193, DOI 10.1007/s00122-013-2210-x; Tang S, 2002, THEOR APPL GENET, V105, P1124, DOI 10.1007/s00122-002-0989-y; Tang SX, 2003, THEOR APPL GENET, V107, P6, DOI 10.1007/s00122-003-1233-0; Upadyayula N, 2006, THEOR APPL GENET, V112, P592, DOI 10.1007/s00122-005-0133-x; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Vear F., 2007, Helia, V30, P1, DOI 10.2298/HEL0746001V; VEAR F, 1984, AGRONOMIE, V4, P789, DOI 10.1051/agro:19840811; Vear F, 2004, P 16 INT SUNFL C FAR, P135; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang S, 2012, WINDOWS QTL CARTOGRA; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; Yu JK, 2003, CROP SCI, V43, P367, DOI 10.2135/cropsci2003.0367; Yue B, 2008, PHYTOPATHOLOGY, V98, P926, DOI 10.1094/PHYTO-98-8-0926; Zubrzycki J, 2012, PROC 15 C LAT GEN AL; Zubrzycki J, 2012, P 18 INT SUNFL C	83	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0189859	10.1371/journal.pone.0189859	http://dx.doi.org/10.1371/journal.pone.0189859			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7SY	29261806	Green Published, Green Submitted, gold			2022-12-26	WOS:000418564200069
J	Wyatt, KH; Griffin, R; Guerry, AD; Ruckelshaus, M; Fogarty, M; Arkema, KK				Wyatt, Katherine H.; Griffin, Robert; Guerry, Anne D.; Ruckelshaus, Mary; Fogarty, Michael; Arkema, Katie K.			Habitat risk assessment for regional ocean planning in the US Northeast and Mid-Atlantic	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; GREAT-BARRIER-REEF; CLIMATE-CHANGE; UNITED-STATES; SERVICES; COASTAL; VULNERABILITY; LESSONS; CONSERVATION; BIODIVERSITY	Coastal habitats provide important benefits to people, including habitat for species targeted by fisheries and opportunities for tourism and recreation. Yet, such human activities also can imperil these habitats and undermine the ecosystem services they provide to people. Cumulative risk assessment provides an analytical framework for synthesizing the influence of multiple stressors across habitats and decision-support for balancing human uses and ecosystem health. To explore cumulative risk to habitats in the U.S. Northeast and Mid-Atlantic Ocean Planning regions, we apply the open-source InVEST Habitat Risk Assessment model to 13 habitats and 31 stressors in an exposure-consequence framework. In doing so, we advance the science priorities of EBM and both regional planning bodies by synthesizing the wealth of available data to improve our understanding of human uses and how they affect marine resources. We find that risk to ecosystems is greatest first, along the coast, where a large number of stressors occur in close proximity and secondly, along the continental shelf, where fewer, higher consequence activities occur. Habitats at greatest risk include soft and hard-bottom nearshore areas, tidal flats, soft-bottom shelf habitat, and rocky intertidal zones-with the degree of risk varying spatially. Across all habitats, our results indicate that rising sea surface temperatures, commercial fishing, and shipping consistently and disproportionally contribute to risk. Further, our findings suggest that management in the nearshore will require simultaneously addressing the temporal and spatial overlap as well as intensity of multiple human activities and that management in the offshore requires more targeted efforts to reduce exposure from specific threats. We offer a transparent, generalizable approach to evaluating cumulative risk to multiple habitats and illustrate the spatially heterogeneous nature of impacts along the eastern Atlantic coast and the importance of spatial scale in estimating such impacts. These results offer a valuable decision-support tool by helping to constrain the decision space, focus attention on habitats and locations at the greatest risk, and highlight effect management strategies.	[Wyatt, Katherine H.; Griffin, Robert; Guerry, Anne D.; Ruckelshaus, Mary; Arkema, Katie K.] Univ Washington, Stanford Univ, Sch Environm & Forest Sci, Nat Capital Project, Seattle, WA 98195 USA; [Wyatt, Katherine H.; Griffin, Robert; Guerry, Anne D.; Ruckelshaus, Mary; Arkema, Katie K.] Stanford Univ, Woods Inst Environm, Nat Capital Project, Stanford, CA 94305 USA; [Fogarty, Michael] NOAA, Northeast Fisheries Sci Ctr, Woods Hole, MA USA	Stanford University; University of Washington; University of Washington Seattle; Stanford University; National Oceanic Atmospheric Admin (NOAA) - USA	Wyatt, KH (corresponding author), Univ Washington, Stanford Univ, Sch Environm & Forest Sci, Nat Capital Project, Seattle, WA 98195 USA.; Wyatt, KH (corresponding author), Stanford Univ, Woods Inst Environm, Nat Capital Project, Stanford, CA 94305 USA.	kwyatt@stanford.edu		Griffin, Robert/0000-0002-6271-5613	Gordon and Betty Moore Foundation [1874.02]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research is funded by the Gordon and Betty Moore Foundation, Grant Number: 1874.02, URL: https//www.moore.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, EXECUTIVE ORDER 1354; [Anonymous], 2016, MID ATL REG OC ACT P; [Anonymous], 2004, 097594620X US COMM O; [Anonymous], 2016, PEOPL BEN NEW HAMPSH; Apitz SE, 2006, INTEGR ENVIRON ASSES, V2, P80, DOI 10.1002/ieam.5630020114; Arkema KK, 2015, P NATL ACAD SCI USA, V112, P7390, DOI 10.1073/pnas.1406483112; Arkema KK, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/114016; Arkema KK, 2013, NAT CLIM CHANGE, V3, P913, DOI 10.1038/NCLIMATE1944; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Chin A, 2010, GLOBAL CHANGE BIOL, V16, P1936, DOI 10.1111/j.1365-2486.2009.02128.x; Chung MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133856; Clarke C., 2013, BELIZE INTEGRATED CO; Colburn LL, 2016, MAR POLICY; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Curtice C, FINAL REPORT MARCO; Day J, 2008, MAR POLICY, V32, P823, DOI 10.1016/j.marpol.2008.03.023; Duggan Jennifer M., 2015, Ecosystem Health and Sustainability, V1, P22, DOI 10.1890/EHS14-0009.1; Ehler CN, 2014, 70 UNESCO INT OC GRA; FAO, 2016, STAT WORLD FISH AQ 2; Field ChristopherB., 2014, IMPACTS ADAPTATION A, P1, DOI [10.1007/BF02986817, DOI 10.1007/BF02986817]; Fogarty MJ, 2014, CAN J FISH AQUAT SCI, V71, P479, DOI 10.1139/cjfas-2013-0203; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Gaichas SK, 2014, ICES J MAR SCI, V71, P2323, DOI 10.1093/icesjms/fsu048; Gold B, 2011, CALAMAR EXPERT PAPER, P23; Guerry A, 2014, MARINE ECOSYSTEM BAS, P217; Guerry AD, 2015, P NATL ACAD SCI USA, V112, P7348, DOI 10.1073/pnas.1503751112; Guerry Anne D., 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P107, DOI 10.1080/21513732.2011.647835; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Hare JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146756; Harrison PA, 2014, ECOSYST SERV, V9, P191, DOI 10.1016/j.ecoser.2014.05.006; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Kappel CV, 2012, EXPERT KNOWLEDGE AND ITS APPLICATION IN LANDSCAPE ECOLOGY, P253, DOI 10.1007/978-1-4614-1034-8_13; Kappel CV, 2012, 03 SEAPLAN; Kildow JT, 2016, STATE US OCEAN COAST; Leslie HM, 2007, FRONT ECOL ENVIRON, V5, P540, DOI 10.1890/060093; Levin PS, 2014, ICES J MAR SCI, V71, P1198, DOI 10.1093/icesjms/fst112; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Lubchenco J, 2010, SCIENCE, V328, P1485, DOI 10.1126/science.1190041; Ma S, 2016, ECOSYST SERV, V19, P6, DOI 10.1016/j.ecoser.2016.03.005; Micheli F, 2014, BIOL CONSERV, V176, P224, DOI 10.1016/j.biocon.2014.05.031; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Miththapala S., 2013, 5 IUNC; Moore RB, 2011, J AM WATER RESOUR AS, V47, P965, DOI 10.1111/j.1752-1688.2011.00582.x; Northeast Regional Planning Body, 2016, NE OC PLAN; Olsen SB, 2014, MAR POLICY, V45, P26, DOI 10.1016/j.marpol.2013.11.003; Olsson P, 2008, P NATL ACAD SCI USA, V105, P9489, DOI 10.1073/pnas.0706905105; Patrick WS, 2010, FISH B-NOAA, V108, P305; Paul LMB, 2004, NAT RESOUR ENV, V19, P10; Peterson C. H., 1997, Nature's services: societal dependence on natural ecosystems., P177; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Rice J, 2014, MARINE SPATIAL PLANN; Salomon AK, 2011, B MAR SCI, V87, P251, DOI 10.5343/bms.2010.1089; Samhouri JF, 2014, ICES J MAR SCI, V71, P1205, DOI 10.1093/icesjms/fst141; Samhouri JF, 2012, BIOL CONSERV, V145, P118, DOI 10.1016/j.biocon.2011.10.021; Sandifer PA, 2015, ECOSYST SERV, V12, P1, DOI 10.1016/j.ecoser.2014.12.007; Santos CF, 2016, NAT GEOSCI, V9, P730, DOI 10.1038/ngeo2821; Sharp R, 2016, NATURAL CAPITAL PROJ; Small C, 2003, J COASTAL RES, V19, P584; Stelzenmuller V, 2015, ICES J MAR SCI, V72, P1022, DOI 10.1093/icesjms/fsu206; Stock A, 2016, GLOBAL ECOL BIOGEOGR, V25, P1321, DOI 10.1111/geb.12493; Teck SJ, 2010, ECOL APPL, V20, P1402, DOI 10.1890/09-1173.1; Teichert N, 2016, SCI TOTAL ENVIRON, V542, P383, DOI 10.1016/j.scitotenv.2015.10.068; United Nations, 2015, WORKING PAPER NO ESA; Williams A, 2011, FISH RES, V112, P154, DOI 10.1016/j.fishres.2011.01.028; World Travel and Tourism Council, 2016, TRAV TOUR EC IMP 201; Zaykoski P, 2016, MID ATLANTIC REGIONA	67	20	20	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2017	12	12							e0188776	10.1371/journal.pone.0188776	http://dx.doi.org/10.1371/journal.pone.0188776			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ7SY	29261672	Green Submitted, Green Published, gold			2022-12-26	WOS:000418564200017
J	Dencker, TS; Pecuchet, L; Beukhof, E; Richardson, K; Payne, MR; Lindegren, M				Dencker, Tim Spaanheden; Pecuchet, Laurene; Beukhof, Esther; Richardson, Katherine; Payne, Mark R.; Lindegren, Martin			Temporal and spatial differences between taxonomic and trait biodiversity in a large marine ecosystem: Causes and consequences	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; NORTH-SEA; SPECIES RICHNESS; LATITUDINAL GRADIENTS; COMMUNITY STRUCTURE; FISH ASSEMBLAGE; CLIMATE-CHANGE; REDUNDANCY; PATTERNS; VULNERABILITY	Biodiversity is a multifaceted concept, yet most biodiversity studies have taken a taxonomic approach, implying that all species are equally important. However, species do not contribute equally to ecosystem processes and differ markedly in their responses to changing environments. This recognition has led to the exploration of other components of biodiversity, notably the diversity of ecologically important traits. Recent studies taking into account both taxonomic and trait diversity have revealed that the two biodiversity components may exhibit pronounced temporal and spatial differences. These apparent incongruences indicate that the two components may respond differently to environmental drivers and that changes in one component might not affect the other. Such incongruences may provide insight into the structuring of communities through community assembly processes, and the resilience of ecosystems to change. Here we examine temporal and spatial patterns and drivers of multiple marine biodiversity indicators using the North Sea fish community as a case study. Based on long-term spatially resolved survey data on fish species occurrences and bio-masses from 1983 to 2014 and an extensive trait dataset we: (i) investigate temporal and spatial incongruences between taxonomy and trait-based indicators of both richness and evenness; (ii) examine the underlying environmental drivers and, (iii) interpret the results in the context of assembly rules acting on community composition. Our study shows that taxonomy and trait-based biodiversity indicators differ in time and space and that these differences are correlated to natural and anthropogenic drivers, notably temperature, depth and substrate richness. Our findings show that trait-based biodiversity indicators add information regarding community composition and ecosystem structure compared to and in conjunction with taxonomy-based indicators. These results emphasize the importance of examining and monitoring multiple indicators of biodiversity in ecological studies as well as for conservation and ecosystem-based management purposes.	[Dencker, Tim Spaanheden; Pecuchet, Laurene; Beukhof, Esther; Payne, Mark R.; Lindegren, Martin] Tech Univ Denmark, Ctr Ocean Life, Natl Inst Aquat Resources DTU Aqua, Lyngby, Denmark; [Richardson, Katherine] Univ Copenhagen, Danish Nat Hist Museum, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen	Dencker, TS (corresponding author), Tech Univ Denmark, Ctr Ocean Life, Natl Inst Aquat Resources DTU Aqua, Lyngby, Denmark.	tspa@aqua.dtu.dk	Payne, Mark/C-6844-2008; Richardson, Katherine/D-7592-2014; Beukhof, Esther/GRR-8969-2022	Payne, Mark/0000-0001-5795-2481; Richardson, Katherine/0000-0003-3785-2787; Pecuchet, Laurene/0000-0002-8930-8786; Lindegren, Martin/0000-0002-9185-951X; Beukhof, Esther/0000-0002-0350-9596; Dencker, Tim Spaanheden/0000-0001-7804-0828	Centre for Ocean Life, a VKR center of excellence, via the Villum Foundation; Centre for Ocean Life, a VKR center of excellence; VILLUM research grant [13159]; MARmaED, a European Union's Horizon 2020 research and innovation programme [675997]; CEFAS project [MF1228]; Natural Environment Research Council [NE/I030062/1, SAH01001] Funding Source: researchfish; Villum Fonden [00007178, 00013159] Funding Source: researchfish; NERC [SAH01001] Funding Source: UKRI	Centre for Ocean Life, a VKR center of excellence, via the Villum Foundation; Centre for Ocean Life, a VKR center of excellence; VILLUM research grant; MARmaED, a European Union's Horizon 2020 research and innovation programme; CEFAS project; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Villum Fonden(Villum Fonden); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project has received funding through the Centre for Ocean Life, a VKR center of excellence, via the Villum Foundation. ML received funding from the Centre for Ocean Life, a VKR center of excellence, as well as a VILLUM research grant (grant number 13159) http://www.vkr-holding.com/Fondene/VILLUM_FONDEN.aspx. EB received funding from MARmaED, a European Union's Horizon 2020 research and innovation programme (grant number 675997). Http://www.marmaed.uio.no/ and https://ec.europa.eu/programmes/horizon2020/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are grateful for the work done by the CEFAS project MF1228 "Fizzyfish", the STECF on the fishing effort data for the North Sea, SAFHOS for providing the phytoplankton color index data and the scientists and crew members involved with the North Sea International Bottom Trawl Survey.	Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], [No title captured]; [Anonymous], 2010, CONVENTION BIOL DIVE; [Anonymous], 2021, LANG ENV STAT COMP; Beare DJ, 2004, MAR ECOL PROG SER, V284, P269, DOI 10.3354/meps284269; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bennema FP, 2015, FISH RES, V161, P384, DOI 10.1016/j.fishres.2014.09.001; Boyer AG, 2014, GLOBAL ECOL BIOGEOGR, V23, P679, DOI 10.1111/geb.12147; Bremner J, 2003, MAR ECOL PROG SER, V254, P11, DOI 10.3354/meps254011; Burnham KP, 2002, ECOL MODEL, V172, P488, DOI DOI 10.1016/J.EC0LM0DEL.2003.11.004; Cadotte MW, 2015, TRENDS ECOL EVOL, V30, P510, DOI 10.1016/j.tree.2015.07.001; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Callaway R, 2002, ICES J MAR SCI, V59, P1199, DOI 10.1006/jmsc.2002.1288; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chaudhary C, 2016, TRENDS ECOL EVOL, V31, P670, DOI 10.1016/j.tree.2016.06.001; Ciannelli L, 2015, ICES J MAR SCI, V72, P285, DOI 10.1093/icesjms/fsu145; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Daan N., 2006, INT COUNC EXPLOR SEA, V20; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Duffy JE, 2016, P NATL ACAD SCI USA, V113, P6230, DOI 10.1073/pnas.1524465113; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Ehrich S, 2009, FISH OCEANOGR, V18, P36, DOI 10.1111/j.1365-2419.2008.00495.x; EMODnet, 2015, EUR MAR OBS DAT NETW; Engelhard GH, 2015, ENVIRON CONSERV, V42, P227, DOI 10.1017/S0376892915000077; Engelhard GH, 2011, ICES J MAR SCI, V68, P580, DOI 10.1093/icesjms/fsq183; Fisher JAD, 2010, ECOLOGY, V91, P2499, DOI 10.1890/09-1914.1; Fonseca CR, 2001, J ECOL, V89, P118, DOI 10.1046/j.1365-2745.2001.00528.x; Froese R., 2021, FISHBASE; Fung T, 2012, ICES J MAR SCI, V69, P235, DOI 10.1093/icesjms/fsr206; Gelman A, 1995, AM J EPIDEMIOL, V146, P800; Genner MJ, 2010, GLOBAL CHANGE BIOL, V16, P517, DOI 10.1111/j.1365-2486.2009.02027.x; Greenstreet SPR, 2011, ICES J MAR SCI, V68, P1, DOI 10.1093/icesjms/fsq156; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Guilhaumon F, 2015, DIVERS DISTRIB, V21, P175, DOI 10.1111/ddi.12280; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hastie T., 1986, STAT SCI, V1, P297; Heessen HJL., 2015, FISH ATLAS CELTIC SE; Hiddink JG, 2008, GLOBAL CHANGE BIOL, V14, P453, DOI 10.1111/j.1365-2486.2007.01518.x; Hildrew Alan G., 2007, P326; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Jennings S, 1999, FISH RES, V40, P125, DOI 10.1016/S0165-7836(98)00208-2; Laliberte A. E., 2015, PACKAGE FD MEASURING; Litchman E, 2013, J PLANKTON RES, V35, P473, DOI 10.1093/plankt/fbt019; Luck GW, 2009, BIOSCIENCE, V59, P223, DOI 10.1525/bio.2009.59.3.7; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Martins GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044297; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mayfield MM, 2010, GLOBAL ECOL BIOGEOGR, V19, P423, DOI 10.1111/j.1466-8238.2010.00532.x; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Micheli F, 2014, BIOL CONSERV, V171, P186, DOI 10.1016/j.biocon.2013.12.029; Mindel BL, 2016, PEERJ, V4, DOI 10.7717/peerj.2387; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Mouillot D, 2007, ESTUAR COAST SHELF S, V71, P443, DOI 10.1016/j.ecss.2006.08.022; Mouillot D, 2014, P NATL ACAD SCI USA, V111, P13757, DOI 10.1073/pnas.1317625111; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Mouillot D, 2011, CURR BIOL, V21, P1044, DOI 10.1016/j.cub.2011.05.005; MuMIn K., 2016, MUMIN MULTIMODEL INF; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Nunez-Riboni I, 2015, J MARINE SYST, V151, P15, DOI 10.1016/j.jmarsys.2015.06.003; Oksanen J, 2017, VEGAN COMMUNITY ECOL; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pecuchet L, 2016, MAR ECOL PROG SER, V546, P239, DOI 10.3354/meps11613; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; PIELOU EC, 1966, J THEOR BIOL, V10, P370, DOI 10.1016/0022-5193(66)90133-0; Reid PC, 2003, PROG OCEANOGR, V58, P117, DOI 10.1016/j.pocean.2003.08.002; Reiss H, 2010, ICES J MAR SCI, V67, P278, DOI 10.1093/icesjms/fsp253; Rice J, 2013, ICES J MAR SCI, V70, P734, DOI 10.1093/icesjms/fst071; Sguotti C, 2016, GLOBAL CHANGE BIOL, V22, P2729, DOI 10.1111/gcb.13316; Sharpe DMT, 2009, EVOL APPL, V2, P260, DOI 10.1111/j.1752-4571.2009.00080.x; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; STECF, 2014, STECF1420; Stelzenmuller V, 2009, AQUAT CONSERV, V19, P554, DOI 10.1002/aqc.1003; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tornroos A, 2015, J SEA RES, V98, P49, DOI 10.1016/j.seares.2014.04.010; Toussaint A, 2016, NAT PUBL GR, P1; van Denderen PD, 2014, ECOSYSTEMS, V17, P1216, DOI 10.1007/s10021-014-9789-x; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Violle C, 2009, J PLANT ECOL-UK, V2, P87, DOI 10.1093/jpe/rtp007; von Humboldt A., 1805, ESSAI GEOGRAPHIE PLA; Wiedmann MA, 2014, MAR ECOL PROG SER, V495, P205, DOI 10.3354/meps10558; Wolff WJ, 2000, BIOL CONSERV, V95, P209, DOI 10.1016/S0006-3207(00)00035-5; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	93	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2017	12	12							e0189731	10.1371/journal.pone.0189731	http://dx.doi.org/10.1371/journal.pone.0189731			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ5HM	29253876	Green Published, gold, Green Submitted			2022-12-26	WOS:000418389500055
